Generic Name,Trade Name,Designation Date,Designation,Orphan Drug Status,FDA Approval Status,Approved Indication,Marketing Approval Date,Exclusivity End Date,Contact Company,Contact Address 1,Contact Address 2,Contact City,Contact State,Contact Zip,Contact Country,CF Grid Key,Year of designation,"Lag, designation to approval"
Diaziquone,n/a,1983-11-10,Treatment of primary brain malignancies (grade III and IV astrocytomas).,Designated/Withdrawn,,,N/A,N/A,Warner-Lambert Company,"2800 Plymouth Rd., P.O. Box 1047",,Ann Arbor,Michigan,48106,USA,383,1983,
Alpha-1-antitrypsin (recombinant DNA Origin),n/a,1984-01-01,As supplementation therapy for alpha-1-antitrypsin deficiency in the ZZ phenotype population.,Designated/Withdrawn,,,N/A,N/A,Chiron Corporation,4560 Horton Street,,Emeryville,California,94608,USA,283,1984,
Altretamine,Hexalen,1984-02-09,Treatment of advanced adenocarcinoma of the ovary.,Designated/Approved,Approved for Orphan Indication,Single agent palliative treatment of patients with persistent or recurrent ovarian cancer following first-line therapy with a cisplatin and/or alkylating agent based combination.,1990-12-26,1997-12-26,"Medimmune Oncology, Inc.",One Tower Bridge,"100 Front St., Suite 400",West Conshohocken,Pennsylvania,19428,USA,983,1984,2512
Pentamidine isethionate,Pentam 300,1984-02-28,Treatment of Pneumocystis carinii pneumonia.,Designated/Approved,Approved for Orphan Indication,,1984-10-16,1991-10-16,"Fujisawa USA, Inc.",3 Parkway North Center,,Deerfield,Illinois,60015,USA,1083,1984,231
Levocarnitine,Carnitor,1984-02-28,Treatment of genetic carnitine deficiency.,Designated/Approved,Approved for Orphan Indication,,1986-04-10,1993-04-10,"Leadiant Biosciences, Inc.",9841 Washingtonian Blvd,Suite 500,Gaithersburg,Maryland,20878,USA,1384,1984,772
Cromolyn sodium,Gastrocrom,1984-03-08,Treatment of mastocytosis.,Designated/Approved,Approved for Orphan Indication,,1989-12-22,1996-12-22,Fisons Corporation,"755 Jefferson Rd., P.O. Box 1710",,Rochester,New York,14603,USA,1183,1984,2115
Bacitracin,Altracin,1984-03-13,Treatment of antibiotic-associated pseudomembranous enterocolitis caused by toxins A and B elaborated by Clostridium difficile.,Designated,,,N/A,N/A,"A. L. Laboratories, Inc.",One Executive Drive,P.O. Box 1399,Fort Lee,New Jersey,7024,USA,1284,1984,
Hemin,Panhematin,1984-03-16,"Amelioration of recurrent attacks of acute intermittent porphyria (AIP) temporarily related to the menstrual cycle in susceptible women and similar symptoms which occur in other patients with AIP, porphyria variegata and hereditary coproporphyria.",Designated/Approved,Approved for Orphan Indication,,1983-07-20,1990-07-20,Abbott Laboratories,Diagnostics Division,,Abbott Park,Illinois,60064,USA,683,1984,-240
Ethanolamine oleate,Ethamolin,1984-03-22,"Treatment of patients with esophageal varices that have recently bled, to prevent rebleeding.",Designated/Approved,Approved for Orphan Indication,,1988-12-22,1995-12-22,QOL Medical,"4445 North Highway A1A, 241",,Vero Beach,Florida,32963,USA,1484,1984,1736
Botulinum toxin type A,Botox,1984-03-22,Treatment of strabismus and blepharospasms,Designated/Approved,Approved for Orphan Indication,Treatment of strabismus associated with dystonia in adults (patients 12 years of age and above),1989-12-29,1996-12-29,"Allergan, Inc.",2525 Dupont Drive,P.O. Box 19534,Irvine,California,92713,USA,483,1984,2108
Botulinum toxin type A,Botox,1984-03-22,Treatment of strabismus and blepharospasms,Designated/Approved,Approved for Orphan Indication,Treatment of blepharospasm associated with dystonia in adults (patients 12 years of age and above),1989-12-30,1996-12-30,"Allergan, Inc.",2525 Dupont Drive,P.O. Box 19534,Irvine,California,92713,USA,483,1984,2109
Epoprostenol,Flolan,1984-03-29,Replacement of heparin in patients requiring hemodialysis and who are at risk of hemmorrage,Designated/Withdrawn,,,N/A,N/A,Glaxo Wellcome Inc.,5 Moore Drive,,Research Triangle Park,North Carolina,27709,USA,783,1984,
Succimer,Chemet Capsules,1984-05-09,Treatment of lead poisoning in children.,Designated/Approved,Approved for Orphan Indication,,1991-01-30,1998-01-30,Bock Pharmacal Company,P.O. Box 419056,,Saint Louis,Missouri,63141,USA,1984,1984,2457
Pegademase bovine,Adagen,1984-05-29,For enzyme replacement therapy for ADA deficiency in patients with severe combined immunodeficiency.,Designated/Approved,Approved for Orphan Indication,,1990-03-21,1997-03-21,"Sigma-tau Pharmaceuticals, Inc.",9841 Washingtonian Blvd,Suite 500,Gaithersburg,Maryland,20878,USA,2084,1984,2122
Monooctanoin,Moctanin,1984-05-30,For dissolution of cholesterol gallstones retained in the common bile duct.,Designated/Approved,Approved for Orphan Indication,,1985-10-31,1992-10-31,"Ethitek Pharmaceuticals, Inc.","7855 Gross Point Road, Unit L",,Skokie,Illinois,60077,USA,2484,1984,519
Clofazimine,Lamprene,1984-06-11,"Treatment of lepromatous leprosy, including dapsone-resistant lepromatous leprosy and lepromatous leprosy complicated by erythema nodosum leprosum.",Designated/Approved,Approved for Orphan Indication,,1986-12-15,1993-12-15,Novartis Pharmaceutical Corporation,59 Route 10,,East Hanover,New Jersey,7936,USA,2684,1984,917
viloxazine HCL,Catatrol,1984-06-11,Treatment of cataplexy and narcolepsy,Designated/Withdrawn,,,N/A,N/A,Stuart Pharmaceuticals,Division of ICI Americas,,Wilmington,Delaware,19897,USA,2384,1984,
Levocarnitine,Carnitor,1984-07-26,Treatment of primary and secondary carnitine deficiency of genetic origin.,Designated/Approved,Approved for Orphan Indication,Treatment of primary systemic carnitine deficiency. (approved 12/27/85) Treatment of secondary carnitine deficiency. (approved 12/16/92),1992-12-16,1999-12-16,"Leadiant Biosciences, Inc.",9841 Washingtonian Blvd,Suite 500,Gaithersburg,Maryland,20878,USA,1584,1984,3065
Iodine 131 6B-iodomethyl-19-norcholesterol,n/a,1984-08-01,For use in adrenal cortical imaging.,Designated,,,N/A,N/A,"David E. Kuhl, M.D.",University of Michigan Medical Center/1500 E. Med.,B1G412 /0028 University Hospital,Ann Arbor,Michigan,48109,USA,2184,1984,
chenodiol,Chenix,1984-09-21,"For patients with radiolucent stones in well opacifying gallbladders, in whom elective surgery would be undertaken except for the presence of increased surgical risk due to systemic disease or age",Designated/Approved,Approved for Orphan Indication,,1983-07-28,1990-07-28,Solvay,901 Sawyer Road,,Marietta,Georgia,30062,USA,3384,1984,-421
Quinacrine hydrochloride,n/a,1984-10-17,For prevention of recurrence of pneumothorax in patients at high risk of recurrence.,Designated/Withdrawn,,,N/A,N/A,"Lyphomed, Inc.",,,,,,,4184,1984,
Spiramycin,Rovamycine,1984-10-17,For symptomatic relief and parasitic cure of chronic cryptosporidiosis in patients with immunodeficiency.,Designated/Withdrawn,,,N/A,N/A,Rhone-Poulenc Rorer Pharmaceuticals,500 Arcola Road,,Collegeville,Pennsylvania,19426,USA,3684,1984,
Cyproterone acetate,Androcur,1984-10-26,Treatment of severe hirsutism.,Designated/Withdrawn,,,N/A,N/A,"Berlex Laboratories, Inc.",300 Fairfield Road,,Wayne,New Jersey,7470,USA,3884,1984,
Epoprostenol,Cycloprostin,1984-10-29,Replacement of heparin in patients requiring hemodialysis and who are at increased risk of hemorrhage.,Designated/Withdrawn,,,N/A,N/A,Upjohn Company,301 Henrietta Street,,Kalamazoo,Michigan,49001,USA,2884,1984,
Pentamidine isethionate,n/a,1984-10-29,Treatment of Pneumocystis carinii pneumonia.,Designated,,,N/A,N/A,Aventis Behring L.L.C.,1020 First Avenue,PO Box 61501,King of Prussia,Pennsylvania,19406,USA,3784,1984,
Potassium citrate,Urocit-K,1984-11-01,1. Prevention of calcium renal stones in patients with hypocitraturia 2. For avoidance of the complication of calcium stone formation in patients with uric lithiasis.,Designated/Approved,Approved for Orphan Indication,Prevention of recurring calcium conating stines associated with a deficiency in the urine.,1985-08-07,1992-08-07,University of Texas Health Science Center at Dallas,5323 Harry Hines Blvd,,Dallas,Texas,75235,USA,9685,1984,279
Potassium citrate,Urocit-K,1984-11-01,Prevention of uric acid nephrolithiasis.,Designated/Approved,Approved for Orphan Indication,,1985-08-30,1992-08-30,University of Texas Health Science Center at Dallas,5323 Harry Hines Blvd,,Dallas,Texas,75235,USA,2784,1984,302
Digoxin immune FAB (Ovine),Digibind,1984-11-01,Treatment of potentially life threatening digitalis intoxication in patients who are refractory to management by conventional therapy.,Designated/Approved,Approved for Orphan Indication,,1986-04-22,1993-04-22,Glaxo Wellcome Inc.,5 Moore Drive,,Research Triangle Park,North Carolina,27709,USA,2584,1984,537
Teniposide,Vumon For Injection,1984-11-01,Treatment of refractory childhood acute lymphocytic leukemia.,Designated/Approved,Approved for Orphan Indication,Induction therapy in patients with refractory childhood acute lymphoblastic leukemia when used in combination with other approved anticancer agents.,1992-07-14,1999-07-14,Bristol-Myers Squibb Pharmaceutical Research Institute,5 Research Parkway,P.O. Box 5100,Wallingford,Connecticut,6492,USA,883,1984,2812
L-5 Hydroxytrytophan,n/a,1984-11-01,Treatment of postanoxic intention myoclonus.,Designated,,,N/A,N/A,"Watson Laboratories, Inc.",33 Ralph Avenue,P.O. Box 30,Copiaque,New York,11726,USA,3984,1984,
Urogastrone,n/a,1984-11-01,For acceleration of corneal epithelial regeneration and healing of stromal incisions from corneal transplant surgery.,Designated,,,N/A,N/A,Chiron Vision,500 Iolab Drive,,Claremont,California,91711,USA,1684,1984,
Selegiline HCl,Eldepryl,1984-11-07,"As an adjuvant to levodopa and carbidopa treatment of idiopathic Parkinson's disease (paralysis agitans), postencephalitic Parkinsonism, and symptomatic Parkinsonism.",Designated/Approved,Approved for Orphan Indication,,1989-06-05,1996-06-05,"Somerset Pharmaceuticals, Inc.","400 Morris Ave., Suite 7s",,Denville,New Jersey,7834,USA,583,1984,1671
Antimelanoma Antibody XMMME-001-DTPA 111 Indium,Antimelanoma Antibody Xmmme-001-Dtpa 111 Indium,1984-11-14,Diagnostic use in imaging systemic and nodal melanoma metastasis.,Designated/Withdrawn,,,N/A,N/A,Xoma Corporation,2910 Seventh Street,,Berkeley,California,94710,USA,3484,1984,
Antimelanoma Antibody XMMME-001-RTA,Antimelanoma Antibody Xmmme-001-Rta,1984-11-14,Treatment of stage III melanoma not amenable to surgical resection.,Designated/Withdrawn,,,N/A,N/A,Xoma Corporation,2910 Seventh Street,,Berkeley,California,94710,USA,3584,1984,
Iobenguane Sulfate I 131,n/a,1984-11-14,For use as a diagnostic adjunct in patients with pheochromocytoma.,Designated/Approved/Withdrawn,,Adjunctive diagnostic agent in the localization of primary or metastatic pheochromocytomas.,N/A,2001-03-25,University of Michigan,UH B1 H410/0028,1500 E. Medical Center Drive,Ann Arbor,Michigan,48109,USA,2284,1984,
Antithrombin III (human),Thrombate Iii,1984-11-26,For replacement therapy in congenital deficiency of AT-III for prevention and treatment of thrombosis and pulmonary emboli.,Designated/Approved,Approved for Orphan Indication,,1991-12-30,1998-12-30,Bayer Corporation,"Pharmaceutical Division, Biological Products",400 Morgan Lane,New Haven,Connecticut,6516,USA,4084,1984,2590
Alpha1-proteinase inhibitor (human),Prolastin,1984-12-07,For replacement therapy in the alpha-1-proteinase inhibitor congenital deficiency state.,Designated/Approved,Approved for Orphan Indication,For chronic replacement therapy of individuals having congenital deficiency of alpha1- proteinase inhibitor with clinically demonstrable panacinar emphysema.,1987-12-02,1994-12-02,Bayer Corporation,"Pharmaceutical Division, Biological Products",400 Morgan Lane,New Haven,Connecticut,6516,USA,3084,1984,1090
Amsacrine,Amsidyl,1984-12-07,Treatment of acute adult leukemia.,Designated/Withdrawn,,,N/A,N/A,Warner-Lambert Company,2800 Plymouth Road,,Ann Arbor,Michigan,48106,USA,4584,1984,
Sodium monomercaptoundecahydro-closo-dodecaborate,n/a,1984-12-18,For use in conjunction with a thermal or epithermal neutron beam in boron nuclear capture therapy of glioblastoma multiforme.,Designated/Withdrawn,,,N/A,N/A,Theragenics Corporation,,,,,,,4284,1984,
Trientine HCl,Syprine,1984-12-24,"Treatment of patients with Wilson's disease who are intolerant, or inadequately responsive to penicillamine.",Designated/Approved,Approved for Orphan Indication,,1985-11-08,1992-11-08,Merck Sharp & Dohme Research,Division Of Merck And Company,,West Point,Pennsylvania,19486,USA,4884,1984,319
Protirelin injection,n/a,1985-01-10,Treatment of amyotrophic lateral sclerosis.,Designated/Withdrawn,,,N/A,N/A,Abbott Laboratories,200 Abbott Park Road,,Abbott Park,Illinois,,USA,5184,1985,
Flumecinol,Zixoryn,1985-01-15,Treatment of hyperbilirubinemia in newborn infants unresponsive to phototherapy.,Designated/Withdrawn,,,N/A,N/A,"Farmacon, Inc.","Post House, Suite 213",1720 Post Road East,Westport,Connecticut,6880,USA,2984,1985,
factor XIII concentrate (human),Corifact,1985-01-16,Treatment of congenital factor XIII deficiency,Designated/Approved,Approved for Orphan Indication,For the routine prophylactic treatment of congenital factor XIII deficiency,2011-02-17,2018-02-17,CSL Behring LLC,1020 First Ave.,PO Box 61501,King of Prussia,Pennsylvania,19406,USA,4484,1985,9528
factor XIII concentrate (human),Corifact,1985-01-16,Treatment of congenital factor XIII deficiency,Designated/Approved,Approved for Orphan Indication,Peri-operative management of surgical bleeding in adult and pediatric patients with congenital Factor XIII deficiency.,2013-01-24,2020-01-24,CSL Behring LLC,1020 First Ave.,PO Box 61501,King of Prussia,Pennsylvania,19406,USA,4484,1985,10235
physostigmine salicylatephysostigmine salicylate,n/a,1985-01-16,Treatment of Friedreich's and other inherited ataxias.,Designated/Withdrawn,,,N/A,N/A,Forest Pharmaceuticals.3-.3-.30 6,150 East 58th Street,,New York,New York,10155,USA,183,1985,
Gamma-hydroxybutyric acid,n/a,1985-01-22,"Treatment of narcolepsy and the auxiliary symptoms of cataplexy, sleep paralysis, hypnagogic hallucinations, and automatic behavior.",Designated/Withdrawn,,,N/A,N/A,Sigma Chemical Company,,,,,,,5384,1985,
Levomethadyl acetate hydrochloride,Orlaam,1985-01-24,Treatment of heroin addicts suitable for maintenance on opiate agonists.,Designated/Approved,Approved for Orphan Indication,For the management of opiate dependence.,1993-07-09,2000-07-09,Biodevelopment Corporation,"8180 Greensboro Drive, Suite 1000",,McLean,Virginia,22102,USA,4784,1985,3088
Erwinia L-asparaginase,n/a,1985-01-25,For use as an alternative to E. coli asparaginase in those situations where repeat courses of asparaginase therapy for acute lymphoblastic leukemia are required or where allergic reactions force the discontinuance of the E. coli preparation.,Designated/Withdrawn,,,N/A,N/A,"Lyphomed, Inc.",,,,,,,4684,1985,
Antithrombin III (human),Atnativ,1985-02-08,For the treatment of patients with hereditary antithrombin III deficiency in connection with surgical or obstetrical procedures or when they suffer from thromboembolism.,Designated/Approved,Approved for Orphan Indication,,1989-12-13,1996-12-13,Pharmacia & Upjohn AB,Lindhagensgatan 133,Stockholm,,,,Sweden,5084,1985,1769
Antipyrine Test,n/a,1985-02-21,For use as an index of hepatic drug-metabolizing capacity.,Designated/Withdrawn,,,N/A,N/A,"Upsher-Smith Laboratories, Inc",4905 23rd Avenue North,,Minneapolis,Minnesota,55447,USA,5284,1985,
Epidermal growth factor (human),n/a,1985-03-06,For promotion of cutaneous wound healing in extreme burn treatment protocols.,Designated/Withdrawn,,,N/A,N/A,"Ethicon, Inc.",P.O. Box 151,,Somerville,New Jersey,8876,USA,5485,1985,
Superoxide dismutase (human),n/a,1985-03-06,"For protection of donor organ tissue from damage or injury mediated by oxygen-derived free radicals that are generated during the necessary periods of ischemia (hypoxia, anoxia), and especially reperfusion, associated with the operative procedure.",Designated,,,N/A,N/A,Pharmacia-Chiron Partnership,4560 Horton Street,,Emeryville,California,94608,USA,5985,1985,
Naltrexone HCl,Trexan,1985-03-11,For blockade of the pharmacological effects of exogenously administered opioids as an adjunct to the maintenance of the opioid-free state in detoxified formerly opioid-dependent individuals.,Designated/Approved,Approved for Orphan Indication,,1984-11-30,1991-11-30,DuPont Pharmaceuticals,E.I. Du Pont De Nemours & Co.,,Wilmington,Delaware,19898,USA,6085,1985,-101
Alglucerase injection,Ceredase,1985-03-11,For replacement therapy in patients with Gaucher's disease type I.,Designated/Approved,Approved for Orphan Indication,"Long-term enzyme replacement therapy for children, adolescents and adult patients with a confirmed diagnosis of Type I Gaucher disease who exhibit signs and symptoms that are severe enough to result in one or more of the following conditions: a) moderate-to-severe anemia; b) thrombocytopenia with bleeding tendency; c) bone disease; d) significant hepatomegaly or splenomegaly.",1991-04-05,1998-04-05,Genzyme Corporation,One Kendall Square,,Cambridge,Massachusetts,2139,USA,5585,1985,2216
Digoxin immune fab(ovine),Digidote,1985-03-11,"Treatment of life-threatening acute cardiac glycoside intoxication manifested by conduction disorders, ectopic ventricular activity and (in some cases) hyperkalemia.",Designated,,,N/A,N/A,Boehringer Mannheim Corp.,1301 Piccard Drive,,Rockville,Maryland,20850,USA,5685,1985,
Oxymorphone,Numorphan H.P.,1985-03-19,For relief of severe intractable pain in narcotic-tolerant patients.,Designated,,,N/A,N/A,DuPont Merck Pharmaceutical Company,P.O. Box 80027,,Wilmington,Delaware,19880,USA,6185,1985,
Tretinoin,n/a,1985-04-15,Treatment of squamous metaplasia of the ocular surface epithelia (conjunctiva and/or cornea) with mucous deficiency and keratinization.,Designated,,,N/A,N/A,"Hannan Ophthalmic Marketing Services, Inc",34 Sherrill Rd.,,Marshfield,Massachusetts,2050,USA,5785,1985,
calfactant,Infasurf,1985-06-07,Treatment and prevention of respiratory failure due to pulmonary surfactant deficiency in preterm infants.,Designated/Approved,Approved for Orphan Indication,Treatment and prevention of respiratory failure due to pulmonary surfactant deficiency in preterm infants.,1998-07-01,N/A,"ONY, Inc.",1576 Sweet Home Road,,Amherst,New York,14228,USA,6285,1985,4772
Gancyclovir,n/a,1985-06-07,Treatment of severe human cytomegalovirus infections in specific immunosuppressed patient populations.,Designated/Withdrawn,,,N/A,N/A,Burroughs Wellcome Company,3030 Cornwallis Road,P.O. Box 12700,Research Triangle Park,North Carolina,27709,USA,5885,1985,
Anagrelide,Agrylin,1985-06-11,Treatment of polycythemia vera.,Designated,,,N/A,N/A,Roberts Pharmaceutical Corp.,Meridian Center II,Four Industrial Way West,Eatontown,New Jersey,7724,USA,6985,1985,
Prednimustine,Sterecyt,1985-06-17,Treatment of malignant non-Hodgkin's lymphomas.,Designated/Withdrawn,,,N/A,N/A,Pharmacia Inc.,P.O. Box 16529,,Columbus,Ohio,43216,USA,6685,1985,
Midodrine HCl,Amatine,1985-06-21,Treatment of patients with symptomatic orthostatic hypotension.,Designated/Approved,Approved for Orphan Indication,Treatment of symptomatic orthostatic hypotension.,1996-09-06,2003-09-06,Shire,725 Chesterbrook Blvd,,Wayne,Pennsylvania,19087,USA,7585,1985,4095
Antithrombin III (human) concentrate IV,Kybernin P,1985-07-02,For prophylaxis and treatment of thromboembolic episodes in patients with genetic AT-III deficiency.,Designated/Withdrawn,,,N/A,N/A,CSL Behring,1020 First Ave.,PO Box 61501,King of Prussia,Pennsylvania,19406,USA,7185,1985,
Defibrotide,n/a,1985-07-05,Treatment of thrombotic thrombocytopenic purpura.,Designated,,,N/A,N/A,Crinos International,Via Belvedere 1,,"Villa Guardia, Italy",,22079,USA,7285,1985,
zidovudine,Retrovir,1985-07-17,Treatment of AIDS,Designated/Approved,Approved for Orphan Indication,Management of certain adult patients with symptomatic HIV infection (AIDS and advanced ARC) who have a history of cytologically confirmed Pneumocytis carinii pneumonia (PCP) or an absolute CD4 (T4 helper/induccer) lymphocyte count of less than 200/mm in the peripheral blood before therapy is begun,1987-03-19,1994-03-19,Glaxo Wellcome Inc.,5 Moore Drive,,Research Triangle Park,North Carolina,27709,USA,8185,1985,610
ammonium 21-tungsto-9-antimoniate,n/a,1985-07-17,Treatment of acquired immunodeficiency syndrome.,Designated/Withdrawn,,,N/A,N/A,Rhone-Poulenc Rorer Pharm.,500 Arcola Road,,Collegeville,Pennsylvania,19426,USA,7785,1985,
Cromolyn sodium 4% ophthalmic solution,Opticrom 4% Ophthalmic Solution,1985-07-24,Treatment of vernal keratoconjunctivitis.,Designated/Approved,Approved for Orphan Indication,,1984-10-03,1991-10-03,Fisons Corporation,755 Jefferson Rd.,P.O. Box 1710,Rochester,New York,14603,USA,8285,1985,-294
Trimetrexate glucuronate,n/a,1985-07-25,Treatment of pancreatic adenocarcinoma.,Designated/Withdrawn,,,N/A,N/A,"Medimmune Oncology, Inc.",One MedImmune Way,,Gaithersburg,Maryland,20878,USA,8385,1985,
Pentosan polysulfate sodium,Elmiron,1985-08-07,Treatment of interstitial cystitis.,Designated/Approved,Approved for Orphan Indication,Relief of bladder pain or discomfort associated with interstitial cystitis.,1996-09-26,2003-09-26,Alza Corporation,950 Page Mill Rd.,PO Box 10950,Palo Alto,California,94303,USA,1784,1985,4068
ifosfamide,n/a,1985-08-07,Treatment of soft tissue and bone sarcomas,Designated,,,N/A,N/A,Bristol-Myers Squibb Company,P.O. Box 4000,Mail Stop D12-02,Princeton,New Jersey,8543,USA,8585,1985,
Pentastarch,Pentaspan,1985-08-28,As an adjunct in leukapheresis to improve the harvesting and increase the yield of leukocytes by centrifugal means.,Designated/Approved,Approved for Orphan Indication,,1987-05-19,1994-05-19,DuPont Pharmaceuticals,E.I. Du Pont De Nemours & Co.,,Wilmington,Delaware,19898,USA,8085,1985,629
tranexamic acid,Cyklokapron,1985-09-09,Treatment of hereditary angioneurotic edema,Designated/Approved/Withdrawn,,Treatment of patients with hemophilia for short term use (2 to 8 days) before and after tooth extraction to reduce or prevent hemorrhage abd reduce the need for replacement therapy,N/A,1993-12-30,Pharmacia Inc.,P.O. Box 16529,,Columbus,Ohio,43216,USA,8885,1985,
"Rifampin, isoniazid, pyrazinamide",Rifater,1985-09-12,For the short-course treatment of tuberculosis.,Designated/Approved,Approved for Orphan Indication,Short-course treatment of tuberculosis.,1994-05-31,2001-05-31,Hoechst Marion Roussel,P.O. Box 9627,,Kansas City,Missouri,64134,USA,6585,1985,3183
Epoprostenol,Flolan,1985-09-25,Treatment of primary pulmonary hypertension.,Designated/Approved,Approved for Orphan Indication,Long-term intravenous treatment of primary pulmonary hypertension in NYHA Class III and Class IV patients.,1995-09-20,2002-09-20,Glaxo Wellcome Inc.,5 Moore Drive,,Research Triangle Park,North Carolina,27709,USA,8785,1985,3647
Hydroxycobalamin/sodium thiosulfate,n/a,1985-10-04,Treatment of severe acute cyanide poisoning.,Designated/Withdrawn,,,N/A,N/A,"Hall, Alan H., M.D.",Mile 5.0 Pass Creek Road,PO Box 24,Elk Mountain,Wyoming,82324,USA,9585,1985,
Methotrexate sodium,Methotrexate,1985-10-21,Treatment of osteogenic sarcoma.,Designated/Approved,Approved for Orphan Indication,For the use of high dose methotrexate with leucovorin rescue in patients with non-metastatic osteosarcoma who have undergone surgical resection or amputation for the primary tumor.,1988-04-07,1995-04-07,Lederle Laboratories,Division of American Cyanamid Company,401 N. Middletown Road,Pearl River,New York,10965,USA,9985,1985,899
Ganciclovir sodium,Cytovene,1985-10-31,Treatment of cytomegalovirus retinitis in immunocompromised patients with AIDS.,Designated/Approved/Withdrawn,,,N/A,1996-06-23,"Syntex (USA), Inc.",3401 Hillview Avenue,,Palo Alto,California,94304,USA,7985,1985,
Monoclonal antiendotoxin antibody XMMEn-0e5,n/a,1985-11-04,Treatment of patients with gram-negative sepsis which has progressed to shock.,Designated/Withdrawn,,,N/A,N/A,"Pfizer, Inc.",235 East 42nd Street,,New York,New York,10017,USA,6885,1985,
Zinc acetate,Galzin,1985-11-06,Treatment of Wilson's disease.,Designated/Approved,Approved for Orphan Indication,For maintenance treatment of patients with Wilson's disease who have been initially treated with a chelating agent.,1997-01-28,2004-01-28,Lemmon Company,1510 Delp Drive,,Kulpsville,Pennsylvania,19443,USA,11185,1985,4101
Mesna,Mesnex,1985-11-14,For use as a prophylactic agent in reducing the incidence of ifosfamide-induced hemorrhagic cystitis.,Designated/Approved,Approved for Orphan Indication,,1988-12-30,1995-12-30,Degussa Corporation,65 Challenger Road,,Ridgefield Park,New Jersey,7660,USA,8685,1985,1142
Allopurinol riboside,n/a,1985-12-04,1. Treatment of Chagas' disease 2. Treatment of cutaneous and visceral leishmaniasis,Designated/Withdrawn,,,N/A,N/A,Burroughs Wellcome Company,3030 Cornwallis Road,P.O. Box 12700,Research Triangle Park,North Carolina,27709,USA,10685,1985,
Somatrem for injection,Protropin,1985-12-09,"1. Long-term treatment of children who have growth failure due to a lack of adequate endogenous growth hormone secretion (prevalence 15,000) 2. Treatment of short stature associated with Turner's syndrome (prevalence 8000).",Designated/Approved,Approved for Orphan Indication,,1985-10-17,1992-10-17,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,USA,10785,1985,-53
Rifampin,Rifadin I.V.,1985-12-09,For antituberculosis treatment where use of the oral form of the drug is not feasible.,Designated/Approved,Approved for Orphan Indication,,1989-05-25,1996-05-25,Hoechst Marion Roussel,P.O. Box 9627,,Kansas City,Missouri,64134,USA,7685,1985,1263
Colchicine,n/a,1985-12-09,For arresting the progression of neurologic disability caused by chronic progressive multiple sclerosis.,Designated/Withdrawn,,,N/A,N/A,Pharmacontrol Corporation,"661 Palisade Ave., P.O. Box 931",,Englewood Cliffs,New Jersey,7632,USA,11085,1985,
Antithrombin III human,Antithrombin Iii Human,1986-01-02,Preventing or arresting episodes of thrombosis in patients with congenital AT-III deficiency and/or to prevent the occurrence of thrombosis in patients with AT-III deficiency who have undergone trauma or who are about to undergo surgery or parturition.,Designated,,,N/A,N/A,American National Red Cross,9312 Old Georgetown Road,,Bethesda,Maryland,20814,USA,11485,1986,
flunarizine,Sibelium,1986-01-06,Treatment of alternating hemiplegia.,Designated,,,N/A,N/A,Janssen Research Foundation,,P.O. Box 200,Titusville,New Jersey,8560,USA,9485,1986,
Guanethidine monosulfate,Ismelin,1986-01-06,Treatment of moderate to severe reflex sympathetic dystrophy and causalgia.,Designated/Withdrawn,,,N/A,N/A,Novartis Pharmaceuticals Corporation,59 Route 10,,East Hanover,New Jersey,7936,USA,6385,1986,
Tiopronin,Thiola,1986-01-17,Prevention of cystine nephrolithiasis in patients with homozygous cystinuria.,Designated/Approved,Approved for Orphan Indication,,1988-08-11,1995-08-11,"Pak, Charles Y.C. M.D.",The University of Texas Health Scienc Center at Da,5323 Harry Hines Boulevard,Dallas,Texas,75235,USA,12386,1986,937
Benzoate and phenylacetate,Ucephan,1986-01-21,"For adjunctive therapy in the prevention and treatment of hyperammonemia in patients with urea cycle enzymopathy due to carbamylphosphate synthetase, ornithine, transcarbamylase, or argininosuccinate synthetase deficiency.",Designated/Approved,Approved for Orphan Indication,,1987-12-23,1994-12-23,ImmunexImmunex,2525 McGaw Avenue,P.O. Box 19791,Irvine,California,92623,USA,11385,1986,701
Anti pan T lymphocyte monoclonal antibody,Anti-T Lymphocyte Immunotoxin Xmmly-H65-Rta,1986-01-29,1. For ex-vivo treatment to eliminate mature T cells from potential bone marrow grafts 2. For in-vivo treatment of bone marrow recipients to prevent graft rejection and graft versus host disease.,Designated/Withdrawn,,,N/A,N/A,Xoma Corporation,2910 Seventh Street,,Berkeley,California,94710,USA,10985,1986,
Beractant,Survanta Intratracheal Suspension,1986-02-05,Treatment of neonatal respiratory distress syndrome,Designated/Approved,Approved for Orphan Indication,"Treatment of (""rescue"") of premature infants with RDS confirmed by x-ray and requiring mechanical ventilation",1991-07-01,1998-07-01,Ross Laboratories,625 Cleveland Avenue,,Columbus,Ohio,43215,USA,10885,1986,1972
Beractant,Survanta Intratracheal Suspension,1986-02-05,Treatment of neonatal respiratory distress syndrome,Designated/Approved,Approved for Orphan Indication,Prevention of RDS (hyaline membrane disease) in premature infants less than 1250 grams birthweight or with evidence of surfactant deficiency,1991-07-02,1998-07-02,Ross Laboratories,625 Cleveland Avenue,,Columbus,Ohio,43215,USA,10885,1986,1973
Potassium citrate and citric acid,n/a,1986-02-14,For the dissolution and control of uric acid and cysteine calculi in the urinary tract.,Designated/Withdrawn,,,N/A,N/A,Willen Drug Company,,,,,,,9785,1986,
Terlipressin,Glypressin,1986-03-06,Treatment of bleeding esophageal varices.,Designated,,,N/A,N/A,Ferring Pharmaceuticals Inc.,100 Interpace Parkway,,Parsippany-Troy Hills,New Jersey,7054,USA,11785,1986,
Etidronate disodium,Didronel,1986-03-21,Treatment of hypercalcemia of malignancy inadequately managed by dietary modification and/or oral hydration.,Designated/Approved,Approved for Orphan Indication,,1987-04-21,1994-04-21,"MGI Pharma, Inc.",5775 West Old Shakopee Rd.,Suite 100,Bloomington,Minnesota,55437,USA,12185,1986,396
Diethyldithiocarbamate,Imuthiol,1986-04-03,Treatment of AIDS.,Designated,,,N/A,N/A,Connaught Laboratories,"Route 611, P.O. Box 187",,Swiftwater,Pennsylvania,18370,USA,13286,1986,
Epoetin alfa,Epogen,1986-04-10,Treatment of anemia associated with end stage renal disease.,Designated/Approved,Approved for Orphan Indication,"Treatment of anemia associated with chronic renal failure, including patients on dialysis (end stage renal disesae) and patients not on dialysis",1989-06-01,1996-06-01,"Amgen, Inc.",1840 Dehavilland Drive,,Thousand Oaks,California,91320,USA,12486,1986,1148
Eflornithine HCl,Ornidyl,1986-04-18,Treatment of Pneumocystis carinii pneumonia in AIDS patients.,Designated/Withdrawn,,,N/A,N/A,"Marion Merrell Dow, Inc.",P.O. Box 9627,,Kansas City,Missouri,64134,USA,13686,1986,
Eflornithine HCl,Ornidyl,1986-04-23,Treatment of Trypanosoma brucei gambiense infection (sleeping sickness).,Designated/Approved,Approved for Orphan Indication,,1990-11-28,1997-11-28,Hoechst Marion Roussel,P.O. Box 9627,,Kansas City,Missouri,64134,USA,13586,1986,1680
Cysteamine,n/a,1986-05-01,Treatment of nephropathic cystinosis.,Designated,,,N/A,N/A,"Thoene, Jess G., M.D.",University of Michigan Medical School,"300 NIB, 1192 SE",Ann Arbor,Michigan,48109,USA,13986,1986,
Monoclonal antibodies (murine or human) to B-cell lymphoma,n/a,1986-05-06,Treatment of B-cell lymphoma.,Designated/Withdrawn,,,N/A,N/A,IDEC Pharmaceuticals Corporation,11011 Torreyana Road,,San Diego,California,92121,USA,7085,1986,
Trimetrexate glucuronate,Neutrexin,1986-05-15,Treatment of Pneumocystis carinii pneumonia in AIDS patients.,Designated/Approved,Approved for Orphan Indication,"Concurrent leucovorin administration as an alternative therapy for the treatment of moderate to severe PCP in immunocompromised patients who are intolerant of, or are refractory to, trimethoprim sulfamethoxazole.",1993-12-17,2000-12-17,"Medimmune Oncology, Inc.",One Tower Bridge,"100 Front St., Suite 400",West Conshohocken,Pennsylvania,19428,USA,14286,1986,2773
Dimethyl sulfoxide,n/a,1986-06-06,Treatment of cutaneous manifestations of scleroderma.,Designated/Withdrawn,,,N/A,N/A,Research Industries Corp.,,,,,,,14986,1986,
Sodium tetradecyl sulfate,Sotradecol,1986-06-10,Treatment of bleeding esophageal varices.,Designated,,,N/A,N/A,"Elkins-Sinn, Inc.",2 Esterbrook Lane,,Cherry Hill,New Jersey,8003,USA,12786,1986,
Somatropin for injection,Humatrope,1986-06-12,For the long-term treatment of children who have growth failure due to inadequate secretion of normal endogenous growth hormone.,Designated/Approved,Approved for Orphan Indication,,1987-03-08,1994-03-08,Eli Lilly and Company,Lilly Corporate Center,,Indianapolis,Indiana,46285,USA,11285,1986,269
Disodium silibinin dihemisuccinate,Legalon,1986-07-10,Treatment of hepatic intoxication by Amanita phalloides (mushroom poisoning).,Designated/Withdrawn,,,N/A,N/A,Pharmaquest Corporation,4470 Redwood Highway,,San Rafael,California,94903,USA,15086,1986,
Anagrelide,Agrylin,1986-07-14,Treatment of thrombocytosis in chronic myelogenous leukemia.,Designated,,,N/A,N/A,Roberts Pharmaceutical Corp.,Meridian Center II,Four Industrial Way West,Eatontown,New Jersey,7724,USA,14586,1986,
Erwinia L-asparaginase,Erwinase,1986-07-30,Treatment of acute lymphocytic leukemia.,Designated/Approved,Approved for Orphan Indication,Treatment of patients with acute lymphoblastic leukemia (ALL) who have developed hypersensitivity to E. coli-derived asparaginase.,2011-11-18,2018-11-18,"Jazz Pharmaceuticals, Inc.",3180 Porter Drive,,Palo Alto,California,94304,USA,15186,1986,9242
Chlorhexidine gluconate mouthrinse,Peridex,1986-08-18,For use in the amelioration of oral mucositis associated with cytoreductive therapy used in conditioning patients for bone marrow transplantation therapy.,Designated,,,N/A,N/A,Procter & Gamble Company,Sharon Wood Technical Center,11370 Reed Hartman Highway,Cincinnati,Ohio,45241,USA,13086,1986,
Botulinum toxin type A,Botox,1986-08-20,Treatment of cervical dystonia.,Designated/Approved,Approved for Orphan Indication,Treatment of cervical dystonia in adults to decrease the severity of abnormal head position and neck pain associated with cervical dystonia.,2000-12-21,2007-12-21,"Allergan, Inc.",2525 Dupont Drive,P.O. Box 19534,Irvine,California,92623,USA,9885,1986,5237
Interferon alfa-nl,Wellferon,1986-08-25,Treatment of AIDS related Kaposi's sarcoma.,Designated/Withdrawn,,,N/A,N/A,Burroughs Wellcome Company,3030 Cornwallis Road,P.O. Box 12700,Research Triangle Pk,North Carolina,27709,USA,12886,1986,
Nebacumab,Centoxin,1986-10-01,Treatment of patients with gram-negative bacteremia which has progressed to endotoxin shock.,Designated,,,N/A,N/A,"Centocor, Inc.",244 Great Valley Parkway,,Malvern,Pennsylvania,19355,USA,14186,1986,
Levocarnitine,Carnitor,1986-11-24,Treatment of manifestations of carnitine deficiency in patients with end stage renal disease who require dialysis.,Designated/Withdrawn,,,N/A,N/A,"Leadiant Biosciences, Inc.",9841 Washingtonian Blvd,Suite 500,Gaithersburg,Maryland,20878,USA,17386,1986,
Leucovorin,Leucovorin Calcium,1986-12-08,For use in combination with 5-fluorouracil for the treatment of metastatic colorectal cancer.,Designated/Approved,Approved for Orphan Indication,For use in combination with 5-fluorouracil to prolong survival in the palliative treatment of patients with advanced colorectal cancer.,1991-12-12,1998-12-12,Immunex Corporation,51 University Street,,Seattle,Washington,98101,USA,16786,1986,1830
Mazindol,Sanorex,1986-12-08,Treatment of Duchenne muscular dystrophy.,Designated,,,N/A,N/A,"Collipp, Platon J. M.D.",176 Memorial Dr.,,Jesup,Georgia,31545,USA,16186,1986,
Zalcitabine,n/a,1986-12-09,Treatment of AIDS.,Designated,,,N/A,N/A,"National Cancer Institute, DCT","NIH, Executive Plaza North, Room 7-18",,Bethesda,Maryland,20892,USA,17586,1986,
Teriparatide,Parathar,1987-01-09,Diagnostic agent to assist in establishing the diagnosis in patients presenting with clinical and laboratory evidence of hypocalcemia due to either hypoparathyroidism or pseudohypoparathyroidism.,Designated/Approved,Approved for Orphan Indication,,1987-12-23,1994-12-23,"Rhone-Poulenc Rorer Pharmaceuticals, Inc.",500 Arcola Road,,Collegeville,Pennsylvania,19426,USA,14486,1987,348
Calcitonin-human for injection,Cibacalcin,1987-01-20,Treatment of symptomatic Paget's disease (osteitis deformans).,Designated/Approved,Approved for Orphan Indication,,1986-10-31,1993-10-31,Novartis Pharmaceutical Corporation,59 Route 10,,East Hanover,New Jersey,7936,USA,13186,1987,-81
Ifosfamide,Ifex,1987-01-20,Treatment of testicular cancer.,Designated/Approved,Approved for Orphan Indication,"In combination with certain other approved antineoplastic agents, for third line chemotherapy in the treatment of germ cell testicular cancer.",1988-12-30,1995-12-30,Bristol-Myers Squibb Pharmaceutical Research Institute,"5 Research Parkway, P.O. Box 5100",,Wallingford,Connecticut,6492,USA,17786,1987,710
"24,25 dihydroxycholecalciferol",n/a,1987-02-27,Treatment of uremic osteodystrophy.,Designated,,,N/A,N/A,Lemmon Company,1510 Delp Drive,,Kulpsville,Pennsylvania,19443,USA,15786,1987,
Somatropin,Nutropin,1987-03-06,For use in the long-term treatment of children who have growth failure due to a lack of adequate endogenous growth hormone secretion.,Designated/Approved,Approved for Orphan Indication,,1985-10-17,1992-10-17,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,USA,12586,1987,-505
Somatropin (rDNA origin),Saizen,1987-03-06,Treatment of idiopathic or organic growth hormone deficiency in children with growth failure.,Designated/Approved,Approved for Orphan Indication,Long term treatment of children with growth failure due to inadequate secretion of endogenous growth hormone.,1996-10-08,N/A,"EMD Serono, Inc.",One Technology Place,,Roackland,Massachusetts,2370,USA,15486,1987,3504
Anti-tap-72 immunotoxin,Xomazyme-791,1987-03-06,Treatment of metastatic colorectal adenocarcinoma.,Designated/Withdrawn,,,N/A,N/A,Xoma Corporation,2910 Seventh Street,,Berkeley,California,94710,USA,17286,1987,
Surfactant (human) (amniotic fluid derived),Human Surf,1987-03-25,Prevention and treatment of neonatal respiratory distress syndrome.,Designated/Withdrawn,,,N/A,N/A,"Merritt, T. Allen M.D.",2516 Stockton Boulevard,,Sacramento,California,95817,USA,16586,1987,
Trisaccharides A and B,Biosynject,1987-04-12,Treatment of moderate to severe clinical forms of hemolytic disease of the newborn arising from placental transfer of antibodies against blood group substances A and B.,Designated,,,N/A,N/A,"Chembiomed, Ltd.",P.O. Box 8050,T6H 4NP,,,,Canada,18086,1987,
Trisaccharides A and B,Biosynject,1987-04-20,"For use in ABO-incompatible solid organ transplantation, including kidney, heart, liver and pancreas.",Designated,,,N/A,N/A,"Chembiomed, Ltd.",P.O. Box 8050,T6H 4NP,,,,Canada,18887,1987,
Gonadorelin acetate,Lutrepulse,1987-04-22,For induction of ovulation in women with hypothalamic amenorrhea due to a deficiency or absence in the quantity or pulse pattern of endogenous GnRH secretion.,Designated/Approved,Approved for Orphan Indication,,1989-10-10,1996-10-10,"Ferring Laboratories, Inc.","400 Rella Boulevard, Suite 201",,Suffern,New York,10901,USA,17086,1987,902
dalfampridine,Ampyra,1987-06-02,Relief of symptoms of multiple sclerosis,Designated/Approved,Approved for Orphan Indication,Treatment to improve walking in patients with multiple sclerosis,2010-01-22,2017-01-22,Acorda Therapeutics,15 Skyline Dr.,,Hawthorne,New York,10532,USA,18186,1987,8270
Technetium Tc99m anti-melanoma murine monoclonal antibody,Oncotrac Melanoma Imaging Kit,1987-06-02,"For use in detecting, by imaging, metastases of malignant melanoma.",Designated/Withdrawn,,,N/A,N/A,NeoRx Corporation,410 West Harrison,,Seattle,Washington,98119,USA,18387,1987,
Interferon alfa-2b (recombinant),Intron A,1987-06-22,Treatment of metastatic renal cell carcinoma.,Designated/Withdrawn,,,N/A,N/A,Schering Corporation,2000 Galloping Hill Road,,Kenilworth,New Jersey,7033,USA,19787,1987,
Interferon alfa-2b (recombinant),Intron A,1987-06-22,Treatment of chronic myelogenous leukemia.,Designated/Withdrawn,,,N/A,N/A,Schering Corporation,2000 Galloping Hill Road,,Kenilworth,New Jersey,7033,USA,20087,1987,
Interferon alfa-2b (recombinant),Intron A,1987-06-24,Treatment of AIDS-related Kaposi's sarcoma.,Designated/Approved,Approved for Orphan Indication,Treatment of selected patients with AIDS-related Kaposi's sarcoma.,1988-11-21,1995-11-21,Schering Corporation,2000 Galloping Hill Road,,Kenilworth,New Jersey,7033,USA,19187,1987,516
Somatropin (rDNA origin) injection,Norditropin,1987-07-10,1. Treatment of growth failure in children due to inadequate growth hormone secretion 2. Treatment of short stature associated with Turner's syndrome,Designated/Approved,Approved for Orphan Indication,Long-term treatment of children who have growth failure due to inadequate secretion of endogenous growth hormone.,2000-06-20,N/A,Novo Nordisk Pharmaceuticals,100 Overlook Center,Suite 200,Princeton,New Jersey,8540,USA,13386,1987,4729
Mitoxantrone HCl,Novantrone,1987-07-13,"Treatment of acute myelogenous leukemia, also referred to as acute nonlymphocytic leukemia.",Designated/Approved,Approved for Orphan Indication,,1987-12-23,1994-12-23,Lederle Laboratories,Division of American Cyanamid Company,401 N. Middletown Road,Pearl River,New York,10965,USA,19287,1987,163
2'-3'-dideoxyadenosine,n/a,1987-07-21,Treatment of aquired immunodeficiency syndrome.,Designated/Withdrawn,,,N/A,N/A,"National Cancer Institute, Dct","NIH, Exec. Plaza N., Room 7-18",,Bethesda,Maryland,20892,USA,20587,1987,
Mefloquine HCl,Mephaquin,1987-07-22,Treatment and prevention of chloroquine-resistant Falciparummalaria,Designated,,,N/A,N/A,Mepha AG,4143 Dornach,Aesch Basel,,,,Switzerland,18687,1987,
Cytomegalovirus immune globulin (human),Cytogam,1987-08-03,Prevention or attenuation of primary cytomegalovirus disease in immunosuppressed recipients of organ transplants.,Designated/Approved,Approved for Orphan Indication,"#1) Attenuation of primary CMV disease associated with kidney transplant recipients who are seronegative for CMV and who receive a kidney from a CMV seropositve donor; #2) Prophylaxis of CMV disease associated transplantation of kidney (all other), lung, liver, pancreas and heart.",1998-12-04,2005-12-04,CSL Behring LLC,1020 First Avenue,P. O. Box 61501,King of Prussia,Pennsylvania,19406,USA,15386,1987,4141
5-aza-2'-deoxycytidine,n/a,1987-08-03,Treatment of acute leukemia.,Designated,,,N/A,N/A,"SuperGen, Inc.",4140 Dublin Blvd.,Suite 200,Dublin,California,94568,USA,20687,1987,
Interferon alfa-2b (recombinant),Intron A,1987-08-03,Treatment of ovarian carcinoma.,Designated/Withdrawn,,,N/A,N/A,Schering Corporation,2000 Galloping Hill Road,,Kenilworth,New Jersey,7033,USA,20187,1987,
Trisaccharides A and B,n/a,1987-08-03,"Treatment of moderate to very severe clinical forms of transfusion reactions arising from ABO incompatible transfusions of blood, blood products, and blood derivatives.",Designated/Withdrawn,,,N/A,N/A,"Chembiomed, Ltd.",P.O. Box 8050,T6H 4NP,,,,Canada,20287,1987,
ST1-RTA immunotoxin (SR 44163),n/a,1987-08-12,1. Prevention of acute graft versus host disease in allogenic bone marrow transplantation 2. Treatment of patients with B-chronic lymphocytic leukemia,Designated/Withdrawn,,,N/A,N/A,"Sanofi Winthrop, Inc.",9 Great Valley Parkway,,Malvern,Pennsylvania,19355,USA,16886,1987,
Acetylcysteine,Mucomyst/Mucomyst 10 Iv,1987-08-13,Intravenous treatment of patients presenting with moderate to severe acetaminophen overdose.,Designated,,,N/A,N/A,Bristol-Myers Squibb Company,P.O. Box 4500,,Princeton,New Jersey,8543,USA,20787,1987,
Erythropoietin (recombinant human),n/a,1987-08-19,Treatment of anemia associated with end stage renal disease.,Designated,,,N/A,N/A,McDonnell Douglas Corp,"P.O. Box 516, 107/2 MS10",,St. Louis,Missouri,63166,USA,17886,1987,
CD5-T lymphocyte immunotoxin,Xomazyme-H65,1987-08-27,Treatment of graft versus host disease and/or rejection in patients who have received bone marrow transplants.,Designated/Withdrawn,,,N/A,N/A,Xoma Corporation,2910 Seventh Street,,Berkeley,California,94710,USA,19587,1987,
Epoetin alpha,Procrit,1987-08-27,Treatment of anemia associated with end stage renal disease.,Designated,,,N/A,N/A,R. W. Johnson Pharmaceutical Research Institute,Route 202 South,P.O. Box 300,Raritan,New Jersey,8869,USA,17186,1987,
Somatropin,Norditropin,1987-09-01,"Adjunct for the induction of ovulation in women with infertility due to hypogonadotropic hypogonadism or bilateral tubal occlusion or unexplained infertility, who are undergoing in vivo or in vitro fertilization procedures.",Designated/Withdrawn,,,N/A,N/A,Novo Nordisk Pharmaceuticals,100 Overlook Center,Suite 200,Princeton,New Jersey,8540,USA,21787,1987,
Pentostatin for injection,Nipent,1987-09-10,Treatment of hairy cell leukemia.,Designated/Approved,Approved for Orphan Indication,Single agent treatment for adult patients with alpha-interferon-refractory hairy cell leukemia.,1991-10-11,1998-10-11,"SuperGen, Inc.","Two Annabel Lane, Suite 220",,San Ramon,California,94583,USA,21287,1987,1492
"Benzylpenicillin, benzylpenicilloic, benzylpenilloic acid",Pre-Pen/Mdm,1987-09-28,Assessing the risk of administrating penicillin when it is the preferred drug of choice in adult patients who have previously received penicillin and have a history of clinical sensitivity.,Designated,,,N/A,N/A,AllerQuest LLC,836 Farmington Avenue,Suite 207,West Hanford,Connecticut,6119,USA,18787,1987,
Piracetam,Nootropil,1987-10-02,Treatment of myoclonus.,Designated/Withdrawn,,,N/A,N/A,"UCB Pharma, Inc.",1950 Lake Park Drive,,Smyrna,Georgia,30080,USA,20987,1987,
Epidermal growth factor (human),n/a,1987-10-05,For acceleration of corneal epithelial regeneration and the healing of stromal tissue in the condition of non-healing corneal defects.,Designated,,,N/A,N/A,Chiron Vision,500 Iolab Drive,,Claremont,California,91711,USA,14386,1987,
Pentamidine isethionate (inhalation),Pneumopent,1987-10-05,Prevention of Pneumocystis carinii pneumonia in patients at high risk of developing this disease,Designated,,,N/A,N/A,Fisons Corporation,"755 Jefferson Rd., P.O. Box 1710",,Rochester,New York,14603,USA,21187,1987,
Interferon alfa-nl,Wellferon,1987-10-16,Treatment of human papillomavirus in patients with severe resistant/recurrent respiratory (laryngeal) papillomatosis.,Designated/Withdrawn,,,N/A,N/A,Glaxo Wellcome Inc.,5 Moore Drive,,Research Triangle Park,North Carolina,27709,USA,12986,1987,
Metronidazole (topical),Metrogel,1987-10-22,Treatment of acne rosacea.,Designated/Approved,Approved for Orphan Indication,,1988-11-22,1995-11-22,"Galderma Laboratories, Inc.",P.O. Box 331329,,Fort Worth,Texas,76163,USA,21687,1987,397
Epoetin beta,Marogen,1987-10-22,Treatment of anemia associated with end stage renal disease.,Designated,,,N/A,N/A,"Chugai-USA, Inc.",3780 Hawthorn Court,,Waukegan,Illinois,60087,USA,22987,1987,
substituted benzaldehyde that binds to the oxy-conformation of Hb between amino terminal residues of the alpha-subunits,n/a,1987-10-23,Treatment of sickle cell disease.,Designated/Withdrawn,,,N/A,N/A,Burroughs Wellcome Company,3030 Cornwallis Road,P.O. Box 12700,Research Triangle Pk,North Carolina,27709,USA,22087,1987,
Iodine I 131 Lym-1 Monoclonal Antibody,n/a,1987-11-02,Treatment of B-cell lymphoma.,Designated/Withdrawn,,,N/A,N/A,Lederle Laboratories Division,American Cyanamide Company,401 N. Middletown Road,Pearl River,New York,10965,USA,21887,1987,
Deslorelin,Somagard,1987-11-05,Treatment of central precocious puberty.,Designated,,,N/A,N/A,Roberts Pharmaceutical Corp.,Meridian Center II,Four Industrial Way West,Eatontown,New Jersey,7724,USA,16086,1987,
Glatiramer acetate,Copaxone,1987-11-09,Treatment of multiple sclerosis.,Designated/Approved,Approved for Orphan Indication,For reduction of the frequency of relapses in patients with relapsing-remitting multiple sclerosis.,1996-12-20,2003-12-20,Teva Pharmaceuticals USA,1510 Delp Drive,,Kulpsville,Pennsylvania,19443,USA,24087,1987,3329
Allopurinol sodium,n/a,1987-11-09,Ex-vivo preservation of cadaveric kidneys for transplantation,Designated/Withdrawn,,,N/A,N/A,Burroughs Wellcome Company,3030 Cornwallis Road,P.O. Box 12700,Research Triangle Pk,North Carolina,27709,USA,22787,1987,
"Ammonium trichloro [dioxoethylene-O,O') tellurium (IV)",n/a,1987-11-09,Treatment of acquired immunodeficiency syndrome.,Designated/Withdrawn,,,N/A,N/A,"NPDC-AS101, Inc.",783 Jersey Avenue,,New Brunswick,New Jersey,8901,USA,22387,1987,
baclofen,Lioresal Intrathecal,1987-11-10,"Treatment of intractable spasticity caused by spinal cord injury, multiple sclerosis, and other spinal diseases (including spinal ischemia, spinal tumor, transverse myelitis, cervical spondylosis, and degenerative myelopathy).",Designated/Approved,Approved for Orphan Indication,Management of severe spasticity of spinal cord origin in patients who are unresponsive to oral baclofen therapy or experience intolerable CNS side effects at effective doses.,1992-06-25,1999-06-25,"Medtronic, Inc.",800 53rd Avenue N.E.,,Minneapolis,Minnesota,55432,USA,23987,1987,1689
Thymoxamine HCl,n/a,1987-11-16,Reversal of phenylephrine-induced mydriasis in patients who have narrow anterior angles and are at risk of developing an acute attack of angle-closure glaucoma following mydriasis.,Designated/Withdrawn,,,N/A,N/A,Iolab Pharmaceuticals,500 Iolab Drive,,Claremont,California,94608,USA,19887,1987,
Dextran sulfate sodium,n/a,1987-11-19,Treatment of aquired immunodeficiency syndrome.,Designated,,,N/A,N/A,"Ueno Fine Chemicals Industry, Ltd.","2-31 Koraibashi, Higashi-ku",,Osaka 541,,,Japan,23187,1987,
"Erythropoietin (human, recombinant)",n/a,1987-11-19,Treatment of anemia associated with end stage renal disease.,Designated/Withdrawn,,,N/A,N/A,Organon Teknika Corporation,,,,,,,18987,1987,
Metronidazole (topical),Flagyl,1987-11-24,"Treatment of grade III and IV, anaerobically infected, decubitus ulcers.",Designated/Withdrawn,,,N/A,N/A,Searle,4901 Searle Parkway,,Skokie,Illinois,60077,USA,17486,1987,
Urofollitropin,Metrodin,1987-11-25,For induction of ovulation in patients with polycystic ovarian disease who have an elevated LH/FSH ratio and who have failed to respond to adequate clomiphene citrate therapy.,Designated/Approved,Approved for Orphan Indication,,1986-09-18,1993-09-18,"EMD Serono, Inc.",One Technology Place,,Roackland,Massachusetts,2370,USA,14086,1987,-433
Gamma hydroxybutyrate,n/a,1987-12-03,"Treatment of narcolepsy and the auxiliary symptoms of cataplexy, sleep paralysis, hypnagogic hallucinations and automatic behavior.",Designated,,,N/A,N/A,"Biocraft Laboratories, Inc.",18-01 River Road,,Fair Lawn,New Jersey,7410,USA,26387,1987,
Interferon alfa-2a (recombinant),Roferon-A,1987-12-14,Treatment of AIDS related Kaposi's sarcoma.,Designated/Approved,Approved for Orphan Indication,,1988-11-21,1995-11-21,"Hoffmann-La Roche, Inc.",340 Kingsland Street,,Nutley,New Jersey,7110,USA,25987,1987,343
Dantrolene sodium,Dantrium,1987-12-14,Treatment of the neuroleptic malignant syndrome.,Designated/Withdrawn,,,N/A,N/A,Norwich Eaton Pharmaceuticals,P.O. Box 191,,Norwich,New York,13815,USA,23287,1987,
Mesna,n/a,1987-12-16,Inhibition of the urotoxic effects induced by oxazaphosphorine compounds such as cyclophosphamide.,Designated/Withdrawn,,,N/A,N/A,"Asta Medica , Inc.",890 East St.,,Tewksbury,Massachusetts,1876,USA,24887,1987,
Pentamidine isethionate,Nebupent,1988-01-12,Prevention of Pneumocystis carinii pneumonia in patients at high risk of developing this disease.,Designated/Approved,Approved for Orphan Indication,,1989-06-15,1996-06-15,"Fujisawa USA, Inc.",3 Parkway North Center,,Deerfield,Illinois,60015,USA,25887,1988,520
Trimetrexate glucuronate,n/a,1988-01-13,Treatment of patients with advanced non-small cell carcinoma of the lung.,Designated/Withdrawn,,,N/A,N/A,"Medimmune Oncology, Inc.",One MedImmune Way,,Gaithersburg,Maryland,20878,USA,14686,1988,
Ceramide trihexosidase/alpha-galactosidase A,Fabrazyme,1988-01-19,Treatment of Fabry's disease.,Designated/Approved,Approved for Orphan Indication,For use in patients with Fabry disease to reduce globotriaosylceramide (GL-3) deposition in capillary endothelium of the kidney and certain other cell types,2003-04-24,2010-04-24,Genzyme Corporation,One Kendall Square,,Cambridge,Massachusetts,2139,USA,15286,1988,5574
Anagrelide,Agrylin,1988-01-27,Treatment of essential thrombocythemia.,Designated/Approved,Approved for Orphan Indication,Treatment of patients with essential thrombocythemia to reduce the elevated platelet count and the risk of thrombosis and to ameliorate associated symptoms.,1997-03-14,2004-03-14,Roberts Pharmaceutical Corp.,Meridian Center III,6 Industrial Way West,Eatontown,New Jersey,7724,USA,20887,1988,3334
Levocabastine HCl ophthalmic suspension 0.05%,n/a,1988-02-29,Treatment of vernal keratoconjunctivitis.,Designated/Withdrawn,,,N/A,N/A,Iolab Pharmaceuticals,500 Iolab Drive,,Claremont,California,94608,USA,24787,1988,
Heme arginate,Normosang,1988-03-10,Treatment of symptomatic stage of acute porphyria.,Designated,,,N/A,N/A,Orphan Europe SARL,Immeuble Le Wilson,70 avenue du General de Gaulle,92800 Puteaux,,,France,9185,1988,
Propamidine isethionate 0.1% ophthalmic solution,Brolene,1988-03-10,Treatment of acanthamoeba keratitis.,Designated/Withdrawn,,,N/A,N/A,Bausch & Lomb,Pharmaceuticals Division,8500 Hidden River Parkway,Tampa,Florida,33637,USA,27288,1988,
Monoclonal antibody 17-1a,Panorex,1988-04-04,Treatment of pancreatic cancer.,Designated/Withdrawn,,,N/A,N/A,"Centocor, Inc.",244 Great Valley Parkway,,Malvern,Pennsylvania,19355,USA,27388,1988,
mefloquine HCL,Lariam,1988-04-13,"For use in the treatment of acute malaria due to Plasmodium falciparum and Plasmodium vivax, and for the prophylaxis of Plasmodium falciparum malaria which is resistant to other available drugs",Designated/Approved,Approved for Orphan Indication,Treatment of acute malaria due to Plasmodium falciparum and Plasmodium vivax,1989-05-02,1996-05-02,"Hoffmann-La Roche, Inc.",340 Kingsland Street,,Nutley,New Jersey,7110,USA,26287,1988,384
mefloquine HCL,Lariam,1988-04-13,"For use in the treatment of acute malaria due to Plasmodium falciparum and Plasmodium vivax, and for the prophylaxis of Plasmodium falciparum malaria which is resistant to other available drugs",Designated/Approved,Approved for Orphan Indication,Prophylaxis of Plasmodium falciparum malaria which is resistant to other available drugs,1989-05-03,1996-05-03,"Hoffmann-La Roche, Inc.",340 Kingsland Street,,Nutley,New Jersey,7110,USA,26287,1988,385
Megestrol acetate,Megace,1988-04-13,"Treatment of patients with anorexia, cachexia, or significant weight loss (=/>10% of baseline body weight) and confirmed diagnosis of AIDS.",Designated/Approved,Approved for Orphan Indication,"Treatment of anorexia, cachexia, or an unexplained significant weight loss in patients with a diagnosis of acquired immune deficiency syndrome.",1993-09-10,2000-09-10,Bristol-Myers Squibb Pharmaceutical Research Institute,2400 West Lloyd Expressway,,Evansville,Indiana,47721,USA,26187,1988,1976
Tocophersolan oral solution (vitamin E-tpgs),n/a,1988-04-15,Treatment of vitamin E deficiency resulting from malabsorption due to prolonged cholestatic hepatobiliary disease.,Designated/Withdrawn,,,N/A,N/A,Sterling Winthrop,9 Great Valley Parkway,,Malvern,Pennsylvania,19355,USA,22687,1988,
Trisaccharides A and B,Biosynject,1988-04-15,Prevention of ABO medical hemolytic reactions arising from ABO-incompatible bone marrow transplantation.,Designated,,,N/A,N/A,"Chembiomed, Ltd.",P.O. Box 8050,T6H 4NP,,,,Canada,27988,1988,
Interferon alfa-2a (recombinant),Roferon-A,1988-04-18,Treatment of renal cell carcinoma.,Designated,,,N/A,N/A,"Hoffmann-La Roche, Inc.",340 Kingsland Street,,Nutley,New Jersey,7110,USA,27488,1988,
Interferon alfa-2b (recombinant),Intron A,1988-04-18,Treatment of invasive carcinoma of the cervix.,Designated/Withdrawn,,,N/A,N/A,Schering Corporation,2000 Galloping Hill Road,,Kenilworth,New Jersey,7033,USA,20387,1988,
Praziquantel,n/a,1988-04-18,Treatment of neurocysticercosis.,Designated/Withdrawn,,,N/A,N/A,"EM Pharmaceuticals, Inc.",,,,,,,19487,1988,
Interferon alfa-2b (recombinant),Intron A,1988-05-13,Treatment of primary malignant brain tumors.,Designated/Withdrawn,,,N/A,N/A,Schering Corporation,2000 Galloping Hill Road,,Kenilworth,New Jersey,7033,USA,21087,1988,
Superoxide dismutase (recombinant human),Oxsodrol,1988-05-17,Prevention of reperfusion injury to donor organ tissue.,Designated/Withdrawn,,,N/A,N/A,Bio-Technology General Corp.,"70 Wood Avenue, South",,Iselin,New Jersey,8830,USA,27188,1988,
Coagulation factor VIIa (recombinant),Novoseven,1988-06-06,Treatment of bleeding episodes in hemophilia A or B patients with inhibitors to Factor VIII or Factor IX.,Designated/Approved,Approved for Orphan Indication,Treatment of bleeding episodes in hemophilia A or B patients with inhibitors to Factor VIII or Factor IX.,1999-03-25,2006-03-25,"Novo Nordisk, Inc.",100 College Road West,,Princeton,New Jersey,8540,USA,26588,1988,3944
Piritrexim isethionate,n/a,1988-06-13,"Treatment of infections caused by Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium-intracellulare.",Designated/Withdrawn,,,N/A,N/A,Burroughs Wellcome Company,3030 Cornwallis Road,P.O. Box 12700,Research Triangle Park,North Carolina,27709,USA,29188,1988,
Aconiazide,n/a,1988-06-20,Treatment of tuberculosis.,Designated/Withdrawn,,,N/A,N/A,Lincoln Diagnostics,P.O. Box 1128,,Decatur,Illinois,62525,USA,28288,1988,
Somatostatin,Zecnil,1988-06-20,"Adjunct to the non-operative management of secreting cutaneous fistulas of the stomach, duodenum, small intestine (jejunum and ileum), or pancreas.",Designated,,,N/A,N/A,"Ferring Laboratories, Inc.","400 Rella Boulevard, Suite 201",,Suffern,New York,10901,USA,21587,1988,
Dideoxyinosine,n/a,1988-06-22,Treatment of acquired immunodeficiency syndrome.,Designated/Withdrawn,,,N/A,N/A,Bristol-Myers Squibb,2400 West Lloyd Expressway,,Evansville,Indiana,47721,USA,29488,1988,
"Ethinyl Estradiol, USP",n/a,1988-06-22,Treatment of Turner's syndrome.,Designated/Withdrawn,,,N/A,N/A,Bio-Technology General Corp.,"70 Wood Avenue, South",,Iselin,New Jersey,8830,USA,28788,1988,
Leucovorin calcium,Wellcovorin,1988-06-23,For use in combination with 5-fluorouracil for the treatment of metastatic colorectal cancer.,Designated/Withdrawn,,,N/A,N/A,Glaxo Wellcome Research and Development,5 Moore Drive,PO Box 13398,Research Triangle Park,North Carolina,27709,USA,29288,1988,
Zalcitabine,Hivid,1988-06-28,Treatment of AIDS.,Designated/Approved,Approved for Orphan Indication,Combination therapy with zidovudine is indicated for the treatment of adult patients with advanced HIV infection (CD4 count < 300) who have demonstrated malignant clinical or immunologic deterioration.,1992-06-19,1999-06-19,"Hoffmann-La Roche, Inc.",340 Kingsland Street,,Nutley,New Jersey,7110,USA,28388,1988,1452
Polyribonucleotide; Polyribo-inosinic/-cyclidylic/-uridylic acid,Ampligen,1988-07-19,Treatment of AIDS,Designated,,,N/A,N/A,"Hemispherx Biopharma, Inc.",One Penn Center,1617 JFK Boulevard,Philadelphia,Pennsylvania,19103,USA,11685,1988,
Nafarelin acetate,Synarel Nasal Solution,1988-07-20,Treatment of central precocious puberty.,Designated/Approved,Approved for Orphan Indication,Treatment of central precocious puberty (gonadotropin-dependent precocious puberty) in children of both sexes.,1992-02-26,1999-02-26,"Syntex (USA), Inc.",3401 Hillview Avenue,,Palo Alto,California,94303,USA,29888,1988,1316
Epoetin alpha,Procrit,1988-07-21,Treatment of anemia of prematurity in preterm infants.,Designated/Withdrawn,,,N/A,N/A,"Janssen Research & Development, LLC",1400 McKean Road,P. O. Box 776,Spring House,Pennsylvania,19477,USA,21987,1988,
Idarubicin HCl for injection,Idamycin,1988-07-25,"Treatment of acute myelogenous leukemia, also referred to as acute nonlymphocytic leukemia.",Designated/Approved,Approved for Orphan Indication,,1990-09-27,1997-09-27,"Adria Laboratories, Inc.",P.O. Box 16529,,Columbus,Ohio,43216,USA,29388,1988,794
Leuprolide acetate,Lupron Injection,1988-07-25,Treatment of central precocious puberty,Designated/Approved,Approved for Orphan Indication,Treatment of children with central precocious puberty,1993-04-16,2000-04-16,"Tap Pharmaceuticals, Inc.",2355 Waukegan Road,,Deerfield,Illinois,60015,USA,28688,1988,1726
Dipalmitoylphosphatidylcholine /phosphatidylglycerol,Alec,1988-07-28,Prevention and treatment of neonatal respiratory distress syndrome.,Designated,,,N/A,N/A,"Forum Products, Inc.",33 Flying Point Road,,Southampton,New York,11968,USA,29688,1988,
Histrelin acetate,Supprelin Injection,1988-08-10,Treatment of central precocious puberty.,Designated/Approved,Approved for Orphan Indication,Treatment of central precocious puberty.,1991-12-24,1998-12-24,Roberts Pharmaceutical Corp.,Meridian Center III,6 Industrial Way West,Eatontown,New Jersey,7724,USA,16986,1988,1231
Interferon alfa-2b (recombinant),Intron A,1988-08-10,Treatment of carcinoma in situ of the urinary bladder.,Designated/Withdrawn,,,N/A,N/A,Schering Corporation,2000 Galloping Hill Road,,Kenilworth,New Jersey,7033,USA,20487,1988,
Leucovorin,Leucovorin Calcium,1988-08-17,For rescue use after high dose methotrexate therapy in the treatment of osteosarcoma.,Designated/Approved,Approved for Orphan Indication,,1988-08-31,1995-08-31,Immunex Corporation,51 University Street,,Seattle,Washington,98101,USA,30588,1988,14
Interferon alfa-2b (recombinant),Intron A,1988-08-17,Treatment of laryngeal (respiratory) papillomatosis.,Designated/Withdrawn,,,N/A,N/A,Schering Corporation,2000 Galloping Hill Road,,Kenilworth,New Jersey,7033,USA,21487,1988,
Fibronectin (human plasma derived),n/a,1988-09-05,Treatment of non-healing corneal ulcers or epithelial defects which have been unresponsive to conventional therapy and the underlying cause has been eliminated.,Designated,,,N/A,N/A,"Melville Biologics, Inc.",310 East 67th Street,,New York,New York,10021,USA,24987,1988,
Levocarnitine,Carnitor,1988-09-06,Treatment of manifestations of carnitine deficiency in patients with end stage renal disease who require dialysis.,Designated/Approved,Approved for Orphan Indication,Prevention and treatment of carnitine deficiency in patients with end stage renal disease who are undergoing dialysis.,1999-12-15,2006-12-15,"Leadiant Biosciences, Inc.",9841 Washingtonian Blvd,Suite 500,Gaithersburg,Maryland,20878,USA,27888,1988,4117
Serratia marcescens extract (polyribosomes),Imuvert,1988-09-07,Treatment of primary brain malignancies.,Designated,,,N/A,N/A,"Cell Technology, Inc.",1668 Valtec Lane,,Boulder,Colorado,80306,USA,30188,1988,
Phosphocysteamine,n/a,1988-09-12,Treatment of cystinosis.,Designated/Withdrawn,,,N/A,N/A,Medea Research Laboratories,Port Jefferson Business Center,"200 Wilson Street, Building D-6",Port Jefferson,New York,11776,USA,29588,1988,
Aldesleukin,Proleukin,1988-09-14,Treatment of metastatic renal cell carcinoma.,Designated/Approved,Approved for Orphan Indication,Treatment of adults (>18 years old) with metastatic renal cell carcinoma.,1992-05-05,1999-05-05,Chiron Corporation,4560 Horton St.,,Emeryville,California,94608,USA,29088,1988,1329
Sermorelin acetate,Geref,1988-09-14,Treatment of idiopathic or organic growth hormone deficiency in children with growth failure.,Designated/Approved,Approved for Orphan Indication,,1997-09-26,2004-09-26,"EMD Serono, Inc.",One Technology Place,,Roackland,Massachusetts,2370,USA,24687,1988,3299
thalidomide,n/a,1988-09-19,1. Treatment of graft versus host disease in patients receiving bone marrow transplantation 2. Prevention of graft versus host disease in patients receiving bone marrow transplantation,Designated,,,N/A,N/A,"Pediatric Pharmaceuticals, Inc.",718 Bradford Avenue,,Westfield,New Jersey,7090,USA,30788,1988,
Caffeine,Cafcit,1988-09-20,Treatment of apnea of prematurity.,Designated/Approved,Approved for Orphan Indication,Short term treatment of apnea of prematurity in infants between 28 and less than 33 weeks gestational age.,1999-09-21,2006-09-21,"O.P.R. Development, L.P.",1501 Wakarusa Drive,,Lawrence,Kansas,66047,USA,31288,1988,4018
Bethanidine sulfate,n/a,1988-09-20,Treatment of primary ventricular fibrillation.,Designated/Withdrawn,,,N/A,N/A,"Medco Research, Inc.",8455 Beverly Blvd.,Suite 308,Los Angeles,California,90048,USA,26087,1988,
Inosine pranobex,Isoprinosine,1988-09-20,Treatment of subacute sclerosing panencephalitis.,Designated,,,N/A,N/A,Newport Pharmaceuticals,897 West Sixteenth Street,,Newport Beach,California,92663,USA,26888,1988,
Sotalol HCl,Betapace,1988-09-23,1. Treatment of life-threatening ventricular tachyarrhythmias 2. Prevention of life treatening ventricular tachyarrhythmias,Designated/Approved,Approved for Orphan Indication,Treatment of life-threatening ventricular tachyarrhythmias,1992-10-30,1999-10-30,"Berlex Laboratories, Inc.",300 Fairfield Road,,Wayne,New Jersey,7470,USA,30088,1988,1498
Interferon gamma 1-b,Actimmune,1988-09-30,Treatment of chronic granulomatous disease.,Designated/Approved,Approved for Orphan Indication,,1990-12-20,1997-12-20,Horizon Pharma Ireland Limited,"Connaught House, 1st Floor",Dublin 4,,,,Ireland,29788,1988,811
Iodine I 123 murine monoclonal antibody to alpha-fetoprotein,n/a,1988-09-30,1. Detection of hepatocellular carcinoma and hepatoblastoma 2. Detection of alpha-fetoprotein producing germ cell tumors,Designated/Withdrawn,,,N/A,N/A,"Immunomedics, Inc.",300 American Road,,Morris Plains,New Jersey,7950,USA,25487,1988,
Iodine I 131 murine monoclonal antibody to alpha-fetoprotein,n/a,1988-09-30,1. Treatment of hepatocellular carcinoma and hepatoblastoma 2. Treatment of alpha-fetoprotein producing germ cell tumors,Designated/Withdrawn,,,N/A,N/A,"Immunomedics, Inc.",300 American Road,,Morris Plains,New Jersey,7950,USA,25687,1988,
Clindamycin,Cleocin,1988-10-28,Prevention of Pneumocystis carinii pneumonia in AIDS patients.,Designated,,,N/A,N/A,Pfizer Inc.,235 East 42nd Street,,New York,New York,10017,USA,27088,1988,
Clindamycin,Cleocin,1988-10-28,Treatment of Pneumocystis carinii pneumonia associated with AIDS patients.,Designated,,,N/A,N/A,Pharmacia & Upjohn,7000 Portage Road,Unit 0633-298-113,Kalamazoo,Michigan,49001,USA,26988,1988,
Iodine I 123 murine monoclonal antibody to hCG,n/a,1988-11-07,Detection of hCG producing tumors such as germ cell and trophoblastic cell tumors.,Designated,,,N/A,N/A,"Immunomedics, Inc.",300 American Road,,Morris Plains,New Jersey,7950,USA,25087,1988,
Iodine I 131 murine monoclonal antibody to hCG,n/a,1988-11-07,Treatment of hCG producing tumors such as germ cell and trophoblastic cell tumors.,Designated/Withdrawn,,,N/A,N/A,"Immunomedics, Inc.",300 American Road,,Morris Plains,New Jersey,7950,USA,25587,1988,
Cyclosporine ophthalmic,Optimmune,1988-11-09,Treatment of severe keratoconjunctivitis sicca associated with Sjogren's syndrome.,Designated,,,N/A,N/A,University Of Georgia,College Of Veterinary Medicine,Department of Small Animal Medicine,Athens,Georgia,30602,USA,29988,1988,
"Interferon beta, recombinant human",Betaseron,1988-11-15,Treatment of acquired immunodeficiency syndrome.,Designated/Withdrawn,,,N/A,N/A,"Berlex Laboratories, Inc.",1401 Harbor Bay Parkway,,Alameda,California,94501,USA,31788,1988,
Thalidomide,n/a,1988-11-15,Treatment and maintenance of reactional lepromatous leprosy.,Designated,,,N/A,N/A,"Pediatric Pharmaceuticals, Inc.",718 Bradford Avenue,,Westfield,New Jersey,7090,USA,32188,1988,
Interferon beta-1b,Betaseron,1988-11-17,Treatment of multiple sclerosis.,Designated/Approved,Approved for Orphan Indication,In ambulatory patients with relapsing-remitting multiple sclerosis to reduce the frequency of clinical exacerbations.,1993-07-23,2000-07-23,Chiron Corp. & Berlex Laboratories,4560 Horton Street,,Emeryville,California,94608,USA,31888,1988,1709
Gangliosides as sodium salts,Cronassial,1988-11-17,Treatment of retinitis pigmentosa.,Designated/Withdrawn,,,N/A,N/A,Fidia Pharmaceutical Corp.,"1401 Eye Street, N.W. Suite 900",,Washington,District of Columbia,20005,USA,31388,1988,
Interferon alfa-2b (recombinant),Intron A,1988-11-17,Treatment of acute hepatitis B.,Designated/Withdrawn,,,N/A,N/A,Schering Corporation,2000 Galloping Hill Road,,Kenilworth,New Jersey,7033,USA,26487,1988,
Ricin (blocked) conjugated murine MCA (anti-B4),n/a,1988-11-17,Treatment of B-cell leukemia and B-cell lymphoma.,Designated/Withdrawn,,,N/A,N/A,"ImmunoGen, Inc.",148 Sidney Street,,Cambridge,Massachusetts,2139,USA,30288,1988,
Fibronectin (plasma derived),n/a,1988-12-05,Treatment of non-healing corneal ulcers or epithelial defects which are unresponsive to conventional therapy and for which any infectious cause of the defect has been eliminated.,Designated/Withdrawn,,,N/A,N/A,Chiron Vision,9342 Jeronimo Road,,Irvine,California,92718,USA,24287,1988,
Gallium nitrate injection,Ganite,1988-12-05,Treatment of hypercalcemia of malignancy.,Designated/Approved/Withdrawn,,,N/A,1998-01-17,Solopak Pharmaceutical Co.,1845 Tonne Road,,Elk Grove Village,Illinois,60007,USA,24487,1988,
Pulmonary surfactant replacement,n/a,1988-12-05,Prevention and treatment of infant respiratory distress syndrome.,Designated/Withdrawn,,,N/A,N/A,"Scios Nova, Inc.",2450 Bayshore Parkway,,Mountain View,California,94043,USA,30988,1988,
Calcium acetate,Phos-Lo,1988-12-22,Treatment of hyperphosphatemia in end stage renal failure.,Designated/Approved,Approved for Orphan Indication,,1990-12-10,1997-12-10,Fresenius Medical Care North America,920 Winter Street,,Waltham,Massachusetts,2451,USA,31588,1988,718
Fomepizole,Antizole,1988-12-22,Treatment of methanol or ethylene glycol poisoning.,Designated/Approved,Approved for Orphan Indication,"As an antidote to ethylene glycol (antifreeze) poisoning, or for use in suspected ethylene glycol ingestion.",1997-12-04,2004-12-04,"Rare Disease Therapeutics, Inc.",12975 Brookprinter Pl,Suite 170,Poway,California,92064,USA,33388,1988,3269
Fomepizole,Antizole,1988-12-22,Treatment of methanol or ethylene glycol poisoning.,Designated/Approved,Approved for Orphan Indication,"Use for suspected or confirmed methanol poisoning, either alone or in combination with hemodialysis",2000-12-08,2007-12-08,"Rare Disease Therapeutics, Inc.",12975 Brookprinter Pl,Suite 170,Poway,California,92064,USA,33388,1988,4369
Cetiedil citrate injection,n/a,1988-12-22,Treatment of sickle cell disease crisis.,Designated/Withdrawn,,,N/A,N/A,"Baker Cummins Pharmaceuticals, Inc.",,,,,,,31488,1988,
Branched chain amino acids,n/a,1988-12-23,Treatment of amyotrophic lateral sclerosis.,Designated,,,N/A,N/A,Mount Sinai Medical Center,One Gustave L. Levy Place,,New York,New York,10029,USA,33588,1988,
Aerosolized pooled immune globulin,n/a,1989-01-03,Treatment of respiratory syncytial virus lower respiratory tract disease.,Designated/Withdrawn,,,N/A,N/A,"Pediatric Pharmaceuticals, Inc.",718 Bradford Avenue,,Westfield,New Jersey,7090,USA,33688,1989,
Mitolactol,n/a,1989-01-23,Treatment of invasive carcinoma of the uterine cervix,Designated,,,N/A,N/A,"Targent, Inc..",155 Lambert Drive,,Princeton,New Jersey,8540,USA,33188,1989,
Felbamate,Felbatol,1989-01-24,Treatment of Lennox-Gastaut syndrome.,Designated/Approved,Approved for Orphan Indication,As adjunctive therapy in the treatment of partial and generalized seizures associated with the Lennox-Gastaut syndrome in children.,1993-07-29,2000-07-29,Wallace Laboratories,301B College Road East,,Princeton,New Jersey,8540,USA,33488,1989,1647
Clonidine,Duraclon,1989-01-24,"For continous epidural administration as adjunctive therapy with intraspinal opiates for the treatment of pain in cancer patients tolerant to, or unresponsive to, intraspinal opiates.",Designated/Approved,Approved for Orphan Indication,In combination with opiates for the treatment of severe pain in cancer patients that is not adequately relieved by opioid analgesics alone.,1996-10-02,2003-10-02,"Roxane Laboratories, Inc.",PO Box 16532,,Columbus,Ohio,43216,USA,34388,1989,2808
Molgramostim,Leucomax,1989-01-24,"Treatment of AIDS patients with neutropenia due to the disease, AZTor ganciclovir.",Designated/Withdrawn,,,N/A,N/A,Schering Corporation,2000 Galloping Hill Road,,Kenilworth,New Jersey,7033,USA,34188,1989,
Imciromab pentetate,Myoscint,1989-01-25,Detecting early necrosis as an indication of rejection of orthotopic cardiac transplants.,Designated,,,N/A,N/A,"Centocor, Inc.",244 Great Valley Parkway,,Malvern,Pennsylvania,19355,USA,32888,1989,
Botulism immune globulin,Babybig,1989-01-31,Treatment of infant botulism.,Designated/Approved,Approved for Orphan Indication,Indicated for treatment of infant botulism caused by type A or type B Clostridium botulinum.,2003-10-23,2010-10-23,California Department of Health Services,2151 Berkeley Way,,Berkeley,California,94704,USA,34488,1989,5378
Fluorouracil,Adrucil,1989-02-06,For use in combination with leucovorin for therapy of metastatic adenocarcinoma of the colon and rectum.,Designated/Withdrawn,,,N/A,N/A,Lederle Laboratories,Division of American Cyanamid Company,401 N. Middletown Road,Pearl River,New York,10965,USA,32088,1989,
L-threonine,Threostat,1989-02-06,Treatment of amyotrophic lateral sclerosis.,Designated/Withdrawn,,,N/A,N/A,Tyson And Associates,12832 Chadron Avenue,,Hawthorne,California,90250,USA,33888,1989,
Epoetin alpha,Procrit,1989-03-07,Treatment of HIV associated anemia related to HIV infection or HIV treatment.,Designated,,,N/A,N/A,R. W. Johnson Pharmaceutical Research Institute,"Route 202, P.O. Box 300",,Raritan,New Jersey,8869,USA,32688,1989,
Cascara sagrada fluid extract,n/a,1989-03-21,Treatment of oral drug overdosage to speed lower bowel evacuation.,Designated,,,N/A,N/A,Intramed Corporation,102 Tremont Way,,Augusta,Georgia,30907,USA,34288,1989,
Aldesleukin,Proleukin,1989-03-22,Treatment of primary immunodeficiency disease associated with T-cell defects.,Designated,,,N/A,N/A,"Prometheus Laboratories, Inc.",9410 Carroll Park Drive,,San Diego,California,92121,USA,28988,1989,
Somatropin for injection,Nutropin,1989-03-23,Treatment of short stature associated with Turner's syndrome.,Designated/Approved,Approved for Orphan Indication,Treatment of growth failure associated with Turner syndrome.,1996-12-30,2003-12-30,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,USA,12686,1989,2839
Antiepilepsirine,n/a,1989-03-23,Treatment of drug resistant generalized tonic-clonic epilepsy in children and adults.,Designated,,,N/A,N/A,Children's Hospital,700 Children's Drive,,Columbus,Ohio,43205,USA,34588,1989,
Botulinum toxin type A,Dysport,1989-03-23,Treatment of essential blepharospasm.,Designated,,,N/A,N/A,"Porton International, Inc.","1155 15th Street, N.W., #315",,Washington,District of Columbia,20005,USA,35789,1989,
Recombinant soluble human CD4 (rCD4),n/a,1989-03-23,Treatment of AIDS in patients infected with HIV virus.,Designated,,,N/A,N/A,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,USA,34889,1989,
Fludarabine phosphate,Fludara,1989-04-18,"Treatment of chronic lymphocytic leukemia (CLL), including refractory CLL.",Designated/Approved,Approved for Orphan Indication,,1991-04-18,1998-04-18,"Berlex Laboratories, Inc.","15049 San Pablo Avenue, P.O. Box 4099",,Richmond,California,94804,USA,27688,1989,730
Fludarabine phosphate,Fludara,1989-04-18,Treatment and management of patients with non-Hodgkins lymphoma.,Designated,,,N/A,N/A,"Berlex Laboratories, Inc.",15049 San Pablo Avenue,P.O. Box 4099,Richmond,California,94804,USA,35889,1989,
Somatropin (rDNA),Saizen,1989-05-03,For the enhancement of nitrogen retention in hospitalized patients suffering from severe burns.,Designated,,,N/A,N/A,"EMD Serono, Inc.",One Technology Place,,Rockland,Massachusetts,2370,USA,24587,1989,
Bromhexine,Bisolvon,1989-05-15,Treatment of mild to moderate keratoconjunctivitis sicca in patients with Sjogren's syndrome.,Designated/Withdrawn,,,N/A,N/A,"Boehringer Ingelheim Pharmaceuticals, Inc.","900 Ridgebury Road, Box 368",,Ridgefield,Connecticut,6877,USA,34789,1989,
Interferon alfa-2a,Roferon A,1989-06-06,Treatment of chronic myelogenous leukemia.,Designated/Approved,Approved for Orphan Indication,Treatment of chronic myelogenous leukemia.,1995-10-19,2002-10-19,"Hoffmann-La Roche, Inc.",340 Kingsland Street,,Nutley,New Jersey,7110,USA,36989,1989,2326
Porfimer sodium,Photofrin,1989-06-06,For the photodynamic therapy of patients with primary or recurrent obstructing (either partially or completely) esophageal carcinoma.,Designated/Approved,Approved for Orphan Indication,"Photodynamic therapy with PHOTOFRIN for the palliation of patients with completely obstructing esophageal cancer, or of patients with partially obstructing esophageal cancer who cannot be satisfactorily treated with Nd:YAG laser therapy.",1995-12-27,2002-12-27,"QLT Phototherapeutics, Inc.",Lederle Laboratories,401 North Middletown Road,Pearl River,New York,10965,USA,35589,1989,2395
Granulocyte macrophage-colony stimulating factor,Leucomax,1989-06-06,Treatment of severe thermal injuries in patients with greater than 40% full or partial thickness burns.,Designated/Withdrawn,,,N/A,N/A,Schering Corporation,2000 Galloping Hill Road,,Kenilworth,New Jersey,7033,USA,27588,1989,
Coagulation factor IX,Mononine,1989-06-27,Replacement treatment and prophylaxis of the hemorrhagic complications of hemophilia B.,Designated/Approved,Approved for Orphan Indication,"Prevention and control of bleeding in factor IX deficiency, also known as hemophilia B or Christmas disease.",1992-08-20,1999-08-20,Armour Pharmaceutical Company,"500 Arcola Road, P.O. Box 1200",,Collegeville,Pennsylvania,19426,USA,36189,1989,1150
Calcium acetate,n/a,1989-06-27,Treatment of hyperphosphatemia in end stage renal disease.,Designated,,,N/A,N/A,Pharmedic Company,"28101 Ballard Road, Suite F",,Lake Forest,Illinois,60045,USA,36489,1989,
poloxamer 188 (purified),n/a,1989-06-27,Treatment of sickle cell disease (this includes the treatment and prevention of complications of sickle cell disease),Designated,,,N/A,N/A,Mast Therapeutics Inc.,3611 Valley Centre rive,Suite 500,San Diego,California,92130,USA,38189,1989,
"T4 endonuclease V, liposome encapsulated",n/a,1989-06-27,To prevent cutaneous neoplasms and other skin abnormalities in xeroderma pigmentosum.,Designated,,,N/A,N/A,AGI Dermatics,205 Buffalo Avenue,,Freeport,New York,11520,USA,38589,1989,
Adenosine,n/a,1989-08-01,For use in conjunction with BCNU in the treatment of brain tumors.,Designated/Withdrawn,,,N/A,N/A,"Medco Research, Inc.",8455 Beverly Boulevard,Suite 308,Los Angeles,California,90048,USA,32388,1989,
Ethiofos,n/a,1989-08-01,Use as a chemoprotective agent for cisplatin and cyclophosphamide in the treatment of ovarian cancer.,Designated/Withdrawn,,,N/A,N/A,U.S. Bioscience,100 Front Street,,West Conshohocken,Pennsylvania,19428,USA,24187,1989,
L-cycloserine,n/a,1989-08-01,Treatment of Gaucher's disease.,Designated,,,N/A,N/A,"Lev, Meir M.D.","The City College, City University Of NY Medical Sc",Convent Avenue at 138 Street,New York,New York,10031,USA,38489,1989,
Lysine acetylsalicylate injectable,n/a,1989-08-01,Treatment of pain and fever secondary to sickle cell disease crisis.,Designated/Withdrawn,,,N/A,N/A,G.D. Searle & Company,4901 Searle Parkway,,Skokie,Illinois,60077,USA,33988,1989,
Technetium Tc99m murine monoclonal antibody to human AFP,Afp-Scan,1989-08-01,Detection of alpha-fetoprotein producing germ cell tumors.,Designated/Withdrawn,,,N/A,N/A,"Immunomedics, Inc.",300 American Road,,Morris Plains,New Jersey,7950,USA,35489,1989,
Technetium Tc99m murine monoclonal antibody to human alpha-fetoprotein,"Immuraid, Afp-Scan",1989-08-01,Detection of hepatocellular carcinoma and hepatoblastoma.,Designated/Withdrawn,,,N/A,N/A,"Immunomedics, Inc.",300 American Road,,Morris Plains,New Jersey,7950,USA,35389,1989,
Ricin (blocked) conjugated murine MCA (anti-my9),n/a,1989-08-03,"Treatment of myeloid leukemia, including AML, and blast crisis of CML.",Designated/Withdrawn,,,N/A,N/A,"ImmunoGen, Inc.",830 Winter Street,,Waltham,Massachusetts,2451,USA,38389,1989,
Somatropin for injection,Nutropin,1989-08-04,Treatment of growth retardation associated with chronic renal failure.,Designated/Approved,Approved for Orphan Indication,Treatment of children with growth failure associated with chronic renal insufficency.,1993-11-17,2000-11-17,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,USA,34989,1989,1566
Granulocyte macrophage-colony stimulating factor,Leucomax,1989-08-07,Treatment of myelodysplastic syndrome.,Designated/Withdrawn,,,N/A,N/A,Schering Corporation,2000 Galloping Hill Road,,Kenilworth,New Jersey,7033,USA,37889,1989,
Growth hormone releasing factor,n/a,1989-08-07,For the long-term treatment of children who have growth failure due to a lack of adequate endogenous growth hormone secretion.,Designated,,,N/A,N/A,Valeant Pharmaceuticals North America,700 Route 202/206,,Bridgewater,New Jersey,8807,USA,37389,1989,
Human IgM monoclonal antibody (C-58) To CMV,Centovir,1989-08-07,Prophylaxis of cytomegalovirus infections in bone marrow transplant patients.,Designated/Withdrawn,,,N/A,N/A,"Centocor, Inc.",200 Great Valley Parkway,,Malvern,Pennsylvania,19355,USA,33088,1989,
Human IgM monoclonal antibody (C-58) To CMV,Centovir,1989-08-07,Treatment of cytomegalovirus infections in allogenic bone marrow transplant patients.,Designated/Withdrawn,,,N/A,N/A,"Centocor, Inc.",200 Great Valley Parkway,,Malvern,Pennsylvania,19355,USA,32988,1989,
Indium In 111 murine monoclonal antibody FAB to myosin,Myoscint,1989-08-07,To aid in the diagnosis of myocarditis.,Designated/Withdrawn,,,N/A,N/A,"Centocor, Inc.",244 Great Valley Parkway,,Malvern,Pennsylvania,19355,USA,33788,1989,
Technetium Tc99m murine monoclonal antibody to hCG,"Immuraid, Hcg-Tc-99m",1989-08-07,Detection of hCG producing tumors such as germ cell and trophoblastic cell tumors.,Designated/Withdrawn,,,N/A,N/A,"Immunomedics, Inc.",300 American Road,,Morris Plains,New Jersey,7950,USA,35689,1989,
somatorelin,Somatrel,1989-08-08,Diagnostic measure of the capacity of the pituitary gland to release growth hormone.,Designated,,,N/A,N/A,"Ferring Laboratories, Inc.","400 Rella Boulevard, Suite 201",,Suffern,New York,10901,USA,36689,1989,
"Citric acid, glucono-delta-lactone and magnesium carbonate",Renacidin Irrigation,1989-08-28,Treatment of renal and bladder calculi of the apatite or struvite variety.,Designated/Approved,Approved for Orphan Indication,,1990-10-02,1997-10-02,"United-Guardian, Inc.",P.O. Box 2500,,Smithtown,New York,11787,USA,40189,1989,400
Iodine I 131 murine monoclonal antibody IgG2a to B cell,"Immurait, Ll-2-I-131",1989-09-18,Treatment of B-cell leukemia and B-cell lymphoma.,Designated/Withdrawn,,,N/A,N/A,"Immunomedics, Inc.",300 American Road,,Morris Plains,New Jersey,7950,USA,38289,1989,
Iloprost solution for infusion,n/a,1989-09-21,Treatment of Raynaud's phenomenon secondary to systemic sclerosis.,Designated/Withdrawn,,,N/A,N/A,"Berlex Laboratories, Inc.",300 Fairfield Road,,Wayne,New Jersey,7470,USA,38789,1989,
Troleandomycin,n/a,1989-09-21,Treatment of severe steroid-requiring asthma.,Designated/Withdrawn,,,N/A,N/A,"Szefler, Stanley M. M.D.",National Jewish Center for Immunology and Respirat,1400 Jackson Street,Denver,Colorado,80206,USA,39089,1989,
Satumomab pendetide,Oncoscint Cr/Ov,1989-09-25,Detection of ovarian carcinoma.,Designated/Approved,Approved for Orphan Indication,For determining the extent and location of extraphepatic malignant disease in patients with known colorectal and ovarian cancer.,1992-12-29,1999-12-29,Cytogen Corporation,600 College Road East,,Princeton,New Jersey,8540,USA,36789,1989,1191
Antihemophilic factor (recombinant),Kogenate,1989-09-25,Prophylaxis and treatment of bleeding in individuals with hemophilia A or for prophylaxis when surgery is required in individuals with hemophilia A.,Designated/Approved,Approved for Orphan Indication,Treatment and prophylaxis of bleeding in patients with hemophilia A (not von Willebrand's disease),1993-02-25,2000-02-25,Bayer Corporation,1884 Miles Avenue,,Elkhart,Indiana,46515,USA,39289,1989,1249
Molgramostim,Leucomax,1989-09-25,Treatment of aplastic anemia.,Designated/Withdrawn,,,N/A,N/A,Schering Corporation,2000 Galloping Hill Road,,Kenilworth,New Jersey,7033,USA,39989,1989,
"Colfosceril palmitate, cetyl alcohol, tyloxapol",Exosurf Neonatal For Intratracheal Suspension,1989-10-20,"1. Prevention of hyaline membrane disease, also known as respiratory distress syndrome, in infants born at 32 weeks gestation or less 2. prevention of hyaline membrane disease (HMD), also known as respiratory distress syndrome (RDS), in infants born at 32 weeks gestation or less and in the treatment of established HMO at all gestational ages.",Designated/Approved,Approved for Orphan Indication,"Prevention of hyaline membrane disease (HMD), also known as respiratory distress syndrome (RDS), in infants born at 32 weeks gestation or less and in the treatment of established HMO at all gestational ages",1990-08-02,1997-08-02,Glaxo Wellcome Inc.,5 Moore Drive,,Research Triangle Park,North Carolina,27709,USA,14886,1989,286
Pegaspargase,Oncaspar,1989-10-20,Treatment of acute lymphocytic leukemia.,Designated/Approved,Approved for Orphan Indication,Combination chemotherapy for the treatment of patients with acute lymphoblastic leukemia who are hypersensitive to native forms of L-asparaginase.,1994-02-01,2001-02-01,"Baxalta US, Inc.",300 Shire Way,,Lexington,Massachusetts,2421,USA,39589,1989,1565
Ancrod,Viprinex,1989-10-20,To establish and maintain anticoagulation in heparin-intolerant patients undergoing cardiopulmonary bypass.,Designated,,,N/A,N/A,Knoll Pharmaceutical Company,"3000 Continental Dr., North",,Mt. Olive,New Jersey,7828,USA,37189,1989,
enisoprost,n/a,1989-10-20,1. For use with cyclosporine in organ transplant recipients to reduce acute transplant rejection 2. For use in organ transplant patients to diminish the nephrotoxicity induced by cyclosporine.,Designated/Withdrawn,,,N/A,N/A,G.D. Searle & Company,4901 Searle Parkway,,Skokie,Illinois,60077,USA,37289,1989,
Fluorouracil,n/a,1989-10-27,"For use in combination with interferon alpha-2a, recombinant, for the treatment of esophageal carcinoma.",Designated,,,N/A,N/A,"Hoffmann-La Roche, Inc.",340 Kingsland Street,,Nutley,New Jersey,7110,USA,40589,1989,
Interferon alfa-2a (recombinant),Roferon-A,1989-10-27,For use in combination with fluorouracil for the treatment of esophageal carcinoma.,Designated,,,N/A,N/A,"Hoffmann-La Roche, Inc.",340 Kingsland Street,,Nutley,New Jersey,7110,USA,40889,1989,
levocarnitine,Carnitor,1989-11-15,1. Prevention of secondary carnitine deficiency in valproic acid toxicity 2. Treatment of secondary carnitine deficiency in valproic acid toxicity,Designated,,,N/A,N/A,"Leadiant Biosciences, Inc.",9841 Washingtonian Blvd,Suite 500,Gaithersburg,Maryland,20878,USA,32488,1989,
Porfimer sodium,Photofrin,1989-11-15,For the photodynamic therapy of patients with transitional cell carcinoma in situ of the urinary bladder.,Designated,,,N/A,N/A,"QLT Phototherapeutics, Inc.",Lederle Laboratories,401 North Middletown Road,Pearl River,New York,10965,USA,39489,1989,
"3'-azido-2',3'dideoxyuridine",Azdu,1989-11-20,Treatment of acquired immunodeficiency syndrome.,Designated/Withdrawn,,,N/A,N/A,"Berlex Laboratories, Inc.",1401 Harbor Bay Parkway,,Alameda,California,94501,USA,39889,1989,
Human T-lymphotropic virus type III Gp160 antigens,Vaxsyn Hiv-1,1989-11-20,Treatment of AIDS.,Designated,,,N/A,N/A,"MicroGeneSys, Inc.",1000 Research Parkway,,Meriden,Connecticut,6450,USA,40989,1989,
Recombinant soluble human CD4,Receptin,1989-11-20,Treatment of acquired immunodeficiency syndrome.,Designated/Withdrawn,,,N/A,N/A,"Biogen, Inc.",14 Cambridge Center,,Cambridge,Massachusetts,2142,USA,38989,1989,
CD4 human truncated 369 AA polypeptide,Soluble T4,1989-11-21,Treatment of acquired immunodeficiency syndrome.,Designated/Withdrawn,,,N/A,N/A,SmithKline Beecham,"Route 23 & Woodmont Ave., P.O. Box 1510",,King Of Prussia,Pennsylvania,19406,USA,38889,1989,
Human immunodeficiency virus immune globulin,n/a,1989-11-21,Treatment of AIDS.,Designated/Withdrawn,,,N/A,N/A,NABI,"5800 Park of Commerce Blvd., NW",,Boca Raton,Florida,33487,USA,37489,1989,
Corticorelin ovine triflutate,Acthrel,1989-11-24,For use in differentiating pituitary and ectopic production of ACTH in patients with ACTH-dependent Cushings syndrome.,Designated/Approved,Approved for Orphan Indication,To differentiate between pituitary and ectopic production of ACTH in patients with ACTH-dependent Cushing's syndrome.,1996-05-23,2003-05-23,"Ferring Laboratories, Inc.","400 Rella Boulevard, Suite 201",,Suffern,New York,10901,USA,35089,1989,2372
Bethanidine sulfate,n/a,1989-11-24,Prevention of recurrence of primary ventricular fibrillation.,Designated/Withdrawn,,,N/A,N/A,"Medco Research, Inc.",8455 Beverly Blvd.,Suite 308,Los Angeles,California,90048,USA,32588,1989,
Perfosfamide,Pergamid,1989-12-04,"For use in the ex-vivo treatment of autologous bone marrow and subsequent reinfusion in patients with acute myelogenous leukemia, also referred to as acute nonlymphocytic leukemia.",Designated/Withdrawn,,,N/A,N/A,"Scios Nova, Inc.",2450 Bayshore Parkway,,Mountain View,California,94043,USA,37789,1989,
Granulocyte macrophage-colony stimulating factor,Leucomax,1989-12-12,Treatment of neutropenia associated with bone marrow transplants.,Designated/Withdrawn,,,N/A,N/A,Schering Corporation,2000 Galloping Hill Road,,Kenilworth,New Jersey,7033,USA,41389,1989,
Multi-vitamin infusion (neonatal formula),n/a,1989-12-12,For establishment and maintenance of total parenteral nutrition in very low birth weight infants.,Designated,,,N/A,N/A,"Astra Pharmaceuticals, L.P.",725 Chesterbrook Blvd.,,Wayne,Pennsylvania,19087,USA,41789,1989,
polifeprosan 20 with carmustine,Gliadel,1989-12-13,Treatment of malignant glioma.,Designated/Approved,Approved for Orphan Indication,As an adjunct to surgery to prolong survival in patients with recurrent glioblastoma multiforme for whom surgical resection is indicated,1996-09-23,2003-09-23,"Guilford Pharmaceuticals, Inc.",6611 Tributary Street,,Baltimore,Maryland,21224,USA,37089,1989,2476
polifeprosan 20 with carmustine,Gliadel,1989-12-13,Treatment of malignant glioma.,Designated/Approved,Approved for Orphan Indication,Expanding the indication to include patients with malignant glioma undergoing primary surgical resection.,2003-02-25,2010-02-25,"Guilford Pharmaceuticals, Inc.",6611 Tributary Street,,Baltimore,Maryland,21224,USA,37089,1989,4822
4-aminosalicylic acid,"Pamisyl (P-D), Rezipas (Squibb)",1989-12-13,Treatment of mild to moderate ulcerative colitis in patients intolerant to sulfasalazine.,Designated,,,N/A,N/A,"Beeken, Warren M.D.",University Of Vermont,Given C-317,Burlington,Vermont,5405,USA,37989,1989,
Carbovir,n/a,1989-12-13,Treatment of persons with AIDS and in patients with symptomatic HIV infection and a CD4 count less than 200/mm3.,Designated/Withdrawn,,,N/A,N/A,Glaxo Wellcome Inc.,5 Moore Drive,,Research Triangle Park,North Carolina,27709,USA,41189,1989,
Rifabutin,Mycobutin,1989-12-18,Prevention of disseminated Mycobacterium avium complex disease in patients with advanced HIV infection.,Designated/Approved,Approved for Orphan Indication,Prevention of disseminated Mycobacterium avium complex disease in patients with advanced HIV infections.,1992-12-23,1999-12-23,"Adria Laboratories, Inc.",P.O. Box 16529,,Columbus,Ohio,43216,USA,41989,1989,1101
Rifabutin,n/a,1989-12-18,Treatment of disseminated Mycobacterium avium complex disease.,Designated,,,N/A,N/A,Pfizer Inc.,235 East 42nd Street,,New York,New York,10017,USA,41889,1989,
Melanoma vaccine,Melacine,1989-12-20,Treatment of stage III - IV melanoma.,Designated,,,N/A,N/A,"Ribi ImmunoChem Research, Inc.",533 Old Corvallis Road,,Hamilton,Montana,59840,USA,41589,1989,
PEG-interleukin-2,n/a,1990-02-01,Treatment of primary immunodeficiencies associated with T-cell defects.,Designated,,,N/A,N/A,Chiron Corporation,4560 Horton Street,,Emeryville,California,94608,USA,42589,1990,
Ricin (blocked) conjugated murine MCA (anti-my9),n/a,1990-02-01,For use in the ex-vivo treatment of autologous bone marrow and subsequent reinfusion in patients with acute myelogenous leukemia.,Designated/Withdrawn,,,N/A,N/A,"ImmunoGen, Inc.",830 Winter Street,,Waltham,Massachusetts,2451,USA,42489,1990,
Dynamine,n/a,1990-02-05,Treatment of Lambert Eaton myasthenic syndrome.,Designated,,,N/A,N/A,Mayo Foundation,200 First Street Southwest,,Rochester,Minnesota,55905,USA,43189,1990,
Interleukin-2,Teceleukin,1990-02-05,Treatment of metastatic renal cell carcinoma.,Designated,,,N/A,N/A,"Hoffmann-La Roche, Inc.",340 Kingsland Street,,Nutley,New Jersey,7110,USA,36289,1990,
Indium In-111 altumomab pentetate,Hybri-Ceaker,1990-02-06,Detection of suspected and previously unidentified tumor foci of recurrent colorectal carcinoma.,Designated/Withdrawn,,,N/A,N/A,"Hybritech, Inc.",11095 Torreyanna Road,,San Diego,California,92196,USA,10085,1990,
Interleukin-2,Teleleukin,1990-02-06,Treatment of metastatic malignant melanoma.,Designated,,,N/A,N/A,"Hoffmann-La Roche, Inc.",340 Kingsland Street,,Nutley,New Jersey,7119,USA,36389,1990,
Sermorelin acetate,Geref,1990-02-13,Adjunct to gonadotropin therapy in the induction of ovulation in women with anovulatory or oligo-ovulatory infertility who fail to ovulate in response to adequate treatment with clomiphene citrate alone and gonadotropin therapy alone.,Designated/Withdrawn,,,N/A,N/A,"EMD Serono, Inc.",One Technology Place,,Rockland,Massachusetts,2370,USA,31988,1990,
Glyceol,n/a,1990-02-22,To decrease intracranial hypertension and/or alleviate cerebral edema in patients who may benefit from osmotherapy.,Designated/Withdrawn,,,N/A,N/A,"Chugai Pharmaceutical Co., Ltd.",,,,,,,28188,1990,
Poloxamer 188,Florcor,1990-02-22,Treatment of severe burns requiring hospitalization.,Designated,,,N/A,N/A,CytRx Corporation,154 Technology Parkway,,Norcross,Georgia,30092,USA,40389,1990,
Disaccharide tripeptide glycerol dipalmitoyl,Immther,1990-03-01,Treatment of pulmonary and hepatic metastases in patients with colorectal adenocarcinoma.,Designated,,,N/A,N/A,"ImmunoTherapeutics, Inc.",3505 Riverview Circle,,Moorhead,Minnesota,56560,USA,39789,1990,
Dextran 70,Dehydrex,1990-03-05,Treatment of recurrent corneal erosion unresponsive to conventional therapy.,Designated,,,N/A,N/A,"Holles Laboratories, Inc.",30 Forest Notch,,Cohasset,Massachusetts,2025,USA,42689,1990,
Disodium clodronate tetrahydrate,Bonefos,1990-03-05,Treatment of increased bone resorption due to malignancy.,Designated,,,N/A,N/A,"Anthra Pharmaceuticals, Inc.","103 Carnegie Center, Suite 102",,Princeton,New Jersey,8540,USA,40689,1990,
Thalidomide,n/a,1990-03-05,Treatment of graft versus host disease.,Designated,,,N/A,N/A,Andrulis Research Corporation,"11800 Baltimore Avenue, Suite 113",,Beltsville,Maryland,20705,USA,43790,1990,
Thalidomide,n/a,1990-03-05,Prevention of graft versus host disease.,Designated,,,N/A,N/A,Andrulis Research Corporation,"11800 Baltimore Avenue, Suite 113",,Beltsville,Maryland,20705,USA,43890,1990,
Monoclonal antibodies PM-81 and AML-2-23,n/a,1990-03-12,For the exogenous depletion of CD14 and CD15 positive acute myeloid leukemic bone marrow cells from patients undergoing bone marrow transplantation.,Designated/Withdrawn,,,N/A,N/A,"Medarex, Inc.",519 Route 173 West,,Bloomsbury,New Jersey,8804,USA,39689,1990,
Sucralfate suspension,n/a,1990-03-12,Treatment of oral complications of chemotherapy in bone marrow transplant patients.,Designated,,,N/A,N/A,"Darby Pharmaceuticals, Inc.",100 Banks Avenue,,Rockville Centre,New York,11570,USA,41089,1990,
N-acetylprocainamide,Napa,1990-03-23,To lower the defibrillation energy requirement sufficiently to allow automatic implantable cardioverter defibrillator therapy in those patients who could otherwise not use the device.,Designated/Withdrawn,,,N/A,N/A,"Medco Research, Inc.",8455 Beverly Blvd.,Suite 308,Los Angeles,California,90048,USA,35989,1990,
Fluorouracil,n/a,1990-04-18,"For use in combination with interferon alpha-2a, recombinant, for the treatment of advanced colorectal carcinoma.",Designated,,,N/A,N/A,"Hoffmann-La Roche, Inc.",340 Kingsland Street,,Nutley,New Jersey,7110,USA,42289,1990,
chelmab-y or chelamusab-Y,Oncorad Ov103,1990-04-24,Treatment of ovarian cancer.,Designated,,,N/A,N/A,Cytogen Corporation,600 College Road East,,Princeton,New Jersey,8540,USA,41689,1990,
Anti-cytomegalovirus monoclonal antibodies,n/a,1990-05-02,1. Treatment of human cytomegalovirus infection in bone marrow and organ transplant patients 2. Prevention of human cytomegalovirus infection in bone marrow and organ transplant patients,Designated/Withdrawn,,,N/A,N/A,Biomedical Research Institute,345 North Smith Avenue,,St. Paul,Minnesota,55102,USA,40489,1990,
Interferon alfa-2a (recombinant),Roferon-A,1990-05-02,For the concomitant administration with Teceleukin for the treatment of metastatic renal cell carcinoma.,Designated,,,N/A,N/A,"Hoffmann-La Roche, Inc.",340 Kingsland Street,,Nutley,New Jersey,7119,USA,44590,1990,
sargramostim,Leukine,1990-05-03,"Treatment of neutropenia associated with bone marrow transplant, for the treatment of graft failure and delay of engraftment, and for the promotion of early engraftment.",Designated/Approved,Approved for Orphan Indication,,1991-03-05,1998-03-05,Immunex Corporation,51 University Street,,Seattle,Washington,98101,USA,44290,1990,306
Anti-cytomegalovirus monoclonal antibodies,n/a,1990-05-03,1. Treatment of human cytomegalovirus infection in patients diagnosed with AIDS 2. Prevention of human cytomegalovirus infection in patients diagnosed with AIDS,Designated/Withdrawn,,,N/A,N/A,Biomedical Research Institute,345 North Smith Avenue,,St. Paul,Minnesota,55102,USA,41489,1990,
Granulocyte macrophage-colony stimulating factor,Leucomax,1990-05-03,Treatment of neutropenia due to hairy cell leukemia.,Designated/Withdrawn,,,N/A,N/A,Schering Corporation,2000 Galloping Hill Road,,Kenilworth,New Jersey,7033,USA,41289,1990,
Interleukin-2,Teceleukin,1990-05-03,In combination with interferon alfa-2a for the treatment of metastatic renal cell carcinoma.,Designated,,,N/A,N/A,"Hoffmann-La Roche, Inc.",340 Kingsland Street,,Nutley,New Jersey,7119,USA,44490,1990,
Granulocyte macrophage-colony stimulating factor,Leucomax,1990-05-04,Treatment of chronic lymphocytic leukemia to increase granulocyte count.,Designated/Withdrawn,,,N/A,N/A,Schering Corporation,2000 Galloping Hill Road,,Kenilworth,New Jersey,7033,USA,43289,1990,
Interferon alfa-2b (recombinant),Intron A,1990-05-04,Treatment of chronic delta hepatitis.,Designated/Withdrawn,,,N/A,N/A,Schering Corporation,2000 Galloping Hill Road,,Kenilworth,New Jersey,7033,USA,40289,1990,
Somatropin,Humatrope,1990-05-08,Treatment of short stature associated with Turner syndrome.,Designated/Approved,Approved for Orphan Indication,Treatment of short stature associated with Turner syndrome in patients whose epiphyses are not closed.,1996-12-30,2003-12-30,Eli Lilly and Company,Lilly Corporate Center,,Indianapolis,Indiana,46285,USA,45090,1990,2428
Group B streptococcus immune globulin,n/a,1990-05-08,Treatment of neonates for disseminated group B streptococcal infection.,Designated/Withdrawn,,,N/A,N/A,"North American Biologicals, Inc.",12280 Wilkins Avenue,,Rockville,Maryland,20852,USA,44190,1990,
Interferon alfa-2a (recombinant),Roferon-A,1990-05-11,For the treatment of metastatic malignant melanoma in combination with Teceleukin.,Designated,,,N/A,N/A,"Hoffmann-La Roche, Inc.",340 Kingsland Street,,Nutley,New Jersey,7119,USA,44690,1990,
Interleukin-2,Teceleukin,1990-05-11,In combination with interferon alfa-2a for the treatment of metastatic malignant melanoma.,Designated,,,N/A,N/A,"Hoffmann-La Roche, Inc.",340 Kingsland Street,,Nutley,New Jersey,7119,USA,44790,1990,
Iloprost solution for infusion,n/a,1990-05-14,Treatment of heparin-associated thrombocytopenia.,Designated/Withdrawn,,,N/A,N/A,"Berlex Laboratories, Inc.",300 Fairfield Road,,Wayne,New Jersey,7470,USA,40089,1990,
Interferon alfa-2a (recombinant),Roferon-A,1990-05-14,For the concomitant administration with fluorouracil for the treatment of advanced colorectal cancer.,Designated,,,N/A,N/A,"Hoffmann-La Roche, Inc.",340 Kingsland Street,,Nutley,New Jersey,7110,USA,42389,1990,
His-D-Trp-Ala-Trp-D-Phe-Lys NH2,n/a,1990-05-23,For the long term treatment of children who have growth failure due to a lack of adequate endogenous growth hormone secretion.,Designated/Withdrawn,,,N/A,N/A,SmithKline Beecham Pharmaceuticals,One Franklin Plaza,,Philadelphia,Pennsylvania,19101,USA,46190,1990,
PR-239 (redox penicillin G),n/a,1990-05-23,Treatment of AIDS associated neurosyphilis.,Designated/Withdrawn,,,N/A,N/A,Pharmos,2 Innovation Drive,,Alachua,Florida,32615,USA,37689,1990,
PR-225 (redox-acyclovir),n/a,1990-05-29,Treatment of herpes simplex encephalitis in individuals afflicted with AIDS.,Designated/Withdrawn,,,N/A,N/A,Pharmos,2 Innovation Drive,,Alachua,Florida,32615,USA,37589,1990,
Short chain fatty acid solution,Colomed,1990-05-29,Treatment of the active phase of ulcerative colitis with involvement restricted to the left side of the colon.,Designated,,,N/A,N/A,Richard I. Breuer,"1000 Central Street, Suite 615",,Evanston,Illinois,60201,USA,44890,1990,
Amifostine,Ethyol,1990-05-30,For use as a chemoprotective agent for cisplatin in the treatment of advanced ovarian carcinoma.,Designated/Approved,Approved for Orphan Indication,To reduce the cumulative renal toxicity associated with repeated administration of cisplatin in patients with advanced ovarian cancer.,1995-12-08,2002-12-08,"Medimmune Oncology, Inc.",One Tower Bridge,"100 Front St., Suite 400",West Conshohocken,Pennsylvania,19428,USA,42789,1990,2018
Amifostine,Ethyol,1990-05-30,For use as a chemoprotective agent for cyclophosphamide in the treatment of advanced ovarian carcinoma.,Designated,,,N/A,N/A,Clinigen Group plc,"Pitcairn House, Crown Square",DE14 2WW,,,,United Kingdom,42889,1990,
Amifostine,Ethyol,1990-05-30,For use as a chemoprotective agent for cisplatin in the treatment of metastatic melanoma.,Designated,,,N/A,N/A,Clinigen Group plc,"Pitcairn House, Crown Square",DE14 2WW,,,,United Kingdom,42989,1990,
Calcium carbonate,R & D Calcium Carbonate/600,1990-06-06,Treatment of hyperphosphatemia in patients with end stage renal disease.,Designated,,,N/A,N/A,"R & D Laboratories, Inc.",4204 Glencoe Avenue,,Marina Del Rey,California,90292,USA,42189,1990,
Sodium dichloroacetate,n/a,1990-06-11,Treatment of congenital lactic acidosis,Designated,,,N/A,N/A,"Stacpoole, Peter W. M.D., Ph.D.",University of Florida,P.O. Box 100277,Gainesville,Florida,32610,USA,45290,1990,
Sodium dichloroacetate,n/a,1990-06-11,Treatment of homozygous familial hypercholesterolemia.,Designated,,,N/A,N/A,"Stacpoole, Peter W. M.D., Ph.D.",University of Florida,P.O. Box 100277,Gainesville,Florida,32610,USA,45390,1990,
Coagulation Factor IX (human),Alphanine,1990-07-05,"For use as replacement therapy in patients with hemophilia B for the prevention and control of bleeding episodes, and during surgery to correct defective hemostasis.",Designated/Approved,Approved for Orphan Indication,,1990-12-31,1997-12-31,Alpha Therapeutic Corporation,5555 Valley Boulevard,,Los Angeles,California,90032,USA,45890,1990,179
Oxandrolone,Oxandrin,1990-07-05,Treatment of short stature associated with Turner's syndrome.,Designated/Withdrawn,,,N/A,N/A,Bio-Technology General Corp.,"70 Wood Avenue, South",,Iselin,New Jersey,8830,USA,45590,1990,
Pr-122 (redox-phenytoin),n/a,1990-07-05,"For the emergency rescue treatment of status epilepticus, grand mal type.",Designated/Withdrawn,,,N/A,N/A,Pharmos,2 Innovation Drive,,Alachua,Florida,32615,USA,43490,1990,
Gentamicin liposome injection,Maitec,1990-07-10,Treatment of disseminated Mycobacterium avium-intracellulare infection.,Designated,,,N/A,N/A,"Liposome Company, Inc.",One Research Way,,Princeton,New Jersey,8540,USA,47390,1990,
Morphine sulfate concentrate (preservative free),Infumorph,1990-07-12,For use in microinfusion devices for intraspinal administration in the treatment of intractable chronic pain.,Designated/Approved,Approved for Orphan Indication,For intrathecal or epidural infusion in the treatment of tractable chronic pain. It was developed for use in continuous microinfusion devices and may require dilution before use as directed.,1991-07-19,1998-07-19,"Elkins-Sinn, Inc.",2 Esterbrook Lane,,Cherry Hill,New Jersey,8003,USA,18587,1990,372
L-baclofen,n/a,1990-07-13,Treatment of trigeminal neuralgia.,Designated,,,N/A,N/A,"Fromm, Gerhard M.D.",University Of Pittsburgh School of Medicine,,Pittsburgh,Pennsylvania,15261,USA,45690,1990,
Mafenide acetate solution,Sulfamylon Solution,1990-07-18,For use as an adjunctive topical antimicrobial agent to control bacterial infection when used under moist dressings over meshed autografts on excised burn wounds.,Designated/Approved,Approved for Orphan Indication,,1998-06-05,2005-06-05,"Mylan Laboratories, Inc.",781 Chestnut Ridge Road,P.O. Box 4310,Morgantown,West Virginia,26504,USA,47890,1990,2879
Amiloride HCl solution for inhalation,n/a,1990-07-18,Treatment of cystic fibrosis.,Designated/Withdrawn,,,N/A,N/A,Glaxo Wellcome Research and Development,5 Moore Drive,PO Box 13398,Research Triangle Park,North Carolina,27709,USA,48190,1990,
Alpha-galactosidase A,Fabrase,1990-07-20,Treatment of Fabry's disease.,Designated,,,N/A,N/A,"Desnick, Robert J. M.D.",The Mount Sinai School Of Medicine,"Fifth Avenue at 100th Street, Box 1203",New York,New York,10029,USA,47190,1990,
Cladribine,Leustatin,1990-07-20,Treatment of acute myeloid leukemia.,Designated/Withdrawn,,,N/A,N/A,"Janssen Research & Development, LLC",920 US Highway 202,,Raritan,New Jersey,8869,USA,47990,1990,
Pr-320 (molecusol-carbamazepine),n/a,1990-07-20,"For the emergency rescue treatment of status epilepticus, grand mal type.",Designated/Withdrawn,,,N/A,N/A,Pharmos,2 Innovation Drive,,Alachua,Florida,32615,USA,43590,1990,
Liothyronine sodium injection,Triostat,1990-07-30,Treatment of myxedema coma/precoma.,Designated/Approved,Approved for Orphan Indication,Treatment of myxedema coma/precoma.,1991-12-31,1998-12-31,SmithKline Beecham Pharmaceuticals,One Franklin Plaza,,Philadelphia,Pennsylvania,19101,USA,46090,1990,519
Triptorelin pamoate,Decapeptyl Injection,1990-08-10,For use in the palliative treatment of advanced ovarian carcinoma of epithelial origin.,Designated/Withdrawn,,,N/A,N/A,Debio R.A. Inc.,"7929 Westpark Drive, Suite 400",,Mclean,Virginia,22102,USA,34688,1990,
C1-inhibitor,"C1-Inhibitor (Human) Vapor Heated, Immuno",1990-08-30,"Prevention of acute attacks of angioedema, including short-term prophylaxis for patients requiring dental or other surgical procedures.",Designated/Withdrawn,,,N/A,N/A,Baxter Healthcare Corp.,One Baxter Way,,Westlake Village,California,91362,USA,46590,1990,
C1-inhibitor,"C1-Inhibitor (Human) Vapor Heated, Immuno",1990-08-30,Treatment of acute attacks of angioedema.,Designated/Withdrawn,,,N/A,N/A,Baxter Healthcare Corp.,One Baxter Way,,Westlake Village,California,91362,USA,46490,1990,
Filgrastim,Neupogen,1990-08-30,Treatment of myelodysplastic syndrome,Designated/Withdrawn,,,N/A,N/A,"Amgen, Inc.",1840 Dehavilland Drive,,Thousand Oaks,California,91320,USA,49090,1990,
Recombinant human CD4 immunoglobulin G,n/a,1990-08-30,Treatment of AIDS resulting from infection with HIV-1.,Designated,,,N/A,N/A,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,USA,44090,1990,
Atovaquone,Mepron,1990-09-10,Treatment of AIDS associated Pneumocystis Carinii Pneumonia.,Designated/Approved,Approved for Orphan Indication,For the acute oral treatment of mild to moderate Pneumocystis carinii pneumonia in patients who are intolerant to trimethoprim-sulfamethoxazole.,1992-11-25,1999-11-25,Glaxo Wellcome Inc.,5 Moore Drive,,Research Triangle Park,North Carolina,27709,USA,48890,1990,807
Anti-CD45 monoclonal antibodies,n/a,1990-09-10,Prevention of acute graft rejection of human organ transplants.,Designated/Withdrawn,,,N/A,N/A,Baxter Healthcare Corporation,1620 Waukegan Road,,Mcgaw Park,Illinois,60085,USA,48390,1990,
Calcium gluconate gel 2.5%,n/a,1990-09-10,Emergency topical treatment of hydrogen fluoride (hydrofluoric acid) burns.,Designated,,,N/A,N/A,"Paddock Laboratories, Inc.",3940 Quebec Avenue North,,Minneapolis,Minnesota,55427,USA,46290,1990,
Sulfapyridine,n/a,1990-09-10,Treatment of dermatitis herpetiformis.,Designated,,,N/A,N/A,Jacobus Pharmaceutical Company,37 Cleveland Avenue,P.O. Box 5290,Princeton,New Jersey,8540,USA,51090,1990,
Lactobin,Lactobin,1990-09-12,Treatment of AIDS-associated diarrhea unresponsive to initial antidiarrheal therapy.,Designated/Withdrawn,,,N/A,N/A,"Roxane Laboratories, Inc.",PO Box 16532,,Columbus,Ohio,43216,USA,46990,1990,
Leupeptin,n/a,1990-09-18,For use as an adjunct to microsurgical peripheral nerve repair.,Designated,,,N/A,N/A,"Neuromuscular Adjuncts, Inc.",S.U.N.Y. at Stony Brook,H.S.C. T18-020,Stony Brook,New York,11794,USA,49690,1990,
Pilocarpine,Salagen,1990-09-24,Treatment of xerostomia induced by radiation therapy for head and neck cancer.,Designated/Approved,Approved for Orphan Indication,Treatment of symptoms of xerostomia from salivary gland hypofunction caused by radiotherapy for cancer of the head and neck.,1994-03-22,2001-03-22,"MGI Pharma, Inc.",5775 West Old Shakopee Rd.,Suite 100,Bloomington,Minnesota,55437,USA,45990,1990,1275
Respiratory syncytial virus immune globulin (Human),Respigam,1990-09-27,Prophylaxis of respiratory syncytial virus lower respiratory tract infections in infants and young children at high risk of RSV disease.,Designated/Approved,Approved for Orphan Indication,For the prevention of serious lower respiratory tract infections caused by RSV in children less than 24 months of age with bronchopulmonary dysplasia or a history of prematurity (less than or equal to 35 weeks gestation).,1996-01-18,2003-01-18,MedImmune & Massachussetts Public Health Biologics Labs.,35 West Watkins Mill Road,,Gaithersburg,Maryland,20878,USA,51190,1990,1939
Respiratory Syncytial Virus Immune Globulin (human),Hypermune Rsv,1990-09-27,Treatment of respiratory syncytial virus lower respiratory tract infections in hospitalized infants and young children.,Designated,,,N/A,N/A,"MedImmune, Inc.",35 West Watkins Mill Road,,Gaithersburg,Maryland,20878,USA,51290,1990,
Filgrastim,Neupogen,1990-10-01,Treatment of neutropenia associated with bone marrow transplants.,Designated/Approved,Approved for Orphan Indication,Reduce the duration of neutropenia and neutropenia sequelae in patients with non-myeloid malignancies undergoing ablative chemotherapy followed by BMT.,1994-06-15,2001-06-15,"Amgen, Inc.",1840 Dehavilland Drive,,Thousand Oaks,California,91320,USA,50090,1990,1353
Hydroxyurea,Droxia,1990-10-01,Treatment of patients with sickle cell anemia as shown by the presence of hemoglobin S.,Designated/Approved,Approved for Orphan Indication,To reduce the frequency of painful crises and to reduce the need for blood transfusions in adult patients with sickle cell anemia with recurrent moderate to severe painful crises (generally at least 3 during the preceding 12 months).,1998-02-25,2005-02-25,Bristol-Myers Squibb Pharmaceutical Research Institute,P.O. Box 4000,,Princeton,New Jersey,8543,USA,49590,1990,2704
"Dextran sulfate (inhaled, aerosolized)",Uendex,1990-10-05,For use as an adjunct to the treatment of cystic fibrosis.,Designated,,,N/A,N/A,"Kennedy & Hoidal, M.D.'s",University of Utah Health Sciences Center,"50 North Medical Drive, Room 4R240",Salt Lake City,Utah,84132,USA,50690,1990,
Oxandrolone,n/a,1990-10-05,Treatment of constitutional delay of growth and puberty.,Designated/Withdrawn,,,N/A,N/A,Bio-Technology General Corp.,"70 Wood Avenue, South",,Iselin,New Jersey,8830,USA,45790,1990,
Methotrexate with laurocapram,Methotrexate/Azone,1990-10-15,Topical treatment of mycosis fungoides.,Designated,,,N/A,N/A,"Echo Therapeutics, Ltd.",8 Penn Center,1628 JFK Blvd,Philadelphia,Pennsylvania,19103,USA,43389,1990,
Taxol isolated from Taxus brevifolia,n/a,1990-10-15,Treatment of ovarian cancer.,Designated/Withdrawn,,,N/A,N/A,Bristol-Myers Squibb,5 Research Parkway,,Wallingford,Connecticut,6492,USA,50190,1990,
Gossypol,n/a,1990-10-22,Treatment of cancer of the adrenal cortex.,Designated,,,N/A,N/A,"Reidenberg, Marcus M. M.D.",The New York Hospital - Cornell Medical Center,"525 East 68th Street, Box 70",New York,New York,10021,USA,46390,1990,
Tretinoin,Vesanoid,1990-10-24,Treatment of acute promyelocytic leukemia.,Designated/Approved,Approved for Orphan Indication,Induction of remission in patients with acute promyelocytic leukemia who are refractory to or unable to tolerate anthracycline based cytotoxic chemotherapeutic regimens.,1995-11-22,2002-11-22,"Hoffmann-La Roche, Inc.",340 Kingsland Street,,Nutley,New Jersey,7110,USA,50990,1990,1855
Calcitonin salmon nasal spray,Miacalcin Nasal Spray,1990-10-29,Treatment of symptomatic Paget's disease (osteitis deformans).,Designated/Withdrawn,,,N/A,N/A,Sandoz Pharmaceuticals Corp.,59 Route 10,,East Hanover,New Jersey,7936,USA,48290,1990,
Succimer,Chemet,1990-11-05,Prevention of cystine kidney stone formation in patients with homozygous cystinuria who are prone to stone development.,Designated,,,N/A,N/A,"Sanofi Winthrop, Inc.",90 Park Avenue,,New York,New York,10016,USA,50790,1990,
Filgrastim,Neupogen,1990-11-07,Treatment of patients with severe chronic neutropenia (absolute neutrophil count less than 500/mm3).,Designated/Approved,Approved for Orphan Indication,Treatment of patients with severe chronic neutropenia.,1994-12-19,2001-12-19,"Amgen, Inc.",1840 Dehavilland Drive,,Thousand Oaks,California,91320,USA,49390,1990,1503
Mucoid exopolysaccharide Pseudomonas hyperimmune globulin,Mep Igiv,1990-11-07,Prevention of pulmonary infections due to Pseudomonas aeruginosa in patients with cystic fibrosis.,Designated/Withdrawn,,,N/A,N/A,"North American Biologicals, Inc.",12280 Wilkins Avenue,,Rockville,Maryland,20852,USA,50490,1990,
Cladribine,Leustatin Injection,1990-11-15,Treatment of hairy cell leukemia.,Designated/Approved,Approved for Orphan Indication,,1993-02-26,2000-02-26,R. W. Johnson Pharmaceutical Research Institute,"Route 202, P.O. Box 300",,Raritan,New Jersey,8869,USA,51690,1990,834
Microbubble contrast agent,Filmix Neurosonographic Contrast Agent,1990-11-16,Intraoperative aid in the identification and localization of intracranial tumors.,Designated,,,N/A,N/A,"Cav-Con, Inc.",55 Knollwood Road,,Farmington,Connecticut,6032,USA,48790,1990,
Bovine colostrum,n/a,1990-11-19,Treatment of AIDS-related diarrhea.,Designated,,,N/A,N/A,"Hastings, Donald DVM",1030 North Parkview Drive,,Bismarck,North Dakota,58501,USA,55190,1990,
levoleucovorin,Fusilev,1990-12-18,For use in combination chemotherapy with the approved agent 5-fluorouracil in the palliative treatment of metastatic adenocarcinoma of the colon and rectum,Designated/Approved,Approved for Orphan Indication,For use in combination chemotherapy with 5-fluorouracil in the palliative treatment of patients with advanced metastatic colorectal cancer,2011-04-29,2018-04-29,"Spectrum Pharmaceuticals, Inc.",157 Technology Drive,,Irvine,California,92618,USA,48590,1990,7437
"3,4-diaminopyridine",n/a,1990-12-18,Treatment of Lambert-Eaton myasthenic syndrome.,Designated,,,N/A,N/A,Jacobus Pharmaceutical Company,37 Cleveland Avenue,P.O. Box 5290,Princeton,New Jersey,8540,USA,51590,1990,
cladribine,n/a,1990-12-31,Treatment of chronic lymphocytic leukemia,Designated/Withdrawn,,,N/A,N/A,"Janssen Research & Development, LLC",Global Regulatory Affairs,920 US Route 202,Raritan,New Jersey,8869,USA,54190,1990,
Mucoid exopolysaccharide Pseudomonas hyperimmune globulin,Mep Igiv,1991-01-09,Treatment of pulmonary infections due to Pseudomonas aeruginosa in patients with cystic fibrosis.,Designated/Withdrawn,,,N/A,N/A,"North American Biologicals, Inc.",12280 Wilkins Avenue,,Rockville,Maryland,20852,USA,50590,1991,
Dronabinol,Marinol,1991-01-15,For the stimulation of appetite and prevention of weight loss in patients with a confirmed diagnosis of AIDS.,Designated/Approved,Approved for Orphan Indication,Treatment of anorexia associated with weight loss in patients with AIDS.,1992-12-22,1999-12-22,"Unimed Pharmaceuticals, Inc.",901 Sawyer Rd.,,Marietta,Georgia,30062,USA,54890,1991,707
Dornase alfa,Pulmozyme,1991-01-16,To reduce mucous viscosity and enable the clearance of airway secretions in patients with cystic fibrosis.,Designated/Approved,Approved for Orphan Indication,In conjunction with standard therapies in the management of cystic fibrosis patients to reduce the frequency of respiratory infections requiring parenteral antibiotics and to improve pulmonary function.,1993-12-30,2000-12-30,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,USA,48090,1991,1079
Testosterone sublingual,n/a,1991-01-16,Treatment of constitutional delay of growth and puberty in boys.,Designated/Withdrawn,,,N/A,N/A,Bio-Technology General Corp.,"70 Wood Avenue, South",,Iselin,New Jersey,8830,USA,52590,1991,
Desmopressin acetate,n/a,1991-01-22,Treatment of mild hemophilia A and von Willebrand's disease.,Designated/Approved,Approved for Orphan Indication,Treatment of patients with hemophilia A or von Willebrand's disease (type I) whose factor VIII coagulant activity level is greater than 5%.,1994-03-07,2001-03-07,"Ferring Pharmaceuticals, Inc.",100 Interpace Parkway,,Parsippany-Troy Hills,New Jersey,7054,USA,51490,1991,1140
Ricin (blocked) conjugated murine mca (anti-b4),n/a,1991-01-24,For the ex-vivo purging of leukemic cells from the bone marrow of non-T cell acute lymphocytic leukemia patients who are in complete remission.,Designated/Withdrawn,,,N/A,N/A,"ImmunoGen, Inc.",830 Winter Street,,Waltham,Massachusetts,2451,USA,49190,1991,
Cysteamine,Cystagon,1991-01-25,Treatment of nephropathic cystinosis.,Designated/Approved,Approved for Orphan Indication,Treatment of nephropathic cystinosis in adults and children.,1994-08-15,2001-08-15,"Mylan Laboratories, Inc.",781 Chestnut Ridge Road,P.O. Box 4310,Morgantown,West Virginia,26504,USA,55690,1991,1298
Ricin (blocked) conjugated murine MCA (n901),n/a,1991-01-25,Treatment of small cell lung cancer,Designated/Withdrawn,,,N/A,N/A,"ImmunoGen, Inc.",830 Winter Street,,Waltham,Massachusetts,2451,USA,52490,1991,
Cytomegalovirus immune globulin intravenous (human),n/a,1991-01-28,For use in conjunction with ganciclovir sodium for the treatment of cytomegalovirus pneumonia in bone marrow transplant patients.,Designated,,,N/A,N/A,Bayer Corporation,"Pharmaceutical Division, Biological Products",400 Morgan Lane,New Haven,Connecticut,6516,USA,52190,1991,
Pentostatin,Nipent,1991-01-29,Treatment of patients with chronic lymphocytic leukemia.,Designated,,,N/A,N/A,"SuperGen, Inc.","Two Annabel Lane, Suite 220",,San Ramon,California,94583,USA,50390,1991,
Gentamicin impregnated PMMA beads on surgical wire,Septopal,1991-01-31,"Treatment of chronic osteomyelitis of post-traumatic, postoperative, or hematogenous origin.",Designated,,,N/A,N/A,"Lipha Pharmaceuticals, Inc.",9 West 57th Street,Suite 3825,New York,New York,10019,USA,52090,1991,
Antivenom (crotalidae) purified (avian),n/a,1991-02-12,Treatment of envenomation by poisonous snakes belonging to the Crotalidae family.,Designated,,,N/A,N/A,"Ophidian Pharmaceuticals, Inc.",5445 East Cheryl Parkway,,Madison,Wisconsin,53711,USA,54690,1991,
Idarubicin HCl for injection,Idamycin,1991-02-12,Treatment of acute lymphoblastic leukemia in pediatric patients.,Designated/Withdrawn,,,N/A,N/A,"Pfizer, Inc.",235 East 42nd Street,,New York,New York,10017,USA,55890,1991,
Interferon beta (recombinant),R-Ifn-Beta,1991-02-12,For the systemic treatment of metastatic renal cell carcinoma.,Designated/Withdrawn,,,N/A,N/A,"Biogen, Inc.",14 Cambridge Center,,Cambridge,Massachusetts,2142,USA,53890,1991,
Ursodiol,Actigall,1991-02-19,Management of the clinical signs and symptoms associated with primary biliary cirrhosis.,Designated/Withdrawn,,,N/A,N/A,Novartis Pharmaceuticals Corporation,59 Route 10,,East Hanover,New Jersey,7936,USA,55390,1991,
Sucralfate suspension,n/a,1991-03-04,Treatment of oral ulcerations and dysphagia in patients with epidermolysis bullosa.,Designated,,,N/A,N/A,"Darby Pharmaceuticals, Inc.",100 Banks Avenue,,Rockville Centre,New York,11570,USA,47090,1991,
Dextran and deferoxamine,Bio-Rescue,1991-03-08,Treatment of acute iron poisoning.,Designated,,,N/A,N/A,"Biomedical Frontiers, Inc.",1095 10th Avenue S.E.,,Minneapolis,Minnesota,55414,USA,52290,1991,
Poloxamer 331,Protox,1991-03-21,Initial therapy of toxoplasmosis in patients with AIDS.,Designated,,,N/A,N/A,CytRx Corporation,154 Technology Parkway,,Norcross,Georgia,30092,USA,55990,1991,
Succimer,Chemet,1991-03-22,Treatment of mercury intoxication.,Designated,,,N/A,N/A,"Sanofi Winthrop, Inc.",90 Park Avenue,,New York,New York,10016,USA,50890,1991,
Ketoconazole,Nizoral,1991-03-27,For use with cyclosporine A to diminish the nephrotoxicity induced by cyclosporine in organ transplantation.,Designated/Withdrawn,,,N/A,N/A,Pharmedic Company,28101 Ballard Road,,Lake Forest,Illinois,60045,USA,51990,1991,
Recombinant secretory leucocyte protease inhibitor,n/a,1991-03-29,Treatment of cystic fibrosis.,Designated,,,N/A,N/A,"Amgen, Inc.",3200 Walnut Street,,Boulder,Colorado,80301,USA,55590,1991,
Recombinant secretory leucocyte protease inhibitor,n/a,1991-03-29,Treatment of congenital alpha-1 antitrypsin deficiency.,Designated/Withdrawn,,,N/A,N/A,Amgen Inc.,3200 Walnut Street,,Boulder,Colorado,80301,USA,55490,1991,
Interferon beta-1a (recombinant),R-Huifn-Beta,1991-04-03,For the systemic treatment of cutaneous malignant melanoma.,Designated/Withdrawn,,,N/A,N/A,"Biogen, Inc.",14 Cambridge Center,,Cambridge,Massachusetts,2142,USA,53290,1991,
ribavirin,Virazole,1991-04-12,Treatment of hemorrhagic fever with renal syndrome,Designated,,,N/A,N/A,Valeant Pharmaceuticals International,3300 Hyland Avenue,,Costa Mesa,California,92626,USA,57491,1991,
Ofloxacin,Ocuflox Ophthalmic Solution,1991-04-18,Treatment of bacterial corneal ulcers.,Designated/Approved,Approved for Orphan Indication,Treatment of bacterial corneal ulcers.,1996-05-22,2003-05-22,"Allergan, Inc.",2525 Dupont Drive,P.O. Box 19534,Irvine,California,92713,USA,56791,1991,1861
Interferon beta (recombinant),R-Huifn-Beta,1991-04-18,For the systemic treatment of cutaneous T-cell lymphoma.,Designated/Withdrawn,,,N/A,N/A,"Biogen, Inc.",14 Cambridge Center,,Cambridge,Massachusetts,2142,USA,53390,1991,
Recombinant human superoxide dismutase,Oxsodrol,1991-04-18,Prevention of bronchopulmonary dysplasia in premature neonates weighing less than 1500 grams.,Designated/Withdrawn,,,N/A,N/A,"Savient Pharmaceuticals, Inc.","One Tower Center Boulevard, 12th floor",,East Brunswick,New Jersey,8816,USA,54990,1991,
Etidronate disodium,Didronel Iv Infusion,1991-05-02,Treatment of degenerative metabolic bone disease occurring in patients who require long term (6 months or greater) total parenteral nutrition.,Designated/Withdrawn,,,N/A,N/A,"MGI Pharma, Inc.",6300 West Old Shakoppe Rd.,Suite 110,Bloomington,Minnesota,55438,USA,49790,1991,
Etidronate disodium,Didronel Iv Infusion,1991-05-02,Prevention of degenerative metabolic bone disease occurring in patients who require long term (6 months or greater) total parenteral nutrition.,Designated/Withdrawn,,,N/A,N/A,"MGI Pharma, Inc.",6300 West Old Shakoppe Rd.,Suite 110,Bloomington,Minnesota,55438,USA,49890,1991,
Histrelin,n/a,1991-05-03,"Treatment of acute intermittent porphyria, hereditary coproporphyria, and variegate porphyria.",Designated,,,N/A,N/A,"Anderson, Karl E., M.D.",University of Texas Medical Branch at Galveston,"Route J-09, 700 The Strand",Galveston,Texas,77550,USA,28488,1991,
Thymalfasin,Zadaxin,1991-05-03,Treatment of chronic active hepatitis B.,Designated,,,N/A,N/A,"SciClone Pharmaceuticals, Inc.",950 Tower Lane,Suite 900,Foster City,California,94404,USA,52990,1991,
Interferon beta (recombinant),R-Huifn-Beta,1991-05-09,For the intralesional and/or systemic treatment of AIDS-related Kaposi's sarcoma.,Designated/Withdrawn,,,N/A,N/A,"Biogen, Inc.",14 Cambridge Center,,Cambridge,Massachusetts,2142,USA,53590,1991,
Interleukin-3 human (recombinant),n/a,1991-05-20,Promotion of erythropoiesis in Diamond-Blackfan anemia (congenital pure red cell aplasia).,Designated/Withdrawn,,,N/A,N/A,Immunex Corporation,51 University Street,,Seattle,Washington,98101,USA,53490,1991,
Poly I: poly C12U,Ampligen,1991-05-20,Treatment of renal cell carcinoma.,Designated,,,N/A,N/A,"Hemispherx Biopharma, Inc.",1617 JFK Boulvard,Suite 500,Philadelphia,Pennsylvania,19103,USA,57091,1991,
Calcium gluconate gel,H-F Gel,1991-05-21,For use in the emergency topical treatment of hydrogen fluoride (hydrofluoric acid) burns.,Designated,,,N/A,N/A,Calgonate Corporation,3310 South Ocean Blvd,Unit 132,Highland Beach,Florida,33487,USA,6485,1991,
Fosphenytoin,Cerebyx,1991-06-04,For the acute treatment of patients with status epilepticus of the grand mal type.,Designated/Approved,Approved for Orphan Indication,For the control of generalized convulsive status epilepticus.,1996-08-05,2003-08-05,Warner-Lambert Company,2800 Plymouth Road,,Ann Arbor,Michigan,48106,USA,55790,1991,1889
Chimeric M-T412 (human-murine) IgG monoclonal anti-CD4,n/a,1991-06-05,Treatment of multiple sclerosis.,Designated/Withdrawn,,,N/A,N/A,"Centocor, Inc.",244 Great Valley Parkway,,Malvern,Pennsylvania,19355,USA,54490,1991,
Nifedipine,n/a,1991-06-13,Treatment of interstitial cystitis.,Designated,,,N/A,N/A,"Fleischmann, Jonathan M.D.",MetroHealth Medical Center,3395 Scranton Road,Cleveland,Ohio,44109,USA,57991,1991,
Alpha-galactosidase A,Cc-Galactosidase,1991-06-17,Treatment of alpha-galactosidase A deficiency (Fabry's disease).,Designated,,,N/A,N/A,"David Calhoun, Ph.D.",Department of Chemistry,Convent Avenue & 138th Street,New York,New York,10031,USA,58691,1991,
"Interleukin-1 alpha, human recombinant",n/a,1991-06-17,For hematopoietic potentiation in aplastic anemia.,Designated/Withdrawn,,,N/A,N/A,Immunex Corporation,51 University Street,,Seattle,Washington,98101,USA,57291,1991,
"Interleukin-1 alpha, human recombinant",n/a,1991-06-17,For the promotion of early engraftment in bone marrow transplantation.,Designated/Withdrawn,,,N/A,N/A,Immunex Corporation,51 University Street,,Seattle,Washington,98101,USA,57191,1991,
Monoclonal antibody to hepatitis B virus (human),n/a,1991-06-17,Prophylaxis of hepatitis B reinfection in patients undergoing liver transplantation secondary to end-stage chronic hepatitis B infection.,Designated/Withdrawn,,,N/A,N/A,"Protein Design Labs, Inc.",34801 Campus Dr.,,Fremont,California,94555,USA,58391,1991,
Ursodiol,Urso 250,1991-06-20,Treatment of patients with primary biliary cirrhosis,Designated/Approved,Approved for Orphan Indication,,1997-12-10,2004-12-10,"Aptalis Pharma US, Inc.",100 Somerset corporate Blvd,,Bridgewater,New Jersey,8807,USA,22187,1991,2365
Monoclonal antibody PM-81,n/a,1991-06-27,Adjunctive treatment of acute myelogenous leukemia.,Designated/Withdrawn,,,N/A,N/A,"Medarex, Inc.",519 Route 173 West,,Bloomsbury,New Jersey,8804,USA,58791,1991,
Myelin,n/a,1991-06-27,Treatment of multiple sclerosis.,Designated/Withdrawn,,,N/A,N/A,"AutoImmune, Inc.",128 Spring Street,,Lexington,Massachusetts,2173,USA,57791,1991,
Epoetin alfa,Epogen,1991-07-01,Treatment of anemia associated with HIV infection or HIV treatment.,Designated/Approved,Approved for Orphan Indication,Treatment of AZT-induced anemia in HIV infected patients.,1990-12-31,1997-12-31,"Amgen, Inc.",1840 Dehavilland Drive,,Thousand Oaks,California,91320,USA,56490,1991,-182
Testosterone propionate ointment 2%,n/a,1991-07-31,Treatment of vulvar dystrophies.,Designated,,,N/A,N/A,"Star Pharmaceuticals, Inc.",1990 N.W. 44th Street,,Pompano Beach,Florida,33064,USA,57691,1991,
Levoleucovorin,Fusilev,1991-08-01,For use in conjunction with high-dose methotrexate in the treatment of osteosarcoma.,Designated/Approved,Approved for Orphan Indication,Levoleucovorin rescue is indicated after high-dose methotrexate therapy in osteosarcoma. Levoleucovorin is also indicated to diminish the toxicity and counteract the effects of impaired methotrexate elimination and of inadvertent overdosage of folic acid antagonists,2008-03-07,2015-03-07,"Spectrum Pharmaceuticals, Inc.",157 Technology Drive,,Irvine,California,92618,USA,48490,1991,6063
cyclosporine 2% ophthalmic ointment,n/a,1991-08-01,"For use in corneal melting syndromes of known or presumed immunologic etiopathogenesis, including Mooren's ulcer",Designated,,,N/A,N/A,"Allergan, Inc.",2525 Dupont Drive,P. O. Box 19534,Irvine,California,92612,USA,58991,1991,
Cyclosporine 2% ophthalmic ointment,n/a,1991-08-01,Treatment of patients at high risk of graft rejection following penetrating keratoplasty,Designated,,,N/A,N/A,"Allergan, Inc.",2525 Dupont Drive,P. O. Box 19534,Irvine,California,92612,USA,51790,1991,
Mecasermin,Myotrophin,1991-08-05,Treatment of amyotrophic lateral sclerosis.,Designated/Withdrawn,,,N/A,N/A,"Teva Branded Pharmaceutical Products R&D, Inc.",41 Moores Road,,Frazer,Pennsylvania,19355,USA,59191,1991,
Tiratricol,Triacana,1991-08-13,For use in combination with levo-thyroxine to suppress thyroid stimulating hormone in patients with well-differentiated thyroid cancer who are intolerant to adequate doses of levo-thyroxine alone.,Designated,,,N/A,N/A,Laphal Laboratoires,"48 Bis, Rue des Belles-Feuilles",75116 Paris,,,,France,46890,1991,
Atovaquone,Mepron,1991-08-14,"Prevention of Pneumocystis carinii pneumonia (PCP) in high-risk, HIV-infected patients defined by a history of one or more episodes of PCP and/or a peripheral CD4+ (T4 helper/inducer) lymphocyte count less than or equal to 200/mm3.",Designated/Approved,Approved for Orphan Indication,Prevention of PCP in patients who are intolerant to trimethoprim-sulfamethoxazole.,1999-01-05,2006-01-05,Glaxo Wellcome Research and Development,5 Moore Drive,PO Box 13398,Research Triangle Park,North Carolina,27709,USA,48990,1991,2701
Filgrastim,Neupogen,1991-09-03,"Treatment of patients with AIDS who, in addition, are afflicted with cytomegalovirus retinitis and are being treated with ganciclovir",Designated/Withdrawn,,,N/A,N/A,"Amgen, Inc.",One Amgen Center Dr.,,Thousand Oaks,California,91320,USA,49990,1991,
Oxandrolone,Oxandrin,1991-09-06,Adjunctive therapy for AIDS patients suffering from HIV-wasting syndrome.,Designated,,,N/A,N/A,Bio-Technology General Corp.,70 Wood Avenue South,,Iselin,New Jersey,8830,USA,59091,1991,
Monoclonal antibody to cytomegalovirus (human),n/a,1991-09-13,Prophylaxis of cytomegalovirus disease in patients undergoing solid organ transplantation.,Designated/Withdrawn,,,N/A,N/A,"Protein Design Labs, Inc.",2375 Garcia Avenue,,Mountain View,California,94043,USA,59491,1991,
Toremifene,Fareston,1991-09-19,Hormonal therapy of metastatic carcinoma of the breast.,Designated/Approved,Approved for Orphan Indication,Treatment of metastatic breast cancer in postmenopausal women with estrogen positive or receptor unknown tumors.,1997-05-29,2004-05-29,Orion Corporation,Orionintie 1,0FI-02200 ESPOO,,,,Finland,60291,1991,2079
Exemestane,Aromasin,1991-09-19,Treatment of advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy.,Designated/Approved,Approved for Orphan Indication,Treatment of advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy.,1999-10-21,2006-10-21,Pharmacia & Upjohn,7000 Portage Road,Mail Stop: 0636-298-113,Kalamazoo,Michigan,49001,USA,60191,1991,2954
"Interleukin-1 receptor antagonist, human recombinant",Antril,1991-09-23,Treatment of juvenile rheumatoid arthritis.,Designated,,,N/A,N/A,Swedish Orphan Biovitrum AB (publ) (SOBI),SE-112 76,,Stockholm,,,Sweden,59991,1991,
Lodoxamide tromethamine,Alomide Ophthalmic Solution,1991-10-16,Treatment of vernal keratoconjunctivitis.,Designated/Approved,Approved for Orphan Indication,"Treatment of ocular disorders referred to by the terms vernal keratoconjunctivitis, vernal conjunctivitis, vernal keratitis.",1993-09-23,2000-09-23,"Alcon Laboratories, Inc.",6201 South Freeway,,Fort Worth,Texas,76134,USA,59791,1991,708
Dynamine,n/a,1991-10-16,Treatment of hereditary motor and sensory neuropathy type I (Charcot-Marie-Tooth disease).,Designated,,,N/A,N/A,Mayo Foundation,200 First Street Southwest,,Rochester,Minnesota,55905,USA,56090,1991,
Botulinum toxin type F,n/a,1991-10-24,Treatment of spasmodic torticollis (cervical dystonia).,Designated,,,N/A,N/A,Ipsen Limited,27 Maple Street,,Milford,Massachusetts,1757,USA,61091,1991,
Metronidazole,Metrogel,1991-10-24,Treatment of perioral dermatitis.,Designated,,,N/A,N/A,"Galderma Laboratories, Inc.",P.O. Box 331329,,Fort Worth,Texas,76163,USA,61891,1991,
"Synthetic derivative of 16-hydroxy-9Z, 12Z, 14E-octadecatrienoic acid",Drepanol,1991-10-24,Prophylactic treatment of sickle cell disease.,Designated,,,N/A,N/A,"Omex International, Inc.","6001 Savoy, Suite 110",,Houston,Texas,77036,USA,32288,1991,
Halofantrine,Halfan,1991-11-04,Treatment of mild to moderate acute malaria caused by susceptible strains of P. falciparum and P. vivax.,Designated/Approved,Approved for Orphan Indication,Treatment of adults who can tolerate oral medication and who have mild to moderate malaria caused by Plasmodium falciparum or Plasmodium vivax.,1992-07-24,1999-07-24,SmithKline Beecham Pharmaceuticals,One Franklin Plaza,P.O. Box 7929,Philadelphia,Pennsylvania,19101,USA,61791,1991,263
Pramiracetam Sulfate,n/a,1991-11-04,For the management of cognitive dysfunction and enhancement of antidepressant activity associated with electroconvulsive therapy.,Designated/Withdrawn,,,N/A,N/A,"Cambridge Neuroscience, Inc.","1 Kendall Square, Bldg. 700",,Cambridge,Massachusetts,2139,USA,61691,1991,
Imiglucerase,Cerezyme,1991-11-05,"Replacement therapy in patients with types I, II, and III Gaucher's disease.",Designated/Approved,Approved for Orphan Indication,Enzyme replacement therapy in patients with type I Gaucher's disease.,1994-05-23,2001-05-23,Genzyme Corporation,One Kendall Square,,Cambridge,Massachusetts,2139,USA,62491,1991,930
Somatropin for injection,Serostim,1991-11-15,Treatment of AIDS-associated catabolism/weight loss.,Designated/Approved,Approved for Orphan Indication,Treatment of AIDS wasting or cachexia.,1996-08-23,2003-08-23,"EMD Serono, Inc.",One Technology Place,,Roackland,Massachusetts,2370,USA,60491,1991,1743
Monoclonal antibody to cytomegalovirus (human),n/a,1991-11-15,Treatment of cytomegalovirus retinitis in patients with AIDS.,Designated/Withdrawn,,,N/A,N/A,"Protein Design Labs, Inc.",2375 Garcia Avenue,,Mountain View,California,94043,USA,59591,1991,
Liposome encapsulated recombinant interleukin-2,n/a,1991-11-25,Treatment of brain and CNS tumors.,Designated,,,N/A,N/A,"Oncothyreon Canada, Inc.","2011-94 St., NW",Suite 200,,,,Canada,62991,1991,
Amphotericin B lipid complex,Abelcet,1991-12-05,Treatment of invasive fungal infections.,Designated/Approved,Approved for Orphan Indication,Treatment of invasive fungal infections in patients who are refractory to or intolerant of conventional amphotericin B therapy.,1996-10-18,2003-10-18,"Liposome Company, Inc.",One Research Way,,Princeton,New Jersey,8540,USA,57891,1991,1779
Botulinum toxin type A,Dysport(R),1991-12-05,Treatment of essential blepharospasm.,Designated,,,N/A,N/A,"Ipsen Biopharmaceuticals, Inc.",106 Allen Road,3rd Floor,Basking Ridge,New Jersey,7920,USA,60891,1991,
Matrix metalloproteinase inhibitor,Galardin,1991-12-05,Treatment of corneal ulcers.,Designated,,,N/A,N/A,"Glycomed, Inc",860 Atlantic Avenue,,Alameda,California,94501,USA,63991,1991,
Sermorelin acetate,Geref,1991-12-05,Treatment of AIDS-associated catabolism/weight loss.,Designated/Withdrawn,,,N/A,N/A,"EMD Serono, Inc.",One Technology Place,,Rockland,Massachusetts,2370,USA,61491,1991,
botulinum toxin type A,Botox,1991-12-06,Treatment of dynamic muscle contracture in pediatric cerebral palsy patients,Designated,,,N/A,N/A,"Allergan, Inc.",2525 Dupont Drive,P.O. Box 19534,Irvine,California,92623,USA,56591,1991,
Interferon beta-1a,Avonex,1991-12-16,Treatment of multiple sclerosis.,Designated/Approved,Approved for Orphan Indication,Treatment of relapsing forms of multiple sclerosis to slow the accumulation of physical disability and decrease the frequency of clinical exacerbations.,1996-05-17,2003-05-17,"Biogen, Inc.",14 Cambridge Center,,Cambridge,Massachusetts,2142,USA,62791,1991,1614
baclofen,n/a,1991-12-16,Treatment of intractable spasticity due to multiple sclerosis or spinal cord injury.,Designated,,,N/A,N/A,"Metacel Pharmaceuticals, LLC",137 N. Broad Street,Suite E,Winder,Georgia,30680,USA,64091,1991,
Dexrazoxane,Zinecard,1991-12-17,For the prevention of cardiomyopathy associated with doxorubicin administration.,Designated/Approved,Approved for Orphan Indication,Cardiomyopathy associated with doxorubicin administration in women with metastatic breast cancer who have received a cumulative dose of 300mg/m2.,1995-05-26,2002-05-26,Pharmacia & Upjohn,7000 Portage Road,,Kalamazoo,Michigan,49001,USA,63291,1991,1256
L-baclofen,n/a,1991-12-17,Treatment of spasticity associated with spinal cord injury or multiple sclerosis.,Designated,,,N/A,N/A,Osmotica Pharmaceutical Corp.,1205 Culbreth Drive,Suite 200,Wilmington,North Carolina,28405,USA,57391,1991,
Dapsone USP,Dapsone,1991-12-24,Prophylaxis for Pneumocystis carinii pneumonia.,Designated,,,N/A,N/A,Jacobus Pharmaceutical Company,37 Cleveland Avenue,P.O. Box 5290,Princeton,New Jersey,8540,USA,61191,1991,
Cryptosporidium hyperimmune bovine colostrum IgG concentrate,n/a,1991-12-30,Treatment of diarrhea in AIDS patients caused by infection with Cryptosporidium parvum.,Designated,,,N/A,N/A,ImmuCell Corporation,56 Evergreen Drive,,Portland,Maine,4103,USA,62591,1991,
Dapsone USP,Dapsone,1992-01-08,For the combination treatment of Pneumocystis carinii pneumonia in conjunction with trimethoprim.,Designated,,,N/A,N/A,Jacobus Pharmaceutical Company,37 Cleveland Avenue,P.O. Box 5290,Princeton,New Jersey,8540,USA,61291,1992,
Cystic fibrosis transmembrane conductance regulator,n/a,1992-01-14,For cystic fibrosis transmembrane conductance regulator protein replacement therapy in cystic fibrosis patients.,Designated/Withdrawn,,,N/A,N/A,Genzyme Corporation,One Mountain Road,P.O. Box 9322,Framingham,Massachusetts,1701,USA,63891,1992,
Botulinum toxin type B,Myobloc,1992-01-16,Treatment of cervical dystonia.,Designated/Approved,Approved for Orphan Indication,Treatment of patients with cervical dystonia to reduce the severity of abnormal head position and neck pain associated with cervical dystonia.,2000-12-08,2007-12-08,"Soltice Neurosciences, LLC",4010 Dupont Circle,Suite L-07,Louisville,Kentucky,40207,USA,64791,1992,3249
"Ananain, comosain",Vianain,1992-01-21,For the enzymatic debridement of severe burns.,Designated,,,N/A,N/A,Genzyme Corporation,One Kendall Square,,Cambridge,Massachusetts,2139,USA,63091,1992,
Ciliary neurotrophic factor,n/a,1992-01-30,Treatment of amyotrophic lateral sclerosis.,Designated,,,N/A,N/A,Regeneron Pharmaceuticals Inc,777 Old Saw Mill River Road,,Tarrytown,New York,10591,USA,63691,1992,
L-baclofen,Neuralgon,1992-01-30,Treatment of intractable spasticity in children with cerebral palsy.,Designated,,,N/A,N/A,Osmotica Pharmaceutical Corp.,1205 Culbreth Drive,Suite 200,Wilmington,North Carolina,28405,USA,65592,1992,
Papaverine topical gel,n/a,1992-02-06,Treatment of sexual dysfunction in spinal cord injury patients.,Designated/Withdrawn by OPD,,,N/A,N/A,Pharmedic Company,417 Harvester Court,,Wheeling,Illinois,60090,USA,64991,1992,
Aminosalicylic acid,Paser Granules,1992-02-19,Treatment of tuberculosis infections,Designated/Approved,Approved for Orphan Indication,Treatment of tuberculosis,1994-06-30,2001-06-30,Jacobus Pharmaceutical Company,37 Cleveland Avenue,P.O. Box 5290,Princeton,New Jersey,8540,USA,65792,1992,862
Melphalan,Alkeran For Injection,1992-02-24,Treatment of patients with multiple myeloma for whom oral therapy is inappropriate.,Designated/Approved,Approved for Orphan Indication,For the palliative treatment of patients with multiple myeloma for whom oral melphalan is not appropriate.,1992-11-18,1999-11-18,Glaxo Wellcome Inc.,5 Moore Drive,,Research Triangle Park,North Carolina,27709,USA,60991,1992,268
Thyrotropin alpha,Thyrogen,1992-02-24,As an adjunct in the diagnosis of thyroid cancer.,Designated/Approved,Approved for Orphan Indication,As an adjunctive diagnostic tool for serum thyroglobulin (Tg) testing with or without radioiodine imaging in the follow-up of patients with thyroid cancer.,1998-11-30,2005-11-30,Genzyme Corporation,One Kendall Square,,Cambridge,Massachusetts,2139,USA,63191,1992,2471
Loxoribine,n/a,1992-02-24,Treatment of common variable immunodeficiency.,Designated/Withdrawn,,,N/A,N/A,R. W. Johnson Pharmaceutical Research Institute,"Route 202, P.O. Box 300",,Raritan,New Jersey,8869,USA,54390,1992,
Diazepam viscous solution for rectal administration,n/a,1992-02-25,"For the management of selected, refractory, patients with epilepsy, on stable regimens of antiepileptic drugs (AEDs), who require intermittent use of diazepam to control bouts of increased seizure activity.",Designated/Approved,Approved for Orphan Indication,,1997-07-29,2004-07-29,Valeant Pharmaceuticals,3300 Hyland Avenue,,Costa Mesa,California,92626,USA,61591,1992,1981
Pilocarpine HCl,Salagen,1992-02-28,Treatment of xerostomia and keratoconjunctivitis sicca in Sjogren's syndrome patients.,Designated/Approved,Approved for Orphan Indication,Treatment of dry mouth in patients with Sjogren's syndrome.,1998-02-11,2005-02-11,"MGI Pharma, Inc.",5775 West Old Shakopee Rd.,Suite 100,Bloomington,Minnesota,55437,USA,62091,1992,2175
Melphalan,Alkeran For Injection,1992-03-03,For use in hyperthermic regional limb perfusion to treat metastatic melanoma of the extremity.,Designated/Withdrawn,,,N/A,N/A,Glaxo Wellcome Research and Development,5 Moore Drive,PO Box 13398,Research Triangle Park,North Carolina,27709,USA,64291,1992,
HIV neutralizing antibodies,Immupath,1992-03-24,Treatment of acquired immunodeficiency syndrome.,Designated/Withdrawn,,,N/A,N/A,Hemacare Corporation,4954 Van Nuys Boulevard,,Sherman Oaks,California,91403,USA,61991,1992,
Butyrylcholinesterase,n/a,1992-03-25,For the reduction and clearance of toxic blood levels of cocaine encountered during a drug overdose.,Designated,,,N/A,N/A,Shire Laboratories Inc.,1550 East Gude Drive,,Rockville,Maryland,20850,USA,63591,1992,
Human immunodeficiency virus immune globulin,n/a,1992-03-25,Treatment of HIV-infected pregnant women and infants of HIV-infected mothers.,Designated/Withdrawn,,,N/A,N/A,NABI,"5800 Park of Commerce Blvd., NW",,Boca Raton,Florida,33487,USA,63791,1992,
Polymeric oxygen,n/a,1992-03-25,Treatment of sickle cell anemia.,Designated,,,N/A,N/A,Capmed USA,P.O. Box 14,,Bryn Mawr,Pennsylvania,19010,USA,31188,1992,
"Ciliary neurotrophic factor, recombinant human",n/a,1992-04-02,Treatment of spinal muscular atrophies.,Designated/Withdrawn,,,N/A,N/A,Syntex-Synergen Neuroscience,3200 Walnut Street,,Boulder,Colorado,80301,USA,66392,1992,
Arginine butyrate,n/a,1992-04-07,Treatment of beta-hemoglobinopathies and beta-thalassemia.,Designated,,,N/A,N/A,"Perrine, Susan P., M.D.",Boston University,Cancer Research Center,Boston,Massachusetts,2118,USA,66292,1992,
Technetium Tc99m murine monoclonal antibody (IgG2a) to B cell,Lymphoscan,1992-04-07,"Diagnostic imaging in the evaluation of the extent of disease in patients with histologically confirmed diagnosis of non-Hodgkin's B-cell lymphoma, acute B-cell lymphoblastic leukemia (in children and adults), and chronic B-cell lymphocytic leukemia.",Designated,,,N/A,N/A,"Immunomedics, Inc.",300 The American Road,,Morris Plains,New Jersey,7950,USA,65492,1992,
Alitretinoin,Panretin,1992-04-10,Treatment of acute promyelocytic leukemia,Designated,,,N/A,N/A,"Ligand Pharmaceuticals, Inc.",10275 Science Center Dr.,,San Diego,California,92121,USA,66592,1992,
Anaritide acetate,Auriculin,1992-04-10,Improvement of early renal allograft function following renal transplantation.,Designated/Withdrawn,,,N/A,N/A,"Scios, Inc.",2450 Bayshore Parkway,,Mountain View,California,94043,USA,62291,1992,
Sodium Monomercaptoundecahydro-closo-dodecaborate,Borocell,1992-04-15,For use in boron neutron capture therapy (BNCT) in the treatment of glioblastoma multiforme.,Designated,,,N/A,N/A,Neutron Technology Corp.& Neutron R&D Partner,"877 Main Street, Suite 402",,Boise,Idaho,83702,USA,65692,1992,
"Ciliary neurotrophic factor, recombinant human",n/a,1992-05-08,"Treatment of motor neuron disease (including amyotrophic lateral sclerosis, progressive muscular atrophy, progressive bulbar palsy, and primary lateral sclerosis).",Designated/Withdrawn,,,N/A,N/A,Syntex-Synergen Neuroscience,3200 Walnut Street,,Boulder,Colorado,80301,USA,66492,1992,
"5,6-dihydro-5-azacytidine",n/a,1992-05-11,Treatment of malignant mesothelioma.,Designated,,,N/A,N/A,"ILEX Oncology, Inc.",4545 Horizon Hill Blvd.,,San Antonio,Texas,78229,USA,67292,1992,
"Imported fire ant venom, allergenic extract",n/a,1992-05-12,"For skin testing of victims of fire ant stings to confirm fire ant sensitivity and if positive, for use as immunotherapy for the prevention of IgE-mediated anaphylactic reactions.",Designated,,,N/A,N/A,"ALK Laboratories, Inc.",Research Center,27 Village Lane,Wallingford,Connecticut,6492,USA,62691,1992,
Dianeal peritoneal dialysis solution with 1.1% amino acids,Nutrineal (Peritoneal Dialysis Solution With 1.1% Amino Acid,1992-06-11,For use as a nutritional supplement for the treatment of malnourishment in patients undergoing continuous ambulatory peritoneal dialysis.,Designated,,,N/A,N/A,Baxter Healthcare Corporation,1620 Waukegan Road,,McGaw Park,Illinois,60085,USA,64191,1992,
Minocycline HCl,Minocin Intravenous,1992-06-19,Treatment of chronic malignant pleural effusion.,Designated/Withdrawn,,,N/A,N/A,Lederle Laboratories Division,Division of American Cyanamid Company,401 N. Middletown Road,Pearl River,New York,10965,USA,67092,1992,
Protein C concentrate,"Protein C Concentrate (Human) Vapor Heated, Immuno",1992-06-19,For replacement therapy in patients with congenital or acquired protein C deficiency for the prevention and treatment of warfarin-induced skin necrosis during oral anticoagulation.,Designated,,,N/A,N/A,Immuno Clinical Research Corp.,750 Lexington Avenue,,New York,New York,10022,USA,65192,1992,
Protein C concentrate,Ceprotin,1992-06-23,"For replacement therapy in congenital protein C deficiency for the prevention and treatment of thrombosis, pulmonary emboli, and purpura fulminans.",Designated/Approved,Approved for Orphan Indication,Prevention and treatment of venous thrombosis and purpura fulminans,2007-03-30,2014-03-30,"Baxalta US, Inc.",One Baxter Way,,West Lake Village,California,91362,USA,65392,1992,5393
Cystic fibrosis gene therapy,n/a,1992-06-30,Treatment of cystic fibrosis.,Designated/Withdrawn,,,N/A,N/A,Genzyme Corporation,One Mountain Rd.,P.O. Box 9322,Framingham,Massachusetts,1701,USA,66192,1992,
Secretory leukocyte protease inhibitor,n/a,1992-06-30,Treatment of bronchopulmonary dysplasia.,Designated,,,N/A,N/A,"Synergen, Inc.",1885 33rd Street,,Boulder,Colorado,80301,USA,68292,1992,
sodium phenylbutyrate,n/a,1992-07-02,"Treatment for sickling disorders, which include S-S hemoglobinopathy, S-C hemoglobinopathy, and S-thalassemia hemoglobinopathy.",Designated,,,N/A,N/A,Medicis Pharmaceutical Corp.,8125 N. Hayden Road,,Scottsdale,Arizona,85258,USA,68192,1992,
fialuridine,n/a,1992-07-24,Adjunctive treatment of chronic active hepatitis B.,Designated,,,N/A,N/A,"Oclassen Pharmaceuticals, Inc.",100 Pelican Way,,San Rafael,California,94901,USA,67892,1992,
Interferon beta-1a (recombinant human),n/a,1992-07-24,"Treatment of acute non-A, non-B hepatitis.",Designated,,,N/A,N/A,"Biogen, Inc.",14 Cambridge Center,,Cambridge,Massachusetts,2142,USA,62891,1992,
L-threonine,n/a,1992-07-24,Treatment of spasticity associated with familial spastic paraparesis.,Designated/Withdrawn,,,N/A,N/A,"Interneuron Pharmaceuticals, Inc.","99 Hayden Ave., Suite 200",,Lexington,Massachusetts,2421,USA,62191,1992,
Anaritide acetate,Auriculin,1992-08-27,Treatment of patients with acute renal failure.,Designated/Withdrawn,,,N/A,N/A,"Scios, Inc.",2450 Bayshore Parkway,,Mountain View,California,94043,USA,62391,1992,
Botulinum toxin type A,n/a,1992-09-15,Treatment of synkinetic closure of the eyelid associated with VII cranial nerve aberrant regeneration.,Designated,,,N/A,N/A,"Botulinum Toxin Research Associates, Inc.",1261 Furnace Brook Parkway,,Quincy,Massachusetts,2169,USA,64591,1992,
Butyrylcholinesterase,n/a,1992-09-30,Treatment of post-surgical apnea.,Designated,,,N/A,N/A,Shire Laboratories Inc.,1550 East Gude Drive,,Rockville,Maryland,20850,USA,69192,1992,
Oxaliplatin,n/a,1992-10-06,Treatment of ovarian cancer.,Designated,,,N/A,N/A,Debio Pharm S.A.,Rue des Terreaux 17,CH-1000,,,,Switzerland,69492,1992,
AI-RSA,n/a,1992-10-08,Treatment of autoimmune uveitis.,Designated/Withdrawn,,,N/A,N/A,"AutoImmune, Inc.",128 Spring Street,,Lexington,Massachusetts,2173,USA,60091,1992,
Immune globulin intravenous (human),"Iveegam, Immuno",1992-10-13,Treatment of polymyositis/dermatomyositis.,Designated/Withdrawn,,,N/A,N/A,Immuno Clinical Research Corp.,155 East 56th Street,,New York,New York,10022,USA,68992,1992,
Allopurinol sodium,Aloprim For Injection,1992-10-16,"Management of patients with leukemia, lymphoma, and solid tumor malignancies who are receiving cancer therapy which causes elevations of serum and urinary uric acid levels and who cannot tolerate oral therapy.",Designated/Approved,Approved for Orphan Indication,"Management of patients with leukemia, lymphoma, and solid tumor malignancies who are receiving cancer therapy which causes elevations of serum and urinary uric acid levels and who cannot tolerate oral therapy.",1996-05-17,2003-05-17,"Catalytica Pharmaceuticals, Inc",PO Box 1887,,Greenville,North Carolina,27835,USA,68392,1992,1309
"Antihemophilic factor/von Willebrand factor complex (human), dried, pasteurized",Humate-P,1992-10-16,Treatment of patients with von Willebrand's disease,Designated/Approved,Approved for Orphan Indication,"(1) In adult patients for treatment and prevention of bleeding in hemophilia A (classic hemophilia) and (2) in adult and pediatric patients for treatment of spontaneous and trauma-induced bleeding episodes in severe von Willebrand disease, and in mild and moderate von Willebrand disease where use of desmopressin is known or suspected to be inadequate.",1999-04-01,2006-04-01,CSL Behring,1020 First Avenue,PO Box 61501,King Of Prussia,Pennsylvania,19406,USA,67992,1992,2358
"C1-esterase-inhibitor, human, pasteurized",Haegarda,1992-10-16,Prevention and/or treatment of acute attacks of hereditary angioedema.,Designated/Approved,Approved for Orphan Indication,Treatment of acute attacks of hereditary angioedema.,2009-10-08,2016-10-08,CSL Behring LLC,1020 First Ave.,PO Box 61501,King of Prussia,Pennsylvania,19406,USA,67592,1992,6201
"C1-esterase-inhibitor, human, pasteurized",Haegarda,1992-10-16,Prevention and/or treatment of acute attacks of hereditary angioedema.,Designated/Approved,Approved for Orphan Indication,For routine prophylaxis to prevent Hereditary Angioedema (HAE) attacks in adolescent and adult patients.,2017-06-22,2024-06-22,CSL Behring LLC,1020 First Ave.,PO Box 61501,King of Prussia,Pennsylvania,19406,USA,67592,1992,9015
Herpes simplex virus gene,n/a,1992-10-16,Treatment of primary and metastatic brain tumors.,Designated,,,N/A,N/A,"Genetic Therapy, Inc.",938 Clopper Road,,Gaithersburg,Maryland,20878,USA,66892,1992,
"Interleukin-1 receptor antagonist, human recombinant",Antril,1992-10-16,Prevention and treatment of graft versus host disease in transplant recipients.,Designated,,,N/A,N/A,Swedish Orphan Biovitrum AB (publ) (SOBI),SE-112 76,,Stockholm,,,Sweden,65892,1992,
Topiramate,Topamax,1992-11-25,Treatment of Lennox-Gastaut syndrome.,Designated/Approved,Approved for Orphan Indication,As adjunctive therapy in patients two years and older with siezures associated with Lennox-Gastaut syndrome.,2001-08-28,2008-08-28,"Johnson & Johnson Pharmaceutical R & D, LLC","Route 202, P.O. Box 300",,Raritan,New Jersey,8869,USA,70792,1992,3198
Idarubicin,Idamycin,1992-12-01,Treatment of myelodysplastic syndromes.,Designated/Withdrawn,,,N/A,N/A,Pharmacia & Upjohn,7000 Portage Road,Unit 0633-298-113,Kalamazoo,Michigan,49001,USA,70892,1992,
Idarubicin,Idamycin,1992-12-02,Treatment of chronic myelogenous leukemia.,Designated/Withdrawn,,,N/A,N/A,Pharmacia & Upjohn,7000 Portage Road,Unit 0633-298-113,Kalamazoo,Michigan,49001,USA,70992,1992,
Interferon beta-1a (recombinant),Rebif,1992-12-02,Treatment of symptomatic patients with AIDS including all patients with CD4 T-cell counts less than 200 cells per mm3.,Designated/Withdrawn,,,N/A,N/A,"EMD Serono, Inc.",One Technology Place,,Roackland,Massachusetts,2370,USA,63391,1992,
PEG-glucocerebrosidase,Lysodase,1992-12-09,For use as chronic enzyme replacement therapy in patients with Gaucher's disease who are deficient in glucocerebrosidase.,Designated,,,N/A,N/A,"National Institute of Mental Health, NIH",49 Convent Dr. MSC4405,"Bldg. 49, Room B1EE16",Bethesda,Maryland,20892,USA,71492,1992,
Immune globulin intravenous (human),"Iveegam, Immuno",1992-12-16,Treatment of juvenile rheumatoid arthritis.,Designated/Withdrawn,,,N/A,N/A,Immuno Clinical Research Corp.,750 Lexington Avenue,,New York,New York,10022,USA,68892,1992,
Isobutyramide,Isobutyramide Oral Solution,1992-12-18,Treatment of beta-hemoglobinopathies and beta-thalassemia syndromes.,Designated,,,N/A,N/A,"Perrine, Susan P., M.D.",Boston University,Cancer Research Center,Boston,Massachusetts,2118,USA,71792,1992,
Transforming growth factor-beta 2,n/a,1992-12-18,Treatment of full thickness macular holes.,Designated,,,N/A,N/A,"Celtrix Pharmaceuticals, Inc.",3055 Patrick Henry Drive,,Santa Clara,California,95054,USA,71092,1992,
Tumor necrosis factor-binding protein 1,n/a,1993-01-06,Treatment of symptomatic patients with AIDS including all patients with CD4 counts less than 200 cells per mm3.,Designated,,,N/A,N/A,"EMD Serono, Inc.",One Technology Place,,Roackland,Massachusetts,2370,USA,63491,1993,
Tumor necrosis factor-binding protein II,n/a,1993-01-06,Treatment of symptomatic patients with the AIDS including all patients with CD4 T-cell counts less than 200 cells per mm3.,Designated,,,N/A,N/A,"EMD Serono, Inc.",One Technology Place,,Roackland,Massachusetts,2370,USA,64691,1993,
Monoclonal antibody for immunization against lupus nephritis,n/a,1993-01-07,Treatment of lupus nephritis.,Designated,,,N/A,N/A,"VivoRx Autoimmune, Inc.","2825 Santa Monica Blvd., Suite 200",,Santa Monica,California,90404,USA,71992,1993,
Cystic fibrosis transmembrane conductance regulator gene,n/a,1993-01-08,Treatment of cystic fibrosis.,Designated,,,N/A,N/A,"Genetic Therapy, Inc.",938 Clopper Road,,Gaithersburg,Maryland,20878,USA,70492,1993,
"Colfosceril palmitate, cetyl alcohol, tyloxapol",Exosurf,1993-01-11,Treatment of adult respiratory distress syndrome.,Designated/Withdrawn,,,N/A,N/A,GlaxoSmithKline,5 Moore Drive,P.O. Box 13398,Research Triangle Park,North Carolina,27709,USA,68492,1993,
Thalidomide,n/a,1993-01-12,Treatment of the clinical manifestations of mycobacterial infection caused by Mycobacterium tuberculosis and non-tuberculous mycobacteria.,Designated,,,N/A,N/A,Celgene Corporation,7 Powder Horn Dr.,,Warren,,,,72092,1993,
Interferon beta (recombinant human),Avonex,1993-01-13,Treatment of primary brain tumors.,Designated/Withdrawn,,,N/A,N/A,"Biogen Idec, Inc.",14 Cambridge Center,,Cambridge,Massachusetts,2142,USA,69392,1993,
Tretinoin,Atra-Iv,1993-01-14,Treatment of acute and chronic leukemia.,Designated,,,N/A,N/A,"Antigenics, Inc.",3 Forbes Road,,Lexington,Massachusetts,2421,USA,71692,1993,
Somatropin,Biotropin,1993-02-12,Treatment of cachexia associated with AIDS.,Designated/Withdrawn,,,N/A,N/A,Bio-Technology General Corp.,"70 Wood Avenue, South",,Iselin,New Jersey,8830,USA,71592,1993,
"Immune globulin intravenous, human",Gamimune N,1993-02-18,Infection prophylaxis in pediatric patients affected with the human immunodeficiency virus.,Designated/Approved,Approved for Orphan Indication,"For prophylaxis of children with clinical or immunologic evidence of human immunodeficiency virus to decrease the frequency of serious and minor bacterial infections and the frequency of hospitalization, and to increase the time free of serious bacterial infections.",1993-12-27,2000-12-27,Bayer Corporation,"Pharmaceutical Division, Biological Products",400 Morgan Lane,New Haven,Connecticut,6516,USA,70592,1993,312
Daclizumab,Zenapax,1993-03-05,Prevention of acute renal allograft rejection.,Designated/Approved,Approved for Orphan Indication,"Prophylaxis of acute organ rejection in patients receiving renal transplants, to be used as a part of an immunosuppressive regimen that includes cyclosporine and corticosteroids.",1997-12-10,2004-12-10,"Hoffmann-La Roche, Inc.",340 Kingsland Street,,Nutley,New Jersey,7110,USA,67692,1993,1741
Humanized anti-tac,Zenapax,1993-03-05,Prevention of acute graft-vs-host disease following bone marrow transplantation.,Designated,,,N/A,N/A,"Hoffmann-La Roche, Inc.",340 Kingsland Street,,Nutley,New Jersey,7110,USA,67792,1993,
Modafinil,Provigil,1993-03-15,Treatment of excessive daytime sleepiness in narcolepsy.,Designated/Approved,Approved for Orphan Indication,Improve wakefulness in patients with excessive daytime sleepiness associated with narcolepsy.,1998-12-24,2005-12-24,"Cephalon, Inc.",145 Brandywine Parkway,,West Chester,Pennsylvania,19380,USA,73793,1993,2110
Riluzole,Rilutek,1993-03-16,Treatment of amyotrophic lateral sclerosis.,Designated/Approved,Approved for Orphan Indication,Treatment of patients with amyotrophic lateral sclerosis. Riluzole extends survival and/or time to tracheostomy.,1995-12-12,2002-12-12,"Rhone-Poulenc Rorer Pharmaceuticals, Inc.","500 Arcola Road, P.O. Box 1200",,Collegeville,Pennsylvania,19426,USA,72792,1993,1001
Atovaquone,Mepron,1993-03-16,Treatment and suppression of Toxoplasma gondii encephalitis.,Designated/Withdrawn,,,N/A,N/A,"GlaxoSmithKline, Inc.",5 Moore Drive,PO Box 13398,Research Triangle Park,North Carolina,27709,USA,66692,1993,
Atovaquone,Mepron,1993-03-16,Primary prophylaxis of HIV-infected persons at high risk for developing Toxoplasma gondii encephalitis.,Designated/Withdrawn,,,N/A,N/A,"GlaxoSmithKline, Inc.",5 Moore Drive,PO Box 13398,Research Triangle Park,North Carolina,27709,USA,66792,1993,
Aminosalicylate sodium,n/a,1993-04-06,Treatment of Crohn's disease.,Designated/Withdrawn,,,N/A,N/A,"Syncom Pharmaceuticals, Inc.",66 Hanover Road,,Florham Park,New Jersey,7932,USA,68592,1993,
Cladribine,Leustatin Injection,1993-04-19,Treatment of non-Hodgkin's lymphoma.,Designated/Withdrawn,,,N/A,N/A,"Janssen Research & Development, LLC",920 US Highway 202,,Raritan,New Jersey,8869,USA,68092,1993,
Apomorphine HCl,Apokyn,1993-04-22,Treatment of the on-off fluctuations associated with late-stage Parkinson's disease.,Designated/Approved,Approved for Orphan Indication,"For the acute, intermittent treatment of hypomobility, ""off"" episodes (""end-of-dose-wearing-off"" and unpredictable :on/off"" episodes) associated with advanced Parkinson's disease",2004-04-20,2011-04-20,"US WorldMeds, LLC",4010 Dupont Circle,Suite L-07,Louisville,Kentucky,40207,USA,57591,1993,4016
"Factor XIII, recombinant",n/a,1993-04-22,Treatment of congenital factor XIII deficiency.,Designated/Withdrawn,,,N/A,N/A,"Zymogenetics, Inc.",4225 Roosevelt Way,,Seattle,Washington,98105,USA,73993,1993,
Protein C concentrate,"Protein C Concentrate (Human) Vapor Heated, Immuno",1993-04-22,For use in the prevention and treatment of purpura fulminans in meningococcemia.,Designated/Withdrawn,,,N/A,N/A,Immuno Clinical Research Corp.,"750 Lexington Avenue, 19th Floor",,New York,New York,10022,USA,65292,1993,
Monolaurin,Glylorin,1993-04-29,Treatment of congenital primary ichthyosis.,Designated,,,N/A,N/A,Glaxo Wellcome Inc.,5 Moore Drive,PO Box 13398,Research Triangle Park,North Carolina,27709,USA,71892,1993,
RII retinamide,n/a,1993-05-06,Treatment of myelodysplastic syndromes.,Designated,,,N/A,N/A,"Sparta Pharmaceuticals, Inc.",111 Rock Road,,Horsham,Pennsylvania,19044,USA,74193,1993,
Daunorubicin citrate liposome injection,Daunoxome,1993-05-14,Treatment of patients with advanced HIV-associated Kaposi's sarcoma.,Designated/Approved,Approved for Orphan Indication,"First line cytotoxic therapy for advanced, HIV related Kaposi's sarcoma.",1996-04-08,2003-04-08,"NeXstar Pharmaceuticals, Inc.",650 Cliffside Drive,,San Dimas,California,91773,USA,73693,1993,1060
Aminosidine,Gabbromicina,1993-05-14,Treatment of tuberculosis.,Designated,,,N/A,N/A,"Kanyok, Thomas P. Pharm.D.",University Of Illinois At Chicago College of Pharm,833 South Wood Street (m/c886) Rm. 176,Chicago,Illinois,60612,USA,74693,1993,
Cytarabine liposomal,Depocyt,1993-06-02,Treatment of neoplastic meningitis.,Designated/Approved,Approved for Orphan Indication,Intrathecal treatment of lymphomatous meningitis.,1999-04-01,2006-04-01,"Pacira Pharmaceuticals, Inc.",10450 Science Center Drive,,San Diego,California,92121,USA,73393,1993,2129
Anti-thymocyte serum,Nashville Rabbit Anti-Thymocyte Serum,1993-06-02,"Treatment of allograft rejection, including solid organ (kidney, liver, heart, lung, and pancreas) and bone marrow transplantation.",Designated,,,N/A,N/A,Applied Medical Research,1600 Hayes Street,,Nashville,Tennessee,37203,USA,64491,1993,
Disodium clodronate,n/a,1993-06-16,Treatment of hypercalcemia of malignancy.,Designated,,,N/A,N/A,"Discovery Experimental & Development, Inc.",29949 S.R. 54 West,,Wesley Chapel,Florida,33543,USA,72292,1993,
Nitric oxide,Inomax,1993-06-22,Treatment of persistent pulmonary hypertension in the newborn.,Designated/Approved,Approved for Orphan Indication,"In conjunction with ventilatory support and other appropriate agents, in the treatment of term and near-term (>34 weeks) neonates with hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension, where it improves oxygenation and reduces the need for extracorporeal membrane oxygenation.",1999-12-23,2006-12-23,Mallinckrodt Hospital Products,1425 U.S. 206,,Bedminster Township,New Jersey,7921,USA,74493,1993,2375
8-methoxsalen,Uvadex,1993-06-22,For use in conjunction with the UVAR photopheresis to treat diffuse systemic sclerosis.,Designated,,,N/A,N/A,"Therakos, Inc.",Oaklands Corporate Center,437 Creamery Way,Exton,Pennsylvania,19341,USA,74293,1993,
Vasoactive intestinal polypeptide,n/a,1993-06-23,Treatment of acute esophageal food impaction.,Designated,,,N/A,N/A,Research Triangle Pharmaceuticals,200 Westpark Corporate Center,4364 South Alston Avenue,Durham,North Carolina,27713,USA,72192,1993,
Roquinimex,Linomide,1993-07-01,To prolong time to relapse in leukemia patients who have undergone autologous bone marrow transplantation.,Designated/Withdrawn,,,N/A,N/A,Pharmacia & Upjohn,7000 Portage Road,,Kalamazoo,Michigan,49001,USA,72893,1993,
Sucralfate,n/a,1993-07-15,Treatment of oral mucositis and stomatitis following radiation therapy for head and neck cancer.,Designated/Withdrawn,,,N/A,N/A,"Fuisz Technologies, Ltd.",14555 Avion at Lakeside,,Chantilly,Virginia,20151,USA,73893,1993,
Primaquine phosphate,n/a,1993-07-23,For use in combination with clindamycin hydrochloride in the treatment of Pneumocystis carinii pneumonia associated with AIDS.,Designated,,,N/A,N/A,"Sanofi Winthrop, Inc.",90 Park Avenue,,New York,New York,10016,USA,74793,1993,
Secalciferol,Osteo-D,1993-07-26,Treatment of familial hypophosphatemic rickets.,Designated,,,N/A,N/A,Teva Pharmaceuticals USA,1090 Horsham Road,,North Wales,Pennsylvania,19454,USA,75193,1993,
"Pulmonary surfactant replacement, porcine",Curosurf,1993-08-02,For the treatment and prevention of respiratory distress syndrome in premature infants.,Designated/Approved,Approved for Orphan Indication,Treatment (rescue) of respiratory distress syndrome in premature infants.,1999-11-18,N/A,"Chiesi USA, Inc.",1255 Crescent Green Drive,Suite 250,Cary,North Carolina,27518,USA,71192,1993,2299
Amiodarone,Amio-Aqueous,1993-08-17,Treatment of incessant ventricular tachycardia.,Designated,,,N/A,N/A,"Academic Pharmaceuticals, Inc.",21 N. Skokie Highway,,Lake Bluff,Illinois,60044,USA,70292,1993,
Toremifene,n/a,1993-08-17,Treatment of desmoid tumors.,Designated,,,N/A,N/A,Orion Corporation,Orionintie 1,0FI-02200 ESPOO,,,,Finland,75393,1993,
Mitomycin-C,n/a,1993-08-20,Treatment of refractory glaucoma as an adjunct to ab externo glaucoma surgery.,Designated,,,N/A,N/A,IOP Inc.,"3100 Airway Avenue, Suite 106",,Costa Mesa,California,92626,USA,73493,1993,
methotrexate,Rheumatrex,1993-08-23,Treatment of juvenile rheumatoid arthritis.,Designated/Withdrawn,,,N/A,N/A,Wyeth-Ayerst Laboratories,P.O. Box 8299,,Philadelphia,Pennsylvania,19101,USA,76693,1993,
Protirelin,n/a,1993-08-24,Prevention of infant respiratory distress syndrome associated with prematurity.,Designated/Withdrawn,,,N/A,N/A,"UCB Pharma, Inc.",1950 Lake Park Drive,,Smyrna,Georgia,30080,USA,75093,1993,
Bleomycin sulfate,Blenoxane,1993-09-17,Treatment of malignant pleural effusion.,Designated/Approved,Approved for Orphan Indication,Treatment of malignant pleural effusion.,1996-02-20,2003-02-20,Bristol-Myers Squibb Pharmaceutical Research Institute,P.O. Box 4000,,Princeton,New Jersey,8543,USA,76193,1993,886
2-0-desulfated heparin,Aeropin,1993-09-17,Treatment of cystic fibrosis.,Designated,,,N/A,N/A,"Kennedy & Hoidal, M.D.'s",University of Utah Health Sciences Center,"50 North Medical Drive, Room 4R240",Salt Lake City,Utah,84132,USA,75593,1993,
Bovine whey protein concentrate,Immuno-C,1993-09-30,Treatment of cryptosporidiosis caused by the presence of Cryptosporidium parvum in the gastrointestinal tract of patients who are immunodeficient/immunocompromised or immunocompetent.,Designated,,,N/A,N/A,"Biomune Systems, Inc.","540 Arapeen Drive, Suite 202",,Salt Lake City,Utah,84108,USA,76593,1993,
"Interleukin-3, human, recombinant",n/a,1993-09-30,For sequential administration with sargramostim to accelerate neutrophil and platelet recovery in patients undergoing autologous bone marrow transplantation for the treatment of Hodgkin's disease or non-Hodgkin's lymphoma.,Designated/Withdrawn,,,N/A,N/A,Sandoz Pharmaceuticals Corp.,59 Route 10,,East Hanover,New Jersey,7936,USA,74093,1993,
Bispecific antibody 520c9x22,n/a,1993-10-05,For in vivo serotherapy of patients with ovarian cancer.,Designated/Withdrawn,,,N/A,N/A,"Medarex, Inc.",519 Route 173 West,,Bloomsbury,New Jersey,8804,USA,72492,1993,
Peldesine,n/a,1993-10-05,Treatment of cutaneous T-cell lymphoma.,Designated,,,N/A,N/A,"BioCryst Pharmaceuticals, Inc.",2190 Parkway Lake Drive,,Birmingham,Alabama,35244,USA,76293,1993,
Alprostadil,n/a,1993-10-20,"Treatment of severe peripheral arterial occlusive disease (critical limb ischemia) in patients where other procedures, grafts or angioplasty, are not indicated.",Designated/Withdrawn,,,N/A,N/A,"Schwarz Pharma, Inc.",P.O. Box 2038,,Milwaukee,Wisconsin,53201,USA,70092,1993,
Rho (D) immune globulin intravenous (human),Winrho Sd,1993-11-09,Treatment of immune thrombocytopenic purpura.,Designated/Approved,Approved for Orphan Indication,Treatment of adults and children with chronic and acute immune thrombocytopenic purpura.,1995-03-24,2002-03-24,"Rh Pharmaceuticals, Inc.",104 Chancellor Matheson Road,R3T 2N2,,,,Canada,74993,1993,500
Aminosidine,Gabbromicina,1993-11-15,Treatment of Mycobacterium avium complex.,Designated,,,N/A,N/A,"Kanyok, Thomas P. Pharm.D.",University Of Illinois At Chicago College of Pharm,833 South Wood Street (m/c886) Rm. 176,Chicago,Illinois,60612,USA,77193,1993,
Melatonin,n/a,1993-11-15,Treatment of circadian rhythm sleep disorders in blind people with no light perception.,Designated,,,N/A,N/A,"Sack, Robert, M.D.",Oregon Health Sciences University,3181 S.W. Sam Jackson Park Road,Portland,Oregon,97201,USA,77593,1993,
Recombinant retroviral vector - glucocerebrosidase,n/a,1993-11-15,"For use as enzyme replacement therapy for patients with types I, II, or III Gaucher disease.",Designated,,,N/A,N/A,"Genetic Therapy, Inc.",938 Clopper Road,,Gaithersburg,Maryland,20878,USA,74393,1993,
Aprotinin,Trasylol,1993-11-17,"For prophylactic use to reduce perioperative blood loss and the homologous blood transfusion requirement in patients undergoing cardiopulmonary bypass surgery in the course of repeat coronary artery bypass graft surgery, and in selected cases of primary coronary artery bypass graft surgery where the risk of bleeding is especially high (impaired hemostasis) or where transfusion is unavailable or unacceptable.",Designated/Approved,Approved for Orphan Indication,,1993-12-29,2000-12-29,Bayer Corporation,Pharmaceutical Division,400 Morgan Lane,West Haven,Connecticut,6516,USA,66992,1993,42
sodium phenylbutyrate,Buphenyl,1993-11-22,"Treatment of urea cycle disorders: carbamylphosphate synthetase deficiency, ornithine transcarbamylase deficiency, and arginiosuccinic acid synthetase deficiency.",Designated/Approved,Approved for Orphan Indication,"Adjunctive therapy in the chronic managment of patients with urea cycle disorders involving deficiencies of carbamylphosphate synthetase, ornithine transcarbamylase, or argininosuccinic acid synthetase.",1996-04-30,2003-04-30,Medicis Pharmaceutical Corp.,8125 N. Hayden Road,,Scottsdale,Arizona,85258,USA,77893,1993,890
benzoate/phenylacetate,Ammonul,1993-11-22,Treatment of acute hyperammonemia and associated encephalopathy in patients with deficiencies in enzymes of the urea cycle.,Designated/Approved,Approved for Orphan Indication,Adjunctive therapy in the treatment of acute hyperammonemia and associated encephalopathy in patients with deficiencies in enzymes of the urea cycle.,2005-02-17,2012-02-17,Medicis Pharmaceutical Corp.,8125 N. Hayden Road,,Scottsdale,Arizona,85258,USA,77993,1993,4105
Immune globulin intravenous (human),"Immune Globulin Intravenous (Human) Immuno, Iveegam",1993-11-22,Treatment of patients with acute myocarditis.,Designated/Withdrawn,,,N/A,N/A,Immuno Clinical Research Corp.,750 Lexington Avenue,,New York,New York,10022,USA,75893,1993,
Levocarnitine,Carnitor,1993-11-22,Treatment of pediatric cardiomyopathy.,Designated,,,N/A,N/A,"Leadiant Biosciences, Inc.",9841 Washingtonian Blvd,Suite 500,Gaithersburg,Maryland,20878,USA,76393,1993,
Poly I: poly C12U,Ampligen,1993-12-09,Treatment of chronic fatigue syndrome,Designated,,,N/A,N/A,"Hemispherx Biopharma, Inc.",One Penn Center,1617 JFK Boulevard,Philadelphia,Pennsylvania,19103,USA,75993,1993,
Poly I: poly C12U,Ampligen,1993-12-09,"Treatment of invasive metastatic melanoma (stage IIb, III, IV).",Designated,,,N/A,N/A,"Hemispherx Biopharma, Inc.",One Penn Center,1617 JFK Boulevard,Philadelphia,Pennsylvania,19103,USA,76893,1993,
Sacrosidase,Sucraid,1993-12-10,Treatment of congenital sucrase-isomaltase deficiency,Designated/Approved,Approved for Orphan Indication,"Oral replacement therapy of the genetically determined sucrase deficiency, which is part of congenital sucrease-isomaltase deficiency.",1998-04-09,2005-04-09,"QOL Medical, LLC",4445 North Highway,"A1A, 241",Vero Beach,Florida,32963,USA,78693,1993,1581
"5a8, monoclonal antibody to CD4",n/a,1993-12-20,For use in post-exposure prophylaxis for occupational exposure to human immunodeficiency virus.,Designated/Withdrawn,,,N/A,N/A,"Biogen, Inc.",14 Cambridge Center,,Cambridge,Massachusetts,2142,USA,70692,1993,
Beractant,Survanta Intratracheal Suspension,1993-12-20,"Treatment of full-term newborn infants with respiratory failure caused by meconium aspiration syndrome, persistent pulmonary hypertension of the newborn, or pneumonia and sepsis.",Designated,,,N/A,N/A,Ross Laboratories,625 Cleveland Avenue,,Columbus,Ohio,43215,USA,76793,1993,
Epoetin alfa,n/a,1993-12-20,Treatment of myelodysplastic syndrome.,Designated,,,N/A,N/A,"Johnson & Johnson Pharmaceutical Research & Dev.,",920 U.S. Highway,"Route 202, P.O. Box 300",Raritan,New Jersey,8869,USA,78793,1993,
Hemin and zinc mesoporphyrin,Hemex,1993-12-20,Treatment of acute porphyric syndromes.,Designated,,,N/A,N/A,"Bonkovsky, Herbert L. M.D.",University Of Massachusetts Medical Center,55 Lake Avenue North,Worcester,Massachusetts,1655,USA,77393,1993,
Neutrophil-endothelial interaction inhibitor,Cylexin,1993-12-22,Treatment of post-ischemic pulmonary reperfusion edema following surgical treatment for chronic thromboembolic pulmonary hypertension.,Designated,,,N/A,N/A,Cytel Corporation,3525 John Hopkins Court,,San Diego,California,92121,USA,77693,1993,
"Antivenin, crotalidae polyvalent immune Fab (ovine)",Crofab,1994-01-12,Treatment of envenomations inflicted by North American crotalid snakes.,Designated/Approved,Approved for Orphan Indication,Treatment of minimal and moderate North American Crotalidae envenomation,2000-10-02,2007-10-02,"Protherics, Inc.","1207 17th Ave. S., Suite 103",,Nashville,Tennessee,37212,USA,78993,1994,2455
Recombinant human gelsolin,n/a,1994-01-12,Treatment of the respiratory symptoms of cystic fibrosis.,Designated,,,N/A,N/A,"BioAegis Therapeutics, Inc.",6 East Cove Lane,,Morristown,New Jersey,7960,USA,78393,1994,
Ammonium tetrathiomolybdate,Coprexa,1994-01-31,Treatment of Wilson's disease.,Designated,,,N/A,N/A,"Pipex Pharmaceuticals, Inc.",3930 Varsity Drive,,Ann Arbor,Michigan,48108,USA,79993,1994,
Tizanidine HCl,Zanaflex,1994-01-31,Treatment of spasticity associated with multiple sclerosis and spinal cord injury.,Designated,,,N/A,N/A,"Athena Neurosciences, Inc.",800 Gateway Boulevard,,South San Francisco,California,94080,USA,79193,1994,
Choline chloride,Intrachol,1994-02-10,"Treatment of choline deficiency, specifically the choline deficiency, hepatic steatosis, and cholestasis, associated with long-term parenteral nutrition.",Designated,,,N/A,N/A,ArTara Therapeutics,302a West 12th Street,Suite 254,New York,New York,10014,USA,76993,1994,
Exisulind,n/a,1994-02-14,For the suppression and control of colonic adenomatous polyps in the inherited disease adenomatous polyposis coli.,Designated,,,N/A,N/A,"OSI Pharmaceuticals, Inc.",41 Pinelawn Road,,Melville,New York,11747,USA,79293,1994,
Reduced L-glutathione,Cachexon,1994-02-14,Treatment of AIDS-associated cachexia.,Designated,,,N/A,N/A,Telluride Pharmaceutical Corporation,146 Flanders Drive,,Hillsborough,New Jersey,8876,USA,77493,1994,
"Bovine immunoglobulin concentrate, Cryptosporidium parvum",Sporidin-G,1994-03-01,Treatment and symptomatic relief of Cryptosporidium parvum infection of the gastrointestinal tract in immunocompromised patients.,Designated,,,N/A,N/A,"GalaGen, Inc.",4001 Lexington Avenue North,,Arden Hills,Minnesota,55126,USA,78293,1994,
Heme arginate,Normosang,1994-03-01,Treatment of myelodysplastic syndromes.,Designated,,,N/A,N/A,Orphan Europe,Immeuble Le Wilson,"70 avenue du General de Gaulle,",92800 Puteaux,,,France,79893,1994,
Sulfadiazine,n/a,1994-03-14,For use in combination with pyrimethamine for the treatment of Toxoplasma gondii encephalitis in patients with and without AIDS.,Designated/Approved,Approved for Orphan Indication,"Toxoplasmosis, as adjunctive with pyrimethamine",1994-07-29,2001-07-29,"Eon Labs Manufacturing, Inc.",227-15 North Conduit Avenue,,Laurelton,New York,11413,USA,78093,1994,137
Amiodarone HCl,Cordarone,1994-03-16,For the acute treatment and prophylaxis of life-threatening ventricular tachycardia or ventricular fibrillation.,Designated/Approved,Approved for Orphan Indication,For initiation of treatment and prophylaxis of frequently recurring ventricular fibrillation and hemodynamically unstable ventricular tachycardia in patients refractory to other therapy.,1995-08-03,2002-08-03,Wyeth-Ayerst Laboratories,P.O. Box 8299,,Philadelphia,Pennsylvania,19101,USA,77293,1994,505
Immunotherapeutic vaccine consisting of (PAM)2-Lys-Ser-Ser-Gln-Tyr-Ile-Lys-Ala-Asn-Ser-Lys-Phe-Ile-Gly-Ile-Thr-Glu-Ala-Ala-Ala-Phe-Leu-Pro-Ser-Asp-Phe-Phe-Pro-Ser-Val,n/a,1994-03-16,Treatment of chronic active hepatitis B infection in HLA-A2 positive patients.,Designated,,,N/A,N/A,Cytel Corporation,3525 John Hopkins Court,,San Diego,California,92121,USA,74893,1994,
Mitoguazone,Apep,1994-03-18,"Treatment of diffuse non-Hodgkin's lymphoma, including AIDS-related diffuse non-Hodgkin's lymphoma.",Designated,,,N/A,N/A,"ILEX Oncology, Inc.",4545 Horizon Hill Blvd.,,San Antonio,Texas,78229,USA,80094,1994,
Oxandrolone,Hepandrin,1994-03-18,Treatment of moderate/severe acute alcoholic hepatitis in the presence of moderate protein calorie malnutrition.,Designated/Withdrawn,,,N/A,N/A,Bio-Technology General Corp.,70 Wood Avenue South,,Iselin,New Jersey,8830,USA,75793,1994,
Cladribine,Mylinax,1994-04-19,Treatment of the chronic progressive form of multiple sclerosis.,Designated,,,N/A,N/A,"Johnson & Johnson Pharmaceutical R & D, LLC",920 Route 202,PO Box 300,Raritan,New Jersey,8869,USA,77793,1994,
Busulfan,Spartaject,1994-04-21,For use as preparative therapy for malignancies treated with bone marrow transplantation.,Designated,,,N/A,N/A,"Sparta Pharmaceuticals, Inc.",111 Rock Road,,Horsham,Pennsylvania,19044,USA,81694,1994,
methoxsalen,Uvadex,1994-05-12,For the prevention of acute rejection of cardiac allografts,Designated,,,N/A,N/A,"Therakos, Inc.",10 North High Street,Suite 300,West Chester,Pennsylvania,19380,USA,80594,1994,
Betaine,Cystadane,1994-05-16,Treatment of homocystinuria.,Designated/Approved,Approved for Orphan Indication,Treatment of homocystinuria to decrease elevated homocysteine blood levels.,1996-10-25,2003-10-25,Orphan Europe SARL,70 Avenue du Général de Gaulle,,Puteaux,,,France,81794,1994,893
Tositumomab and iodine I 131 tositumomab,Bexxar,1994-05-16,Treatment of non-Hodgkin's B-cell lymphoma.,Designated/Approved,Approved for Orphan Indication,"Treatment of patients with CD20 positive, follicular, non-Hodgkin's lymphoma, with and without transformation, whose disease is refractory to Rituximab and has relapsed following chemotherapy",2003-06-27,2010-06-27,GlaxoSmithKline LLC,Corporation Service Company,"2711 Centerville Road, Suite 400",Wilmington,Delaware,19808,USA,79493,1994,3329
L-cysteine,n/a,1994-05-16,For the prevention and lessening of photosensitivity in erythropoietic protoporphyria.,Designated,,,N/A,N/A,Brigham and Women's Hospital,Channing Laboratory,181 Longwood Ave.,Boston,Massachusetts,2115,USA,79693,1994,
Treosulfan,Ovastat,1994-05-16,Treatment of ovarian cancer.,Designated,,,N/A,N/A,Medac GmbH,Fehlandtstrasse 3,D-20354 Hamburg,,,,Germany,81294,1994,
Valrubicin,Valstar,1994-05-23,Treatment of carcinoma in situ of the urinary bladder.,Designated/Approved,Approved for Orphan Indication,For intravesical therapy of BCG-refractory carcinoma in situ of the urinary bladder in patients for whom immediate cystectomy would be associated with unacceptable morbidity or mortality.,1998-09-25,2005-09-25,"Anthra Pharmaceuticals, Inc.","103 Carnegie Center, Suite 102",,Princeton,New Jersey,8540,USA,82194,1994,1586
Arginine butyrate,n/a,1994-05-25,Treatment of sickle cell disease and beta thalassemia.,Designated/Withdrawn,,,N/A,N/A,Vertex Pharmaceuticals Inc.,130 Waverly Street,,Cambridge,Massachusetts,2139,USA,82094,1994,
Ganaxolone,n/a,1994-05-25,Treatment of infantile spasms.,Designated,,,N/A,N/A,"Marinus Pharmaceuticals, Inc.",21 Business Park Drive,,Branford,Connecticut,6405,USA,81894,1994,
Isobutyramide,n/a,1994-05-25,Treatment of sickle cell disease and beta thalassemia.,Designated,,,N/A,N/A,Alpha Therapeutic Corporation,5555 Valley Boulevard,,Los Angeles,California,90032,USA,82494,1994,
rituximab,Rituxan,1994-06-13,Treatment of non-Hodgkin's B-cell lymphoma,Designated/Approved,Approved for Orphan Indication,,1997-11-26,2004-11-26,"Genentech, Inc.","1 DNA Way, MS 242",,South San Francisco,California,94080,USA,79793,1994,1262
L-2-oxothiazolidine-4-carboxylic acid,Procysteine,1994-06-14,Treatment of adult respiratory distress syndrome.,Designated,,,N/A,N/A,"Transcend Therapeutics, Inc.","640 Memorial Drive, 3rd Floor West",,Cambridge,Massachusetts,2139,USA,81994,1994,
Buprenorphine hydrochloride,Subutex,1994-06-15,Treatment of opiate addiction in opiate users.,Designated/Approved,Approved for Orphan Indication,Treatment of opioid dependence in patients 16 years of age or older,2002-10-08,2009-10-08,"Indivior, Inc.",10710 Midlothian Turnpike,Suite 430,Richmond,Virginia,23235,USA,75293,1994,3037
Liposome encapsulated recombinant interleukin-2,n/a,1994-06-20,Treatment of cancers of the kidney and renal pelvis,Designated,,,N/A,N/A,"Oncothyreon Canada, Inc.",2011 - 94th Street NW,Canada T6N 1H1,,,,Canada,78493,1994,
Autolymphocyte therapy,n/a,1994-07-12,Treatment of renal cell carcinoma.,Designated,,,N/A,N/A,Cytogen Corporation,600 College Road East,CN 5308,Princeton,New Jersey,8540,USA,79593,1994,
Dehydroepiandrosterone,n/a,1994-07-13,Treatment of systemic lupus erythematosus (SLE) and the reduction in the use of steroids in steroid-dependent SLE patients.,Designated/Withdrawn,,,N/A,N/A,GlaxoSmithKline,P. O. Box 13398,Five Moore Drive,Research Triangle Park,North Carolina,27709,USA,83794,1994,
Gammalinolenic acid,n/a,1994-07-27,Treatment of juvenile rheumatoid arthritis.,Designated,,,N/A,N/A,"Zurier, Robert B. M.D.",University of Massachusetts Medical Center,55 Lake Avenue,Worcester,Massachusetts,1655,USA,82994,1994,
Busulfan,Busulfex,1994-07-28,As preparative therapy in the treatment of malignancies with bone marrow transplantation.,Designated/Approved,Approved for Orphan Indication,For use in combination with cyclophosphamide as a conditioning regimen prior to allogeneic hematopoietic progenitor cell transplantation for chronic myelogenous leukemia.,1999-02-04,2006-02-04,Otsuka Pharmaceutical Company,,Tokyo,,,,Japan,83094,1994,1652
Clonazepam,Klonopin,1994-08-04,Treatment of hyperekplexia (startle disease).,Designated,,,N/A,N/A,"Hoffmann-La Roche, Inc.",340 Kingsland Street,,Nutley,New Jersey,7110,USA,82794,1994,
Buffered intrathecal electrolyte/dextrose injection,Elliotts B Solution,1994-08-24,For use as a diluent in the intrathecal administration of methotrexate and cytarabine for the prevention or treatment meningeal leukemia and lymphocytic lymphoma,Designated/Approved,Approved for Orphan Indication,For the intrathecal administration of methotrexate and cytarabine for the prevention or treatment of meningeal leukemia and lymphocytic lymphoma.,1996-09-27,2003-09-27,"Lukare Medical, LLC",4 Julia Court,P. O. Box 782,Scotch Plains,New Jersey,7076,USA,83994,1994,765
Recombinant vaccinia (human papillomavirus),Ta-Hpv,1994-08-24,Treatment of cervical cancer.,Designated/Withdrawn,,,N/A,N/A,Xenova Research Limited,310 Cambridge Science Park,Cambridge CB4 OWG,,,,USA,84394,1994,
Somatropin,Genotropin,1994-09-06,Treatment of adults with growth hormone deficiency.,Designated/Approved,Approved for Orphan Indication,,1997-10-31,2004-10-31,Pharmacia & Upjohn,7000 Portage Road,,Kalamazoo,Michigan,49001,USA,83594,1994,1151
ibritumomab tiuxetan,Zevalin,1994-09-06,Treatment of B-cell non-Hodgkin's lymphoma.,Designated/Approved,Approved for Orphan Indication,"Treatment of patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma, including patients with Rituximab (Rituxan?) refractory follicular non-Hodgkin?s lymphoma",2002-02-19,2009-02-19,"Spectrum Pharmaceuticals, Inc.",157 Technology Drive,,Irvine,California,92618,USA,84894,1994,2723
Ricin (blocked) conjugated murine monoclonal antibody (CD6),n/a,1994-09-06,"Treatment of cutaneous T-cell lymphomas, acute T-cell leukemia-lymphoma, and related mature T-cell malignancies.",Designated/Withdrawn,,,N/A,N/A,"ImmunoGen, Inc.",830 Winter Street,,Waltham,Massachusetts,2451,USA,77093,1994,
Aminosidine,Paromomycin,1994-09-09,Treatment of visceral leishmaniasis (kala-azar).,Designated,,,N/A,N/A,"Kanyok, Thomas P. Pharm.D.",University of Illinois at Chicago College of Pharm,833 South Wood Street (m/c886) Rm. 176,Chicago,Illinois,60612,USA,83194,1994,
Neurotrophin-1,n/a,1994-09-13,Treatment of motor neuron disease/amyotrophic lateral sclerosis.,Designated,,,N/A,N/A,"Ericsson, Arthur Dale, M.D.",Institute of Biologic Research,"6560 Fannin, Suite 720",Houston,Texas,77030,USA,84594,1994,
Monoclonal Ab(murine) anti-idiotype melanoma-associated antigen,Melimmune,1994-09-19,Treatment of invasive cutaneous melanoma.,Designated/Withdrawn,,,N/A,N/A,IDEC Pharmaceuticals Corporation,3030 Callan Road,,San Diego,California,92121,USA,84094,1994,
Baclofen,Lioresal Intrathecal,1994-09-26,Treatment of spasticity associated with cerebral palsy.,Designated,,,N/A,N/A,"Medtronic, Inc.",800 53rd Avenue N.E.,P.O. 1250,Minneapolis,Minnesota,55440,USA,80494,1994,
Coagulation Factor IX (recombinant),Benefix,1994-10-03,Treatment of hemophilia B.,Designated/Approved,Approved for Orphan Indication,"For the control and prevention of hemorrhagic episodes in patients with hemophilia B (congenital factor IX deficiency and Christmas disease), including control and prevention of bleeding in surgical settings.",1997-02-11,2004-02-11,"Genetics Institute, Inc.",87 Cambridge Park Drive,,Cambridge,Massachusetts,2140,USA,82294,1994,862
Recombinant human luteinizing hormone,Luveris,1994-10-07,For use in association with recombinant human follicle stimulating hormone for the treatment of women with chronic anovulation due to hypogonadotropic hypogonadism.,Designated/Approved,Approved for Orphan Indication,"Luveris (lutropin alfa for injection), concomitantly administered with Gonal-f (follitropin alfa for injection), is indicated for stimulation of follicular development in infertile hypogonadotropic hypogonadal women with profound LH deficiency (LH (less than) 1.2 IU/L).",2004-10-08,2011-10-08,"EMD Serono, Inc.",One Technology Place,,Rockland,Massachusetts,2370,USA,80292,1994,3654
Tobramycin for inhalation,Tobi,1994-10-13,Treatment of bronchopulmonary infections of Pseudomonas aeruginosa in cystic fibrosis patients.,Designated/Approved,Approved for Orphan Indication,Management of cystic fibrosis patients with P.aeruginosa.,1997-12-22,2004-12-22,Novartis Pharmaceuticals Corp,Drug Regulatory Affairs,One Health Plaza,East Hanover,New Jersey,7936,USA,84494,1994,1166
Melanoma cell vaccine,Canvaxin,1994-10-13,Treatment of invasive melanoma.,Designated,,,N/A,N/A,CancerVax Corporation,2110 Rutherford Road,,Carlsbad,California,92008,USA,84194,1994,
buprenorphine in combination with naloxone,Suboxone,1994-10-27,Treatment of opiate addiction in opiate users,Designated/Approved,Approved for Orphan Indication,Treatment of opioid dependence in patients 16 years of age or older,2002-10-08,2009-10-08,"Indivior, Inc.",10710 Midlothian Turnpike,Suite 430,Richmond,Virginia,23235,USA,79093,1994,2903
oxybate,Xyrem,1994-11-07,Treatment of narcolepsy.,Designated/Approved,Approved for Orphan Indication,Treatment of cataplexy associated with narcolepsy,2002-07-17,2009-07-17,"Rare Disease Therapeutics, Inc.",12975 Brookprinter Pl,Suite 170,Poway,California,92064,USA,85894,1994,2809
oxybate,Xyrem,1994-11-07,Treatment of narcolepsy.,Designated/Approved,Approved for Orphan Indication,Treatment of excessive daytime sleepiness in patients with narcolepsy,2005-11-18,2012-11-18,"Rare Disease Therapeutics, Inc.",12975 Brookprinter Pl,Suite 170,Poway,California,92064,USA,85894,1994,4029
Dapsone,n/a,1994-11-07,Prophylaxis of toxoplasmosis in severely immunocompromised patients with CD4 counts below 100.,Designated,,,N/A,N/A,"Jacobus Pharmaceutical Company, Inc.",37 Cleveland Lane,P.O. Box 5290,Princeton,New Jersey,8540,USA,85694,1994,
Sodium dichloroacetate,n/a,1994-11-10,Treatment of lactic acidosis in patients with severe malaria.,Designated,,,N/A,N/A,"Stacpoole, Peter W. M.D., Ph.D.",University of Florida,P.O. Box 100277,Gainesville,Florida,32610,USA,83694,1994,
Soluble recombinant human complement receptor type 1,n/a,1994-11-21,Prevention or reduction of adult respiratory distress syndrome.,Designated,,,N/A,N/A,"T Cell Sciences, Inc.",119 Fourth Avenue,,Needham Heights,Massachusetts,2194,USA,82894,1994,
Dimethyl sulfoxide,n/a,1994-11-22,"Treatment of increased intracranial pressure in patients with severe, closed-head injury, also known as traumatic brain coma, for whom no other effective treatment is available.",Designated,,,N/A,N/A,"Abela Pharmaceuticals, Inc.",21581 Midcrest Drive,,Lake Forest,California,92630,USA,81394,1994,
Recombinant methionyl brain-derived neurotrophic factor,n/a,1994-11-28,Treatment of amyotrophic lateral sclerosis.,Designated,,,N/A,N/A,"Amgen, Inc.",One Amgen Center Dr.,M/S: 17-2-B,Thousand Oaks,California,91320,USA,86394,1994,
Coumarin,Onkolox,1994-12-22,Treatment of renal cell carcinoma.,Designated,,,N/A,N/A,Drossapharm LTD,4002 Basel,,,,,Switzerland,84294,1994,
Orgotein for injection,n/a,1994-12-22,"Treatment of familial amyotrophic lateral sclerosis associated with a mutation of the gene (on chromosome 21q) for copper, zinc superoxide dismutase.",Designated/Withdrawn,,,N/A,N/A,"Oxis International, Inc.","6040 N. Cutter Circle, Suite 317",,Portland,Oregon,97217,USA,87294,1994,
progesterone,n/a,1994-12-22,Establishment and maintenance of pregnancy in women undergoing in vitro fertilization or embryo transfer procedures.,Designated,,,N/A,N/A,"Watson Laboratories, Inc.",311 Bonnie Circle,,Corona,California,91720,USA,82694,1994,
Somatostatin,n/a,1994-12-22,Treatment of bleeding esophageal varices.,Designated,,,N/A,N/A,Eumedica Pharmaceuticals A.G. (Schweiz),Arnold Bocklin-Strasse 1,CH-4051,BASEL,,,Switzerland,86094,1994,
Human immunodeficiency virus immune globulin,Hivig,1995-01-04,Treatment of HIV-infected pediatric patients.,Designated/Withdrawn,,,N/A,N/A,NABI,"5800 Park of Commerce Blvd., NW",,Boca Raton,Florida,33487,USA,85994,1995,
Aminocaproic acid,Caprogel,1995-01-06,For the topical treatment of traumatic hyphema of the eye.,Designated,,,N/A,N/A,Eastern Virginia Medical School,Department of Ophthalomology,"880 Kempsville Road, Suite 2500",Norfolk,Virginia,23502,USA,83294,1995,
Chondroitinase,n/a,1995-02-09,Treatment of patients undergoing vitrectomy.,Designated/Withdrawn,,,N/A,N/A,"Bausch & Lomb Pharmaceuticals, Inc.",8500 Hidden River Pkwy.,,Tampa,Florida,33637,USA,87794,1995,
Purified type II collagen,Colloral,1995-02-09,Treatment of juvenile rheumatoid arthritis.,Designated,,,N/A,N/A,"AutoImmune, Inc.",128 Spring Street,,Lexington,Massachusetts,2421,USA,87494,1995,
Glyceryl trioleate and glyceryl trierucate,n/a,1995-02-14,Treatment of adrenoleukodystrophy.,Designated,,,N/A,N/A,"Moser, Hugo W. M.D.",Johns Hopkins University,"Kennedy Krieger Institute, 707 North Broadway",Baltimore,Maryland,21205,USA,87594,1995,
Adeno-associated viral-based vector cystic fibrosis gene therapy,n/a,1995-02-15,Treatment of cystic fibrosis.,Designated/Withdrawn,,,N/A,N/A,Targeted Genetics Corporation,"1100 Olive Way, Suite 100",,Seattle,Washington,98101,USA,84994,1995,
Sargramostim,Leukine,1995-03-06,To reduce neutropenia and leukopenia and decrease the incidence of death due to infection in patients with acute myelogenous leukemia.,Designated/Approved,Approved for Orphan Indication,Following induction chemotherapy in older adult patients with acute myelogenous leukemia to shorten time to neutrophil recovery and to reduce the incidence of severe and life-threatening infections and infections resulting in death.,1995-09-15,2002-09-15,Immunex Corporation,51 University Street,,Seattle,Washington,98101,USA,81494,1995,193
Somatropin (r-DNA),Zorbtive,1995-03-06,For use alone or in combination with glutamine in the treatment of short bowel syndrome.,Designated/Approved,Approved for Orphan Indication,Treatment of short bowel syndrome in patients receiving specialized nutritional support,2003-12-01,2010-12-01,"EMD Serono, Inc.",One Technology Place,,Roackland,Massachusetts,2370,USA,80394,1995,3192
Glutamine,Nutrestore,1995-03-06,For use with human growth hormone in the treatment of short bowel syndrome (nutrient malabsorption from the gastrointestinal tract resulting from an inadequate absorptive surface).,Designated/Approved,Approved for Orphan Indication,Treatment of short bowel syndrome in patients receiving specialized nutritional support when used in conjunction with a recombinant human growth hormone that is approved for this indication.,2004-06-10,2011-06-10,"Emmaus Medical, Inc.",20725 S. Western Avenue,Suite 136,Torrence,California,90501,USA,85794,1995,3384
Recombinant human gelsolin,n/a,1995-03-06,Treatment of acute and chronic respiratory symptoms of bronchiectasis.,Designated,,,N/A,N/A,"BioAgeis, Therapeutics, Inc.",6 East Cove Lane,,Morristown,New Jersey,7960,USA,85394,1995,
Facilitated DNA Plasmid Vaccine,n/a,1995-03-08,Treatment of cutaneous T cell lymphoma.,Designated,,,N/A,N/A,Wyeth-Lederle Vaccines and Pediatrics,211 Bailey Rd.,,West Henrietta,New York,14586,USA,88295,1995,
Hepatitis B immune globulin intravenous (human),Nabi-Hb,1995-03-08,Prophylaxis against hepatitis B virus reinfection in liver transplant patients.,Designated,,,N/A,N/A,Biotest Pharmaceuticals Corporation,"5800 Park of Commerce Blvd., NW",,Boca Raton,Florida,33487,USA,76093,1995,
Phenylalanine ammonia-lyase,Phenylase. Ravpal-Peg,1995-03-08,Treatment of hyperphenylalaninemia,Designated,,,N/A,N/A,BioMarin Pharmaceutical,105 Digital Drive,,Novato,California,94949,USA,88195,1995,
Tyloxapol,Supervent,1995-03-08,Treatment of cystic fibrosis.,Designated,,,N/A,N/A,"Kennedy & Hoidal, M.D.'s",University of Utah Health Sciences Center,"50 North Medical Drive, Room 4R240",Salt Lake City,Utah,84132,USA,87994,1995,
Cystic fibrosis Tr gene therapy (recombinant adenovirus),Adgvcftr.10,1995-03-09,Treatment of cystic fibrosis.,Designated,,,N/A,N/A,"GenVec, Inc.",12111 Parklawn Drive,,Rockville,Maryland,20852,USA,87694,1995,
Clotrimazole,n/a,1995-04-24,Treatment of sickle cell disease.,Designated,,,N/A,N/A,"Brugnara, Carlo M.D.",The Children's Hospital,"300 Longwood Avenue, Bader 760",Boston,Massachusetts,2115,USA,88094,1995,
Thalidomide,n/a,1995-05-01,"Treatment of severe recurrent aphthous stomatitis in severely, terminally immunocompromised patients.",Designated,,,N/A,N/A,Celgene Corporation,7 Powder Horn Dr.,,Warren,,,,80194,1995,
Thalidomide,n/a,1995-05-15,"Treatment and prevention of recurrent aphthous ulcers in severely, terminally immunocompromised patients.",Designated,,,N/A,N/A,Andrulis Research Corporation,"11800 Baltimore Avenue, Suite 113",,Beltsville,Maryland,20705,USA,82594,1995,
Nitisinone,Orfadin,1995-05-16,Treatment of tyrosinemia type 1.,Designated/Approved,Approved for Orphan Indication,Adjunctive therapy to dietary restriction of tyrosine and phenylalanine in the treatment of hereditary tyrosinemia type 1,2002-01-18,2009-01-18,Swedish Orphan Biovitrum AB,"890 Winter Street, Suite 115",,Waltham,Massachusetts,2451,USA,89095,1995,2439
Nitisinone,Orfadin,1995-05-16,Treatment of tyrosinemia type 1.,Designated/Approved,Approved for Orphan Indication,Treatment of hereditary tyrosinemia type 1 in combination with dietary restriction of tyrosine and phenylalanine.,2016-04-22,N/A,Swedish Orphan Biovitrum AB,"890 Winter Street, Suite 115",,Waltham,Massachusetts,2451,USA,89095,1995,7647
N-[4-(trifluoromethyl)phenyl] 5 methylisoxazole-4-carboxamide,n/a,1995-05-25,Treatment of malignant glioma.,Designated,,,N/A,N/A,"Sugen, Inc.",230 East Grand Ave.,,South San Francisco,California,94080,USA,89895,1995,
Ganciclovir intravitreal implant,Vitrasert Implant,1995-06-07,Treatment of cytomegalovirus retinitis.,Designated/Approved,Approved for Orphan Indication,Treatment of CMV retinitis in patients with acquired immunodeficiency syndrome.,1996-03-04,2003-03-04,"Bausch & Lomb Surgical, Chiron Vision Products",9342 Jeronimo Road,,Irvine,California,92718,USA,86494,1995,271
Recombinant human insulin-like growth factor 1,Igf-1,1995-06-07,Treatment of antibody-mediated growth hormone resistance in patients with isolated growth hormone deficiency Ia.,Designated/Withdrawn,,,N/A,N/A,Pharmacia & Upjohn,7000 Portage Road,,Kalamazoo,Michigan,49001,USA,90895,1995,
Recombinant human insulin-like growth factor 1,Igf-1,1995-06-07,Treatment of growth hormone receptor deficiency.,Designated/Withdrawn,,,N/A,N/A,Pharmacia & Upjohn,7000 Portage Road,,Kalamazoo,Michigan,49001,USA,89795,1995,
Rifapentine,Priftin,1995-06-09,Treatment of pulmonary tuberculosis.,Designated/Approved,Approved for Orphan Indication,,1998-06-22,2005-06-22,Hoechst Marion Roussel,P.O. Box 9627,Mail Station: H3-M2516,Kansas City,Missouri,64134,USA,89495,1995,1109
Rifapentine,Priftin,1995-06-09,Treatment of Mycobacterium avium complex in patients with AIDS.,Designated,,,N/A,N/A,"Hoechst Marion Roussel , Inc.",P.O. Box 9627,Mail Station: H3-M2516,Kansas City,Missouri,64134,USA,89595,1995,
Trisodium citrate concentration,Hemocitrate,1995-06-15,For use in leukapheresis procedures.,Designated,,,N/A,N/A,"Hemotec Medical Products, Inc.",Box 19255,,Johnston,Rhode Island,2919,USA,87094,1995,
Ancestim,Stemgen,1995-07-05,For use in combination with filgrastim to decrease the number of phereses required to collect peripheral blood progenitor cells capable of providing rapid multi-lineage hematopoietic reconstitution following myelosuppressive or myeloablative therapy.,Designated/Withdrawn,,,N/A,N/A,"Amgen, Inc.",One Amgen Center Drive,,Thousand Oaks,California,91320,USA,86594,1995,
Encapsulated porcine islet preparation,Betarx,1995-07-05,Treatment of type I diabetic patients who are already on immunosuppression.,Designated,,,N/A,N/A,VivoRx,2825 Santa Monica Blvd.,2nd Floor,Santa Monica,California,90404,USA,90195,1995,
gabapentin,Neurontin,1995-07-05,Treatment of amyotrophic lateral sclerosis,Designated,,,N/A,N/A,Warner-Lambert Company,Parke-Davis Pharmaceutical Research Division,2800 Plymouth Road,Ann Arbor,Michigan,48105,USA,88695,1995,
Nitric oxide,n/a,1995-07-10,Treatment of acute respiratory distress syndrome in adults.,Designated,,,N/A,N/A,Mallinckrodt Hopspital Products,1425 U.S. 206,,Bedminster Township,New Jersey,7921,USA,90595,1995,
Mitolactol,n/a,1995-07-12,As adjuvant therapy in the treatment of primary brain tumors.,Designated,,,N/A,N/A,"Targent, Inc.",155 Lambert Drive,,Princeton,New Jersey,8540,USA,90295,1995,
Filgrastim,Neupogen,1995-07-17,For use in the mobilization of peripheral blood progenitor cells for collection in patients who will receive myeloablative or myelosuppressive chemotherapy.,Designated/Approved,Approved for Orphan Indication,For use in the mobilization of hematopoietic progenitor cells into the peripheral blood collection by leukapheresis.,1995-12-28,2002-12-28,"Amgen, Inc.",1840 Dehavilland Drive,,Thousand Oaks,California,91320,USA,89395,1995,164
Apomorphine,n/a,1995-07-17,Treatment of the on-off fluctuations associated with late-stage Parkinson's disease.,Designated,,,N/A,N/A,"Pentech Pharmaceuticals, Inc.",1110 Lake Cook Rd.,Suite 257,Buffalo Grove,Illinois,60089,USA,89295,1995,
Lucinactant,Surfaxin,1995-07-17,Treatment of acute respiratory distress syndrome in adults.,Designated,,,N/A,N/A,"Windtree Therapeutics, Inc.",2600 Kelly Road,Suite 100,Warrington,Pennsylvania,18976,USA,89995,1995,
Synsorb Pk,n/a,1995-07-17,Treatment of verocytotoxogenic E. coli infections.,Designated,,,N/A,N/A,Synsorb Biotech Inc.,"201, 1204 Kensington Road, N.W.","Calgary, Alberta",,,,Canada,90395,1995,
Alglucerase injection,Ceredase,1995-07-21,Replacement therapy in patients with Type II and III Gaucher's disease.,Designated,,,N/A,N/A,Genzyme Corporation,One Kendall Square,,Cambridge,Massachusetts,2139,USA,91095,1995,
Thalidomide,Thalomid,1995-07-26,Treatment of erythema nodosum leprosum.,Designated/Approved,Approved for Orphan Indication,Acute treatment of the cutaneous manifestations of moderate to severe erythema nodosum leprosum (ENL) and as maintenance therapy for prevention and suppression of the cutaneous manifestations of ENL recurrences.,1998-07-16,2005-07-16,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,USA,90795,1995,1086
Lamotrigine,Lamictal,1995-08-23,Treatment of Lennox-Gastaut syndrome.,Designated/Approved,Approved for Orphan Indication,Adjunctive treatment of Lennox-Gastaut syndrome in pediatric and adult patients.,1998-08-24,2005-08-24,Glaxo Wellcome Research and Development,5 Moore Drive,P.O. Box 13398,Research Triangle Park,North Carolina,27709,USA,91695,1995,1097
Fibrinogen (human),n/a,1995-08-23,For the control of bleeding and prophylactic treatment of patients deficient in fibrinogen.,Designated,,,N/A,N/A,Alpha Therapeutic Corporation,5555 Valley Boulevard,,Los Angeles,California,90032,USA,88595,1995,
"RGG0853, E1A lipid complex",n/a,1995-09-15,Treatment of ovarian cancer.,Designated/Withdrawn,,,N/A,N/A,Targeted Genetics Corporation,"1100 Olive Way, Suite 100",,Seattle,Washington,98101,USA,90995,1995,
Sterile talc powder,Sclerosol Intrapleural Aerosol,1995-09-18,Treatment of malignant pleural effusion.,Designated/Approved,Approved for Orphan Indication,Prevention of recurrence of malignant pleural effusions in symptomatic patients.,1997-12-24,2004-12-24,Bryan Corporation,4 Plympton Street,,Woburn,Massachusetts,1801,USA,91595,1995,828
Broxuridine,Broxine/Neomark,1995-09-18,Radiation sensitizer in the treatment of primary brain tumors.,Designated,,,N/A,N/A,"NeoPharm, Inc.","225 East Deerpath, Suite 250",,Lake Forest,Illinois,60045,USA,91295,1995,
Porfiromycin,Promycin,1995-09-19,Treatment of head and neck cancer.,Designated,,,N/A,N/A,"Boehringer Ingelheim Pharmaceuticals, Inc.",900 Ridgebury Road,PO Box 368,Ridgefield,Connecticut,6877,USA,91495,1995,
Elcatonin,n/a,1995-09-25,Intrathecal treatment of intractable pain.,Designated,,,N/A,N/A,"Innapharma, Inc.",10 Mountainview Road,,Upper Saddle River,New Jersey,7458,USA,81594,1995,
Mycobacterium avium sensitin RS-10,n/a,1995-10-11,For use in the diagnosis of invasive Mycobacterium avium disease in immunocompetent individuals.,Designated,,,N/A,N/A,Statens Seruminstitut,5 Artillerivej,DK-2300 Copenhagen S,,,,Sweden,90495,1995,
Recombinant human insulin-like growth factor-I,n/a,1995-10-13,Treatment of post-poliomyelitis syndrome.,Designated/Withdrawn,,,N/A,N/A,"Teva Branded Pharmaceutical Product R&D, Inc.",41 Moores Road,,Frazer,Pennsylvania,19355,USA,91995,1995,
Lucinactant,Surfaxin,1995-10-18,Treatment of respiratory distress syndrome in premature infants.,Designated,,,N/A,N/A,"Windtree Therapeutics, Inc.",2600 Kelly Road,Suite 100,Warrington,Pennsylvania,18976,USA,91395,1995,
Lidocaine patch 5%,Lidoderm Patch,1995-10-24,"For relief of allodynia (painful hypersensitivity), and chronic pain in postherpetic neuralgia.",Designated/Approved,Approved for Orphan Indication,,1999-03-19,2006-03-19,"Teikoku Pharma USA, Inc.",745-D Camden Ave.,,Campbell,California,95008,USA,92395,1995,1242
Etiocholanedione,n/a,1995-11-03,Treatment of aplastic anemia.,Designated,,,N/A,N/A,"SuperGen, Inc.",4140 Dublin Blvd.,Suite 200,Dublin,California,94568,USA,92695,1995,
Recombinant human relaxin,n/a,1995-11-03,Treatment of progressive systemic sclerosis.,Designated/Withdrawn,,,N/A,N/A,Connetics Corporation,3400 West Bayshore Road,,Palo Alto,California,94303,USA,92995,1995,
Sorivudine,Bravavir,1995-11-09,Treatment of herpes zoster (shingles) in immunocompromised patients,Designated/Withdrawn,,,N/A,N/A,Bristol-Myers Squibb,5 Research Parkway,P.O. Box 5100,Wallingford,Connecticut,6492,USA,92295,1995,
infliximab,Remicade,1995-11-14,Treatment of Crohn's disease,Designated/Approved,Approved for Orphan Indication,"Treatment of moderately to severely active Crohn's disease for the reduction of the signs and symptoms, in patients who have an inadequate response to conventional therapies; and treatment of patients with fistulizing Crohn's disease for the reduction in the number of draining enterocutaneous fistula(s).",1998-08-24,2005-08-24,"Centocor, Inc.",200 Great Valley Parkway,,Malvern,Pennsylvania,19355,USA,92495,1995,1014
Omega-3 (n-3) polyunsaturated fatty acid with all double bonds in the cis configuration,n/a,1995-11-22,Prevention of organ graft rejection.,Designated,,,N/A,N/A,Research Triangle Pharmaceuticals,4364 South Alston Avenue,,Durham,North Carolina,27713,USA,93195,1995,
Recombinant methionyl human stem cell factor,n/a,1995-11-22,Treatment of primary bone marrow failure.,Designated/Withdrawn,,,N/A,N/A,"Amgen, Inc.",One Amgen Center Drive,,Thousand Oaks,California,91320,USA,88395,1995,
Interferon gamma-1b,Actimmune,1995-12-04,Treatment of renal cell carcinoma.,Designated,,,N/A,N/A,Horizon Pharma Ireland Limited,"Connaught House, 1st Floor",1 Burlington Road,Dublin 4,,,Ireland,93595,1995,
Uridine 5'-triphosphate,n/a,1995-12-04,Treatment of cystic fibrosis.,Designated/Withdrawn,,,N/A,N/A,"Inspire Pharmaceuticals, Inc.","4222 Emperor Boulevard, Suite 470",,Durham,North Carolina,27703,USA,93495,1995,
Mecasermin,Increlex,1995-12-12,Treatment of growth hormone insensitivity syndrome.,Designated/Approved,Approved for Orphan Indication,Long-term treatment of growth failure in children with severe primary IGF-1 deficiency (Primary IGFD) or with growth hormone (GH) gene deletion who have developed neutralizing antibodies to growth hormone.,2005-08-30,2012-08-30,"Ipsen Biopharmaceuticals, Inc.",106 Allen Road,,Basking Ridge,New Jersey,7920,USA,93695,1995,3549
Antihemophilic factor (human),Alphanate,1996-01-05,Treatment of von Willebrand's disease,Designated/Approved,Approved for Orphan Indication,For surgical and/or invasive procedures in patients with von Willebrand Disease (VWD) in whom desmopressin is either ineffective or contraindicated. It is not indicated for patients with severe VWD (Type 3) undergoing major surgery,2007-01-31,2014-01-31,Grifols Biologicals Inc.,5555 Valley Boulevard,,Los Angeles,California,90032,USA,93895,1996,4044
"Valine, isoleucine and leucine",Vil,1996-01-05,Treatment of hyperphenylalaninemia,Designated,,,N/A,N/A,Leas Research Products,78 Fallon Drive,,North Haven,Connecticut,6473,USA,93095,1996,
Albendazole,Albenza,1996-01-17,Treatment of hydatid disease (cystic echinococcosis due to E. granulosus larvae or alveolar echinococcosis due to E. multilocularis larvae).,Designated/Approved,Approved for Orphan Indication,"Treatment of cystic hydatid disease of the liver, lung, and peritoneum, caused by the larval form of the dog tapeworm, Echinococcus granulosus.",1996-06-11,2003-06-11,Amedra Pharmaceuticals LLC,2 Walnut Grove Drive,Suite 190,Horsham,Pennsylvania,19044,USA,94195,1996,146
Albendazole,Albenza,1996-01-18,"Treatment of neurocysticercosis due to Taenia solium as: 1) chemotherapy of parenchymal, subarachnoidal and racemose (cysts in spinal fluid) neurocysticercosis in symptomatic cases and 2) prophylaxis of epilepsy and other sequelae in asymptomatic neurocysticercosis.",Designated/Approved,Approved for Orphan Indication,"Treatment of parenchymal neurocysticercosis due to active lesions caused by larval forms of the pork tapeworm, Taenia solium.",1996-06-11,2003-06-11,Amedra Pharmaceuticals LLC,2 Walnut Grove Drive,Suite 190,Horsham,Pennsylvania,19044,USA,94295,1996,145
Dihydrotestosterone,Androgel -Dht,1996-02-05,Treatment of weight loss in AIDS patients with HIV-associated wasting.,Designated,,,N/A,N/A,"Besins Internaitonal, US Inc.",610 Herndon Parkway,Suite 750,Herndon,Virginia,20170,USA,93995,1996,
Testosterone,Androgel,1996-02-05,Treatment of weight loss in AIDS patients with HIV-associated wasting.,Designated/Withdrawn,,,N/A,N/A,"Unimed Pharmaceuticals, Inc.",901 Sawyer Rd.,,Marietta,Georgia,30062,USA,94595,1996,
Antihemophilic factor (recombinant),"Refacto, Xyntha",1996-02-08,For the control and prevention of hemorrhagic episodes and for surgical prophylaxis in patients with hemophilia A (congenital factor VIII deficiency or classic hemophilia).,Designated/Approved,Approved for Orphan Indication,,2000-03-06,N/A,"Wyeth Pharmaceuticals, Inc.",P. O. Box 8299,,Philadelphia,Pennsylvania,19101,USA,94495,1996,1488
Interferon beta-1a,Rebif,1996-03-11,Treatment of patients with secondary progressive multiple sclerosis.,Designated/Withdrawn,,,N/A,N/A,"EMD Serono, Inc.",One Technology Place,,Rockland,Massachusetts,2370,USA,95195,1996,
Thalidomide,Synovir,1996-03-11,Treatment of HIV-associated wasting syndrome.,Designated,,,N/A,N/A,Celgene Corporation,7 Powder Horn Dr.,,Warren,,,,94995,1996,
collagenase clostridium histolyticum,Xiaflex,1996-03-12,Treatment of Peyronie's disease.,Designated/Approved,Approved for Orphan Indication,Treatment of adult men with Peyronie's disease with a palpable plaque and curvature deformity of at least 30 degrees at the start of therapy.,2013-12-06,2020-12-06,"Auxilium Pharmaceuticals, Inc.",640 Lee Road,,Chesterbrook,Pennsylvania,19087,USA,95496,1996,6478
N-[4-(trifluoromethyl)phenyl]-5-methylisoxazole-4-carboxamide,n/a,1996-03-12,Treatment of ovarian cancer.,Designated,,,N/A,N/A,"Sugen, Inc.",230 East Grand Ave.,,South San Francisco,California,94080,USA,95095,1996,
Rifapentine,Priftin,1996-03-12,Prophylactic treatment of Mycobacterium avium complex in patients with AIDS and a CD4+ count less than or equal to 75/mm3.,Designated,,,N/A,N/A,"Hoechst Marion Roussel, Inc.",P.O. Box 9627,Mail Station: H3-M2516,Kansas City,Missouri,64134,USA,89695,1996,
Somatropin (r-DNA) for injection,Serostim,1996-03-26,Treatment of children with AIDS-associated failure-to-thrive including AIDS-associated wasting.,Designated,,,N/A,N/A,"EMD Serono, Inc.",One Technology Place,,Roackland,Massachusetts,2370,USA,94695,1996,
Idoxuridine,n/a,1996-04-08,Treatment of nonparenchymatous sarcomas.,Designated,,,N/A,N/A,"NeoPharm, Inc.","225 East Deerpath, Suite 250",,Lake Forest,Illinois,60045,USA,95696,1996,
Lipid/DNA human cystic fibrosis gene,n/a,1996-04-08,Treatment of cystic fibrosis.,Designated/Withdrawn,,,N/A,N/A,Genzyme Corporation,Metrowest Place,15 Pleasant St. Connector,Framingham,Massachusetts,1701,USA,90095,1996,
Liposomal prostaglandin E1 injection,n/a,1996-04-25,Treatment of acute respiratory distress syndrome.,Designated/Withdrawn,,,N/A,N/A,"Liposome Company, Inc.",One Research Way,,Princeton,New Jersey,8540,USA,95596,1996,
Amphotericin B lipid complex,Abelcet,1996-05-06,Treatment of invasive zygomycosis.,Designated/Withdrawn,,,N/A,N/A,"The Liposome Company, Inc.",One Research Way,,Princeton,New Jersey,8540,USA,97096,1996,
Amphotericin B lipid complex,Abelcet,1996-05-06,Treatment of invasive coccidioidomycosis.,Designated/Withdrawn,,,N/A,N/A,"The Liposome Company, Inc.",One Research Way,,Princeton,New Jersey,8540,USA,97396,1996,
Etiocholanedione,n/a,1996-05-07,Treatment of Prader-Willi syndrome.,Designated,,,N/A,N/A,"SuperGen, Inc.",4140 Dublin Blvd.,Suite 200,Dublin,California,94568,USA,95896,1996,
Arcitumomab,99m Tc-Labeled Cea-Scan,1996-05-10,"Diagnosis and localization of primary, residual, recurrent and metastatic medullary thyroid carcinoma.",Designated/Withdrawn,,,N/A,N/A,"Immunomedics, Inc.",300 American Road,,Morris Plains,New Jersey,7950,USA,96596,1996,
collagenase clostridium histolyticum,Xiaflex,1996-05-23,Treatment of advanced (involutional or residual stage) Dupuytren's disease.,Designated/Approved,Approved for Orphan Indication,Treatment of adult patients with Dupuytren's contracture with a palpable cord,2010-02-02,2017-02-02,"Auxilium Pharmaceuticals, Inc.",40 Valley Stream Parkway,,Malvern,Pennsylvania,19335,USA,92595,1996,5003
Selective inhibitor of polymorphonuclear leukocyte (PMN) elastase,n/a,1996-06-04,Therapeutic management of patients with lung disease attributable to cystic fibrosis.,Designated,,,N/A,N/A,DuPont Pharmaceuticals Company,"Chestnut Run, Maple Run",Centre Rd.,Wilmington,Delaware,19805,USA,96496,1996,
Methylnaltrexone,Relistor,1996-06-17,Treatment of chronic opioid-induced constipation unresponsive to conventional therapy.,Designated/Withdrawn by OPD,,,N/A,N/A,"Progenics Pharmaceuticals, Inc.",765 Old Saw Mill River Rd.,,Tarrytown,New York,10591,USA,92195,1996,
Uridine 5'-triphosphate,n/a,1996-06-26,To facilitate the removal of lung secretions in the treatment of patients with primary ciliary dyskinesia.,Designated/Withdrawn,,,N/A,N/A,"Inspire Pharmaceuticals, Inc.","4222 Emperor Boulevard, Suite 470",,Durham,North Carolina,27703,USA,99096,1996,
Amphotericin B lipid complex,Abelcet,1996-06-27,Treatment of invasive candidiasis.,Designated/Withdrawn,,,N/A,N/A,"The Liposome Company, Inc.",One Research Way,,Princeton,New Jersey,8540,USA,96996,1996,
Gusperimus,Spanidin,1996-06-27,Treatment of acute renal graft rejection episodes.,Designated/Withdrawn,,,N/A,N/A,Bristol-Myers Squibb Pharmaceutical Research Institute,5 Research Parkway,P.O. Box 5100,Wallingford,Connecticut,6492,USA,96896,1996,
L-2-oxothiazolidine-4-carboxylic acid,Procysteine,1996-07-30,Treatment of amyotrophic lateral sclerosis.,Designated,,,N/A,N/A,"Transcend Therapeutics, Inc.","640 Memorial Drive, 3rd Floor West",,Cambridge,Massachusetts,2139,USA,99296,1996,
Lucinactant,Surfaxin,1996-07-30,Treatment of meconium aspiration syndrome in newborn infants,Designated/Withdrawn,,,N/A,N/A,"Windtree Therapeutics, Inc.",2600 Kelly Road,Suite 100,Warrington,Pennsylvania,18976,USA,99796,1996,
Mitoxantrone,Novantrone,1996-08-21,Treatment of hormone refractory prostate cancer.,Designated/Approved,Approved for Orphan Indication,In combination with corticosteroids as initial chemotherapy for the treatment of patients with pain related to advanced hormone-refractory prostate cancer.,1996-11-13,2003-11-13,Serono,One Technology Place,,Rockland,Massachusetts,2370,USA,96696,1996,84
denileukin diftitox,Ontak,1996-08-21,Treatment of patients with cutaneous T-cell lymphoma,Designated/Approved,Approved for Orphan Indication,Treatment of patients with persistent or recurrent cutaneous T-cell lymphoma whose malignant cells express the CD25 component of the IL-2 receptor.,1999-02-05,2006-02-05,"Eisai, Inc.",300 Tice Boulevard,,Woodcliff Lake,New Jersey,7677,USA,99396,1996,898
Amphotericin B lipid complex,Abelcet,1996-08-21,Treatment of invasive protothecosis.,Designated/Withdrawn,,,N/A,N/A,"The Liposome Company, Inc.",One Research Way,,Princeton,New Jersey,8540,USA,97796,1996,
C1 esterase inhibitor (human),n/a,1996-08-21,Treatment and prevention of angioedema caused by C1-esterase inhibitor deficiency.,Designated,,,N/A,N/A,Alpha Therapeutic Corporation,5555 Valley Boulevard,,Los Angeles,California,90032,USA,95296,1996,
Methionine/L-methionine,n/a,1996-08-21,Treatment of AIDS myelopathy.,Designated,,,N/A,N/A,"Genopia USA, Inc.","90 Gold Street, 6N",,New York,New York,10038,USA,91795,1996,
2'-deoxycytidine,n/a,1996-09-09,As a host-protective agent in the treatment of acute myelogenous leukemia.,Designated,,,N/A,N/A,"Grant, Steven M.D.","Massey Cancer Center, VCU",P.O. Box 980230,Richmond,Virginia,23298,USA,99996,1996,
Aldesleukin,Proleukin,1996-09-10,Treatment of metastatic melanoma.,Designated/Approved,Approved for Orphan Indication,Treatment of adults with metastatic melanoma.,1998-01-09,2005-01-09,Chiron Corporation,4560 Horton St.,,Emeryville,California,94608,USA,100696,1996,486
"Human acid precursor alpha-glucosidase, recombinant",n/a,1996-09-10,Treatment of glycogen storage disease type II.,Designated/Withdrawn,,,N/A,N/A,Pharming/Genzyme LLC,c/o Genzyme Corporation,1 Mountain Rd.,Framingham,Massachusetts,1701,USA,100496,1996,
Prostaglandin E1 in lipid emulsion,Lipo-Pge1,1996-09-10,Treatment of ischemic ulceration of the lower limbs due to peripheral arterial disease.,Designated/Withdrawn,,,N/A,N/A,Alpha Therapeutic Corporation,5555 Valley Boulevard,,Los Angeles,California,90032,USA,88795,1996,
9-nitro-20-(S)-camptothecin,n/a,1996-09-16,Treatment of pancreatic cancer.,Designated,,,N/A,N/A,"SuperGen, Inc.","Two Annabel Lane, Suite 220",,San Ramon,California,94583,USA,100196,1996,
Amphotericin B lipid complex,Abelcet,1996-09-23,Treatment of invasive sporotrichosis.,Designated/Withdrawn,,,N/A,N/A,"The Liposome Company, Inc.",One Research Way,,Princeton,New Jersey,8540,USA,97696,1996,
Interferon gamma-1b,Actimmune,1996-09-30,"Delaying time to disease progression in patients with severe, malignant osteopetrosis.",Designated/Approved,Approved for Orphan Indication,"Delaying time to disease progression in patients with severe, malignant osteopetrosis.",2000-02-10,2007-02-10,Horizon Pharma Ireland Limited,"Connaught House, 1st Floor",1 Burlington Road,Dublin 4,,,Ireland,98796,1996,1228
Riluzole,Rilutek,1996-10-15,Treatment of Huntington's disease.,Designated,,,N/A,N/A,"Rhone-Poulenc Rorer Pharmaceuticals, Inc.",500 Arcola Road,PO Box 5096,Collegeville,Pennsylvania,19426,USA,100796,1996,
Leflunomide,n/a,1996-10-18,Prevention of acute and chronic rejection in patients who have received solid organ transplants.,Designated,,,N/A,N/A,"Williams, MD, James W.","Rush-Presbyterian-St. Luke's Medical Ctr., Dept. o",1653 West Congress Parkway,Chicago,Illinois,60612,USA,100296,1996,
Ibuprofen lysine,Neoprofen,1996-10-29,Treatment of patent ductus arteriosus,Designated/Approved,Approved for Orphan Indication,"For closure of a clinically significant patent ductus arteriosus in premature infants weighing between 500 and 1500 g, who are no more than 32 weeks gestational age when usual medical management (e.g., fluid restriction, diuretics, respiratory support, etc.) is ineffective",2006-04-13,2013-04-13,"Lundbeck, Inc.",Four Parkway North,,Deerfield,Illinois,60015,USA,101496,1996,3453
Ibuprofen i.v. solution,Salprofen,1996-10-29,Prevention of patent ductus arteriosus.,Designated,,,N/A,N/A,"Farmacon-IL, LLC",1720 Post Road East,Suite 213,Westport,Connecticut,6880,USA,100896,1996,
Filgrastim,Neupogen,1996-11-07,"Reduction in the duration of neutropenia, fever, antibiotic use, and hospitalization, following induction and consolidation treatment for acute myeloid leukemia.",Designated/Approved,Approved for Orphan Indication,"Reducing the time to neutrophil recovery and the duration of fever, following induction or consolidation chemotherapy treatment of adults with acute myeloid leukemia.",1998-04-02,2005-04-02,"Amgen, Inc.",One Amgen Center Dr.,,Thousand Oaks,California,91320,USA,101096,1996,511
Imexon,n/a,1996-11-08,Treatment of multiple myeloma.,Designated,,,N/A,N/A,AmpliMed Corporation,2321 Camino La Zorrela,,Tucson,Arizona,85718,USA,100996,1996,
Somatropin for injection,Nutropin,1996-11-18,As replacement therapy for growth hormone deficiency in adults after epiphyseal closure.,Designated/Approved,Approved for Orphan Indication,,1997-12-15,2004-12-15,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,USA,100396,1996,392
Monoclonal antibody-B43.13,Ovarex Mab-B43.13,1996-11-25,Treatment of epithelial ovarian cancer.,Designated,,,N/A,N/A,"Quest PharmaTech, Inc.",9407 20 Avenue,"Edmonton, Alberta T6N 1E5",,,,Canada,101396,1996,
Liposomal amphotericin B,Ambisome,1996-12-06,Treatment of visceral leishmaniasis.,Designated/Approved,Approved for Orphan Indication,Treatment of visceral leishmaniasis.,1997-08-11,2004-08-11,"Fujisawa USA, Inc.",3 Parkway North Center,,Deerfield,Illinois,60015,USA,99596,1996,248
Liposomal amphotericin B,Ambisome,1996-12-10,Treatment of cryptococcal meningitis.,Designated/Approved,Approved for Orphan Indication,Treatment of disseminated cryptococcosis including meningitis.,1997-08-11,2004-08-11,"Fujisawa USA, Inc.",3 Parkway North Center,,Deerfield,Illinois,60015,USA,99496,1996,244
Liposomal amphotericin B,Ambisome,1996-12-10,Treatment of histoplasmosis.,Designated,,,N/A,N/A,"Fujisawa USA, Inc.",3 Parkway North Center,,Deerfield,Illinois,60015,USA,99696,1996,
N-acetyl-procainamide,n/a,1996-12-10,Prevention of life-threatening ventricular arrhythmias in patients with documented procainamide-induced lupus.,Designated,,,N/A,N/A,NAPA of the Bahamas,"3560 Pennsylvania Avenue, Suite 7",,Dubuque,Iowa,52002,USA,99196,1996,
Porcine fetal neural gabaergic cells and/or precursors aseptically prepared and coated with anti-MHC-1 Ab for intracerebral implantation,Neurocell-Hd,1996-12-10,Treatment of Huntington's disease.,Designated,,,N/A,N/A,Diacrin/Genzyme LLC,One Kendall Square,,Cambridge,Massachusetts,2129,USA,102896,1996,
Porcine fetal neural gabaergic cells and/or precursors aseptically prepared for intracerebral implantation for Huntington's disease.,Neurocell-Hd,1996-12-10,Treatment of Huntington's disease.,Designated,,,N/A,N/A,Diacrin/Genzyme LLC,One Kendall Square,,Cambridge,Massachusetts,2139,USA,93295,1996,
Nitazoxanide,Alinia,1996-12-12,Treatment of cryptosporidiosis.,Designated/Approved,Approved for Orphan Indication,Treatment of diarrhea caused by Cryptosporidium parvum and Giardia lamblia,2002-11-22,2009-11-22,"Romark Laboratories, L.C.",6200 Courtney Campbell Causeway,Suite 880,Tampa,Florida,33607,USA,91895,1996,2171
Oprelvekin,Neumega,1996-12-17,Prevention of severe chemotherapy-induced thrombocytopenia.,Designated/Approved,Approved for Orphan Indication,,1997-11-25,2004-11-25,"Genetics Institute, Inc.",87 Cambridge Park Drive,,Cambridge,Massachusetts,2140,USA,96796,1996,343
Porcine fetal neural dopaminergic cells and/or precursors aseptically prepared and coated with anti-MHC-1 Ab for intracerebral implantation,Neurocell-Pd,1996-12-17,Treatment of Hoehn and Yahr stage 4 and 5 Parkinson's disease.,Designated,,,N/A,N/A,Diacrin/Genzyme LLC,One Kendall Square,,Cambridge,Massachusetts,2129,USA,102596,1996,
Porcine fetal neural dopaminergic cells and/or precursors aseptically prepared for intracerebral implantation.,Neurocell-Pd,1996-12-17,Treatment of Hoehn and Yahr stage 4 and 5 Parkinson's disease.,Designated,,,N/A,N/A,Diacrin/Genzyme LLC,One Kendall Square,,Cambridge,Massachusetts,2139,USA,93395,1996,
9-cis-retinoic acid,n/a,1997-01-02,Prevention of retinal detachment due to proliferative vitreoretinopathy.,Designated/Withdrawn,,,N/A,N/A,"Allergan, Inc.",2525 Dupont Drive,P.O. Box 19534,Irvine,California,92623,USA,101296,1997,
Dehydroepiandrosterone sulfate sodium,n/a,1997-01-28,To accelerate the re-epithelialization of donor sites in those hospitalized burn patients who must undergo autologous skin grafting.,Designated,,,N/A,N/A,"Pharmadigm, Inc.",2401 Foothill Drive,,Salt Lake City,Utah,84109,USA,101996,1997,
Enadoline hydrochloride,n/a,1997-01-28,Treatment of severe head injury.,Designated,,,N/A,N/A,Warner-Lambert Company,Parke-Davis Pharmaceutical Research Division,2800 Plymouth Road,Ann Arbor,Michigan,48105,USA,102496,1997,
Dehydroepiandrosterone sulfate sodium,n/a,1997-01-29,Treatment of serious burns requiring hospitalization.,Designated,,,N/A,N/A,"Pharmadigm, Inc.",2401 Foothill Drive,,Salt Lake City,Utah,84109,USA,102196,1997,
Lepirudin,Refluden,1997-02-13,Treatment of heparin-associated thrombocytopenia type II.,Designated/Approved,Approved for Orphan Indication,For anticoagulation in patients with heparin-induced thrombocytopenia and associated thromboembolic disease in order to prevent further thromboembolic complications.,1998-03-06,2005-03-06,Hoechst Marion Roussel,Frankfurt am Main,P.O. Box 1140,Marburg,,,Germany,102796,1997,386
chlorobutanol/propylene glycol/hydrochloric acid,Patul-End,1997-02-18,Treatment of patulous eustachian tube,Designated,,,N/A,N/A,Ear Foundation,"2420 Castillo Street, Suite 100",,Santa Barbara,California,93105,USA,98896,1997,
Porfiromycin,Promycin,1997-03-13,Treatment of cervical cancer.,Designated,,,N/A,N/A,"Boehringer Ingelheim Pharmaceuticals, Inc.",900 Ridgebury Road,PO Box 368,Ridgefield,Connecticut,6877,USA,103597,1997,
Poly-ICLC,Hiltonol,1997-03-17,Treatment of primary brain tumors.,Designated,,,N/A,N/A,Oncovir,3202 Cleveland Avenue N.W.,,Washington,District of Columbia,20008,USA,103197,1997,
"8 Cyclopentyl 1,3-dipropylxanthine",n/a,1997-03-24,Treatment of cystic fibrosis.,Designated/Withdrawn,,,N/A,N/A,"SciClone Pharmaceuticals, Inc.",901 Mariner's Island Boulevard,,San Mateo,California,94404,USA,103997,1997,
Beta alethine,Betathine,1997-03-24,Treatment of metastatic melanoma.,Designated,,,N/A,N/A,"Dovetail Technologies, Inc.","Bldg. 337, Paint Branch Drive",,College Park,Maryland,20742,USA,103397,1997,
Beta alethine,Betathine,1997-03-24,Treatment of multiple myeloma.,Designated,,,N/A,N/A,"Dovetail Technologies, Inc.","Bldg. 337, Paint Branch Drive",,College Park,Maryland,20742,USA,103297,1997,
Paclitaxel,Taxol,1997-03-25,Treatment of AIDS-related Kaposi's sarcoma.,Designated/Approved,Approved for Orphan Indication,For the second line treatment of AIDS-related Kaposi's sarcoma.,1997-08-04,2004-08-04,Bristol-Myers Squibb Pharmaceutical Research Institute,5 Research Parkway,P.O. Box 5100,Wallingford,Connecticut,6492,USA,103497,1997,132
Gp100 adenoviral gene therapy,n/a,1997-03-25,Treatment of metastatic melanoma.,Designated,,,N/A,N/A,Genzyme Corporation,500 Kendall Street,,Cambridge,Massachusetts,2142,USA,104397,1997,
MART-1 adenoviral gene therapy for malignant melanoma,n/a,1997-03-28,Treatment of metastatic melanoma.,Designated/Withdrawn,,,N/A,N/A,Genzyme Corporation,500 Kendall Street,,Cambridge,Massachusetts,1701,USA,103096,1997,
Levocarnitine,Carnitor,1997-04-07,Treatment of zidovudine-induced mitochondrial myopathy.,Designated,,,N/A,N/A,"Leadiant Biosciences, Inc.",9841 Washingtonian Blvd,Suite 500,Gaithersburg,Maryland,20878,USA,103897,1997,
Dimethylsulfoxide,n/a,1997-04-15,Topical treatment for the prevention of soft tissue injury following extravastion of cytotoxic drugs.,Designated,,,N/A,N/A,"Cancer Technologies, Inc.",7301 East 22nd Street,Suite 10E,Tucson,Arizona,85710,USA,104097,1997,
Paclitaxel,Paxene,1997-04-15,Treatment of AIDS-related Kaposi's sarcoma.,Designated,,,N/A,N/A,"Baker Norton Pharmaceuticals, Inc.",4400 Biscayne Boulevard,,Miami,Florida,33137,USA,104797,1997,
Oxandrolone,Oxandrin,1997-04-22,Treatment of patients with Duchenne's muscular dystrophy and Becker's muscular dystrophy.,Designated,,,N/A,N/A,"Savient Pharmaceuticals, Inc.","One Tower Center Boulevard, 12th floor",,East Brunswick,New Jersey,8816,USA,103797,1997,
"Retroviral vector, R-GC and GC gene 1750",n/a,1997-05-06,Treatment of Gaucher disease.,Designated/Withdrawn,,,N/A,N/A,Genzyme Corporation,500 Kendall Street,,Cambridge,Massachusetts,1701,USA,102396,1997,
Suramin,Metaret,1997-05-06,Treatment of hormone-refractory prostate cancer.,Designated,,,N/A,N/A,Warner-Lambert Company,Parke-Davis Pharmaceutical Research Division,2800 Plymouth Road,Ann Arbor,Michigan,48105,USA,104897,1997,
Fampridine,Neurelan,1997-06-02,"Treatment of chronic, incomplete spinal cord injury.",Designated,,,N/A,N/A,"Acorda Therapeutics, Inc.",15 Skyline Dr.,,Hawthorne,New York,10532,USA,104497,1997,
treprostinil,Remodulin,1997-06-04,Treatment of pulmonary arterial hypertension.,Designated/Approved,Approved for Orphan Indication,Treatment of pulmonary arterial hypertension.,2002-05-21,2009-05-21,United Therapeutics Corp.,55 T.W. Alexander Dr.,,Research Triangle Park,North Carolina,27709,USA,105197,1997,1812
Allogeneic peripheral blood mononuclear cells sensitized against patient alloantigens by mixed lymphocyte culture,Cytoimplant,1997-06-13,Treatment of pancreatic cancer,Designated,,,N/A,N/A,"Applied Immunotherapeutics, LLC",14132 E. Firestone Boulevard,,Santa Fe Springs,California,90670,USA,104997,1997,
Pegvisomant,Somavert,1997-06-24,Treatment of acromegaly.,Designated/Approved,Approved for Orphan Indication,"Treatment of acromegaly in patients who have had an inadequate response to surgery and/or radiation therapy and/or other medical therapies, or for whom these therapies are not appropriate",2003-03-25,2010-03-25,Sensus Corporation,"Suite 430,",98 San Jacinto Boulevard,Austin,Texas,78701,USA,105097,1997,2100
Porcine Sertoli cells aseptically prepared for intracerebral co-implantation with fetal neural tissue,N-Graft,1997-06-24,Treatment of Hoehn and Yahr stage four and five Parkinson's disease.,Designated,,,N/A,N/A,"Titan Pharmaceuticals, Inc.",Post Office Plaza,"50 Division Street, Suite 503",Somerville,New Jersey,8876,USA,104697,1997,
Busulfan,Spartaject,1997-07-07,Treatment of primary brain malignancies.,Designated,,,N/A,N/A,"SuperGen, Inc.","Two Annabel Lane, Suite 220",,San Ramon,California,94583,USA,105897,1997,
Icodextrin 7.5% with Electrolytes Peritoneal Dialysis Solution,Extraneal (With 7.5% Icodextrin) Peritoneal Dialysis Solutio,1997-07-18,Treatment of those patients having end stage renal disease and requiring peritoneal dialysis treatment.,Designated/Approved,Approved for Orphan Indication,For use as a single daily exchange for the long (8-16 hour) dwell during continuous ambulatory peritoneal dialysis (CAPD) or automated peritoneal dialysis (APD) for the management of chronic renal failure.,2002-12-20,2009-12-20,Baxter Healthcare Corporation,Renal Division,1620 Waukegan Road,McGaw Park,Illinois,60085,USA,105697,1997,1981
Allogeneic human retinal pigment epithelial cells on gelatin microcarriers,Spheramine,1997-07-18,Treatment of Hoehn and Yahr stage 3 and 4 Parkinson's disease.,Designated/Withdrawn,,,N/A,N/A,"Bayer Healthcare Pharmaceuticals, Inc.",100 Bayer Boulevard,,Whippany,New Jersey,7981,USA,105797,1997,
"Pentasaccharide ethyl glycoside consisting of one alpha-D-sialylosyl residue as a sodium salt, two beta-D-galactopyranosyl residues, one 2-acetamido-beta-D-glucopyranosyl unit, and one alpha-L-fucopyranosyl unit",Cylexin,1997-07-18,Treatment of neonates and infants undergoing cardiopulmonary bypass during surgical repair of congenital heart lesions.,Designated,,,N/A,N/A,Cytel Corporation,3525 John Hopkins Court,,San Diego,California,92121,USA,106297,1997,
Poloxamer 188,n/a,1997-08-05,Treatment of vasospasm in subarachnoid hemorrhage patients following surgical repair of a ruptured cerebral aneurysm.,Designated,,,N/A,N/A,CytRx Corporation,154 Technology Parkway,,Norcross,Georgia,30092,USA,102696,1997,
Recombinant human acid alpha-glucosidase; alglucosidase alfa,1. Myozyme 2. Lumizyme,1997-08-19,Treatment of glycogen storage disease type II.,Designated/Approved,Approved for Orphan Indication,"Myozyme for use in patients with Pompe disease (GAA deficiency). Alglucosidase alfa has been shown to improve ventilator-free survival in patients with infantile onset Pompe disease as compared to an untreated historical control, whereas use of Alphaglucosidase in patients with other forms of Pompe disease has not been adequately studied to assure safety and efficacy.",2006-04-28,2013-04-28,Genzyme Corporation,500 Kendall Street,,Cambridge,Massachusetts,2142,USA,106597,1997,3174
Recombinant human acid alpha-glucosidase; alglucosidase alfa,1. Myozyme 2. Lumizyme,1997-08-19,Treatment of glycogen storage disease type II.,Designated/Approved,Approved for Orphan Indication,"Lumizyme for patients 8 years and older with late (non-infantile) onset Pompe disease (GAA deficiency) who do not have evidence of cardiac hypertrophy. The safety and efficacy of Lumizyme (alglucosidase alfa) have not been evaluated in controlled clinical trials in infantile-onset patients, or in late (non-infantile) onset patients less than 8 years of age",2010-05-24,N/A,Genzyme Corporation,500 Kendall Street,,Cambridge,Massachusetts,2142,USA,106597,1997,4661
Cysteamine hydrochloride,Cystaran,1997-08-19,Treatment of corneal cystine crystal accumulation in cystinosis patients.,Designated/Approved,Approved for Orphan Indication,Treatment of corneal cystine crystal accumulation in patients with cystinosis,2012-10-02,2019-10-02,"Leadiant Biosciences, Inc.",9841 Washingtonian Blvd,Suite 500,Gaithersburg,Maryland,20878,USA,105997,1997,5523
Recombinant human acid alpha-glucosidase; alglucosidase alfa,1. Myozyme 2. Lumizyme,1997-08-19,Treatment of glycogen storage disease type II.,Designated/Approved,Approved for Orphan Indication,(Lumizyme) Patients with Pompe disease (acid alpha-glucosidase (GAA deficiency)).,2014-08-01,N/A,Genzyme Corporation,500 Kendall Street,,Cambridge,Massachusetts,2142,USA,106597,1997,6191
Alpha-melanocyte stimulating hormone,n/a,1997-08-19,Prevention and treatment of intrinsic acute renal failure due to ischemia.,Designated,,,N/A,N/A,"National Institute of Diabetes, and Digestive and Kidney Diseases","National Institutes of Health, 31 Center Drive MSC","Building 31, Room 9N-222",Bethesda,Maryland,20892,USA,106497,1997,
Short chain fatty acid enema,Colomed,1997-08-19,Treatment of chronic radiation proctitis.,Designated,,,N/A,N/A,"Richard I. Breuer, M.D.","1000 Central Street, Suite 615",,Evanston,Illinois,60201,USA,106397,1997,
Purified extract of Pseudomonas aeruginosa,Immudyn,1997-09-22,Treatment of immune thrombocytopenia purpura where it is required to increase platelet counts.,Designated,,,N/A,N/A,"Able Laboratories, Inc.",200 Highland Avenue,Suite 30,Needham,Massachusetts,2494,USA,106697,1997,
Testosterone,Theraderm Testosterone Transdermal System,1997-09-22,For use as physiologic testosterone replacement in androgen deficient HIV+ patients with an associated weight loss.,Designated,,,N/A,N/A,Watson Laboratories,Research Park,417 Wakara Way,Salt Lake City,Utah,84108,USA,104197,1997,
laronidase,Aldurazyme,1997-09-24,Treatment of patients with mucopolysaccharidosis-I.,Designated/Approved,Approved for Orphan Indication,Treatment for patients with Hurler and Hurler-Scheie forms of Mucopolysaccharidosis I (MPS I) and for patients with the Scheie form who have moderate to severe symptoms,2003-04-30,2010-04-30,"BioMarin Pharmaceutical, Inc.",105 Digital Drive,,Novato,California,94949,USA,106097,1997,2044
Recombinant human thrombopoietin,n/a,1997-09-29,For use in accelerating platelet recovery in patients undergoing hematopoietic stem cell transplantation.,Designated,,,N/A,N/A,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,USA,106897,1997,
alemtuzumab,Campath,1997-10-20,Treatment of chronic lymphocytic leukemia.,Designated/Approved,Approved for Orphan Indication,The treatment of patients with B-cell chronic lymphocytic leukemia who have been treated with alkylating agents and who have failed fludarabine therapy.,2001-05-07,2008-05-07,Genzyme Corporation,4545 Horizon Hill Blvd.,,San Antonio,Texas,78229,USA,107197,1997,1295
Apomorphine,n/a,1997-10-20,For use as rescue treatment for early morning motor dysfunction in late-stage Parkinson's disease.,Designated/Withdrawn,,,N/A,N/A,Scherer DDS,Frankland Road,Swindon SN5 8RU,Wiltshire,,,United Kingdom,107997,1997,
Pegylated recombinant human megakaryocyte growth and development factor,Megagen,1997-10-20,For reducing the period of thrombocytopenia in patients undergoing hematopoietic stem cell transplantation.,Designated/Withdrawn,,,N/A,N/A,"Amgen, Inc.",One Amgen Center Dr.,,Thousand Oaks,California,91320,USA,107097,1997,
Recombinant human interleukin-12,n/a,1997-10-20,Treatment of renal cell carcinoma.,Designated,,,N/A,N/A,"Genetics Institute, Inc.",87 Cambridge Park Drive,,Cambridge,Massachusetts,2140,USA,107597,1997,
Calcium gluconate,Calgonate,1997-11-20,For use as a wash for hydrofluoric acid spills on human skin.,Designated,,,N/A,N/A,Calgonate Corp.,3310 South Ocean Blvd,Unit 132,Highland Beach,Florida,33487,USA,108997,1997,
Pergolide,Permax,1997-11-20,Treatment of Tourette's syndrome.,Designated/Withdrawn,,,N/A,N/A,"Sallee, Floyd R. M.D., Ph.D.",Cincinnati Children's Hospital Medical Center,3333 Burnet Ave.,Cincinnati,Ohio,45229,USA,108197,1997,
Chondrocyte-alginate gel suspension,n/a,1997-12-01,For use in correcting vesicoureteral reflux in the pediatric population.,Designated,,,N/A,N/A,"Curis, Inc.",61 Moulton Street,,Cambridge,Massachusetts,2138,USA,107697,1997,
Urofollitropin,Fertinex,1997-12-05,"For the initiation and re-initiation of spermatogenesis in adult males with reproductive failure due to hypothalamic or pituitary dysfunction, hypogonadotropic hypogonadism.",Designated/Withdrawn,,,N/A,N/A,"EMD Serono, Inc.",One Technology Place,,Rockland,Massachusetts,2370,USA,107397,1997,
Sterile talc,Steritalc,1997-12-08,Treatment of pneumothorax,Designated/Approved,Approved for Orphan Indication,To decrease the recurrence of pneumothorax in adults.,2017-05-01,2024-05-01,Novatech SA,Z.I. Athelia III,13705 La Ciotat Cedex,,,,France,109297,1997,7084
Sterile talc,Steritalc,1997-12-08,Treatment of malignant pleural effusion,Designated/Approved,Approved for Orphan Indication,To decrease the recurrence of malignant pleural effusions in symptomatic patients following maximal drainage of the pleural effusion.,2017-05-01,TBD,Novatech SA,Z.I. Athelia III,13705 La Ciotat Cedex,,,,France,106797,1997,7084
Tetrabenazine,Xenazine,1997-12-11,Treatment of Huntington's disease,Designated/Approved,Approved for Orphan Indication,Treatment of chorea associated with Huntington's disease,2008-08-15,2015-08-15,"Prestwick Pharmaceuticals, Inc",1825 K Street NW,Suite 1475,Washington,District of Columbia,20006,USA,108897,1997,3900
Duramycin,n/a,1997-12-11,Treatment of cystic fibrosis.,Designated,,,N/A,N/A,"Lantibio, Inc.",100 Europa Drive,Suite 421,Chapel Hill,North Carolina,27517,USA,107897,1997,
Genetically engineered human recombinant IgG4 monoclonal antibody directed against human TNF alpha,n/a,1997-12-11,Treatment of Crohn's disease.,Designated,,,N/A,N/A,Celltech Chiroscience Limited,216 Bath Road,Berkshire,,,,United Kingdom,108497,1997,
Basiliximab,Simulect,1997-12-12,Prophylaxis of solid organ rejection.,Designated/Approved,Approved for Orphan Indication,Prophylaxis of acute organ rejection in patients receiving renal transplantation when used as part of an immunosuppressive regimen that includes cyclosporine and corticosteroids.,1998-05-12,2005-05-12,Novartis Pharmaceuticals Corporation,59 Route 10,,East Hanover,New Jersey,7936,USA,109197,1997,151
Sodium dichloroacetate,n/a,1997-12-31,Treatment of congenital lactic acidosis.,Designated/Withdrawn,,,N/A,N/A,"Questcor Pharmaceuticals, Inc.",3260 Whipple Rd.,,Union City,California,94587,USA,108797,1997,
L-baclofen,n/a,1998-01-06,Treatment of trigeminal neuralgia,Designated,,,N/A,N/A,Osmotica Pharmaceutical Corp.,1205 Culbreth Drive,Suite 200,Wilmington,North Carolina,28405,USA,109397,1998,
Thymalfasin,Zadaxin,1998-01-08,Treatment of DiGeorge anomaly with immune defects.,Designated,,,N/A,N/A,"SciClone Pharmaceuticals, Inc.",901 Mariner's Island Blvd.,,San Mateo,California,94404,USA,109597,1998,
carglumic acid,Carbaglu,1998-01-20,Treatment of N-acetylglutamate synthetase deficiency.,Designated/Approved,Approved for Orphan Indication,As an adjunctive therapy for the treatment of acute hyperammonemia due to the deficiency of the hepatic enzyme N-acetylglutamate synthase (NAGS) and as manitenance therapy for chronic hyperammonemia due to NAGS deficiency,2010-03-18,2017-03-18,Orphan Europe SARL,Immeuble Le Wilson,70 avenue du General de Gaulle,92800 Puteaux,,,France,109997,1998,4440
Bindarit,n/a,1998-02-03,Treatment of lupus nephritis.,Designated,,,N/A,N/A,"Angelini Pharmaceuticals, Inc.",70 Grand Avenue,Suite 109,River Edge,New Jersey,7661,USA,110097,1998,
Recombinant humanized monclonal antibody 5c8,n/a,1998-02-03,Treatment of immune thrombocytopenic purpura.,Designated,,,N/A,N/A,"Biogen, Inc.",14 Cambridge Center,,Cambridge,Massachusetts,2142,USA,109897,1998,
rifaximin,Normix,1998-02-10,Treatment of hepatic encephalopathy,Designated/Approved,Approved for Orphan Indication,Reduction in the risk of overt hepatic encephalopathy (HE) recurrence in patients greater than or equal to 18 years of age,2010-03-24,2017-03-24,"Salix Pharmaceuticals, Inc.",400 Somerset Corporate Blvd,,Somerset,New Jersey,8807,USA,109497,1998,4425
Recombinant humanized monoclonal antibody 5c8,n/a,1998-02-18,Treatment of systemic lupus erythematosus.,Designated,,,N/A,N/A,"Biogen, Inc.",14 Cambridge Center,,Cambridge,Massachusetts,2142,USA,111298,1998,
Thalidomide,n/a,1998-02-27,Treatment of primary brain malignancies.,Designated,,,N/A,N/A,Celgene Corporation,7 Powder Horn Dr.,,Warren,,,,110197,1998,
Arsenic trioxide,Trisenox,1998-03-03,Treatment of acute promyelocytic leukemia.,Designated/Approved,Approved for Orphan Indication,"For induction of remission and consolidation in patients with acute promyelocytic leukemia (APL) who are refractory to, or have relapsed from, retinoid and anthracycline chemotherapy, and whose APL is characterized by the presence of the t(15;17) translocation of PML/RAR-alpha gene expression.",2000-09-25,2007-09-25,"Teva Branded Pharmaceutical Products R&D, Inc.",41 Moores Road,,Frazer,Pennsylvania,19355,USA,109697,1998,937
Arsenic trioxide,Trisenox,1998-03-03,Treatment of acute promyelocytic leukemia.,Designated/Approved,Approved for Orphan Indication,In combination with tretinoin for treatment of adults with newly-diagnosed low-risk acute promyelocytic leukemia (APL) whose APL is characterized by the presence of the t(15;17) translocation or PML/RAR-alpha gene expression.,2018-01-12,2025-01-12,"Teva Branded Pharmaceutical Products R&D, Inc.",41 Moores Road,,Frazer,Pennsylvania,19355,USA,109697,1998,7255
Phenylacetate,n/a,1998-03-06,"For use as an adjunct to surgery, radiation therapy and chemotherapy for the treatment of patients with primary or recurrent malignant glioma.",Designated,,,N/A,N/A,"Elan Drug Delivery, Inc.",1300 Gould Dr.,,Gainesville,Georgia,30504,USA,110698,1998,
recombinant human alpha-1 antitrypsin,n/a,1998-03-06,Treatment of cystic fibrosis.,Designated,,,N/A,N/A,PPL Therapeutics (Scotland) Limited,"Roslin, Edinburgh",EH259PP Scotland,,,,United Kingdom,111098,1998,
Alitretinoin,Panretin,1998-03-24,Treatment of AIDS-related Kaposi's sarcoma.,Designated/Approved,Approved for Orphan Indication,Topical treatment of cutaneous lesions in patients with AIDS-related Kaposi's sarcoma.,1999-02-02,2006-02-02,"Eisai, Inc",300 Tice Blvd,,Woodcliff Lake,New Jersey,7677,USA,110998,1998,315
Beclomethasone dipropionate,n/a,1998-03-27,For oral administration in the treatment of intestinal graft-versus-host disease.,Designated,,,N/A,N/A,"Soligenix, Inc.",29 Emmons Drive,,Princeton,New Jersey,8540,USA,111198,1998,
Pentostatin,Nipent,1998-03-27,Treatment of cutaneous T-cell lymphoma.,Designated,,,N/A,N/A,"SuperGen, Inc.",4140 Dublin Blvd.,Suite 200,Dublin,California,94568,USA,111998,1998,
"Corticotropin-releasing factor, human",Xerecept,1998-04-06,Treatment of peritumoral brain edema.,Designated,,,N/A,N/A,"Neurobiological Technologies, Inc.",1387 Marina Way South,,Richmond,California,94804,USA,108097,1998,
Dimethylsulfoxide,n/a,1998-04-06,Treatment of palmar-plantar erythrodysethesia syndrome.,Designated,,,N/A,N/A,"Cancer Technologies, Inc.",7301 East 22nd Street,Suite 10E,Tucson,Arizona,85710,USA,108697,1998,
Tacrolimus,Prograf,1998-04-06,Prophylaxis of graft-versus-host-disease.,Designated,,,N/A,N/A,"Fujisawa USA, Inc.",3 Parkway North Center,,Deerfield,Illinois,60015,USA,111398,1998,
Tiapride,n/a,1998-04-21,Treatment of Tourette's syndrome.,Designated/Withdrawn,,,N/A,N/A,"Sanofi-Synthelabo, Inc.",9 Great Valley Parkway,PO Box 3026,Malvern,Pennsylvania,19355,USA,111798,1998,
Sodium phenylbutyrate,n/a,1998-04-24,"For use as an adjuct to surgery, radiation therapy and chemotherapy for the treatment of patients with primary or recurrent malignant glioma.",Designated,,,N/A,N/A,"Elan Drug Delivery, Inc.",1300 Gould Dr.,,Gainesville,Georgia,30504,USA,110598,1998,
Liposomal cyclosporin A,Cyclospire,1998-04-30,For aerosolized administration in the prevention and treatment of lung allograft rejection and pulmonary rejection events associated with bone marrow transplantation.,Designated,,,N/A,N/A,"Vernon Knight, M.D.","Baylor College of Medicine, Dept. of Molecular Phy",One Baylor Plaza,Houston,Texas,77030,USA,112798,1998,
S-adenosylmethionine,n/a,1998-04-30,Treatment of AIDS-myelopathy.,Designated,,,N/A,N/A,"Genopia USA, Inc.","90 Gold Street, 6N",,New York,New York,10038,USA,111498,1998,
Amifostine,Ethyol,1998-05-12,Reduction of the incidence of moderate to severe xerostomia in patients undergoing post-operative radiation treatment for head and neck cancer.,Designated/Approved,Approved for Orphan Indication,"Reduction of the incidence of moderate to severe xerostomia in patients undergoing post-operative radiation treatment for head and neck cancer, where the radiation port includes a substantial portion of the parotid glands.",1999-06-24,2006-06-24,"Medimmune Oncology, Inc.",One Tower Bridge,"100 Front St., Suite 400",West Conshohocken,Pennsylvania,19428,USA,111698,1998,408
"1,5-(Butylimino)-1,5 dideoxy,D-glucitol",n/a,1998-05-12,Treatment of Fabry's disease.,Designated,,,N/A,N/A,Oxford GlycoSciences,"10, The Quadrant",Abington Science Park,United Kingdom,,,United Kingdom,112198,1998,
Tetrabenazine,n/a,1998-05-12,Treatment of moderate/severe tardive dyskinesia.,Designated,,,N/A,N/A,"Prestwick Pharmaceuticals, Inc.","1825 K Street, NW",Suite 1475,Washington,District of Columbia,20006,USA,109797,1998,
"Ethyl 4-(3,4-dimethoxyphenyl)-6,7-dimethoxy-2-(1,2,4-triazol-1-ylmethyl)quinoline-3-carboxylate",n/a,1998-05-13,Treatment of Crohn's disease.,Designated/Withdrawn,,,N/A,N/A,Tap Holdings Inc.,2355 Waukegan Road,,Deerfield,Illinois,60015,USA,112698,1998,
Benzydamine hydrochloride,Tantum,1998-05-18,Prophylactic treatment of oral mucositis resulting from radiation therapy for head and neck cancer.,Designated,,,N/A,N/A,"Angelini Pharmaceuticals, Inc.",70 Grand Avenue,,River Edge,New Jersey,7661,USA,111898,1998,
miglustat,Zavesca,1998-05-29,Treatment of Gaucher disease.,Designated/Approved,Approved for Orphan Indication,"Treatment of mild to moderate Type I Gaucher disease in adults for whom enzyme replacement therapy is not a therapeutic option (e.g., due to constraints such as allergy, hypersensitivity, or poor venous access).",2003-07-31,2010-07-31,Actelion Pharmaceuticals Ltd,Gewerbestrasse 16,CH - 4123 Allschwi,,,,Switzerland,112598,1998,1889
"Fructose-1,6-diphosphate",Cordox,1998-05-29,Treatment of painful vaso-occlusive episodes associated with sickle cell disease.,Designated/Withdrawn,,,N/A,N/A,"Questcor Pharmaceuticals, Inc.",3260 Whipple Road,,Union City,California,94587,USA,112398,1998,
Liposomal N-Acetylglucosminyl-N-Acetylmuramly-L-Ala-D-isoGln-L-Ala -gylcerolidpalmitoyl,Immther,1998-06-10,Treatment of Ewing's sarcoma.,Designated,,,N/A,N/A,Endorex Corp.,900 North Shore Drive,,Lake Bluff,Illinois,60044,USA,114898,1998,
Liposomal N-Acetylglucosminyl-N-Acetylmuramly-L-Ala-D-isoGln-L-Ala -gylcerolidpalmitoyl,Immther,1998-06-10,Treatment of osteosarcoma.,Designated,,,N/A,N/A,Endorex Corp.,900 North Shore Drive,,Lake Bluff,Illinois,60044,USA,114098,1998,
Prostaglandin E1 enol ester (AS-013),Circulase,1998-06-12,Treatment of Fontaine Stage IV chronic critical limb ischemia.,Designated,,,N/A,N/A,"LTT Baio-Pharma Co., Ltd",Research & Development Division,"2-5-1 Atago, Minato-ku, Tokyo",,,,Japan,112898,1998,
Alpha-galactosidase A,Replagal,1998-06-22,Long-term enzyme replacement therapy for the treatment of Fabry disease,Designated,,,N/A,N/A,"Shire Human Genetic Therapies, Inc.",700 Main Street,,Cambridge,Massachusetts,2139,USA,112998,1998,
Recombinant bactericidal/permeability-increasing protein,Neuprex,1998-06-22,Treatment of severe meningococcal disease.,Designated/Withdrawn,,,N/A,N/A,Xoma (US) LLC,2910 Seventh Street,,Berkeley,California,94710,USA,112298,1998,
epratuzumab,Lymphocide,1998-07-13,Treatment of non-Hodgkin's lymphoma,Designated,,,N/A,N/A,"Immunomedics, Inc.",300 The American Road,,Morris Plains,New Jersey,7950,USA,113298,1998,
Peginterferon alfa-2a,Pegasys,1998-07-13,Treatment of renal cell carcinoma.,Designated,,,N/A,N/A,Hoffman-La Roche Inc.,340 Kingsland St.,,Nutley,New Jersey,7110,USA,113898,1998,
Recombinant human Clara Cell 10kDa protein,n/a,1998-07-13,Prevention of neonatal bronchopulmonary dysplasia in premature neonates with respiratory distress syndrome.,Designated,,,N/A,N/A,"Therabron Therapeutics, Inc.",9430 Key West Avenue,Suite 150,Rockville,Maryland,20850,USA,113998,1998,
Thalidomide,n/a,1998-07-29,Treatment of Kaposi's sarcoma.,Designated,,,N/A,N/A,Celgene Corporation,7 Powder Horn Dr.,,Warren,,,,114998,1998,
Aldesleukin,Proleukin,1998-07-31,Treatment of acute myelogenous leukemia.,Designated/Withdrawn,,,N/A,N/A,Chiron Corporation,4560 Horton St.,,Emeryville,California,94608,USA,113098,1998,
Botulinum toxin type A,Dysport,1998-08-12,Treatment of spasmodic torticollis (cervical dystonia).,Designated,,,N/A,N/A,Ipsen Biopharm Limited,1 Bath Road,Maidenhead,"Berkshire, SL6 4UH",,,United Kingdom,114198,1998,
Octreotide,Sandostatin Lar,1998-08-24,Treatment of severe diarrhea and flushing associated with malignant carcinoid tumors.,Designated/Approved,Approved for Orphan Indication,Supression of severe diarrhea and flushing associated with malignant carcinoid syndrome.,1998-11-25,2005-11-25,Novartis Pharmaceuticals Corporation,59 Route 10,,East Hanover,New Jersey,7936,USA,114698,1998,93
Octreotide,Sandostatin Lar,1998-08-24,Treatment of diarrhea associated with vasoactive intestinal peptide tumors (VIPoma).,Designated/Approved,Approved for Orphan Indication,Treatment of profuse watery diarrhea associated with VIPoma.,1998-11-25,2005-11-25,Novartis Pharmaceuticals Corporation,59 Route 10,,East Hanover,New Jersey,7936,USA,116898,1998,93
Octreotide,Sandostatin Lar,1998-08-24,Treatment of acromegaly.,Designated/Approved,Approved for Orphan Indication,Reduction of growth hormone and IGF-1 (somatomedin C) in acromegaly.,1998-11-25,2005-11-25,Novartis Pharmaceuticals Corporation,59 Route 10,,East Hanover,New Jersey,7936,USA,114598,1998,93
dexamethasone intravitreal implant,Ozurdex,1998-09-11,"Treatment of non-infectious ocular inflammation of the posterior segment in patients with intermediate, posterior, and panuveitis",Designated/Approved,Approved for Orphan Indication,For treatment of non-infectious uveitis affecting the posterior segment of the eye,2010-09-24,2017-09-24,Allergan,2525 Dupont Drive,,Irvine,California,92623,USA,115298,1998,4396
"3-(3,5-dimethyl-1H-2ylmethylene)-1,3-dihydro-indol-2-one",n/a,1998-09-11,Treatment of Kaposi's sarcoma.,Designated,,,N/A,N/A,"Sugen, Inc.",230 East Grand Ave.,,South San Francisco,California,94080,USA,116398,1998,
Humanized anti-human CD2 MAb,Medi-507,1998-09-17,"For the induction of donor-specific immunologic unresponsiveness resulting in prophylaxis of organ rejection without the need for chronic immunosuppressive therapy, in patients receiving allogeneic renal transplants.",Designated/Withdrawn,,,N/A,N/A,"Biotransplant, Inc.","Building 75, 3rd. Ave.",Charlestown Navy Yard,Charlestown,Massachusetts,2129,USA,107797,1998,
MN14 monoclonal antibody to carcinoembryonic antigen,Cea-Cide,1998-09-18,Treatment of small cell lung cancer,Designated,,,N/A,N/A,"Immunomedics, Inc.",300 The American Road,,Morris Plains,New Jersey,7950,USA,113498,1998,
temozolomide,Temodar,1998-10-05,Treatment of recurrent malignant glioma.,Designated/Approved,Approved for Orphan Indication,"Treatment of adult patients with refractory anaplastic astrocytoma, i.e., patients at first relapse who have experienced disease progression on a drug regimen containing a nitrosourea and procarbazine",1999-08-11,2006-08-11,Schering-Plough Research Institute,2000 Galloping Hill Rd.,,Kenilworth,New Jersey,7033,USA,116798,1998,310
temozolomide,Temodar,1998-10-05,Treatment of recurrent malignant glioma.,Designated/Approved,Approved for Orphan Indication,Treatment of adult patients with newly diagnosed glioblastoma multiforme concomitatly with radiotherapy and then as maintenance treatment,2005-03-15,2012-03-15,Schering-Plough Research Institute,2000 Galloping Hill Rd.,,Kenilworth,New Jersey,7033,USA,116798,1998,2353
Thalidomide,Thalomid,1998-10-14,Treatment of multiple myeloma,Designated/Approved,Approved for Orphan Indication,Treatment of patients with newly diagnosed multiple myeloma,2006-05-25,2013-05-25,Celgene Corporation,7 Powder Horn Dr.,,Warren,,,,115598,1998,2780
interferon Beta-1a,Avonex,1998-10-14,Treatment of juvenile rheumatoid arthritis.,Designated/Withdrawn,,,N/A,N/A,"Biogen, Inc.",14 Cambridge Center,,Cambridge,Massachusetts,2142,USA,115498,1998,
Mecamylamine,Inversine,1998-10-14,Treatment of Tourette's syndrome.,Designated,,,N/A,N/A,"Targacept, Inc.",200 East First St.,Suite 300,Winston-Salem,North Carolina,27101,USA,117598,1998,
Methoxsalen,Uvadex,1998-10-14,For use in conjunction with the UVAR photopheresis system to treat graft versus host disease.,Designated,,,N/A,N/A,"Therakos, Inc.",1001 Route 202,,Raritan,New Jersey,8869,USA,117298,1998,
Recombinant humanized MAb 5c8,n/a,1998-10-14,Prevention and treatment of Factor VIII/Factor IX inhibitors in patients with hemophilia A or B.,Designated,,,N/A,N/A,"Biogen, Inc.",14 Cambridge Center,,Cambridge,Massachusetts,2142,USA,113798,1998,
Temozolomide,Temodal,1998-10-14,Treatment of advanced metastatic melanoma.,Designated/Withdrawn,,,N/A,N/A,Merck & Company,2000 Galloping Hill Rd.,,Kenilworth,New Jersey,7033,USA,117198,1998,
etanercept,Enbrel,1998-10-27,Reduction in signs and symptoms of moderately to severely active polyarticular-course juvenile rheumatoid arthritis in patients who have had an inadequate response to one or more disease-modifying anti-rheumatic drugs.,Designated/Approved,Approved for Orphan Indication,Reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis (JIA) in patients ages 2 and older,1999-05-27,2006-05-27,Immunex Corporation,One Amgen Center Drive,,Thousand Oaks,California,91320,USA,116198,1998,212
"P1, P4-Di(uridine 5'-tetraphosphate), tetrasodium salt",n/a,1998-10-27,Treatment of cystic fibrosis.,Designated/Withdrawn,,,N/A,N/A,"Inspire Pharmaceuticals, Inc.","4222 Emperor Blvd., Suite 470",,Durham,North Carolina,27703,USA,116998,1998,
Doxorubicin liposome,Doxil,1998-11-04,Treatment of ovarian cancer.,Designated/Approved,Approved for Orphan Indication,"Treatment of metastatic carcinoma of the ovary in patients with disease that is refractory to both paclitaxel- and platinium-based chemotherapy regimens. Refractory disease is defined as disease that has progressed while on treatment, or within 6 months of completing treatment.",1999-06-28,2006-06-28,Alza Corporation,1550 Plymouth St.,PO Box 7210,Mountain View,California,94039,USA,117398,1998,236
Oxypurinol,n/a,1998-11-09,Treatment of hyperuricemia in patients intolerant to allopurinol.,Designated,,,N/A,N/A,Cardiome Pharma Corp.,3650 Westbrook Mall,"Vancouver, B.C.",,,,Canada,115798,1998,
Humanized anti-CD2 monoclonal antibody,n/a,1998-11-13,Treatment of graft-versus-host disease.,Designated/Withdrawn,,,N/A,N/A,"MedImmune, Inc.",35 West Watkins Mill Rd.,,Gaithersburg,Maryland,20878,USA,116498,1998,
Aldesleukin,Proleukin,1998-11-24,For the treatment non-Hodgkin's lymphoma.,Designated,,,N/A,N/A,"Prometheus Laboratories, Inc.",9410 Carroll Park Drive,,San Diego,California,92121,USA,116598,1998,
Amifostine,Ethyol,1998-11-24,For the reduction of the incidence and severity of toxicities associated with cisplatin administration.,Designated,,,N/A,N/A,Clinigen Group plc,"Pitcairn House, Crown Square",DE14 2WW,,,,United Kingdom,116298,1998,
MN14 monoclonal antibody to carcinoembryonic antigen,Cea-Cide,1998-11-24,Treatment of pancreatic cancer.,Designated/Withdrawn,,,N/A,N/A,"Immunomedics, Inc.",300 The American Road,,Morris Plains,New Jersey,7950,USA,117998,1998,
Murine MAb (Lym-1) and Iodine 131-I radiolabeled murine MAb (Lym-1) to human B-cell lymphoma,Oncolym,1998-11-27,Treatment of B-cell non-Hodgkin's lymphoma.,Designated,,,N/A,N/A,"Peregrine Pharmaceuticals, Inc.",14272 Franklin Ave.,Suite 100,Tustin,California,92780,USA,118198,1998,
Xenogeneic hepatocytes,Hepatassist Liver Assist System,1998-11-27,Treatment of severe liver failure.,Designated,,,N/A,N/A,"Circe Biomedical, Inc.",99 Hayden Ave.,,Lexington,Massachusetts,2421,USA,117098,1998,
"Follitropin alfa, recombinant",Gonal-F,1998-12-21,"For the initiation and re-initiation of spermatogenesis in adult males with reproductive failure due to hypothalamic or pituitary dysfunction, hypogonadotropic hypogonadism. AMENDED indication 6/27/00: For the induction of spermatogenesis in men with primary and secondary hypogonadotropic hypogonadism in whom the cause of infertility is not due to primary testicular failure.",Designated/Approved,Approved for Orphan Indication,For the induction of spermatogenesis in men with primary and secondary hypogonadotropic hypogonadism in whom the cause of infertility is not due to primary testicular failure.,2000-05-24,2007-05-24,"EMD Serono, Inc.",One Technology Place,,Rockland,Massachusetts,2370,USA,119398,1998,520
deferoxamine starch conjugate,n/a,1998-12-21,Treatment of chronic iron overload resulting from conventional transfusional treatment of beta-thalassemia major and sickle cell anemia.,Designated,,,N/A,N/A,"Biomedical Frontiers, Inc.","108710th Ave., S.E.",,Minneapolis,Minnesota,55414,USA,117698,1998,
"Papain, trypsin, and chymotrypsin",Wobe-Mugos,1998-12-21,Treatment of multiple myeloma.,Designated,,,N/A,N/A,"Marlyn Nutraceuticals, Inc.",14851 N. Scottsdale Rd.,,Scottsdale,Arizona,85254,USA,117498,1998,
Polyethylene glycol-modified uricase,Zurase,1998-12-21,Treatment of tumor lysis syndrome in cancer patients undergoing chemotherapy.,Designated,,,N/A,N/A,"EnzymeRx, LLC",17 Arcadian Avenue,Suite 104,Paramus,New Jersey,7652,USA,117798,1998,
Interferon beta-1a (recombinant human),Avonex,1999-01-07,Treatment of pulmonary fibrosis.,Designated/Withdrawn,,,N/A,N/A,"Biogen Idec, Inc.",14 Cambridge Center,,Cambridge,Massachusetts,2142,USA,111598,1999,
L-5-hydroxytryptophan,n/a,1999-01-20,Treatment of tetrahydrobiopterin deficiency.,Designated,,,N/A,N/A,"Watson Laboratories, Inc.",311 Bonnie Circle,P.O. Box 1900,Corona,California,91718,USA,118298,1999,
Bleomycin,Blenoxane,1999-02-09,Treatment of pancreatic cancer.,Designated,,,N/A,N/A,"Genetronics, Inc.",11199 Sorrento Valley Rd.,,San Diego,California,92121,USA,118498,1999,
Humanized MAb (IDEC-131) to CD40L,n/a,1999-02-09,Treatment of systemic lupus erythematosus.,Designated/Withdrawn,,,N/A,N/A,Biogen IdecInc.,3030 Callan Rd.,,San Diego,California,92121,USA,119298,1999,
Chelating agent delivering Holmium-166,n/a,1999-02-10,Treatment of multiple myeloma.,Designated,,,N/A,N/A,NeoRx Corporation,410 W. Harrison Street,,Seattle,Washington,98119,USA,119998,1999,
Iodine I-131 radiolabeled chimeric MAb tumor necrosis treatment (TNT-1B),131ichtnt-1,1999-02-12,Treatment of glioblastoma multiforme and anaplastic astrocytoma.,Designated,,,N/A,N/A,"Peregrine Pharmaceuticals, Inc.",14282 Franklin Ave.,,Tustin,California,92780,USA,119098,1999,
"N-acetylgalactosamine-4-sulfatase, recombinant human",Naglazyme,1999-02-17,Treatment of mucopolysaccharidosis Type VI (Maroteaux-Lamy syndrome).,Designated/Approved,Approved for Orphan Indication,For patients with mucopolysaccharidosis VI. Galsulfase has been shown to improve walking and stair-climbing capacity.,2005-05-31,2012-05-31,"BioMarin Pharmaceutical, Inc.",105 Digital Drive,,Novato,California,94949,USA,119898,1999,2295
C1-esterase inhibitor (recombinant),Ruconest,1999-02-23,Treatment of (acute attacks of) angioedema caused by hereditary or acquired C1-esterase inhibitor deficiency.,Designated/Approved,Approved for Orphan Indication,Treatment of acute attacks of hereditary angioedema (HAE) in adult and adolescent patients.,2014-07-16,2021-07-16,Pharming Group N.V.,P. O. Box 451 Darwinweg 24,2300 Al Leiden,Leiden,,,Netherlands,123599,1999,5622
Autologous DNP-conjugated tumor vaccine,M-Vax,1999-02-23,For adjuvant therapy in melanoma patients with surgically resectable lymph node metastasis (Stage III and limited Stage IV disease).,Designated,,,N/A,N/A,"Avax Technologies, Inc.",9200 Indian Creek Parkway,"Building 9, Suite 200",Overland Park,Kansas,66210,USA,119498,1999,
Recombinant human C1-esterase inhibitor,n/a,1999-02-23,Prophylactic treatment of angioedema caused by hereditary or acquired C1-esterase inhibitor deficiency.,Designated,,,N/A,N/A,Pharming Group N.V.,P. O. Box 451 Darwinweg 24,2300 Al Leiden,Leiden,,,Netherlands,122498,1999,
decitabine,Dacogen,1999-03-08,Treatment of myelodysplastic syndromes.,Designated/Approved,Approved for Orphan Indication,"for treatment of patients with myelodysplastic syndromes (MDS) including previously treated and untreated, de novo and secondary MDS of all French-American-British subtypes (refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, and chronic myelomonocytic leukemia) and intermediate-1, intermediate-2, and high-risk International Prognostic Scoring System groups",2006-05-02,2013-05-02,Otsuka Pharmaceutical Development,"and Commercialization, Inc.",508 Carnegie Center Drive,Princeton,New Jersey,8540,USA,122298,1999,2612
decitabine,n/a,1999-03-08,Treatment of chronic myelogenous leukemia.,Designated/Withdrawn,,,N/A,N/A,Otsuka Pharmaceutical Development &,"Commercialization, Inc.",508 Carnegie Center Drive,Princeton,New Jersey,8540,USA,123399,1999,
epoprostenol,Flolan,1999-03-22,Treatment of secondary pulmonary hypertension due to intrinsic precapillary pulmonary vascular disease.,Designated/Approved,Approved for Orphan Indication,treatment of pulmonary arterial hypertension (WHO Group 1) to improve exercise capacity. Studies establishing effectiveness included predominantly patients with NYHA Functional Class III-IV symptoms and etiologies of idiopathic or heritable PAH or PAH associated with connective tissue diseases.,2000-04-14,2007-04-14,GlaxoSmithKline,2301 Renaissance Blvd,P. O. Box 61540,King of Prussia,Pennsylvania,19406,USA,121698,1999,389
"Murine MAb to polymorphic epithelial mucin, human milk fat globule 1",Theragyn,1999-03-22,Adjuvant treatment of ovarian cancer.,Designated,,,N/A,N/A,Antisoma plc,West Africa House,Hanger Lane Ealing,London W5 3QR,,,United Kingdom,118098,1999,
Recombinant humanized MAb 5c8,n/a,1999-03-22,Prevention of rejection of pancreatic islet cell transplants.,Designated,,,N/A,N/A,"Biogen, Inc.",14 Cambridge Center,,Cambridge,Massachusetts,2142,USA,123499,1999,
Recombinant humanized MAb 5c8,n/a,1999-03-22,Prevention of rejection of solid organ transplants.,Designated,,,N/A,N/A,"Biogen, Inc.",14 Cambridge Center,,Cambridge,Massachusetts,2142,USA,120098,1999,
pegylated arginine deiminase,Hepacid,1999-03-26,Treatment of hepatocellular carcinoma,Designated,,,N/A,N/A,"Polaris Pharmaceuticals, Inc.",A Polaris Group Company,6370 Nancy Ridge Drive,San Diego,California,92121,USA,118398,1999,
6-hydroxymethylacylfulvene,n/a,1999-04-06,Treatment of histologically confirmed advanced or metastatic pancreatic cancer.,Designated/Withdrawn,,,N/A,N/A,"Eisai, Inc.",300 Tice Blvd,,Woodcliff Lake,New Jersey,7677,USA,122198,1999,
Eprodisate,Kiacta(Tm),1999-04-06,Treatment of secondary amyloidosis,Designated,,,N/A,N/A,"C. T. Development America, Inc.",663 Fifth Avenue,7th Floor,New York,New York,10022,USA,118998,1999,
Etanercept,Enbrel,1999-04-06,Treatment of Wegener's granulomatosis.,Designated/Withdrawn,,,N/A,N/A,Immunex Corporation,51 University Street,,Seattle,Washington,98101,USA,122999,1999,
Thalidomide,Thalomid,1999-04-06,Treatment of Crohn's disease.,Designated,,,N/A,N/A,Celgene Corporation,7 Powder Horn Dr.,,Warren,,,,121898,1999,
Pegylated arginine deiminase,Melanocid,1999-04-12,Treatment of invasive malignant melanoma.,Designated,,,N/A,N/A,"Polaris Pharmaceuticals, Inc.",A Polaris Group Company,Suite 106,San Diego,California,92121,USA,120898,1999,
Recombinant replication deficient adenovirus vector carrying human p53 gene,n/a,1999-04-12,Treatment of primary ovarian cancer.,Designated/Withdrawn,,,N/A,N/A,Schering Corporation,2000 Galloping Hill Rd.,,Kenilworth,New Jersey,7033,USA,122398,1999,
Rifalazil,n/a,1999-04-13,Treatment of pulmonary tuberculosis.,Designated,,,N/A,N/A,PathoGenesis Corporation,201 Elliott Avenue West,Suite 150,Seattle,Washington,98119,USA,122699,1999,
CT-2584 mesylate,n/a,1999-04-16,Treatment of malignant mesothelioma.,Designated/Withdrawn,,,N/A,N/A,"Cell Therapeutics, Inc.","501 Elliott Avenue West, #400",,Seattle,Washington,98119,USA,124899,1999,
CT-2584 Mesylate,n/a,1999-04-16,Treatment of adult soft tissue sarcoma.,Designated/Withdrawn,,,N/A,N/A,"Cell Therapeutics, Inc.","501 Elliott Avenue West, #400",,Seattle,Washington,98119,USA,121798,1999,
Recombinant human nerve growth factor,n/a,1999-04-16,Treatment of HIV-associated sensory neuropathy.,Designated,,,N/A,N/A,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,USA,110898,1999,
Beraprost,n/a,1999-04-29,"Treatment of pulmonary arterial hypertension associated with any New York Heart Association classification (Class I, II, III, or IV).",Designated,,,N/A,N/A,"LungRx, Inc.",1040 Spring Street,,Silver Spring,Maryland,20910,USA,123099,1999,
Fluoxetine,Prozac,1999-04-30,Treatment of autism.,Designated,,,N/A,N/A,"Neuropharm, Ltd.",Felcham Park House,Surrey KT229HD,,,,United Kingdom,123199,1999,
Parvovirus B19 (recombinant VP1 and VP2; S.frugiperda cells) vaccine,Medi-491,1999-05-07,Prevention of transient aplastic crisis in patients with sickle cell anemia.,Designated,,,N/A,N/A,"MedImmune, Inc.",35 West Watkins Mill Rd.,,Gaithersburg,Maryland,20878,USA,123699,1999,
"Japanese encephalitis vaccine (live, attenuated)",n/a,1999-05-19,Prevention of Japanese encephalitis.,Designated,,,N/A,N/A,"Glovax Co., Ltd.","Room 307, Koryo Academytel, 437-3","Ahyun-Dong, Mapo-Gu, Seoul 121-010",,,,,120998,1999,
Transgenic human alpha 1 antitrypsin,n/a,1999-05-19,Treatment of emphysema secondary to alpha 1 antitrypsin deficiency.,Designated,,,N/A,N/A,PPL Therapeutics (Scotland) Limited,"Roslin, Edinburgh",EH259PP Scotland,,,,United Kingdom,122899,1999,
Marijuana,n/a,1999-05-25,Treatment of HIV-associated wasting syndrome.,Designated,,,N/A,N/A,"Multidisciplinary Association for Psychedelic Studies, Inc.",3 Francis St.,,Belmont,Massachusetts,2478,USA,105397,1999,
111Indium pentetreotide,Somatother,1999-06-10,Treatment of somatostatin receptor positive neuroendocrine tumors.,Designated,,,N/A,N/A,Louisiana State University Medical Center Foundation,1600 Canal St.,10th Floor,New Orleans,Louisiana,70112,USA,121198,1999,
Lisofylline,n/a,1999-06-10,Treatment of patients undergoing induction therapy for acute myeloid leukemia.,Designated,,,N/A,N/A,"Cell Therapeutics, Inc.",501 Elliott Avenue West,Suite 400,Seattle,Washington,98119,USA,124099,1999,
Sodium dichloroacetate,Ceresine,1999-06-14,Treatment of severe head injury.,Designated/Withdrawn,,,N/A,N/A,"Questcor Pharmaceuticals, Inc.",3260 Whipple Rd.,,Union City,California,94587,USA,114798,1999,
Recombinant human insulin-like growth factor-I/insulin-like growth factor binding protein-3,n/a,1999-06-15,Treatment of major burns that require hospitalization.,Designated,,,N/A,N/A,"Insmed, Inc.",10 Finderne Ave,Building 10,Bridgewater,New Jersey,8807,USA,114298,1999,
Synthetic human secretin,Chirostim,1999-06-16,For use in the diagnosis of gastrinoma associated with Zollinger-Ellison syndrome.,Designated/Approved,Approved for Orphan Indication,"Stimulation of pancreatic secretions, including bicarbonate, to aid in the diagnosis of pancreatic exocrine dysfunction, stimulation of gastrin secretion to aid in the diagnosis of gastrinoma, and stimulation of pancreatic secretions to facilitate the identification of the ampulla of Vater and accessory papilla during endoscopic retrograde cholangiopancreatography",2004-04-09,N/A,"ChiRhoClin, Inc.",1550 Gallaudet Ave.,,Silver Spring,Maryland,20905,USA,120798,1999,1759
Synthetic human secretin,n/a,1999-06-16,For use in obtaining desquamated pancreatic cells for cytopathologic examination in pancreatic carcinoma.,Designated,,,N/A,N/A,"ChiRhoClin, Inc.",1550 Gallaudet Ave.,,Silver Spring,Maryland,20905,USA,120698,1999,
Synthetic human secretin,n/a,1999-06-16,For use in the evaluation of exocrine pancreas function.,Designated,,,N/A,N/A,"ChiRhoClin, Inc.",1550 Gallaudet Ave.,,Silver Spring,Maryland,20905,USA,120598,1999,
Bexarotene,Targretin,1999-06-18,Treatment of cutaneous T-cell lymphoma.,Designated/Approved,Approved for Orphan Indication,Treatment of cutaneous manifestations of cutaneous T-cell lymphoma in patients who are refractory to at least one prior systemic therapy.,1999-12-29,2006-12-29,"Eisai, Inc.",300 Tice Blvd,,Woodcliff Lake,New Jersey,7677,USA,124699,1999,194
Synthetic porcine secretin,Secreflo,1999-06-18,For use in the diagnosis of gastrinoma associated with Zollinger-Ellison syndrome.,Designated/Approved,Approved for Orphan Indication,Use in secretin stimulation testing for stimulation of gastrin secretion to aid in the diagnosis of gastrinoma,2002-04-04,2009-04-04,"ChiRhoClin, Inc.",1550 Gallaudet Ave.,,Silver Spring,Maryland,20905,USA,120498,1999,1021
Synthetic porcine secretin,Secreflo,1999-06-18,For use in the evaluation of exocrine pancreas function.,Designated/Approved,Approved for Orphan Indication,For use in secretin stimulation testing for: Stimulation of pancreatic secretions to facilitate the identification of the ampulla of Vater and accessory papilla during endoscopic retrograde cholangio-pancreatography (ERCP),2002-11-01,2009-11-01,"ChiRhoClin, Inc.",1550 Gallaudet Ave.,,Silver Spring,Maryland,20905,USA,120298,1999,1232
Synthetic porcine secretin,n/a,1999-06-18,For use in obtaining desquamated pancreatic cells for cytopathologic examination in pancreatic carcinoma.,Designated,,,N/A,N/A,"ChiRhoClin, Inc.",1550 Gallaudet Ave.,,Silver Spring,Maryland,20905,USA,120398,1999,
Tobramycin,Tobi,1999-06-18,Treatment of bronchiectasis patients infected with Pseudomonas aeruginosa.,Designated,,,N/A,N/A,Novartis Pharmaceuticals Corp.,"Bldg 100, Room 130",One Health Plaza,East Hanover,New Jersey,7936,USA,121098,1999,
Lactic acid,Aphthaid,1999-06-29,"Treatment of severe aphthous stomatitis in severely, terminally immunocompromised patients.",Designated,,,N/A,N/A,"Frontier Pharmaceutical, Inc.",SUNY Farmingdale,Conklin Hall,Farmingdale,New York,11735,USA,122098,1999,
Somatropin [rDNA],Genotropin,1999-07-06,Treatment of short stature in patients with Prader-Willi syndrome.,Designated/Approved,Approved for Orphan Indication,Long-term treatment of pediatric patients who have growth failure due to Prader-Willi syndrome (PWS).,2000-06-20,2007-06-20,Pharmacia & Upjohn,7000 Portage Rd.,0633-298-113,Kalamazoo,Michigan,49001,USA,124799,1999,350
irofulven,n/a,1999-07-06,Treatment of ovarian cancer.,Designated/Withdrawn,,,N/A,N/A,"Eisai, Inc.",300 Tice Blvd,,Woodcliff Lake,New Jersey,7677,USA,124399,1999,
Artesunate,n/a,1999-07-19,Treatment of malaria.,Designated,,,N/A,N/A,World Health Organization,Special Programme for Research and Training in Tro,"Via Appia , Geneva 27",,,,Switzerland,125599,1999,
irofulven,n/a,1999-07-27,Treatment of renal cell carcinoma.,Designated/Withdrawn,,,N/A,N/A,"Eisai, Inc.",300 Tice Blvd,,Woodcliff Lake,New Jersey,7677,USA,125399,1999,
Yttrium-90 radiolabeled humanized monoclonal anti-carcinoembroyonic antigen IgG antibody,Cea-Cide,1999-08-03,Treatment of ovarian carcinoma.,Designated,,,N/A,N/A,"Immunomedics, Inc.",300 The American Road,,Morris Plains,New Jersey,7950,USA,124499,1999,
guanfacine,Tenex,1999-08-05,Treatment of fragile X syndrome.,Designated,,,N/A,N/A,"Watson Laboratories, Inc.",311 Bonnie Circle,P.O. Box 1900,Corona,California,91718,USA,124199,1999,
Mitoxantrone,Novantrone,1999-08-13,Treatment of secondary-progressive multiple sclerosis.,Designated/Approved,Approved for Orphan Indication,"Reducing neurologic disability and/or the frequency of clinical relapses in patients with secondary (chronic) progressive, progressive relapsing, or worsening relapsing-remitting multiple sclerosis (i.e., patients whose neurologic status is significantly adnormal between relapses).",2000-10-13,2007-10-13,"Serono, Inc.",One Technoloogy Place,,Rockland,Massachusetts,2370,USA,125199,1999,427
Mitoxantrone,Novantrone,1999-08-13,Treatment of progressive-relapsing multiple sclerosis.,Designated/Approved,Approved for Orphan Indication,"Reducing neurologic disability and/or the frequency of clinical relapses in patients with secondary (chronic) progressive, progressive relapsing, or worsening relapsing-remitting multiple sclerosis (i.e., patients whose neurologic status is significantly adnormal between relapses).",2000-10-13,2007-10-13,"Serono, Inc.",One Technology Place,,Rockland,Massachusetts,2370,USA,128499,1999,427
"Liposomal-cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane-Pt (II)",Aroplatin,1999-09-01,Treatment of malignant mesothelioma.,Designated/Withdrawn,,,N/A,N/A,Antigenics Incorporated,3 Forbes Road,,Lexington,Massachusetts,2421,USA,126599,1999,
nelarabine,n/a,1999-09-02,Treatment of chronic lymphocytic leukemia.,Designated,,,N/A,N/A,Novartis Pharmaceuticals Corp.,One Health Plaza,,East Hanover,New Jersey,7936,USA,125999,1999,
Epirubicin,Ellence,1999-09-14,Treatment of breast cancer.,Designated/Approved,Approved for Orphan Indication,Component of adjuvant therapy in patients with evidence of axillary node tumor involvement following resection of primary breast cancer.,1999-09-15,2006-09-15,Pharmacia & Upjohn Company,0634-298-113,7000 Portage Rd.,Kalamazoo,Michigan,49001,USA,121498,1999,1
Azathioprine,Imuran,1999-09-14,Treatment of oral manifestations of graft-versus-host disease.,Designated,,,N/A,N/A,"Oral Solutions, Inc.","787 Seventh Ave., 48th Floor",,New York,New York,10019,USA,128099,1999,
Polyethylene glycol-modified uricase,Zurase,1999-09-14,Prophylaxis of hyperuricemia in cancer patients prone to develop tumor lysis syndrome during chemotherapy.,Designated,,,N/A,N/A,"EnzymeRx, LLC",17 Arcadian Avenue,Suite 104,Paramus,New Jersey,7652,USA,118598,1999,
HLA-B7/Beta2M DNA Lipid (DMRIE/DOPE) Complex,Allovectin-7,1999-09-30,"Treatment of invasive and metastatic melanoma (Stages II, III, and IV).",Designated,,,N/A,N/A,Vical Incorporated,"9373 Towne Centre Dr., Suite 100",,San Diego,California,92121,USA,128199,1999,
Peginterferon alfa-2a,Pegasys,1999-09-30,Treatment of chronic myelogenous leukemia.,Designated,,,N/A,N/A,Hoffman-La Roche Inc.,340 Kingsland St.,,Nutley,New Jersey,7110,USA,125299,1999,
Amifostine,Ethyol,1999-10-04,Treatment of myelodysplastic syndromes.,Designated,,,N/A,N/A,Clinigen Group plc,"Pitcairn House, Crown Square",DE14 2WW,,,,United Kingdom,128399,1999,
Botulinum toxin type A,Dysport,1999-10-20,Treatment of dynamic muscle contractures in pediatric cerebral palsy patients.,Designated/Approved,Approved for Orphan Indication,Treatment of lower limb spasticity in pediatric cerebral patients 2 years of age and older,2016-07-29,2023-07-29,Ipsen Limited,"1 Bath Rd., Maidenhead",,Berkshire SL6 4UH,,,United Kingdom,128299,1999,6127
L-glutamyl-L-tryptophan,n/a,1999-10-20,Treatment of AIDS-related Kaposi's sarcoma.,Designated,,,N/A,N/A,Implicit Bioscience Pty Ltd,P. O. Box 2072.,Toowong Business Center,,,,Australia,126799,1999,
Somatropin (rDNA origin),Nutropin Depot,1999-10-28,Long-term treatment of children who have growth failure due to a lack of adequate endogenous growth hormone secretion.,Designated/Approved,Approved for Orphan Indication,Long-term treatment of growth failure due to a lack of adequate endogenous growth hormone secetion for once- or twice-a-month administration.,1999-12-22,N/A,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,USA,115098,1999,55
Temoporfin,Foscan,1999-10-28,"Palliative treatment of recurrent, refractory or second primary squamous cell carcinomas of the head and neck in patients considered to be incurable with surgery or radiotherapy.",Designated,,,N/A,N/A,Biolitec Pharma Ireland Ltd.,United Drug House,Dublin,,,,Ireland,128899,1999,
Teriparatide,Parathar,1999-10-28,Treatment of idiopathic osteoporosis.,Designated,,,N/A,N/A,"Biomeasure, Inc.",27 Maple St.,,Milford,Massachusetts,1757,USA,127099,1999,
pVGI.1(VEGF2),n/a,1999-11-09,Treatment of thromboangiitis obliterans.,Designated/Withdrawn,,,N/A,N/A,"Corautus Genetics, Inc.","75 Fifth St., NW",Suite 700,Atlanta,Georgia,30308,USA,124599,1999,
Silver sulfadiazine and cerium nitrate,Flammacerium,1999-11-17,Treatment of patients with severe dermal burns,Designated,,,N/A,N/A,Alliance Pharmaceuticals Ltd,Avonbridge House,"Bath Road, Chippenham","Wiltshire, SN15 2BB",,,United Kingdom,110798,1999,
Gemtuzumab ozogamicin,Mylotarg,1999-11-24,Treatment of acute myeloid leukemia,Designated/Approved,Approved for Orphan Indication,Treatment of patients with CD33 positive acute myeloid leukemia in first relapse who are 60 years of age or older and who are not considered candidates for cytotoxic chemotherapy,2000-05-17,2007-05-17,"Wyeth Pharmaceuticals, Inc., a Pfizer Company",10646 Science Center Drive,,San Diego,California,92121,USA,127899,1999,175
Gemtuzumab ozogamicin,Mylotarg,1999-11-24,Treatment of acute myeloid leukemia,Designated/Approved,Approved for Orphan Indication,Treatment of newly-diagnosed CD33-positive acute myeloid leukemia in adults and treatment of relapsed or refractory CD33-positive acute myeloid leukemia in adults and in pediatric patients 2 years and older,2017-09-01,2024-09-01,"Wyeth Pharmaceuticals, Inc., a Pfizer Company",10646 Science Center Drive,,San Diego,California,92121,USA,127899,1999,6491
Alpha1-proteinase inhibitor (human),n/a,1999-11-24,For slowing the progression of emphysema in alpha1-antitrypsin deficient patients.,Designated/Withdrawn,,,N/A,N/A,CSL Behring L.L.C.,1020 First Ave.,PO Box 61501,King of Prussia,Pennsylvania,19406,USA,124299,1999,
Dimerizing drug that binds to mutated Fas protein/drug-binding domain fusion protein (FKBP),n/a,1999-11-24,Treatment of acute graft-versus-host disease in patients undergoing bone marrow transplantation.,Designated,,,N/A,N/A,"Bellicum Pharmaceuticals, Inc.",6400 Fannin Street,Suite 2300,Houston,Texas,77030,USA,126299,1999,
Pentostatin,Nipent,1999-11-24,Treatment of peripheral T-cell lymphomas.,Designated,,,N/A,N/A,"SuperGen, Inc.",4140 Dublin Blvd.,Suite 200,Dublin,California,94568,USA,123899,1999,
trastuzumab,Herceptin,1999-12-14,Treatment of patients with pancreatic cancer that overexpress p185HER2.,Designated,,,N/A,N/A,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,USA,129399,1999,
Ubiquinone,Ubi-Q-Gel,1999-12-14,Treatment of mitochondrial cytopathies.,Designated,,,N/A,N/A,"Gel-Tec, Division of Tishcon Corp.",30 New York Avenue,P. O. Box 331,Westbury,New York,11590,USA,125099,1999,
Adenovirus-based vector Factor VIII complementary DNA to somatic cells,Miniadfviii,1999-12-15,Treatment of hemophilia A.,Designated,,,N/A,N/A,GenStar Therapeutics Corporation,10835 Altman Row,Suite 150,San Diego,California,92121,USA,127499,1999,
Histamine,Ceplene,1999-12-15,Adjunct to cytokine therapy in the treatment of acute myeloid leukemia.,Designated,,,N/A,N/A,EpiCept Corporation,777 Old Saw Mill River Road,,Tarrytown,New York,10591,USA,127399,1999,
Recombinant human keratinocyte growth factor,n/a,1999-12-20,Reducing the incidence and severity of radiation-induced xerostomia.,Designated,,,N/A,N/A,Swedish Orphan Biovitrum AB (publ) (SOBI),SE-112 76,,Stockholm,,,Sweden,130699,1999,
vapreotide,Octastatin,2000-01-10,Treatment of gastrointestinal and pancreatic fistulas.,Designated,,,N/A,N/A,Debiopharm S.A.,17 rue des Terreaux,CH-1000 Lausanne 9,,,,Switzerland,129599,2000,
vapreotide,Sanvar,2000-01-10,Treatment of esophageal variceal hemorrhage patients with portal hypertension.,Designated,,,N/A,N/A,"Debiovision, Inc.",666 Sherbrooke Street West,Suite 1400,"Montreal, Quebec H3A 1E7",,,Canada,129899,2000,
levodopa and carbidopa,Duopa,2000-01-18,Treatment of late stage Parkinson's disease,Designated/Approved,Approved for Orphan Indication,Treatment of motor flucuations in patients with advanced Parkinson's disease,2015-01-09,2022-01-09,"AbbVie, Inc.",1 N. Waukegan Road,Building AP30-1,North Chicago,Illinois,60064,USA,129499,2000,5470
"1-(11-dodecylamino-10-hydroxyundecyl)-3,7-dimethylxanthine hydrogen methanesulfonate",n/a,2000-01-18,Treatment of hormone refractory prostate carcinoma.,Designated/Withdrawn,,,N/A,N/A,"Cell Therapeutics, Inc.",201 Elliott Avenue West,Suite 400,Seattle,Washington,98119,USA,125899,2000,
Natural human lymphoblastoid interferon-alpha,n/a,2000-01-18,Treatment of Behcet's disease,Designated,,,N/A,N/A,"Amarillo Biosciences, Inc.",4134 Business Park Drive,,Amarillo,Texas,79110,USA,131299,2000,
Phenylbutyrate,n/a,2000-01-19,Treatment of acute promyelocytic leukemia.,Designated,,,N/A,N/A,"Elan Drug Delivery, Inc.",1300 Gould Dr.,,Gainesville,Georgia,30504,USA,126199,2000,
Histamine,Maxamine,2000-02-01,For use as an adjunct to cytokine therapy in the treatment of malignant melanoma.,Designated,,,N/A,N/A,EpiCept Corporation,777 Old Saw Mill River Road,,Tarrytown,New York,10591,USA,127199,2000,
Brimonidine,Alphagan,2000-02-07,Treatment of anterior ischemic optic neuropathy.,Designated,,,N/A,N/A,"Allergan, Inc.",2525 Dupont Dr.,,Irvine,California,92612,USA,125699,2000,
Halofuginone,Stenorol,2000-02-07,Treatment of systemic sclerosis.,Designated,,,N/A,N/A,Collgard Biopharmaceuticals Ltd.,"Textile House, 2 Koifman St.",Tel-Aviv 68012,,,,Israel,131699,2000,
Hypericin,n/a,2000-02-07,Treatment of cutaneous T-cell lymphoma.,Designated,,,N/A,N/A,"Soligenix, Inc.",29 Emmons Drive,Suite C-10,Princeton,New Jersey,8540,USA,131099,2000,
Angiotensin 1-7,n/a,2000-02-16,Treatment of neutropenia associated with autologous bone marrow transplantation.,Designated,,,N/A,N/A,Tarix Pharmaceuticals Ltd,12 Bow Street,,Cambridge,Massachusetts,2138,USA,129999,2000,
etarfolatide,n/a,2000-02-16,For the identification of ovarian carcinomas,Designated,,,N/A,N/A,"Endocyte, Inc.",3000 Kent Ave.,Suite A1-100,West Lafayette,Indiana,47906,USA,131399,2000,
Recombinant human insulin-like growth factor-I,Pv802,2000-02-16,Treatment of short-bowel syndrome as a result of resection of the small bowel or as a result of congenital dysfunction of the intestines.,Designated,,,N/A,N/A,GroPep Pty Ltd.,"Gate 11, Victoria Dr.",Adelaide SA 5000,,,,Australia,128999,2000,
Iodine I 131 bis(indium-diethylenetriaminepentaacetic acid)tyrosyllysine/hMN-14 x m734 F(ab')2 bispecific monoclonal antibody,Pentacea,2000-02-22,Treatment of small-cell lung cancer.,Designated,,,N/A,N/A,"IBC Pharmaceuticals, L.L.C.",300 American Rd.,,Morris Plains,New Jersey,7950,USA,132400,2000,
Bis(4-fluorophenyl)phenylacetamide,n/a,2000-03-02,Treatment of sickle cell disease.,Designated,,,N/A,N/A,ICAgen Inc.,Ion Channel Advances,PO Box 14487,Durham,North Carolina,27709,USA,131999,2000,
Remacemide,Ecovia,2000-03-06,Treatment of Huntington's disease.,Designated/Withdrawn,,,N/A,N/A,AstraZeneca LP,725 Chesterbrook Blvd.,,Wayne,Pennsylvania,19087,USA,130599,2000,
Soluble complement receptor type 1,n/a,2000-03-06,Prevention of post-cardiopulmonary bypass syndrome in children undergoing cardiopulmonary bypass.,Designated,,,N/A,N/A,"Avant Immunotherapeutics, Inc.",119 Fourth Ave.,,Needham,Massachusetts,2494,USA,131899,2000,
Thymalfasin,Zadaxin,2000-03-06,Treatment of hepatocellular carcinoma.,Designated,,,N/A,N/A,"SciClone Pharmaceuticals, Inc.",950 Tower Lane,Suite 900,Foster city,California,94404,USA,132600,2000,
vapreotide,Octastatin,2000-03-06,Prevention of early postoperative complications following pancreatic resection.,Designated,,,N/A,N/A,Debiopharm S.A.,17 rue des Terreaux,CH-1000 Lausanne 9,,,,Switzerland,129699,2000,
Synthetic porcine secretin,Secreflo,2000-03-07,"For use in conjunction with diagnostic, therapeutic, or combined diagnostic/therapeutic procedures for pancreatic disorders to increase pancreatic fluid secretion.",Designated/Approved,Approved for Orphan Indication,"Use in secretin stimulation testing for stimulation of pancreatic secretions, including bicarbonate, to aid in the diagnosis of pancreatic exocrine dysfunction",2002-04-04,2009-04-04,"ChiRhoClin, Inc.",15500 Gallaudet Ave.,,Silver Spring,Maryland,20905,USA,130299,2000,758
Synthetic human secretin,n/a,2000-03-07,"For use in conjunction with diagnostic, therapeutic, or combined diagnostic/therapeutic procedures for pancreatic disorders to increase pancreatic fluid secretion.",Designated,,,N/A,N/A,"ChiRhoClin, Inc.",15500 Gallaudet Ave.,,Silver Spring,Maryland,20905,USA,130199,2000,
"3-(3,5-Dimethyl-1H-2ylmethylene)-1,3-dihydro-indol-2-one",n/a,2000-03-23,Treatment of von Hippel-Lindau disease.,Designated,,,N/A,N/A,"Sugen, Inc.",230 East Grand Ave.,,South San Francisco,California,94080,USA,127699,2000,
Cisplatin/epinephrine,Intradose,2000-04-03,Treatment of squamous cell carcinoma of the head and neck.,Designated,,,N/A,N/A,"Matrix Pharmaceutical, Inc.",34700 Campus Drive,,Fremont,California,94555,USA,133200,2000,
rSP-C lung surfactant,Venticute,2000-04-03,Treatment of adult respiratory distress syndrome.,Designated,,,N/A,N/A,Byk Gulden Pharmaceuticals,Byk-Gulden StraBe 2,78467 Konstanz,,,,Germany,119198,2000,
Ethyl eicosapentaenoate,n/a,2000-04-06,Treatment of Huntington's disease.,Designated,,,N/A,N/A,Laxdale Ltd.,"Kings Park House, Laurelhill Business Park","Polmaise Road, Stirling FK7 9JQ",,,,United Kingdom,134300,2000,
IL-4 Pseudomonas Toxin Fusion Protein (IL-4(38-37)-PE38KDEL),n/a,2000-04-06,Treatment of astrocytic glioma.,Designated,,,N/A,N/A,"Medicenna Therapeutics, Inc.",220-1075 West George Street,"Vancouver, British Columbia",,,,Canada,132199,2000,
Recombinant human antithrombin III,n/a,2000-04-06,Treatment of antithrombin III dependent heparin resistance requiring anticoagulation.,Designated,,,N/A,N/A,AT III LLC,c/o Genzyme Corporation,"15 Pleasant St. Connector, P.O. Box 9322",Framingham,Massachusetts,1701,USA,118798,2000,
Meropenem,Merrem Iv,2000-04-27,"Management of acute pulmonary exacerbations, in cystic fibrosis patients, due to respiratory tract infection with susceptible organisms.",Designated/Withdrawn,,,N/A,N/A,AstraZeneca Pharmaceuticals,1800 Concord Pike,PO Box 15437,Wilmington,Delaware,19850,USA,130799,2000,
Arsenic trioxide,Trisenox,2000-04-28,Treatment of multiple myeloma.,Designated,,,N/A,N/A,"TEVA Branded Pharmaceutical Products R & D, Inc.",41 Moores Road,,Frazer,Pennsylvania,19355,USA,134700,2000,
"DNA-lipid complex (DMRIE/DOPE)/plasmid vector (VCL-1102, Vical) expressing human interleukin-2",Leuvectin,2000-04-28,Treatment of renal cell carcinoma.,Designated,,,N/A,N/A,Vical Incorporated,9373 Towne Center Dr.,Suite 100,San Diego,California,92121,USA,134400,2000,
Tetraiodothyroacetic acid,n/a,2000-05-01,Suppression of thyroid stimulating hormone in patients with well-differentiated cancer of the thyroid gland.,Designated,,,N/A,N/A,"Danforth, Jr., MD, Elliot",University of Vermont,84 Beartown Rd.,Underhill,Vermont,5489,USA,133100,2000,
Omega-3 (n-3) polyunsaturated fatty acids,Omacor,2000-05-04,Treatment of IgA nephropathy.,Designated,,,N/A,N/A,"Pronova Biocare, AS",PO Box 420,1327 Lysaker,,,,Norway,128799,2000,
vigabatrin,Sabril,2000-06-12,Treatment of infantile spasms.,Designated/Approved,Approved for Orphan Indication,For infantile spasms (IS) - 1 month to 2 years of age.,2009-08-21,2016-08-21,H. Lundbeck A/S,Four Parkway North,,Deerfield,Illinois,60015,USA,135100,2000,3357
Centruroides immune F(ab)2,Anascorp,2000-06-12,Treatment of scorpion envenomations requiring medical attention.,Designated/Approved,Approved for Orphan Indication,Treatment of clinical signs of scorpion envenomation,2011-08-04,2018-08-04,"Rare Disease Therapeutics, Inc.",12975 Brookprinter Drive,Suite 170,Poway,California,92064,USA,135900,2000,4070
Liposomal nystatin,Nyotran,2000-06-13,Treatment of invasive fungal infections.,Designated,,,N/A,N/A,The University of Texas,M.D. Anderson Cancer Center,Unit 038,Houston,Texas,77030,USA,133800,2000,
teduglutide [rDNA origin],Gattex,2000-06-29,Treatment of short bowel syndrome.,Designated/Approved,Approved for Orphan Indication,Treatment of adult patients with short bowel syndrome (SBS) who are dependent on parenteral support,2012-12-21,2019-12-21,"NPS Pharmaceuticals, Inc.",550 Hills Drive,Third Floor,Bedminster,New Jersey,7921,USA,126999,2000,4558
Fluorouracil,n/a,2000-06-29,Treatment of glioblastoma multiforme.,Designated,,,N/A,N/A,Ethypharm SA,194 Bureaux de la Colline - Batiment D,92213 Saint-Cloud Cedex,,,,USA,131799,2000,
cetuximab,Erbitux,2000-07-03,Treatment of squamous cell cancer of the head and neck in patients who express epidermal growth factor receptor,Designated/Approved,Approved for Orphan Indication,"For use in combination with radiation therapy, for the treatment of locally or regionally advanced squamous cell carcinoma of the head and neck (SCCHN) and for use as a single agent for the treatment of patients with recurrent or metastatic SCCHN for whom prior platinum-based therapy has failed",2006-03-01,2013-03-01,ImClone Systems Incorporated,33 ImClone Drive,,Branchburg,New Jersey,8876,USA,132700,2000,2067
Carmustine,n/a,2000-07-03,Treatment of intracranial malignancies.,Designated,,,N/A,N/A,"Direct Therapeutics, Inc.",460 Seaport Court,Suite 220,Redwood,California,94063,USA,134500,2000,
arsenic trioxide,Trisenox,2000-07-17,Treatment of myelodysplastic syndrome.,Designated,,,N/A,N/A,"Teva Branded Pharmaceutical Products R&D, Inc.",41 Moores Road,P.O. Box 4011,Frazer,Pennsylvania,19355,USA,135200,2000,
Chimeric (human-murine) G250 IgG monoclonal antibody,n/a,2000-07-24,Treatment of renal cell carcinoma.,Designated/Withdrawn,,,N/A,N/A,Wilex Biotechnology GmbH,Grillparzerstrasse 10B,81675 Munich,,,,Germany,133300,2000,
Abetimus,n/a,2000-07-28,Treatment of lupus nephritis.,Designated,,,N/A,N/A,La Jolla Pharmaceutical Co.,6455 Nancy Ridge Dr.,,San Diego,California,92121,USA,133600,2000,
Fluocinolone,Retisert,2000-07-31,Treatment uveitis involving the posterior segment of the eye.,Designated/Approved,Approved for Orphan Indication,Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye,2005-04-08,2012-04-08,"Bausch & Lomb Pharmaceuticals, Inc.",8500 Hidden River Parkway,,Tampa,Florida,33637,USA,132800,2000,1712
oblimersen,Genasense,2000-07-31,"Treatment of advanced malignant melanoma (Stages II,III, IV).",Designated,,,N/A,N/A,"Genta, Inc.",200 Connell Drive,,Berkeley Heights,New Jersey,7922,USA,134600,2000,
"Chimeric, humanized monoclonal antibody to staphylococcus",n/a,2000-08-03,Prophylaxis of Staphylococcus epidermidis sepsis in low birth weight (1500 grams or less) infants.,Designated,,,N/A,N/A,"Biosynexus, Inc.",9298 Gaither Road,,Rockville,Maryland,20877,USA,132099,2000,
Hypericin,n/a,2000-08-03,Treatment of glioblastoma multiforme.,Designated,,,N/A,N/A,"HyBiopharma, Inc.",2500 York Road,Suite 100,Jamison,Pennsylvania,18929,USA,131199,2000,
olipudase alfa,n/a,2000-08-03,Treatment of acid sphingomyelinase deficiency (Niemann-Pick disease),Designated,,,N/A,N/A,Genzyme Corporation,500 Kendall Street,,Cambridge,Massachusetts,2142,USA,132900,2000,
Natural human lymphoblastoid interferon-alpha,n/a,2000-08-10,Treatment of papillomavirus warts in the oral cavity of HIV positive patients.,Designated,,,N/A,N/A,"Amarillo Biosciences, Inc.",4134 Business Park Drive,,Amarillo,Texas,79110,USA,136000,2000,
Trimetrexate,Neutrexin,2000-08-10,Treatment of metastatic osteogenic sarcoma.,Designated/Withdrawn,,,N/A,N/A,"Medimmune Oncology, Inc.",One MedImmune Way,,Gaithersburg,Maryland,20878,USA,132299,2000,
Zoledronate,"Zometa, Zabel",2000-08-18,Treatment of tumor induced hypercalcemia.,Designated/Approved,Approved for Orphan Indication,Treatment of hypercalcemia of malignancy.,2001-08-20,2008-08-20,Novartis Pharmaceuticals Corp.,59 Route 10,,East Hanover,New Jersey,7936,USA,130899,2000,367
calfactant,Infasurf,2000-09-05,Treatment of acute respiratory distress syndrome (ARDS),Designated,,,N/A,N/A,"ONY, Inc.",Baird Research Park,Suite 114,Amherst,New York,14228,USA,136400,2000,
anti-thymocyte Globulin (rabbit),Thymoglobulin,2000-09-06,Treatment of myelodysplastic syndrome,Designated/Withdrawn,,,N/A,N/A,Genzyme Corporation,A Sanofi Company,500 Kendall Street,Cambridge,Massachusetts,2142,USA,136800,2000,
Cisplatin/epinephrine,Intradose,2000-09-07,Treatment of metastatic malignant melanoma.,Designated,,,N/A,N/A,"Matrix Pharmaceutical, Inc.",34700 Campus Drive,,Fremont,California,94555,USA,134800,2000,
Lanreotide,Somatuline Depot,2000-09-11,Treatment for acromegly,Designated/Approved,Approved for Orphan Indication,Long-term treatment of acromegalic patients who have had an inadequate response to or cannot be treated with surgery and/or radiotherapy,2007-08-30,2014-08-30,"IPSEN, Inc.",27 Maple Street,,Milford,Massachusetts,1757,USA,136300,2000,2544
"3,5,3'-triiodothyroacetate",n/a,2000-09-20,"Treatment of well-differentiated papillary, follicular or combined papillary/follicular carcinomas of the thyroid gland.",Designated,,,N/A,N/A,"Elliot Danforth, Jr., M.D.",University of Vermont,84 Beartown Road,Underhill,Vermont,5489,USA,137200,2000,
Recombinant human highly phosphorylated acid alpha-glucosidase,Tbd,2000-09-20,"For enzyme replacement therapy in patients with all subtypes of glycogen storage disease type II (GSDII, Pompe Disease)",Designated,,,N/A,N/A,"Novazyme Pharmaceuticals, Inc.",800 Research Parkway,Suite 200,Oklahoma City,Oklahoma,73104,USA,137800,2000,
DNP-Modified autologous tumor vaccine,O-Vax,2000-09-21,Adjuvant therapy for the treatment of ovarian cancer,Designated,,,N/A,N/A,"AVAX Technologies, Inc.",9200 Indian Creek Parkway,"Building 9, Suite 200",Overland Park,Kansas,66210,USA,138000,2000,
Eculizumab,n/a,2000-09-21,Treatment of dermatomyositis,Designated,,,N/A,N/A,"Alexion Pharmaceuticals, Inc.",352 Knotter Drive,,Cheshire,Connecticut,6410,USA,136100,2000,
Hydroxocobalamin,n/a,2000-09-22,Treatment of acute cyanide poisoning,Designated,,,N/A,N/A,"Rare Disease Therapeutics, Inc.",12975 Brookprinter Pl,Suite 170,Poway,California,92064,USA,137600,2000,
bosentan,Tracleer,2000-10-06,Treatment of pulmonary arterial hypertension,Designated/Approved,Approved for Orphan Indication,Treatment of pulmonary arterial hypertension.,2001-11-20,2008-11-20,"Actelion Pharmaceuticals, Ltd.",1840 Gateway Drive,Suite 300,Cherry Hill,New Jersey,8002,USA,134200,2000,410
bosentan,Tracleer,2000-10-06,Treatment of pulmonary arterial hypertension,Designated/Approved,Approved for Orphan Indication,"Treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) in pediatric patients aged 3 years and older with idiopathic or congenital PAH to improve pulmonary vascular resistance (PVR), which is expected to result in an improvement in exercise ability",2017-09-05,2024-09-05,"Actelion Pharmaceuticals, Ltd.",1840 Gateway Drive,Suite 300,Cherry Hill,New Jersey,8002,USA,134200,2000,6178
rasburicase,Elitek,2000-10-11,Treatment of malignancy-associated or chemotherapy-induced hyperuricemia.,Designated/Approved,Approved for Orphan Indication,"Initial management of plasma uric acid levels in pediatric patients with leukemia,lymphoma, and solid tumor malignancies who are receiving anti-cancer therapy expected to result in tumor lysis and subsequent elevation of plasma uric acid.",2002-07-12,2009-07-12,Sanofi-Synthelabo Research,9 Great Valley Parkway,,Malvern,Pennsylvania,19355,USA,131499,2000,639
Recombinant urate oxidase,n/a,2000-10-11,Prophylaxis of chemotherapy-induced hyperuricemia.,Designated,,,N/A,N/A,Sanofi-Synthelabo Research,9 Great Valley Parkway,,Malvern,Pennsylvania,19355,USA,131599,2000,
taberminogene vadenovec,Trinam,2000-10-24,Prevention of complications due to neointimal hyperplasia disease in certain vascular anastomoses.,Designated,,,N/A,N/A,"Finvector Vision Therapies, Ltd.",1 Fitzroy Mews,London,,,,United Kingdom,123299,2000,
Technetium Tc99m rh-Annexin V,Apomate,2000-11-03,"Diagnosis or assessment of rejection status in heart, heart-lung, single lung, or bilateral lung transplants.",Designated,,,N/A,N/A,Theseus Imaging Corporation,124 Mount Auburn Street,Suite 200 North,Cambridge,Massachusetts,2138,USA,135500,2000,
Gavilimomab,n/a,2000-11-20,Acute graft-versus-host disease (aGVHD),Designated/Withdrawn,,,N/A,N/A,Amgen,One Amgen Center Drive,Mail Stop 17-2-A,Thousand Oaks,California,91320,USA,136900,2000,
Cyclosporine in combination with omega-3 polyunsaturated fatty acids,n/a,2000-12-06,Prevention of solid organ graft rejection.,Designated,,,N/A,N/A,RTP Pharma Corporation,200 Westpark Corporate Center,4364 South Alston Avenue,Durham,North Carolina,27713,USA,138500,2000,
N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-Maystansine-Conjugated Humanized C242 Monoclonal Antibody,n/a,2000-12-07,For pancreatic cancer,Designated,,,N/A,N/A,SmithKline Beecham Pharmaceuticals,1250 S. Collegeville Road,,Collegeville,Pennsylvania,19426,USA,138400,2000,
somatropin [rDNA],Genotropin,2000-12-27,Treatment of growth failure in children who were born small for gestational age.,Designated/Approved,Approved for Orphan Indication,For long-term treatment of growth failure in children born small for gestational age who fail to manifest catch-up growth by two years of age.,2001-07-25,2008-07-25,Pharmacia and Upjohn Company,7000 Portage Road,,Kalamazoo,Michigan,49001,USA,135400,2000,210
N-acetylcysteinate Lysine,Nacystelyn Dry Powder Inhaler,2000-12-27,For the management of cystic fibrosis,Designated,,,N/A,N/A,"Galephar Pharmaceutical Research, Inc.","Road 198, No. 100 km. 14.7",Juncos Industrial Park,Juncos,,,Puerto Rico,139200,2000,
Tiazofurin (2-Beta-D-ribofuranosyl-4-thiazolecarboxamide),n/a,2000-12-27,Chronic myelogenous leukemia (CML),Designated,,,N/A,N/A,Valeant Pharmaceuticals North America,3300 Hyland Avenue,,Costa Mesa,California,92626,USA,139500,2000,
MTC-DOX for Injection,n/a,2001-01-03,Treatment of hepatocellular carcinoma,Designated,,,N/A,N/A,FeRx Incorporated,4330 La Jolla Village Drive,Suite #250,San Diego,California,92122,USA,139800,2001,
Novel Acting Thrombolytic (NAT),n/a,2001-01-26,Treatment of peripheral arterial occlusion (PAO),Designated/Withdrawn,,,N/A,N/A,"Nuvelo, Inc. Inc.",201 Industrial Road,Suite 310,San Carlos,California,94070,USA,137700,2001,
Synthetic Human Parathyroid Hormone 1-34,n/a,2001-01-26,Treatment of hypoparathyroidism,Designated/Withdrawn,,,N/A,N/A,"Rare Disease Therapeutics, Inc.",2550 Meridian Blvd,,Nashville,Tennessee,37217,USA,138100,2001,
Imatinib,Gleevec,2001-01-31,Treatment of chronic myelogenous leukemia,Designated/Approved,Approved for Orphan Indication,"Treatment of patients with chronic myeloid leukemia (CML) in blast crisis, accelerated phase, or in chronic phase after failure of interferon-alpha therapy",2001-05-10,2008-05-10,Novartis Pharmaceuticals Corporation,59 Route 10,,East Hanover,New Jersey,7936,USA,140100,2001,99
Virulizin,Virulizin,2001-02-01,Treatment of pancreatic cancer.,Designated,,,N/A,N/A,"ZOR Pharmaceuticals, LLC",100-A Eastwood Center Drive,Suite 118,Wilmington,North Carolina,28403,USA,139600,2001,
Alendronate disodium,Fosamax,2001-02-13,Treatment of the bone manifestations of Gaucher disease,Designated,,,N/A,N/A,"Richard J. Wenstrup, M.D.",Division of Human Genetics,Children's Hospital Research Foundation,Cincinnati,Ohio,45229,USA,140000,2001,
pegloticase,Krystexxa,2001-02-21,To control the clinical consequences of hyperuricemia in patients with severe gout in whom conventional therapy is contraindicated or has been ineffective.,Designated/Approved,Approved for Orphan Indication,Treatment of chronic gout in adult patients refractory to conventional treatment,2010-09-14,2017-09-14,"Horizon Pharma Rheumatology, LLC",150 S. Saunders RoadDrive,Suite 400,Lake Forest,Illinois,60045,USA,135600,2001,3492
B Lymphocyte Stimulator,Blys,2001-02-21,Treatment of common variable immunodeficiency (CVID),Designated/Withdrawn,,,N/A,N/A,"Human Genome Sciences, Inc.",9410 Key West Avenue,,Rockville,Maryland,20850,USA,140600,2001,
Nitroprusside,n/a,2001-02-21,Treatment and prevention of cerebral vasospasm following subarachnoid hemorrhage.,Designated,,,N/A,N/A,"Thomas, MD, Jeffrey Evan",Thomas Jefferson University and Wills Neurosensory,"834 Walnut Street, Suite 650",Philadelphia,Pennsylvania,19107,USA,112498,2001,
Pyruvate,n/a,2001-02-21,Treatment of interstitial lung disease.,Designated,,,N/A,N/A,"Cellular Sciences, Inc",84 park Avenue,P.O. Box 968,Flemington,New Jersey,8822,USA,140900,2001,
Medroxyprogesterone acetate,Hematrol,2001-02-22,Treatment of immune thrombocytopenic purpura.,Designated,,,N/A,N/A,"ZaBeCor Pharmaceutical Company, LLC",821 Westview Street,,Philadelphia,Pennsylvania,19119,USA,141901,2001,
Recombinant Human Alpha-Fetoprotein (rhAFP),n/a,2001-02-22,Treatment of myasthenia gravis,Designated,,,N/A,N/A,"Alpha Cancer Technologies, Inc.","MaRS Discovery District, South Tower",200-101 College St.,Toronto,Ontario,,Canada,140300,2001,
Busulfan,Spartajet-Busulfan,2001-03-05,Intrathecal therapy for neoplastic meningitis,Designated/Withdrawn,,,N/A,N/A,"SuperGen, Inc.",4140 Dublin Boulevard,,Dublin,California,94568,USA,140700,2001,
Coenzyme Q10,n/a,2001-03-05,Treatment of Huntington's disease,Designated,,,N/A,N/A,"Integrative Therapeutics, Inc.",825 Challenger Drive,,Green Bay,Wisconsin,54311,USA,138700,2001,
docosahexanoic acid-paclitaxel,Taxoprexin,2001-03-05,Treatment of hormone-refractory prostate cancer.,Designated/Withdrawn,,,N/A,N/A,"Luitpold Pharmaceuticals, Inc.",One Luitpold Drive,,Shirley,New York,11976,USA,141701,2001,
eculizumab,n/a,2001-03-05,Treatment of idiopathic membranous glomerular nephropathy,Designated,,,N/A,N/A,"Alexion Pharmaceuticals, Inc.",352 Knotter Drive,,Cheshire,Connecticut,6410,USA,138800,2001,
"p1-(uridine 5'-)-p4-(2'-deoxycytidine 5'-) tetraphosphate, tetrasodium salt",n/a,2001-03-07,For the treatment of cystic fibrosis,Designated/Withdrawn,,,N/A,N/A,"Inspire Pharmaceuticals, Inc.",4222 Emperor Blvd.,Suite 200,Durham,North Carolina,27703,USA,139400,2001,
Vasoactive intestinal peptide,n/a,2001-03-09,Treatment of Acute Respiratory Distress Syndrome.,Designated,,,N/A,N/A,mondoBIOTECH,Europark,FL - 9490 Vaduz,,,,USA,142001,2001,
Recombinant fusion protein of Mycobacterium bovis BCG Hsp65 and HPV16 E7,n/a,2001-03-19,Treatment of recurrent respiratory papillomatosis (RRP),Designated,,,N/A,N/A,"StressGen Biotechnologies, Inc. is now Nventa",Nventa Biopharmaceuticals Corporation,6055 Lusk Boulevard,San Diego,California,19426,USA,141200,2001,
Girentuximab,Rencarex,2001-03-22,Treatment of renal cell carcinoma.,Designated,,,N/A,N/A,Heidelberg Pharma AG,101 Schriesheimer Straße,,Ladenburg,,,Germany,139000,2001,
Recombinant human highly phosphorylated alpha-L-iduronidase (rhHP-IDUA),n/a,2001-04-11,Enzyme replacement therapy in patients with all subtypes of Mucopolysaccharidosis I.,Designated,,,N/A,N/A,"Novazyme Pharmaceuticals, Inc.",800 Research Parkway,Suite 200,Oklahoma City,Oklahoma,73104,USA,141801,2001,
Interferon-alfa-1b,n/a,2001-04-17,Treatment of multiple myeloma,Designated,,,N/A,N/A,Ernest C.Borden,Center for Cancer Drud Discovery and Development,9500 Euclid Avenue,Clevland,Ohio,44195,USA,142601,2001,
Perflubron,Liquivent(Tm),2001-04-26,Treatment of acute respiratory distress disease (ARDS) in adults,Designated,,,N/A,N/A,PFC Development/New Alliance Pharmaceutical,15021 Venture Blvd,,Sherman Oaks,California,91403,USA,141100,2001,
squalamine lactate,n/a,2001-05-11,Treatment of ovarian cancer refractory or resistant to standard chemotherapy,Designated,,,N/A,N/A,Genaera Corporation,5110 Campus Drive,,Plymouth Meeting,Pennsylvania,19462,USA,143101,2001,
9-nitro-20-(S)-camptothecin,Camvirex,2001-05-15,Treatment of pediatric HIV infection/AIDS,Designated,,,N/A,N/A,"NovoMed Pharmaceuticals, Inc.",P.O. Box 900,,Germantown,Maryland,20875,USA,142201,2001,
human gammaglobulin,Oralgam,2001-05-25,Treatment for juvenile rheumatoid arthritis,Designated,,,N/A,N/A,"Latona Life Sciences, Inc.",10 Village St.,,Mills,Massachusetts,2054,USA,142901,2001,
Glatiramer acetate for injection,Copaxone,2001-06-05,Treatment of primary-progressive multiple sclerosis,Designated,,,N/A,N/A,Teva Pharmaceuticals USA,1090 Horsham Road,,North Wales,Pennsylvania,19454,USA,140500,2001,
mifamuritide,Junovan,2001-06-05,Treatment of osteosarcoma,Designated,,,N/A,N/A,"Millennium Pharmaceuticals, Inc.",40 Landsdowne Street,,Cambridge,Massachusetts,2139,USA,143401,2001,
Adeno-associated viral vector containing the gene for human coagulation factor IX,Coagulin-B,2001-06-13,Intramuscular treatment of patients with moderate to severe hemophilia,Designated,,,N/A,N/A,"Avigen, Inc.",1301 Harbor Bay Parkway,,Alameda,California,94502,USA,144401,2001,
Adeno-associated viral vector containing the gene for human coagulation factor IX,Coagulin-B,2001-06-13,Intrahepatic treatment of patients with moderate to severe hemophilia,Designated,,,N/A,N/A,"Avigen, Inc.",1301 Harbor Bay Parkway,,Alameda,California,94502,USA,145301,2001,
Staphylococcal immunoglobulin (human),Veronate,2001-06-13,Reduction (prevention) of nosocomial bacteremia caused by staphylococci in very low birth weight infants.,Designated/Withdrawn,,,N/A,N/A,"Inhibitex, Inc.",8995 Westside Parkway,Suite 150,Alpharetta,Georgia,30004,USA,144501,2001,
Latrodectus immune F(ab)2,Analatro,2001-06-18,Treatment of black widow spider envenomations,Designated,,,N/A,N/A,"Instituto Bioclon, S.A. de C.V.","Tlalpan,",No. 4687 Colonia Toriello Guerra,Tlalpan,,,Mexico,144001,2001,
Reviparin sodium,Clivarine,2001-06-18,Treatment of deep vein thrombosis which may lead to pulmonary embolism in pediatric patients,Designated,,,N/A,N/A,Abbott,"Abbott Laboratories, Dept. 389, Bldg. J-45",200 Abbott Park Rd.,Abbott Park,Illinois,60064,USA,143601,2001,
Reviparin sodium,Clivarine,2001-06-18,Long-term treatment of acute deep vein trombosis with or without pulmonary embolism in pregnant patients,Designated,,,N/A,N/A,Abbott,"Abbott Laboratories, Dept. 389, Bldg. J-45",200 Abbott Park Rd.,Abbott Park,Illinois,60064,USA,143501,2001,
2-methoxyestradiol,Panzem,2001-07-10,Treatment of multiple myeloma,Designated/Withdrawn,,,N/A,N/A,"EntreMed, Inc.",Research Triangle Park Center,Suite 400,Durham,North Carolina,27703,USA,143801,2001,
Intraoral fluoride releasing system,Ifrs,2001-07-31,Prevention of dental caries due to radiation-induced xerostomia in patients with head and neck cancer,Designated,,,N/A,N/A,"Digestive Care, Inc.",1120 Win Drive,,Bethlehem,Pennsylvania,18017,USA,143901,2001,
sitimagene ceradenovec,Cerepro,2001-07-31,Use with gancyclovir in the treatment of malignant glioma,Designated,,,N/A,N/A,"Gliotherapy, Ltd.",Sanderum House,Oakley Road,London,,,United Kingdom,145801,2001,
L-glutamine,Endari,2001-08-01,Treatment of sickle cell disease,Designated/Approved,Approved for Orphan Indication,To reduce the acute complications of sickle cell disease in adult and pediatric patients 5 years of age and older.,2017-07-07,2024-07-07,"Emmaus Medical, Inc.","21250 Hawthorne Blvd., Suite 800",,Torrance,California,90503,USA,145901,2001,5819
Thyrotropin alfa,Thyrogen,2001-08-03,"Treatment of well-differentiated papillary, follicular or combined papillary/follicular carcinomas of the thyroid",Designated/Approved,Approved for Orphan Indication,For use as an adjunctive treatment for radioiodine ablation of thyroid tissue remnants in patients who have undergone thyroidectomy for well-differentiated thyroid cancer and who do not have evidence of metastatic thyroid cancer,2007-12-14,2014-12-14,Genzyme Corporation,One Kendall Square,,Cambridge,Massachusetts,2139,USA,142301,2001,2324
2-chloroethyl-3-sarcosinamide-1-nitrosourea,n/a,2001-08-03,Treatment for malignant gliomas,Designated,,,N/A,N/A,"Lawrence Panasci, MD","Professor of Medicine, McGill University",3755 Cote Ste Catherine,,,,USA,146101,2001,
Angiotensin 1-7,Marstem,2001-08-03,Treatment of myelodysplastic syndrome,Designated,,,N/A,N/A,"Tarix Pharmaceuticals, Ltd",12 Bow Street,,Cambridge,Massachusetts,2138,USA,144601,2001,
Imexon,n/a,2001-08-03,Treatment of metastatic malignant melanoma,Designated/Withdrawn,,,N/A,N/A,AmpliMed Corporation,2321 Camino La Zorrela,,Tucson,Arizona,85718,USA,142501,2001,
"Benzophenone-3, octylmethoxycinnamate, avobenzone, titanium dioxide, zinc oxide",Total Block Vl Spf 75,2001-08-13,For the prevention of visible light induced skin photosensitivity as a result of porfimer sodium photodynamic therapy,Designated,,,N/A,N/A,Fallien Cosmeceuticals Ltd.,677 W. Dekalb Pike,,King of Prussia,Pennsylvania,19406,USA,142401,2001,
Recombinant human endostatin protein,n/a,2001-08-13,Treatment of neuroendocrine tumors,Designated,,,N/A,N/A,"EntreMed, Inc.",9640 Medical Center Drive,,Rockville,Maryland,20850,USA,146301,2001,
metreleptin,Myalept,2001-08-22,Treatment of metabolic disorders secondary to lipodystrophy,Designated/Approved,Approved for Orphan Indication,Adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy.,2014-02-24,2021-02-24,"Aegerion Pharmaceuticals, Inc.",101 Main Street,Suite 1850,Cambridge,Massachusetts,2142,USA,146701,2001,4569
metreleptin,n/a,2001-08-22,Treatment of leptin deficiency secondary to generalized lipodystrophy and partial familial lipodystrophy,Designated,,,N/A,N/A,"Aegerion Pharnaceuticals, Inc.",101 Main Street,Suite 1850,Cambridge,Massachusetts,2142,USA,144301,2001,
pemetrexed disodium,Alimta,2001-08-28,Treatment of malignant pleural mesothelioma,Designated/Approved,Approved for Orphan Indication,Treatment of patients with malignant pleural mesothelioma whose disease is either unresectable or who are otherwise not candidates for curative surgery,2004-02-04,2011-02-04,Eli Lilly and Company,Lilly Corporate Center,,Indianapolis,Indiana,46285,USA,145101,2001,890
"beclomethasone 17,21-dipropionate",Bec,2001-08-28,Prevention of gastrointestinal graft-versus-host disease,Designated,,,N/A,N/A,"Soligenix, Inc.",29 Emmons Drive,,Princeton,New Jersey,8540,USA,146501,2001,
oblimersen,Genasense,2001-08-28,Treatment of multiple myeloma,Designated,,,N/A,N/A,"Genta, Inc.",200 Connell Drive,,Berkeley Heights,New Jersey,7922,USA,145601,2001,
oblimersen,Genasense,2001-08-28,Treatment of acute myelocytic leukemia,Designated,,,N/A,N/A,"Genta, Inc.",200 Connell Drive,,Berkeley Heights,New Jersey,7922,USA,144901,2001,
oblimersen,Genasense,2001-08-28,Treatment of chronic lymphocytic leukemia,Designated,,,N/A,N/A,"Genta, Inc.",200 Connell Drive,,Berkeley Heights,New Jersey,7922,USA,145501,2001,
recombinant human alpha-1 antitrypsin (rAAT),n/a,2001-08-28,To delay progression of chronic obstructive pulmonary disease resulting from AAT deficiency-mediated emphysema and bronchiectasis,Designated,,,N/A,N/A,AiroMedica LLC,6114 LaSalle Avenue,Suite 141,Alameda,California,94611,USA,147601,2001,
humanized monoclonal antibody against Shiga-like toxin II,n/a,2001-09-12,To prevent the development of or to decrease the incidence and severity of hemolytic uremic syndrome and associated sequelae of Shiga-like toxin-producing E. coli.,Designated/Withdrawn,,,N/A,N/A,"Teijin America, Inc.",600 Alexander Park,Suite 304,Princeton,New Jersey,8540,USA,148101,2001,
lenalidomide,Revlimid,2001-09-20,Treatment of multiple myeloma,Designated/Approved,Approved for Orphan Indication,For use in combination with dexamethasone for the treatment of multiple myeloma patients who have received at least one prior therapy,2006-06-29,2013-06-29,Celgene Corporation,86 Morris Avenue,Suite 7000,Summit,New Jersey,7901,USA,147701,2001,1743
lenalidomide,Revlimid,2001-09-20,Treatment of multiple myeloma,Designated/Approved,Approved for Orphan Indication,For use in combination with dexamethasone for the treatment of patients with multiple myeloma who have not received at least one prior therapy (first line treatment),2015-02-17,2022-02-17,Celgene Corporation,86 Morris Avenue,Suite 7000,Summit,New Jersey,7901,USA,147701,2001,4898
lenalidomide,Revlimid,2001-09-20,Treatment of multiple myeloma,Designated/Approved,Approved for Orphan Indication,"Treatment of multiple myeloma (MM), as maintenance following autologous hematopoietic stem cell transplantation (auto-HSCT)",2017-02-22,2024-02-22,Celgene Corporation,86 Morris Avenue,Suite 7000,Summit,New Jersey,7901,USA,147701,2001,5634
oglufanide disodium,n/a,2001-09-24,Treatment of ovarian cancer,Designated,,,N/A,N/A,Implicit Bioscience Pty Ltd,P. O. Box 2072,Toowong Business Center,,,,Australia,147901,2001,
DHA-paclitaxel,Taxoprexin,2001-09-25,Treatment of pancreatic cancer,Designated/Withdrawn,,,N/A,N/A,"Luitpold Pharmaceuticals, Inc.",One Luitpold Drive,,Shirley,New York,11976,USA,147801,2001,
(R)-N-[2-(6-chloro-5-methoxy-1H-indol-3-yl)propyl]acetamide,n/a,2001-10-03,Treatment of circadian rhythm sleep disorders in blind people with no light perception,Designated,,,N/A,N/A,"Phase 2 Discovery, Inc.","3130 Highland Avenue, Third Floor",,Cincinnati,Ohio,45219,USA,147501,2001,
arsenic trioxide,Trisenox,2001-10-18,Treatment of chronic myeloid leukemia,Designated,,,N/A,N/A,"Teva Branded Pharmaceutical Products R*D, Inc.",41 Moores Road,,Frazer,Pennsylvania,19355,USA,145701,2001,
digitoxin,n/a,2001-10-18,Treatment of soft tissue sarcomas,Designated,,,N/A,N/A,SimRx Advisors LLC,247 West 87th Street,Suite 7G,New York,New York,10024,USA,149701,2001,
nolatrexed,Thymitaq,2001-10-18,Treatment of hepatocellular carcinoma,Designated/Withdrawn,,,N/A,N/A,EXIMIAS Pharmaceutical Corporation,1055 Westlakes Drive,Suite 200,Berwyn,Pennsylvania,19312,USA,148801,2001,
porfimer,Photofrin,2001-10-19,For the ablation of High-Grade Dysplasia in Barrett's Esophagus in patients who are not considered to be candidates for esophagectomy,Designated/Approved,Approved for Orphan Indication,For the ablation of high-grade dysplasia in Barrett's esophagus patients who do not undergo esophagectomy,2003-08-01,2010-08-01,Axcan Scandipharm Inc.,22 Inverness Parkway,Suite 310,Birmingham,Alabama,35242,USA,146601,2001,651
acetylcysteine,Acetadote,2001-10-19,For the intravenous treatment of moderate to severe acetaminophen overdose,Designated/Approved,Approved for Orphan Indication,"For the use of Acetadote(registered TM) Injection, administered intravenously within 8 to 10 hours after ingestion of a potentially heptotoxic quantity of acetaminophen, to prevent or lessen hepatic injur",2004-01-23,2011-01-23,"Cumberland Pharmaceuticals, Inc.",209 10th Street South,Suite 332,Nashville,Tennessee,37203,USA,148401,2001,826
Nitisinone,Orfadin,2001-10-19,Treatment of alkaptonuria,Designated,,,N/A,N/A,Swedish Orphan AB,"Kungsgatan 37, 7th Floor",SE-111 56,,,,Sweden,148701,2001,
nitazoxanide,Cryptaz,2001-10-23,Treatment for intestinal amebiasis,Designated,,,N/A,N/A,"Romark Laboratories, L.C.",6200 Courtney Campbell Causeway,Suite 880,Tampa,Florida,33607,USA,150501,2001,
imatinib mesylate,Gleevec,2001-11-01,Treatment of gastrointestinal stromal tumors,Designated/Approved,Approved for Orphan Indication,Treatment of patients with Kit (CD117) positive unresectable and/or metastatic malignant gastrointestinal stromal tumors (GIST),2002-02-01,2009-02-01,Novartis Pharmaceuticals Corp.,One Health Plaza,Mail Code 105/1E870D,East Hanover,New Jersey,7936,USA,149201,2001,92
imatinib mesylate,Gleevec,2001-11-01,Treatment of gastrointestinal stromal tumors,Designated/Approved,Approved for Orphan Indication,Adjuvant treatment of adult patients following complete resection Kit (CD 117) positive gastrointestinal stromal tumors (GIST).,2008-12-19,2015-12-19,Novartis Pharmaceuticals Corp.,One Health Plaza,Mail Code 105/1E870D,East Hanover,New Jersey,7936,USA,149201,2001,2605
T-cell depleted stem cell enriched cellular product from peripheal b lood stem cells,n/a,2001-11-01,Treatment of chronic granulomatous disease,Designated,,,N/A,N/A,Nexell Therapeutics Inc.,9 Parker,,Irvine,California,92618,USA,149001,2001,
arsenic,Trisenox,2001-11-02,"Treatment of acute myelocytic leukemia subtypes M0, M1, M2, M4, M5, M6 and M7",Designated,,,N/A,N/A,"Teva Branded Pharmaceutical Products R&D, Inc.",41 Moores Road,P. O. Box 4011,Frazer,Pennsylvania,19355,USA,146001,2001,
cintredekin besudotox,n/a,2001-11-02,Treatment of malignant glioma,Designated/Withdrawn,,,N/A,N/A,"Insys Development Company, Inc.","1333 South Sprectum Blvd, Suite 100",,Chandler,Arizona,85286,USA,149801,2001,
digitoxin,n/a,2001-11-02,Treatment of ovarian cancer,Designated,,,N/A,N/A,SimRx Advisors LLC,247 West 87th Street,Suite 7G,New York,New York,10024,USA,149601,2001,
2-chloroethyl-3-sarcosinamide-1-nitrosourea,Sarmustine,2001-11-15,Treatment for malignant glioma,Designated,,,N/A,N/A,Pangene Corporation,5500 Stewart Avenue,,Fremont,California,94538,USA,150601,2001,
recombinant human alpha 1-antitrypsin (rAAT),n/a,2001-11-20,Treatment of cystic fibrosis,Designated,,,N/A,N/A,AiroMedica LLC,6114 LaSalle Avenue,Suite 141,Alameda,California,94611,USA,149301,2001,
tri-antennary glycotripeptide derivative of 5-fluorodeoxyuridine monophosphate,n/a,2001-11-23,Treatment for hepatocellular carcinoma,Designated,,,N/A,N/A,Cell Works Inc.,6200 Seaforth Street,,Baltimore,Maryland,21224,USA,150301,2001,
idursulfase,Elaprase,2001-11-28,Long term enzyme replacement therapy for patients with mucopolysaccharidosis II (Hunter Syndrome),Designated/Approved,Approved for Orphan Indication,"Indicated for patients with Hunter syndrome (mucopolysaccharidosis II, MPS II). Idursulfase has been shown to improve walking capacity in these patients",2006-07-24,2013-07-24,"Shire Human Genetic Therapies, Inc.",700 Main Street,,Cambridge,Massachusetts,2139,USA,147301,2001,1699
"Hu1D10, humanized monoclonal antibody",Remitogen,2001-11-28,For use in the treatment of 1D10+ B cell non-Hodgkin's lymphoma,Designated,,,N/A,N/A,"PDL BioPharma, Inc.",34801 Campus Drive,,Fremont,California,94555,USA,144701,2001,
azacitidine,Vidaza,2001-12-03,Treatament of myelodysplastic syndromes,Designated/Approved,Approved for Orphan Indication,"Treatment of patients with the following myelodysplastic syndrome subtypes: refractory anemia or refractory anemia with ringed sideroblasts (if accompanied by neutropenia or thrombocytopenia and requiring transfusions), refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, and chronic myelomonocytic leukemia",2004-05-19,2011-05-19,Celgene Corporation,9900 W. 109th Street,Suite 300,Overland Park,Kansas,66210,USA,150101,2001,898
bryostatin-1,n/a,2001-12-03,For use in combination with paclitaxel in the treatment of esophageal cancer,Designated,,,N/A,N/A,"GPC Biotech, Inc.",610 Lincoln Street,,Waltham,Massachusetts,2451,USA,148201,2001,
conjugate of human transferrin and a mutant diphtheria toxin (CRM 107),Transmid,2001-12-03,Treatment of malignant tumors of the central nervous system,Designated,,,N/A,N/A,Xenova Biomedix Limited,957 Budkingham Avenue,Slough,,,,United Kingdom,150901,2001,
deferiprone,Ferriprox,2001-12-12,Treatment of iron overload in patients with hematologic disorders requiring chronic transfusion therapy,Designated/Approved,Approved for Orphan Indication,Treatment of patients with transfusional iron overload due to thalassemia syndromes when current chelation therapy is inadequate,2011-10-14,2018-10-14,"ApoPharma, Inc. A Division of",Apotex Research Inc.,"Toronto, Canada M9L 1T9",,,,Canada,150701,2001,3593
human anti-transforming growth factor beta 1 monoclonal antibody,n/a,2002-01-11,Treatment of systemic sclerosis,Designated/Withdrawn,,,N/A,N/A,Genzyme Corporation,One Kendall Square,,Cambridge,Massachusetts,2139,USA,151101,2002,
"carbamic acid, [[4-[[3-[[4-[1-(4-hydroxyphenyl)-1-methyl-ethyl]phenoxy]methyl]phenyl]methoxy]-phenyl]iminomethyl]-,ethyl ester",n/a,2002-01-15,Management of cystic fibrosis,Designated/Withdrawn,,,N/A,N/A,"Boehringer Ingelheim Pharmaceuticals, Inc",900 Ridgebury Road,P.O. Box 368,Ridgefield,Connecticut,6877,USA,148601,2002,
"lactic acid bacteria (Lactobacilli, Bifidobacteria, and Steptococci)",n/a,2002-01-15,Treatment of active chronic pouchitis,Designated,,,N/A,N/A,"VSL Pharmaceuticals, Inc.",800 S. Frederick Ave.,,Gaithersburg,Maryland,20877,USA,145201,2002,
"lactic acid bacteria (Lactobacilli, Bifidobacteria, and Streptococcus species)",n/a,2002-01-15,Prevention of disease relapse in patients with chronic pouchitis,Designated,,,N/A,N/A,"VSL Pharmaceuticals, Inc.",800 S. Frederick Ave.,,Gaithersburg,Maryland,20877,USA,154102,2002,
"lipase, amylase, and protease",Theraclec-Total,2002-01-23,Treatment of pancreatic insufficiency,Designated/Withdrawn by OPD,,,N/A,N/A,Altus Biologics Inc.,625 Putnam Avenue,,Cambridge,Massachusetts,2139,USA,148501,2002,
clofarabine,Clolar,2002-02-07,Treatment of acute lymphoblastic leukemia,Designated/Approved,Approved for Orphan Indication,Treatment of pediatric patients 1 to 21 years old with relapsed or refractory acute lymphoblastic leukemia after at least two prior regimens,2004-12-28,2011-12-28,Genzyme Corporation,4545 Horizon Hill Blvd.,,San Antonio,Texas,78229,USA,153201,2002,1055
homoharringtonine,n/a,2002-02-08,Treatment for chronic myelogenous leukemia,Designated,,,N/A,N/A,"American BioScience, Inc.",2730 Wilshire Blvd. #110,,Santa Monica,California,90403,USA,152901,2002,
Bioartificial liver system utilizing xenogenic hepatocytes in a hollow fiber bioreactor cartridge (BAL),n/a,2002-02-11,Treatment of patients with acute liver failure presenting with encephalopathy deteriorating beyond Parson's grade 2,Designated,,,N/A,N/A,"Excorp Medical, Inc.",Suite 235,7200 Hudson Blvd.,Oakdale,Minnesota,55128,USA,136600,2002,
Recombinant immunotoxin combining the functional components of antibody against mesothelin and the enzymatic activity of a pseudomonas exotoxin,n/a,2002-02-11,Treatment of epithelial ovarian cancer,Designated,,,N/A,N/A,National Institutes of Health,Cancer Therapy Evaluation Program,"6130 Executive Blvd, Suite 7111",Rockville,Maryland,20852,USA,150801,2002,
Recombinant immunotoxin combining the functional components of antibody against mesothelin and the enzymatic activity of a pseudomonas exotoxin,n/a,2002-02-11,Treatment of malignant mesothelioma,Designated,,,N/A,N/A,National Institutes of Health,Cancer Therapy Evaluation Program,"6130 Executive Blvd, Suite 7111",Rockville,Maryland,20852,USA,151801,2002,
creatine,Creapure,2002-02-12,Treatment of amyotrophic lateral sclerosis,Designated,,,N/A,N/A,"Avicena Group, Inc.",580 California St.,Suite 1600,San Francisco,California,94104,USA,152701,2002,
nitazoxanide,Alinia,2002-02-14,Treatment of intestinal giardiasis,Designated/Approved,Approved for Orphan Indication,Treatment of diarrhea caused by Cryptosporidium parvum and Giardia lamblia,2002-11-22,2009-11-22,"Romark Laboratories, L.C.",6200 Courtney Campbell Causeway,Suite 880,Tampa,Florida,33607,USA,150401,2002,281
I(131)-TM-601 (chlorotoxin),n/a,2002-02-14,Treatment of malignant glioma,Designated,,,N/A,N/A,"Morphotek, Inc.",210 Welsh Pool Road,,Exon,Pennsylvania,19341,USA,152201,2002,
phenylephrine,n/a,2002-02-14,Treatment of ileal pouch anal anastomosis related fecal incontinence,Designated,,,N/A,N/A,S.L.A. Pharma,"Unit 3, Hill Farm Industrial Estate","Leavesden, Watford",,,,United Kingdom,147201,2002,
recombinant human endostatin protein,n/a,2002-02-21,Treatment of metastatic melanoma,Designated,,,N/A,N/A,"EntreMed, Inc.",9640 Medical Center Drive,,Rockville,Maryland,20850,USA,153101,2002,
aztreonam,Cayston,2002-03-12,Inhalation therapy for control of gram-negative bacteria in the respiratory tract of patients with cystic fibrosis,Designated/Approved,Approved for Orphan Indication,To improve respiratory symptoms in cystic fibrosis (CF) patients with Pseudomonas aeruginosa,2010-02-22,2017-02-22,Gilead Sciences (formerly Corus Pharma),199 East Blaine St,,Seattle,Washington,98102,USA,155002,2002,2904
Albuterol,n/a,2002-03-12,Prevention of paralysis due to spinal cord injury,Designated,,,N/A,N/A,"MotoGen, Inc.",3 Pine View Road,,Mount Kisco,New York,10549,USA,152501,2002,
rituximab,Rituxan,2002-03-12,Treatment of immune thrombocytopenic purpura,Designated,,,N/A,N/A,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,USA,155102,2002,
clofarabine,Clofarex,2002-03-14,Treatment of acute myelogenous leukemia,Designated,,,N/A,N/A,"Genzyme Corp (Ilex Products, Inc.)",4545 Horizon Hill Blvd.,,San Antonio,Texas,78229,USA,154802,2002,
S(-)-3-[3-amino-phthalimido]-glutaramide,n/a,2002-03-14,Treatment of multiple myeloma,Designated,,,N/A,N/A,EntreMed Incorporated,9640 Medical Center Dr.,,Rockville,Maryland,20850,USA,151701,2002,
toralizumab,n/a,2002-03-14,Treatment of immune thrombocytopenic purpura,Designated/Withdrawn,,,N/A,N/A,Biogen IDEC Inc.,3030 Callan Road,,San Diego,California,92121,USA,154302,2002,
hyaluronic acid,n/a,2002-03-19,Treatment of emphysema in patients due to alpha-1 antitrypsin deficiency,Designated,,,N/A,N/A,CoTherix,5000 Shoreline Court,Suite 101,South San Francisco,California,94080,USA,153501,2002,
tinidazole,Tindamax,2002-04-18,Treatment of giardiasis,Designated/Approved,Approved for Orphan Indication,Treatment of giardiasis caused by G. duodenalis (also termed G. lamblia) in both adults and pediatric patients older than three years of age,2004-05-17,2011-05-17,"Presutti Laboratories, Inc.",1607 N. Douglas Avenue,,Arlington Heights,Illinois,60004,USA,155402,2002,760
autologous antigen presenting cells pulsed with autologous tumor Ig idiotype,Mylovenge,2002-04-18,Treatment of multiple myeloma,Designated/Withdrawn,,,N/A,N/A,Dendreon Corporation,3005 First Avenue,,Seattle,Washington,98121,USA,153701,2002,
genetically engineered herpes simplex virus (G207),n/a,2002-04-29,Treatment of malignant glioma,Designated,,,N/A,N/A,"Aettis, Inc.",128 Penarth Road,,Bala Cynwyd,Pennsylvania,19004,USA,155202,2002,
retroviral gamma-c cDNA containing vector,n/a,2002-04-29,Treatment of X linked severe combined immune deficiency disease,Designated,,,N/A,N/A,"AVAX technologies, Inc.",9200 Indian Creek Parkway,"Building 9, Suite 200",Overland Park,Kansas,66210,USA,151601,2002,
autologous tumor-derived gp96 heat shock protein-peptide complex,Oncophage,2002-05-10,Treatment of renal cell carcinoma,Designated,,,N/A,N/A,"Agenus, Inc.",3 Forbes Rd.,,Lexington,Massachusetts,2421,USA,150201,2002,
"N-[4-bromo-2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]-N'-[3,5-bis(trifluoromethyl)phenyl]urea",n/a,2002-05-13,Treatment of sickle cell disease,Designated/Withdrawn,,,N/A,N/A,NeuroSearch A/S,93 Pederstrupvej,DK-2750 Ballerup,,,,Denmark,153901,2002,
octavalent Psuedomonas aeruginosa O-polysaccaharide-toxin A conjugate,Aerugen,2002-05-16,Prevention of Psuedomonas aeruginosa infections in patients with cystic fibrosis,Designated/Withdrawn,,,N/A,N/A,Berna Biotech Ltd.,Rehhagstrass 79,CH-3018,Berna,,,Switzerland,155702,2002,
mecasermin rinfabate,Iplex,2002-05-17,Treatment of growth hormone insensitivity syndrome (GHIS),Designated/Approved,Approved for Orphan Indication,Treatment of growth failure in children with severe primary IGF-1 deficiency (Primary IGFD) or with growth hormone (GH) gene deletion who have developed neutralizing antibodies to growth hormone,2005-12-12,2012-12-12,"Insmed, Inc.",10 Finderne Ave,Building 10,Bridgewater,New Jersey,8807,USA,156302,2002,1305
trabedersen,Oncomun,2002-06-05,Treatment of malignant glioma,Designated,,,N/A,N/A,Oncotelic Inc.,29397 Agoura Road,Suite 107,Agoura Hills,California,91301,USA,155602,2002,
Cells produced using the AastromReplicelle System and SC-I Therapy Kit,n/a,2002-07-10,For use in patients receiving high dose chemotherapy who are unable to generate an acceptable dose of peripheral blood stem cells and who have a sufficient bone marrow aspirate without morphological evidence of tumor,Designated,,,N/A,N/A,Aastrom Biosciences Incorporated,P.O. Box 376,,Ann Arbor,Michigan,48106,USA,153401,2002,
G17DT Immunogen,Gastrimmune(Tm),2002-07-10,Treatment of adenocarcinoma of the pancreas,Designated,,,N/A,N/A,"Cancer Advances, Inc.",Westpark Corporate Center,Suite 210,Durham,North Carolina,27713,USA,156902,2002,
autologous tumor-derived gp96 heat shock protein-peptide complex,Oncophage,2002-07-11,Treatment of metastatic melanoma,Designated,,,N/A,N/A,"Agenus, Inc.",3 Forbes Rd.,,l,Massachusetts,2421,USA,154202,2002,
"recombinant human porphobilinogen deaminase, erythropoetic form",n/a,2002-07-11,Treatment of acute intermittent porphyria preventing attacks,Designated,,,N/A,N/A,Zymenex A/S,Roskildevej 12C,3400 Hillerod,,,,Denmark,157302,2002,
rubitecan,n/a,2002-07-17,Treatment of pediatric patients infected with human immunodeficiency virus and acquired immunodeficiency syndrome,Designated,,,N/A,N/A,"SuperGen, Inc.",4140 Dublin Blvd.,Suite 200,Dublin,California,94568,USA,156602,2002,
G17DT Immunogen,Gastrimmune(Tm),2002-07-18,Treatment of gastric cancer,Designated,,,N/A,N/A,"Cancer Advances, Inc.",Westpark Corporate Center,Suite 210,Durham,North Carolina,27713,USA,157002,2002,
polyinosinic-polycytidilic acid,Poly-Iclc,2002-08-02,As an adjuvant to smallpox vaccination,Designated,,,N/A,N/A,Oncovir,"3203 Cleveland Ave., NW",,Washington,District of Columbia,20008,USA,157802,2002,
decitabine,n/a,2002-09-09,Treatment of sickle cell anemia,Designated/Withdrawn,,,N/A,N/A,Otsuka Pharmaceutical Development &,"Commercialization, Inc.",508 Carnegie Center Drive,Princeton,New Jersey,8540,USA,159702,2002,
lintuzumab,Zamyl,2002-09-09,Treatment of acute myelogenous leukemia,Designated/Withdrawn,,,N/A,N/A,"Protein Design Labs, Inc.",34801 Campus Drive,,Fremont,California,94555,USA,158502,2002,
N-acetylcysteine,n/a,2002-09-09,Treatment of acute liver failure,Designated,,,N/A,N/A,"Cumberland Pharmaceuticals, Inc.",2525 West End Ave.,Suite 950,Nashville,Tennessee,37203,USA,158102,2002,
recombinant human porphobilinogen deaminase,Porphozyme,2002-09-09,Treatment of acute intermittent porphyria attacks,Designated,,,N/A,N/A,Zymenex A/S,Roskildevej 12C,3400 Hillerod,,,,Denmark,157202,2002,
interferon gamma-1b,Actimmune,2002-09-12,Treatment of idiopathic pulmonary fibrosis,Designated/Withdrawn,,,N/A,N/A,"InterMune, Inc.",3280 Bayshore Boulevard,,Brisbane,California,94005,USA,152301,2002,
human gammaglobulin,Oralgam,2002-09-16,"Treatment of gastrointestinal disturbances (to include constipation, diarrhea, and abdominal pain) associated with regression-onset autism in pediatric patients.",Designated,,,N/A,N/A,"Latona Life Sciences, Inc.",10 Village St.,,Mills,Massachusetts,2054,USA,152101,2002,
recombinant human monoclonal antibody to hsp90,Mycograb,2002-09-16,Treatment of invasive candidiasis,Designated/Withdrawn,,,N/A,N/A,Novartis Pharmaceuticals Corp.,One Health Plaza,,East Hanover,New Jersey,,United Kingdom,158402,2002,
DHA-paclitaxel,Taxoprexin,2002-10-10,Treatment of metastatic malignant melanoma,Designated/Withdrawn,,,N/A,N/A,"Luitpold Pharmaceuticals, Inc.",One Luitpold Drive,P. O. Box 9001,Shirley,New York,11967,USA,153001,2002,
antiangiogenic components extracted from marine cartilage,Neovastat (Ae-941),2002-10-16,Treatment of renal cell carcinoma,Designated,,,N/A,N/A,"AEterna Zentaris, Inc.",Dr. Claude Hariton,"Chief Medical Officer, VP, Cli","Quebec G1P 4P5, Canada",,,Canada,159202,2002,
capsaicin,n/a,2002-10-23,Treatment of erythromelalgia,Designated,,,N/A,N/A,"Acorda Therapeutics, Inc.",420 Saw Mill River Road,,Ardsley,New York,10502,USA,158202,2002,
D-peptide of the sequence AKRHHGYKRKFH - NH2,Pulmadex,2002-10-23,Treatment of cystic fibrosis,Designated,,,N/A,N/A,"Demegen, Inc.",100 Technology Drive,Suite 440 B,Pittsburgh,Pennsylvania,15219,USA,156502,2002,
infliximab,Remicade,2002-10-23,Treatment of juvenile rheumatoid arthritis,Designated,,,N/A,N/A,"Centocor, Inc.",,200 Great Valley Parkway,Malvern,Pennsylvania,19355,USA,160202,2002,
inolimomab,Leukotac,2002-10-23,Treatment of graft versus host disease,Designated,,,N/A,N/A,ElsaLys Biotech SAS,317 Avenue Jean Jaures,Batiment Accinov,Lyon,,,France,158602,2002,
tirapazamine,n/a,2002-10-23,Treatment of head and neck cancer,Designated,,,N/A,N/A,"Sanofi-Aventis US, Inc.",11 Great Valley Parkway,P. O. Box 3026,Malvern,Pennsylvania,19355,USA,155502,2002,
cobiprostone,n/a,2002-11-14,Treatment of cystic fibrosis,Designated/Withdrawn,,,N/A,N/A,"Sucampo Pharma Americas, LLC.",4520 East-West Highway,Suite 300,Bethesda,Maryland,20814,USA,158302,2002,
Hepatitis C virus immune globulin (human),Civacir(Tm),2002-11-14,Prophylaxis of hepatitis C infection in liver transplant recipients.,Designated/Withdrawn,,,N/A,N/A,"ADMA Biologics, Inc.",465 Route 17 South,,Ramsey,New Jersey,7446,USA,73193,2002,
natural human lymphoblastoid interferon-alpha,n/a,2002-11-18,Treatment of polycythemia vera,Designated,,,N/A,N/A,"Amarillo Biosciences, Inc.",4134 Business Park Drive,,Amarillo,Texas,79110,USA,159602,2002,
polyinosinic-polycytidilic acid (Poly-ICLC),Hiltonol,2002-11-19,Treatment for orthopox virus infections,Designated,,,N/A,N/A,Oncovir,"3203 Cleveland Ave., NW",,Washington,District of Columbia,20008,USA,157702,2002,
Deferasirox,Exjade; Jadenu Sprinkles,2002-11-21,Treatment of chronic iron overload in patients with transfusion-dependent anemias,Designated/Approved,Approved for Orphan Indication,Treatment of chronic iron overload due to blood transfusions (transfusional hemosiderosis) in patients 2 years of age or older,2005-11-02,2012-11-02,Novartis Pharmaceuticals Corp.,One Health Plaza,,East Hanover,New Hampshire,7936,USA,161002,2002,1077
Deferasirox,Exjade; Jadenu Sprinkles,2002-11-21,Treatment of chronic iron overload in patients with transfusion-dependent anemias,Designated/Approved,Approved for Orphan Indication,treatment of chronic iron overload due to blood transfusions (transfusional hemosiderosis) in patients 2 years of age and older,2017-05-18,N/A,Novartis Pharmaceuticals Corp.,One Health Plaza,,East Hanover,New Hampshire,7936,USA,161002,2002,5292
allantoin,Alwextin,2002-11-21,Treatment of skin blistering and erosions associated with inherited epidermolysis bullosa,Designated,,,N/A,N/A,"Scioderm, Inc.",1007 Slater Road,Suite 170,Durham,North Carolina,27703,USA,151001,2002,
heat killed mycobacterium w immunomodulator,Cadi Mw,2002-11-21,Adjuvant to multi-drug therapy in the management of multibacillary leprosy,Designated,,,N/A,N/A,"CPL, Inc.",16020 Swingley Ridge Road,Suite 145,Chesterfield,Missouri,63017,USA,161202,2002,
meloxicam,Mobic,2002-11-22,Treatment of juvenile rheumatoid arthritis,Designated/Approved,Approved for Orphan Indication,For relief of the signs and symptoms of pauciarticular or polyarticular course Juvenile Rheumatoid Arthritis in patients 2 years of age or older,2005-08-11,2012-08-11,"Boehringer Ingelheim Pharmaceuticals, Inc.",900 Ridgebury Road,P. O. Box 368,Ridgefield,Connecticut,6877,USA,160602,2002,993
busulfan,Partaject,2002-11-25,Preparative therapy for pediatric patients undergoing bone marrow transplantation,Designated,,,N/A,N/A,"SuperGen, Inc.",4140 Dublin Blvd.,Suite 200,Dublin,California,94568,USA,160402,2002,
"(4S)-4-ethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1-H-pyrano[3?,4?:6,7]-indolizino-[1,2-b]-quinoline-11-carbaldehyde O-(tert-butyl)-(E)-oxime",Gimatecan,2002-11-29,Treatment malignant glioma,Designated/Withdrawn,,,N/A,N/A,"Sigma-Tau Research, Inc.",9841 Washingtonian Blvd,Suite 502,Gaithersburg,Maryland,20878,USA,161602,2002,
Autologous dendritic cells pulsed with autologous antigens from primay malignant brain tumor cells,Dcvax-Brain,2002-11-29,Treatment of primary brain malignant cancer,Designated,,,N/A,N/A,"Northwest Biotherapeutics, Inc.",22322 20th Avenue SE,Suite 150,Bothell,Washington,98021,USA,162902,2002,
civamide,Zucapsaicin,2002-12-09,Treatment of postherpetic neuralgia of the trigeminal nerve,Designated,,,N/A,N/A,"Winston Laboratories, Inc.",100 Fairway Drive,Suite 134,Vernon Hills,Illinois,60061,USA,159102,2002,
R-etodolac,n/a,2002-12-09,Treatment of chronic lymphocytic leukemia,Designated/Withdrawn,,,N/A,N/A,"Cephalon, Inc.",41 Moores Road,,Frazer,Pennsylvania,19355,USA,162702,2002,
"2',3',5'-tri-o-acetyluridine",n/a,2003-01-13,Treatment of mitochondrial disease,Designated/Withdrawn,,,N/A,N/A,Repligen Corporation,41 Seyon Street,"Building 1, Suite 100",Waltham,Massachusetts,2453,USA,163202,2003,
bortezomib,Velcade,2003-01-15,Treatment of multiple myeloma,Designated/Approved,Approved for Orphan Indication,Treatment of multiple myeloma patients who have received at least two prior therapies and have demonstrated disease progression on the last therapy,2003-05-13,2010-05-13,"Millennium Pharmaceuticals, Inc.",40 Landsdowne Street,,Cambridge,Massachusetts,2139,USA,163002,2003,118
bortezomib,Velcade,2003-01-15,Treatment of multiple myeloma,Designated/Approved,Approved for Orphan Indication,Treatment of multiple myeloma patients who have received at least one prior therapy,2005-03-25,2012-03-25,"Millennium Pharmaceuticals, Inc.",40 Landsdowne Street,,Cambridge,Massachusetts,2139,USA,163002,2003,800
bortezomib,Velcade,2003-01-15,Treatment of multiple myeloma,Designated/Approved,Approved for Orphan Indication,First-line therapy of multiple myeloma.,2008-06-20,2015-06-20,"Millennium Pharmaceuticals, Inc.",40 Landsdowne Street,,Cambridge,Massachusetts,2139,USA,163002,2003,1983
pomalidomide,Pomalyst,2003-01-15,Treatment of multiple myeloma,Designated/Approved,Approved for Orphan Indication,Treatment of patients with multiple myeloma who have received at least two prior therapies including lenalidomide and bortezomib and have demonstrated disease progression on or within 60 days of completion of the last therapy.,2013-02-08,2020-02-08,Celgene Corporation,400 Connell Drive,Suite 7000,Berkeley Heights,New Jersey,7922,USA,161402,2003,3677
bifidobacterium longum infantis 35624,n/a,2003-01-16,Treatment of pediatric Crohn's disease,Designated,,,N/A,N/A,Alimentary Health Limited,"Guardwell, Kinsale",,County Cork,,,Ireland,161902,2003,
Human Anti-tumor Necrosis factor alpha monoclonal antibody,n/a,2003-01-16,"Treatment of uveitis of the posterior segment of non-infectious etiology, and uveitis of the anterior segment of non-infectious etiology and refractory to conventional therapy",Designated/Withdrawn,,,N/A,N/A,"Centocor, Inc.",200 Great Valley Parkway,,Malvern,Pennsylvania,19355,USA,159402,2003,
a-Galactosidase A,Plant-Produced Human A-Glactosidase A,2003-01-21,Treatment of Fabry's disease,Designated,,,N/A,N/A,"iBio, Inc.",9 Innovation Way,Suite 100,Newark,Delaware,19711,USA,162302,2003,
Mafosfamide,n/a,2003-01-21,Treatment of neoplastic meningitis,Designated,,,N/A,N/A,Baxter Healthcare Corporation,Route 120 & Wilson Road,,Round Lake,Illinois,60073,USA,162202,2003,
alteplase,Activase,2003-01-27,Treatment of intraventricular hemorrhage associated with intracerebral hemorrhage,Designated,,,N/A,N/A,"Daniel F. Hanley, MD",Johns Hopkins University,"600 N. Wolfe St., Jefferson 1-109",Baltimore,Maryland,21287,USA,163502,2003,
motexafin gadolinium,Xcytrin,2003-01-27,For use in conjunction with whole brain radiation for the treatment of brain metastases arising from solid tumors,Designated,,,N/A,N/A,"Pharmacyclics, LLC",995 E. Arques Avenue,,Sunnyvale,California,94085,USA,152401,2003,
recombinant adeno-associated virus alpha 1-antitrypsin vector,Raav-Aat,2003-01-27,Treatment of alpha1-antitrypsin deficiency,Designated,,,N/A,N/A,Applied Genetic Technologies Corp.,11801 Research Drive,Suite D,Alachua,Florida,32615,USA,164302,2003,
reparixin,n/a,2003-01-27,Prevention of delayed graft function in solid organ transplant,Designated,,,N/A,N/A,Dompe S.p.A.,Via Campo di Pile,67100 - L'Aquila,,,,Italy,162802,2003,
Replication defective recombinant adenovirus serotype 5 vector carrying the p53 gene in its E1 deleted region,Advexin,2003-01-27,Treatment of head and neck cancer,Designated,,,N/A,N/A,"Introgen Therapeutics, Inc.",,2250 Holcombe Blvd,Houston,Texas,77030,USA,160302,2003,
Tezacitabine,n/a,2003-01-27,Treatment of adenocarcinoma of the esophagus and stomach,Designated,,,N/A,N/A,"Sanofi-Aventis US, Inc.",9 Great valley Parkway,,Malvern,Pennsylvania,19355,USA,164002,2003,
ecallantide,Kalbitor,2003-02-04,Treatment of angioedema,Designated/Approved,Approved for Orphan Indication,Treatment of acute attacks of hereditary angioedema in patients 16 years of age and older,2009-12-01,2016-12-01,Dyax Corp.,300 Shire Way,,Lexington,Massachusetts,2421,USA,160802,2003,2492
ecallantide,Kalbitor,2003-02-04,Treatment of angioedema,Designated/Approved,Approved for Orphan Indication,Treatment of acute attacks of hereditary angioedema (HAE) in patients 12 years of age and older,2014-03-28,2021-03-28,Dyax Corp.,300 Shire Way,,Lexington,Massachusetts,2421,USA,160802,2003,4070
"anti-CD23 IgG1, kappa monoclonal antibody",n/a,2003-02-12,Treatment of chronic lymphocytic leukemia,Designated/Withdrawn,,,N/A,N/A,"Biogen IDEC, Inc.",,5200 Research Place,San Diego,California,92122,USA,160502,2003,
MaxAdFVIII,n/a,2003-03-03,Treatment of Hemophilia A,Designated,,,N/A,N/A,GenStar Therapeutics Corporation,10865 Altman Row,Suite 200,San Diego,California,92121,USA,164402,2003,
polyinosinic-polycytidilic acid,Poly-Iclc,2003-03-03,"Treatment of flavivirus infections including those due to West Nile, Japanese encephalitis, dengue, St. Louis encephalitis, yellow fever, Murray valley, and Banzai viruses",Designated,,,N/A,N/A,Oncovir,"3203 Cleveland Ave., NW",,Washington,District of Columbia,20008,USA,163302,2003,
antisense 20-mer phosphorothioate oligonucleotide [complementary to the coding region of R2 component of the human ribonucleotide reductase mRNA],Gti-2040,2003-03-12,Treatment for renal cell carcinoma,Designated,,,N/A,N/A,"Lorus Therapeutics, Inc",2 Meridan Road,M9W427,,,,Canada,165202,2003,
dextran 1,n/a,2003-03-21,Treatment of cystic fibrosis,Designated,,,N/A,N/A,BCY LifeSciences Inc.,160 Eglinton Ave. East,Suite 600,"Toronto, Ontario M4P 3B",,,Canada,157602,2003,
romiplostim,Nplate,2003-03-27,Treatment of immune thrombocytopenic purpura,Designated/Approved,Approved for Orphan Indication,"Treatment of thrombocytopenia in patients with chronic immune (idiopathic) thrombocytopenic purpura (ITP) who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy",2008-08-22,2015-08-22,"Amgen, Inc.",One Amgen Center Drive,,Thousand Oaks,,,,165402,2003,1975
"(+/-)-7-[3-(4-acetyl-3-methoxy-2-propylphenoxy)propoxy]-3,4-dihydro-8-propyl-2H-1-benzopyran-2-carboxylic acid",n/a,2003-03-31,Prevention of serious adverse events associated with vascular leak syndrome caused by Interleukin-2 therapy,Designated/Withdrawn,,,N/A,N/A,"Intarcia Therapeutics, Inc.",24650 Industrial Blvd,,Hayward,California,94545,USA,164102,2003,
alendronate,Fosamax,2003-03-31,Treatment of osteogenesis imperfecta in pediatric patients 4 years of age and older,Designated/Withdrawn,,,N/A,N/A,"Merck, Sharpe & Dohme Corp.",126 East Lincoln Ave.,RY 33-212,Rahway,New Jersey,7065,USA,166603,2003,
Sodium pyruvate,n/a,2003-03-31,Treatment of cystic fibrosis,Designated,,,N/A,N/A,"Cellular Sciences, Inc",84 park Avenue,P.O. Box 968,Flemington,New Jersey,8822,USA,165602,2003,
ribavirin,Rebetol,2003-04-04,Treatment of chronic hepatitis C in pediatric patients,Designated/Approved,Approved for Orphan Indication,Treatment of chronic hepatitis C among previously untreated pediatric patients at least three years of age or older.,2003-07-29,2010-07-29,Schering Corporation,2000 Galloping Hill Road,,Kenilworth,New Jersey,7033,USA,162402,2003,116
"4,5-dibromorhodamine 123",Theralux Irradiation Device,2003-04-10,Treatment of chronic myelogenous leukemia,Designated/Withdrawn,,,N/A,N/A,"Kiadis Pharma Canada, Inc.",2525 Marie-Curie,Saint-Laurent (Quebec) H4S 2E1,,,,Canada,166203,2003,
Tretinoin,Atra-Iv,2003-04-11,Treatment of T-cell non-Hodgkin's lymphoma,Designated,,,N/A,N/A,"Antigenics, Inc.",3 Forbes Road,,Lexington,Massachusetts,2421,USA,165802,2003,
iron(III)-hexacyanoferrate(II),Radiogardase,2003-05-01,Treatment of patients with known or suspected internal contamination with radioactive or non-radioactive cesium or thallium,Designated/Approved,Approved for Orphan Indication,Treatment of patients with known or suspected internal contamination with radioactive cesium and/or radioactive or non-radioactive thallium to increase their rates of elimination,2003-10-02,2010-10-02,"Heyl Chemisch-Pharmzeutische Fabrik GMBH & Co, KG",Goerzallee 253,"D-14167 Berlin, Federal Republic of Germany",,,,Germany,169203,2003,154
DHA-paclitaxel,Taxoprexin,2003-05-01,Treatment of adenocarcinoma of the stomach or lower esophagus,Designated/Withdrawn,,,N/A,N/A,"Luitpold Pharmaceuticals, Inc.",One Luitpold Drive,P. O. Box 9001,Shirley,New York,11967,USA,153301,2003,
capsaicin,Qutenza,2003-05-02,Treatment of painful HIV-associated neuropathy,Designated,,,N/A,N/A,"Acorda Therapeutics, Inc.",420 Saw Mill River Road,,Ardsley,New York,10502,USA,165502,2003,
Recombinant T-cell receptor ligand,n/a,2003-05-02,Treatment of multiple sclerosis patients who are both HLA-DR2 positive and autoreactive to myelin oligodendrocyte glycoprotein residues 35-55,Designated,,,N/A,N/A,"Artielle ImmunoTherapeutics, Inc.",9020 SW Washington Square Road,Suite 450,"Tigard,",Oregon,97223,USA,163102,2003,
infliximab,Remicade,2003-05-06,Treatment of giant cell arteritis,Designated/Withdrawn,,,N/A,N/A,"Centocor, Inc.",200 Great Valley Parkway,,Malvern,Pennsylvania,19355,USA,166303,2003,
cinacalcet,Sensipar,2003-05-12,Treatment of hypercalcemia in patients with parathyroid carcinoma,Designated/Approved,Approved for Orphan Indication,Treatment of hypercalcemia in patients with parathyroid carcinoma,2004-03-08,2011-03-08,"Amgen, Inc.",,One Amgen Center Drive,Thousand Oaks,California,91320,USA,163402,2003,301
Arsenic trioxide,Trisenox,2003-05-13,Treatment of chronic lymphocytic leukemia,Designated,,,N/A,N/A,"Teva Branded Pharmaceutical Products R&D, Inc.",41 Moores Road,P.O. Box 4011,Frazer,Pennsylvania,19355,USA,167203,2003,
resiniferatoxin,n/a,2003-05-13,Treatment of intractable pain at end-stage disease,Designated,,,N/A,N/A,"Sorrento Theraeputics, Inc.",9380 Judicial Drive,,San Diego,California,92121,USA,164802,2003,
repository corticotropin or adrenocorticotropic hormone,H.P. Acthar Gel,2003-05-21,Treatment of infantile spasms,Designated/Approved,Approved for Orphan Indication,To treat infantile spasms,2010-10-15,2017-10-15,"Questcor Pharmaceuticals, Inc.",26118 Research Road,,Hayward,California,94545,USA,168103,2003,2704
defibrotide,Defitelio,2003-05-21,For the treatment of hepatic veno-occlusive disease,Designated/Approved,Approved for Orphan Indication,"For the treatment of adult and pediatric patients with hepatic veno-occlusive disease (VOD), also known as sinusoidal obstruction syndrome (SOS), with renal or pulmonary dysfunction following hematopoietic stem cell transplantation (HSCT).",2016-03-30,2023-03-30,"Jazz Pharmaceuticals, Inc.",3180 Porter Dr.,,Palo Alto,California,94304,USA,168803,2003,4697
Anti-CEA Sheep-human chimeric monoclonal antibody labeled w/iodine-131 (KAb201),n/a,2003-05-21,Treatment of pancreatic cancer,Designated/Withdrawn,,,N/A,N/A,Avaant Pharmaceuticals India Ltd.,"3rd Floor, Neelkanth Commercial Centre",Mumbai - 400 099,,,,India,168003,2003,
"Factor XIII [A2] homodimer, recombinant DNA origin",n/a,2003-05-21,Treatment of congenital FXIII deficiency,Designated,,,N/A,N/A,"Novo Nordisk Pharmaceuticals, INc.",100 College Road West,,Princeton,New Jersey,8540,USA,168603,2003,
Infliximab,Remicade,2003-05-21,Treatment of chronic sarcoidosis,Designated,,,N/A,N/A,"Centocor, Inc.",200 Great Valley Parkway,,Malvern,Pennsylvania,19355,USA,168303,2003,
myristoylated recombinant SCR1-3 of human complement reseptor type I,Apt070,2003-05-21,Prevention of delayed graft function in solid organ transplant,Designated/Withdrawn,,,N/A,N/A,Orexo AB,Box 303,Virdings alle 32 A,,,,Sweden,166903,2003,
Protaxel,n/a,2003-05-21,Treatment of ovarian cancer,Designated,,,N/A,N/A,"Biophysica, Inc.",2159 Avenida de la Playa,Suite B,La Jolla,California,92037,USA,168203,2003,
vorinostat,n/a,2003-06-12,Treatment of multiple myeloma,Designated/Withdrawn,,,N/A,N/A,Merck Research Laboratories,"Merck & Co., Inc.","P. O. Box 2000, RY 32-605",Rahway,New Jersey,7065,USA,169503,2003,
arsenic trioxide,Trisenox,2003-06-13,Treatment of liver cancer,Designated,,,N/A,N/A,"Teva Branded Pharmaceutical Products R&D, Inc.",41 Moores Road,P. O. Box 4011,Frazer,Pennsylvania,19355,USA,167303,2003,
diferuloylmethane,n/a,2003-06-13,Treatment of cystic fibrosis,Designated/Withdrawn,,,N/A,N/A,"Allertein Therapeutics, LLC",640 Sasco Hill Road,,Fairfield,Connecticut,6824,USA,167603,2003,
diphenylcyclopenone,n/a,2003-06-13,Treatment of chronic severe forms of alopecia areata (Alopecia Totalis [AT]/Alopecia Universalis [AU]),Designated,,,N/A,N/A,"Lloyd E. King, Jr.",1900 Patterson Street,Suite 104,Nashville,Tennessee,37203,USA,164502,2003,
"ferric hexacyanoferrate (II) ""Prussian Blue""",n/a,2003-06-26,Treatment of patients with known or suspected internal contamination with radioactive or non-radioactive cesium or thallium,Designated,,,N/A,N/A,Degussa AG,Weissfrauenstr.9,D-60287,Frankfurt,,,Germany,173403,2003,
(R)-N-[2-(6-Chloro-methoxy-1H-indol-3yl)propyl]acetamide,n/a,2003-07-03,Treatment of neuroleptic-induced tardive dyskinesia in schizophrenia patients,Designated,,,N/A,N/A,"Phase 2 Discovery, Inc.",3130 Highland Ave.,Third Floor,Cincinnati,Ohio,45219,USA,157102,2003,
sodium dichloroacetate,n/a,2003-07-03,Use as an antidote in the management of systemic monochloroacetic acid poisoning,Designated,,,N/A,N/A,EBD Group,2032 Corte del Nogal,Suite 120,Carlsbad,California,92011,USA,169803,2003,
plerixafor,Mozobil (R),2003-07-10,For use to improve the yield of progentor cells in the apheresis product for subsequest stem cell transplantation following myelosuppressive or myeloablative chemotherapy,Designated/Approved,Approved for Orphan Indication,To enhance mobilization of hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in patients with lymphoma and multiple myeloma,2008-12-15,2015-12-15,Genzyme Corporation,500 Kendall Street,,Cambridge,Massachusetts,2142,USA,167903,2003,1985
"Dual antibody including HBV-Ab 17, libivirumab, and HBV-Ab 19, exbivirumab",Hepex-B,2003-07-15,For the prevention of hepatitis B virus (HBV) reinfection in patients who have received a liver transplantation,Designated/Withdrawn,,,N/A,N/A,Cubist Pharmaceuticals,65 Hayden Avenue,,Lexington,Massachusetts,2421,USA,171103,2003,
siplizumab,n/a,2003-07-15,Treatment of T-cell lymphomas,Designated/Withdrawn,,,N/A,N/A,"MedImmune, LLC",One MedImmune Way,,Gaithersburg,,20878,USA,170603,2003,
cholic acid,Cholbam,2003-07-18,Treatment of inborn errors of cholesterol and bile acid synthesis and metabolism,Designated/Approved,Approved for Orphan Indication,Treatment of bile acid synthesis disorders due to single enzyme defects,2015-03-17,2022-03-17,"Retrophin, Inc.",777 Third Avenue,22nd Floor,New York,New York,10017,USA,170503,2003,4260
Chimeric monoclonal antibody to CD30 (anti-CD30 antibody),n/a,2003-07-18,Treatment of Hodgkin's disease,Designated/Withdrawn,,,N/A,N/A,"Seattle Genetics, Inc","21823 30th Drive, Southeast",,Bothell,Washington,98021,USA,171303,2003,
conjugated bile acids,Cobartin,2003-07-18,Treatment of steatorrhea in patients with short bowel syndrome,Designated,,,N/A,N/A,"Jarrow Formulas, Inc.",1824 S. Robertson Blvd.,,Los Angeles,California,90035,USA,151301,2003,
Erlotinib Hydrochloride,Tarceva,2003-07-18,Treatment of malignant gliomas,Designated,,,N/A,N/A,"Genentech, Inc",1 DNA Way,,South San Francisco,California,94080,USA,172003,2003,
Combretastatin A4 Phosphate,n/a,2003-07-23,"Treatment of anaplastic thyroid cancer, medullary thyroid cancer, and stage IV papillary or follicular thyroid cancer",Designated,,,N/A,N/A,"Mateon Therapeutics, Inc.",701 Gateway Boulevard,Suite 210,South San Francisco,California,94080,USA,167503,2003,
"2-0-Butyryl-1-0-octyl-myo-inositol 3,4,5,6-tetrakisphosphate",n/a,2003-08-15,Treatment of cystic fibrosis,Designated,,,N/A,N/A,"Inologic, Inc.","101 Elliott Ave., West",,Seattle,Washington,98119,USA,169003,2003,
"cultured, partially T-Cell depleted, allogenic thymic tissue for transplantation",n/a,2003-08-15,As a therapy for primary immune deficiency resulting from athymia associated with complete DiGeorge Syndrome,Designated,,,N/A,N/A,Enzyvant Therapeutics GmbH,Viaduktstrasse 8,CH-4051 Basel,,,,Switzerland,172603,2003,
Mx-dnG1 or Rexin-G retroviral vector,Rexin-G,2003-08-15,Treatment of pancreatic cancer,Designated,,,N/A,N/A,Epeius Biotechnologies Corporation,"345 Pioneer Drive, 1803W",,Glendale,California,91203,USA,171703,2003,
niprisan,Hemoxin,2003-08-15,Treatment of sickle cell disease,Designated,,,N/A,N/A,"Xechem International, Inc.",379 Thornall Street,,Edison,New Jersey,8837,USA,169703,2003,
glucarpidase,Voraxaze,2003-08-19,Treatment of patients at risk of methotrexate toxicity,Designated/Approved,Approved for Orphan Indication,Treatment of toxic (>1 micromole/liter) plasma methotrexate concentrations in patients with delayed methotrexate clearance due to impaired renal function.,2012-01-17,2019-01-17,BTG International Inc.,5214 Maryland Way,Suite 405,Brentwood,Tennessee,37027,USA,163702,2003,3073
"(3S)-3-[(2S)-2-({N-[2-tert-butyl)phenyl]carbamoyl}carbonylamino) propanoylamino]-4-oxo-5-(2,3,5,6-tetrafluorophenoxy) pentanoci acid",n/a,2003-08-19,Treatment of patients undergoing solid organ transplantation.,Designated,,,N/A,N/A,Pfizer Global Research and Development,50 Pequot Avenue,,New London,Connecticut,6320,USA,169603,2003,
Dehydroepiandrosterone (DHEA),Fidelin,2003-08-19,Replacement therapy in individuals with adrenal insufficiency,Designated,,,N/A,N/A,"Paladin Labs, Inc.","6111 Royalmount Avenue, Suite 102",Montreal,Quebec H4P 2T4,,,Canada,172303,2003,
Tinidazole,Tindamax,2003-08-20,Treatment of amebiasis,Designated/Approved,Approved for Orphan Indication,Treatment of intestinal amebiasis and amebic liver abcess caused by E. histolytica in both adults and pediatric patients older than three years of age. It is not indicated for the treatment of asymptomatic cyst passage.,2004-05-17,2011-05-17,"Presutti Laboratories, Inc.",1607 N. Douglas Avenue,,Arlington Heights,Illinois,60004,USA,173603,2003,271
eculizumab,Soliris,2003-08-20,Treatment of paroxysmal nocturnal hemoglobinuria,Designated/Approved,Approved for Orphan Indication,Treatment of paroxysmal nocturnal hemoglobinuria to reduce hemolysis,2007-03-16,2014-03-16,"Alexion Pharmaceuticals, Inc.",352 Knotter Drive,,Cheshire,Connecticut,6410,USA,173203,2003,1304
"5,5',5""-[Phosphinothioylidyne-tris(imino-2,1-ethanediyl)]tris[5-methylchelidoninium]trihydroide hexahydrochloride",n/a,2003-08-20,Treatment of pancreatic cancer,Designated,,,N/A,N/A,Now Pharm AG,"241, route d'Arlon",L-1150,,,,,169303,2003,
debrase,Debridase,2003-08-20,"Debridement of acute, deep dermal burns in hospitalized patients",Designated,,,N/A,N/A,"MediWound, Ltd.",42 Hayarkon Street,Industrial Zone,,,,Israel,156102,2003,
talactoferrin alfa,n/a,2003-08-20,For the treatment of graft versus host disease,Designated,,,N/A,N/A,"Agennix, Inc.",Greenway Plaza,Suite 910,Houston,Texas,77046,USA,165703,2003,
talactoferrin alfa,n/a,2003-08-20,For the prevention of graft-versus-host disease,Designated,,,N/A,N/A,"Agennix, Inc.",Greenway Plaza,Suite 910,Houston,Texas,77046,USA,162102,2003,
Atomoxetine hydrochloride,Strattera,2003-08-26,Treatment of Tourette's Syndrome,Designated/Withdrawn,,,N/A,N/A,Eli Lilly & Company,Lilly Corporate Center,,Indianapolis,Indiana,46285,USA,173003,2003,
Imexon,n/a,2003-11-01,Treatment of pancreatic adenocarcinoma,Designated/Withdrawn,,,N/A,N/A,AmpliMed Corporation,4380 North Campbell Avenue,Suite 205,Tucson,Arizona,85718,USA,165903,2003,
tin ethyl etiopurpurin,n/a,2003-11-04,Prevention of access graft disease in hemodialysis patients,Designated,,,N/A,N/A,Miravant Medical Technologies,336 Bollay Drive,,Goleta,California,93117,USA,168703,2003,
vapreotide,Sanvar,2003-11-04,Treatment of acromegaly,Designated,,,N/A,N/A,"H3 Pharma, Inc.","666 Sherbrooke Street West, Suite 1400","Montreal, Quebec",,,,USA,175203,2003,
"[5,10,15,20-tetrakis(1,3-diethylimidazolium-2-yl)porphyrinato] manganese(III)pentachloride",n/a,2003-11-04,Treatment of Amyotrophic Lateral Sclerosis,Designated,,,N/A,N/A,"Aeolus Pharmaceuticals, Inc.",PO Box 14287; 79 T.W. Alexander Dr.,Suite 200,Research Triangle Park,North Carolina,27709,USA,176703,2003,
bevacizumab,Avastin,2003-11-06,Treatment of renal cell carcinoma,Designated/Approved,Approved for Orphan Indication,Treatment of renal cell carcinoma in combination with interferon alfa,2009-07-31,2016-07-31,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,USA,172903,2003,2094
coagulation factor XIII A-subunit (recombinant),Tretten,2003-11-06,Prophylaxis of bleeding associated with congential factor XIII deficiency,Designated/Approved,Approved for Orphan Indication,Routine prophylaxis of bleeding in patients with congenital Factor XIII A-subunit deficiency.,2013-12-23,2020-12-23,"Novo Nordisk, Inc.",800 Scudders Mill Rd.,,Plainsboro,New Jersey,8536,USA,174803,2003,3700
Infliximab,Remicade,2003-11-12,Treatment of pediatric (0 to 16 years of age) Crohn's Disease,Designated/Approved,Approved for Orphan Indication,For reducing signs and symptoms and inducing and maintaining clinical remission in pediatric patients with moderately to severely active Crohn's disease who have had an inadequate response to conventional therapy,2006-05-19,2013-05-19,"Centocor, Inc.",200 Great Valley Parkway,,Malvern,Pennsylvania,19355,USA,175803,2003,919
infliximab,Remicade,2003-11-12,Treatment of pediatric (0 to 16 years of age) ulcerative colitis,Designated/Approved,Approved for Orphan Indication,For reducing signs and symptoms and inducing and maintaining clinical remission in pediatric patients 6 years of age and older with moderately to severely active ulcerative colitis who have had an inadequate response to conventional therapy,2011-09-23,2018-09-23,Janssen Biotech Inc.,200 Great Valley Parkway,,Malvern,Pennsylvania,19355,USA,175903,2003,2872
raxibacumab,Abthraxtm,2003-11-12,Treatment of anthrax,Designated/Approved,Approved for Orphan Indication,"Treatment of inhalation anthrax due to Bacillus anthracis in combination with appropriate antibacterial drugs,",2012-12-14,2019-12-14,"Human Genome Sciences, Inc.",14200 Shady Grove Road,,Rockville,Maryland,20850,USA,175503,2003,3320
SC-1 monoclonal antibody,n/a,2003-11-12,Treatment of patients with CD55 (sc-1) positive gastric tumors,Designated,,,N/A,N/A,Patrys Limited,"Suite 614, Level 6, Equitable House","Melbourne, Victoria 3000",,,,Australia,175703,2003,
human gammaglobulin,Oralgam,2003-11-14,Treatment of idiopathic inflammatory myopathies,Designated,,,N/A,N/A,"Latona Life Sciences, Inc.",10 Village St.,,Mills,Massachusetts,2054,USA,176003,2003,
monarsen,n/a,2003-11-14,Treatment of myasthenia gravis,Designated/Withdrawn,,,N/A,N/A,"Bioline Rx, Ltd.",19 Hartum Street,P. O. Box 45158,Jerusalem,,,Israel,173903,2003,
anti-interferon-gamma Fab from goats,n/a,2003-11-18,For the treatment of immunologic corneal allograft rejection,Designated,,,N/A,N/A,"Advanced Biotherapy, Inc.",6355 Topanga Canyon Blvd.,Suite 510,Woodland Hills,California,91367,USA,177103,2003,
Hydroxocobalamin,Cyanokit,2003-11-25,Treatment of acute cyanide poisoning,Designated/Approved,Approved for Orphan Indication,Treatment on known or suspected cyanide poisoning,2006-12-15,2013-12-15,"SERB, S.A.",480 Avenue Louise,,Brussels,,,Belgium,177403,2003,1116
icatibant,Firazyr,2003-11-25,Treatment of angioedema,Designated/Approved,Approved for Orphan Indication,Treatment of acute attacks of hereditary angioedema in adults 18 years of age and older,2011-08-25,2018-08-25,Shire,300 Shire Way,,Lexington,Massachusetts,2421,USA,176203,2003,2830
abagovomab,n/a,2003-11-25,Treatment of epithelial ovarian cancer,Designated/Withdrawn,,,N/A,N/A,Menarini Ricerche S.p.A.,Via Tito Speri 10,Pomezia Roma,,,,Italy,171803,2003,
Cyclosporine,n/a,2003-11-25,Prophylaxis of organ rejection in patients receiving allogeneic lung transplant,Designated,,,N/A,N/A,"APT Pharmaceuticals, Inc.",700 Airport Blvd.,Suite 350,Burlingame,California,94010,USA,180103,2003,
Cyclosporine,Pluminiq,2003-11-25,Treatment of acute rejection in patients requiring allogenic lung transplants,Designated,,,N/A,N/A,"APT Pharmaceuticals, Inc.",700 Airport Blvd.,Suite 350,Burlingame,California,94010,USA,176303,2003,
"2-(3-diethylaminopropyl)-8,8-dipropyl-2-azaspiro [4,5] decan dimaleate",Atiprimod,2003-12-02,Treatment of mulitple myeloma and associated bone resorption,Designated,,,N/A,N/A,"Callisto Pharmaceuticals, Inc.",2 Executive Drive,Suite 450,Somerset,New Jersey,8873,USA,167103,2003,
baclofen,n/a,2003-12-02,Treatment of dystonia,Designated,,,N/A,N/A,Medtronic Neurological,710 Medtronic Parkway NE,,Minneapolis,Minnesota,55432,USA,174703,2003,
Tranilast,Rizaben,2003-12-02,For the treatment of maligant glioma,Designated,,,N/A,N/A,"Angiogen Pharmaceuticals, Pty. Ltd.","Level 31, ABN AMRO Tower","88 Phillip Street Sydney, N.S.W. 2000",,,,Australia,176803,2003,
liposomal p-ethoxy growth receptor bound protein-2 antisense product,n/a,2003-12-05,Treatment of chronic myelogenous leukemia,Designated,,,N/A,N/A,"Bio-Path, Inc.","3293 Harrison Blvd., Suite 230",,Ogden,Utah,84403,USA,179103,2003,
N-acetyl-sarcosyl-glycyl-L-valyl-D-alloisoleucyl-L-threonyl-L-norvalyl-L-isoleucyl-L-arginyl_L-prolylethylaminde acetate,n/a,2003-12-09,Treatment of soft tissue sarcoma,Designated/Withdrawn,,,N/A,N/A,"AbbVie, Inc.",1 N. Waukegan Road,,North Chicago,Illinois,60064,USA,177803,2003,
recombinant human neutrophil inhibitor (hNE),n/a,2003-12-09,Treatment of cystic fibrosis,Designated,,,N/A,N/A,Dyax Corporation,300 Technology Square,,Cambridge,Massachusetts,2139,USA,173503,2003,
rhIGF-I/rhIGFBP-3,Somatokine,2003-12-09,"Treatment of extreme insulin resistance syndromes (type A, Rabson-Mendenhall syndrome, Leprechaunism, Type B syndrome)",Designated,,,N/A,N/A,"Insmed, Inc.",10 Finderne Ave,Building 10,Bridgewater,New Jersey,8807,USA,168903,2003,
lenalidomide,Revlimid,2004-01-29,Treatment of myelodysplastic syndromes,Designated/Approved,Approved for Orphan Indication,Treatment of patients with transfusion dependant anemia due to low or intermediate-1 risk myelodysplastic syndromes associated with a deletion 5 q cytogenetic abnormality with or without additional cytogenetic abnormalities,2005-12-27,2012-12-27,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,USA,180303,2004,698
sapropterin,Kuvan,2004-01-29,Treatment of hyperphenylalaninemia,Designated/Approved,Approved for Orphan Indication,Indicated to reduce blood phenylalanine (Phe) levels in patients with hyperphenylalaninemia (HPA) due to tetrahydrobiopterin- (BH4-) responsive Phenylketonuria (PKU). Kuvan is to be used in conjunction with a Phe-restricted diet.,2007-12-13,2014-12-13,"BioMarin Pharmaceutical, Inc.",105 Digital Drive,,Novato,California,94949,USA,181503,2004,1414
rituximab,Rituxan,2004-01-29,Treatment of chronic lymphocytic leukemia,Designated/Approved,Approved for Orphan Indication,Treatment of patients previously untreated for CD20-positive chronic lymphocytic leukemia in combination wih fludarbine and cyclophosphamide,2010-02-18,2017-02-18,"Genentech, Inc.",1DNA Way,MS 241A,South San Francisco,California,94080,USA,177603,2004,2212
Antivenin crotaline (pit-viper) equine immune F(ab)2),Anavip,2004-01-29,Treatment of envenomation by Crotaline snakes,Designated/Approved,Approved for Orphan Indication,Management of adult and pediatric patients with North American rattlesnake envenomation,2015-05-06,N/A,"Rare Disease Therapeutics, Inc.",12975 Brookprinter Place,Suite 170,Poway,California,92064,USA,177503,2004,4115
"(1S)-1-(9-deazahypoxanthin-9-yl)-1,4-dideoxy-1,4-imino-D-ribitol-hydrochloride",n/a,2004-01-29,Treatment of T-cell non-Hodgkin's lymphoma,Designated,,,N/A,N/A,Mundipharma Research Limited,Cambridge Science Park,Cambridge CB4 0GW,England,,,United Kingdom,172403,2004,
90Y-hPAMA4,Pan-Cide,2004-01-29,Treatment of pancreatic cancer,Designated/Withdrawn,,,N/A,N/A,"Immunomedics, Inc.",300 American Road,,Morris Plains,New Jersey,7950,USA,178503,2004,
Chenodeoxycholic acid,Chenofalk,2004-01-29,Treatment of cerebrotendinous xanthomatosis,Designated,,,N/A,N/A,Dr. Falk Pharma GmbH,Leinenweberstrasse 5,"9041 Freiburg, GERMANY",,,,Germany,175303,2004,
oral unfractionated heparin,n/a,2004-01-29,Treatment of sickle cell disease,Designated,,,N/A,N/A,"TRF Technologies, Inc.","863 Mitten Road, Suite 101",,Burlingame,California,94010,USA,178103,2004,
recombinant human fibroblast growth factor-20,n/a,2004-01-29,Treatment of radiation induced oral mucositis,Designated/Withdrawn,,,N/A,N/A,CuraGen Corporation,322 East Main Street,,Branford,Connecticut,6405,USA,179203,2004,
Staphylococcus aureus Immune Globulin (Human),Altastaph,2004-01-29,Prophylaxis against Staphylococcus aureus infections in low birth weight neonates,Designated,,,N/A,N/A,Biotest Pharmaceuticals Corporation,"5800 Park of Commerce Blvd, NW",,Boca Raton,Florida,33487,USA,178703,2004,
Chimeric monoclonal antibody to CD30 (anti-CD30 antibody),n/a,2004-02-18,Treatment of CD30 positive T-cell lymphomas,Designated/Withdrawn,,,N/A,N/A,"Seattle Genetics, Inc.",21823 30th Drive Southeast,,Bothell,Washington,98021,USA,178203,2004,
migalastat hydrochloride,n/a,2004-02-25,Treatment of Fabry Disease,Designated,,,N/A,N/A,"Amicus Therapeutics, Inc.",1 Cedarbrook Drive,,Cranbury,New Jersey,8512,USA,180003,2004,
Trisodium zinc Diethylenetriaminepentaacetate,n/a,2004-02-27,"Treatment of patients with known or suspected internal contamination with plutonium, americium, or curium to increase the rate of elimination.",Designated,,,N/A,N/A,CustomCare Pharmacy,5710 Hoover Blvd,,Tampa,Florida,33634,USA,181003,2004,
DEAE-rebeccamycin,n/a,2004-03-01,Treatment of bile duct tumors,Designated,,,N/A,N/A,Helsinn Healthcare SA,"Via Pian Scairolo, 6912 Pazzallo",Lugano,,,,Switzerland,179903,2004,
pirfenidone,Esbriet,2004-03-05,Treatment of idiopathic pulmonary fibrosis,Designated/Approved,Approved for Orphan Indication,Treatment of idiopathic pulmonary fibrosis,2014-10-15,2021-10-15,Genentech,1 DNA Way,,South San Francisco,California,94080,USA,177903,2004,3876
Alpha-1-acid glycoprotein,n/a,2004-03-05,Treatment of cocaine overdose,Designated/Withdrawn,,,N/A,N/A,Bio Products Laboratory,"Dagger Lane, Elstree, Hertfordshire",WD6 3BX,,,,United Kingdom,173103,2004,
multi-vitamin infusion without vitamin K,M.V.I.-12,2004-03-08,Prevention of vitamin deficiency and thromboembolic complications in people receiving home parenteral nutrition and warfarin-type anticoagulant therapy,Designated/Approved,Approved for Orphan Indication,Prevention of vitamin deficiency and thrombormbolic complications in people receiving home parenteral nutrition who also receive warfarin-type anticoagulant therapy,2004-09-09,2011-09-09,Mayne Pharma (USA) Inc.,Mack-Cali Centre II,Second Floor,Paramus,New Jersey,7652,USA,182003,2004,185
vorinostat,Zolinza,2004-03-16,Treatment of T-cell non-Hodgkin's lymphoma,Designated/Approved,Approved for Orphan Indication,"Treatment of cutaneous manifestations in patients with cutaneous T-cell lymphoma (CTCL) who have progressive, persistant or recurrent disease on or following two systemic therapies.",2006-10-06,2013-10-06,"Merck & Co., Inc.","P. O. Box 2000, RY 32-605",,Rahway,New Jersey,7065,USA,174203,2004,934
"antihemophilic factor (recombinant), porcine sequence",Obizur,2004-03-16,Treatment and prevention of episodic bleeding in patients with inhibitor antibodies to human coagulation factor VIII,Designated/Approved,Approved for Orphan Indication,Treatment of bleeding episodes in adults with acquired hemophilia A.,2014-10-23,2021-10-23,"Baxalta US, Inc.",1 Baxter Way,Mail Box Number 1A-3,Westlake Village,California,91362,USA,181403,2004,3873
"rh-microplasmin, ocriplasmin",Jetrea,2004-03-16,Adjunct to surgery in cases of pediatric vitrectomy,Designated,,,N/A,N/A,ThromboGenics Inc.,Unit 14,Walkinstown Avenue,Dublin 12,,,Ireland,180703,2004,
rofecoxib,Vioxx,2004-03-16,Treatment of juvenile rheumatoid arthritis,Designated,,,N/A,N/A,"MERCK & Co., Inc.",126 East Lincoln Ave.,,Rahway,New Jersey,7065,USA,181703,2004,
Somatropin,Serostim,2004-03-16,Treatment of patients with HIV-associated adipose redistribution syndrome,Designated,,,N/A,N/A,"EMD Serono, Inc.",One Technology Place,,Rockland,Massachusetts,2370,USA,169403,2004,
Alpha-1-acid glycoprotein,n/a,2004-03-17,Treatment of tricyclic antidepressant poisoning,Designated/Withdrawn,,,N/A,N/A,Bio Products Laboratory,"Dagger Lane, Elstree, Hertfordshire",WD6 3BX,,,,United Kingdom,172803,2004,
Immune Globulin (Human) containing high titers of West Nile virus antibodies,Omr-Igg-Am (Tm) 5% (Wnv),2004-03-17,Treatment of the West Nile virus infection,Designated,,,N/A,N/A,"OMRIX Biopharmaceuticals, Ltd.",Plasma Fractionation Institute,Ramat Gan 52621,,,,Israel,181803,2004,
Sodium thiosulfate,n/a,2004-03-17,Prevention of platinum-induced ototoxicity in pediatric patients,Designated,,,N/A,N/A,"Fennec Pharmaceuticals, Inc.",PO Box 13628,68 T.W. Alexander Drive,Research Triangle Park,North Carolina,27709,USA,177303,2004,
vorinostat,n/a,2004-03-17,Treatment of mesothelioma,Designated/Withdrawn,,,N/A,N/A,"Merck & Co., Inc.","P. O. Box 2000, RY 32-605",,Rahway,New Jersey,7065,USA,177203,2004,
dexrazoxane,Totect(R),2004-03-25,Treatment of anthracycline extravasation during chemotherapy,Designated/Approved,Approved for Orphan Indication,Treatment of extravasation resulting from IV anthracycline chemotherapy,2007-09-06,2014-09-06,Clinigen Healthcare Ltd.,"Pitcairn House, First Avenue",Burton on Trent,Staffordshire,,,United Kingdom,181103,2004,1260
idebenone,n/a,2004-03-25,Treatment of Friedreich's ataxia,Designated,,,N/A,N/A,Santhera Pharmaceuticals (Switzerland) Ltd.,25 Hammerstrasse,,Liestal,,,Switzerland,178303,2004,
Vapreotide,Sanvar,2004-04-06,Treatment of symptomatic carcinoid tumors,Designated,,,N/A,N/A,"H3 Pharma, Inc.",666 Sherbrooke Street West Suite 1400,"Montreal, Quebec,",,,,Canada,175403,2004,
Hydralazine,n/a,2004-04-09,Treatment of severe intrapartum hypertension (diastolic blood pressure greater than or equal to 110 or systolic blood pressure greater than or equal to 160) associated with severe preeclampsia/eclampsia of pregnancy,Designated,,,N/A,N/A,Bioniche Pharma USA LLC,272 E. Deerpath Road,Suite 304,Lake Forest,Illinois,60045,USA,166703,2004,
pentetate trisodium,Diethylenetriaminepentaacetate,2004-04-12,"Treatment of patients with known or suspected internal contamination with plutonium, americium, or curium.",Designated,,,N/A,N/A,Heyl Chemisch-Pharmazeutische Fabrik GMBH & Co. KG,Goerzallee 253,Fedderal of Republic of Germany,,,,Germany,183004,2004,
ubiquinol,"Ubi-Q-Nol, Li-Q-Nol",2004-04-12,Treatment of Huntington's Disease,Designated,,,N/A,N/A,"Gel-Tec, Division of Tishcon Corp.",30 New York Avenue,P. O. Box 331,Westbury,New York,11590,USA,179403,2004,
"Ubiquinol, coenzyme Q10, ubiquinone",Ubi-Q-Nol,2004-04-12,Treatment of pediatric congestive heart failure,Designated,,,N/A,N/A,"Gel-Tec, Division of Tishcon Corporation",30 New York Avenue,P. O. Box 331,Westbury,New York,11590,USA,174603,2004,
Deferitrin,n/a,2004-04-14,Treatment of iron overload,Designated/Withdrawn,,,N/A,N/A,Genzyme Corporation,153 Second Avenue,,Waltham,Massachusetts,2451,USA,178603,2004,
diethylenetriaminepentaacetate (DPTA),n/a,2004-04-14,"For treatment of patients with known or suspected internal contamination with plutonium, americium or curium to increase the rates of elimination.",Designated,,,N/A,N/A,CIS-US,10 DeAngelo Drive,,Bedford,Massachusetts,1730,USA,180203,2004,
etaracizumab,Abegrin,2004-04-14,"For the treatment of of stage IIb, stage IIc, stage III and stage IV melanoma",Designated/Withdrawn,,,N/A,N/A,"MedImmune, LLC",One MedImmune Way,,Gaithersburg,Maryland,20878,USA,178403,2004,
Fluoxetine,Prozac,2004-04-14,Treatment of body dysmorphic disorder in children and adolescents,Designated,,,N/A,N/A,"Hollander, Eric MD",The Mount Sinai School of Medicine,One Gustave L. Levy Place,New York,New York,10029,USA,183504,2004,
temocillin sodium,Negaban,2004-04-21,Treatment of pulmonary infections caused by Burkholderia cepacia,Designated,,,N/A,N/A,Belpharma S.A.,"5, Rue de Bonnevoie",L-2160,Luxembourg,,,Germany,182903,2004,
mannopentaose phosphate sulfate,n/a,2004-04-27,"Treatment of high-risk Stage II, Stage III, and Stage IV melanoma",Designated,,,N/A,N/A,Medigen Biotechnology Corp.,"14F, No. 3, Yuancyu St.",Nangang District,,,,,179603,2004,
Diethylenetriaminepentaacetic acid (DTPA),n/a,2004-04-28,"Treatment of patients with known or suspected internal contamination with plutonium, americium, or curium to increase the rates of elimination.",Designated/Approved,Approved for Orphan Indication,"Treatment of internal contamination with plutonium, americium or curium",2004-08-11,2011-08-11,Hameln Pharmaceuticals gmbh,Langes Feld 13,,Hameln,,,Germany,186804,2004,105
Immune Globulin Intravenous (human),Carimune Nf,2004-05-04,Treatment for Guillain Barre Syndrome,Designated,,,N/A,N/A,ZLB Bioplasma AG,Wankdorfstrasse 10,CH-3000 Bern 22,,,,Switzerland,184704,2004,
icatibant,n/a,2004-05-05,Treatment of burn patients hospitalized with burn-induced edema,Designated/Withdrawn,,,N/A,N/A,Shire Human Genetic Therapies,700 Main Street,,Cambridge,Massachusetts,2139,USA,184804,2004,
Diethylnorspermine (DENSPM),n/a,2004-05-25,Treatment for hepatocellular carcinoma,Designated/Withdrawn,,,N/A,N/A,Genzyme Corporation,153 Second Avenue,,Waltham,Massachusetts,2451,USA,182803,2004,
mepolizumab,Nucala,2004-05-28,For first-line treatment in patients with hypereosinophilic syndrome,Designated,,,N/A,N/A,GlaxoSmithKline LLC,Corporation Service Company,Suite 400,Wilmington,Delaware,19808,USA,182103,2004,
Thymosin beta 4,n/a,2004-05-28,Treatment of epidermolysis bullosa.,Designated,,,N/A,N/A,"GtreeBNT Co., Ltd","22nd Fl, Parkview Tower","248 Jungjail-ro, Bundang-gu",Gyeonggi-do,,,"Korea, Republic of",165302,2004,
quinine Sulfate,n/a,2004-06-03,Treatment of malaria,Designated/Approved,Approved for Orphan Indication,Treatment of uncomplicated Plasmodium falciparum malaria,2005-08-12,2012-08-12,"AR Holding Company, Inc.",1100 Orthodox Street,,Philadelphia,Pennsylvania,19124,USA,185004,2004,435
ipilimumab,Yervoy,2004-06-03,"Treatment of high risk Stage II, Stage III, and Stage IV melanoma",Designated/Approved,Approved for Orphan Indication,Treatment of unresectable or metastatic melanoma,2011-03-25,2018-03-25,Bristol-Myers Squibb Company,P. O. Box 4000,,Princeton,New Jersey,8543,USA,177703,2004,2486
ipilimumab,Yervoy,2004-06-03,"Treatment of high risk Stage II, Stage III, and Stage IV melanoma",Designated/Approved,Approved for Orphan Indication,"For the adjuvant treatment of patients with cutaneous melanoma with pathologic involvement of regional lymph nodes of more than 1 mm, who have undergone complete resection including total lymphadenectomy.",2015-10-28,2022-10-28,Bristol-Myers Squibb Company,P. O. Box 4000,,Princeton,New Jersey,8543,USA,177703,2004,4164
ipilimumab,Yervoy,2004-06-03,"Treatment of high risk Stage II, Stage III, and Stage IV melanoma",Designated/Approved,Approved for Orphan Indication,An expansion of the indication for the treatment of unresectable or metastatic melanoma in pediatric patients (12 years and older).,2017-07-21,2024-07-21,Bristol-Myers Squibb Company,P. O. Box 4000,,Princeton,New Jersey,8543,USA,177703,2004,4796
Vaccinia Immune Globulin (Human) Intravenous,n/a,2004-06-18,Treatment of severe complications from the smallpox vaccine,Designated/Approved,Approved for Orphan Indication,"Treatment and modification of aberrant infections induced by vaccinia virus that include its accidental implantation in eyes (except in cases of isolated keratitis), mouth, or other areas where vaccinia infection would constitute a special hazard; eczema vaccinatum; progressive vaccinia; severe generalized vaccinia, and vaccinia infections in individuals who have skin conditions such as burns, impetigo, varicella-zoster, or poison ivy; or in individuals who have eczematous skin lesions because of either the activity or extensiveness of such lesions",2005-02-18,2012-02-18,DynPort Vaccine Company LLC,64 Thomas Johnson Drive,,Frederick,Maryland,21702,USA,184204,2004,245
Vaccinia Immune Globulin (Human) Intravenous,Cnj-016,2004-06-18,Treatment of complications of vaccinia vaccination,Designated/Approved,Approved for Orphan Indication,"treatment and/or modification of the following conditions, which are complications resulting from smallpox vaccination: Eczema vaccinatum Progressive vaccinia Severe generalized vaccinia Vaccinia infections in individuals who have skin conditions such as burns, impetigo, varicella-zoster, or poison ivy; or in individuals who have eczematous skin lesions because of either the activity or extensiveness of such lesions Aberrant infections induced by vaccinia virus that include its accidental implantation in eyes (except in cases of isolated keratitis), mouth, or other areas where vaccinia infection would constitute a special hazard.",2005-05-02,N/A,Cangene Corporation,104 Chancellor Matheson Road,,"Winnipeg, ManitobaR3T 5Y3",,,Canada,179303,2004,318
Coagulation factor VIIa (recombinant),Novoseven,2004-06-18,"Prevention of bleeding episodes in patients with hemophilia A or B, with or without inhibitors",Designated/Approved,Approved for Orphan Indication,Prevention of bleeding in surgical interventions or invasive procedures in hemophilia A or B patients with inhibitors to Factor VIII or Factor IX,2005-08-12,2012-08-12,"Novo Nordisk, Inc.",100 College Road West,,Princeton,New Jersey,8540,USA,186104,2004,420
coagulation factor VIIa (recombinant),Novoseven Rt,2004-06-18,Treatment of bleeding episodes in Glanzmann's thrombasthenia,Designated/Approved,Approved for Orphan Indication,"Treatment of bleeding episodes and peri-operative management in adults and children with Glanzmann's thrombasthenia with refractoriness to platelet transfusions, with or without antibodies to platelets.",2014-07-02,2021-07-02,Novo Nordisk Inc.,800 Scudders Mill Rd.,,Plainsboro,New Jersey,8536,USA,186004,2004,3666
Coagulation factor VIIa (recombinant),Novoseven,2004-06-18,Prevention of bleeding episodes in Glanzmann's thrombasthenia,Designated,,,N/A,N/A,"Novo Nordisk, Inc.",100 College Road West,,Princeton,New Jersey,8540,USA,190004,2004,
liarozole,n/a,2004-06-18,Treatment of congenital ichthyosis,Designated/Withdrawn,,,N/A,N/A,"Stiefel Laboratories, Inc.",20 T.W. Alexander Drive,P. O. Box 14910,Research Triangle Park,North Carolina,27709,USA,183904,2004,
Plitidepsin,Aplidin,2004-06-18,Treatment of acute lymphoblastic leukemia,Designated/Withdrawn,,,N/A,N/A,"PharmaMar USA, Inc",University Park at M.I.T.,Sidney Street,Cambridge,Massachusetts,2139,USA,187404,2004,
sarsasapogenin,n/a,2004-06-18,Treatment of amyotrophic lateral sclerosis (ALS),Designated/Withdrawn,,,N/A,N/A,Phytopharm plc,Corpus Christi House,"Godmanchester, Cambridgeshire PE29 2HY",,,,United Kingdom,185704,2004,
Tipifarnib,Zarnestra,2004-07-06,Treatment of acute myeloid leukemia,Designated,,,N/A,N/A,Johnson & Johnson Pharmaceutical Research & Dev.,920 U.S. Highway 202,,Raritan,New Jersey,8869,USA,187104,2004,
"human anti-transforming growth factor-B1,2,3",n/a,2004-07-09,Treatment of idiopathic pulmonary fibrosis,Designated/Withdrawn,,,N/A,N/A,Genzyme Corporation,500 Kendall Street,,Cambridge,Massachusetts,2142,USA,187304,2004,
Melatonin,Circadin,2004-07-09,Treatment of non-24-hour sleep-wake disorder in blind individuals without light perception,Designated,,,N/A,N/A,"Neurim Pharmaceuticals, Ltd.",8 Hanechoshet St.,,Tel-Aviv,,,Israel,181203,2004,
Coagulation Factor VIIa (Recombinant),Novoseven,2004-07-16,Treatment of bleeding episodes in patients with acquired inhibitors to Factor VIII or Factor IX,Designated/Approved,Approved for Orphan Indication,Treatment of bleeding episodes in surgical interventions or invasive procedures in patients with acquired hemophilia,2006-10-13,2013-10-13,"Novo Nordisk, Inc.",100 College Road West,,Princeton,New Jersey,8540,USA,186204,2004,819
ambrisentan,Letairis,2004-07-16,Treatment of pulmonary arterial hypertension,Designated/Approved,Approved for Orphan Indication,Treatment of pulmonary arterial hypertension (WHO group I) in patients with WHO class II or III symptoms to improve exercise capacity and delay clinical worsening,2007-06-15,2014-06-15,Gilead Colorado,7575 West 103rd Avenue,Suite 102,Westminister,Colorado,80021,USA,183604,2004,1064
C1 esterase inhibitor (human),Cinryze(R),2004-07-16,Treatment of angioedema,Designated/Approved,Approved for Orphan Indication,Routine prophylaxis against angioedema attacks in patients with Hereditary Angioedema (HAE),2008-10-10,2015-10-10,Shire,300 Shire Way,,Lexington,Massachusetts,2421,USA,185804,2004,1547
Doripenem,n/a,2004-07-16,Treatment of bronchopulmonary infection in patients with cystic fibrosis who are colonized with Pseudomonas aeruginosa or Burkholderia cepacia.,Designated,,,N/A,N/A,"Shionogi, Inc.",300 Campus Drive,Suite 300,Florham Park,New Jersey,7932,USA,188104,2004,
Immortalized human liver cells found in the extracorporeal liver assist device,Elad,2004-07-16,Treatment of fulminant hepatic failure (acute liver failure),Designated,,,N/A,N/A,"Vital Therapies, Inc.",15222 Avenue of Science,Suite C,San Diego,California,92128,USA,184104,2004,
posaconazole,n/a,2004-07-16,Treatment of zygomycosis,Designated,,,N/A,N/A,"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.",351 N. Sumneytown Pike,UG2CD-48,North Wales,Pennsylvania,19454,USA,187604,2004,
Coagulation factor VIIa (recombinant),Novoseven,2004-07-21,Prevention of bleeding episodes in patients with acquired inhibitors to Factor VIII or Factor IX,Designated/Approved,Approved for Orphan Indication,Prevention of bleeding in surgical interventions or invasive procedures in patients with acquired hemophilia,2006-10-13,2013-10-13,"Novo Nordisk, Inc.",100 College Road West,,Princeton,New Jersey,8540,USA,190104,2004,814
Immune Globulin (Human),Gamunex(R)-C,2004-07-27,Treatment of chronic inflammatory demyelinating polyneuropathy,Designated/Approved,Approved for Orphan Indication,Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) to improve neuromuscular disability and impairment and for maintenance therapy to prevent relapse,2008-09-12,2015-09-12,"Grifols Therapeutics, Inc.",8368 US 70 Business Hwy West,,Clayton,North Carolina,27520,USA,185604,2004,1508
Multi-ligand somatostatin analog,n/a,2004-07-27,"Treatment of patients with functional gastroenteropancreatic (GEP) neuroendocrine tumors (specifically, carcinoid, insulinoma, gastrinoma, somastatinoma, GRFoma, VIPoma and glucagonoma.",Designated/Withdrawn,,,N/A,N/A,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,USA,188804,2004,
efaproxiral,n/a,2004-07-28,Adjunct to whole brain radiation therapy for the treatment of brain metastases in patients with breast cancer,Designated,,,N/A,N/A,"Allos Therapeutics, Inc.",11080 CirclePoint Road,Suite 200,Westminster,Colorado,80020,USA,158802,2004,
nelarabine,Arranon,2004-08-10,Treatment of acute lymphoblastic leukemia and lymphoblastic lymphoma,Designated/Approved,Approved for Orphan Indication,Treatment of patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma whose disease has not responded to or has relapsed following treatment with at least two chemotherapy regimens,2005-10-28,2012-10-28,Novartis Pharmaceuticals Corp.,One Health Plaza,,East Hanover,New Jersey,7936,USA,184404,2004,444
"(1S)-1-(9-deazahypoxanthin-9-yl)-1,4-dideoxy-1,4-imino-D-ribitol-hydrochloride",n/a,2004-08-10,"Treatment of chronic lymphocytic leukemia and related leukemias to include prolymphocytic leukemia, adult T-cell leukemia, and hairy cell leukemia",Designated,,,N/A,N/A,Mundipharma Research Ltd.,Cambridge Science Park,Cambridge CB4 0GW,,,,United Kingdom,190504,2004,
dexanabinol,n/a,2004-08-11,For the attenuation or amelioration of the long-term neurological sequelae associated with moderate and severe traumatic brain injury,Designated,,,N/A,N/A,Pharmos Corporation,99 Wood Avenue,Suite 311,Iselin,New Jersey,8830,USA,179803,2004,
"(1S)-1-(9-deazahypoxanthin-9-yl)-1,4-dideoxy-1,4-imino-D-ribitol-hydrochloride",n/a,2004-08-13,Treatment of acute lymphoblastic leukemia,Designated,,,N/A,N/A,Mundipharma Research Limited,Cambridge Science Park,Cambridge CB4 0GW,England,,,United Kingdom,190404,2004,
"(6R,S)5,10-methylene-tetrahydrofolic acid",Cofactor,2004-08-13,For use in combination with 5-fluorouracil for the treatment of patients with pancreatic cancer,Designated,,,N/A,N/A,"Adventrx Pharmaceuticals, Inc.",6725 Mesa Ridge Road,Suite 100,San Diego,California,92121,USA,189304,2004,
dacetuzumab,n/a,2004-08-13,Treatment of multiple myeloma.,Designated,,,N/A,N/A,"Seattle Genetics, Inc.",21823 30th Drive Southeast,,Bothell,Washington,98021,USA,188004,2004,
human anti-CD4 monoclonal antibody,Humax-Cd4,2004-08-13,Treatment of mycosis fungoides,Designated,,,N/A,N/A,"Emergent Product Development Seattle, LLC",,2401 Fourth Avenue,Seattle,Washington,98121,USA,188504,2004,
Implitapide,n/a,2004-08-13,Treatment of homozygous familial hypercholesterolemia,Designated/Withdrawn,,,N/A,N/A,Medical Research Laboratories International,2 Tesseneer Drive,,Highland Heights,Kentucky,41076,USA,188904,2004,
"N-[4-(4-amino-2-ethyl-1H-imidazo[4,5-c]quinolin-1-yl)butyl]methanesulfonamide",n/a,2004-08-13,Treatment of stages IIB-IV melanoma,Designated/Withdrawn,,,N/A,N/A,"Pfizer, Inc.",50 Pequot,6025-A3106,New London,Connecticut,6320,USA,176603,2004,
Iloprost inhalation solution,Ventavis,2004-08-17,Treatment of pulmonary arterial hypertension,Designated/Approved,Approved for Orphan Indication,Treatment of pulmonary arterial hypertension (WHO Group I) in patients with NYHA Class III or IV symptoms,2004-12-29,2011-12-29,"CoTherix, Inc.",5000 Shoreline Court,,South San Francisco,California,94080,USA,186904,2004,134
meclorethamine,Valchlor,2004-08-17,Treatment of mycosis fungoides,Designated/Approved,Approved for Orphan Indication,Topical treatment of Stage 1A and 1B mycosis fungoides-type cutaneous T-cell lymphoma in patients who have received prior skin-directed therapy.,2013-08-23,2020-08-23,Actelion Pharmaceuticals Ltd.,Gewerberstrass16,Allschwil CH-4123,,,,Switzerland,188404,2004,3293
Nucleic acid aptamer binding to tumor cell nucleolin,n/a,2004-08-17,Treatment of pancreatic cancer,Designated,,,N/A,N/A,Antisoma Research Ltd.,Hanger Lane,London,,,,United Kingdom,189604,2004,
Implitapide,n/a,2004-08-19,Treatment of patients with Fredrickson type I or V hyperlipoproteinemia,Designated/Withdrawn,,,N/A,N/A,Medical Research Laboratories International,2 Tesseneer Drive,,Highland Heights,Kentucky,41076,USA,188704,2004,
Allogeneic retinal epithelial cells transfected with plasmid vector expressing ciliary neurotrophic growth factor,n/a,2004-09-01,Treatment of retinitis pigmentosa,Designated,,,N/A,N/A,"Neurotech USA, Inc.",6 Blackstone Valley Place,,Lincoln,Rhode Island,2865,USA,189704,2004,
Alpha1-Proteinase Inhibitor (Human),Arc-Api,2004-09-01,Treatment of cystic fibrosis,Designated,,,N/A,N/A,Kamada Ltd.,7 Sapir Street,,Ness Ziona,,,Israel,190704,2004,
ataluren,n/a,2004-09-01,For use in the treatment of cystic fibrosis resulting fron a nonsense (premature stopcodon) mutation in the cystic bibrosis transmembrane conductance regulatory gene,Designated/Withdrawn,,,N/A,N/A,"PTC Therapeutics, Inc.",100 Corporate Court,,South Plainfield,New Jersey,7080,USA,192004,2004,
17-allylamino-17-demethoxygeldanamycin (17-AGG),n/a,2004-09-03,Treatment of chronic myelogenous leukemia,Designated,,,N/A,N/A,Bristol-Myers Squibb Company,Research & Development,5 Research Parkway,Wallingford,Connecticut,6492,USA,191304,2004,
A10 & AS2-1 Antineoplaston,n/a,2004-09-03,Treatment for patients with brain stem glioma,Designated,,,N/A,N/A,"Burzynski Research Institute, Inc.",9432 Old Katy Road,,Houston,Texas,77055,USA,189804,2004,
Autologous incubated macrophage,n/a,2004-09-03,Therapy to improve the motor and sensory neurological outcome in acute cases of spinal cord injury,Designated,,,N/A,N/A,"Proneuron Biotechnologies, Inc.",2029 Century Park East,Sixth Floor,Los Angeles,California,90067,USA,186704,2004,
Buffered Ursodeoxycholic Acid,Ursocarb,2004-09-03,Treatment of pruritus in patients with Alagille Syndrome,Designated,,,N/A,N/A,"Digestive Care, Inc.",1120 Win Drive,,Bethlehem,Pennsylvania,18017,USA,191204,2004,
heat killed Mycobacterium w immunomodulator,Cadi Mw,2004-09-03,Active tuberculosis,Designated,,,N/A,N/A,"Cadila Pharmaceuticals Limited, Inc.",9801 Washingtonian Blvd,Suite 220,Gaithersburg,Maryland,20878,USA,185304,2004,
Nine amino acid polypeptide derived from proteinase 3,n/a,2004-09-03,Treatment of acute myelogenous leukemia,Designated,,,N/A,N/A,The Vaccine Company,P. O. Box 93921,,Carmel,California,93921,USA,187804,2004,
Nine amino acid polypeptide derived from proteinase 3,n/a,2004-09-03,Treatment of myelodysplastic syndromes requiring therapy,Designated,,,N/A,N/A,The Vaccine Company,P. O. Box 93921,,Carmel,California,93921,USA,187904,2004,
Nine amino acid polypeptide derived from proteinase 3,n/a,2004-09-03,Treatment of chronic myelogenous leukemia.,Designated,,,N/A,N/A,The Vaccine Company,P. O. Box 93921,,Carmel,California,93921,USA,187704,2004,
Tanespimycin,n/a,2004-09-09,Treatment of multiple myeloma,Designated,,,N/A,N/A,Bristol-Myers Squibb,Research and Development,5 Research Parkway,Wallingford,Connecticut,6492,USA,191504,2004,
Coagulation factor VIIa (recombinant),Novoseven,2004-09-10,Treatment of bleeding episodes in patients with congenital factor VII deficiency,Designated/Approved,Approved for Orphan Indication,Treatment of bleeding episodes in patients with Factor VII Deficiency,2005-07-11,2012-07-11,"Novo Nordisk, Inc.",100 College Road West,,Princeton,New Jersey,8540,USA,185904,2004,304
Coagulation factor VIIa (recombinant),Novoseven,2004-09-10,Prevention of bleeding episodes in patients with congenital Factor VII deficiency,Designated/Approved,Approved for Orphan Indication,Prevention of bleeding in surgical interventions or invasive procedures in patients with congenital F VII deficiency,2005-07-11,2012-07-11,"Novo Nordisk, Inc.",100 College Road West,,Princeton,New Jersey,8540,USA,189904,2004,304
L-tyrosine-L-serine-L-leucine,Cms-024,2004-09-10,Treatment of hepatocellular carcinoma.,Designated,,,N/A,N/A,CMS Peptides Patent Holding Company Limited,"Unit 2106, 21st Floor, Island Place Tower",510 King's Rd,North Point,,,Hong Kong,190604,2004,
Immune Globulin Subcutaneous (Human),Vivaglobin P (Proposed),2004-09-22,Treatment of patients with primary immune deficiency (PID) that are intolerant to immune globulin intravenous (IGIV) due to severe adverse events or poor venous access,Designated/Withdrawn,,,N/A,N/A,CSL Behring,1020 First Avenue,P.O. Box 61501,King of Prussia,Pennsylvania,19406,USA,180503,2004,
Human anti-CD30 monoclonal antibody,n/a,2004-09-27,Treatment of Hodgkin's disease,Designated,,,N/A,N/A,"Bristol-Myers Squibb, Inc.",519 Route 173 West,,Bloomsbury,New Jersey,8804,USA,192904,2004,
Nitric oxide,Inomax,2004-09-27,To reduce the risk of chronic lung disease in premature neonates,Designated,,,N/A,N/A,Mallinckrodt Hospital Products,1425 U.S. 206,,Bedminster Township,New Jersey,7921,USA,192104,2004,
Thalidomide,Thalomid,2004-09-27,Treatment of myelodysplastic syndrome,Designated,,,N/A,N/A,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,USA,187204,2004,
romidepsin,Istodax,2004-09-30,Treatment of non-Hodgkin T-cell lymphomas,Designated/Approved,Approved for Orphan Indication,Treatment of cutaneous T-cell lymphoma (CTCL) in patients who have received at least one prior systemic therapy,2009-11-05,2016-11-05,Celgene Corporation,One Broadway,14th Floor,Cambridge,Massachusetts,2142,USA,193404,2004,1862
romidepsin,Istodax,2004-09-30,Treatment of non-Hodgkin T-cell lymphomas,Designated/Approved,Approved for Orphan Indication,Treatment of peripheral T-cell lymphoma (PTCL) in patients who have received at least one prior therapy,2011-06-16,2018-06-16,Celgene Corporation,One Broadway,14th Floor,Cambridge,Massachusetts,2142,USA,193404,2004,2450
trabectedin,Yondelis,2004-09-30,Treatment of soft tissue sarcoma,Designated/Approved,Approved for Orphan Indication,For the treatment of patients with unresectable or metastatic liposarcoma or leiomyosarcoma who received a prior anthracycline-containing regimen,2015-10-23,2022-10-23,"Janssen Research & Development, LLC",920 US Highway 202,P. O. Box 300,Raritan,New Jersey,8869,USA,193604,2004,4040
N-[2-[(4-hydroxyphenyl)amino]-3-pyridinyl]-4-methoxybenzenesulfonamide,n/a,2004-09-30,Treatment of neuroblastoma,Designated/Withdrawn,,,N/A,N/A,"AbbVie, Inc.",1 N. Waukegan Road,,North Chicago,Illinois,60064,USA,188604,2004,
Plitidepsin,Aplidin,2004-09-30,Treatment of multiple myeloma,Designated,,,N/A,N/A,"PharmaMar USA, Inc.",205 East 42nd St.,Suite 15003,New York,New York,10017,USA,191604,2004,
Sorafenib,Nexavar,2004-10-08,Treatment of renal cell carcinoma.,Designated/Approved,Approved for Orphan Indication,Treatment of patients with advanced renal cell carcinoma,2005-12-20,2012-12-20,Bayer Pharmaceutical Corporation,400 Morgan Lane,,West Haven,Connecticut,6516,USA,185204,2004,438
rufinamide,Banzel,2004-10-08,Treatment of Lennox-Gastaut Syndrome.,Designated/Approved,Approved for Orphan Indication,Adjunctive therapy of seizures associated with Lennox-Gastaut syndrome.,2008-11-14,2015-11-14,"Eisai, Inc.",300 Tice Blvd,,Woodcliff Lake,New Jersey,7677,USA,193504,2004,1498
obatoclax mesylate,n/a,2004-10-08,Treatment of chronic lymphocytic leukemia,Designated/Withdrawn,,,N/A,N/A,"Teva Branded Pharmaceutical Products R&D, Inc.",41 Moores Road,P. O. Box 4011,Frazer,Pennsylvania,19355,USA,193804,2004,
Temozolomide,Temodal,2004-10-18,Treatment of newly diagnosed high grade glioma,Designated/Withdrawn,,,N/A,N/A,Merck & Company,2000 Galloping Hill Road,,Kenilworth,New Jersey,7033,USA,193904,2004,
bevacizumab,Avastin,2004-10-20,Treatment of pancreatic cancer,Designated,,,N/A,N/A,"Genentech, Inc.","1 DNA Way, MS #242",,South San Francisco,California,94080,USA,193704,2004,
laromustine,Onrigin,2004-10-21,Treatment of acute myelogenous leukemia,Designated,,,N/A,N/A,"Vion Pharmaceuticals, Inc.",Four Science Park,,New Haven,Connecticut,6511,USA,194104,2004,
Desmoglein 3 synthetic peptide (PI-0824),n/a,2004-10-26,Treatment of pemphigus vulgaris,Designated,,,N/A,N/A,"Peptimmune, Inc.",64 Sidney Street,,Cambridge,Massachusetts,2139,USA,190904,2004,
Cyclosporin A,Mitogard,2004-10-29,Treatment of amyotrophic lateral sclerosis and its variants,Designated,,,N/A,N/A,"Maas Biolab,LLC",Tecnology Ventures Corporation Technopolis,"1155 University Blvd., SE",Albuquerque,New Mexico,87106,USA,194704,2004,
terlipressin,n/a,2004-10-29,Treatment of Hepatorenal Syndrome,Designated,,,N/A,N/A,Mallinckrodt Hospital Products IP Limited,Perryville III Corporate Park,,Dublin,,,Ireland,191804,2004,
golimumab,n/a,2004-11-02,Treatment of chronic sarcoidosis,Designated/Withdrawn,,,N/A,N/A,"Centocor, Inc.",200 Great Valley Parkway,,Malvern,Pennsylvania,19355,USA,194204,2004,
Human monoclonal antibody against platelet-derived growth factor D,n/a,2004-11-02,To slow the progression of IgA nephropathy and delay kidney failure in patients affected by the disease.,Designated,,,N/A,N/A,CuraGen Corporation,322 East Main Street,,Branford,Connecticut,6405,USA,194404,2004,
Sitaxsentan Sodium,n/a,2004-11-02,For the treatment of pulmonary arterial hypertension in the absence of chronic obstructive pulmonary disease or congestive heart failure.,Designated,,,N/A,N/A,Pfizer Global Research and Development,50 Pequot Avenue 6025-B4137,,New London,Connecticut,6320,USA,180803,2004,
Potassium Iodide Oral Solution,Thyroshield,2004-11-17,For use as a thyroid blocking agent in pediatric patients exposed to radiactive iodine,Designated/Approved,Approved for Orphan Indication,For use as a thyroid blocking agent in pediatric patients exposed to radiactive iodine,2005-01-12,N/A,"Fleming & Company, Pharmaceuticals",1733 Gilsinn Lane,,Fenton,Missouri,63026,USA,190304,2004,56
Nimotuzumab,n/a,2004-11-17,Treatment of glioma,Designated,,,N/A,N/A,InnoKeys PTE Ltd.,26 Bukit Batok East Avenue 2 #03-10,,,,,Singapore,192504,2004,
Porfimer sodium,Photofrin,2004-11-18,Treatment of cholangiocarcinoma,Designated,,,N/A,N/A,"Concordia Laboratories, Inc.",Canewood Business Centre,"St. Michael, Barbados BB",,,,,191904,2004,
20-mer oligonucleotide complementary to Akt mRNA,n/a,2004-12-01,Treatment of ovarian cancer,Designated,,,N/A,N/A,Rexahn Corporation,9620 Medical Center Drive,,Rockville,Maryland,20850,USA,195504,2004,
20-mer oligonucleotide complementary to Akt mRNA,n/a,2004-12-01,Treatment of renal cell carcinoma,Designated,,,N/A,N/A,Rexahn Corporation,9620 Medical Center Drive,,Rockville,Maryland,20850,USA,195704,2004,
human anti-integrin receptor avb3/avb5 monoclonal antibody,n/a,2004-12-01,"Treatment of patients with high-risk stage II, stage III, and stage IV malignant melanoma",Designated/Withdrawn,,,N/A,N/A,"Janssen Research & Development, LLC",920 Route 202 South,,Raritan,New Jersey,8869,USA,173803,2004,
"(9-[N-(3-morpholinopropyl)-sulfonyl]-5,6-dihydro-5-oxo-11-H-indeno [1,2-c] isoquinoline methanesulfonic acid",n/a,2004-12-08,Prevention of post-operative complications of aortic anuerysm surgical repair,Designated,,,N/A,N/A,Inotek Pharmaceuticals Corporation,100 Cummings Center,,Beverly,Massachusetts,1915,USA,195404,2004,
20-mer oligonucleotide complementary to Akt mRNA,n/a,2004-12-08,Treatment of pancreatic cancer,Designated,,,N/A,N/A,Rexahn Corporation,9620 Medical Center Drive,,Rockville,Maryland,20850,USA,196204,2004,
20-mer oligonucleotide complementary to Akt mRNA,n/a,2004-12-08,Treatment of glioblastoma,Designated,,,N/A,N/A,Rexahn Corporation,9620 Medical Center Drive,,Rockville,Maryland,20850,USA,196004,2004,
20-mer complementary to Akt mRNA,n/a,2004-12-10,Treatment of stomach cancer,Designated,,,N/A,N/A,Rexahn Corporation,9620 Medical Center Drive,,Rockville,Maryland,20850,USA,196104,2004,
Temsirolimus,Torisel,2004-12-16,Treatment of renal cell carcinoma,Designated/Approved,Approved for Orphan Indication,Treatment of advanced renal cell carcinoma,2007-05-30,2014-05-30,"Wyeth Pharmaceuticals, Inc.",P. O. Box 8299,,Philadelphia,Pennsylvania,19101,USA,196404,2004,895
Rilonacept,Arcalyst,2004-12-20,Treatment of CIAS1-Associated Periodic Syndromes,Designated/Approved,Approved for Orphan Indication,Treatment of Cryopyrin-Assisted Periodic Syndromes (CAPS),2008-02-27,2015-02-27,"Regeneron Pharmaceuticals, Inc.",777 Old Saw Mill River Road,,Tarrytown,New York,10591,USA,196904,2004,1164
Alpha1-Proteinase Inhibitor (Human),n/a,2004-12-22,Inhalation therapy for the treatment of congential deficiency of alpha1-proteinase inhibitor.,Designated,,,N/A,N/A,Kamada Ltd.,7 Sapir Street,,Ness Ziona,,,Israel,190804,2004,
"Floxuridine, FUDR",n/a,2004-12-22,Intraperitoneal treatment of gastric cancer.,Designated,,,N/A,N/A,"Franco Muggia, M.D.",160 East 34th Street,,New York,New York,10016,USA,195104,2004,
paclitaxel,Tocosol,2004-12-22,Treatment of non-superficial urothelial cancer,Designated/Withdrawn,,,N/A,N/A,"Sonus Pharmaceuticals, Inc.",22026 20th Avenue SE,,Bothell,Washington,98021,USA,186404,2004,
doxorubicin HCL liposome injection,Doxil,2004-12-29,Treatment of multiple myeloma,Designated/Approved,Approved for Orphan Indication,For use in combination with bortezomib for the treatment of patients with multiple myeloma who have not previously received bortezomib and have at least one prior therapy.,2007-05-17,2014-05-17,Johnson & Johnson Pharmaceutical Research & Dev.,"920 US Highway 202, P. O. Box 300",,Raritan,,8869,USA,191704,2004,869
"bedaquiline; (1R,2S) 6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-(1-naphthyl)-beta-phenyl-3-quinolineethanol",Sirturo,2005-01-10,Treatment of active tuberculosis,Designated/Approved,Approved for Orphan Indication,Part of combination therapy in adults (greater than or equal to 18 years) with pulmonary multi-drug resistant tuberculosis (MDR-TB).,2012-12-28,2019-12-28,"Janssen Research & Development, LLC",920 Route 202 South,,Raritan,New Jersey,8869,USA,199304,2005,2909
(2Z)-2-cyano-3-3hydroxy-N-[4-(trifluoromethly)phenyl]-2-hepten-6-ynamide,Fk778,2005-01-10,"Prevention of acute rejection following kidney, heart, and liver transplantation",Designated,,,N/A,N/A,"Astellas Pharma US, Inc.",Three Parkway North,,Deerfield,Illinois,60015,USA,187004,2005,
ataluren,n/a,2005-01-10,Treatment of Muscular Dystrophy resulting from premature stop mutations in the dystrohin gene,Designated,,,N/A,N/A,"PTC Therapeutics, Inc.",100 Corporate Court,,South Plainfield,New Jersey,7080,USA,197204,2005,
misoprostol,Gymiso,2005-01-10,Treatment of intrauterine fetal death not accompanied by complete expulsion of the products of conception in the second and third trimesters of pregnancy.,Designated,,,N/A,N/A,"Gynuity Health Projects, LLC",15 East 26th Street,,New York,New York,10010,USA,186604,2005,
"N-(2,3-dihydro-3,3-dimethyl-1H-indol-6-yl)-2-[(4-pyridinylmethyl)amino]-3-pyridinecarboxamide, phosphate (1:2)",n/a,2005-01-13,Treatment of gastrointestinal stromal tumors,Designated/Withdrawn,,,N/A,N/A,"Amgen, Inc.",One Amgen Center Drive,,Thousand Oaks,California,91320,USA,197104,2005,
"Allogeneic T-cells cultured with anti-CD3 and IL-2; transduced with retroviral vector (SFCMM-3), expressing herpes simplex 1 virus-thymidine kinase (HSV-TK) and truncated low affinity nerve growth factor receptor; selected with anti-low affinity nerve gro",n/a,2005-01-28,Immunotherapy for acceleration of T-cell reconstitution in patients undergoing allogeneic hematopoietic stem cell transplantation,Designated,,,N/A,N/A,MolMed S.p.A.,Via Olgettina 58,,Milan,,,Italy,192304,2005,
deferoxamine starch conjugate,n/a,2005-01-28,Treatment of acute iron poisoning,Designated,,,N/A,N/A,"Biomedical Frontiers, Inc.","1087 10th Avenue, SE",,Minneapolis,Minnesota,55414,USA,197704,2005,
recombinant fusion protein with a truncated form of the cytotoxic protein Pseudomonas exotoxin,Proxinium,2005-01-28,Treatment of Ep-CAM-positive squamous cell carcinoma of the head and neck,Designated,,,N/A,N/A,"Eleven Biotherapeutics, Inc.",3711 Market Street,8th Floor,Philadelphia,Pennsylvania,19104,USA,195304,2005,
Tramadol hydrochloride,n/a,2005-01-28,Treatment of painful HIV-associated neuropathy,Designated,,,N/A,N/A,"TheraQuest Biosciences, LLC",146 Medinah Drive,,Blue Bell,Pennsylvania,19422,USA,197004,2005,
Mifepristone,n/a,2005-02-07,Treatment of Cushing's syndrome secondary to ectopic ACTH secretion,Designated/Withdrawn,,,N/A,N/A,HRA Pharma,"15 , rue Beranger",75003 Paris,,,,France,196304,2005,
Mannitol,Bronchitol,2005-02-11,For use to facilitate clearance of mucus in patients with bronchiectasis and in patients with cystic fibrosis at risk for bronchiectasis,Designated,,,N/A,N/A,"Chiesi Farmaceutici S.p.A (Chiesi USA, Inc.)",1255 Crescent Green,Suite 250,Cary,North Carolina,27518,USA,198704,2005,
rAAV2-CB-hRPE65,n/a,2005-02-11,Treatment of type II Leber's Congential Amaurosis,Designated,,,N/A,N/A,Applied Genetic Technologies Corp.,11801 Research Drive,Suite D,Alachua,Florida,32615,USA,197404,2005,
Nitric oxide,n/a,2005-02-16,Diagnosis of sarcoidosis,Designated,,,N/A,N/A,SensorMedics Corporation,22705 Savi Ranch Parkway,,Yorba Linda,California,92887,USA,193304,2005,
Recombinant human anti-GDF-8 (growth and differentiation factor-8) antibody,n/a,2005-02-16,Treatment of Duchenne and Becker muscular dystrophies,Designated/Withdrawn,,,N/A,N/A,"Wyeth Pharmaceuticals, Inc.",P. O. Box 8299,,Philadelphia,Pennsylvania,19101,USA,199104,2005,
aviptadil,n/a,2005-02-22,Treatment of pulmonary arterial hypertension,Designated,,,N/A,N/A,Mondobiotech Laboratories AG,Herrengasse 21,Furstentum Liechtenstein,,,,Switzerland,180903,2005,
c-myb antisense oligodeoxynucleotide,n/a,2005-02-22,Treatment of chronic myelogenous leukemia,Designated/Withdrawn,,,N/A,N/A,"Genta, Inc.",Two Conell Drive,,Berkeley Heights,New Jersey,7922,USA,198504,2005,
Arsenic trioxide,Trisenox,2005-03-04,Treatment of malignant glioma,Designated,,,N/A,N/A,"Teva Branded Pharmaceutical Products R&D, Inc.",41 Moores Road,P. O. Box 4011,Frazer,Pennsylvania,19355,USA,201305,2005,
Sodium aluminosilicate,n/a,2005-03-04,Treatment of chronic hepatic encephalopathy,Designated,,,N/A,N/A,Castle Creek Pharmaceuticals LLC,1033 Skokie Blvd,Suite 600,Northbrook,Illinois,60062,USA,192704,2005,
Stem and progenitor cells derived from ex vivo expanded allogeneic umbilical cord blood,Stemex,2005-03-04,For use as hematopoietic support in patients with relapsed or refractory hematologic malignancies who are receiving high-dose therapy,Designated/Withdrawn,,,N/A,N/A,Gamida Cell Ltd - Teva Joint Venture,"5, Nahum Hafzadi St.",P. O. Box 34670,Jerusalem,,,Israel,195204,2005,
doxorubicin nanoparticles,Doxorubicin Transdrug,2005-03-14,Treatment of hepatocellular carcinoma,Designated,,,N/A,N/A,Onxeo SA,"49 Boulevard du general Martial Valin, 75015",,Paris,,,France,199904,2005,
adalimumab,Humira,2005-03-21,Treatment of juvenile rheumatoid arthritis,Designated/Approved,Approved for Orphan Indication,Reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis in patients 4 years of age and older.,2008-02-21,2015-02-21,AbbVie Inc.,1 North Waukegan Road,,North Chicago,Illinois,60064,USA,200905,2005,1067
adalimumab,Humira,2005-03-21,Treatment of juvenile rheumatoid arthritis,Designated/Approved,Approved for Orphan Indication,Reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis in patients 2 years to 4 years of age.,2014-09-30,2021-09-30,AbbVie Inc.,1 North Waukegan Road,,North Chicago,Illinois,60064,USA,200905,2005,3480
humanized anti-human CD16 monoclonal antibody,n/a,2005-03-21,Treatment of adult idiopathic thrombocytopenic purpura,Designated/Withdrawn,,,N/A,N/A,Genzyme Corporation,500 Kendall Street,,Cambridge,Massachusetts,2142,USA,199504,2005,
aminosidine,Paromomycin,2005-03-29,Treatment of visceral leishmaniasis,Designated,,,N/A,N/A,The Institute for One World Health,50 California Street,Suite 500,San Francisco,California,94111,USA,201705,2005,
arimoclomol,n/a,2005-03-29,Treatment of amyotrophic lateral sclerosis,Designated,,,N/A,N/A,Orphazyme ApS,3 Ole Maaløes Vej,,Copenhagen,,,Denmark,202705,2005,
Melanoma peptide vaccine,n/a,2005-03-29,"Treatment of HLA-A2+ patients with stage IIB, IIC, III, and IV malignant melanoma",Designated,,,N/A,N/A,Bristol-Myers Squibb Research Inst,5 Research Parkway,P. O. Box 5100,Wallingford,Connecticut,6492,USA,194604,2005,
Plasmid DNA vector expressing cystic fibrosis transmembrane gene,n/a,2005-03-29,Treatment of cystic fibrosis,Designated,,,N/A,N/A,"Copernicus Therapeutics, Inc.",11000 Cedar Avenue,,Cleveland,Ohio,44106,USA,202205,2005,
trabectedin,Yondelis,2005-03-29,Treatment of patients with ovarian cancer,Designated,,,N/A,N/A,"Janssen Research & Development, LLC",920 US Highway 202,P. O. Box 300,Raritan,New Jersey,8869,USA,199004,2005,
2-methoxyestradiol,Panzem Ncd,2005-04-04,Treatment of ovarian cancer,Designated/Withdrawn,,,N/A,N/A,"EntreMed, Inc.",4819 Emperor Blvd,Suite 400,Durham,North Carolina,27703,USA,201405,2005,
DNA plasmid vector expressing human IL-12 gene,n/a,2005-04-04,Treatment of ovarian cancer.,Designated,,,N/A,N/A,Celsion Corporation,997 Lenox Drive,Suite 100,Lawrenceville,New Jersey,8068,USA,198304,2005,
"Human alpha 2,6 sialyltransferase adenoviral gene therapy",n/a,2005-04-04,"Treatment of patients with invasive (malignant) brain and central nervous system tumors lacking alpha 2,6 sialyltransferase.",Designated,,,N/A,N/A,Falk Center for Molecular Therapeutics,1801 Maple Avenue,Suite 4300,Evanston,Illinois,60201,USA,201805,2005,
Interleukin-1 Trap,n/a,2005-04-04,Treatment of Still's disease including juvenile rheumatoid arthritis and adult-onset Still's disease,Designated,,,N/A,N/A,"Regeneron Pharmaceuticals, Inc.",777 Old Saw Mill River Road,,Tarrytown,New York,10591,USA,197604,2005,
Troxacitabine,Troxatyl,2005-04-04,Treatment of acute myeloid leukemia,Designated/Withdrawn,,,N/A,N/A,"Structural GenomiX, Inc. (SGX)",10505 Roselle Street,,San Diego,California,92121,USA,202005,2005,
myo-inositol,n/a,2005-04-07,Prevention of retinopathy of prematurity in preterm infants at risk for developing retinopathy of prematurity,Designated,,,N/A,N/A,Abbott Nutrition,Abbott Laboratories,625 Cleveland Ave.,Columbus,Ohio,43215,USA,202105,2005,
2-methoxyestradiol,Pulmolar,2005-04-11,Treatment of pulmonary arterial hypertension,Designated,,,N/A,N/A,"PR Pharmaceuticals, Inc.",1716 Heath Parkway,,Fort Collins,Colorado,80524,USA,202905,2005,
Tilarginine acetate,n/a,2005-04-11,Treatment of cardiogenic shock,Designated,,,N/A,N/A,"Arginox Pharmceuticals, Inc.",120 Constitution Drive,,Menlo Park,California,94025,USA,198804,2005,
Anatibant,n/a,2005-04-15,Treatment of patients having experienced a severe traumatic brain injury (Glasgow Coma Scale 3 to 8) in order to decrease early mortality and improve long-term functional and neurological outcome,Designated,,,N/A,N/A,"Xytis, Inc.",400 South El Camino Real,Suite 1200,San Mateo,California,94402,USA,153801,2005,
Antisense 20-mer oligonucleotide complementary to R2 component of ribonucleotide reductase mRNA,n/a,2005-04-15,Treatment of acute myeloid leukemia,Designated,,,N/A,N/A,"Lorus Therapeutics, Inc.",2 Meridan Road,,M9W 4Z7,,,Canada,203005,2005,
hydroxyurea,n/a,2005-04-15,Treatment of pediatric patients with sickle cell anemia.,Designated,,,N/A,N/A,"UPM Pharmaceuticals, Inc.",6200 Seaforth Street,,Baltimore,Maryland,21224,USA,202605,2005,
masitinib,n/a,2005-04-20,Treatment of malignant gastrointestinal stromal tumors,Designated,,,N/A,N/A,AB Science,"3, avenue George V",,Paris,,,France,201005,2005,
L-threonyl-L-prolyl-L-prolyl-L-threonine,n/a,2005-04-26,Treatment of neuropathic pain associated with spinal cord injury,Designated,,,N/A,N/A,"Nyxis Neurotherapies, Inc.",1801 Maple Avenue,Suite 4300,Evanston,Illinois,60201,USA,199404,2005,
Tramadol hydrochloride,n/a,2005-04-26,Management of postherpetic neuralgia,Designated,,,N/A,N/A,"TheraQuest Biosciences, LLC",146 Medinah Drive,,Blue Bell,Pennsylvania,19422,USA,192804,2005,
Recombinant human alpha 1-antitrypsin,n/a,2005-04-28,Prevention of bronchopulmonary dysplasia,Designated,,,N/A,N/A,"Arriva Pharmaceuticals, Inc.",1010 Atlantic Avenue,,Alameda,California,94501,USA,203705,2005,
Human anti-integrin receptor av monoclonal antibody,n/a,2005-05-05,Treatment of patients with angiosarcoma,Designated/Withdrawn,,,N/A,N/A,"Janssen Research & Development, LLC",920 Route 202 South,,Raritan,New Jersey,8869,USA,203605,2005,
Glyceryl tri (4-phenylbutyrate),n/a,2005-05-24,Treatment of spinal muscular atrophy,Designated,,,N/A,N/A,"Ucyclyd Pharma, Inc",Subsidiary of Medicis Pharmaceutical Corporation,7720 N. Dobson Road,Scottsdale,Arizona,85256,USA,204205,2005,
Titanium dioxide and bisoctrizole,n/a,2005-05-25,"For the secondary prevention (prevention of lesional induction) of disorders with UV-A and visible light-induced photosensitivity, specifically Actinic prurigo, Hydroa vacciniforme, Solar urticara (SU), Chronic Actinic Dermatitis (CAD), the cutaneous prophyrias, Smith-Lemli-Optiz Syndrome, and Hartnup's Disease.",Designated/Withdrawn,,,N/A,N/A,Orfagen,CRDPF - LANGLADE,31035 Toulouse Cedex,,,,France,199204,2005,
cilengitide,n/a,2005-05-27,Treatment of malignant glioma,Designated/Withdrawn,,,N/A,N/A,"EMD Serono, Inc.",One Technology Place,,Rockland,Massachusetts,2370,USA,205205,2005,
digitoxin,n/a,2005-05-27,Treatment of cystic fibrosis,Designated,,,N/A,N/A,Silver Pharmaceuticals,350 Seven Locks Road,Suite 211,Rockville,Maryland,20854,USA,205005,2005,
Cytomegalovirus DNA vaccine with plasmids expressing pp65 and gB genes,n/a,2005-06-03,"Prevention of clinically significant cytomegalovirus (CMV) viremia, CMV disease and associated complications in at-risk hematopoietic cell transplant and solid transplant populations",Designated,,,N/A,N/A,"Astellas Pharma Global Development, Inc.",1 Astellas Way,,Northbrook,Illinois,60062,USA,193104,2005,
Iboctadekin,n/a,2005-06-03,Treatment of renal cell carcinoma,Designated/Withdrawn,,,N/A,N/A,GlaxoSmithKline LLC,Corporation service Company,Suite 400,Wilmington,Delaware,19808,USA,193004,2005,
Sodium phenylacetate/sodium benzoate 10%/10% Injection,Ammonul(R),2005-06-03,Treatment of grade III and IV hepatic encephalopathy,Designated,,,N/A,N/A,"Ucyclyd Pharma, Inc.",7720 N. Dobson Road,,Scottsdale,Arizona,85256,USA,197804,2005,
Tacrolimus,Prograf,2005-06-06,Prophylaxis of organ rejection in patients receiving heart transplants.,Designated/Approved,Approved for Orphan Indication,Prophylaxis of organ rejection in patients receiving allogenic heart transplants.,2006-03-29,2013-03-29,"Astellas Pharma US, Inc.",Three Parkway North,,Deerfield,Illinois,60015,USA,203305,2005,296
Geneticin,n/a,2005-06-06,Treatment of amoebiasis.,Designated,,,N/A,N/A,"ProcesScience, Inc (PSI)",117 Woodberry Lane,,Fayetteville,New York,13066,USA,204605,2005,
Polyethylene glycol-modified uricase,n/a,2005-06-06,Treatment of hyperuricemia in patients with gout refractory to conventional therapy or in whom conventional therapy is contraindicated,Designated,,,N/A,N/A,"EnzymeRx, LLC",17 Arcadian Avenue,Suite 104,Paramus,New Jersey,7652,USA,118698,2005,
Clotrimazole,n/a,2005-06-14,Topical treatment of children and adults with pouchitis,Designated,,,N/A,N/A,"AesRx, LLC",275 Grove Street,Suite 2-400,Newton,Massachusetts,2466,USA,204005,2005,
Adenoviral vector expressing Herpes simplex virus thymidine kinase gene,n/a,2005-06-17,Treatment of malignant brain tumors,Designated,,,N/A,N/A,"Advantagene, Inc.",160 Paulson Road,,Waban,Massachusetts,2468,USA,206105,2005,
Liposomal annamycin,n/a,2005-06-17,Treatment of acute myeloid leukemia,Designated,,,N/A,N/A,"Callisto Pharmaceuticals, Inc.",420 Lexington Avenue,,New York,New York,10170,USA,206305,2005,
Liposomal annamycin,n/a,2005-06-17,Treatment of acute lymphoblastic leukemia,Designated,,,N/A,N/A,"Callisto Pharmaceuticals, Inc.",420 Lexington Avenue,,New York,New York,10170,USA,206205,2005,
Recombinant truncated SPINT2 protease inhibitor,n/a,2005-06-24,Treatment of cystic fibrosis,Designated,,,N/A,N/A,"Aerovance, Inc.",2929 Seventh Street,,Berkeley,California,94710,USA,205905,2005,
"Valproic acid, sodium",Peac(R),2005-06-24,Treatment of familial adenomatous polyposis,Designated/Withdrawn,,,N/A,N/A,Topotarget A/S,Fruebjergvej 3,DK-2100,Copenhagen,,,Denmark,200705,2005,
Contulakin-G,n/a,2005-07-07,Intrathecal treatment of neuropathic pain associated with spinal cord injury,Designated,,,N/A,N/A,"Cognetix, Inc.",421 Wakara Way,,Salt Lake City,Utah,84108,USA,205505,2005,
human leukocyte-derived cytokine mixture,n/a,2005-07-07,Neoadjuvant therapy in patients with squamous cell carcinoma of the head and neck,Designated,,,N/A,N/A,"IRX Therapeutics, Inc.",Suite 2100,,Brooklyn,New York,11220,USA,199604,2005,
SDF-1 (108) Lysine Dlmer,n/a,2005-07-07,Treatment of osteogenic sarcoma,Designated,,,N/A,N/A,Chemokine Therapeutics Corporation,190 Agronomy Road (UBC),Suite 405,"Vancouver, BC V6T 1Z3",,,Canada,182403,2005,
Alfentanil,n/a,2005-07-08,Management of postherpetic neuralgia,Designated,,,N/A,N/A,"Cinergen, LLC",146 Medinah Drive,,Blue Bell,Pennsylvania,19422,USA,206505,2005,
raloxifene,Evista,2005-07-14,Reduction of the risk of breast cancer in postmenopausal women,Designated/Approved,Approved for Orphan Indication,Reduction in risk of invasive breast cancer in postmenopausal women with osteoporosis and reduction in risk of invasive breast cancer in postmenopausal women at high risk for invasive breast cancer,2007-09-13,2014-09-13,Eli Lilly and Company,Lilly Corporate Center,Drop Code 1853,Indianapolis,Indiana,46285,USA,197504,2005,791
Autologous or allogeneic limbal epithelial stem cells expanded ex vivo on human amniotic membrane,n/a,2005-07-14,Treatment of ocular surface diseases that are characterized by total limbal stem cell deficiency,Designated,,,N/A,N/A,"TissueTech, Inc.",7000 SW 97th Avenue,,Miami,Florida,33173,USA,198004,2005,
Recombinant human lysosomal acid lipase or cholesteryl ester hydrolase,Cholestrase,2005-07-14,"Treatment of lipase deficiencies, including Wolman Disease and cholesteryl ester storage disease",Designated,,,N/A,N/A,"Lysosomal Acid Lipase, LLC","Subsidiary of Kentucky BioProcessing, LLC",3700 Airpark Drive,Owensboro,Kentucky,42301,USA,205805,2005,
Edotreotide,Onalta(Tm),2005-07-28,Treatment of somatostatin receptor-positive neuroendocrine gastroenteropancreatic tumors,Designated,,,N/A,N/A,"Molecular Insight Pharmaceuticals, Inc. (Progenics Subsidiary)",777 Old Saw Mill River Road,,Tarrytown,New York,10591,USA,160902,2005,
Nucleic acid aptamer binding to tumor cell nucleon,n/a,2005-07-28,Treatment of renal cell carcinoma,Designated,,,N/A,N/A,Antisoma Inc.,300 Technology Square,,Cambridge,Massachusetts,,USA,207105,2005,
Capsaicin,n/a,2005-08-03,Treatment of postherpetic neuralgia.,Designated,,,N/A,N/A,"TheraQuest Biosciences, LLC",146 Medinah Drive,,Blue Bell,Pennsylvania,19422,USA,205705,2005,
biocarbonate infusate,Normocarb Hf,2005-08-09,Use in the management of patients undergoing continuous renal replacement therapy with hemofiltration,Designated/Approved,Approved for Orphan Indication,Use as a replacement solution in Continuous Renal Replacement Therapy (CRRT) to replace water and to correct electrolytes and acid-base imbalances in adults and children,2006-07-26,2013-07-26,"Dialysis Solutions, Inc.",14 Emmett Place,"Whitby, Ontario L1R 2B4",,,,Canada,198904,2005,351
Alfentanil,n/a,2005-08-09,Treatment of painful HIV-associated neuropathy,Designated,,,N/A,N/A,"Cinergen, LLC",146 Medinah Drive,,Blue Bell,Pennsylvania,19422,USA,206405,2005,
Rapamycin (mTOR) inhibitor,n/a,2005-08-09,Treatment of bone sarcoma.,Designated/Withdrawn,,,N/A,N/A,Merck Sharp & Dohme Corp.,"S Merck & Co., Inc. Subsidiary","P. O. Box 1000, UG-2C50",North Wales,Pennsylvania,19454,USA,207705,2005,
Balsalazide disodium,Colazal,2005-08-12,Treatment of pediatric patients with ulcerative colitis,Designated/Approved,Approved for Orphan Indication,Treatment of mildly to moderately active ulcerative colitis in patients 5 years of age and older. Safety and Effectiveness of Colazal beyond 8 weeks in children (ages 5-17) and 12 weeks in adults have not been established.,2006-12-20,2013-12-20,"Salix Pharmaceuticals, Inc.",400 Somerset Corporate Blvd,,Bridgewater,New Jersey,8807,USA,208205,2005,495
imexon,Amplimexon,2005-08-12,Treatment of ovarian cancer.,Designated,,,N/A,N/A,AmpliMed Corporation,4380 N. Campbell Ave.,,Tucson,Arizona,85718,USA,207205,2005,
Recombinant anti-CD40 monoclonal antibody,n/a,2005-08-12,Treatment of chronic lymphocytic leukemia,Designated/Withdrawn,,,N/A,N/A,Novartis Pharmaceutical Corporation,Oncology Business Unit,"One Health Plaza, Bldg 104",East Hanover,New Jersey,7936,USA,207605,2005,
ridaforolimus,n/a,2005-08-12,Treatment of soft tissue sarcoma,Designated/Withdrawn,,,N/A,N/A,Merck Sharp & Dohme Corp.,"Merck & Co., Inc. Subsidiary","P. Box 1000, UG-2C50",North Wales,Oregon,19454,USA,207805,2005,
Recombinant Epstein-Barr virus gp350 glycoprotein vaccine,n/a,2005-08-18,Prevention of post-transplantation lymphoproliferative disorders in pediatric recipients of solid-organ transplantation,Designated,,,N/A,N/A,Henogen S.A.,"Rue des Professeurs Jenner et Brachet, 12",B-6041-Gosselies,,,,Belgium,148001,2005,
Imatinib mesylate,Gleevec,2005-08-25,Treatment of idiopathic hypereosinophilic syndrome including acute and chronic eosinophilic leukemia,Designated/Approved,Approved for Orphan Indication,Treatment of adult patients with hypereosinophic syndrome (HES) and/or chronic eosinophilic leukemia (CEL) who have the FIP1L1-PDGFRÃ¿}Ã¿Â± fusion kinase (mutational analysis or FISH demonstration of CHIC2 allele deletion) and for patients with HES and/or CEL who are FIP1L1-PDGFRÃ¿}Ã¿Â± fusion kinase negative or unknown,2006-10-19,2013-10-19,Novartis Pharmaceuticals Corporation,One Health Plaza,Mail Code 105/1E870D,East Hanover,New Jersey,7936,USA,209005,2005,420
Imatinib mesylate,Gleevec,2005-09-09,Treatment of systemic mastocytosis without the D816V c-kit mutation,Designated/Approved,Approved for Orphan Indication,Treatment of adult patients with aggressive mastocytosis (ASM) without the D816V c-Kit mutation or with c-Kit mutational status unknown,2006-10-19,2013-10-19,Novartis Pharmaceuticals Corporation,One Health Plaza,Mail Code 105/1E870D,East Hanover,New Jersey,7936,USA,209205,2005,405
masitinib,n/a,2005-09-14,Treatment of mastocytosis,Designated,,,N/A,N/A,AB Science,"3, avenue George V",,,,,France,201505,2005,
Enzastaurin,n/a,2005-09-19,Treatment of glioblastoma multiforme,Designated,,,N/A,N/A,Denovo Biopharma LLC,6331 Nancy Ridge Drive,,San Diego,California,92121,USA,208505,2005,
Anti-tenascin 81C6 monoclonal antibody labeled w/ I 131,Neuradiab,2005-10-04,Treatment of primary malignant brain tumors,Designated,,,N/A,N/A,"Bradmer Pharmaceuticals, Inc.",9900 Corporate Campus Drive,Suite 3000,Louisville,Kentucky,40223,USA,209405,2005,
"Chimeric monoclonal antibodies, c-alphaStx2",n/a,2005-10-04,For treatment of shiga-toxin producing bacterial infection,Designated,,,N/A,N/A,Taro Pharmaceuticals Inc.,130 East Drive,,Brampton,Ontario,,Canada,208105,2005,
Patupilone,n/a,2005-10-04,Treatment of ovarian cancer.,Designated/Withdrawn,,,N/A,N/A,Novartis Pharmaceutical Corporation,One Health Plaza,,East Hanover,New Jersey,7936,USA,210205,2005,
Recombinant Human Interleukin-21 (rIL-21),n/a,2005-10-04,"Treatment of stage II (T4), III or IV malignant melanoma.",Designated,,,N/A,N/A,"Zymo Genetics, Inc",1201 Eastlake Avenue East,,Seattle,Washington,98102,USA,208005,2005,
Imatinib mesylate,Gleevec,2005-10-05,Treatment of myeloproliferative disorders/myelodysplastic syndromes associated with platelet-derived growth factor gene re-arrangements,Designated/Approved,Approved for Orphan Indication,Treatment of adult patients with myelodysplastic/myeloproliferative diseases (MDS/MPD) associated with PDGFR (platelet-derived growth factor receptor) gene re-arrangements,2006-10-19,2013-10-19,Novartis Pharmaceuticals Corporation,One Health Plaza,Mail Code 105/1E870D,East Hanover,New Jersey,7936,USA,209105,2005,379
brivaracetam,n/a,2005-10-05,Treatment of symtomatic myoclonus,Designated,,,N/A,N/A,"UCB Pharma, Inc.",1950 Lake Park Drive,,Smyra,Georgia,30080,USA,207305,2005,
Buthionine sulfoxamine,n/a,2005-10-05,Use as a modulator of chemotherapy for the treatment of pediatric patients with primary malignant brain tumors,Designated,,,N/A,N/A,USC-CHLA Institute for Pediatric Clinical Research,Childrens Hospital of Los Angeles,"4650 Sunset Blvd, MS 55",Los Angeles,California,90027,USA,213205,2005,
Buthionine sulfoxamine,n/a,2005-10-05,For use in children as a modulator of chemotherapy for the treatment of pediatric patients with neuroblastoma,Designated,,,N/A,N/A,USC-CHLA Institute for Pediatric Clinical Research,Childrens Hospital of Los Angeles,"4650 Sunset Blvd, MS 55",Los Angeles,California,90027,USA,209705,2005,
Fenretinide,n/a,2005-10-05,Treatment of neuroblastoma,Designated,,,N/A,N/A,USC-CHLA Institute for Pediatric Clinical Research,Childrens Hospital of Los Angeles,"4650 Sunset Blvd, MS 55",Los Angeles,California,90027,USA,209805,2005,
dacetuzumab,n/a,2005-10-06,Treatment of chronic lymphocytic leukemia,Designated,,,N/A,N/A,"Seattle Genetics, Inc.",21823 30th Drive Southeast,,Bothell,Washington,98021,USA,209305,2005,
Doxorubicin HCl with pluronic L-61 and pluronic F-127,n/a,2005-10-07,Treatment of esophageal carcinoma,Designated,,,N/A,N/A,Supratek Pharma Inc.,6100 Royalmount Avenue,Montreal,Quebec H4P 2R2,,,Canada,210705,2005,
imatinib,Gleevec,2005-10-11,Treatment of Philadelphia-positive acute lymphoblastic leukemia,Designated/Approved,Approved for Orphan Indication,Treatment of adult patients with relapsed or refractory Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL),2006-10-19,2013-10-19,Novartis Pharmaceuticals Corporation,One Health Plaza,Mail Code 105/1E870D,East Hanover,New Jersey,7936,USA,208905,2005,373
imatinib,Gleevec,2005-10-11,Treatment of Philadelphia-positive acute lymphoblastic leukemia,Designated/Approved,Approved for Orphan Indication,"Treatment of pediatric patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) in combination with chemotherapy, approved under NDA #21588/S-037",2013-01-25,2020-01-25,Novartis Pharmaceuticals Corporation,One Health Plaza,Mail Code 105/1E870D,East Hanover,New Jersey,7936,USA,208905,2005,2663
Creatine,Creapure,2005-10-11,Treatment of Huntington's disease,Designated/Withdrawn,,,N/A,N/A,"Marathon Pharmaceuticals, LLC",1033 Skokie Blvd,Suite 600,Northbrook,Illinois,60062,USA,210005,2005,
siltuximab,n/a,2005-10-11,Treatment of multiple myeloma,Designated/Withdrawn,,,N/A,N/A,"Janssen Research & Development, LLC",920 Route 202 South,,Raritan,New Jersey,8869,USA,200505,2005,
Iobenguane Sulfate I-123,Omaclear,2005-10-17,"For scintigraphic detection, localization and staging of neuroblastoma.",Designated,,,N/A,N/A,"Brogan Pharmaceuticals, LLC",312 Lacebark Street,,Schererville,Indiana,46375,USA,208405,2005,
N-(methyl-diazacyclohexyl-methylbenzamide)-azaphenyl-aminothiopyrrole) mesylate,n/a,2005-10-17,Treatment of multiple myeloma.,Designated,,,N/A,N/A,AB Science,"3, avenue George V",,,,,France,210505,2005,
vandetanib,Caprelsa(R),2005-10-21,"Treatment of patients with follicular thyroid carcinoma, medullary thyroid carcinoma, anaplastic thyroid carcinoma, and locally advanced and metastatic papillary thyroid carcinoma",Designated/Approved,Approved for Orphan Indication,Treatment of asymptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease,2011-04-06,2018-04-06,Genzyme Corporation,500 Kendall Street,,Cambridge,Massachusetts,2142,USA,211005,2005,1993
iobenguane sulfate I-123,Omaclear,2005-10-21,"For the detection, localization, and staging of pheochromocytomas.",Designated,,,N/A,N/A,"Brogan Pharmaceuticals, Inc.",9800 Connecticut Drive,c/o Purdue Technology Center,Crown Point,Indiana,46307,USA,208305,2005,
Lucinactant,Surfaxin,2005-10-21,Treatment of bronchopulmonary dysplasia in premature infants.,Designated,,,N/A,N/A,"Windtree Therapeutics, Inc.",2600 Kelly Road,Suite 100,Warrington,Pennsylvania,18976,USA,208705,2005,
bivalirudin,Angiomax,2005-11-02,For use as an anticoagulant in patients with or at risk of heparin-induced thrombocytopenia/heparin-induced thrombocytopenia thrombosis syndrome,Designated,,,N/A,N/A,The Medicines Company,8 Sylvan Way,,Parsippany,New Jersey,7054,USA,200204,2005,
Picoplatin,n/a,2005-11-02,Treatment of small cell lung cancer,Designated,,,N/A,N/A,Poniard Pharmaceuticals,300 Elliott Avenue West,,Seattle,Washington,98119,USA,212305,2005,
Solasonine and solamargine,Coramsine,2005-11-02,Treatment of renal cell carcinoma,Designated,,,N/A,N/A,Solbec Pharmaceuticals Limited,P. O. Box 2142,WA 6018,,,,Australia,211805,2005,
Heparin,n/a,2005-11-03,Treatment of cystic fibrosis,Designated/Withdrawn,,,N/A,N/A,"Vectura Group, Inc.",1 Prospect West,Wiltshire SN14 6FH,,,,United Kingdom,211305,2005,
Dasatinib,Sprycel,2005-11-18,Treatment of Philadelphia-positive acute lymphoblastic leukemia,Designated/Approved,Approved for Orphan Indication,Treatment of adults with Philadelphia chromosome-positive acute lymphoblastic leukemia with resistance or intolerance to prior therapy,2006-06-28,2013-06-28,Bristol-Myers Squibb Company,5 Research Parkway,,Wallingford,Connecticut,6492,USA,214605,2005,222
Histrelin,Supprelin La,2005-11-18,Treatment of central precocious puberty,Designated/Approved,Approved for Orphan Indication,Treatment of central precocious puberty,2007-05-03,2014-05-03,"Endo Pharmaceuticals Solutions, Inc.",100 Endo Blvd,,Chadds Ford,Pennsylvania,19317,USA,212605,2005,531
Exon 46 specific phosphorothioate oligonucleotide,n/a,2005-11-18,Treatment of Duchenne muscular dystrophy,Designated/Withdrawn,,,N/A,N/A,Prosensa Therapuetics BV,"J. H. Oortweg, 2333 CH",,Leiden,,,Netherlands,211905,2005,
recombinant deriative of C3 transferase,Cethrin,2005-11-18,Treatment of acute spinal cord injury,Designated,,,N/A,N/A,"Vertex Pharmaceuticals, Inc.",50 Northern Avenue,,Boston,Massachusetts,2210,USA,213505,2005,
dasatinib,Sprycel,2005-11-28,Treatment of chronic myelogenous leukemia,Designated/Approved,Approved for Orphan Indication,Treatment of adults with chronic myeloid leukemia with resistance or intolerance to prior therapy including imatinib,2006-06-28,2013-06-28,Bristol-Myers Squibb Company,"3401 Princeton Pike, B-3043C",,Lawrence Township,New Jersey,8648,USA,212405,2005,212
dasatinib,Sprycel,2005-11-28,Treatment of chronic myelogenous leukemia,Designated/Approved,Approved for Orphan Indication,Treatment of pediatric patients with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase,2017-11-09,2024-11-09,Bristol-Myers Squibb Company,"3401 Princeton Pike, B-3043C",,Lawrence Township,New Jersey,8648,USA,212405,2005,4364
"4-cholest-en-3-one, oxime",n/a,2005-12-01,Treatment of amyotrophic lateral sclerosis,Designated/Withdrawn,,,N/A,N/A,Trophos SA,"Parc scientifique de Lumigny, Case 931",1322 Marseille cedex,,,,France,214305,2005,
4-(3-Methanesulfonyl-phenyl)-1-propylpiperidine HCl,n/a,2005-12-12,Treatment of Huntington's disease.,Designated,,,N/A,N/A,Teva Branded Pharmaceutical Products R&D,41 Moores Road,,Frazer,Pennsylvania,19355,USA,213905,2005,
solvent/detergent treated non-blood-group specific human coagulation active plasma,Uniplas,2005-12-12,Treatment of thrombotic thrombocytopenic purpura,Designated,,,N/A,N/A,"Octapharma USA, Inc.",121 River Street,12th Floor,Hoboken,New Jersey,7030,USA,211605,2005,
4-Aminopyridine,n/a,2005-12-14,Treatment chronic functional motor and sensory deficits from Guillain-Barre syndrome,Designated,,,N/A,N/A,"Acorda Therapeutics, Inc.",420 Saw Mill River Road,,Ardsley,New York,10502,USA,214205,2005,
Ex vivo cultured adult human mesenchymal stem cells,Prochymal(R),2005-12-14,Treatment of acute graft versus host disease,Designated,,,N/A,N/A,"Mesoblast, Inc.",505 Fifth Avenue,Third Floor,New York,New York,10017,USA,214805,2005,
Urea for intravitreal injection,Neurosolve,2005-12-14,Treatment of retinitis pigmentosa,Designated,,,N/A,N/A,"Vitreo Retinal Techologies, Inc",2 Venture Plaza,,Irvine,California,92618,USA,192204,2005,
Somatropin,Humatrope,2005-12-15,Treatment of short stature in pediatric patients with short stature homeobox-containing gene (SHOX) deficiency,Designated/Approved,Approved for Orphan Indication,Treatment of short stature or growth failure in children with SHOX (short stature homeobox-containing gene) deficiency whose epiphyses are not closed,2006-11-01,2013-11-01,Eli Lilly and Company,Lilly Corporate Center,,Indianapolis,Indiana,46285,USA,211205,2005,321
Amphotericin B inhalation powder,n/a,2005-12-15,"Prevention of pulmonary fungal infections in patients at risk for aspergillosis due to immunosuppressive therapy including those receiving organ or stem cell transplants, or treated with chemotherapy or radiation for hematologic malignancies",Designated,,,N/A,N/A,Novartis Pharmaceuticals Corporation,150 Industrial Road,,San Carlos,California,94070,USA,210805,2005,
Coxsackievirus A21,Cavatak,2005-12-15,"Treatment of stage II (T4), stage III, and stage IV melanoma",Designated,,,N/A,N/A,Viralytics Limited,P. O. Box 1045,"Unit 8/33 Ryde Road, Pymble, NSW 22073",,,,Australia,212105,2005,
eniluracil,n/a,2005-12-15,Treatment of hepatocellular carcinoma.,Designated,,,N/A,N/A,"Adherex Technologies, Inc.",501 Eastowne Drive,Suite 140,Chapel Hill,North Carolina,27514,USA,211505,2005,
Zosuquidar trihydrochloride,n/a,2005-12-15,Treatment of acute myeloid leukemia,Designated,,,N/A,N/A,"Kanisa Pharmaceuticals, Inc.",12264 El Camino Real,,San Diego,California,2130,USA,212805,2005,
imatinib mesylate,Gleevec,2005-12-19,Treatment of dermatofibrosarcoma protuberans,Designated/Approved,Approved for Orphan Indication,"Treatment of adult patients with unresectable, recurrent and/or metastatic dermatofibrosarcoma protuberans (DFSP)",2006-10-19,2013-10-19,Novartis Pharmaceuticals Corporation,One Health Plaza,Mail Code 105/1E870D,East Hanover,New Jersey,7936,USA,208805,2005,304
Mycophenolate mofetil,Cellcept,2005-12-19,Treatment of myasthenia gravis,Designated/Withdrawn,,,N/A,N/A,"Hoffman-LaRoche, Inc.",340 Kingsland Street,,Nutley,New Jersey,7110,USA,215405,2005,
Human immunoglobin anti-CD30 monoclonal antibody,n/a,2006-01-10,Treatment of CD30+ T-cell lymphoma,Designated,,,N/A,N/A,Bristol-Myers Squibb,519 Route 173 West,,Bloombury,New Jersey,8804,USA,215905,2006,
Inalimarev and falimarev,n/a,2006-01-10,Treatment of adenocarcinoma of the pancreas,Designated,,,N/A,N/A,Therion Biologics Corporation,76 Rogers Street,,Cambridge,Massachusetts,2142,USA,215705,2006,
isofagomine tartrate,n/a,2006-01-10,Treatment of Gaucher disease,Designated,,,N/A,N/A,"Amicus Therapeutics, Inc.",6 Cedar Brook Drive,,Cranbury,New Jersey,8512,USA,215605,2006,
Fusion protein consisting of human immunoglobim G1 constant region Fc region fused to the human receptor binding domain of ectodysplasin-A1,n/a,2006-01-11,Treatment of X-linked hypohidrotic ectodermal dysplasia,Designated,,,N/A,N/A,"Edimer Pharmaceuticals, Inc.",1 Broadway,8th Floor,Cambridge,Massachusetts,2142,USA,216005,2006,
Lentiviral vector encoded with a human beta-globin gene plasmid,Thalagen,2006-01-11,Treatment of beta-thalassemia major and beta-thalassemia intermedia,Designated,,,N/A,N/A,Memorial Sloan-Kettering Cancer Center,1275 York Avenue,Box 65,New York,New York,10065,USA,215505,2006,
Iobenguane I 131,Azedra Ultratrace,2006-01-18,Treatment of neuroendocrine tumors,Designated,,,N/A,N/A,"Progenics Pharmaceuticals, Inc.",One World Trade Center.,"47th Floor, Suite J",New York,New York,10007,USA,216205,2006,
L-aminocarnityl-succinyl-leucyl-argininal-diethylacetal,n/a,2006-01-18,Treatment of Duchenne and Becker muscular dystrophy,Designated,,,N/A,N/A,CepTor Corporation,200 International Circle,,Hunt Valley,Maryland,21030,USA,214405,2006,
Recombinant human microplasmin,n/a,2006-01-23,Treatment of peripheral arterial occlusion,Designated,,,N/A,N/A,ThromboGenics Ltd,"Unit 14, Bridgecourt Office Park",,Dublin,,,Ireland,215805,2006,
aripiprazole,Abilify,2006-01-25,Treatment of Tourette's syndrome,Designated/Approved,Approved for Orphan Indication,Treatment of pediatric patients with Tourette's,2014-12-12,2021-12-12,Otsuka Pharmaceutical Development,and Commercialization,1st Floor,Princeton,New Jersey,8540,USA,207905,2006,3243
Recombinant anti-CD-40 monoclonal antibody,n/a,2006-01-25,Treatment of multiple myeloma,Designated/Withdrawn,,,N/A,N/A,Novartis Pharmaceutical Corporation,Oncology Business Unit,"One Health Plaza, Bldg 104",East Hanover,New Jersey,7936,USA,214505,2006,
Recombinant human alpha-mannosidase,n/a,2006-02-02,Treatment of alpha-mannosidosis,Designated,,,N/A,N/A,"Chiesi USA, Inc.",1255 Crescent Green,Suite 250,Cary,North Carolina,27518,USA,212005,2006,
"6,8-bis-benzylsulfanyl-octanoic acid",n/a,2006-02-06,Treatment of pancreatic cancer,Designated,,,N/A,N/A,"Cornerstone Pharmaceuticals, Inc.",25 Health Science Drive,,Stony Brook,New York,11790,USA,216505,2006,
blinatumomab,n/a,2006-02-06,"Treatment of indolent B-cell lymphoma, excluding CLL and NHL with CNS involvement",Designated,,,N/A,N/A,"Amgen, Inc.",One Amgen Center Drive,,Thousand Oaks,California,91230,USA,203405,2006,
N-acetyl-glucosamine thiazoline,n/a,2006-02-06,Treatment of adult Tay-Sachs disease,Designated,,,N/A,N/A,ExSAR Corporation,11 Deer Park Drive,,Monmouth Junction,New Jersey,8852,USA,216805,2006,
otelixizumab,n/a,2006-02-06,Treatment of new-onset type I diabetes mellitus,Designated,,,N/A,N/A,GlaxoSmithKline,2301 Renaissance Blvd (RN0420),P. O. Box 61540,King of Prussia,Pennsylvania,19406,USA,216605,2006,
Solasonine and solamargine,Coramsine,2006-02-06,"Treaatment of high risk stage II, stage III and stage IV melanoma",Designated,,,N/A,N/A,Solbec Pharmaceuticals Limited,P. O. Box 2142,"Osbourne Park, Western Australia 6017",,,,Australia,211705,2006,
bevacizumab,Avastin,2006-02-09,Therapeutic treatment of patients with ovarian cancer,Designated/Approved,Approved for Orphan Indication,"In combination with paclitaxel, pegylated liposomal doxorubicin, or topotecan for treatment of patients with platinum-resistant, recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who received no more than 2 prior chemotherapy regimens",2014-11-14,2021-11-14,"Genentech, Inc",1 DNA Way,M/S# 355E,South San Francisco,California,94080,USA,216405,2006,3200
bevacizumab,Avastin,2006-02-09,Therapeutic treatment of patients with ovarian cancer,Designated/Approved,Approved for Orphan Indication,"Either in combination with carboplatin and paclitaxel or in combination with carboplatin and gemcitabine, followed by Avastin as a single agent, is indicated for the treatment of patients with platinum-sensitive recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer.",2016-12-06,2023-12-06,"Genentech, Inc",1 DNA Way,M/S# 355E,South San Francisco,California,94080,USA,216405,2006,3953
rituximab,Rituxan,2006-02-14,"Treatment of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis (Wegener's Granulomatosis, Microscopic Polyangiitis, and Churg-Strauss Syndrome)",Designated/Approved,Approved for Orphan Indication,For the use of Rituxan (rituximab) in combination with glucocorticoids for the treatment of patients with Wegener's Granulomatosis (WG) and Microscopic Polyangiitis (MPA). ),2011-04-19,2018-04-19,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,USA,216305,2006,1890
Nikkomycin Z,n/a,2006-02-14,Treatment of coccidioidomycosis,Designated,,,N/A,N/A,Valley Fever Center for Excellence (1-111 INF),University of Arizona,,Tucson,Arizona,85723,USA,217505,2006,
Clazosentan,Erajet,2006-02-16,Treatment of cerebral vasospasm following subarachnoid hemorrhage,Designated,,,N/A,N/A,Idorsia Pharmaceuticals US Inc.,1820 Chapel Avenue West,Suite 150,Cherry Hill,New Jersey,8002,USA,217105,2006,
Recombinant fully human monoclonal antibody to anthrax protective antigen,Valortim,2006-02-16,Treatment of anthrax infection,Designated,,,N/A,N/A,"PharmAthene, Inc.",One Park Place,Suite 450,Annapolis,Maryland,21401,USA,218005,2006,
liposomal amikacin,Arikace,2006-03-09,Treatment of bronchopulmonary Pseudomonas aeruginosa infections in cystic fibrosis patients,Designated,,,N/A,N/A,"Insmed, Inc.",Princeton Corporate Plaza,"9 Deer Park Drive, Suite C",Monmouth Junction,New Jersey,8852,USA,217305,2006,
omacetaxine mepesuccinate,Synribo,2006-03-10,Treatment of chronic myelogenous leukemia,Designated/Approved,Approved for Orphan Indication,Treatment of adult patients with chronic or accelerated phase chronic myeloid leukemia (CML) with resistance and/or intolerance to two or more tyrosine kinase inhibitors (TKI),2012-10-26,2019-10-26,IVAX International GmbH,Alpenstrasse 2,8640 Rapperswil,Frazer,,,Switzerland,218205,2006,2422
Clotrimazole,n/a,2006-03-13,Treatment of Huntington's disease,Designated,,,N/A,N/A,"EnVivo Pharmaceuticals, Inc.",480 Arsenal Street,,Watertown,Massachusetts,2472,USA,216705,2006,
Ethanol gel,n/a,2006-03-13,Treatment of congenital lymphatic malformations,Designated/Withdrawn,,,N/A,N/A,Orfagen,CRDPF - LANGLADE,31035 Toulouse Cedex,,,,France,212505,2006,
Human umbilical tissue-derived cells,n/a,2006-03-13,Treatment of retinitis pigmentosa,Designated/Withdrawn,,,N/A,N/A,"Janssen Research and Development, LLC",1400 McKean Road,P. O. Box 776,Spring House,Pennsylvania,19477,USA,219006,2006,
Thymalfasin,Zadaxin,2006-03-13,Treatment of stage IIb through Stage IV malignant melanoma,Designated,,,N/A,N/A,"SciClone Pharmaceuticals, Inc.",950 Tower Lane,Suite 900,Foster City,California,94404,USA,218806,2006,
Tissue repair cells obtained from autologous bone marrow expanded ex vivo with a cell production system,n/a,2006-03-13,Treatment of osteonecrosis.,Designated,,,N/A,N/A,"Aastrom Biosciences, Inc.","Domino's Farms, Lobby K",24 Frank Lloyd Wright Drive,Ann Arbor,Michigan,48105,USA,218906,2006,
Lestaurtinib,n/a,2006-03-24,Treatment of acute myeloid leukemia,Designated,,,N/A,N/A,"Teva Branded Pharmaceutical Products R&D, Inc.",41 Moores Road,P. O. Box 4011,Frazer,Pennsylvania,19355,USA,219406,2006,
"N-[4-(4-amino-2-ethyl-lH-imidazo[4,5-c]quinolin-1-yl)butyl]methanesulfonamide",n/a,2006-03-24,Treatment of cutaneous T-cell lymphoma,Designated/Withdrawn,,,N/A,N/A,"Pfizer, Inc.",50 Pequot Avenue,6025-A3106,New London,Connecticut,6320,USA,218105,2006,
(UDU-stereoisomer of c-UJUun UNU-terminal UkUnhibitor),n/a,2006-03-28,Treatment of acute sensorineural hearing loss,Designated,,,N/A,N/A,"Auris Medical, Inc.",444 North Michagan Ave.,Suite 1200,Chicago,Illinois,60611,USA,214905,2006,
Alpha-tocopherol quinone,n/a,2006-03-28,Treatment of inherited mitochondrial respiratory chain diseases,Designated,,,N/A,N/A,Penwest Pharmaceuticals Company,39 Old Ridgebury Road,Suite 11,Danbury,Connecticut,6810,USA,215205,2006,
Artesunate,n/a,2006-03-28,Immediate treatment of malaria,Designated,,,N/A,N/A,US Army Medical Materiel Development Activity,Office of the Surgeon General,622 Neiman Street,Ft. Detrick,Maryland,21702,USA,221206,2006,
Ceftriaxone sodium,Rocephin,2006-03-28,Treatment of amyotrophic lateral sclerosis,Designated,,,N/A,N/A,Mass General Hospital,"Merit E. Cudkowicz, MD, MSc","Building 149 13th Street, Room 2274",Charlestown,Massachusetts,2129,USA,218606,2006,
Minocycline hydrochloride,n/a,2006-03-28,Treatment of sarcoidosis,Designated,,,N/A,N/A,Autoimmunity Research Foundation,3423 Hill Canyon Avenue,,Thousand Oaks,California,91360,USA,213305,2006,
Ethanol gel,n/a,2006-03-29,Treatment of congenital venous malformations,Designated/Withdrawn,,,N/A,N/A,Orfagen,CRDPF - LANGLADE,31035 Toulouse Cedex,,,,France,212205,2006,
Human immune globulin,Flebogamma(R) 5% Dif,2006-03-29,Treatment of post-polio syndrome,Designated,,,N/A,N/A,"Instituto Grifols, S.A.","Can Guasch, 2",08150 Parets del Valles,Barcelona,,,Spain,219706,2006,
Oxalobacter formigenes,n/a,2006-03-29,Treatment of primary hyperoxaluria,Designated,,,N/A,N/A,"OxThera, AB",13709 Progress Blvd. #17,,Stockholm,,,Sweden,219206,2006,
Recombinant P-Selectin glycoprotein ligand,n/a,2006-03-29,Prevention of delayed graft function in renal transplant patients,Designated,,,N/A,N/A,"Y's Therapeutics, Inc.",1111 Bayhill Drive,Suite 405,San Bruno,California,94066,USA,215305,2006,
Liposomal ciprofloxacin for inhalation,n/a,2006-04-19,Management of cystic fibrosis,Designated,,,N/A,N/A,Aradigm Corporation,3929 Point Eden Way,,Hayward,California,94545,USA,216905,2006,
Sorafenib,Nexavar,2006-04-20,Treatment of hepatocellular carcinoma,Designated/Approved,Approved for Orphan Indication,Treatment of unresectable hepatocellular carcinoma,2007-11-16,2014-11-16,Bayer Pharmaceuticals Corporation,400 Morgan Lane,,West Haven,Connecticut,6516,USA,220206,2006,575
4-aminosalicylic acid,Paser Granules,2006-04-26,Treatment of acute flares in pediatric patients with ileo-cecal Crohn's disease,Designated,,,N/A,N/A,"Jacobus Pharmaceutical Co., Inc.",37 Cleveland Lane,,Princeton,New Jersey,8540,USA,220506,2006,
Peptide 144 TGF beta-1-inhibitor,n/a,2006-04-26,Treatment of localized scleroderma,Designated,,,N/A,N/A,"Digna Biotech, S.L.",Avenida Pio XII 22,Pamplona (Navarra),,,,Spain,221006,2006,
Recombinant coagulation factor VIIa,n/a,2006-04-26,Treatment of diffuse alveolar hemorrhage,Designated,,,N/A,N/A,Savara Inc.,900 S. Capital Texas Highway,Suite 150,Austin,Texas,78746,USA,213005,2006,
nilotinib,Tasigna,2006-04-27,Treatment of chronic myelogenous leukemia,Designated/Approved,Approved for Orphan Indication,For the use for chronic phase (CP) and accelerated phase (AP) Philadelphia chromosome positive chronic myelogenous leukemia (CML) in adult patients resistant to or intolerant to prior therapy that included imatinib.,2007-10-29,2014-10-29,Novartis Pharmaceutical Corporation,One Health Plaza,,East Hanover,New Jersey,7936,USA,220806,2006,550
nilotinib,Tasigna,2006-04-27,Treatment of chronic myelogenous leukemia,Designated/Approved,Approved for Orphan Indication,TASIGNA® (nilotinib) is indicated for the treatment of pediatric patients greater than or equal to 1 year of age with newly diagnosed Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase and pediatric patients greater than or equal to 1 year of age with chronic phase Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) with resistance or intolerance to prior tyrosine-kinase inhibitor (TKI) therapy.,2018-03-22,2025-03-22,Novartis Pharmaceutical Corporation,One Health Plaza,,East Hanover,New Jersey,7936,USA,220806,2006,4347
Bio-engineered oral mucosal tissue,n/a,2006-04-27,For use as a graft for restoring a cornea-like epithelial phenotype to substitute for the normal corneal epithelium that is lost in patients due to total limbal stem cell deficiency,Designated,,,N/A,N/A,"TissueTech, Inc.",7000 SW 97th Avenue,,Miami,Florida,33173,USA,219806,2006,
Peptide 144 TGF beta-1 inhibitor,n/a,2006-04-27,Treatment of systemic sclerosis,Designated,,,N/A,N/A,"Digna Biotech, S.L.",Calloe ORENSE No. 85,Edificio Lexington,Madrid,,,Spain,219506,2006,
cenersen,n/a,2006-05-08,Treatment of acute myeloid leukemia,Designated,,,N/A,N/A,"Eleos, Inc.",1001 Twelve Oaks Center Drive,Suite 1002,Wayzata,Minnesota,55391,USA,220906,2006,
Combretastatin A4 phosphate,n/a,2006-05-08,Treatment of ovarian cancer,Designated,,,N/A,N/A,"Mateon Therapeutics, Inc.",701 Gateway Blvd,Suite 210,South San Francisco,California,94080,USA,217805,2006,
midazolam,n/a,2006-05-08,Treatment of bouts of increased seizure activity in selected refractory patients with epilepsy who are on stable regimens of anti-epileptic drugs and who require intermittent use of midazolam,Designated,,,N/A,N/A,"UCB, Inc",1950 Lake Park rive,,Smyrna,Georgia,30080,USA,217405,2006,
Talotrexin,n/a,2006-05-08,Treatment of acute lymphoblastic leukemia,Designated/Withdrawn,,,N/A,N/A,"Hana Biosciences, Inc.",7000 Shoreline Court,Suite 370,South San Francisco,California,94080,USA,221306,2006,
mipomersen,Kynamro,2006-05-23,Treatment of homozygous familial hypercholesterolemia,Designated/Approved,Approved for Orphan Indication,"Adjunct to lipid-lowering medications and diet to reduce low density lipoprotein-cholesterol (LDL-C), apolipoprotein B (apo B), total cholesterol (TC), and non-high density lipoprotein-cholesterol (non-HDL-C) in patients with homozygous familial hypercholesterolemia (HoFH).",2013-01-29,2020-01-29,"Kastle Therapeutics, LLC",181 West Madison Street,Suite 3745,Chicago,Illinois,60602,USA,221406,2006,2443
Apomorphine hydrochloride,n/a,2006-05-23,For the treatment of patients in a vegetative state or minimally conscious state for up to 12 months following a severe traumatic brain injury (traumatic or spontaneous),Designated,,,N/A,N/A,"NeuroHealing Pharmaceuticals, Inc.",50 Undine Road,,Newton,Massachusetts,2135,USA,204305,2006,
Liposomal cisplatin,Lipova-Pt,2006-05-23,Treatment of ovarian cancer,Designated,,,N/A,N/A,Eleison Pharmaceuticals LLC,263 13th Avenue,Suite 375,St. Petersburg,Florida,33701,USA,221906,2006,
Lucinactant,Surfaxin,2006-05-23,Prevention of bronchopulmonary dysplasia in premature infants,Designated,,,N/A,N/A,"Windtree Therapeutics, Inc.",2600 Kelly Road,Suite 100,Warrington,Pennsylvania,18976,USA,211405,2006,
tafamidis,n/a,2006-05-23,Treatment of familial amyloid polyneuropathy,Designated,,,N/A,N/A,"Pfizer, Inc.",P. O. Box 8299,,Philadelphia,Pennsylvania,19101,USA,220606,2006,
bevacizumab,Avastin,2006-05-26,Treatment of malignant glioma,Designated/Approved,Approved for Orphan Indication,Treatment of glioblastoma with progressive disease following prior therapy,2009-05-05,2016-05-05,"Genentech, Inc.","1 DNA Way, MS 241B",,South San Francisco,California,94080,USA,222906,2006,1075
siltuximab,Sylvant,2006-05-26,Treatment of Castleman's disease,Designated/Approved,Approved for Orphan Indication,Treatment of patients with multicentric Castleman's disease (MCD) who are human immunodeficiency virus (HIV) negative and human herpesvirus-8 (HHV-8) negative.,2014-04-23,2021-04-23,"Janssen Biotech, Inc.",920 Route 202 South,PO Box 300,Raritan,New Jersey,8869,USA,200605,2006,2889
bevacizumab,Avastin,2006-05-26,Treatment of malignant glioma,Designated/Approved,Approved for Orphan Indication,Treatment of adult patients with recurrent glioblastoma,2017-12-05,N/A,"Genentech, Inc.","1 DNA Way, MS 241B",,South San Francisco,California,94080,USA,222906,2006,4211
5-hydroxymethyl-2-furfuraldehyde,n/a,2006-05-26,Treatment of sickle cell disease,Designated,,,N/A,N/A,"Baxalta US, Inc.",ONe Baxter Way,,Westlake Village,California,91362,USA,222406,2006,
5-iodo-2-pytimidinone-2'-deoxyribose,n/a,2006-05-26,Treatment of malginant glioma,Designated,,,N/A,N/A,"Hana Biosciences, Inc.",7000 Shoreline Court,Suite 370,South San Francisco,California,94080,USA,222606,2006,
Mycophenolate mofetil,Cellcept,2006-05-26,Treatment of pemphigus vulgaris,Designated/Withdrawn,,,N/A,N/A,"Hoffman-La Roche, Inc.",340 Kingsland Street,,Nutley,New Jersey,7110,USA,223106,2006,
Triheptanoin,Triheptanoim-Sasol Special Oil,2006-05-26,Treatment of fatty acid disorders,Designated,,,N/A,N/A,Baylor Research Institute,Institute of Metabolic Disease,3812 Elm Street,Dallas,Texas,75226,USA,220306,2006,
glycopyrrolate,Cuvposa,2006-06-09,Treatment of pathologic (chronic moderate to severe) drooling in pediatric patients,Designated/Approved,Approved for Orphan Indication,To reduce chronic drooling in patients aged 3 - 16 with neurologic conditions associated with problem drooling (e.g. cerebral palsy),2010-07-28,2017-07-28,"Shionogi, Inc.",300 Campus Drive,,Florham,New Jersey,7932,USA,204105,2006,1510
obiltoxaximab,Anthim,2006-06-09,Treatment of exposure to B. anthracis spores,Designated/Approved,Approved for Orphan Indication,Treatment of adult and pediatric patients with inhalational anthrax due to Bacillus anthracis in combination with appropriate antibacterial drugs and for prophylaxis of inhalational anthrax when alternative therapies are not available or are not appropriate.,2016-03-18,2023-03-18,"Elusys Therapeutics, Inc.",25 Riverside Drive,P.O. Box 102,Pine Brook,New Jersey,7058,USA,224306,2006,3570
Catumaxomab,Removab,2006-06-09,Treatment of ovarian cancer,Designated,,,N/A,N/A,"Neoviibiotech North America, Inc.",920 Winter Street,,Waltham,Massachusetts,2451,USA,223406,2006,
"Polyvalent, shed-antigen melanoma vaccine",n/a,2006-06-09,Treatment of stage IIb to stage IV melanoma,Designated,,,N/A,N/A,Polynoma LLC,11622 El Camino Real #100,,San Diego,California,92130,USA,223206,2006,
Recombinant human C1 inhibitor,n/a,2006-06-09,Prevention and/or treatment of delayed graft function after solid organ transplantation,Designated,,,N/A,N/A,Pharming Group N.V.,P. O. Box 451 Darwinweg 24,2300 Al Leiden,Leiden,,,Netherlands,218306,2006,
Recombinant human C1 inhibitor,n/a,2006-06-09,Treatment of capillary leakage syndrome,Designated,,,N/A,N/A,Pharming Group N.V.,P. O. Box 451 Darwinweg 24,2300 Al Leiden,Leiden,,,Netherlands,218406,2006,
TD-K6a.513a.12,Reveker,2006-06-15,Treatment of pachyonychia congenita,Designated,,,N/A,N/A,"TransDerm, Inc.",2161 Delaware Aenue,,Santa Cruz,California,95060,USA,222806,2006,
2-methoxyestradiol,Panzem,2006-06-16,Treatment of multiforme glioblastoma,Designated/Withdrawn,,,N/A,N/A,"EntreMed, Inc.",4819 Emperor Blvd,Suite 400,Durham,North Carolina,27703,USA,224006,2006,
farletuzumab,n/a,2006-06-16,Treatment of ovarian cancer,Designated,,,N/A,N/A,"Morphotek, Inc.",210 Welsh Pool Road,,Exton,Pennsylvania,19341,USA,204905,2006,
Indium-111 pentetreotide,Neuroendomedix,2006-06-16,Treatment of neuroendocrine tumors,Designated,,,N/A,N/A,RadioIsotope Therapy of America (RITA) Foundation,9701 Richmond Avenue,,Houston,Texas,77042,USA,224706,2006,
Sodium stibogluconate,n/a,2006-06-16,Treatment of cutaneous leishmaniasis,Designated,,,N/A,N/A,"VioQuest Pharmaceuticals, Inc.",180 Mt. Airy Road,Suite 102,Basking Ridge,New Jersey,7920,USA,225906,2006,
"Sodium thiosulfate, sodium nitrite, amyl nitrite",Cyanide Antidote Package,2006-06-16,Treatment of cyanide poisoning,Designated,,,N/A,N/A,"Keystone Pharmaceuticals, Inc.",26072 Merit Circle,,Laguna Hills,California,92653,USA,225606,2006,
vibriolysin,Vibrilase,2006-06-16,"Debridement of severe, deep dermal burns in hospitalized patients",Designated,,,N/A,N/A,BioMarin Pharmaceutical Inc.,105 Digital Drive,,Novato,California,94949,USA,128599,2006,
Heparin sodium,n/a,2006-06-29,Treatment of cystic fibrosis,Designated,,,N/A,N/A,Ockham Biotech Limited,Manor Farm,"Swanwick, Hampshire SO31 7HA",,,,United Kingdom,222106,2006,
pralatrexate,Folotyn,2006-07-20,Treatment of T-cell lymphoma,Designated/Approved,Approved for Orphan Indication,Treatment of patients with relapsed or refractory peripheral T-cell lymphoma,2009-09-25,2016-09-25,"Allos Therapeutics, Inc.","11080 Circle Point Road, Suite 200",,Westminister,Colorado,80020,USA,225306,2006,1163
immune globulin infusion (human),Gammagard Liquid,2006-07-20,Treatment of multifocal motor neuropathy,Designated/Approved,Approved for Orphan Indication,Maintenance therapy to improve muscle strength and disability in adult patients with Multifocal Motor Neuropathy (MMN).,2012-06-22,2019-06-22,"Baxalta US, Inc.",One Baxter Way,,Westlake Village,California,91362,USA,224906,2006,2164
4-cyano-N-[2-(1-cyclohexen-1-yl)-4-[1-[dimethylamino)acetyl]-4-piperidinyl]phenyl]-1H-imidazole-2-carboxamide monohydrochloride,n/a,2006-07-20,Treatment of acute myeloid leukemia,Designated,,,N/A,N/A,"Johnson & Johnson Pharmaceutical Research & Dev,",920 U S Highway 202,P.O. Box 300,Raritan,New Jersey,8869,USA,224206,2006,
Choline chloride,Intrachol,2006-07-20,Prevention and/or treatment of choline deficiency in patients on long-term parenteral nutrition,Designated,,,N/A,N/A,ArTara Therapeutics,302a West 12th Street,Suite 254,New York,New York,10014,USA,225206,2006,
Human telomerase reverse transcriptase peptide vaccine,n/a,2006-07-20,Treatment of pancreatic cancer,Designated,,,N/A,N/A,GemVax A/S,Froyas Gate 1,0273 Oslo,,,,Norway,226306,2006,
Tegafur/gimeracil/oteracil,n/a,2006-07-20,Treatment of gastric cancer,Designated,,,N/A,N/A,"Taiho Oncology, Inc.",101 Carnegie Center,Suite 101,Princeton,New Jersey,8540,USA,225006,2006,
Recombinant human granulocyte colony stimulating factor,n/a,2006-07-24,Prevention of implantation failure and unexplained recurrent miscarriage,Designated/Withdrawn,,,N/A,N/A,"Nora Therapeutics, Inc.",530 Lytton Avenue,2nd Floor,Palo Alto,California,94301,USA,219606,2006,
Trypan blue,Membraneblue,2006-08-02,Selectively staining epiretinal membranes during ophthalmic surgical vitrectomy procedures,Designated/Approved,Approved for Orphan Indication,"For use as an aid in ophthalmic surgery by staining the epiretinal membranes during ophthalmic surgical vitrectomy procedures, facilitating removal of the tissue",2009-02-20,2016-02-20,Dutch Ophthalmic Research Center Int'l BV,Scheijdelveweg 2,P.O. Box 43 3214ZG Zuidland,,,,Netherlands,207505,2006,933
decitabine,Dacogen,2006-08-04,Treatment of acute myeloid leukemia,Designated/Withdrawn,,,N/A,N/A,Otsuka Pharmaceutical Development &,"Commercialization, Inc.",508 Carnegie Center Drive,Princeton,New Jersey,8540,USA,227106,2006,
Procarbazine HCl,Matulane,2006-08-08,Treatment of malignant glioma,Designated,,,N/A,N/A,"Leadiant Biosciences, Inc.",9841 Washingtonian Blvd,Suite 500,Gaithersburg,Maryland,20878,USA,217005,2006,
Somatropin,Norditropin,2006-08-09,Treatment of short stature in patients with Noonan syndrome,Designated/Approved,Approved for Orphan Indication,Treatment of short stature in patients with Noonan syndrome,2007-05-31,2014-05-31,Novo Nordisk Inc.,100 College Road West,,Princeton,New Jersey,8540,USA,226606,2006,295
Bacillus Calmette-Guerin vaccine,n/a,2006-08-09,Treatment of stage IIb through IV metastatic melanoma,Designated,,,N/A,N/A,OncoVac Corporation,P. O. Box 970,,Pacific Palisades,California,90272,USA,223806,2006,
Clindamycin hydrochloride,n/a,2006-08-09,Treatment of sarcoidosis,Designated,,,N/A,N/A,Autoimmunity Research Foundation,3423 Hill Canyon Avenue,,Thousand Oaks,California,91360,USA,213405,2006,
Melanoma autologous dendritic cell vaccine,n/a,2006-09-06,Treatment of stage IIIb through IV metastatic melanoma,Designated,,,N/A,N/A,Caladrius Biosciences,110 Allen Road,2nd Floor,Basking Ridge,New Jersey,7920,USA,222706,2006,
"2-(3-Diethylaminopropyl)-8,8-dipropyl-2-azaspiro[4,5] decane dimaleate",Atiprimod,2006-09-18,Treatment of carcinoid tumors,Designated,,,N/A,N/A,"Callisto Pharmaceuticals, Inc.",420 Lexington Avenue,,New York,New York,10170,USA,227706,2006,
glufosfamide,n/a,2006-09-18,For treatment of pancreatic cancer.,Designated,,,N/A,N/A,Eleison Pharmaceuticals LLC,263 13th Avenue,Suite 375,St. Petersburg,Florida,33701,USA,221606,2006,
Heparin-binding epidermal growth factor-like growth factor,n/a,2006-09-18,"Prevention and treatment of necrotizing enterocolitis (NEC) in preterm infants with birth weight less than 1,500 grams",Designated,,,N/A,N/A,"Trillium Therapeutics, Inc.",96 Skyway Avenue,M9W 4Y4,,,,Canada,221506,2006,
Human monoclonal antibody directed against serotype 011 Pseudomonas aeruginosa,Aerumab 11,2006-09-18,Treatment of hospital acquired pneumonia caused by serotype 011 positive Pseudomonas aeruginosa,Designated,,,N/A,N/A,Kenta Biotech Limited,Rehhagstrsase,,,,,Switzerland,223706,2006,
rSP-C surfactant,Venticute,2006-09-18,"For use in patients with pneumonia or aspiration of gastric contents leading to intubation, mechanical ventilation, and severe oxygen impairment",Designated,,,N/A,N/A,Altana Pharma,220 Park avenue,,Florham Park,New Jersey,7932,USA,224406,2006,
Synthetic human secretin,n/a,2006-09-18,For use in conjunction with diagnostic procedures (excluding ERCP) for pancreatic disorders to increase pancreatic fluid secretion,Designated,,,N/A,N/A,"Innovate Biopharmaceuticals, Inc.",8601 Six Forks Road,Suite 400,Raleigh,North Carolina,27615,USA,219906,2006,
tremelimumab,n/a,2006-09-18,Treatment of stage IIb to stage IV metastatic melanoma,Designated,,,N/A,N/A,MedImmune,One Medimmune Way,,Gaithersburg,Maryland,20878,USA,227306,2006,
Yttrium (90Y) antiferritin polyclonal antibodies,Ferritarg P,2006-09-18,Treatment of Hodgkin's disease.,Designated,,,N/A,N/A,"Alissa Pharma, LLC",341 North Woodland St.,,Englewood,New Jersey,7631,USA,228606,2006,
Cytomegalovirus DNA Vaccine w/Copolymer/Benzalkonium Chloride,n/a,2006-09-23,"For use in prevention of clinically significant CMV viremia, CMV disease and associated complications in at-risk hematopoietic cell transplant and solid organ transplant populations",Designated,,,N/A,N/A,Vical Inc.,10390 Pacific Center Court,,San Diego,California,92121,USA,194504,2006,
Rabbit anti-human thymocyte globulin (rATG),Thymoglobulin,2006-09-26,Induction treatment to prevent rejection and to minimize maintenance immunosupression in pediatric liver transplant recipients,Designated,,,N/A,N/A,Children's Hospital of Pittsburgh,University of Pittsburgh,,Pittsburgh,Pennsylvania,15213,USA,226006,2006,
capsaicin,n/a,2006-09-29,Treatment of intermetatarsal neuroma (Morton's Neuroma) that does not respond to conservative treatment and requires either neurectomy or neurolysis,Designated,,,N/A,N/A,Centrexion Corporation,509 S. Exeter Street,Suite 202,Baltimore,Maryland,21202,USA,222506,2006,
Eflornithine,n/a,2006-09-29,Treatment of anaplastic glioma,Designated,,,N/A,N/A,"Orbus Therapeutics, Inc.",1043 Via Tornasol,,Aptos,California,95003,USA,229306,2006,
Sorafenib,Nexavar,2006-09-29,Treatment of stage IIB through stage IV melanoma,Designated/Withdrawn,,,N/A,N/A,Bayer Pharmaceuticals Corp.,100 Bayer Blvd,P. O. Box 915,Whippany,New Jersey,7981,USA,229206,2006,
talactoferrin alfa,n/a,2006-09-29,Treatment of renal cell carcinoma,Designated/Withdrawn,,,N/A,N/A,"Agennix, Inc.",8 Greenway Plaza,Suite 910,Houston,Texas,77046,USA,182203,2006,
teplizumab,n/a,2006-09-29,Treatment of recent-onset Type I diabetes,Designated,,,N/A,N/A,"MacroGenics, Inc.",9704 Medical Center Drive,,Rockville,Maryland,20850,USA,229606,2006,
Coagulation Factor VIIa (Recombinant),Novoseven,2006-10-03,Treatment of bleeding in patients experiencing intracranial hemorrhage.,Designated/Withdrawn,,,N/A,N/A,"Novo Nordisk, Inc.",P. O. Box 846,,Plainsboro,New Jersey,8536,USA,192404,2006,
Dovitinib,n/a,2006-10-03,Treatment of multiple myeloma,Designated/Withdrawn,,,N/A,N/A,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,USA,210105,2006,
miltefosine,Impavido,2006-10-10,Treatment of leishmaniasis.,Designated/Approved,Approved for Orphan Indication,"Treatment of visceral leishmaniasis due to Leishmania donovani; cutaneous leishmaniasis due to Leishmania braziliensis, Leishmania guyanensis, and Leishmania panamensis; and mucosal leishmaniasis due to Leishmania braziliensis.",2014-03-19,2021-03-19,Knight Therapeutics (USA),Corporation Trust Center,1209 Orange Street,Wilmington,Delaware,19801,USA,229406,2006,2717
4-(2-fluorophenyl)-6-methyl-2-(1-piperzinyl),n/a,2006-10-11,Treatment of Chronic Functional Vomiting to include functional vomiting and cyclic vomiting syndrome.,Designated,,,N/A,N/A,"Dynogen Pharmaceuticals, Inc.",52 Second Avenue,,Waltham,Massachusetts,2451,USA,199704,2006,
"5,12-Naphthacenedione, 10-[[3-amino-2,3,6-trideoxy-4-O-(phenylmethyl)-a-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S,10S)- (9CI)",n/a,2006-10-11,Treatment of malignant gliomas,Designated/Withdrawn,,,N/A,N/A,"Reata Pharmaceuticals, Inc.",1950 N. Stemmons Freeway,,Dallas,Texas,75207,USA,227606,2006,
mepivacaine,n/a,2006-10-18,Treatment of painful HIV-associated neuropathy,Designated,,,N/A,N/A,"Relmada Therapeutics, Inc.",750 3rd Avenue,9th Floor,New York,New York,10017,USA,206705,2006,
adalimumab,Humira,2006-10-19,Treatment of pediatric Crohn's disease.,Designated/Approved,Approved for Orphan Indication,"Reducing signs and symptoms and inducing and maintaining clinical remission in patients 6 years of age and older with moderately to severely active Crohn's disease who have had an inadequate response to corticosteroids or immunomodulators such as azathioprine, 6-mercaptopurine, or methotrexate. (Orphan approval for patients from 6 through 16 years of age.)",2014-09-23,2021-09-23,"AbbVie, Inc.",1 N. Waukegan Road,"Bldg AP30, Dept. PA77",North Chicago,Illinois,60064,USA,230306,2006,2896
cysteamine enteric coated,Procysbi,2006-10-24,Treatment of cystinosis,Designated/Approved,Approved for Orphan Indication,For management of nephropathic cystinosis in adults and children ages 6 years and older,2013-04-30,2020-04-30,"Horizon Pharma USA, Inc.",150 S. Saunders Road,Suite 100,Lake Forest,Illinois,60045,USA,231006,2006,2380
cysteamine enteric coated,Procysbi,2006-10-24,Treatment of cystinosis,Designated/Approved,Approved for Orphan Indication,To expand the indication to pediatric patients 2-6 years of age with nephropathic cystinosis,2015-08-14,2022-08-14,"Horizon Pharma USA, Inc.",150 S. Saunders Road,Suite 100,Lake Forest,Illinois,60045,USA,231006,2006,3216
cysteamine enteric coated,Procysbi,2006-10-24,Treatment of cystinosis,Designated/Approved,Approved for Orphan Indication,To expand the indication to pediatric patients 1 year of age to less than 2 years of age with nephropathic cystinosis,2017-12-22,2024-12-22,"Horizon Pharma USA, Inc.",150 S. Saunders Road,Suite 100,Lake Forest,Illinois,60045,USA,231006,2006,4077
carlumab,n/a,2006-10-24,Treatment of pancreatic cancer,Designated,,,N/A,N/A,"Centocor, Inc.",200 Great Valley PArkway,,Malvern,Pennsylvania,19355,USA,231506,2006,
R-(-)-gossypol,n/a,2006-10-24,Treatment of chronic lymphocytic leukemia.,Designated,,,N/A,N/A,"Ascenta Therapeutics, Inc.",101 Lindenwood Drive,Suite 405,Malvern,Pennsylvania,19355,USA,230206,2006,
Chimeric monoclonal antibody to mesothelin,n/a,2006-10-31,Treatment of pancreatic cancer,Designated/Withdrawn,,,N/A,N/A,"Morphotek, Inc.",210 Welsh Pool Road,,Exton,Pennsylvania,19341,USA,231606,2006,
estradiol Gel,n/a,2006-10-31,Estrogen replacement therapy in females with Turner syndrome,Designated,,,N/A,N/A,"Ascend Therapeutics US, LLC",607 Herndon Parkway,Suite 110,Herndon,Virginia,21070,USA,231706,2006,
idebenone,n/a,2006-10-31,Treatment of Leber's hereditary optic neuropathy.,Designated,,,N/A,N/A,Santhera Pharmaceuticals (Switzerland) Ltd.,25 Hammerstrasse,,Liestal,,,Switzerland,232006,2006,
Obatoclax mesylate,n/a,2006-11-06,Treatment of myelodysplastic syndrome,Designated/Withdrawn,,,N/A,N/A,"Gemin X, Inc.",400 Chesterfield Parkway,Suite 100,Malvern,Pennsylvania,19355,USA,232106,2006,
Varicella Zoster Immune Globulin (Human),Varizig,2006-11-07,"Passive immunization for the treatment of exposed, susceptible individuals who are at risk of complications from varicella",Designated/Approved,Approved for Orphan Indication,Post exposure prophylaxis of varicella in high risk individuals to reduce the severity of varicella,2012-12-20,2019-12-20,"Cangene bioPharma, Inc.",155 Innovation Drive,Winnipeg,Manitoba R3T5Y3,,,Canada,228006,2006,2235
pafuramidine maleate,n/a,2006-11-17,Treatment of pneumocystis jiroveci pneumonia,Designated,,,N/A,N/A,"Immtech Pharmaceuticals, Inc.",150 Fairway Drive,,Vernon Hills,Illinois,60061,USA,220706,2006,
Fenobam hydrochloride,n/a,2006-11-20,Treatment of fragile X syndrome,Designated,,,N/A,N/A,"Neuropharm, Ltd.",87 Church Street,"Crowthorne, Berkshire",,,,United Kingdom,232406,2006,
Iobenguane I 123,Adreview,2006-12-01,For the diagnosis of pheochromocytomas,Designated/Approved,Approved for Orphan Indication,To be used in the detection of primary or metastatic pheochromocytomas or neuroblastomas as an adjunct to other diagnostic tests,2008-09-19,2015-09-19,"GE Healthcare, Inc.",101 Carnegie Center,,Princeton,New Jersey,8540,USA,226506,2006,658
Iobenguane I 123,Adreview,2006-12-01,For the diagnosis of neuroblastomas,Designated/Approved,Approved for Orphan Indication,To be used in the detection of primary or metastatic pheochromocytomas or neuroblastomas as an adjunct to other diagnostic tests,2008-09-19,2015-09-19,"GE Healthcare, Inc.",101 Carnegie Center,,Princeton,New Jersey,8540,USA,226406,2006,658
Obatoclax mesylate,n/a,2006-12-01,Treatment of myelofibrosis,Designated/Withdrawn,,,N/A,N/A,"Gemin X Pharmaceuticals US, Inc.",400 Chesterfield Pkwy.,Suite 100,Malvern,Pennsylvania,19355,USA,233006,2006,
tadalafil,Adcirca,2006-12-18,Treatment of pulmonary arterial hypertension,Designated/Approved,Approved for Orphan Indication,Treatment of pulmonary arterial hypertension (WHO Group I) to improve exercise ability,2009-05-22,2016-05-22,Eli Lilly and Company,Lilly Corporate Center,,Indianapolis,Indiana,46285,USA,228206,2006,886
"Amyl nitrite, sodium nitrite, sodium thiosulfate",Cyanide Antidote Kit,2006-12-18,Treatment of cyanide poisoning,Designated,,,N/A,N/A,"Akorn, Inc.",2500 Millbrook Drive,,Buffalo Grove,Illinois,60089,USA,232506,2006,
risedronate sodium,Actonel,2006-12-18,Treatment of patients with osteogenesis imperfecta.,Designated/Withdrawn,,,N/A,N/A,Warner Chilcott Pharmaceuticals,100 Enterprise Drive,,Roakaway,New Jersey,7866,USA,229106,2006,
salirasib,n/a,2006-12-18,Treatment of pancreatic cancer.,Designated/Withdrawn,,,N/A,N/A,"Kadmon Corporation, LLC",450 East 29th Street,5th Floor,New York,New York,10016,USA,231306,2006,
Sodium thiosulfate and sodium nitrite,n/a,2006-12-18,Treatment of cyanide poisoning,Designated,,,N/A,N/A,"Akorn, Inc.",2500 Millbrook Drive,,Buffalo Grove,Illinois,60089,USA,233306,2006,
tecovirimat,n/a,2006-12-18,post exposure prophylaxis against smallpox,Designated,,,N/A,N/A,"SIGA Technologies, Inc.",4575 SW Research Way,Suite 230,Corvallis,Oregon,97333,USA,233506,2006,
ivacaftor,Kalydeco,2006-12-20,Treatment of patients with cystic fibrosis,Designated/Approved,Approved for Orphan Indication,Treatment of cystic fibrosis (CF) in patients age 6 years and older who have a G551D mutation in the CFTR gene.,2012-01-31,2019-01-31,"Vertex Pharmaceuticals, Inc.",130 Waverly St.,,Cambridge,Massachusetts,2139,USA,228306,2006,1868
budesonide,n/a,2006-12-20,Treatment of patients with eosinophilic esophagitis,Designated,,,N/A,N/A,Shire ViroPharma Incorporated,300 Shire Way,,Lexington,Massachusetts,2421,USA,227406,2006,
Amonafide L-malate,Xanafide,2006-12-20,Treatment of acute myeloid leukemia,Designated/Withdrawn,,,N/A,N/A,"Xanthus Pharmaceuticals, Inc.",An Antisoma Group Company,300 Technology Square,Cambridge,Massachusetts,2139,USA,227506,2006,
"Cyclo {{(E,Z)-(2S,3R,4R)-3-hydroxy-4-methyl-2-(methylamino)nona-6,8-dienoyl}-L-2-aminobytyrl-N-methyl-glycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl-L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl}",n/a,2006-12-20,"Treatment and chronic control of non-infectious posterior, intermediate and pan-uveitis",Designated,,,N/A,N/A,"Lux Biosciences, Inc.",Hoarborside Financial Center,"Plaza 10, 14th Floor",Jersey City,New Jersey,7302,USA,227806,2006,
Human cytomegalovirus immunoglobulin,n/a,2006-12-20,Prevention of congenital cytomegalovirus (CMV) infection following primary CMV infection in pregnant women,Designated,,,N/A,N/A,Biotest Pharmaceuticals Corporation's (BPC),901 Yamato Road,Suite 101,Boca Raton,Florida,33431,USA,232806,2006,
Rose Bengal Disodium,n/a,2006-12-21,Treatment of metastatic melanoma,Designated,,,N/A,N/A,"Provectus Pharmaceuticals, Inc.",7327 Oak Ridge Highway,,Knoxville,Tennessee,37931,USA,233706,2006,
Epstein Barr Virus specific cytotoxic T lymphocytes,n/a,2006-12-27,Prevention and treatment of EBV-post transplant lymphoproliferative disease after hematopoietic stem cell transplant or solid organ transplant.,Designated/Withdrawn,,,N/A,N/A,Center for Cell and Gene Therapy,Feigin Center,Suite 1120,Houston,Texas,77030,USA,223906,2006,
Liposomal ciprofloxacin for inhalation,n/a,2006-12-27,Management of bronchiectasis,Designated,,,N/A,N/A,Aradigm Corporation,3929 Point Eden Way,,Hayward,California,94545,USA,230806,2006,
Liposomal doxorubicin hydrochloride,Sarcodoxome,2006-12-27,Treatment of soft tissue sarcomas,Designated,,,N/A,N/A,GP-Pharm SA,"Pol. Ind. Els Vinyets els Fogars n 2,",Quinti de Mediona,Barcelona,,,Spain,229006,2006,
"N-[3-(4',5'-bipyrimidin-2-ylamino)-4-methylphenyl]-4-{[(3S)-3-(dimethylamino)pyrrolidin-1-yl]methyl}-3-(trifluoromethyl)benzamide",n/a,2006-12-27,Treatment of Philadelphia chromosome-positive chronic myelogenous leukemia.,Designated,,,N/A,N/A,CytRx Corporation,3030 Bunker Hill Street,Suite 101,San Diego,California,92109,USA,233206,2006,
tecovirimat,n/a,2006-12-27,Treatment of smallpox,Designated,,,N/A,N/A,"SIGA Technologies, Inc.",4575 SW Research Way,Suite 230,Corvallis,Oregon,97333,USA,229806,2006,
vinCRIStine sulfate LIPOSOME injection,Marqibo,2007-01-08,Treatment of acute lymphoblastic leukemia,Designated/Approved,Approved for Orphan Indication,Treatment of adult patients with Philadelphia chromosome-negative (Ph-) acute lymphoblastic leukemia (ALL) in second or greater relapse or whose disease has progressed following two or more anti-leukemia therapies.,2012-08-09,2019-08-09,"Talon Therapeutics, Inc.",400 Oyster Point Blvd,Suite 200,South San Francisco,California,94080,USA,234406,2007,2040
Cyclosporine A implant,n/a,2007-01-08,For the prevention of acute rejection in cornea transplant patients,Designated/Withdrawn,,,N/A,N/A,"Lux Biosciences, Inc.",Harborside Financial Center,"Plaza 10, 14th Floor",Jersey City,New Jersey,7302,USA,224106,2007,
defibrotide,n/a,2007-01-08,For the prevention of hepatic veno-occlusive disease.,Designated,,,N/A,N/A,"Jazz Pharmaceuticals, Inc.",3180 Porter Drive,,Palo Alto,California,94304,USA,228406,2007,
dihydroartemisinin and piperaquine,Eurartesim,2007-01-08,"Treatment of uncomplicated malaria caused by ""Plasmodium falciparum,"" Plasmodium vivax,"" Plasmodium malariae,"" or ""Plasmodium ovale.""",Designated,,,N/A,N/A,Alfasigma S.p.A,223 Viale Sarca,,Milano,,,Italy,234006,2007,
mepivacaine,n/a,2007-01-08,Treatment of postherpetic neuralgia,Designated,,,N/A,N/A,"Relmada Therapeutics, Inc.",546 Fifth Avenue,14th Floor,New York,New York,10036,USA,206805,2007,
potassium sodium aluminosilicate,n/a,2007-01-08,For treatment of poisoning by or exposure to cesium.,Designated,,,N/A,N/A,"Castle Creek Pharmaceuticals, LLC",1033 Skokie Blvd,Suite 600,Northbrook,Illinois,60062,USA,232306,2007,
droxidopa,Northera,2007-01-17,"Treatment of neurogenic symptomatic orthostatic hypotension in patients with primary autonomic failure, dopamine-beta-hydroxylase deficiency, and nondiabetic autonomic neuropathy.",Designated/Approved,Approved for Orphan Indication,"Treatment of orthostatic dizziness, lightheadedness, or the ""feeling that you are about to black out"" in adult patients with symptomatic neurogenic orthostatic hypotension caused by primary autonomic failure (Parkinson's disease, multiple system atrophy, and pure autonomic failure), dopamine beta-hydroxylase deficiency, and non-diabetic autonomic neuropathy.",2014-02-18,2021-02-18,Lundbeck LLC,Four Parkway North,,Deerfield,Illinois,60015,USA,229506,2007,2589
lenalidomide,Revlimid,2007-01-17,Treatment of chronic lymphocytic leukemia,Designated,,,N/A,N/A,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,USA,230606,2007,
Sodium nitrite,n/a,2007-01-17,Prevention of vasospasm associated with subarachnoid hemorrhage,Designated,,,N/A,N/A,Hope Pharmaceuticals,16416 N. 92nd Street,,Scottsdale,Arizona,85260,USA,233906,2007,
hydroxyprogesterone caproate,Makena,2007-01-25,Prevention of preterm birth in singleton pregnancies,Designated/Approved,Approved for Orphan Indication,To reduce the risk of preterm birth in women with singleton pregnancy who have a history of singleton spontaneous preterm birth,2011-02-03,2018-02-03,"AMAG Pharma USA, Inc.",1100 Winter Street,,Waltham,Massachusetts,2154,USA,218706,2007,1470
ixmyelocel-T,n/a,2007-01-25,Treatment of dilated cardiomyopathy,Designated,,,N/A,N/A,Vericel Corporation.,"Domino's Farms, Lobby L",24 Frank Lloyd Wright Drive,Ann Arbor,Michigan,48105,USA,232606,2007,
Microvesiculated modified glycosylated tissue factor,n/a,2007-01-25,"Treatment of non-life threatening, mild to severe bleeding episodes due to cutaneous injuries or dental procedures in hemophiliac patients",Designated,,,N/A,N/A,Thrombotargets Corp.,2530 Meridian Parkway,Suite 3023,Durham,North Carolina,27713,USA,234706,2007,
ranprinase,Onconase,2007-01-25,Treatment of malignant mesothelioma,Designated,,,N/A,N/A,Alfacell Corporation,225 Belleville Ave.,,Bloomfield,New Jersey,7003,USA,236206,2007,
recombinant ovine interferon tau,Tauferon,2007-01-25,Treatment of pediatric multiple sclerosis,Designated,,,N/A,N/A,PEPGEN Corporation,1301 Harbor Bay Parkway,,Alameda,California,94502,USA,235306,2007,
Sodium phenylbutyrate,Buphenyl,2007-01-25,Treatment of spinal muscular atrophy,Designated,,,N/A,N/A,"OrphaMed, Inc.",7720 N. Dobson Road,subsidiary of Medicis Pharmaceutical Corp.,Scottsdale,Arizona,85256,USA,235806,2007,
brentuximab vedotin,Adcetris,2007-01-30,Treatment of Hodgkin's lymphoma,Designated/Approved,Approved for Orphan Indication,The treatment of patients with Hodgkin lymphoma after failure of autologous stem cell transplant (ASCT) or after failure of at least two prior multi-agent chemotherapy regimens in patients who are not ASCT candidates,2011-08-19,2018-08-19,"Seattle Genetics, Inc.",21823 30th Drive Southeast,,Bothell,Washington,98021,USA,235606,2007,1662
brentuximab vedotin,Adcetris,2007-01-30,Treatment of Hodgkin's lymphoma,Designated/Approved,Approved for Orphan Indication,Treatment of patients with classical Hodgkin lymphoma at high risk of relapse or progression as post-autologous hematopoietic stem cell transplantation (auto-HSCT).,2015-08-17,2022-08-17,"Seattle Genetics, Inc.",21823 30th Drive Southeast,,Bothell,Washington,98021,USA,235606,2007,3121
brentuximab vedotin,Adcetris,2007-01-30,Treatment of Hodgkin's lymphoma,Designated/Approved,Approved for Orphan Indication,"ADCETRIS® is indicated for the treatment of adult patients with previously untreated Stage III or IV classical Hodgkin lymphoma (cHL), in combination with chemotherapy.",2018-03-20,2025-03-20,"Seattle Genetics, Inc.",21823 30th Drive Southeast,,Bothell,Washington,98021,USA,235606,2007,4067
cytarabine liposome,Depocyt,2007-01-30,Treatment of gliomas,Designated,,,N/A,N/A,"Bruce Frankel, MD",Medical University of South Carolina,"96 Jonathan Lucas Street, Suite 428 CSB",Charleston,South Carolina,29425,USA,234806,2007,
lintuzumab,n/a,2007-01-30,Treatment of acute myeloid leukemia.,Designated/Withdrawn,,,N/A,N/A,"Seattle Genetics, Inc.",21823 30th Drive Southeast,,Bothell,Washington,98021,USA,235106,2007,
fenretinide,n/a,2007-02-01,Treatment of Ewing's sarcoma family of tumors.,Designated,,,N/A,N/A,Cancer Research UK,61 Lincoln's Inn Fields,London WC2A 3PX,,,,United Kingdom,236106,2007,
Fibrin-based agent containing a N-terminally modified parathyroid hormone fragment TGplPTH1-34,n/a,2007-02-01,Treatment of solitary (unicameral) bone cysts,Designated,,,N/A,N/A,Kuros Biosurgery AG,Technoparkstrasse 1,,Zurich,,,Switzerland,217905,2007,
maribavir,n/a,2007-02-01,Prevention of cytomegalovirus viremia and disease in the populations at risk.,Designated,,,N/A,N/A,"Shire ViroPharma, Inc.",300 Shire Way,,Lexington,Massachusetts,2421,USA,229906,2007,
Recombinant human platelet derived growth factor BB,n/a,2007-02-01,Treatment of osteonecrosis of the jaws,Designated,,,N/A,N/A,"Luitpold Pharmaceuticals, Inc.",800 Adams Avenue,Suite 100,Norristown,Pennsylvania,19403,USA,233106,2007,
chenodeoxycholic acid,n/a,2007-02-12,Treatment of cerebrotendinous xanthomatosis,Designated,,,N/A,N/A,"Leadiant Biosciences, Inc.",9841 Washingtonian Boulevard,Suite 500,Gaithersburg,Maryland,20878,USA,235406,2007,
idebenone,n/a,2007-02-16,Treatment of Duchenne muscular dystrophy,Designated,,,N/A,N/A,Santhera Pharmaceuticals (Switzerland) Ltd.,25 Hammerstrasse,,Liestal,,,Switzerland,231906,2007,
cethromycin,n/a,2007-02-28,Prophylactic treatment of patients exposed to inhalation anthrax.,Designated,,,N/A,N/A,"Advanced LIfe Sciences, Inc.",1440 Davey Road,,Woodridge,Illinois,60517,USA,235906,2007,
Adeno-associated viral vector expressing human acid alpha glucosidase gene,n/a,2007-03-20,Treatment of Pompe disease,Designated,,,N/A,N/A,"Audentes Therapeutics, Inc.","101 Montgomery St., #2650",,San Francisco,California,94104,USA,237107,2007,
aminolevulinic acid hydrochloride,Levulan,2007-03-20,Treatment of esophageal dysplasia,Designated,,,N/A,N/A,"DUSA Pharmaceuticals, Inc.",25 Upton Place,,Wilmington,Massachusetts,1887,USA,236807,2007,
Cisplatin in liposomal formulation,Slit Cisplatin For Inhalation,2007-03-20,Treatment of osteosarcoma,Designated,,,N/A,N/A,Eleison Pharmaceuticals LLC,263 13th Avenue,Suite 375,St. Petersburg,Florida,33701,USA,238607,2007,
lintuzumab,n/a,2007-03-20,Treatment of myelodysplastic syndrome,Designated/Withdrawn,,,N/A,N/A,"Seattle Genetics, Inc.",21823 30th Drive Southeast,,Bothell,Washington,98021,USA,238007,2007,
nilotinib,Tasigna,2007-03-20,Treatment of gastrointestinal stromal tumors.,Designated/Withdrawn,,,N/A,N/A,Novartis Pharmaeuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,USA,237307,2007,
Rapamycin,n/a,2007-03-20,Treatment of tuberous sclerosis complex,Designated,,,N/A,N/A,"OncoImmune, Inc.",333 Parkland Plaza,Suite 1000,Ann Arbor,Michigan,48103,USA,237007,2007,
Sodium phenylbutyrate,n/a,2007-03-20,Treatment of spinal muscular atrophy,Designated,,,N/A,N/A,"Tikvah Therapeutics, Inc.","75 5th Street, NW.",,Atlanta,Georgia,30308,USA,236907,2007,
ganciclovir,Zirgan,2007-03-22,Treatment of acute herpetic keratitis (dendritic and geographic ulcers),Designated/Approved,Approved for Orphan Indication,Treatment of acute herpetic keratitis (dendritic ulcers),2009-09-15,2016-09-15,"Sirion Therapeutics, Inc.",9314 East Broadway Avenue,,Tampa,Florida,33619,USA,237607,2007,908
Sodium nitrite/sodium thiosulfate,Cyanide Antidote Package,2007-03-23,Treatment of cyanide poisoning,Designated,,,N/A,N/A,"Keystone Pharmaceuticals, Inc.",26072 Merit Circle,,Laguna Hills,California,92653,USA,239207,2007,
Thiotepa,Tepadina,2007-04-02,Conditioning treatment prior to hematopoietic stem cell transplantation,Designated/Approved,Approved for Orphan Indication,Indicated for reducing the risk of graft rejection when used in conjunction with high-dose busulfan and cyclophosphamide as a preparative regimen for allogenic hematopoietic progenitor cell transplantation for pediatric patients with class 3 beta-thalassemia,2017-01-26,2024-01-26,ADIENNE S.A.,"Via Zurigo, 46",6900 Lugano,,,,Switzerland,237807,2007,3587
Sodium nitrite,n/a,2007-04-02,Treatment of vaso-occlusive crisis associated with sickle cell disease,Designated,,,N/A,N/A,Hope Pharmaceuticals,16416 N. 92nd Street,,Scottsdale,Arizona,85260,USA,238707,2007,
Alvocidib,n/a,2007-04-13,Teatment of B-cell chronic lymphocytic leukemia (B-CLL) or prolymphocytic leukemia arising from CLL.,Designated,,,N/A,N/A,"Tolero Pharmaceuticals, Inc.",2975 West Executive Parkway,Suite 320,Lehi,Utah,84043,USA,239607,2007,
Human plasma coagulation Factor VIII and human plasma von Willebrand Factor,Wilate,2007-04-18,Treatment of von Willebrand disease except for surgical and/or invasive procedures in patients with von Willebrand disease in whom desmopressin is either ineffective or contraindicated,Designated/Approved,Approved for Orphan Indication,Treatment of spontaneous or trauma-induced bleeding episodes in patients with severe von Willebrand disease (VWD) as well as patients with mild or moderate VWD in whom the use of desmopressin is known or suspected to be ineffective or contraindicated,2009-12-04,N/A,"Octapharma USA, Inc.",121 River Street,12th Floor,Hoboken,New Jersey,7030,USA,234106,2007,961
Sodium nitrite,n/a,2007-04-18,Treatment of cyanide poisoning,Designated,,,N/A,N/A,Hope Pharmaceuticals,16416 N. 92nd Street,,Scottsdale,Arizona,85260,USA,233806,2007,
Attenuated autologous cancer cells and granulocyte macrophage colony stimulating factor in combination with activated autologous blood derived T-cells,n/a,2007-04-27,Treatment of primary central nervous system malignancies,Designated,,,N/A,N/A,"TVAX Biomedical, LLC",8006 Reeder Street,,Lenexa,Kansas,66214,USA,239307,2007,
Cyclosporine A,n/a,2007-05-04,Treatment of vernal keratoconjunctivitis,Designated,,,N/A,N/A,Santen SAS,Batiment Genavenir IV,F-91058-Evry cedex,,,,France,239907,2007,
leukocyte interleukin,Multikine,2007-05-04,Neoadjuvant therapy in patients with squamous cell carcinoma of the head and neck,Designated,,,N/A,N/A,CEL-SCI Corporation,8229 Boone Blvd.,Suite 802,Vienna,Virginia,22182,USA,221706,2007,
N-Methyl-2-[3-[((E)-2-pyridin-2-yl-vinyl)-1H-indazol-6-ylsulfanyl]benzamide,Axitinib,2007-05-04,"Treatment of follicular, medullary and anaplastic thyroid carcinoma and metastatic or locally advanced papillary thyroid cancer.",Designated/Withdrawn,,,N/A,N/A,"Pfizer, Inc.",10646 Science Center Drive,,San Diego,California,92121,USA,230706,2007,
macimorelin acetate,Macrelin,2007-05-14,Diagnosis of growth hormone deficiency,Designated/Approved,Approved for Orphan Indication,For the diagnosis of adult growth hormone deficiency,2017-12-20,TBD,Strongbridge Ireland Ltd,10 Earlsfort Terrace,,Dublin,,,Ireland,225506,2007,3873
Pafuramidine maleate,n/a,2007-05-14,Treatment of malaria,Designated,,,N/A,N/A,"Immtech Pharmaceuticsl, Inc.",150 Fairway Drive,,Vernon Hills,Illinois,60061,USA,241207,2007,
Plevitrexed,Plevitrexed,2007-05-14,Treatment of ovarian cancer,Designated/Withdrawn,,,N/A,N/A,BTG International Ltd,10 Fleet Place,London EC4M 7SB,,,,United Kingdom,240307,2007,
Adeno-associated vector expressing the human lipoprotein lipase protein,n/a,2007-05-21,Treatment of lipoprotein lipase deficiency,Designated/Withdrawn,,,N/A,N/A,uniQure B.V.,Meibergdreef 61,1100 DA,Amsterdam,,,Netherlands,240007,2007,
adeno-associated viral vector expressing human retinoschisin-1 gene,n/a,2007-05-21,Treatment of X-linked juvenile retinoschisis (XLRS).,Designated,,,N/A,N/A,Applied Genetic Technologies Corporation,11801 Research Drive,,Alachua,Florida,32615,USA,238907,2007,
valine-valine-ganciclovir,n/a,2007-05-21,Treatment of primary keratoconjunctivitis and recurrent epithelial keratitis due to HSV1 and HSV2.,Designated,,,N/A,N/A,"Verenta Pharmaceuticals, Inc.",10901 Granada Lane,Suite 101,Leawood,Kansas,66211,USA,239007,2007,
N-[4-(3-amino1H-indazol-4-yl)phenyl]-N1-(2-fluoro-5-methylphenyl)urea,n/a,2007-05-23,Treatment of hepatocellular carcinoma,Designated/Withdrawn,,,N/A,N/A,"AbbVie, Inc.",1 N Waukegan Road,AP34/RA72,North Chicago,Illinois,60064,USA,240807,2007,
Plevitrexed,Plevitrexed,2007-05-29,Treatment of gastric (stomach cancer,Designated/Withdrawn,,,N/A,N/A,BTG International Ltd,10 Fleet Place,London EC4M 7SB,,,,United Kingdom,240207,2007,
axitinib,n/a,2007-05-31,Treatment of pancreatic cancer,Designated/Withdrawn,,,N/A,N/A,"Pfizer, Inc.",10646 Science Center Drive,,San Diego,California,92121,USA,240607,2007,
Autologous cultured endothelial cells on a donor human corneal disk,n/a,2007-06-01,"Treatment of Fuch's dystrophy, pseudophakic bullous keratopathy, and bullous keratopathy",Designated,,,N/A,N/A,"Cellular Bioengineering, Inc.",1946 Young Street,,Honolulu,Hawaii,96826,USA,235206,2007,
5(S)-(2'-hydroxy ethoxy)-20(S)-Camptothecin,n/a,2007-06-15,Treatment of osteosarcoma (bone cancer),Designated,,,N/A,N/A,"Dr. Reddy's Laboratories, Inc.",200 Somerset Corporate Blvd,"Building II, 7th Floor",Bridgewater,New Jersey,8807,USA,242107,2007,
cetuximab,Erbitux,2007-06-15,Treatment of pancreatic cancer,Designated/Withdrawn,,,N/A,N/A,ImClone Systems Incorporated,33 ImClone Drive,,Branchburg,New Jersey,8876,USA,237907,2007,
mibefradil,n/a,2007-06-15,Treatment of ovarian cancer,Designated,,,N/A,N/A,"Cavion, LLC",600 E. Water Street,,Charlottesville,Virginia,22902,USA,224806,2007,
"5,7-dihydroxy-3-(4-hydroxyphenyl)-chromen-4-one",n/a,2007-06-18,Prevention of acute radiation syndrome,Designated,,,N/A,N/A,Humanetics Corporation,1550 Utica Avenue South,Suite 770,Eden Prairie,Minnesota,55416,USA,241107,2007,
duvoglustat hydrochloride,n/a,2007-06-18,Treatment of Pompe disease,Designated,,,N/A,N/A,"Amicus Therapeutics, Inc",1 Cedarbrook Drive,,Cranbury,New Jersey,8512,USA,238507,2007,
mifepristone,Korlym,2007-07-05,Treatment of the clinical manifestations of endogenous Cushing's syndrone,Designated/Approved,Approved for Orphan Indication,for the control of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for surgery.,2012-02-17,2019-02-17,"Corcept Therapeutics, Inc.",149 Commonwealth Drive,,Menlo Park,California,94025,USA,239507,2007,1688
"(3S)-3-(4-trifluoromethoxybenzyloxy)-6-nitro-2H-3,4-dihydroimidazo[2,1-b]oxazine",n/a,2007-07-05,Treatment of tuberculosis,Designated,,,N/A,N/A,Global Alliance for TB Drug Development,40 Wall Street,24th Floor,New York,New York,10005,USA,243107,2007,
Cordycepin,n/a,2007-07-05,Treatment of TdT-positive acute lymphocytic leukemia,Designated,,,N/A,N/A,"OncoVista, Inc.",14785 Omicron Drive,,San Antonio,Texas,78245,USA,242507,2007,
iobenguane I 131,n/a,2007-07-05,Treatment of neuroendocrine tumors,Designated,,,N/A,N/A,"Jubilant DraxImage, Inc.","Div. of Draxis Specialty Pharmaceuticals, Inc.","Kirkland, Quebec H9H 4J4",,,,Canada,241907,2007,
"(R)-2-methyl-6-nitro-2-{4-[4-(4-trifluoromethoxyphenoxy)piperidin-1-yl]phenoxymethyl}-2,3-dihydroimidazo[2,1-b]oxazole",n/a,2007-07-12,Treatment of pulmonary tuberculosis.,Designated,,,N/A,N/A,"Otsuka Pharmaceutical Company, Ltd",2440 Research Blvd,,Rockville,Maryland,20850,USA,244007,2007,
Intravenous immune globulin,Vitigam,2007-07-26,Treatment of Stage IIB to IV malignant melanoma,Designated,,,N/A,N/A,GammaCan Ltd.,39 Jerusalem Street,,,,,Israel,243307,2007,
Recombinant P-selectin glycoprotein ligand-immunoglobulin Ig,n/a,2007-07-26,Prevention of ischemia reperfusion injury in all solid organ transplants,Designated,,,N/A,N/A,"Y's Therapeutics, Inc.",1539 Granger Way,,Redwood City,California,94061,USA,243407,2007,
Sodium ascorbate and menadione sodium bisulfite,Apatone,2007-07-31,Treatment of metastatic or locally advanced inoperable transitional cell carcinoma of the urothelium (stage III and IV bladder cancer),Designated,,,N/A,N/A,IC-MedTech Corporation,9902 Indian Creek Lane,,San Diego,California,92021,USA,236606,2007,
N-(2-amino-phenyl)-4-[(4-pyridin-3-yl-pyrimidin-2-ylamino)-methyl] benzamide dihydrobromide,n/a,2007-08-08,Treatment of Hodgkin's lymphoma,Designated,,,N/A,N/A,"Mirati Therapeutics, Inc.",9363 Towne Centre Drive,Suite 200,San Diego,California,92121,USA,244307,2007,
Talactoferrin alfa,n/a,2007-08-08,Treatment of stage III/IV non-small cell lung cancer,Designated/Withdrawn,,,N/A,N/A,"Agennix, Inc.",8 Greenway Plaza,Suite 910,Houston,Texas,77046,USA,236707,2007,
Betulinic acid,n/a,2007-08-09,Topical treatment of metastatic melanoma,Designated,,,N/A,N/A,"Advanced Life Sciences, Inc. (ALS)",1440 Davey Road,,Woodridge,Illinois,60517,USA,244107,2007,
Bendamustine hydrochloride,Treanda,2007-08-17,Treatment of chronic lymphocytic leukemia,Designated/Approved,Approved for Orphan Indication,Treatment of patients with chronic lymphocytic leukemia,2008-03-20,2015-03-20,"Cephalon, Inc.",41 Moores Road,,Frazer,Pennsylvania,19355,USA,244807,2007,216
"4-Amino-1-[5-O-[(2R, 4S)-2-oxido-4-(4-pyridinyl)-1, 3, 2-dioxaphosphorinan-2-yl]-b-D-arabinofuranosyl]-2(1H)-pyrimidinone",n/a,2007-08-22,Treatment of hepatocellular carcinoma.,Designated,,,N/A,N/A,"Ligand Pharmaceuticals, Inc.",11085 N. Torrey Pines Road,Suite 300,LaJolla,California,92037,USA,228106,2007,
artemether/lumefantrine,Coartem,2007-08-31,For the treatment of infections due to Plasmodium falciparum or mixed infections including P. falciparum.,Designated/Approved,Approved for Orphan Indication,"Treatment of malaria in patients of 5 kg bodyweight or above with acute, uncomplicated malaria due to Plasmodium falciparum or mixed infections including P. falciparum",2009-04-07,2016-04-07,Novartis Pharmaceuticals,Bldg 405/4051,One Health Plaza,East Hanover,New Jersey,7936,USA,245507,2007,585
parathyroid hormone,Natpara,2007-08-31,Treatment of hypoparathyroidism,Designated/Approved,Approved for Orphan Indication,An adjunct to calcium and vitamin D to control hypocalcemia in patients with hypoparathyroidism,2015-01-23,2022-01-23,"Shire-NPS Pharmaceuticals, Inc.",300 Shire Way,,Lexington,Massachusetts,2421,USA,246707,2007,2702
ascorbic acid,Ascor,2007-08-31,Treatment of scurvy,Designated/Approved,Approved for Orphan Indication,"for the treatment of scurvy in adult and pediatric patients age 5 months and older for whom oral administrtaion is not possible, insufficient or contraindicated",2017-10-02,2024-10-02,McGuff Pharmaceuticals Inc.,2921 W. MacArthur Blvd.,Suite 141,Santa Ana,California,92704,USA,243707,2007,3685
Pafuramidine maleate,n/a,2007-08-31,Treatment of human African trypanosomiasis (sleeping sickness),Designated,,,N/A,N/A,"Immtech Pharmaceuticals, Inc.",150 Fairway Drive,,Vernon Hills,Illinois,60061,USA,244507,2007,
retaspimycin,n/a,2007-08-31,Treatment for gastrointestinal stromal tumor,Designated/Withdrawn,,,N/A,N/A,"Infinity Pharmaceuticals, Inc.",780 Memorial Drive,,Cambridge,Massachusetts,2139,USA,242907,2007,
colchicine,Colcrys,2007-09-25,Treatment of familial Mediterranean fever,Designated/Approved,Approved for Orphan Indication,Treatment of familial Mediterranean fever,2009-07-29,2016-07-29,"AR Holding Company, Inc.",1100 Orthodox Street,,Philadelphia,Pennsylvania,19124,USA,245807,2007,673
Colchicine,n/a,2007-09-25,Treatment of Behcet's Syndrome,Designated,,,N/A,N/A,"AR Scientific, Inc.",1100 Orthodox Street,,Philadelphia,Pennsylvania,19124,USA,245707,2007,
Panobinostat,Faridak,2007-09-26,Treatment of cutaneous T-cell lymphoma,Designated/Withdrawn,,,N/A,N/A,Novartis Pharmaceuticals Corporation,"One Health Plaza, 105/3W038",,East Hanover,New Jersey,7936,USA,244407,2007,
Recombinant human fibrinogen,n/a,2007-10-04,Treatment of bleeding in patients deficient in fibrinogen,Designated,,,N/A,N/A,Pharming Technologies B.V.,Archimedesweg 4,,,,,Netherlands,230906,2007,
dexpramipexole,n/a,2007-10-11,Treatment of amyotrophic lateral sclerosis,Designated,,,N/A,N/A,Knopp Biosciences LLC,2100 Wharton Street,Suite 615,Pittsburgh,Pennsylvania,15203,USA,247107,2007,
Interferon gamma,n/a,2007-10-11,Treatment of idiopathic pulmonary fibrosis,Designated,,,N/A,N/A,mondoBIOTECH Laboratories AG,"Herrengasse 21, 9490 Vaduz",Liechtenstein,,,,Germany,246107,2007,
Microvesiculated modified glycosylated tissue factor,n/a,2007-10-11,"Treatment of non-life threatening, mild to severe bleeding episodes due to cutaneous injuries or dental procedures in patients with von Willebrand disease.",Designated,,,N/A,N/A,Thrombotargets Corp.,2530 Meridian Parkway,,Durham,North Carolina,27713,USA,246407,2007,
Tamibarotene,n/a,2007-10-11,Treatment of acute promyelocytic leukemia (APL).,Designated,,,N/A,N/A,CytRx Corporation,3030 Bunker Hill Road,Suite 101,San Diego,California,92109,USA,247007,2007,
N-adamantanyl-N'-Geranyl-ethylenediamine,n/a,2007-10-16,Treatment of tuberculosis.,Designated,,,N/A,N/A,"Sequella, Inc.",9610 Medical Center Drive,,Rockville,Maryland,20850,USA,247307,2007,
lomitapide,Juxtapid,2007-10-23,Treatment of homozygous familial hypercholesterolemia,Designated/Approved,Approved for Orphan Indication,"Adjunct to a low-fat diet and other lipid-lowering treatments, including LDL apheresis where available, to reduce low-density lipoprotein cholesterol (LDL-C), total cholesterol (TC), apolipoprotein B (apo B), and non-high-density lipoprotein cholesterol (non-HDL-C) in patients with homozygous familial hypercholesterolemia (HoFH).",2012-12-21,2019-12-21,"Aegerion Pharmaceuticals, Inc.","101 Main St., Suite 1850",,Cambridge,Massachusetts,2142,USA,245907,2007,1886
eteplirsen,Exondys 51,2007-10-23,Treatment of Duchenne Muscular Dystrophy.,Designated/Approved,Approved for Orphan Indication,Treatment of Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 51 skipping,2016-09-19,2023-09-19,"Sarepta Therapeutics, Inc.",215 First Street,Suite 415,Cambridge,Massachusetts,2142,USA,248407,2007,3254
"4,5 dibromorhodamine methyl ester",Theralux Photodynamic Therapy,2007-10-23,For immune reconstitution and prevention of graft versus host disease following allogeneic hematopoietic stem cell transplantation.,Designated,,,N/A,N/A,Kiadis Pharma Netherlands B.V.,Entrada 231 - 234,,,,,Netherlands,246307,2007,
N-[4-(3-amino-1H-indazol-4-yl)phenyl]-N1-(2-fluoro-5-methylphenyl) urea,n/a,2007-10-23,Treatment of acute myelogenous leukemia,Designated/Withdrawn,,,N/A,N/A,"AbbVie, Inc.",1 N Waukegan Road,AP34/RA72,North Chicago,Illinois,60064,USA,248007,2007,
ursodiol,Ursofalk Suspension,2007-10-23,Treatment of cystic fibrosis liver disease,Designated,,,N/A,N/A,"Asklepion Pharmaceuticals, LLC",5200 Maryland Way,,Brentwood,Tennessee,37027,USA,242607,2007,
romiplostim,n/a,2007-10-31,Treatment of thrombocytopenia associated with myelodysplasia syndrome,Designated,,,N/A,N/A,Amgen Inc.,One Amgen Center Drive,Mail Stop 17-2-B,Thousand Oaks,California,91320,USA,234506,2007,
Human factor X,Coagadex,2007-11-08,Treatment of hereditary factor X deficiency,Designated/Approved,Approved for Orphan Indication,Treatment of patients with hereditary Factor X Deficiency,2015-10-20,2022-10-20,Bio Products Laboratory,Dagger Lane,"Hertfordshire, WD6 3BX",,,,United Kingdom,246907,2007,2903
Betahistine dihydrochloride,n/a,2007-11-08,Treatment of obesity associated with Prader Willi syndrome,Designated,,,N/A,N/A,"Floyd R. Sallee, M.D., Ph.D.",University of Cincinnati School of Medicine,ML 0559,Cincinnati,Ohio,45267,USA,247407,2007,
carlumab,n/a,2007-11-08,Treatment of idiopathic pulmonary fibrosis,Designated/Withdrawn,,,N/A,N/A,"Janssen Biotech, Inc.",Welsh & McKean Roads,P.O. Box 776,Spring House,Pennsylvania,19477,USA,250007,2007,
human coagulation factor XI,Hemoleven,2007-11-08,Treatment of severe congential Factor XI deficiency.,Designated/Withdrawn,,,N/A,N/A,Laboratoire francais du Fractionnement et des Biot,3 Avenue des Tropiques,91985 Courtaboeuf Cedex,,,,France,229706,2007,
Metronidazole 10% ointment,n/a,2007-11-08,Topical treatment of active perianal Crohn's disease,Designated,,,N/A,N/A,SLA Pharma (UK) Ltd,Elite House,Hill Farm Industrial Estate,Watford WD25 7SA,,,United Kingdom,247907,2007,
phosphorothioate oligonucleotide,n/a,2007-11-09,Treatment of amyotrophic lateral sclerosis,Designated/Withdrawn,,,N/A,N/A,"Ionis Pharmaceuticals, Inc.",2855 Gazelle Court,,Carlsbad,California,92010,USA,226706,2007,
glatiramer acetate,Copaxone,2007-11-14,Treatment of amyotrophic lateral sclerosis (ALS).,Designated,,,N/A,N/A,"Teva Neurosciences, Inc.",P. O. Box 1005,,Horsham,Pennsylvania,19044,USA,247507,2007,
Brivudin,n/a,2007-11-15,Adjunct treatment of pancreatic cancer,Designated/Withdrawn,,,N/A,N/A,"SciClone Pharmaceuticals, Inc.",901 Mariner's Island Blvd.,,San Mateo,California,94404,USA,247807,2007,
moxetumomab pasudotox,n/a,2007-11-15,Treatment of hairy cell leukemia,Designated,,,N/A,N/A,MedImmune/AstraZeneca,One MedImmune Way,,Gaithersburg,Maryland,20878,USA,248707,2007,
moxetumomab pasudotox,n/a,2007-11-15,Treatment of CD22-positive chronic lymphocytic leukemia,Designated,,,N/A,N/A,MedImmune/AstraZeneca,One MedImmune Way,,Gaithersburg,Maryland,20878,USA,248807,2007,
rindopepimut,n/a,2007-11-19,Treatment of EGFRvIII-expressing glioblastoma multiforme,Designated,,,N/A,N/A,"Celldex Therapeutics, Inc.",119 Fourth Avenue,,Needham,Massachusetts,2494,USA,249207,2007,
varespladib sodium,n/a,2007-11-19,Prevention of acute chest syndrome in at-risk patients with sickle cell disease,Designated/Withdrawn,,,N/A,N/A,"Anthera Pharmaceuticals, Inc.",25801 Industrial Blvd.,Suite B,Hayward,California,94545,USA,240107,2007,
mecasermin,Iplex,2007-12-03,Treatment of myotonic dystrophy,Designated,,,N/A,N/A,"Insmed, Inc.",10 Finderne Avenue,Building 10,Bridgewater,New Jersey,8817,USA,249707,2007,
recombinant human antithrombin,Atryn,2007-12-07,"Treatment of congenital antithrombin deficiency to prevent the occurrence of serious, potentially life-threatening venous thromboembolisms which may develop as a result of surgical or obstetrical procedures",Designated/Approved,Approved for Orphan Indication,"Prevention of peri-operative and peri-partum thromboembolic events, in hereditary antithrombin deficient patients.",2009-02-06,2016-02-06,"GTC Biotherapeutics, Inc.",175 Crossing Blvd,,Framingham,Massachusetts,1702,USA,246807,2007,427
Fludarabine phosphate oral tablets,n/a,2007-12-18,Treatment of B-cell chronic lymphocytic leukemia,Designated/Approved,Approved for Orphan Indication,Treatment of adult patients with B-cell chronic lymphocytic leukemia (CLL) whose disease has not responded to or has progressed during or after treatment with at least one standard alkylating-agent containing regimen,2008-12-18,2015-12-18,"Sanofi-Aventis U.S., Inc.",55 Corproate Drive,P. O. Box 5925,Bridgewater,New Jersey,8807,USA,250607,2007,366
canakinumab,Ilaris,2007-12-18,Treatment of cryopyrin-associated periodic syndromes,Designated/Approved,Approved for Orphan Indication,"Treatment of cryopyrin-associated periodic syndromes (CAPS), in adults and children 4 years of age and older.",2009-06-17,2016-06-17,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,USA,250507,2007,547
clobazam,Onfi,2007-12-18,Treatment of Lennox-Gastaut Syndrome,Designated/Approved,Approved for Orphan Indication,Adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome inpatients 2 years of age or older,2011-10-21,2018-10-21,"Lundbeck, Inc.",Four Parkway North,,Deerfield,Illinois,60015,USA,248307,2007,1403
2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimadazole-4-carboxamide,n/a,2007-12-18,Treatment of malignant melanoma stages IIb through IV.,Designated,,,N/A,N/A,"AbbVie, Inc.",1 N. Waukegan Road,,North Chicago,Illinois,60064,USA,246607,2007,
"beclomethasone 17,21-diproprionate",n/a,2007-12-18,Treatment of pediatric patients with Crohn disease.,Designated,,,N/A,N/A,"Soligenix, Inc.",29 Emmons Drive,Suite C-10,Princeton,New Jersey,8540,USA,144201,2007,
Chlorotoxin,n/a,2007-12-18,Treatment of malignant glioma,Designated,,,N/A,N/A,"Morphotek, Inc.",210 Welsh Pool Road,,Exon,Pennsylvania,19341,USA,250407,2007,
Elesclomol,n/a,2007-12-18,Treatment of metastatic melanoma in combination with paclitaxel,Designated,,,N/A,N/A,Synta Pharmaceuticals Corporation,45 Hartwell Ave.,,Lexington,Massachusetts,2421,USA,243607,2007,
Hemoximer (pyridoxalated hemoglobin polyoxyethylene),n/a,2007-12-18,Treatment of cardiogenic shock,Designated,,,N/A,N/A,"Apex Bioscience, Inc.",109 Conner Drive,`,Chapel Hill,North Carolina,27514,USA,249807,2007,
coccidioidin SD Skin Test Antigen,n/a,2007-12-19,For the diagnosis of Coccidioidomycosis,Designated/Approved,Approved for Orphan Indication,"For the detection of delayed type hypersensitivity to C. immitis in individuals, 18-64 years of age, with a history of pulmonary coccidioidomy-cosis",2011-07-29,N/A,"Allermed Labortories, Inc.",7203 Convoy Court,,San Diego,California,92111,USA,246007,2007,1318
"(R)-4-(3-morpholin-4-yl-1-phenylsulfanylmethyl-propylamino)-N-(4-{4-[2-(4-chlorophenyl)-5,5-dimethylcyclohex-1-enylmethyl]-piperazin-1-yl}-benzoyl)-3-trifluoromethanesulfonylbenzenesulfonamide bis-hydrochloride",n/a,2007-12-19,Treatment of small cell lung cancer.,Designated,,,N/A,N/A,"AbbVie, Inc",1 North Waukegan Road,"Dept. PA77, Bldg. AP30-1",North Chicago,Illinois,60064,USA,251307,2007,
"(R)-4-(3-morpholin-4-yl-l-phenylsulfanylmenthyl-propylamino)-N-(4-{4-[2-(4-chlorophenyl)-5,5-dimethylcyclohex-l-enylmethyl]-piperazin-l-yl}-benzoyl)-3-trifluoromethanesulfonylbenzenesulfonamide bis-hydrochloride",n/a,2007-12-19,Treatment of chronic lymphocytic leukemia,Designated/Withdrawn,,,N/A,N/A,"AbbVie, Inc.",1 N Waukegan Road,AP34/RA72,North Chicago,Illinois,60064,USA,249107,2007,
Alefacept,Amevive,2007-12-19,For use as prophylaxis of rejection in patients receiving allogenic solid organ transplants.,Designated/Withdrawn,,,N/A,N/A,"Astellas Pharma Global Development, Inc.",Three Parkway North,,Deerfield,Illinois,60015,USA,249307,2007,
Clonazepam Intranasal Spray,n/a,2007-12-19,Treatment of recurrent acute repetitive seizures,Designated,,,N/A,N/A,"Jazz Pharmaceuticals, Inc.",3180 Porter Drive,,Palo Alto,California,94304,USA,243507,2007,
reslizumab,n/a,2007-12-19,Treatment of children with eosinophilic esophagitis,Designated,,,N/A,N/A,"Teva Respiratory, LLC",41 Moores Road,P. O. Box 4011,Frazer,Pennsylvania,19335,USA,237507,2007,
spherical carbon adsorbent,n/a,2007-12-19,Treatment of chronic pouchitis,Designated,,,N/A,N/A,"Ocera Therapeutics, Inc.",12651 High Bluff Drive,,San Diego,California,92130,USA,249007,2007,
recombinant human rod-derived cone viability factor,n/a,2008-01-07,Treatment of retinitis pigmentosa,Designated/Withdrawn,,,N/A,N/A,Fovea Pharmaceuticals,12 Rue Jean Antoine de Baif,,Paris,,,France,251007,2008,
mitomycin-C,Mitosol,2008-01-08,Treatment of refractory glaucoma as an adjunct to surgery,Designated/Approved,Approved for Orphan Indication,An adjunct to ab externo glaucoma surgery.,2012-02-07,2019-02-07,"Mobius Therapeutics, LLC",1141 South 7th Street,,St. Louis,Missouri,63104,USA,251407,2008,1491
Tiotropium bromide,Spiriva,2008-01-08,To improve pulmonary function in conjunction with standard therapy in the management of patients with cystic fibrosis,Designated,,,N/A,N/A,"Boehringer Ingelheim Pharmaceuticals, Inc.",P. O. Box 368,900 Ridgebury Road,Ridgefield,Connecticut,6877,USA,241507,2008,
"(+/-)-cis-3-(4-hydroxyphenyl)-4-(4-methoxyphenyl)-3,4-dihydro-2H-cromen-7-ol",n/a,2008-01-10,Treatment of cholangiocarcinoma,Designated/Withdrawn,,,N/A,N/A,"Marshall Edwards, Inc.",11975 El Camino Real,Suite 101,San Diego,California,92130,USA,254407,2008,
"(+/-)-cis-3-(4-hydroxyphenyl)-4-(4-methoxyphenyl)-3,4-dihydro-2H-cromen-7-ol",n/a,2008-01-10,Treatment of pancreatic cancer,Designated/Withdrawn,,,N/A,N/A,"Marshall Edwards, Inc.",11975 El Camino Real,Suite 101,San Diego,California,92130,USA,251707,2008,
IDUA-HIRMAb fusion protein,n/a,2008-01-10,Treatment of mucopolysaccharidosis Type 1 (MPS),Designated,,,N/A,N/A,"ArmaGen Technologies, Inc.",914 Colorado Ave.,,Santa Monica,California,90401,USA,250907,2008,
carfilzomib,Kyprolis,2008-01-18,Treatment of multiple myeloma,Designated/Approved,Approved for Orphan Indication,Treatment of patients with multiple myeloma who have received at least two prior therapies including bortezomib and an immunomodulatory agent and have demonstrated disease progression on or within 60 days of completion of the last therapy.,2012-07-20,2019-07-20,"Onyx Therapeutics, Inc.",249 East Grand Avenue,,South San Francisco,California,94080,USA,252507,2008,1645
paromomycin sulfate/gentamicin sulfate,n/a,2008-01-18,Treatment of all uncomplicated cutaneous leishmaniasis (both New World and Old World),Designated,,,N/A,N/A,Office of the Surgeon General,Department of the Army,1430 Veteran's Drive,Ft. Detrick,Maryland,21702,USA,231206,2008,
pramipexole,Mirapex,2008-01-31,Treatment of Tourette's syndrome in pediatric patients,Designated,,,N/A,N/A,"Boehringer-Ingelheim Pharmaceuticals, Inc.",900 Ridgebury Road,,Ridgefield,Connecticut,6877,USA,252007,2008,
"(+/-)-cis-3-(4-hydroxyphenyl)-4-(4-methoxyphenyl)-3,4-dihydro-2H-cromen-7-ol",n/a,2008-02-01,Treatment of Stage IIB through Stage IV malignant melanoma,Designated/Withdrawn,,,N/A,N/A,"Marshall Edwards, Inc.",11975 El Camino Real,Suite 101,San Diego,California,92130,USA,252307,2008,
Autologous olfactory neural progenitors,Rhinocytes,2008-02-01,"Treatment of spinal cord injury patients with ASIA Impairment grades A, B, or C",Designated,,,N/A,N/A,"RhinoCyte, Inc.",201 E. Jefferson Street,,Louisville,Kentucky,40202,USA,246207,2008,
Human prothrombin complex concentrate,Octaplex,2008-02-01,Reversal of anticoagulation therapy in patients needing treatment of serious or life threatening bleeding and/or needing urgent surgery or invasive procedures,Designated,,,N/A,N/A,"Octapharma USA, Inc.",121 River Street,12th Floor,Hoboken,New Jersey,7030,USA,225806,2008,
N-(2-amino-phenyl)-4-[(4-pyridin-3-yl-pyrimidin-2-ylamino)-methyl] benzamide dihydrobromide,n/a,2008-02-01,Treatment of acute myeloid leukemia,Designated,,,N/A,N/A,"Mirati Therapeutics, Inc.",9363 Towne Center Drive,Suite 200,San Diego,California,92121,USA,253007,2008,
paclitaxel aqueous gel,Oncogel(Tm),2008-02-01,Treatment of esophageal cancer,Designated,,,N/A,N/A,"BTG International, Inc.",5214 Maryland Way,Suite 405,Brentwood,Tennessee,37027,USA,252907,2008,
triciribine,n/a,2008-02-01,Treatment of multiple myeloma,Designated,,,N/A,N/A,"VioQuest Pharmaceuticals, Inc.",180 Mt. Airy Road,,Basking Ridge,New Jersey,7920,USA,249907,2008,
Triheptanoin,Triheptanoin-Sasol Special Oil,2008-02-01,Treatment of glycogen storage disorder II (Pompe disease),Designated,,,N/A,N/A,Baylor Research Institute,3330 Live Oak Blvd,,Dallas,Texas,75204,USA,220406,2008,
Type 1 native bovine skin collagen,n/a,2008-02-01,Treatment of diffuse systemic sclerosis,Designated,,,N/A,N/A,"arGentis Pharmaceuticals, LLC",20 South Dudley Street,,Memphis,Tennessee,38139,USA,253407,2008,
everolimus,Afinitor,2008-02-14,Treatment of neuroendocrine tumors,Designated/Approved,Approved for Orphan Indication,"Treatment of progressive neuroendocrine tumors of pancreatic origin (PNET) in patients with unresectable, locally advanced or metastatic disease",2011-05-05,2018-05-05,Novartis Pharmaceuticals Corp.,"One Health Plaza, 315/5450A",,East Hanover,New Jersey,7936,USA,254107,2008,1176
everolimus,Afinitor,2008-02-14,Treatment of neuroendocrine tumors,Designated/Approved,Approved for Orphan Indication,"Treatment of adult patients with progressive, well-differentiated, non-functional, neuroendocrine tumors (NET) of gastrointestinal (GI) or lung origin, (excluding pancreatic) with unresectable, locally advanced or metastatic disease.",2016-02-26,2023-02-26,Novartis Pharmaceuticals Corp.,"One Health Plaza, 315/5450A",,East Hanover,New Jersey,7936,USA,254107,2008,2934
Cys-His-Ala-Val-Cys,n/a,2008-02-14,"For use in conjunction with melphalen for the treatment of malignant melanoma, AJCC stages IIB, IIC, III and IV",Designated,,,N/A,N/A,"Adherex Technologies, Inc.",4620 Creekstone Drive,,Durham,North Carolina,27703,USA,252607,2008,
belatacept,Nulojix,2008-02-20,Prophylaxis of organ rejection in renal allograft recipients,Designated/Approved,Approved for Orphan Indication,Prophylaxis of organ rejection in adult patients receiving kidney transplants,2011-06-15,2018-06-15,Bristol-Myers Squibb Company,P. O. Box 4000,,Princeton,New Jersey,8543,USA,253907,2008,1211
doxorubicin with pluronics F-127 and L-61,n/a,2008-02-20,Treatment of gastric cancer,Designated,,,N/A,N/A,"Supratek Pharma, Inc.",6100 Royalmount Avenue,Montreal,Quebec H4P 2R2,,,Canada,248107,2008,
arylsulfatase A (rhASA),n/a,2008-02-27,Treatment of metachromatic leukodystrophy,Designated,,,N/A,N/A,"Shire Human Genetic Therapies, Inc.",300 Shire Way,,Lexington,Massachusetts,2421,USA,254207,2008,
cenersen,Aezea,2008-02-27,Treatment of chronic lymphocytic leukemia,Designated,,,N/A,N/A,"Eleos, Inc.",1001 Twelve Oaks Center Drive,Suite 1002,Wayzata,Minnesota,55391,USA,252807,2008,
Levofloxacin,n/a,2008-02-27,Treatment of pulmonary infections due to Pseudomonas aeruginosa and other bacteria in patients with cystic fibrosis patients,Designated,,,N/A,N/A,"Horizon Pharma USA, Inc.",150 S. Saunders Road,Suite 100,Lake Forest,Illinois,60045,USA,253707,2008,
Manganese superoxide dismutase mimetic,n/a,2008-02-27,Prevention of radiation- or chemotherapy-induced oral mucositis in cancer patients,Designated,,,N/A,N/A,"Galera Therapeutics, LLC",2 West Liberty Blvd,Suite 110,Malvern,Pennsylvania,19355,USA,243907,2008,
mesalamine; 5-aminosalicylic acid,Lialda,2008-02-27,Treatment of ulcerative colitis in pediatric patients (revised indication 10/21/2010).,Designated,,,N/A,N/A,Shire,725 Chesterbrook Blvd.,,Wayne,Pennsylvania,19087,USA,253607,2008,
N2'-Deacetyl-N2'-[4-methyl-4-(oxobuthyldithio)-1-oxopentyl]-maytansine-chimerized anti-CD138 IgG4 Monoclonal Antibody,n/a,2008-02-27,Treatment of multiple myeloma,Designated,,,N/A,N/A,Biotest AG,5 Landsteinerstraße,,Dreieich,,,Germany,255407,2008,
Omegaven emulsion,Omegaven,2008-02-27,Treatment of parenteral nutrition-associated liver disease,Designated,,,N/A,N/A,"Fresenius Kabi USA, LLC",3 Corporate Drive,,Lake Zurich,Illinois,60047,USA,251507,2008,
amrubicin,n/a,2008-03-10,Treatment of small cell lung cancer,Designated/Withdrawn,,,N/A,N/A,Celgene Corporation,9900 W. 109th Street,Suite 300,Overland Park,Kansas,66210,USA,255307,2008,
ataluren,n/a,2008-03-10,Treatment of spinal muscular atrophy,Designated,,,N/A,N/A,"PTC Therapeutics, Inc.",100 Corporate Court,,South Plainfield,New Jersey,7080,USA,255907,2008,
milatuzumab,n/a,2008-03-10,Treatment of multiple myeloma,Designated,,,N/A,N/A,"Immunomedics, Inc.",300 The American Road,,Morris Plains,New Jersey,7950,USA,255807,2008,
"human fibrinogen concentrate, pasteurized",Riastap,2008-03-13,Treatment of fibrinogen deficient patients.,Designated/Approved,Approved for Orphan Indication,Treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency (afibrinogenemia and hypofibrinogenemia),2009-01-16,2016-01-16,"CSL Behring, LLC",1020 First Avenue,P.O. Box 61501,King of Prussia,Pennsylvania,19406,USA,245107,2008,309
"5-[(E)-2-(4-hydroxyphenyl)-ethenyl] benzene-1,3 diol",Resveratrol,2008-03-13,Treatment of MELAS syndrome,Designated,,,N/A,N/A,"Sirtris Pharmaceuticals, Inc.",200 Technology Square,,Cambridge,Massachusetts,2139,USA,241707,2008,
pacritinib,n/a,2008-03-13,"Treatment of primary myelofibrosis (MF), post-polycythemia vera MF, and post-essential thrombocythemia MF",Designated,,,N/A,N/A,CTI BioPharma Corporation,3101 Western Avenue,Suite 600,Seattle,Washington,98121,USA,245607,2008,
hepatitis B immune globulin (human),Hepagam,2008-03-24,Prevention of hepatitis B recurrence following orthotopic liver transplant,Designated/Approved,Approved for Orphan Indication,Prevention of hepatitis B recurrence following liver transplantation in HBsAG-positive liver transplant patients,2007-04-06,2014-04-06,Cangene Corporation,155 Innovation Drive,,,,,Canada,228506,2008,-353
bifidobacterium infantis 35624,n/a,2008-03-24,Treatment of pediatric ulcerative colitis,Designated,,,N/A,N/A,Alimentary Health Limited,"Cork Airport Business Park, Building 2800",Cork,,,,Ireland,255107,2008,
Human autologous bone-forming cell derived from bone marrow stem cells,n/a,2008-03-24,Treatment of osteonecrosis,Designated,,,N/A,N/A,Bone Therapeutics S.A.,"Rue Auguste Piccard, 37",,Gosselies,,,Belgium,250207,2008,
talampanel,n/a,2008-03-24,Treatment of amyotrophic lateral sclerosis,Designated/Withdrawn,,,N/A,N/A,TEVA Neuroscience,P. O. Box 1005,425 Privet Road,Horsham,Pennsylvania,19044,USA,256007,2008,
Alpha1-antitrypsin(human),n/a,2008-04-03,Treatment of bronchiectasis,Designated,,,N/A,N/A,Kamada Ltd.,7 Sapir Street,,Ness Ziona,,,Israel,256508,2008,
"autologous lymphocytes depleted ex vivo of immunoreactive T cells using 4,5",Theralux Photodynamic Therapy,2008-04-03,Treatment of chronic graft versus host disease,Designated,,,N/A,N/A,"Kiadis Pharma Canada, Inc.",2525 Marie Curie,,,,,Canada,255607,2008,
sodium nitrite and sodium thiosulfate,Nithiodote,2008-04-09,Treatment of known or suspected cyanide poisoning,Designated/Approved,Approved for Orphan Indication,For sequential use for the treatment of cyanide poisoning that is judged to be life-threatening,2011-01-14,2018-01-14,Hope Pharmaceuticals,16416 N. 92nd Street,,Scottsdale,Arizona,85260,USA,244207,2008,1010
peginterferon alfa-2b,Sylatron,2008-04-09,Treatment of malignant melanoma stages IIb through IV.,Designated/Approved,Approved for Orphan Indication,Adjuvant treatment of melanoma with microscopic or gross nodal involvement within 84 days of definitive surgical resection including complete lymphadenectomy,2011-03-29,N/A,"Merck, Sharpe & Dohme Corp.",1 Merck Drive,,Whitehouse Station,New Jersey,8889,USA,249507,2008,1084
obeticholic acid,Ocaliva,2008-04-09,Treatment of primary biliary cirrhosis,Designated/Approved,Approved for Orphan Indication,"Treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA, or as monotherapy in adults unable to tolerate UDCA",2016-05-27,2023-05-27,"Intercept Pharmaceuticals, Inc.",4760 Eastgate Mall,,San Diego,California,92122,USA,253207,2008,2970
6-alpha-ethylchenodeoxycholic acid,n/a,2008-04-09,Treatment of primary sclerosing cholangitis,Designated,,,N/A,N/A,"Intercept Pharmaceuticals, Inc.",18 Desbrosses Street,,New York,New York,10013,USA,259008,2008,
Anti-von Willebrand Aptamer,n/a,2008-04-09,Treatment of thrombotic thrombocytopenic purpura,Designated/Withdrawn,,,N/A,N/A,Archemix Corporation,300 Third Street,,Cambridge,Massachusetts,2142,USA,256207,2008,
cyclosporine A,Nova22007,2008-04-09,Treatment of herpes simplex virus stromal keratitis,Designated,,,N/A,N/A,Santen SAS,1 rue Pierre Fontaine,91058 Evry cedex,,,,France,254807,2008,
recombinant human arylsulphatase A,n/a,2008-04-11,Treatment of metachromatic leukodystrophy (MLD).,Designated/Withdrawn,,,N/A,N/A,Shire Human Genetic Therapies,300 Patriot Way,,Lexington,Massachusetts,2421,USA,170903,2008,
terguride,n/a,2008-05-02,Treatment of pulmonary arterial hypertension,Designated/Withdrawn,,,N/A,N/A,ErgoNex Pharma GmbH,Ruetistr. 20,CH-9050 Appenzell,,,,Switzerland,255007,2008,
eltrombopag,Promacta,2008-05-05,Treatment of idiopathic thrombocytopenia purpura,Designated/Approved,Approved for Orphan Indication,"Treatment of thrombocytopenia in patients with chronic immune (idiopathic) thrombocytopenic purpura who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy",2008-11-20,2015-11-20,Novartis Pharmaceuticals Corp.,One Health Plaza,,East Hanover,New Jersey,7936,USA,251907,2008,199
"(R)-4-(3-morpholin-4-yl-1-phenylsulfanylmethyl-propylamino)-N-(4-{4-[2-(4-chlorophenyl)-5,5-dimethylcyclohex-1-enylmethyl]-piperazin-1-yl}-benzoyl)-3-trifluoromethanesulfonylbenzenesulfonamide bis-hydrochloride",n/a,2008-05-05,Treatment of multiple myeloma,Designated/Withdrawn,,,N/A,N/A,"AbbVie, Inc.",1 N Waukegan Road,AP34/RA72,North Chicago,Illinois,60064,USA,257408,2008,
ammonium tetrathiomolybdate,n/a,2008-05-05,Treatment of idiopathic pulmonary fibrosis,Designated,,,N/A,N/A,"Pipex Pharmaceuticals, Inc.",3930 Varsity Drive,,Ann Arbor,Michigan,48108,USA,254007,2008,
nabumetone,n/a,2008-05-05,Treatment of pediatric juvenile rheumatoid arthritis,Designated,,,N/A,N/A,Cook Pharma,109 Graylyn Drive,,Chapel Hill,North Carolina,27516,USA,255207,2008,
Palifosfamide,n/a,2008-05-05,Treatment of soft tissue sarcomas,Designated/Withdrawn,,,N/A,N/A,"ZIOPHARM Oncology, Inc.","One First Avenue, Parris Building #34",Navy Yard Plaza,Boston,Massachusetts,2129,USA,257508,2008,
Valproate,n/a,2008-05-05,Treatment of fragile X syndrome,Designated,,,N/A,N/A,"Neuropharm Ltd,",Fetcham Park House,Surrey KT22 9HD,,,,United Kingdom,256908,2008,
cysteamine,n/a,2008-05-09,Treatment of Huntington's disease,Designated,,,N/A,N/A,"Horizon Pharma USA, Inc.",150 S. Saunders Road,Suite 100,Lake Forest,Illinois,60045,USA,258008,2008,
dimethyl sulfoxide,n/a,2008-05-09,For use in combination with antimicrobial drugs for the treatment of drug resistant tuberculosis,Designated,,,N/A,N/A,"Abela Pharmaceuticals, Inc.",21581 Midcrest Drive,,Lake Forest,California,92630,USA,254707,2008,
veliparib,n/a,2008-05-09,Treatment of glioblastoma multiforme when used in combination with DNA-damaging agents,Designated,,,N/A,N/A,"AbbVie, Inc.",1 N. Waukegan Road,,North Chicago,Illinois,60064,USA,257108,2008,
blinatumomab,Blincyto,2008-05-16,Treatment of acute lymphocytic leukemia,Designated/Approved,Approved for Orphan Indication,Treatment of Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).,2014-12-03,2021-12-03,"Amgen, Inc.",One Amgen Center Dr.,Mail Stop 17-2-A,Thousand Oaks,California,91320,USA,255707,2008,2392
blinatumomab,Blincyto,2008-05-16,Treatment of acute lymphocytic leukemia,Designated/Approved,Approved for Orphan Indication,BLINCYTO® is indicated for the treatment of B-cell precursor acute lymphoblastic leukemia (ALL) in first or second complete remission with minimal residual disease (MRD) greater than or equal to 0.1% in adults and children.,2018-03-29,2025-03-29,"Amgen, Inc.",One Amgen Center Dr.,Mail Stop 17-2-A,Thousand Oaks,California,91320,USA,255707,2008,3604
blinatumomab,n/a,2008-05-16,Treatment of prolymphocytic leukemia,Designated,,,N/A,N/A,"Amgen, Inc.",One Amgen Center Drive,,Thousand Oaks,California,91230,USA,261908,2008,
Blinatumomab,n/a,2008-05-16,Treatment of chronic lymphocytic leukemia,Designated,,,N/A,N/A,"Amgen, Inc.",One Amgen Center Drive,,Thousand Oaks,California,91230,USA,261708,2008,
blinatumomab,n/a,2008-05-16,Treatment for hairy cell leukemia.,Designated,,,N/A,N/A,"Amgen, Inc.",One Amgen Center Drive,,Thousand Oaks,California,91230,USA,261808,2008,
sulfamidase,n/a,2008-05-22,For treatment of Sanfilippo Syndrome (MPS IIIA),Designated,,,N/A,N/A,"Shire Human Genetic Therapies, Inc.",300 Shire Way,,Lexington,Massachusetts,2421,USA,258408,2008,
2 dimethylbutyrate,n/a,2008-06-18,Treatment of beta thalassemia,Designated,,,N/A,N/A,"HemaQuest Pharmaceuticals, Inc.",1001 Fourth Avenue,Suite 3317,Seattle,Washington,98154,USA,259608,2008,
4-[[[4-(4-Chlorophenoxy)phenyl]sulfonyl]-methyl] tetrahydro-N-hydroxy-2H-pyran-4-carboxamide,n/a,2008-06-18,Prophylaxis of organ rejection in patients receiving allogeneic liver transplants,Designated/Withdrawn,,,N/A,N/A,"Conatus Pharmaceuticals, Inc.",4365 Executive Drive,,San Diego,California,92121,USA,258308,2008,
Azacitidine,Vidaza,2008-06-18,Treatment of acute myeloid leukemia,Designated,,,N/A,N/A,Celgene Corporation,9900 W. 109th Street,Suite 300,Overland Park,Kansas,66210,USA,257008,2008,
bupivacaine,Transdur,2008-06-18,Relief of persistent pain associated with postherpetic neuralgia,Designated,,,N/A,N/A,DURECT Corporation,10260 Bubb Road,,Cupertino,California,95014,USA,237207,2008,
cenersen,Aezea,2008-06-18,Treatment of stage IIB through IV melanoma,Designated,,,N/A,N/A,"Eleos, Inc.",1001 Twelve Oaks Center Drive,Suite 1002,Wayzata,Minnesota,55391,USA,224506,2008,
elacytarabine,n/a,2008-06-18,Treatment of acute myeloid leukemia (AML),Designated,,,N/A,N/A,Clavis Pharma ASA,Parkveien 53 B,,,,,Norway,259408,2008,
humanized monocloncal antibody against human integrin alphaVbeta6,n/a,2008-06-18,Treatment of fibrosis-associated chronic allograft nephropathy in kidney transplant patients.,Designated,,,N/A,N/A,"Stromedix, Inc.",14 Cambridge Center,BIO 7-2,Cambridge,Massachusetts,2142,USA,258908,2008,
hydrocortisone modified release tabs,Duocort,2008-06-18,Treatment of adrenal insufficiency,Designated,,,N/A,N/A,"Shire ViroPharma, Inc.",300 Shire Way,,Lexington,Massachusetts,2421,USA,234906,2008,
recombinant human type VII collagen,n/a,2008-06-18,Treatment of hereditary dystrophic epidermolysis bullosa (DEB),Designated,,,N/A,N/A,"David T. Woodley, MD and Mei Chen, MD","USC Department of Dermatology, Cancer Research Lab",1303 North Mission Road,Los Angeles,California,90033,USA,258208,2008,
alicaforsen,n/a,2008-06-24,Treatment of pouchitis.,Designated,,,N/A,N/A,Atlantic Healthcare Limited,Maple House,"Halsted, Essex CO9 4BB",,,,United Kingdom,260808,2008,
carbon monoxide,Covox,2008-06-24,For use in the reduction of the incidence and severity of delayed graft function in patients undergoing solid organ transplanation.,Designated/Withdrawn,,,N/A,N/A,INO Therapeutics,Perryville III Corporate Park,P. O. Box 9001,Hampton,New Jersey,8827,USA,241807,2008,
cardiotrophin-1,n/a,2008-06-24,To protect the liver from ischemia-reperfusion injury inherent to the procedure of transplantation.,Designated,,,N/A,N/A,"Digna Biotech, S.L.",Avenids Carlos III de Noble,Pamplona (Navarra),,,,Spain,244907,2008,
cicletanine hydrochloride,n/a,2008-06-24,Treatment for pulmonary arterial hypertension.,Designated/Withdrawn,,,N/A,N/A,"Gilead Sciences, Inc.",333 Lakeside Drive,,Foster City,California,94404,USA,261608,2008,
liposomal cyclosporine for inhalation,n/a,2008-06-24,Prevention of bronchiolitis obliterans.,Designated,,,N/A,N/A,"Breath Therapeutics, Inc.",90 Canal Street,4th Floor,Boston,Massachusetts,2114,USA,252207,2008,
milatuzumab,n/a,2008-06-24,Treatment of chronic lymphocytic leukemia.,Designated,,,N/A,N/A,"Immunomedics, Inc.",300 The American Road,,Morris Plains,New Jersey,7950,USA,256608,2008,
Mx-dnG1,Rexin-G,2008-06-24,Treatment of osteosarcoma.,Designated,,,N/A,N/A,Epeius Biotechnologies Corporation,475 Huntington Drive,,San Marino,California,91108,USA,261208,2008,
Mx-dnG1,Rexin-G(R),2008-06-24,Treatment of soft tissue sarcoma,Designated,,,N/A,N/A,Epeius Biotechnologies Corporation,475 Huntington Drive,,San Marino,California,91108,USA,262108,2008,
omigapil,n/a,2008-06-24,Treatment of congenital muscular dystrophy.,Designated,,,N/A,N/A,Santhera Pharmaceuticals (Switzerland) Ltd.,25 Hammerstrasse,,Liestal,,,Switzerland,260508,2008,
Recombinant adeno-associated virus retinal pigment epithelium gene vector AAV2-hRPE65v2,n/a,2008-06-24,Treatment of Leber congenital amaurosis due to RPE65 mutations.,Designated,,,N/A,N/A,"Spark Therapeutics, Inc.",3737 Market Street,Suite 1300,Philadelphia,Pennsylvania,19104,USA,259308,2008,
retaspimycin hydrochloride,n/a,2008-06-24,Treatment of melanoma stages IIb through IV.,Designated/Withdrawn,,,N/A,N/A,AstraZeneca Pharmaceuticals LP,P. O. Box 8355,1800 Concord Pike,Wilmington,Delaware,19803,USA,260608,2008,
vascular endothelial growth factor 165b,n/a,2008-06-24,Treatment of advanced melanoma stages IIb through IV.,Designated,,,N/A,N/A,"PhiloGene, Inc.",174 Summit Avenue,,Summit,New Jersey,7901,USA,261108,2008,
vincristine sulfate liposomes,Marqibo,2008-06-24,Treatment of metastatic uveal melanoma.,Designated,,,N/A,N/A,Talon Therapeutics,400 Oyster Point Blvd,Suite 200,South San Francisco,California,94080,USA,259108,2008,
sodium nitrite,n/a,2008-07-08,Treatment of pulmonary arterial hypertension,Designated,,,N/A,N/A,"Airess Pharmaceuticals, Inc.","(subsidiary of Mast Therapeutics, Inc)",3611 Valley Centre Drive,San Diego,California,92130,USA,252707,2008,
afamelanotide,n/a,2008-07-17,Treatment of erythropoietic porphyrias,Designated,,,N/A,N/A,Clinuvel Inc.,40 Worth Street,Suite 1053,New York,New York,10013,USA,263208,2008,
polyphenon E,n/a,2008-07-17,Treatment of chronic lymphocytic leukemia,Designated/Withdrawn,,,N/A,N/A,"Mitsui Norin Co., Ltd",223-1 Miyabara,426-0133,,,,Japan,260208,2008,
humanized IgG2 antibody,n/a,2008-07-22,Treatment of vaso-occlusive crisis in patients with sickle cell disease.,Designated,,,N/A,N/A,Novartis Pharmaceuticals Corporation,One Health Plaza,Building 337 B11.3D,East Hanover,New Jersey,-7936,USA,259708,2008,
sotalol (IV),So-Aqueous,2008-07-25,"For ventricular tachycardia, ventricular fibrillation, or the maintenance of sinus rhythm in patients converted from atrial fibrillation or atrial flutter when oral administration is not possible.",Designated/Approved,Approved for Orphan Indication,"For use as a substitute for oral sotalol in patients who are unable to take sotalol orally [oral sotalol is indicated for maintenance of normal sinus rhythm in patients with history of highly symptomatic atrial fibrillation /flutter, and for treatment of documented life-threatening ventricular arrhythmias]",2009-07-02,2016-07-02,Academic Pharmaceuticals,21 N. Skokie Hwy,,Lake Bluff,Illinois,60044,USA,247707,2008,342
metyrosine,Demser,2008-07-25,Treatment of velocardiofacial syndrome associated psychosis.,Designated,,,N/A,N/A,"Cerberus Princeton, LLC",c/o Cerberus Capital Management L.P.,875 Third Avenue,New York,New York,10022,USA,265008,2008,
"sodium 2, 2 dimethylbutyrate",n/a,2008-07-25,Treatment of sickle cell disease.,Designated,,,N/A,N/A,"HemaQuest Pharmaceuticals, Inc.",1001 Fourth Avenue,Suite 3317,Seattle,Washington,98154,USA,265108,2008,
3-fluoro-5-[5-(2-menthyl-thiazol-4-ylethylnyl)-pyridin-2-yl]-benzonitrile dihydrochloride,n/a,2008-07-28,Treatment of behavioral abnormalities associated with fragile X syndrome.,Designated,,,N/A,N/A,Seaside Therapeutics,840 Memorial Drive,,Cambridge,Massachusetts,2139,USA,263608,2008,
anthrax immune globulin (human),n/a,2008-07-29,Treatment of inhalational anthrax,Designated/Approved,Approved for Orphan Indication,Treatment of inhalational anthrax in adult and pediatric patients in combination with appropriate antibacterial drugs,2015-03-24,2022-03-24,Cangene Corp. - Emergent Biosolutions,155 Innovation Drive,R3T 5Y3,"Winnipeg, MB",,,Canada,263008,2008,2429
human anti-cellular adhesion molecule-1 monoclonal antibody,n/a,2008-07-29,Treatment of multiple myeloma,Designated,,,N/A,N/A,BioInvent International AB,Solvegatan 41,,,,,Sweden,258708,2008,
Recombinant disintegrin and metalloprotease with thrombospondin type 1 motifs,n/a,2008-07-29,"Treatment of thrombotic thrombocytopenic purpura including its congential, acquired idiopathic, and secondary forms.",Designated,,,N/A,N/A,Baxalta US Inc.,1 Baxter Way,,Westlake Village,California,91362,USA,262208,2008,
Recombinant disintegrin and metalloprotease with thrombospondin type 1 motifs,n/a,2008-07-29,"Prevention of thrombotic thrombocytopenic purpura including its congential, acquired idiopathic and secondary forms.",Designated,,,N/A,N/A,Baxalta US Inc.,1 Baxter Way,,Westlake Village,California,91362,USA,265208,2008,
"4-[1]benzofuro[3,2-d]pyrimidin-4-yl-N-(1,3-benzodioxol-5-ylmethyl)piperazine-1-carbothioamide",n/a,2008-07-30,"Treatment, in combination with radiotherapy and temozolomide chemotherapy, of patients with glioblastoma multiforme.",Designated,,,N/A,N/A,"SuperGen, Inc.",4140 Dublin Blvd,,Dublin,California,94568,USA,262608,2008,
deferiprone,n/a,2008-07-31,Treatment of Friedreich's ataxia,Designated,,,N/A,N/A,"ApoPharma, Inc.",200 Barmac Drive,M9L 2Z7,,,,Canada,264308,2008,
Intravenous immune globulin (human) 10%,Octagam(R),2008-07-31,Treatment of stiff-person syndrome,Designated,,,N/A,N/A,"Octapharma USA, Inc.",121 River Street,,Hoboken,New Jersey,7030,USA,264208,2008,
Bardoxolone,n/a,2008-08-06,Treatment of pancreatic cancer,Designated,,,N/A,N/A,"Reata Pharmaceuticals, Inc.",2801 Gateway Drive,,Irving,Texas,75063,USA,264108,2008,
cysteamine,n/a,2008-08-06,Treatment of neuronal ceroid lipofuscinoses (Batten disease),Designated,,,N/A,N/A,"Raptor Pharmaceuticals, Inc.",9 Commercial Blvd.,Suite 200,Novato,California,94949,USA,262408,2008,
Cytarabine:daunorubicin liposome injection,Vyxeos,2008-08-22,Treatment of acute myeloid leukemia,Designated/Approved,Approved for Orphan Indication,Treatment of adults with newly-diagnosed therapy-related acute myeloid leukemia (t-AML) or AML with myelodysplasia-related changes (AML-MRC),2017-08-03,2024-08-03,"Celator Pharmaceuticals, Inc.",200 Princeton South Corporate Center,Suite 180,Ewing,New Jersey,8628,USA,265808,2008,3268
Arenegyr,n/a,2008-08-22,Treatment of malignant pleural mesothelioma,Designated,,,N/A,N/A,MolMed S.p.A.,Via Olgettina 58,,Milan,,,Italy,263908,2008,
glycafilin,n/a,2008-08-22,Prevention of delayed graft function after solid organ transplantation,Designated,,,N/A,N/A,ProtAffin Biotechnologie AG,Impulszentrum Graz - West,A-8020 Graz,,,,Austria,264808,2008,
Seneca Valley virus,n/a,2008-08-22,Treatment of neuroendocrine tumors,Designated,,,N/A,N/A,"Neotropix, Inc.",351 Phoenixville Pike,,Malvern,Pennsylvania,19355,USA,266008,2008,
"2-[(3-methyl-4-(2,2,2-trifluoroethoxy) pyridin-2-yl)methylsulfinyl] -1H-benzoimidazole",Prevonco (Tm),2008-08-27,Treatment of hepatocellular carcinoma.,Designated,,,N/A,N/A,"BioQuant, Inc.",6330 Nancy Ridge Drive,,San Diego,California,92121,USA,264508,2008,
granulocyte macrophage colony stimuling factor,n/a,2008-08-27,Treatment of cystic fibrosis,Designated,,,N/A,N/A,Savara Inc.,900 S. Capital Texas Highway,Suite 150,Austin,Texas,78746,USA,264908,2008,
veltuzumab,n/a,2008-08-28,Treatment of chronic lymphocytic leukemia,Designated,,,N/A,N/A,"Immunomedics, Inc.",300 The American Road,,Morris Plains,New Jersey,7950,USA,261308,2008,
ruxolitinib phosphate,Jakafi,2008-09-05,Treatment of myelofibrosis,Designated/Approved,Approved for Orphan Indication,"Treatment of patients with intermediate or high-risk myelofibrosis, including primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis",2011-11-16,2018-11-16,Incyte Corporation,1801 Augustine Cut-Off,,Wilmington,Delaware,19803,USA,265308,2008,1167
propranolol,Hemangeol,2008-09-05,Treatment of proliferating infantile hemangiomas requiring systemic therapy,Designated/Approved,Approved for Orphan Indication,Treatment of proliferating infantile hemangioma requiring systemic therapy.,2014-03-14,2021-03-14,Pierre Fabre Dermatologie,"8 Campus Drive, 2nd Floor",,Parsippany,New Jersey,7054,USA,266708,2008,2016
Daunorubicin liposomal,n/a,2008-09-05,Treatment of acute myeloid leukemia,Designated,,,N/A,N/A,"Diatos USA, LLC",15310 Amberly Drive,,Tampa,Florida,33647,USA,266508,2008,
insecticidal toxin derived from Bacillus thuringiensis,n/a,2008-09-05,Treatment of soil transmitted helminth infection strongyloidiasis,Designated,,,N/A,N/A,"University of California, San Diego","Aroian Laboratory, Div. of Biological Sciences",Department 0322,LaJolla,California,92093,USA,266408,2008,
nitric oxide,Inomax,2008-09-05,Use in combination with a drug delivery device for acute treatment of sickle cell vaso-occlusive crisis (pain crises),Designated,,,N/A,N/A,Mallinckrodt Hospital Products,1425 U.S. 206,,Bedminster Township,New Jersey,7921,USA,265708,2008,
lysosomal enzyme N-acetylgalactosamine-6-sulfate sulfatase,n/a,2008-09-10,Treatment of mucopolysaccharidosis Type IVA (Morquio Syndrome),Designated,,,N/A,N/A,Vivendy Therapeutics LTD,Peter Merian -Strasse 45,,,,,Switzerland,267708,2008,
Asfotase alfa,Strensiq,2008-09-12,Treatment of hypophosphatasia,Designated/Approved,Approved for Orphan Indication,For the treatment of patients with perinatal/infantile-and juvenile-onset hypophosphatasia (HPP),2015-10-23,2022-10-23,"Alexion Pharmaceuticals, Inc.",100 College St.,,New Haven,Connecticut,6510,USA,266608,2008,2597
"anti-T-lymphocyte immune globulin, rabbit",n/a,2008-09-12,Prophylaxis of acute allograft rejection in adult recipients in solid organ transplantation,Designated,,,N/A,N/A,"Neovii Biotech NA, Inc.",430 Bedford Street,Suite 195,Lexington,Massachusetts,2420,USA,182503,2008,
AQ-13 (4-aminoquinoline analog),n/a,2008-09-12,Treatment of malaria,Designated,,,N/A,N/A,"Immtech Pharmaceuticals, Inc.",150 Fairway Drive,,Vernon Hills,Illinois,60061,USA,266808,2008,
"Human Allogeneic HLA-matched, Umbilical Cord Blood Hematopoietic Progenitor Cells Ex Vivo Expanded on Allogeneic Mesenchymal Precursor Cells",n/a,2008-09-12,Treatment of insufficient hematopoietic stem cell production in patients with hematologic malignancies who have failed treatment with conventional chemotherapy.,Designated,,,N/A,N/A,"Mesoblast, Inc.",275 Madison Avenue,4th Floor,New York,New York,10016,USA,263308,2008,
eliglustat,Cerdelga,2008-09-17,Treatment of Type I Gaucher disease,Designated/Approved,Approved for Orphan Indication,"Long-term treatment of adult patients with Gaucher disease type 1 who are CYP2D6 extensive metabolizers (EMs), intermediate metabolizers (IMs), or poor metabolizers (PMs) as detected by an FDA-cleared test.",2014-08-19,2021-08-19,Genzyme Corporation,500 Kendall Street,,Cambridge,Massachusetts,2142,USA,265408,2008,2162
metronidazole,n/a,2008-09-17,Treatment of pouchitis,Designated,,,N/A,N/A,Avivia Project BV,Leeuwenhoekweg 12,5482 TK Schijndel,,,,Netherlands,267008,2008,
[131I]-N-(2-(diethylamino) ethyl-4-(4 flurobenzamido)-5-(iodo)-2-methoxybenzamide,n/a,2008-09-17,"Treatment of metastatic melanoma, stages IIB, IIC, III and IV",Designated,,,N/A,N/A,"Molecular Insight Pharmaceuticals, Inc. (Progenics Subsidiary)",777 Old Saw Mill River Road,,Tarrytown,New York,10591,USA,268008,2008,
Full Phosphorothioate Antisense Oligonucleotide against EWS-Fli-1 nanoparticles,n/a,2008-09-22,Treatment of Ewing's sarcoma,Designated,,,N/A,N/A,The Cure Our Children Foundation,1730 Michael Lane,,Pacific Palisades,California,90272,USA,202505,2008,
phosphorothioate antisense olignucleotide against EWS-Fli-1,n/a,2008-09-22,Treatment of Ewing's sarcoma,Designated,,,N/A,N/A,The Cure Our Children Foundation,1730 Michael Lane,,Pacific Palisades,California,90272,USA,268208,2008,
difluprednate,Durezol,2008-09-30,Treatment of endogenous and traumatic anterior uveitis and panuveitis.,Designated/Approved,Approved for Orphan Indication,Treatment of endogenous anterior uveitis,2012-06-13,2019-06-13,Alcon Pharmaceuticals. Ltd.,Route Des Arsenaux 41,1701 Fribourg (P.O. Box 61),,,,Switzerland,265608,2008,1352
canakinumab,Ilaris,2008-09-30,Treatment of pediatric (age 16 and under) juvenile rheumatoid arthritis.,Designated/Approved,Approved for Orphan Indication,Treatment of active Systemic Juvenile Idiopathic Arthritis (SJIA) in patients aged 2 through 16 years.,2013-05-09,2020-05-09,Novartis Pharmaceuticals Corporation,One Health Plaza,Bldg 135-566G,East Hanover,New Jersey,7936,USA,260408,2008,1682
Adeno-associated viral vector serotype 5 containing human ABCA4 gene,n/a,2008-09-30,Treatment of Stargardt's disease.,Designated/Withdrawn,,,N/A,N/A,Fondazione Telethon,Via Varese 16 - 00185 Roma,,,,,Italy,267908,2008,
bosentan,Tracleer,2008-09-30,Treatment of idiopathic pulmonary fibrosis,Designated/Withdrawn,,,N/A,N/A,Actelion Pharmaceuticals Ltd,Gewerbestrasse 16,CH-4123,,,,Switzerland,267608,2008,
cyclosporine A,n/a,2008-09-30,Prevention of corneal graft rejection,Designated,,,N/A,N/A,Santen SAS,Batiment Genavenir IV,F-91058-Evry cedex,,,,France,254907,2008,
epratuzumab,n/a,2008-09-30,Treatment of acute lymphoblastic leukemia,Designated,,,N/A,N/A,"Immunomedics, Inc.",300 The American Road,,Morris Plains,New Jersey,7950,USA,260908,2008,
mibefradil,n/a,2008-10-16,Treatment of pancreatic cancer.,Designated,,,N/A,N/A,"Cavion, LLC",600 E. Water Street,,Charlottesville,Virginia,22902,USA,268608,2008,
monoclonal antibody 3F8,n/a,2008-10-16,Treatment of neuroblastoma,Designated,,,N/A,N/A,United Therapeutics Corporation,55 TW Alexander Drive,P. O. Box 14186,Research Triangle Park,North Carolina,27709,USA,268808,2008,
anti human Nogo-A human monoclonal antibody,n/a,2008-10-20,Treatment of acute spinal cord injury,Designated,,,N/A,N/A,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,USA,268108,2008,
pralatrexate,n/a,2008-10-20,Treatment of diffuse large B-cell lymphoma,Designated,,,N/A,N/A,"Allos Therapeutics, Inc.","11080 Circle Point Road, Suite 200",,Westminister,Colorado,80020,USA,268308,2008,
pralatrexate,n/a,2008-10-20,Treatment of follicular lymphoma,Designated,,,N/A,N/A,"Allos Therapeutics, Inc.","11080 Circle Point Road, Suite 200",,Westminister,Colorado,80020,USA,269008,2008,
recombinant human histone H1.3; recombinant human N-bis-met-histone H1.3,Oncohist,2008-10-20,Treatment of acute myeloid leukemia,Designated,,,N/A,N/A,Xenetic Biosciences Plc,London Bioscience Innovation Centre,2 Royal College Street,London,,,United Kingdom,267508,2008,
brentuximab vedotin,Adcetris,2008-10-23,Treatment of anaplastic large cell lymphoma,Designated/Approved,Approved for Orphan Indication,The treatment of patients with systemic anaplastic large cell lymphoma (sALCL) after failure of at least one prior multi-agent chemotherapy regimen,2011-08-19,2018-08-19,"Seattle Genetics, Inc.",21823 30th Drive Southeast,,Bothell,Washington,98021,USA,268908,2008,1030
brentuximab vedotin,Adcetris,2008-10-23,Treatment of anaplastic large cell lymphoma,Designated/Approved,Approved for Orphan Indication,For adult patients with primary cutaneous anaplastic large cell lymphoma who have received prior systemic therapy,2017-11-09,TBD,"Seattle Genetics, Inc.",21823 30th Drive Southeast,,Bothell,Washington,98021,USA,268908,2008,3304
Thawed donor matched banked umbilical cord blood enriched by cell sorting to produce a subpopulation expressing high levels of intracellular aldehyde dehydrogenase,n/a,2008-10-23,To improve patient outcomes by decreasing time to platlet and neutrophil engraftment in patients with inherited metabolic diseases (IMD) undergoing umbilical cord blood transplantation.,Designated,,,N/A,N/A,"Aldagen, Inc.",2810 Meridian Parkway,,Durham,North Carolina,27713,USA,259908,2008,
"Coagulation factor IX (recombinant), Fc fusion protein",Alprolix,2008-10-30,Control and prevention of hemorrhagic episodes in patients with hemophilia B (congenital factor IX deficiency or Christmas disease),Designated/Approved,Approved for Orphan Indication,"Adults and children with Hemophilia B for control and prevention of bleeding episodes, perioperative management, and routine prophylaxis to prevent or reduce the frequency of bleeding episodes.",2014-03-28,2021-03-28,"Bioverativ Therapeutics, Inc.",225 2nd Avenue,,Waltham,Massachusetts,2451,USA,261508,2008,1975
"4, 5 dibromorhodamine methyl ester",Theralux Photodynamic Therapy,2008-10-30,Treatment of follicular lymphoma,Designated,,,N/A,N/A,"Kiadis Pharma Canada, Inc.",2525 Marie Curie,,,,,Canada,269808,2008,
"4, 5 dibromorhodamine methyl ester",Theralux Photodynamic Therapy,2008-10-30,Treatment of diffuse large B-cell lymphoma,Designated,,,N/A,N/A,"Kiadis Pharma Canada, Inc.",2525 Marie Curie,,,,,Canada,255507,2008,
Itraconazole suspension,n/a,2008-10-30,Topical treatment of fungal otitis externa (otomycosis),Designated,,,N/A,N/A,"Fairfield Clinical Trials, LLC",200 Steep Hill Road,,Weston,Connecticut,6883,USA,257308,2008,
liposomal topotecan hydrochloride,n/a,2008-10-30,Treatment of gliomas,Designated,,,N/A,N/A,"MedGenesis Therapeutix, Inc.",730-730 View Street,"Victoria, BC V8W 3Y7",,,,Canada,268508,2008,
stiripentol,Diacomit,2008-10-30,Treatment of Dravet syndrome,Designated,,,N/A,N/A,Biocodex,"7, avenue Gallieni",94250 Gentilly,,,,France,266108,2008,
liposomal gadodiamide,n/a,2008-11-12,Treatment of glioma,Designated,,,N/A,N/A,"MedGenesis Therapeutix, Inc.",730-730 View Street,"Victoria, BC V8W 3Y7",,,,Canada,268408,2008,
melphalan hydrochloride,n/a,2008-11-12,Treatment of patients with cutaneous melanoma.,Designated,,,N/A,N/A,"Delcath Systems, Inc.",1301 6th Avenue,43rd Floor,New York,New York,10019,USA,270508,2008,
melphalan hydrochloride,n/a,2008-11-12,Treatment of patients with ocular (uveal) melanoma.,Designated,,,N/A,N/A,"Delcath Systems, Inc.",1301 6th Avenue,43rd Floor,New York,New York,10019,USA,271708,2008,
miglustat,Zavesca,2008-11-12,"Treatment of the neurological manifestations of Niemann-Pick disease,type C.",Designated/Withdrawn,,,N/A,N/A,Actelion Pharmaceuticals Ltd,Innovation Centre,"CH-4123, Allschwil",,,,Switzerland,270708,2008,
GNE Lipoplex,n/a,2008-11-13,Treatment of hereditary inclusion body myopathy-2,Designated,,,N/A,N/A,"Gradalis, Inc.",2545 Golden Bear Drive,,Carrollton,Texas,75006,USA,267108,2008,
"antineoplaston A10, antineoplaston AS2-1",n/a,2008-11-21,Treatment of gliomas,Designated,,,N/A,N/A,"Burzynski Research Institute, Inc.",9432 Old Katy Road,,Houston,Texas,77055,USA,267408,2008,
pentosan polysulfate sodium,n/a,2008-11-21,Treatment of sickle cell disease.,Designated,,,N/A,N/A,"TRF Pharma, Inc.",863 Mitten Road,,Burlingame,California,94010,USA,251607,2008,
tesetaxel,n/a,2008-11-21,"Treatment of stages IIB, IIC, III, and stage IV melanoma",Designated,,,N/A,N/A,"Genta, Inc.",200 Connell Drive,,Berkley Heights,New Jersey,7922,USA,269108,2008,
melphalan,Evomela,2008-11-24,High dose conditioning treatment prior to hematopoietic progenitor (stem) cell transplantation,Designated/Approved,Approved for Orphan Indication,for high-dose conditioning treatment prior to hematopoietic progenitor (stem) cell transplantation in patients with multiple myeloma,2016-03-10,2023-03-10,"Spectrum Pharmaceuticals, INc.",157 Technology Drive,,Irvine,California,92618,USA,270008,2008,2663
MAGE-A3 cancer therapeutic Trojan peptide vaccine,n/a,2008-11-24,Treatment of MAGE-A3 expressing head and neck squamous cell carcinoma,Designated,,,N/A,N/A,"Gliknik, Inc.",801 W. Baltimore Street,Suite 501A,Baltimore,Maryland,21201,USA,269708,2008,
fosfomycin/tobramycin,n/a,2008-11-28,Treatment of pulmonary infections associated with cystic fibrosis,Designated,,,N/A,N/A,"CURx Pharmaceuticals, Inc.",3210 Merryfield Row,,San Diego,California,92121,USA,271908,2008,
R-4-amino-3-(4-chlorophenyl)butanoic acid,n/a,2008-11-28,Treatment of the behavorial abnormalities associated with fragile X syndrome,Designated,,,N/A,N/A,"Clinical Research Associates, LLC",160 Fifth Avenue,7th Floor,New York,New York,10010,USA,271808,2008,
anti-CD30 Fc engineered humanized monoclonal antibody,n/a,2008-12-02,Treatment of Hodgkin lymphoma,Designated,,,N/A,N/A,"Xencor, Inc.",111 W. Lemon Avenue,,Monrovia,California,91016,USA,271208,2008,
chlorotoxin,n/a,2008-12-02,"Treatment of stage IIb, IIc, III & IV melanoma",Designated,,,N/A,N/A,"Morphotek, Inc.",210 Welsh Pool Road,,Exon,Pennsylvania,19341,USA,264008,2008,
dexamethasone phosphate,n/a,2008-12-02,Treatment of corneal graft rejection.,Designated,,,N/A,N/A,"EyeGate Pharmaceuticals, Inc.",100 Beaver Street,,Waltham,Massachusetts,2453,USA,270608,2008,
quinine sulfate,n/a,2008-12-02,Treatment of malaria excluding Plasmodium faliparum,Designated,,,N/A,N/A,"Zydus Pharmaceuticals, Inc.",210 Carnegie Center,,Princeton,New Jersey,8540,USA,272008,2008,
recombinant human proinsulin (Including rhPI-Methionine),n/a,2008-12-10,Treatment of retinitis pigmentosa,Designated,,,N/A,N/A,"ProRetina Therapeutics, S.L.",Pza. CEIN,31110 Noain (Navarra),,,,Spain,271408,2008,
Tosedostat,n/a,2008-12-10,Treatment of acute myeloid leukemia,Designated,,,N/A,N/A,CTI BioPharma Corporation,3101 Western Avenue,Suite 600,Seattle,Washington,98121,USA,272408,2008,
2-(2-phenylvinyl)-4-[4-methylpiperazin-l-yl)]-6-(5-methyl-2H-pyrazol-3-yl-amino)-pyrimidine L(+) tartrate salt,n/a,2008-12-22,Treatment of multiple myeloma.,Designated,,,N/A,N/A,"EntreMed, Inc.",Research Triangle Park Center,Suite 400,Durham,North Carolina,27703,USA,270408,2008,
tesetaxel,n/a,2008-12-22,Treatment of gastric cancer,Designated,,,N/A,N/A,Genta Inc.,200 Connell Drive,,Berkeley Heights,New Jersey,7922,USA,272508,2008,
paclitaxel aqueous gel,Oncogel (Tm),2008-12-23,Treatment of brain cancer.,Designated,,,N/A,N/A,BTG International Inc.,5214 Maryland Way,Suite 405,Brentwood,Tennessee,37027,USA,270208,2008,
autologous olfactory neural progenitors,Rhinocytes,2008-12-31,Treatment of amyotrophic lateral sclerosis,Designated,,,N/A,N/A,"RhinoCyte, Inc.",201 E. Jefferson Street,,Louisville,Kentucky,40202,USA,260108,2008,
lutetium Lu 177 dotatate,n/a,2009-01-12,Treatment of gastro-entero-pancreatic neuroendocrine tumors,Designated/Approved,Approved for Orphan Indication,"Treatment of somatostatin receptor positive GEP-NETs including foregut, midgut, and hindgut neuroendocrine tumors in adults",2018-01-26,2025-01-26,Advanced Accelerator Applications,The Empire State Building,350 5th Avenue,New York,New York,10118,USA,271008,2009,3301
HPV-16 cancer therapeutic trojan peptide vaccine,n/a,2009-01-12,Treatment of HPV-16 expressing head and neck squamous cell carcinoma.,Designated,,,N/A,N/A,"Gliknik, Inc.",801 W. Baltimore Street,,Baltimore,Maryland,21201,USA,273508,2009,
omacetaine mepesuccinate,n/a,2009-01-12,Treatment of myelodysplastic syndromes,Designated,,,N/A,N/A,IVAX International GmbH,Alpenstrasse 2,8640 Rapperswil,,,,Switzerland,272608,2009,
"(S)-4,5-dihydro-2[2-hydroxy-3-(3,6,9-trioxadecyloxy)phenyl]-4-methyl-4-thiaxolecarboxylic acid",n/a,2009-02-04,Treatment of chronic iron overload in patients with transfusion-dependent anemias,Designated,,,N/A,N/A,Shire Development LLC,300 Shire Way,,Lexington,Massachusetts,2421,USA,269408,2009,
gene encoding chimeric CD40 ligand,n/a,2009-02-04,Treatment of chronic lymphocytic leukemia,Designated,,,N/A,N/A,"Memgen, LLC",402 W. Broadway,Suite 400,San Diego,California,92101,USA,273608,2009,
recombinant human minibody against complement component C5,Mubodina,2009-02-04,Treatment of primary membranoproliferative glomerulonephritis,Designated,,,N/A,N/A,ADIENNE S.A.,Via Zurigo 46,6900 Lugno,,,,Switzerland,270908,2009,
recombinant human minibody against complement component C5 fused with RGD-motif,n/a,2009-02-04,Prevention of ischemia/reperfusion injury associated with solid organ transplantation.,Designated,,,N/A,N/A,ADIENNE S.A.,Via Zurigo 46,6900 Lugno,,,,Switzerland,270308,2009,
"(1R,3R,4R,5S)-3-O-[2-O-benzoyl-3-O-(sodium(2S)-3-cyclohexyl-propanoate-",n/a,2009-02-17,Treatment of vaso-occlusive crisis in patients with sickle cell disease.,Designated,,,N/A,N/A,"Pfizer, Inc.",500 Arcola Road,,Collegeville,Pennsylvania,19426,USA,274608,2009,
"cholest-4-en-3-one, oxime",n/a,2009-02-17,Treatment of spinal muscular atrophy.,Designated,,,N/A,N/A,"Genentech, Inc.",A Roche Group Member,1 DNA Way,South San Francisco,California,94080,USA,273108,2009,
civamide,n/a,2009-02-17,Treatment of postherpetic neuralgia.,Designated,,,N/A,N/A,"Winston Laboratories, Inc.",100 Fairway Drive,,Vernon Hills,Illinois,60061,USA,272308,2009,
cyclosporine,n/a,2009-02-17,Treatment of graft-versus-host disease,Designated,,,N/A,N/A,Sigmoid Pharma Limited,Dublin City University,,,,,Ireland,275108,2009,
cyclosporine,n/a,2009-02-17,Prophylaxis of graft-versus-host disease,Designated,,,N/A,N/A,Sigmoid Pharma Limited,Dublin City University,,,,,Ireland,273308,2009,
talampanel,n/a,2009-02-17,Treatment of glioma,Designated/Withdrawn,,,N/A,N/A,"TEVA Neuroscience, Inc.",425 Privet Road,,Horsham,Pennsylvania,19044,USA,274408,2009,
alpha1-proteinase inhibitor (human),n/a,2009-02-20,Treatment of cystic fibrosis,Designated,,,N/A,N/A,CSL Behring LLC,1020 First Avenue,P. O. Box 61501,King of Prussia,Pennsylvania,19406,USA,272908,2009,
peptide-based vaccine targeting telomerase reverse transcriptase,n/a,2009-02-20,Treatment of telomerase reverse transcriptase (TERT) positive non-small cell lung cancer in HLA-A*0201 positive patients,Designated,,,N/A,N/A,VAXON-Biotech,3-5 impasse Reille,,,,,France,272108,2009,
bosutinib,Bosulif,2009-02-24,Treatment of chronic myelogenous leukemia,Designated/Approved,Approved for Orphan Indication,"Treatment of adult patients with chronic, accelerated or blast phase Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) with resistance, or intolerance to prior therapy",2012-09-04,2019-09-04,Pfizer Inc.,445 Eastern Point Road,,Groton,Connecticut,6340,USA,274808,2009,1288
bosutinib,Bosulif,2009-02-24,Treatment of chronic myelogenous leukemia,Designated/Approved,Approved for Orphan Indication,Treatment of adult patients with newly-diagnosed chronic phase Philadelphia chromosome-positive chronic myelougenous leukemia,2017-12-19,2024-12-19,Pfizer Inc.,445 Eastern Point Road,,Groton,Connecticut,6340,USA,274808,2009,3220
2-iminobiotin,n/a,2009-02-24,Treatment of perinatal asphyxia.,Designated,,,N/A,N/A,Neurophyxia B.V.,Onderwijsboulevard 219,,,,,Netherlands,275609,2009,
beclomethasone,n/a,2009-03-04,Treatment of pediatriac patients with ulcerative colitis,Designated,,,N/A,N/A,"Aptalis Pharma US, Inc.",100 Somerset corporate Blvd,,Bridgewater,New Jersey,8807,USA,274908,2009,
enzastaurin,n/a,2009-03-04,Treatment of diffuse large B-cell lymphoma,Designated,,,N/A,N/A,Denovo Biopharma LLC,6331 Nancy Ridge Drive,,San Diego,California,92121,USA,277209,2009,
ofatumumab,Arzerra,2009-03-10,Treatment of chronic lymphocytic leukemia,Designated/Approved,Approved for Orphan Indication,Treatment of chronic lymphocytic leukemia (CLL) refractory to alemtuzumab and fludarabine,2009-10-26,2016-10-26,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,USA,275809,2009,230
ofatumumab,Arzerra,2009-03-10,Treatment of chronic lymphocytic leukemia,Designated/Approved,Approved for Orphan Indication,"Ofatumumab in combination with chlorambucil, for the treatment of previously untreated patients with chronic lymphocytic leukemia (CLL) for whom fludarabine-based therapy is considered inappropriate.",2014-04-17,2021-04-17,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,USA,275809,2009,1864
ofatumumab,Arzerra,2009-03-10,Treatment of chronic lymphocytic leukemia,Designated/Approved,Approved for Orphan Indication,For extended treatment of patients who are in complete or partial response after at least two lines of therapy for recurrent or progressive CLL.,2016-01-19,2023-01-19,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,USA,275809,2009,2506
ofatumumab,Arzerra,2009-03-10,Treatment of chronic lymphocytic leukemia,Designated/Approved,Approved for Orphan Indication,Arzerra in combination with fludarabine and cyclophosphamide for the treatment of patients with relapsed chronic lymphocytic leukemia (CLL).,2016-08-30,N/A,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,USA,275809,2009,2730
tenofovir,Viread,2009-03-17,Treatment of pediatric HIV infection.,Designated/Approved,Approved for Orphan Indication,Treatment of HIV infection in combination with other antiretroviral agents in patients 12 to less than 18 years of age,2010-03-24,2017-03-24,"Gilead Sciences, Inc.",333 Lakeside Drive,,Foster city,California,94404,USA,276209,2009,372
"Technetium Tc99m sulfur colloid injection, lyophilized",Technetium Tc99m Sulfur Colloi,2009-03-17,For localization of sentinel lymph nodes in patients with melanoma.,Designated/Approved,Approved for Orphan Indication,Localization of lymph nodes draining a primary tumor in patients with melanoma when used with a hand-held gamma counter,2012-08-13,2019-08-13,"Pharmalucence, Inc.",10 DeAngelo Drive,,Bedford,Massachusetts,1730,USA,271608,2009,1245
lyso-thermosensitive lipsomal doxorubicin,Thermodox (R),2009-03-17,Treatment of hepatocellular carcinoma,Designated,,,N/A,N/A,Celsion Corporation,997 Lenox Drive,Suite 100,Lawrenceville,New Jersey,8648,USA,276009,2009,
2-(2-phenylvinyl)-4-[4-methylpiperazin-l-yl)]-6-(5-methyl-2H-pyrazol-3-ylamino)-pyrimidine L(+) tartrate salt,n/a,2009-03-18,Treatment of ovarian carcinoma,Designated,,,N/A,N/A,"EntreMed, Inc.",Research Triangle Park Center,Suite 400,Durham,North Carolina,27703,USA,277409,2009,
miltefosine,Miltex/Impavido,2009-03-18,Topical treatment of cutaneous lymphoma encompassing cutaneous manifestations of T-cell lymphoma and B-cell lymphoma,Designated,,,N/A,N/A,ExperGen Drug Development GmbH,Hernalser Haupstrasse 24/16,,,,,Austria,275409,2009,
"N-(5-tert-Butylisoxazol-3-yl)-N'-{4-[7-(2-(morpholin-4-yl)ethoxy) imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea di-hydrochloride salt",n/a,2009-03-18,Treatment of acute myeloid leukemia,Designated,,,N/A,N/A,"Daiichi Sankyo, Inc.",211 Mount Airy Road,,Basking Ridge,New Jersey,7920,USA,277109,2009,
D-Phe-Cys-Tyr-D-Trp-Lys-Cys-Thr-Nh2 (disulfide bridge: 2-6) acetate,n/a,2009-03-19,"Treatment of melanoma, stages IIb through IV",Designated/Withdrawn,,,N/A,N/A,"Thallion Pharmaceuticals, Inc.",7150 Alexander-Fleming,,,,,Canada,277709,2009,
plasmin (human),n/a,2009-03-30,Treatment of acute peripheral arterial occlusion,Designated/Withdrawn,,,N/A,N/A,"Grifols Therapeutics, Inc.",8368 US 70 Business Hwy West,,Clayton,North Carolina,27520,USA,275308,2009,
Allogeneic human aortic endothelial cells cultured in a porcine gelatin matrix,Vascugel (R),2009-04-03,Prevention of arteriovenous fistula or arteriovenous graft failure in patients with end satge renal disease receiving hemodialysis or preparing for hemodialysis,Designated/Withdrawn,,,N/A,N/A,Shire,300 Shire Way,,Lexington,Massachusetts,2421,USA,270108,2009,
Anti-T cell receptor murine monoclonal antibody,n/a,2009-04-03,Prophylaxis of acute rejection of solid organ transplantation,Designated,,,N/A,N/A,"Tolera Therapeutics, Inc.",4717 Campus Drive #800,,Kalamazoo,Michigan,49008,USA,275709,2009,
chimeric murine/human IgG1 monoclonal antibody to human interleukin-3 receptor alpha chain,n/a,2009-04-03,Treatment of acute myeloid leukemia,Designated/Withdrawn,,,N/A,N/A,CSl Limited,45 Poplar Road,,,,,Australia,277309,2009,
"paclitaxel, micellar",Paclical,2009-04-03,Treatment of ovarian cancer,Designated,,,N/A,N/A,Oasmia Pharmaceutical AB,Vallongatan,,Uppsala,,,Sweden,278309,2009,
"sodium 4-{ [9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido [5,4-d] [2] benzazepin-2-yl]-2-methoxybenzoate",n/a,2009-04-03,Treatment of ovarian cancer,Designated/Withdrawn,,,N/A,N/A,"Millennium Pharmaceuticals, Inc.",40 Landsdowne Street,,Cambridge,Massachusetts,2139,USA,276309,2009,
vonapanitase,n/a,2009-04-03,Prevention of arteriovenous fistula and arteriovenous graft failure in patients with chronic kidney disease (CKD) who are receiving hemodialysis or preparing for hemodialysis,Designated,,,N/A,N/A,"Proteon Therapeutics, Inc.",200 West Street,,Waltham,Massachusetts,2451,USA,273908,2009,
Caplacizumab,n/a,2009-04-14,Treatment of thrombotic thrombocytopenic purpura,Designated,,,N/A,N/A,Ablynx NV,Technologiepark 21,B-9052,Zwijnaarde,,,Belgium,277909,2009,
macitentan,n/a,2009-04-14,Treatment of idiopathic pulmonary fibrosis.,Designated/Withdrawn,,,N/A,N/A,Actelion Pharmaceuticals Ltd.,Gewerbestrasse 16,,,,,Switzerland,279309,2009,
oncophage,n/a,2009-04-14,Treatment of glioma,Designated,,,N/A,N/A,"Agenus, Inc.",3 Forbes Road,,Lexington,Massachusetts,2421,USA,274208,2009,
tobramycin liposomal for inhalation,Fluidosomes,2009-04-14,Treatment of chronic pulmonary infection due to P. aeruginosa in cystic fibrosis patients,Designated/Withdrawn,,,N/A,N/A,Axentis Pharma AG,138 Limmatquai,CH-8001,Zurich,,,Switzerland,278009,2009,
D-mannitol and L-proline,Prodarsan,2009-04-20,Treatment of Cockayne syndrome,Designated,,,N/A,N/A,DNage B.V.,Darwinweg 24,,,,,Netherlands,277009,2009,
glycerol phenylbutyrate,Ravicti,2009-04-27,Maintenance treatment of patients with deficiencies in enzymes of the urea cycle,Designated/Approved,Approved for Orphan Indication,"Use as a nitrogen-binding adjunctive therapy for chronic management of adult and pediatric patients at least 2 years of age with urea cycle disorders (UCDs) that cannot be managed by dietary protein restriction and/or amino acid supplementation alone. RAVICTI must be used with dietary protein restriction and, in some cases, dietary supplements (eg, essential amino acids, arginine, citrulline, protein-free calorie supplements).",2013-02-01,2020-02-01,"Horizon Pharma USA, INc.",150 South Saunders Road,Suite 400,Lake Forest,Illinois,60045,USA,203505,2009,1376
lenalidomide,Revlimid,2009-04-27,Treatment of mantle cell lymphoma,Designated/Approved,Approved for Orphan Indication,"Treatment of mantle cell lymphoma whose disease has relapsed or progressed after two prior therapies, one of which included bortezomib.",2013-06-05,2020-06-05,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,USA,278809,2009,1500
glycerol phenylbutyrate,Ravicti,2009-04-27,Maintenance treatment of patients with deficiencies in enzymes of the urea cycle,Designated/Approved,Approved for Orphan Indication,For use as a nitrogen-binding agent for chronic management of pediatric patients =2 months and <2 years of age with urea cycle disorders (UCDs) who cannot be managed by dietary protein restriction and/or amino acid supplementation alone,2017-04-28,2024-04-28,"Horizon Pharma USA, INc.",150 South Saunders Road,Suite 400,Lake Forest,Illinois,60045,USA,203505,2009,2923
"4,6,8-trihydroxy-10-(3,7,11-trimethyldodeca-2,6,10-trienyl)-5,10-dihydrodibenzo b,e][1,4]diazepin-11-one",n/a,2009-04-27,Treatment of malignant glioma.,Designated/Withdrawn,,,N/A,N/A,"Thallion Pharmaceuticals, Inc.",7150 Alexander-Fleming,,,,,Canada,278709,2009,
Antisense oligonucleotide directed against connexin43,Nexagon,2009-04-27,Treatment of persistent corneal epithelial defects,Designated,,,N/A,N/A,"CoDa Therapeutics, Inc.",10505 Sorrento Valley Road,,San Diego,California,92121,USA,279609,2009,
purified bovine type collagen,n/a,2009-04-27,Treatment of idiopathic pulmonary fibrosis,Designated,,,N/A,N/A,"ImmuneWorks, Inc.",351 West 10th Street,,Indianapolis,Indiana,46202,USA,280609,2009,
eculizumab,Soliris,2009-04-29,Treatment of atypical hemolytic uremic syndrome,Designated/Approved,Approved for Orphan Indication,For the treatment of atypical Hemolytic Uremic Syndrome (aHUS),2011-09-23,2018-09-23,"Alexion Pharmaceuticals, Inc.",352 Knotter Drive,,Cheshire,Connecticut,6410,USA,279509,2009,877
Antihemophilic factor (recombinant) formulated with sucrose reconstituted with liposome diluent,Kogenate Fs/Liposomal Diluent,2009-04-29,Treatment of hemophilia A,Designated/Withdrawn,,,N/A,N/A,Bayer HealthCare LLC,555 Whiteplains Road,,Tarrytown,New York,10591,USA,280309,2009,
uridine triacetate,n/a,2009-05-01,An antidote in the treatment of 5-fluorouracil or capecitabine poisoning,Designated/Approved,Approved for Orphan Indication,"For the emergency treatment of adult and pediatric patients following a fluorouracil or capecitabine overdose regardless of the presence of symptoms, or who exhibit early-onset, severe or life-threatening toxicity affecting the cardiac or central nervous system, and/or early-onset, unusually severe adverse reactions (e.g., gastrointestinal toxicity and/or neutropenia) within 96 hours following the end of fluorouracil or capecitabine administration",2015-12-11,2022-12-11,Wellstat Therapeutics Corp.,14200 Shady Grove Road,Suite 600,Rockville,Maryland,20850,USA,273808,2009,2415
paclitaxel,n/a,2009-05-01,Treatment of pancreatic cancer,Designated,,,N/A,N/A,"SynCore Biotechnology Co., Ltd.",No. 84 Chung Shan Rd,Tung-Shan Shine I-Lan 269,,,,Taiwan,280409,2009,
ascorbic acid,n/a,2009-05-11,Treatment of Charcot-Marie-Tooth disease type 1A.,Designated,,,N/A,N/A,Murigenetics SAS,Faculte de Medecine Timone,13005 Marseille,,,,France,280909,2009,
liposomal cyclosporine,n/a,2009-05-11,Treatment of bronchiolitis obliterans,Designated,,,N/A,N/A,"Breath Therapeutics, Inc.",90 Canal Street,4th Floor,Boston,Massachusetts,2114,USA,252107,2009,
Recombinant adeno-associated virus (serotype 2) (rAAV2) gene transfer agent expressing RPE65,n/a,2009-05-11,Treatment of Leber's congential amaurosis,Designated,,,N/A,N/A,AmpliPhi Biosciences Corporation,601 Union St.,Suite 4200,Seattle,Washington,98111,USA,279209,2009,
tobramycin liposomal,Fluidosoes(Tm)-Tobramycin,2009-05-11,Treatment of pulmonary infection due to Burkholderia cepacia complex pathogens in cystic fibrosis patients,Designated/Withdrawn,,,N/A,N/A,Axentis Pharma AG,138 Limmatquai,Zurich,,,,Switzerland,281709,2009,
dimebon,n/a,2009-05-12,Treatment of Huntington's Disease.,Designated,,,N/A,N/A,"Medivation, Inc.",201 Spear Street,,San Francisco,California,94105,USA,282309,2009,
S-nitrosoglutathione,n/a,2009-05-12,Management of cystic fibrosis patients to improve airway clearance and to improve or stabilize pulmonary function,Designated,,,N/A,N/A,"N30 PHARMAceuticals, LLC",3122 Sterling Circle,,Boulder,Colorado,80301,USA,281609,2009,
elosulfase alfa,Vimizim,2009-05-15,Use in the treatment of mucopolysaccharidosis (MPS) Type IV A (Morquio A syndrome),Designated/Approved,Approved for Orphan Indication,Patients with Mucopolysaccharidosis type IVA (MPS IVA; Morquio A syndrome),2014-02-14,2021-02-14,BioMarin Pharmaceutical Inc.,105 Digital Drive,,Novato,California,94949,USA,280809,2009,1736
aztreonam,n/a,2009-05-15,Improvement of respiratory symptoms in patients with bronchiectasis and gram-negative bacteria in the airways.,Designated/Withdrawn,,,N/A,N/A,"Gilead Sciences, Inc.",2025 1st Avenue,,Seattle,Washington,98121,USA,266208,2009,
picibanil,n/a,2009-05-15,Treatment of patients with lymphatic malformations,Designated,,,N/A,N/A,"Royds Pharmaceuticals, Inc.",4365 Route 1 South,,Princeton,New Jersey,8540,USA,282009,2009,
tenecteplase,n/a,2009-05-15,Restore function to hemodialysis catheters,Designated/Withdrawn,,,N/A,N/A,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,USA,276709,2009,
N-tert-butyl-3-[5-methyl-2-{[4-(2-pryyolidin-1-ylethoxy)phenyl]amino}pyrimidin-4-yl-amino] benzenesulfonamide dihydrochloride monohydrate,n/a,2009-05-18,Treatment of secondary and primary myelofibrosis,Designated,,,N/A,N/A,Impact Biomedicines,12526 High Bluff Drive,Suite 260,San Diego,California,92130,USA,279409,2009,
capsaicin,Qutenza,2009-05-22,Management of neuropathic pain in patients with postherpetic neuralgia,Designated/Approved,Approved for Orphan Indication,Management of neuropathic pain associated with postherpetic neuralgia,2009-11-16,2016-11-16,"Acorda Therapeutics, Inc.",420 Saw Mill River Road,,Ardsley,New York,10502,USA,269508,2009,178
idebenone,n/a,2009-05-22,"Treatment of mitochondrial myopathy, encephalopathy, lactic acidosis with stroke-like episodes syndrome (MELAS)",Designated,,,N/A,N/A,Santhera Pharmaceuticals (Switzerland) Ltd.,25 Hammerstrasse,,Liestal,,,Switzerland,281909,2009,
melphalan hydrochloride,n/a,2009-05-22,Treatment of neuroendocrine tumors,Designated,,,N/A,N/A,"Delcath Systems, Inc.",1301 6th Avenue,43rd Floor,New York,New York,10019,USA,281809,2009,
astuprotimut-R,n/a,2009-05-29,Treatment of MAGE-A3 positive stages IIb to IV malignant melanoma,Designated/Withdrawn,,,N/A,N/A,"GlaxoSmithKline Biologicals, S.A.",Rue de l'Institut 89,,,,,Belgium,283809,2009,
astuprotimut-R,n/a,2009-05-29,Treatment of MAGE-A3 positive non-small cell lung cancer,Designated,,,N/A,N/A,"GlaxoSmithKline Biologicals, S.A.",Rue de I'Institut 89,B-1330 Rixensart,,,,Belgium,283709,2009,
lapatinib,Tykerb,2009-05-29,Treatment of ErbB2 positive gastric cancer,Designated/Withdrawn,,,N/A,N/A,Novartis Pharmaceuticals Corp.,One Health Plaza,,East Hanover,New Jersey,7936,USA,284209,2009,
lapatinib ditosylate hydrochloride,Tykerb,2009-05-29,Treatment of ErbB2 positive esophageal cancer,Designated/Withdrawn,,,N/A,N/A,Novartis Pharmaceuticals Corp.,One Health Plaza,,East Hanover,New Hampshire,7936,USA,284309,2009,
pentagastrin,n/a,2009-05-29,To aid in the diagnosis of medullary thyroid carcinoma,Designated,,,N/A,N/A,"Medical Defense Technologies, LLC",717 Pinehurst Drive,,Chapel Hill,North Carolina,27517,USA,277509,2009,
ranagengliotucel-L,Glionix(Tm),2009-05-29,Treatment of astrocytic tumors,Designated,,,N/A,N/A,NovaRx Corporation,6828 Nancy Ridge Drive,,San Diego,California,92121,USA,280009,2009,
"Sterile Bicarbonate Infusate, Hemofiltration, Hemodiafiltration, and Hemopdialysis Solution",Accusol,2009-05-29,For use as a replacement solution in adults and children during Continous Renal Replacement Therapy,Designated,,,N/A,N/A,"Nikkiso America, Inc.",5910 Pacific Center Blvd,Suite 110,San Diego,California,92121,USA,276609,2009,
velaglucerase-alfa,Vpriv,2009-06-08,Treatment of Gaucher disease,Designated/Approved,Approved for Orphan Indication,Treatment of Type I Gaucher Disease,2010-02-26,N/A,"Shire Human Genetics Therapies, Inc.",700 Main Street,,Cambridge,Massachusetts,2139,USA,283509,2009,263
everolimus,Afinitor,2009-06-08,"Treatment of tuberous sclerosis complex including TSC-associated subependymal giant cell astrocytoma (SEGA), TSC-associated angiomyolipoma and TSC-associated lymphangioleiomyomatosis (LAM)",Designated/Approved,Approved for Orphan Indication,Treatment of patients with subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis who require therapeutic intervention but are not candidates for curative surgical resection,2010-10-29,2017-10-29,Novartis Pharmaceuticals Corp.,"One Health Plaza, 315/5450A",,East Hanover,New Jersey,7936,USA,283609,2009,508
everolimus,Afinitor,2009-06-08,"Treatment of tuberous sclerosis complex including TSC-associated subependymal giant cell astrocytoma (SEGA), TSC-associated angiomyolipoma and TSC-associated lymphangioleiomyomatosis (LAM)",Designated/Approved,Approved for Orphan Indication,Treatment of adults with renal angiomyolipoma and tuberous sclerosis complex (TSC) not requiring immediate surgery.,2012-04-26,2019-04-26,Novartis Pharmaceuticals Corp.,"One Health Plaza, 315/5450A",,East Hanover,New Jersey,7936,USA,283609,2009,1053
everolimus,Afinitor,2009-06-08,"Treatment of tuberous sclerosis complex including TSC-associated subependymal giant cell astrocytoma (SEGA), TSC-associated angiomyolipoma and TSC-associated lymphangioleiomyomatosis (LAM)",Designated/Approved,Approved for Orphan Indication,For the adjunctive treatment of adult and pediatric patients age 2 years and older with tuberous sclerosis complex (TSC)-associated partial-onset seizures.,2018-04-11,TBD,Novartis Pharmaceuticals Corp.,"One Health Plaza, 315/5450A",,East Hanover,New Jersey,7936,USA,283609,2009,3229
pertuzumab,n/a,2009-06-08,Treatment of ovarian cancer,Designated,,,N/A,N/A,"Genentech, Inc.",1 DNA Way,MS # 355C,South San Francisco,California,94080,USA,284409,2009,
catumaxomab,n/a,2009-07-01,Treatment of gastric cancer,Designated,,,N/A,N/A,"Neoviibiotech North America, Inc.",920 Winter Street,,Waltham,Massachusetts,2451,USA,284509,2009,
tetrabenazine,n/a,2009-07-01,"Treatment of Tourette's Syndrome in school-age children, ages 5-16",Designated,,,N/A,N/A,Valeant International (Barbados) SRL,Welches Christ Church,"Barbados, BB17154",,,,Barbados,278109,2009,
midostaurin,Rydapt,2009-07-07,Treatment of acute myeloid leukemia,Designated/Approved,Approved for Orphan Indication,"Treatment of adult patients with newly diagnosed acute myeloid leukemia (AML) that is FLT3 mutation-positive as detected by an FDA approved test, in combination with standard cytarabine and daunorubicin induction and cytarabine consolidation.",2017-04-28,2024-04-28,Novartis Pharmaceuticals Corporation,"One Health Plaza, 105/3W038",,East Hanover,New Jersey,7936,USA,285909,2009,2852
anti-nogo-A monoclonal antibody,n/a,2009-07-07,Treatment of amyotrophic lateral sclerosis,Designated/Withdrawn,,,N/A,N/A,GlaxoSmithKline,Glaxo Wellcome House,"Greenford, Middlesex, UK UB6 0NN",,,,United Kingdom,285709,2009,
Gastrin 17C Diphtheria Toxoid Immunogen,n/a,2009-07-07,Treatment of pancreatic cancer,Designated,,,N/A,N/A,Astrimmune Ltd.,Mansfield i-cente,Hamilton Way,Mansfield,,,United Kingdom,256708,2009,
ecopipam hydrochloride,n/a,2009-07-21,Symptomatic treatment of self injurious behaviors in patients with Lesch-Nyhan disease.,Designated,,,N/A,N/A,"Psyadon Pharmaceuticals, Inc.",20451 Seneca Meadows Parkway,,Germantown,Maryland,20876,USA,284109,2009,
masitinib,n/a,2009-07-21,Treatment of patients with pancreatic cancer,Designated,,,N/A,N/A,AB Science,"3, avenue George V",,,,,France,285309,2009,
trabedersen,n/a,2009-07-21,Treatment of pancreatic cancer.,Designated,,,N/A,N/A,"Oncotelic, Inc.",29397 Agoura Road,Suite 107,Agoura Hills,California,91301,USA,286709,2009,
pasireotide,Signifor,2009-07-24,Treatment of Cushing's disease,Designated/Approved,Approved for Orphan Indication,Treatment of adult patients with Cushing's disease for whom pituitary surgery is not an option or has not been curative,2012-12-14,2019-12-14,Novartis Pharmaceuticals Corporation,One Health Plaza,"Bldg 104, 3K28",East Hanover,New Jersey,7936,USA,288709,2009,1239
"beclomethasone 17,21-dipropionate",Orbec(R),2009-07-24,Treatment of gastrointestinal symptoms with chronic graft versed host disease in patients undergoing allogenic hematopoietic cell transplantation,Designated,,,N/A,N/A,"Soligenix, Inc.",29 Emmons Drive,,Princeton,New Jersey,8540,USA,285609,2009,
Anti-EphA1 monoclonal antibody conjugated to mcMMAF,n/a,2009-07-27,Treatment of ovarian cancer,Designated/Withdrawn,,,N/A,N/A,"MedImmune, LLC",One MedImmune Way,,Gaithersburg,Maryland,20878,USA,288009,2009,
DNA plasmid expressing diphtheria toxin triggered by the presence of oncofetal gen H19,n/a,2009-08-20,Treatment of ovarian cancer,Designated,,,N/A,N/A,"BioCancell Therapeutics US, Inc.",1 Kendall Square,"Building 1400, Suite 14303",Cambridge,Massachusetts,2139,USA,287009,2009,
expanded allogeneic human dermal fibroblasts in hypothermosol(r)-FRS,n/a,2009-08-20,Treatment of Dystrophic Epidermolysis Bullosa.,Designated,,,N/A,N/A,Intercytex Ltd.,St. John's Innovation Centre,Cambridge CB4 0WS,,,,United Kingdom,287909,2009,
methotrexate,n/a,2009-08-20,Treatment of acute lymphoblastic leukemia,Designated,,,N/A,N/A,Orbona Pharma Ltd,Old Chambers,93-94 West Street,England,,,United Kingdom,286409,2009,
Recombinant antibody construct against human CD30 and CD16A,n/a,2009-08-20,Treatment of Hodgkin lymphoma,Designated,,,N/A,N/A,Affimed GmbH,Technologie Park,"Heidelberg,",,,,Germany,288109,2009,
pasireotide,n/a,2009-08-25,Treatment of acromegaly,Designated/Approved,Approved for Orphan Indication,Treatment of patients with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option,2014-12-15,2021-12-15,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,USA,288609,2009,1938
"5-[1-(2,6-Dichlorobenzyl)-piperidin-4-yl]methoxyquinazoline-2,4-diamine",n/a,2009-08-25,Treatment of spinal muscular atrophy,Designated,,,N/A,N/A,CureSMA,925 Busse Avenue,,Elk Grove Village,Illinois,60007,USA,289509,2009,
doxorubicin,n/a,2009-08-25,Treatment of hepatocellular carcinoma.,Designated,,,N/A,N/A,"Delcath Systems, Inc.",1301 6th Avenue,43rd Floor,New York,New York,10019,USA,286109,2009,
Exon 51 specific phosphorothioate oligonucleotide,n/a,2009-08-25,Treatment of Duchenne Muscular Dystrophy.,Designated,,,N/A,N/A,"BioMarin Pharmaceutical, Inc.",105 Digital Drive,,Novato,California,94949,USA,287209,2009,
liposomal amikacin,Arikace,2009-08-25,Treatment of bronchiectasis in patients with Pseudomonas aeruginosa or other susceptible microbial pathogens,Designated,,,N/A,N/A,"Insmed, Inc.",Princeton Corpoarate Plaza,Suite C,Monmouth Junction,New Jersey,8852,USA,282109,2009,
mibefradil,n/a,2009-08-25,Treatment of glioblastoma multiforme.,Designated,,,N/A,N/A,"Cavion, LLC",600 E. Water Street,,Charlottesville,Virginia,22902,USA,289209,2009,
recombinant adeno-associated virus encoded gene for X-linked mammalian inhibitor of apoptosis protein (XIAP),n/a,2009-08-25,Treatment of Huntington's disease.,Designated,,,N/A,N/A,"Neurologix, Inc.","One Bridge Plaza, North",,Fort Lee,New Jersey,7024,USA,287409,2009,
autologus CD34+ cells transfected with retroviral vector containing adenosine deaminase gene,n/a,2009-08-26,Treatment of severe combined immunodeficiency due to adenosine deaminase deficiency.,Designated,,,N/A,N/A,Glaxo Group Limited,I-3 Iron Bridge Road,Stockley Park West,,,,United Kingdom,286209,2009,
Taliglucerase alfa,Elelyso For Injection,2009-09-03,Treatment of Gaucher's disease,Designated/Approved,Approved for Orphan Indication,Use as long-term enzyme replacement therapy in patients with Type 1 Gaucher disease,2012-05-01,N/A,"Pfizer, Inc.",235 East 42nd Street,,New York,New York,10017,USA,191004,2009,971
paclitaxel protein-bound particles,Abraxane,2009-09-03,Treatment of pancreatic cancer.,Designated/Approved,Approved for Orphan Indication,"Treatment of metastatic adenocarcinoma of the pancreas as first-line treatment, in combination with gemcitabine.",2013-09-06,2020-09-06,"Abraxis BioScience, LLC","9225 Indian Creek Parkway, Suite 900",,Overland Park,Kansas,66210,USA,291009,2009,1464
macitentan,Opsumit,2009-09-03,Treatment of pulmonary arterial hypertension,Designated/Approved,Approved for Orphan Indication,"Treatment of pulmonary arterial hypertension (PAH, WHO Group 1) to delay disease progression. Disease progression included: death, initiation of intravenous (IV) or subcutaneous prostanoids, or clinical worsening of PAH (decreased 6-minute walk distance, worsened PAH symptoms and need for additional PAH treatment). Opsumit also reduced hospitalization for PAH.",2013-10-18,2020-10-18,Actelion Pharmaceuticals Ltd,Gewerbestrasse 16,,Allschwil,,,Switzerland,282209,2009,1506
Belinostat,Beleodaq,2009-09-03,Treatment of peripheral T-cell lymphoma (PTCL).,Designated/Approved,Approved for Orphan Indication,Treatment of patients with relapsed or refractory peripheral T-cell lymphoma,2014-07-03,2021-07-03,"Spectrum Pharmaceuticals, Inc.",157 Technology Drive,,Irvine,California,92618,USA,289309,2009,1764
"8-[4-(1-aminocyclobutyl)phenyl]-9-phenyl-1,2,4-triazolo[3,4-f][1,6]naph-thyrin-3(2H)-one mono-hydrochloride",n/a,2009-09-03,Treatment of ovarian cancer.,Designated,,,N/A,N/A,Merck Sharp & Dohme Corp.,P. O. Box 1000,UG-2C50,North Wales,Pennsylvania,19454,USA,291309,2009,
anthrax immune globulin,n/a,2009-09-03,Treatment of inhalation anthrax disease,Designated/Withdrawn,,,N/A,N/A,"Emergent Biosolutions, Inc.",300 Professional Drive,,Gaithersburg,Maryland,20879,USA,288509,2009,
gylceryl tri (4-pheynlybutyrate),n/a,2009-09-03,For intermittent or chronic treatment of patients with cirrhosis and any grade hepatic encephalopathy.,Designated,,,N/A,N/A,"Horizon Therapeutics, Inc.",520 Lake Cook Road,Suite 520,Deerfield,Illinois,60015,USA,269308,2009,
idursulfase IT,n/a,2009-09-03,For treatment of neurocognitive symptoms associated with Hunter Syndrome,Designated,,,N/A,N/A,Shire Human Genetic Therapies,300 Shire Way,,Lexington,Massachusetts,2421,USA,289709,2009,
lestaurtinib,n/a,2009-09-03,Treatment of Philadelphia-negative classic myeloproliferative disorders,Designated,,,N/A,N/A,"Teva Branded Pharmaceutical Products R&D, Inc.",41 Moores Road,P. O. Box 4011,Frazer,Pennsylvania,19355,USA,289109,2009,
peptide-conjugated phosporodiamidate morpholino oligomer (PPMO),n/a,2009-09-03,"Treatment of Duchenne muscular dystrophy in patients with a deletion, duplication or frame shift mutation correctable by skipping of exon 50 of the dystrophin gene to allow restoration of the reading frame (including mutations within exons 51, 51-53, or 51-55).",Designated,,,N/A,N/A,"Sarepta Therapeutics, Inc.",215 First Street,Suite 415,Cambridge,Massachusetts,2142,USA,286009,2009,
perifosine,n/a,2009-09-03,Treatment of multiple myeloma.,Designated/Withdrawn,,,N/A,N/A,Aeterna Zentaris GmbH,Weismuellerstrasse 50,D-60314 Frankfurt Am Main,,,,Germany,290909,2009,
progesterone,n/a,2009-09-03,For early intervention in the treatment of moderate to severe closed-head traumatic brain injury,Designated/Withdrawn,,,N/A,N/A,"BHR Pharma, LLC",607 Herndon Parkway,Suite 110,Herndon,Virginia,20170,USA,284809,2009,
Rebastinib,n/a,2009-09-03,Treatment of Philadelphia chromosome positive chronic myeloid leukemia,Designated,,,N/A,N/A,"Deciphera Pharmaceuticals, LLC",643 Massachusetts,Suite 200,Lawrence,Kansas,66044,USA,290509,2009,
rigosertib,n/a,2009-09-03,Treatment of myelodysplastic syndromes,Designated,,,N/A,N/A,"Onconova Therapeutics, Inc.",375 Pheasant Run,,Newtown,Pennsylvania,18940,USA,289409,2009,
sodium nitrite,n/a,2009-09-03,Prevention of ischemia reperfusion injury to donor organ tissue associated with solid organ transplantation,Designated,,,N/A,N/A,Hope Pharmaceuticals,16416 N. 92nd Street,,Scottsdale,Arizona,85260,USA,288209,2009,
tasisulam sodium,n/a,2009-09-03,Treatment of melanoma stages IIB through IV,Designated/Withdrawn,,,N/A,N/A,Eli Lilly and Company,Lilly Corporate Center,,Indianapolis,Indiana,46285,USA,289909,2009,
uridine triacetate,n/a,2009-09-03,Treatment of mitchondrial disease,Designated,,,N/A,N/A,Wellstat Therapeutics Corporation,14200 Shady Grove Road,Suite 600,Rockville,Maryland,20850,USA,290009,2009,
veliparib,n/a,2009-09-03,Treatment of epithelial ovarian cancer in combination with DNA-damaging agents,Designated,,,N/A,N/A,"AbbVie, Inc.",1 N. Waukegan Road,,North Chicago,Illinois,60064,USA,290209,2009,
cethromycin,Restanza(Tm),2009-09-09,Prophylactic treatment of plague due to Yersinia pestis,Designated,,,N/A,N/A,"Advanced Life Sciences, Inc.",1440 Davey Road,,Woodridge,Illinois,60517,USA,289009,2009,
cethromycin,Restanza(Tm),2009-09-09,Prophylactic treatment of tularemia due to Francisella tularensis.,Designated,,,N/A,N/A,"Advanced Life Sciences, Inc.",1440 Davey Road,,Woodridge,Illinois,60517,USA,288909,2009,
mesalamine and N-acetycysteine,n/a,2009-09-10,Treatment of pediatric patients with ulcerative colitis (inclusive through age 16 years),Designated,,,N/A,N/A,"Altheus Therapeutics, Inc.",755 Research Parkway,Suite 435,Oklahoma City,Oklahoma,73104,USA,275909,2009,
Netazepide,n/a,2009-09-10,Treatment of gastric carcinoids,Designated,,,N/A,N/A,Trio Medicines Ltd.,Pavillion View,Brighton BN1 1EY,,,,United Kingdom,243207,2009,
Nucleic acid aptamer binding to tumor cell nucleolin,n/a,2009-09-10,Treatment of acute myeloid leukemia,Designated,,,N/A,N/A,"Antisoma, Inc.",300 Technology Square,,Cambridge,Massachusetts,2139,USA,291609,2009,
L-pyr-L-glu-L-gln-L-leu-L-glu-L-arg-L-ala-L-leu-L-asn-L-ser-L-ser,n/a,2009-09-18,Prevention of delayed graft function following renal transplant,Designated,,,N/A,N/A,"Araim Pharmaceuticals, Inc.",712 Kitchawan Road,,Ossining,New York,10562,USA,289609,2009,
panobinostat,Faridak,2009-09-18,Treatment of Hodgkin's lymphoma,Designated/Withdrawn,,,N/A,N/A,Novartis Pharmaceuticals Corporation,"One Health Plaza, 105/3W038",,East Hanover,New Jersey,7936,USA,291509,2009,
human tumor necrosis factor coupled to the C terminus of CNGRCG peptide,n/a,2009-10-01,Treatment of liver cancer,Designated,,,N/A,N/A,Molecular Medicine S.p.A. (Molmed),Via Olgettina 58,,,,,Italy,204405,2009,
Paclitaxel protein-bound particles for injection suspension,Abraxane,2009-10-01,Treatment of stage IIb to IV melanoma,Designated/Withdrawn,,,N/A,N/A,Celgene Corporation,400 Connell Drive,Suite 7000,Berkeley Heights,New Jersey,7922,USA,290709,2009,
trastuzumab,Herceptin,2009-10-13,"Treatment of HER2-overexpressing advanced adenocarcinoma of the stomach, including gastroesophageal junction",Designated/Approved,Approved for Orphan Indication,"Treatment of patients with HER2 overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma, who have not received prior treatment for metastatic disease",2010-10-20,2017-10-20,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,USA,292409,2009,372
"4-benzyl-2-(a-naphtyl)-1,2,4-thiadiazolidine-3,5-dione",n/a,2009-10-13,Treatment of progressive supranuclear palsy,Designated/Withdrawn,,,N/A,N/A,"NOSCIRA, S.A.","Avda. de la Industria, 52",,Madrid,,,Spain,290109,2009,
bevacizumab,Avastin,2009-10-13,Treatment of melanoma stages IIb through IV as part of a combination chemotherapy regimen,Designated,,,N/A,N/A,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,USA,291709,2009,
Recombinant fusion protein-extracellular portion of CD95 fused to the Fc part of human IgG1,n/a,2009-10-13,Treatment of glioblastoma multiforme,Designated,,,N/A,N/A,Apogenix GmbH,Im Meuenheimer Feld 584,,,,,Germany,293009,2009,
pazopanib,Votrient,2009-10-20,Treatment of soft tissue sarcomas,Designated/Approved,Approved for Orphan Indication,Advanced soft tissue sarcoma (STS) who have received prior chemotherapy,2012-04-26,2019-04-26,Novartis Pharmaceuticals Corp,1 Health Plaza,,East Hanover,New Jersey,7936,USA,293809,2009,919
low molecular weight dextran sulfate,Ibsolvmir,2009-10-20,Prevention of graft rejection during pancreatic islet transplantation,Designated,,,N/A,N/A,TikoMed AB,Dag Hammarskjolds vag 10A,,,,,Sweden,292609,2009,
midazolam,n/a,2009-10-20,"Rescue treatment of seizures in patients who require control of intermittent bouts of increased seizure activity (e.g. acute repetitive seizures, seizure clusters)",Designated,,,N/A,N/A,"Proximagen, LLC",505 Waterford Park,Hwy 169 N,Plymouth,Minnesota,55441,USA,277809,2009,
"S-[2,3-bispalmitoyloxy-(2R)-propyl]-cysteinly-GNNDESNISFKEK",n/a,2009-10-20,Treatment of pancreatic cancer,Designated,,,N/A,N/A,MBiotec GmBH,"Hohenweg 13, D-82229 Seefeld",,,,,Germany,292809,2009,
caprine hyperimmune serum against HIV lysate,n/a,2009-10-28,Treatment of amyotrophic lateral sclerosis,Designated,,,N/A,N/A,Daval International Limited,50 Lady Somerset Road,,,,,United Kingdom,291109,2009,
dasiprotimut-T,Biovaxid,2009-10-28,Treatment of follicular lymphoma,Designated,,,N/A,N/A,"Biovest International, Inc.",324 S. Hyde Park Avenue,,Tampa,Florida,33606,USA,291909,2009,
diannexin,n/a,2009-10-28,Prevention of ischemia-reperfusion injury in solid organ transplants,Designated,,,N/A,N/A,"Astellas Pharma Global Development, Inc.",Three Parkway North,,Deerfield,Illinois,60015,USA,294109,2009,
golnerminogene pradenovec,Tnferade(Tm) Biologic,2009-10-28,Treatment of pancreatic cancer.,Designated,,,N/A,N/A,"GenVec, Inc.",65 West Watkins Mill Road,,Gaithersburg,Maryland,20878,USA,294209,2009,
sodium stibogluconate,n/a,2009-10-28,Treatment of cutaneous leishmaniasis,Designated,,,N/A,N/A,Surgeon General of the US Army,US Army Medical Research & Materiel Command,1430 Veterans Drive,Ft. Detrick,Maryland,21702,USA,293609,2009,
vosaroxin,n/a,2009-10-28,Treatment of acute myeloid leukemia,Designated,,,N/A,N/A,"Sunesis Pharmaceuticals, Inc.",395 Oyster Point Blvd,Suite 400,South San Francisco,California,94080,USA,294509,2009,
salmeterol xinafoate/fluticasone propionate,n/a,2009-10-29,Treatment of symptomatic exophthalmos associated with thyroid related eye disease,Designated,,,N/A,N/A,"Lithera, Inc.",9191 Towne Center Drive,,San Diego,California,92122,USA,273208,2009,
cyclic pyranopterin monophosphate (cPMP),n/a,2009-11-05,Treatment of molybdenum cofactor deficiency type A (MoCD),Designated,,,N/A,N/A,"Alexion Pharmaceuticals, Inc.",100 College Street,,New Haven,Connecticut,6510,USA,291209,2009,
Exon 44 specific phosphorothioate oligonucleotide,n/a,2009-11-05,Treatment of Duchenne Muscular Dystrophy in patients who have a mutation correctable by skipping of exon 44of the dystrophin gene.,Designated,,,N/A,N/A,"BioMarin Pharmaceutical, Inc.",105 Digital Drive,,Novato,California,94949,USA,288309,2009,
Hypothiocyanite and lactoferrin,Meveol,2009-11-05,Treatment of cystic fibrosis,Designated,,,N/A,N/A,Alaxia Biotechnologies Sante,3-11 Rue de la Perlerie,F- 69120 Vaulx-en-velin,,,,France,294609,2009,
Varbulin,Azixa,2009-11-05,Treatment of glioblastoma multiforme.,Designated,,,N/A,N/A,"Myrexis, Inc.",305 Chipeta Way,,Salt Lake City,Utah,84108,USA,290809,2009,
1-Cyclopropyl-3-[3-(5-morpholin-4-ylmethyl-1H-benzoimidazol-2-yl)-1H-pyrazol-4-yl]-urea,n/a,2009-11-12,Treatment of acute myeloid leukemia,Designated,,,N/A,N/A,Astex Therapeutics Ltd,436 Cambridge Science Park,CB4 0QA,,,,United Kingdom,291809,2009,
amifampridine phosphate,n/a,2009-11-12,Treatment of Lambert-Eaton Myasthenic Syndrome,Designated,,,N/A,N/A,"Catalyst Pharmaceuticals, Inc.",355 Alhambra Circle,Suite 1250,Coral Gables,Florida,33134,USA,295309,2009,
ponatinib,Iclusig,2009-11-20,Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL),Designated/Approved,Approved for Orphan Indication,Treatment of adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL) that is resistant or intolerant to prior tyrosine kinase inhibitor therapy.,2012-12-14,2019-12-14,ARIAD Pharmaceuticals Inc.,26 Landsdowne Street,,Cambridge,Massachusetts,2139,USA,294809,2009,1120
ponatinib,Iclusig,2009-11-20,Treatment of chronic myeloid leukemia,Designated/Approved,Approved for Orphan Indication,"Treatment of adult patients with chronic phase, accelerated phase, or blast phase chronic myeloid leukemia (CML) that is resistant or intolerant to prior tyrosine kinase inhibitor therapy.",2012-12-14,2019-12-14,ARIAD Pharmaceuticals Inc.,26 Landsdowne Street,,Cambridge,Massachusetts,2139,USA,294709,2009,1120
bevacizumab,Avastin,2009-11-20,In combination with a platinum and 5-FU or capecitabine for the treatment of stomach cancer.,Designated,,,N/A,N/A,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,USA,294409,2009,
veliparib,n/a,2009-11-20,Treatment of hepatocellular carcinoma in combination with DNA-damaging agents,Designated,,,N/A,N/A,"AbbVie, Inc.",1 N. Waukegan Road,,North Chicago,Illinois,60064,USA,295509,2009,
late stage human motor neutron progenitors,Motorgraft(Tm),2009-11-25,Treatment of spinal muscular atrophy,Designated/Withdrawn,,,N/A,N/A,Caladrius Biosciences,110 Allen Road,2nd Floor,Basking Ridge,New Jersey,7920,USA,293509,2009,
nevirapine,n/a,2009-11-25,Prevention of HIV infection in pediatric patients under the age of 16 years,Designated,,,N/A,N/A,Auritec Pharmaceuticals,1434 6th Street,,Santa Monica,California,90401,USA,293409,2009,
inebilizumab,n/a,2009-12-03,Treatment of scleroderma,Designated,,,N/A,N/A,MedImmune,One MedImmune Way,,Gaithersburg,Maryland,20878,USA,295209,2009,
pegsitacase,Uricase-Peg 20,2009-12-03,Treatment of Lesch-Nyhan syndrome.,Designated,,,N/A,N/A,"EnzymeRx, LLC",17 Arcadian Avenue,,Paramus,New Jersey,7652,USA,296309,2009,
"5'-O-(trans-9""-octadecenoyl)-1-beta-D-2'deoxy-2',2'-difluorocytidine",n/a,2009-12-07,Treatment of pancreatic cancer,Designated/Withdrawn,,,N/A,N/A,"Clovis Oncology, Inc.",5500 Flatiron Parkway,Suite 100,Boulder,Colorado,80301,USA,295909,2009,
6-mercaptopurine oral liquid,n/a,2009-12-07,Treatment of acute lymphoblastic leukemia in the pediatric population,Designated,,,N/A,N/A,Orbona Pharma Ltd,Old Chambers,"Farnham, England",Surrey,,,United Kingdom,286309,2009,
complement factor H,n/a,2009-12-07,Treatment of atypical hemolytic uremic syndrome associated with an inherited abnormality of the complement system,Designated/Withdrawn,,,N/A,N/A,LFB Biotechnologies S.A.,"3, avenue des Tropiques",91943 Courtaboeuf Cedex,,,,France,260308,2009,
davunetide,n/a,2009-12-07,Treatment of progressive supranuclear palsy.,Designated,,,N/A,N/A,"Allon Therapeutics, Inc.",506-1168 Hamilton Street,"Vancouver, BC V6B 2S2",,,,Canada,293909,2009,
monoclonal antibody 11-1F4,n/a,2009-12-07,For use as a radioimmaging agent in amyloidosis,Designated,,,N/A,N/A,"Caelum Biosciences, Inc.",2 Gansevoort Street,9th Floor,New York,New York,10014,USA,293709,2009,
octreotide acetate subcutaneous implant,n/a,2009-12-07,Treatment of acromegaly,Designated,,,N/A,N/A,"Endo Pharmaceuticals Solutions, Inc.",100 Endo Blvd,,Chadds Ford,Pennsylvania,19317,USA,286509,2009,
selisistat,n/a,2009-12-07,Treatment of Huntington's disease,Designated,,,N/A,N/A,AOP Orphan Pharmaceuticals AG,91/llf Wilhelminenstraße,,Wien,,,Austria,295709,2009,
afamelanotide,n/a,2009-12-11,Treatment of solar urticaria,Designated,,,N/A,N/A,"Clinuvel, Inc.",P. O. Box 2176,,Blue Bell,Pennsylvania,19422,USA,292009,2009,
monoclonal antibody 11-1F4,n/a,2009-12-11,For use as a therapeutic agent for patients AL amyloidosis.,Designated,,,N/A,N/A,"Caelum Biosciences, Inc.",2 Gansevoort Street,9th Floor,New York,New York,10014,USA,290309,2009,
burosumab,n/a,2009-12-14,Treatment of X-linked hypophosphatemia (formerly known as vitamin D-resistant rickets),Designated/Approved,Approved for Orphan Indication,CRYSVITA is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older,2018-04-17,TBD,"Ultragenyx Pharmaceutical, Inc.",60 Leveroni Court,Suite 200,Novato,California,94949,USA,296109,2009,3046
brilliant blue G,Brilliant Peel,2009-12-16,For use in ophthalmic surgery to aid in the removal of the inner limiting membrane of the eye.,Designated,,,N/A,N/A,Fluoron GmbH,Biberkopfweg 1,,,,,Germany,257908,2009,
ambrisentan,Letairis,2009-12-23,Treatment of idiopathic pulmonary fibrosis,Designated/Withdrawn,,,N/A,N/A,"Gilead Sciences, Inc.",199 East Blaine Street,,Seattle,Washington,98102,USA,266908,2009,
synthetic double-stranded siRNA oligonucleotide against p53 mRNA,n/a,2009-12-23,Prophylaxis of delayed graft function in renal transplant patients,Designated,,,N/A,N/A,"Quark Pharmaceuticals, Inc.",6501 Dumbarton Circle,,Fremont,California,94555,USA,296509,2009,
human monoclonal antibody directed against serotype O1 Pseudomonas aeruginosa,n/a,2010-01-06,Treatment of pneumonia caused by serotype O1 positive Pseudomonas aeruginosa,Designated,,,N/A,N/A,Kenta Biotech Limited,Rehhagstrasase 79,,,,,Switzerland,297009,2010,
L-asparaginase encapsulated in red blood cells,Graspa,2010-01-06,Treatment of acute lymphoblastic leukemia,Designated,,,N/A,N/A,Erytech Pharma,Batiment Adenine,"60, Avenue Rockfeller",LYON,,,France,239807,2010,
tasimelteon,Hetlioz,2010-01-19,Non-24-hour sleepwake disorder in blind individuals without light perception,Designated/Approved,Approved for Orphan Indication,Treatment of non-24-hour sleep-wake disorder,2014-01-31,2021-01-31,"Vanda Pharmaceuticals, Inc.","2200 Penn. Ave., NW",Suite 300 E,Washington,District of Columbia,20037,USA,297409,2010,1473
"(1S, 2S, 3R, 4R)-3-(5-Fluoro-2-(3-methyl-4-(4-methylpiperazin-1-yl)-phenylamino)-pyrimidin-4-ylamino)bicycle[2.2.1]hept-5-ene-2-carboxamide benzoate",n/a,2010-01-19,Treatment of acute myeloid leukemia,Designated/Withdrawn,,,N/A,N/A,"EMD Serono, Inc.",1 Technology Place,,Rockland,Massachusetts,2370,USA,299109,2010,
2-[[3-({4-[(5-{2-[(3-Fluorophenyl)amino]-2-oxoethyl}-1H-pyrazol-3-yl)amino]-quinazolin-7-yl}propyl](ethyl)amino]ethyl dihydrogen phosphate trihydrate,n/a,2010-01-19,Treatment of acute myeloid leukemia,Designated,,,N/A,N/A,AstraZeneca Pharmaceuticals LP,1800 Concord Pike,P. O. Box 8355,Wilmington,Delaware,19803,USA,298509,2010,
amitriptyline and ketamine,Amiket(Tm),2010-01-19,Treatment of postherpetic neuralgia,Designated,,,N/A,N/A,"Immune Pharmaceuicals, Inc.",Alexandria Center for LIfe Sciences,430 E. 29th St.,New York,New York,10016,USA,288809,2010,
"cis-adamantane-2-spiro-3'-8'-[4'-[2'-(4'-morpholinyl)ethoxy]phenyl]-1',2,'4'-trioxaspiro[4.5] decane mesylate",n/a,2010-01-19,"Treatment of malaria caused by Plasmodium falciparum, Plasmodium vivax, Plasmodium ovale, or Plasmodium malariae",Designated,,,N/A,N/A,Medicines for Malaria Venture (MMV),International Centre Cointrin,P. O. Box 1826,CH-1215 Geneva 15,,,Switzerland,297309,2010,
mesalamine,Canasa,2010-01-19,Treatment of pediatric ulcerative colitis,Designated,,,N/A,N/A,"Forest Laboratories, Inc.",Harborside Financial Center,"Plaza V, Suite 1900",Jersey City,New Jersey,7311,USA,298109,2010,
naltrexone,n/a,2010-01-19,Treatment of Crohn's disease in pediatric patients,Designated,,,N/A,N/A,"Immune Therapeutics, Inc.",37 North Orange Avenue,Suite 607,Orlando,Florida,32801,USA,296909,2010,
poloxamer-188 NF,n/a,2010-01-19,Treatment of Duchenne muscular dystrophy,Designated,,,N/A,N/A,"Phrixus Pharmaceuticals, Inc.",300 N. Fifth Avenue,,Ann Arbor,Michigan,48104,USA,296409,2010,
sodium phenylbutyrate,n/a,2010-01-19,Treatment of urea cycle disorder.,Designated,,,N/A,N/A,Navinta LLC,1499 Lower Ferry Road,,Ewing,New Jersey,8618,USA,293309,2010,
17 amino acid peptide,n/a,2010-01-29,Prevention of ischemia reperfusion injury in the lung during lung tranplantation,Designated,,,N/A,N/A,Apeptico Forschung und Entwicklung GmbH,Mariahilferstrabe 136,Top 1150,Vienna,,,Austria,298009,2010,
2-(2-phenylvinyl)-4-[-methylpiperazin-l-yl)]-6-(5-methyl-2H-pyrazol-3-yl-amino)-pyrimidine L(+) tartrate salt,n/a,2010-01-29,Treatment of acute myeloid leukemia.,Designated,,,N/A,N/A,"EntreMed, Inc.",Research Triangle Park Center,Suite 400,Durham,North Carolina,27703,USA,298609,2010,
alpha1 proteinase inhibitor (human),n/a,2010-01-29,Treatment of emphysema secondary to congenital alpha1-antitrypsin deficiency.,Designated,,,N/A,N/A,"Grifols Therapeutics, Inc.",79 TW Alexander Drive,,Research Triangle Park,North Carolina,27709,USA,294309,2010,
angiotensin 1-7,n/a,2010-01-29,Treatment of sarcoma.,Designated,,,N/A,N/A,"W. Jeffrey Petty, MD",Wake Forest University Health Sciences,,Winston-Salem,North Carolina,27157,USA,295809,2010,
Inhibitor of Tissue Factor Pathway Inhibitor (TFPI),n/a,2010-01-29,Treatment of hemophilia A and hemophilia B.,Designated,,,N/A,N/A,"Baxter Healthcare Corporation, Baxter BioScience",One Baxter Way,,Westlake Village,California,91362,USA,298409,2010,
pimasertib,n/a,2010-01-29,Treatment of pancreatic cancer,Designated,,,N/A,N/A,"EMD Serono, Inc.",1 Technology Place,,Rockland,Massachusetts,2370,USA,297909,2010,
allogeneic ex vivo expanded umbilical cord blood cells,Stemex,2010-02-01,For use as hematopoietic support in patients with chronic myeloid leukemia,Designated/Withdrawn,,,N/A,N/A,Gamida Cell - Teva Joint Venture,PO Box 34670,,,,,Israel,297609,2010,
allogeneic ex vivo expanded unbilical cord blood cells,Stemex,2010-02-01,For use as hematopoietic support in patients with myelodysplastic syndromes,Designated/Withdrawn,,,N/A,N/A,Gamida Cell - Teva Joint Venture,PO Box 34670,,,,,Israel,299009,2010,
mPEG-r-crisantaspase,Asparec(Tm),2010-02-01,Treatment of acute lymphoblastic leukemia.,Designated,,,N/A,N/A,"Jazz Pharmaceuticals, Inc.",3180 Porter Drive,,Palo Alto,California,94304,USA,299609,2010,
allogeneic hematopoietic stem cell,Atir,2010-02-02,"Prevention (reduction) of transplant related mortality (TRM, which is caused by graft versus host disease and/or infections) following mismatched (haploidentical) allogeneic hematopoietic stem cell transplantation.",Designated,,,N/A,N/A,Kiadis Pharma Netherlands B.V.,Entrada 231 - 234,,,,,Netherlands,296709,2010,
ciprofloxacin DPI,Ciprofloxacin Pulmosphere(R),2010-02-02,Management of pulmonary infection due to Pseudomonas aeruginosa in cystic fibrosis patients,Designated,,,N/A,N/A,"Bayer HealthCare Pharmaceuticals, Inc.",100 Bayer Blvd,P. O. Box 915,Whippany,New Jersey,7981,USA,297209,2010,
MA09-hRPE cells,n/a,2010-02-02,Treatment of Stargardt's macular dystrophy,Designated,,,N/A,N/A,Astellas Pharma Global Development Inc.,1 Astellas Parkway,,Northbrook,Illinois,60062,USA,299409,2010,
patupilone,n/a,2010-02-02,Treatment of primary pertitoneal cancer.,Designated/Withdrawn,,,N/A,N/A,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,USA,298909,2010,
patupilone,n/a,2010-02-02,Treatment of primary fallopian tube cancer.,Designated/Withdrawn,,,N/A,N/A,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,USA,298809,2010,
Replication-incompetent GM-CSF-expressing gene-modified allogeneic pancreatic cancer cell lines,Gvax Pancreas,2010-03-01,Treatment of pancreatic cancer.,Designated,,,N/A,N/A,"Aduro BioTech, Inc.",740 Heinz Avenue,,Berkeley,California,94710,USA,299709,2010,
"3-(6-(1-(2,2-difluorobenzo[d] [1,3]dioxyl-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid",n/a,2010-03-02,Treatment of cystic fibrosis,Designated/Withdrawn,,,N/A,N/A,Vertex Pharmaceuticals Inc.,130 Waverly Street,,Cambridge,Massachusetts,2139,USA,301610,2010,
immune globulin (human),n/a,2010-03-02,Treatment of Guillain-Barre syndrome,Designated,,,N/A,N/A,"Octapharma USA, Inc.",121 River Street,12th Floor,Hoboken,New Jersey,7030,USA,301110,2010,
maytansinoid DM1-conjugated humanized monoclonal antibody N901,n/a,2010-03-02,Treatment of Merkel cell carcinoma,Designated/Withdrawn,,,N/A,N/A,"ImmunoGen, Inc.",830 Winter Street,,Waltham,Massachusetts,2451,USA,300309,2010,
Replication-incompetent GM-CSF-expressing gene-modified allogeneic acute myeloid leukemia cancer cell lines,Gvax Acute Myeloid Leukemia,2010-03-02,Treatment of acute myeloid leukemia,Designated,,,N/A,N/A,"Aduro BioTech, Inc.",740 Heinz Avenue,,Berkeley,California,94710,USA,300710,2010,
tirasemtiv,n/a,2010-03-02,Treatment of amyotrophic lateral sclerosis (ALS),Designated,,,N/A,N/A,Cytokinetics Inc.,280 East Grand Avenue,,South San Francisco,California,94080,USA,301710,2010,
chenodiol,Chenodal,2010-03-22,Treatment of cerebrotendinous xanthomatosis,Designated,,,N/A,N/A,"Retrophin, Inc.",3721 Valley Centre Drive,Suite 200,San Diego,California,92130,USA,300510,2010,
Recombinant human glutamic acid decarboxylase 65KDa isoform,n/a,2010-03-22,Treatment of Type I diabetes with residual beta cell function,Designated,,,N/A,N/A,Diamyd Therapeutics AB,Linnegatan 89B,,,,,Sweden,274508,2010,
Recombinant Human soluble Fc-gamma Receptor IIb,n/a,2010-03-22,Treatment of idiopathic thrombocytopenic purpura,Designated,,,N/A,N/A,"Baxalta US Inc., now part of Shire Plc",650 Kendall Street,,Cambridge,Massachusetts,2142,USA,287709,2010,
ruxolitinib phosphate,Jakafi,2010-03-22,Treatment of essential thrombocythemia,Designated,,,N/A,N/A,Incyte Corporation,1801 Augustine Cut-Off,,Wilmington,Delaware,19803,USA,302510,2010,
taurine,n/a,2010-03-22,Treatment of cystathionine beta-synthase deficient homocystinuria,Designated,,,N/A,N/A,"Johan L. Van Hove, MD, PhD",Department of Pediatrics/University of Colorado De,"13121 E. 17th Ave., P. O. Box 6508",Aurora,Colorado,80045,USA,298709,2010,
ruxolitinib,Jakafi,2010-03-26,Treatment of polycythemia vera,Designated/Approved,Approved for Orphan Indication,Treatment of patients with polycythemia vera who have had an inadequate response to or are intolerant of hydroxyurea.,2014-12-04,2021-12-04,Incyte Corporation,1801 Augustine Cut-Off,,Wilmington,Delaware,19803,USA,302310,2010,1714
"anti-T-lymphocyte immune globulin, rabbit",Atg-Fresenius(R),2010-03-26,Prevention of graft versus host disease (GVHD),Designated,,,N/A,N/A,"Neovii Biotech NA, Inc.",430 Bedford Street,Suite 195,Lexington,Massachusetts,2420,USA,301810,2010,
Fully human anti-interferon gamma monoclonal antibody,Ni-0501,2010-03-26,Treatment of hemophagocytic lymphohistiocytosis,Designated,,,N/A,N/A,NovImmune S.A.,14 chemin des Aulx,,,,,Switzerland,302910,2010,
GNE plasmid(H001),n/a,2010-03-26,Treatment of hereditary inclusion body myopathy type 2,Designated,,,N/A,N/A,HIBM Research Group,18341 Sherman Way #201A,,Reseda,California,91335,USA,303610,2010,
Reversal agent linked to chloroquine-like moiety,n/a,2010-03-26,Treatment of malaria,Designated,,,N/A,N/A,DesignMedix,2828 SW Corbett Avenue,,Portland,Oregon,97201,USA,303710,2010,
secukinumab,n/a,2010-03-26,Adjunctive treatment of chronic non-infectious uveitis requiring systemic immunosuppression,Designated/Withdrawn,,,N/A,N/A,Novartis Pharmaceutical Corporation,One Health Plaza,Bldg 404/470,East Hanover,New Jersey,7936,USA,281309,2010,
Water-miscible vitamin A palmitate,Aquasol A Parenteral,2010-03-26,Prevention of bronchopulmonary dysplasia.,Designated,,,N/A,N/A,"Fox Pharma, Inc.",6097 Hidden Valley Drive,,Doylestown,Pennsylvania,18902,USA,295109,2010,
N-Acetylmannosamine (ManNAc),n/a,2010-04-05,Treatment of GNE Myopathy (Hereditary Inclusion Body Myopathy Type 2),Designated,,,N/A,N/A,"National Human Genome Research Institute,NIH",10 Center Drive,"Bldg. 10, Room 10C-103",Bethesda,Maryland,20892,USA,303510,2010,
Fenretinide,n/a,2010-04-07,Treatment of Pseudomonas aeruginosa lung infections in cystic fibrosis patients,Designated,,,N/A,N/A,McGill University,McGill University,"Montreal, Quebec, H3A 2T5",,,,Canada,303210,2010,
imatinib,n/a,2010-04-07,Treatment of pulmonary arterial hypertension,Designated/Withdrawn,,,N/A,N/A,Novartis,One Health Plaza,,East Hanover,New Jersey,7936,USA,303810,2010,
L-ornithine phenylacetate,n/a,2010-04-07,Treatment of hyperammonemia and resultant hepatic encephalopathy (HE) in patients with acute liver failure or acute on chronic liver disase,Designated,,,N/A,N/A,"Ocera Therapeutics, Inc.",5001 South Miami Blvd,Suite 300,Durham,North Carolina,27703,USA,287309,2010,
cinacalcet,Sensipar,2010-04-30,"Treatment of hypercalcemia in patients with primary hyperparathyroidism for whom parathyroidectomy would be indicated on the basis of serum calcium levels, but who are unable to undergo surgery",Designated/Approved,Approved for Orphan Indication,Treatment of severe hypercalcemia in patients with primary hyperparathyroidism who are unable to undergo parathyroidectomy,2011-02-25,2018-02-25,"Amgen, Inc.",One Amgen Center Drive,"Bldg 17, 1A-4-4, Mail Stop 17-1-B",Thousand Oaks,California,91320,USA,165102,2010,301
cinacalcet,Sensipar,2010-04-30,"Treatment of hypercalcemia in patients with primary hyperparathyroidism for whom parathyroidectomy would be indicated on the basis of serum calcium levels, but who are unable to undergo surgery",Designated/Approved,Approved for Orphan Indication,"Treatment of hypercalcemia in adult patients with primary hyperparathyroidism for whom parathyroidectomy would be indicated on the basis of serum calcium levels, but who are unable to undergo parathyroidectomy.",2014-11-21,2021-11-21,"Amgen, Inc.",One Amgen Center Drive,"Bldg 17, 1A-4-4, Mail Stop 17-1-B",Thousand Oaks,California,91320,USA,165102,2010,1666
selexipag,Uptravi,2010-04-30,Treatment of pulmonary arterial hypertension,Designated/Approved,Approved for Orphan Indication,"For use of Uptravi (Selexipag) Tablets, 200, 400, 600, 800, 1000, 1200, 1400, and 1600 mcg for treatment of pulmonary arterial hypertension (PAH, WHO Group I) to reduce the risks of disease progression and hospitalization for PAH",2015-12-21,2022-12-21,Actelion Ltd,Gewerbestrasse 16,,Allschwil CH-4123,,,Switzerland,304810,2010,2061
niraparib,Zejula,2010-04-30,Treatment of ovarian cancer,Designated/Approved,Approved for Orphan Indication,"Indicated for maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response to platinum-based chemotherapy",2017-03-27,2024-03-27,"TESARO, Inc.",1000 Winter St.,Suite 3300,Waltham,Massachusetts,2451,USA,306510,2010,2523
midostaurin,Rydapt,2010-04-30,Treatment of mastocytosis,Designated/Approved,Approved for Orphan Indication,"Treatment of adult patients with aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematological neoplasm (SM-AHN), or mast cell leukemia (MCL)",2017-04-28,2024-04-28,Novartis Pharmaceuticals Corporation,"One Health Plaza, 105/3W038",,East Hanover,New Jersey,7936,USA,306410,2010,2555
"3,4 diaminopyridine and choline bitartrate",n/a,2010-04-30,Treatment of Lambert-Eaton myasthenic syndrome,Designated,,,N/A,N/A,MS Therapeutics Limited,Beechy House,Berkshire RG45 7AW,,,,United Kingdom,299909,2010,
AEZS-108 (LHRH-agonist linked to doxorubicin),n/a,2010-04-30,Treatment of ovarian cancer,Designated/Withdrawn,,,N/A,N/A,Aeterna Zentaris,"100 Marketplace, Suite 203",25 Mountainview Blvd,Basking Ridge,New Jersey,7920,USA,304410,2010,
auranofin,Ridaura,2010-04-30,Treatment of amebiasis,Designated,,,N/A,N/A,Ctr for Discovery & Innovation in Parasitic Diseas,"U. of CA, San Francisco","QB3, Byers Hall 508B",San Francisco,California,94158,USA,305210,2010,
Autologous CD34+ cells transfected with lentiviral vector containing the human WAS cDNA (Telethon 003),n/a,2010-04-30,Treatment of Wiskott Aldrich syndrome,Designated,,,N/A,N/A,GlaxoSmithKline Intellectual Property Development,980 Great West Road,TW8 9GS England,,,,United Kingdom,304310,2010,
Cintredekin Besudotox,n/a,2010-04-30,Treatment of idiopathic pulmonary fibrosis,Designated,,,N/A,N/A,"Insys Development Company, Inc.","1333 South Sprectum Blvd, Suite 100",,Chandler,Arizona,85286,USA,305110,2010,
denileukin diftitox,Ontak,2010-04-30,Treatment of peripheral T-cell lymphoma,Designated,,,N/A,N/A,"Eisai, Inc.",300 Tice Boulevard,,Woodcliff Lake,New Jersey,7677,USA,302010,2010,
ex-vivo cultered adult human mesenchymal stem cells,Prochymal(R),2010-04-30,Treatment of Type 1 diabetes patients with residual beta cell function,Designated,,,N/A,N/A,"Mesoblast, Inc.",505 Fifth Avenue,Third Floor,New York,New York,10017,USA,284009,2010,
fingolimod,n/a,2010-04-30,Treatment of chronic inflammatory demyelinating polyneuropathy,Designated,,,N/A,N/A,Novartis Pharmaceutical Corporation,One Health Plaza,,East Hanover,New Jersey,7936,USA,305910,2010,
Glyeraldehyde-3-phosphate dehydrogenase,Proenzy,2010-04-30,Treatment of pediatric multiple sclerosis,Designated,,,N/A,N/A,"BPT Pharmaceuticals, Inc.",743 North Sweetzer Avenue #103,,Los Angeles,California,90069,USA,304710,2010,
Human monoclonal antibody targeting CC-chemokine ligand 2 (CNTO 888),n/a,2010-04-30,Treatment of ovarian cancer,Designated,,,N/A,N/A,Ortho Biotech,200 Great Valley Parkway,,Malvern,Pennsylvania,19355,USA,306810,2010,
Lentiviral vector containing the human ABCA4 gene,Stargen (Tm),2010-04-30,Treatment of Stargardt disease,Designated,,,N/A,N/A,"Sanofi US Services, Inc.",55 Corporate Drive,Mail Stop 55D-220B,Bridgewater,New Jersey,8807,USA,306610,2010,
levetiracetam,Keppra,2010-04-30,Treatment of neonatal seizures,Designated,,,N/A,N/A,University of California,UCSD Medical Center 0935,,La Jolla,California,92093,USA,303310,2010,
Liposomal Glutathione,n/a,2010-04-30,Support of glutathione deficiency in individuals with inborn errors of metabolism of glutathione (IEMG),Designated,,,N/A,N/A,"Your Energy Systems, LLC",555 Bryant Street #305,,Palo Alto,California,94301,USA,303410,2010,
Replication-incompetent GM-CSF-expressing gene-modified allogeneic chronic myeloid leukemia cancer cell lines,Gvax Chronic Myeloid Leukemia,2010-04-30,Treatment of chronic myeloid leukemia,Designated,,,N/A,N/A,"Aduro BioTech, Inc.",740 Heinz Avenue,,Berkeley,California,94710,USA,300810,2010,
"superoxide dismutase, gliadin",Etr019,2010-04-30,Treatment of amyotrophic lateral sclerosis,Designated,,,N/A,N/A,Verius Limited,Chartwell House,"Cambridge, CB5 8LP, UK",,,,United Kingdom,302110,2010,
tasimelteon,n/a,2010-04-30,Treatment of sleep-wake disorder in Smith-Magenis syndrome associated with diurnal melatonin secretion,Designated,,,N/A,N/A,"Vanda Pharmaceuticals, Inc.",9605 Medical Center Drive,,Rockville,Maryland,20850,USA,301410,2010,
pralatrexate,n/a,2010-05-03,Treatment of advanced or metastatic transitional cell carcinoma of the urinary bladder,Designated,,,N/A,N/A,"Allos Therapeutics, Inc.","11080 Circle Point Road, Suite 200",,Westminister,Colorado,80020,USA,260708,2010,
BF2.649 (Pitolisant),n/a,2010-05-17,Treatment of narcolepsy,Designated,,,N/A,N/A,Bioprojet Pharma,"9, rue Rameau",,Paris,,,France,307210,2010,
Bone marrow-derived mononuclear cells,n/a,2010-05-17,Treatment of thromboangiitis obliterans (Buerger's disease),Designated,,,N/A,N/A,t2cure GmbH,Kennedyallee 93,60596 Frankfurt am Main,,,,Germany,307310,2010,
budesonide,Nefecon,2010-05-17,To slow the progression of immunoglobulin A nephropathy & delay kidney failure in patients affected by the disease.,Designated,,,N/A,N/A,Calliditas Therapeutics AB,Wallingata 26b,,Stockholm,,,Sweden,305710,2010,
Hydroxy-Propyl-Beta-Cyclodextrin,Trappsol,2010-05-17,"Treatment of Niemann Pick Disease, Type C",Designated,,,N/A,N/A,"Sphingo Biotech, LLC",14120 NW 126th Terrace,,Alachua,Florida,32615,USA,303910,2010,
Lentiviral vector containing the human MY07A gene,Ushstat(Tm),2010-05-17,Treatment of retinitis pigmentosa associated with Usher syndrome 1B gene defect.,Designated,,,N/A,N/A,"Sanofi US Services, Inc.",55 Corporate Drive,Mail Stop 55D-220B,Bridgewater,New Jersey,8807,USA,306710,2010,
N-(6-2-aminophenylamino)-6-oxohexyl)-4-methylbenzamide,n/a,2010-05-17,Treatment of Friedreich's ataxia.,Designated/Withdrawn,,,N/A,N/A,Repligen Corporation,"Building 1, Suite 100",,Waltham,Massachusetts,2453,USA,306110,2010,
telatinib,n/a,2010-05-17,Treatment of gastric cancer,Designated,,,N/A,N/A,ACT Biotech Inc.,717 market St #650,Suite 650,San Francisco,California,94103,USA,307410,2010,
anti-thymocyte globulin [rabbit],Thymoglobulin,2010-05-25,Prophylaxis of acute organ rejection in patients receiving renal transplants,Designated,,,N/A,N/A,Genzyme Corporation,500 Kendall Street,,Cambridge,Massachusetts,2142,USA,308710,2010,
refanalin,n/a,2010-05-25,To improve renal function and prevent delayed graft function following renal transplantation,Designated,,,N/A,N/A,Angion Biomedica Corporation,1050 Stewart Avenue,,Garden City,New York,11530,USA,307510,2010,
"anti-TCR murine monoclonal antibody (MAb, type IgM)",n/a,2010-06-07,Treatment of patients 16 years of age and younger with immune-mediated T1DM and preserved pancreatic beta cell function,Designated,,,N/A,N/A,"Tolera Therapeutics, Inc.",350 E. Michigan Avenue,,Kalamazoo,Michigan,49001,USA,293209,2010,
bosentan,Tracleer,2010-06-07,Reduction of the number (treatment) of new digital ulcers in patients with systemic sclerosis,Designated/Withdrawn,,,N/A,N/A,Actelion Ltd.,Gewerbestrasse 16,CH-4123,,,,Switzerland,292209,2010,
"dendritic cells pulsed with synthetic peptides derived from antigens MAGE1, HER-2, AIM-2,TRP-2, gp100 and interleukin-13 receptor alpha",n/a,2010-06-07,Treatment of glioblastoma or brain stem glioma,Designated,,,N/A,N/A,ImmunoCellular Therapeutics Ltd.,21900 Burbank Blvd,,Woodland Hills,California,91367,USA,308010,2010,
human plasminogen,n/a,2010-06-07,Treatment of ligneous conjunctivitis,Designated,,,N/A,N/A,"Kedrion, S.p.A.",Loc. ai Conti,55051 Castelvecchio Pascoli,Barga (Lucca),,,Italy,309210,2010,
recombinant human vascular endothelial growth factor,n/a,2010-06-07,Treatment of amyotrophic lateral sclerosis,Designated,,,N/A,N/A,NeuroNova AB,Fiskartorpsvagen 15 A-D,Stockholm,,,,Sweden,309010,2010,
treprostinil (inhalational),Tyvaso,2010-06-17,Treatment of pulmonary arterial hypertension,Designated/Approved,Approved for Orphan Indication,"Treatment of pulmonary arterial hypertension (WHO Group I) in patients with NYHA Class III symptoms, to increase walk distance",2009-07-30,2016-07-30,"LungRx, Inc.",A Subsidary of United Therapeutics Corp.,1077 Highway A1A,Satellite Beach,Florida,32937,USA,189104,2010,-322
angiotensin 1-7,n/a,2010-06-17,"To accelerate engraftment of hematopoietic cells (treatment of neutropenia, thrombocytopenia, lymphoma, and aneima)in hematopoietic stem cell transplants.",Designated,,,N/A,N/A,"Tarix Pharmaceuticals, Ltd.",12 Bow Street,,Cambridge,Massachusetts,2138,USA,308810,2010,
dasiprotimut-T,Biovax Id,2010-06-17,Treatment of mantle cell lymphoma,Designated,,,N/A,N/A,"Biovest International, Inc.",324 S. Hyde Park Ave.,,Tampa,Florida,33606,USA,309710,2010,
glycopyrrolate 2%,n/a,2010-06-17,Treatment of Frey's syndrome,Designated,,,N/A,N/A,"Wellesley Therapeutics, Inc.","200 Gerrard St., East","Toronto, Ontario M5A 2E6",,,,Canada,309810,2010,
octreotide (oral),Octreolin(Tm),2010-06-17,For the oral treatment of acromegaly,Designated,,,N/A,N/A,"Chiasma, Inc.",460 Totten Pond Road,Suite 530,Waltham,Massachusetts,2451,USA,309310,2010,
1-(2-C-cyano-2-deoxy-B-D-arabino-pentafuranosyl)-N4-palmitoylcytosine,Sapacitabine,2010-06-24,Treatment of acute myelogenous leukemia,Designated,,,N/A,N/A,Cyclacel Limited,1 James Linday Place,Dundee DD1 5JJ,,,,United Kingdom,263508,2010,
1-(2-C-cyano-2-deoxy-B-D-arabino-pentafuranosyl)-N4-palmitoylcytosine,Sapacitabine,2010-06-24,Treatment of myelodysplastic syndrome,Designated,,,N/A,N/A,Cyclacel Limited,1 James Linday Place,Dundee DD1 5JJ,,,,United Kingdom,263408,2010,
sebelipase alfa,Kanuma,2010-07-01,Treatment of lysosomal acid lipase deficiency,Designated/Approved,Approved for Orphan Indication,Indicated for the treatment of patients with a diagnosis of Lysosomal Acid Lipase (LAL) deficiency,2015-12-08,2022-12-08,Alexion Pharmaceuticals,100 College Street,,New Haven,Connecticut,6510,USA,309410,2010,1986
perifosine,n/a,2010-07-09,Treatment of neuroblastoma,Designated/Withdrawn,,,N/A,N/A,Aeterna Zentaris GmbH,Weismuellerstrasse 50,D-60314 Frankfurt Am Main,,,,Germany,310010,2010,
gevokizumab,n/a,2010-07-27,Treatment of Behcet's disease,Designated,,,N/A,N/A,XOMA (US) LLC,2910 Seventh St.,,Berkeley,California,94710,USA,310810,2010,
14-amino acid peptide derived from wound growth factor,n/a,2010-08-05,Prevention of delayed graft function in renal transplant recipients,Designated/Withdrawn,,,N/A,N/A,NephRx Corporation,4717 Campus Drive,,Kalamazoo,Michigan,49008,USA,311210,2010,
humanized monoclonal antibody against human integrin alphaVbeta6,n/a,2010-08-05,Treatment of idiopathic pulmonary fibrosis,Designated,,,N/A,N/A,"Biogen Idec, Inc.",14 Cambridge Center,,Cambridge,Massachusetts,2142,USA,311310,2010,
N-(cyanomethyl)-4-(2-{[4-(morpholin-4-yl(phenyl]amino}pyrimidin-4-yl)benzamide,n/a,2010-08-05,Treatment of myelofibrosis,Designated,,,N/A,N/A,"Gilead Sciences, Inc.",333 Lakeside Drive,,Foster City,California,94404,USA,311610,2010,
nifurtimox,Lampit,2010-08-05,Treatment of Chagas disease (American Typanosomiasis)caused by T. cruzi,Designated,,,N/A,N/A,"Bayer HealthCare Pharmaceuticals, Inc.",P. O. Box 1000,,Montville,New Jersey,7045,USA,310110,2010,
octreotide,Sandostatin Lar,2010-08-05,Treatment of neuroendocrine tumors,Designated,,,N/A,N/A,Novartis Pharmaceuticals Corporation,One Health laza,,East Hanover,New Jersey,7936,USA,310710,2010,
Double-stranded DNA plasmid carrying the gene for the diphtheria toxin A (DT-A) chain,n/a,2010-08-06,Treatment of pancreatic cancer,Designated,,,N/A,N/A,"BioCancell Therapeutics USA, Inc.",1 Kendall Square,"Building 1400, Suite 14303",Cambridge,Massachusetts,2139,USA,297809,2010,
mycobacterium vaccae,n/a,2010-08-06,Treatment of pancreatic cancer,Designated/Withdrawn,,,N/A,N/A,Immodulon Therapeutics Ltd.,22 Devonshire Place,"London, W1G 6JA",,,,United Kingdom,312810,2010,
recombinant human platelet derived growth factor-BB,n/a,2010-08-06,Treatment of osteochondritis dissecans,Designated/Withdrawn,,,N/A,N/A,"Biomimetic Therapeutics, Inc.",389-A Nichol Mill Lane,,Franklin,Tennessee,37067,USA,310410,2010,
ublituximab,n/a,2010-08-06,Treatment of chronic lymphocytic leukemia,Designated,,,N/A,N/A,"TG Therapeutics, Inc.",787 Seventh Avenue,48th Floor,New York,New York,10019,USA,296609,2010,
14-amino acid peptide derived from wound growth factor,n/a,2010-08-16,Treatment of delayed graft function in renal transplant recipients,Designated/Withdrawn,,,N/A,N/A,NephRx Corporation,4717 Campus Drive,,Kalamazoo,Michigan,49008,USA,312410,2010,
ActRIIB-IgG1),n/a,2010-08-16,Treatment of Duchenne muscular dystrophy,Designated/Withdrawn,,,N/A,N/A,"Acceleron Pharma, Inc.",128 Sidney St.,,Cambridge,Massachusetts,2139,USA,312310,2010,
Glutathione pegylated liposomal doxorubicin hydrochloride,n/a,2010-08-16,Treatment of glioma,Designated,,,N/A,N/A,to-BBB technologies BV,"Niels Bohrweg 11, 2333 CA Leiden",,,,,Netherlands,311910,2010,
Maytansinoid DM-1 Conjugated Humanized Monoclonal Antibody N901,n/a,2010-08-17,Treatment of small cell lung cancer.,Designated/Withdrawn,,,N/A,N/A,"ImmunoGen, Inc.",830 Winter Street,,Waltham,Massachusetts,2451,USA,311010,2010,
anakinra,Kineret,2010-08-19,Treatment of cryopyrin-associated periodic syndromes,Designated/Approved,Approved for Orphan Indication,Treatment of neonatal-onset multisystem inflammatory disease (NOMID),2012-12-21,2019-12-21,Swedish Orphan Biovitrum AB (publ),SE-011276,,Stockholm,,,Sweden,312110,2010,855
mycobacterium vaccae,n/a,2010-08-20,Treatment of tuberculosis,Designated,,,N/A,N/A,Immodulon Therapeutics Ltd,22 Devonshire Place,B2,,,,United Kingdom,312710,2010,
raloxifene hydrochloride,Evista,2010-08-20,Treatment of hereditary hemorrhagic telangiectasia,Designated,,,N/A,N/A,Consejo Superior de Investigaciones Cientificas,C/ Serrano 142,,Madrid,,,,309910,2010,
reveglucosidase alfa,n/a,2010-08-20,Treatment of Pompe disease.,Designated,,,N/A,N/A,"BioMarin Pharmaceutical, Inc.",105 Digital Drive,,Novato,California,94949,USA,308310,2010,
dichlorphenamide,n/a,2010-09-02,Treatment of primary periodic paralyses,Designated/Approved,Approved for Orphan Indication,"Treatment of primary hyperkalemic periodic paralysis, primary hypokalemic period paralysis, and related variants",2015-08-07,2022-08-07,Strongbridge US Inc.,900 Northbrook Drives,Suite 200,trevose,Pennsylvania,19053,USA,314210,2010,1800
alpha melanotropin,n/a,2010-09-02,Treatment of chronic beryllium disease,Designated,,,N/A,N/A,mondoBIOTECH Laboratories AG,Herrengasse 21,Furstentum Liechtenstein,,,,Germany,308910,2010,
Epitalon,n/a,2010-09-02,Treatment of retinitis pigmentosa,Designated/Withdrawn,,,N/A,N/A,BioDiem Ltd,"Level 10, South Tower",Victoria 3000,Melbourne,,,Australia,312010,2010,
mexiletine,n/a,2010-09-02,Treatment of nondystrophic myotonia,Designated,,,N/A,N/A,University of Rochester Medical Center,1351 Mt. Hope Ave.,Suite 203,Rochester,New York,14620,USA,314410,2010,
recombinant human lecithin:cholesterol acyltransferase (rhLCAT),n/a,2010-09-02,Treatment of familial lecithin-cholesterol acyltransferase deficiency (FLD).,Designated,,,N/A,N/A,MedImmune,1 Medimmune Way,,Gaithersburg,Maryland,20878,USA,314010,2010,
crizotinib,Xalkori,2010-09-13,"Treatment of ALK-positive, MET-positive, or ROS-positive non-small cell lung cancer",Designated/Approved,Approved for Orphan Indication,Treatment of patients with locally advanced or metastatic non-small cell lungcancer (NSCLC) that is anaplastic lymphoma kinase (ALK)-positive as detected by an FDAapprovedtest,2011-03-11,2018-03-11,"Pfizer, Inc.",10646 Science Center Drive,,San Diego,California,92121,USA,310610,2010,179
crizotinib,Xalkori,2010-09-13,"Treatment of ALK-positive, MET-positive, or ROS-positive non-small cell lung cancer",Designated/Approved,Approved for Orphan Indication,Treatment of patients with metastatic NSCLC whose tumors are ROS1-positive,2016-03-11,2023-03-11,"Pfizer, Inc.",10646 Science Center Drive,,San Diego,California,92121,USA,310610,2010,2006
Autologous dendritic cells pulsed with recombinant human fusion protein (mucin1- glutathione S transferase) coupled to oxidized polymannose,Cvac(Tm),2010-09-13,Treatment of ovarian cancer.,Designated,,,N/A,N/A,Prima Biomed Ltd.,1233 High Street,Suite 1,"Armadale, Victoria 3143",,,Australia,315510,2010,
Darinaparsin,n/a,2010-09-13,Treatment of peripheral T-cell lymphoma.,Designated,,,N/A,N/A,Solasia Pharma K.K.,"3F, Shiodome Building",Toyko 105-0022,,,,Japan,313810,2010,
pentamidine,n/a,2010-09-13,Treatment of pancreatic cancer.,Designated/Withdrawn,,,N/A,N/A,"Oncozyme Pharma, Inc.",555 Rene-Levesque West - 9th Floor,,,,,Canada,279709,2010,
rozrolimupab,n/a,2010-09-13,Treatment of primary immune thrombocytopenia.,Designated,,,N/A,N/A,Symphogen A/S,"Elektrovey, Building 375",,,,,Denmark,312610,2010,
"(1S,3S)-3-amino-4-(difluoromethylene)cyclopentanecarboxylic acid hydrochloride, (1S,3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid hydrochloride",n/a,2010-09-15,Treatment of infantile spasms,Designated,,,N/A,N/A,"Catalyst Pharmaceuticals, Inc.",355 Alhambra Circle,Suite 1250,Coral Gables,Florida,33134,USA,300410,2010,
adeno-associated viral vector containing modified U11 snRNA,n/a,2010-09-15,Treatment of Duchenne muscular dystrophy.,Designated,,,N/A,N/A,uniQure Biopharma B.V.,Paasheuvelweg 25,1105 BP,Amsterdam,,,Netherlands,288409,2010,
amphotericin B,n/a,2010-09-15,Treatment of visceral leishmaniasis.,Designated,,,N/A,N/A,iCo Therapeutics Inc.,760-777 Hornby Street,,"Vancouver, BC V6Z 1S4",,,Canada,315310,2010,
Multistem(r),n/a,2010-09-15,Prophylaxis of graft vs host disease,Designated,,,N/A,N/A,"Athersys, Inc.",3201 Carnegie Avenue,,Cleveland,Ohio,44115,USA,314710,2010,
Peptide that inhibits mechanosensitive ion channel (MSC) activity,n/a,2010-09-15,Treatment of Duchenne Muscular Dystrophy (DMD.),Designated,,,N/A,N/A,Rose Pharmaceuticals,8210 Godlen Oak Circle,,Williamsville,New York,14221,USA,315710,2010,
acyclovir,n/a,2010-09-16,Treatment of herpetic keratitis,Designated/Withdrawn,,,N/A,N/A,GlaxoSmithKline,One Franklin Plaza,,Philadelphia,Pennsylvania,19101,USA,313210,2010,
C20-D3-retinyl acetate,n/a,2010-09-16,Treatment of Stargardt's disease,Designated,,,N/A,N/A,"Alkeus pharmaceuticals, Inc.",2103 Massachusetts Avenue,,Cambridge,Massachusetts,2140,USA,317210,2010,
deflazacort,Calcort,2010-09-16,Treatment of Duchenne muscular dystrophy,Designated,,,N/A,N/A,University of Rochester Medical Center,1351 Mt. Hope Avenue,Suite 203,Rochester,New York,14620,USA,315110,2010,
everolimus,Afinitor,2010-09-16,Treatment of Waldenstrom macroglobulinemia (also known as lymphoplasmacytic lymphoma),Designated/Withdrawn,,,N/A,N/A,Novartis Pharmaceuticals Corp.,"One Health Plaza, 315/5450A",,East Hanover,New Jersey,7936,USA,315410,2010,
unoprostone isopropyl,Rescula,2010-09-16,Treatment of retinitis pigmentosa,Designated/Withdrawn,,,N/A,N/A,"R-Tech Ueno, Ltd.","Kobe Hybrid Business Center, 3F","Chuo-ku, Kobe City, Hyogo 650-0047",,,,Japan,314810,2010,
"2-(2-chlorophenyl)-4-[3-(dimethylamino)phenyl]-5-methyl-1H-pyrazolo[4,3-C]pyridine-3,6(2H,5H)-dione",n/a,2010-09-21,Treatment of idiopathic pulmonary fibrosis.,Designated,,,N/A,N/A,GenKyoTex S.A.,14 Chemin des Aulx,,Geneva,,,Switzerland,316110,2010,
pomalidomide,n/a,2010-09-21,Treatment of persons with myeloproliferative neoplasm-associated myelofibrosis and anemia who are red blood cell tranfusion dependent.,Designated/Withdrawn,,,N/A,N/A,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,USA,308610,2010,
ecopipam hydrochloride,n/a,2010-09-29,Treatment of Tourette's syndrome in children 0-16 years old.,Designated,,,N/A,N/A,"Psyadon Pharmaceuticals, Inc.",20451 Seneca Meadows Parkway,,Germantown,Maryland,20876,USA,308210,2010,
MOD-423 hGH analogue,n/a,2010-09-29,Treatment of growth hormone deficiency,Designated,,,N/A,N/A,Pfizer Inc.,445 Eastern Point Road,,Groton,Connecticut,6340,USA,313410,2010,
moxidectin,n/a,2010-09-29,Treatment of onchocerciasis volvulus in children and adults.,Designated,,,N/A,N/A,Medicines Development Limited,"Level 1, 18 Kevanagh Street",Southbank VIC 3006,Melbourne,,,Australia,316510,2010,
tecovirimat,n/a,2010-09-29,Treatment of orthopoxvirus infections.,Designated,,,N/A,N/A,"SIGA Technologies, Inc.",4575 SW Research Way,,Corvallis,Oregon,97333,USA,316210,2010,
"(S)-10-[(dimethylamino)methyl]-4-ethyl-9hydroxy-4-O-[a-(2"",4"",5"",7""-tetranitro-9""-fluorenylideneaminooxy)propionyl]- 1H-pyrano[3',4',6',7',] indolizino [1,2-B]-quinoline-3, 14-(4H, 12H)-dione, hydrochloride",Lipotecan,2010-10-06,Treatment of hepatocellular carcinoma,Designated,,,N/A,N/A,"TLC Biopharmaceuticals, Inc.",432 N Canal St,Suite 20,South San Francisco,California,94080,USA,317610,2010,
"5-((4-(6-chlorothieno[2,3-d]pyrimidine-4-ylamino)piperidin-1-yl)methyl)-2-fluorobenzonitrile monofumurate",n/a,2010-10-21,Treatment of pulmonary arterial hypertension,Designated/Withdrawn,,,N/A,N/A,"Forest Laboratories, Inc.",Harborside Financial Center,Plaza V,Jersey City,New Jersey,7311,USA,308510,2010,
algenpantucel-L,Hyperacute(R)-Pancreatic Cance,2010-10-21,Treatment of pancreatic cancer.,Designated/Withdrawn,,,N/A,N/A,NewLink Genetics Corporation,2503 S. Loop Drive,,Ames,Iowa,50010,USA,315810,2010,
alpha-tocotrienol quinone,n/a,2010-10-21,Treatment of inherited mitochondrial respiratory chain diseases.,Designated,,,N/A,N/A,BioElectron Technology Corporation,350 N. Bernardo Ave.,,Mountain View,California,94043,USA,316310,2010,
BCL-005 (fused (hybrid) melanoma-dendritic cells),n/a,2010-10-21,Treatment of stage IIb to IV melanoma in HLA-A2 positive patients,Designated/Withdrawn,,,N/A,N/A,Brucells SA,Rue de Ransbeekstraat 310,,Brussel,,,Belgium,314610,2010,
bevacizumab,n/a,2010-10-21,Treatment of hereditary hemorrhagic telangiectasia,Designated,,,N/A,N/A,"Terence M. Davidson, MD",UCSD Medical Center,,San Diego,California,92103,USA,317510,2010,
ensituximab,n/a,2010-10-21,Treatment of pancreatic cancer.,Designated,,,N/A,N/A,"Neogenix Oncology, Inc.",9700 Great Seneca Highway,,Rockville,Maryland,20850,USA,320210,2010,
fresolimumab,n/a,2010-10-21,Treatment of primary focal segmental glomerulosclerosis,Designated/Withdrawn,,,N/A,N/A,"Genzyme, a Sanofi Company",200 Crossing Boulevard,,Framingham,Massachusetts,1702,USA,313510,2010,
human monoclonal anti-PA antibody,Yervoy,2010-10-21,For post-exposure prophylaxis and treatment of inhalation anthrax.,Designated/Withdrawn,,,N/A,N/A,"Emergent Product Development Gaithersburg, Inc.",300 Professional Drive,,Gaithersburg,Maryland,20879,USA,317710,2010,
Lucinactant,"Surfaxin(R), Aerosurf(R)",2010-10-21,Treatment of cystic fibrosis.,Designated,,,N/A,N/A,"Windtree Therapeutics, Inc.",2600 Kelly Road,Suite 100,Warrington,Pennsylvania,18976,USA,318910,2010,
N-acetylcysteine,"Acetadote(C), Mucomist(C)",2010-10-21,Treatment of apnea of prematurity,Designated/Withdrawn,,,N/A,N/A,Galleon Pharmaceuticals,213 Witmer Road,,Horsham,Pennsylvania,19044,USA,309110,2010,
pegylated carboxyhemoglobin,n/a,2010-10-21,Treatment of acute painful sickling crises in patients with sickle cell disease,Designated,,,N/A,N/A,"Sangart, Inc.",6175 Lusk Blvd,,San Diego,California,92121,USA,315210,2010,
chloropyramine,n/a,2010-10-22,Treatment of pancreatic cancer,Designated,,,N/A,N/A,"CurFAKtor Pharmaceuticals, LLC",14 Rock Dove Lane,,Orchard Park,New York,14127,USA,321110,2010,
bevacizumab,Avastin,2010-11-02,Treatment of primary peritoneal carcinoma.,Designated/Approved,Approved for Orphan Indication,"In combination with paclitaxel, pegylated liposomal doxorubicin, or topotecan for treatment of patients with platinum-resistant, recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who received no more than 2 prior chemotherapy regimens",2014-11-14,2021-11-14,"Genentech, Inc",1 DNA Way,M/S# 355E,South San Francisco,California,94080,USA,317810,2010,1473
bevacizumab,Avastin,2010-11-02,Treatment of primary peritoneal carcinoma.,Designated/Approved,Approved for Orphan Indication,"Either in combination with carboplatin and paclitaxel or in combination with carboplatin and gemcitabine, followed by Avastin as a single agent, is indicated for the treatment of patients with platinum-sensitive recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer.",2016-12-06,2023-12-06,"Genentech, Inc",1 DNA Way,M/S# 355E,South San Francisco,California,94080,USA,317810,2010,2226
4-pyridinylmethyl 3(4-chlorophenyl)adamantine carboxamide,n/a,2010-11-02,Treatment of pancreatic cancer.,Designated,,,N/A,N/A,Apogee Biotechnology Corporation,Hershey Center for Applied Research,Suite 1016,Hummelstown,Pennsylvania,17036,USA,318110,2010,
menatetrenone,Mk4(R),2010-11-02,Treatment of acute promyelocytic leukemia.,Designated,,,N/A,N/A,"NBI Pharmaceuticals, Inc.",c/o Neil & Co CPAs,"1184 N. 15th Ave., Suite 1",Bozeman,Montana,59715,USA,320810,2010,
menatetrenone,Mk4(R),2010-11-02,Treatment of hepatocellular carcinoma (HCC).,Designated,,,N/A,N/A,"NBI Pharmaceuticals, Inc.",1087 Stoneridge Drive,,Bozeman,Montana,59718,USA,319910,2010,
mogamulizumab,n/a,2010-11-02,Treatment of peripheral T-cell lymphoma.,Designated,,,N/A,N/A,"Kyowa Kirin Pharmaceutical Development, Inc.",212 Carnegie Center #101,,Princeton,New Jersey,8540,USA,313710,2010,
mogamulizumab,n/a,2010-11-02,Treatment of patients with cutaneous T-cell lymphoma.,Designated,,,N/A,N/A,Kyowa Kirin Pharmaceutical Development Inc.,212 Carnegie Center # 101,,Princeton,New Jersey,8540,USA,322010,2010,
"Phosphatidylinositol 3-Kinase ""PI3K"" Inhibitor",n/a,2010-11-02,Treatment of chronic lymphocytic leukemia (CLL),Designated,,,N/A,N/A,Semafore Pharmaceuticals,17338 Westfield Park Road,Suite 3,Westfield,Indiana,46074,USA,313910,2010,
trientine hydrochloride,Syprine(R),2010-11-02,Treatment of manganism.,Designated,,,N/A,N/A,"Cerberus Princeton, LLC",c/o Cerberus Capital Management L.P.,875 Third Avenue,New York,New York,10022,USA,301210,2010,
gabapentin,Gralise,2010-11-08,Management of postherpetic neuralgia,Designated/Approved,Approved for Orphan Indication,For the management of postherpetic neuralgia,2011-01-28,2018-01-28,"Depomed, Inc.",1360 O'Brien Drive,,Menlo Park,California,94025,USA,236506,2010,81
"antihemophilic factor (recombinant), Fc fusion protein",Eloctate,2010-11-23,Treatment of hemophilia A,Designated/Approved,Approved for Orphan Indication,"Treatment of adults and children with Hemophilia A (congenital Factor VIII deficiency) for control and prevention of bleeding episodes, perioperative management, and routine prophylaxis to prevent or reduce the frequency of bleeding episodes.",2014-06-06,2021-06-06,"Bioverativ Therapeutics, Inc.",225 2nd Avenue,,Waltham,Massachusetts,2451,USA,321610,2010,1291
bevacizumab,Avastin,2010-11-23,Treatment of fallopian tube carcinoma,Designated/Approved,Approved for Orphan Indication,"In combination with paclitaxel, pegylated liposomal doxorubicin, or topotecan for treatment of patients with platinum-resistant, recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who have received no more than 2 prior chemotherapy regimens.",2014-11-14,2021-11-14,"Genentech, Inc",1 DNA Way,M/S# 355E,South San Francisco,California,94080,USA,318010,2010,1452
recombinant von Willebrand factor (rhVWF),n/a,2010-11-23,Treatment of von Willebrand disease.,Designated/Approved,Approved for Orphan Indication,Indicated for on-demand treatment and control of bleeding episodes in adults diagnosed with von Willebrand disease (VWD),2015-12-08,2022-12-08,"Baxalta US, Inc.",One Baxter Way,,Westlake Village,California,91362,USA,322210,2010,1841
bevacizumab,Avastin,2010-11-23,Treatment of fallopian tube carcinoma,Designated/Approved,Approved for Orphan Indication,"Either in combination with carboplatin and paclitaxel or in combination with carboplatin and gemcitabine, followed by Avastin as a single agent, is indicated for the treatment of patients with platinum-sensitive recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer.",2016-12-06,2023-12-06,"Genentech, Inc",1 DNA Way,M/S# 355E,South San Francisco,California,94080,USA,318010,2010,2205
cyclosporine; ciclosporin,Neurostat(R)/Ciclomulsion(R),2010-11-23,Treatment of moderate to severe traumatic brain injury.,Designated,,,N/A,N/A,NeuroVive Pharmaceutical AB,Medicon Village,SE-223 81,Lund,,,Sweden,319710,2010,
eflornithine,n/a,2010-11-23,Treatment of neuroblastoma,Designated,,,N/A,N/A,"Cancer Prevention Pharmaceutical, Inc.",1760 East River Road,,Tucson,Arizona,85718,USA,319610,2010,
FliC Flagellin Deletion Variant TLR5 Agonist,n/a,2010-11-23,Prevention of death following a potentially lethal dose of total body irradiation during or after a radiation disaster,Designated,,,N/A,N/A,"Cleveland BioLabs, Inc.",73 High Street,,Buffalo,New York,14203,USA,310910,2010,
ganitumab,n/a,2010-11-23,Treatment of pancreatic cancer.,Designated,,,N/A,N/A,Nantcell,9920 Jefferson Blvd,,Culver City,California,90232,USA,321510,2010,
naloxone,n/a,2010-11-23,Topical treatment of pruritus associated with mycosis fungoides,Designated,,,N/A,N/A,"Elorac, Inc.",100 Fairway Drive,,Vernon Hills,Illinois,60061,USA,280209,2010,
recombinant kallikrein inhibitor,n/a,2010-11-23,Treatment of Netherton Syndrome.,Designated,,,N/A,N/A,Dermadis SA,Batiment Le Forum,74160 Archamps,,,,France,323710,2010,
cabozantinib,Cometriq,2010-11-29,"Treatment of follicular, medullary and anaplastic thyroid carcinoma and metastatic or locally advanced papillary thyroid cancer.",Designated/Approved,Approved for Orphan Indication,"Treatment of progressive, metastatic medullary thyroid cancer (MTC).",2012-11-29,2019-11-29,"Exelixis, Inc.",210 East Grand Avenue,,South San Francisco,California,94083,USA,297109,2010,731
filociclovir,n/a,2010-11-29,Treatment of active cytomegalovirus infections,Designated,,,N/A,N/A,"Microbiotix, Inc.",One Innovation Drive,,Worcester,Massachusetts,1605,USA,319010,2010,
maytansinoid DM1-conjugated humanized monoclonal antibody N901,n/a,2010-11-29,Treatment of multiple myeloma.,Designated/Withdrawn,,,N/A,N/A,"ImmunoGen, Inc.",830 Winter Street,,Waltham,Massachusetts,2451,USA,322610,2010,
sodium dichloroacetate,n/a,2010-11-29,For pulmonary arterial hypertension.,Designated,,,N/A,N/A,"Peter W. Stackpoole, PhD, MD",University of FL College of Medicine,P. O. Box 100226,Gainesville,Florida,32611,USA,313010,2010,
ustekinumab,Stelara,2010-11-29,Treatment of type 1 diabetes mellitus patients with residual beta-cell function.,Designated,,,N/A,N/A,Johnson & Johnson Pharmaceutical & Development LLC,902 Route 202 South,Room 1654,Raritan,New Jersey,8869,USA,314510,2010,
"(2E, 4E, 6Z, 8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-l-yl) nona-2,4,6,8-tetraen-l-yl acetate",n/a,2010-12-02,Treatment of retinitis pigmentosa,Designated,,,N/A,N/A,"Novelion Therapeutics, Inc.",887 Great Northern Way - Suite 250,"Vancouver, British Columbia, V5T 4T5",,,,Canada,324410,2010,
"(2E,4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetraenyl acetate 9-cis-retinyl acetate (API)",n/a,2010-12-02,Treatment of Leber congential amaurosis (LCA) due to inherited mutations in RPE65 (encoding the protein retinal pigment epithelial protein 65) or LRAT (encoding the enzyme lecithin:retinol acyltransferase)genes.,Designated,,,N/A,N/A,"Novelion Therapeutics, Inc.",887 Great Northern Way - Suite 250,"Vancouver, British Columbia",V5T 4T5,,,Canada,320410,2010,
"allogeneic cord blood cells, ex vivo modulated with 16,16 dimethyl prostaglandin E2 (dmPGE2)",n/a,2010-12-02,"Enhancement of stem cell engraftment through ex vivo treatment of human allogeneic hematopoietic stem cells (treatment of neuropenia, thrombocytopenia, lymphopenia, and anemia).",Designated,,,N/A,N/A,"Fate Therapeutics, Inc.",3535 General Atomics Court,,San Diego,California,92121,USA,321810,2010,
sodium thiosulfate,n/a,2010-12-02,Treatment of extravasation of meclorethamine hydrochloride into subcutaneous tissues.,Designated,,,N/A,N/A,Hope Pharmaceuticals,16416 N. 92nd Street,,Scottsdale,Arizona,85260,USA,322410,2010,
acyclovir,n/a,2010-12-13,Treatment of acute herpetic keratitis caused by Herpes Simplex Virus type 1 and 2,Designated,,,N/A,N/A,Fera Pharmaceuticals,134 Birch Hill Road,,Locust Valley,New York,11560,USA,325010,2010,
cediranib,n/a,2010-12-13,Treatment of glioblastoma,Designated,,,N/A,N/A,National Institutes of Health,National Cancer Institute,9609 Medical Center Dr.,Bethesda,Maryland,20892,USA,310510,2010,
Dermagraft,n/a,2010-12-13,Treatment of epidermolysis bullosa,Designated,,,N/A,N/A,"Shire Regenerative Medicine, Inc.",11095 Torreyana Road,subsidiary of Shire Pharmaceuticals.,San Diego,California,92121,USA,327010,2010,
DNA plasmid vector expressing eIF5Ak50,n/a,2010-12-13,Treatment of multiple myeloma.,Designated,,,N/A,N/A,"Senesco Technologies, Inc.",303 George Street,,New Brunswick,New Jersey,8901,USA,324910,2010,
fidaxomicin,Dificid,2010-12-13,Treatment of pediatric Clostridium difficile infection,Designated,,,N/A,N/A,"Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc.",20 Weystrasse,,Luzern,,,Switzerland,325210,2010,
iferanserin (S-MPEC),n/a,2010-12-13,For use in pulmonary arterial hypertension.,Designated,,,N/A,N/A,"Sam Amer & Company, Inc.",P. O. Box 5685,,Montecito,California,93150,USA,315910,2010,
lithium citrate tetrahydrate (in reverse micelle formulation),n/a,2010-12-13,Treatment of Huntington's disease.,Designated,,,N/A,N/A,Medesis Pharma,L'Oree des Mas,34 670 Baillargues,,,,France,325510,2010,
recombinant thymidine phosphorylase encapsulated with autologous erythrocytes,n/a,2010-12-13,Treatment of mitochondrial neurogastrointestinal encephalomyopathydue to thymidine phosphorylase deficiency.,Designated,,,N/A,N/A,St. George's University of London,Joint Research Office,London SW17 ORE,,,,United Kingdom,324810,2010,
NDX-peptides,n/a,2010-12-14,Treatment of amyotrophic lateral sclerosis,Designated,,,N/A,N/A,NeoDiagnostic Research Ltd,Sheraton House 1st Floor,Chorleywood,Herts WD3 5LH,,,United Kingdom,326010,2010,
vemurafenib,Zelboraf,2010-12-20,Treatment of patients with IIb to Stage IV melanoma positive for the BRAF(v600) mutation,Designated/Approved,Approved for Orphan Indication,Treatment of unresectable or metastatic melanoma with the BRAFV600E mutation as detected by an FDA-approved test.,2011-08-17,2018-08-17,"Hoffmann-La Roche, Inc.",340 Kingsland Street,,Nutley,New Jersey,7110,USA,325310,2010,240
trametinib,Mekinist,2010-12-20,Treatment of Stage IIb through Stage IV melanoma,Designated/Approved,Approved for Orphan Indication,Treatment of patients with unresectable or metastatic melanoma with BRAF V600E or V600K mutations as detected by an FDA approved test.,2013-05-29,2020-05-29,Novartis Pharmaceuticals Corp.,One Health Plaza,,East Hanover,New Jersey,7936,USA,325410,2010,891
denosumab,Xgeva,2010-12-20,Treatment of patients with giant cell tumor of bone,Designated/Approved,Approved for Orphan Indication,Treatment of adults and skeletally mature adolescents with giant cell tumor of bone that is unresectable or where surgical resection is likely to result in severe morbidity.,2013-06-13,2020-06-13,"Amgen, Inc.",One Amgen Center Drive,,Thousand Oaks,California,91320,USA,324110,2010,906
dinutuximab,Unituxin,2010-12-20,Treatment of neuroblastoma,Designated/Approved,Approved for Orphan Indication,"For use in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2 (IL-2) and 13-cis-retinoic acid (RA), for the treatment of pediatric patients with high-risk neuroblastoma who achieve at least a partial response to prior first-line multiagent, multimodality therapy",2015-03-10,2022-03-10,United Therapeutics Corporation,55 TW Alexander Drive,,Research Triangle Park,North Carolina,27709,USA,324210,2010,1541
Bleomycin,n/a,2010-12-20,Treatment of pancreatic cancer.,Designated,,,N/A,N/A,CIRJ Company Ltd.,1800 Loma Vista St.,,Pasadena,California,91004,USA,326510,2010,
calcium benzoate and risperidone,n/a,2010-12-20,Treatment of pediatric patients with schizophrenia,Designated,,,N/A,N/A,"University of California, Los Angeles",Dept. of Psychiarty,"HH212, 1000 W. Carson Street",Torrance,California,90509,USA,326110,2010,
crenolanib besylate,n/a,2010-12-20,Treatment of malignant glioma,Designated,,,N/A,N/A,"AROG Pharmaceuticals, LLC",Two Lincoln Centre,Suite 410,Dallas,Texas,75240,USA,320910,2010,
ex-vivo expanded autologous bone marrow-derived mesenchymal stem cells,n/a,2010-12-20,Treatment of Amyotrophic Lateral Sclerosis,Designated,,,N/A,N/A,"TCA Cellular Therapy, LLC",101 Judge Tanner Blvd.,,Covington,Louisiana,70433,USA,328810,2010,
live attenuated E. Coli expressing Beta catenin shRNA,n/a,2010-12-20,Treatment of Familial Adenomatous Polyposis,Designated,,,N/A,N/A,Marina Biotech,One Kendall Square,"Building 400, Suite B4401",Cambridge,Massachusetts,2139,USA,326210,2010,
GVAX melanoma,n/a,2010-12-23,Treatment of stage IIb to IV melanoma,Designated,,,N/A,N/A,"Aduro BioTech, Inc.",740 Heinz Avenue,,Berkeley,California,94710,USA,313110,2010,
tranilast,Rizaben,2010-12-23,Prevention of scarring following glaucoma filtration surgery,Designated,,,N/A,N/A,Altacor Ltd,St. John's Innovation Centre,,Cambridge CB4 0WS,,,United Kingdom,311810,2010,
4-[131I]iodo-L-phenylalanine,n/a,2011-01-04,Treatment of glioma.,Designated,,,N/A,N/A,Therapeia GmbH & Co KG,Veilchenweg 38,D-01326 Dresden,,,,Germany,328710,2011,
bortezomib,Velcade,2011-01-04,Treatment of follicular non-Hodgkin lymphoma,Designated,,,N/A,N/A,"Millennium Pharmaceuticals, Inc.",40 Landsdowne Street,,Cambridge,Massachusetts,2139,USA,328610,2011,
ricin vaccine,Rivax(R),2011-01-07,Prevention of ricin intoxication.,Designated,,,N/A,N/A,"Soligenix, Inc.",29 Emmons Drive,Suite C-10,Princeton,New Jersey,8540,USA,329110,2011,
regorafenib,Stivarga,2011-01-12,Treatment gastrointestinal stromal tumors,Designated/Approved,Approved for Orphan Indication,"Treatment of patients with locally advanced, unresectable or metastatic gastrointestinal stromal tumor (GIST) who have been previously treated with imatinib mesylate and sunitinib malate.",2013-02-25,2020-02-25,"Bayer HealthCare Pharmaceuticals, Inc.",100 Bayer Blvd,P. O. Box 915,Whippany,New Jersey,7981,USA,329410,2011,775
dabrafenib,Tafinlar,2011-01-12,Treatment BRAF V600 mutation positive Stage IIB through IV melanoma,Designated/Approved,Approved for Orphan Indication,Treatment of patients with unresectable or metastatic melanoma with BRAF V600E mutation as detected by an FDA approved test.,2013-05-29,2020-05-29,Novartis Pharmaceuticals Corp.,One Health Plaza,,East Hanover,New Jersey,7936,USA,329610,2011,868
"anti-TCR murine monoclonal antibody (MAB, type IgM)",n/a,2011-01-12,Treatment of pediatric multiple sclerosis in patients less than or equal to 16 years of age,Designated,,,N/A,N/A,"Tolera Therapeutics, Inc.",350 E. Michigan Ave.,,Kalamazoo,Michigan,49008,USA,329310,2011,
cridanimod,n/a,2011-01-12,Treatment of progesterone receptor negative endometrial cancer in conjunction with progesterone therapy.,Designated,,,N/A,N/A,"Xenetic Biosciences, Inc.",99 Hayden Avenue,Suite 230,Lexington,Massachusetts,2421,USA,328910,2011,
glioma derived cell lysates and irradiated cells,n/a,2011-01-12,Treatment of glioma.,Designated,,,N/A,N/A,Epitopoietic Research Corp.,1055 E. Colorado Blvd,,Pasadena,California,91160,USA,329210,2011,
"L-amino acids, vitamins and minerals combined with omega-3 fatty acids",n/a,2011-01-12,Treatment of patients with pediatric Crohn's disease,Designated,,,N/A,N/A,"Immunopath Profile, Inc.",325 Dunes Blvd - Suite 403 (zip code 34110),,Naples,Florida,34110,USA,285809,2011,
"N-[(2S)-2,3-dihydroxypropyl]-3-[(2-fluoro-4-iodophenyl)amino] isonicotinamide hydrochloride",n/a,2011-01-12,Treatment of acute myeloid leukemia (AML).,Designated,,,N/A,N/A,"EMD Serono, Inc.",1 Technology Place,,Rockland,Massachusetts,2370,USA,328110,2011,
reslizumab,Cinquil,2011-01-12,Treatment of hypereosinophilic syndrome,Designated,,,N/A,N/A,"Teva Pharmaceuticals, Inc.",41 Moores Road,P. O. Box 4011,Frazer,Pennsylvania,19355,USA,328510,2011,
vocimagene amiretrorepvec and flucytosine,n/a,2011-01-12,Treatment of malignant glioma in addition to glioblastoma multiforme,Designated,,,N/A,N/A,"Tocagen, Inc.",3030 Bunker Hill St.,,San Diego,California,92109,USA,327910,2011,
mitomycin,n/a,2011-01-13,Prevention of recurrence of pterygium after its surgical excision.,Designated,,,N/A,N/A,"Mobius Therapeutics, LLC",4041 Forest Park Avenue,,St. Louis,Missouri,63108,USA,312510,2011,
fluticasone propionate,n/a,2011-01-19,Treatment of pediatric and adult eosinophilic esophagitis,Designated,,,N/A,N/A,"Adare Pharmaceuticals, Inc.",845 Center Drive,,Vandalia,Ohio,45377,USA,319410,2011,
iduvec,n/a,2011-01-21,Treatment of Mucopolysaccharidosis Type I,Designated,,,N/A,N/A,Zebraic Corporation,8837 Stratford Crossing,,Brooklyn Park,Minnesota,55443,USA,327110,2011,
monoclonal antibody,n/a,2011-01-21,Prevention of congential cytomegalovirus (CMV)infection following primary CMV infection in pregnant women.,Designated/Withdrawn,,,N/A,N/A,Theraclone Sciences,1124 Columbia Street,,Seattle,Washington,98104,USA,325710,2011,
D-peptide,Nerofe,2011-02-04,Treatment of acute myelogenous leukemia,Designated,,,N/A,N/A,"Immune System Key, Ltd",POB 23365,,Jerusalem 91233,,,Israel,331210,2011,
eflornithine,n/a,2011-02-04,Treatment of Familial Adenomatous Polyposis,Designated,,,N/A,N/A,Cancer Prevention Pharmaceuticals,1760 E. River Road #250,,Tucson,Arizona,85718,USA,321210,2011,
human spinal cord derived neural stem cells,n/a,2011-02-04,Treatment of amyotrophic lateral sclerosis,Designated,,,N/A,N/A,"Neuralstem, Inc.",20271 Goldenrod LAne,,Germantown,Maryland,20876,USA,329710,2011,
inhibitor of microRNA-451,n/a,2011-02-04,Treatment of polycythemia vera,Designated/Withdrawn,,,N/A,N/A,"miRagen Therapeutics, Inc.",6200 Lookout Road,,Boulder,Colorado,80301,USA,316410,2011,
menatetrenone,Mk4(R),2011-02-04,Treatment of myelodysplastic syndrome.,Designated,,,N/A,N/A,"NBI Pharmaceuticals, Inc.",1087 Stoneridge Drive,,Bozeman,Montana,59718,USA,319110,2011,
mesenchymal stromal cells secreting neurotrophic factors,Nurown,2011-02-04,Treatment of Amyotrophic Lateral Sclerosis,Designated,,,N/A,N/A,BrainStorm Cell Therapeutics Ltd.,"12 Bazel St., Kiryat Arie",,,,,Israel,331910,2011,
MLN4924-Inhibitor of Nedd8-activating enzyme (NAE),n/a,2011-02-04,Treatment of acute myelogenous leukemia.,Designated,,,N/A,N/A,Millennium Pharmaceuticals,40 Landsdowne St.,,Cambridge,Massachusetts,2139,USA,331510,2011,
MLN4924-Inhibitor of Nedd8-activating enzyme (NAE),n/a,2011-02-04,Treatment of Myelodysplastic syndrome,Designated,,,N/A,N/A,"Millennium Pharmaceuticals, Inc.",40 Landsdowne St.,,Cambridge,Massachusetts,2139,USA,331310,2011,
"N-{[(5S)-3-(3-fluoro-4-thiomorpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl}acetamide",n/a,2011-02-04,Treatment of tuberculosis.,Designated,,,N/A,N/A,"Sequella, Inc.",9610 Medical Center Drive,Suite 200,Rockville,Maryland,20820,USA,328210,2011,
peptides mimicking antigen receptors on autoimmune B cells and autoimmune T cells associated with myasthenia gravis,n/a,2011-02-04,Treatment of myasthenia gravis,Designated,,,N/A,N/A,CuraVac Europe SPRL,Avenue de Villefranche 80,,,,,Belgium,332610,2011,
recombinant adeno-associated virus vector expressing the cyclic nucleotide gated channel beta subunit (rAAV-CNGB3),n/a,2011-02-04,Treatment of achromatopsia caused by mutations in the CNGB3 gene.,Designated,,,N/A,N/A,Applied Genetic Technologies Corporation,11801 Research Drive,Suite D,Alachua,Florida,32615,USA,332310,2011,
thymopentin,n/a,2011-02-04,Treatment of sarcoidosis.,Designated,,,N/A,N/A,Mondobiotech Laboratories AG,Herrengasse 21,Furstentum Liechtenstein,,,,Switzerland,330010,2011,
human heterologous liver cells,n/a,2011-02-14,Treatment of urea cycle disorders,Designated,,,N/A,N/A,Promethera Biosciences S.A./N.V.,rue Granbonpre 11,Watson & Crick Hill,,,,Belgium,331810,2011,
S-59 treated FFP (plasma treated with amotosalen hydrochloride & ultraviolet A light,Intercept Blood System For,2011-02-14,Treatment of thrombotic thrombocytopenic purpura,Designated,,,N/A,N/A,Cerus Corporation,2550 Stanwell Drive,,Concord,California,94520,USA,331710,2011,
ixazomib citrate,Ninlaro,2011-02-18,Treatment of multiple myeloma,Designated/Approved,Approved for Orphan Indication,Use in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy,2015-11-20,2022-11-20,Millennium Pharmaceuticals,40 Landsdowne St.,,Cambridge,Massachusetts,2139,USA,330510,2011,1736
acetyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-cysteinyl-D-glutaminyl-D-cysteinyl-D-arginyl-D-arginyl-D-lysyl-Dasparaginylamide disulfide,n/a,2011-02-18,Treatment of pancreatic cancer.,Designated/Withdrawn,,,N/A,N/A,"Genus Oncology, LLC",2458 N. Racine Avenue,,Chicago,Illinois,60614,USA,333311,2011,
human interleukin-3 genetically conjugated to diphtheria toxin protein,n/a,2011-02-18,Treatment of acute myeloid leukemia.,Designated,,,N/A,N/A,"Stemline Therapeutics, Inc.",750 Lexington Avenue,,New York,New York,10022,USA,332811,2011,
met-enkephalin; Met-N,n/a,2011-02-18,Treatment of pancreatic cancer.,Designated,,,N/A,N/A,"NBI Pharmaceuticals, Inc.",c/o Neil & Co CPAs,"1184 N. 15th Ave., Suite 1",Bozeman,Montana,59715,USA,333011,2011,
murine monoclonal antibody against CD26,Begedina,2011-02-18,Treatment of graft versus host disease,Designated,,,N/A,N/A,ADIENNE S.A.,"Via Zurigo, 46",6900 Lugano,,,,Switzerland,332510,2011,
oral potent and selective antagonist,n/a,2011-02-18,Treatment of patients with chondrosarcoma.,Designated/Withdrawn,,,N/A,N/A,"Infinity Pharmaceuticals, Inc.",780 Memorial Drive,,Cambridge,Massachusetts,2139,USA,333511,2011,
Revimmune,n/a,2011-02-18,Treatment of autoimmune hemolytic anemia.,Designated,,,N/A,N/A,Accentia Biopharmaceuticals,324 South Hyde Park Avenue #350,,Tampa,Florida,33606,USA,333711,2011,
acadesine,n/a,2011-03-03,Treatment of chronic lymphocytic leukemia,Designated,,,N/A,N/A,"Avanced In Vitro Cell Technologies, S.L.",(Advancell),08028 Barcelona,,,,Spain,203105,2011,
Adenosine triphosphate type 1 competitive inhibitor of JAK2 V617F tyrosine kinase,n/a,2011-03-03,"Treatment of myeloproliferative disorders (polycythemia vera, essential throbocythemia, and myelofibrosis)",Designated,,,N/A,N/A,Eli Lilly and Company,Lilly Corporate Center,,Indianapolis,Indiana,46285,USA,334211,2011,
lomitapide,n/a,2011-03-03,Treatment of Familial Chylomicronemia,Designated,,,N/A,N/A,"Aegerion Pharmaceuticals, Inc.",One Main St,Suite 800,Cambridge,Massachusetts,2142,USA,332110,2011,
"ombrabulin; N-{2-methoxy-5-[(Z)-2-(3,4,5-trimethozyphenyl)vinyl]phenyl}-L-serinamide hydrochloride",n/a,2011-03-03,Treatment of soft tissue sarcoma,Designated,,,N/A,N/A,"Sanofi-Aventis U.S., Inc.",55 Corporate Drive,,Bridgewater,New Jersey,8807,USA,334511,2011,
pyridoxine; vitamin B6,n/a,2011-03-03,Treatment of pyridoxine dependent seizures.,Designated,,,N/A,N/A,"NBI Pharmaceuticals, Inc.",c/o Neil & Co CPAs,"1184 N. 15th Ave., Suite 1",Bozeman,Montana,59715,USA,334311,2011,
sodium thiosulfate,n/a,2011-03-03,Treatment of sulfur mustard poisoning,Designated,,,N/A,N/A,Hope Pharmaceuticals,16416 N. 92nd Street,,Scottsdale,Arizona,85260,USA,335311,2011,
eicosapentaenoic acid,n/a,2011-03-08,Treatment of familial adenomatous polyposis,Designated,,,N/A,N/A,S.L.A. Pharma Ltd. (UK),Elite House,"Leavesden, Watford WD25 7SA",,,,United Kingdom,283409,2011,
talimogene laherparepvec,Imlygic,2011-03-14,Treatment of stage IIb-stage IV melanoma,Designated/Approved,Approved for Orphan Indication,"Indicated for the local treatment of unresectable cutaneous, subcutaneous, and nodal lesions in patients with melanoma recurrent after initial surgery",2015-10-27,2022-10-27,"BioVex, Inc. (subsidiary of Amgen)",Amgen,Mail Stop 17-2-B,Thousand Oaks,California,91320,USA,334011,2011,1688
coenzyme Q10 and d-alpha-tocopherol,n/a,2011-03-14,Treatment of Friedreich's Ataxia.,Designated,,,N/A,N/A,"NBI Pharmaceuticals, Inc.",c/o Neil & Co CPAs,"1184 N. 15th Ave., Suite 1",Bozeman,Montana,59715,USA,335111,2011,
"Sar9, Met(O2)11-Substance P",Homspera,2011-03-16,Treatment of idiopathic pulmonary fibrosis,Designated,,,N/A,N/A,"ImmuneRegen BioSciences, Inc.","IR Biosciences Holdings, Inc",,Scottsdale,Arizona,85258,USA,304110,2011,
adeno associated viral vector containing human ARSB gene,n/a,2011-03-17,Treatment of mucopolysaccharidosis type VI (MPS VI; Maroteaux-Lamy syndrome),Designated,,,N/A,N/A,Fondazione Telethon,Via Varese 16 - 00185 Roma,,,,,Italy,335011,2011,
hydralazine - magnesium valproate,Transkrip(R),2011-03-17,Treatment of cutaneous T-cell lymphoma.,Designated,,,N/A,N/A,Neolpharma S.A.DE C.V.,Boulevard de los Ferrocarriles 277,Azcapotzalco,Mexico City,,,Mexico,334411,2011,
hydralazine - magnesium valproate,Transkrip(R),2011-03-17,Treatment of myelodysplastic syndrome,Designated,,,N/A,N/A,Neolpharma S.A.DE C.V.,Boulevard de los Ferrocarriles 277,Azcapotzalco,Mexico City,,,Mexico,334611,2011,
menatetrenone,Mk4,2011-03-17,Treatment of acute myeloid leukemia,Designated,,,N/A,N/A,"NBI Pharmaceuticals, Inc.",1087 Stoneridge Drive,,Bozeman,Montana,59718,USA,319210,2011,
picibanil,n/a,2011-03-17,Treatment of lymphatic malformations,Designated,,,N/A,N/A,"Richard Smith, M.D.",University of Iowa Hospitals & Clinics,21151-PFP,Iowa City,Iowa,52242,USA,335811,2011,
"(3,5-Bis trifluoromethyl)-N-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2-yl amino) phenyl] benzamide",n/a,2011-03-18,Treatment of chronic myelogenous leukemia.,Designated,,,N/A,N/A,NATCO Pharma Limited,Natco House,,Hyderbad 500033,,,India,336911,2011,
"(3,5-Bis trifluoromethyl)-N-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2-yl amino) phenyl] benzamide",n/a,2011-03-18,Treatment of pancreatic cancer,Designated,,,N/A,N/A,NATCO Pharma Limited,Natco House,,Hyderabad 500033,,,India,337011,2011,
"(3,5-Bis trifluoromethyl)-N-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2-yl amino) phenyl] benzamideNRC-AN-019",n/a,2011-03-18,Treatment of Glioma,Designated,,,N/A,N/A,NATCO Pharma Limited,Natco House,,Hyderbad 500033,,,India,336811,2011,
acetyl-l-carnitine (ALC),n/a,2011-03-18,Treatment of Rett syndrome,Designated/Withdrawn,,,N/A,N/A,"Leadiant Biosciences, Inc.",9841 Washingtonian Blvd.,Suite 500,Gaithersburg,Maryland,20878,USA,329010,2011,
brivanib alaninate,n/a,2011-03-18,Treatment of hepatocellular carcinoma,Designated/Withdrawn,,,N/A,N/A,Bristol-Myers Squibb,P. O. Box 4000,,Princeton,New Jersey,8543,USA,336311,2011,
crenolanib,n/a,2011-03-18,Treatment of soft tissue sarcoma,Designated,,,N/A,N/A,"AROG Pharmaceuticals, LLC",12400 Coit Road,Suite 570,Dallas,Texas,75251,USA,335911,2011,
FTV1+GDP-fucose,n/a,2011-03-18,To improve homing to bone (treatment of myeloablation) in patients receiving hematopoietic stem cell transplantation.,Designated,,,N/A,N/A,"America Stem Cell, Inc.",11014 Bar X Trail,,Helotes,Texas,78023,USA,321010,2011,
Heat Shock Protein 70,n/a,2011-03-18,Treatment of amyotrophic lateral sclerosis,Designated,,,N/A,N/A,"ALS Biopharma, LLC",3805 Old Easton Rd,,Doylestown,Pennsylvania,18902,USA,330410,2011,
rigosertib,n/a,2011-03-18,Treatment of pancreatic cancer.,Designated,,,N/A,N/A,"Onconova Therapeutics, Inc",375 Pheasant Run,,Newtown,Pennsylvania,18940,USA,333611,2011,
lenalidomide,Revlimid,2011-03-28,Treatment of diffuse large B-cell lymphoma,Designated,,,N/A,N/A,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,USA,333811,2011,
selective deacylglycerol acyltransferase 1 inhibitor,n/a,2011-03-28,"Treatment of hypertriglyceridemia in te setting of Type I hyperlipoproteinemia, also known as Familial Chylomicronemia Syndrome",Designated,,,N/A,N/A,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,USA,335711,2011,
(R)-1-phenylethyl-5-(4-biphenyl-4-cyclopropanecarboxylic acid)-3-methylisoxazole-4-yl carbamate sodium salt,n/a,2011-04-15,Treatment of idiopathic pulmonary fibrosis,Designated,,,N/A,N/A,Bristol-Myers Squibb Company,P. O. Box 4000,,Princeton,New Jersey,8543,USA,327810,2011,
nusinersen,Spinraza,2011-04-18,Treatment of spinal muscular atrophy,Designated/Approved,Approved for Orphan Indication,Treatment of spinal muscular atrophy in pediatric and adult patients,2016-12-23,2023-12-23,"Biogen, Inc",225 Binney Street,,Cambridge,Massachusetts,2142,USA,336711,2011,2076
"4,5,6,7-tetrachloro-2',4',5',7'-tetraiodofluorescein disodium salt",n/a,2011-04-18,Treatment of hepatocellular carcinoma.,Designated,,,N/A,N/A,"Provectus Pharmaceuticals, Inc.",7327 Oak Ridge Highway,,Knoxville,Tennessee,37931,USA,339611,2011,
"5-(3-ethyl-1,2,4-oxadiazol-5-yl)-1,4,5,6-tetrahydropyrimidine hydrochloride",n/a,2011-04-18,Treatment of progressive supranuclear palsy.,Designated,,,N/A,N/A,"Mithridion, Inc.",505 Science Drive,,Madison,Wisconsin,53711,USA,327510,2011,
abeotaxane inhibitor of microtubules,n/a,2011-04-18,Treatment of pediatric neuroblastoma.,Designated,,,N/A,N/A,Cortice Biosciences,1345 Avenue of the Americas,42nd Floor,New York,New York,10105,USA,335611,2011,
bi-shRNAfurin and granulocyte macrophage colony stimulating factor augmented autologus tumor cell vaccine,n/a,2011-04-18,Treatment of ovarian cancer,Designated,,,N/A,N/A,"Gradalis, Inc.",2545 Golden Bear Drive,,Carrollton,Texas,75006,USA,336011,2011,
DNA plasmid encoding the acetylcholine receptor,n/a,2011-04-18,Treatment of myasthenia gravis.,Designated/Withdrawn,,,N/A,N/A,Bayhill Therapeutics,1804 Embarcadero Rd.,Suite 201,Palo Alto,California,94303,USA,337711,2011,
DOXO-EMCH,n/a,2011-04-18,Treatment of adenocarcinoma of the pancreas.,Designated,,,N/A,N/A,"NantCell, Inc.",9920 Jefferson Boulevard,,Culver City,California,90232,USA,337211,2011,
etirinotecan pegol,n/a,2011-04-18,Treatment of ovarian cancer.,Designated,,,N/A,N/A,Nektar Therapeutics,"455 Mission Bay Blvd, South",,San Francisco,California,94158,USA,338011,2011,
firtecan pegol,n/a,2011-04-18,Treatment of neuroblastoma.,Designated,,,N/A,N/A,"Enzon Pharmaceuticals, Inc.",20 Kingsbridge Road,,Piscataway,New Jersey,8854,USA,338311,2011,
lonafarnib,n/a,2011-04-18,Treatment of Hutchinson-Gilford progeria syndrome,Designated,,,N/A,N/A,"The Progeria Research Foundation, Inc.",P. O. Box 3453,,Peabody,Massachusetts,1961,USA,333411,2011,
"Methyl O-4-O-[2-[2-[2-[2-[[N-[(1R)-1-[[4-(aminoiminomethyl)phenyl]methyl]-2-oxo-2-(1-piperidinyl)ethyl]-N2-[(4-methoxy-2,3,6-trimethylphenyl)sulfonyl]-L-Ã?ÂÃÃ?Ã?Â&Ã?ÃÂ½Ã?ÂÃÃ?ÂÃ?ÃÂ±-aspararginyl-4-aminobutanoyl-N6-[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[",n/a,2011-04-18,Prevention of ischemia reperfusion injury associated wth solid organ transplantation,Designated,,,N/A,N/A,Endotis Pharma,"102, avenue Gaston Roussel",,,,,France,336211,2011,
peptide YY,n/a,2011-04-18,Treatment of hepatocellular carcinoma.,Designated,,,N/A,N/A,Mondobiotech Laboratories AG,Herrengasse 21,Furstentum Liechtenstein,,,,Switzerland,338911,2011,
perillyl alcohol,n/a,2011-04-18,Treatment of glioma,Designated,,,N/A,N/A,"NeOnc Technologies, Inc.",10524 South La Cienega Blvd.,,Inglewood,California,90304,USA,340411,2011,
Recombinant humanized anti-LOXL2 monoclonal antibody,n/a,2011-04-18,Treatment of idiopathic pulmonary fibrosis,Designated/Withdrawn,,,N/A,N/A,"Gilead Sciences, Inc.",199 East Blaine St.,,Seattle,Washington,98102,USA,336611,2011,
recombinant IgA protease of bacterium Heamophilus influenzae,n/a,2011-04-18,"Treatment of immunoglobulin A nephropathy (IgAN, Berger's disease).",Designated,,,N/A,N/A,Shire Human Genetics Therapies,300 Shire Way,,Lexington,Massachusetts,2421,USA,339411,2011,
Tissue Plasminogen activator,n/a,2011-04-18,Treatment of acute ischemic stroke (AIS) in children age 16 years and younger.,Designated,,,N/A,N/A,"Catherine Amlie-Lefond, MD",University of Washington,4800 Sand Point Way NE - M/S B5552,Seattle,Washington,98105,USA,331410,2011,
"clarithromycin, rifabutin, clofazimine",n/a,2011-04-26,Treatment of pediatric Crohn's disease.,Designated,,,N/A,N/A,RedHill Biopharma Ltd.,42 Givati St.,,,,,Israel,338811,2011,
humanized monoclonal antibody to tissue factor,n/a,2011-04-26,Treatment of pancreatic cancer.,Designated,,,N/A,N/A,"Morphotek, Inc.",210 Welsh Pool Road,,Exton,Pennsylvania,19341,USA,340311,2011,
levothyroxine sodium,n/a,2011-04-26,The preservation of organ function in brain-dead organ donors.,Designated,,,N/A,N/A,"Fera Pharmaceuticals, LLC",134 Birch Hill Road,,Locust Valley,New York,11560,USA,334711,2011,
metronidazole,n/a,2011-04-26,Treatment of pouchitis.,Designated,,,N/A,N/A,S.L.A. Pharma Limited (UK),Elite House,"Watford, Hertfordshire. WD25 7SA.",,,,United Kingdom,339111,2011,
immune globulin intraveous (human),Gammaplex,2011-04-29,Treatment of idiopathic thrombocytopenic purpura (also known as primary immune thrombocytopenia),Designated/Approved,Approved for Orphan Indication,Idiopathic thrombocytopenic purpura,2013-03-08,N/A,Bio Products Laboratory,Dagger Lane,"Hertfordshire, WD3BX,",England,,,United Kingdom,335211,2011,679
ferumoxytol,Feraheme,2011-04-29,For use in MR imaging for the mangement of brain tumors,Designated,,,N/A,N/A,"Edward A. Neuwelt, MD",Oregon Health & Science University,3181 SW Sam Jackson Park Road - Mail Code L603,Portland,Oregon,97239,USA,338411,2011,
Humanized monoclonal antibody to TumorEndothelial Marker-1,n/a,2011-04-29,Treatment of soft tissue sarcoma,Designated,,,N/A,N/A,Morphotek,210 Welsh Pool Rd,,Exton,Pennsylvania,19341,USA,337311,2011,
sobetirome,n/a,2011-04-29,Treatment of X-linked adrenoleukodystrophy,Designated,,,N/A,N/A,"NeuroVia, Inc.",332 Broadway,Suite 1,Cambridge,Massachusetts,2139,USA,334811,2011,
acadesine,n/a,2011-05-04,Treatment of multiple myeloma,Designated,,,N/A,N/A,Advancell-Advanced In Vitro Cell Technologies S.A.,"Via Augusta 59, 3rd floor, door 313",,Barcelona,,,Spain,341011,2011,
human umbilical tissue derived cells (hUTC),n/a,2011-05-10,Treatment of amyotrophic lateral sclerosis,Designated/Withdrawn,,,N/A,N/A,"Janssen Research & Development, LLC",1400 McKean Road,P. O. Box 776,Spring House,Pennsylvania,19477,USA,339811,2011,
adalimumab,Humira,2011-05-11,Treatment of pediatric patients with ulcerative colitis,Designated,,,N/A,N/A,"AbbVie, Inc.",1 N. Waukegan Road,,North Chicago,Illinois,60064,USA,340911,2011,
human Hepatocarcinoma-Intestine-pancreas/pancreatitis associated protein,n/a,2011-05-11,Treatment of acute liver failure,Designated,,,N/A,N/A,Alfact Innovation SAS,"320, rue Saint Honore",,,,,France,340711,2011,
"recombinant humanized anti-LOXL2 monoclonal antibody, IgG4(S241P)",n/a,2011-05-17,Treatment of pancreatic cancer.,Designated/Withdrawn,,,N/A,N/A,"Gilead Sciences, Inc.",199 E. Blaine St.,,Seattle,Washington,98102,USA,339311,2011,
camostat,n/a,2011-05-18,Treatment of chronic pancreatitis,Designated,,,N/A,N/A,NIXS Corporation,"Nichi-Iko Pharmaceutical Co., Ltd.",7th Floor - NOF Nihonbashi Honcho Bldg,Tokyo,,,Japan,338211,2011,
everolimus,Afinitor,2011-05-24,Treatment of gastric cancer,Designated/Withdrawn,,,N/A,N/A,Novartis Pharmaceuticals Corp.,"One Health Plaza, 315/5450A",,East Hanover,New Jersey,7936,USA,340111,2011,
humanized IgG1 monoclonal anti-CD20 antibody,n/a,2011-05-26,Treatment of follicular lymphoma,Designated,,,N/A,N/A,"MENTRIK Biotech, LLC",12400 Coit Rd,,Dallas,Texas,75251,USA,341111,2011,
recombinant human erythropoietin (rHuEPO),n/a,2011-05-26,Treatment of mutliple myeloma,Designated,,,N/A,N/A,"XTL Biopharmaceuticals, Ltd",85 Medinat Hayehudim St.,,Herzliya Pituach 46766,,,Israel,341711,2011,
adeno-associated virus vector serotype 9 expressing human sulfamidase,n/a,2011-06-01,Treatment of mucopolysaccharidosis type IIIA (Sanfilippo A Syndrome).,Designated,,,N/A,N/A,"Laboratorios del Dr. Esteve, S.A.","Av. Marie de Deu de Montserrat, 221",,Barcelona,,,Spain,341611,2011,
ciprofloxacin,n/a,2011-06-01,The management of bronchiectasis,Designated,,,N/A,N/A,Aradigm Corporation,3929 Point Eden Way,,Hayward,California,94545,USA,339911,2011,
exendin-(9-39),n/a,2011-06-01,Treatment of congential hyperinsulinenic hypoglycemia and other causes of hyperinsulinemic hypoglycemia in adults and children,Designated,,,N/A,N/A,The Children's Hospital of Philadelphia,Children's Hospital of Phil. Research Institute,Abramson Research Center,Philadelphia,Pennsylvania,19104,USA,321310,2011,
mitomycin,n/a,2011-06-01,Prevention of corneal sub-epithelial haze formation following surface ablation laser keratectomy,Designated,,,N/A,N/A,"Mobius Therapeutics, LLC",1141 South 7th Street,,St. Louis,Missouri,63104,USA,305610,2011,
"Recombinant humanized anti-LOXL2 monoclonal antibody, IgG4(S241P)",n/a,2011-06-01,Treatment of myelofibrosis.,Designated/Withdrawn,,,N/A,N/A,"Gilead Sciences, Inc.",199 E. Blaine St.,,Seattle,Washington,98102,USA,340511,2011,
gabapentin enacarbil,Horizant,2011-06-07,Treatment of postherpetic neuralgia,Designated/Approved,Approved for Orphan Indication,Management of postherpetic neuralgia in adults.,2012-06-06,2019-06-06,"Arbor Pharmaceuticals, LLC",6 Concourse Parkway,Suite 1800,Atlanta,Georgia,30328,USA,330710,2011,365
12-A-p21 RAS(5-21). 12-C-p21 RAS(5-21). 12-D-p21 RAS(5-21). 12-Rp21 RAS(5-21). 12-S-p21 RAS(5-21). 12-V-p21 RAS(5-21). 13-D-p21 RAS(5-21),n/a,2011-06-07,Treatment of pancreatic cancer,Designated,,,N/A,N/A,Targovax OY,Saukonpaadenranta 2,,Helsinki,,,Finland,343011,2011,
autologous neo-uninary conduit,n/a,2011-06-07,Treatment of bladder dysfunction requiring incontinent urinary diversion.,Designated,,,N/A,N/A,"Tengion, Inc.",2900 Potshop Lane,,East Norriton,Pennsylvania,19403,USA,332410,2011,
cyclophosphamide,Cyrevia(Tm),2011-06-07,Treatment of systemic sclerosis.,Designated,,,N/A,N/A,"Accentia Biopharmaceuticals, Inc.","324 South Hyde Avenue, Suite 350",,Tampa,Florida,33606,USA,333911,2011,
maribavir,n/a,2011-06-07,Treatment of clinically significant cytomegalovirus viremia and disease in at-risk patients.,Designated,,,N/A,N/A,"Shire ViroPharma, Inc.",300 Shire Way,,Lexington,Massachusetts,2421,USA,332210,2011,
recombinant human minibody against complement component,Mubodina(R),2011-06-07,Treatment of atypical hemolytic uremic syndrome associated with an inherited abnormality of the complement system.,Designated,,,N/A,N/A,ADIENNE S.A,Via Zurigo 46,6900 Lugano,,,,Switzerland,269908,2011,
7-B-Hydroxy Cholesteryl-3-B-Oleate-Ester,n/a,2011-06-15,Treatment of gliomas.,Designated,,,N/A,N/A,Intsel Chimos SA,1 rue Royale,91123 Saint-Cloud Cedex,,,,France,343511,2011,
cyclophosphamide,Cyrevia(Tm),2011-06-17,Prevention of graft versus host disease following allogeneic hematopoietic stem cell transplant,Designated,,,N/A,N/A,"Accentia Biopharmaceuticals, Inc.",324 S. Hyde Park Avenue,,Tampa,Florida,33606,USA,343611,2011,
"cytochrome C, flavin mononucleotide and thiamin diphosphate",n/a,2011-06-17,Treatment of mitochondrial disorders,Designated,,,N/A,N/A,"NBI Pharmaceuticals, Inc.",c/o Neil & Co CPAs,"1184 N. 15th Ave., Suite 1",Bozeman,Montana,59715,USA,342311,2011,
NanoDTPA(tm),n/a,2011-06-17,"Treatment of known or suspected cases of internal contamination with plutonium, americium, or curium",Designated,,,N/A,N/A,"Nanotherapeutics, Inc.",13859 Progress Blvd,,Alachua,Florida,32615,USA,335511,2011,
IgG1 chimeric monoclonal antibody,n/a,2011-06-22,Treatment of multiple myeloma.,Designated,,,N/A,N/A,Immune System Therapeutics Ltd,"Suite 1, Level 1","Ultimo, NW 2007",,,,Australia,344411,2011,
"botulism antitoxin heptavalent (A, B, C, D, E, F, G) (Equine)",n/a,2011-06-29,Treatment of botulism.,Designated/Approved,Approved for Orphan Indication,"Treatment of symptomatic botulism following documented or suspected exposure to botulinum neurotoxin serotypes A, B, C, D, E, F, or G in adults and pediatric patients",2013-03-22,2020-03-22,Cangene Corporation,155 Innovation Drive,"Winnipeg, Manitoba R3T5Y3",,,,Canada,345011,2011,632
nintedanib,Ofev,2011-06-29,Treatment of patients with idiopathic pulmonary fibrosis.,Designated/Approved,Approved for Orphan Indication,Treatment of idiopathic pulmonary fibrosis,2014-10-15,2021-10-15,"Boehringer Ingelheim Pharmaceuticals, Inc.",900 Ridgebury Rd.,PO Box 368,Ridgefield,Connecticut,6877,USA,344511,2011,1204
(6-maleimidocaproyl)hydrazone of doxorubicin,n/a,2011-06-29,Treatment of soft tissue sarcoma,Designated,,,N/A,N/A,"NantCell, Inc.",9920 Jefferson Boulevard,,Culver City,California,90232,USA,339711,2011,
ambroxol,n/a,2011-06-29,Treatment of Gaucher disease,Designated,,,N/A,N/A,"Belrose Pharma, Inc.",500 College Road E,Suite 205,Princeton,New Jersey,8540,USA,262308,2011,
denileukin diftitox,n/a,2011-06-29,Treatment of peripheral T-cell lymphoma (PTCL),Designated,,,N/A,N/A,"Eisai, Inc.",155 Tice Blvd.,,Woodcliff Lake,New Jersey,5271,USA,342611,2011,
Fibronectin Peptide,n/a,2011-06-29,"Prevention of burn injury progression of acute, deep dermal burns in hospitalized patients.",Designated,,,N/A,N/A,"NeoMatrix Therapeutics, Inc.",Long Island High Tech Incubator,25 Health Sciences Drive,Stony Brook,New York,11790,USA,311510,2011,
gusperimus trihydrochloride,n/a,2011-06-29,Treatment of Wegener's granulomatosis,Designated,,,N/A,N/A,Nordic Group B.V.,Siriusdreef 22,2132 WT Hoofdorp,,,,Netherlands,342711,2011,
resminostat,n/a,2011-06-29,Treatment of hepatocellular carcinoma,Designated,,,N/A,N/A,4SC AG,Am Klopferspitz 19a,82152 Martinsried,,,,Germany,345511,2011,
corifungin,n/a,2011-07-06,Treatment of visceral leishmaniasis,Designated,,,N/A,N/A,Sandler Center for Drug Discovery,"University of CA, San Francisco",1700 4th Street,San Francisco,California,94158,USA,342211,2011,
low molecular weight dextran sulfate,Ibsolvmir(R),2011-07-06,Treatment to mobilze progenitor cells prior to stem cell transplantation,Designated,,,N/A,N/A,TikoMed AB,P.O. Box 81 (Karlsfaltsvagen 349),"SE-263 03, Viken",,,,Sweden,344711,2011,
mepolizumab,Nucala,2011-07-14,Treatment of Churg-Strauss Syndrome,Designated/Approved,Approved for Orphan Indication,Treatment of adult patients with Eosinophilic Granulomatosis Polyangiitis (EGPA),2017-12-12,2024-12-12,GlaxoSmithKline LLC,Corporation Service Company,1250 S. Collegeville Rd.,Collegeville,Pennsylvania,19426,USA,345111,2011,2343
mogamulizumab,n/a,2011-07-14,Treatment of adult T-cell leukemia/lymphoma (ATLL).,Designated,,,N/A,N/A,"Kyowa Kirin Pharmaceutical Development, Inc.",212 Carnegie Center,Suite 101,Princeton,New Jersey,8540,USA,345311,2011,
liposomal irinotecan,n/a,2011-07-21,Treatment of pancreatic cancer,Designated/Approved,Approved for Orphan Indication,"For use in combination with 5-fluorouracil and leucovorin, for the treatment of patients with metastatic adenocarcinoma of the pancreas that has progressed following gemcitabine-based therapy",2015-10-22,2022-10-22,"Ipsen Bioscience,Inc.",650 East Kendall Street,,Cambridge,Massachusetts,2142,USA,344311,2011,1554
laminin-111 (human),n/a,2011-07-21,Treatment of Duchenne Muscular Dystrophy,Designated,,,N/A,N/A,"Prothelia, Inc.",30 Haven Street,,Milford,Massachusetts,1757,USA,337411,2011,
smilagenin,Cogane,2011-07-21,Treatment of amyotrophic lateral sclerosis,Designated,,,N/A,N/A,"Junaxo, Inc.",First Canadian Place,Suite 5600,,,,Canada,345811,2011,
trans sodium crocetinate,n/a,2011-07-21,Treatment of glioblastoma in conjunction with radiotherapy,Designated,,,N/A,N/A,"Diffusion Pharmaceuticals, LLC",2020 Avon Court,Suite 4,Charlottesville,Virginia,22902,USA,345911,2011,
"1-(4-{4-amino-7-[1-(2-hydroxyethyl)-1H-pyrazol-4-yl]thieno[3,2-c]pyridine-3-yl}phenyl)-3-(3-fluorophenyl)urea)",n/a,2011-07-28,Treatment of acute myelogenous leukemia,Designated/Withdrawn,,,N/A,N/A,"AbbVie, Inc.",1 N Waukegan Road,AP34/RA72,North Chicago,Illinois,60064,USA,337811,2011,
alpha-1 proteinase inhibitor (human),Glassia,2011-07-28,Treatment of patients with recent onset (<15 years)with Type 1A diabetes mellitus with residual beta-cell function,Designated,,,N/A,N/A,"Kamada, Ltd.",2 Holtzman Street,,Rehovot,,,Israel,344111,2011,
plerixafor,Mozobil (R),2011-07-28,Treatment of acute myeloid leukemia,Designated/Withdrawn,,,N/A,N/A,Genzyme Corporation,500 Kendall Street,,Cambridge,Massachusetts,2142,USA,346111,2011,
sildenafil,Revatio,2011-07-28,Treatment of pediatric (defined as children less than 17 years of age) pulmonary arterial hypertension,Designated,,,N/A,N/A,"Pfizer, Inc.",Worldwide Regulatory strategy,,New York,New York,10017,USA,344211,2011,
pyrimethamine,n/a,2011-08-16,Treatment of GM-2 gangliosidoses (Tay-Sachs disease and Sandhoff disease).,Designated,,,N/A,N/A,ExSAR Corporation,11 Deer Park Drive,,Monmouth Junction,New Jersey,8852,USA,232206,2011,
"6,8-bis-benzylsulfanyl-octanoic acid",n/a,2011-08-22,Treatment of acute myeloid leukemia.,Designated,,,N/A,N/A,"Cornerstone Pharmaceuticals, Inc.",25 Health Science Drive,,Stony Brook,New Mexico,11790,USA,349911,2011,
allogeneic ex-vivo expanded placental adherent stromal cells,n/a,2011-08-22,Treatment of thromboangiitis obliterans (Buerger's disease),Designated,,,N/A,N/A,"Novella Clinical, Inc.",MATAM Advanced Technology Park,Haifa 31905,,,,Israel,348611,2011,
corifungin,n/a,2011-08-22,Treatment of amebic meningoencephalitis.,Designated,,,N/A,N/A,Ctr for Discovery & Innovation in Parasitic Diseas,"University of CA, San Francisco","Byers Hall Room 508B, QB3",San Francisco,California,94158,USA,348811,2011,
menatetrenone and Vitamin D3,n/a,2011-08-22,Treatment of myelodysplastic syndrome,Designated,,,N/A,N/A,"NBI Pharmaceuticals, Inc.",c/o Neil & Co CPAs,"1184 N. 15th Ave., Suite 1",Bozeman,Montana,59715,USA,348111,2011,
sodium chlorite,n/a,2011-08-22,For slowing the progression of amyotrophic lateral sclerosis.,Designated,,,N/A,N/A,"Neuraltus Pharmaceuticals, Inc.",1111 Bayhill Drive,Suite 210,San Bruno,California,94066,USA,343311,2011,
trabedersen,n/a,2011-08-22,Treatment of Stage IIB through Stage IV malignant melanoma.,Designated,,,N/A,N/A,"Oncotelic, Inc.",29397 Agoura Road,Suite 107,Agoura Hills,California,91301,USA,346011,2011,
lanreotide acetate,Somatuline Depot,2011-08-25,Treatment of neuroendocrine tumors,Designated/Approved,Approved for Orphan Indication,"Treatment of patients with unresectable,well- or moderately-differentiated locally advanced or metastatic gastroenteropancreatic neuroendocrine tumors to improve progression-free survival",2014-12-16,2021-12-16,"Ipsen Biopharmaceuticals, Inc.",106 Allen Road,,Basking Ridge,New Jersey,7920,USA,347811,2011,1209
choline tetrathiomolybdate,n/a,2011-08-25,Treatment of Wilson's disease.,Designated,,,N/A,N/A,Wilson Therapeutics AB,Strandvagen 5b,"114 51 Stockholm, Sweden",,,,USA,346511,2011,
dinaciclib,n/a,2011-08-25,Treatment of chronic lymphocytic leukemia.,Designated,,,N/A,N/A,Merck Sharp & Dohme Ltd.,"Hertford Road, Hoddesdon",Hertfordshire EN11 9BU,,,,United Kingdom,347211,2011,
idelalisib,n/a,2011-08-25,Treatment of chronic lymphocytic leukemia,Designated,,,N/A,N/A,"Gilead Sciences, Inc.",199 E. Blaine St.,,Seattle,Washington,98102,USA,347511,2011,
elotuzumab,Empliciti,2011-09-01,Treatment of multiple myeloma,Designated/Approved,Approved for Orphan Indication,Indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received one to three prior therapies,2015-11-30,2022-11-30,Bristol-Myers Squibb Co.,Route 206 & Province Line Road,,Princeton,New Jersey,8540,USA,348411,2011,1551
"1-(3-chloro-5-{[4-(4-chloro-2-thienyl)-5-(4-cyclohexylpiperazin-l-yl)-1,3-thiazol-2-yl]carbamoyl}- 2-pyridyl) piperidine-4-caboxylic acid Monomaleate",n/a,2011-09-01,Treatment of idiopathic thrombocytopenic purpura,Designated,,,N/A,N/A,"Dova Pharmaceuticals, Inc.",240 Leigh Farm Road,Suite 245,Durham,North Carolina,27707,USA,325110,2011,
deferiprone,n/a,2011-09-01,Treatment of superficial siderosis,Designated,,,N/A,N/A,"ApoPharma, Inc.",200 Barmac Drive,,,,,Canada,340011,2011,
HPV16 E6/E7 synthetic long peptides vaccine,n/a,2011-09-01,Treatment of epithelial neoplasias of the vulva positive for human papilloma virus type 16.,Designated,,,N/A,N/A,ISA Therapeutics BV,J.H. Oortweg 19,2333 CH Leiden,,,,Netherlands,324310,2011,
riboflavin ophthalmic solution & ultraviolet A,Photrexa Viscous,2011-09-02,Treatment of keratoconus,Designated/Approved,Approved for Orphan Indication,Treatment of progressive keratoconus,2016-04-15,2023-04-15,"Avedro, Inc.",230 Third Avenue,,Waltham,Massachusetts,2451,USA,344911,2011,1687
domperidone,n/a,2011-09-02,"Treatment of hypoprolactinemia in breastfeeding mothers, and in some hypoprolactinemic conditions following the use of cabergoline or bromocriptine in mothers who wish to initiate or return to breastfeeding",Designated,,,N/A,N/A,"Thomas W. Hale, RPh, PhD",Texas Tech University Health Sciences Ctr.,1400 Coulter Suite 1400,Amarillo,Texas,79106,USA,336111,2011,
ribavirin elaidate,n/a,2011-09-02,"Treatment of follicular, medullary, and anaplastic thyroid carcinoma and metastatic or locally advanced papillary thyroid cancer",Designated,,,N/A,N/A,"Translational Therapeutics, Inc.",163 Scituate Street,,Arlington,Massachusetts,2476,USA,344011,2011,
lanreotide acetate,n/a,2011-09-08,Treatment of carcinoid syndrome,Designated/Approved,Approved for Orphan Indication,"treatment of adults with carcinoid syndrome; when used, it reduces the frequency of short-acting somatostatin analog rescue therapy",2017-09-15,2024-09-15,"Ipsen Biopharmaceuticals, Inc.",106 Allen Road,,Basking Ridge,New Jersey,7920,USA,347111,2011,2199
Angiotensin-(1-7),n/a,2011-09-13,Treatment of pulmonary arterial hypertension.,Designated,,,N/A,N/A,"US Biotest, Inc.",231 Bonetti Drive,Suite 240,San Luis Obispo,California,93401,USA,345411,2011,
cardiotrophin-1,n/a,2011-09-13,Treatment of acute liver failure,Designated,,,N/A,N/A,Digna Biotech S.L.,C/Boix y Morer 6-8,28003 Madrid,,,,Spain,350711,2011,
L-pyr-L-glu-L-gln-L-leu-L-glu-L-arg-L-ala-L-leu-L-asn-L-ser-L-ser,n/a,2011-09-13,Treatment of neuropathic pain in patients with sarcoidosis.,Designated,,,N/A,N/A,"Araim Pharmaceuticals, Inc.",712 Kitchawan Road,,Ossining,New York,10562,USA,349111,2011,
bispecific antibody targeting interleukin 4 (IL-4) and interleukin 13 (IL-13),n/a,2011-09-14,Treatment of idiopathic pulmonary fibrosis.,Designated/Withdrawn,,,N/A,N/A,"Sanofi US Services, Inc.",55 Corporate Drive,Mail Stop 55D-220B,Bridgewater,New Jersey,8807,USA,342811,2011,
nimodipine,Nymalize,2011-09-16,Treatment of subarachnoid hemorrhage.,Designated/Approved,Approved for Orphan Indication,"Improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in adult patients with subarachnoid hemorrhage (SAH) from ruptured intracranial berry aneurysms regardless of their post-ictus neurological condition (i.e., Hunt and Hess Grades I-V).",2013-05-10,2020-05-10,"Arbor Pharmaceuticals, Inc.",6 Concourse Parkway,Suite 1800,Atlanta,Georgia,30328,USA,338611,2011,602
pentosan polysulfate sodium,n/a,2011-09-16,Treatment of sickle cell disease.,Designated,,,N/A,N/A,"Vanguard Therapeutics, Inc.",108 Eagle Trace Drive,,Half Moon Bay,California,94019,USA,352311,2011,
resminostat,n/a,2011-09-16,Treatment of Hodgkin's lymphoma.,Designated,,,N/A,N/A,4SC AG,Am Klopferspitz 19a,82152 Martinsried,,,,Germany,351411,2011,
"4-[[9-(3S)-tetrahydro-3-furanyl]-8-[(2,4,6-trifluorophenyl)amino]-9H-purin-2-yl]amino]-trans-cyclohexanol",n/a,2011-09-23,Treatment of idiopathic pulmonary fibrosis,Designated/Withdrawn,,,N/A,N/A,Celgene Corporation,33 Technology Drive,,Warren,New Jersey,7059,USA,348911,2011,
aceneuramic acid,n/a,2011-09-23,Treatment of hereditary inclusion body myopathy,Designated,,,N/A,N/A,"Ultragenyx Pharmaceutical, Inc.",60 Leveroni Court,Suite 200,Novato,California,94949,USA,351511,2011,
dendritic hybrid cell vaccine,Neuroblaxin,2011-09-23,Treatment of neuroblastoma,Designated,,,N/A,N/A,"Orbis Health Solutions, LLC",111 Smith Hines Road,Suite E & F,Greenville,South Carolina,29607,USA,351011,2011,
human laminin-111,n/a,2011-09-23,Treatment of merosin (laminin-alpha2) deficient congential muscular dystrophy type 1A.,Designated,,,N/A,N/A,"Prothelia, Inc.",30 Haven Street,,Milford,Massachusetts,1757,USA,351811,2011,
peretinoin,n/a,2011-09-23,Treatment of hepatocellular carcinoma.,Designated,,,N/A,N/A,Kowa Pharmaceutical Europe Co. Ltd.,105 Wharfedale Road,RG41 5RB,Wokingham,,,United Kingdom,352011,2011,
"4-[2-(3-Propyl-[1,2,4]0xadiazol-5-yl)-vinyl]-benzene-1,2-diol",n/a,2011-10-04,Treatment of chronic myeloid leukemia,Designated,,,N/A,N/A,Piramal Enterprises Limited,1 Nirlon Complex,"Goregaon (East) 400063, Maharashtra",Mumbai,,,India,349611,2011,
lactobacillus brevis CD2,n/a,2011-10-04,Treatment Behcet's disease,Designated,,,N/A,N/A,"VSL Pharmaceuticals, Inc.",100 West Road,,Towson,Maryland,21204,USA,351711,2011,
abeotaxane inhibitor of microtubules,n/a,2011-10-07,Treatment of gliomas,Designated,,,N/A,N/A,Cortice Biosciences,1345 Avenue of the Americas,42nd Floor,New York,New York,10105,USA,352811,2011,
ferumoxytol,n/a,2011-10-07,For use in magnetic resonance imaging in brain metastases,Designated,,,N/A,N/A,Oregon Health & Science University,3181 SW Sam Jackson Pk Road,Mailcode L603,Portland,Oregon,97239,USA,350111,2011,
"(-)-(3aR,4S,7aR)-4-Hydroxy-4-m-tolylethynyl-octahydro-indole-1-carboxylic acid methyl ester",n/a,2011-10-12,Treatment of Fragile X syndrome,Designated,,,N/A,N/A,Novartis Pharmaceuticals Corp.,One Health Plaza,,East Hanover,New Jersey,7936,USA,353611,2011,
sarcosine,n/a,2011-10-12,Treatment of obsessive compulsive disorder in pediatric patients (0 to 16 years of age),Designated,,,N/A,N/A,"Guochuan Emil Tsai, MD, PhD","David Geffen School of Medicine, UCLA","1000 W., Carson St.",Torrance,California,90502,USA,346611,2011,
synthetic peptide H-D-Ala-Ser-Pro-Met-Leu-Val-Ala-Tyr-Asp-D-Ala-OH,n/a,2011-10-12,Treatment of necrotizing soft tissue infections (NSTI),Designated,,,N/A,N/A,"Atox Bio, Inc.",3 Golda Meir St.,,Ness Ziona,,,Israel,352211,2011,
halofuginone hydrobromide,n/a,2011-10-13,Treatment of Duchenne Muscular Dystrophy,Designated,,,N/A,N/A,"Akashi Therapeutics, Inc.",245 First Street,18th Floor,Cambridge,Massachusetts,2142,USA,352711,2011,
sodium thiosulfate,n/a,2011-10-13,Prevention of platinum-induced ototoxicity in pediatric patients,Designated,,,N/A,N/A,Hope Pharmaceuticals,16416 N. 92nd Street,,Scottsdale,Arizona,85260,USA,353311,2011,
Autologous lymphoma-derived immunoglobulin idiotype antigen vaccine conjugated to keyhole limpet hemocyanin,Biovaxid,2011-10-18,Treatment of Waldenstrom's macroglobulinemia,Designated,,,N/A,N/A,"Biovest International, Inc.",324 S. Hyde Park Avenue,Suite 350,Tampa,Florida,33606,USA,354111,2011,
eculizumab,Soliris,2011-10-18,Treatment of Shiga-Toxin producing escherichia coli hemolytic uremic syndrome,Designated,,,N/A,N/A,"Alexion Pharmaceuticals, Inc.",352 Knotter Drive,,Cheshire,Connecticut,6410,USA,354511,2011,
sodium 4-phenylbutyrate,n/a,2011-10-18,Treatment of spinal muscular atrophy,Designated,,,N/A,N/A,GMP-Orphan SAS,"7, rue du Pasteur Wagner",F-75011,Paris,,,France,354011,2011,
heparin activated recombinant human fibroblast growth factor 1 (FGF1)in combination with a surgically implanted biodegradable device,n/a,2011-10-24,Treatment of patients with a confirmed traumatic complete spinal cord injury where no motor or sensory function is preserved below the injury(Scale A),Designated,,,N/A,N/A,BioArctic Neuroscience AB,"Warfvinges vag 39, SE-112 51",,Stockholm,,,Sweden,342111,2011,
interferon gamma,n/a,2011-11-04,Treatment of Friedreich's ataxia,Designated,,,N/A,N/A,"Roberto Testi, MD",School of Medicine,via Michelini-Tocci 82,Rome,,,Italy,354711,2011,
ramucirumab,n/a,2011-11-04,Treatment of hepatocellular carcinoma,Designated,,,N/A,N/A,Eli Lilly and Company,ImClone Systems LLC-Lilly Subsdiary,33 ImClone Drive,Branchburg,New Jersey,8876,USA,353911,2011,
sirolimus,n/a,2011-11-04,"Treatment of chronic/refractory anterior noninfectious uveitis, noninfectious intermediate uveitis, noninfectious panuveitis and non-infectious, uveitis affecting the posterior of the eye (NICUPS).",Designated,,,N/A,N/A,Santen Inc.,"2100 Powell St., 16th Floor",,Emeryville,California,94608,USA,327210,2011,
urea,n/a,2011-11-07,"Treatment of rare congenital ichthyoses (CHILD syndrome, collodion baby, congenital ichthyosform erythroderma, Conradi-flunermann, epidermolytic hyperkeratosis, erythrokeratoderma variabilis, harlequin ichthyosis, KID syndrome, lamellar ichthyosis, Netherton syndrome, neutral lipid storage disease, Sjorgren-Larsson syndrome, trichothiodystrophy, X-linked ichthyosis).",Designated,,,N/A,N/A,"Orenova Group, LLC",10 New King Street,Suite 106,White Plains,New York,10604,USA,346211,2011,
sodium thiosulfate,n/a,2011-11-09,Treatment of uremic and non-uremic calciphylaxis,Designated,,,N/A,N/A,Hope Pharmaceuticals,16416 N. 92nd Street,,Scottsdale,Arizona,85260,USA,352611,2011,
humanized single chain monoclonal antibody(scFV: IgG1 hinge: IgG1 CH2 and CH3 domains),n/a,2011-11-17,Treatment of chronic lymphocytic leukemia,Designated,,,N/A,N/A,"Aptevo Therapeutics, Inc.",2401 Fourth Avenue,Suite 1050,Seattle,Washington,98121,USA,353411,2011,
5-(ethylsulfonyl)-2-(naphthalen-2-yl)benzp[d]oxazole,n/a,2011-11-22,Treatment of Duchenne Muscular Dystrophy,Designated,,,N/A,N/A,Summit (Oxford) Limited,136a Eastern Avenue,Milton Park,Abingdon,,,United Kingdom,351111,2011,
MCMV5322A/MCMV3068A,n/a,2011-11-22,Prevention of maternal-fetal transmission of congenital CMV in pregnant women who acquire CMV infection during pregnancy,Designated/Withdrawn,,,N/A,N/A,Genentech,1 DNA Way,MS#241B,South San Francisco,California,94080,USA,355911,2011,
riboflavin ophthalmic solution ultraviolet-A (UVA) irradiation,Photrexa Viscous,2011-12-02,Treatment of corneal ectasia following refractive surgery,Designated/Approved,Approved for Orphan Indication,Treatment of corneal ectasia following refractive surgery,2016-07-15,2023-07-15,"Avedro, Inc.",230 Third Avenue,,Waltham,Massachusetts,2451,USA,352511,2011,1687
opium tincture,n/a,2011-12-02,Treatment of chronic diarrhea in short bowel syndrome patients with an inadequate response to anti-diarrheal treatment,Designated,,,N/A,N/A,"Valeant Pharmaceuticals International, Inc.",400 Somerset Corporate Blvd,,Bridgewater,New Jersey,8807,USA,307710,2011,
profimer sodium,Photofrin(R),2011-12-02,Treatment of malignant mesothelioma,Designated,,,N/A,N/A,"Concordia Laboratories, Inc.",Canewood Business Centre,"St. Michael, Barbados BB",,,,,357011,2011,
vamorolone,n/a,2011-12-02,Treatment of Duchenne muscular dystrophy,Designated,,,N/A,N/A,ReveraGen Biopharma,"155 Gibbs Road, Suite 433",,Rockville,Maryland,20850,USA,343111,2011,
sorafenib,Nexavar,2011-12-12,"Treatment of medullary thyroid cancer, anaplastic thyroid cancer, and recurrent or metastatic follicular or papillary thyroid cancer",Designated/Approved,Approved for Orphan Indication,"Treatment of patients with locally recurrent or metastatic, progressive, differentiated thyroid carcinoma (DCT) that is refractory to radioactive iodine treatment.",2013-11-22,2020-11-22,"Bayer HealthCare Pharmaceuticals, Inc.",100 Bayer Blvd.,PO Box 915,Whippany,New Jersey,7981,USA,320310,2011,711
letermovir,Prevymis,2011-12-12,Prevention of human cytomegalovirus viremia and disease in at risk populations,Designated/Approved,Approved for Orphan Indication,Prophylaxis of cytomegalovirus (CMV) infection and disease in adult CMV-seropositive recipients [R+] of an allogeneic hematopoietic stem cell transplant (HSCT).,2017-11-08,2024-11-08,Merck Sharpe & Dhome Corporation,"P. O. Box 1000, UG2D-68",,North Wales,Pennsylvania,19454,USA,340211,2011,2158
humanized IgG4 monoclonal antibody,n/a,2011-12-12,Prevention of ischemia/reperfusion injury associated with solid organ tranplantation,Designated,,,N/A,N/A,Opsona Theraeputics,Trinity Centre for Health sciences,St. James's Hospital,Dublin 8,,,Ireland,355311,2011,
losartan,n/a,2011-12-12,Treatment of Marfan Syndrome,Designated,,,N/A,N/A,National Marfan Foundation,22 Manhhasset Avenue,,Port Washington,New York,11050,USA,357211,2011,
recombinant human galactocerebrosidase (rhGALC);,Galaczym,2011-12-12,Treatment of globoid cell leukodystrophy (Krabbe Disease),Designated,,,N/A,N/A,ACE BioSciences A/S,Roskildevej 12C,DK-3400 Hillerod,,,,Denmark,357711,2011,
an adeno-associated viral vector containing a codon-optimised human factor IX gene (AAV5-hFIXco),n/a,2011-12-22,Treatment of hemophilia B,Designated,,,N/A,N/A,"uniQure, B.V.",Meiberdreef 61,1100 DA,Amsterdam,,,Netherlands,357511,2011,
beraprost sodium 314d,n/a,2011-12-22,Treatment of pulmonary arterial hypertension,Designated,,,N/A,N/A,"Lung Rx, Inc.",1040 Spring Street,,Silver Spring,Maryland,20910,USA,355711,2011,
H-(D)p-Benzoylphenylalanyl-(D)seryl-(D)tryptophanyl-(D)seryl-(D)pentafluorophenylalanyl-(D)cyclohexylalanyl-(D)arginyl-(D)arginyl-(D)arginyl-(D)glutaminyl-(D)arginyl-(D)arginine acetate salt,n/a,2011-12-22,For use in combination with cisplatin and pemetrexed for the treatment of patients with mesothelioma,Designated,,,N/A,N/A,"CanBas Company, Ltd.",2-2-1 Otemachi,,"Numazu City, Shizuoka",,,Japan,358411,2011,
rVIIa-FP,n/a,2011-12-22,Treatment and prophyllaxis of bleeding episodes in patients with congenital hemophilia and inhibitors to coagulation factor VIII or IX,Designated,,,N/A,N/A,CSL Behring,1020 First Avenue,P. O. Box 61501,King of Prussia,Pennsylvania,19406,USA,356111,2011,
sodium benzoate and clozapine,n/a,2011-12-22,Treatment of treatment-resistant schizophrenia,Designated,,,N/A,N/A,SyneuRx International Corp.,"20F-9 99 Section 1, Xintaiwu Road",Xizhi District,,,,Taiwan,357411,2011,
ustekinumab; human monocloncal antibody to interkeukin 12p40,Stelara,2011-12-22,Treatment of primary biliary cirrhosis,Designated/Withdrawn,,,N/A,N/A,"Janssen Biotech, Inc.",200 Great Valley Parkway,,Malvern,Pennsylvania,19355,USA,343811,2011,
nitric oxide,Inomax,2011-12-28,Treatment of pulmonary arterial hypertension,Designated,,,N/A,N/A,Bellerophon Therapeutics,53 Frontage Road,Suite 301,Hampton,New Jersey,8827,USA,340811,2011,
ustekinumab,Stelara,2011-12-28,Treatment of chronic sarcoidosis,Designated/Withdrawn,,,N/A,N/A,"Janssen Biotech, Inc.",800 & 850 Ridgeview Drive,,Horsham,Pennsylvania,19044,USA,358111,2011,
"1-[(2-Chloro-4-methoxyphenoxy)methyl]-4-[(2,6-dichlorophenoxy) methyl]benzene",n/a,2012-01-09,Treatment of poliovirus infection.,Designated,,,N/A,N/A,"ViroDefense, Inc.",155 Gibbs Street,Suite 529,Rockville,Maryland,20850,USA,357811,2012,
sodium nitrite,n/a,2012-01-09,Treatment of chlorine gas poisoning,Designated,,,N/A,N/A,Hope Pharmaceuticals,16416 N. 92nd Street,,Scottsdale,Arizona,85260,USA,359111,2012,
heterologous human adult liver derived progenitor cells (HHALPC),n/a,2012-01-13,Treatment of urea cycle disorders,Designated,,,N/A,N/A,Promethera Biosciences,Watson & Crick Hill,"Rue Granbonpre, 11",,,,Belgium,358011,2012,
N-Hydroxy-4-(3-methyl-2-(S)phenyl-butyrylamino)benzamide,n/a,2012-01-13,Treatment of meningioma,Designated,,,N/A,N/A,"Arno Therapeutics, Inc.",200 Route 31 North,Suite 104,Flemington,New Jersey,8822,USA,355511,2012,
N-Hydroxy-4-(3-methyl-2-(S)phenyl-butyrylamino)benzamide,n/a,2012-01-13,Treatment of Schwannoma of the central nervous system,Designated,,,N/A,N/A,"Arno Therapeutics, Inc.",200 Route 31 North,Suite 104,Flemington,New Jersey,8822,USA,355611,2012,
"1,2:5,6-Dianhdrogalactitol",n/a,2012-01-31,Treatment of malignant gliomas,Designated,,,N/A,N/A,"DelMar Pharmaceuticals, Inc.",3475 Edison Way,Suite R,Menlo Park,California,94025,USA,361311,2012,
Adeno-Associated Viral Vector Expressing Low-Density Lipoprotein Receptor,n/a,2012-01-31,Treatment of homozygous familial hypercholesterolemia,Designated,,,N/A,N/A,ReGenX Biosciences LLC,"750 17th Street, NW",Suite 1100,Washington,District of Columbia,20006,USA,359411,2012,
phenylephrine,n/a,2012-01-31,Treatment of Tetralogy of Fallot,Designated,,,N/A,N/A,"Luitpold Pharmaceuticals, Inc.",One Luitpold Drive,P. O. Box 9001,Shirley,New York,11967,USA,359011,2012,
digoxin immune fab (ovine),n/a,2012-02-03,Treatment of severe preeclampsia and eclampsia,Designated,,,N/A,N/A,"Velo Bio, LLC",90001 Aerial Center Parkway,Suite 110,Morrisville,North Carolina,27560,USA,343911,2012,
ramucirumab,Cyramza,2012-02-16,Treatment of gastric cancer,Designated/Approved,Approved for Orphan Indication,"Treatment of advanced gastric cancer or gastro-esophageal junction adenocarcinoma, as a single-agent after prior fluoropyrimidine-or platinum-containing therapy.",2014-04-21,2021-04-21,Eli Lilly and Company,33 ImClone Drive,,Branchburg,New Jersey,8876,USA,359711,2012,795
ramucirumab,Cyramza,2012-02-16,Treatment of gastric cancer,Designated/Approved,Approved for Orphan Indication,"Treatment of advanced gastric or gastro-esophageal junction adenocarcinoma, as a single agent or in combination with paclitaxel, after prior fluoropyrimidine- or platinium-containing chemotherapy.",2014-11-05,N/A,Eli Lilly and Company,33 ImClone Drive,,Branchburg,New Jersey,8876,USA,359711,2012,993
vestronidase alfa-vjbk,Mepsevii,2012-02-16,"Treatment of mucopolysaccharidosis VII (MPS VII, Sly Syndrome)",Designated/Approved,Approved for Orphan Indication,"Treatment of mucoploysaccharidosis type VII (MPS VII, Sly syndrome) in pediatric and adult patients",2017-11-15,TBD,"Ultragenyx Pharmaceutical, Inc.",60 Leveroni Court,,Novato,California,94949,USA,359811,2012,2099
Sodium Thiosulfate,n/a,2012-02-16,Treatment of uremic and non-uremic calciphylaxis,Designated,,,N/A,N/A,"Luitpold Pharmaceuticals, Inc.",800 Adams Avenue,Suite 100,Norristown,Pennsylvania,19403,USA,356511,2012,
obinutuzumab,Gazyva,2012-02-17,Treatment of chronic lymphocytic leukemia,Designated/Approved,Approved for Orphan Indication,Treatment of patients with previously untreated chronic lymphocytic leukemia in combination with chlorambucil.,2013-11-01,2020-11-01,"Genentech Inc., a member of the Roche Group",1 DNA Way,MS #355e,South San Francisco,California,94080,USA,359911,2012,623
2-Chloro-N6--(3-iodobenzyl)adenosine-5'-N-methyluronamide,n/a,2012-02-17,Treatment of hepatocellular carcinoma,Designated,,,N/A,N/A,Can-Fite BioPharma Ltd.,10 Bareket Street,P. O. Box 7537,Petah-Tikva,,,Israel,363512,2012,
bi-shRNAfurin and granulocyte macrophage colony stimulating factor augmented autologus tumor cell vaccine,Fang,2012-02-17,Treatment of stage IIB to IV melanoma,Designated,,,N/A,N/A,"Gradalis, Inc.",2545 Golden Bear Drive,Suite 110,Carrollton,Texas,75006,USA,356611,2012,
humanized IgG1 anti-serum amyloid A monoclonal antibody,n/a,2012-02-17,Treatment of AA amyloidosis and AL amyloidosis,Designated,,,N/A,N/A,Prothena Therapeutics Limited,Treasury Building,Lower Grand Canal Street,Dublin 2,,,Ireland,361411,2012,
neostigmine methylsulfate,n/a,2012-02-17,Treatment of Myasthenia Gravis,Designated,,,N/A,N/A,"Luitpold Pharmaceuticals, Inc.",One Luitpold Drive,P. O. Box 9001,Shirley,New York,11967,USA,359611,2012,
obinutuzumab,n/a,2012-02-17,Treatment of diffuse large B cell lymphoma,Designated,,,N/A,N/A,"Genentech Inc., a member of the Roche Group",1 DNA Way,MS #355e,South San Francisco,California,94080,USA,360011,2012,
recombinant human Pentraxin-2; recombinant human Serum Amyloid P,n/a,2012-02-17,Treatment of idiopathic pulmonary fibrosis.,Designated,,,N/A,N/A,"Promedior, Inc.",101 Hartwell Avenue,,Lexington,Massachusetts,19355,USA,361111,2012,
Recombinant humanized monoclonal antibody directed against an epidermal growth factor receptor,n/a,2012-02-17,Treatment of glioblastoma multiforme,Designated/Withdrawn,,,N/A,N/A,"AbbVie, Inc.",1 N. Waukegan Road,,North Chicago,Illinois,60064,USA,361811,2012,
salicylic acid 6%,n/a,2012-02-17,Treatment of rare congenital ichthyoses.,Designated,,,N/A,N/A,"Orenova Group, LLC",10 New King Street,Suite 106,White Plains,New York,10604,USA,359211,2012,
"Silibinin-C-2',3-dihydrogensuccinate, disodium salt",Legalon Sil,2012-02-17,Prevention of recurrent hepatitis C in liver transplant patients,Designated,,,N/A,N/A,Mylan Specialty LP,781 Chestnut Ridge Road,P. O. Box 4310,Morgantown,West Virginia,26505,USA,362811,2012,
sulfonated monophosphorylated mannose oligosaccharide,n/a,2012-02-17,Treatment of hepatocellular carcinoma,Designated,,,N/A,N/A,Medigen Biotechnology Corporation,"14F, No. 3, Yuancyu Street",Nangang District,Taipei City,,,Taiwan,360111,2012,
tafamidis meglumine,n/a,2012-02-17,Treatment of symptomatic transthyretin (TTR) amyloid cardiomyopathy.,Designated,,,N/A,N/A,"Pfizer, Inc.",500 Arcola Road,,Collegeville,Pennsylvania,19426,USA,363312,2012,
telotristat etiprate,Xermelo,2012-03-09,Treatment of carcinoid syndrome in patients with neuroendocrine tumors,Designated/Approved,Approved for Orphan Indication,Treatment of carcinoid syndrome diarrhea in combination with somatostatin analog (SSA) therapy in adults inadequately controlled by SSA therapy.,2017-02-28,2024-02-28,"Lexicon Pharmaceuticals, Inc.",8800 Technology Forest Drive,,The Woodlands,Texas,77381,USA,266308,2012,1817
"(1-methyl-2-nitro-1H-imidazole-5-yl)methyl N,N'-bis(2-bromoethyl) diamidophosphate",n/a,2012-03-09,Treatment of soft tissue sarcoma,Designated,,,N/A,N/A,"Threshold Pharmaceuticals, Inc.",170 Harbor Way,Suite 300,South San Francisco,California,94080,USA,365812,2012,
"(N-[2,6-bis(1-methylethyl)-pheyl-N'-[[1-4-dimethyl-amino)phenyl]cyclopentyl]methyl]urea, hydrochloride salt",n/a,2012-03-09,Treatment of adrenocortical carcinoma,Designated,,,N/A,N/A,"Millendo Therapeutics, Inc.",301 North Main Street,Suite 100,Ann Arbor,Michigan,48104,USA,364712,2012,
"2,2'-{2-[1R)-1-({[(2,5-dichlorobenzoyl)amino]acetyl}amino)-3-methylbutyl]-5-oxo-1,3,2-dioxaborolane-4,4-diyl}diacetic acid (ixazomib citrate)",n/a,2012-03-09,Treatment of systemic light chain (AL) amyloidosis.,Designated,,,N/A,N/A,"Millennium Pharmaceuticals, Inc.",40 Landsdowne Street,,Cambridge,Massachusetts,2139,USA,361911,2012,
"2S,4R ketoconazole",n/a,2012-03-09,Treatment of endogenous Cushing's syndrome,Designated,,,N/A,N/A,Cortendo AB (HQ address),Box 47,SE-433 21 Partille,,,,Sweden,364412,2012,
anti-Lewis Y humanized monoclonal antibody,n/a,2012-03-09,Treament of ovarian cancer,Designated,,,N/A,N/A,Recepta Biopharma S.A.,"Rua Tabapua, 1123 cj.36",04533-014,,,,Brazil,282409,2012,
basimglurant,n/a,2012-03-09,Treatment of Fragile X Syndrome,Designated,,,N/A,N/A,"Hoffmann-La Roche, Inc.",340 Kingsland Street,,Nutley,New Jersey,7110,USA,333211,2012,
Hanferon,Hanferon,2012-03-09,Treatment of Behcet's disease,Designated,,,N/A,N/A,"HanAll BioPharma Co., Ltd.",Jamsil I-Space Building 6F,138 420,Seoul,,,"Korea, Republic of",362911,2012,
heterologous human liver derived progenitor cells,n/a,2012-03-09,Treatment of Crigler-Najjar syndrome,Designated,,,N/A,N/A,Promethera Biosciences,Watson & Crick Hill,"Rue Granbonpre, 11",,,,Belgium,341411,2012,
linsitinib,n/a,2012-03-09,Treatment of adrenocortical carcinoma,Designated/Withdrawn,,,N/A,N/A,"Astellas Pharma Global Development, Inc.",1 Astellas Way,,Northbrook,Illinois,60062,USA,362311,2012,
verteporfin,Visudyne(R),2012-03-09,Treatment of chronic or recurrent central serous chorioretinopathy,Designated,,,N/A,N/A,Valeant Pharmaceuticals North America LLC,700 Route 202/206 North,,Bridgewater,New Jersey,8807,USA,350511,2012,
carisbamate,n/a,2012-03-16,Management of patients with infantile spasms,Designated,,,N/A,N/A,"SK Life Science, Inc.",22-10 Route 208 South,,Fair Lawn,New Jersey,7410,USA,362511,2012,
dehydrated alcohol,n/a,2012-03-16,Treatment of trigeminal neuralgia,Designated,,,N/A,N/A,"Luitpold Pharmaceuticals, Inc.",One Luitpold Drive,P. O. Box 9001,Shirley,New York,11967,USA,361611,2012,
golimumab,Simponi,2012-03-16,Treatment of pediatric ulcerative colitis,Designated,,,N/A,N/A,"Janssen Biotech, Inc.",1400 McKean Road,,Spring House,Pennsylvania,19477,USA,365112,2012,
ilorasertib,n/a,2012-03-16,Treatment of ovarian cancer,Designated/Withdrawn,,,N/A,N/A,"AbbVie, Inc.",1 N. Waukegan Road,,North Chicago,Illinois,60064,USA,364212,2012,
"O2-(2,4-dinitrophenyl) 1-[(4-ethoxycarbonyl)piperazin-1-yl]diazen-1-ium-1,2-diolate",n/a,2012-03-16,Treatment of acute myeloid leukemia,Designated,,,N/A,N/A,"JSK Therapeutics, Inc.",85 Fort Douglas Boulevard,P. O. Box 58986,Salt Lake City,Utah,84158,USA,363412,2012,
rigosertib,n/a,2012-03-16,Treatment of ovarian cancer,Designated,,,N/A,N/A,"Onconova Therapeutics, Inc.",375 Pheasant Run,,Newton,Pennsylvania,18940,USA,366412,2012,
"synthetic surfactant comprised of DPPC, POPG Na, synthetic SP-C analogue and synthetic SP-B analogue",n/a,2012-03-16,Treatment of preterm neonatal respiratory distress syndrome,Designated,,,N/A,N/A,"Chiesi USA, Inc.",1255 Crescent Green Drivve,Suite 250,Cary,North Carolina,27518,USA,360811,2012,
talarazole,n/a,2012-03-16,Treatment of congenital ichthyosis,Designated/Withdrawn,,,N/A,N/A,"Stiefel Laboratories, Inc.",20 T.W. Alexander Drive,,Research Triangle Park,North Carolina,27709,USA,365412,2012,
ibrutinib,n/a,2012-03-27,Treatment of chronic lymphocytic leukemia (CLL).,Designated/Withdrawn,,,N/A,N/A,"Pharmacyclics, LLC",995 E. Arques Avenue,,Sunnyvale,California,94085,USA,366212,2012,
adenovirus containing a human FAS-c gene,n/a,2012-04-02,Treatment of malignant glioma,Designated,,,N/A,N/A,Vascular Biogenics Ltd,6 Jonathan Netanyahu St,,Or Yehuda,,,Israel,364912,2012,
pegylated proline-interferon alpha-2b; PEG-P-IFNa-2b,n/a,2012-04-02,Treatment of polycythemia vera,Designated,,,N/A,N/A,PharmaEssentia Corporation,"13F, No. 3 YuanQu St.",Nankang Dist.,Taipei 115,,,Taiwan,367012,2012,
ibrutinib,Imbruvica,2012-04-06,Treatment of chronic lymphocytic leukemia (CLL),Designated/Approved,Approved for Orphan Indication,Treatment of patients with chronic lymphocytic leukemia (CLL) who have received at least one prior therapy,2014-02-12,2021-02-12,"Pharmacyclics, LLC",995 E. Arques Avenue,,Sunnyvale,California,94085,USA,368012,2012,677
ibrutinib,Imbruvica,2012-04-06,Treatment of chronic lymphocytic leukemia (CLL),Designated/Approved,Approved for Orphan Indication,Treatment of patients with chronic lymphocytic leukemia with 17p deletion who have not received at least one prior therapy,2014-07-28,2021-07-28,"Pharmacyclics, LLC",995 E. Arques Avenue,,Sunnyvale,California,94085,USA,368012,2012,843
ibrutinib,Imbruvica,2012-04-06,Treatment of chronic lymphocytic leukemia (CLL),Designated/Approved,Approved for Orphan Indication,Indicated for the treatment of patients with chronic lymphocytic leukemia without 17p deletion who have not received at least one prior therapy (first line therapy).,2016-03-04,2023-03-04,"Pharmacyclics, LLC",995 E. Arques Avenue,,Sunnyvale,California,94085,USA,368012,2012,1428
alpha1-proteinase inhibitor (human),n/a,2012-04-06,Treatment of cystic fibrosis,Designated,,,N/A,N/A,"Grifols Therapeutics, Inc.",8368 US 70 BUS Hwy W.,,Clayton,North Carolina,27520,USA,368112,2012,
ferumoxytol,n/a,2012-04-06,"For use in magnetic resonance imaging to assess, and monitor treatment of solid tumor malignancies previously diagnosed in pediatric patients (age 16 years and younger)",Designated,,,N/A,N/A,"ArsNova Partners, LLC",38 Frederick Street,,Newton,Massachusetts,2460,USA,365212,2012,
iloprost,n/a,2012-04-06,Treatment of pulmonary arterial hypertension,Designated,,,N/A,N/A,"Algorithum Sciences, LLC",World Trade Center Delaware,702 West Street,Wilmington,Delaware,19801,USA,324610,2012,
"N,N'-bis(2-mercaptoethyl)isophthalamide (NBMI)",n/a,2012-04-06,Treatment of mercury toxicity,Designated,,,N/A,N/A,NBMI Science LLC,c/o Philip Lee Solicitors,119 Burnside Drive,Nicholasville,,,Ireland,367312,2012,
tolvaptan,Jynarque,2012-04-06,Treatment of autosomal dominant polycystic kidney disease,Designated,,JYNARQUE is indicated to slow kidney function decline in adults at risk of rapidly progressing autosomal dominant polycystic kidney disease (ADPKD),N/A,TBD,"Otsuka Pharmaceuticals Co., Ltd.","2-9, Kanda-Tsukasamachi",101-8535,Tokyo,,,Japan,347311,2012,
autologous CD34+ hematopoietic stem cells tranduced with lentiviral vector Lenti-D encoding the human ABCD1 cDNA,n/a,2012-04-19,Treatment of andrenoleukodystrophy,Designated,,,N/A,N/A,"bluebird bio, Inc.",60 Binney Street,,Cambridge,Massachusetts,2142,USA,368212,2012,
eptifibatide and iloprost,n/a,2012-04-20,Treatment of purpura fulminans,Designated,,,N/A,N/A,Thrombologic,COBIS/Ole Maaloesvej 3,2200 Copenhagen,,,,Denmark,364012,2012,
recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP),Idelvion,2012-04-27,Treatment of patients with congenital factor IX deficiency (hemophilia B).,Designated/Approved,Approved for Orphan Indication,"Indicated for the (1) on-demand control and prevention of bleeding episodes, (2) perioperative management of bleeding, and (3) routine prophylaxis to prevent or reduce the frequency of bleeding episodes.",2016-03-04,2023-03-04,"CSL Behring, LLC",1020 First Avenue,P.O. Box 61501,King of Prussia,Pennsylvania,19406,USA,366712,2012,1407
sirolimus in an implantable collagen matrix,"Coll-R, Sirogen",2012-05-10,"Prevention of arteriovenous(AV) fistula or AV graft failure in patients with end stage renal disease, receiving hemodialysis or preparing for hemodialysis",Designated,,,N/A,N/A,"Vascular Therapies, LLC",105 Union Avenue,,Cresskill,New Jersey,7626,USA,184304,2012,
eribulin mesylate,Halaven,2012-05-14,Treatment of soft tissue sarcoma,Designated/Approved,Approved for Orphan Indication,Treatment of patients with unresectable or metastatic liposarcoma who have received a prior anthracyclne-containing regimen,2016-01-28,2023-01-28,Eisai Inc.,155 Tice Blvd,,Woodcliff Lake,New Jersey,7677,USA,367112,2012,1354
alisertib,n/a,2012-05-14,Treatment of peripheral T-cell lymphoma,Designated/Withdrawn,,,N/A,N/A,"Millennium Pharmaceuticals, Inc.",40 Landsdowne Street,,Cambridge,Massachusetts,2139,USA,369112,2012,
copper histidine,n/a,2012-05-14,Treatment of Menkes disease,Designated,,,N/A,N/A,"Stephen G. Kaler, M.D.","Head, Unit on Human Copper Metabolism","10 Center Drive-Rm 10N313, MSC 1853",Bethesda,Maryland,20892,USA,366312,2012,
"Extract of sea cucumber, sea sponge, shark fin, sea urchin, and sargassum grass",n/a,2012-05-14,Treatment of multiple myeloma,Designated,,,N/A,N/A,Unicorn Pacific Corporation,No. 1 Monmount Road,Bellevue Estate,Port Vila,,,Vanuatu,368612,2012,
golimumab,Simponi Aria,2012-05-21,Treatment of sarcoidosis,Designated/Withdrawn,,,N/A,N/A,"Janssen Biotech, Inc.",Welsh & McKean Roads,P.O. Box 776,Spring House,Pennsylvania,19477,USA,368412,2012,
Heat Shock Protein (hsp60) antigen,Diapep277,2012-05-21,For use in type 1 diabetic mellitus patients with residual beta-cell function,Designated/Withdrawn,,,N/A,N/A,"AndromedA Biotech, LTD",42 Hayarkon St.,,Yavne 81227,,,Israel,337111,2012,
skin tissue,Stratagraft,2012-05-21,Treatment of hospitalized patients with complex skin defects resulting from partial and full thickness skin burns requiring excision and grafting,Designated,,,N/A,N/A,Stratatech Corporation,505 S. Rosa Road,Suite 169,Madison,Wisconsin,53719,USA,365312,2012,
bortezomib,Velcade,2012-05-30,Treatment of mantle cell lymphoma.,Designated/Approved,Approved for Orphan Indication,Treatment of patients with mantle cell lymphoma who have received at least 1 prior therapy.,2006-12-08,2013-12-08,"Millennium Pharmaceuticals, Inc.",40 Landsdowne Street,,Cambridge,Massachusetts,2139,USA,226106,2012,-2000
bortezomib,Velcade,2012-05-30,Treatment of mantle cell lymphoma.,Designated/Approved,Approved for Orphan Indication,Treatment of patients with mantle cell lymphoma who have not received at least 1 prior therapy,2014-10-08,2021-10-08,"Millennium Pharmaceuticals, Inc.",40 Landsdowne Street,,Cambridge,Massachusetts,2139,USA,226106,2012,861
Autologous Engineered Skin Substitute,Permaderm,2012-06-01,Treatment of hospitalized patients with deep partial and full thickness burns requiring grafting.,Designated,,,N/A,N/A,"Amarantus BioScience Holdings, Inc.",655 Montgomery St.,Suite 900,San Francisco,California,94111,USA,356211,2012,
liposomal ciprofloxacin plus ciprofloxacin,n/a,2012-06-01,For the management of cystic fibrosis,Designated,,,N/A,N/A,Aradigm Corporation,3929 Point Eden Way,,Hayward,California,94545,USA,369812,2012,
recilisib sodium,Ex-Rad(R),2012-06-01,Prevention of acute radiation syndrome,Designated,,,N/A,N/A,"Onconova Therapeutics, Inc.",375 Pheasant Run,,Newtown,Pennsylvania,18940,USA,350311,2012,
patisiran,n/a,2012-06-07,Treatment of transthyretin-mediated amyloidosis,Designated,,,N/A,N/A,"Alnylam Pharmaceuticals, Inc.",300 Third Street,,Cambridge,Maryland,2142,USA,371112,2012,
interferon-alpha secreting autologous micro-organ tissue converting into a biopump,Infradure Biopump,2012-06-14,Treatment of chronic hepatitis D,Designated,,,N/A,N/A,"Medgenics, Inc.",555 California Street,Suite 365,San Francisco,California,94104,USA,370312,2012,
pentoxifylline,n/a,2012-06-14,Treatment of Behcet's disease,Designated,,,N/A,N/A,Keck Graduate Institute of Applied Life Sciences,535 Watson Drive,,Claremont,California,91711,USA,369712,2012,
perhexiline maleate,n/a,2012-06-14,Treatment of moderate to severe symptomatic hypertrophic cardiomyopathy,Designated,,,N/A,N/A,"Heart Metabolics, Limited.",88 Harcourt Street,Dublin 2,,,,Ireland,360211,2012,
bimagrumab,n/a,2012-06-18,Treatment of inclusion body myositis,Designated,,,N/A,N/A,Novartis Pharmaceuticals Corp.,One Health Plaza,,East Hanover,New Jersey,7936,USA,369012,2012,
CNDO-109-activated allogeneic natural killer cells,n/a,2012-06-18,Treatment of acute myeloid leukemia,Designated,,,N/A,N/A,"Fortress Biotech, Inc.",2 Gansevoort Street,9th Floor,New York,New York,10014,USA,371512,2012,
cyclocreatine,n/a,2012-06-18,Treatment of creatine transporter deficiency,Designated,,,N/A,N/A,Lumos Pharma,4200 Marathon Blvd.,Suite 200,Austin,Texas,78756,USA,362711,2012,
nitric oxide,n/a,2012-06-18,Treatment of persistent pulmonary hypertension in newborns,Designated,,,N/A,N/A,"GeNo, LLC",2941 Oxbow Circle,,Cocoa,Florida,32926,USA,368512,2012,
rilotumumab,n/a,2012-06-18,Treatment of gastric cancer including gastroesophageal junction adenocarcinoma,Designated/Withdrawn,,,N/A,N/A,"Amgen, Inc.",One Amgen Center Drive,M/S 17-2-B,Thousand Oaks,California,91320,USA,369412,2012,
antimesothelin-ADC (antibody drug conjugate),n/a,2012-07-05,Treatment of mesothelioma,Designated,,,N/A,N/A,"Bayer HealthCare Pharmaceuticals, Inc.",340 Changebridge Road,,Pine Brook,New Jersey,7058,USA,370112,2012,
PG2 (Astragalus polysaccharides extracted and purified from the dry root of Astragalus membranaceus),n/a,2012-07-05,Treatment of idiopathic thrombocytopenic purpura,Designated,,,N/A,N/A,PhytoHealth Corporation,Fl. 5 No. 167,"Taipei City, 105",Taipei ROC,,,Taiwan,365912,2012,
adult adherent bone marrow-derived multipotent stem cells,Multistem,2012-07-06,"Treatment of MPS-1, including Hurler syndrome",Designated,,,N/A,N/A,"Athersys, Inc.",3201 Carnegie Avenue,,Cleveland,Ohio,44115,USA,372812,2012,
benzoate,Naben,2012-07-06,Treatment of pediatric schizophrenia,Designated,,,N/A,N/A,SyneuRx International (Taiwan) Corp.,1380 S. Marengo Ave,,Pasadena,California,91106,USA,365712,2012,
human MHC non-restricted cytotoxic T-cell line,n/a,2012-07-06,Treatment of ovarian cancer,Designated,,,N/A,N/A,Galileo Research srl,Via Paradiso 6,56019 Migliarino Pisano,Pisa,,,Italy,364812,2012,
"human recombinant DNA-derived, IgG1 kappa monoclonal anti-body to connective growth factor",n/a,2012-07-06,Treatment of idiopathic pulmonary fibrosis,Designated,,,N/A,N/A,"FibroGen, Inc.",409 Illinois Street,,San Francisco,California,94158,USA,351211,2012,
L-asparaginase encapsulated in red blood cells,Graspa,2012-07-06,Treatment of pancreatic cancer.,Designated,,,N/A,N/A,ERYTECH Pharma,Batiment Adenine,60 Avenue Rockefeller,lyon,,,France,370712,2012,
"N-(4-Fluoro-benzoyl)-L-arginyl-L-arginyl-[L-3-(naphthyl-alanyl]-L-cysteinyl-L-tyrosyl-L-citrullinyl-L-lysyl-D-lysyl-L-prolyl-L-trosyl-L-arginyl-L-citrullinyl-L-cysteinyl-L-aginine amide, cyclic (4-13)-disulfide",n/a,2012-07-06,For use to mobilize hematopoietic stem cells (HSCs) from the marrow to peripheral blood for collection for autologous or allogeneic transplantation,Designated,,,N/A,N/A,"BioLineRx, Ltd.",Modi'in Technology Park,2 HaMa'ayan Street,Modi'in,,,Israel,371912,2012,
tacrolimus,n/a,2012-07-06,Treatment of hemorrhagic cystitis,Designated,,,N/A,N/A,Lipella Pharmaceuticals Inc.,"400 N. Lexington Ave, LL105",,Pittsburgh,Pennsylvania,15208,USA,314310,2012,
N-acetylcysteine,n/a,2012-07-19,Prevention of ototoxicity caused by platinum-based chemotherapeutic agents used to treat pediatric cancers,Designated,,,N/A,N/A,"Edward A. Neuwelt, MD",Oregon Health & Science University,3181 SW Sam Jackson Park Road - Mail Code L603,Portland,Oregon,97239,USA,370012,2012,
everolimus,Afinitor,2012-07-23,Treatment of hepatocellular carcinoma,Designated,,,N/A,N/A,Novartis Pharmaceuticals Corp.,"One Health Plaza, 315/5450A",,East Hanover,New Jersey,7936,USA,374012,2012,
human retinal progenitor cells,n/a,2012-07-23,Treatment of retinitis pigmentosa,Designated,,,N/A,N/A,"jCyte, Inc.",42 Whitman Court,,Irvine,California,92617,USA,372712,2012,
mecasermin rinfabate,Iplex,2012-07-23,Treatment of amyotropic lateral sclerosis,Designated,,,N/A,N/A,"PCUT BioPartners, Inc.",2196 Glenkirk Drive,,San Jose,California,95124,USA,364312,2012,
acetyl-l-carnitine,n/a,2012-07-24,Treatment of Fragile X syndrome,Designated/Withdrawn,,,N/A,N/A,"Leadiant Biosciences, Inc.",9841 Washingtonian Blvd.,Suite 500,Gaithersburg,Maryland,20878,USA,373112,2012,
allogenic retinal epithelial cells transfected with plasmid vector expressing ciliary neurotrophic growth factor,n/a,2012-07-24,Treatment of macular telangiectasia type 2 (MacTel),Designated,,,N/A,N/A,"Neurotech USA, Inc.",701 George Washington Highway,,Lincoln,Rhode Island,2865,USA,368812,2012,
antisense oligonucleotide targeted to human transthyretin (TTR) mRNA,n/a,2012-07-24,Treatment of familial amyloid polyneuropathy,Designated,,,N/A,N/A,"Ionis Pharmaceuticals, Inc.",2855 Gazelle Court,,Carlsbad,California,92010,USA,374512,2012,
autologous umbilical cord blood,n/a,2012-07-24,Treatment of pediatric (0-16 yrs old inclusive) cerebral palsy due to acquired brain injury,Designated,,,N/A,N/A,Duke University,2301 Erwin Road,,Durham,North Carolina,27710,USA,372312,2012,
cantharidin,n/a,2012-07-24,"Treatment of perforating diseases, including Kyrle's disease, reactive perforating collangenosis, perforating folliculitis and elastosis perforans serpiginosa",Designated,,,N/A,N/A,"Orenova Group, LLC",10 New King Street,Suite 106,White Plains,New York,10604,USA,359311,2012,
dexamethasone sodium phosphate encapsulated in autologous erythrocytes,n/a,2012-07-24,Treatment of ataxia-telangiectasia,Designated,,,N/A,N/A,EryDel S.p.A.,Via Sasso 36,61029 Urbino (PU),,,,Italy,373212,2012,
"DNA plasmid vector expressing eIF5Ak50R protein, siRNA directed against the nastive eIF5A mRNA, and PEI (polyethyleneimine)",n/a,2012-07-24,Treatment of diffuse large B cell lymphoma,Designated,,,N/A,N/A,"Senesco Technologies, Inc.",721 Route 202/206,Suite 130,Bridgewater,New Jersey,8807,USA,373712,2012,
"DNA plasmid vector expressing eIF5Ak50R protein, siRNA directed against the native eIF5A mRNA, and PEI (polyethyleneimine)",n/a,2012-07-24,Treatment of mantle cell lymphoma,Designated,,,N/A,N/A,"Senesco Technologies, Inc.",721 Route 202/206,Suite 130,Bridgewater,New Jersey,8807,USA,373612,2012,
methylene blue,n/a,2012-07-24,Treatment of methemoglobinemia,Designated,,,N/A,N/A,"Fera Pharmaceuticals, LLC",134 Birch Hill Road,,Locust Valley,New York,11560,USA,345711,2012,
midazolam,n/a,2012-07-24,Treatment of nerve agent-induced seizures,Designated,,,N/A,N/A,"Meridian Medical Technologies, Inc.",A Pfizer Company,6350 Stevens Forest Road,Columbia,Maryland,21046,USA,373912,2012,
oxaloacetate,n/a,2012-07-24,Treatment of gliomas,Designated,,,N/A,N/A,Terra Biological LLC,3830 Valley Centre Drive,Suite 705-561,San Diego,California,92130,USA,370412,2012,
Recombinant Fusion Protein,n/a,2012-07-24,Treatment of Myelodysplastic Syndrome,Designated,,,N/A,N/A,Apogenix GmbH,Im Neuenheimer Feld 584,69120,Heidelberg,,,Germany,371612,2012,
recombinant human anti-GDF-8 monoclonal antibody,n/a,2012-07-24,Treatment of Duchenne Muscular Dystrophy.,Designated,,,N/A,N/A,"Pfizer, Inc.",500 Arcola Road,,Collegeville,Pennsylvania,19426,USA,373412,2012,
tralokinumab,n/a,2012-07-24,Treatment of idiopathic pulmonary fibrosis,Designated/Withdrawn,,,N/A,N/A,MedImmune Ltd.,Milstein Building,Granta Park,Cambridge CB21 6GH,,,United Kingdom,373812,2012,
tocilizumab,Actemra,2012-07-31,Treatment of pediatric patients (age 16 years and younger) with polyarticular-course juvenile idiopathic arthritis,Designated/Approved,Approved for Orphan Indication,Treatment of active polyarticular juvenile idiopathic arthritis in patients 2 through 16 years of age.,2013-04-29,2020-04-29,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,USA,367812,2012,272
rucaparib,Rubraca,2012-07-31,Treatment of ovarian cancer,Designated/Approved,Approved for Orphan Indication,As monotherapy for the treatment of patients with deleterious BRCA mutation (germline and/or somatic) associated advanced ovarian cancer who have been treated with two or more chemotherapies,2016-12-19,2023-12-19,"Clovis Oncology, Inc.",5500 Flatiron Parkway,Suite 100,Boulder,Colorado,80301,USA,374712,2012,1602
rucaparib,Rubraca,2012-07-31,Treatment of ovarian cancer,Designated/Approved,Approved for Orphan Indication,"For the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in complete or partial response to platinum-based chemotherapy.",2018-04-06,TBD,"Clovis Oncology, Inc.",5500 Flatiron Parkway,Suite 100,Boulder,Colorado,80301,USA,374712,2012,2075
Brilliant Blue G,Dorc Ilm-Blue,2012-07-31,"To selectively stain the thickened internal limiting membrane, which has formed onto the inner side of the retina in vitreo-retinal disorders",Designated,,,N/A,N/A,Dutch Opthalmic Research Center,"Scheijdelveweg 2, 3214 VN",,Zuidland,,,Netherlands,341811,2012,
diazepam (intranasal),n/a,2012-07-31,Management of patients with acute repetitive seizures,Designated,,,N/A,N/A,SK Life Sciences Inc.,22-10 New Jersey 208,,Fair Lawn,New Jersey,7410,USA,334911,2012,
heat killed mycobacterium w immunomodulator,Cadi-Mw,2012-07-31,Treatment of non-small cell lung cancers that express desmocollin-3,Designated,,,N/A,N/A,Cadila Pharmaceuticals Limited,"Sarkhej-Dholka Road, Bhat",Ahmedabad - 382210,Gujarat,,,India,349211,2012,
methylene blue injection,n/a,2012-08-11,Treatment of congenital and acquired methemoglobinemia,Designated,,,N/A,N/A,"Luitpold Pharmaceuticals, Inc.",One Luitpold Drive,P. O. Box 9001,Shirley,New York,11967,USA,357111,2012,
mercaptopurine oral solution,Purixan,2012-08-20,Treatment of acute lymphoblastic leukemia in pediatric patients,Designated/Approved,Approved for Orphan Indication,Treatment of patients with acute lymphoblastic leukemia as part of a combination regimen.,2014-04-28,2021-04-28,Nova Laboratories Limited,Martin House,"Wigston, Leicester LE18 4YL",England,,,United Kingdom,373512,2012,616
panobinostat,Farydak,2012-08-20,Treatment of multiple myeloma,Designated/Approved,Approved for Orphan Indication,"Treatment of patients with multiple myeloma who have received at least 2 prior regimens, including bortezomib and an immunomodulatory agent",2015-02-23,2022-02-23,Novartis Pharmaceuticals Corporation,"One Health Plaza, 105/3W038",,East Hanover,New Jersey,7936,USA,376212,2012,917
triptorelin pamoate,Triptodur,2012-08-20,Treatment of central precocious puberty,Designated/Approved,Approved for Orphan Indication,Treatment of pediatric patients 2 years of age and older with central precocious puberty,2017-06-29,2024-06-29,"Arbor Pharmaceuticals, LLC",6 Concourse Parkway,Suite 1800,Atlanta,Georgia,30328,USA,376012,2012,1774
gevokizumab,n/a,2012-08-20,"Treatment of non-infectious intermediate, posterior or pan uveitis, or chronic non-infectious anterior uveitis",Designated,,,N/A,N/A,XOMA (US) LLC,2910 Seventh St.,,Berkeley,California,94710,USA,364512,2012,
lurbinectedin,n/a,2012-08-20,Treatment of ovarian cancer,Designated,,,N/A,N/A,"PharmaMar USA, Inc.",205 East 42nd St.,Suite 15003,New York,New York,10017,USA,376512,2012,
modified recombinant mitochondrial transcription factor A (TFAM) containing the mitochondrial transduction domain,n/a,2012-08-20,Treatment of inherited mitochondrial respiratory chain disease,Designated,,,N/A,N/A,Gencia Corporation,200 Garrett Street,Suite H,Charlottesville,Virginia,22902,USA,375012,2012,
optically pure phenylalanine derivative,n/a,2012-08-20,Treatment of narcolepsy,Designated,,,N/A,N/A,Jazz Pharmaceuticals International III Limited,3180 Porter Drive,,Palo Alto,California,94304,USA,375112,2012,
caffeine and sodium benzoate,n/a,2012-08-22,Treatment of seizure prolongation in patients undergoing electroconvulsive therapy,Designated,,,N/A,N/A,"Luitpold Pharmaceuticals, Inc.","800 Adams Ave., Suite 100",,Norristown,Pennsylvania,19403,USA,367512,2012,
canakinumab,Ilaris,2012-09-04,Treatment of TNF-receptor associated periodic syndrome (TRAPS),Designated/Approved,Approved for Orphan Indication,Indicated for Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS) in adult and pediatric patients,2016-09-23,2023-09-23,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,USA,376912,2012,1480
menaquinone,Menaquinonegold,2012-09-04,Treatment of calciphylaxis,Designated,,,N/A,N/A,"Nu Science Trading, LLC",428 East Thunderbird Road,Suite 510,Phoenix,Arizona,85022,USA,357311,2012,
recilisib sodium,Ex-Rad(R),2012-09-04,Treatment of acute radiation syndrome,Designated,,,N/A,N/A,"Onconova Therapeutics, Inc.",375 Pheasant Run,,Newton,Pennsylvania,18940,USA,350411,2012,
trametinib and dabrafenib,Mekinist And Tafinlar,2012-09-20,Treatment of Stage IIb through IV melanoma.,Designated/Approved,Approved for Orphan Indication,MEKINIST (trametinib) in combination with dabrafenib for treatment of patients with unresectable or metastatic melanoma with BRAF V600E or V600K mutations as detected by an FDA-approved test. This indication is based on the demonstration of durable response rate. Improvement in disease-related symptoms or overall survival has not been demonstrated for MEKINIST in combination with dabrafenib.,2014-01-08,2021-01-08,Novartis Pharmaceuticals Corp.,One Health Plaza,,East Hanover,New Jersey,7936,USA,376812,2012,475
trametinib and dabrafenib,Mekinist And Tafinlar,2012-09-20,Treatment of Stage IIb through IV melanoma.,Designated/Approved,Approved for Orphan Indication,TAFINLAR (dabrafenib) in combination with trametinib for treatment of patients with unresectable or metastatic melanoma with BRAF V600E or V600K mutations as detected by an FDA-approved test. This indication is based on the demonstration of durable response rate. Improvement in disease-related symptoms or overall survival has not been demonstrated for TAFINLAR in combination with trametinib.,2014-01-09,2021-01-09,Novartis Pharmaceuticals Corp.,One Health Plaza,,East Hanover,New Jersey,7936,USA,376812,2012,476
venetoclax,Venclexta,2012-09-20,Treatment of chronic lymphocytic leukemia,Designated/Approved,Approved for Orphan Indication,"Treatment of patients with chronic lymphocytic leukemia (CLL) with 17p deletion, as detected by an FDA approved test, who have received at least one prior therapy",2016-04-11,2023-04-11,"AbbVie, Inc",1 North Waukegan Road,"Dept. PA77, Bldg. AP30-1",North Chicago,Illinois,60064,USA,375612,2012,1299
alfimeprase,n/a,2012-09-20,Treatment of ST-elevation myocardial infarcted patients who are undergoing primary percutaneous coronary intervention,Designated,,,N/A,N/A,"Niche Therapeutics, LLC",2009 Morton Avenue,,Ann Arbor,Michigan,48104,USA,370512,2012,
H-Leu-Pro-Pro-Ser-Arg-OH,n/a,2012-09-20,Treatment of Kaposi sarcoma,Designated,,,N/A,N/A,"Immuno Tech, Inc.","6329 256th Street, NE",,Arlington,Washington,98223,USA,375312,2012,
mecasermin rinfabate,n/a,2012-09-20,Prevention of retinopathy of prematurity in premature infants born at risk for the disease,Designated,,,N/A,N/A,Premacure AB,Dag Hammarskjolds vag 10B,SE-751 83,Uppsala,,,Sweden,372612,2012,
milciclib maleate,n/a,2012-09-20,Treatment of thymic epithelial tumors.,Designated,,,N/A,N/A,Tiziana Life Sciences PLC,18 South Street,W1K 1DG,London,,,United Kingdom,375512,2012,
mouse-human chimeric monoclonal anti-GD2 IgG1 antibody,n/a,2012-09-20,Treatment of neuroblastoma.,Designated,,,N/A,N/A,EUSA Pharma (UK) Limited,Breakspear Park,Breakspear Way,,,,United Kingdom,377712,2012,
paclitaxel poliglumex,Opaxio,2012-09-20,Treatment of glioblastoma multiforme,Designated,,,N/A,N/A,CTI BioPharma Corporation,3101 Western Ave,Suite 600,Seattle,Washington,98119,USA,377312,2012,
vancomycin hydrochloride (inhalational),n/a,2012-09-20,Treatment of persistent methicillin-resistant S. aureus lung infection in patients with cystic fibrosis,Designated,,,N/A,N/A,"Savara Pharmaceuticals, Inc.",5900 Shepherd Mountasin Cove,Suite 2-205,Austin,Texas,78730,USA,374212,2012,
"Japanese encephalitis vaccine, inactivated, adsorbed",Ixiaro,2012-09-25,Prevention of Japanese encephalitis virus in pediatric patients.,Designated/Approved,Approved for Orphan Indication,"To extend the age range to include infants, children, and adolescents 2 months to less than 17 years of age for active immunization for the prevention of disease caused by Japanese encephalitis virus.",2013-05-17,2020-05-17,Intercell AG,Campus Vienna Biocenter 3,A-1030,Vienna,,,Austria,376112,2012,234
dantrolene sodium,n/a,2012-09-25,Treatment of heat stroke,Designated,,,N/A,N/A,"Eagle Pharmaceuticals, Inc.",50 Tice Blvd,Suite 315,Woodcliff Lake,New Jersey,7677,USA,377512,2012,
metyrapone,n/a,2012-09-25,Treatment of Cushing's syndrome,Designated,,,N/A,N/A,Laboratoire HRA Pharma,"15 rue Beranger,",,Paris,,,France,377212,2012,
reparixin,n/a,2012-09-25,Prevention of graft loss in pancreatic islet transplantation,Designated,,,N/A,N/A,Dompe S.p.A.,Via Campo di Pile,,L'Aquila,,,Italy,373312,2012,
Synthetic double-stranded siRNA oligonucleotide against caspase 2 mRNA,n/a,2012-09-25,Treatment of ischemic optic neuropathy,Designated,,,N/A,N/A,"Quark Pharmaceuticals, Inc.",6501 Dumbarton Circle,,Fremont,California,94555,USA,317410,2012,
glycosylated recombinant human interleukin-7,n/a,2012-09-27,Treatment of progressive multifocal leukoencephalopathy,Designated,,,N/A,N/A,"Cytheris, Inc.",1700 Rockville Pike,Suite 230,Rockville,Maryland,20852,USA,379112,2012,
ADF-APO-CCN-GUC-K67-MET-MMP-MUC-RGS; HLA class I/II binding tumor associated peptides,n/a,2012-09-28,Treatment of renal cell carcinoma in HLA-A*2 positive patients,Designated/Withdrawn,,,N/A,N/A,Immatics Biotechnologies GmbH,Paul-Ehrlich-Strasse 15,72072 Tubingen,,,,Germany,378812,2012,
amatuximab,n/a,2012-09-28,Treatment of mesothelioma,Designated,,,N/A,N/A,"Morphotek, Inc.",210 Welsh Pool Road,,Exton,Pennsylvania,19341,USA,241607,2012,
carbon monoxide,n/a,2012-09-28,Treatment of sickle cell disease,Designated,,,N/A,N/A,"Hillhurst Biopharmaceuticals, Inc.",2029 Verdugo Blvd,Suite 125,Montrose,California,91020,USA,379612,2012,
crizotinib,Xalkori,2012-09-28,Treatment of anaplastic large cell lymphoma,Designated,,,N/A,N/A,"Pfizer, Inc.",10646 Science Center Drive,,San Diego,California,92121,USA,379712,2012,
liposomal Ã}Â±-galactosylceramide,Lip. Alpha Galactosylceramide,2012-09-28,Prevention of graft-versus-host disease,Designated,,,N/A,N/A,REGiMMUNE Corporation,320 Logue Avenue,,Mountain View,California,94043,USA,370612,2012,
quinacrine,n/a,2012-09-28,Treatment of hepatocellular carcinoma,Designated,,,N/A,N/A,"Cleveland BioLabs, Inc & Incuron, LLC Joint Ventur",73 High Street,,Buffalo,New York,14203,USA,379912,2012,
pralmorelin hydrochloride,n/a,2012-10-18,As a diagnostic agent for the detection of growth hormone deficiency,Designated,,,N/A,N/A,"Sella Pharmaceuticals, Inc.",412 Wister Road,,Wynnewood,Pennsylvania,19096,USA,372912,2012,
coagulation factor IX (recombinant),Rixubis,2012-10-31,Prophylactic use to prevent or reduce the frequency of bleeding episodes in patients with hemophilia B (routine prophylaxis in patients where there is no evidence or suspicion of bleeding),Designated/Approved,Approved for Orphan Indication,Adults with Hemophilia B for routine prophylaxis to prevent or reduce the frequency of bleeding episodes.,2013-06-26,2020-06-26,"Baxalta US, Inc.",One Baxter Way,,Westlake Village,California,91362,USA,377412,2012,238
sirolimus,Rapamune,2012-10-31,Treatment of lymphangioleiomyomatosis,Designated/Approved,Approved for Orphan Indication,Treatment of lymphangioleiomyomatosis (LAM),2015-05-28,2022-05-28,"Pfizer, Inc.",500 Arcola Road,,Collegeville,Pennsylvania,19426,USA,379312,2012,939
"(2S)-2-{[(2R)-2-[({[3,3-dibutyl-7-(methylthio)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro- 1,2,5-benzothiadiazepin-8-yl]oxy}acetyl)amino]-2-(4-hydroxyphenyl)acetyl]amino}butanoic acid",n/a,2012-10-31,Treatment of progressive familial intrahepatic cholestatis,Designated,,,N/A,N/A,Albireo AB,Arvid Wallgrens Backe 20,S-413 46 Gothenburg,,,,USA,370912,2012,
"(2S)-2-{[(2R)-2-[({[3,3-dibutyl-7-(methylthio)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro- 1,2,5-benzothiadiazepin-8-yl]oxy}acetyl)amino]-2-(4-hydroxyphenyl)acetyl]amino}butanoic acid",n/a,2012-10-31,Treatment of primary biliary cirrhosis,Designated,,,N/A,N/A,Albireo AB,Arvid Wallgrens Backe 20,S-413 46 Gothenburg,,,,Sweden,371012,2012,
2'-O-methyl phosphorothioate 5'-GCUAGGUUUACGGGACCUCU-3',n/a,2012-10-31,Treatment of amyotrophic lateral sclerosis,Designated,,,N/A,N/A,LifeSplice Pharma LLC,1 Great Valley Parkway,Suite 20,Malvern,Pennsylvania,19355,USA,380012,2012,
5'-GCCATGGTTTTTTCTCAGG-3',n/a,2012-10-31,Prophylaxis for patients following documented or suspected exposure to ebolavirus,Designated,,,N/A,N/A,"Sarepta Therapeutics, Inc.",215 First Street,,Cambridge,Massachusetts,2142,USA,347611,2012,
"5Ã¿Â¿Ã¿Ã¿Ã¿Â¢Ã¿Â¿Ã¿Ã¿Â¬""-GAATATTAACAIACTGACAAGTC-3Ã¿Â¿Ã¿Ã¿Ã¿Â¢Ã¿Â¿Ã¿Ã¿Â¬""",n/a,2012-10-31,Prophylaxis following documented or suspected exposure to marburg virus,Designated,,,N/A,N/A,"Sarepta Therapeutics, Inc.",215 First Street,,Cambridge,Massachusetts,2142,USA,347711,2012,
crenolanib,n/a,2012-10-31,Treatment of acute myelogenous leukemia,Designated,,,N/A,N/A,"AROG Pharmaceuticals, LLC",12400 Coit Road,Suite 570,Dallas,Texas,75251,USA,363812,2012,
crizotinib,Xalkori,2012-10-31,Treatment of neuroblastoma,Designated,,,N/A,N/A,"Pfizer, Inc.",10646 Science Center Drive,,San Diego,California,92121,USA,379812,2012,
"recombinant human GM-CSF, molgramostim",n/a,2012-10-31,Treatment of pulmonary alveolar proteinosis,Designated,,,N/A,N/A,Savara Inc.,900 S. Capitol of Texas Highway,Suite 150,Austin,Texas,78746,USA,377912,2012,
"sodium sulfate, potassium sulfate, and magnesium sulfate",Suprep,2012-10-31,For cleansing of the colon in preparation for colonoscopic diagnosis of colonic disease in children and adolescents,Designated,,,N/A,N/A,"Braintree Laboratories, Inc.",60 Cloumbian Street West,PO Box 850929,Braintree,Massachusetts,2185,USA,379212,2012,
tetracosactide hexaacetate (beta 1-24-corticotrophin),"Synacthen Depot, S. Retard",2012-10-31,Treatment of infantile spasms,Designated,,,N/A,N/A,"Cerium Pharmaceuticals, Inc.",817-B Linsdale Street,,Gaithersburg,Maryland,20878,USA,378212,2012,
Hantaan virus and Puumala virus DNA vaccines,n/a,2012-11-13,Prevention of hemorrhagic fever with renal syndrome caused by Hantaan virus and Puumala virus,Designated,,,N/A,N/A,Surgeon General of the U. S. Army,1430 Veterans Drive,ATTN: USAMR and MC,Fort Detrick,Maryland,21702,USA,369312,2012,
pembrolizumab,Keytruda,2012-11-19,Treatment of Stage IIB through IV malignant melanoma,Designated/Approved,Approved for Orphan Indication,"Treatment of patients with unresectable or metastatic melanoma and disease progression following ipilimumab and, if BRAF V600 mutation positive, a BRAF inhibitor.",2014-09-04,2021-09-04,"Merck, Sharp & Dohme Corp.",351 North Sumneytown Pike,UG2CDS-015,North Wales,Pennsylvania,19454,USA,381012,2012,654
pembrolizumab,Keytruda,2012-11-19,Treatment of Stage IIB through IV malignant melanoma,Designated/Approved,Approved for Orphan Indication,Treatment of patients with unresectable or metastatic melanoma.,2015-12-18,2022-12-18,"Merck, Sharp & Dohme Corp.",351 North Sumneytown Pike,UG2CDS-015,North Wales,Pennsylvania,19454,USA,381012,2012,1124
brentuximab vedotin,Adcetris,2012-11-19,Treatment of mycosis fungoides,Designated/Approved,Approved for Orphan Indication,Treatment for adult patients with CD30-expressing mycosis fungoides who have received prior systemic therapy,2017-11-09,TBD,"Seattle Genetics, Inc.",21823 30th Drive Southeast,,Bothell,Washington,98021,USA,362611,2012,1816
"1'-{[5-(trifluoromethyl)-2-furyl]methyl}spiro[furo[2,3-f][1,3]benzodioxole-7,3'-indol]-2'(1'H)-one",n/a,2012-11-19,Treatment of erythromelalgia,Designated,,,N/A,N/A,Teva Pharmaceuticals,41 Moores Road,P. O. Box 4011,Frazer,Pennsylvania,19355,USA,378012,2012,
adeno-associated virus transgene of follistatin,n/a,2012-11-19,Treatment of Duchennes and Becker's muscular dystrophy,Designated,,,N/A,N/A,Milo Biotechnology,2322 Delaware Drive,,Cleveland Heights,Ohio,44106,USA,378512,2012,
"beclomethasone 17,21-dipropionate",n/a,2012-11-19,Prevention of death following a potentially lethal dose of total body irradiation during or after a radiation disaster,Designated,,,N/A,N/A,"Soligenix, Inc","29 Emmons Drive, Suite C-10",,Princeton,New Jersey,8540,USA,356311,2012,
combretastatin A 1 diphosphate,n/a,2012-11-19,Treatment of acute myelogenous leukemia,Designated,,,N/A,N/A,"Mateon Therapeutics, Inc.",701 Gateway Blvd,Suite 210,South San Francisco,California,94080,USA,382412,2012,
extract of sorghum bicolor extract,n/a,2012-11-19,Treatment of sickle cell disease,Designated,,,N/A,N/A,"Invenux, LLC",1550 Main Street,Suite A3,Windsor,Colorado,80550,USA,358811,2012,
melphalan,n/a,2012-11-19,Treatment of retinoblastoma,Designated,,,N/A,N/A,"Icon Bioscience, Inc.",1253 Reamwood Avenue,,Sunnyvale,California,94089,USA,378112,2012,
melphalan,n/a,2012-11-19,Treatment of Stage IIB through IV melanoma,Designated,,,N/A,N/A,"OncoTx, LLC",9 Brandeis Road,,Newton,Massachusetts,2459,USA,381412,2012,
sodium thiosulfate,n/a,2012-11-19,Treatment of calciphylaxis,Designated,,,N/A,N/A,Edinburg BioQuarter,University Medical School 47,EH16 4TJ,Edinburgh,,,United Kingdom,381912,2012,
tabalumab,n/a,2012-11-19,Treatment of multiple myeloma,Designated/Withdrawn,,,N/A,N/A,Eli Lilly and Company,Lilly Corporate Center,,Indianapolis,Indiana,46285,USA,381612,2012,
chimeric monoclonal antibody to claudin 18 splice variant 2,n/a,2012-11-20,Treatment of gastric cancer,Designated,,,N/A,N/A,Astellas Pharma Global Development Inc.,1 Astellas Way,,Northbrook,Illinois,60062,USA,383312,2012,
marzeptacog alfa (activated),n/a,2012-11-30,Routine prophylaxis to prevent bleeding episodes in patients with hemophilia A and B patients with inhibitors,Designated,,,N/A,N/A,"Catalyst Biosciences, Inc.",260 Littlefield Avenue,,South San Francisco,California,94080,USA,377612,2012,
hexasodium phytate,n/a,2012-12-02,Treatment of calciphylaxis,Designated,,,N/A,N/A,"Laboratoris Sanifit, S.L.",Parc Bit - Building Disset - Office D3,07121 Palma de Mallorca,,,,Spain,380412,2012,
afatinib,Gilotrif,2012-12-03,Treatment of epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC).,Designated/Approved,Approved for Orphan Indication,First-line treatment of patients with metastatic non-small cell lung cancer (NSCLS) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test.,2013-07-12,2020-07-12,"Boehringer Ingelheim Pharmaceuticals, Inc.",P. O. Box 368,900 Ridgebury Road,Ridgefield,Connecticut,6877,USA,375712,2012,221
ibrutinib,Imbruvica,2012-12-03,Treatment of mantle cell lymphoma,Designated/Approved,Approved for Orphan Indication,Treatment of patients with mantle cell lymphoma (MCL) who have received at least one prior therapy,2013-11-13,2020-11-13,"Pharmacyclics, LLC",995 E. Arques Avenue,,Sunnyvale,California,94085,USA,383112,2012,345
apolipoprotein E mimetic peptide,n/a,2012-12-03,Treatment of homozygous familial hypercholesterolemia,Designated,,,N/A,N/A,"LipimetiX Development, LLC",5 Commonwealth Road,Suite 2A,Natick,Massachusetts,1760,USA,381712,2012,
diazoxide,n/a,2012-12-03,Treatment of Prader Willi Syndrome,Designated,,,N/A,N/A,"Sedogen, LLC",1701 East Lake Avenue,Suite260,Glenview,Illinois,60025,USA,383712,2012,
human coagulation factor VIII,Octanate,2012-12-03,Immune tolerance induction in hemophilia A patients with inhibitors,Designated,,,N/A,N/A,"OCTAPHARMA USA, Inc.",121 River Street,12th Floor,Hoboken,New Jersey,7030,USA,382812,2012,
porcine GM1 ganglioside,n/a,2012-12-03,Treatment of acute spinal cord injury,Designated,,,N/A,N/A,TRB Chemedica International S.A.,Rue Michel-Servet 12,CH-1211,Geneva 12,,,Switzerland,374412,2012,
recombinant human gowth hormone in an ocular delivery system,n/a,2012-12-03,Treatment of persistent corneal epithelial defects,Designated,,,N/A,N/A,Jade Therapeutics LLC,7585 Ranch Club Trail,,Park City,Utah,84098,USA,384012,2012,
recombinant human monoclonal antibody of the IgG1 kappa class against prostate stem cell antigen,n/a,2012-12-03,Treatment of pancreatic cancer,Designated/Withdrawn,,,N/A,N/A,"Astellas Pharma Global Development, Inc.",1 Astellas Way,,Northbrook,Illinois,60062,USA,383812,2012,
trans sodium crocetinate,n/a,2012-12-03,Treatment of brain metastasis,Designated,,,N/A,N/A,"Diffusion Pharmaceuticals, LLC",2020 Avon Court #4,,Charlottesville,Virginia,22902,USA,378312,2012,
Yttrium(90Y)-DTPA-radiolabelled chimeric monoclonal antibody against frizzled homologue 10,n/a,2012-12-03,Treatment of soft tissue sarcoma,Designated,,,N/A,N/A,"OncoTherapy Science, Inc.",Kanagawa Science Park R & D D-6F,"Kawasaki-shi, Kanagawa, 213-0012",,,,Japan,383012,2012,
glucagon,n/a,2012-12-05,Prevention of hypoglycemia in the congenital hyperinsulinism population,Designated,,,N/A,N/A,"Biodel, Inc.",100 Saw Mill Road,,Danbury,Connecticut,6810,USA,366812,2012,
perampanel,Fycompa,2012-12-07,Treatment of Lennox-Gastaut Syndrome,Designated,,,N/A,N/A,"Eisai, Inc.",155 Tice Blvd,,Woodcliff,New Jersey,7677,USA,380912,2012,
adeno-associated viral vector containing DNA encoding an RNAi targeting rhodopsin in combination with an adeno-associated viral vector containing DNA encoding a rhodopsin gene,Rhonova (Tm),2012-12-13,treatment of retinitis pigmentosa,Designated,,,N/A,N/A,Spark Therapeutics Ireland Ltd.,Smurfit Institute of Genetics,Trinity College,Dublin 2,,,Ireland,383412,2012,
methylene blue0.5%,Provayblue,2012-12-18,Treatment of hereditary and acquired methemoglobinemia,Designated/Approved,Approved for Orphan Indication,For treatment of pediatric and adult patients with acquired methemoglobinemia.,2016-04-08,2023-04-08,Provepharm SAS,Technopote de Chateau-Combert,13013 Marseille,,,,France,385512,2012,1207
prothrombin complex concentrate (human),Kcentra,2012-12-27,Treatment of patients needing urgent reversal of Vitamin K antagonist therapy for treatment of major bleeding and/or surgical procedures,Designated/Approved,Approved for Orphan Indication,"Urgent reversal of acquired coagulation factor deficiency induced by Vitamin K antagonist (VKA, e.g., warfarin) therapy in adult patients with acute major bleeding.",2013-04-29,2020-04-29,CSL Behring,1020 First Avenue,PO Box 61501,King of Prussia,Pennsylvania,19406,USA,305310,2012,123
prothrombin complex concentrate (human),Kcentra,2012-12-27,Treatment of patients needing urgent reversal of Vitamin K antagonist therapy for treatment of major bleeding and/or surgical procedures,Designated/Approved,Approved for Orphan Indication,"Urgent reversal of acquired coagulation factor deficiency induced by vitamin K antagonist therapy (VKA, e.g., warfarin) in adult patients with the need for urgent surgery/invasive procedure.",2013-12-13,2020-12-13,CSL Behring,1020 First Avenue,PO Box 61501,King of Prussia,Pennsylvania,19406,USA,305310,2012,351
lenvatinib,Lenvima,2012-12-27,"Treatment of follicullar, medullary, anaplastic, and metastatic or locally advanced papillary thyroid cancer",Designated/Approved,Approved for Orphan Indication,"Treatment of patients with locally recurrent or metastatic, progressive, radioactive iodine refractory differentiated thyroid cancer",2015-02-13,2022-02-13,"Eisai, Inc.",155 Tice Blvd,,Woodcliff Lake,New Jersey,7677,USA,378412,2012,778
adeno-associated viral vector serotype 9 containing human N-acetylglucosaminidase alpha gene,n/a,2012-12-27,Treatment of mucopolysaccharidosis type IIIB (Sanfilippo B syndrome),Designated,,,N/A,N/A,"Laboratorios del Dr. Esteve, S.A.","Av. Marie de Deu de Montserrat, 221",,Barcelona,,,Spain,384712,2012,
PGC-C12E-terlipressin,n/a,2012-12-27,Treatment of ascites due to all etiologies except for cancer,Designated,,,N/A,N/A,PharmaIN Corporation,19805 N. Creek Pkwy,Suite 200,Bothell,Washington,98011,USA,374812,2012,
vancomycin,n/a,2012-12-27,Treatment of endophthalmitis,Designated,,,N/A,N/A,"Fera Pharmaceuticals, LLC",134 Birch Hill Road,,Locust Valley,New York,11560,USA,361211,2012,
S-nitrosoglutathione,n/a,2012-12-28,Treatment of severe preeclampsia,Designated,,,N/A,N/A,Salupont Consulting Ltd,"The Old Quarters, Hazells Hall","Everton Road, Sandy",Bedfordshire SG19 2DD,,,United Kingdom,358511,2012,
tiprelestat,Elafin,2012-12-28,Treatment of pulmonary arterial hypertension,Designated,,,N/A,N/A,Proteo Biotech AG,Am Kiel-Kanal 44,,,,,Germany,241007,2012,
paclitaxel nanoparticles,n/a,2013-01-02,Treatment of pancreatic cancer,Designated,,,N/A,N/A,"CIRJ Co., Ltd.",1800 Loma Vista Street,,Pasadena,California,91104,USA,384912,2013,
ezatiostat hydrochloride,Telintra,2013-01-09,Treatment of myelodysplastic syndrome,Designated,,,N/A,N/A,"Telik, Inc.",700 Hansen Way,,Palo Alto,California,94304,USA,382312,2013,
P140K MGMT transduced human CD34 cells,n/a,2013-01-09,For bone marrow protection in the treatment of glioblastoma multiforme,Designated,,,N/A,N/A,Lentigen Corporation,910 Clopper Road,Suite 200 South Building,Gaithersburg,Maryland,20878,USA,385212,2013,
rilonacept,Arcalyst,2013-01-09,Treatment of familial Mediterranean fever,Designated,,,N/A,N/A,"Philip J Hashkes, MD, MSc.","Head, Section of Pediatric Rheumatology",9500 Euclid Avenue,Cleveland,Ohio,44195,USA,292509,2013,
5-aminolevulinic acid,Gleolan,2013-01-15,Visualization of malignant tissue during surgery for malignant glioma (WHO grades III and IV),Designated/Approved,Approved for Orphan Indication,Optical imaging agent indicated in patients with glioma (suspected World Health Organization Grades III or IV on preoperative imaging) as an adjunct for the visualization of malignant tissue during surgery,2017-06-06,2024-06-06,NX Development Corporation,1827 South Bayshore Lane,,Miami,Florida,33133,USA,387312,2013,1603
beloranib,n/a,2013-01-15,Treatment of Prader-Willi syndrome,Designated/Withdrawn,,,N/A,N/A,"Zafgen, Inc.",175 Portland Street,4th Floor,Boston,Massachusetts,2114,USA,385012,2013,
Efdispo (tm),Efdispo (Tm),2013-01-15,Treatment of Ewings Sarcoma.,Designated,,,N/A,N/A,"TDP Biotherapeutics, Inc.",113 Summer Walk Drive,,Gaithersburg,Maryland,20878,USA,386912,2013,
O-(3-piperidino-2-hydroxyl-1-propyl)-nicotinic acid amidoxime hydrochloride,n/a,2013-01-15,Treatment of Duchenne Muscular Dystrophy,Designated,,,N/A,N/A,Vudbenk Life Sciences,Tancsics Mihaly utca 18,5900 Oroshaza,,,,Hungary,386512,2013,
tafenoquine,n/a,2013-01-15,Treatment of malaria,Designated,,,N/A,N/A,"Glaxo Group Limited, England",Glaxo Wellcome House,"Greenford, Middlesex, UB6 0NN",,,,United Kingdom,385812,2013,
synthetic peptide; cyclo-Cys-Gly-Gln-Arg-Glu-Thr-Pro-Glu-Gly-Ala-Glu-ALA-Lys-Pro-Trp-Tyr-Cys,n/a,2013-01-16,Treatment of high altitude pulmonary edema,Designated,,,N/A,N/A,Apeptico Forschung und Entwicklung GmbH,c/o mingo bueros,1150,Vienna,,,Austria,382912,2013,
apremilast,n/a,2013-01-17,Treatment of Behcet's disease,Designated,,,N/A,N/A,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,USA,384812,2013,
lisuride,n/a,2013-01-17,Treatment of pulmonary arterial hypertension,Designated,,,N/A,N/A,Sinoxa Pharma GmbH,Thomasiusstr.13,,,,,Germany,316610,2013,
modified recombinant human C-type natriuretic peptide (CNP),n/a,2013-01-17,Treatment of achondroplasia,Designated,,,N/A,N/A,"BioMarin Pharmaceutical, Inc.",105 Digital Drive,,Novato,California,94949,USA,386012,2013,
eflornithine plus sulindac,n/a,2013-01-22,Treatment of familial adenomatous polyposis,Designated,,,N/A,N/A,"Cancer Prevention Pharmaceuticals, Inc.",1760 East River Road,Suite 250,Tucson,Arizona,85718,USA,387012,2013,
nivolumab,Opdivo,2013-01-23,Treatment of Stage IIb to IV melanoma,Designated/Approved,Approved for Orphan Indication,"Treatment of patients with unresectable or metastatic melanoma and disease progression following ipilimumab and, if BRAF V600 mutation positive, a BRAF inhibitor",2014-12-22,2021-12-22,Bristol-Myers Squibb Co.,Route 206 & Province Line Road,,Princeton,New Jersey,8540,USA,387612,2013,698
nivolumab,Opdivo,2013-01-23,Treatment of Stage IIb to IV melanoma,Designated/Approved,Approved for Orphan Indication,Treatment of patients with melanoma with involement of lymph nodes or metestatic disease who have undergone complete resection,2017-12-20,TBD,Bristol-Myers Squibb Co.,Route 206 & Province Line Road,,Princeton,New Jersey,8540,USA,387612,2013,1792
10 synthetic peptides targeting 5 tumor asociated antigens,n/a,2013-01-23,Treatment of non-small cell lung cancer in patients expressing HLA-A2,Designated,,,N/A,N/A,Orphan Synergy Europe Pharma (OSE Pharma),OSE Pharma Pepiniere Paris Sante Cochin,29 bis rue du faubourg Saint Jacques,Paris,,,France,387212,2013,
Exon 45 specific phosphorothioate oligonucleotide,n/a,2013-01-23,Treatment of Duchenne Muscular Dystrophy patients bearing mutations that can be corrected by skipping exon 45,Designated,,,N/A,N/A,"BioMarin Pharmaceutical, Inc.",105 Digital Drive,,Novato,California,94949,USA,384512,2013,
Exon 52 specific phosphorothiate oligonucleotide,n/a,2013-01-23,Treatment of Duchenne Muscular Dystrophy patients bearing mutations that can be corrected by skipping exon 52,Designated,,,N/A,N/A,"BioMarin Pharmaceutical, Inc.",105 Digital Drive,,Novato,California,94949,USA,384412,2013,
exon 53 specific phosphorothioate oligonucleotide,n/a,2013-01-23,treatment of Duchenne Muscular Dystrophy patients bearing mutations that can be corrected by skipping exon 53,Designated,,,N/A,N/A,"BioMarin Pharmaceutical, Inc.",105 Digital Drive,,Novato,California,94949,USA,384612,2013,
Exon 55 specific phosphorothioate oligonucleotide,n/a,2013-01-23,Treatment of Duchenne Muscular Dystrophy patients bearing mutations that can be corrected by skipping exon 55,Designated,,,N/A,N/A,"BioMarin Pharmaceutical, Inc.",105 Digital Drive,,Novato,California,94949,USA,384312,2013,
onartuzumab,n/a,2013-01-23,Treatment of gastric cancer including gastroesophageal cancer,Designated/Withdrawn,,,N/A,N/A,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,USA,387712,2013,
[met5]-enkephalin,Opioid Growth Factor,2013-01-24,Treatment of pancreatic cancer,Designated,,,N/A,N/A,"TNI BioTech, Inc.",6701 Democracy Blvd,Suite 300,Bethesda,Maryland,20817,USA,388312,2013,
enalapril maleate (powder for oral solution),Epaned,2013-01-30,Treatment of hypertension in pediatric patients,Designated/Withdrawn by OPD,,,N/A,N/A,"Silvergate Pharmaceuticals, Inc.",5371 Gordon Way,,Dublin,Ohio,43017,USA,376712,2013,
human insulin beta chain peptide with incomplete Freund's adjuvant vaccine,n/a,2013-02-11,Treatment of Type 1 diabetes patients with residual beta cell function,Designated,,,N/A,N/A,"Orban Biotech, LLC",64 Aspinwall Avenue,,Brookline,Massachusetts,2446,USA,369912,2013,
idursulfase beta,n/a,2013-02-11,Treatment of Hunter Syndrome (mucopolysaccharidoses),Designated,,,N/A,N/A,Green Cross Corp.,"303 Bojeong-dong, Giheung-gu",446-770,,,,"Korea, Republic of",385712,2013,
testosterone undecanoate (oral),n/a,2013-02-13,Treatment of constitutional delay in growth and puberty in adolescent boys (14-17 yrs of age),Designated,,,N/A,N/A,"Marius Pharmaceuticals, LLC",8601 Six Forks Road,Suite 630,Raleigh,North Carolina,27615,USA,366012,2013,
2-hydroxypropyl-B-cyclodextrin,Kleptose,2013-02-18,"Treatment of Niemann Pick disease, type C.",Designated,,,N/A,N/A,"Vtesse, Inc.",700 Technology Square,Third Floor,Cambridge,Massachusetts,2139,USA,386412,2013,
allogeneic ex-vivo expanded placental adherent stromal cells,n/a,2013-02-18,Treatment of Aplastic Anemia,Designated,,,N/A,N/A,"Novella Clinical, Inc.",MATAM Advanced Technology Park,Haifa 31905,,,,Israel,379512,2013,
Minnelide,Minnelide (Tm),2013-02-18,Treatment of pancreatic cancer,Designated,,,N/A,N/A,"Minneamrita Therapeutics, LLC",6 Hickory Court,,Rock Island,Illinois,61201,USA,388512,2013,
3-bromopyruvate,n/a,2013-03-05,Treatment of liver and intrahepatic bile duct cancer,Designated,,,N/A,N/A,"Primocure Pharma, Inc.",1732 1st Avenue,#23222,New York,New York,10128,USA,390013,2013,
plasminogen (human),n/a,2013-03-05,"Treatment of hypoplasminogenemia, or type I plasminogen deficiency",Designated,,,N/A,N/A,"ProMetic BioTherapeutics, Inc",1330 Piccard Drive,Suite 201,Rockville,Maryland,20850,USA,389112,2013,
recombinant human Naglu- insulin-like growth factor II,n/a,2013-03-05,Treatment of mucopolysaccharidosis type IIIB (Sanfilippo syndrome type B),Designated,,,N/A,N/A,"Shire Human Genetic Therapies, Inc.",300 Shire Way,,Lexington,Massachusetts,2421,USA,388712,2013,
AAV-G6Pase vector,n/a,2013-03-11,Treatment of glycogen storage disease type Ia,Designated,,,N/A,N/A,"GlyGenix Therapeutics, Inc.",15 Research Drive,,Woodbridge,Connecticut,6443,USA,378912,2013,
aerosolized beractant,n/a,2013-03-11,Treatment of respiratory distress syndrome,Designated,,,N/A,N/A,"Beena G. Sood, MD, MS",Wayne State University School of Medicine,Children's Hospital fo MI,Detroit,Michigan,48201,USA,390113,2013,
C66H100N6O27,n/a,2013-03-11,Treatment of of hepatocellular carcinoma,Designated,,,N/A,N/A,"GenSpera, Inc.",2511 North Loop 1604 W,Suite 204,San Antonio,Texas,78258,USA,389613,2013,
His-His-Ile-Tyr-Leu-Gly-Ala-Val-Asn-Tyr-Ile-Tyr,n/a,2013-03-11,Treatment of retinal detachment,Designated,,,N/A,N/A,"ONL Therapeutics, Inc",1600 Huron Parkway,Second Floor,Ann Arbor,Michigan,48109,USA,390313,2013,
recombinant fusion protein consisting of a modified form of the extracellular domain of human activin receptor IIB (ActRIIB) linked to a human IgG1 Fc domain,n/a,2013-03-11,Treatment of B-thalassemia,Designated,,,N/A,N/A,Celgene Corporation,"Corporate Woods Bldg 32, Suite 900",9225 Indian Creek Parkway,Overland Park,Kansas,66210,USA,389813,2013,
transforming growth factor-beta receptor 1 kinase inhibitor,n/a,2013-03-11,Treatment of glioma,Designated,,,N/A,N/A,Eli Lilly and Company,Lilly Corporate Center,,Indianapolis,Indiana,46285,USA,389412,2013,
40K PEGylated recombinant factor IX,n/a,2013-03-18,Routine prophylactic administration for prevention of bleeding in patients with hemophilia B (Christmas disease),Designated,,,N/A,N/A,"Novo Nordisk, Inc.",100 College Road West,,Princeton,,8540,USA,276509,2013,
autologous CD34+ hematopoietic stem cells transduced with LentiGlobin BB305 lentiviral vector encoding the human BA-T87Q-globin gene,n/a,2013-03-18,Treatment of B-thalassemia major and intermedia,Designated,,,N/A,N/A,"bluebird bio, Inc.",60 Binney Street,,Cambridge,Massachusetts,2142,USA,390513,2013,
cell based therapeutic composed of allogeneic donor apoptotic cells,Apocell,2013-03-18,Prevention of graft versus host disease,Designated,,,N/A,N/A,Enlivex Therapeutics Ltd.,POB 12167,Hadassah Ein Kerem,Jerusalem,,,Israel,390213,2013,
chimeric monoclonal antibody against Claudin 6,n/a,2013-03-18,Treatment of ovarian cancer,Designated,,,N/A,N/A,"Astellas Pharma Global Development, Inc.",1 Astellas Way,,Northbrook,Illinois,60062,USA,390613,2013,
neostigmine,n/a,2013-03-18,Treatment of acute colonic pseudo-obstruction,Designated,,,N/A,N/A,"Luitpold Pharmaceuticals, Inc.",One Luitpold Drive,P. O. Box 9001,Shirley,New York,11967,USA,388812,2013,
recombinant elafin,n/a,2013-03-18,Prevention of inflammatory complications of transthoracic esophagectomy,Designated,,,N/A,N/A,Proteo Biotech AG,Am Kiel Kanal 44,D-24106 Kiel,,,,Germany,364612,2013,
recombinant fusion protein consisiting of a modified form of extracellular domain of human Activin receptor IIB,n/a,2013-03-18,Treatment of myelodysplastic syndrome,Designated,,,N/A,N/A,Celgene Corporation,"Corporate Woods Bldg 32, Suite 900",9225 Indian Creek Parkway,Overland Park,Kansas,66210,USA,387112,2013,
sirolimus,n/a,2013-03-18,Treatment of pachyonychia congenita,Designated,,,N/A,N/A,Palvella Therapeutics LLC,515 Red Fox Lane,Suite B,Wayne,Pennsylvania,19087,USA,391013,2013,
N-tert-butyl-3-[(5-methyl-2-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}pyrimidin-4-yl)amino] benzenesulfonamide dihydrochloride monohydrate,n/a,2013-03-21,Treatment of polycythemia vera,Designated,,,N/A,N/A,Impact Biomedicines,12526 High Bluff Drive,Suite 260,San Diego,California,92130,USA,390913,2013,
inotuzumab ozogamicin,n/a,2013-03-25,Treatment of B-cell acute lymphoblastic leukemia,Designated/Approved,Approved for Orphan Indication,Treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL),2017-08-17,2024-08-17,"Pfizer, Inc.",10646 Science Center Drive,,San Diego,California,92121,USA,391413,2013,1606
acamprosate,n/a,2013-03-25,Treatment of fragile X syndrome,Designated,,,N/A,N/A,"Confluence Pharmaceuticals, LLC",Box 528,351 West 10th Street,Indianapolis,Indiana,46202,USA,392413,2013,
liposomal amikacin,Arikace,2013-03-25,Treatment infections caused by non-tuberculous mycobacteria,Designated,,,N/A,N/A,"Insmed, Inc.",10 Finderne Avenue,Building 10,Bridgewater,New Jersey,8817,USA,342011,2013,
neridronate,n/a,2013-03-25,"Treatment of complex regional pain syndrome (CRPS-1, CRPS-II, CRPS-NOS)",Designated,,,N/A,N/A,"Grunenthal USA, Inc.",One Pluckemin Way,,Bedminster,New Jersey,7921,USA,372412,2013,
recombinant adeno- associated virus vector AAV2/rh8 expressing human B-hexosaminidase A and B subunits,n/a,2013-03-25,For the treatment of Sandhoff disease,Designated,,,N/A,N/A,Nat'l Tay-Sachs & Allied Diseases Association,2001 Beacon Street,Suite 204,Boston,Massachusetts,2135,USA,392713,2013,
recombinant adenovirus vector AAV2/rh8 expressing human B-hexosaminidase A & B subunits,n/a,2013-03-25,Treatment of Tay-Sachs disease,Designated,,,N/A,N/A,Na't Tay-Sachs & Allied Diseases Association,2001 Beacon Street,Suite 204,Boston,Massachusetts,2135,USA,392813,2013,
cerliponase alfa,Brineura,2013-04-01,Treatment of neuronal ceroid lipofuscinosis type 2,Designated/Approved,Approved for Orphan Indication,"To slow the progression of loss of ambulation in symptomatic pediatric patients 3 years of age and older with late infantile neuronal ceroid lipofuscinosis type 2 (CLN2), also known as tripeptidyl peptidase 1 (TPP1) deficiency.",2017-04-27,2024-04-27,"BioMarin Pharmaceutical, Inc.",105 Digital Drive,,Novato,California,94949,USA,391913,2013,1487
Kre-Celazine,n/a,2013-04-01,Treatment of juvenile rheumatoid arthritis joint and related tissue inflammation in the pediatric population,Designated,,,N/A,N/A,All American Pharmaceutical & Natural Foods Corpor,2376 Main Street,,Billings,Montana,59105,USA,298309,2013,
transforming growth factor-beta receptor 1 kinase inhibitor,n/a,2013-04-01,Treatment of hepatocellular carcinoma,Designated,,,N/A,N/A,Eli Lilly and Company,Lilly Corporate Center,,Indianapolis,Indiana,46285,USA,378712,2013,
anti-inhibitor coagulant complex,Feiba,2013-04-12,Routine prophylaxis to prevent or reduce the frequency of bleeding episodes in hemophilia A and B patients with inhibitors,Designated/Approved,Approved for Orphan Indication,Routine prophylaxis to prevent or reduce the frequency of bleeding episodes in hemophilia A and B patients with inhibitors,2013-12-16,2020-12-16,"Baxalta US, Inc.",One Baxter Way,,West Lake Village,California,91362,USA,393913,2013,248
givinostat,n/a,2013-04-12,Treatment of Duchenne Muscular Dystrophy and Becker Muscular Dystrophy,Designated,,,N/A,N/A,Italfarmaco SpA,"Via dei Lavoratori, 54",20092 Cinisello Balsamo,,,,Italy,391613,2013,
melatonin,n/a,2013-04-12,Treatment of neonatal hypoxic ischemic encephalopathy,Designated,,,N/A,N/A,Scharper S.p.A.,Viale Ortles 12,,Milan,,,Italy,391313,2013,
recombinant humanized IgG1k monoclonal antibody to human invariant T cell receptor (iTCR),n/a,2013-04-12,Treatment of sickle cell disease,Designated,,,N/A,N/A,"NKT Therapeutics, Inc.",880 Winter Street,Suite 350,Waltham,Massachusetts,2451,USA,391513,2013,
"4-(6-(4-(piperazin-1-yl)phenyl_pyrazolo[1,5-a]pyrimidin-3-yl)quinoline hydrochloride",n/a,2013-04-15,Treatment of fibrodysplasia ossificans progressiva,Designated,,,N/A,N/A,"La Jolla Pharmaceutical Company, Inc.","10182 Telesis Court, Suite 600",,San Diego,California,92121,USA,393513,2013,
brentuximab vedotin,Adcetris,2013-04-15,"Treatment of patients with peripheral T-cell lymphoma, not otherwise specified",Designated,,,N/A,N/A,"Seattle Genetics, Inc.",21823 30th Drive Southeast,,Bothell,Washington,98021,USA,394013,2013,
daunorubicin citrate liposome,Daunoxome,2013-04-15,Treatment of acute myeloid leukemia,Designated/Withdrawn,,,N/A,N/A,Galen Limited,Seagoe Industrial Estate,"Graigavon, BT63 5UA",,,,United Kingdom,393413,2013,
duvelisib,n/a,2013-04-15,Treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma,Designated,,,N/A,N/A,"Verastem, Inc.",117 Kendrick Street,,Needham,Massachusetts,2494,USA,394413,2013,
methylparaben suberohydroxamic acid phenyl ester,n/a,2013-04-15,Treatment of cutaneous T-cell lymphoma,Designated,,,N/A,N/A,Medivir AB,Box 1086,,Huddinge,,,Sweden,292109,2013,
prolactin receptor antagonist,Prolanta,2013-04-15,Treatment of ovarian cancer,Designated,,,N/A,N/A,"Oncolix, Inc.",14405 Walters Road,Suite 780,Houston,Texas,77014,USA,392613,2013,
recombinant human alpha-N-acetylglucosaminidase,n/a,2013-04-15,Treatment of mucopolysaccharidosis IIIB (Sanfilippo B syndrome),Designated/Withdrawn,,,N/A,N/A,"Alexion Pharmaceuticals, Inc.",100 College Street,,Hew Haven,Connecticut,6510,USA,394113,2013,
sdTD-K6a.513a.12; small interfering RNA composed of 2 strands of hybridized RNAs,n/a,2013-04-15,Treatment of pachyonychia congenita,Designated,,,N/A,N/A,"TransDerm, Inc.",2161 Delaware Avenue,,Santa Cruz,,95060,USA,387912,2013,
sodium ascorbate and menadione sodium bisulfite,Apatone,2013-04-15,Treatment of autosomal dominant polycystic liver disease,Designated,,,N/A,N/A,IC-Medtech Corporation,9902 Indian Creek Lane,,El Cajon,California,92021,USA,395413,2013,
sodium ascorbate and menadione sodium bisulfite,Apatone,2013-04-15,Treatment of autosomal dominant polycystic kidney disease,Designated,,,N/A,N/A,IC-MedTech Corporation,9902 Indian Creek Lane,,El Cajon,California,92021,USA,394313,2013,
opioid growth factor,n/a,2013-04-16,Treatment of liver and intrahepatic bile duct cancer,Designated,,,N/A,N/A,"Primocure Pharma, Inc.",1732 1st Avenue,#23222,New York,New York,10128,USA,392213,2013,
tocilizumab,Actemra,2013-04-17,Treatment of systemic sclerosis,Designated,,,N/A,N/A,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,USA,381212,2013,
replication-deficient recombinant serotype 2 adeno-associated viral vector containing hAQP1 cDNA,n/a,2013-05-03,Treatment of symptoms of Grade 2 and Grade 3 late xerostomia from parotid gland hypofunction caused by radiotherapy for cancer of the oral cavity.,Designated,,,N/A,N/A,"MeiraGTx, LLC",450 East 29th Street,15th Floor,New York,New York,10016,USA,365012,2013,
isavuconazonium sulfate,Cresemba,2013-05-06,Treatment of invasive aspergillosis,Designated/Approved,Approved for Orphan Indication,Treatment of invasive aspergillosis in patienst 18 years of age and older,2015-03-06,2022-03-06,Astellas Pharma Global Development Inc.,1 Astellas Way,,Northbrook,Illinois,60062,USA,394913,2013,669
daratumumab,Darzalex,2013-05-06,Treatment of multiple myeloma,Designated/Approved,Approved for Orphan Indication,For the treatment of patients with multiple myeloma who have received at least 3 prior lines of therapy including a proteasome inhibitor and an immunomodulatory agent or are double refractory to a proteasome inhibitor and an immunomodulatory agent,2015-11-16,2022-11-16,"Janssen Biotech, Inc.",920 Route 202 South,PO Box 300,Raritan,New Jersey,8869,USA,397113,2013,924
daratumumab,Darzalex,2013-05-06,Treatment of multiple myeloma,Designated/Approved,Approved for Orphan Indication,"DARZALEX in combination with lenalidomide and dexamethasone, or bortezomib and dexamethasone, for the treatment of patients with multiple myeloma who have received at least one prior therapy.",2016-11-21,2023-11-21,"Janssen Biotech, Inc.",920 Route 202 South,PO Box 300,Raritan,New Jersey,8869,USA,397113,2013,1295
daratumumab,Darzalex,2013-05-06,Treatment of multiple myeloma,Designated/Approved,Approved for Orphan Indication,In combination with pomalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least two prior therapies including lenalidomide and a proteasome inhibitor.,2017-06-16,2024-06-16,"Janssen Biotech, Inc.",920 Route 202 South,PO Box 300,Raritan,New Jersey,8869,USA,397113,2013,1502
adeno associated viral vector serotype rh.10 carrying the human SGSH and SUMF1 cDNAs,n/a,2013-05-06,Treatment of mucopolysaccharidosis type IIIA (Sanfilippo type A syndrome),Designated,,,N/A,N/A,Lysogene,52 rue La Boetie,,Paris,,,France,395813,2013,
budesonide,Uceris,2013-05-06,Treat of ulcerative colitis in pediatric patients aged 0 through 16 years.,Designated,,,N/A,N/A,"Santarus, Inc.","3611 Valley Centre Drive, Suite 400",,San Diego,California,92130,USA,394613,2013,
hepatitis B virus neutralizing human monoclonal antibody,Hepabig Gene,2013-05-06,Prevention of hepatitis B recurrence following liver transplantation,Designated,,,N/A,N/A,Green Cross Corp.,"303, Bojeong-Dong, Giheung-Gu","Gyunggi-Do, 446-770",,,,"Korea, Republic of",395113,2013,
pazopanib,n/a,2013-05-06,Treatment of ovarian cancer.,Designated,,,N/A,N/A,Novartis Pharmaceuticals Corp.,One Health Plaza,,East Hanover,New Jersey,7936,USA,383912,2013,
pexastimogene devacirepvec,n/a,2013-05-06,Treatment of hepatocellular carcinoma,Designated,,,N/A,N/A,"SillaJen Biotherapeutics, Inc.",450 Sansome Street,Suite 200,San Francisco,California,94111,USA,394213,2013,
recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa-FP),n/a,2013-05-06,Treatment of congenital factor VII deficiency which includes treatment and prophylaxis of bleeding episodes in patients with congenital factor VII deficiency,Designated,,,N/A,N/A,CSL Behring,1020 First Avenue,PO Box 61501,King of Prussia,Pennsylvania,19406,USA,396313,2013,
teprotumumab,n/a,2013-05-06,Treatment of active (dynamic) phase Grave's orbitopathy,Designated,,,N/A,N/A,"Horizon Pharma USA, Inc.",150 South Saunders Road,,Lake Forest,Illinois,60045,USA,387812,2013,
zoledronic acid,"Zometa, Reclast, Aclasta",2013-05-06,Treatment of complex regional pain syndrome (CRPS).,Designated,,,N/A,N/A,"Axsome Therapeutics, Inc.",45 Rockefeller Plaza,Suite 2000,New York,New York,10111,USA,374112,2013,
2-[4-Methoxy-3-(2-m-tolyl-ethoxy)-benzoylamino]-indian-2-carboxylic acid,n/a,2013-05-14,Treatment of patients with systemic sclerosis,Designated,,,N/A,N/A,"Sanofi U. S., Inc.",55 Corporate Drive,,Bridgewater,New Jersey,8807,USA,393813,2013,
"3,5-diiodothyropropionic acid",n/a,2013-05-14,Treatment of Allan-Herndon-Dudley syndrome,Designated,,,N/A,N/A,Zarion Pharmaceuticals P/L,8 Grandview Grove,Sassafras 3787,Victoria,,,Australia,395613,2013,
DCVAC OvCa,n/a,2013-05-14,Treatment of ovarian cancer,Designated,,,N/A,N/A,SOTIOS a.s.,Jankovcova 1518/2,170 00 Praha 7,,,,Czech Republic,393213,2013,
H-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-alys-aleu-Ser-Ser-Ile-Glu-Ser-Asp-Val-OH,n/a,2013-05-14,Treatment of subarachnoid hemorrhage,Designated,,,N/A,N/A,"NoNO, Inc.",399 Bathurst Street,Toronto M5T 2S8,Ontario,,,Canada,377812,2013,
rociletinib,n/a,2013-05-14,Treatment of non-small cell lung cancer and mutations in the epidermal growth factor receptor,Designated,,,N/A,N/A,"Clovis Oncology, Inc.",5500 Flatiron Parkway,Suite 100,Boulder,Colorado,80301,USA,380212,2013,
HIRMAb-IDS,n/a,2013-05-15,Treatment of mucopolysaccharidosis Type II (Hunter Syndrome),Designated,,,N/A,N/A,"ArmaGen Technologies, Inc.",914 Colorado Avenue,,Santa Monica,California,90401,USA,396913,2013,
ibrutinib,n/a,2013-05-16,Treatment of multiple myeloma,Designated,,,N/A,N/A,"Pharmacyclics, LLC",995 E. Arques Avenue,,Sunnyvale,California,94085,USA,397313,2013,
terguride,"Mysalfon, Teluron",2013-05-17,Treatment of systemic sclerosis,Designated,,,N/A,N/A,Medac GmbH,TheaterstraBe 6+,,Wedel,,,Germany,380512,2013,
ibrutinib,Imbruvica,2013-05-30,Treatment of small lymphocytic lymphoma,Designated/Approved,Approved for Orphan Indication,For treatment of patients with small lymphocytic lymphoma (SLL),2016-05-06,2023-05-06,"Pharmacyclics, LLC",995 E. Arques Avenue,,Sunnyvale,California,94085,USA,395513,2013,1072
abatacept,Orencia,2013-05-30,Treatment of type 1 diabetes mellitus patients with residual beta cell function,Designated,,,N/A,N/A,Orban Biotech LLC,64 Aspinwall Avenue,,Brookline,Massachusetts,2446,USA,395713,2013,
diazepam auto-injector,n/a,2013-05-30,"Management of selected, refractory patients with epilepsy on stable regimens of antiepileptic drugs, who require intermittent use of diazepam to control bouts of increased seizure activity",Designated,,,N/A,N/A,Meridian Medical Technologies-a Pfizer subsidiary,445 Eastern Point Road,,Groton,Connecticut,6340,USA,384112,2013,
modified recombinant human Factor VIIa (rFVIIa) molecule,n/a,2013-05-30,Treatment of bleeding episodes in hemophilia A or B subjects with inhibitors,Designated/Withdrawn,,,N/A,N/A,"Bayer Healthcare Pharmaceuticals, Inc.",100 Bayer Boulevard,,Whippany,New Jersey,7981,USA,396213,2013,
"(1-methyl-2-nitro-1H-imidazole-5-yl)methyl N,N'-bis(2-broethyl) diamidophosphate",n/a,2013-06-05,Treatment of pancreatic cancer,Designated,,,N/A,N/A,EMD Serono,One Technology Place,,Rockland,Massachusetts,2370,USA,396513,2013,
human interleukin-3 genetically conjugated to diphtheria toxin protein,n/a,2013-06-06,Treatment of blastic plasmacytoid dendritic cell neoplasm,Designated,,,N/A,N/A,"Stemline Therapeutics, Inc.",750 Lexington Avenue,11 th Floor,New York,New York,10022,USA,397413,2013,
sodium phenylbutyrate,Pheburane,2013-06-06,Treatment of urea cycle disorders,Designated,,,N/A,N/A,Lucane Pharma SA,172 rue de Charonne,,Paris,,,France,372112,2013,
Multi-peptide cancer vaccine,n/a,2013-06-23,Treatment of multiple myeloma,Designated,,,N/A,N/A,"OncoPep, Inc.",520 Boston Street,,North Andover,Massachusetts,1845,USA,392313,2013,
(S)-4-(5-chloro-2-(isopropylamino)pyridin-4-yl)-N-(1-(3-chlorophenyl)-2-hydroxyethyl)-1H-pyrrole-2-carboxamide hydrochloride,n/a,2013-06-24,Treatment of Stage IIb through Stage IV BRAF mutant melanoma,Designated,,,N/A,N/A,"BioMed Valley Discoveries, Inc.",4520 Main Street,16th Floor,Kansas City,Missouri,64111,USA,398213,2013,
"cyclo(-y-aminobutyryl-L-phenylalanyl-L-tryptophanyl-D-tryptophanyl-L-lysyl-L-threonly-L-phenylalanyl-N-3-carboxypropyl)-glycine amide, acetate salt",n/a,2013-06-24,Treatment of acromegaly,Designated,,,N/A,N/A,Cortendo AB,900 Northbrook Drive,,Trevose,Pennsylvania,19053,USA,397713,2013,
eculizumab,Soliris,2013-06-24,Treatment of neuromyelitis optica,Designated,,,N/A,N/A,"Alexion Pharmaceuticals, Inc.",100 College Street,,New Haven,Connecticut,6510,USA,398713,2013,
flunarizine,n/a,2013-06-24,Treatment of alternating hemiplegia,Designated/Withdrawn,,,N/A,N/A,"Marathon Pharmaceuticals, LLC",1033 Skokie Blvd.,Suite 600,Northbrook,Illinois,60062,USA,398513,2013,
Humanized 3F8-IgG1 monoclonal antibody,n/a,2013-06-24,Treatment of neuroblastoma,Designated,,,N/A,N/A,"Y-mAbs Therapeutics, Inc.",750 3rd Avenue,9th Floor,New York,New York,10017,USA,399613,2013,
IL-12 secreting dendritic cells loaded with autologous tumor lysate,n/a,2013-06-24,Treatment of malignant glioma,Designated,,,N/A,N/A,Activartis Biotech GmbH,1090 Vienna,Zimmermannplatz 10,,,,Austria,377012,2013,
liposomal busulfan,Busulipo,2013-06-24,For use as a conditioning regimen for patients with malignancies undergoing autologous or allogenic hematopoietic stem cell transplantation,Designated,,,N/A,N/A,Pharmalink AB,Engelbrekts kyrkogata 7B,SE-114 26 Stockholm,,,,Sweden,394513,2013,
intravenous carbamazepine,Carnexiv,2013-06-27,Treatment of epilepsy patients who cannot take anything by mouth (NPO),Designated/Approved,Approved for Orphan Indication,"Replacement therapy for oral carbamazepine formulations, when oral administration is temporarily not feasible, in adults with the following seizure types: (1) Partial seizures with complex symptomology; (2)Generalized clonic-tonic seizures; and (3) Mixed seizure patterns which include the above or other partial or generalized seizures",2016-10-07,2023-10-07,Lundbeck LLC,Four Parkway North,,Deerfield,Illinois,60015,USA,265508,2013,1198
human platelet antigen-1a immunoglobulin (anti-HPA-1a),Tromplate,2013-06-27,Prevention of fetal and neonatal alloimmune thrombocytopenia,Designated,,,N/A,N/A,Prophylix Pharma AS,Forskningsparken,9292,Tromso,,,Norway,398413,2013,
moxetumomab pasudotox,n/a,2013-06-28,Treatment of acute lymphoblastic leukemia,Designated,,,N/A,N/A,"MedImmune, LLC",One MedImmune Way,,Gaithersburg,Maryland,20878,USA,396813,2013,
repository corticortropin injection,H.P. Acthar Gel,2013-06-28,Treatment of amyotrophic lateral sclerosis,Designated,,,N/A,N/A,"Mallinckrodt Pharmaceuticals, Inc.",Perryville III Corporate Park,P. O. Box 9001,Hampton,New Jersey,8827,USA,399113,2013,
alisertib,n/a,2013-07-12,Treatment of small cell lung cancer,Designated,,,N/A,N/A,"Millennium Pharmaceuticals, Inc.",40 Landsdowne Street,,Cambridge,Massachusetts,2139,USA,400313,2013,
allopregnanolone,n/a,2013-07-12,"Treatment of Neimann-Pick disease, type C",Designated,,,N/A,N/A,"La Jolla Pharmaceutical Company, Inc.",10182 Telesis Court,"6th Floor, Suite 600",San Diego,California,92121,USA,399013,2013,
denileukin diftitox,n/a,2013-07-12,Treatment of cutaneous T-cell lymphoma,Designated,,,N/A,N/A,Eisai Inc.,155 Tice Blvd,,Woodcliff Lake,New Jersey,7677,USA,341311,2013,
pertuzumab,n/a,2013-07-12,"Treatment of gastric cancer, including gastroesophageal junction cancer",Designated,,,N/A,N/A,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,USA,400713,2013,
N-methyl-4-({4-[({3-methyl(methylsulfonyl)amino]pyrazin-2-yl}methyl)amino]-5-(trifluoromethyl)pyrimidin-2-yl}amino)benzamide hydrochloride,n/a,2013-07-18,Treatment of mesothelioma,Designated,,,N/A,N/A,"Verastem, Inc.",117 Kendrick Street,Suite 500,Needham,Massachusetts,2494,USA,393313,2013,
hydroxycarbamide (hydroxyurea),Siklos,2013-07-24,Treatment of sickle cell disease in patients under 18 years of age,Designated/Approved,Approved for Orphan Indication,"To reduce the frequency of painful crises and to reduce the need for blood transfusions in pediatric patients, 2 years of age amd older, with sickle cell anemia with recurrent moderate to severe painful crisis",2017-12-21,TBD,addmedica Laboratories,37 rue de Caumartin,,Paris,,,France,400413,2013,1611
"(5R)-5-(4-{[2-fluorophenyl)methyl]oxy}phenyl)-L-prolinamide, hydrochloride",n/a,2013-07-24,Treatment of trigeminal neuralgia,Designated,,,N/A,N/A,"Biogen, Inc.",300 Binney Street,,Cambridge,Massachusetts,2142,USA,401613,2013,
bezafibrate,Bezalip,2013-07-24,For therapeutic treatment of Barth syndrome,Designated,,,N/A,N/A,"Barth Sydrome Foundation, Inc.",P. O. Box 618,,Larchmont,New York,10538,USA,400013,2013,
"granulocyte-macrophage colony stimulating factor-coding oncolytic adenovirus, Ad5/3-D24-GMCSF",n/a,2013-07-24,Treatment of soft tissue sarcoma,Designated,,,N/A,N/A,Targovax OY,Saukonpaadenranta 2,,Helsinki,,,Finland,399513,2013,
topiramate injection,n/a,2013-07-24,Treatment of partial onset or primary generalized tonic-clonic seizures for hospitalized epilepsy patients or epilepsy patients being treated in an emergency care setting who are unable to take oral topiramate,Designated,,,N/A,N/A,"CURx Pharmaceuticals, Inc.",3210 Merryfield Row,,San Diego,California,92121,USA,283909,2013,
angiotensin (1-7)[A(1-7)],n/a,2013-07-25,Treatment of Duchenne muscular dystrophy,Designated,,,N/A,N/A,Tarix Pharmaceuticals Ltd.,12 Bow Street,,Cambridge,Massachusetts,2138,USA,400813,2013,
sulthiame,n/a,2013-07-25,Treatment of patients with benign epilepsy of childhood with centrotemporal spikes (BECTS) also known as rolandic epilepsy,Designated/Withdrawn,,,N/A,N/A,"Marathon Pharmaceuticals, LLC","1033 Skokie Blvd.,",Suite 600,Northbrook,Illinois,60062,USA,401213,2013,
(S)-3-(1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1(2H)-one,n/a,2013-08-01,Treatment of follicular lymphoma,Designated,,,N/A,N/A,"Verastem, Inc.",117 Kendrick Street,,Needham,Massachusetts,2494,USA,399913,2013,
L. reuteri,n/a,2013-08-01,"Prevention of necrotizing enterocolitis in preterm infants with birth weight less than or equal to 1,500 grams",Designated,,,N/A,N/A,Infant Bacterial Therapeutics,Kungsbroplan 3A,P. O. Box 3242,Stockholm,,,Sweden,393013,2013,
Conjugate of a dengue virus specific small chemical ligand and an amphiphilic PEG based polymer,n/a,2013-08-06,Treatment of dengue fever (includes dengue hemorrhagic fever and dengue shock syndrome),Designated,,,N/A,N/A,NanoViricides Incorporated,"135 Wood Street, Suite 205",,West Haven,Connecticut,6516,USA,402313,2013,
Human Hemin,n/a,2013-08-06,Prevention of ischemia reperfusion injury in patients undergoing solid organ transplantation,Designated,,,N/A,N/A,Borders Technology Management Ltd,2 Broomlee Mains Court,"Peeblesshire, EH467JG",Scotland,,,United Kingdom,402413,2013,
bispecific antibody (monoclonal antibody),n/a,2013-08-08,Treatment of HER2-expressing advanced adenocarcinoma of the stomach and gastroesophageal junction,Designated,,,N/A,N/A,"Merrimack Pharmaceuticals, inc.",One Kendall Square,Suite B7201,Cambridge,Massachusetts,2139,USA,401413,2013,
bispecific antibody (monoclonmal antibody),n/a,2013-08-08,Treatment of HER2-expressing adenocarcinoma of the esophagus,Designated,,,N/A,N/A,"Merrimack Pharmaceuticals, Inc.",1 Kendall Square,Suite B7201,Cambridge,Massachusetts,2139,USA,401113,2013,
recombinant human nerve growth factor,n/a,2013-08-08,Treatment of retinitis pigmentosa,Designated,,,N/A,N/A,Dompe s.p.a.,"Via S. Martino 12-12/A, 20122",,Milan,,,Italy,402013,2013,
small molecule inhibitor of histone methyltransferase DOT1L,n/a,2013-08-08,Treatment of acute lymphoblastic leukemia (ALL),Designated,,,N/A,N/A,Epizyme Inc.,"400 Technology Square, 4th Floor",,Cambridge,Massachusetts,2139,USA,402213,2013,
uridine triacetate,n/a,2013-08-09,Treatment of hereditary orotic aciduria,Designated/Approved,Approved for Orphan Indication,Treatment of hereditary orotic aciduria,2015-09-04,2022-09-04,"Wellstat Therapeutics, Inc.",14200 Shady Grove Road,Suite 600,Rockville,Maryland,20850,USA,401013,2013,756
ADXS11-001,n/a,2013-08-12,Treatment of HPV-positive associated anal cancer,Designated,,,N/A,N/A,"Advaxis, Inc.",305 College Road East,,Princeton,New Jersey,8540,USA,401813,2013,
pentamidine,n/a,2013-08-12,Treatment of liver and intrahepatic bile duct cancer,Designated/Withdrawn,,,N/A,N/A,"Verlyx Pharma, Inc.","555 Rene-Levesque West, 9th Floor","Montreal, Quebec H2Z 1B1",,,,Canada,389312,2013,
pentamidine,n/a,2013-08-12,Treatment of ovarian cancer,Designated/Withdrawn,,,N/A,N/A,"Oncozyme Pharma, Inc.",555 Rene-Levesque West,"Montreal, Quebec H2Z 1B1",,,,Canada,389212,2013,
synthetic double-stranded siRNA oligonucleotide against antithrombin mRNA,n/a,2013-08-12,Treatment of hemophilia B,Designated,,,N/A,N/A,Genzyme Corporation,500 Kendall Street,,Cambridge,Massachusetts,2142,USA,402913,2013,
small molecule inhibitor of histone methyltransferase DOT1L,n/a,2013-08-15,Treatment of Acute Myeloid Leukemia,Designated,,,N/A,N/A,Epizyme Inc.,"400 Technology Square, 4th Floor",,Cambridge,Massachusetts,2139,USA,402113,2013,
dantrolene sodium suspension for injection,Ryanodex,2013-08-16,Treatment of malignant hyperthermia syndrome,Designated/Approved,Approved for Orphan Indication,Treatment of malignant hyperthermia in conjunction with appropriate supportive measures and for the prevention of malignant hyperthermia in patients at high risk.,2014-07-22,2021-07-22,"Eagle Pharmaceuticals, Inc.",50 Tice Blvd,Suite 315,Woodcliff Lake,New Jersey,7677,USA,179703,2013,340
deflazacort,Emflaza,2013-08-16,Treatment of Duchenne muscular dystrophy,Designated/Approved,Approved for Orphan Indication,Treatment of Duchenne Muscular Dystrophy in patients 5 years of age and older,2017-02-09,2024-02-09,"PTC Therapeutics, Inc.",100 Corporate Court,,South Plainfield,New Jersey,7080,USA,403413,2013,1273
ruxolitinib,Jakafi,2013-08-16,Treatment of pancreatic cancer,Designated,,,N/A,N/A,Incyte Corporation,Experimental Station,"Bldg 400, Rm 6220A",Wilmington,Delaware,19880,USA,400613,2013,
synthetic double-stranded siRNA oligonucleotide against antithrombin (AT) mRNA,n/a,2013-08-16,Treatment of hemophilia A,Designated,,,N/A,N/A,Genzyme Corporation,500 Kendall Street,,Cambridge,Massachusetts,2142,USA,402813,2013,
expanded human allogeneic neural retinal progenitor cells extracted from neural retina,n/a,2013-08-22,Treatment of retinitis pigmentosa,Designated,,,N/A,N/A,ReNeuron Ltd,Pencod Business Park,"Pencod, Bridgend",,,,United Kingdom,402613,2013,
pomalidomide,n/a,2013-08-22,Treatment of systemic sclerosis,Designated/Withdrawn,,,N/A,N/A,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,USA,363212,2013,
angiotensin (1-7),n/a,2013-08-30,Treatment of patients requiring stem cell transplantation to accelerate the mobilization of hematopoietic stem cells (CD34+) from the bone marrow to the peripheral blood when combined with a granulocyte colony-stimulating factor,Designated,,,N/A,N/A,"US Biotest, Inc.","231 Bonetti Dr.,",Suite 240,San Luis Obispo,California,93401,USA,402713,2013,
trebananib,n/a,2013-08-30,Treatment of ovarian cancer,Designated,,,N/A,N/A,"Amgen, Inc.",One Amgen Center Drive,,Thousand Oaks,California,91320,USA,403313,2013,
"(4R,5R)-1-[[4-[[4-[3,3-Dibutyl-7-(dimethylamino)-2,3,4,5-tetrahydro-4-hydroxy-1,1-dioxido-1-benzothiepin-5-yl]phenoxy]methyl]phenyl]methyl]-4-aza-l-azoniabicyclo[2.2.2]octane Chloride",n/a,2013-09-04,Treatment of primary sclerosing cholangitis,Designated,,,N/A,N/A,"Shire Human Genetic Therapies, Inc.",300 Shire Way,,Lexington,California,2421,USA,406213,2013,
"(4R,5R)-1-[[4-[[4-[3,3-Dibutyl-7-(dimethylamino)-2,3,4,5-tetrahydro-4-hydroxy-1,1-dioxido-1-benzothiepin-5-yl]phenoxy]methyl]phenyl]methyl]-4-aza-l-azoniabicyclo[2.2.2]octane Chloride",n/a,2013-09-04,Treatment of alagille syndrome,Designated,,,N/A,N/A,"Shire Human Genetic Therapies, Inc.",300 Shire Way,,Lexington,Massachusetts,2421,USA,401513,2013,
"(4R,5R)-1-[[4-[[4-[3,3-Dibutyl-7-(dimethylamino)-2,3,4,5-tetrahydro-4-hydroxy-1,1-dioxido-1-benzothiepin-5-yl]phenoxy]methyl]phenyl]methyl]-4-aza-l-azoniabicyclo[2.2.2]octane Chloride",n/a,2013-09-04,Treatment of primary biliary cirrhosis,Designated,,,N/A,N/A,"Shire Human Genetic Therapies, Inc.",300 Shire Way,,Lexington,Massachusetts,2421,USA,406113,2013,
fenretinide,n/a,2013-09-04,Treatment of peripheral T-cell lymphoma,Designated,,,N/A,N/A,"CerRx, Inc.",Reese Technology Center,"9801 Reese Blvd, Suite 104",Lubbock,Texas,79416,USA,404013,2013,
fenretinide,n/a,2013-09-04,Treatment of cutaneous T-cell lymphoma,Designated,,,N/A,N/A,"CerRx, Inc.",Reese Technology Center,"9801 Reese Blvd, Suite 104",Lubbock,Texas,79416,USA,409913,2013,
maralixibat,n/a,2013-09-04,Treatment of progressive familial intrahepatic cholestasis,Designated,,,N/A,N/A,"Shire Human Genetic Therapies, Inc.",300 Shire Way,,Lexington,Massachusetts,2421,USA,406013,2013,
"sodium sulfate, potassium sulfate, and magnesium sulfate; PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride",Suclear,2013-09-04,For use in cleansing of the colon in preparation for colonoscopy in children and adolescents,Designated,,,N/A,N/A,"Braintree Laboratories, Inc.",60 Columbian Street West,P.O. Box 850929,Braintree,Massachusetts,2185,USA,403513,2013,
listeria monocytogenes,n/a,2013-09-05,Treatment of pancreatic cancer,Designated,,,N/A,N/A,"Aduro BioTech, Inc.",740 Heinz Avenue,,Berkeley,California,94710,USA,386212,2013,
selective antagonist of the chemokine receptor type 4,n/a,2013-09-05,Treatment of acute myeloid leukemia,Designated,,,N/A,N/A,"BioLineRx, Ltd.",Modi'in Technology Park,2 HaMa'ayan Street,Modi'in 7177871,,,Israel,403213,2013,
ublituximab,n/a,2013-09-05,"Treatment of Extranodal marginal zone lymphoma (mucosa-associated lymphatic tissue, MALT)",Designated,,,N/A,N/A,"TG Therapeutics, Inc.","787 Seventh Avenue, 48th Floor",,New York,New York,10019,USA,403813,2013,
ublituximab,n/a,2013-09-05,Treatment of Nodal marginal zone lymphoma,Designated,,,N/A,N/A,"TG Therapeutics, Inc.","787 Seventh Avenue, 48th Floor",,New York,New York,10019,USA,410913,2013,
bendamustine hydrochloride with betadex sulfobutyl ether sodium,n/a,2013-09-10,Treatment of chronic lymphocytic leukemia,Designated,,,N/A,N/A,"Supratek Pharma, Inc.",6100 Royalmount Avenue,H4P 2R2,Quebec,,,Canada,386612,2013,
denosumab,Xgeva,2013-09-11,Treatment of hypercalcemia in malignancy,Designated/Approved,Approved for Orphan Indication,To treat hypercalcemia of malignancy refractory to biphosphonate therapy.,2014-12-05,2021-12-05,"Amgen, Inc.",One Amgen Center Drive,MS 17-2-C,Thousand Oaks,California,91320,USA,404213,2013,450
cysteamine,n/a,2013-09-11,Treatment of pancreatic cancer,Designated,,,N/A,N/A,"Horizon Pharma USA, Inc.",150 S. Saunders Road,,Lake Forest,Illinois,60045,USA,404613,2013,
dehydrated alcohol,Ablysinol,2013-09-11,Treatment of hypertrophic obstructive cardiomyopathy,Designated,,,N/A,N/A,"Belcher Pharmaceuticals, LLC",6911 Bryan Dairy Road,,Largo,Florida,33777,USA,402513,2013,
dimethyl fumarate,n/a,2013-09-11,Treatment of Friedreich's Ataxia,Designated,,,N/A,N/A,"Ixchel Pharma, LLC",608 12th Street,,Davis,California,95616,USA,406713,2013,
human glial restricted progenitor cells and their progeny,Q-Cells,2013-09-11,Treatment of amyotrophic lateral sclerosis,Designated,,,N/A,N/A,"Q Therapeutics, Inc.",615 Arapeen Drive,Suite 102,Salt Lake City,Utah,84108,USA,406513,2013,
L-arginyl-L-isoleucyl-L-valyl-L-prolyl-L-alanine-amide,n/a,2013-09-11,Treatment of acute radiation syndrome,Designated,,,N/A,N/A,"Soligenix, Inc.",29 Emmons Drive,Suite C-10,Princeton,New Jersey,8540,USA,395913,2013,
Nitric oxide,n/a,2013-09-11,Treatment of cystic fibrosis,Designated,,,N/A,N/A,"Novoteris, LLC",7245 Garden Grove Blvd.,Suite C,Garden Grove,California,92841,USA,403613,2013,
evolocumab,Repatha,2013-09-12,Treatment of homozygous familial hypercholesterolemia,Designated/Approved,Approved for Orphan Indication,"As an adjunct to diet and other LDL-lowering therapies (e.g., statins, ezetimibe, LDL apheresis) in patients with HoFH who require additional lowering of LDL-C.",2015-08-27,2022-08-27,Amgen Inc.,One Amgen Center Drive,M/S 17 2 B,Thousand Oaks,California,91320,USA,404113,2013,714
"aadeno-associated viral vector, serotype 2, containing the human choroideremia gene encoding human Rab escort protein 1",n/a,2013-09-12,Treatment of choroideremia due to mutations in the human choroideremia gene (CHM),Designated,,,N/A,N/A,"Sparks Therapeutics, Inc.",3737 Market Street,Suite 1300,Philadelphia,Pennsylvania,19104,USA,404713,2013,
anti-CD3 mAb (SPV-T3a)-ricin A chain fusion protein and anti-CD7 mAb (WT1)-ricin A chain fusion protein,n/a,2013-09-13,Treatment of graft versus host disease,Designated,,,N/A,N/A,Xenikos BV,Molenveldlaan 152A,6523RN,NIJMEGEN,,,Netherlands,405013,2013,
autologous ex vivo expanded CD4+-enriched leukocytes treated with the de-methylating agent 5-aza-2Ã¢â¿¬â¿¢-deoxycytidine,Alecsat,2013-09-13,Treatment of glioblastoma multiforme,Designated,,,N/A,N/A,CytoVac A/S,Science & Technology Park Scion DTU,DK-2970,Horsholm,,,Denmark,405513,2013,
brentuximab vedotin,Adcetris,2013-09-13,Treatment of patients with angioimmunoblastic T-cell lymphoma,Designated,,,N/A,N/A,"Seattle Genetics, Inc.",21823 30th Drive Southeast,,Bothell,Washington,98021,USA,404913,2013,
melarsoprol-hydroxypropylbetadex,n/a,2013-09-13,Treatment of human African trypanosomiasis (sleeping sickness),Designated,,,N/A,N/A,"Peter Kennedy, CBE, MD, PhD, DSc, FRCP FMedSci,","Glasgow University, Neurology Dept., Institute of","Neurlogy Block, Southern General Hospital-G51 4TF",Glasgow,,,United Kingdom,406613,2013,
osilodrostat,n/a,2013-09-13,Treatment of Cushing's disease,Designated,,,N/A,N/A,Novartis Pharmaceuticals corporation,One Health Plaza,Bldg 104,East Hanover,New Jersey,7936,USA,405113,2013,
lenalidomide,Revlimid,2013-09-17,Treatment of follicular lymphoma,Designated,,,N/A,N/A,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,USA,390813,2013,
riociguat,Adempas,2013-09-19,Treatment of chronic thromboembolic pulmonary hypertension,Designated/Approved,Approved for Orphan Indication,"Treatment of adults with persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH) WHO Group 4, after surgical treatment, or inoperable CTEPH, to improve exercise capacity and WHO functional class",2013-10-08,2020-10-08,"Bayer HealthCare Pharmaceuticals, Inc.",100 Bayer Blvd.,,Whippany,New Jersey,7981,USA,406913,2013,19
riociguat,Adempas,2013-09-19,Treatment of pulmonary arterial hypertension.,Designated/Approved,Approved for Orphan Indication,"Treatment of adults with pulmonary arterial hypertension (PAH) WHO Group 1, to improve exercise capacity, WHO functional class and to delay clinical worsening.",2013-10-08,2020-10-08,"Bayer HealthCare Pharmaceuticals, Inc.",100 Bayer Blvd.,,Whippany,New Jersey,7981,USA,392113,2013,19
anti-sense oligonucleotide consisting of 2’0-Me RNA with a phosphorothioate backbone,n/a,2013-09-23,Treatment of cystic fibrosis,Designated,,,N/A,N/A,ProQR Therapeutics III B.V.,"Zernikedreef 9, 2333 CK Leiden",The Netherlands,,,,Netherlands,403713,2013,
ethiodized oil injection,Lipiodol,2013-09-26,Management of patients with known hepatocellular carcinoma (HCC),Designated/Approved,Approved for Orphan Indication,Selective hepatic intra-arterial use for imaging tumors in adults with known hepatocellular carcinoma (HCC),2014-04-04,2021-04-04,Guerbet LLC,"120 West 7th St., Suite 108",,Bloomington,Indiana,47404,USA,400113,2013,190
idelalisib,Zydelig,2013-09-26,Treatment of follicular lymphoma,Designated/Approved,Approved for Orphan Indication,Relapsed follicular B-cell non-Hodgkin lymphoma (FL) in patients who have received at least two prior systemic therapies.,2014-07-23,2021-07-23,"Gilead Sciences, Inc.",199 E. Blaine St,,Seattle,Washington,98102,USA,405813,2013,300
"1-(4-benzhydrylpiperazin-1-yl)-3,3-diphenylpropan-1-one",n/a,2013-09-26,Management of postherpetic neuralgia,Designated/Withdrawn,,,N/A,N/A,Zalicus Pharmaceuticals Ltd.,245 First Street,,Cambridge,Massachusetts,2142,USA,387412,2013,
"6,8-bis-benzylsulfanyl-octanoic acid",n/a,2013-09-26,Treatment of myelodysplastic syndrome,Designated,,,N/A,N/A,"Cornerstone Pharmaceuticals, Inc.",25 Health Science Drive,,Stony Brook,New Mexico,11790,USA,406813,2013,
bacterium Bacteroides thetaiotaomicron,n/a,2013-09-26,Treatment of active Crohn's disease in the pediatric population,Designated,,,N/A,N/A,4D Pharma Research Ltd,Life Sciences Innovation Bldg.,Cornhill Rd.,,,,United Kingdom,308110,2013,
chimeric monoclonal antibody against claudin-18 splice variant 2,n/a,2013-09-26,Treatment of pancreatic cancer,Designated,,,N/A,N/A,Astellas Pharma Global Development Inc.,1 Astellas Way,,Northbrook,Illinois,60062,USA,407813,2013,
dovitinib,n/a,2013-09-26,Treatment of adenoid cystic carcinoma,Designated,,,N/A,N/A,Novartis Pharmaceuticals Corporation,"One Health Plaza, Bldg 315",,East Hanover,New Jersey,7936,USA,388012,2013,
idelalisib,n/a,2013-09-26,Treatment of lymphoplasmacytic lymphoma with or without Walenstrom's macroglobulinemia,Designated,,,N/A,N/A,"Gilead Sciences, Inc.",199 E. Blaine St,,Seattle,Washington,98102,USA,405713,2013,
manganese (II) chloride tetrahydrate (with L-alanine and vitamin D3 as promoters of absorption),n/a,2013-09-26,Use as a targeted contrast agent for diagnostic MRI for the detection and localization of focal liver lesions in patients where use of gadolinium based contrast agents may be medically inadvisable or where gadolinium based contrast agents cannot be administered,Designated,,,N/A,N/A,Ascelia Pharma AB,Scion DTU,DK-2800 Lyngby,,,,Denmark,342911,2013,
melphalan hydrochloride,n/a,2013-09-26,Treatment of patients with hepatocellular carcinoma,Designated,,,N/A,N/A,"Delcath Systems, Inc.",1301 6th Avenue,43rd Floor,New York,New York,10019,USA,405413,2013,
small molecule inhibitor of phosphodiesterase 10,n/a,2013-09-26,Treatment of Huntington's disease,Designated,,,N/A,N/A,Omeros Corporation,201 Elliott Avenue West,,Seattle,Washington,98119,USA,400213,2013,
ceritinib,Zykadia,2013-09-27,Treatment of patients with non-small cell lung cancer (NSCLC) that is anaplastic lymphoma kinase(ALK)-positive,Designated/Approved,Approved for Orphan Indication,Treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) who have progressed on or are intolerant to crizotinib.,2014-04-29,2021-04-29,Novartis Pharmaceuticals Corp.,One Health Plaza,,East Hanover,New Jersey,7936,USA,405213,2013,214
ceritinib,Zykadia,2013-09-27,Treatment of patients with non-small cell lung cancer (NSCLC) that is anaplastic lymphoma kinase(ALK)-positive,Designated/Approved,Approved for Orphan Indication,Treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test,2017-05-26,2024-05-26,Novartis Pharmaceuticals Corp.,One Health Plaza,,East Hanover,New Jersey,7936,USA,405213,2013,1337
"self-complimentary adeno-associated virus vector, serotype 9, packaging the full lenght GAN gene in the viral capsid",n/a,2013-09-27,Treatment of Giant Axonal Neuropathy,Designated,,,N/A,N/A,Hannah's Hope Fund,19 Blue Jay Way,,Rexford,New York,12148,USA,408813,2013,
idelalisib,Zydelig,2013-10-15,Treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma,Designated/Approved,Approved for Orphan Indication,"(1) Relapsed chronic lymphocytic leukemia (CLL), in combination with rituximab, in patients for whom rituximab alone would be considered appropriate therapy due to other co-morbidities; and (2) Relapsed small lymphocytic lymphoma (SLL) in patients who have received at least two prior systemic therapies.",2014-07-23,2021-07-23,"Gilead Sciences, Inc.",199 E. Blaine St,,Seattle,Washington,98102,USA,405913,2013,281
ibrutinib,Imbruvica,2013-10-15,Treatment of Waldenstrom's macroglobulinemia,Designated/Approved,Approved for Orphan Indication,Treatment of patients with Waldenstrom's macroglobulinemia,2015-01-29,2022-01-29,"Pharmacyclics, LLC",995 E. Arques Avenue,,Sunnyvale,California,94085,USA,407413,2013,471
6-amino-5-chloro-N-[1R)-1-[5-[[[5-hloro-4-(trifluoromethyl)-2pyridinyl]amino]carbonyl]-2-thiazoyl]ethyl]-4-pyrimdinecarboxamide,n/a,2013-10-15,Treatment of stage IIb-IV melanoma,Designated,,,N/A,N/A,"Millennium Pharmaceuticals, Inc.",40 Landsdowne Street,,Cambridge,Massachusetts,2139,USA,410813,2013,
human monoclonal antibody againt human interleukin 13 (IL-13),n/a,2013-10-15,Treatment of eosinophilic esophagitis,Designated,,,N/A,N/A,Novartis Pharmaceuticals Corporaton,One Health Plaza,,East Hanover,New Jersey,7936,USA,408513,2013,
idelalisib,n/a,2013-10-15,Treatment of splenic marginal zone lymphoma,Designated,,,N/A,N/A,"Gilead Sciences, Inc.",199 E. Blaine St,,Seattle,Washington,98102,USA,412613,2013,
idelalisib,n/a,2013-10-15,Treatment of extranodal marginal zone lymphoma,Designated,,,N/A,N/A,"Gilead Sciences, Inc.",199 E. Blaine St,,Seattle,Washington,98102,USA,405613,2013,
idelalisib,n/a,2013-10-15,Treatment of nodal marginal zone lymphoma.,Designated,,,N/A,N/A,"Gilead Sciences, Inc.",199 E. Blaine St,,Seattle,Washington,98102,USA,412513,2013,
olaparib,Lynparza,2013-10-16,Treatment of ovarian cancer,Designated/Approved,Approved for Orphan Indication,Use of as monotherapy for patients with deleterious or suspected deleterious germline BRCA mutated (as detected by an FDA-approved test) advanced ovarian cancer who have been treated with three or more prior lines of chemotherapy,2014-12-19,2021-12-19,AstraZeneca Pharmaceuticals LP,1 Medimmune Way,,Gaithersburg,Maryland,20878,USA,409213,2013,429
olaparib,Lynparza,2013-10-16,Treatment of ovarian cancer,Designated/Approved,Approved for Orphan Indication,"Maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer, who are in a complete or partial response to platinum-based chemotherapy; and treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated advanced ovarian cancer who have been treated with three or more prior lines of chemotherapy. Select patients for therapy based on an FDA-approved companion diagnostic for Lynparza.",2017-08-17,TBD,AstraZeneca Pharmaceuticals LP,1 Medimmune Way,,Gaithersburg,Maryland,20878,USA,409213,2013,1401
human IgG1k monoclonal antibody,n/a,2013-10-16,Treatment of systemic sclerosis,Designated,,,N/A,N/A,MedImmune,One MedImmune Way,,Gaithersburg,Maryland,20878,USA,299209,2013,
mTOR kinase inhibitor (CC-223),n/a,2013-10-16,Treatment of hepatocellular carcinoma,Designated,,,N/A,N/A,Celgene Corporation,400 Connell Drive,Suite 7000,Berkeley Heights,New Jersey,7922,USA,407913,2013,
somavaratan,n/a,2013-10-16,Treatment of growth hormone deficiency,Designated,,,N/A,N/A,"Versartis, Inc.",275 Shoreline Drive,Suite 450,Redwood City,,94065,USA,379412,2013,
tivantinib,n/a,2013-10-16,Treatment of hepatocellular carcinoma,Designated/Withdrawn,,,N/A,N/A,Daiichi Sankyo Pharma Development,399 Thornall Street,,Edison,New Jersey,8837,USA,407513,2013,
ibrutinib,n/a,2013-10-23,Treatment of diffuse large B-cell lymphoma,Designated,,,N/A,N/A,"Pharmacyclics, LLC",995 E. Arques Avenue,,Sunnyvale,California,94085,USA,409713,2013,
phenobarbitol sodium injection,n/a,2013-10-23,Treatment of hypoxic-ischemic encephalopathy to prevent siezures in neonates,Designated,,,N/A,N/A,"Fera Pharmaceuticals, LLC",134 Birch Hill Road,,Locust Valley,New York,11560,USA,408413,2013,
sodium fusidate,n/a,2013-10-23,Treatment of patients with prosthetic joint infections,Designated,,,N/A,N/A,"Cempra Pharmaceuticals, Inc.",6340 Quadrangle Drive,Suite 100,Chapel Hill,North Carolina,27517,USA,400513,2013,
tigecycline,n/a,2013-10-23,Treatment of acute myeloid leukemia.,Designated,,,N/A,N/A,"Trillium Therapeutics, Inc.",96 Skyway Avenue,"Toronto, ON M9W 4Y9",,,,Canada,406313,2013,
Trofinetide,n/a,2013-10-23,Treatment of Fragile X Syndrome,Designated,,,N/A,N/A,Neuren Pharmaceuticals Ltd,697 Burke Road,Suite 201,Camberwell,,,Australia,409013,2013,
isavuconazonium sulfate,Cresemba,2013-10-25,Treatment of zygomycosis,Designated/Approved,Approved for Orphan Indication,Treatment of invasive mucormycosis in patients 18 years of age and older,2015-03-06,2022-03-06,Astellas Pharma Global Development Inc.,1 Astellas Way,,Northbrook,Illinois,60062,USA,395013,2013,497
3-chloro-4-fluorophenyl-[4-fluoro-4-[[(5-methylpyrimidin-2-ylmethyl)amino]methyl]piperidin-1yl]methanone,n/a,2013-10-25,Treatment of Rett syndrome,Designated,,,N/A,N/A,"Neurolixis, Inc.",3210 Merryfield Row,,San Diego,California,92121,USA,410613,2013,
flubendazole,n/a,2013-10-25,Treatment of onchocerciasis caused by Onchocerca volvulus,Designated/Withdrawn,,,N/A,N/A,"Janssen Research & Development, LLC",920 Route 202 South,,Raritan,New Jersey,8869,USA,396713,2013,
Gallium-68 (DOTA0-Phel-Tyr3)octreotide,n/a,2013-10-25,The management of neuroendocrine tumors,Designated,,,N/A,N/A,University of Iowa Hospital & Clinics,Department of Radiology/PET Imaging Center,200 Hawkins Drive,Iowa City,Iowa,52242,USA,409513,2013,
oleylphosphocholine,n/a,2013-10-25,Treatment of leishmaniasis,Designated,,,N/A,N/A,Dafra Pharma International nv,Slachthuisstraat 30 b7,,,,,Belgium,410313,2013,
PEGylated recombinant anti-Pseudomonas aeruginosa PcrV Fab' antibody,n/a,2013-10-25,Treatment of cystic fibrosis patients with Pseudomonas aeruginosa lung infections,Designated,,,N/A,N/A,"KaloBios Pharmaceuticals, Inc.",442 Littlefield Avenue,,South San Francisco,California,94080,USA,398013,2013,
poly(lactide-co-glycolide) carboxylated microparticle,n/a,2013-10-25,Treatment of acute encephalitis syndrome,Designated,,,N/A,N/A,"Cour Pharmaceutical Development Company, Inc.",428 S. Hillside Avenue,,Elmhurst,Illinois,60126,USA,410413,2013,
recombinant human monoclonal IgM antibody targeting glucose regulated protein 78,n/a,2013-10-25,Treatment of multiple myeloma,Designated,,,N/A,N/A,Patrys Ltd.,"Suite 614, Level 6","Melbourne, Victoria 3000",,,,Australia,410013,2013,
trastuzumab emtansine,Kadcyla Ã¿Æ¿Ã¿Â¿¿Ã¿Â¢Ã¢Â¿¿Â¬Ã¿Â¡Ã¿Æ¿Ã¢Â¿¬Å¡Ã¿Â¿¿Ã¿Â®,2013-10-25,For the treatment of gastric cancer including gastroesophageal junction cancer.,Designated/Withdrawn,,,N/A,N/A,"Genethech, Inc.",1 DNA Way,,south San Francisco,California,94080,USA,412213,2013,
trehalose,Cabaletta,2013-10-25,Treatment of occulopharyngeal muscular dystrophy,Designated,,,N/A,N/A,"BioBlast Pharma, Ltd.",64 Quarry Lane,,Bedford,New York,10506,USA,410713,2013,
TXA127,n/a,2013-10-25,Treament of acute radiation syndrome,Designated,,,N/A,N/A,"US Biotest, Inc.","231 Bonetti Dr.,",Suite 240,San Luis Obispo,California,93401,USA,411813,2013,
live attenuated bioengineered Listeria monocytogenes immunotherapy,n/a,2013-11-04,Treatment of human papilloma virus-associated head and neck cancer,Designated,,,N/A,N/A,"Advaxis, Inc.",305 College Road East,,Princeton,New Jersey,8540,USA,403113,2013,
monoclonal antibody directed at hepatitis C virus E2 glycoprotein,n/a,2013-11-04,Prevention of Hepatitis C recurrence in patients receiving liver transplantation,Designated,,,N/A,N/A,MassBiologics-University of MA Medical School,460 Walk HIll Street,,Boston,Massachusetts,2126,USA,407013,2013,
eltrombopag,Promacta,2013-11-08,Treatment of aplastic anemia,Designated/Approved,Approved for Orphan Indication,Treatment of patients with severe aplastic anemia who have had an insufficient response to immunosuppressive therapy.,2014-08-26,2021-08-26,Novartis Pharmaceuticals Corp.,One Health Plaza,,East Hanover,New Jersey,7936,USA,410213,2013,291
poloxamer 188,n/a,2013-11-08,Treatment of Acute Limb Ischemia,Designated,,,N/A,N/A,Mast Therapeutics Inc.,3611 Valley Centre rive,Suite 500,San Diego,California,92130,USA,408113,2013,
cannabidiol,n/a,2013-11-14,Treatment of Dravet syndrome.,Designated,,,N/A,N/A,GW Pharma Ltd.,Porton Down Science Park,"Salisbury, Wiltshire SP4 0JQ",,,,United Kingdom,409313,2013,
autologous CD4+CD25hiFoxP3+regulatory T cells,n/a,2013-11-19,Prevention of graft rejection following solid organ transplantation,Designated,,,N/A,N/A,iREG Medical AB,"Tallmov 2A,",,Uppsala,,,Sweden,409613,2013,
avalglucosidase alfa,n/a,2013-11-19,Treatment of Pompe Disease,Designated,,,N/A,N/A,"Genzyme, a Sanofi Company",500 Kendall Street,,Cambridge,Massachusetts,2142,USA,411913,2013,
binimetinib,n/a,2013-11-19,Treatment Stage IIB-IV melanoma.,Designated,,,N/A,N/A,"Array BioPharma, Inc.",125 Cambridge Park Drive,Suite 301,Cambridge,Massachusetts,2140,USA,411513,2013,
encorafenib,n/a,2013-11-19,Treatment of Stage IIB-IV melanoma positive for BRAF mutation,Designated,,,N/A,N/A,"Array BioPharma, Inc.",125 Cambridge Park Drive,Suite 301,Cambridge,Massachusetts,2140,USA,411413,2013,
encorafenib + binimetinib,n/a,2013-11-19,Treatment in Stage IIB-IV melanoma positive for the BRAF mutation.,Designated,,,N/A,N/A,"Array BioPharma, Inc.",125 Cambridge Park Drive,Suite 301,Cambridge,Massachusetts,2140,USA,411613,2013,
human haptoglobin,n/a,2013-11-19,Treatment of sickle cell disease,Designated,,,N/A,N/A,BioProducts Laboratory Limited,"Dagger Lane, Elstree",WD6 3BX,,,,United Kingdom,359511,2013,
Lonafarnib,n/a,2013-11-19,Treatment of Hepatitis Delta Virus (HDV)infection,Designated,,,N/A,N/A,"Eiger Biopharmaceuticals, Inc.",PO Box 430,,San Carlos,California,94070,USA,411713,2013,
pirfenidone,n/a,2013-11-19,Treatment of systemic sclerosis (including the associated interstitial lung disease),Designated,,,N/A,N/A,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,USA,411113,2013,
filgrastim,Neupogen,2013-11-20,Treatment of subjects at risk of developing myelosuppression after a radiological or nuclear incident,Designated/Approved,Approved for Orphan Indication,To increase survival in patients acutely exposed to myelosuppressive doses of radiation (Hematopoietic Syndrome of Acute Radiation Syndrome).,2015-03-30,2022-03-30,"Amgen, Inc.",One Amgen Center Drive,M/S 17-1-C,Thousand Oaks,California,91320,USA,413113,2013,495
Pegfilgrastim,Neulasta,2013-11-20,Treatment of subjects at risk of developing myelosuppression after a radiological or nuclear incident,Designated/Approved,Approved for Orphan Indication,To increase survival in patients acutely exposed to myelosuppressive doses of radiation (Hematopoietic Subsyndrome of Acute Radiation Syndrome),2015-11-13,2022-11-13,"Amgen, Inc.",One Amgen Center Drive,M/S 17-1-C,Thousand Oaks,California,91320,USA,413013,2013,723
adeno-associated viral vector containing the human NADH Dehydrogenase 4 Gene,n/a,2013-11-20,Treatment of Leber Hereditary Optic Neuropathy,Designated,,,N/A,N/A,Gen Sight Biologics,,,,,,,412013,2013,
emricasan,n/a,2013-11-20,Treatment of liver transplant recipients with reestablished fibrosis to delay the progression to cirrhosis and end stage liver disease,Designated,,,N/A,N/A,Conatus Pharmaceuticals Inc.,16745 W. Bernardo Drive,Suite 200,San Diego,California,92127,USA,396113,2013,
bendamustine hydrochloride,Treanda,2013-11-26,"Treatment of Follicular Lymphoma, Small Lymphocytic Lymphoma, Lymphoplasmacytic Lymphoma, Splenic Marginal Zone Lymphoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-Associated Lymphoma Tissue (MALT), and Nodal Marginal Zone Lymphoma (Collectively Indolent B-cell Non-Hodgkin's Lymphoma)",Designated/Approved,Approved for Orphan Indication,Treatment of Indolent B-cell non-Hodgkin lymphoma (NHL) that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen.,2008-10-31,2015-10-31,"Cephalon, Inc.",A wholly owned subsidiary of Teva Pharmaceuticals,PO Box 4011,Frazer,Pennsylvania,19355,USA,253107,2013,-1852
Angiotensin (1-7),n/a,2013-11-26,Treatment of limb-girdle muscular dystrophy,Designated,,,N/A,N/A,Tarix Pharmaceuticals Ltd,12 Bow Street,,Cambridge,Massachusetts,2138,USA,412313,2013,
human monoclonal antibody directed against active plasma kallikrein,n/a,2013-11-26,Treatment of hereditary angioedema (HAE),Designated,,,N/A,N/A,Dyax Corporation,55 Network Drive,,Burlington,Massachusetts,1803,USA,397213,2013,
human umbilical cord blood-derived mesenchymal stem cells,Pneumostem,2013-11-26,Prevention of bronchopulmonary dysplasia,Designated,,,N/A,N/A,"MEDIPOST America, Inc.",9601 Medical Center Drive,,Rockville,,20850,USA,389713,2013,
N-(3-fluorobenzyl)-2-(5-(4-morpholinophenyl) pyridin-2-yl) Acetamide Besylate,n/a,2013-11-26,Treatment of gliomas,Designated,,,N/A,N/A,"Kinex Pharmaceuticals, Inc.",701 Ellicott Street,,Buffalo,New York,14203,USA,413513,2013,
Siponimod,n/a,2013-11-26,Treatment of polymyositis,Designated,,,N/A,N/A,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,USA,413413,2013,
vemurafenib,Zelboraf,2013-11-26,Treatment of anaplastic thyroid carcinoma and advanced papillary thyroid cancer whose tumors harbor a BRAF V600 mutation,Designated,,,N/A,N/A,"Genentech, Inc.",1 DNA Way,MS 241b,South San Francisco,California,94080,USA,399213,2013,
sacituzumab govitecan,n/a,2013-11-27,Treatment of small cell lung cancer,Designated,,,N/A,N/A,"Immunomedics, Inc.",300 The American Road,,Morris Plains,New Jersey,7950,USA,415413,2013,
canakinumab,Ilaris,2013-12-05,Treatment of hyperimmunoglobulinemia D and periodic fever syndrome,Designated/Approved,Approved for Orphan Indication,Indicated for Hyperimmunoglobulin D Syndrome (HIDS)/Mevalonate Kinase Deficiency (MKD) in adult and pediatric patients,2016-09-23,2023-09-23,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,USA,412913,2013,1023
canakinumab,Ilaris,2013-12-05,Treatment of familial mediterranean fever,Designated/Approved,Approved for Orphan Indication,Indicated for Familial Mediterranean Fever (FMF) in adult and pediatric patients,2016-09-23,2023-09-23,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,USA,412813,2013,1023
sotatercept,n/a,2013-12-05,Treatment of beta-thalassemia intermedia and major,Designated,,,N/A,N/A,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,USA,413713,2013,
marizomib,n/a,2013-12-13,Treatment of multiple myeloma,Designated,,,N/A,N/A,Celgene International II Sàrl,4 Rue des Moulins,,Couvet,,,Switzerland,414313,2013,
"O2-(2,4-dinitrophenyl) 1-[(4-ethoxycarbonyl)piperazin-1yl]diazen-1-ium-1,2-diolate",n/a,2013-12-13,Treatment of multiple myeloma,Designated,,,N/A,N/A,"JSK Therapeutics, Inc.",85 Fort Douglas Boulevard,P.O. Box 58986,Salt Lake City,Utah,84158,USA,414013,2013,
Human monoclonal antibody inhibitor of mannan-binding lectin-associated serine protease-2 (MASP-2),n/a,2013-12-16,Prevention (inhibition) of complement-mediated thrombotic microangiopathy,Designated,,,N/A,N/A,Omeros Corporation,201 Elliott Avenue West,,Seattle,Washington,98119,USA,397813,2013,
metadoxine,n/a,2013-12-16,Treatment of Fragile X Syndrome,Designated,,,N/A,N/A,"Alcobra, Inc.",2 Weizman Street,,Tel-Aviv,,,Israel,414513,2013,
onartuzumab (MetMab),n/a,2013-12-16,Treatment of hepatocellular carcinoma,Designated/Withdrawn,,,N/A,N/A,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,USA,417113,2013,
vintafolide,n/a,2013-12-16,Treatment of ovarian cancer,Designated,,,N/A,N/A,"Endocyte, Inc.",3000 Kent Avenue,Suite A1-100,West Lafayette,Indiana,47906,USA,415513,2013,
tacrolimus,Envarsus Xr,2013-12-20,Prophylaxis of organ rejection in patients receiving allogeneic kidney transplant,Designated/Approved,Approved for Orphan Indication,Prophylaxis of organ rejection in kidney transplant patients converted from tacrolimus immediate-release formulations in combination with other immunosuppressants,2015-07-10,2022-07-10,"Veloxis Pharmaceuticals, Inc.",499 Thornall Street,3rd Floor,Edison,New Jersey,8837,USA,407113,2013,567
CD40/CD80/CD86 modified autologous dendritic cell therapy,n/a,2013-12-20,Treatment Type 1 diabetes mellitus patients with residual beta cell function,Designated,,,N/A,N/A,"DiaVacs, Inc.",410 Tower Drive,,Edgewater,New Jersey,7020,USA,396613,2013,
erdosteine,n/a,2013-12-20,Treatment of bronchiectasis.,Designated,,,N/A,N/A,"Alitair Pharmaceuticals, Inc.",55 Madison Avenue,Suite 400,Morristown,New Jersey,7960,USA,417413,2013,
fenfluramine HCI,Brabafen,2013-12-20,For the Treatment of Dravet Syndrome,Designated,,,N/A,N/A,"Zogenix, Inc.","5858 Horton Street, Suite 455",RG9 2LT,Emeryville,California,,United Kingdom,414613,2013,
recombinant human acid ceramidase,Plexcerase,2013-12-24,Treatment of Farber disease,Designated,,,N/A,N/A,Enzyvant Farber GmbH,Clarendon House,2 Church Street,Hamilton HM11,,,Bermuda,415313,2013,
Tolcapone,n/a,2013-12-24,Treatment of transthyretin amyloidosis,Designated,,,N/A,N/A,"Corino Therapeutics, Inc.",57 West 57th Street,18th Floor,New York,New York,10019,USA,413913,2013,
"Gallium [Ga-68]-N-[(4,7,10-Tricarboxymethyl-1,4,7,10-tetraazacyclododec-1-yl)acetyl]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophanyl-L-lysyl-L-threoninyl-L-cysteinyl-L-threonine-cyclic(2-7)disulfide",Netspot,2013-12-31,Diagnostic for the clinical management of neuroendocrine tumors,Designated/Approved,Approved for Orphan Indication,"For use after radiolabeling with Ga 68, with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adult and pediatric patients.",2016-06-01,2023-06-01,"Advanced Accelerator Applications, USA",350 Fifth Avenue,Suite 6902,New York,New York,10118,USA,413613,2013,883
N-acetyl cysteine amide,n/a,2013-12-31,Treatment of retinitis pigmentosa,Designated,,,N/A,N/A,"Nacuity Pharmaceuticals, Inc.",Fort Worth Club Building,306 W 17th Street,Fort Worth,Texas,76106,USA,417513,2013,
nifurtimox,n/a,2013-12-31,Treatment of Chagas disease,Designated,,,N/A,N/A,"MetronomX Therapeutics, LLC",7000 Fannin Street,Suite 1960,Houston,Texas,77030,USA,419213,2013,
NorLeu3-Angiontensin(1-7)) [NorLeu3-A(1-7)],n/a,2013-12-31,Treatment of leakage from the surgical site following penetrating keratoplasty,Designated,,,N/A,N/A,"US Biotest, Inc.","231 Bonetti Dr.,",Suite 240,San Luis Obispo,California,93401,USA,414813,2013,
radiolabeled somastatin analog,Galiomedix(Tm),2013-12-31,Diagnostic for the management of neuroendocrine tumors,Designated,,,N/A,N/A,"RadioMedix, Inc.",9701 Richmond Avenue,Suite 222,Houston,Texas,77042,USA,404813,2013,
thymosin beta 4,n/a,2013-12-31,Treatment of patients with neurotrophic keratopathy,Designated,,,N/A,N/A,"ReGenTree, LLC",116 Village Blvd,Suite 200,Princeton,New Jersey,8540,USA,416613,2013,
emicizumab-kxwh,Hemlibra,2014-01-10,Treatment of hemophilia A,Designated/Approved,Approved for Orphan Indication,Routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients with hemophilia A (congenital factor VIII deficiency) with factor VIII inhibitors,2017-11-16,2024-11-16,Genentech,1 DNA Way,,South San Francisco,California,94080,USA,416913,2014,1406
eculizumab,Soliris,2014-01-10,Prevention of delayed graft function after renal transplantation,Designated,,,N/A,N/A,"Alexion Pharmaceuticals, Inc.",352 Knotter Drive,,Cheshire,Connecticut,6410,USA,417213,2014,
enchochleate amphotericin B,n/a,2014-01-10,Treatment of visceral leishmaniasis,Designated,,,N/A,N/A,"Aquarius Biotechnologies, Inc.",2037 West Carroll Avenue,,Chicago,Illinois,60612,USA,416113,2014,
human allogeneic bone marrow derived osteoblastic cells,Allob,2014-01-10,Treatment of osteonecrosis,Designated,,,N/A,N/A,Bone Therapeutics SA,"8, rue Adrienne Bolland",6041 Gosselies,,,,Belgium,416813,2014,
monoclonal antibody Hu3F8,n/a,2014-01-10,Treatment of osteosarcoma,Designated,,,N/A,N/A,Memorial Sloan-Kettering Cancer Center,1275 York Avenue,,New York,New York,10065,USA,416313,2014,
rsATP7A cDNA,n/a,2014-01-10,Treatment of Menkes disease,Designated,,,N/A,N/A,"Stephen G. Kaler, MD","Translational Neuroscience, Molecular Med. Program","10 Center Drive, MSC 1853",Bethesda,Maryland,20892,USA,416413,2014,
Allogeneic motor neuron progenitor cells derived from human embryonic stem cells,Motorgraft (Tm),2014-01-17,Treatment of Amyotrophic Lateral Sclerosis,Designated/Withdrawn,,,N/A,N/A,Caladrius Biosciences,110 Allen Road,2nd Floor,Basking Ridge,New Jersey,7920,USA,415013,2014,
ethanolamine,Ethamolin,2014-01-17,Prophylactic use in pediatric patients (age 0 through 16 years) with esophageal varices that are at risk of bleeding to obliterate varices and to prevent bleeding,Designated,,,N/A,N/A,"QOL Medical, LLC","4445 North Highway A1A, 241",,Vero Beach,Florida,32963,USA,416713,2014,
paquinimod,n/a,2014-01-17,Treatment of systemic sclerosis,Designated,,,N/A,N/A,Active Biotech AB,Scheelevagen 22,SE-220 07,LUND,,,Sweden,356911,2014,
tetra substituted prophyrin derivative containing manganese (III),n/a,2014-01-17,For use in patients exposed to radiation following a nuclear accident or detonation in order to treat or mitigate acute radiation syndrome.,Designated,,,N/A,N/A,"Aeolus Pharmaceuticals, Inc.",26361 Crown Valley Parkway,Suite 150,Mission Viejo,California,92691,USA,354611,2014,
flubendazole,n/a,2014-01-23,"Treatment of lymphatic filariasis caused by nematodes of the family Filariodidea, in children and adults.",Designated/Withdrawn,,,N/A,N/A,"Janssen Research and Development, LLC",920 Route 202 South,,Raritan,New Jersey,8869,USA,399813,2014,
cobimetinib,n/a,2014-01-31,"Treatment of stage IIb, IIc, III, and IV melanoma with BRAFV600 mutation",Designated/Approved,Approved for Orphan Indication,"For the treatment of patients with unresectable or metastatic melanoma with BRAF V600E or V600K mutation, in combination with vemurafenib. COTELLIC is not indicated for treatment of patients with wild-type BRAF melanoma",2015-11-10,2022-11-10,"Genentech, Inc.","1 DNA Way, MS 241A",,South San Francisco,California,94080,USA,419513,2014,648
(tisagenlecleucel) Autologous T Cells transduced with lentiviral vector containing a chimeric antigen receptor directed against CD19,Kymriah (Tisagenlecleucel),2014-01-31,For the treatment of Acute Lymphoblastic Leukemia,Designated/Approved,Approved for Orphan Indication,Treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia (ALL) that is refractory or in second or later relapse,2017-08-30,2024-08-30,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,USA,415113,2014,1307
brentuximab vedotin,Adcetris(R),2014-01-31,Treatment of patients with diffuse large B-cell lymphoma.,Designated/Withdrawn,,,N/A,N/A,"Seattle Genetics, Inc.",21823 30th Drive Southeast,,Bothell,Washington,98021,USA,418713,2014,
NorLeu3-Angiotensin(1-7) [NorLeu3-A(1-7)],n/a,2014-01-31,Treatment of dermal injury due to nuclear/radiation incident,Designated,,,N/A,N/A,"US Biotest, Inc.","231 Bonetti Dr.,",Suite 240,San Luis Obispo,California,93401,USA,414713,2014,
recombinant DNA plasmid,n/a,2014-01-31,"Treatment of stage IIb, IIc, III and IV melanoma.",Designated,,,N/A,N/A,Scancell Ltd.,Dept of Clinical Oncology - City Hospital,NG5 1 PB,Nottingham,,,United Kingdom,417313,2014,
vatiquinone,Vincerinone,2014-01-31,Treatment of Friedreich's ataxia,Designated,,,N/A,N/A,BioElectron Technology Corporation,350 N. Bernardo Ave.,,Mountain View,California,94043,USA,418413,2014,
DNA plasmid vector (pCK-HGFX7) expressing human hepatocyte growth factor,n/a,2014-02-06,Treatment of amyotrophic lateral sclerosis,Designated,,,N/A,N/A,"ViroMed Co., Ltd.","2221 Peachtree RD, NE",Suite D258,Atlanta,Georgia,30309,USA,417013,2014,
Engineered variant of recombinant human fibroblast growth factor 19,n/a,2014-02-06,Treatment of primary biliary cirrhosis,Designated,,,N/A,N/A,"NGM Biopharmaceuticals, Inc.",630 Gateway Blvd,,South San Francisco,California,94080,USA,415813,2014,
gemcabene,n/a,2014-02-06,Treatment of homozygous familial hypercholesterolemia,Designated,,,N/A,N/A,"Gemphire Therapeutics, Inc.",17199 N. Laurel Park Drive,Suite 401,Livonia,Michigan,48152,USA,419313,2014,
Re188 P2045 somatostatin analog,n/a,2014-02-06,Treatment of small cell lung cancer,Designated,,,N/A,N/A,Andarix Pharmaceuticals,"141 Powderhouse Blvd, Suite 1",,Somerville,Massachusetts,2144,USA,403013,2014,
"T cell receptor (TCR) peptide (BV5S2, BV6S5, BV13S1) vaccine",Neurovax,2014-02-06,Treatment of Pediatric Multiple Sclerosis,Designated,,,N/A,N/A,"Immune Response BioPharma, Inc.",244 5th Avenue,Suite 1727,New York,,10001,USA,385412,2014,
Bruton's tyrosine kinase inhibitor,n/a,2014-02-10,Treatment of chronic lymphocytic leukemia,Designated/Withdrawn,,,N/A,N/A,Celgene Corporation,400 Connell Drive,Suite 700,Berkeley Heights,New Jersey,7922,USA,408313,2014,
sotalol hydrochloride,Sotylize,2014-02-10,Treatment of life-threatening ventricular arrhythmias in pediatric patients,Designated,,,N/A,N/A,"Arbor Pharmaceuticals, LLC",980 Hammond Drive,"Bldg Two, Suite 1250",Atlanta,Georgia,30328,USA,397613,2014,
phoxilium,n/a,2014-02-14,For use as a replacement solution in patients undergoing continuous renal replacement therapy,Designated/Approved,Approved for Orphan Indication,As a replacement solution in Continuous Renal Replacement Therapy (CRRT) and in case of drug poisoning when CRRT is used to remove dialzable substances,2015-01-13,2022-01-13,"Gambro Renal Products, Inc.",1845 Mason Avenue,,Daytona Beach,Florida,32117,USA,382012,2014,333
rosuvastatin,Crestor,2014-02-14,For the treatment of pediatric homozygous familial hypercholesterolemia,Designated/Approved,Approved for Orphan Indication,"An adjunct to diet to reduce LDL-C, Total-C, nonHDL-C and ApoB in children and adolescents 7 to 17 years of age with homozygous familial hypercholesterolemia, either alone or with other lipid-lowering treatments (e.g., LDL apheresis).",2016-05-27,2023-05-27,"iPR Pharmaceuticals, Inc.",1 MedImmune Way,,Gaithersburg,Maryland,20878,USA,420513,2014,833
bisantrene HCl,n/a,2014-02-14,Treatment of acute myeloid leukemia,Designated,,,N/A,N/A,"Race Oncology, Ltd",50 Kings Park Road,Level 2,West Perth WA 6005,,,Australia,419613,2014,
caprine hyperimmune serum against HIV lysate,n/a,2014-02-14,Treatment of systemic sclerosis,Designated,,,N/A,N/A,Daval International Limited,"4a Gildredge Road,","East Sussex, BN21 4RL",East Sussex,,,United Kingdom,420313,2014,
doxofylline,n/a,2014-02-14,Treatment of bronchiectasis,Designated,,,N/A,N/A,"Alitair Pharmaceuticals, Inc.",55 Madison Avenue,Suite 400,Morristown,New Jersey,7960,USA,399413,2014,
REMUNE HIV 1,n/a,2014-02-14,Treatment of pediatric HIV/AIDS (age through 16 years),Designated,,,N/A,N/A,"Immune Response BioPharma, Inc.",1801 Atlantic Avenue,Suite 8352,Atlantic City,New Jersey,8401,USA,420113,2014,
"[5-(5-Chloro-1H-pyrrolo[2,3-b]pyridin-3-ylmethyl)-pyridin-2-yl]-(6-trifluoromethyl-pyridin-3-ylmethyl)-amine hydrochloride salt",n/a,2014-02-14,Treatment of pigmented villonodular synovitis/giant cell tumor of the tendon sheath,Designated,,,N/A,N/A,"Daiichi Sankyo, Inc.",399 Thornall Street,,Edison,New Jersey,8837,USA,419913,2014,
"(6-[4-Deoxy-4-[(2E,4E)-tetradecadienoylglycyl] amino-L-glyceroB-L-manno-heptopyranosyl]amino-9H-purine)",n/a,2014-02-21,"Parenteral treatment of painful, chronic, chemotherapy-induced peripheral neuropathy that is refractory to conventional analgesics",Designated/Withdrawn,,,N/A,N/A,"DARA Therapeutics, Inc.",8601 Six Forks Road,Suite 160 (Forum 1),Raleigh,North Carolina,27615,USA,385312,2014,
gevokizumab,n/a,2014-02-21,Treatment of pyoderma gangrenosum,Designated,,,N/A,N/A,XOMA (US) LLC,2910 Seventh St.,,Berkeley,California,94710,USA,419113,2014,
autologous CD34+ hematopoietic stem cells transduced with LentiGlobin BB305 lentiviral vector encoding the human BA-T87Q-globin gene,n/a,2014-02-26,For the treatment of Sickle Cell Disease,Designated,,,N/A,N/A,bluebird bio Inc.,840 Memorial Dr.,4th Floor,Cambridge,Massachusetts,2139,USA,420413,2014,
cannabidiol;,n/a,2014-02-27,Treatment of Lennox-Gastaut syndrome,Designated,,,N/A,N/A,GW Pharma Ltd.,Porton Down Science Park,"Salisbury, Wiltshire SP4 OJQ",,,,United Kingdom,421213,2014,
long acting recombinantFactor VIIa-CTP3,n/a,2014-02-27,Treatment and prophylaxis of bleeding episodes in patients with hemophilia A or B with inhibitors to factor VIII or factor IX,Designated,,,N/A,N/A,"PROLOR Biotech, Ltd",7 Golda Meir St.,P. O. Box 4101,Nes Ziona,,,Israel,417913,2014,
oligopeptide containing 6 amino acids (H-Phe-Ser-Arg-Tyr-Ala-Arg-OH),n/a,2014-02-27,Treatment of amyotrophic lateral sclerosis,Designated,,,N/A,N/A,"Genervon Biopharmaceuticals, LLC",1055 E. Colorado Blvd,Suite 500,Pasadena,California,91106,USA,424714,2014,
pracinostat,n/a,2014-02-27,Treatment of acute myeloid leulemia,Designated,,,N/A,N/A,MEI Pharma Inc.,"11975 El Camino Real, Suite 101",,San Diego,California,92130,USA,421313,2014,
fecal microbiota,n/a,2014-03-10,Prevention of recurrent Clostridium difficile infection (CDI) in individuals with recurrent Clostridium difficile infection,Designated,,,N/A,N/A,"Rebiotix, Inc.",2660 Patton Road,,Roseville,Minnesota,55113,USA,421013,2014,
adeno associated virus with modified transthyretin and sequence encoding factor IX variant gene,n/a,2014-03-14,Treatment of hemophilia B,Designated,,,N/A,N/A,"Baxalta US, Inc.",One Baxter Way,,Westlake Village,California,91362,USA,421814,2014,
autologous T cells transduced with lentiviral vector containing a chimeric antigen receptor directed against CD19,n/a,2014-03-14,Treatment of chronic lymphocytic leukemia,Designated,,,N/A,N/A,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,USA,422013,2014,
"(RS)-baclofen, naltrexone and D-sorbitol",n/a,2014-03-17,Treatment of Charcot-Marie-Tooth disease type 1A,Designated,,,N/A,N/A,Pharnext SA,"11, rue des Peupliers",92130 Issey les Moulineaux,,,,France,422914,2014,
Ad5/3-D24-granulocyte-macrophage colony stimulating factor (GMCSF)-encoding oncolytic adenovirus,n/a,2014-03-17,Treatment of ovarian cancer,Designated,,,N/A,N/A,Targovax YO,Saukonpaadenranta 2,,Helsinki,,,Finland,422814,2014,
recombinant human collagen alpha-1 (VII) chain homo-trimer (rC7),n/a,2014-03-17,Treatment of dystrophic epidermolysis bullosa,Designated,,,N/A,N/A,Phoenix Tissue Repair,P. O. Box 370,,Andover,Massachusetts,1810,USA,422514,2014,
lenvatinib,n/a,2014-03-26,Treatment of stage IIB to Stage IV melanoma,Designated,,,N/A,N/A,"Eisai, Inc.",155 Tice Blvd,,Woodcliff Lake,New Jersey,7677,USA,423614,2014,
axicabtagene ciloleucel,Yescarta,2014-03-27,Treatment of diffuse large B-cell lymphoma,Designated/Approved,Approved for Orphan Indication,"Treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy, including diffuse large B-cell lymphoma (DLBCL) not otherwise specified, primary mediastinal large B-cell lymphoma, high-grade B-cell lymphoma, and DLBCL arising from follicular lymphoma",2017-10-18,2024-10-18,"Kite Pharma, Inc.",2225 Colorado Avenue,,Santa Monica,California,90404,USA,423914,2014,1301
"4-(4-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl}piperazin-1-yl)-N-({3-nitro-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl}sulfonyl)-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide",n/a,2014-03-27,Treatment of diffuse large B-cell lymphoma.,Designated,,,N/A,N/A,AbbVie,Research and Development,1 North Waukegan Road,North Chicago,Illinois,60064,USA,423814,2014,
L-asparaginase,n/a,2014-03-27,Treatment of acute myeloid leukemia,Designated,,,N/A,N/A,ERYTECH Pharma S.A.,Batiment Adenine,"60, avenue Rockefeller",Lyon,,,France,424114,2014,
Laromustine,Cloretazine,2014-03-27,Treatment of acute myelogenous leukemia,Designated,,,N/A,N/A,"Nanotherapeutics, Inc.",13859 Progress Blvd,Suite 300,Alachua,Florida,32615,USA,424014,2014,
lenvatinib,n/a,2014-03-27,Treatment of hepatocellular carcinoma,Designated,,,N/A,N/A,"Eisai, Inc.",155 Tice Blvd,,Woodcliff Lake,New Jersey,7677,USA,423714,2014,
isotretinoin,n/a,2014-04-10,Treatment of congenital ichthyosis,Designated,,,N/A,N/A,"Patagonia Pharmaceuticals, LLC",50 Tice Blvd,Suite A35,Woodcliff Lake,New Jersey,7677,USA,424614,2014,
pegylated proline interferon alpha-2b,n/a,2014-04-10,Treatment of myelofibrosis,Designated,,,N/A,N/A,"PharmaEssentia, Corporation","13F, No 3, YuanQu Street",Taipei 115,,,,Taiwan,424414,2014,
"{2-amino-8-[4-(pyrrolidinylcarbonyl)phenyl](3H-benzo[f]azepin-4-yl)}-N,N-dipropycarboxamide",n/a,2014-04-10,Treatment of ovarian cancer,Designated/Withdrawn,,,N/A,N/A,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,USA,425014,2014,
Anthrax Vaccine Adsorbed,Biothrax,2014-04-11,For post-exposure prophylaxis of anthrax disease resulting from suspected or confirmed Bacillus anthracis exposure,Designated/Approved,Approved for Orphan Indication,"For post-exposure prophylaxis of disease following suspected or confirmed Bacillus anthracis exposure, when administered in conjunction with recommended antibacterial drugs.",2015-11-23,2022-11-23,Emergent BioDefense Operations Lansing LLC,300 Proessional Drive,,Gaithersburg,Maryland,20879,USA,424914,2014,591
carbetocin (nasal spray),n/a,2014-04-11,Treatment of Prader Willi syndrome,Designated,,,N/A,N/A,"Levo Therapeutics, Inc.",5215 Old Orchard Road,Suite 450,Skokie,Illinois,60077,USA,423014,2014,
H-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Lys-Leu-Ser-Ser-Ile-Glu- Ser-Asp-Val-OH,n/a,2014-04-11,Treatment of acute ischemic stroke patients presenting within 3 hours of symptom onset,Designated,,,N/A,N/A,"NoNO, Inc.",399 Bathurst Street,Suite 4W-435,Toronto,,,Canada,412713,2014,
pegylated proline interferon alpha-2b,n/a,2014-04-11,Treatment of essential thrombocythemia,Designated,,,N/A,N/A,"PharmaEssentia, Corporation","13F, No 3, YuanQu Street",Taipei 115,,,,Taiwan,424514,2014,
benznidazole,n/a,2014-04-14,Treatment of Chagas disease,Designated/Approved,Approved for Orphan Indication,for use in children ages 2 to 12 years old with Chagas disease,2017-08-29,2024-08-29,"Chemo Research, S.L.",,"Edificio Nectar, c/Quintanapalla, 2, 3 planta",Madrid,,,Spain,425214,2014,1233
entospletinib,n/a,2014-04-14,Treatment of chronic lymphocytic leukemia,Designated,,,N/A,N/A,"Gilead Sciences, Inc.",333 Lakeside Drive,,Foster City,California,94404,USA,426714,2014,
naltrexone/clonidine combination,n/a,2014-04-14,Treatment of postherpetic neuralgia,Designated,,,N/A,N/A,Allodynic Therapeutics LLC,1785 NE 123rd Street,,North Miami,Florida,33181,USA,425614,2014,
volasertib,n/a,2014-04-14,Treatment of acute myeloid leukemia,Designated,,,N/A,N/A,"Boehringer Ingelheim Pharmaceuticals, Inc.",900 Ridgebury Road,P. O. Box 368,Ridgefield,Connecticut,6877,USA,415913,2014,
ciprofloxacin dry powder inhaler,n/a,2014-04-17,Treatment of non-cystic fibrosis bronchiectasis,Designated,,,N/A,N/A,"Bayer HealthCare Pharmaceuticals, Inc.",P. O. Box 1000,,Montville,New Jersey,7045,USA,422314,2014,
teriparatide,Forteo,2014-04-18,Treatment of hypoparathyroidism,Designated,,,N/A,N/A,"Entera Bio, Ltd.","Kiryat Hadassah Minrav Bldg, 5th Floor",P. O. Box 12117,Jeusalem,,,Israel,425814,2014,
Ac-Ile-Cys-Val-Trp(1-Me)-Gln-Asp-Trp-Gly-Ala-His-Arg-Cys-Thr-AEEA-Lys-PEG 40KDa-Lys-AEEA-Thr-Cys-Arg-His-ALa-Gly-Trp-Asp-Gln-(1-Me)Trp-Val-Cys-Ile-Ac,n/a,2014-04-20,Treatment of paroxysmal nocturnal hemoglobinuria,Designated,,,N/A,N/A,"Apellis Pharmaceuticals, Inc.",6400 Westwind Way,Suite A,Crestwood,Kentucky,40014,USA,427614,2014,
allopregnanolone,n/a,2014-04-20,Treatment of status epilepticus,Designated,,,N/A,N/A,Sage Therapeutics,215 First Street,Suite 220,Cambridge,Massachusetts,2142,USA,426114,2014,
alvocidib,n/a,2014-04-21,Treatment of acute myeloid leukemia,Designated,,,N/A,N/A,"Tolero Pharmaceuticals, Inc.",2975 West Executive Parkway,Suite 320,Lehi,Utah,84043,USA,426214,2014,
Tezacaftor,n/a,2014-04-24,Treatment of cystic fibrosis,Designated,,,N/A,N/A,Vertex Pharmaceuticals Inc.,50 Northern Avenue,,Boston,Massachusetts,2210,USA,427414,2014,
sotatercept,n/a,2014-04-28,Treatment of anemias associated with myelodysplastic syndrome and myelodysplastic/myeloproliferative neoplasms.,Designated,,,N/A,N/A,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,USA,428614,2014,
stem/progenitor cells derived from ex vivo expanded allogeneic umbilical cord blood cells,Nicord,2014-04-28,For the treatment of acute myeloid leukemia,Designated,,,N/A,N/A,Gamida Cell Ltd,PO Box 34670,,Jerusalem,,,Israel,426814,2014,
3-bromopyruvate,n/a,2014-04-29,Treatment of pancreatic cancer,Designated,,,N/A,N/A,"PreScience Labs, LLC",9500 Reach Road,,Potomac,Maryland,20854,USA,430514,2014,
a live attenuated bioengineered Listeria monocytogenes cancer immunotherapy,n/a,2014-04-29,Treatment of Stage II to IV invasive cervical carcinoma,Designated,,,N/A,N/A,"Advaxis, Inc.",305 College Road East,,Princeton,New Jersey,8540,USA,429814,2014,
humanized Fc engineered monoclonal antibody against CD19,n/a,2014-04-29,Treatment of patients with chronic lymphocytic leukemia/small lymphocytic lymphoma,Designated,,,N/A,N/A,MorphoSys AG,Semmelweisstrasse 7,82152 Planegg,,,,Germany,427914,2014,
recombinant AAV9 expressing human sulfoglucosamine sulfohydrolase,n/a,2014-04-29,Treatment of mucopolysaccharidosis type III-A (Sanfilippo Syndrome Type A),Designated,,,N/A,N/A,Abeona Therapeutics,6555 Carnegie Blvd,Suite 401,Cleveland,Ohio,44103,USA,433714,2014,
"(3E,5E)-3,5-bis[(4-fluoro-3-nitrophenyl)methylidene]-1-(prop-2-enoyl)azepan-4-0ne",n/a,2014-04-30,Treatment of multiple myeloma,Designated,,,N/A,N/A,VivoLux AB,Uppsala Science Park,SE-751 83 Uppsala,,,,Sweden,428714,2014,
18-(p-[124I]-iodophenyl)octadecyl phosphocholine,n/a,2014-04-30,Diagnostic for the management of glioma,Designated,,,N/A,N/A,"Cellectar Biosciences, Inc.",3301 Agriculture Drive,,Madison,Wisconsin,53716,USA,429514,2014,
demcizumab,n/a,2014-04-30,Treatment of pancreatic cancer,Designated/Withdrawn,,,N/A,N/A,"OncoMed Pharmaceuticals, Inc.",800 Chesapeake Drive,,Redwood City,California,94063,USA,427314,2014,
Human plasma derived conagulation protein-Factor XI,n/a,2014-04-30,For the treatment of congenital Factor XI deficiency,Designated,,,N/A,N/A,Cambryn Biologics,600Tallevast Rd,Unit 201,Sarasota,Florida,34243,USA,427214,2014,
Ipatasertib,n/a,2014-04-30,For the treatment of gastric cancer including cancer of the gastro-esophageal junction.,Designated/Withdrawn,,,N/A,N/A,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,USA,429714,2014,
moxifloxacin hydrochloride,n/a,2014-04-30,Treatment of tuberculosis,Designated/Withdrawn,,,N/A,N/A,"Bayer HealthCare Pharmaceuticals, Inc.",100 Bayer Boulevard,P. O. Box 915,Whippany,New Jersey,7981,USA,428014,2014,
pegylated granulocyte colony stimulating factor,n/a,2014-04-30,Treatment of patients at risk of developing myelosuppression following a radiological or nuclear incident,Designated,,,N/A,N/A,PharmaEssentia,"13 F, No.3, YuanQu Street",Taipei 115,,,,Taiwan,426514,2014,
Recombinant AAV9 expressing human alpha-N-acetylglucosaminidase,n/a,2014-04-30,Mucopolysaccharidosis III-B (Sanfilippo Syndrome Type B),Designated,,,N/A,N/A,Abeona Therapeutics LLC,10000 Cedar Avenue,,Cleveland,Ohio,44106,USA,433814,2014,
autologous dendritic cells pulsed with allogeneic tumor cell lysate,n/a,2014-05-06,Treatment of malignant mesothelioma,Designated,,,N/A,N/A,Amphera BV,Onderwijs Blvd 219,5223 DE's-Hertogenbosch,,,,Netherlands,430214,2014,
filanesib,n/a,2014-05-06,Treatment of multiple myeloma.,Designated,,,N/A,N/A,"Array BioPharma, Inc.",3200 Walnut Street,,Boulder,Colorado,80301,USA,431114,2014,
imatinib mesylate,n/a,2014-05-06,Treatment of progressive multifocal leukencephalopathy,Designated,,,N/A,N/A,"Inhibikase Therapeutics, Inc.",3350 Riverwood Parkway,Suite 1927,Atlanta,Georgia,30339,USA,428914,2014,
ex vivo cultured human mesenchymal stromal cells,n/a,2014-05-08,Prevention of graft rejection following solid organ transplantation,Designated,,,N/A,N/A,iCell Science AB,Tallmov. 2A,756 45 Uppsala,,,,Sweden,428814,2014,
adalimumab,Humira,2014-05-13,"Treatment of non-infectious intermediate, posterior, or pan-uveitis, or chronic non-infectious anterior uveitis",Designated/Approved,Approved for Orphan Indication,"Indicated for the treatment of non-infectious intermediate, posterior and panuveitis in adult patients",2016-06-30,2023-06-30,"AbbVie, Inc.",1 North Waukegan Road,,North Chicago,Illinois,60064,USA,318510,2014,779
diazoxide choline,n/a,2014-05-13,Treatment of Prader-Willi Syndrome,Designated,,,N/A,N/A,"Soleno Therapeutics, Inc.",1235 Radio Road,Suite 110,Redwood City,California,94065,USA,428214,2014,
vasoactive intestinal peptide (VIP)-elastin-like peptide (ELP) fusion protein,n/a,2014-05-13,"Treatment of pulmonary arterial hypertension, WHO Group 1",Designated,,,N/A,N/A,"PhaseBio Pharmaceuticals, Inc.",1 Great Valley Parkway,Suite 30,Malvern,Pennsylvania,19355,USA,397513,2014,
"(Z)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-N-(pyrazin-2-yl)acrylohydrazide",n/a,2014-05-14,Treatment of diffuse large B-cell lymphoma,Designated,,,N/A,N/A,"Karyopharm Therapeutics, Inc.",2 Mercer Road,,Natick,Massachusetts,1760,USA,436414,2014,
177Lu-tetraxetan-tetulomab,Betalutin,2014-05-14,Treatment of Follicular Lymphoma,Designated,,,N/A,N/A,Nordic Nanovector AS,Anniken Hagen,"Kjelsasveien 168B, NO-0884",Oslo,,,Norway,433014,2014,
afamelanotide,n/a,2014-05-14,Treatment of familial benign chronic pemphigus (Hailey-Hailey disease),Designated,,,N/A,N/A,"Clinuvel, Inc.",40 Worth Street,10th Floor - Suite 1053,New York,New York,10013,USA,430014,2014,
Inecalcitol,n/a,2014-05-14,Treatment of chronic lymphocytic leukemia,Designated,,,N/A,N/A,"Hybrigenics, S.A.",3-5 Impasse Reille,75014,Paris,,,France,432914,2014,
Menadione Sodium Bisulfite,n/a,2014-05-14,For the treatment of autosomal dominant polycystic kidney disease,Designated,,,N/A,N/A,IC-MedTech Corporation,9902 Indian Creek Lane,,El Cajon,California,92021,USA,429014,2014,
menadione sodium bisulfite,n/a,2014-05-14,Treatment of autosomal dominant polycystic liver disease,Designated,,,N/A,N/A,IC-MedTech Corporation,9902 Indian Creek Lane,,El Cajon,California,92021,USA,430114,2014,
recombinant humanized monoclonal antibody of the immunoglobulin G1 subclass directed against colony stimulating factor-1 receptor expressed on macrophages,n/a,2014-05-14,Treatment of pigmented villonodular synovitis and tenosynovial giant cell tumor,Designated/Withdrawn,,,N/A,N/A,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,USA,431614,2014,
"Selinexor; (Z)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-N-(pyrazin-2-yl)acrylohydrazide",n/a,2014-05-14,Treatment of acute myeloid leukemia,Designated,,,N/A,N/A,"Karyopharm Therapeutics, Inc.",2 Mercer Road,,Natick,Massachusetts,1760,USA,432414,2014,
Targeted Gastrin 17 Complexed Peptide,n/a,2014-05-14,Treatment of pancreatic cancer,Designated,,,N/A,N/A,Tyg Oncology Ltd,"Synergy House, 7 Acorn Business Park",Nottinghamshire NG18 1 EX,,,,United Kingdom,431314,2014,
[a-N-(2'succinyl-paclitaxel)Thr]-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-[epsilon-N-(2'succinyl-paclitaxel)Lys]-Arg-Asn-Asn-Phe-[epsilon-N-(2'succinyl-paclitaxel)Lys]-Thr-Glu-Glu-Tyr,n/a,2014-05-14,Treatment of glioblastoma multiforme,Designated,,,N/A,N/A,"Angiochem, Inc.",201 President-Kennedy Avenue,MOntreal QCH2X 3Y7,,,,Canada,432514,2014,
"4-{[(2R,3S,4R,5S)-4-(4-Chloro-2-fluoro-phenyl)-3-(3-chloro-2-fluoro-phenyl)-4-cyano-5-(2,2-dimethyl-propyl)-pyrrolidine-2-carbonyl]-amino}-3-methoxy-benzoic acid",n/a,2014-05-19,Treatment of Acute Myeloid Leukemia,Designated,,,N/A,N/A,Roche Genentech,F. Hoffmann-La Roche Ltd.,430 East 29th Street,New York,New York,10016,USA,429614,2014,
recombinant lens epithelium derived growth factor 1-326,n/a,2014-05-19,Treatment of retinitis pigmentosa,Designated,,,N/A,N/A,"Ocugen, Inc.",Bioscience Park Center,Suite 100,Aurora,Colorado,80045,USA,432314,2014,
"all-cis-docosa-4,7,10,13,16,19-hexaenoic acid",Retriacyl,2014-05-21,Treatment of retinitis pigmentosa,Designated,,,N/A,N/A,"Natac Pharma, S.L.",C/ Faraday 7,28049,Madrid,,,Spain,432814,2014,
live attenuated bioengineered Listeria monocytogenes immunotherapy,n/a,2014-05-21,Treatment of osteosarcoma.,Designated,,,N/A,N/A,"Advaxis, Inc.",305 College Road East,,Princeton,New Jersey,8540,USA,437714,2014,
humanized immunoglobulin monoclonal antibody against CD38,n/a,2014-05-22,Treatment of multiple myeloma.,Designated,,,N/A,N/A,"Sanofi U.S. Services, Inc.",500 Kendall Street,,Cambridge,Massachusetts,2142,USA,431914,2014,
miconazole,n/a,2014-05-22,Treatment of fungal otitis externa (otomycosis),Designated,,,N/A,N/A,"Hill Dermaceuticals, Inc.",2650 S. Mellonville Ave.,,Sanford,Florida,32773,USA,406413,2014,
spironolactone,Aldactone,2014-05-22,Use in pediatric patients with primary hyperaldosteronism,Designated,,,N/A,N/A,"CMP Pharma, Inc.",PO Box 147,8026 US Highway 264A,Farmville,North Carolina,27828,USA,430614,2014,
p38 mitogen-activated kinase inhibitor,n/a,2014-05-27,"Treatment of dilated cardiomyopathy, including dilated cardiomyopathy secondary to lamin A/C gene mutations",Designated,,,N/A,N/A,"Array BioPharma, Inc.",3200 Walnut Street,,Boulder,Colorado,80301,USA,431714,2014,
heparan sulfate mimetic,n/a,2014-05-29,Treatment of pancreatic cancer,Designated,,,N/A,N/A,"Momenta Pharmaceuticals, Inc.",675 West Kendall Street,,Cambridge,Massachusetts,2142,USA,433314,2014,
Human Monoclonal Antibody against Epidermal Growth Factor Receptor Linked to Monomethylauristatin F,n/a,2014-05-29,Treatment of glioblastoma multiforme,Designated,,,N/A,N/A,"AbbVie, Inc.",1 N. Waukegan Road,,North Chicago,Illinois,60064,USA,433214,2014,
metformin,n/a,2014-05-29,Treatment of pediatric polycystic ovary syndrome,Designated,,,N/A,N/A,EffRx Pharmaceuticals SA,Wolleraustrass 41 B,8807 Freienbach (SZ),,,,Switzerland,432214,2014,
sacituzumab govitecan,n/a,2014-05-29,Treatment of pancreatic cancer.,Designated,,,N/A,N/A,"Immunomedics, Inc.",300 The American Road,,Morris Plains,New Jersey,7950,USA,433514,2014,
von Willebrand Factor Human Concentrate,Wilfactin,2014-05-29,Treatment of Von Willebrand Disease,Designated,,,N/A,N/A,"rEVO Biologics, Inc.",175 Crossing Blvd,,Framingham,Massachusetts,1702,USA,424814,2014,
2-[4-(1-Methyl-4-pyridin-4-yl-lH-pyrazol-3-yl)-phenoxymethyl]-quinoline succinic acid,n/a,2014-06-02,Treatment of Huntington's disease.,Designated/Withdrawn,,,N/A,N/A,Pfizer Inc.,445 Eastern Point Road,,Groton,Connecticut,6340,USA,429914,2014,
antagonist of the complement 5a receptor,n/a,2014-06-02,"Treatment of anti-neutrophil cytoplasmic autoantibodies associated vasculitides (granulomatosis with polyangiitis or Wegener's granulomatosis), microscopic polyangiitis, and Churg-Strauss syndrome.",Designated,,,N/A,N/A,"ChemoCentryx, Inc.",850 Maude Avenue,,Mountain View,California,94043,USA,432014,2014,
echothiophate iodide,n/a,2014-06-02,Treatment of Stargardt's disease,Designated,,,N/A,N/A,"Makindus, Inc.",3805 Old Easton Road,,Doylestown,Pennsylvania,18902,USA,430914,2014,
everolimus,n/a,2014-06-02,Treatment of diffuse large B-cell lymphoma,Designated,,,N/A,N/A,Novartis Pharmaceuticals Corp.,"One Health Plaza, 315/5450A",,East Hanover,New Jersey,7936,USA,431214,2014,
afatinib,Gilotrif,2014-06-04,Treatment of malignant brain and central nervous system tumors,Designated,,,N/A,N/A,"Boehringer Ingelheim Pharmaceuticals, Inc.",900 Ridgebury Road,P. O. Box 368,Ridgefield,Connecticut,6877,USA,433414,2014,
vatiquinone,Vincerinone,2014-06-04,Treatment of Leigh Syndrome,Designated,,,N/A,N/A,BioElectron Technology Corporation,350 North Bernardo Ave.,,Mountain View,California,94043,USA,435014,2014,
trifarotene,n/a,2014-06-06,Treatment of congenital ichthyosis,Designated,,,N/A,N/A,"Galderma R&D, LLC",5 Cedar Brook Drive,Suite 1,Cranbury,New Jersey,8512,USA,431014,2014,
autologous genetically modified human dermal fibroblasts,n/a,2014-06-10,Treatment of dystrophic epidermolysis bullosa.,Designated,,,N/A,N/A,"Fibrocell Technologies, Inc.",405 Eagleview Blvd,,Exton,Pennsylvania,19341,USA,434614,2014,
enasidenib,Idhifa,2014-06-12,Treatment of acute myelogenous leukemia,Designated/Approved,Approved for Orphan Indication,Treatment of adult patients with relapsed or refractory acute myeloid leukemia with an isocitrate dehydrogenase-2 (IDH2) mutation as detected by an FDA-approved test,2017-08-01,2024-08-01,Celgene Corporation,"Corporate Woods Bldg 32, Suite 900",9225 Indian Creek Parkway,Overland Park,Kansas,66210,USA,434514,2014,1146
eculizumab,Soliris,2014-06-12,Treatment of Myasthenia Gravis,Designated/Approved,Approved for Orphan Indication,for the treatment of adult patients with generalized Myasthenia Gravis (gMG) who are anti-acetylcholine receptor (AchR) antibody positive,2017-10-23,2024-10-23,"Alexion Pharmaceuticals, Inc.",100 College Steet,,New Haven,Connecticut,6510,USA,434214,2014,1229
"6-[4-Deoxy-4-[(2E,4E)-tetradecadienoylglycyl]amino-L-glycero-B-L-manno-heptopyranosyl]amino-9H-purine",n/a,2014-06-12,Treatment of multiple myeloma,Designated/Withdrawn,,,N/A,N/A,"DARA Therapeutics, Inc.",8601 Six Forks Road,Suite 160 (Forum 1),Raleigh,North Carolina,27615,USA,434414,2014,
Epstein-Barr virus-specific autologous cytotoxic T lymphocytes,n/a,2014-06-12,Treatment of Epstein-Barr virus positive head and neck cancers (which includes nasopharyngeal carcinoma),Designated,,,N/A,N/A,Tessa Therapeutics Pte.,8 Temasek Blvd #24-02,Suntec Tower Three,,,,Singapore,434714,2014,
Mocetinostat,n/a,2014-06-12,Treatment of myelodysplastic syndrome,Designated,,,N/A,N/A,"Mirati Therapeutics, Inc.",9363 Towne Centre Drive,Suite 200,San Diego,California,92121,USA,435414,2014,
small molecule normalizing the p53 function,n/a,2014-06-12,Treatment of ovarian cancer,Designated,,,N/A,N/A,"Critical Outcome Technologies, Inc.",700 Collip Circle - Suite 213,"London, ON N6G 4X8",London,,,Canada,434314,2014,
carglumic acid,Carbaglu,2014-06-17,Treatment of organic acidemias,Designated,,,N/A,N/A,Orphan Europe SARL,Immeuble Le Wilson,70 avenue du General de Gaulle,92800 Puteaux,,,France,352111,2014,
human fully IgG1 antibody specific for CD33,n/a,2014-06-19,Treatment of acute myeloid leukemia,Designated,,,N/A,N/A,"Boehringer Ingelheim Pharmaceuticals, Inc.",900 Ridgebury Road,P. O. Box 368,Ridgefield,Connecticut,6877,USA,435614,2014,
Re188 P2045 somatostatin peptide analogue,n/a,2014-06-19,Treatment of pancreatic cancer.,Designated,,,N/A,N/A,"Andarix Pharmaceuticals, Inc.",141 Powderhouse Blvd,Suite 1,Somerville,Massachusetts,2144,USA,434914,2014,
"(2'R,3'S)-2'-hydroxy-N-carboxy-3'-amino-5'-methyl-hexanoic,N-tert-butyl ester, 13 ester 5B-20-epoxy-1B,2a,4a,7B,9a,10a,13a-heptahydroxy-4,10-diacetate-2-benzoate-(1""S)-7,9-acrolein acetal-11(15-1)-abeotaxane",n/a,2014-06-23,Treatment of progressive supranuclear palsy,Designated,,,N/A,N/A,"Cortice Biosciences, Inc.",1345 Avenue of the Americas,42nd Floor,New York,New York,10105,USA,436014,2014,
cannabidiol,n/a,2014-06-23,Treatment of Lennox-Gastaut syndrome,Designated,,,N/A,N/A,"Insys Development Company, Inc.",1333 S. Spectrum Blvd,Suite 100,Chandler,Arizona,85286,USA,438214,2014,
recombinant human nerve growth factor,n/a,2014-06-23,Treatment of neurotrophic keratitis,Designated,,,N/A,N/A,Dompe s.p.a.,Via S. Martino 12-12/A,,Milan,,,Italy,436214,2014,
recombinant human surfactant protein D,n/a,2014-06-23,Prevention of bronchopulmonary dysplasia,Designated,,,N/A,N/A,Airway Therapeutics LLC,11804 Conrey Road,Suite 175,Cincinnati,Ohio,45249,USA,347011,2014,
clofazimine,Lamprene,2014-06-25,Treatment of active tuberculosis,Designated,,,N/A,N/A,Novartis Pharmaceuticals Corp.,One Health Plaza,Bldg 135/409,East Hanover,New Jersey,7936,USA,436314,2014,
sirolimus,n/a,2014-06-25,Treatment of lymphangioleiomyomatosis,Designated,,,N/A,N/A,"LAM Therapeutics, Inc.",530 Old Whitfield Street,,Guilford,Connecticut,,USA,434114,2014,
lumacaftor/ivacaftor,Orkambi,2014-06-30,Treatment of cystic fibrosis,Designated/Approved,Approved for Orphan Indication,Treatment of cystic fibrosis in patients age 12 years and older who are homozygous for F508del mutation in the CFTR gene,2015-07-02,2022-07-02,Vertex Pharmaceuticals Inc.,50 Northern Avenue,,Boston,Massachusetts,2210,USA,434814,2014,367
lumacaftor/ivacaftor,Orkambi,2014-06-30,Treatment of cystic fibrosis,Designated/Approved,Approved for Orphan Indication,Treatment of cystic fibrosis (CF) in patients age 6-11 year old who are homozygous for the F508del mutation in the CFTR gene,2016-09-28,2023-09-28,Vertex Pharmaceuticals Inc.,50 Northern Avenue,,Boston,Massachusetts,2210,USA,434814,2014,821
humanized anti-IL-6R receptor neutralizing IgG2 monoclonal antibody,n/a,2014-06-30,Treatment of neuromyelitis optica and neuromyelitis optica spectrum disorder,Designated,,,N/A,N/A,"Chugai Pharma USA, LLC",300 Connell Drive,Suite 3100,Berkeley Heights,New Jersey,7922,USA,436114,2014,
plasmid DNA encoding the human cystic fibrosis transmembrane conductance regulator gene complexed with a nonviral cationic lipid based gene transfer agent,n/a,2014-06-30,Treatment of cystic fibrosis,Designated,,,N/A,N/A,Imperial Innovations Limited,52 Princess Gate,"London, SW7 2PG",,,,United Kingdom,437314,2014,
2-(2-phenylvinyl)-4-[4-methylpiperazin-1-yl)]-6-(5-methyl-2H-pyrazol-3-yl-amino)-pyrimidine L(+) tartrate salt,n/a,2014-07-01,Treatment of hepatocellular carcinoma,Designated,,,N/A,N/A,"CASI Pharmaceuticals, Inc.",9620 Medical Center Drive,Suite 300,Rockville,Maryland,20850,USA,437214,2014,
cannabidiol,n/a,2014-07-01,Treatment of Dravet syndrome,Designated,,,N/A,N/A,"Insys Development Company, Inc.",1333 S. Spectrum Blvd,Suite 100,Chandler,Arizona,85286,USA,439414,2014,
bendamustine for 50 ml admixture,Bendeka,2014-07-02,Treatment of chronic lymphocytic leukemia,Designated/Approved,Approved for Orphan Indication,Treatment of patients with CLL and treatment of patients with indolent B-cell NHL,2015-12-07,N/A,"Eagle Pharmaceuticals, INc.",50 Tice Blvd,Suite 315,Woodcliff Lake,New Jersey,7677,USA,431814,2014,523
bendamustine for 50ml admixture,Bendeka,2014-07-02,"Treatment of Follicular Lymphoma, Small Lymphocytic Lymphoma, Lymphoplasmacytic Lymphoma, Splenic Marginal Zone Lymphoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-Associated Lymphoma Tissue (MALT), and Nodal Marginal Zone Lymphoma (Collectively Indolent B-cell Non-Hodgkin's Lymphoma)",Designated/Approved,Approved for Orphan Indication,Treatment of patients with CLL and treatment of patients with indolent B-cell NHL,2015-12-07,N/A,"Eagle Pharmaceuticals, Inc.",50 Tice Blvd,Suite 315,Woodcliff Lake,New Jersey,7677,USA,430314,2014,523
carbenoxolone,n/a,2014-07-02,Treatment of Huntington's Disease,Designated,,,N/A,N/A,"Oxalys Pharmaceuticals, Inc.",4 Mollard Road,,"Toronto, ON M1S 2L4",,,Canada,429414,2014,
adalimumab,n/a,2014-07-10,Treatment of Behcet's disease,Designated,,,N/A,N/A,Mucora,32b Eisenberg St,Rehovot 7628810,,,,Israel,436714,2014,
siponimod,n/a,2014-07-10,Treatment of dermatomyositis,Designated,,,N/A,N/A,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,USA,437614,2014,
maytansinoid conjugated humanized monoclonal antibody against FOLRI,n/a,2014-07-14,Treatment of ovarian cancer,Designated,,,N/A,N/A,"ImmunoGen, Inc.",830 Winter Street,,Waltham,Massachusetts,2451,USA,435214,2014,
oxfendazole,n/a,2014-07-14,Treatment of cysticercosis (including neurocysticercosis),Designated,,,N/A,N/A,"Robert H. Gilman, MD, DTMH and",Johns Hopkins School of Public Health,"615 N. Wolfe St, Room W5515",Baltimore,Maryland,21205,USA,435514,2014,
paclitaxel-coated buttress,n/a,2014-07-15,For use as local administration at the time of curative surgery in the treatment of stage 0 to III non-small cell lung cancer.,Designated,,,N/A,N/A,"AcuityBio, Inc.",200 Upland Road,,Newton,Massachusetts,2460,USA,394813,2014,
"2-[(6S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thienol[3,2,-f]-[1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl]-N-(4-hydroxyphenyl)-acetamide dihydrate",n/a,2014-07-16,Treatment of acute myeloid leukemia,Designated,,,N/A,N/A,OncoEthix GmbH (Merck Subsidiary),Weystrasse 20,6000 Lucerne,,,,Switzerland,433914,2014,
"single stranded, chemically modified oligonucleotide that binds to and inhibits the function of micro RNA-21",n/a,2014-07-17,Treatment of Alport syndrome,Designated,,,N/A,N/A,"Regulus Therapeutics, Inc.",3545 John Hopkins Court,Suite 210,San Diego,,92121,USA,438614,2014,
antibody drug conjugate consisting of fully human anti-guanylyl cyclase C monoclonal antibody linked to the cytotoxic drug monomethyl auristatin E,n/a,2014-07-21,Treatment of gastric cancer,Designated/Withdrawn,,,N/A,N/A,"Millennium Pharmaceuticals, Inc.",40 Landsdowne Street,,Cambridge,Massachusetts,2139,USA,437914,2014,
palovarotene,n/a,2014-07-21,Treatment of fibrodysplasia ossificans progressiva,Designated,,,N/A,N/A,"Clementia Pharmaceuticals, Inc.",1375 TransCanada Highway,"Dorval, Quebec H9P 2W8",,,,Canada,438714,2014,
pegargiminase,n/a,2014-07-21,Treatment of mesothelioma.,Designated,,,N/A,N/A,Polaris Group,"Polaris Pharmaceuticals, Inc.","9373 Town Centre Dr., Suite 150",San Diego,California,92121,USA,437014,2014,
triterpenoid saponin,n/a,2014-07-23,Treatment of mantle cell lymphoma,Designated,,,N/A,N/A,"Avicin Therapeutics, Ltd.",Westpark Corporate Center,4364 S. Alston Avenue,Durham,North Carolina,27713,USA,435314,2014,
riociguat,Adempas,2014-07-24,Treatment of systemic sclerosis,Designated,,,N/A,N/A,Bayer HealthCare Pharmaceuticals,100 Bayer Blvd,P. O. Box 915,Whippany,New Jersey,7981,USA,439514,2014,
Antibody drug conjugate consisting of a humanized IgG1 anti-NaPi2b monoclonal antibody and monomethyl auristatin E,n/a,2014-07-29,Treatment of ovarian cancer,Designated/Withdrawn,,,N/A,N/A,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,USA,440714,2014,
monomethyl auristatin E conjugated to a monoclonal antibody which targets guanylyl cyclase C,n/a,2014-07-29,Treatment of pancreatic cancer.,Designated/Withdrawn,,,N/A,N/A,"Millennium Pharmaceuticals, Inc.",40 Landsdowne Street,,Cambridge,Massachusetts,2139,USA,438014,2014,
binimetinib,n/a,2014-07-31,Treatment of ovarian cancer,Designated,,,N/A,N/A,"Array Biopharma, Inc.",3200 Walnut Street,,Boulder,Colorado,80301,USA,440414,2014,
pirfenidone,n/a,2014-07-31,Treatment of idiopathic pulmonary fibrosis,Designated,,,N/A,N/A,"Avalyn Pharma, Inc.",701 Pike Street,Suite 1500,Seattle,Washington,98101,USA,436914,2014,
Roseburia hominis,Rosburix,2014-08-04,Treatment of ulcerative colitis in pediatric patients age 0 through 16 years,Designated,,,N/A,N/A,4D Pharma Research Ltd,Life Sciences Innovation Bldg,Cornhill Road,,,,United Kingdom,439114,2014,
nivolumab,Opdivo,2014-08-07,Treatment of Hodgkin lymphoma,Designated/Approved,Approved for Orphan Indication,Treatment of adult patients with Classical Hodgkin lymphoma that has relapsed or progressed after autologous hematopoietic stem cell transplantation (HSCT) and brentuximab vedotin,2016-05-17,2023-05-17,Bristol-Myers Squibb Company,Route 206 & Province Line Road,P. O. Box 4000,Princeton,New Jersey,8543,USA,442614,2014,649
nivolumab,Opdivo,2014-08-07,Treatment of Hodgkin lymphoma,Designated/Approved,Approved for Orphan Indication,Treatment of adult patients with Classical Hodgkin lymphoma that has relapsed or progressed after 3 or more lines of systemic therapy that includes autologous HSCT,2017-04-25,2024-04-25,Bristol-Myers Squibb Company,Route 206 & Province Line Road,P. O. Box 4000,Princeton,New Jersey,8543,USA,442614,2014,992
Anti-Beta1 integrin monoclonal antibody,n/a,2014-08-07,Treatment of glioblastoma,Designated,,,N/A,N/A,"OncoSynergy, Inc.",409 Illinois Street,Room 3044,San Francisco,California,94158,USA,440614,2014,
dry extract from Betulae Cortex (birch bark),n/a,2014-08-07,Treatment of epidermolysis bullosa,Designated,,,N/A,N/A,Birken AG,Streiflingsweg 11,,Niefern-Oeschelbronn,,,Germany,438114,2014,
mocetinostat,n/a,2014-08-07,Treatment of diffuse large B-cell lymphoma,Designated,,,N/A,N/A,"Mirati Therapeutics, Inc.",9363 Towne Centre Drive,Suite 200,San Diego,California,92121,USA,441514,2014,
"N1,N14,-diethyl-3,12,-dihydroxyhomospermine",n/a,2014-08-07,Treatment of pancreatic cancer,Designated,,,N/A,N/A,"Sun BioPharma, Inc.",712 Vista Blvd,Suite 305,Waconia,Minnesota,55387,USA,441214,2014,
"Immune Globulin Subcutaneous (Human), 20% Liquid",Hizentra,2014-08-18,Treatment of chronic inflammatory demyelinating polyneuropathy (CIDP),Designated/Approved,Approved for Orphan Indication,Indicated for the treatment of adult patients with chronic inflammatory demyelinating polyneuropathy (CIPD) as maintenance therapy to prevent relapse of neuromuscular disability and impairment.,2018-03-15,TBD,CSL Behring,1020 First Avenue,PO Box 61501,King of Prussia,Pennsylvania,19406,USA,439914,2014,1305
recombinant human deoxyribonuclease I,n/a,2014-08-18,Treatment of graft-vs-host disease,Designated,,,N/A,N/A,SciVac Ltd.,13 Gad Feinstei Road,Rehovot 7610303,,,,Israel,447114,2014,
recombinant human deoxyribonuclease I (DNase I),n/a,2014-08-18,Prevention of graft-vs-host disease,Designated,,,N/A,N/A,SciVac Ltd.,13 Gad Feinstei Road,Rehovot 7610303,,,,Israel,439614,2014,
altiratinib,n/a,2014-08-19,Treatment of glioblastoma multiforme.,Designated,,,N/A,N/A,"Deciphera Pharmaceuticals, LLC",643 Massachusetts,Suite 200,Lawrence,Kansas,66044,USA,441714,2014,
dexrazoxane hydrochloride,n/a,2014-08-19,Prevention of cardiomyopathy for chilren and adolescents 0 through 16 years of age treated with anthracyclines,Designated,,,N/A,N/A,"Satiscor, LLC",45 Marine Road,,Boston,Massachusetts,2127,USA,441314,2014,
Lacnotuzumab,n/a,2014-08-19,"Treatment of pigmented villonodular synovitis, including giant cell tumor of the tendon sheath",Designated,,,N/A,N/A,Novartis Pharmaceuticals Corp,One Health Plaza,,East Hanover,New Jersey,7936,USA,439314,2014,
olaptesed pegol,n/a,2014-08-19,Treatment of glioblastoma in conjunction with radiotherapy.,Designated,,,N/A,N/A,Noxxon Pharma AG,Max-Dohrn0Strasse 8-10,,Berlin,,,Germany,443114,2014,
selective inhibitor of fungal lanosterol demethylase,n/a,2014-08-19,Treatment of cryptococcal meningitis,Designated,,,N/A,N/A,"Viamet Pharmaceuticals, Inc.",4505 Emperor Blvd,Suit 300,Durham,North Carolina,27703,USA,439214,2014,
sodium phenylbutyrate,n/a,2014-08-19,Treatment of maple syrup urine disease,Designated,,,N/A,N/A,"Acer Therapeutics, Inc.",222 Third Street,Suite 2240,Cambridge,Massachusetts,2142,USA,439714,2014,
cannabidiol,n/a,2014-08-20,Treatment of glioblastoma multiforme,Designated,,,N/A,N/A,"Insys Development Company, Inc.",1333 S. Spectrum Blvd,Suite 100,Chandler,Arizona,85286,USA,444814,2014,
"monoclonal antibody consisting of three mouse/human chimeric IgG1 monoclonal antibodies (c2G4, c4G7, and c13C6) that target Ebola virus",n/a,2014-08-25,Treatment of Ebola virus infection,Designated,,,N/A,N/A,"LeafBio, Inc.","6160 Lusk Blvd.,",Suite C105,San Diego,California,90121,USA,440914,2014,
oprozomib,n/a,2014-08-25,Treatment of Waldenstrom's macroglobulinemia,Designated,,,N/A,N/A,"Onyx Therapeutics, Inc.",249 E. Grand Avenue,,South San Francisco,California,94080,USA,443614,2014,
gefitinib,Iressa,2014-08-26,Treatment of epidermal growth factor receptor mutation-positive non-small cell lung cancer,Designated/Approved,Approved for Orphan Indication,For the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test,2015-07-13,2022-07-13,AstraZeneca Pharmaceuticals LP,1800 Concord Pike,P. O. Box 8355,Wilmington,Delaware,19803,USA,443014,2014,321
recombinant human Pentraxin-2,n/a,2014-08-26,Treatment of myelofibrosis,Designated,,,N/A,N/A,"Promedior, Inc.",101 Hartwell Avenue,,Lexington,Massachusetts,2421,USA,416013,2014,
vemurafenib,Zelboraf,2014-08-26,Treatment of hairy cell leukemia (HCL).,Designated,,,N/A,N/A,"Genentech, Inc.",1 DNA Way,MS 241b,South San Francisco,California,94080,USA,444114,2014,
Venglustat,n/a,2014-08-26,Treatment of Fabry's disease,Designated,,,N/A,N/A,Genzyme Corporation,500 Kendall Street,,Cambridge,Massachusetts,1242,USA,439814,2014,
Spanlecortemlocel,n/a,2014-08-27,Hematopoietic support in patients with acute lymphoblastic leukemia (ALL),Designated,,,N/A,N/A,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,USA,443514,2014,
"2-{[(1r,4r)-4-(((4-chlorophenyl)(phenyl)carbamoyloxy)methyl)cyclohexy]methoxy} acetic acid",n/a,2014-08-28,Treatment of pulmonary arterial hypertension,Designated,,,N/A,N/A,"Arena Pharmaceuticals, Inc.",6154 Nancy Ridge Drive,,San Diego,California,92121,USA,440214,2014,
Methotrexate,Amethopterin,2014-08-28,Treatment of Myasthenia Gravis,Designated,,,N/A,N/A,The Universtiy of Kanasa Medical Center,3901 Rainbow Blvd,MSN 2012,Kanasa City,Kansas,66160,USA,440314,2014,
mebendazole,Vermox 500 Mg Chewable Tablets,2014-09-03,"Treatment of single or mixed gastrointestinal infestations by Trichuris trichiura (whipworm), Ascaris lumbricoides (large roundworm), and Ancylostoma duodenale and Nectar americanus (hookworm).",Designated/Approved,Approved for Orphan Indication,treatment of patients one year of age and older withgastrointestinal infections caused by Ascaris lumbricoides (roundworm) and Trichuris trichiura (whipworm),2016-10-19,N/A,"Janssen Pharmaceutical Research & Development, LLC",920 Route 202 South,,Raritan,New Jersey,8869,USA,397013,2014,777
osimertinib,Tagrisso,2014-09-04,Treatment of epidermal growth factor receptor mutation-positive non-small cell lung cancer,Designated/Approved,Approved for Orphan Indication,"For treatment of patients with metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC), as detected by an FDA-approved test, who have progressed on or after EGFR TKI therapy",2015-11-13,2022-11-13,AstraZeneca Pharmaceuticals LP,P. O. Box 8355,1800 Concord Pike,Wilmington,Delaware,19803,USA,445214,2014,435
osimertinib,Tagrisso,2014-09-04,Treatment of epidermal growth factor receptor mutation-positive non-small cell lung cancer,Designated/Approved,Approved for Orphan Indication,"TAGRISSO® is indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 L858R mutations, as detected by an FDA-approved test",2018-04-18,TBD,AstraZeneca Pharmaceuticals LP,P. O. Box 8355,1800 Concord Pike,Wilmington,Delaware,19803,USA,445214,2014,1322
"5,7-dichloro-2-dimethylaminomethyl-8-hydroxyquinoline hydrochloride",n/a,2014-09-04,Treatment of Huntington's disease,Designated,,,N/A,N/A,Prana Biotechnology Limited,"Level 2, 369 Royal Parade",Parkville,Victoria 3052,,,Australia,353711,2014,
"6-((3S,4S)-4-Methyl-1-pyrimidin-2-ylmethyl-pyrrolidin-3-yl-1-(tetrahydro-pyran-4-yl)-1,5-dihydro-pryazolo[3,4-d]pyrimidin-4-one",n/a,2014-09-04,Treatment of sickle cell disease,Designated,,,N/A,N/A,"Pfizer, Inc.",500 Arcola Road,,Collegeville,Pennsylvania,19426,USA,440514,2014,
Adenoassociated virus vector (AAV) carrying a modified AAV serotype 2 backbone and coding sequence of human thymidine phosphorylase preceded by a human thyroxin-binding globulin promoter,n/a,2014-09-04,For the treatment of Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE),Designated,,,N/A,N/A,Columbia University Medical Center,Department of Neurology,"630 West 168th Street, P&S 4-423",New York,New York,10032,USA,441014,2014,
"Adenovirus serotype-5 (Ad5) vector that contains a modified non-oncogenic fused early 6 (E6) and early 7 (E7) gene of the human papillomavirus (HPV); (Ad5 [E1-, E2b-]-E6/E7)",n/a,2014-09-04,Treatment of human papillomavirus (HPV)-associated head and neck squamous cell carcinoma (HNSCC),Designated,,,N/A,N/A,Etubics Corporation,410 West Harrison Street,Suite 100,Seattle,Washington,98119,USA,444514,2014,
inBreath airway transplant system,n/a,2014-09-04,"To restore the structure and/or function of the trachea subsequent to tracheal damage due to cancer, injury or infection",Designated,,,N/A,N/A,"Biostage, Inc.",84 October Hill Road,Suite 11,Holliston,Massachusetts,1746,USA,419813,2014,
ibrutinib,n/a,2014-09-08,Treatment of follicular lymphoma,Designated,,,N/A,N/A,"Pharmacyclics, LLC",995 E. Arques Avenue,,Sunnyvale,California,94085,USA,444414,2014,
mitomycin,Mitogel,2014-09-08,Treatment of upper tract urothelial cell cancers (transitional cell carcinoma of the renal pelvis and ureter),Designated,,,N/A,N/A,Urogen,"9 Ha'Ta'asiya St., POB 2397",Ra'anana 4365007,,,,Israel,445114,2014,
vemurafenib,Zelboraf,2014-09-08,Treatment of patients with non-small cell lung cancer (NSCLC) with BRAF V600 mutation,Designated,,,N/A,N/A,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,USA,444314,2014,
single chain urokinase plasminogen activator,n/a,2014-09-11,Treatment of empyema (pleural),Designated,,,N/A,N/A,"Lung Therapeutics, Inc.",P. O. Box 150183,,Austin,Texas,78715,USA,442514,2014,
"(3S)-1-azabicyclo[2.2.2]oct-3-yl {2-[2-(4-fluorophenyl)-1,3-thiazol-4-yl]propan-2-yl}carbamate",n/a,2014-09-11,Treatment of Gaucher disease,Designated,,,N/A,N/A,Genzyme,500 Kendall Street,,Cambridge,Massachusetts,2142,USA,443414,2014,
Cysteamine,Lynovex,2014-09-11,Treatment of cystic fibrosis,Designated,,,N/A,N/A,NovaBiotics Ltd.,Cruickshank Building,Craibstone,Aberdeen AB21 9TR,,,United Kingdom,368712,2014,
humanized monoclonal antibodies hu1B7 and hu11E6,n/a,2014-09-11,Treatment of Bordetella pertussis,Designated,,,N/A,N/A,"Synthetic Biologics, Inc.",155 Gibbs Street,Suite 412,Rockville,Maryland,20850,USA,442914,2014,
"silibinin-C-2',3-dihydrogensuccinate, disodium salt",Legalon Sil,2014-09-11,"Treatment of amatoxin poisoning, which includes the prevention and treatment of amatoxin induced hepatic failure",Designated,,,N/A,N/A,Mylan Specialty LP,781 Chestnut Ridge Road,P. O. Box 4310,Morgantown,West Virginia,26504,USA,444214,2014,
technetium Tc 99m tilmanocept,Lymphoseek,2014-09-17,"Use in sentinel lymph node detection (SLN) with a hand-held gamma-counter, with scintigraphic imaging, in patients with cancer of the head and neck",Designated/Approved,Approved for Orphan Indication,"Guiding sentinel lymph node biopsy, using a hand-held gamma counter in patients with clinically node negative squamous cell carcinoma of the oral cavity.",2014-06-13,2021-06-13,"Cardinal Health 414, LLC",7000 Cardinal Place,,Dublin,Ohio,43017,USA,427814,2014,-96
"4-amino-1-[(1S,4R,5S)-2-fluoro-4,5-dihydroxy-3-(hydroxymethyl) cyclopent-2-en-1-yl] pyrimidin-2-one",n/a,2014-09-23,Treatment of pancreatic cancer.,Designated,,,N/A,N/A,"Rexahn Pharmaceuticals, Inc.",15245 Shady Grove Road,,Rockville,Maryland,20850,USA,447314,2014,
heat killed whole cell mycobacterium obuense,n/a,2014-09-23,Treatment of pancreatic cancer,Designated,,,N/A,N/A,Immodulon Therapeutics Limited,22 Devonshire Place,"B2, London W1G 6JA",,,,United Kingdom,446114,2014,
"MV-NB-02, its bivalent ganglioside vaccine consisting of GD2-lactone and GD3-lactone each covalently conjugated to keyhole hemocyanin",n/a,2014-09-23,Treatment of Neuroblastoma,Designated,,,N/A,N/A,"MabVax Therapeutics, Inc.",11588 Sorrento Road,Suite 20,San Diego,California,92121,USA,445914,2014,
nitric oxide,n/a,2014-09-23,Treatment of cystic fibrosis,Designated,,,N/A,N/A,"Advanced Inhalation Therapies, Ltd.",2 Ilan Ramon Street,,Ness Ziyona,,,Israel,443914,2014,
"68G-OPS202, small somatostatin analog labeled with 68Gallium",n/a,2014-09-24,Management of gastroenteropancreatic neuroendocrine tumors.,Designated,,,N/A,N/A,"Ipsen Biosciences, Inc.",650 East Kendall Street,,Cambridge,Massachusetts,2142,USA,449514,2014,
aldoxorubicin,n/a,2014-09-24,Treatment of ovarian cancer,Designated,,,N/A,N/A,"NantCell, Inc.",9920 Jefferson Boulevard,,Culver City,California,90232,USA,446814,2014,
aldoxorubicin,n/a,2014-09-24,Treatment of small cell lung cancer,Designated,,,N/A,N/A,"NantCell, Inc.",9920 Jefferson Boulevard,,Culver City,California,90232,USA,446914,2014,
aldoxorubicin,n/a,2014-09-24,Treatment of glioblastoma multiforme,Designated,,,N/A,N/A,"NantCell, Inc.",9920 Jefferson Boulevard,,Culver City,California,90232,USA,447014,2014,
cannabidiol,n/a,2014-09-24,Treatment of glioma,Designated,,,N/A,N/A,"Insys Development Company, Inc.",1333 S. Spectrum Blvd,Suite 100,Chandler,Arizona,85286,USA,450814,2014,
glucagon infusion,G-Pump (Tm),2014-09-25,"Prevention of chronic, severe hypoglycemia related to congential hyperinsulinism",Designated,,,N/A,N/A,"Xeris Pharmaceuticals, Inc.",3208 Red River Street,Suite 300,Austin,Texas,78705,USA,427514,2014,
adeno-associated virus serotype 9 expressing the human Survival Motor Neuron gene,n/a,2014-09-30,Treatment of spinal muscular atrophy,Designated,,,N/A,N/A,"AveXis, Inc.",One Energy Square,Suite 604,Dallas,Texas,75206,USA,444714,2014,
"adenovirus delta 24-RGD, an oncolytic adenovirus genetically modified for treatment of glioma",n/a,2014-10-01,Treatment of glioma,Designated,,,N/A,N/A,"DNAtrix, Inc.",3210 Merryfield Row,,San Diego,California,92121,USA,447214,2014,
interferon gamma-1b,Actimmune,2014-10-01,Treatment of Friedreich's Ataxia,Designated,,,N/A,N/A,Horizon Pharma Ireland Limited,"Connaught House, 1st Floor",1 Burlington Road,Dublin 4,,,Ireland,445514,2014,
PEGylated recombinant human hyaluronidase PH20,n/a,2014-10-01,Treatment of pancreatic cancer,Designated,,,N/A,N/A,"Halozyme Therapeutics, Inc.",11388 Sorrento Valley Road,,San Diego,California,92121,USA,447914,2014,
Theranost 68 Ga RGD,n/a,2014-10-01,A Diagnostic for the management of Moyamoya disease (MMD),Designated,,,N/A,N/A,"Advanced Imaging Projects, LLC (AIP)",3651 FAU Blvd.,,Boca Raton,Florida,33467,USA,452214,2014,
adeno-associated viral vector serotype 9 containing the human cardiac calsequestrin gene,Calmarythm,2014-10-02,Treatment of catecholaminergic polymorphic ventricular tachycardia,Designated,,,N/A,N/A,"Audentes Therapeutics, Inc.","101 Montgomery St., #2650",,San Francisco,California,94104,USA,445614,2014,
Inhibitor of primary and secondary KIT and PDGFR alpha kinase mutants found in GIST,n/a,2014-10-02,Treatment of gastrointestinal stromal tumors (GIST),Designated,,,N/A,N/A,"Deciphera Pharmaceuticals, LLC",643 Massachusetts,Suite 200,Lawrence,Kansas,66044,USA,447414,2014,
Combination of nivolumab and ipilimumab,n/a,2014-10-09,Treatment of Stage IIb to Stage IV melanoma,Designated/Approved,Approved for Orphan Indication,"Treatment of patients with BRAF V600 wild-type, unresectable or metastatic melanoma",2015-09-30,2022-09-30,Bristol-Myers Squibb Company,5 Research Parkway,,Wallingford,Connecticut,6492,USA,445014,2014,356
olaratumab,Lartruvo,2014-10-09,Treatment of soft tissue sarcoma,Designated/Approved,Approved for Orphan Indication,"In combination with doxorubicin, for the treatment of adult patients with soft tissue sarcoma (STS) with a histologic subtype for which an anthracycline-containing regimen is appropriate and which is not amenable to curative treatment with radiotherapy or surgery.",2016-10-19,2023-10-19,Eli Lilly and Company,"Lilly Corporate Center, Drop Code 2543",,Indianapolis,Indiana,46285,USA,448414,2014,741
A-dmDT390-bisFv(UCHT1),Resimmune,2014-10-09,Treatment of cutaneous T-cell lymphoma,Designated,,,N/A,N/A,"Angimmune, LLC",American Red Cross Holland Laboratory,15601 Crabbs Branch Way,Rockville,Maryland,20855,USA,448114,2014,
"S3,S13-cyclo(D-tyrolsyl-L-isoleucyl-L-cysteinyl-L-valyl-1-methyl-L-tryptophyl-L-glutaminyl-L-aspartyl-L-tryptophyl-N-methyl-L-glycyl-L-alanyl-L-histidyl-L-arginyl-L-cysteinyl-N-methyl-L-isoleucinamide)",n/a,2014-10-09,Treatment of paroxysmal nocturnal hemoglobinuria (PNH),Designated,,,N/A,N/A,Amyndas Pharmaceuticals,N.Zerva 28,,Glyfada,,,Greece,446714,2014,
diacerein,n/a,2014-10-15,Treatment of epidermolysis bullosa,Designated,,,N/A,N/A,Castle Creek Pharmaceuticals,1033 Skokie Blvd,Suite 600,Northbrook,Illinois,60062,USA,448614,2014,
"N-(3,4-dihydroxyphenyl)-3,4-dihydroxybenzamide",n/a,2014-10-15,Treatment of AL Amyloidosis,Designated,,,N/A,N/A,"ProtaMed, Inc.","14241 Woodinville Duvall Road, Suite # 370",,Woodinville,Washington,98072,USA,434014,2014,
N-Methanocarbathymidine,n/a,2014-10-15,Treatment of neonatal herpes,Designated,,,N/A,N/A,"N & N Pharmaceuticals, Inc.",2400 Research Blvd,Suite 310,Rockville,Maryland,20850,USA,426014,2014,
cardiotrophin-1,n/a,2014-10-16,Prevention of ischemia-reperfusion injury in kidney transplant recipients,Designated,,,N/A,N/A,"Digna Biotech, S.L.",Avenida Pio XII 22,Pamplona (Navarra),,,,Spain,432714,2014,
ibalizumab,Trogarzo,2014-10-20,Treatment of HIV-1 infection in treatment experienced adult patients with documented multi-antiretroviral class resistance and evidence of HIV-1 replication despite ongoing antiretroviral therapy,Designated/Approved,Approved for Orphan Indication,"TROGARZO, in combination with other antiretroviral(s), is indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in heavily treatment-experienced adults with multidrug resistant HIV-1 infection failing their current antiretroviral regimen.",2018-03-06,2025-03-06,"TaiMed Biologics, Inc.",2 Executive Circle,,Irvine,California,92614,USA,321910,2014,1233
alteplase,Activase,2014-10-20,Treatment of plastic bronchitis,Designated,,,N/A,N/A,"Kathleen A Stringer, PharmD, FCCP - Professor",University of MI,428 Church St.,Ann Arbor,Michigan,48109,USA,431414,2014,
dabrafenib,Tafinler,2014-10-20,Treatment of patients with BRAF mutation positive non-small cell lung cancer,Designated,,,N/A,N/A,Novartis Pharmaceuticals Corporation,1 Health Plaza,,East Hanover,New Jersey,7936,USA,448214,2014,
isavuconazonium sulfate,n/a,2014-10-20,Treatment of invasive candidiasis/candidemia,Designated,,,N/A,N/A,"Astellas Pharma Global Development, Inc.",1 Astellas Way,,Northbrook,Illinois,60062,USA,447814,2014,
non-replicating recombinant adeno-associated virus vector containing a fragment of the gene encoding channelrhodopsin-2 protein,n/a,2014-10-20,Treatment of retinitis pigmentosa,Designated,,,N/A,N/A,"Allergan, Inc.",2525 Dupont Drive,,Irvine,California,92612,USA,447714,2014,
tipelukast,n/a,2014-10-20,Treatment of idiopathic pulmonary fibrosis,Designated,,,N/A,N/A,"MediciNova, Inc.",4275 Executive Square,Suite 300,La Jolla,California,92037,USA,448914,2014,
"[5-Amino-1-(4-fluoro-phenyl)-1H-pyrazol-4-yl]-[3-(2,3-dihydroxy-propoxy)-phenyl]-methanone",n/a,2014-10-20,Treatment of pancreatic cancer,Designated,,,N/A,N/A,Synovo GmbH,Paul-Ehrlich-Str. 15,D-72076 Tubingen,,,,Germany,449814,2014,
"autologous bone marrow CD34+ cells transduced ex vivo with a self activating HIV-1 -based lentiviral vector, EFS-ADA",n/a,2014-10-21,Treatment of adenosine deaminase deficient severe combined immunodeficiency,Designated,,,N/A,N/A,Orchard Therapeutics Ltd.,Birchin Court,20 Birchin Lane,London,,,United Kingdom,449114,2014,
N-(4-{3-(2-aminopyrimidin-4-yl)pyridin-2-yl]oxy}phenyl)-4-(4-methylthiophen-2-yl)phthalazin-1-amine bis-mesylate dihydrate,n/a,2014-10-21,Treatment of ovarian cancer,Designated,,,N/A,N/A,"Amgen, Inc.",One Amgen Center Drive,Mail Stop 17-2-B,Thousand Oaks,California,91320,USA,450414,2014,
triheptanoin,n/a,2014-10-21,Treatment of glucose transporter type-1 deficiency syndrome,Designated,,,N/A,N/A,"Ultragenyx Pharmaceutical, Inc.",60 Leveroni Court,,Novato,California,94949,USA,426414,2014,
autologous adipose derived mesenchymal stromal cells,n/a,2014-10-22,Treatment of amyotrophic lateral sclerosis,Designated,,,N/A,N/A,Mayo Clinic,200 First Street SW,,Rochester,Minnesota,55905,USA,427014,2014,
bi-shRNA furin and GMCSF Autologous Tumor Cell Vaccine,Fang,2014-10-22,Treatment of Ewing's sarcoma,Designated,,,N/A,N/A,"Gradalis, Inc.",2545 Golden Bear Drive,Suite 110,Carrollton,Texas,75006,USA,442114,2014,
Istiratumab,n/a,2014-10-22,Treatment of pancreatic cancer,Designated,,,N/A,N/A,"Merrimack Pharmaceuticals, Inc.",1 Kendall Square,Suite B7201,Cambridge,Massachusetts,2139,USA,450314,2014,
alpha-1 proteinase inhibitor (human),Glassia,2014-10-23,Treatment of graft versus host disease,Designated,,,N/A,N/A,Kamada Ltd.,2 Holtsman Street,,Rehovot,,,Israel,448014,2014,
clenbuterol,"Spiropent, Ventipulmin",2014-10-27,Adjunctive therapy with enzyme replacement therapy in the treatment of Pompe disease,Designated,,,N/A,N/A,Duke University Medical Center,Box 103856,,Durham,North Carolina,27710,USA,451614,2014,
oprozomib,n/a,2014-10-28,Treatment of multiple myeloma,Designated,,,N/A,N/A,"Onyx Therapeutics, Inc.",249 E. Grand Avenue,,South San Francisco,California,94080,USA,449614,2014,
pritumumab,n/a,2014-10-28,Treatment of glioma,Designated,,,N/A,N/A,"Nascent Biotech, Inc.",10246 Parkdale Avenue,,San Diego,California,92126,USA,448514,2014,
sodium thiosulfate,n/a,2014-10-28,Treatment of dermatomyositis,Designated,,,N/A,N/A,Hope Pharmaceuticals,16416 N. 92nd Street,,Scottsdale,Arizona,85260,USA,450114,2014,
"d6-tetrabenazine, deutetrabenazine",Austedo,2014-11-05,Treatment of Huntington's Disease,Designated/Approved,Approved for Orphan Indication,Treatment of chorea associated with Huntington’s disease,2017-04-03,2024-04-03,"Teva Branded Pharmaceutical Products R&D, Inc.",3333 N. Torrey Pines Court,Suite 400,La Jolla,California,92037,USA,383212,2014,880
"(S)-1-(6,7-Dihydro-5H-benzo[6,7]cyclohepta[1,2-c]pyridazin-3-yl)-N3-(7-(pyrrolidin-1-yl)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-yl)-1H-1,2,4-triazole-3,5-diamine",n/a,2014-11-05,Treatment of acute myeloid leukemia,Designated,,,N/A,N/A,BerGenBio AS,Jonas Lies vei 91,N-5021 Bergen,,,,Norway,452314,2014,
adeno-associated viral vector serotype 2 containing the human Rab escort protein 1 gene,n/a,2014-11-05,Treatment of choroideremia,Designated,,,N/A,N/A,NightstaRx Ltd.,215 Euston Road,NW1 2BE,London,,,United Kingdom,450514,2014,
autologous CD4+/CD8+ T cells transduced with lentiviral vector containing a chimeric antigen receptor directed against CD19,n/a,2014-11-06,Treatment of acute lymphoblastic leukemia (inclusive of B-cell acute lymphoblastic leukemia),Designated,,,N/A,N/A,"Juno Therapeutics, Inc.","307 Westlake Avenue, North",Suite 300,Seattle,Washington,98109,USA,450614,2014,
(S)-perillyl alcohol temozolomide,n/a,2014-11-12,Treatment of glioma,Designated,,,N/A,N/A,"NeOnc Technologies, Inc.","8335 Sunset Blvd., #240",,Los Angeles,California,90069,USA,453314,2014,
Autologous CD3+ T cells transduced with retroviral vector containing a chimeric antigen receptor directed against CD19 (Autologous CD3+ T cells containing CD19 chimeric antigen receptor),n/a,2014-11-13,Treatment of acute lymphoblastic leukemia (ALL),Designated,,,N/A,N/A,"Juno Therapeutics, Inc.","307 Westlake Ave. N., St. 300",,Seattle,Washington,98109,USA,452814,2014,
stem/progenitor cells derived from ex vivo expanded allogeneic umbilical cord blood cells,Nicord(R),2014-11-13,Treatment of Hodgkin lymphoma.,Designated,,,N/A,N/A,Gamida Cell Ltd.,P. O. Box 34670,,Jerusalem,,,Israel,454514,2014,
stem/progenitor cells derived from ex vivo expanded allogeneic umbilical cord blood cells,Nicord(R),2014-11-13,Treatment of acute lymphoblastic leukemia.,Designated,,,N/A,N/A,Gamida Cell Ltd.,P. O. Box 34670,,Jerusalem,,,Israel,454414,2014,
stem/progenitor cells derived from ex vivo expanded allogeneic umbilical cord blood cells,Nicord(R),2014-11-13,Treatment of myelodysplastic syndrome.,Designated,,,N/A,N/A,Gamida Cell Ltd.,P. O. Box 34670,,Jerusalem,,,Israel,455314,2014,
"(S)-3-((3-(1-((6-((3,4-dimethoxyphenyl)pryazin-2-yl)amino)ethyl)phenyl)carbamoyl)-5-methylpridin-1-ium",n/a,2014-11-17,Treatment of pulmonary arterial hypertension,Designated,,,N/A,N/A,"Pulmokine, Inc.",7 University Place,B127B,Rensselaer,New York,12144,USA,441914,2014,
"(S)-6-hydroxy-2,5,7,8-tetramethyl-N-((R)-piperidin-3-yl)chroman-2-carboxamide hydrochloride",n/a,2014-11-17,Treatment of inherited mitochondrial respiratory chain diseases,Designated,,,N/A,N/A,Khondrion BV,Philips van Leydenlaan 15,6525 Ex Nijmegen,,,,Netherlands,450714,2014,
antagonist of the complement 5a receptor,n/a,2014-11-17,Treatment of atypical hemolytic uremic syndrome,Designated,,,N/A,N/A,"ChemoCentryx, Inc.",850 Maude Avenue,,Mountain View,California,94043,USA,443714,2014,
anti-tumor necrosis factor (TNF) polyclonal antibody (bovine),n/a,2014-11-17,Treatment of pediatric ulcerative colitis (0 through 16 years of age),Designated,,,N/A,N/A,"Circle33, LLC",P. O. Box 11329,,Jackson,Wyoming,83002,USA,452414,2014,
cannabidiol,n/a,2014-11-17,Treatment of pediatric schizophrenia (pediatrics is defined as 0 through 16 years of age),Designated,,,N/A,N/A,"Insys Development Company, Inc.",1333 S. Spectrum Blvd,Suite 100,Chandler,Arizona,85286,USA,452614,2014,
Edasalonexent,n/a,2014-11-17,Treatment of Duchenne muscular dystrophy,Designated,,,N/A,N/A,"Catabasis Pharmaceuticals, Inc.","One Kendall Square, Suite B14202",Suite B14202,Cambridge,Massachusetts,2139,USA,453714,2014,
N-(2-amino-2-oxoethyl)-2-(2-((4-fluorophenethyl)amino)-N-isobutylacetamido)-N-(3-(2-oxopyrrolidin-1-yl)propyl)acetamide N-({Carbamoylmethyl-[3-(2-oxo-pyrrolidin-1-yl)propyl}-carbamoyl}-methyl)-2-[2-(2-fluorophenyl)-ethylamino]-N-isobutyl-acetamide,n/a,2014-11-17,Treatment of optic neuritis,Designated,,,N/A,N/A,Bionure Farma SL,Dalmases 27,8017,Barcelona,,,Spain,440014,2014,
N-(9-methoxynonyl)-1-deoxynojirimycin hydrochloride,n/a,2014-11-17,"Treatment of acute dengue illness (inclusive of acute dengue illness, dengue fever, dengue hemorrhagic fever, and dengue shock syndrome)",Designated,,,N/A,N/A,"Emergent Virology, LLC",400 Professional Drive,,Gaithersburg,Maryland,20879,USA,442714,2014,
recombinant neuroglobin (rNgb) containing mutations H64Q/C46G/C55S/C120S,n/a,2014-11-17,Treatment of patients with carbon monoxide poisoning,Designated,,,N/A,N/A,University of Pittsburgh,4200 Fifth Ave.,,Pittsburgh,Pennsylvania,15260,USA,451314,2014,
sirolimus,n/a,2014-11-17,Treatment of lymphangioleiomyomatosis,Designated,,,N/A,N/A,"Cote Orphan Consulting, LLC","8630 Fenton St., #222",,Silver Spring,Maryland,20910,USA,453114,2014,
trehalose,n/a,2014-11-17,Treatment of spinal cerebellar ataxia type 3 (also known as SCA3 or Machado Joseph disease),Designated,,,N/A,N/A,BioBlast Pharma Ltd,64 Quarry Lane,,Bedford,New York,10506,USA,442014,2014,
vatiquinone,Vincerinone,2014-11-17,Treatment of Rett syndrome,Designated,,,N/A,N/A,BioElectron Technology Corporation,350 N. Bernardo Ave.,,Mountain View,California,94043,USA,453014,2014,
veltuzumab,n/a,2014-11-17,Treatment of pemphigus,Designated,,,N/A,N/A,"Immunomedics, Inc.",300 The American Rd.,,Morris Plains,New Jersey,7950,USA,454714,2014,
oxytocin,n/a,2014-11-24,Treatment of Prader-Willi syndrome,Designated,,,N/A,N/A,Pr Maithe Tauber,Hospital des enfants,TSA70034 31059,Toulouse,,,France,453614,2014,
PyNTTTTGT class of oligodeoxynucleotide with a 24-base single chain composed of nucleotide sequence 5'TCATCATTTTGTCATTTTGTCATT 3',Imt504,2014-11-24,Treatment of rabies virus infections,Designated,,,N/A,N/A,"Mid-Atlantic BioTherapeutics, Inc.",3805 Old Easton Rd.,,Doylestown,Pennsylvania,18902,USA,451914,2014,
225Ac-lintuzumab,n/a,2014-11-25,Treatment of acute myelogenous leukemia,Designated,,,N/A,N/A,"Actinium Pharmaceuticals, Inc.",379 Thornall Avenue,6th Floor,Edison,New Jersey,8837,USA,451714,2014,
chimeric fusion protein of recombinant human alpha-N-acetylglucosaminidase and human insulin-like growth factor 2,n/a,2014-11-25,"Treatment of mucopolysaccharidosis III Type B (MPS IIIB, Sanfilippo Syndrome Type B)",Designated,,,N/A,N/A,"BioMarin Pharmaceutical, Inc.",105 Digital Drive,,Novato,California,94949,USA,450014,2014,
humanized Fc engineered monoclonal antibody against CD19,n/a,2014-12-01,Treatment of diffuse large B-cell lymphoma.,Designated,,,N/A,N/A,MorphoSys AG,Semmelweisstrasse 7,82152 Plannegg,,,,Germany,456014,2014,
1 8-(p[131I]-iodophenyl)octadecyl phosphocholine,n/a,2014-12-03,Treatment of multiple myeloma,Designated,,,N/A,N/A,"Cellectar Biosciences, Inc.",3301 Agriculture Drive,,Madison,Wisconsin,53716,USA,455614,2014,
Imiquimod,n/a,2014-12-03,Treatment of carcinoma in situ (CIS) of the urinary bladder,Designated,,,N/A,N/A,UroGen Pharma Ltd,9 Ha'Ta'asiya Street,P. O. Box 2397,Ra'anana,,,Israel,425314,2014,
liposome encapsulated paclitaxel,n/a,2014-12-03,Treatment of gastric cancer,Designated,,,N/A,N/A,"Insys Development Company, Inc.","1333 South Sprectum Blvd, Suite 100",,Chandler,Arizona,85286,USA,454014,2014,
"non-replicating adeno-associated viral vector, serotype 8, expressing human myotubularin gene",At001,2014-12-03,Treatment of x-linked myotubular myopathy,Designated,,,N/A,N/A,"Audentes Therapeutics, Inc.","101 Montgomery St., #2650",,San Francisco,California,94104,USA,453814,2014,
xenon gas,n/a,2014-12-03,Treatment of hypoxic ischemic encephalopathy,Designated,,,N/A,N/A,Neuroprotexeon,Imperial Innovations,London SW7 2PG,,,,United Kingdom,455714,2014,
recombinant nematode anticoagulant protein c2 (rNAPc2),n/a,2014-12-08,Treatment of viral hemorrhagic fever post-exposure to Ebola virus (treatment of Ebola),Designated,,,N/A,N/A,"ARCA Biopharma, Inc.",11080 Circle Point Rd.,Suite 140,Westminster,Colorado,80020,USA,329810,2014,
theranost 68Ga-RGD,n/a,2014-12-08,Diagnostic for clinical management of patients with neuroblastoma,Designated,,,N/A,N/A,"Advanced Imaging Projects, LLC",Florida Atlantic University Research Park,3651 FAU Blvd,Boca Raton,Florida,33431,USA,454814,2014,
ataluren,Translarna,2014-12-10,Treatment of mucopolysaccharidosis type I,Designated/Withdrawn,,,N/A,N/A,"PTC Therapeutics, Inc.",100 Corporate Court,,South Plainfield,New Jersey,7080,USA,455814,2014,
non-peptide small molecule orally available agonist of the parathyroid hormone receptor type I,n/a,2014-12-15,Treatment of hypoparathyroidism,Designated,,,N/A,N/A,"Chugai Pharma USA, LLC",300 Connell Drive,Suite 300,Berkeley Heights,New Jersey,7922,USA,455914,2014,
cytochrome P450 isoform 2B1 gene transfected human embryonic kidney 293 cells encapsulated in polymeric cellulose sulphate,n/a,2014-12-17,Treatment of pancreatic cancer in combination with ifosfamide,Designated,,,N/A,N/A,"PharmaCyte Biotech, Inc.",23046 Avenida de la Carlota,Suite 600,Laguna Hills,California,92652,USA,457014,2014,
"docosahexaenoic acid, DHA",n/a,2014-12-17,Treatment of primary sclerosing cholangitis,Designated,,,N/A,N/A,"Sancilio and Company, Inc.",3874 Fiscal Ct.,Suite 100,Riviera Beach,Florida,33404,USA,456414,2014,
hepcortespenlisimut-L,n/a,2014-12-17,Treatment of hepatocellular carcinoma,Designated,,,N/A,N/A,"Immunitor, Inc.",365-2906 West Broadway,"Vancouver, BC, V6K 2G8",,,,Canada,457714,2014,
veliparib,n/a,2014-12-17,Treatment of brain metastases when used in combination with DNA-damaging agents,Designated,,,N/A,N/A,AbbVie Inc.,1 North Waukegan Road,,North Chicago,Illinois,60064,USA,456514,2014,
chromium picolinate and chromium histidinate,n/a,2014-12-22,Treatment of pediatic polycystic ovary syndrome (0 through 16 years of age),Designated,,,N/A,N/A,"JDS Therapeutics, LLC",3 Manhattanville Rd,Suite 201,Purchase,New York,10577,USA,456814,2014,
"entrectinib;N-[5-(3,5-difluorobenzyl)-1H-indazol-3-yl]-4-(4-methylpiperazin-1yl)-2-(tetrahydro-2H-pyran-4-ylamino)benzamide",n/a,2014-12-22,Treatment of neuroblastoma,Designated,,,N/A,N/A,"Ignyta, Inc.",4545 Towne Centre Court,,San Diego,California,92121,USA,462414,2014,
"human recombinant mesencephalic, astrocyte derived neurotrophic factor",n/a,2014-12-22,Treatment of retinitis pigmentosa,Designated,,,N/A,N/A,"Amarantus BioScience Holdings, Inc.",655 Montgomery Street,Suite 900,San Francisco,California,94111,USA,457514,2014,
Oncolytic adenovirus coding for granulocyte macrophage colony stimulating factor (ONCOS-102),n/a,2014-12-22,Treatment of malignant mesothelioma,Designated,,,N/A,N/A,Targovax OY,Saukonpaadenranta 2,,Helsinki,,,Finland,457314,2014,
pleconaril,n/a,2014-12-22,Treatment of symptomatic enteroviral infection in the neonate,Designated,,,N/A,N/A,"AntiVirus Therapeutics, Inc.",7 Ardsley Ct.,,Princeton,New Jersey,8550,USA,457214,2014,
3-[2-(4-carbamimidoyl-phenylcarbamoyl)-5-methoxy-4-vinyl-phenyl]-6-(cyclopropylmethyl-carbamoyl)-pyridine-2-carboxylic acid,n/a,2014-12-23,Prevention of acute attacks of angioedema in individuals with hereditary angioedema,Designated/Withdrawn,,,N/A,N/A,"BioCryst Pharmaceuticals, Inc.",4505 Emperor Blvd,Suite 200200,Durham,North Carolina,27703,USA,457114,2014,
"antagonist of the endosomal Toll-like receptors (TLRs) 7, 8, and 9",n/a,2014-12-23,Treatment of Waldenstrom's macroglobulinemia,Designated,,,N/A,N/A,"Idera Pharmaceuticals, Inc.",167 Sidney Street,,Cambridge,Massachusetts,2139,USA,417813,2014,
herpes simplex type 1 virus containing cellular B-myb gene as tumor-specific promoter,n/a,2014-12-23,Treatment of pancreatic cancer,Designated,,,N/A,N/A,Karcinolys S.A.S.,"16, rue des Pervenches",92500 Rueil-Mamaison,,,,France,456614,2014,
OTL38; conjugate of pteroi acid and S0456 near infrared dye,n/a,2014-12-23,Detecting folic receptor alpha positive lesions in ovarian cancer patients (diagnostic for the management of ovarian cancer),Designated,,,N/A,N/A,"On Target Laboratories, LLC",1282 Win Hentschel Blvd,,West Lafayette,Indiana,47906,USA,458714,2014,
amikacin sulfate,n/a,2015-01-05,Management of cystic fibrosis patients with Pseudomonas aeruginosa lung infections,Designated,,,N/A,N/A,PlumeStars s.r.l.,Via Lago Scuro11,43124 Parma,,,,Italy,458114,2015,
celiprolol,n/a,2015-01-05,Treatment of Ehlers-Danlos syndrome,Designated,,,N/A,N/A,"Acer Therapeutics, Inc.",222 Third Street,Suite 2240,Cambridge,Massachusetts,2142,USA,456714,2015,
pentosan polysulfate sodium,Lysosan (Tm),2015-01-05,Treatment of mucopolysaccharidosis (MPS) type VI,Designated,,,N/A,N/A,"Plexcera Therapeutics, LLC",4445 North Highway A1A,Suite 241,Vero Beach,Florida,32963,USA,458614,2015,
pyrvinium,n/a,2015-01-05,Treatment of familial adenomatous polyposis,Designated,,,N/A,N/A,"StemSynergy Therapeutics, Inc.",1951 NW 7th Avenue,Suite 300,Miami,Florida,33136,USA,458314,2015,
selinexor,n/a,2015-01-05,Treatment of multiple myeloma,Designated,,,N/A,N/A,"Karyopharm Therapeutics, Inc.",85 Wells Avenue,,Newton,Maryland,2459,USA,459014,2015,
simtuzumab,n/a,2015-01-05,Treatment of primary sclerosing cholangitis,Designated/Withdrawn,,,N/A,N/A,"Gilead Sciences, Inc.",333 Lakeside Drive,,Foster City,California,94404,USA,458214,2015,
sparsentan,n/a,2015-01-05,Treatment of Focal Segmental Glomerulosclerosis,Designated,,,N/A,N/A,"Retrophin, LLC",330 Madison Avenue,6th Floor,New York,New York,10031,USA,410113,2015,
monoclonal antibody targeting eotaxin-2,n/a,2015-01-06,Treatment of systemic sclerosis,Designated,,,N/A,N/A,"ChemomAb, Ltd.",6 Hanehoset St.,,Tel Aviv,,,Israel,442214,2015,
"N-[2,6-bis(1-methylethyl)phenyl]-N'-[[1-[4-(dimethylamino)phenyl]cyclopentyl]methyl]urea, hydrochloride salt",n/a,2015-01-07,For the treatment of Cushing's Syndrome,Designated,,,N/A,N/A,"Millendo Therapeutics, Inc.",301 North Main St.,Suite 100,"Ann Arbor,",Michigan,48104,USA,414913,2015,
ulocuplumab,n/a,2015-01-12,Treatment of acute myeloid leukemia,Designated,,,N/A,N/A,Bristol-Myers Squibb Company,"3401 Princeton Pike, B-3043C",,Lawrence Township,New Jersey,8648,USA,457414,2015,
anti-Beta1 integrin monoclonal antibody,n/a,2015-01-13,Treatment of ovarian cancer,Designated,,,N/A,N/A,"OncoSynergy, Inc.",409 Illinois Street,Room 3044,San Francisco,California,94158,USA,460114,2015,
arimoclomol citrate,n/a,2015-01-13,"Treatment of Neimann-Pick disease, type C",Designated,,,N/A,N/A,Orphazyme ApS,Ole Maaloes Vej 3,2200 Copenhagen,,,,Denmark,458814,2015,
deutetrabenazine,n/a,2015-01-13,Treatment of Tourette syndrome in the pediatric population (defined as 0 through 16 years of age),Designated,,,N/A,N/A,TEVA Pharmaceuticals,3366 North Torrey Pines Court,Suite 225,LaJolla,California,92037,USA,442314,2015,
naltrexone,n/a,2015-01-13,Treatment of autoimmune hepatitis,Designated,,,N/A,N/A,"TaiwanJ Pharmaceuticals Co., Ltd.","Room 204 A, Bldg 53","195 Chung Hsing Rd., Sec 4","Chutung, Hsinchu",,,Taiwan,460314,2015,
pentapeptide with sequence Ac-VSRRR-NH2,n/a,2015-01-13,Treatment of intracerebral hemorrhage,Designated,,,N/A,N/A,"AegisCN, LLKC",3105 Cone Manor Lane,Suite B,Raleigh,North Carolina,27613,USA,449014,2015,
synthetic oligomer of 16 nucleotides,n/a,2015-01-13,Treatment of myotonic dystrophy Type I,Designated/Withdrawn,,,N/A,N/A,"Ionis Pharmaceuticals, Inc.",2855 Gazelle Ct.,,Carlsbad,California,92010,USA,457914,2015,
"2,5-dimethyl-3-[2-methyl-4-(methyloxy)phenyl]-N-[(1S)-1-(3-methyl-1,2,4-oxadiazol-5-",n/a,2015-01-15,Treatment of congenital adrenal hyperplasia (CAH),Designated/Withdrawn,,,N/A,N/A,"Neurocrine Biosciences, Inc.",12780 El Camino Real,,San Diego,California,92130,USA,399713,2015,
"5-(4-Cyclopropyl-1H-imidazol-l-yl)-2-fluoro-N-(6-(4-isopropyl-4H-1,2,4-triazol-3-yl)pyridin-2-yl)-4-methylbenzamide",n/a,2015-01-15,Treatment pulmonary arterial hypertension,Designated,,,N/A,N/A,"Gilead Sciences, Inc.",333 Lakeside Drive,,Foster City,California,94404,USA,459114,2015,
autologous CD34+ bone marrow derived stem cells transduced with a self-inactivating gammaretroviral vector encoding the human IL2RG (yc),n/a,2015-01-15,Treatment of severe combined immune deficiency-X1,Designated,,,N/A,N/A,Boston Children's Hospital,Div. of Hematology/Oncology,Karp 08215,Boston,Massachusetts,2115,USA,458514,2015,
pegylated carboxyhemoglobin bovine,Sanguinate,2015-01-15,Treatment of the comorbidities associated with Sickle Cell Disease,Designated,,,N/A,N/A,"Prolong Pharmaceuticals, LLC",300 B Corporate Court,,South Plainfield,New Jersey,7080,USA,407713,2015,
8-(1-Hydroxy-ethyl)-2-methoxy-3-(4-methoxy-benzyloxy)-benzo[c]chromen-6-one,n/a,2015-01-21,Treatment of glioblastoma multiforme,Designated,,,N/A,N/A,"Diffusion Pharmaceuticals, Inc.",2020 Avon Court,Suite 4,Charlottesville,Virginia,22902,USA,463714,2015,
antroquinonol,n/a,2015-01-21,Treatment of pancreatic cancer,Designated,,,N/A,N/A,Golden Biotechnology Corp.,"10F., No. 9, Ln 3","Tamsui Dist., New Taipei City 251",,,,Taiwan,460814,2015,
liposomal encapsulated paclitaxel,n/a,2015-01-21,Treatment of ovarian cancer,Designated,,,N/A,N/A,"Insys Development Company, Inc.","1333 South Sprectum Blvd, Suite 100",,Chandler,Arizona,85286,USA,454114,2015,
recombinant humanized anti-tau antibody,n/a,2015-01-22,Treatment of progressive supranuclear palsy,Designated,,,N/A,N/A,"AbbVie, Inc.",1 North Waukegan Road,,North Chicago,Illinois,60064,USA,460914,2015,
"(S)-2-(1-((6-amino-5-cyanopyrimidin-4-yl)amino)ethyl)-4-oxo-3-phenyl-3,4-dihydropyrrolo[2,1-f][1,2,4]triazine-5-carbonitrile",n/a,2015-01-26,Treatment of pemphigus vulgaris,Designated/Withdrawn,,,N/A,N/A,Almirall S.A.,"Ronda General Mitre, 151",,Barcelona,,,Spain,444614,2015,
18Fluorine-N-3-Fluoropropyl-2beta-carbomethoxy-3beta-(4-iodophenyl) Nortropane,n/a,2015-01-26,Diagnostic to be used in the management of multiple system atrophy (MSA),Designated,,,N/A,N/A,"Advanced Imaging Projects, LLC",7947 Brookside Ct.,,Lake Worth,Florida,33467,USA,451114,2015,
"2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-l-yl)-1-(1-(3-fluoro-2-(trifluoromethyl)isonicotinoyl)piperidin-4-yl)azetidin-3-yl)acetonitrile adipate",n/a,2015-01-26,Treatment of pancreatic cancer,Designated,,,N/A,N/A,Incyte Corporation,1801 Augustine Cut-Off,,Wilmington,Delaware,19803,USA,462014,2015,
double stranded RNA which targets the mutated KRAS oncogene,n/a,2015-01-26,Treatment of pancreatic cancer,Designated,,,N/A,N/A,Silenseed Ltd,Goldyne Savad Institute of Gene Therapy,"Jerusalem, 9112001",,,,Israel,463214,2015,
human leukocyte antigen-A2 restricted peptides,n/a,2015-01-26,Treatment of glioma.,Designated,,,N/A,N/A,"Stemline Therapeutics, Inc.",750 Lexington Avenue,11 th Floor,New York,New York,10022,USA,433614,2015,
leukotriene A4 hydrolase inhibitor,n/a,2015-01-26,Treatment of cystic fibrosis,Designated,,,N/A,N/A,"Celtaxsys, Inc.","201 17th Street, NW",Suite 530,Atlanta,Georgia,30363,USA,432114,2015,
tarextumab,n/a,2015-01-26,Treatment of pancreatic cancer,Designated/Withdrawn,,,N/A,N/A,"OncoMed Pharmaceuticals, Inc.",800 Chesapeake Drive,,Redwood City,California,94063,USA,461414,2015,
tarextumab,n/a,2015-01-26,Treatment of small cell lung cancer,Designated/Withdrawn,,,N/A,N/A,"OncoMed Pharmaceuticals, Inc.",800 Chesapeake Drive,,Redwood City,California,94063,USA,461314,2015,
Theranost 68Ga RGD,n/a,2015-01-26,Diagnostic for the clinical management of patients with tuberculosis,Designated,,,N/A,N/A,"Advanced Imaging Projects, LLC",FL ATlantic University Research Park,3651 FAU Blvd,Boca Raton,Florida,33431,USA,461514,2015,
alectinib,Alecensa,2015-01-27,Treatment of ALK-positive non-small cell lung cancer,Designated/Approved,Approved for Orphan Indication,"Treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC), who have progressed on or are intolerant to crizotinib",2015-12-11,2022-12-11,"Hoffmann-La Roche, Inc. (c/o Genentech, Inc.)","1 DNA Way, MS #355E",,South San Francisco,California,94080,USA,462814,2015,318
alectinib,Alecensa,2015-01-27,Treatment of ALK-positive non-small cell lung cancer,Designated/Approved,Approved for Orphan Indication,"Treatment of patients with anaplastic lymphoma kinase (ALK)-positive, metastatic non-small cell lung cancer (NSCLC) as detected by an FDA-approved test, excluding patients who have progressed on or are intolerant to crizotinib",2017-11-06,2024-11-06,"Hoffmann-La Roche, Inc. (c/o Genentech, Inc.)","1 DNA Way, MS #355E",,South San Francisco,California,94080,USA,462814,2015,1014
filgrastim,n/a,2015-01-27,Treatment of amyotrophic lateral sclerosis (ALS),Designated,,,N/A,N/A,Neurovision Pharma GmbH,Emil-Geis Str. 4,,Grunwald,,,Germany,461814,2015,
lisinopril oral solution,n/a,2015-01-27,Treatment of primary hypertension with complications and secondary hypertension in pediatric patients (ages 0 through 16 years of age),Designated/Withdrawn by OPD,,,N/A,N/A,"BioRamo, LLC",5319 NW 35th Terrace,,Ft. Lauderdale,Florida,33309,USA,365512,2015,
recombinant human fucosyltransferase VI [ FTVI ] + GDP-fucose,n/a,2015-01-27,To increase the activity of regulatory T-cells (Tregs) used in the prevention of graft versus host disease in patients undergoing hematopoietic stem cell transplantation,Designated,,,N/A,N/A,"TargaZyme, Inc.",2100 Palomar Airport Road,Suite 214-219,Carlsbad,California,92011,USA,459214,2015,
antinuclear antibody conjugated liposomal doxorubicin,n/a,2015-02-03,Treatment of Ewing's sarcoma.,Designated,,,N/A,N/A,"NanoSmart Pharmaceuticals, Inc.",27071 Cabot Road,Suite 104,Laguna Hills,California,92653,USA,455414,2015,
bortezomib,Velcade,2015-02-03,Treatment of acute lymphoblastic leukemia,Designated,,,N/A,N/A,"Millennium Pharmaceuticals, Inc.",40 Landsdowne Street,,Cambridge,Massachusetts,2139,USA,464014,2015,
"N-[5-(3,5-difluorobenzyl)-1H-indazol-3-yl]-4-(4-methylpiperazin-1yl)-2-(tetrahydro-2H-pyran-4-ylamino)benzamide",n/a,2015-02-03,"Treatment of TrkA-positive, TrkB-positive, TrkC-positive ROS1-positive or ALK-positive non-small cell lung cancer",Designated,,,N/A,N/A,"Ignyta, Inc.",4545 Towne Centre Court,,San Diego,California,92121,USA,462914,2015,
saposin C,n/a,2015-02-03,Treatment of glioblastoma multiforme,Designated,,,N/A,N/A,"Bexion Pharmaceuticals, LLC",632 Russell St.,,Covington,Kentucky,41011,USA,463814,2015,
tisagenlecleucel-T,n/a,2015-02-03,Treatment of diffuse large B-cell lymphoma,Designated,,,N/A,N/A,Novartis Pharmaceuticals Corporation,"One Health Plaza,",Bldg 315 - Room 3450B,East Hanover,New Jersey,7936,USA,463114,2015,
ibrutinib,Imbruvica,2015-02-05,Treatment of splenic marginal zone lymphoma,Designated/Approved,Approved for Orphan Indication,Treatment of patients with Marginal Zone Lymphoma (MZL) who require systemic therapy and have received at least one prior anti-CD20-based therapy.,2017-01-18,2024-01-18,"Pharmacyclics, LLC",995 E. Arques Avenue,,Sunnyvale,California,94085,USA,462314,2015,713
ibrutinib,Imbruvica,2015-02-05,Treatment of nodal marginal zone lymphoma,Designated/Approved,Approved for Orphan Indication,Treatment of patients with Marginal Zone Lymphoma (MZL) who require systemic therapy and have received at least one prior anti-CD20-based therapy.,2017-01-18,2024-01-18,"Pharmacyclics, LLC",995 E. Arques Avenue,,Sunnyvale,California,94085,USA,462214,2015,713
copanlisib,Aliqopa,2015-02-05,Treatment of follicular lymphoma,Designated/Approved,Approved for Orphan Indication,Treatment of adult patients with relapsed follicular lymphoma who have received at least two prior systemic therapies,2017-09-14,2024-09-14,Bayer US LLC,100 Bayer Boulevard,P. O. Box 915,Hanover,New Jersey,7981,USA,463314,2015,952
tolerogen,n/a,2015-02-05,Treatment of myasthenia gravis,Designated,,,N/A,N/A,Toleranzia AB,Arvid Wallgrens backe 20,SE-413 46 Goteborg,,,,Sweden,462514,2015,
5-[8-methyl-9-(1-methylethyl)-2-(4-morpholinyl)-9H-purin-6yl]-2-pyrimidinamine,n/a,2015-02-10,Treatment of malignant mesothelioma,Designated/Withdrawn,,,N/A,N/A,"Verastem, Inc.",117 Kendrick Street,Suite 500,Needham,Massachusetts,2494,USA,463614,2015,
bivalent anti-human myostatin adnectin-IgG1,n/a,2015-02-10,Treatment of duchenne muscular dystrophy,Designated,,,N/A,N/A,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,USA,450914,2015,
carboxy pyrrolidine hexanoyl pyrrolidine carboxylate,n/a,2015-02-10,Treatment of AL amyloidosis,Designated,,,N/A,N/A,"Glaxo Group Limited, England d/b/a GlaxoSmithKline",980 Great West Road,"Middlesex, TW8 9GS",,,,United Kingdom,462614,2015,
levomefolate calcium,n/a,2015-02-10,Treatment of megaloblastic anemia caused by folate deficiency,Designated,,,N/A,N/A,Cox Biosciences LLC,"267 West 71st Street, #3F",,New York,New York,10023,USA,428514,2015,
omeprazole-lansoprazole with buffer,n/a,2015-02-10,Treatment of esophageal ulcers,Designated,,,N/A,N/A,"Effexus Pharmaceuticals, LLC",10901 Granada Lane,Suite 101,Leawood,Kansas,66211,USA,446014,2015,
pelareorep,Reolysin(R),2015-02-10,Treatment of ovarian cancer,Designated,,,N/A,N/A,"Oncolytics Biotech, Inc.","210, 1167 Kensington Crescent NW",Calgary AB T2N1X7,,,,Canada,464414,2015,
recombinant monoclonal antibody to human serum amyloid P component,n/a,2015-02-10,Treatment of AL amyloidosis,Designated,,,N/A,N/A,"Glaxo Group Limited, England d/b/a GlaxoSmithKline",980 Great West Road,"Middlesex, TW8, 9GS",,,,United Kingdom,462714,2015,
3-pentylbenzenacetic acid sodium salt,n/a,2015-02-11,Treatment of idiopathic pulmonary fibrosis.,Designated,,,N/A,N/A,"ProMetic Life Sciences, Inc.",440 Blvd Armand Frappier,"Laval, Quebec, H7V 4B4",,,,Canada,464214,2015,
paromomycin,n/a,2015-02-11,Treatment of cutaneous leishmaniasis (Old World and New World),Designated,,,N/A,N/A,"The Surgeon General, Dept. of the Army",USAMRMC,504 Scott Street,Ft. Detrick,Maryland,21702,USA,464314,2015,
pelareorep,Reolysin(R),2015-02-11,Treatment of pancreatic cancer,Designated,,,N/A,N/A,"Oncolytics Biotech, Inc.","210, 1167 Kensington Crescent NW",Calgary AB T2N1X7,,,,Canada,464514,2015,
recombinant humanized anti-interleukin 13 (IL-13) monoclonal antibody,n/a,2015-02-11,Treatment of eosinophilic esophagitis,Designated,,,N/A,N/A,Celgene Corporation,3033 Science Park Road,Suite 300,San Diego,California,92121,USA,443314,2015,
Trofinetide,n/a,2015-02-11,Treatment of Rett syndrome,Designated,,,N/A,N/A,Neuren Pharmaceuticals Ltd,697 Burke Road,Suite 201,Camberwell,,,Australia,363111,2015,
defactinib,n/a,2015-02-12,Treatment of ovarian cancer,Designated,,,N/A,N/A,"Verastem, Inc.",117 Kendrick Street,Suite 500,Needham,Massachusetts,2494,USA,463514,2015,
"N-[5-(3,5-difluorobenzyl)-1H-indazol-3-yl]-4-(4-methylpiperazin-1yl)-2-(tetrahydro-2H-pyran-4-ylamino)benzamide",n/a,2015-02-12,"Treatment of TrkA-positive, TrkB-positive, TrkC-positive, ROS1-positive, or ALK-positive colorectal cancer",Designated,,,N/A,N/A,"Ignyta, Inc.",4545 Towne Centre Court,,San Diego,California,92121,USA,463014,2015,
bovine lactoferrin,n/a,2015-02-19,Prevention of late-onset sepsis in very low birth weight infants,Designated,,,N/A,N/A,"Metrodora Therapeutics, LLC",2502 Avenue I,,Brooklyn,New York,11210,USA,460514,2015,
polidocanol,n/a,2015-02-19,Treatment of congenital venous malformations,Designated,,,N/A,N/A,Provensis Ltd,5 Fleet Place,London EC4M 7RD,,,,United Kingdom,464614,2015,
andexanet alfa,n/a,2015-02-23,For reversing the anticoagulant effect of direct or indirect factor Xa inhibitors in patients experiencing a serious uncontrolled bleeding event or who require urgent or emergent surgery,Designated,,,N/A,N/A,Portola Pharmaceuticals,270 East Grand Avenue,,South San Francisco,California,94080,USA,437414,2015,
bovine lactoferrin,n/a,2015-02-23,Prevention of necrotizing enterocolitis in very low birth weight infants (birth weight less than or equal to 1500 grams),Designated,,,N/A,N/A,"Metrodora Therapeutics, LLC",2502 Avenue I,,Brooklyn,New York,11210,USA,460714,2015,
naltrexone,n/a,2015-02-23,Treatment of postherpetic neuralgia,Designated,,,N/A,N/A,Allodynic Therapeutics LLC,1785 NE 123rd Street,,North Miami,Florida,33181,USA,465614,2015,
rituximab,Rituxan(R); Mabthera(R),2015-02-23,Treatment of pemphigus vulgaris.,Designated,,,N/A,N/A,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,,United States Minor Outlying Islands,465014,2015,
deferasirox,Exjade; Jadenu Sprinkles,2015-02-24,Treatment of chronic iron overload in alpha-thalassemia,Designated/Approved,Approved for Orphan Indication,Treatment of chronic iron overload in patients 10 years of age and older with non-transfusion dependent thalassemia (NTDT) syndromes and with a liver iron concentration (LIC) of at least 5 milligrams of iron per gram of liver dry weight (mg Fe/g dw) and serum ferritin greater than 300 mcg/L.,2013-01-23,2020-01-23,Novartis Pharmaceuticals Corporation,One Health Plaza,Building 105/W112,East Hanover,New Jersey,7936,USA,354411,2015,-762
acetylcysteine effervescent tablets for oral solution,Cetylev,2015-02-24,Preventing hepatic injury from acetaminophin overdose,Designated/Approved,Approved for Orphan Indication,Indicated to prevent or lessen hepatic injury after ingestion of a potentially hepatotoxic quantity of acetaminophen in patients with acute ingestion or from repeated supratherapeutic ingestion,2016-01-29,N/A,"Arbor Pharmaceuticals, Inc.",6 Concourse Parkway,Suite 1800,Atlanta,Georgia,30328,USA,401713,2015,339
deferasirox,Exjade; Jadenu Sprinkles,2015-02-24,Treatment of chronic iron overload in alpha-thalassemia,Designated/Approved,Approved for Orphan Indication,Treatment of chronic iron overload in patients 10 years of age and older with non-transfusion-dependent thalassemia (NTDT) syndromes and with a liver iron concentration (LIC) of at least 5 milligrams of iron per gram of liver dry weight (mg Fe/g dw) and a serum ferritin greater than 300 mcg/L.,2017-05-18,N/A,Novartis Pharmaceuticals Corporation,One Health Plaza,Building 105/W112,East Hanover,New Jersey,7936,USA,354411,2015,814
pelareorep,Reolysin,2015-02-24,Treatment of fallopian tube cancer,Designated,,,N/A,N/A,"Oncolytics Biotech, Inc.","210, 1167 Kensington Crescent NW",Calgary AB T2N1X7,,,,Canada,470115,2015,
pelareorep,Reolysin(R),2015-02-24,Treatment of primary peritoneal cancer,Designated,,,N/A,N/A,"Oncolytics Biotech, Inc.","210, 1167 Kensington Crescent NW",Calgary AB T2N1X7,,,,Canada,470215,2015,
propranolol hydrochloride and etodolac,n/a,2015-02-24,Treatment of hepatocellular carcinoma,Designated,,,N/A,N/A,"Vicus Therapeutics, LLC",55 Madison Avenue,Suite 400,Morristown,New Jersey,7960,USA,454614,2015,
ketotifen,n/a,2015-02-25,Treatment of mastocytosis,Designated,,,N/A,N/A,"Valcrest Pharmaceuticals, LLC",520 White Plains Road,Suite 500,Tarrytown,New York,10591,USA,464714,2015,
alpha1-proteinase inhibitor (human),Prolastin(R)-C,2015-03-03,Treatment of Type 1 diabetes mellitus patients with residual beta-cell function.,Designated,,,N/A,N/A,"Grifols Therapeutics, Inc.",8368 US Business Hwy 70 West,,Clayton,North Carolina,27520,USA,418913,2015,
amifampridine phosphate,n/a,2015-03-03,Treatment of congenital myasthenic syndromes,Designated,,,N/A,N/A,Catalyst Pharmaceuticals,"(dba Catalyst Pharmaceutical Partner, Inc)",Suite 1500,Coral Gables,Florida,33134,USA,464814,2015,
dacomitinib,n/a,2015-03-03,"Treatment of non-small cell lung cancer with EGFR, HER2, HER4, or DDR2 mutations.",Designated,,,N/A,N/A,"Pfizer, Inc.",235 East 42nd Street,,New York,New York,10017,USA,435114,2015,
recombinant activated Factor X variant,n/a,2015-03-03,Treatment of intracerebral hemorrhage,Designated,,,N/A,N/A,"Pfizer, Inc.",500 Arcola Road,,Collegeville,Pennsylvania,19426,USA,439014,2015,
autologous Epstein-Barr virus specific T-cells,n/a,2015-03-09,Treatment of Epstein-Barr virus positive non-Hodgkin lymphomas.,Designated,,,N/A,N/A,"Cell Medica, Inc.","7505 Fannin Street, Suite 200",,Houston,Texas,77054,USA,421513,2015,
hydrocinnamate-[Orn-Pro-dCha-Trp-Arg](CH3COO),n/a,2015-03-09,Treatment of amyotrophic lateral sclerosis,Designated,,,N/A,N/A,Alsonex Pty Ltd,210 Alice Street,"OLD, 4000",Brisbane,,,Australia,469014,2015,
lebrikizumab,n/a,2015-03-09,Treatment of idiopathic pulmonary fibrosis,Designated,,,N/A,N/A,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,USA,381112,2015,
edaravone,n/a,2015-03-12,Treatment of amyotrophic lateral sclerosis,Designated,,,N/A,N/A,Treeway B.V.,Sevillaweg 142,3047 AL Rotterdam,,,,Netherlands,465514,2015,
ponatinib,Iclusig(R),2015-03-12,Treatment of gastrointestinal stromal tumors (GIST).,Designated/Withdrawn,,,N/A,N/A,"ARIAD Pharmaceuticals, Inc.",26 Landsdowne Street,,Cambridge,Massachusetts,2339,USA,466714,2015,
hydroxyurea,Pedroxa,2015-03-16,"Treatment of symptomatic sickle cell disease in pediatric patients, less than 17 years of age.",Designated,,,N/A,N/A,Ebelle D'Ebelle Pharmaceuticals LLC,5 Witherwood Drive,,Hamburg,New Jersey,7419,USA,463414,2015,
melphalan flufenamide hydrochloride,n/a,2015-03-16,"Treatment of plasma cell myeloma, also referred to as multiple myeloma",Designated,,,N/A,N/A,Oncopeptides AB,Vastra Tradgardsgatan 15,111 53 Stockholm,,,,Sweden,465314,2015,
naproxcinod,n/a,2015-03-16,Treatment of Duchenne muscular dystrophy.,Designated,,,N/A,N/A,Nicox SA,2105 route des Dolines,Drakkar bat D-CS 10313,Valbonne,,,France,467414,2015,
pegylated human recombinant arginase I,n/a,2015-03-16,Treatment of arginase I deficiency (hyperargininemia).,Designated,,,N/A,N/A,"AERase, Inc.",815-A Brazos Street,Suite 101,Austin,Texas,78701,USA,466614,2015,
"phenol, 4-[2-(aminomethyl)-4-thiazolyl]-2,6-bis (1,1-dimethyethyl) monohydrochloride",n/a,2015-03-16,Treatment of Huntington's disease.,Designated/Withdrawn,,,N/A,N/A,"Ipsen Biopharmaceuticals, Inc.",106 Allen Road,3rd Floor,Basking Ridge,New Jersey,7920,USA,468314,2015,
tacrolimus,n/a,2015-03-16,Treatment of pulmonary arterial hypertension.,Designated,,,N/A,N/A,"VIVUS, Inc.",900 East Hamilton Avenue,Suite 550,Campbell,California,95008,USA,468214,2015,
tetra-substituted porphyrin derivative containing manganese (III),n/a,2015-03-16,Treatment of idiopathic pulmonary fibrosis,Designated,,,N/A,N/A,Aeolus Pharmaceuticals,26361 Crown Valley Parkway,Suite 150,Mission Viejo,California,92691,USA,465414,2015,
polyethylene glycol modified recombinant C-terminal truncate of human cystathionine beta-synthase,n/a,2015-03-17,Treatment of homocystinuria,Designated,,,N/A,N/A,Orphan Technologies Limited,P. O. Box 662,Tortola,,,,,469715,2015,
sevuparin,n/a,2015-03-17,Treatment of sickle cell disease,Designated,,,N/A,N/A,Modus Therapeutics,Sankt Eriksgatan 117,SE-113 43,Stockholm,,,Sweden,467314,2015,
voretigene neparvovec-rzyl,Luxturna,2015-03-18,Treatment of inherited retinal dystrophy due to biallelic RPE65 gene mutations,Designated/Approved,Approved for Orphan Indication,an adeno-associated virus vector-based gene therapy indicated for the treatment of patients with confirmed biallelic RPE65 mutation-associated retinal dystrophy. Patients must have viable retinal cells determined by a treating physician,2017-12-19,2024-12-19,"Spark Therapeutics, Inc.",3737 Market Street,Suite 1300,Philadelphia,Pennsylvania,19104,USA,466414,2015,1007
2-[4-[[(2R)-2-ethoxy-3-[4-(trifluoromethyl)phenoxy]propyl]thio]-2-methylphenoxy]acetic acid (1:1) lysine dihydrate,n/a,2015-03-18,Treatment of homozygous familial hypercholesterolemia (HoFH),Designated,,,N/A,N/A,"CymaBay Therapeutics, Inc.",7999 Gateway Blvd,Suite 130,Newark,California,94560,USA,429214,2015,
hydrocortisone modified release capsules,Chronocort,2015-03-18,Treatment of congenital adrenal hyperpasia,Designated,,,N/A,N/A,Diurnal Limited,Cardiff Medicentre,Cardiff CF14 4UJ,,,,United Kingdom,467014,2015,
masitinib mesylate,n/a,2015-03-18,Treatment of amyotrophic lateral sclerosis.,Designated,,,N/A,N/A,AB Science,"3, avenuve George V",75008 Paris,,,,France,469415,2015,
methotrexate oral liquid formulation,n/a,2015-03-18,Treatment of acute lymphoblastic leukemia in pediatric patients aged 0 through 16 years.,Designated,,,N/A,N/A,Chesapeake Therapeutics,1498-M Reistertown Road,Suite 313,Pikesville,Maryland,21208,USA,469315,2015,
tremelimumab,n/a,2015-03-18,Treatment of malignant mesothelioma,Designated,,,N/A,N/A,"MedImmune, LLC",One MedImmune Way,,Gaithersburg,Maryland,20878,USA,466014,2015,
(monomethoxypolyethylene glycol) recombinant adenosine deaminase,n/a,2015-03-19,Treatment of adenosine deaminase deficiency in patients with severe combined immunodeficiency,Designated,,,N/A,N/A,"Leadiant Biosciences, Inc.",9841 Washingtonian Blvd,Suite 500,Gaithersburg,Maryland,20878,USA,467514,2015,
cladribine,n/a,2015-03-19,Treatment of neuromyelitis optica and neuromyelitis optica spectrum disorder,Designated,,,N/A,N/A,Chord Therapeutics S.a.r.l.,c/o Eclosion,CH-1228 Plan-les-Ouates,,,,Switzerland,467214,2015,
roneparstat,n/a,2015-03-19,Treatment of multiple myeloma,Designated,,,N/A,N/A,"Leadiant Biosciences, Inc.",Via Motta 2,CH-6850 Mendrisio,,,,Switzerland,468914,2015,
sonidegib,n/a,2015-03-23,Treatment of medulloblastoma,Designated,,,N/A,N/A,Novartis Pharmaceuticals Corp.,One Health Plaza,,East Hanover,New Jersey,7936,USA,468814,2015,
4-(4-Methoxy-phenylamino)-6-methylcarbamyl-quinoline-3-carboxylic acid,n/a,2015-03-24,Prevention of scarring post ab externo glaucoma surgery,Designated,,,N/A,N/A,Clanotech AB,"Fogdevreten 2, Solna S-171 65",,,,,Sweden,468714,2015,
allosteric activator of the red blood cell-specific form of pyruvate kinase,n/a,2015-03-24,Treatment of pyruvate kinase deficiency,Designated,,,N/A,N/A,"Agios Pharmaceuticals, Inc.",88 Sidney Street,,Cambridge,Massachusetts,2139,USA,442814,2015,
amylopectin,n/a,2015-03-24,Treatment of glycogen storage disease types Ia and Ib,Designated,,,N/A,N/A,"Michael K. Davis, MD, MBA",University of Florida Health,7046 SW Archer Road,Gainesville,Florida,32608,USA,469515,2015,
avicin d,n/a,2015-03-24,Treatment of multiple myeloma,Designated,,,N/A,N/A,Avicin Therapeutics Ltd.,Westpark Corporate Center,4634 S. Alston Avenue,Durham,North Carolina,27713,USA,467714,2015,
ganaxolone,n/a,2015-03-24,Treatment of Protocadherin 19 (PCDH19) female epilepsy.,Designated,,,N/A,N/A,"Marinus Pharmaceuticals, Inc.",3 Radnor Corporate Center,Suite 304,Radnor,Pennsylvania,19087,USA,473515,2015,
Lactobacillus acidophilus and Bifidobacterium animalis subsp. lactis,n/a,2015-03-24,Prevention of necrotizing enterocolitis (NEC) in premature infants with very low birth weight less than or equal to 1500 grams,Designated,,,N/A,N/A,"Leadiant Biosciences, Inc.",9841 Washingtonian Blvd.,Suite 500,Gaithersburg,Maryland,20878,USA,422414,2015,
Live-attenuated Listeria monocytogenes actA/inlB/human mesothelin (hMeso) Strain hMeso38,Not Determined,2015-03-24,Treatment of mesothelioma.,Designated,,,N/A,N/A,"Aduro BioTech, Inc.",740 Heinz Avenue,,Berkeley,California,94710,USA,468614,2015,
"mouse-human chimeric antibody of the IgG1 isotype, directed against human CD37",n/a,2015-03-24,Treatment of chronic lymphocytic leukemia (CLL).,Designated,,,N/A,N/A,"Boehringer Ingelheim Pharmaceuticals, Inc.","900 Ridgebury Rd., PO Box 368",,Ridgefield,Connecticut,6877,USA,451514,2015,
bardoxolone,n/a,2015-03-30,Treatment of pulmonary arterial hypertension,Designated,,,N/A,N/A,"Reata Pharmaceuticals, Inc.",2801 Gateway Drive,Suite 150,Irving,Texas,75063,USA,456114,2015,
C21H27O10P,Minnelide,2015-03-30,Treatment of gastric cancer.,Designated,,,N/A,N/A,"Minneamrita Therapeutics, LLC",6 Hickory Court,,Rock Island,Illinois,61201,USA,471615,2015,
dalbavancin,Dalvance,2015-03-30,Treatment of acute osteomyelitis in children (0 through 16 years of age),Designated,,,N/A,N/A,Durata Therapeutics International B.V.,"Spaces Zuidas II, Kantoor 4.03","1083HN, Amsterdam",,,,Netherlands,459714,2015,
1-(6-benzothiazolylsulfonyl)-5-chloro-1H-indole-2-butanoic acid,n/a,2015-03-31,Treatment of systemic sclerosis,Designated,,,N/A,N/A,Inventiva Pharma,50 rue de Dijon,Daix 21121,,,,France,470315,2015,
5'-CTATCTGUC*G1TTCTCTGU-3'.17 Na+,n/a,2015-03-31,Treatment of diffuse large B-cell lymphoma.,Designated,,,N/A,N/A,"Idera Pharmaceuticals, Inc.",167 Sidney Street,,Cambridge,Massachusetts,2139,USA,472615,2015,
bryostatin 1,n/a,2015-03-31,Treatment of Fragile X Syndrome.,Designated,,,N/A,N/A,"Neurotrope BioScience, Inc.",50 Park Place,Suite 1401,Newark,New Jersey,7102,USA,471415,2015,
Bulevertide,n/a,2015-03-31,Treatment of hepatitis D virus infection.,Designated,,,N/A,N/A,MYR GmbH,Weinbergsweg 66,61348 Bad Homburg,,,,Germany,470915,2015,
C24H28N8O7S2,n/a,2015-04-02,Treatment of diffuse large B-cell lymphoma (DLBCL).,Designated,,,N/A,N/A,"Curis, Inc.",4 Maguire Road,,Lexington,Massachusetts,2421,USA,467814,2015,
golimumab,Simponi Aria,2015-04-02,Treatment of polyarticular juvenile idiopathic arthritis in patients 0 through 18 years of age.,Designated,,,N/A,N/A,"Janssen Research & Development, LLC",1400 McKean Road,,Spring House,Pennsylvania,19477,USA,325610,2015,
"PEG-b-PLA micelles containing (1) paclitaxel, (2) sirolimus (rapamycin) and (3) tanespimycin (17-AAG)(also known as: triolimus)",n/a,2015-04-02,Treatment of angiosarcoma,Designated,,,N/A,N/A,"Co-D Therapeutics, Inc.",1625 Kings Mill Way,Suite 205,Madison,Wisconsin,53718,USA,469915,2015,
doxorubicin,n/a,2015-04-06,Treatment of cutaneous T-cell lymphoma,Designated,,,N/A,N/A,"Louis D. Falo, Jr.","University of Pittsburgh, Dep. of Dermatology",3500 Fifth Avenue,Pittsburgh,Pennsylvania,15213,USA,469215,2015,
human insulin (rDNA),n/a,2015-04-06,Treatment of short bowel syndrome (SBS).,Designated,,,N/A,N/A,"Nutrinia, Ltd.","15 Abba Hillel Silver Rd, 7th Floor",Ramat-Gan 5252208,,,,Israel,469115,2015,
eflornithine HCL,n/a,2015-04-07,Treatment of gastric cancer,Designated,,,N/A,N/A,"Cancer Prevention Pharmaceuticals, Inc.",1760 East River Road,Suite 250,Tucson,Arizona,85718,USA,472715,2015,
"fluciclovine (18F)(anti-1-amino-3-fluorocyclobutane-1-carboxylic acid, labelled with Fluorine-18)",n/a,2015-04-07,For the diagnosis of glioma,Designated,,,N/A,N/A,Blue Earth Diagnostics Ltd.,215 Euston Rd,"London, NW1 2BE",,,,United Kingdom,465814,2015,
modified human papillomavirus capsid protein conjugated to a near infrared dye,n/a,2015-04-08,Treatment of uveal melanoma,Designated,,,N/A,N/A,"Aura Biosciences, Inc.",85 Bolton Street,,Cambridge,Massachusetts,2140,USA,472515,2015,
treosulfan,n/a,2015-04-08,Conditioning treatment prior to hematopoietic stem cell transplantation (HSCT) in malignant and non-malignant diseases in adults and pediatric patients.,Designated,,,N/A,N/A,Medac GmbH,TheaterstraBe 6,22880 Wedel,,,,Germany,468014,2015,
Amantadine hydrochloride,Gocovri,2015-04-09,Treatment of levodopa-induced dyskinesia,Designated/Approved,Approved for Orphan Indication,treatment of dyskinesia in patients with Parkinson's disease receiving levodopa-based therapy with or without concomitant dopminergic medications,2017-08-24,2024-08-24,"Adamas Pharmaceuticals, Inc.",1900 Powell Street,Suite 750,Emeryville,California,94608,USA,413213,2015,868
"2-Pyrazinecarbonitrile, 5-[[5-2-(3-aminopropoxy)-6-methoxyphenyl]-1H-pyrazol-3-yl]amino] monomesylate monohydrate",n/a,2015-04-09,Treatment of anal cancer,Designated,,,N/A,N/A,Eli Lilly and Company,Lilly Corporate Center,,Indianapolis,Indiana,46285,USA,472015,2015,
sodium ascorbate and menadione sodium bisulfite,Apatone,2015-04-09,Treatment of noninfected painful total joint without mechanical complication,Designated,,,N/A,N/A,IC-MedTech Corporation,9902 Indian Creek Lane,,El Cajon,California,92021,USA,392513,2015,
obinutuzumab,Gazyva,2015-04-15,Treatment of follicular lymphoma,Designated/Approved,Approved for Orphan Indication,"Indicated for the treatment of patients with follicular lymphoma (FL) who relapsed after, or are refractory to, a rituximab-containing regimen",2016-02-26,2023-02-26,"Genentech Inc., a member of the Roche Group",1 DNA Way,MS #355e,South San Francisco,California,94080,USA,473415,2015,317
obinutuzumab,Gazyva,2015-04-15,Treatment of follicular lymphoma,Designated/Approved,Approved for Orphan Indication,"in patients achieving at least a partial remission for the treatment of adult patients with previously untreated stage II bulky, III or IV follicular lymphoma",2017-11-16,2024-11-16,"Genentech Inc., a member of the Roche Group",1 DNA Way,MS #355e,South San Francisco,California,94080,USA,473415,2015,946
2-[4-[[(2-R)-2-ethoxy-3-[4-(trifluoromethyl)phenoxy]propyl]thio]-2-methylphenoxy]acetic acid (1:1) lysine dihydrate,n/a,2015-04-15,Treatment of patients with Frederickson Type I or V hyperlipoproteinemia,Designated,,,N/A,N/A,"CymaBay Therapeutics, Inc.",7999 Gateway Blvd,Suite 130,Newark,California,94560,USA,470715,2015,
Diphenylcyclopropenone gel,Samcyprone (Tm),2015-04-15,Treatment of malignant melanoma stage IIB to IV,Designated,,,N/A,N/A,RXi Pharmaceuticals Corp.,257 Simarano Drive,Suite 101,Marlborough,Massachusetts,1752,USA,473615,2015,
pelareorep,Reolysin,2015-04-15,Treatment of malignant glioma,Designated,,,N/A,N/A,"Oncolytics Biotech, Inc.","210, 1167 Kensington Crescent NW",Calgary AB T2N1X7,,,,Canada,472915,2015,
selumetinib,n/a,2015-04-15,Treatment of uveal melanoma.,Designated/Withdrawn,,,N/A,N/A,AstraZeneca Pharmaceuticals LP,1800 Concord Pike,P. O. Box 8355,Wilmington,Delaware,19803,USA,471015,2015,
triheptanoin,n/a,2015-04-15,Treatment of fatty acid oxidation disorders,Designated,,,N/A,N/A,"Ultragenyx Pharmaceutical, Inc.",60 Leveroni Court,,Novato,California,94949,USA,474015,2015,
"zoledronate D,L-lysine monohydrate (ZLM)",n/a,2015-04-15,Treatment of complex regional pain syndrome (CRPS),Designated,,,N/A,N/A,"Grunenthal USA, Inc.",360 Mount Kemble Ave,,Morristown,New Jersey,7960,USA,461014,2015,
[Î±â¿¿N-(2â¿¿succinyl-paclitaxel)Thr]-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-[Îµâ¿¿N-(2â¿¿succinyl-paclitaxel)Lys]-Arg-Asn-Asn-Phe-[Îµâ¿¿N-(2â¿¿succinyl-paclitaxel)Lys]-Thr-Glu-Glu-Tyr,n/a,2015-04-15,Treatment of breast cancer patients with brain metastases,Designated,,,N/A,N/A,"Angiochem, Inc.",201 President Kennedy,"Montreal, Quebec H2X 3Y7",,,,Canada,446614,2015,
177-LU-DOTA-GlyGlyNle-CycMSHhex,n/a,2015-04-16,Treatment of Stage IIB through IV malignant melanoma,Designated,,,N/A,N/A,"SolaranRx, Inc.","5901 Indian School Road, NE",,Albuquerque,New Mexico,87110,USA,470015,2015,
cantrixil,n/a,2015-04-20,Treatment of ovarian cancer,Designated,,,N/A,N/A,Kazia Therapeutics Limited,20 George Street,Suite 207,Hornsby,,,Australia,474815,2015,
allogeneic cardiosphere-derived cells,n/a,2015-04-21,Treatment of Duchenne Muscular Dystrophy,Designated,,,N/A,N/A,"Capricor, Inc.",8840 Wilshire Blvd.,2nd Floor,Beverly HIlls,California,90211,USA,474615,2015,
cannabidiol,n/a,2015-04-22,Treatment of neonatal hypoxic ischemic encephalopathy,Designated,,,N/A,N/A,GW Pharma Ltd.,15 T.W. Alexander Drive,P. O. Box 13547,Research Triangle Park,North Carolina,27709,USA,471815,2015,
recombinant human histidyl tRNA synthetase,n/a,2015-04-22,Treatment of facioscapulohumeral muscular dystrophy,Designated,,,N/A,N/A,"aTyr Pharma, Inc.",3545 John Hopkins Court,Suite 250,San Diego,California,92121,USA,474215,2015,
synthetic double-stranded (hybridized duplex) ribonucleic acid oligonucleotide specific to hydroxyacid oxidase 1 gene,n/a,2015-04-22,Treatment of primary hyperoxaluria type 1,Designated,,,N/A,N/A,"Dicerna Pharmaceuticals, Inc.",87 Cambridgepark Drive,,Cambridge,Massachusetts,2140,USA,473915,2015,
docosahexaenoic acid,n/a,2015-04-27,Treatment of sickle cell disease,Designated,,,N/A,N/A,"Sancilio & Company, Inc.","3874 Fiscal Ct., #100",,Riviera Beach,Florida,33404,USA,454314,2015,
liposomal P-ethoxy growth factor receptor-bound protein 2 antisense oligonucleotide,n/a,2015-04-27,Treatment of acute myeloid leukemia,Designated,,,N/A,N/A,"Bio-Path Holdings, Inc.",4710 Bellaire Blvd,Suite 210,Houston,Texas,77401,USA,472115,2015,
propranolol and etodolac,n/a,2015-04-27,Treatment of pancreatic cancer.,Designated,,,N/A,N/A,"Vicus Therapeutics, LLC",55 Madison Avenue,Suite 400,Morristown,New Jersey,7960,USA,475715,2015,
"(S)-7-(1-(9H-purin-6-ylamino)ethyl)-6-(3-fluorophenyl)-3-methyl-5H-thiazolo[3,2-a]pyrimidin-5-one",n/a,2015-04-29,Treatment of Hodgkin lymphoma,Designated,,,N/A,N/A,Incyte Corporation,1801 Augustine Cut-Off,,Wilmington,Delaware,19803,USA,476215,2015,
lenalidomide,Revlimid,2015-04-29,Treatment of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue,Designated,,,N/A,N/A,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,USA,476115,2015,
antroquinonol,Hocena(R),2015-04-30,Treatment of acute myeloid leukemia,Designated,,,N/A,N/A,Golden Biotechnology Corporation,"10F, No. 9, Ln. 3, Sec. 1, Zhong-Zheng E. Rd",New Taipei City 251,,,,Taiwan,476315,2015,
"4-(pyrimidin-2-ylmethyl)-7-[4-(trifluoromethoxy)phenyl]-3,4-dihydro-1,4-benzoxazepin-5(2H)-one",n/a,2015-05-04,Treatment of congenital long QT syndrome,Designated/Withdrawn,,,N/A,N/A,"Gilead Sciences, Inc.",333 Lakeside Drive,,Foster City,California,94404,USA,446214,2015,
"LOAd703, a modified adenovirus 5/35 containing a CMV promoter-driven transgene cassette with the human transgenes for a membrane-bound CD40 ligand (TMZ-CD40L) and full length 4-1BBL",n/a,2015-05-04,Treatment of pancreatic cancer,Designated,,,N/A,N/A,Lokon Pharma AB,"Dag Hammarskjoldsvag 40c, 751 83",Uppsala,,,,Sweden,477315,2015,
pantothenate phosphate,n/a,2015-05-04,Treatment of pantothenate kinase associated neurodegeneration (PKAN).,Designated,,,N/A,N/A,"Retrophin, Inc.",777 Third Avenue,22nd Floor,New York,New York,10017,USA,427114,2015,
pelareorep,Reolysin,2015-05-04,Treatment of gastric cancer,Designated,,,N/A,N/A,"Oncolytics Biotech, Inc.","210, 1167 Kensington Crescent NW",Calgary AB T2N1X7,,,,Canada,478315,2015,
tacrolimus,n/a,2015-05-04,Treatment of pulmonary arterial hypertension,Designated,,,N/A,N/A,Stanford University School of Medicine,300 Pasteur Drive,Room H3143,Stanford,California,94305,USA,472815,2015,
tadalafil,Cialis(R); Adcirca(R),2015-05-04,Treatment of Duchenne Muscular Dystrophy (DMD),Designated,,,N/A,N/A,Eli Lilly and Company,Lilly Corporate Center,,Indianapolis,Indiana,46285,USA,476415,2015,
humanized monoclonal antibody that targets the a-subunit of the human IL-3 receptor also known as the CD123 antigen; (JNJ-56022473),n/a,2015-05-05,Treatment of acute myeloid leukemia,Designated,,,N/A,N/A,"Janssen Research & Development, LLC",920 Route 202,Box 300,Raritan,New Jersey,8869,USA,478715,2015,
"autologous tumor cells fused with polyethylene glycol to human allogeneic FO-1, DNA plasmid transfected tumor cell line",n/a,2015-05-06,Treatment of glioblastoma,Designated,,,N/A,N/A,"Sebastiano Gattoni-Celli, MD",Med. University of SC- Dept of Radiation Oncology,114 Doughty St.,Charleston,South Carolina,29403,USA,456914,2015,
edaravone,Radicava,2015-05-12,Treatment of amyotrophic lateral sclerosis,Designated/Approved,Approved for Orphan Indication,Treatment of amyotrophic lateral sclerosis (ALS),2017-05-05,2024-05-05,Mitsubishi Tanabe Pharma Corporation,"17-10, Nihonbashi-Koamicho","Chuo-ku, Tokyo 103-8405",,,,Japan,478215,2015,724
N-t-butylhydroxylamine,n/a,2015-05-12,Treatment of infantile neuronal ceroid lipofuscinosis.,Designated,,,N/A,N/A,Andrew Lim,California Institute of Technology,1200 East California Blvd.,Pasadena,California,91125,USA,478615,2015,
adalimumab,Humira,2015-05-13,Treatment of moderate to severe hidradenitis suppurativa (Hurley stage 2 and Hurley stage 3 disease),Designated/Approved,Approved for Orphan Indication,Treatment of moderate to severe hidradenitis suppurativa,2015-09-09,2022-09-09,"AbbVie, Inc.",1 North Waukegan Road,,North Chicago,Illinois,60064,USA,446414,2015,119
2-(7-ethoxy-4-(3-fluorophenyl)-1-oxophthalazin-2(1H)-yl)-N-methyl-N-(2-methylbenzo[d]oxazol-6-yl)acetamide,n/a,2015-05-13,Treatment of cystic fibrosis,Designated,,,N/A,N/A,Flatley Discovery Lab,529 Main Street,Suite 115,Charlestown,Massachusetts,2129,USA,479115,2015,
acalabrutinib,n/a,2015-05-13,Treatment of chronic lymphocytic leukemia (CLL).,Designated,,,N/A,N/A,"Acerta Pharma, LLC (a member of the AstraZeneca Group)",121 Oyster Point Blvd.,,South San Francisco,California,94080,USA,477415,2015,
Anti-eTau Humanized IgG4 Monoclonal Antibody,n/a,2015-05-13,Treatment of Progressive Supranuclear Palsy,Designated,,,N/A,N/A,"Biogen, Inc.",225 Binney Street,,Cambridge,Massachusetts,2142,USA,477515,2015,
E-selectin antagonist,n/a,2015-05-13,Treatment of acute myeloid leukemia (AML),Designated,,,N/A,N/A,"GlycoMimetics, Inc.",401 Professional Drive,Suite 250,Gaithersburg,Maryland,20879,USA,475315,2015,
hydrocortisone oral granules,Infacort(R),2015-05-13,Treatment of pediatric adrenal insufficiency (0 through 16 years of age).,Designated,,,N/A,N/A,Diurnal Limited,Cardiff Medicentre,Cardiff CF14 4UJ,,,,United Kingdom,441614,2015,
recombinant human alkaline phosphatase,n/a,2015-05-13,Treatment of hypophosphatasia.,Designated,,,N/A,N/A,AM-Pharma BV,Rumpsterweg 6,3891 AK Bunnik,,,,Netherlands,476815,2015,
revusiran,n/a,2015-05-18,Treatment of transthyretin amyloidosis,Designated,,,N/A,N/A,"Alnylam Pharmaceuticals, Inc.",300 Third Street,,Cambridge,Massachusetts,2142,USA,477615,2015,
xenon gas,n/a,2015-05-18,To improve neurological outcome in hospitalized cardiac arrest patients.,Designated,,,N/A,N/A,Neuroprotexeon,Imperial Innovations,London SW7 2PG,,,,United Kingdom,461914,2015,
chloroquine,n/a,2015-05-20,Treatment of glioblastoma multiforme.,Designated,,,N/A,N/A,"DualTpharma B.,V.",Boschstraat 111-D01,6211 A W Maastricht,,,,Netherlands,475015,2015,
echinomycin,n/a,2015-05-21,Treatment of acute myeloid leukemia.,Designated,,,N/A,N/A,"OncoImmune, Inc.","502 E. Street, NE",,Washington,District of Columbia,20002,USA,479815,2015,
lutetium (177Lu)-edotreotide,n/a,2015-05-21,Treatment of gastro-entero-pancreatic neuroendocrine tumors,Designated,,,N/A,N/A,ITM Solucin GmbH,Lichtenbergstrasse 1,85748 Garching,,,,Germany,479215,2015,
poly-CD-PEG-camptothecin,n/a,2015-05-21,Treatment of ovarian cancer.,Designated,,,N/A,N/A,"Cerulean Pharma, Inc.",35 Gatehouse Drive,,Waltham,Massachusetts,2451,USA,479915,2015,
prasugrel hydrochloride,Effient,2015-05-26,Treatment of sickle cell disease,Designated,,,N/A,N/A,Eli Lilly,Lilly Corporate Center,,Indianapolis,Indiana,46285,USA,473015,2015,
adult hemogenic endothelial cells,n/a,2015-05-27,Treatment of aplastic anemia,Designated,,,N/A,N/A,HemoGenyx LLC,640 Elliott Street,Suite 108,Buffalo,New York,14203,USA,477715,2015,
idarucizumab,n/a,2015-05-28,To reverse the anticoagulant effect of dabigatran due to uncontrolled life-threatening bleeding requiring urgent intervention or a need to undergo an emergency surgery/urgent invasive procedure,Designated/Approved,Approved for Orphan Indication,For use in patients treated with Pradaxa® when reversal of the anticoagulant effects of dabigatran is needed for emergency surgery/urgent procedures and in life-threatening or uncontrolled bleeding,2015-10-16,2022-10-16,"Boehringer Ingelheim Pharmaceuticals, Inc.",PO Box 368,900 Ridgebury Road,Ridgefield,Connecticut,6877,USA,445714,2015,141
methotrexate oral solution,Xatmep,2015-05-28,Treatment of acute lymphoblastic leukemia in pediatric patients (0 through 16 years of age),Designated/Approved,Approved for Orphan Indication,Treatment of pediatric patients with acute lymphoblastic leukemia (ALL) as a component of a combination chemotherapy maintenance regimen,2017-04-25,2024-04-25,"Silvergate Pharmaceuticals, Inc.",6251 Greenwood Plaza Blvd.,Suite 101,Greenwood Village,Colorado,80111,USA,479615,2015,698
intraventricular nimodipine,n/a,2015-05-28,Treatment of subarachnoid hemorrhage,Designated,,,N/A,N/A,"Edge Therapeutics, Inc.",211 Warren Street,,Newark,New Jersey,7103,USA,343711,2015,
17-a-hydroxyprogesterone caporate (oral formulation),n/a,2015-06-01,Prevention of preterm birth in women with a singleton pregnancy,Designated,,,N/A,N/A,"Lipocine, Inc.",675 Arapeen Drive,Suite 202,Salt Lake City,Utah,84108,USA,445314,2015,
"2-(5-fluoro-2-methyl-1H-indol-3-yl)-1H-imidazo[4,5-f][1,10] phenanthroline",n/a,2015-06-01,Treatment of acute myeloid leukemia,Designated,,,N/A,N/A,"Aptose Biosciences, Inc.",5955 Airport Road,Suite 228,"Mississauga, Ontario L4V",,,Canada,480415,2015,
docosahexaenoic acid,n/a,2015-06-01,Treatment of short bowel syndrome,Designated,,,N/A,N/A,"Sancilio and Company, Inc.",3874 Fiscal Court,Suite 200,Riviera Beach,Florida,33404,USA,450214,2015,
ibudilast,n/a,2015-06-01,Treatment of Krabbe disease,Designated,,,N/A,N/A,"MediciNova, Inc.",4275 Executive Square,Suite 300,La Jolla,California,92037,USA,480015,2015,
immunologically active synthetic peptides,n/a,2015-06-01,Treatment of Hemophilia A,Designated,,,N/A,N/A,Apitope International NV,"Agoralaan, Building A-bis",3590 Diepenbeek,,,,Belgium,479315,2015,
regorafenib,Stivarga,2015-06-04,Treatment of hepatocellular carcinoma,Designated/Approved,Approved for Orphan Indication,Treatment of patients with hepatocellular carcinoma (HCC or liver cancer) who have been previously treated with the drug sorafenib.,2017-04-27,2024-04-27,"Bayer HealthCare Pharmaceuticals, Inc.",100 Bayer Blvd,P. O. Box 915,Whippany,New Jersey,7981,USA,478015,2015,693
synthetic 14-mer phosphorothioate antisense oligonucleotide directed against TGF-beta2 mRNA,n/a,2015-06-04,Prevention of scarring post glaucoma filtration surgery,Designated,,,N/A,N/A,Isarna Therapeutics GmbH,Leopoldstrasse 254-256,D-80807 Munich,,,,Germany,475215,2015,
adenoviral vector expressing the E.coli purine nucleoside phosphorylase gene and fludarabine,n/a,2015-06-08,"Intratumoral treatment of anatomically accessible oral and pharyngeal cancers (lip, tongue, gum, floor of mouth, salivary gland, and other oral cavity)",Designated,,,N/A,N/A,"PNP Therapeutics, Inc.",15 Richard Arrington Jr. Blvd North,,Birmingham,Alabama,35203,USA,443814,2015,
double stranded oligomer AD00370 RNA interference-based liver targeted therapeutic,n/a,2015-06-09,Treatment of Alpha-1 Antitrypsin deficiency,Designated/Withdrawn,,,N/A,N/A,Arrowhead Research Corporation,225 South Lake Avenue,Suite 1050,Pasadena,California,91101,USA,480515,2015,
fully human IgG2 monoclonal antibody that binds insulin receptors,n/a,2015-06-09,Treatment of congenital hyperinsulinism,Designated,,,N/A,N/A,XOMA (US) LLC,2910 Seventh St.,,Berkeley,California,94710,USA,430714,2015,
ivosidenib,n/a,2015-06-09,Treatment of acute myeloid leukemia (AML),Designated,,,N/A,N/A,"Agios Pharmaceuticals, Inc.",88 Sidney Street,,Cambridge,Massachusetts,2139,USA,481515,2015,
recombinant human CD24FcIg (humanized fusion protein consisting of the extracellular domain of CD24 linked to IgG1 Fc domain,n/a,2015-06-09,Prevention of graft-versus-host disease,Designated,,,N/A,N/A,"OncoImmune, Inc.","502 E Street, NE",,Washington,District of Columbia,20002,USA,478915,2015,
tumor-inflitrating lymphocytes; LN-144,n/a,2015-06-09,Treatment of malignant melanoma Stages IIb to IV,Designated,,,N/A,N/A,"Iovance Biotherapeutics, Inc.",999 Skyway Road,Suite 150,San Carlos,California,94070,USA,477215,2015,
"(6aR, 10aR)-3-(1â¿¿,1â¿¿-dimethylheptyl)-Î¿8-tetrahydro-cannabinol-9-carboxylic acid",n/a,2015-06-10,Treatment of systemic sclerosis,Designated,,,N/A,N/A,"Corbus Pharmaceuticals, Inc.",100 River Ridge Drive,Suite 103,Norwood,Massachusetts,2062,USA,480715,2015,
staphylococcal aureus protein A,n/a,2015-06-10,Treatment of immune thrombocytopenic purpura,Designated,,,N/A,N/A,"Protalex, Inc.",131 Columbia Turnpike,Suite 1,Florham Park,New Jersey,7932,USA,427714,2015,
imetelstat,n/a,2015-06-11,Treatment of myelofibrosis,Designated,,,N/A,N/A,"Janssen Research & Development, LLC",P. O. Box 300,920 US Route 202,Raritan,New Jersey,8869,USA,481315,2015,
obinutuzumab,Gazyva,2015-06-11,Treatment of splenic marginal zone lymphoma,Designated/Withdrawn,,,N/A,N/A,"Genentech, Inc.",1 DNA Way,MS# 214A,South San Francisco,California,94080,USA,473315,2015,
pembrolizumab,Keytruda,2015-06-16,"Treatment of gastric cancer, including gastroesophageal junction adenocarcinoma",Designated/Approved,Approved for Orphan Indication,"Treatment of patients with recurrent locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma whose tumors express PD-L1 [Combined Positive Score (CPS) >or =1] as determined by an FDA-approved test, with disease progression on or after two or more prior lines of therapy including fluoropyrimidine- and platinum-containing chemotherapy and if appropriate, HER2/neu targeted therapy excluding microsatellite instability-high or mismatch repair deficient gastric or gastroesophageal adenocarcinomas that have progressed and have no satisfactory alternative treatment options.",2017-09-22,2024-09-22,Merck Research Laboratories,351 North Sumneytown Pike,UG2C-50,North Wales,Pennsylvania,19454,USA,481715,2015,829
"2-{3-[(3R)-3-({[2-chloro-3-(trifluoromethyl)phenyl]methyl}(2,2-diphenylethyl)amino)butoxy]phenyl}acetic acid",n/a,2015-06-16,Treatment of ovarian cancer.,Designated,,,N/A,N/A,"Rgenix, Inc.",310 East 67th St.,Suite 1-12,New York,New York,10065,USA,483115,2015,
"2-{3-[(3R)-3-({[2-chloro-3-(trifluoromethyl)phenyl]methyl}(2,2-diphenylethyl)amino)butoxy]phenyl}acetic acid",n/a,2015-06-16,Treatment of glioblastoma multiforme.,Designated,,,N/A,N/A,"Rgenix, Inc.",310 East 67th St.,Suite 1-12,New York,New York,10065,USA,483215,2015,
"recombinant adeno-associated virus serotype rhesus 74 (rh74) expressing the human CT GalNac transferase (GALGT2) gene, also called the Sda or Cad GAlNac transferase or b4Galnt2, under control of the muscle creatine kinase (MCK) promoter",n/a,2015-06-16,Treatment of Duchenne muscular dystrophy,Designated,,,N/A,N/A,Nationwide Children's Hospital,700 Children's Drive,Rm WA2025,Columbus,Ohio,43205,USA,482515,2015,
synthetic signal peptide of human mucin-1 (amino acids 1-21),n/a,2015-06-16,Treatment of multiple myeloma.,Designated,,,N/A,N/A,Vaxil Bio Therapeutics Ltd.,"13 Einstein St., Building 13A",Nes-Ziona 7414001,,,,Israel,482115,2015,
"6-ethoxy-7-methoxy-2-(2-methylsulfanylphenyl)-3,1-bensoxazin-4-one",n/a,2015-06-18,Treatment of Netherton syndrome,Designated,,,N/A,N/A,Sixera Pharma AB,Erik Dahlbergsgaten 11a2t,Vastra Gotaland 41126,,,,Sweden,481815,2015,
"(1OR)-7-amino-12-fluoro-2,10,16-trimethyl-15 oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile",n/a,2015-06-23,Treatment of anaplastic lymphoma kinase (ALK)-positive or ROS1-positive non-small cell lung cancer,Designated,,,N/A,N/A,"Pfizer, Inc.",235 East 42nd Street (M/S 219/9/30),,New York,New York,10017,USA,481015,2015,
"2-{3-[(3R)-3-({[2-chloro-3-(trifluoromethyl)phenyl]methyl}(2,2-diphenylethyl)amino)butoxy]phenyl}acetic acid",n/a,2015-06-23,Treatment of malignant melanoma stages IIB to IV.,Designated,,,N/A,N/A,"Rgenix, Inc.",310 East 67th St.,Suite 1-12,New York,New York,10065,USA,483015,2015,
chlorotoxin conjugated to indocyanine green dye,n/a,2015-06-23,Diagnostic for the management of malignant brain tumors,Designated,,,N/A,N/A,"Blaze Bioscience, Inc.","530 Fairview Avenue, North",Suite 1400,Seattle,Washington,98109,USA,482615,2015,
"volanesorsen sodium, apolipotrotein C-III antisense oligonucleotide",n/a,2015-06-23,treatment of familial chylomicronemia syndrome,Designated,,,N/A,N/A,"Akcea Therapeutics, Inc.",55 Cambridge Parkway,Suite 100,Cambridge,Massachusetts,2142,USA,480815,2015,
gemcitabine ready-to-use,n/a,2015-06-24,Treatment of pancreatic cancer,Designated,,,N/A,N/A,Sun Pharmaceutical Industries Ltd.,Acme Plaza,"Andheri (East), Mumbai 400059",,,,India,476915,2015,
gemcitabine ready-to-use,n/a,2015-06-24,Treatment of ovarian cancer,Designated,,,N/A,N/A,Sun Pharmaceutical Industries Ltd.,Acme Plaza,"Andheri (East), Mumbai 400059",,,,India,477015,2015,
Gallium (68Ga) edotreotide,Somakit Toc,2015-07-01,Diagnostic for the clinical management of neuroendocrine tumors.,Designated,,,N/A,N/A,"Advanced Accelerator Applications, USA",350 Fifth Avenue,Suite 6902,New York,New York,10118,USA,483915,2015,
ANA-conjugated dactunomycin nanoemulsion,n/a,2015-07-07,Treatment of Ewing sarcoma,Designated,,,N/A,N/A,"NanoSmart Pharmaceuticals, Inc.",27071 Cabot Road,Suite 104,Laguna Hills,California,92653,USA,481115,2015,
sarizotan,n/a,2015-07-07,Treatment of Rett syndrome.,Designated,,,N/A,N/A,"Newron Pharmaceuticals US, Inc.",89 Headquarter Plaza North,Suite 1438,Morristown,New Jersey,7960,USA,484015,2015,
"1-(4-(benzylamino)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-2-yl)-2-methyl-1H-indole-4-carboxamide",n/a,2015-07-08,Treatment of multiple myeloma,Designated/Withdrawn,,,N/A,N/A,"Cleave Biosciences, Inc.",866 Malcolm Road,Suite 100,Burlingame,California,94010,USA,483815,2015,
propranolol and etodolac,n/a,2015-07-08,Treatment of malignant glioma.,Designated,,,N/A,N/A,"Vicus Therapeutics, LLC",55 Madison Avenue,Suite 400,Morristown,New Jersey,7960,USA,484315,2015,
nano-diamino-tetraiodothyroacetic acid,n/a,2015-07-09,Treatment of glioblastoma multiforme (GBM),Designated,,,N/A,N/A,"NanoPharmaceuticals, LLC",1 Discovery Place,,Rensselaer,New York,12144,USA,485115,2015,
"3-(4-(1,5-Napthrydine)-Imidazole[1,2-a]pyridine-7-(1-phenyl-4-(1-(4-methyl piperazine)",n/a,2015-07-14,Treatment of fibrodysplasia ossificans progressiva.,Designated,,,N/A,N/A,"La Jolla Pharmaceutical Company, Inc.",10182 Telesis Court,Suite 600,San Diego,California,92121,USA,484615,2015,
"3-(4-(8-fluoroquinoline)-Imidazole[1,2-a]pyridine-7-(1-phenyl-4-(1-(4-methyl piperazine)",n/a,2015-07-14,Treatment of fibrodysplasia ossificans progressiva.,Designated,,,N/A,N/A,"La Jolla Pharmaceutical Company, Inc.",10182 Telesis Court,Suite 600,San Diego,California,92121,USA,484915,2015,
adenovirus vaccine encoding reduced expression in immortalized cell protein,n/a,2015-07-14,Treatment of mesothelioma,Designated,,,N/A,N/A,MTG Biotherapeutics,8195 Run of the Knolls Court,,San Diego,California,92127,USA,485315,2015,
anisina,n/a,2015-07-14,Treatment of neuroblastoma.,Designated,,,N/A,N/A,Novogen Ltd,16-20 Edgeworth David Avenue,"Hornsbsy, NSW 2077",,,,Australia,485815,2015,
cannabidiol,n/a,2015-07-14,Prevention of Graft versus Host Disease (GVHD).,Designated,,,N/A,N/A,Talent biotechs Ltd.,14 - 18 Baruch Hirsch St.,Bnei Brak 5120206,,,,Israel,482315,2015,
DPX-Survivac,n/a,2015-07-14,Treatment of ovarian cancer.,Designated,,,N/A,N/A,"Immunovaccine Technologies, Inc.",1344 Summer Street,"Halifax, Nova Scotia B3H",,,,Canada,481615,2015,
melphalan,n/a,2015-07-14,Treatment of cholangiocarcinoma.,Designated,,,N/A,N/A,"Delcath Systems, Inc.",1633 Broadway,Suite 22C,New York,New York,10019,USA,485515,2015,
recombinant multimerized human IgG1 Fc,n/a,2015-07-14,Treatment of chronic inflammatory demyelinating polyneuropathy (CIDP).,Designated,,,N/A,N/A,"Pfizer, Inc.",500 Arcola Road,,Collegeville,Pennsylvania,19426,USA,484815,2015,
thioureidobutyronitrile,Kevetrin,2015-07-14,Treatment of ovarian cancer,Designated,,,N/A,N/A,"Innovation Pharmaceuticals, Inc.",100 Cummings Center,Suite 151-B,Beverly,Massachusetts,1915,USA,485615,2015,
vitamin A palmitate,n/a,2015-07-14,Prevention of bronchopulmonary dysplasia.,Designated,,,N/A,N/A,"Advent Therapeutics, Inc.",6500 Old Carversville Road,,Lumberville,Pennsylvania,18933,USA,483315,2015,
adeno-associated virus serotype 9 vector containing human Iduronate-2-sulfatase transgene,n/a,2015-07-16,Treatment of mucopolysaccharidosis type II (Hunter syndrome).,Designated,,,N/A,N/A,"Laboratorios del Dr. Esteve, S.A.","Av. Marie de Deu de Montserrat, 221",,Barcelona,,,Spain,486315,2015,
ombitasvir/paritaprevir/ritonavir and dasabuvir,Viekira Pak,2015-07-16,Treatment of pediatric patients with hepatitis C virus infection (0 through 16 years of age),Designated,,,N/A,N/A,"Abbvie, Inc.",1 North Waukegan Road,,North Chicago,Illinois,60064,USA,484715,2015,
recombinant humanized anti-matrix metalloprotein 9 (MMP9) monoclonal antibody IgG4,n/a,2015-07-16,Treatment of gastric cancer,Designated,,,N/A,N/A,"Gilead Sciences, Inc.",199 E. Blaine St.,,Seattle,Washington,98102,USA,473815,2015,
Amantadine HCl,n/a,2015-07-20,Treatment of levodopa-induced dyskinesia,Designated,,,N/A,N/A,Osmotica Pharmaceutical Corporation,"Regulatory, Clinical Operations & Legal","Lumina Station #2, Suite 209-A",Wilmington,North Carolina,28403,USA,257608,2015,
mongersen,n/a,2015-07-20,Treatment of pediatric Crohn's disease,Designated,,,N/A,N/A,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,USA,484215,2015,
Adenoviral vector-RheoSwitch Therapeutic System-human interleukin 12 + veledimex,n/a,2015-07-23,Treatment of malignant glioma.,Designated,,,N/A,N/A,"Ziopharm Oncology, Inc.",One First Avenue,Navy Yard Plaza,Boston,Massachusetts,2129,USA,486015,2015,
antroquinonol,n/a,2015-07-23,Treatment of hepatocellular carcinoma,Designated,,,N/A,N/A,Golden Biotechnology Corporation,"10F, No. 9, Ln. 3","Tamsui Dist., New Taipei City 251",,,,Taiwan,488115,2015,
cannabidiol,n/a,2015-07-23,Treatment of infantile spasms,Designated,,,N/A,N/A,"Insys Development Company, Inc.",1333 South Spectrum Boulevard,Suite 100,Chandler,Arizona,85286,USA,486115,2015,
procaspase-activating compound 1,n/a,2015-07-23,Treatment of malignant glioma,Designated,,,N/A,N/A,"Vanquish Oncology, Inc.",2001 S. First Street,Suite 201,Champaign,Illinois,61820,USA,486615,2015,
veltuzumab,n/a,2015-07-28,Treatment of immune thrombocytopenic purpura.,Designated,,,N/A,N/A,"Immunomedics, Inc.",300 The American Road,,Morris Plains,New Jersey,7950,USA,486915,2015,
afatinib,Gilotrif,2015-08-03,Treatment of non-small cell lung cancer with squamous histology.,Designated/Approved,Approved for Orphan Indication,"Treatment of patients with metastatic, squamous, non-small cell lung cancer progressing after platinum-based chemotherapy",2016-04-15,2023-04-15,"Boehringer Ingelheim Pharmaceuticals, Inc.",900 Ridgebury Road,P. O. Box 368,Ridgefield,Connecticut,6877,USA,484115,2015,256
inecalcitol,n/a,2015-08-03,Treatment of acute myeloid leukemia.,Designated,,,N/A,N/A,"Hybrigenics, S.A.",3-5 Impasse Reille,75014,Paris,,,France,479715,2015,
butylidenephthalide,n/a,2015-08-05,Treatment of Malignant Glioma,Designated,,,N/A,N/A,"Everfront Biotech, Inc.","11F., No. 31, Ln. 169, Kangning St.",New Taipei City 221,,,,Taiwan,485715,2015,
sodium valproate,n/a,2015-08-05,Treatment of Wolfram syndrome,Designated,,,N/A,N/A,The University of Birmingham,Birmingham Research Park - Vincent Drive,Birmingham B15 2SQ,,,,United Kingdom,486515,2015,
varlitinib,n/a,2015-08-05,treatment of biliary tract cancer,Designated,,,N/A,N/A,"ASLAN Pharmaceuticals Pte, Ltd.",83 Clemenceau Avenue,#12-03,Singapore,,,Singapore,485915,2015,
daratumumab,n/a,2015-08-06,Treatment of follicular lymphoma,Designated,,,N/A,N/A,"Janssen Research & Development, LLC",1400 McKean Road,P. O. Box 776,Spring House,Pennsylvania,19477,USA,487415,2015,
encapsulated spores from fecal microbiota,n/a,2015-08-19,Treatment of recurrent Clostridium difficile infection (CDI),Designated,,,N/A,N/A,"Seres Therapeutics, Inc.",200 Sidney Street,,Cambridge,Massachusetts,2139,USA,466214,2015,
daratumumab,n/a,2015-08-20,Treatment of mantle cell lymphoma.,Designated,,,N/A,N/A,"Janssen Research & Development, LLC",1400 McKean Road,P. O. Box 776,Spring House,Pennsylvania,19477,USA,488615,2015,
humanized monoclonal antibody of the IgG4 kappa isotype targeting CD47,n/a,2015-08-20,Treatment of acute myeloid (myelogenous) leukemia.,Designated,,,N/A,N/A,"Forty Seven, Inc.",1490 O'Brien Drive,Suit A,Menlo Park,California,94025,USA,488515,2015,
fostamatinib disodium,n/a,2015-08-25,Treatment of immune thrombocytopenic purpura,Designated/Approved,Approved for Orphan Indication,TAVALISSE is indicated for the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous treatment.,2018-04-17,TBD,"Rigel Pharmaceuticals, Inc.",1180 Veterans Boulevard,,South San Francisco,California,94080,USA,487715,2015,966
Adeno-associated virus serotype rh10 vector encoding the human factor IX gene,n/a,2015-08-25,Treatment of hemophilia B.,Designated,,,N/A,N/A,Dimension Therapeutics,840 Memorial Drive,,Cambridge,Massachusetts,2139,USA,487615,2015,
sodium 2-hydroxylinoleate,n/a,2015-08-25,Treatment of neuroblastoma.,Designated,,,N/A,N/A,"Ability Pharmaceuticals, SL",Edifici Eureka,Campus de la UAB,Bellaterra,,,Spain,489315,2015,
methotrexate oral solution,Xatmep,2015-08-27,Management of pediatric patients with active polyarticular juvenile idiopathic arthritis (pJIA) who are intolerant of or had an inadequate response to first-line therapy.,Designated/Approved,Approved for Orphan Indication,"Treatment of oligoarticular juvenile idiopathic arthritis (persistent oligoarthritis, psoriatic juvenile idiopathic arthritis, enthesitis-related arthritis, or undifferentiated arthritis) and polyarticular juvenile idiopathic arthritis in children 0 through 16 years of age.",2017-04-25,2024-04-25,"Silvergate Pharmaeuticals, Inc.",6251 Greenwood Plaza Blvd,Suite 101,Greenwood Village,Colorado,80111,USA,479515,2015,607
nivolumab,n/a,2015-08-27,Treatment of glioblastoma,Designated,,,N/A,N/A,Bristol-Myers Squibb Co,P. O. Box 4000,,Princeton,New Jersey,8543,USA,469615,2015,
Larotrectinib,n/a,2015-08-31,Treatment of soft tissue sarcoma.,Designated,,,N/A,N/A,"Loxo Oncology, Inc.",281 Tresser Boulevard,9th Floor,Stamford,Connecticut,6901,USA,490115,2015,
N-acetylcysteine and sodium thiosulfate,n/a,2015-08-31,Prevention of platinum-induced toxicities in pediatric patients (0 through 16 years of age).,Designated,,,N/A,N/A,"Edward A. Neuwelt, MD",Oregon Health & Science University,3181 SW Sam Jackson Park Road - Mail Code L603,Portland,Oregon,97239,USA,479415,2015,
udenafil,n/a,2015-08-31,Treatment of single ventricle congenital heart disease with Fontan physiology,Designated,,,N/A,N/A,Mezzion Pharma Co. Ltd.,3rd Floor C & H Building,Gangnam-gu 135-879,Seoul,,,"Korea, Republic of",449714,2015,
ataluren,n/a,2015-09-01,Treatment of aniridia,Designated,,,N/A,N/A,"PTC Therapeutics, Inc.",100 Corporate Court,,South Plainfield,New Jersey,7080,USA,490215,2015,
modified a-cobratoxin,n/a,2015-09-01,Treatment of pediatric multiple sclerosis (0 through 16 years of age).,Designated,,,N/A,N/A,Nutra Pharma Corporation,12502 W. Atlantic Blvd,,Coral Springs,Florida,33071,USA,489115,2015,
purified autologous type 1 regulatory T lymphocytes specific for human type II collagen,n/a,2015-09-01,Treatment of chronic non-infectious uveitis,Designated,,,N/A,N/A,TxCell SA,Allee de la Nertiere,06560 Valbonne - Sophia-Antipolis,,,,France,457814,2015,
nivolumab,Opdivo,2015-09-02,Treatment of hepatocellular carcinoma,Designated/Approved,Approved for Orphan Indication,Treatment of patients with hepatocellular carcinoma (HCC) who have been previously treated with sorafenib,2017-09-22,2024-09-22,Bristol-Myers Squibb Company,P. O. Box 4000,,Princeton,New Jersey,8543,USA,489915,2015,751
hydrocortisone modified release capsules,Chronocort(R),2015-09-03,Treatment of adrenal insufficiency.,Designated,,,N/A,N/A,Diurnal Ltd.,Cardiff Medicentre,Heath Park,,,,United Kingdom,487515,2015,
nimotuzumab,n/a,2015-09-08,Treatment of pancreatic cancer.,Designated,,,N/A,N/A,InnoCIMab Pte Ltd,21 Bukit Batok Crescent,WCEGA Tower #14-78,,,,Singapore,487915,2015,
pentetrazol,n/a,2015-09-09,Treatment of idiopathic hypersomnia,Designated,,,N/A,N/A,"Balance Therapeutics, Inc.",1250 Bayhill Drive,Suite 125,San Bruno,California,94066,USA,488815,2015,
2-(2-chlorobenzylidene)hydrazinecarboximidamide acetate,n/a,2015-09-10,Treatment of Charcot-Marie Tooth disease.,Designated,,,N/A,N/A,InFlectis BioScience,21 rue de la Noue Bras de Fer,44200 Nantes,,,,France,488415,2015,
everolimus ointment,n/a,2015-09-10,Topical treatment of Tuberous Sclerosis Complex-related skin lesions,Designated,,,N/A,N/A,"Aucta Pharmaceuticals, LLC",675 US Highway One,,North Brunswick,New Jersey,8902,USA,489715,2015,
immunoglobulin G degrading enzyme of Streptococcus pyogenes,n/a,2015-09-10,Prevention of antibody mediated organ rejection in solid organ transplant patients.,Designated,,,N/A,N/A,Hansa Medical AB,P. O. Box 785,SE-220 07 Lund,,,,Sweden,455114,2015,
"mesencephalic, astrocyte-derived neurotrophic factor",n/a,2015-09-10,Treatment of retinal artery occlusion.,Designated,,,N/A,N/A,"Amarantus BioScience Holdings, Inc.",655 Montgomery Street,Suite 900,San Francisco,California,94111,USA,466314,2015,
masitinib mesylate,n/a,2015-09-14,Treatment of gastric cancer including cancer of the gastroesophageal junction,Designated,,,N/A,N/A,AB Science,"3, avenue George V",,Paris,,,France,490815,2015,
small molecule FGFR4 inhibitor,n/a,2015-09-14,Treatment of hepatocellular cancer (HCC).,Designated,,,N/A,N/A,Blueprint Medicines Corporation,38 Sidney Street,Suite 200,Cambridge,Massachusetts,2139,USA,490915,2015,
interleukin-1 receptor antagonist anakinra,Kineret,2015-09-15,Treatment of Still's disease including systemic juvenile idiopathic arithritis and adult-onset Still's disease.,Designated,,,N/A,N/A,Swedish Orphan Biovitrum AB,SE-112,75 Stockholm,,,,Sweden,488715,2015,
Mononuclear enriched fraction of human umbilical cord blood,U-Cord-Cell(R),2015-09-15,Treatment of amyotrophic lateral sclerosis (ALS).,Designated,,,N/A,N/A,"Saneron CCEL Therapeutics, Inc.",13014 North Dale Mabry Highway,Suite 266,Tampa,Florida,33618,USA,491515,2015,
nivolumab,n/a,2015-09-15,Treatment of small cell lung cancer.,Designated,,,N/A,N/A,Bristol-Myers Squibb Company,Route 206 & Province Line Road,Mail Stop D32-07,Princeton,New Jersey,8543,USA,491415,2015,
Remdesivir,n/a,2015-09-18,Treatment of Ebola virus disease,Designated,,,N/A,N/A,"Gilead Sciences, Inc.",333 Lakeside Drive,,Foster City,California,94404,USA,490515,2015,
Upadacitinib,n/a,2015-09-18,Treatment of pediatric (aged 0 through 16 years) juvenile idiopathic arthritis (JIA) ILAR categories excluding systemic JIA,Designated,,,N/A,N/A,"AbbVie, Inc.",1 North Waukegan Road,,North Chicago,Illinois,60064,USA,485415,2015,
avelumab (Recombinant human monoclonal IgG1 antibody against programmed death ligand-1),Bavencio,2015-09-21,Treatment of merkel cell carcinoma.,Designated/Approved,Approved for Orphan Indication,Treatment of adults and pediatric patients 12 years and older with metastatic Merkel cell carcinoma,2017-03-23,2024-03-23,"EMD Serono Research and Development Institute, Inc.",45A Middlesex Turnpike,,,,,USA,491815,2015,549
acalabrutinib,Calquence,2015-09-21,Treatment of mantle cell lymphoma.,Designated/Approved,Approved for Orphan Indication,treatment of adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy,2017-10-31,2024-10-31,"Acerta Pharma, LLC (a member of the AstraZeneca Group)",121 Oyster Point Blvd.,,South San Francisco,California,94080,USA,488915,2015,771
adeno-associated viral vector composed of a bioengineered AAV capsid and a codon-optimized expression cassette encoding a high-specific activity variant of human coagulation factor IX,n/a,2015-09-21,Treatment of hemophilia B.,Designated,,,N/A,N/A,"Spark Therapeutics, Inc.",3737 Market Street,Suite 1300,Philadelphia,Pennsylvania,19104,USA,490715,2015,
marizomib,n/a,2015-09-21,Treatment of malignant glioma.,Designated,,,N/A,N/A,Celgene International II Sàrl,4 Rue des Moulins,,Couvet,,,Switzerland,490015,2015,
"mecasermin, recombinant human insulin-like growth factor-1",Increlex,2015-09-21,Treatment of Rett Syndrome.,Designated,,,N/A,N/A,Keck Graduate Institute of Applied Life Sciences,535 Watson Drive,,Claremont,California,91711,USA,491915,2015,
setmelanotide,n/a,2015-09-21,Treatment of Prader-Willi Syndrome.,Designated,,,N/A,N/A,"Rhythm Metabolics, Inc.",855 Boylston Street,11th Floor,Boston,Massachusetts,2116,USA,480615,2015,
"2-[(4S)-6-(4-chlorophenyl)-1,7,8-trimethylthiophenol[3,2-f]1,2,4-triazolo[4,3-a]1,4-diazepin-4-yl]-N-[3-(4-methylpiperazinyl)propyl]acetamide",n/a,2015-09-29,Treatment of nuclear protein in testis (NUT) midline carcinoma.,Designated,,,N/A,N/A,"Genentech, Inc (a Roche Group Member)",1 DNA Way,M/S# 35-5e,South San Francisco,California,94080,USA,492615,2015,
"4-Hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl",n/a,2015-09-29,Treatment of cerebral cavernous malformation.,Designated,,,N/A,N/A,"Recursion Pharmaceuticals, LLC",383 S. Colorow Drive,,Salt Lake City,Utah,84108,USA,487815,2015,
aden-associated virus vector serotype 9 expressing human a-L-iduronidase,n/a,2015-09-29,Treatment of mucopolysaccharidosis Type I (MSP I).,Designated,,,N/A,N/A,"REGENXBIO, Inc.",9712 Medical Center Drive,Suite 100,Rockville,Maryland,20850,USA,492015,2015,
glyburide,n/a,2015-09-29,Treatment of acute spinal cord injury,Designated,,,N/A,N/A,"Remedy Pharmaceuticals, Inc.","233 Broadway, Suite 1750",,New York,New York,10279,USA,491215,2015,
guadecitabine,n/a,2015-09-29,Treatment of acute myeloid leukemia.,Designated,,,N/A,N/A,"Astex Pharmaceuticals, Inc.",4420 Rosewood Drive,Suite 200,Pleasanton,California,94588,USA,492515,2015,
"(S)-8-{2-Amino-6-[1-(5-chloro-biphenyl-2-yl)-(R)-2,2,2-trifluoro-ethoxy]-pyrimidin-4-yl}-2,8-diaza-spiro[4.5]decane-3-carboxylic acid ethyl ester",n/a,2015-10-06,Treatment of pulmonary arterial hypertension (PAH).,Designated,,,N/A,N/A,Roivant Sciences GmbH,8 Viaduktstrasse,,Basel,,,Switzerland,492715,2015,
"2-amino-2-[2-[2-chloro-4-[[3-(phenylmethoxy) phenyl] thio]phenyl]ethyl]1,3-propanediol hydrochloride",n/a,2015-10-06,Prevention of graft versus host disease.,Designated/Withdrawn,,,N/A,N/A,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,USA,491315,2015,
nanoparticulate paclitaxel,Nanotax,2015-10-06,Treatment of ovarian cancer,Designated,,,N/A,N/A,"NanOlogy, LLC",231 Bonetti Drive,,San Luis Obispo,California,93401,USA,482015,2015,
betamethasone,n/a,2015-10-07,Treatment of Ataxia Telangiectasia.,Designated,,,N/A,N/A,"Grace Therapeutics, LLC",675 U.S. 1,,North Brunswick Township,New Jersey,8902,USA,492415,2015,
Mixture of 2 anti-rabies humanized monoclonal immunoglobulin (Ig)G1k antibodies,n/a,2015-10-07,Post-exposure prophylaxis against rabies virus infection,Designated,,,N/A,N/A,"Synermore Biologics Co., Ltd","6F, No 5-6, Aly 22, Ln 513 Ruiguang Rd.",Neihu Dist.,,,,Taiwan,489515,2015,
recombinant fusion protein comprising exenatide and XTEN,n/a,2015-10-07,Treatment of short bowel syndrome.,Designated,,,N/A,N/A,"NAIA Pharmaceuticals, Inc.",215 McAllister Avenue,,Kentfield,California,94904,USA,489615,2015,
"(6aR, 10aR)-3-(1’,1’-dimethylheptyl)-delta8-tetrahydro-cannabinol-9-carboxylic acid",n/a,2015-10-13,Treatment of cystic fibrosis.,Designated,,,N/A,N/A,"Corbus Pharmaceuticals, Inc.",100 River Ridge Drive,Suite 103,Norwood,Massachusetts,2062,USA,493415,2015,
"(2-(2-chlorophenyl)-4-[3-(dimethylamino)phenyl]-5-methyl-1h-pyrazolo [4,3-c] pyridine-3,6(2h,5h)-dione)",n/a,2015-10-14,Treatment of systemic sclerosis.,Designated,,,N/A,N/A,Genkyotex Innovation SAS,18 Avenue Marie Curie,,Archamps,,,France,493115,2015,
human soluble receptor-Fc fusion protein that targets human activin A,n/a,2015-10-14,Treatment of ovarian cancer.,Designated,,,N/A,N/A,Atara Biotherapeutics,4360 Park Terrace Drive,Suite 100,Westlake Village,California,91361,USA,489415,2015,
lisinopril oral solution,n/a,2015-10-14,Treatment of hypertension in pediatric patients 0 through 16 years of age.,Designated/Withdrawn by OPD,,,N/A,N/A,"Silvergate Pharmaceuticals, Inc.",6251 Greenwood Plaza Blvd.,Suite 101,Greenwood Village,Colorado,80111,USA,481915,2015,
ondansetron inhalation powder,n/a,2015-10-14,Prevention of chemotherapy-induced nausea and vomiting due to highly emetogenic chemotherapy in pediatric patients (0 through 16 years of age) .,Designated,,,N/A,N/A,"Luxena Pharmaceuticals, Inc.",1400 Coleman Avenue,Suite D27,Santa Clara,California,95050,USA,491115,2015,
acalabrutinib,n/a,2015-10-22,Treatment of Waldenstrom macroglobulinemia.,Designated,,,N/A,N/A,"Acerta Pharma, LLC (a member of the AstraZeneca Group)",121 Oyster Point Blvd.,,South San Francisco,California,94080,USA,489015,2015,
bucillamine,n/a,2015-10-22,Treatment of cystinuria,Designated,,,N/A,N/A,"Revive Therapeutics, Ltd.",5 Director Court,Suite 105,Vaughan,Ontario,,Canada,493615,2015,
deflazacort,n/a,2015-10-22,Treatment of pediatric (0 through 16 years of age) juvenile idiopathis arthritis (JIA) International League of Associations for Rheumatology (ILAR) categories excluding systemic JIA.,Designated,,,N/A,N/A,"PTC Therapeutics, Inc.",100 Corporate Court,,South Plainfield,New Jersey,7080,USA,491715,2015,
paricalcitol,Zemplar,2015-10-27,Treatment of pediatric hyperparathyroidism,Designated/Approved,Approved for Orphan Indication,Indicated in pediatric patients 10 years and older for the prevention and treatment of secondary hyperparathyroidism associated with Chronic kidney disease (CKD) Stages 3 and 4 and CKD Stage 5 in patients on hemodialysis or peritoneal dialysis,2016-10-18,2023-10-18,"Abbvie, inc.",1 North Waukegan Road,,North Chicago,Illinois,60064,USA,492815,2015,357
ABCA4 DNA nanoparticles,n/a,2015-10-28,Treatment of Stargardt Macular Degeneration,Designated,,,N/A,N/A,"Copernicus Therapeutics, Inc.",11000 Cedar Avenue,,Cleveland,Ohio,44106,USA,494015,2015,
baclofen,Gablofen,2015-10-28,Treatment of complex regional pain syndrome.,Designated,,,N/A,N/A,"Piramal Critical Care, Inc.",261 Brodhead Road,Suite 221,Bethlehem,Pennsylvania,18017,USA,493915,2015,
nano-diamino-tetraiodothyroacetic acid,n/a,2015-10-28,Treatment of pancreatic cancer,Designated,,,N/A,N/A,"NanoPharmaceuticals, LLC",1 Discovery Place,,Rensselaer,New York,12144,USA,493715,2015,
valsartan oral solution,n/a,2015-10-28,Treatment of hypertension in pediatric patients 0 through 16 years of age,Designated/Withdrawn by OPD,,,N/A,N/A,Carmel Biosciences,5673 Peachtree Dunwoody Road,Suite 440,Atlanta,Georgia,30342,USA,494115,2015,
dabrafenib and trametinib,Mekinist,2015-10-29,Treatment of patients with BRAF mutation positive non-small cell lung cancer.,Designated/Approved,Approved for Orphan Indication,"Mekinist in combination with dabrafenib, for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) with BRAF V600E mutation as detected by an FDA-approved test; AND Tafinlar in combination with trametinib, for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) with BRAF V600E mutation as detected by an FDA-approved test.",2017-06-22,2024-06-22,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,USA,495915,2015,602
lucerastat,n/a,2015-10-29,Treatment of Fabry Disease.,Designated,,,N/A,N/A,Idorsia Pharmaceuticals US Inc.,1820 Chapel Avenue West,Suite 150,Cherry Hill,New Jersey,8002,USA,495815,2015,
monoclonal antibody targeting eotaxin-2,n/a,2015-10-29,Treatment of idiopathic pulmonary fibrosis.,Designated,,,N/A,N/A,"ChemomAb, Ltd.",6 Hanehoset St.,,Tel Aviv,,,Israel,494615,2015,
"N'-(7-Chloroquinolin-4-yl)-N,N-diethyl-propane-1,3-diamine",n/a,2015-10-29,Treatment of malaria.,Designated,,,N/A,N/A,"Donald J. Krogstad, MD","1430 Tulane Ave., #8317",J.B. Johnson Building,New Orleans,Louisiana,70112,USA,494715,2015,
recombinant adeno-associated virus serotype 9 vector containing the transgene UBE3A encoding for ubiquitin protein ligase E3A/E6-AP,n/a,2015-10-29,Treatment of Angelman Syndrome.,Designated,,,N/A,N/A,"Agilis Biotherapeutics, LLC",245 First Street,Suite 1800,Cambridge,Massachusetts,2142,USA,494815,2015,
arsenic trioxide capsule (oral),n/a,2015-11-02,Treatment of acute promyelocytic leukemia.,Designated,,,N/A,N/A,Orsenix Holdings BV,1105 North Market Street,Suite 1800,Wilmington,Delaware,19801,USA,496415,2015,
Cisplatin ChemoThin Wafer,n/a,2015-11-03,"Treatment of anatomically accessible oral cancers (lip, tongue, gum, floor of mouth, salivary gland, and other oral cavity)",Designated,,,N/A,N/A,Privo Technologies,13 Bristol Street,Unit #1,Cambridge,Massachusetts,2141,USA,447514,2015,
human cystic fibrosis transmembrane conductance regulator (hCFTR) messenger RNA (mRNA) complexed with branched polyethyleneimine (bPEI),n/a,2015-11-03,Treatment of patients with cystic fibrosis.,Designated,,,N/A,N/A,Translate Bio,200 Sidney Street,Suite 310,Cambridge,Massachusetts,2139,USA,496215,2015,
Bendamustine oral doseage formulation,n/a,2015-11-05,Treatment of chronic lymphocytic leukemia,Designated,,,N/A,N/A,Exinda Theapeutics LLC,8430 Rovana Circle,Suite B,Sacramento,California,95828,USA,486215,2015,
"3-{3-[4-(1-aminocyclobutyl)phenyl]-5-phenyl-3H-imidazo[4,5-b]pyridin-2-yl}cpyridin-2-amine bis-mesylate",n/a,2015-11-09,Treatment of Proteus Syndrome.,Designated,,,N/A,N/A,"ArQule, Inc.",One Wall Street,,Burlington,Massachusetts,1803,USA,497115,2015,
daratumumab,Humax (R) - Cd38,2015-11-09,Treatment of diffuse large B-cell lymphoma.,Designated,,,N/A,N/A,"Janssen Research and Development, LLC",1400 McKean Road,P. O. Box 776,Spring hOuse,Pennsylvania,19477,USA,496815,2015,
human allogeneic bone marrow derived osteoblastic cells,n/a,2015-11-09,Treatment of osteogenesis imperfecta.,Designated,,,N/A,N/A,Bone Therapeutics SA,"37, Rue Auguste Piccard",Gosselies,Gosselies,,,Belgium,495015,2015,
sodium nitrite and EDTA,n/a,2015-11-10,Treatment of Pseudomonas aeruginosa pulmonary infections in patients with cystic fibrosis,Designated,,,N/A,N/A,"Arch Biopartners, Inc.",27 Saint Clair Avenue East,P. O. Box 305,Toronto,Ontario,,Canada,495615,2015,
vadastuximab talirine,n/a,2015-11-10,Treatment of acute myeloid leukemia.,Designated,,,N/A,N/A,"Seattle Genetics, Inc.",21823 30th Drive Southeast,,Bothell,Washington,98021,USA,494515,2015,
adeno-associated virus type 8 delivering a vector genome with human retinoschisin promoter (RS/IRBP) and the human retinoschisin cDNA (hRS),n/a,2015-11-16,Treatment of X-linked retinoschisis,Designated,,,N/A,N/A,"Paul A. Sievig, MD, PhD, National Eye Institute, NIH",31 Center Drive,"Bldg 31, Room 6A03",Bethesda,Maryland,20892,USA,496015,2015,
diazepam (intranasal),n/a,2015-11-16,Management of acute repetitive seizures.,Designated,,,N/A,N/A,"Neurelis Pharmaceuticals, Inc.",1042-B N. El Camino Real,Suite 430,Encinitas,California,92024,USA,382512,2015,
recombinant adeno-associated virus vector expressing the cyclic nucleotide gated channel alpha subunit (CNGA3),n/a,2015-11-16,Treatment of achromatopsia caused by mutations in the CNGA3 gene,Designated,,,N/A,N/A,Applied Genetic Technologies Corp.,11801 Research Drive,Suite D,Alachua,Florida,32615,USA,496615,2015,
"S3,S13-cyclo(D-tyrolsyl-L-isoleucyl-L-cysteinyl-L-valyl-1-methyl-L-tryptophyl-L-glutaminyl-L-aspartyl-L-tryptophyl-N-methyl-L-glycyl-L-alanyl-L-histidyl-L-arginyl-L-cysteinyl-N-methyl-L-isoleucinamide",n/a,2015-11-16,Treatment of C3 glomerulopathy.,Designated,,,N/A,N/A,Amyndas Pharmaceuticals,N.Zerva 28,,Glyfada,,,Greece,494915,2015,
thioureidobutyronitrile,Kevetrin,2015-11-17,Treatment of retinoblastoma.,Designated,,,N/A,N/A,"Innovation Pharmaceuticals, Inc.",100 Cummings Center,Suite 151-B,Beverly,Massachusetts,1915,USA,502515,2015,
"4-[(7-Methoxy-2,3-dihydro-1,4-benzothiazepin-4(5H)-yl)methyl]benzoic acid, hemifumarate",n/a,2015-11-18,Treatment of patients with Duchenne Muscular Dystrophy.,Designated,,,N/A,N/A,"ARMGO Pharma, Inc.",777 Old Saw Mill River Road,,Tarrytown,New York,10591,USA,501515,2015,
adeno-associated viral (AAV) vector serotype rh. 10 encoding the human N-sulfoglycosamine sulphohydrolase cDNA (SGSH),n/a,2015-11-18,Treatment of mucopolysaccharidosis type IIIA or Sanfilippo type A syndrome,Designated,,,N/A,N/A,LYSOGENE,20 Rue Jacques Dulud,,Neuilly-sur-Seine,,,France,499115,2015,
Oxaloacetic acid,n/a,2015-11-18,Treatment of amyotrophic lateral sclerosis,Designated,,,N/A,N/A,Terra Biological LLC,3830 Valley Centre Drive,Suite 705-561,San Diego,California,92130,USA,488015,2015,
"(R)-6-(2-fluorophenyl)-N-(3-(2-((2-methoxyethyl)amino)ethyl)phenyl)-5,6-dihydrobenzo[h]quinazolin-2-amine dihydrochloride",n/a,2015-11-19,Treatment of cholangiocarcinoma.,Designated,,,N/A,N/A,"ArQule, Inc.",One Wall Street,,Burlington,Massachusetts,1803,USA,497615,2015,
ubenimex,n/a,2015-11-19,Treatment of pulmonary arterial hypertension.,Designated,,,N/A,N/A,"Eiger BioPharmaceuticals, Inc.",350 Cambridge Avenue,Suite 350,Palo Alto,California,94306,USA,498115,2015,
Vasomera,n/a,2015-11-19,"Treatment of cardiomyopathy associated with dystrophinopathies; Duchenne Muscular Dystrophy (DMD), Becker Muscular Dystrophy BMD), and X-linked dilated cardiomyopathy (XL-dCMP).",Designated,,,N/A,N/A,"PhaseBio Pharmaceuticals, Inc.",1 Great Valley Parkway,Suite 30,Malvern,Pennsylvania,19355,USA,492215,2015,
necitumumab,n/a,2015-11-20,Treatment of squamous non-small cell lung cancer,Designated/Approved,Approved for Orphan Indication,"Use in combination with gemcitabine and cisplatin, for first-line treatment of patients with metastatic, squamous, non-small cell lung cancer. PORTRAZZA is not indicated for treatment of non-squamous, non-small cell lung cancer",2015-11-24,2022-11-24,Eli Lilly and Company,33 ImClone Drive,,Branchburg,New Jersey,8876,USA,418213,2015,4
acetyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-cysteinyl-D-glutaminyl-D-cystenyl-D-arginyl-D-arginyl-D-lysyl-D-asparaginylmaide disulfide,n/a,2015-11-24,Treatment of acute myeloid leukemia.,Designated,,,N/A,N/A,"Genus Oncology, LLC",2458 N. Racine Avenue,,Chicago,Illinois,60614,USA,494415,2015,
temozolomide,n/a,2015-11-25,Treatment glioblastoma multiforme in pediatric patients,Designated,,,N/A,N/A,"AmpliPharm Pharmaceuticals, LLC",970 Peachtree Industrial Boulevard,Suite 100,Suwanee,Georgia,30024,USA,497215,2015,
tirapazamine,n/a,2015-11-30,Treatment of hepatocellular carcinoma,Designated,,,N/A,N/A,Teclison Limited,28 Baltusrol Way,,Short Hills,New Jersey,7078,USA,498815,2015,
Azurin-p28,n/a,2015-12-02,Treatment of glioma,Designated,,,N/A,N/A,"CDG Therapeutics, Inc.",840 South Wood Street,M/C 820,Chicago,Illinois,60612,USA,507415,2015,
dodecafluoropentane emulsion (DDFPe),n/a,2015-12-02,Radiosensitizer to be used during radiation treatment of glioblastoma multiforme (GBM).,Designated,,,N/A,N/A,NuvOx Pharma,1635 East 18th Street,,Tucson,Arizona,85719,USA,497715,2015,
delta-9-tetrahydrocannibinol and cannabidiol,n/a,2015-12-03,Treatment of glioma.,Designated,,,N/A,N/A,GW Research Ltd.,"Sovereign House, Vision Park",Chivers Way,Histon,,,United Kingdom,498215,2015,
multi-epitope folate receptor alpha peptide vaccine with GM-CSF adjuvant (TPIV200),n/a,2015-12-07,Treatment of ovarian cancer.,Designated,,,N/A,N/A,"Tapimmune, Inc.",50 North Laura Street,,Jacksonville,Florida,32202,USA,498915,2015,
non-replicating recombinant adeno-associated virus (AAV) vector of serotype 9 expressing human iduronate-2-sulfatase,n/a,2015-12-08,Treatment of Mucopolysaccharidosis Type II,Designated,,,N/A,N/A,"REGENXBIO, Inc.",9712 Medical Center Drive,Suite 100,Rockville,Maryland,20850,USA,501815,2015,
"(3S)-(+)-(5-chloro-2-methoxyphenyl)-1,3-dihydro-3-fluoro-6-(trifluoromethyl)-2H-indol-2-one",n/a,2015-12-09,Treatment of Fragile X Syndrome.,Designated,,,N/A,N/A,Centre National de la Recherche Scientifique (CNRS),3 Rue Michel-Ange,,Paris,,,France,497515,2015,
cromolyn sodium for inhalation,n/a,2015-12-09,Treatment of mastocytosis.,Designated,,,N/A,N/A,"Patara Pharma, LLC",11455 El Camino Real,Suite 460,San Diego,California,92130,USA,497415,2015,
propagermanium and irbesartan,n/a,2015-12-09,Treatment of focal segmental glomerulosclerosis.,Designated,,,N/A,N/A,Dimerix Bioscience Ltd.,"Level 2, 25 Flinders Lane",,Melbourne,,,Australia,496715,2015,
stemchymal,n/a,2015-12-16,Treatment of polyqlutamine spinocerebellar ataxia,Designated,,,N/A,N/A,"Steminent Biotherapeutics, Inc.",No. 16 Wenhu Street,Neihu Dist.,,,,Taiwan,498615,2015,
carbon dioxide,n/a,2015-12-17,Treatment of trigeminal neuralgia,Designated,,,N/A,N/A,"Capnia, Inc.",3 Twin Dolphin Drive,Suite 160,Redwood City,California,94065,USA,465114,2015,
rovalpituzumab tesirine,n/a,2015-12-22,Treatment of small cell lung cancer,Designated,,,N/A,N/A,AbbVie Inc.,"Dept. PA77, Bldg. AP30-1",1 Waukegan Road,Lake Bluff,Illinois,60044,USA,500315,2015,
Substituted imidazopyridine amide,n/a,2015-12-22,Treatment of active tuberculosis (TB).,Designated,,,N/A,N/A,"Qurient Co., Ltd.","C-dong 8th floor, 242 Pangyo-ro","Bundang-gu, Seongnam-si",Gyeonggi-do,,,"Korea, Republic of",499015,2015,
Human Wilms tumor protein 1 peptides,n/a,2015-12-23,Treatment of acute myeloid leukemia,Designated,,,N/A,N/A,SELLAS Life Sciences Group,75 Baarerstrasse,,Zug,,,Switzerland,500915,2015,
imetelstat,n/a,2015-12-23,Treatment of myelodysplastic syndrome,Designated,,,N/A,N/A,"Janssen Research & Development, LLC",920 U.S. 202,,Raritan,New Jersey,8869,USA,501415,2015,
magnesium lysinate bis eicosapentaenoate,n/a,2015-12-23,Treatment of familial adenomatous polyposis.,Designated,,,N/A,N/A,Thetis Pharmaceuticals,167 Old Post Road,2nd Floor,Southport,Connecticut,6890,USA,501115,2015,
2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl) methoxy)benzaldehyde,n/a,2015-12-29,Treatment of sickle cell disease (SCD).,Designated,,,N/A,N/A,"Global Blood Therapeutics, Inc.",400 East Jamie Court,Suite 101,South San Francisco,California,94080,USA,499715,2015,
allogeneic ex-vivo expanded placental adherent stromal cells,n/a,2015-12-29,For the treatment of severe preeclampsia,Designated,,,N/A,N/A,"Pluristem Therapeutics, Inc",MATAM Advanced Technology Park,Building # 5,Haifa,,,Israel,429114,2015,
Antisense oligonucleotide targeted to the huntingtin protein,n/a,2015-12-29,Treatment of Huntington's disease,Designated,,,N/A,N/A,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,USA,499215,2015,
Cyclo{-Asn-Leu-d-Phe-Al[(N5-acetyl-N5-hydroxy-Orn)-(N5-acetyl-N5-hydroxy-Orn)-(N5-hydroxy-Orn)]-} . Al(III),n/a,2015-12-29,Treatment of invasive aspergillosis.,Designated,,,N/A,N/A,Vical Incorporated,10390 Pacific Center Court,,San Diego,California,92121,USA,498415,2015,
dipraglurant,n/a,2015-12-29,Treatment of levodopa-induced dyskinesias,Designated,,,N/A,N/A,Addex Pharma SA,Chemin des Aulx 14,1228 Plan-Les-Ouates,Geneva,,,Switzerland,485215,2015,
fluticasone propionate,n/a,2015-12-29,Treatment of eosinophilic esophagitis,Designated,,,N/A,N/A,"Banner Life Sciences, LLC",4125 Premier Drive,,High Point,North Carolina,27265,USA,499815,2015,
fosbretabulin tromethamine,n/a,2015-12-29,Treatment of neuroendocrine tumors,Designated,,,N/A,N/A,"Mateon Therapeutics, Inc.",701 Gateway Blvd,Suite 210,South San Francisco,California,94080,USA,500715,2015,
noscapine,n/a,2015-12-29,Treatment of amyotrophic lateral sclerosis.,Designated,,,N/A,N/A,KineMed Inc.,5980 Horton Street,Suite 470,Emeryville,California,94608,USA,500615,2015,
ozanimod,n/a,2015-12-29,Treatment of pediatric (0 through 16 years of age) ulcerative colitis,Designated,,,N/A,N/A,Celgene Corporation,3033 Science Park Road,Suite 300,San Diego,California,92121,USA,499515,2015,
recombinant adeno-associated virus serotype AAV8 vector encoding human ornithine transcarbamylase,n/a,2015-12-29,Treatment of ornithine transcarbamylase deficiency,Designated,,,N/A,N/A,Dimension Therapeutics,840 Memorial Drive,,Cambridge,Massachusetts,2139,USA,499315,2015,
"treprostinil sodium solution enclosed within a pre-filled, pre-programmed, single-use, electronically-controlled infusion pump",n/a,2015-12-29,Treatment of pulmonary arterial hypertension,Designated,,,N/A,N/A,SteadyMed Therapeutics,2603 Camino Ramon,Suite 350,San Ramon,California,94583,USA,478815,2015,
pembrolizumab,Keytruda,2015-12-30,Treatment of Hodgkin lymphoma.,Designated/Approved,Approved for Orphan Indication,"Treatment for patients with refractory classical Hodgkin Lymphoma (cHL), or who have relapsed after greater than or equal to 3 prior lines of therapy.",2017-03-14,2024-03-14,"Merck Sharp & Dohme Corp. a subsidiary of Merck & Co., Inc",126 E. Lincoln Avenue,P. O. Box 2000,Rathway,Pennsylvania,7065,USA,502415,2015,440
gemcitabine,n/a,2015-12-30,Treatment of upper tract urothelial carcinoma,Designated,,,N/A,N/A,TARIS Biomedical LLC,113 Hartwell Avenue,,Lexington,Massachusetts,2421,USA,502015,2015,
5-imino-13-deoxydoxorubicin HCl,n/a,2015-12-31,Treatment of soft tissue sarcoma,Designated,,,N/A,N/A,"Monopar Therapeutics, Inc.",5 Revere Drive,Suite 200,Northbrook,Illinois,60062,USA,490315,2015,
adeno-associated viral vector expressing the human vascular endothelial growth factor gene,n/a,2015-12-31,"Treatment of critical limb ischemia in no-option patients where other procedures, grafts, or angioplasty are not indicated",Designated,,,N/A,N/A,"Integene International Holding, LLC",1951 NW 7th Avenue,Suite 300,Miami,Florida,33136,USA,482815,2015,
anlotinib hydrochloride,n/a,2015-12-31,Treatment of ovarian cancer,Designated,,,N/A,N/A,"Advenchen Laboratories, LLC",887 Patriot Drive,Suite A,Moorpark,California,93021,USA,502715,2015,
1-(2-Nitro-imidazolyl)-3-[18F]fluoro-2-propanol;1H-1-(3-[18F]fluoro-2-hydroxypropyl)-2-nitroimidazole,n/a,2016-01-06,"As a diagnostic for clinical management of soft tissue sarcoma, including rhabdomyosarcoma.",Designated,,,N/A,N/A,"Advanced Imaging Projects, LLC",7947 Brookside Ct.,,Lake Worth,Florida,33467,USA,509715,2016,
"dendritic-cell targeting, lentiviral vector encoding the NY-ESO-1 gene",n/a,2016-01-06,Treatment of soft tissue sarcoma.,Designated,,,N/A,N/A,Immune Design Corp.,1616 Eastlake Ave. E,Suite 310,Seattle,Washington,98102,USA,497915,2016,
recombinant NY-ESO-1 protein mixed with glucopyranosyl lipid A,n/a,2016-01-06,Treatment of soft tissue sarcoma.,Designated,,,N/A,N/A,Immune Design Corp.,1616 Eastlake Ave. E,Suite 310,Seattle,Washington,98102,USA,497815,2016,
Small Molecule Inhibitor of Exon 17 mutant KIT,n/a,2016-01-06,Treatment of gastrointestinal stromal tumors (GIST).,Designated,,,N/A,N/A,Blueprint Medicines Corporation,38 Sidney Street,Suite 200,Cambridge,Massachusetts,2139,USA,500415,2016,
Cabiralizumab,n/a,2016-01-11,Treatment of pigmented villonodular synovitis and tenosynovial giant cell tumor,Designated,,,N/A,N/A,"Five Prime Therapeutics, Inc.",2 Corporate Drive,,South San Francisco,California,94080,USA,502315,2016,
gemcitabine,n/a,2016-01-11,Treatment of cholangiocarcinoma.,Designated,,,N/A,N/A,"InnoPharmax, Inc.","9F, No. 22, Lane 478",Rueiguang Road,Taipei,,,Taiwan,504815,2016,
S-nitrosoglutathione reductase inhibitor,n/a,2016-01-13,Treatment of cystic fibrosis,Designated/Withdrawn,,,N/A,N/A,Alpine Immune Sciences,201 Elliott Ave. West,Suite 230,Seattle,Washington,98119,USA,435714,2016,
His-His- Ile-Tyr-Leu-Gly-Ala-Val-Asn-Tyr-Ile-Tyr-NH2,n/a,2016-01-13,Treatment of retinal detachment,Designated,,,N/A,N/A,"ONL Therapeutics, Inc",1600 Huron Parkway,"NCRC Bldg. 520, 2nd Floor",Ann Arbor,Michigan,48109,USA,501215,2016,
recombinant human serum albumin human growth hormone,n/a,2016-01-13,Treatment of growth hormone deficiency,Designated,,,N/A,N/A,"TEVA Branded Pharmaceutical Products R&D, Inc.",41 Moores Road,P. O. Box 4011,Frazer,Pennsylvania,19355,USA,410513,2016,
mifepristone,Korlym,2016-01-14,Treatment of ovarian cancer.,Designated,,,N/A,N/A,"Corcept Therapeutics, Inc.",149 Commonwealth Drive,,Menlo Park,California,94025,USA,506015,2016,
pembrolizumab,Ketruda,2016-01-14,Treatment of primary mediastinal B cell lymphoma.,Designated,,,N/A,N/A,"Merck, Sharp & Dohme Corp.",One Merck Drive,,Whitehouse Station,New Jersey,8889,USA,495415,2016,
90Y-DOTA-tyr3-Octreotide,n/a,2016-01-20,Treatment of neuroendocrine tumors,Designated,,,N/A,N/A,"M. Sue O'Dorisio, MD, PhD","2519 JPP, 200 Hawkins Drive",,Iowa City,Iowa,52242,USA,504015,2016,
Human/Murine Chimeric Monoclonal antibody to Endoglin,n/a,2016-01-20,Treatment of soft tissue sarcoma.,Designated,,,N/A,N/A,"Tracon Pharmaceuticals, Inc.",4350 LaJolla Village Dr.,Suite 800,San Diego,California,92122,USA,504715,2016,
thioureidobutyronitrile,Kevetrin,2016-01-20,Treatment of pancreatic cancer.,Designated,,,N/A,N/A,"Innovation Pharmaceuticals, Inc.",100 Cummings Center,Suite 151-B,Beverly,Massachusetts,1915,USA,503815,2016,
Endothelin receptor B antagonist,n/a,2016-01-21,Treatment of malignant melanoma Stages IIB to IV.,Designated,,,N/A,N/A,"ENB Therapeutics, LLC",166 5th Avenue,2nd Floor,New York,New York,10010,USA,506215,2016,
HLA-A2-selective gp100-specific T cell redirector,n/a,2016-01-21,Treatment of uveal melanoma.,Designated,,,N/A,N/A,Immunocore Ltd,Milton Park,90 Park Drive,Milton,,,United Kingdom,503615,2016,
small molecule inhibitor of Exon 17 Mutant KIT,n/a,2016-01-21,Treatment of mastocytosis,Designated,,,N/A,N/A,Blueprint Medicines Corporation,38 Sidney Street,Suite 200,Cambridge,Massachusetts,2139,USA,506515,2016,
bevacizumab,Avastin,2016-01-27,Treatment of mesothelioma,Designated,,,N/A,N/A,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,USA,505115,2016,
ibrutinib,Imbruvica,2016-02-02,Treatment of patients with extranodal marginal zone lymphoma (mucosa associated lymphoid tissue [MALT type] lymphoma),Designated/Approved,Approved for Orphan Indication,Treatment of patients with Marginal Zone Lymphoma (MZL) who require systemic therapy and have received at least one prior anti-CD20-based therapy.,2017-01-18,2024-01-18,"Pharmacyclics, LLC",995 E. Arques Avenue,,Sunnyvale,California,94085,USA,462114,2016,351
oligodendrocyte progenitor cells,n/a,2016-02-02,Treatment of acute spinal cord injury,Designated,,,N/A,N/A,Asterias Biotherapeutics,6300 Dumbarton Circle,,Fremont,California,94555,USA,500815,2016,
afamelanotide,n/a,2016-02-04,Treatment of cutaneous variants of porphyria (which includes treatment and prevention of cutaneous manifestations of disease),Designated,,,N/A,N/A,Clinuvel Inc.,40 Worth Street,Suite 1053,New York,New York,10013,USA,502815,2016,
allogeneic Epstein-Barr virus cytotoxic T lymphocytes,n/a,2016-02-04,Treatment of Epstein-Barr virus-positive post-transplant lymphoproliferative disorders.,Designated,,,N/A,N/A,"ATARA Biotherapeutics, Inc.",4360 Park Terrace Drive,Suite 100,Westlake Village,California,91361,USA,487015,2016,
human recombinant dual-variable domain immunoglobulin G1 monoclonal antibody that selectively neutralizes tumor necrosis factor-alpha and interkeukin-17A,n/a,2016-02-04,Treatment of pediatric patients 0 to <18 yrs of age with oligoarticular-course and polyarticular-course juvenile idiopathic arthritis.,Designated/Withdrawn,,,N/A,N/A,"AbbVie, Inc.",1 North Waukegan Road,,North Chicago,Illinois,60064,USA,503715,2016,
midazolam,n/a,2016-02-04,Treatment of status epilepticus,Designated,,,N/A,N/A,"Meridian Medical Technologies, Inc.",A Pfizer Company,6350 Stevens Forest Road,Columbia,Maryland,21046,USA,508215,2016,
solnatide,n/a,2016-02-04,Treatment of primary graft dysfunction following lung transplantation,Designated,,,N/A,N/A,Apeptico Forschung und Entwicklung GmbH,c/o mingo bueros,1150,Vienna,,,Austria,504415,2016,
"somatic cell therapy product containing hematopoietic progenitor cells (HPC), Facilitating Cells (FC), and alpha beta T cells.",n/a,2016-02-04,Prevention of organ rejection in living donor kidney transplant recipients,Designated,,,N/A,N/A,Regenerex LLC,570 South Preston Street,Suite 404,Louisville,Kentucky,40202,USA,507015,2016,
Synthesized peptide of the L-amino acids with the sequence H-Lys-Glu-Phe-Leu-His-Pro-Ser-Lys-Val-Asp-Leu-Pro-Arg-OH,n/a,2016-02-04,Treatment of ovarian cancer.,Designated,,,N/A,N/A,Soricimed Biopharma Inc.,18 Botsford Street,Suite 201,Moncton,New Brunswick,,Canada,505215,2016,
tazemetostat,n/a,2016-02-04,Treatment of malignant rhabdoid tumors (MRTs),Designated,,,N/A,N/A,Epizyme Inc.,400 Technology Square,4th Floor,Cambridge,Massachusetts,2139,USA,508415,2016,
venetoclax,n/a,2016-02-04,Treatment of acute myeloid leukemia.,Designated,,,N/A,N/A,AbbVie Inc.,1 Waukegan Road,"Dept PA77, Bldg. AP30",North Chicago,Illinois,60044,USA,506815,2016,
"4-[(2E)-1-Oxo-3-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2-propen-1-yl]-1-piperazinecarboxamide",n/a,2016-02-08,Treatment of retinitis pigmentosa,Designated/Withdrawn,,,N/A,N/A,"Shire HGT, Inc.",300 Shire Way,,Lexington,Massachusetts,2421,USA,506615,2016,
Angiotensin (1-7),n/a,2016-02-08,Treatment of LAMA2-related muscular dystrophy,Designated,,,N/A,N/A,"Tarix Orphan, LLC",12 Bow Street,,Cambridge,Massachusetts,2138,USA,508815,2016,
dabrafenib,Tafinlar,2016-02-08,Treatment of malignant glioma with BRAF V600 mutation,Designated,,,N/A,N/A,Novartis Pharmaceuticals Corporation,1 Health Plaza,Bldg 337,East Hanover,New Jersey,7936,USA,506415,2016,
eltoprazine HCl,n/a,2016-02-08,Treatment of levodopa-induced dyskinesia associated with Parkinson's disease.,Designated,,,N/A,N/A,"Amarantus BioScience Holdings, Inc.",655 Montgomery St.,Suite 900,San Francisco,California,94111,USA,504215,2016,
evinacumab,n/a,2016-02-08,Treat of homozygous familial hypercholesterolemia.,Designated,,,N/A,N/A,"Regeneron Pharmaceuticals, Inc.",777 Old Saw Mill River Road,,Tarrytown,New York,10591,USA,507815,2016,
glyburide,n/a,2016-02-08,Treatment of acute subarachnoid hemorrhage,Designated,,,N/A,N/A,"Remedy Pharmaceuticals, Inc.","233 Broadway, Suite 1750",,New York,New York,10279,USA,502615,2016,
midazolam,n/a,2016-02-08,Treatment of seizures induced by organophosporous insecticide poisoning.,Designated,,,N/A,N/A,"Meridian Medical Technologies, Inc.",A Pfizer Company,6350 Stevens Forest Road,Columbia,Maryland,21046,USA,507615,2016,
Rezafungin,n/a,2016-02-08,Treatment of candidemia and invasive candidiasis infections caused by susceptible Candida spp.,Designated,,,N/A,N/A,"Cidara Therapeutics, Inc.",6310 Nancy Ridge Drive,Suite 101,San Diego,California,92121,USA,507215,2016,
solnatide,n/a,2016-02-08,Treatment of generalized systemic pseudohypoaldosteronism type 1 (also known as autosomal recessive PHA-I or PHA-IB),Designated,,,N/A,N/A,Apeptico Forschung und Entwicklung GmbH,Mariahilferstrabe 136,Top 1150,Vienna,,,Austria,504515,2016,
synthetic double-stranded siRNA oligonucleotide directed against hydroxyacid oxidase 1 (HAO1) mRNA,n/a,2016-02-08,Treatment of primary hyperoxaluria type 1,Designated,,,N/A,N/A,"Alnylam Pharmaceuticals, Inc.",300 Third Street,,Cambridge,Massachusetts,2142,USA,505315,2016,
"humanized affinity-optimized, afucosylated immunoglobulin G1 kappa monoclonal antibody against CD19",n/a,2016-02-10,Treatment of neuromyelitis optica and neuromyelitis optica spectrum disorders,Designated,,,N/A,N/A,"MedImmune, LLC",1 Medimmune Way,,Gaithersburg,Maryland,20878,USA,490415,2016,
"6-{4-[l-(propan-2-yl)piperidin-4-yl]-1,4-diazepan-1-yl}-N-(pyridin-4-yl)pyridine-2-carboxamide",n/a,2016-02-11,Treatment of glioblastoma multiforme (GBM).,Designated,,,N/A,N/A,"Proximagen, LLC",505 Waterford Park,Hwy 169 North,Plymouth,Minnesota,55441,USA,503415,2016,
dodecafluoropentane emulsion,n/a,2016-02-11,Treatment of sickle cell disease,Designated,,,N/A,N/A,NuvOx Pharma,1635 East 18th Street,,Tucson,Arizona,85719,USA,507515,2016,
epacadostat,n/a,2016-02-11,Treatment of stage IIB-IV melanoma.,Designated,,,N/A,N/A,Incyte Corporation,1801 Augustine Cut-Off,,Wilmington,Delaware,19803,USA,493015,2016,
"1E,6E)-1,7-Bis(3,4-dimethoxyphenyl)-4-cyclobutylmethyl-1,6-heptadiene-3,5-dione or [(1E, 4Z,6E)-4-(cyclobutylmethyl)-1,7-bis(3,4-dimethoxyphenyl)-5-hydroxyhepta-1,4,6-trien-3-one]",n/a,2016-02-17,Treatment of spinal and bulbar muscular atrophy,Designated,,,N/A,N/A,Allianz Pharmascience Ltd.,8630 Fenton Street,Suite 724,Silver Spring,Maryland,20910,USA,509315,2016,
dantrolene sodium,n/a,2016-02-17,Treatment of Wolfram Syndrome,Designated,,,N/A,N/A,Washington University in St. Louis,660 S. Euclid Avenue,Campus Box 8127,St. Louis,Missouri,63110,USA,474515,2016,
pembrolizumab,Keytruda,2016-02-17,Treatment of multiple myeloma.,Designated,,,N/A,N/A,"Merck, Sharp & Dohme Corp.",One Merck Drive,,Whitehouse Station,New Jersey,8889,USA,513115,2016,
CaspaCIDe System (combination product) consisting of allogeneic T Cell genetically modified to contain an inducible caspase 9 gene and Rimiducid,n/a,2016-02-18,Replacement T-cell therapy for the treatment of immunodeficiency and graft versus host disease after allogeneic hematopoietic stem cell transplant,Designated,,,N/A,N/A,"Bellicum Pharmaceuticals, Inc.",2130 West Holcombe Boulevard,,Houston,Texas,77030,USA,496915,2016,
midazolam,n/a,2016-02-18,Treatment of status epilepticus,Designated,,,N/A,N/A,Shire Development LLC,300 Shire Way,,Lexington,Massachusetts,2421,USA,514115,2016,
"N-(4-Methoxyphenyl)-N,2,6-trimethylfuro[2,3-d] pyrimidin-4-amine",n/a,2016-02-18,Treatment of glioma.,Designated,,,N/A,N/A,"Flag Therapeutics, Inc.",9168 Wooden Road,,Raleigh,North Carolina,27617,USA,509015,2016,
cannabidiol,n/a,2016-02-23,Treatment of Fragile X syndrome,Designated,,,N/A,N/A,"Zynerba Pharmaceuticals, Inc.",80 West Lancaster Avenue,Suite 300,Devon,Pennsylvania,19333,USA,488315,2016,
"growth hormone releasing hormone, 1-44 human amide",n/a,2016-02-23,Treatment of growth hormone deficiency,Designated,,,N/A,N/A,"Hollenbeck Pharmaceuticals, Inc.",P. O. Box 429,,Falls Village,Connecticut,6031,USA,436814,2016,
Human wilms tumor protein 1 peptides,n/a,2016-02-23,treatment of mesothelioma.,Designated,,,N/A,N/A,SELLAS Life Sciences Group,75 Baarerstrasse,,Zug,,,Switzerland,508915,2016,
riluzole,n/a,2016-02-23,Treatment of spinocereballar ataxia,Designated,,,N/A,N/A,"Biohaven Pharmaceutical Holding Company, Ltd.",234 Church Street,Suite 304,New Haven,Connecticut,6511,USA,510015,2016,
Ombitasvir/Paritaprevir/Ritonavir,Technivie® Tablets,2016-02-24,Treatment of pediatric patients with chronic hepatitis C virus infection,Designated,,,N/A,N/A,AbbVie Inc.,1 North Waukegan Road,,North Chicago,Illinois,60064,USA,509215,2016,
rapamycin,n/a,2016-02-24,Treatment of facial angiofibromas (FA) associated with tuberous sclerosis complex (TSC).,Designated,,,N/A,N/A,DSLP,129 Hurstmere Road,"Level 1, Nielsen Building",Auckland,,,New Zealand,508515,2016,
sodium alginate oligosaccharide,n/a,2016-02-24,Treatment of cystic fibrosis.,Designated,,,N/A,N/A,AlgiPharma AS,Industriveien 33,N-1337,Sandvika,,,Norway,320110,2016,
adeno-associated virus vector encoding the SQ variant of human blood clotting factor VIII,n/a,2016-02-29,Treatment of Hemophilia A.,Designated,,,N/A,N/A,"BioMarin Pharmaceutical, Inc.",105 Digital Drive,,Novato,California,94949,USA,510915,2016,
Bacillus subtilis oxalate decarboxylase,n/a,2016-02-29,Treatment of pediatric hyperoxaluria,Designated,,,N/A,N/A,"Allena Pharmaceuticals, Inc.",1 Executive Park Drive,Suite 202,Newton,Massachusetts,2462,USA,508015,2016,
human monoclonal antibody targeting human sclerostin,n/a,2016-02-29,Treatment of osteogenesis imperfecta.,Designated,,,N/A,N/A,Mereo Biopharma 3 Limited,1 Cavendish Place,4th Floor,London,,,United Kingdom,508615,2016,
Tesevatinib,n/a,2016-03-01,Treatment of patients with autosomal recessive polycystic kidney disease (ARPKD),Designated,,,N/A,N/A,"Kadmon Corporation, LLC",450 East 29th Street,,New York,New York,10016,USA,506715,2016,
encochleated amikacin,n/a,2016-03-03,Treatment of non-tuberculous mycobacteria (NTM) infections,Designated,,,N/A,N/A,"Aquarius Biotechnologies, Inc.",1545 U.S. 206,,Bedminster Township,New Jersey,7921,USA,507715,2016,
selective inhibitor of fungal CYP51,n/a,2016-03-03,Treatment of coccidioidomycosis.,Designated,,,N/A,N/A,"Viamet Pharmaceuticals, Inc.",4505 Emperor Boulevard,Suite 300,Durham,North Carolina,27703,USA,511515,2016,
"1,2:5,6-dianhydrogalactitol",n/a,2016-03-10,Treatment of medulloblastoma.,Designated,,,N/A,N/A,"DelMar Pharmaceuticals, Inc.",3475 Edison Way,Suite R,Menlo Park,California,94025,USA,512515,2016,
adenovirus associated viral vector serotype 5 containing the human RPE65 gene,n/a,2016-03-10,Treatment of Leber congenital amaurosis,Designated,,,N/A,N/A,MeiraGTx Limited,450 East 29th Street,15th Floor,New York,New York,10016,USA,511115,2016,
adenovirus associated viral vector serotype 8 containing the human CNGB3 gene,n/a,2016-03-10,Treatment of achromatopsia due to mutations in the CNGB3 gene.,Designated,,,N/A,N/A,MeiraGTx Limited,450 East 29th Street,15th Floor,New York,New York,10016,USA,511615,2016,
anfibatide,n/a,2016-03-10,Treatment of thrombotic thrombocytopenic purpura.,Designated,,,N/A,N/A,Lee's Pharmaceutical (Hong Kong) Limited,"Unit 110-11, Bio-Informatics Centre","Hong Kong Science Park, Shatin, Hong Kong",,,,China,471215,2016,
bevacizumab,n/a,2016-03-10,Treatment of Coat's disease,Designated,,,N/A,N/A,"MicroSert, Ltd.",Bar Yehuda Street,,Nesher,,,Israel,512215,2016,
competetive small molecule inhibitor of the enzyme O-GlcNAcase,n/a,2016-03-10,Treatment of progressive supranuclear palsy.,Designated/Withdrawn,,,N/A,N/A,"Merck & Company, Inc.",126 East Lincoln Avenue,P. O. Box 2000,Rahway,New Jersey,7065,USA,512815,2016,
Rosomidnar,n/a,2016-03-10,Treatment of diffuse large B-cell lymphoma.,Designated/Withdrawn,,,N/A,N/A,"ProNAi Therapeutics, Inc.",46701 Commerce Center Drive,,Plymouth,Michigan,48170,USA,512415,2016,
trientine tetrahydrochloride,n/a,2016-03-10,treatment of Wilson’s disease,Designated,,,N/A,N/A,GMP-Orphan SAS,"Voisin Consulting, Inc.","222 Third Street, Suite 3121",Cambridge,Massachusetts,2142,USA,492915,2016,
adeno-associated viral serotype 2 vector under the regulatory control of a CMV promoter encoding the human tripeptidyl peptidase-1 (hTPP1) cDNA,n/a,2016-03-16,Treatment of CLN2 disease (neuronal ceroid lipofuscinosis (NCL)) caused by TPP1 deficiency.,Designated,,,N/A,N/A,"Spark Therapeutics, Inc.",3737 Market Street,Suite 1300,Philadelphia,Pennsylvania,19104,USA,518516,2016,
guanfacine and amphetamine,n/a,2016-03-17,Treatment of pediatric patients with Tourette's syndrome (0 through 16 years of age),Designated,,,N/A,N/A,"KemPharm, Inc.",1180 Celebration Boulevard,Suite 103,Celebration,Florida,34747,USA,405313,2016,
ivabradine,n/a,2016-03-23,Treatment of pediatric patients (0 through 16 years of age) with dilated cardiomyopathy.,Designated,,,N/A,N/A,"Amgen, Inc.,",1 Amgen Center Drive,,Thousand Oaks,California,91320,USA,511915,2016,
lentiviral vector containing the human liver and erythroid pyruvate kinase gene,n/a,2016-03-23,Treatment of pyruvate kinase deficiency.,Designated,,,N/A,N/A,"Consorcio Centro de Investigación Biomédica en Red, M.P.",Monforte de Lemos,3-5 Pabellion 11,Madrid,,,Spain,516816,2016,
131I-BC8 monoclonal antibody (Anti-CD45 murine monoclonal antibody radiolabeled with 131I,n/a,2016-03-28,Treatment of Acute Myeloid Leukemia (AML),Designated,,,N/A,N/A,"Actinium Pharmaceuticals, Inc.",379 Thornall Avenue,6th Floor,Edison,New Jersey,8837,USA,510615,2016,
Autologous CD4+/CD8+ T cells transduced with lentiviral vector directed against the NY-ESO-1 protein,n/a,2016-03-28,Treatment of soft tissue sarcoma.,Designated,,,N/A,N/A,"Adaptimmune, LLC",Two Commerce Square,2001 Market Street,Philadelphia,Pennsylvania,19103,USA,512315,2016,
"3-(5-Fluoro-benzofuran-3-yl)-4-(5-methyl-5H-[1,3]dioxolo[4,5-f]indol-7-yl)-pyrrole-2,5-dione",n/a,2016-03-29,Treatment of glioblastoma,Designated,,,N/A,N/A,Actuate Therapeutics,1401 Foch Street,Suite 140,Fort Worth,Texas,76107,USA,513815,2016,
gentamicin C2 congener,n/a,2016-03-29,Treatment of cystic fibrosis,Designated,,,N/A,N/A,La Jolla Pharmaceuticals Company,10182 Telesis Court,Suite 600,San Diego,California,92121,USA,513215,2016,
immune globulin infusion 10% (human) with recombinant human hyaluronidase),n/a,2016-03-31,Treatment of chronic inflammatory demyelinating polyneuropathy,Designated,,,N/A,N/A,"Baxalta US, Inc.",1 Baxter Way,,Westlake Village,California,91362,USA,514315,2016,
fexinidazole,n/a,2016-04-04,Treatment of human African trypanosomiasis (HAT) or sleeping sickness,Designated,,,N/A,N/A,"Sanofi US Services, Inc.",55 Corporate Drive,Mail Code 55D-225A,Bridgewater,New Jersey,8807,USA,513915,2016,
setmelanotide,n/a,2016-04-04,Treatment of pro-opiomelanocortin (POMC) deficiency due to mutations in the POMC gene,Designated,,,N/A,N/A,"Rhythm Pharmaceuticals, Inc.",855 Boylston Street,11th Floor,Boston,Massachusetts,2116,USA,514815,2016,
metronidazole,n/a,2016-04-05,Treatment of clostridium difficile infection in pediatric patients (0 through 16 years of age).,Designated,,,N/A,N/A,"Appili Therapeutics, Inc.",1344 Summer Street,Suite 415,Halifax,Nova Scotia,,Canada,514715,2016,
peptide fraction derived from porcine brain protein,Cerebrolysin,2016-04-05,"Treatment of frontotemporal dementia, including all subvariants",Designated,,,N/A,N/A,EVER Neuro Pharma GmbH,3 Oberburgau,4866 Unterach,,,,Austria,513315,2016,
"poly-N,N'-hexamethyleneguanidine-poly-N1,N4-hexamethyleneaminoguanidine",n/a,2016-04-05,"Treatment of pulmonary infections in patients with cystic fibrosis including infections due to pseudomonas aeruginosa,Burkholderia cepacia and other bacteria",Designated,,,N/A,N/A,"TGV-Inhalonix, Inc.",303 5th Avenue,Suite 2012,New York,New York,10016,USA,511215,2016,
"1-(2,8-Dimethyl-1-thia-3,8-diazaspiro[4.5]dec-3-yl)-3-(1H-indol-3-yl)propan-1-one",n/a,2016-04-06,Treatment of frontotemporal dementia.,Designated,,,N/A,N/A,Anavex Life Sciences Corp.,51 West 52nd Street,7th Floor,New York,New York,10019,USA,512615,2016,
1-(2-Nitro-imidazolyl)-3-[18F]fluoro-2-propanol; 1H-1-(3-[18F]fluoro-2-hydroxypropyl0-2-nitroimidazole (18F-Misonidazole),n/a,2016-04-06,Diagnostic for management of glioma.,Designated,,,N/A,N/A,"Advanced Imaging Projects, LLC",7947 Brookside Ct.,,Lake Worth,Florida,33467,USA,521116,2016,
pritumumab,n/a,2016-04-06,Treatment of pancreatic cancer.,Designated,,,N/A,N/A,"Nascent Biotech, Inc.",8400 Miramar Road,Suite 247,San Diego,California,92126,USA,476615,2016,
7-ethyl-10-hydroxycamptothecin (EHC),n/a,2016-04-13,Treatment of small cell lung cancer.,Designated,,,N/A,N/A,"Nippon Kayaku Co., Ltd.","1-1, Marunouchi 2-chome",,Chiyoda,,,Japan,513715,2016,
"(5S,8S, 10aR)-N-benzhydryl-5-((S)-2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo[1,2-a][1,5] diazocine-8-carboxyamide",n/a,2016-04-14,Treatment of ovarian cancer,Designated,,,N/A,N/A,DebioPharm International SA,"Forum ""apres-demain""","Chemin Messidor, 5-7",Lausanne,,,Switzerland,515315,2016,
ganaxolone,n/a,2016-04-14,Treatment of status epilepticus.,Designated,,,N/A,N/A,"Marinus Pharmaceuticals, Inc.",Three Radnor Corporate Center,100 Matsonford Road,Radnor,Pennsylvania,19087,USA,489215,2016,
"1,2:5,6-dianhydrogalactitol",n/a,2016-04-19,Treatment of ovarian cancer.,Designated,,,N/A,N/A,"DelMar Pharmaceuticals, Inc. (Clinical Operations)",3475 Edison Way,Suite R,Menlo Park,California,94025,USA,514915,2016,
Adenovirus encoding the recombinant CD40 ligand,n/a,2016-04-19,Treatment of stage IIb through IV melanoma.,Designated,,,N/A,N/A,Memgen LLC,12 Greenway Plaza,Suite 1100,Houston,Texas,77046,USA,516716,2016,
cannabidiol,n/a,2016-04-19,Treatment of tuberous sclerosis complex.,Designated,,,N/A,N/A,GW Pharma Ltd.,15 T.W. Alexander Drive,P. O. Box 13547,Research Triangle Park,North Carolina,27709,USA,510716,2016,
HDF-LV-RTS-MMP1 (human dermal fibroblasts genetically modified with LV-RTS-MMP1) and Veledimex,n/a,2016-04-19,Treatment of localized scleroderma.,Designated,,,N/A,N/A,"Fibrocell Technologies, Inc.",405 Eagleview Blvd,,Exton,Pennsylvania,19341,USA,493815,2016,
axicabtagene ciloleucel,Yescarta,2016-04-20,Treatment of primary mediastinal B-cell lymphoma.,Designated/Approved,Approved for Orphan Indication,"Treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy, including diffuse large B-cell lymphoma (DLBCL) not otherwise specified, primary mediastinal large B-cell lymphoma, high-grade B-cell lymphoma, and DLBCL arising from follicular lymphoma",2017-10-18,2024-10-18,"Kite Pharma, Inc.",2225 Colorado Avenue,,Santa Monica,California,90404,USA,515915,2016,546
allogeneic ex-vivo generated CD56+CD3-natural killer cells from CD34+ umbilical cord blood progenitor cells,n/a,2016-04-20,Treatment of acute myeloid leukemia,Designated,,,N/A,N/A,IPD-Therapeutics BV,(Trading as Glycostem-Therapeutics),Molenstraat 110 5342 CC Oss,,,,Netherlands,455514,2016,
aphidicolin,n/a,2016-04-20,Treatment of Ebola virus infection,Designated,,,N/A,N/A,Biospherics.net LLC,Department of Pharmaceutical Sciences,University of Kentucky,Nicholasville,Kentucky,40356,USA,472415,2016,
autologous T-cells transduced with retroviral vector encoding an anti-CD19 CD28/CD3-zeta chimeric antigen receptor,n/a,2016-04-20,Treatment of chronic lymphocytic leukemia.,Designated,,,N/A,N/A,"Kite Pharma, Inc.",2225 Colorado Avenue,,Santa Monica,California,90404,USA,516015,2016,
Autologous T-cells transduced with retroviral vector encoding an anti-CD19 CD28/CD3-zeta chimeric antigen receptor,n/a,2016-04-20,Treatment of acute lymphoblastic leukemia. (ALL).,Designated,,,N/A,N/A,"Kite Pharma, Inc.",2225 Colorado Avenue,,Santa Monica,California,90404,USA,515815,2016,
"(E, Z)-4,5,9-trithiadodeca-1, 6, 11-triene 9-oxide (Ajoene)",n/a,2016-04-21,Treatment of Pseudomonas aeruginosa pulmonary infections in cystic fibrosis patients,Designated,,,N/A,N/A,Neem Biotech Ltd.,Units G & H,Roseheyworth Business Park,Blaenau Gwent,,,United Kingdom,516316,2016,
axicabtagene ciloleucel,Yescarta,2016-04-25,Treatment of follicular lymphoma.,Designated/Approved,Approved for Orphan Indication,"Treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy, including diffuse large B-cell lymphoma (DLBCL) not otherwise specified, primary mediastinal large B-cell lymphoma, high-grade B-cell lymphoma, and DLBCL arising from follicular lymphoma",2017-10-18,2024-10-18,"Kite Pharma, Inc.",2225 Colorado Avenue,,Santa Monica,California,90404,USA,515615,2016,541
"(3S)-3-[({1-(2-Chlorobenzyl)-4-hydroxy-5-methyl-2-oxo-1,2-dihydropyridin-3yl}amino)carbonyl]amino-3-(4-methylphenyl)propanoic acid monosodium salt",n/a,2016-04-25,For mobilization of hematopoietic stem cells,Designated,,,N/A,N/A,"Aviara Pharmaceuticals, Inc/",3331 Green Tree Park,,Houston,Texas,77027,USA,515216,2016,
"6-{[(1S)-1-phenylethyl]amino}-3-(propan-2-yl)-1,2,3,4 tetrahydropyrimidine-2,4-dione",n/a,2016-04-27,Treatment of symptomatic obstructive hypertrophic cardiomyopathy,Designated,,,N/A,N/A,"MyoKardia, Inc.",333 Allerton Avenue,,South San Francisco,California,94080,USA,515015,2016,
autologous CD4+/CD8+ T cells expressing a CD19 chimeric antigen receptor and truncated epidermal growth factor receptor,n/a,2016-04-27,Treatment of diffuse large B-cell lymphoma,Designated,,,N/A,N/A,"Juno Therapeutics, Inc.",400 Dexter Avenue North,Suite 1200,Seattle,Washington,98109,USA,516115,2016,
brigatinib,Alunbrig,2016-04-28,"Treatment of anaplastic lymphoma kinase-positive (ALK+), c-ros 1 oncogene positive (ROS1+), or epidermal growth factor receptor positive (EGFR+) non-small cell lung cancer (NSCLC).",Designated/Approved,Approved for Orphan Indication,Treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) who have progressed on or are intolerant to crizotinib,2017-04-28,2024-04-28,"ARIAD Pharmaceuticals, Inc.",26 Landsdowne Street,,Cambridge,Massachusetts,2139,USA,505415,2016,365
autologous T-cells transduced with retroviral vector encoding an anti-CD19 CD28/CD3-zeta chimeric antigen receptor,n/a,2016-04-28,Treatment of mantle cell lymphoma.,Designated,,,N/A,N/A,"Kite Pharma, Inc.",2225 Colorado Avenue,,Santa Monica,California,90404,USA,515715,2016,
combinatorial regimen of LV305 (lentiviral vector encoding NY-ESO-1 gene) and G305 (NY-ESO-1 recombinant protein plus GLA-SE),n/a,2016-05-02,Treatment of soft tissue sarcoma,Designated,,,N/A,N/A,Immune Design Corp.,1616 Eastlake Ave. E,Suite 310,Seattle,Washington,98102,USA,467914,2016,
Fancalen (lentiviral vector containing the Fanconi anemia-A (FANCA) gene,n/a,2016-05-02,Treatment of Fanconi anemia type A patients.,Designated,,,N/A,N/A,"Consorcio Centro de Investigación Biomédica en Red, M.P.",Montforte de Lemos,3-5 Pabellon 11,Madrid,,,Spain,519316,2016,
acyclovir,n/a,2016-05-03,Treatment of herpetic keratitis.,Designated,,,N/A,N/A,Cumulus Pharmaceuticals LLC,1712 Pioneer Avenue,Suite 1377,Cheyenne,Wyoming,82001,USA,513615,2016,
autologous adipose tissue derived mesenchymal stem cells,n/a,2016-05-04,Treatment of Buerger's disease (thromboangiitis obliterans).,Designated,,,N/A,N/A,Biostar Stem Cell Research Institute,"305 Lotte IT Castle 2,",550-1 Gasan-dong,Seoul,,,"Korea, Republic of",518116,2016,
human recombinant bone morphogenetic protein 4,n/a,2016-05-04,Treatment of glioblastoma multiforme.,Designated,,,N/A,N/A,"HyperStem Therapeutics, Inc.",13223-1 Black Mountain Road,,San Diego,California,92129,USA,520216,2016,
2'-O-(2-methoxyethyl)phosphorothioate antisense oligonucleotide,n/a,2016-05-10,Treatment of acromegaly,Designated,,,N/A,N/A,Antisense Therapeutics Limited,6 Wallace Avenue,TOORAK VIC 3142,Trevose,,,Australia,517016,2016,
autologous ex vivo expanded polyclonal CD4+CD25+CD1271o/-FOXP3+ Regulatory T cells,n/a,2016-05-10,Treatment of type 1 diabetes mellitus with residual beta cell function,Designated,,,N/A,N/A,Caladrius Biosciences,110 Allen Road,2nd Floor,Basking Ridge,New Jersey,7920,USA,519716,2016,
clotrimazole otic solution,n/a,2016-05-10,Treatment of fungal otitis externa (otomycosis).,Designated,,,N/A,N/A,Laboratorios SALVAT S.A.,"C/ Gall, 30-36",Esplugues de Llobregat,Barcelona,,,Spain,520516,2016,
"enfumafungin derivative B-(1,3)-D-glucan synthestis inhibitor",n/a,2016-05-10,"Treatment of invasive Candida infections, including candidemia",Designated,,,N/A,N/A,"SCYNEXIS, Inc.",101 Hudson Street,Suite 3610,Jersey City,New Jersey,7302,USA,519616,2016,
Recombinant protein inhibitor of complement factor 5,n/a,2016-05-10,Treatment of Guillain-Barre Syndrome.,Designated,,,N/A,N/A,Akari Therapeutics Plc,24 West 40th Street,8th Floor,New York,New York,10018,USA,520316,2016,
selumetinib,n/a,2016-05-10,Adjuvant treatment of patients with stage III or stage IV differentiated thyroid cancer.,Designated,,,N/A,N/A,AstraZeneca Pharmaceuticals LP,1800 Concord Pike,P. O. Box 8355,Wilmington,Delaware,19803,USA,475815,2016,
"6-methoxy-3-(3',4',5'-trimethoxybenzoyl) indole",n/a,2016-05-11,Treatment of cholangiocarcinoma,Designated,,,N/A,N/A,SynCore Biotechnology Co. Ltd.,"4F, 69 Dongxing Road",XinYi Dist,,,,Taiwan,524516,2016,
autologous T-lymphocytes transduced with anti-BCMA02 CAR lentiviral vector encoding a chimeric antigen receptor (CAR) specific for the human B cell maturation antigen,n/a,2016-05-11,Treatment of multiple myeloma,Designated,,,N/A,N/A,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,USA,520416,2016,
florilglutamic acid,n/a,2016-05-11,Diagnostic for the management of glioma,Designated,,,N/A,N/A,Piramal Imaging S.A.,13 Route de l'Ecole,,Matran,,,Switzerland,517616,2016,
Ceclazepide,n/a,2016-05-12,Treatment of gastric neuroendocrine tumors (gastric NETs).,Designated,,,N/A,N/A,Trio Medicines Ltd.,Pavillion View,Brighton BN1 1EY,,,,United Kingdom,520116,2016,
Naratuximab emtansine,n/a,2016-05-12,Treatment of diffuse large B-cell lymphoma,Designated,,,N/A,N/A,Debiopharm International S.A.,"Forum ""apres-demain""","Chemin Messidor 5-7, CP 5911",,,,Switzerland,518016,2016,
taurolidine,n/a,2016-05-16,Treatment of pancreatic cancer.,Designated,,,N/A,N/A,"Geistlich Pharma NA, Inc.",202 Carnegie Center Drive,,Princeton,New Jersey,8540,USA,500015,2016,
"(2,2-diphenyl-tetrahydro-furan-3-yl-methyl)-dimethylamine hydrochloride",n/a,2016-05-18,Treatment of Rett Syndrome.,Designated,,,N/A,N/A,Anavex Life Sciences Corporation,51 West 52nd Street,7th Floor,New York,New York,10019,USA,520816,2016,
2-amino-N-({methyl-[(6-trifluoromethoxy-benzothiazol-2-ylcarbamoyl)-methyl]-carbamoyl}-methyl)-acetamide monohydrochloride,n/a,2016-05-18,Treatment of spinocerebellar ataxia.,Designated,,,N/A,N/A,"Biohaven Pharmaceuticals, Inc.",234 Church Street,Suite 304,New Haven,Connecticut,6510,USA,520016,2016,
anti-HER2 bispecific antibody,n/a,2016-05-18,Treatment of ovarian cancer,Designated,,,N/A,N/A,Zymeworks Inc.,18 West Mercer Street,Suite 370,Seattle,Washington,98119,USA,519516,2016,
combination of disulfiram and copper gluconate,n/a,2016-05-18,Treatment of glioblastoma multiforme.,Designated,,,N/A,N/A,"Cantex Pharmaceuticals, Inc.",1792 Bell Tower Lane,,Weston,Florida,33326,USA,522516,2016,
Copper 64-DOTA-TATE,Netmedix (Tm),2016-05-18,Diagnostic for the management of neuroendocrine tumors.,Designated,,,N/A,N/A,"RadioMedix, Inc.",9701 Richmond Avenue,Suite 222,Houston,Texas,77042,USA,520716,2016,
human monoclonal antibody directed against tissue factor pathway inhibitor,n/a,2016-05-18,"Treatment of hemophilia A and hemophilia B patients with or without inhibitors, which includes routine prophylaxis to prevent or reduce the frequency of bleeding in hemophilia A and hemophilia B patients.",Designated,,,N/A,N/A,"Pfizer, Inc.",500 Arcola Road,,Collegeville,Pennsylvania,19426,USA,521916,2016,
liposomal glutathione,n/a,2016-05-18,Treatment of Dengue Virus infection.,Designated,,,N/A,N/A,"Your Energy Systems, LLC",555 Bryant Street #305,,Palo Alto,California,94301,USA,519216,2016,
ustekinumab,Stelara,2016-05-18,Treatment of pediatric Crohn's disease (0 through 16 years of age),Designated,,,N/A,N/A,"Janssen Research & Development, LLC",P. O. Box 776,1400 McKean Road,Spring House,Pennsylvania,19477,USA,520916,2016,
Itraconazole,n/a,2016-05-19,Treatment of basal cell carcinoma nevus syndrome.,Designated,,,N/A,N/A,"HedgePath Pharmaceuticals, Inc",324 South Hyde Park Avenue,Suite 350,Tampa,Florida,33606,USA,473715,2016,
ropidoxuridine (5-iodo-2-pyrimidinone-2'-deoxyribose),n/a,2016-05-19,Radiosensitizer to be used during radiation treatment of glioblastoma multiforme.,Designated,,,N/A,N/A,"EMEK, Inc.",196 Channel View,,Warwick,Rhode Island,2889,USA,519016,2016,
tetrandrine,n/a,2016-05-19,Treatment of chronic myeloid leukemia.,Designated,,,N/A,N/A,"Escend Pharmaceuticals, Inc.",3475 Edison Way,Suite R,Menlo Park,California,94025,USA,518916,2016,
"9-cis, 12-cis-11,11-d2-linoleic acid ethyl ester",n/a,2016-05-23,Treatment of Friedreich's Ataxia,Designated,,,N/A,N/A,"Retrotope, Inc.",4300 El Camino Real,Suite 201,Los Altos,California,94022,USA,492315,2016,
brentuximab vedotin,n/a,2016-05-23,Treatment of adult T-cell leukemia/lymphoma,Designated,,,N/A,N/A,"Seattle Genetics, Inc.",21823 30th Drive Southeast,,Bothell,Washington,98021,USA,521716,2016,
Nanocomplex consisting of a small interfering RNA that targets the human EV11 oncogenic transcription factor and an elastin-like polypeptide drug carrier.,n/a,2016-05-23,Treatment of ovarian cancer.,Designated,,,N/A,N/A,PeptiMed,922 Walsh Road,Suite 208,Madison,Wisconsin,53714,USA,523316,2016,
"non-replicating recombinant adeno-associated viral vector, serotype 8, expressing the 1A1 isoform of the bilirubin-uridine diphosphate glucuronosyltransferase gene",n/a,2016-05-24,Treatment of Crigler Najjar syndrome.,Designated,,,N/A,N/A,"Audentes Therapeutics, Inc.",600 California Street,17th Floor,San Francisco,California,94109,USA,529416,2016,
antisense oligonucleotide complementary to the exonic splicer enhancer sequence at intron 26 of the centrosomal protein 290 pre-mRNA,n/a,2016-05-25,Treatment of Leber's congenital amaurosis.,Designated,,,N/A,N/A,ProQR Therapeutics IV B.V.,"Zernikedreef 9, 2333 CK Leiden",,Leiden,,,Netherlands,521316,2016,
diazepam subcutaneous injection,Diazepen(Tm),2016-05-26,Treatment of acute repetitive seizures.,Designated,,,N/A,N/A,"Xeris Pharmaceuticals, Inc.",3208 Red River Street,Suite 300,Austin,Texas,78705,USA,518316,2016,
"recombinant, non-pathogenic poliovirus:rhinovirus chimera that consists of the genome of the live attenuated poliovirus serotype 1 vaccine with its cognate IRES element replaced with that of HRV2",n/a,2016-05-26,Treatment of glioma,Designated,,,N/A,N/A,"Istari Oncology, Inc.",Duke University Medical Center,"177 MSRB, Box 3156",Durham,North Carolina,27710,USA,521816,2016,
bupivacaine hydrochloride,n/a,2016-05-31,treatment of pain associated with postherpetic neuralgia.,Designated,,,N/A,N/A,"Grace Therapeutics, LLC",675 U.S. 1,,North Brunswick Township,New Jersey,8902,USA,510515,2016,
d-methadone,n/a,2016-06-02,Treatment of postherpetic neuralgia,Designated,,,N/A,N/A,"Relmada Therapeutics, Inc.",750 Third Avenue,9th Floor,New York,New York,10017,USA,499915,2016,
human donor hematopoietic stem and progenitor cells (HSPC) that have been treated ex vivo with TBX-4000,n/a,2016-06-02,Enhancement of cell engraftment in patients receiving hematopoietic stem cell transplant.,Designated,,,N/A,N/A,"Taiga Biotechnologies, Inc.",12635 Montview Boulevard,Fitzsimmons BBioscience Park Center,Aurora,Colorado,80045,USA,507115,2016,
methimazole and liothyronine sodium,n/a,2016-06-02,Treatment of glioblastoma multiforme.,Designated,,,N/A,N/A,Musli Thyropeutics Ltd,6 HaGefen Street,,zur Moshe,,,Israel,523216,2016,
oral testosterone,n/a,2016-06-02,Treatment of constitutional delay of growth and puberty in adolescent boys 14 to 17 years of age.,Designated,,,N/A,N/A,"TesoRx Pharma, LLC",3670 West Temple Avenue,Suite 270,Pomona,California,91768,USA,523916,2016,
folate binding protein peptide: Glu-Ile-Trp-Thr-His-Ser-Tyr-Lys-Val,n/a,2016-06-08,Treatment (including prevention of recurrence) of ovarian cancer,Designated,,,N/A,N/A,"Galena Biopharma, Inc.",Crow Canyon Place,Suite 380,San Ramon,California,94583,USA,522416,2016,
Folate Binding Protein Peptide: Glu-Ile-Trp-Thr-Phe-Ser-Thr-Lys-Val,n/a,2016-06-08,Treatment (including prevention of recurrence) of ovarian cancer,Designated,,,N/A,N/A,"Galena Biopharma, Inc.",Crow Canyon Place,Suite 380,San Ramon,California,94583,USA,528616,2016,
fosbretabulin tromethamine,n/a,2016-06-08,Treatment of glioma,Designated,,,N/A,N/A,"Mateon Therapeutics, Inc.",701 Gateway Boulevard,Suite 210,South San Francisco,California,94080,USA,524816,2016,
glibentek (glibenclamide oral suspension),n/a,2016-06-08,Treatment of neonatal diabetes (monogenic forms of diabetes that present in infancy),Designated,,,N/A,N/A,AMMTeK,15 Rue Béranger,,Paris,,,France,518816,2016,
recombinant human cerebral dopamine neurotrophic factor,n/a,2016-06-08,Treatment of amyotrophic lateral sclerosis,Designated,,,N/A,N/A,Herantis Pharma Plc,4 Viikinkaari,,Helsinki,,,Finland,515515,2016,
"recombinant, adeno-associated virus serotype 2 vector carrying linear single-stranded AADC mRNA cDNA",n/a,2016-06-08,Treatment of aromatic L-amino acid decarboxylase deficiency.,Designated,,,N/A,N/A,"Agilis Biotherapeutics, LLC",Kendall Square,245 First Street,Cambridge,Massachusetts,2142,USA,526916,2016,
cannabidiol,n/a,2016-06-13,Treatment of infantile spasms,Designated,,,N/A,N/A,GW Research Ltd.,"Sovereign House, Vision Park",Chivers Way,Histon,,,United Kingdom,521416,2016,
L-pyr-L-glu-L-gln-L-leu-L-glu-L-arg-L-ala-L-leu-L-asn-L-ser-L-ser,n/a,2016-06-13,Treatment to increase survival and improve functioning of pancreatic islets following transplantation,Designated,,,N/A,N/A,"Araim Pharmaceuticals, Inc.",580 White Plains Road,Suite 210,Tarrytown,New York,10591,USA,523116,2016,
L-pyr-L-glu-L-gln-L-leu-L-glu-L-arg-L-ala-L-leu-L-asn-L-ser-L-ser,n/a,2016-06-13,Treatment of sarcoidosis.,Designated,,,N/A,N/A,"Araim Pharmaceuticals, Inc.",580 White Plains Road,Suite 210,Tarrytown,New York,10591,USA,523816,2016,
antisense oligonucleotide targeting the U isoform of SNP rs362307,n/a,2016-06-16,Treatment of Huntington's disease (prodromal stage Huntington's disease and diagnosed Huntington's disease),Designated,,,N/A,N/A,Wave LIfe Sciences,733 Concord Avenue,,Cambridge,Massachusetts,2138,USA,525516,2016,
hydromorphone hydrochloride (intrathecal infusion),n/a,2016-06-16,Treatment of complex regional pain syndrome,Designated,,,N/A,N/A,"Piramal Critical Care, Inc.",261 Brodhead Road,Suite 221,Bethlehem,Pennsylvania,18017,USA,499415,2016,
napabucasin,n/a,2016-06-20,Treatment of gastric cancer including gastroesophageal junction cancer.,Designated,,,N/A,N/A,"Boston Biomedical, Inc.",640 Memorial Drive,,Cambridge,Massachusetts,2139,USA,526116,2016,
"tetrahydro-N,N-dimethyl-2,2-diphenyl-3-furanmethanamine hydrochloride",n/a,2016-06-20,Treatment of infantile spasms,Designated,,,N/A,N/A,Anavex Life Sciences Corp.,51 West 52nd Street,7th Floor,New York,New York,10019,USA,524416,2016,
varlitinib,n/a,2016-06-20,Treatment of gastric cancer.,Designated,,,N/A,N/A,ASLAN Pharmaceuticals,10A Bukit Pasoh Road,,,,,Singapore,524216,2016,
sirolimus,n/a,2016-06-21,Treatment of beta-thalassemia.,Designated,,,N/A,N/A,Rare Partners srl Impresa Sociale,31 Corso Magenta,,Milano,,,Italy,524916,2016,
Sperm Protein-17 oral microparticle vaccine,n/a,2016-06-21,Treatment of ovarian cancer,Designated,,,N/A,N/A,"Kiromic, LLC",2707 Fannin Street,Fannin St. Professional Building,Houston,Texas,77002,USA,523416,2016,
ibrutinib,Imbruvica,2016-06-23,Treatment of chronic Graft versus Host disease.,Designated/Approved,Approved for Orphan Indication,Treatment of adult patients with chronic graft versus host disease (cGVHD),2017-08-02,2024-08-02,"Pharmacyclics, LLC",995 East Arques Avenue,,Sunnyvale,California,94085,USA,525616,2016,405
"(S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydroprazolo[1,5-a]pyrimidine-3-carboxamide",n/a,2016-06-23,Treatment of mantle cell lymphoma.,Designated,,,N/A,N/A,"BeiGene USA, Inc.",2115 Linwood Avenue,4th Floor,Fort Lee,New Jersey,7024,USA,527416,2016,
"7-benzyl-4-(2-methylbenzyl)-1,2,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(4H)-one*2HCl",n/a,2016-06-23,Treatment of glioblastoma.,Designated,,,N/A,N/A,"Oncoceutics, Inc.",3624 Market Street,Suite 5E,Philadelphia,Pennsylvania,19104,USA,527916,2016,
"high molecular weight multimer of E3-Fc, an endostatin C-terminus and IgG1-Fc fusion protein",n/a,2016-06-27,Treatment of systemic sclerosis,Designated,,,N/A,N/A,"iBio, Inc.",600 Madison Avenue,Suite 1601,New York,New York,10022,USA,526716,2016,
triclabendazole,Triclathera,2016-06-27,Treatment of fascioliasis,Designated,,,N/A,N/A,"Tropicalis Pharmaceuticals, LLC",22345 Bracketts Road,,Excelsior,Minnesota,55331,USA,525416,2016,
"(S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide",n/a,2016-06-29,Treatment of Waldenstrom's macroglobulinemia,Designated,,,N/A,N/A,"BeiGene USA, Inc.",2115 Linwood Avenue,4th Floor,Fort Lee,New Jersey,7024,USA,527616,2016,
Peptide consisting of L-amino acids with the sequence H-lys-glu-phe-leu-his-pro-ser-lys-val-asp-leu-pro-arg-OH,n/a,2016-06-29,Treatment of pancreatic cancer.,Designated,,,N/A,N/A,"Soricimed Biopharma, Inc.",18 Botsford Street,Suite 201,Moncton,New Brunswick,,Canada,526016,2016,
"recombinant, glycoenfineered humanized IgG1 kappa monoclonal antibody directed against Fibroblast Growth Factor Receptor 2b",n/a,2016-06-29,Treatment of gastric cancer including cancer of the gastroesophageal junction.,Designated,,,N/A,N/A,"Five Prime Therapeutics, Inc.",2 Corporate Drive,,South San Francisco,California,94080,USA,527716,2016,
autologous osteogenic cells cultured from adipose tissue derived stem cells embedded in extracellular matrix with demineralized bone matrix.,n/a,2016-06-30,Treatment of congenital pseudarthrosis of the tibia,Designated,,,N/A,N/A,Novadip Biosciences,11 Granbonpré,,Mont-Saint-Guibert,,,Belgium,525316,2016,
Small molecule Ewing Sarcoma breakpoint region 1/Friend leukemia virus integration 1 fusion protein inhibitor,n/a,2016-06-30,Treatment of Ewing sarcoma,Designated,,,N/A,N/A,"Tokalas, Inc.",P. O. Box 1269,,Rancho Santa Fe,California,92067,USA,525716,2016,
adenovirus-associated viral vector serotype 5 containing the human pde6B gene,n/a,2016-07-05,Treatment of retinitis pigmentosa due to pde6B gene mutations,Designated,,,N/A,N/A,"HORAMA, SAS",9 Rue de l'Éperon,,Paris,,,France,527216,2016,
bortezomib,Velcade,2016-07-05,Treatment of neurofibromatosis type 2 (NF2),Designated,,,N/A,N/A,BioXcel Corporation,780 East Main Street,Suite 2,Branford,Connecticut,6405,USA,525816,2016,
"modified mRNA encoding UGT1A1 protein, formulated in lipid nanoparticles",n/a,2016-07-05,Treatment of Crigler-Najjar syndrome,Designated,,,N/A,N/A,"Moderna Therapeutics, Inc.",320 Bent Street,,Cambridge,Massachusetts,2141,USA,526616,2016,
anti-HER2 bispecific antibody drug conjugate,n/a,2016-07-06,Treatment of ovarian cancer,Designated,,,N/A,N/A,Zymeworks Inc.,18 West Mercer Street,Suite 370,Seattle,Washington,98119,USA,522616,2016,
mazindol,n/a,2016-07-06,Treatment of narcolepsy,Designated,,,N/A,N/A,NLS-0 Pharma AG,10 Breitenweg,CH-6370,Stans NW,,,Switzerland,526816,2016,
"metavert, N-hydroxy-4-(5-((4-methoxyphenyl)amino)-1,3,4-oxadiazol-2-yl)benzamide",n/a,2016-07-06,Treatment of pancreatic cancer,Designated,,,N/A,N/A,"Avenzoar Pharmaceuticals, Inc.",662 Encinitas Blvd,Suite 248,Encinitas,California,92024,USA,526216,2016,
nintedanib,n/a,2016-07-06,Treatment of systemic sclerosis (including the associated interstitial lung disease).,Designated,,,N/A,N/A,"Boehringer Ingelheim Pharmaceuticals, Inc.",900 Ridgebury Road,Box 368,Ridgefield,Connecticut,6877,USA,528516,2016,
1-(2-chlorophenyl)-1-(S)-hydroxy-2-(S)-carbamoyloxy-propane,n/a,2016-07-07,Treatment of status epilepticus,Designated,,,N/A,N/A,"Bio-Pharm Solutions Co., Ltd.",Advanced Institute of Convergence Technology,"6F, C Bldg",Yeongtong Suwon,,,"Korea, Republic of",528216,2016,
brentuximab vedotin,Adcetris,2016-07-07,Treatment of enteropathy-associated T-cell lymphoma.,Designated,,,N/A,N/A,"Seattle Genetics, Inc.",21823 30th Drive Southeast,,Bothell,Washington,98021,USA,528716,2016,
deoxythymidine monophosphate and deoxycytidine monophosphate,n/a,2016-07-07,Treatment of thymidine kinase 2 deficiency.,Designated,,,N/A,N/A,Columbia University Medical Center,Department of Neurology,"630 West 168th Street, P&S 4-423",New York,New York,10032,USA,532716,2016,
selinexor,n/a,2016-07-07,Treatment of soft tissue sarcoma,Designated,,,N/A,N/A,"Karyopharm Therapeutics, Inc.",85 Wells Avenue,,Newton,Maryland,2459,USA,527816,2016,
recombinant human biglycan,n/a,2016-07-13,Treatment of Duchenne Muscular Dystrophy,Designated,,,N/A,N/A,"Tivorsan Pharmaceuticals, Inc.",3 Davol Square,A340,Providence,Rhode Island,2903,USA,526416,2016,
tolfenamic acid,n/a,2016-07-13,Treatment of Frontotemporal Dementia,Designated,,,N/A,N/A,Nasser H. Zawia,83 Castle Rocks Road,,Warwick,Rhode Island,2886,USA,517816,2016,
tolfenamic acid,n/a,2016-07-13,Treatment of progressive supranuclear palsy,Designated,,,N/A,N/A,Nasser H. Zawia,83 Castle Rocks Road,,Warwick,Rhode Island,2886,USA,517916,2016,
[F18] florilglutamic acid,n/a,2016-07-13,For the diagnosis of hepatocellular carcinoma,Designated,,,N/A,N/A,Piramal Imaging S.A.,13 Route de l'Ecole,,Matran,,,Switzerland,517516,2016,
[F18] florilglutamic acid,n/a,2016-07-13,Diagnostic for the management of hepatocellular carcinoma,Designated,,,N/A,N/A,Piramal Imaging S.A.,13 Route de l'Ecole,,Matran,,,Switzerland,538716,2016,
"three human IgG1 mAbs (REGN3470, REGN3471, and REGN3479) directed against different epitopes on Ebola virus glycoprotein",n/a,2016-07-14,Treatment of ebola virus infection,Designated,,,N/A,N/A,"Regeneron Pharmaceuticals, Inc.",777 Old Saw Mill River Road,,Tarrytown,New York,10591,USA,536316,2016,
Pegylated recombinant human interleukin-10,n/a,2016-07-18,Treatment of pancreatic cancer,Designated,,,N/A,N/A,"ARMO BioSciences, Inc.",575 Chesapeake Drive,,Redwood City,California,94063,USA,528416,2016,
Ruxolitinib,n/a,2016-07-18,Treatment of acute lymphoblastic leukemia.,Designated,,,N/A,N/A,Incyte Corporation,1801 Augustine Cut-off,,Wilmington,Delaware,19803,USA,529116,2016,
"(S)-7-(1acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide",n/a,2016-07-20,Treatment of chronic lymphocytic leukemia.,Designated,,,N/A,N/A,"BeiGene USA, Inc.",2115 Linwood Avenue,4th Floor,Fort Lee,New Jersey,7024,USA,527516,2016,
flunarizine,n/a,2016-07-20,Treatment of hemiplegic migraine,Designated,,,N/A,N/A,"Xenon Pharmaceuticals, Inc.",3650 Gilmore Way,,Burnaby,British Columbia,,Canada,528116,2016,
"recombinant, adeno-associated virus serotype 5 vector, containing the transgene, which encodes for the human protein, frataxin",n/a,2016-07-25,Treatment of Friedreich's Ataxia,Designated,,,N/A,N/A,"Agilis Biotherapeuties, LLC",245 First Street,Suite 1800,Cambridge,Massachusetts,2142,USA,498515,2016,
"humanized IgG4 monoclonal antibody against total complement component 1, subcomponent s (C1s)",n/a,2016-07-27,Treatment of autoimmune hemolytic anemia (AIHA),Designated,,,N/A,N/A,"Bioverativ USA, Inc.",951 Gateway Boulevard,,South San Francisco,California,94080,USA,506115,2016,
chimeric antigen receptor directed against the target protein CD4 lentivirally transfected T cells,n/a,2016-07-28,Treatment of peripheral T-cell lymphoma,Designated,,,N/A,N/A,iCell Gene Therapeutics,25 Health Sciences Drive,Suite 118,Stony Brook,New York,11793,USA,522216,2016,
vemurafenib,Zelboraf,2016-08-02,Treatment of Erdheim-Chester Disease,Designated/Approved,Approved for Orphan Indication,Treatment of patients with Erdheim-Chester Disease with BRAF V600 mutation,2017-11-06,2024-11-06,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,USA,529616,2016,461
vedolizumab,n/a,2016-08-04,Prevention of graft versus host disease.,Designated,,,N/A,N/A,"Millennium Pharmaceuticals, Inc.",40 Landsdowne Street,,Cambridge,Massachusetts,2139,USA,523516,2016,
ceramide,n/a,2016-08-08,Treatment of liver cancer,Designated,,,N/A,N/A,"Keystone Nano, Inc.",1981 Pine Hall Road,,State College,Pennsylvania,16801,USA,531416,2016,
Retinol palmitate,n/a,2016-08-08,Prevention of bronchopulmonary dysplasia.,Designated,,,N/A,N/A,Orphanix GmbH,41 Peter-Rosegger-Straße,,Ried im Innkreis,,,Austria,525116,2016,
dusquetide,n/a,2016-08-10,Treatment of macrophage activation syndrome,Designated,,,N/A,N/A,"Soligenix, Inc.",29 Emmons Drive,Suite C-10,Princeton,New Jersey,8540,USA,528016,2016,
carbon monoxide,n/a,2016-08-16,Treatment of idiopathic pulmonary fibrosis (IPF).,Designated,,,N/A,N/A,"Proterris, Inc.",197 West Springfield Street,,Boston,Massachusetts,2118,USA,530816,2016,
humanized IgG4 monoclonal antibody that binds to the SEMA4D antigen,n/a,2016-08-16,Treatment of Huntington's disease,Designated,,,N/A,N/A,"Vaccinex, Inc.",1895 Mount Hope Avenue,,Rochester,New York,14620,USA,530916,2016,
itraconazole inhalation powder,n/a,2016-08-16,Treatment of pulmonary fungal infections in patients with cystic fibrosis,Designated,,,N/A,N/A,"Pulmatrix, Inc",99 Hayden Avenue,,Lexington,Massachusetts,2421,USA,509515,2016,
propofol hemisuccinate,n/a,2016-08-19,Treatment of acute repetitive seizures,Designated,,,N/A,N/A,EpaleX Corporation,305 Lytton Avenue,,Palo Alto,California,94301,USA,530016,2016,
rituximab and recombinant human hyaluronidase,Rituxin Sc,2016-08-22,Treatment of chronic lymphocytic leukemia (CLL),Designated/Approved,Approved for Orphan Indication,Treatment of adult patients with previously untreated and previously treated CLL in combination with fludarabine,2017-06-22,2024-06-22,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,USA,545616,2016,304
rituximab and recombinant human hyaluronidase,Rituxan Sc,2016-08-22,Treatment of follicular lymphoma,Designated/Approved,Approved for Orphan Indication,"Treatment of adult patients with relapsed or refractory, follicular lymphoma as a single agent, previously untreated follicular lymphoma in combination with first line chemotherapy and, in patients achieving a complete or partial response to rituximab in combination with chemotherapy, as single-agent maintenance therapy, non-progressing (including stable disease), follicular lymphoma as a single agent after first-line cyclophosphamide, vincristine, and prednisone (CVP) chemotherapy",2017-06-22,2024-06-22,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,USA,529816,2016,304
"(1,3)-ß-D-glucan synthesis inhibitor",n/a,2016-08-22,Treatment of invasive Aspergillus infections,Designated,,,N/A,N/A,"SCYNEXIS, Inc.",101 Hudson Street,Suite 3610,Jersey City,New Jersey,7302,USA,531716,2016,
ambrisentan/tadalafil fixed combination,n/a,2016-08-22,Treatment of pulmonary arterial hypertension,Designated/Withdrawn,,,N/A,N/A,"Gilead Sciences, Inc.",333 Lakeside Drive,,Foster City,California,94404,USA,528316,2016,
cultured skin substitute (CSS),Novaderm,2016-08-22,Treatment of burns requiring skin grafting.,Designated,,,N/A,N/A,Regenicin Inc.,10 High Court,,Little Falls,New Jersey,7424,USA,532116,2016,
Disufenton sodium,n/a,2016-08-22,Treatment of glioblastoma multiforme.,Designated,,,N/A,N/A,"Oblato, Inc.",116 Village Boulevard,,Princeton,New Jersey,8540,USA,531616,2016,
etrolizumab,n/a,2016-08-22,Treatment of pediatric patients with ulcerative colitis,Designated,,,N/A,N/A,"Genentech, Inc.",1 Dna Way,,South San Francisco,California,94080,USA,531116,2016,
live E. coli Nissle bacterium modified to assimilate ammonia,n/a,2016-08-22,Treatment of urea cycle disorders,Designated,,,N/A,N/A,"Synlogic, Inc.",200 Sidney Street,#320,Cambridge,Massachusetts,2139,USA,529516,2016,
nivolumab,Opdivo,2016-08-22,Treatment of esophageal cancer,Designated,,,N/A,N/A,Bristol-Myers Squibb Co.,5 Research Parkway,,Wallingford,Connecticut,6492,USA,531016,2016,
recombinant human interleukin-12,Hemamax,2016-08-22,Treatment of acute radiation syndrome,Designated,,,N/A,N/A,"Neumedicines, Inc.",133 Altadena Drive,Suite 133,Pasadena,California,91107,USA,531916,2016,
stabilized sulforaphane,n/a,2016-08-22,Treatment of subarachnoid hemorrhage,Designated,,,N/A,N/A,Evgen Pharma PLC,146 Brownlow Hill,,Liverpool,,,United Kingdom,530616,2016,
phosphoinositide-3-kinase delta inhibitor,n/a,2016-08-23,Treatment of chronic lymphocytic leukemia,Designated,,,N/A,N/A,"TG Therapeutics, Inc.",3 Columbus Circle,15th Floor,New York,New York,10019,USA,533016,2016,
"recombinant, fully-human, IgG4 immunoglobulin with antigen-binding specificity for human vascular adhesion protein-1 (VAP-1)",n/a,2016-08-25,Treatment of primary sclerosing cholangitis.,Designated,,,N/A,N/A,"Acorda Therapeutics, Inc.",420 Saw Mill River Road,,Ardsley,New York,10502,USA,531516,2016,
ublituximab,n/a,2016-08-25,Treatment of neuromyelitis optica and neuromyelitis optica spectrum disorder,Designated,,,N/A,N/A,"TG Therapeutics, Inc.",3 Columbus Circle,15th Floor,New York,New York,10019,USA,533116,2016,
131-I-8H9 monoclonal antibody,n/a,2016-08-29,Treatment of neuroblastoma,Designated,,,N/A,N/A,"Y-mAbs Therapeutics, Inc.",750 3rd Avenue,9th Floor,New York,New York,10017,USA,535716,2016,
"9,10-dimethoxy-5,6-dihydro-[1,3] dioxolo[4,5-g]isoquinolino[3,2-alpha]isoquinolin-7-ium(R)-4-((3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyhexadecahydro-1H-cyclopenta[alpha]",n/a,2016-08-29,Treatment of primary sclerosing cholangitis,Designated,,,N/A,N/A,HighTide Biopharma Pty. Ltd.,1 Melissa Street,,Mount Waverley,,,Australia,509915,2016,
anti-STAT3 (Signal Transducer and Activator of Transcription 3) B VHH13 single domain antibody,n/a,2016-08-29,Treatment of pancreatic cancer,Designated,,,N/A,N/A,"Singh Biotechnology, LLC",4708 Rue Bordeaux,,Lutz,Florida,33558,USA,533616,2016,
S-ethylisothiourea diethylphosphate,n/a,2016-08-29,"Treatment of symptomatic intradialytic hypotension, including symptomatic hypotension in the immediate post-dialytic period.",Designated,,,N/A,N/A,"TrioxBio, Inc.",P. O. Box 1000,,Wilmington,Delaware,19801,USA,514615,2016,
Synthetic double-stranded small interfering RNA (siRNA) oligonucleotide targeting delta-aminoevulinic acid synthase 1,n/a,2016-08-29,Treatment of acute hepatic porphyria,Designated,,,N/A,N/A,Alnylam Pharmaceuticals,300 Third Street,,Cambridge,Massachusetts,2142,USA,535516,2016,
Venetoclax,Venclexta,2016-08-29,Treatment of multiple myeloma,Designated,,,N/A,N/A,AbbVie Inc.,Regualtory Affairs,1 North Waukegan Road,North Chicago,Illinois,60064,USA,536116,2016,
humanized IgG4 monoclonal antibody to Toll-Like Receptor 2 (TLR2),n/a,2016-08-30,Treatment of myelodysplastic syndrome,Designated,,,N/A,N/A,Opsona Therapeutics Ltd.,2nd Floor Ashford House,Dublin 2,,,,Ireland,455014,2016,
Adeno-associated viral vector differentially expressing microdystrophin 5 gene via the muscle-specific promoter CK8 (rAAV9-CK8-h-µD5),n/a,2016-08-31,Treatment of Duchenne muscular dystrophy,Designated,,,N/A,N/A,"Solid GT, LLC",161 First Street,Suite 3A,Cambridge,Massachusetts,2142,USA,518216,2016,
amifampridine phosphate,n/a,2016-08-31,Treatment of myasthenia gravis,Designated,,,N/A,N/A,"Catalyst Pharmaceuticals, Inc.",355 Alhambra Circle,Suite 1250,Coral Gables,Florida,33134,USA,534916,2016,
Adeno-associated virus serotype 2/6 (rAAV2/6) vectors encoding zinc finger nucleases (ZFNs) and human factor 9 gene (SB-FIX),n/a,2016-09-01,Treatment of hemophilia B,Designated,,,N/A,N/A,"Sangamo Therapeutics, Inc.",Point Richmond Tech Center,501 Canal Boulevard,Richmond,California,94804,USA,535216,2016,
Angiotensin (1-7),n/a,2016-09-01,Treatment of recessive dystrophic epidermolysis bullosa (RDEB).,Designated,,,N/A,N/A,"Tarix Orphan, LLC",12 Bow Street,,Cambridge,Massachusetts,2138,USA,546416,2016,
dabrafenib and trametinib,Tafinlar(R) Capsules A Nd Mekinist(R) Tablets,2016-09-01,Treatment of patients with anaplastic thyroid cancer and locally advanced or metastatic papillary thyroid cancer whose tumors harbor a BRAF V600 mutation.,Designated,,,N/A,N/A,Novartis Pharmaceuticals Corporation,1 Health Plaza,Building 337,East Hanover,New Jersey,7936,USA,521616,2016,
recombinant adeno-associated virus vector serotype 9 expressing human iduronate-2-sulfatase,n/a,2016-09-01,"Treatment of mucopolysaccharidosis II, also called Hunter syndrome A.",Designated,,,N/A,N/A,Research Institute at Nationwide Children's Hospital,Center for Gene Therapy,700 Childrens Drive,Columbus,Ohio,43205,USA,534016,2016,
recombinant adeno-associated virus vector serotype 9 expressing human N-Sulfoglucosamine Sulfohydrolase,n/a,2016-09-01,"Treatment of mucopolysaccharidosis type III A, also called Sanfilippo syndrome A",Designated,,,N/A,N/A,Research Institute at Nationwide Children's Hospital,Center for Gene Therapy,700 Childrens Drive,Columbus,Ohio,43205,USA,534116,2016,
"4,5,6,7-tetrahydroisoxazolo(5,4-c)pyridin-3-ol",n/a,2016-09-06,Treatment of Angelman syndrome.,Designated,,,N/A,N/A,Ovid Therapeutics,1460 Broadway,,New York,New York,10036,USA,533816,2016,
"bilayer, engineered collagen hydrogel-based skin graft composed of autologous keratinocytes and fibroblasts",Primeskin,2016-09-06,Treatment of partial deep dermal and full thickness burn wounds,Designated,,,N/A,N/A,Curtiss AG,35 Weinbergstrasse,,Zürich,,,Switzerland,532816,2016,
Cisplatin,n/a,2016-09-06,Treatment of anal cancer,Designated,,,N/A,N/A,Privo Technologies,13 Bristol Street,Unit #1,Cambridge,Massachusetts,2141,USA,536616,2016,
mesylate synthetic small molecule inhibitor of HDAC and PI3K,n/a,2016-09-06,Treatment of nuclear protein in testis (NUT) midline carcinoma,Designated,,,N/A,N/A,"Curis, Inc.",4 Maguire Road,,Lexington,Massachusetts,2421,USA,482415,2016,
rituximab and recombinant human hyaluronidase,Rituxan Sc,2016-09-07,Treatment of diffuse large B-cell lymphoma,Designated/Approved,Approved for Orphan Indication,"Treatment of adult patients with previously untreated diffuse large B-cell lymphoma in combination with cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) or other anthracycline-based chemotherapy regimens",2017-06-22,2024-06-22,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,USA,546516,2016,288
"6-fluoro-(18F)-L-3,4-dihydroxyphenylalanine",n/a,2016-09-07,A diagnostic for management of patients with Lesch-Nyhan syndrome,Designated,,,N/A,N/A,"Advanced Imaging Projects, LLC",7947 Brookside Ct.,,Lake Worth,Florida,33467,USA,543716,2016,
autologous CD4+/CD8+ T cells expressing a CD19 chimeric antigen receptor and a truncated epidermal growth factor receptor,n/a,2016-09-07,Treatment of acute lymphoblastic leukemia,Designated,,,N/A,N/A,"Juno Therapeutics, Inc.",400 Dexter Avenue North,Suite 1200,Seattle,Washington,98109,USA,533416,2016,
Brentuximab vedotin,Adcetris,2016-09-07,Treatment of primary cutaneous CD30-positive T-cell lymphoproliferative disorders,Designated,,,N/A,N/A,"Seattle Genetics, Inc.",21823 30th Drive Southeast,,Bothell,Washington,98021,USA,536516,2016,
cinacalcet,Sensipar,2016-09-07,Treatment of secondary hyperparathyroidism (HPT) in pediatric patients with chronic kidney disease receiving dialysis,Designated,,,N/A,N/A,"Amgen, Inc.",One Amgen Center Drive,"Bldg 17, 1A-4-4, Mail Stop 17-1-B",Thousand Oaks,California,91320,USA,511315,2016,
coversin; rEV675,n/a,2016-09-08,Treatment of paroxysmal nocturnal hemoglobinuria,Designated,,,N/A,N/A,Akari Therapeutics Plc,24 West 40th Street,8th Floor,New York,New York,10018,USA,533916,2016,
terlipressin,n/a,2016-09-08,Treatment of ascites due to all etiologies except cancer,Designated,,,N/A,N/A,Bio Vie Inc.,100 Cummings Center,Suite 247-C,Beverly,Massachusetts,1915,USA,534216,2016,
emodepside,n/a,2016-09-13,"Treatment of onchocerhiasis (""river blindness"") caused by the filarial nematode onchocerca volvulus",Designated,,,N/A,N/A,"Bayer HealthCare Pharmaceuticals, Inc.",100 Bayer Boulevard,P. O. Box 915,Whippany,New Jersey,7981,USA,535416,2016,
poly(lactide-co-glycolide) carboxylated microparticle,n/a,2016-09-13,Treatment of malaria,Designated,,,N/A,N/A,"Cour Pharmaceutical Development Company, Inc.",428 S. Hillside Avenue,,Elmhurst,Illinois,60126,USA,534816,2016,
riluzole oral suspension,Teglutik,2016-09-15,Treatment of amyotrophic lateral sclerosis (ALS).,Designated,,,N/A,N/A,Italfarmaco SpA,54 Via dei Lavoratori,,Cinisello Balsamo,,,Italy,508715,2016,
"3-(5-amino-2-methyl-4-oxoquinazolin-3(4H)-yl)piperidine-2,6-dione hydrochloride",n/a,2016-09-19,Treatment of diffuse large B-cell lymphoma,Designated,,,N/A,N/A,Celgene Corporation,400 Connell Drive,Suite 7000,Berkeley Heights,New Jersey,7922,USA,536816,2016,
Adeno-associated virus delivered transgene of follistatin,n/a,2016-09-19,Treatment of inclusion body myositis,Designated,,,N/A,N/A,Milo Biotechnology,2322 Delaware Drive,,Cleveland Heights,Ohio,44106,USA,369612,2016,
antisense oligonucleotide inhibitor of the expression of superoxide dismutase 1 gene,n/a,2016-09-19,Treatment of amyotrophic lateral sclerosis,Designated,,,N/A,N/A,Biogen,225 Binney Street,,Cambridge,Massachusetts,2142,USA,537216,2016,
decitabine and tetrahydrouridine,n/a,2016-09-19,Treatment of sickle cell disease,Designated,,,N/A,N/A,EpiDestiny Inc.,7536 Royal Portrush Drive,,Solon,Ohio,44139,USA,537716,2016,
"disulfide-stabilized single-chain variable region fragment of the anti-EGFR wild type/EGFRvIII dual specificity monoclonal antibody with variable fragments fused to a truncated version of the Pseudomonas exotoxin A, PE38, and KDEL",n/a,2016-09-19,Treatment of glioma.,Designated,,,N/A,N/A,"Darell D. Bigner, MD, PhD",Duke University Medical Center,Oreuss Laboratory -Brain Tumor Research,Durham,North Carolina,27710,USA,519816,2016,
fixed dose combination of modafinil and flecainide,n/a,2016-09-19,Treatment of narcolepsy,Designated,,,N/A,N/A,Theranexus S.A,86 Rue de Paris,,Orsay,,,France,536716,2016,
methylprednisolone oral suspension,n/a,2016-09-19,Treatment of adrenal insufficiency in pediatric patients,Designated,,,N/A,N/A,Generic Specialty Pharma,"Unit 10, Block 3",City North Business Campus,Stamullin,,,Ireland,531816,2016,
ProTmune (ex vivo Programmed Mobilized Peripheral Blood),n/a,2016-09-19,Prevention of graft-versus-host disease in patients undergoing allogenic hematopoietic cell transplantation,Designated,,,N/A,N/A,Fate Therapeutics,3535 General Atomics Court,Suite 200,San Diego,California,92121,USA,535616,2016,
recombinant adeno-associated virus serotype rhesus 74 expressing the human dysferin gene (AAVrh74.MHCK7.DYSF.DV),n/a,2016-09-19,Treatment of Limb Girdle Muscular Dystrophy Type 2B,Designated,,,N/A,N/A,Nationwide Children's Hospital,700 Children's Drive,Rm WA2025,Columbus,Ohio,43205,USA,537616,2016,
Autologous dendritic cell/tumor antigens,n/a,2016-09-27,Treatment of glioblastoma multiforme (GBM),Designated,,,N/A,N/A,China Medical University Hospital,"No. 2, Yude Road, North District",,,,,Taiwan,537016,2016,
tenofovir disoproxil fumarate,Viread,2016-09-27,Prevention of mother to child transmission of hepatitis B virus,Designated,,,N/A,N/A,"Gilead Sciences, Inc.",333 Lakeside Drive,,Foster City,California,94404,USA,538416,2016,
Wharton's jelly mesenchymal stem cells,n/a,2016-09-27,Treatment of graft-versus-host disease,Designated,,,N/A,N/A,Midwest Stem Cell Therapy Center,University of Kansas Medical Center,3901 Rainbow Boulevard,Kansas City,Kansas,66160,USA,535016,2016,
recombinant adeno-associated virus serotype 8 vector encoding human glucose-6-phosphatase-alpha (G6Pase or G6PC),n/a,2016-09-28,Treatment of glycogen storage disease type Ia (von Gierke Disease),Designated,,,N/A,N/A,Dimension Therapeutics,840 Memorial Drive,,Cambridge,Massachusetts,2139,USA,536016,2016,
Atrasentan,n/a,2016-09-29,Treatment of pediatric nephrotic syndrome,Designated,,,N/A,N/A,AbbVie Inc.,Regulatory Affairs,1 North Waukegan Road,North Chicago,Illinois,60044,USA,537116,2016,
autologous CD4+/CD8+ T cells expressing a CD19 chimeric antigen receptor (CAR) and a truncated epidermal growth factor receptor.,n/a,2016-10-04,Treatment of chronic lymphocytic leukemia,Designated,,,N/A,N/A,"Juno Therapeutics, Inc.",400 Dexter Avenue North,Suite 1200,Seattle,Washington,98109,USA,538816,2016,
Posaconazole,Noxafil,2016-10-04,Treatment of invasive aspergillosis,Designated,,,N/A,N/A,"Merck, Sharp & Dohme Corp.",1 Merck Drive,,Whitehouse Station,New Jersey,8889,USA,539016,2016,
Tacrolimus granules for oral suspension,n/a,2016-10-04,"Prevention of rejection in kidney, liver or heart transplant in pediatric patients.",Designated,,,N/A,N/A,"Astellas Pharma Global Development, Inc.",1 Astellas Way,,Northbrook,Illinois,60062,USA,534516,2016,
ibudilast,n/a,2016-10-06,Treatment of amyotrophic lateral sclerosis,Designated,,,N/A,N/A,"MediciNova, Inc.",4275 Executive Square,Suite 300,La Jolla,California,92037,USA,445814,2016,
Recombinant human monoclonal antibody against human complement component C5a,n/a,2016-10-06,Treatment of acute graft versus host disease,Designated/Withdrawn,,,N/A,N/A,"Alexion Pharmaceuticals, Inc.",100 College Street,,New Haven,Connecticut,6510,USA,539416,2016,
pembrolizumab,Keytruda,2016-10-11,Treatment of nasopharyngeal carcinoma,Designated,,,N/A,N/A,"Merck, Sharp & Dohme Corp., a subsidiary of Merck & Co.",1 Merck Drive,,Whitehouse Station,New Jersey,8889,USA,511715,2016,
ledipasvir/sofosbuvir,Harvoni,2016-10-12,Treatment of chronic hepatitis C virus (HCV) infection in pediatric patients,Designated/Approved,Approved for Orphan Indication,"Treatment of pediatric patients 12 years of age and older or weighing at least 35 kg with chronic hepatitis C virus genotype 1, 4, 5, or 6 infection without cirrhosis or with compensated cirrhosis",2017-04-07,2024-04-07,"Gilead Sciences, Inc.",333 Lakeside Drive,,Foster City,California,94404,USA,535916,2016,177
liposomal vinorelbine,n/a,2016-10-12,Treatment of cutaneous t-cell lymphoma (CTCL),Designated,,,N/A,N/A,"Taiwan Liposome Company, Ltd.","11F-1, No. 3, Yuanqu Street",,Taipei City,,,Taiwan,540716,2016,
Vibrio alginolyticus collagenase,n/a,2016-10-12,Treatment of advanced Dupuytren's disease (Dupuytren's contracture),Designated,,,N/A,N/A,Fidia Farmaceutici S.p.A.,"Via Ponte della Fabbrica, 3/A",,Abano Terme PD,,,Italy,539616,2016,
Atezolizumab,n/a,2016-10-13,Treatment of small cell lung cancer (SCLC),Designated,,,N/A,N/A,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,USA,541216,2016,
"Combination of an inactivated purified rabies virus (IPRV) and the PIKA adjuvant (Poly I:C, kanamycin and calcium)",n/a,2016-10-13,Treatment of hepatocellular carcinoma,Designated,,,N/A,N/A,"Yisheng US Biopharma, Inc.",11 Firstfield Road,Suite A,Gaithersburg,Maryland,20878,USA,539916,2016,
vorinostat,n/a,2016-10-13,"Treatment of advanced melanoma (stages IIb, IIc, III, and IV)",Designated,,,N/A,N/A,Qameleon Therapeutics,Moslaan 32,1433 WJ,Kudelstaart,,,Netherlands,540116,2016,
"6-(R)-Methyl-5-O-(5-amino-5,6-dideoxy-a-L-talofuranosyl)- paromamine sulfate",n/a,2016-10-18,Treatment of mucopolysaccharidosis type 1 (MPS I),Designated,,,N/A,N/A,"Eloxx Pharmaceuticals, Ltd.",Weizmann Science Park,7 Golda Meir Street,Ness Ziona,,,Israel,540816,2016,
2-amino-3-[3-[[4-(2-pyridyloxymethyl)phenyl]methyl]isoxazol-5-yl]pyridin-1-ium-1-yl]methyl hydrogen phosphate,n/a,2016-10-19,Treatment of invasive candidiasis,Designated,,,N/A,N/A,"Amplyx Pharmaceuticals, Inc.",12730 High Bluff Drive,Suite 160,San Diego,California,92130,USA,538616,2016,
fixed dose combination formulation of macitentan and tadalafil,n/a,2016-10-19,Treatment of pulmonary arterial hypertension,Designated,,,N/A,N/A,"Actelion Clinical Research, Inc.",1820 Chapel Avenue West,Suite 300,Cherry Hill,New Jersey,8002,USA,509615,2016,
Partial agonist at the opioid receptor-like 1 receptor with amino acid sequence Ac-Arg-Tyr-Tyr-Arg-Trp-Lys-Lys-Lys-Lys-Lys-Lys-Lys-NH2,n/a,2016-10-19,Treatment of pulmonary arterial hypertension,Designated,,,N/A,N/A,Serodus ASA,Gaustadalléen 21,,Oslo,,,Norway,541316,2016,
rapamycin,n/a,2016-10-20,Treatment of pulmonary arterial hypertention,Designated,,,N/A,N/A,Lam Therapeutics,530 Old Whitfield Street,,Guilford,Connecticut,6437,USA,540516,2016,
sofosbuvir,Sovaldi,2016-10-25,Treatment of pediatric chronic hepatitis C virus infection,Designated/Approved,Approved for Orphan Indication,Treatment of chronic HCV genotype 2 or 3 infection in pediatric patients 12 years of age and older or weighing at least 35 kg without cirrhosis or with compensated cirrhosis for use in combination with ribavirin,2017-04-07,2024-04-07,"Gilead Sciences, Inc.",333 Lakeside Drive,,Foster City,California,94404,USA,541716,2016,164
napabucasin,n/a,2016-10-25,Treatment of pancreatic cancer.,Designated,,,N/A,N/A,"Boston Biomedical, Inc.",640 Memorial Drive,,Cambridge,Massachusetts,2139,USA,542316,2016,
2-amino-3-[3-[[4-(2-pyridyloxymethyl)phenyl]methyl]isoxazol-5-yl]pyridin-1-ium-1-yl]methyl hydrogen phosphate,n/a,2016-10-26,Treatment of invasive aspergillosis,Designated,,,N/A,N/A,"Amplyx Pharmaceuticals, Inc.",12730 High Bluff Drive,Suite 160,San Diego,California,92130,USA,551416,2016,
2-amino-3-[3-[[4-(2-pyridyloxymethyl)phenyl]methyl]isoxazol-5-yl]pyridin-1-ium-1-yl]methyl hydrogen phosphate,n/a,2016-11-02,"Treatment of invasive rare mold infections caused by scedosporium spp., fusarium spp., and mucorales fungi (including mucor spp., and rhizopus spp.)",Designated,,,N/A,N/A,"Amplyx Pharmaceuticals, Inc.",12730 High Bluff Drive,Suite 160,San Diego,California,92130,USA,554916,2016,
2-amino-3-[3-[[4-(2-pyridyloxymethyl)phenyl]methyl]isoxazol-5-yl]pyridin-1-ium-1-yl]methyl hydrogen phosphate,n/a,2016-11-03,Treatment of coccidioidomycosis,Designated,,,N/A,N/A,"Amplyx Pharmaceuticals, Inc.",12730 High Bluff Drive,Suite 160,San Diego,California,92130,USA,555016,2016,
"6'-(R)-Methyl-5-O-(5-amino-5,6-dideoxy-a-L-talofuranosyl)- paromamine sulfate",n/a,2016-11-03,Treatment of Rett syndrome,Designated,,,N/A,N/A,"Eloxx Pharmaceuticals, Ltd.",Weizmann Science Park,7 Golda Meir Street,Ness Ziona,,,Israel,541516,2016,
H-(4-amino-3-iodo)-D-Phe-c[Cys-(3-iodo)-Tyr-D-Trp-Lys-Val-Cys]-Thr-NH2,n/a,2016-11-03,Treatment of acromegaly,Designated,,,N/A,N/A,Amryt Research Ltd.,18 Fitzwilliam Place,,Dublin,,,Ireland,540916,2016,
melatonin,n/a,2016-11-03,Treatment of smith-magenis syndrome in combination with a beta-blocker,Designated,,,N/A,N/A,Therapicon SrL,21 Via Malachia Marchesi de Taddei,,Milano,,,Italy,541016,2016,
ruxolitinib,Jakafi,2016-11-03,Treatment of graft versus host disease,Designated,,,N/A,N/A,Incyte Corporation,1801 Augustine Cut-Off,,Wilmington,Delaware,19803,USA,542716,2016,
veliparib,n/a,2016-11-03,Treatment of squamous non-small cell lung cancer,Designated,,,N/A,N/A,AbbVie Inc.,1 North Waukegan Road,,North Chicago,Illinois,60064,USA,542916,2016,
2-[4-[[(2R)-2-ethoxy-3-[4-(trifluoromethyl)phenoxy]propyl]thio]-2-methylphenoxy]acetic acid (1:1) lysine dihydrate,n/a,2016-11-07,Treatment of primary biliary cholangitis,Designated,,,N/A,N/A,CymaBay Therapeutics,7999 Gateway Boulevard,Suite 130,Newark,California,94560,USA,543416,2016,
aganirsen,n/a,2016-11-07,Prevention of corneal graft rejection.,Designated,,,N/A,N/A,Gene Signal International SA,Route Cantonale,,Lausanne,,,Switzerland,500515,2016,
riboflavin-vitamin E-TPGS topical solution,Ribocross,2016-11-08,Treatment of keratoconus in patients undergoing crosslinking procedure,Designated,,,N/A,N/A,Institute of Refractive & Ophthalmic Surgery,"Via Andrea D'Isernia 31,",,Napoli,,,Italy,468414,2016,
sargramostim,Leukine,2016-11-09,Treatment of individuals acutely exposed to myelosuppressive doses of radiation (hematopoietic syndrome of acute radiation syndrome),Designated/Approved,Approved for Orphan Indication,LEUKINE® is indicated to increase survival in adult and pediatric patients from birth to 17 years of age acutely exposed to myelosuppressive doses of radiation (Hematopoietic Syndrome of Acute Radiation Syndrome [H-ARS]).,2018-03-29,2025-03-29,"Partner Therapeutics, Inc.",19 Muzzey Street,,Lexington,Massachusetts,2421,USA,541816,2016,505
"6-(4-(4-(2,3-dichlorophenyl)-piperazin-1-yl)-butoxy)-2H-benzo[b][1,4]oxazin-3(4H)-one hydrochloride",n/a,2016-11-09,Treatment of pulmonary arterial hypertension (WHO Group 1),Designated,,,N/A,N/A,"Reviva Pharmaceuticals, Inc.",3900 Freedom Circle,Suite 101,Santa Clara,California,95054,USA,541616,2016,
Autologous stromal vascular cell fraction from adipose tissue (central facitily processed),Eccs-50,2016-11-09,Treatment of impaired hand function due to systemic sclerosis,Designated,,,N/A,N/A,"Cytori Therapuetics, Inc.",3020 Callan Road,,San Diego,California,92121,USA,539816,2016,
hematopoietic stem cells modified with a lentiviral vector containing the CD18 (Integrin Beta 2) gene,Ladilen,2016-11-09,Treatment of leukocyte adhesion deficiency Type I,Designated,,,N/A,N/A,"Consorcio Centro de Investigación Biomédica en Red, M.P.",Montforte de Lemos,3-5 Pabellon 11,Madrid,,,Spain,543016,2016,
NiCord (cord blood-derived exvivo expanded CD34+ cells and the non-expanded cell fraction of the same cord blood unit),n/a,2016-11-09,Treatment of chronic myelogenous leukemia (CML),Designated,,,N/A,N/A,Gamida Cell Ltd.,P. O. Box 34670,,Jerusalem,,,Israel,544116,2016,
recombinant growth hormone fused to hyFc,n/a,2016-11-09,Treatment of growth hormone deficiency.,Designated,,,N/A,N/A,"Genexine, Inc.",700 Daewangpangyo-ro,"Korea Bio Pk Bldg B, Bundang-gu",Gyeonggi-do,,,"Korea, Republic of",523716,2016,
rituximab,n/a,2016-11-09,Treatment of Rasmussen's encephalitis,Designated,,,N/A,N/A,Keck Graduate Institute of Applied Life Sciences,535 Watson Drive,,Claremont,California,91711,USA,542416,2016,
Diazepam buccal soluble film,n/a,2016-11-10,"Treatment of selected, refractory patients with epilepsy who are on stable regimens of antiepileptic drugs (AED) and who require intermittent use of diazepam to control bouts of increased seizure activity (acute repetitive seizures)",Designated,,,N/A,N/A,Aquestive Therapeutics,30 Technology Drive South,,Warren,New Jersey,7059,USA,543516,2016,
"5-(4,6-dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)-pyridin-2-amine",n/a,2016-11-21,Treatment of primary central nervous system lymphoma.,Designated,,,N/A,N/A,PIQUR Therapeutics AG,Hochbergerstrasse 60C,CH-4057 Basel,,,,Switzerland,543116,2016,
"Isoindolin-1,3-Di Thione",n/a,2016-11-21,Treatment of Frontotemporal dementia,Designated,,,N/A,N/A,"P2D, Inc.",10101 Alliance Road,Suite 105,Cincinnati,Ohio,45242,USA,542616,2016,
mRNA encoding human ornithine transcarbamylase,n/a,2016-11-23,Treatment of ornithine transcarbamylase deficiency,Designated,,,N/A,N/A,"PhaseRx, Inc.",410 West Harrison Street,Suite 300,Seattle,Washington,98119,USA,542216,2016,
sodium 2-hydroxylinoleate,n/a,2016-11-23,Treatment of pancreatic cancer.,Designated,,,N/A,N/A,"Ability Pharmaceuticals, SL",Edifici Eureka,Campus de la UAB,Bellaterra,,,Spain,543816,2016,
(2-((2-chlorophenyl)(phenyl)amino)-N-(7-(hydroxyamino)-7-oxoheptyl)pyrimidine-5-carboxamide),n/a,2016-11-29,Treatment of multiple myeloma,Designated,,,N/A,N/A,"Acetylon Pharmaceuticals, Inc.",(Celgene Subsidiary),86 Morris Avenue,Summit,New Jersey,7901,USA,544316,2016,
adenovirus associated viral vector serotype 5 containing the RPGR gene,n/a,2016-11-29,Treatment of retinitis pigmentosa,Designated,,,N/A,N/A,MeiraGTx Limited,450 East 29th Street,15th Floor,New York,New York,10016,USA,544816,2016,
cannabidiol,n/a,2016-11-29,Treatment of Graft versus Host Disease,Designated,,,N/A,N/A,Talent biotechs Ltd.,14-18 Baruch Hirsch Street,,Bnei Brak,,,Israel,545316,2016,
cellspan esophageal implant,n/a,2016-11-29,"Restore the structure and function of the esophagus subsequent to esophageal damage due to cancer, injury, or congenital abnormality",Designated,,,N/A,N/A,"Biostage, Inc.",84 October Hill Road,Suite 11,Holliston,Massachusetts,1746,USA,542816,2016,
nanoparticles containing Zoledronic acid,Edroma,2016-11-29,Treatment of Glioma,Designated,,,N/A,N/A,Laboratorio Italiano Biochimico Farmaceutico Lisapharma SpA,Via Licinio 11,,Erba (CO),,,Italy,543616,2016,
risankizumab,n/a,2016-11-29,Treatment of pediatric Crohn's disease,Designated,,,N/A,N/A,AbbVie Inc.,Regulatory Affair,1 North Waukegan Road,North Chicago,Illinois,60044,USA,544716,2016,
C1 esterase inhibitor (Human),Cinryze,2016-11-30,Treatment of acute antibody mediated rejection following kidney transplantation,Designated,,,N/A,N/A,"Shire ViroPharma, Inc.",300 Shire Way,,Lexington,Massachusetts,2421,USA,510415,2016,
cannabidivarin,n/a,2016-11-30,Treatment of Rett syndrome,Designated,,,N/A,N/A,GW Research Ltd.,"Sovereign House, Histon",,Cambridge,,,United Kingdom,549216,2016,
lactobacillus plantarum,n/a,2016-11-30,Treatment of amyotrophic lateral sclerosis (ALS),Designated,,,N/A,N/A,"New Biotic, LLC",19546 Rogan Court,,Rowland Heights,California,91748,USA,550016,2016,
riluzole orally disolving tablet,n/a,2016-11-30,Treatment of amyotrophic lateral sclerosis (ALS),Designated,,,N/A,N/A,"Biohaven Pharmaceutical Holding Company, Ltd",234 Church Street,Suite 304,New Haven,Connecticut,6511,USA,509415,2016,
Yersinia pestis plague recombinant antigen (rF1V; F1 capsular protein fused to V antigen; E. coli) vaccine with aluminum hydroxide,n/a,2016-11-30,Prevention of plague (Yersinia pestis),Designated,,,N/A,N/A,"DynPort Vaccine Company, LLC, a CSRA Comapny","110 Thomas Johnson Drive, Suite 200",,Frederick,Maryland,21702,USA,491615,2016,
"5-{[(3R,4R)-1-(4-chloro-2,6-difluorophenyl)-3,4-dihydroxypiperidin-4-yl]methoxy}-8-fluoro-3,4-dihydroquinolin-2(1H)-one",n/a,2016-12-05,Treatment of active tuberculosis,Designated,,,N/A,N/A,"Otsuka Pharmaceutical Company, Ltd",2440 Research Blvd,,Rockville,Maryland,20850,USA,547216,2016,
"Propanoic acid, 2,2-dimethyl-,1,1'-[[[[4-[[4-hydroxy-3-(phenylmethyl)phenyl]methyl]-3,5-dimethylphenoxy]methyl]phosphinylidene]bis(oxymethylene)] ester",n/a,2016-12-05,Treatment of X-linked adrenoleukodystrophy.,Designated,,,N/A,N/A,"Viking Therapeutics, Inc.",12340 El Camino Real,Suite 250,San Diego,California,92130,USA,494215,2016,
miltefosine,Impavido,2016-12-06,Treatment of Acanthamoeba keratitis,Designated,,,N/A,N/A,"Profounda, Inc.",5790 Hoffner Avenue,Suite 507,Orlando,Florida,32822,USA,565016,2016,
miltefosine,Impavido,2016-12-06,Treatment of primary amebic encephalitis (PAM),Designated,,,N/A,N/A,"Profounda, Inc.",5790 Hoffner Avenue,Suite 507,Orlando,Florida,32822,USA,540216,2016,
Exendin 9-39 (Competitive antagonist of glucagon-like peptide-1),n/a,2016-12-08,Treatment of hyperinsulinemic hypoglycemia,Designated,,,N/A,N/A,"Eiger BioPharmaceuticals, Inc.",350 Cambridge Avenue,Suite 350,Palo Alto,California,94306,USA,522116,2016,
ascorbic acid,n/a,2016-12-12,Treatment of lung dysfunction following lung transplant,Designated,,,N/A,N/A,"Renovion, Inc.",2 Briar Bridge Lane,,Chapel Hill,North Carolina,27516,USA,545816,2016,
immune globulin (human),Gamunex (R)-C,2016-12-12,Treatment of Myasthenia Gravis,Designated,,,N/A,N/A,"Grifols Therapeutics, Inc.",79 TW Alexander Drive,,Research Triangle Park,North Carolina,27709,USA,544616,2016,
Nintedanib,n/a,2016-12-12,Treatment of mesothelioma,Designated,,,N/A,N/A,"Boehringer Ingelheim Pharmaceuticals, Inc.",900 Ridgebury Road,P. O. Box 368,Ridgefield,Connecticut,6877,USA,547916,2016,
polatuzumab vedotin,n/a,2016-12-12,Treatment of diffuse large B-cell lymphoma,Designated,,,N/A,N/A,"Genentech, Inc.",1 DNA Way,MS# 355E,South San Francisco,California,94080,USA,547416,2016,
3-aminopropyl-butyl phosphinic acid,n/a,2016-12-13,Treatment of succinic semialdehyde dehydrogenase deficiency.,Designated,,,N/A,N/A,"Speragen, Inc.",13492 Research Boulevard,Suite 120-475,Austin,Texas,78750,USA,545416,2016,
tetrandrine,n/a,2016-12-13,Treatment of acute myeloid leukemia.,Designated,,,N/A,N/A,"Escend Pharmaceuticals, Inc.",3475 Edison Way,Suite R,Menlo Park,California,94025,USA,545716,2016,
eflornithine,n/a,2016-12-14,Treatment of pancreatic cancer.,Designated,,,N/A,N/A,"Cancer Prevention Pharmaceutical, Inc.",1760 East River Road,Suite 250,Tucson,Arizona,85718,USA,547716,2016,
nivolumab,Opdivo,2016-12-20,Treatment of gastric cancer and gastro-esophageal junction cancer.,Designated,,,N/A,N/A,Bristol-Myers Squibb Co.,5 Research Parkway,,Wallingford,Connecticut,6492,USA,545016,2016,
Nivolumab and Ipilimumab,n/a,2016-12-20,Treatment of gastric cancer and gastric-esophageal junction cancer.,Designated,,,N/A,N/A,Bristol-Myers Squibb Co.,5 Research Parkway,,Wallingford,Connecticut,6492,USA,545116,2016,
CD123 x CD3 dual affinity re-targeting (DART®) protein,n/a,2016-12-22,Treatment of acute myeloid leukemia (AML),Designated,,,N/A,N/A,"MacroGenics, Inc.",9704 Medical Center Drive,,Rockville,Maryland,20850,USA,563516,2016,
Silmitasertib,n/a,2016-12-22,Treatment of cholangiocarcinoma,Designated,,,N/A,N/A,"Senhwa Biosciences, Inc.","No. 205-1, Peihsin Road",Section 3,New Taipei City,,,Taiwan,548516,2016,
ganaxolone,n/a,2016-12-28,Treatment of Fragile X Syndrome,Designated,,,N/A,N/A,Marinus Pharmaceuticals,170 North Radnor Chester Road,Suite 250,Radnor,Pennsylvania,19087,USA,547116,2016,
pembrolizumab,Keytruda,2016-12-28,Treatment of Merkel cell carcinoma,Designated,,,N/A,N/A,"Merck, Sharp, and Dohme Corp.",1 Merck Access Road,,,New Jersey,8889,USA,548216,2016,
"Inactivated purified rabies virus (IPRV) and the PIKA adjuvant (Poly I:C, kanamycin and calcium)",n/a,2016-12-29,Prevention of rabies virus infection including post-exposure prophylaxis (PEP) for rabies,Designated,,,N/A,N/A,"Yisheng US Biopharma, Inc.",11 Firstfield Road,Suite A,Gaithersburg,Maryland,20878,USA,549316,2016,
emixustat,n/a,2017-01-04,Treatment of Stargardt disease (STGD),Designated,,,N/A,N/A,Acucela Inc.,1301 2nd Avenue,Suite 4200,Seattle,Washington,98101,USA,548816,2017,
humanized monoclonal antibody that blocks activity of complement component C5,n/a,2017-01-04,Treatment of paroxysmal nocturnal hemoglobinuria,Designated,,,N/A,N/A,"Alexion Pharmaceuticals, Inc.",55 Cambridge Parkway,Suite 800,Cambridge,Massachusetts,2142,USA,513015,2017,
lenalidomide,n/a,2017-01-04,Treatment of splenic marginal zone lymphoma,Designated,,,N/A,N/A,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,USA,475915,2017,
lenalidomide,Revlimid,2017-01-04,Treatment of nodal marginal zone lymphoma,Designated,,,N/A,N/A,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,USA,476015,2017,
pyridopyrimidinone SMN2 splicing modifier,n/a,2017-01-04,Treatment of spinal muscular atrophy,Designated,,,N/A,N/A,"Hoffmann-La Roche, Inc.","c/o Genentech, Inc.",1 DNA Way,South San Francisco,California,94080,USA,548116,2017,
pyridoxal-5’ phosphate monohydrate (P5P),n/a,2017-01-04,Treatment of seizures associated with pyridox(am)ine 5'-phosphate oxidase (PNPO) deficiency,Designated,,,N/A,N/A,Medicure International Inc.,2-1250 Waverley Street,,Winnipeg,Manitoba,,Canada,557116,2017,
"(S)-2-(1-((6-amino-5-cyanopyrimidin-4-yl)amino)ethyl)-4-oxo-3-phenyl3,4-dihydropyrrolo[2,1-f][1,2,4]triazine-5-carbonitrile",n/a,2017-01-05,Treatment of epidermolysis bullosa acquisita,Designated/Withdrawn,,,N/A,N/A,"Almirall, S.A.","Ctra. Laurea Miro, 408-410",Sant Feliu de Llobregat,Barcelona,,,Spain,548916,2017,
Celecoxib oral liquid suspension,Nu-Celecoxib,2017-01-05,Treatment of pediatric juvenile idiopathic arthritis,Designated,,,N/A,N/A,"NuBioPharma, LLC",111 Dennis Drive,Suite 121,Sanford,North Carolina,27330,USA,549716,2017,
cytomegalovirus specific cytotoxic T lymphocytes,n/a,2017-01-05,Treatment of cytomegalovirus infection in severely immunocompromised patients,Designated,,,N/A,N/A,"ViraCyte, LLC","33 - 5th Avenue, NW",Suite 700,New Brighton,Minnesota,55112,USA,418613,2017,
echinomycin,n/a,2017-01-05,Treatment of graft-versus-host disease (GVHD),Designated,,,N/A,N/A,"OncoImmune, Inc.","502 E. Street, NE",,Washington,District of Columbia,20002,USA,549016,2017,
Ublituximab and phosphoinositide-3-kinase delta inhibitor,n/a,2017-01-05,Treatment of chronic lymphocytic leukemia,Designated,,,N/A,N/A,"TG Therapeutics, Inc.",2 Gansevoort Street,9th Floor,New York,New York,10014,USA,554216,2017,
adeno-associated virus serotype 2/6 (rAAV2/6) vectors encoding zinc finger nucleases (ZFNs) and the human alpha-L-iduronidase (hIDUA) gene,n/a,2017-01-09,Treatment of mucopolysaccharidosis type I (MPS I),Designated,,,N/A,N/A,"Sangamo Therapeutics, Inc.",Point Richmond Tech Center,501 Canal Boulevard,Richmond,California,94804,USA,546716,2017,
Clenbuterol,n/a,2017-01-09,Treatment of Pompe disease (glycogen storage disease type II),Designated,,,N/A,N/A,"Dwight D. Koeberl, MD, PhD",Duke University Medical Center,"Pediatrics Dept., Div. of Genetics",Durham,North Carolina,27710,USA,546316,2017,
glecaprevir and pibrentasvir,n/a,2017-01-09,Treatment of pediatric patients with chronic hepatitis C virus infection,Designated,,,N/A,N/A,"AbbVie, Inc.",1 Waukegan Road,,North Chicago,Illinois,60044,USA,550516,2017,
L-citrulline,n/a,2017-01-09,Prevention of clinical sequelae of acute lung injury induced by cardiopulmonary bypass in pediatric patients,Designated,,,N/A,N/A,"Asklepion Pharmaceuticals, LLC",729 East Pratt Street,Suite 360,Baltimore,Maryland,21202,USA,544216,2017,
Vancomycin HCL and Tobramycin sulfate multi-pack component of the Joint Purification Systems X7 Spacer,n/a,2017-01-09,Treatment of periprosthetic joint infection,Designated,,,N/A,N/A,Joint Purification Systems LLC,c/o Cor Medical Ventures LLC,215 S. Highway 101,Solana Beach,California,92075,USA,536416,2017,
Ritonavir powder for oral suspension,Norvir Powder For Oral Suspension,2017-01-11,Use with other antiretroviral agents for the treatment of pediatric HIV-1 infection,Designated/Approved,Approved for Orphan Indication,Used in combination with other antiretroviral agents for the treatment of pediatric patients with HIV-1 infection,2017-06-07,TBD,AbbVie Inc.,Regulatory Affairs,1 Waukegan Road,North Chicago,Illinois,60044,USA,549816,2017,147
4-methylpiperazine-1-carboxylic acid [1-(3-benzenesufonyl-1-phenethylallyl-carbamoyl)-2-phenylethyl] amide,n/a,2017-01-11,Treatment of Chagas disease.,Designated,,,N/A,N/A,Center for Discovery & Innovation in Parasitic Diseases,"University of CA, San Francisco",9500 Gilman Drive,LaJolla,California,92093,USA,550316,2017,
human single domain antibody-like protein inhibitor of the chemokine receptor type 4,n/a,2017-01-11,Treatment of idiopathic pulmonary fibrosis,Designated,,,N/A,N/A,AdAlta Limited,15/2 Park Drive,,Bundoora,,,Australia,535816,2017,
"Monovalent replication-incompetent adenovirus serotype 26 (Ad26) vaccine, AD26.ZEBOV in combination with multivalent replication-defective Modified Vaccinia Ankara (MVA)-Bavarian Nordic (BN) vaccine, MVA-mBN226B",n/a,2017-01-11,Pre-exposure prophylaxis of Ebola virus disease,Designated,,,N/A,N/A,Crucell Holland B.V.,Archimedesweg 4-6,,Leiden,,,Netherlands,490615,2017,
Non-replicating recombinant adeno-associated viral vector expressing the human acid alpha-glucosidase gene,n/a,2017-01-11,Treatment of Pompe disease,Designated,,,N/A,N/A,Actus Therapeutics,870 Martin Luther King Junior Boulevard,,Chapel Hill,North Carolina,27514,USA,547316,2017,
"protoplasmic protein matrix, omega-3 fatty oils, vitamins, minerals and trace elements, cell membrane matrix phospholipid, entracellular matrix, lipids, medium chain triglycerides, longer chain triglycerides, carbohydrates, probiotic, and phytonutrients",n/a,2017-01-11,Treatment of juvenile rheumatoid arthritis.,Designated,,,N/A,N/A,"Leonard S. Girsh, MD","Immunopath Profile, Ind.",P. O. Box 770805,Naples,Florida,34107,USA,393713,2017,
(E)-N’-(1-(5-Chloro-2-hydroxy phenyl)Ethylidene)-3-((4-Methyl Piperazin-1-yl) Sulfonyl) Benzohydrazide Mesylate,n/a,2017-01-12,Treatment of Ewing's sarcoma.,Designated,,,N/A,N/A,Salarius Pharmaceuticals,2450 Holcombe Boulevard,Suite J-608,Houston,Texas,77021,USA,571316,2017,
anti-interleukin 21 (NNC0114-0006) in combination with liraglutide,n/a,2017-01-12,Treatment of Type I Diabetes Mellitus with residual beta cell function.,Designated,,,N/A,N/A,"Novo Nordisk, Inc.",800 Scudders Mill Road,P. O. Box 846,,New Jersey,8536,USA,529716,2017,
Exon 53 specific antisense morpholino oligonucleotide.,n/a,2017-01-12,Treatment of Duchenne Muscular Dystrophy,Designated,,,N/A,N/A,"NS Pharma, Inc.",140 East Ridgewood Avenue,Suite 280S,Paramus,New Jersey,7652,USA,565616,2017,
Glyburide,Cirara,2017-01-12,Treatment of severe cerebral edema in patients with acute ischemic stroke,Designated,,,N/A,N/A,Biogen Chesapeake LLC,225 Binney Street,,Cambridge,Massachusetts,2142,USA,539316,2017,
methyldopa,n/a,2017-01-12,Treatment of type 1 diabetes in DQ8 positive patients with residual beta cell function,Designated,,,N/A,N/A,IM Therapeutics LLC,11001 West 120th Avenue,Suite 400,Broomfield,Colorado,80021,USA,548616,2017,
tadekinig alfa,n/a,2017-01-12,Treatment of hemophagocytic lymphohistiocytosis.,Designated,,,N/A,N/A,AB2 Bio Ltd,EPFL Innovation Park,Building B,Lausanne,,,Switzerland,543916,2017,
"2-Amino-4-[11C]methylsulfanyl-butanoic acid, l-[S methyl[11C]methionine",n/a,2017-01-17,Diagnostic agent for the Clinical Management of Medulloblastoma,Designated,,,N/A,N/A,"Advanced Imaging Projects, LLC",7947 Brookside Ct.,,Lake Worth,Florida,33467,USA,566416,2017,
3-[3-(6-guanidino-1-oxoisoindolin-2yl) propanamido]-3-(pyridine-3yl) propanoic acid dihydrochloride,Ocurin,2017-01-17,Treatment of retinopathy of prematurity,Designated,,,N/A,N/A,"Advanced Imaging Projects, LLC",7947 Brookside Ct.,,Lake Worth,Florida,33467,USA,566316,2017,
D9-ivacaftor,n/a,2017-01-18,Treatment of cystic fibrosis (CF),Designated,,,N/A,N/A,"Vertex Pharmaceuticals, Inc.",50 Northern Avenue,,Boston,Massachusetts,2210,USA,551016,2017,
hyaluronic acid,n/a,2017-01-18,Treatment of emphysema due to alpha1-antitrypsin deficiency.,Designated,,,N/A,N/A,"Gerard M. Turino, MD","Division of Pulmonary, Critical Care & Sleep Medicine",Mt. Sinai Roosevelt Hospital Center,New York,New York,10019,USA,550716,2017,
D-tagatose,n/a,2017-01-19,Treatment of Prader-Willi Syndrome,Designated,,,N/A,N/A,Biospherics.net LLC,Department of Pharmaceutical Sciences,University of Kentucky,Nicholasville,Kentucky,40356,USA,459614,2017,
Human monoclonal antibody directed against human Activin A,n/a,2017-01-19,Treatment of fibrodysplasia ossificans progressiva,Designated,,,N/A,N/A,"Regeneron Pharmaceuticals, Inc.",777 Old Saw Mill River Road,,Tarrytown,New York,10591,USA,547016,2017,
humanized IgG4 monoclonal antibody binding to human C1q,n/a,2017-01-19,Treatment of Guillain-Barre Syndrome,Designated,,,N/A,N/A,"Annexon, Inc.",180 Kimball Way,,South San Francisco,California,94080,USA,550416,2017,
Ublituximab in combination with phosphoinositide-3-kinase (PI3K) delta inhibitor,n/a,2017-01-19,Treatment of diffuse large B-cell lymphoma,Designated,,,N/A,N/A,"TG Therapeutics, Inc.",2 Gansevoort Street,9th Floor,New York,New York,10014,USA,552216,2017,
"(R)-2-(5-cyano-2-(6-(methoxycarbonyl)-7-methyl-3-oxo-8-(3-(trifluoromethyl)phenyl)-2,3,5,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrimidin-5-yl)phenyl)-N,N,N-trimethylethanaminium methanesulfonate dehydrate",n/a,2017-01-25,Treatment of cystic fibrosis,Designated,,,N/A,N/A,Chiesi Farmaceutici S.p.A.,26A Via Palermo,,Parma,,,Italy,551216,2017,
3-[4-(lH-imidazol-l-ylmethyl)phenyl]-5-(2-methylpropyl) thiophene-2-[(N-butyloxylcarbamate)-sulphonamide] sodium salt,n/a,2017-01-25,Treatment of idiopathic pulmonary fibrosis,Designated,,,N/A,N/A,Vicore Pharma,c/o AstraZeneca,Pepparedsleden 1,Mölndal,,,Sweden,550816,2017,
adeno-associated viral vector serotype 2.7m8 containing the chrimsonR-tdTomato gene,n/a,2017-01-25,Treatment of retinitis pigmentosa,Designated,,,N/A,N/A,GenSight Biologics,74 Rue du Faubourg Saint-Antoine,,Paris,,,France,551516,2017,
Dendritic cell/tumor cell fusion vaccine + recombinant human interleukin 12,n/a,2017-01-25,Treatment of malignant glioma,Designated,,,N/A,N/A,CyTIX Inc.,"7F Terada Bldg, 2-3-3 Shibakoen",,Minato-ku,,,Japan,552316,2017,
melatonin,n/a,2017-01-25,Treatment of necrotizing enterocolitis,Designated,,,N/A,N/A,Therapicon SrL,21 Via Malachia Marchesi de Taddei,,Milano,,,Italy,552016,2017,
nicotinamide riboside,Niasun,2017-01-25,"Treatment of mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes syndrome (MELAS)",Designated,,,N/A,N/A,Rejuvenation Therapeutics,774 Mays Boulevard,10-509 PMB,Incline Village,Nevada,89451,USA,548716,2017,
nitric oxide,n/a,2017-01-25,Treatment of pulmonary arterial hypertension excluding persistent pulmonary hypertension of the newborn,Designated,,,N/A,N/A,"GeNo, LLC",2941 Oxbow Circle,,Cocoa,Florida,32926,USA,551616,2017,
"(5R)-5-(4-{[(2-fluorophenyl)methyl]oxy}phenyl)-L-prolinamide, hydrochloride",n/a,2017-01-30,Treatment of erythromelalgia,Designated,,,N/A,N/A,"Biogen, Inc.",300 Binney Street,,Cambridge,Massachusetts,2142,USA,553016,2017,
adeno-associated virus (AAV) serotype rh.10 expressing beta-galactosidase,n/a,2017-01-30,Treatment of GM1 gangliosidosis,Designated,,,N/A,N/A,"Lysogene, Inc.",245 First Street,18th Floor,Cambridge,Massachusetts,2142,USA,560916,2017,
hydroxypioglitazone,n/a,2017-01-30,Treatment of X-linked adrenoleukodystrophy,Designated,,,N/A,N/A,Minoryx Therapeutics S.L.,TecnoCampus Mataro-Maresme. TCM3 602,"Av. Ernest Lluch, 32.",Mataró,,,Spain,552716,2017,
Para-toluenesulfonamide,n/a,2017-01-30,Treatment of adenoid cystic carcinoma,Designated,,,N/A,N/A,PTS International Inc.,2211 Newoak Park,,San Antonio,Texas,78230,USA,553516,2017,
"6-[(3S,4S-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl-7H-imadazo[1,5-a]pyrazin-8-one",n/a,2017-01-31,Treatment of sickle cell disease (SCD),Designated,,,N/A,N/A,Imara Inc.,700 Technology Square,3rd Floor,Cambridge,Massachusetts,2139,USA,564316,2017,
laquinimod sodium,n/a,2017-01-31,Treatment of Huntington's Disease,Designated,,,N/A,N/A,Teva Branded Pharmaceutical Products R&D,41 Moores Road,P. O. Box 4011,Frazer,Pennsylvania,19355,USA,466114,2017,
nitric oxide,n/a,2017-01-31,Treatment of idiopathic pulmonary fibrosis,Designated,,,N/A,N/A,"GeNo, LLC",2941 Oxbow Circle,,Cocoa,Florida,32926,USA,551716,2017,
allogeneic human islets of Langerhans,n/a,2017-02-01,Treatment of Brittle Type 1 Diabetes,Designated,,,N/A,N/A,CellTrans Inc.,2201 W. Campbell Park Drive,,Chicago,Illinois,60612,USA,549916,2017,
Anti-HER2 bispecific antibody,n/a,2017-02-06,"Treatment of gastric cancer, including cancer of the gastroesophageal junction",Designated,,,N/A,N/A,Zymeworks Inc.,18 West Mercer Street,Suite 370,Seattle,Washington,98119,USA,554716,2017,
Brentuximab vedotin,n/a,2017-02-06,Treatment of cutaneous T-cell lymphoma,Designated,,,N/A,N/A,"Seattle Genetics, Inc.",21823 30th Drive Southeast,,Bothell,Washington,98021,USA,550916,2017,
"7-benzyl-4-(2-methylbenzyl)-1,2,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(4H)-one-2HCL",n/a,2017-02-07,Treatment of mantle cell lymphoma (MCL),Designated,,,N/A,N/A,"Oncoceutics, Inc.",3624 Market Street,Suite 5E,Philadelphia,Pennsylvania,19104,USA,553316,2017,
copanlisib,n/a,2017-02-07,Treatment of splenic marginal zone lymphoma,Designated,,,N/A,N/A,"Bayer HealthCare Pharmaceuticals, Inc.",100 Bayer Boulevard,P. O. Box 915,Hanover,New Jersey,7981,USA,552616,2017,
copanlisib,n/a,2017-02-07,Treatment of nodal marginal zone lymphoma,Designated,,,N/A,N/A,"Bayer HealthCare Pharmaceuticals, Inc.",100 Bayer Boulevard,P. O. Box 915,Hanover,New Jersey,7981,USA,552516,2017,
copanlisib,n/a,2017-02-07,Treatment of extranodal marginal zone lymphoma,Designated,,,N/A,N/A,"Bayer HealthCare Pharmaceuticals, Inc.",100 Bayer Boulevard,P. O. Box 915,Hanover,New Jersey,7981,USA,552416,2017,
Modified cholera toxin,n/a,2017-02-07,Treatment of Gaucher disease,Designated,,,N/A,N/A,"ERAD Therapeutics, Inc.",11500 Dahlia Terrace,,Potomac,Maryland,20854,USA,552816,2017,
"N-[(2S)-5-{[(2S)-2-(4-fluorophenyl)cyclopropyl]amino}-1-(4-methylpiperazin-1-yl)-1-oxopentan-2-yl]-4-(1H-1,2,3-triazol-1-yl)benzamide bis-tosylate salt",n/a,2017-02-07,Treatment of acute myeloid leukemia (AML),Designated,,,N/A,N/A,"Imago BioSciences, Inc.",2729 Debbie Court,,San Carlos,California,94070,USA,553716,2017,
"(3'R,4'S,5'R)-N-[(3R,6S)-6-Carbamoyltetrahydro-2H-pyran-3-yl]-6''-chloro-4'-(2-chloro-3-fluoropyridin-4-yl)-4,4-dimethyl-2''-oxo-1'',2''-dihydrodispiro[cyclohexane-1,2'-pyrrolidine-3',3''-indole]-5'-carboxamide mono(4-methylbenzenesulfonate) monohydrate",n/a,2017-02-13,Treatment of liposarcoma,Designated,,,N/A,N/A,"Daiichi Sankyo, Inc.",399 Thornall Street,,Edison,New Jersey,8837,USA,555416,2017,
Atezolizumab,Tecentriq® +Cotellic®,2017-02-13,"Treatment of patients with stage IIb, IIc, III, and IV melanoma",Designated,,,N/A,N/A,"Genentech, Inc.",1 DNA Way,MS 35-5E,South San Francisco,California,94080,USA,574817,2017,
atezolizumab,Tecentriq(Tm),2017-02-13,"Treatment of Stage llb, llc, lll and IV melanoma",Designated,,,N/A,N/A,"Genentech, Inc.",1 DNA Way,MS 35-5E,South San Francisco,California,94080,USA,550616,2017,
sirolimus,n/a,2017-02-13,Treatment of tuberous sclerosis complex-related facial angiofibromas,Designated,,,N/A,N/A,"Aucta Pharmaceuticals, LLC",675 US Highway One,,North Brunswick,New Jersey,8902,USA,555516,2017,
"6-{[(1R,2S)-2-aminocyclohexyl]amino}-7-fluoro-4-(1-methyl-1H-pyrazol-4-yl)-1,2-dihydro-3H-pyrrolo[3,4-c]pyridine-3-one monocitrate",n/a,2017-02-14,Treatment of diffuse large B-cell lymphoma,Designated,,,N/A,N/A,"Millennium Pharmaceuticals, Inc.",40 Landsdowne Street,,Cambridge,Massachusetts,2139,USA,556916,2017,
dextromethorphan hydrobromide/quinidine sulfate,Nuedexta,2017-02-14,Treatment of amyotrophic lateral sclerosis (ALS),Designated,,,N/A,N/A,Avanir Pharmaceuticals,30 Enterprise,Suite 400,Aliso Viejo,California,92656,USA,556716,2017,
EnGeneIC delivery vehicles loaded with doxorubicin and targeted to tumor with sequences from Vectibix and mouse monoclonal antibody,n/a,2017-02-14,Treatment glioblastoma multiforme,Designated,,,N/A,N/A,EnGeneIC Ltd,25 Sirius Road,Building 2,Lane Cove West,,,Australia,553116,2017,
Glucopyranosyl lipid A stable emulsion,n/a,2017-02-14,Treatment of follicular lymphoma,Designated,,,N/A,N/A,Immune Design Corp.,1616 Eastlake Ave. E,Suite 310,Seattle,Washington,98102,USA,554616,2017,
melatonin,n/a,2017-02-14,Treatment of short bowel syndrome,Designated,,,N/A,N/A,Therapicon SrL,21 Via Malachia Marchesi de Taddei,,Milano,,,Italy,551916,2017,
nelfinavir,Viracept,2017-02-14,Treatment of multiple myeloma,Designated,,,N/A,N/A,Swiss Group for Clinical Cancer Research (SAKK),Effingerstrasse 33,,Bern,,,Switzerland,554316,2017,
"5-aza-2'-dexocytidine combined with 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydroxy-1,3-diazinan-2-one",n/a,2017-02-16,Treatment of thalassemia,Designated,,,N/A,N/A,EpiDestiny Inc.,7536 Royal Portrush Drive,,Solon,Ohio,44139,USA,555916,2017,
abatacept,n/a,2017-02-22,Treatment of idiopathic inflammatory myopathy (IIM),Designated,,,N/A,N/A,Bristol-Myers Squibb Research & Development,Marketed Products Development - Regulatory Strategy,P.O. Box 5326,Princeton,New Jersey,8543,USA,556216,2017,
Abatacept,n/a,2017-02-22,Treatment of giant cell arteritis,Designated,,,N/A,N/A,Bristol-Myers Squibb Research & Development,Marketed Products Development - Regulatory Strategy,P.O. Box 5326,Princeton,New Jersey,8543,USA,556316,2017,
sofosbuvir/velpatasvir,Epclusa,2017-02-22,Treatment of pediatric chronic hepatitis C virus (HCV) infection,Designated,,,N/A,N/A,"Gilead Sciences, Inc.",333 Lakeside Drive,,Foster City,California,94404,USA,554816,2017,
ustekinumab,Stelara,2017-02-22,Treatment of pediatric ulcerative colitis,Designated,,,N/A,N/A,"Janssen Biotech, Inc.",1400 McKean Road,,Spring House,Pennsylvania,19477,USA,537516,2017,
"6'-((6-aminopyrimidin-4-yl)amino)-8'-methyl-2'H-spiro[cyclohexane-1,3'-imidazo[1,5a]pyridine]-1',5'-dione hydrochloride",n/a,2017-02-23,Treatment of diffuse large B-cell lymphoma,Designated,,,N/A,N/A,eFFECTOR Therapeutics,11180 Roselle Street,Suite A,San Diego,California,92121,USA,554516,2017,
Recombinant human histidyl-tRNA synthetase,n/a,2017-02-23,Treatment of patients with limb girdle muscular dystrophy,Designated,,,N/A,N/A,aTyr Pharma,3545 John Hopkins Court,Suite 250,San Diego,California,92121,USA,548416,2017,
Adeno-associated virus serotype 2/6 (rAAV2/6) vectors encoding zinc finger nucleases (ZFNs) and the human iduronate 2-sulfatase (hIDS) gene,n/a,2017-02-27,Treatment of mucopolysaccharidosis type II,Designated,,,N/A,N/A,"Sangamo Therapeutics, Inc.",Point Richmond Tech Center,501 Canal Boulevard,Richmond,California,94804,USA,553416,2017,
asciminib,n/a,2017-02-27,Treatment of chronic myelogenous leukemia,Designated,,,N/A,N/A,Novartis Pharmaceutical Corporation,One Health Plaza,,East Hanover,New Jersey,7936,USA,556416,2017,
Fully human IgG1 antibody specific for CD33,n/a,2017-02-27,Treatment of myelodysplastic syndromes (MDS),Designated,,,N/A,N/A,"Boehringer Ingelheim Pharmaceuticals, Inc.",900 Ridgebury Rd.,PO Box 368,Ridgefield,Connecticut,6877,USA,555316,2017,
(s)-perillyl alcohol temozolomide carbamate,n/a,2017-02-28,Treatment of intracranially located metastases from breast cancer,Designated,,,N/A,N/A,"NeOnc Technologies, Inc.","8335 Sunset Blvd., #240",,Los Angeles,California,90069,USA,557316,2017,
3-pentylbenzeneacetic acid sodium salt,n/a,2017-02-28,Treatment of Alström syndrome,Designated,,,N/A,N/A,"ProMetic BioTherapeutics, Inc",1330 Piccard Drive,Suite 201,Rockville,Maryland,20850,USA,557016,2017,
cabozantinib,n/a,2017-03-02,Treatment of hepatocellular carcinoma.,Designated,,,N/A,N/A,"Exelixis, Inc.",210 East Grand Avenue,,South San Francisco,California,94083,USA,552916,2017,
Hydroxyurea,n/a,2017-03-02,Treatment of sickle cell anemia in pediatric patients,Designated,,,N/A,N/A,Nova Laboratories Limited,Martin House,Gloucester Crescent,Leicester,,,United Kingdom,555116,2017,
melatonin,n/a,2017-03-02,Treatment of acute acetaminophen overdose,Designated,,,N/A,N/A,Therapicon SrL,21 Via Malachia Marchesi de Taddei,,Milano,,,Italy,557416,2017,
fixed dose combination of methimazole and liothyronine,n/a,2017-03-06,Treatment of brain metastases in patients with primary lung cancer,Designated,,,N/A,N/A,Musli Thyropeutics Ltd.,6 Hagefen Street,P. O. Box 529,Zur Moshe,,,Israel,539116,2017,
activated natural killer[aNK]),n/a,2017-03-15,Treatment of Merkel cell carcinoma,Designated,,,N/A,N/A,"NantKwest, Inc.",9920 Jefferson Boulevard,,Culver City,California,90232,USA,562116,2017,
Mutated form of human acetylcholine receptor a1 extracellular domain subunit,n/a,2017-03-16,Treatment of myasthenia gravis,Designated,,,N/A,N/A,Toleranzia AB,Arvid Wallgrens backe 20,,Gothenburg,,,Sweden,561116,2017,
Pentetrazol,n/a,2017-03-16,Treatment of narcolepsy,Designated,,,N/A,N/A,"Balance Therapeutics, Inc.",1250 Bayhill Drive,Suite 125,San Bruno,California,94066,USA,558716,2017,
Recombinant human placental growth factor,n/a,2017-03-16,Treatment of severe preeclampsia,Designated,,,N/A,N/A,"Aggamin, LLC",3960 Broadway,Suite 330B,New York,New York,10032,USA,559716,2017,
"synthetic, single stranded, fully phosphorothioated 2’-OMethyl-RNA and DNA mixmer oligonucleotide-based compound targeted against natural antisense transcripts (NATs)",n/a,2017-03-16,Treatment of Dravet Syndrome,Designated,,,N/A,N/A,OPKO Ireland Global Holdings Ltd.,10 Market Street,Suite 721,Camana Bay,,,Cayman Islands,557616,2017,
Talabostat,n/a,2017-03-16,Treatment of pancreatic cancer,Designated,,,N/A,N/A,BioXcel Corporation,780 East Main Street,Suite 2,Branford,Connecticut,6405,USA,559616,2017,
1-(2-chlorophenyl)-1-(S)-hydroxy-2-(S)-carbamoyloxy-propane,n/a,2017-03-20,Treatment of infantile spasms,Designated,,,N/A,N/A,"Bio-Pharm Solutions, Co., Ltd.","6F, C Bldg., Advanced Institute of Convergence Technology","145 Gwanggyo-Ro, Yeongtong-Gu",Suwon,,,"Korea, Republic of",555216,2017,
Avacopan,n/a,2017-03-20,Treatment of C3 glomerulopathy,Designated,,,N/A,N/A,"ChemoCentryx, Inc.",850 Maude Avenue,,Mountain View,California,94043,USA,559016,2017,
Cell-penetrating dominant-negative activating transcription factor 5,n/a,2017-03-20,Treatment of glioma,Designated,,,N/A,N/A,"Sapience Therapeutics, Inc",500 Mamaroneck Avenue,Suite 320,Harrison,New York,10528,USA,560116,2017,
liposomal annamycin,n/a,2017-03-20,Treatment of acute myeloid leukemia.,Designated,,,N/A,N/A,"Moleculin Biotech, Inc.",2575 West Bellfort Avenue,Suite 333,Houston,Texas,77054,USA,550116,2017,
N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine disulphate salt,n/a,2017-03-20,Treatment of progressive supranuclear palsy,Designated,,,N/A,N/A,Alzprotect sas,70 rue du docteur Alexandre Yersin,,Loos,,,France,504115,2017,
Talabostat,n/a,2017-03-20,Treatment of stages IIb through IV melanoma,Designated,,,N/A,N/A,BioXcel Corporation,780 East Main Street,Suite 2,Branford,Connecticut,6405,USA,559416,2017,
ganitumab,n/a,2017-03-21,Treatment of Ewing sarcoma.,Designated,,,N/A,N/A,"NantCell, Inc.",9920 Jefferson Boulevard,,Culver City,California,90232,USA,578217,2017,
Vedolizumab,n/a,2017-03-21,Treatment of graft versus host disease,Designated,,,N/A,N/A,"Millennium Pharmaceuticals, Inc.",40 Landsdowne Street,,Cambridge,Massachusetts,2139,USA,558216,2017,
"generation 4 hydroxyl-terminated polyamidoamine dendrimer containing an ethylene diamine (EDA) core, amidoamine repate units, and 64 hydroxyl end groups",n/a,2017-03-22,Treatment of x-linked adrenoleukodystrophy,Designated,,,N/A,N/A,"Orpheris, Inc.",303 Twin Dolphin Drive,Suite 600,Redwood City,California,94065,USA,551316,2017,
(+)-a-dihydrotetrabenazine,n/a,2017-03-30,Treatment pediatric patients with Tourette's syndrome,Designated,,,N/A,N/A,"Adeptio Pharmaceuticals, Ltd",22 Bedford Row,WC1R 4JS,London,,,United Kingdom,498715,2017,
"3,4-diaminopyridine",n/a,2017-03-30,Treatment of congenital myasthenic syndrome (CMS),Designated,,,N/A,N/A,"Jacobus Pharmaceutical Co., Inc.",37 Cleveland Lane,,Princeton,New Jersey,8540,USA,556516,2017,
4-pyridinylmethyl 3(4-chlorophenyl)adamantine carboxamide,Yeliva,2017-03-30,Treatment of cholangiocarcinoma,Designated,,,N/A,N/A,RedHill Biopharma Ltd.,21 Ha'arba'a Street,,Tel Aviv-Yafo,,,Israel,559116,2017,
liposomal oxaliplatin,n/a,2017-03-30,Treatment of cholangiocarcinoma,Designated,,,N/A,N/A,"KC Specialty Therapeutics, LLC",2002 West 39th Avenue,,Kansas City,Arkansas,66103,USA,561716,2017,
MRG-106 oligonucleotide inhibitor of microRNA miR-155-5p,n/a,2017-03-30,Treatment of mycosis fungoides,Designated,,,N/A,N/A,"miRagen Therapeutics, Inc.",6200 Lookout Road,Suite 100,Boulder,Colorado,80301,USA,560316,2017,
Valproic acid,n/a,2017-03-30,Treatment of diffuse large B-cell lymphoma,Designated,,,N/A,N/A,Valcuria AB,Scheelevägen 2,,Lund,,,Sweden,563116,2017,
bromodomain and Extra-Terminal (BET) Inhibitor,n/a,2017-04-05,Treatment of acute myeloid leukemia,Designated,,,N/A,N/A,"FORMA Therapeutics, Inc.",500 Arsenal Street,Suite 100,Watertown,Massachusetts,2472,USA,561016,2017,
levosimendan,n/a,2017-04-10,Treatment of amyotrophic lateral sclerosis,Designated,,,N/A,N/A,Orion Corporation,Orionintie 1,0FI-02200 ESPOO,,,,Finland,495515,2017,
merestinib,n/a,2017-04-10,Treatment of biliary tract cancer,Designated,,,N/A,N/A,Eli Lilly and Company,Lilly Corporate Center,,Indianapolis,Indiana,46285,USA,563316,2017,
recombinant human club cell protein,n/a,2017-04-10,Treatment of bronchiolitis obliterans,Designated,,,N/A,N/A,"Therabron Therapeutics, Inc.",9430 Key West Avenue,,Rockville,Maryland,20850,USA,550216,2017,
Tasquinimod,n/a,2017-04-10,Treatment of multiple myeloma,Designated,,,N/A,N/A,Active Biotech AB,Scheelevägen 22,P.O. Box 724,Lund,,,Sweden,561916,2017,
tubimod,n/a,2017-04-10,Treatment of active tuberculosis,Designated,,,N/A,N/A,"Immunitor, Inc.",365-2906 West Broadway,"Vancouver, BC, V6K 2G8",,,,Canada,563716,2017,
Huperzine A,n/a,2017-04-12,Treatment of Dravet syndrome,Designated,,,N/A,N/A,"Biscayne Neurotherapeutics, Inc.",4770 Biscayne Boulevard,Suite 660,Miami,Florida,33137,USA,559916,2017,
Redaporfin,n/a,2017-04-12,Treatment of cholangiocarcinoma,Designated,,,N/A,N/A,"Luzitin, S.A.",Edificio Bluepharma,S Martinho do Bispo,Coimbra,,,Portugal,556616,2017,
2-(3-amino-6-chloroquinolin-2-yl)-propan-2-ol,n/a,2017-04-17,Treatment of congenital ichthyosis,Designated,,,N/A,N/A,Aldeyra Therapeutics,131 Hartwell Avenue,Suite 320,Lexington,Massachusetts,2421,USA,530116,2017,
Human major histocompatibility complex (MHC) non-restricted T-cell line 104,n/a,2017-04-17,Treatment of multiple myeloma,Designated,,,N/A,N/A,Galileo Research srl,Via Paradiso 6,56019 Migliarino Pisano,Pisa,,,Italy,562016,2017,
itacitinib,n/a,2017-04-17,Treatment of graft versus host disease,Designated,,,N/A,N/A,Incyte Corporation,1801 Augustine Cut-Off,,Wilmington,Delaware,19803,USA,562716,2017,
lorcaserin,Belviq,2017-04-17,Treatment of Dravet syndrome,Designated,,,N/A,N/A,"Epygenix Therapeutics, Inc.",140 East Ridgewood Avenue,Suite 415 South Tower,Paramus,New Jersey,7652,USA,565816,2017,
modified vitamin D binding protein,n/a,2017-04-17,Treatment of recurrent respiratory papillomatosis.,Designated,,,N/A,N/A,"Efranat, Ltd.",7 Oppenheimer Street,,Rehovot,,,Israel,577017,2017,
Triclabendazole,Egaten,2017-04-17,Treatment of fascioliasis,Designated,,,N/A,N/A,Novartis Pharmaceuticals Corporation,1 Health Plaza,,East Hanover,New Jersey,7936,USA,564216,2017,
trifluridine/tipiracil,n/a,2017-04-17,Treatment of gastric cancer including cancer of the gastroesophageal junction,Designated,,,N/A,N/A,"Taiho Oncology, Inc.",101 Carnegie Center,Suite 101,Princeton,New Jersey,8540,USA,564116,2017,
clemizole,n/a,2017-04-19,Treatment of Dravet syndrome,Designated,,,N/A,N/A,"Epygenix Therapeutics, Inc.",140 East Ridgewood Avenue,Suite 415 South Tower,Paramus,New Jersey,7652,USA,566116,2017,
Immune globulin intravenous (human) octagam 10%,n/a,2017-04-19,Treatment of dermatomyositis,Designated,,,N/A,N/A,"OCTAPHARMA USA, Inc.",121 River Street,12th Floor,Hoboken,New Jersey,7030,USA,564716,2017,
Peptide inhibiting murine double minute 2 (MDM2) and murine double minute X (MDMX),n/a,2017-04-19,Treatment of acute myeloid leukemia,Designated,,,N/A,N/A,"Aileron Therapeutics, Inc.",81 Albany Street,,Cambridge,Massachusetts,2139,USA,565316,2017,
Triciribine phosphate,n/a,2017-04-24,Treatment of acute myeloid leukemia,Designated,,,N/A,N/A,Prescient Therapeutics LTD,2644 North Kitty Hawk Drive,,Palm Springs,California,92262,USA,558516,2017,
small molecule Mas receptor agonist,n/a,2017-04-25,Treatment of Duchenne muscular dystrophy,Designated,,,N/A,N/A,"RASRx, LLC",231 Bonetti Drive,Suite 240,San Luis Obispo,California,93401,USA,557916,2017,
ivosidenib,n/a,2017-04-26,Treatment of cholangiocarcinoma,Designated,,,N/A,N/A,"Agios Pharmaceuticals, Inc.",88 Sidney Street,,Cambridge,Massachusetts,2139,USA,562216,2017,
mutated isocitrate dehydrogenase 1 (IDH1) inhibitor,n/a,2017-04-27,Treatment of acute myeloid leukemia,Designated,,,N/A,N/A,"FORMA Therapeutics, Inc.",500 Arsenal Street,Suite 100,Watertown,Massachusetts,2472,USA,565716,2017,
Cisplatin loaded hyaluronate film for implant,Hyalcis,2017-05-02,Treatment of mesothelioma,Designated,,,N/A,N/A,PlumeStars s.r.l.,Via Lago Scuro11,43124 Parma,,,,Italy,557716,2017,
macromolecular conjugate of heparin sodium on a polymer backbone,n/a,2017-05-02,Prevention of ischemia-reperfusion injury associated with solid organ tranplantation,Designated,,,N/A,N/A,Corline Biomedical AB,5 Lefflersgatan,,Uppsala,,,Sweden,506915,2017,
Autologous CD34+ hematopoietic stem cells transduced with an hCD11b lentiviral vector encoding for the human N-sulfoglucosamine sulfohydrolase (SGSH) gene,n/a,2017-05-03,Treatment of mucopolysaccharidosis IIIA,Designated,,,N/A,N/A,Orchard Therapeutics North America,1118 Chess Drive,Suite A,Foster City,California,94404,USA,562516,2017,
"Recombinant adeno-associated viral vector, AAV2 serotype 6 (rAAv2/6), expressing human factor 8 (hf8) cDNA",n/a,2017-05-03,Treatment of hemophilia A,Designated,,,N/A,N/A,"Sangamo Therapeutics, Inc.",Point Richmond Tech Center,501 Canal Boulevard,Richmond,California,94804,USA,562616,2017,
"humanized anti-CD19, Fc engineered, monoclonal antibody with enhanced binding to FcyRIIb",Xmab(R)5871,2017-05-09,Treatment of immunoglobulin G4-related disease,Designated,,,N/A,N/A,"Xencor, Inc.",111 West Lemon Avenue,,Monrovia,California,91016,USA,566516,2017,
larotrectinib,n/a,2017-05-09,Treatment of solid tumors with NTRK-fusion proteins,Designated,,,N/A,N/A,"Loxo Oncology, Inc.",281 Tresser Boulevard,9th Floor,Stamford,Connecticut,6901,USA,578317,2017,
Rilonacept,n/a,2017-05-09,Treatment of deficiency of interleukin-1 receptor antagonist (DIRA),Designated,,,N/A,N/A,"Regeneron Pharmaceuticals, Inc.",777 Old Saw Mill River Road,,Tarrytown,New York,10591,USA,561616,2017,
"2-amino-1-[2-(4-fluoro-phenyl)-3-(4-fluoro-phenyl)amino)-8,8-dimethyl-5,6-dihydro-imidazo[1,2-a]pyrazin-7(8H)-yl)-ethanone diphosphate",n/a,2017-05-11,Treatment of malaria.,Designated,,,N/A,N/A,Novartis Pharmaceuticals Corporation,1 Health Plaza,,East Hanover,New Jersey,7936,USA,568216,2017,
fast skeletal muscle troponin activator,n/a,2017-05-11,Treatment of spinal muscular atrophy,Designated,,,N/A,N/A,"Cytokinetics, Inc.",280 East Grand Avenue,,South San Francisco,California,94080,USA,516215,2017,
povidone-iodine 0.5% (w/w) in dimethylsulfoxide 44% (w/w),n/a,2017-05-11,Treatment of microbial keratitis (which includes Acanthamoeba keratitis).,Designated,,,N/A,N/A,Veloce BioPharma LLC,7008 Lafayette Avenue,,Fort Washington,Pennsylvania,19034,USA,566216,2017,
Ritanserin,n/a,2017-05-11,Treatment of glioblastoma,Designated,,,N/A,N/A,The University of Virginia/Benjamin Purow,1215 Lee Street,,Charlottesville,Virginia,22908,USA,575017,2017,
exenatide,n/a,2017-05-16,Treatment of idiopathic intracranial hypertension,Designated,,,N/A,N/A,Alan Boyd Consultants Limited,Electra House,Crewe Business Park,Crewe,,,United Kingdom,530516,2017,
bictegravir/emtricitabine/tenofovir disoproxil fumarate,n/a,2017-05-17,Treatment of Human Immunodeficiency Virus type 1 infection in pediatric patients,Designated,,,N/A,N/A,"Gilead Sciences, Inc.",333 Lakeside Drive,,Foster City,California,94404,USA,559316,2017,
sirolimus,n/a,2017-05-17,Treatment of angiofibroma associated with tuberous sclerosis,Designated,,,N/A,N/A,"NobelPharma Co., LTD",12-10 Nihonbashi-kobunacho,,Chuo-ku,,,Japan,568416,2017,
Recombinant adeno-associated virus serotype 9 vector expressing codon-optimized miniaturized version of DMD gene,n/a,2017-05-22,Treatment of Duchenne Muscular Dystrophy (DMD),Designated,,,N/A,N/A,"Bamboo Therapeutics, w wholly owned subsidiary of Pfizer",Worldwide Safety & Regulatory,Pfizer Inc.,Groton,Connecticut,6340,USA,583117,2017,
ex-vivo-expanded autologous keratinocytes transduced with retroviral vector containing the human COL7A1 gene.,n/a,2017-05-24,Treatment of dystrophic Epidermolysis Bullosa,Designated,,,N/A,N/A,Abeona Therapeutics,6555 Carnegie Blvd,Suite 401,Cleveland,Ohio,44103,USA,568716,2017,
irinotecan liposome injection,Onivyde,2017-05-24,Treatment of small cell lung cancer,Designated,,,N/A,N/A,"Ipsen Bioscience, Inc.",650 East Kendall Street,,Cambridge,Massachusetts,2142,USA,567516,2017,
resiquimod,n/a,2017-05-24,Treatment of cutaneous T-cell lymphoma,Designated,,,N/A,N/A,"Galderma Research and Development, LLC",14501 North Freeway,,Fort Worth,Texas,76177,USA,569016,2017,
autologous Epstein-Barr specific T-cells,n/a,2017-05-31,Treatment of post-transplant lymphoproliferative disorder,Designated,,,N/A,N/A,"Cell Medica, Inc.","7505 Fannin Street, Suite 200",,Houston,Texas,77054,USA,567416,2017,
etelcalcetide,Parsabivtm,2017-05-31,Treatment of pediatric hyperparathyroidism,Designated,,,N/A,N/A,"Amgen, Inc.",1 Amgen Center Drive,,Thousand Oaks,California,91320,USA,567616,2017,
"L-3,4-Dihydroxy-6-[18F]fluorophenylalanine",n/a,2017-05-31,Diagnostic agent for the management of patients with aromatic L-amino acid decarboxylase deficiency (AADC).,Designated,,,N/A,N/A,"Advanced Imaging Projects, LLC",7947 Brookside Ct.,,Lake Worth,Florida,33467,USA,567816,2017,
Recombinant human fibroblast growth factor receptor 3,n/a,2017-06-02,Treatment of achondroplasia.,Designated,,,N/A,N/A,TherAchon AG,36 Aeschenvorstadt,,Basel,,,Switzerland,567916,2017,
"6-Amino-9-[(3R)-1-(but-2-ynoyl)pyrrolidin-3-yl]-7-(4-phenoxyphenyl)-7,9-dihydro-8H-purin-8-one monohydrochloride",n/a,2017-06-05,Treatment of chronic lymphocytic leukemia.,Designated,,,N/A,N/A,"Gilead Sciences, Inc.",199 East Blaine Street,,Seattle,Washington,98102,USA,571116,2017,
bis-choline tetrathiomolybdate,n/a,2017-06-05,Treatment of Amyotrophic Lateral Sclerosis (ALS),Designated,,,N/A,N/A,Wilson Therapeutics AB,Strandvagen 5b,"114 51 Stockholm, Sweden",,,,USA,569516,2017,
recombinant human palmitoyl-protein thioeserase-1 (rhPPT1),n/a,2017-06-05,Treatment of PPT1-deficient neuronal ceroid lipofuscinoses,Designated,,,N/A,N/A,"Collaborations Pharmaceuticals, Inc.",840 Main Campus Drive,Lab 3510,Raleigh,North Carolina,27606,USA,570116,2017,
Sodium Stibogluconate,n/a,2017-06-05,Treatment of acute myeloid leukemia,Designated,,,N/A,N/A,BioXcel Corporation,780 East Main Street,Suite 2,Branford,Connecticut,6405,USA,572516,2017,
tucatinib,n/a,2017-06-05,Treatment of breast cancer patients with brain metastases.,Designated,,,N/A,N/A,"Cascadian Therapeutics, Inc.",2601 4th Avenue,Suite 500,Seattle,Washington,98121,USA,570716,2017,
4”-(p-fluorobenzyl)tylosin A,n/a,2017-06-06,Treatment of lymphatic filariasis,Designated,,,N/A,N/A,AbbVie Inc.,Regulatory Affairs,1 Waukegan Road,North Chicago,Illinois,60044,USA,572916,2017,
Cannabidivarin,n/a,2017-06-06,Treatment of Fragile X syndrome,Designated,,,N/A,N/A,GW Research Ltd.,"Sovereign House, Histon",,Cambridge,,,United Kingdom,572416,2017,
DNA Plasmid Vector encoding IL-12 (pUMVC3-hIL-12-NGVL331),n/a,2017-06-06,"Treatment of Stage IIB, IIc, III, and IV melanoma (which includes use in combination with pembrolizumab)",Designated,,,N/A,N/A,OncoSec Medical Incorporated,5820 Nancy Ridge Drive,,San Diego,California,92121,USA,568316,2017,
emtricitabine and tenofovir alafenamide combination,Descovy(R),2017-06-06,Treatment of HIV-1 infection in pediatric patients under 12 years of age,Designated,,,N/A,N/A,"Gilead Sciences, Inc.",333 Lakeside Drive,,Foster City,California,94404,USA,569716,2017,
human IgG4-based anti-CD20 x anti-CD3 bispecific monoclonal antibody,n/a,2017-06-06,Treatment of diffuse large b-cell lymphoma.,Designated,,,N/A,N/A,"Regeneron Pharmaceuticals, Inc.",777 Old Saw Mill River Road,,Tarrytown,New York,10591,USA,569816,2017,
Humanized IgG4 monoclonal antibody that antagonizes endothelin-1 receptor subtype A,n/a,2017-06-06,Treatment of pulmonary arterial hypertension (PAH),Designated,,,N/A,N/A,"GenThera, Inc.",3254 Bordero Lane,,Thousand Oaks,California,91362,USA,575717,2017,
Macitentan,n/a,2017-06-06,Treatment of Fontan-Palliated patients,Designated,,,N/A,N/A,"Actelion Clinical Research, Inc.",1820 Chapel Avenue West,Suite 300,Cherry Hill,New Jersey,8002,USA,574917,2017,
pembrolizumab,Keytruda(Tm),2017-06-06,Treatment of follicular lymphoma.,Designated,,,N/A,N/A,"Merck, Sharp & Dohme Corp",1 Merck Access Road,,Whitehouse Station,New Jersey,8889,USA,570816,2017,
small molecule inhibitor of the Wnt pathway,n/a,2017-06-06,Treatment of idiopathic pulmonary fibrosis (IPF).,Designated,,,N/A,N/A,"Samumed, LLC",9381 Judicial Drive,Suite 160,San Diego,California,92121,USA,568516,2017,
"2-((2-ethyl-6-(4-(2-(3-hydroxyazetidin-1-yl)-2-oxoethyl)-piperazin-1-yl)-8-methylimidazo[1,2-a]pyridin-3-yl)-(methyl)amino)-4-(4-fluorophenyl)-thiazole-5-carbonitrile",n/a,2017-06-08,Treatment of idiopathic pulmonary fibrosis.,Designated,,,N/A,N/A,Galapagos NV,Generaal de Wittelaan,L11 A#,Mechelen,,,Belgium,570616,2017,
20% Lipid emulsion solution,Lipidrescue,2017-06-08,Treatment of local anesthetic systemic toxicity,Designated,,,N/A,N/A,ResQ Pharma,621 Rose Street,,Lincoln,Nebraska,68502,USA,522816,2017,
4”-(p-fluorobenzyl)tylosin A,n/a,2017-06-08,Treatment of onchocerciasis,Designated,,,N/A,N/A,AbbVie Inc.,Regulatory Affairs,1 Waukegan Road,North Chicago,Illinois,60044,USA,573016,2017,
humanized monoclonal antibody against human PD-1,n/a,2017-06-08,Treatment of neuroendocrine tumors,Designated,,,N/A,N/A,Novartis Pharmaceuticals Corp.,"One Health Plaza, 315/5450A",,East Hanover,New Jersey,7936,USA,576417,2017,
Humanized monoclonal immunoglobulin G1 antibody directed against human CD19 conjugated to SG3199 through a protease cleavable valine-alanine linker,n/a,2017-06-08,Treatment of diffuse large B-cell lymphoma,Designated,,,N/A,N/A,ADC Therapeutics SA,"Route de la Corniche, 3B",,Epalinges,,,Switzerland,572716,2017,
Humanized monoclonal immunoglobulin G1 antibody directed against human CD19 conjugated to SG3199 through a protease cleavable valine-alanine linker,n/a,2017-06-08,Treatment of mantle cell lymphoma,Designated,,,N/A,N/A,ADC Therapeutics SA,"Route de la Corniche, 3B",,Epalinges,,,Switzerland,572816,2017,
Oleoylethanolamide,n/a,2017-06-08,Treatment of Prader-Willi syndrome,Designated,,,N/A,N/A,"NutriForward, LLC",1312 Brown Trail,Suite E,Bedford,Texas,76022,USA,577117,2017,
sodium trans-[tetrachlorobis(1H-indazole)ruthenate(III)],n/a,2017-06-08,Treatment of pancreatic cancer,Designated,,,N/A,N/A,"Intezyne Technologies, Inc.",3720 Spectrum Boulevard,Suite 104,Tampa,Florida,33612,USA,573817,2017,
"5,5-dimethyl-3-[2-(7-methylspiro[2H-benzofuran-3,1'-cyclopropane]-4-yl)oxypyrimidin-5-yl]imidazolidine-2,4-dione",n/a,2017-06-12,Treatment of fragile X syndrome,Designated,,,N/A,N/A,Autifony Therapeutics Limited,Gunnels Wood Road,Stevenage,,,,United Kingdom,579217,2017,
adenovirus-associated viral vector serotype 5 containing the human RLBP1 gene,n/a,2017-06-12,Treatment of retinitis punctata albescens due to RLBP1 gene mutation,Designated,,,N/A,N/A,"HORAMA, SAS",9 Rue de l'Éperon,,Paris,,,France,579017,2017,
Bacillus subtilis oxalate decarboxylase,n/a,2017-06-12,Treatment of primary hyperoxaluria,Designated,,,N/A,N/A,"Allena Pharmaceuticals, Inc.",1 Executive Park Drive,Suite 202,Newton,Massachusetts,2462,USA,578917,2017,
Human alpha-1-antitrypsin,n/a,2017-06-12,Treatment of acute graft versus host disease,Designated,,,N/A,N/A,"Paul Maher, MD",10644 Weymouth Street,Suite 104,Bethesda,Maryland,20814,USA,576717,2017,
ibrutinib,n/a,2017-06-12,Treatment of pancreatic cancer,Designated,,,N/A,N/A,"Pharmacyclics, LLC",995 East Arques Avenue,,Sunnyvale,California,94085,USA,574317,2017,
pembrolizumab,Keytruda,2017-06-12,Treatment of hepatocellular carcinoma (HCC),Designated,,,N/A,N/A,"Merck, Sharp & Dohme Corp",1 Merck Drive,,Whitehouse Station,New Jersey,8889,USA,576917,2017,
Active calcium sensing receptor antagonist derived from tetrahydropyrazolopyrimidine,n/a,2017-06-13,Treatment of pulmonary arterial hypertension,Designated,,,N/A,N/A,"Takeda Development Centre Europe, Ltd.",61 Aldwych,,London,,,United Kingdom,568816,2017,
nandrolone decanoate,n/a,2017-06-13,Treatment of Duchenne's Muscular Dystrophy.,Designated,,,N/A,N/A,Sarcomed AB,25 Störtloppsvägen,,Hägersten-Liljeholmen,,,Sweden,569116,2017,
palm tocotrienol complex,n/a,2017-06-13,Treatment of cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL),Designated,,,N/A,N/A,Hovid Berhad,121 Jalan Tunku Abdul Rahman,,Ipoh,,,Malaysia,576117,2017,
humanized IgG1 monoclonal antibody targeting KIR3DL2,n/a,2017-06-14,Treatment of cutaneous T-cell lymphoma.,Designated,,,N/A,N/A,Innate Pharma,117 Avenue de Luminy,BP 30191,Marseille,,,France,574717,2017,
"N-((4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl)methyl)-2-fluoroaniline",n/a,2017-06-14,Treatment of hepatocellular carcinoma,Designated,,,N/A,N/A,"MedPacto, Inc.",145 Gwanggyo-ro,Advanced Institutes of Convergence Technology,Suwon,,,"Korea, Republic of",575617,2017,
Tezacaftor and Ivacaftor combination therapy,n/a,2017-06-15,Treatment of cystic fibrosis (CF),Designated/Approved,Approved for Orphan Indication,"SYMDEKO a combination of tezacaftor and ivacaftor, is indicated for the treatment of patients with cystic fibrosis (CF) aged 12 years and older who are homozygous for the F508del mutation or who have at least one mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that is responsive to tezacaftor/ivacaftor based on in vitro data and/or clinical evidence",2018-02-12,2025-02-12,Vertex Pharmaceuticals Inc.,50 Northern Avenue,,Boston,Massachusetts,2210,USA,577517,2017,242
"(3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide hydrate",n/a,2017-06-15,Treatment of Pediatric Crohn's disease,Designated,,,N/A,N/A,AbbVie,1 North Waukegan Road,,North Chicago,Illinois,60044,USA,575517,2017,
alirocumab,n/a,2017-06-15,Treatment of homozygous familial hypercholesterolemia,Designated,,,N/A,N/A,"Sanofi-Aventis US, LLC",55 Corporate Drive,,Bridgewater,New Jersey,8807,USA,580617,2017,
apatinib mesylate,n/a,2017-06-15,Treatment of gastric cancer,Designated,,,N/A,N/A,"LSK BioPartners, Inc.",8 East Broadway,Suite 611,Salt Lake City,Utah,84111,USA,579117,2017,
burosumab,n/a,2017-06-15,Treatment of tumor-induced osteomalacia (TIO) syndrome,Designated,,,N/A,N/A,Ultragenyx Pharmaceutical Inc.,60 Leveroni Court,Suite 200,Novato,California,94949,USA,576217,2017,
cobicistat,Tybost®,2017-06-15,Treatment of human immunodeficiency virus type 1 (HIV-1) infection in pediatric patients,Designated,,,N/A,N/A,"Gilead Sciences, Inc.",333 Lakeside Drive,,Foster City,California,94404,USA,577917,2017,
Cotsiranib,n/a,2017-06-15,Treatment of primary sclerosing cholangitis,Designated,,,N/A,N/A,"Sirnaomics, Inc.",401 Professional Drive,Suite 280,Gaithersburg,Maryland,20879,USA,580717,2017,
deferiprone,n/a,2017-06-15,Treatment of neurodegeneration with brain iron accumulation (NBIA),Designated,,,N/A,N/A,"ApoPharma, Inc.",200 Barmac Drive,M9L 2Z7,,,,Canada,581217,2017,
entospletinib,n/a,2017-06-15,Treatment of acute myeloid leukemia,Designated,,,N/A,N/A,Gilead Sciences (formerly Corus Pharma),199 East Blaine St,,Seattle,Washington,98102,USA,569616,2017,
Human monoclonal antibody against phosphorylcholine,n/a,2017-06-15,Prevention of arteriovenous fistula or arteriovenous graft failure in patients with end stage renal disease receiving hemodialysis or preparing for hemodialysis,Designated,,,N/A,N/A,"Athera Biotechnologies, AB",117 Sankt Eriksgatan,4th Floor,Norrmalm,,,Sweden,579717,2017,
humanized immunoglobulin G4-variant monoclonal antibody directed against the p19 subunit of interleukin (IL)-23,n/a,2017-06-15,Treatment of ulcerative colitis in pediatric patients,Designated,,,N/A,N/A,Eli Lilly & Company,Lilly Corporate Center,,Indianapolis,Indiana,46285,USA,577817,2017,
ibutamoren mesylate,n/a,2017-06-15,Treatment of growth hormone deficiency,Designated,,,N/A,N/A,"Ammonett Pharma, LLC",3606 Salles Ridge Court,,Midlothian,Virginia,23113,USA,579617,2017,
macitentan,n/a,2017-06-15,Treatment of chronic thromboembolic pulmonary hypertension (CTEPH),Designated,,,N/A,N/A,"Actelion Clinical Research, Inc.",1820 Chapel Avenue West,Suite 300,Cherry Hill,New Jersey,8002,USA,580117,2017,
monomethoxypolyethylene glycol recombinant adenosine deaminase,n/a,2017-06-15,Treatment of systemic sclerosis,Designated,,,N/A,N/A,"Leadiant Biosciences, Inc.",9841 Washingtonian Boulevard,Suite 500,Gaithersburg,Maryland,20878,USA,570316,2017,
"N-(bromoacetyl)-3,3-dinitroazetidine",n/a,2017-06-15,Treatment of small cell lung cancer,Designated,,,N/A,N/A,"EpicentRx, Inc.",4445 Eastgate Mall,Suite 200,San Diego,California,92121,USA,577317,2017,
"N-(bromoacetyl)-3,3-dinitroazetidine",n/a,2017-06-15,Treatment of neuroendocrine tumors,Designated,,,N/A,N/A,"EpicentRx, Inc.",4445 Eastgate Mall,Suite 200,San Diego,California,92121,USA,579817,2017,
oxytocin,n/a,2017-06-15,Treatment of Prader-Willi syndrome,Designated,,,N/A,N/A,"Eric Hollander, MD",Montefiore Medical Center,Univ. Hosp for Albert Einstein College of Medicine,Bronx,New York,10467,USA,582717,2017,
pembrolizumab,Keytruda,2017-06-15,Treatment of esophageal carcinoma,Designated,,,N/A,N/A,"Merck, Sharp & Dohme, subsidiary of Merck & Co., Inc.",1 Merck Drive,,Whitehouse Station,New Jersey,8889,USA,578717,2017,
tazemetostat,n/a,2017-06-15,Treatment of soft tissue sarcoma,Designated,,,N/A,N/A,"Epizyme, Inc.",400 Technology Square,4th Floor,Cambridge,Massachusetts,2139,USA,578417,2017,
Anlotinib,n/a,2017-06-19,Treatment of soft tissue sarcoma,Designated,,,N/A,N/A,"Advenchen Laboratories, LLC",887 Patriot Drive,Suite A,Moorpark,California,93021,USA,576017,2017,
Fenfluramine,n/a,2017-06-19,Treatment of Lennox-Gastaut syndrome,Designated,,,N/A,N/A,Zogenix Inc.,5858 Horton Street,Suite 455,Emeryville,California,94608,USA,584217,2017,
miltefosine,Impavido,2017-06-19,Treatment of disseminated amebiasis,Designated,,,N/A,N/A,"Profounda, Inc.",5790 Hoffner Avenue,Suite 507,Orlando,Florida,32822,USA,565216,2017,
miltefosine,Impavido,2017-06-19,Treatment of granulomatous amebic encephalitis (GAE),Designated,,,N/A,N/A,"Profounda, Inc.",5790 Hoffner Avenue,Suite 507,Orlando,Florida,32822,USA,565116,2017,
NELATIMOTIDE AND ADEGRAMOTIDE combination,n/a,2017-06-19,Treatment of myelodysplastic syndrome.,Designated,,,N/A,N/A,"Boston Biomedical, Inc.",640 Memorial Drive,,Cambridge,Massachusetts,2139,USA,571516,2017,
omaveloxolone,n/a,2017-06-19,Treatment of Friedreich's Ataxia,Designated,,,N/A,N/A,"Reata Pharmaceuticals, Inc.",2801 Gateway Drive,Suite 150,Irving,Texas,75063,USA,461214,2017,
Pamrevlumab,n/a,2017-06-19,Treatment of pancreatic cancer,Designated,,,N/A,N/A,"FibroGen, Inc.",409 Illinois Street,,San Francisco,California,94158,USA,581617,2017,
Tideglusib,n/a,2017-06-19,Treatment of myotonic dystrophy type 1 (DM1),Designated,,,N/A,N/A,AMO Pharma Ltd.,Throwsters,The Street,Wonersh,,,United Kingdom,577417,2017,
Trypsinogen/Chymotrypsinogen,n/a,2017-06-19,Treatment of pancreatic cancer,Designated,,,N/A,N/A,Propanc Pty Ltd.,302/6 Butler Street,,Camberwell,,,Australia,575917,2017,
"(2S,3S,4E,6S,7R,10R)-7,10-Dihydroxy-3,7-dimethyl-12-oxo-2-[(2E,4E,6R)-6-(pyridin-2-yl)hepta-2,4-dien-2-yl]oxacyclododec-4-en-6-yl 4-methylpiperazine-1-carboxylate",n/a,2017-06-21,Treatment of acute myeloid leukemia (AML),Designated,,,N/A,N/A,"H3 Biomedicine Inc. (US Research Subsidiary of Eisai Co., Ltd.)",300 Technology Square,Floor 5,Cambridge,Massachusetts,2139,USA,581817,2017,
"(S)-3-((S)-2-(2-((2,6-difluorophenyl)amino)-2-oxoacetamido)propanamido-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid",n/a,2017-06-21,Treatment of primary sclerosing cholangitis (PSC),Designated,,,N/A,N/A,Conatus Pharmaceuticals,16745 West Bernardo Drive,Suite 200,San Diego,California,92127,USA,583717,2017,
anti-angiogenic peptide,n/a,2017-06-21,Treatment of ovarian cancer,Designated,,,N/A,N/A,Almac Group,20 Seagoe Industrial Estate,,Craigavon,,,United Kingdom,523616,2017,
citric acid monohydrate,n/a,2017-06-21,Treatment of acute-on-chronic liver failure,Designated,,,N/A,N/A,Versantis AG,7 Otto-Stern-Weg,HPL D16.2,Zürich,,,Switzerland,583217,2017,
"two identical 11-mer oligodeoxynucleotide phosphorothioate sequences linked together at their 3'-ends by glycerol-1,3-diphosphorothioate linkages",n/a,2017-06-21,Treatment of melanoma stages IIb-IV.,Designated,,,N/A,N/A,"Idera Pharmaceuticals, Inc.",167 Sidney Street,,Cambridge,Massachusetts,2139,USA,571016,2017,
"(2S,3S,4E,6S,7R,10R)-7,10-Dihydroxy-3,7-dimethyl-12-oxo-2-[(2E,4E,6R)-6-(pyridin-2-yl)hepta-2,4-dien-2-yl]oxacyclododec-4-en-6-yl 4-methylpiperazine-1-carboxylate",n/a,2017-06-22,Treatment of chronic myelomonocytic leukemia (CMML),Designated,,,N/A,N/A,"H3 Biomedicine Inc. (US Research Subsidiary of Eisai Co., Ltd.)",300 Technology Square,Floor 5,Cambridge,Massachusetts,2139,USA,581717,2017,
"(7S,13R)-11-fluoro-7,13-dimethyl-6,7,13,14-tetrahydro-1,15-ethenopyrazolo[4,3-f][1,4,8,10]benzoxatriazacyclotridecin-4(5H)-one",n/a,2017-06-22,Treatment of non-small cell lung adenocarcinomas with adenocarcinoma histology,Designated,,,N/A,N/A,"TP Therapeutics, Inc.",10628 Science Center Drive,Suite 225,San Diego,California,92121,USA,573517,2017,
bendamustine,n/a,2017-06-22,Treatment of multiple myeloma,Designated,,,N/A,N/A,"Paul Maher, MD",10644 Weymouth Street,Suite 104,Bethesda,Maryland,20814,USA,584417,2017,
chrysoeriol,n/a,2017-06-22,Treatment of acute myeloid leukemia,Designated,,,N/A,N/A,Flavocure Biotech,701 East Pratt Street,Suite 2033,Baltimore,Maryland,21202,USA,582017,2017,
Humanized anti-BCMA (B-cell maturation antigen) monoclonal antibody,n/a,2017-06-22,Treatment of multiple myeloma,Designated,,,N/A,N/A,GlaxoSmithKline,980 Great West Road,,Brentford-Middlesex,,,United Kingdom,590517,2017,
tipifarnib,n/a,2017-06-22,Treatment of multiple myeloma,Designated,,,N/A,N/A,"Paul Maher, MD",10644 Weymouth Street,Suite 104,Bethesda,Maryland,20814,USA,585317,2017,
[(S)-1-(L-valyl)-N_((S)-1-phenyl-2-(pyridin-2-yl)ethyl)pyrrolidine-2-carboxamide fumarate],n/a,2017-06-22,Treatment of Rett Syndrome,Designated,,,N/A,N/A,"Biohaven Pharmaceutical Holding Company, Ltd.",234 Church Street,Suite 304,New Haven,Connecticut,6511,USA,582217,2017,
"N-[(2S)-5-{[(1R,2S)-2-(4-fluorophenyl)cyclopropyl]amino}-1-(4-methylpiperazin-1-yl)-1-oxopentan-2-yl]-4-(1H-1,2,3-triazol-1-yl)benzamide, bis-tosylate salt",n/a,2017-06-26,Treatment of myelofibrosis,Designated,,,N/A,N/A,"Imago BioSciences, Inc.",2729 Debbie Court,,San Carlos,California,94070,USA,565516,2017,
(R)-praziquantel,n/a,2017-06-27,Treatment of schistosomiasis,Designated,,,N/A,N/A,"Tongli Biomedical Co., Ltd. (TLB)",Guotaibei Road,"Room 401, Building D",Zhangjiagang,,,China,584317,2017,
hydrocortisone acetate,n/a,2017-06-27,Treatment of pediatric ulcerative colitis,Designated,,,N/A,N/A,"Cristcot HCA, LLC",555 Virginia Road,Suite 202,Concord,Massachusetts,1742,USA,568616,2017,
"scAAV9.MeCP2.hCLN3, a self-complementary AAV serotype 9 expressing human CLN3 (hCLN3)",n/a,2017-06-27,Treatment of neuronal ceroid lipofuscinosis Type 3 (CLN3),Designated,,,N/A,N/A,Abeona Therapeutics,6555 Carnegie Blvd,Suite 401,Cleveland,Ohio,44103,USA,570016,2017,
"(2S)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(4-fluorobenzoyl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide",n/a,2017-06-28,Treatment of multiple myeloma,Designated,,,N/A,N/A,"Paul Maher, MD",10644 Weymouth Street,Suite 104,Bethesda,Maryland,20814,USA,582917,2017,
antisense oligonucleotide targeting the c.7595-2144A>G mutation in intron 40 of the USH2A gene,n/a,2017-06-28,Treatment of retinitis pigmentosa,Designated,,,N/A,N/A,ProQR Therapeutics IV B.V.,"Zernikedreef 9, 2333 CK Leiden",,Leiden,,,Netherlands,582317,2017,
chemically modified recombinant sulfamidase,n/a,2017-06-28,Treatment of mucopolysaccharidosis type IIIA (MPS IIIA),Designated,,,N/A,N/A,Swedish Orphan Biovitrum AB (publ),DÄNSKEBO,,Linköping SV,,,Sweden,583617,2017,
ganaxolone,n/a,2017-06-28,Treatment of cyclin-dependent kinase-like 5 (CDKL5) gene-related early-onset infantile epileptic encephalopathy,Designated,,,N/A,N/A,Marinus Pharmaceuticals,170 North Radnor Chester Road,Suite 250,Radnor,Pennsylvania,19087,USA,578017,2017,
Glasdegib,n/a,2017-06-28,Treatment of acute myeloid leukemia (AML),Designated,,,N/A,N/A,"Pfizer, Inc.",445 Eastern Point Road,,Groton,Connecticut,6340,USA,585517,2017,
"O,O'-Bis({4-[3,5-diiodo-4-(1-methylene-1,2,3-triazol-4-ylmethoxy)phenoxy]-3,5-diiodophenyl}acetic acid)polyethylene glycol",n/a,2017-06-28,Treatment of glioblastoma multiforme,Designated,,,N/A,N/A,"NanoPharmaceuticals, LLC",1 Discovery Place,,Rensselaer,New York,12144,USA,582117,2017,
oral tyrosine kinase inhibitor,n/a,2017-06-28,Treatment of chronic myeloid leukemia,Designated,,,N/A,N/A,"Fusion Pharma, LLC",Territory of the Skolkovo innovation center,Nobelya St. 7,,,,Russian Federation,585217,2017,
retinol palmitate (vitamin A palmitate),n/a,2017-06-28,Prevention of retinopathy of prematurity (ROP),Designated,,,N/A,N/A,orphanix GmbH,41 Peter-Rosegger-Straße,,Ried im Innkreis,,,Austria,583417,2017,
Small Molecule Bruton's Agammaglobulinemia Tyrosine Kinase (BKT) Inhibitor,n/a,2017-06-29,Treatment of Pemphigus Vulgaris,Designated,,,N/A,N/A,Principia Biopharma Inc.,400 East Jamie Court,,South San Francisco,California,94080,USA,582517,2017,
"3-(5-amino-2-methyl-4-oxoquinazolin-3(4H)-yl)piperidine-2,6-dione hydrochloride",n/a,2017-07-03,Treatment of hepatocellular carcinoma (HCC),Designated,,,N/A,N/A,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,USA,585117,2017,
Angiotensin II type 2 receptor agonist,n/a,2017-07-03,Treatment of pediatric cardiomyopathy,Designated,,,N/A,N/A,"Novopyxis, Inc.",1 Broadway,14th Floor,Cambridge,Massachusetts,2142,USA,575417,2017,
antagonist of chemokine Ligand-2,n/a,2017-07-03,Treatment of pancreatic cancer,Designated,,,N/A,N/A,"Pfizer, Inc.",300 Technology Square,,Cambridge,Massachusetts,2139,USA,570416,2017,
autologous T cells transduced with retroviral vector encoding a hepatitis B virus antigen-specific T cell receptor,Liocyx-D,2017-07-03,Treatment of hepatocellular carcinoma,Designated,,,N/A,N/A,Lion TCR Pte. Ltd.,11-07/08 Maxwell House,20 Maxwell Road,,,,Singapore,579517,2017,
Autologous T cells transfected with mRNA encoding hepatitis B virus antigen-specific T cell receptor,Liocyx-M,2017-07-03,Treatment of hepatocellular carcinoma,Designated,,,N/A,N/A,Lion TCR Pte. Ltd.,11-07/08 Maxwell House,20 Maxwell Road,,,,Singapore,579417,2017,
bardoxolone methyl,n/a,2017-07-03,Treatment of Alport Syndrome,Designated,,,N/A,N/A,"Reata Pharmaceuticals, Inc.",2801 Gateway Drive,Suite 150,Irving,Texas,75063,USA,568016,2017,
sirukumab,Plivensia™,2017-07-03,Treatment of juvenile idiopathic arthritis (JIA) in pediatric patients,Designated,,,N/A,N/A,"Janssen Research & Development, LLC",1400 McKean Road,P.O. Box 776,Spring House,Pennsylvania,19477,USA,575217,2017,
tadekinig alfa,n/a,2017-07-03,"Treatment of Still's disease, including adult-onset Still's disease (AoSD) and systemic juvenile idiopathic arthritis (sJIA)",Designated,,,N/A,N/A,AB2 Bio Ltd,EPFL Innovation Park,Building B,Lausanne,,,Switzerland,585017,2017,
benznidazole,n/a,2017-07-05,Treatment of Chagas disease,Designated,,,N/A,N/A,"Humanigen, Inc.",1000 Marina Boulevard,Suite 250,Brisbane,California,94005,USA,586517,2017,
entrectinib,n/a,2017-07-05,Treatment of NTRK fusion-positive solid tumors,Designated,,,N/A,N/A,"Ignyta, Inc.",4545 Towne Centre Court,,San Diego,California,92121,USA,587117,2017,
"(1'R,6'R)-3-(Benzylamine)-6-hydroxy-3'-methyl-4-pentyl-6'-(prop-1-en-2-yl)-[1,1'-bi(cyclohexane)]-2',3,6-triene-2,5-dione",n/a,2017-07-06,Treatment of systemic scleroderma (SSc),Designated,,,N/A,N/A,Emerald Health Pharmaceuticals Inc.,5820 Nancy Ridge Drive,,San Diego,California,92121,USA,585717,2017,
"5-cholesten-3ß, 25-diol 3-sulfate sodium salt (25HC3S)",n/a,2017-07-06,Treatment of primary sclerosing cholangitis (PSC),Designated,,,N/A,N/A,DURECT Corporation,10260 Bubb Road,,Cupertino,California,95014,USA,586317,2017,
blinatumomab,Bincyto®,2017-07-06,Treatment of diffuse large B-cell lymphoma (DLBCL),Designated,,,N/A,N/A,Amgen Inc.,1 Amgen Center Drive,,Thousand Oaks,California,91320,USA,585917,2017,
cosyntropin,n/a,2017-07-06,Treatment of Duchenne muscular dystrophy.,Designated,,,N/A,N/A,Mallinckrodt ARD Inc.,675 McDonnell Boulevard,,Hazelwood,Missouri,63042,USA,545216,2017,
humanized immunoglobulin G4-variant monoclonal antibody directed against the p19 subunit of interleukin (IL)-23,n/a,2017-07-06,Treatment of pediatric Crohn's disease,Designated,,,N/A,N/A,Eli Lilly & Company,Lilly Corporate Center,,Indianapolis,Indiana,46285,USA,584617,2017,
electrokinetically altered saline solution with an elevated dissolved oxygen concentration,n/a,2017-07-10,Treatment of amyotrophic lateral sclerosis (ALS),Designated,,,N/A,N/A,Revalesio Corporation,1202 East D Street,,Tacoma,Washington,98421,USA,581017,2017,
tbo-filgrastim,n/a,2017-07-10,For the mobilization of peripheral blood progenitor cells (PBPCs) in healthy donors prior to allogeneic PBPC transplantation,Designated,,,N/A,N/A,Sicor Biotech UAB,5 Moletu pl. 5,,Vilnius,,,Lithuania,577617,2017,
(20S)-7-tert-butyldimethysilyl-10-hydroxycamptothecin,n/a,2017-07-13,Treatment of glioblastoma multiforme (GBM),Designated,,,N/A,N/A,"Vivacitas Oncology, Inc.",1990 North California Boulevard,8th Floor,Walnut Creek,California,94596,USA,586917,2017,
autologous mononuclear cells derived from umbilical cord blood,n/a,2017-07-13,Treatment of severe pediatric congenital heart disease,Designated,,,N/A,N/A,"Timothy Nelson, MD, PhD",Mayo Clinic,Hypoplastic Left Heart Syndrome Program,Rochester,Minnesota,55902,USA,583817,2017,
epirubicin-conjugated polymer micelles,n/a,2017-07-13,Treatment of soft tissue sarcoma,Designated,,,N/A,N/A,"NanoCarrier Co., Ltd",Chuou 144-15,226-39 Wakashiba,Kashiwa,,,Japan,588517,2017,
etrolizumab,n/a,2017-07-13,Treatment of pediatric Crohn's disease.,Designated,,,N/A,N/A,"Genentech, Inc.",1 Dna Way,,South San Francisco,California,94080,USA,531216,2017,
Gilteritinib,n/a,2017-07-13,Treatment of acute myeloid leukemia (AML),Designated,,,N/A,N/A,"Astellas Pharma US, Inc.",1 Astellas Way,,Northbrook,Illinois,60062,USA,587217,2017,
liposomal vinorelbine,n/a,2017-07-13,Treatment of soft tissue carcinoma,Designated,,,N/A,N/A,"Taiwan Liposome Company, Ltd.",3 Yuanqu Street,,,,,Taiwan,588417,2017,
Ranpirnase,n/a,2017-07-14,Treatment of Ebola virus disease (EVD),Designated,,,N/A,N/A,"Tamir Biotechnology, Inc.",51 John F Kennedy Parkway,1st Floor West,Short Hills,New Jersey,7078,USA,596317,2017,
filgotinib maleate,n/a,2017-07-18,Treatment of pediatric Crohn's disease,Designated,,,N/A,N/A,"Gilead Sciences, Inc.",199 E. Blaine St.,,Seattle,Washington,98102,USA,588017,2017,
"One, two, three, or four antisense oligonucleotides of Phosphorodiamidate morpholino oligomer combination that skips exons 4, 5, 6, and 7 of the gamma sarcoglycan (SGCG) gene",n/a,2017-07-18,"Treatment of limb-girdle muscular dystrophy type 2C that have mutations or deletions in exons 4, 5, 6, or 7of gamma sarcoglycan gene",Designated,,,N/A,N/A,Kurt+Peter Foundation,P. O. Box 691,,Menlo Park,California,94025,USA,587017,2017,
ustekinumab,Stelara,2017-07-18,Treatment of pediatric systemic lupus erythematosus,Designated,,,N/A,N/A,"Janssen Biotech, Inc.",800 Ridgeview Drive,,Horsham,Pennsylvania,19044,USA,586217,2017,
"(R)-3-[3-Fluoro-4-(1-methyl-1,4,5,6-tetrahydro-1,2,4-triazin-4-yl)phenyl]-5(R)-(hydroxymethyl)oxazolidin-2-one",n/a,2017-07-19,Treatment of tuberculosis,Designated,,,N/A,N/A,"LegoChem Biosciences, Inc.",8-26 Munpyeongseo-ro,,Daejeon,,,"Korea, Republic of",590317,2017,
artemisone,n/a,2017-07-19,Treatment of malaria,Designated,,,N/A,N/A,"Artemis Therapeutics, Inc.",18 East 16th Street,Suite 307,New York,New York,10003,USA,590117,2017,
Fusion protein linking human frataxin to a cell-penetrant peptide,n/a,2017-07-19,Treatment of Friedreich's ataxia,Designated,,,N/A,N/A,"Chondrial Therapeutics, Inc.",150 Monument Road,,Bala Cynwyd,Pennsylvania,19004,USA,590617,2017,
patidegib,n/a,2017-07-19,Treatment of nevoid basal cell carcinoma syndrome (Gorlin syndrome),Designated,,,N/A,N/A,"PellePharm, Inc.",275 Middlefield Road,,Menlo Park,California,94025,USA,587917,2017,
recombinant adeno-associated viral vector serotype HSC expressing human phenylalanine hydroxylase,n/a,2017-07-19,Treatment of phenylalanine hydroxylase deficiency,Designated,,,N/A,N/A,"Homology Medicines, Inc.",45 Wiggins Avenue,,Bedford,Massachusetts,1730,USA,588217,2017,
Recombinant adenovirus carrying the cDNA coding sequence for the human interferon gamma gene,n/a,2017-07-19,"Treatment of basal cell carcinomas in individuals with basal cell nevus syndrome (BCNS), also known as Gorlin syndrome",Designated,,,N/A,N/A,Ascend Biopharmaceuticals Ltd,"Level 1, 159 Dorcas Street",,South Melbourne,,,Australia,589517,2017,
Synthetic 15-amino-acid macrocyclic peptide acylated with a ethyleneglycol palmitoylated linker,n/a,2017-07-19,Treatment of paroxysmal nocturnal hemoglobinuria (PNH),Designated,,,N/A,N/A,"Ra Pharmaceuticals, Inc.",87 Cambridge Park Drive,,Cambridge,Massachusetts,2140,USA,589717,2017,
thalidomide,Taldo,2017-07-19,Treatment of hereditary hemorrhagic telangiectasia,Designated,,,N/A,N/A,PlumeStars s.r.l.,Via Lago Scuro11,43124 Parma,,,,Italy,585417,2017,
"(R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dien-1-yl) butanamide",n/a,2017-07-27,Treatment of amyotrophic lateral sclerosis,Designated,,,N/A,N/A,BioElectron Technology Corporation,350 North Bernardo Avenue,,Mountain View,California,94043,USA,592517,2017,
(s)-perillyl alcohol temozolomide carbamate,n/a,2017-07-27,Treatment of nasopharyngeal carcinoma,Designated,,,N/A,N/A,"NeOnc Technologies, Inc.","8335 Sunset Blvd., #240",,Los Angeles,California,90069,USA,575117,2017,
antisense oligonucleotide targeting exon 13 of the USH2A gene,n/a,2017-07-27,Treatment of retinitis pigmentosa,Designated,,,N/A,N/A,ProQR Therapeutics IV B.V.,"Zernikedreef 9, 2333 CK Leiden",,Leiden,,,Netherlands,588917,2017,
Bedaquiline,n/a,2017-07-27,Treatment of Nontuberculosis Mycobacteria infection,Designated,,,N/A,N/A,"Janssen Research & Development, LLC",125 Trenton-Harbourton Road,,Titusville,New Jersey,8560,USA,589917,2017,
Cipargamin,n/a,2017-07-27,Treatment of malaria,Designated,,,N/A,N/A,"Paul Maher, MD",10644 Weymouth Street,Suite 104,Bethesda,Maryland,20814,USA,595417,2017,
Cis-diamminedichloroplatinum (II) polyethylene glycol-polyglutamate (cis platinum PEG-pGlu) polymeric micelles,n/a,2017-07-27,Treatment of biliary tract carcinoma,Designated,,,N/A,N/A,"NanoCarrier Co., Ltd.",144-15 Chuno Gaiku,226-39 Wakashiba,Kashiwa,,,Japan,588717,2017,
combination of sodium phenylbutyrate and tauroursodeoxycholic acid dihydrate,n/a,2017-07-27,Treatment of amyotrophic lateral sclerosis (ALS),Designated,,,N/A,N/A,Amylyx Pharmaceuticals Inc.,210 Broadway,Suite 201,Cambridge,Massachusetts,2139,USA,588117,2017,
humanized immunoglobulin G1 (IgG1) T-cell bispecific (TCB) antibody targeting carcinoembryonic antigen (CEA) and CD3 epsilon chain (CD3e) on T-cells,n/a,2017-07-27,Treatment of pancreatic cancer,Designated,,,N/A,N/A,"Genentech, Inc.",1 DNA Way,MS 35-5E,South San Francisco,California,94080,USA,589817,2017,
Picropodophyllin,n/a,2017-07-27,Treatment of glioma,Designated,,,N/A,N/A,Axelar AB,Karolinska Institutet Science Park,2 Fogdevreten,Solna,,,Sweden,593617,2017,
Pro-Pro-Thr-Val-Pro-Thr-Arg,n/a,2017-07-27,Treatment of xeroderma pigmentosum,Designated,,,N/A,N/A,ProGeLife S.A.S,8 Rue Sainte-Barbe,,Marseille,,,France,587417,2017,
alpha-1 proteinase inhibitor (human),Glassia,2017-07-31,Prevention of graft versus host disease,Designated,,,N/A,N/A,Kamada Ltd.,Kiryat Weizmann,Science Park,Ness Ziona,,,Israel,590417,2017,
canakinumab,n/a,2017-07-31,Treatment of adult-onset Still's Disease,Designated,,,N/A,N/A,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,USA,591317,2017,
recombinant adeno-associated virus vector expressing the retinitis pigmentosa GTPase regulator,n/a,2017-07-31,Treatment of retinitis pigmentosa,Designated,,,N/A,N/A,Applied Genetic Technologies Corporation,11801 Research Drive,Suite D,Alachua,Florida,32615,USA,524616,2017,
tocilizumab,Actemra,2017-08-01,Treatment of chimeric antigen receptor (CAR) T cell-induced cytokine release syndrome,Designated/Approved,Approved for Orphan Indication,Treatment of chimeric antigen receptor (CAR) T cell-induced severe or life-threatening cytokine release syndrome (CRS) in adults and pediatric patients 2 years of age and older,2017-08-30,2024-08-30,"Genentech Inc., a member of the Roche Group",1 DNA Way,MS #355e,South San Francisco,California,94080,USA,589317,2017,29
"1-{2-[3-(3,4-Dichlorophenyl)ureido]-6-methyl-pyrimidin-4-yl}-amino-3(dimethylamino)propane Di methansulfonate",n/a,2017-08-02,Treatment of glioma,Designated,,,N/A,N/A,"Curtana Pharmaceuticals, Inc.",1624 Headway Circle,,Austin,Texas,78754,USA,599417,2017,
carisbamate,n/a,2017-08-02,Treatment of Lennox-Gastaut syndrome,Designated,,,N/A,N/A,"SK Life Sciences, Inc.",22-10 New Jersey 208 South,,Fair Lawn,New Jersey,7410,USA,594117,2017,
cosyntropin,n/a,2017-08-02,Treatment of infantile spasms.,Designated,,,N/A,N/A,"West Therapeutic Development, LLC",540 Ziegler Drive,,Grayslake,Illinois,60030,USA,594017,2017,
crofelemer,Mytesi,2017-08-02,Treatment of short bowel syndrome,Designated,,,N/A,N/A,"Napo Pharmaceuticals, Inc.",201 Mission Street,Suite 2375,San Francisco,California,94105,USA,592017,2017,
gemfibrozil,n/a,2017-08-02,Treatment of neuronal ceroid lipofuscinoses,Designated,,,N/A,N/A,"Polaryx Therapeutics, Inc.",140 East Ridgewood Avenue,"Suite 415, South Tower",Paramus,New Jersey,7652,USA,591917,2017,
miltefosine,Impavido,2017-08-02,Treatment of schistosomiasis,Designated,,,N/A,N/A,"Profounda, Inc.",5790 Hoffner Avenue,Suite 507,Orlando,Florida,32822,USA,590217,2017,
synthetic survivin peptide SVN53-67/M57-keyhole limpet hemocyanin,n/a,2017-08-02,Treatment of glioblastoma,Designated,,,N/A,N/A,"MimiVax, LLC",Elm & Carlton Streets,,Buffalo,New York,14263,USA,594717,2017,
"1,4-diamino-2,3-dicyano-1,4-bis[2-aminophenylthio] butadiene",n/a,2017-08-03,Treatment of subarachnoid hemorrhage (SAH),Designated,,,N/A,N/A,Edvince AB,Medicon Village,Scheelevägen 2,Lund,,,Sweden,593217,2017,
brimonidine,n/a,2017-08-03,Treatment of ocular graft versus host disease,Designated,,,N/A,N/A,"Ocugen, Inc.",5 Great Valley Parkway,Suite 160,Malvern,Pennsylvania,19355,USA,564016,2017,
Granexin® gel (aCTI peptide),n/a,2017-08-03,Treatment of cutaneous radiation injury due to radiation disaster,Designated,,,N/A,N/A,"FirstString Research, Inc.",300 West Coleman Boulevard,Suite 203,Mount Pleasant,South Carolina,29464,USA,573217,2017,
human monoclonal antibody inhibitor of mannan-binding lectin-associated serine protease-2,n/a,2017-08-03,Treatment of immunoglobulin A nephropathy (IgAN),Designated,,,N/A,N/A,Omeros Corporation,201 Elliott Avenue West,,Seattle,Washington,98119,USA,561516,2017,
odiparcil,n/a,2017-08-03,Treatment of mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome),Designated,,,N/A,N/A,Inventiva Pharma,50 rue de Dijon,Daix 21121,,,,France,592317,2017,
papaverine,n/a,2017-08-03,Treatment of mesenteric ischemia,Designated,,,N/A,N/A,"Nir Barak, MD",CO Noa Avtalion,161 Jefferson Avenue,Tenafly,New Jersey,7670,USA,581417,2017,
recombinant B-domain deleted human coagulation factor VIII Fc-von Willebrand factor-XTEN fusion protein,n/a,2017-08-03,Treatment of hemophilia A,Designated,,,N/A,N/A,"Bioverativ Therapeutics, Inc.",225 2nd Avenue,,Waltham,Massachusetts,2451,USA,591217,2017,
seletalisib,n/a,2017-08-03,Treatment of activated phosphoinositide 3-kinase delta syndrome (APDS),Designated,,,N/A,N/A,"UCB, Inc.",1650 Lake Park Drive,,Smyrna,Georgia,30080,USA,579917,2017,
tesevatinib,n/a,2017-08-03,Treatment of non-small cell lung cancer with epithelial growth factor receptor-activating mutations,Designated,,,N/A,N/A,"Kadmon Corporation, LLC",450 East 29th Street,,New York,New York,10016,USA,584917,2017,
apolipoprotein E mimetic peptide (AEM-28(R)-14),n/a,2017-08-07,Treatment of homozygous familial hypercholesterolemia (HoFH),Designated,,,N/A,N/A,"LipimetiX Development, LLC",5 Commonwealth Road,Suite 2A,Natick,Massachusetts,1760,USA,596517,2017,
blisibimod,n/a,2017-08-07,Treatment of patients with immunoglobulin A nephropathy,Designated,,,N/A,N/A,"Anthera Pharmaceuticals, Inc.",25801 Industrial Boulevard,Suite B,Hayward,California,94545,USA,560216,2017,
KIT and PDGFR inhibitor,n/a,2017-08-07,Treatment of glioblastoma multiforme and anaplastic astrocytomas,Designated,,,N/A,N/A,"Deciphera Pharmaceuticals, LLC",500 Totten Pond Road,,Waltham,Massachusetts,2451,USA,597617,2017,
Leu-Lys-Gly-Gln-Leu-Arg-Cys-Ile,n/a,2017-08-07,Treatment of pancreatic cancer,Designated,,,N/A,N/A,"Kalos Therapeutics, Inc.",6351 W. Lone Cactus Drive,,Glendale,Arizona,85308,USA,593517,2017,
nivolumab,Opdivo,2017-08-07,Treatment of anal cancer,Designated,,,N/A,N/A,Bristol-Myers Squibb Co.,5 Research Parkway,,Wallingford,Connecticut,6492,USA,591617,2017,
oxfendazole,n/a,2017-08-07,Treatment of cysticercosis,Designated,,,N/A,N/A,Oxfendazole Development Group,736 Cathcart Road,,Blue Bell,Pennsylvania,19422,USA,597217,2017,
cadazolid,n/a,2017-08-08,Treatment of clostridium difficile infection in pediatric patients,Designated,,,N/A,N/A,Actelion Pharmaceuticals Ltd.,16 Gewerbestrasse,,Allschwil,,,Switzerland,592917,2017,
cobitolimod,n/a,2017-08-08,Treatment of ulcerative colitis in pediatric patients,Designated,,,N/A,N/A,InDex Pharmaceuticals AB,23a Tomtebodavägen,,Hagalund,,,Sweden,594417,2017,
dasiglucagon,n/a,2017-08-10,Treatment of hypoglycemia in patients with congenital hyperinsulinism (CH),Designated,,,N/A,N/A,Zealand Pharma A/S,36 Smedeland,,Glostrup,,,Denmark,569416,2017,
entospletinib,n/a,2017-08-10,Prevention of chronic graft-versus-host disease,Designated,,,N/A,N/A,"Gilead Sciences, Inc.",333 Lakeside Drive,,Foster City,California,94404,USA,510115,2017,
nimodipine intravenous,n/a,2017-08-10,Treatment of subarachnoid hemorrhage,Designated,,,N/A,N/A,"Grace Therapeutics, LLC",675 U.S. 1,,North Brunswick Township,New Jersey,8902,USA,566016,2017,
Recombinant human antibody directed against human misfolded superoxide dismutase 1,n/a,2017-08-10,Treatment of amyotrophic lateral sclerosis (ALS),Designated,,,N/A,N/A,AL-S Pharma SA,13 Wagistrasse,,Schlieren,,,Switzerland,596417,2017,
yinfenidone,n/a,2017-08-10,Treatment of idiopathic pulmonary fibrosis,Designated,,,N/A,N/A,"Sunshine Lake Pharma Co., Ltd",Northern Industry Road #1,Song Shan Lake,Dongguan,,,China,594517,2017,
mobilized perioheral blood cells that have undergone ex-vivo negative functionial selection of GvHD-causing T-cells by short term incubation with Fas-ligand,n/a,2017-08-15,Prevention of graft versus host disease (GvHD),Designated,,,N/A,N/A,Cellect Biotherapeutics,23 Ha'Taas Street,P.O. Box 2442,Kfar Saba,,,Israel,589217,2017,
(R)-Azasetron besylate,n/a,2017-08-16,Prevention of platinum-induced ototoxicity in pediatric patients,Designated,,,N/A,N/A,Sensorion SA,"375, rue du Professeur Joseph Blayac",,Montpellier,,,France,593417,2017,
bitopertin,n/a,2017-08-16,Treatment of ß-thalassemia,Designated,,,N/A,N/A,Hoffmann-La Roche Inc.,"c/o Genentech, Inc.",1 DNA Way,South San Francisco,California,94080,USA,596717,2017,
nivolumab,n/a,2017-08-16,Treatment of mesothelioma,Designated,,,N/A,N/A,Bristol-Myers Squibb Company,5 Research Parkway,,Wallingford,Connecticut,6492,USA,595817,2017,
nivolumab and ipilimumab,n/a,2017-08-16,Treatment of mesothelioma,Designated,,,N/A,N/A,Bristol-Myers Squibb Company,5 Research Parkway,,Wallingford,Connecticut,6492,USA,595917,2017,
tamibarotene,n/a,2017-08-16,Treatment of acute myeloid leukemia (AML),Designated,,,N/A,N/A,"Syros Pharmaceuticals, Inc.",620 Memorial Drive,Suite 300,Cambridge,Massachusetts,2139,USA,596017,2017,
trans-resveratrol,Jotrol,2017-08-16,Treatment of Friedreich’s Ataxia (FRDA),Designated,,,N/A,N/A,Jupiter Orphan Therapeutics,601 Heritage Drive,,Jupiter,Florida,33458,USA,597817,2017,
upadacitinib,n/a,2017-08-16,Treatment of pediatric systemic juvenile idiopathic arthritis,Designated,,,N/A,N/A,"AbbVie, Inc.",1 North Waukegan Road,,North Chicago,Illinois,60064,USA,522916,2017,
"humanized IgG4 Monoclonal Antibody against total complement component 1, subcomponent s (C1s)",n/a,2017-08-17,Treatment of bullous pemphigoid (BP).,Designated,,,N/A,N/A,"True North Therapeutics, Inc.",951 Gateway Boulevard,,South San Francisco,California,94080,USA,597117,2017,
"N-[2,6-bis(1-methylethyl)phenyl]-N'-[[1-[4-(dimethylamino)phenyl]cyclopentyl]methyl]urea, hydrochloride salt",n/a,2017-08-17,Treatment of congenital adrenal hyperplasia,Designated,,,N/A,N/A,"Millendo Therapeutics, Inc.",301 North Main Street,Suite 100,Ann Arbor,Michigan,48104,USA,497315,2017,
obinutuzumab,Gazyva,2017-08-17,Treatment of splenic marginal zone lymphoma,Designated,,,N/A,N/A,"Genentech Inc., a member of the Roche Group",1 DNA Way,MS #355e,South San Francisco,California,94080,USA,592717,2017,
tetravalent tandem diabody binding both CD3 and CD33,n/a,2017-08-17,Treatment of patients with acute myeloid leukemia (AML),Designated,,,N/A,N/A,"Amphivena Therapeutics, Inc.",601 Gateway Boulevard,Suite 350,South San Francisco,California,94080,USA,593317,2017,
fully human monoclonal antibody specific for lymphocyte activation gene 3 and nivolumab,n/a,2017-08-18,Treatment of stage IIb to IV melanoma,Designated,,,N/A,N/A,Bristol-Myers Squibb Co.,5 Research Parkway,,Wallingford,Connecticut,6492,USA,595017,2017,
"2-(1,1-difluoroethyl)-5-methyl-N-[4-(pentafluoro-¿{6}-sulfanyl)phenyl]-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine",n/a,2017-08-18,Treatment of malaria,Designated,,,N/A,N/A,"Paul Maher, MD",10644 Weymouth Street,Suite 104,Bethesda,Maryland,20814,USA,598417,2017,
"3-(5-Fluoro-benzofuran-3-yl)-4-(5-methyl-5H-[1,3]dioxolo[4,5 f]indol-7-yl)-pyrrole-2,5-dione",n/a,2017-08-18,Treatment of Neuroblastoma,Designated,,,N/A,N/A,Actuate Therapeutics,1401 Foch Street,Suite 140,Fort Worth,Texas,76107,USA,598217,2017,
"O,O'-Bis({4-[3,5-diiodo-4-(1-methylene-1,2,3-triazol-4-ylmethoxy)phenoxy]-3,5-diiodophenyl}acetic acid)polyethylene glycol",n/a,2017-08-18,Treatment of pancreatic cancer,Designated,,,N/A,N/A,"NanoPharmaceuticals, LLC",1 Discovery Place,,Rensselaer,New York,12144,USA,598917,2017,
trazodone,n/a,2017-08-18,Treatment of Dravet syndrome,Designated,,,N/A,N/A,"Epygenix Therapeutics, Inc.",140 E. Ridgewood Avenue,Suite 415 South Tower,Paramus,New Jersey,7652,USA,593917,2017,
Peginterferon lambda-1a,n/a,2017-08-25,Treatment of hepatitis Delta virus infection,Designated,,,N/A,N/A,"Eiger BioPharmaceuticals, Inc.",350 Cambridge Avenue,Suite 350,Palo Alto,California,94306,USA,594817,2017,
5-(4-carboxymethyl-phenylazo)-2-hydroxybenzoic acid disodium salt,n/a,2017-08-31,Treatment of pediatric ulcerative colitis (UC),Designated,,,N/A,N/A,"Innovate Biopharmaceuticals, Inc.",8480 Honeycutt Road,Suite 200,Raleigh,North Carolina,27615,USA,599917,2017,
Allogeneic cytomegalovirus cytotoxic T lymphocytes,n/a,2017-08-31,Treatment of cytomegalovirus viremia and disease in immunocompromised patients,Designated,,,N/A,N/A,"Atara Biotherapeutics, Inc.",4360 Park Terrace Drive,Suite 100,Westlake Village,California,91361,USA,541416,2017,
Salmonella Typhi strain Ty21a transfected with a plasmid vector encoding for the human vascular endothelial growth factor receptor 2,n/a,2017-08-31,Treatment of malignant glioma,Designated,,,N/A,N/A,Vaximm GmbH,1 Julius-Hatry-Straße,,Mannheim,,,Germany,596117,2017,
Venetoclax,Venclexta,2017-08-31,Treatment of mantle cell lymphoma,Designated,,,N/A,N/A,AbbVie Inc.,1 North Waukegan Road,,North Chicago,Illinois,60064,USA,600117,2017,
Artesunate,n/a,2017-09-05,Treatment of malaria,Designated,,,N/A,N/A,"Guilin Pharmaceutical Co., Ltd.",No. 43 Qilidian Road,,Guilin Guangxi,,,China,598517,2017,
daratumumab,n/a,2017-09-05,Treatment of systemic amyloid light-chain (AL) amyloidosis,Designated,,,N/A,N/A,"Janssen Research & Development, LLC",920 Routh 202 South,,Raritan,New Jersey,8869,USA,536216,2017,
dupilumab,n/a,2017-09-05,Treatment of eosinophilic esophagitis,Designated,,,N/A,N/A,"Regneron Pharmaceuticals, Inc.",777 Old Saw Mill River Road,,Tarrytown,New York,10591,USA,599317,2017,
elamipretide,Bendavia,2017-09-05,Treatment of primary mitochondrial myopathy,Designated,,,N/A,N/A,Stealth BioTherapeutics,275 Grove Street,Suite 3-107,Newton,Massachusetts,2466,USA,597417,2017,
"N-(3-(2-(2,3-difluoro-4-(4-(2-hydroxyethyl)piperazin-1-yl)phenylamino)quinazolin-8-yl)phenyl)acrylamide",n/a,2017-09-05,Treatment of epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC),Designated,,,N/A,N/A,"Checkpoint Therapeutics, Inc.",2 Gansevoort Street,9th Floor,New York,New York,10014,USA,599817,2017,
omaveloxolone,n/a,2017-09-05,Treatment of stage IIb through IV malignant melanoma,Designated,,,N/A,N/A,"Reata Pharmaceuticals, Inc.",2801 Gateway Drive,Suite 150,Irving,Texas,75063,USA,461114,2017,
recombinant humanized anti-complement component 5 monoclonal antibody,n/a,2017-09-05,Treatment of paroxysmal nocturnal hemoglobinuria (PNH),Designated,,,N/A,N/A,Hoffmann-La Roche Inc.,"c/o Genentech, Inc.",1 DNA Way,South San Francisco,California,94080,USA,590717,2017,
recombinant humanized IgG4P monoclonal antibody with specificity for human tau,n/a,2017-09-05,Treatment of progressive supranuclear palsy (PSP),Designated,,,N/A,N/A,"UCB, Inc.",1650 Lake Park Drive,,Smyrna,Georgia,30080,USA,598117,2017,
synthetic stereopure antisense oligonucleotide specific to the mutant huntingtin mRNA transcript at the U variant of single nucleotide polymorphism rs326331,n/a,2017-09-05,Treatment of Huntington's disease,Designated,,,N/A,N/A,Wave Life Sciences Ltd.,733 Concord Avenue,,Cambridge,Massachusetts,2138,USA,598817,2017,
"(N-{2-[(6-{[(2,6-Dichloro-3,5-dimethoxyphenyl)carbamoyl](methyl)amino}pyrimidin-4- yl)amino]-5-(4-ethylpiperazin-1-yl)phenyl}prop-2-enamide)",n/a,2017-09-07,Treatment of hepatocellular carcinoma (HCC),Designated,,,N/A,N/A,"H3 Biomedicine Inc., a US Research Subsidiary of Eisai Co., Ltd.",300 Technology Square,Floor 5,Cambridge,Massachusetts,2139,USA,597717,2017,
adeno-associated viral vector serotype Anc80 containing the truncated human ATP7B gene under the control of the human alpha-1 antitrypsin promoter,n/a,2017-09-07,Treatment of Wilson's disease (WD),Designated,,,N/A,N/A,Vivet Therapeutics SAS,29 Rue Tronchet,,Paris,,,France,601817,2017,
autologous CD4+/CD8+ T cells transduced with lentiviral vector that expresses CD19 chimeric antigen receptor,n/a,2017-09-07,Treatment of follicular lymphoma (FL),Designated,,,N/A,N/A,"Juno Therapeutics, Inc.","307 Westlake Avenue, North",Suite 300,Seattle,Washington,98109,USA,600517,2017,
rusalatide acetate,Chrysalin,2017-09-07,Treatment of acute radiation syndrome (ARS),Designated,,,N/A,N/A,"Chrysalis BioTherapeutics, Inc.",2200 Market Street,Suite 609,Galveston,Texas,77550,USA,601417,2017,
antisense oligonucleotide targeting exon 73 in the COL7A1 gene,n/a,2017-09-13,Treatment of dystrophic epidermolysis bullosa,Designated,,,N/A,N/A,ProQR Therapeutics IV B.V.,"Zernikedreef 9, 2333 CK Leiden",,Leiden,,,Netherlands,600217,2017,
N-{2-[4-(2-Amino-5-chloropyridin-3-yl)phenoxy]pyrimidin-5-yl}-N'-[2-(methanesulfonyl)-5-(trifluoromethyl)phenyl]urea mono-4-toluenesulfonate,n/a,2017-09-13,Treatment of tropomyosin receptor kinase (Trk) gene fusion-positive cancer,Designated,,,N/A,N/A,Ono Pharmaceuticals Co. Ltd.,"8-2, Kyutaromachi l-chome",,Chuo-ku,,,Japan,599717,2017,
recombinant human acid a-glucosidase co-administered with N-butyl-deoxynojirimycin (reconbinant human acid a-glucosidase/miglustat),n/a,2017-09-13,Treatment of Pompe disease,Designated,,,N/A,N/A,"Amicus Therapeutics, Inc.",1 Cedarbrook Drive,,Cranbury Township,New Jersey,8512,USA,601617,2017,
iclaprim,n/a,2017-09-14,Treatment of Staphylococus aureus lung infections in patients with cystic fibrosis,Designated,,,N/A,N/A,Motif Bio PLC,330 Madison Avenue,6th Floor,New York,New York,10017,USA,514415,2017,
Adeno-associated virus serotype 8 vector expressing B domain deleted codon optimized factor VIII,n/a,2017-09-18,Treatment of hemophilia A,Designated,,,N/A,N/A,Baxalta US Inc.,1 Baxter Way,,Westlake Village,California,91362,USA,603017,2017,
liposomal oxaliplatin,n/a,2017-09-18,Treatment of pancreatic adenocarcinoma,Designated,,,N/A,N/A,"KC Specialty Therapeutics, LLC",2002 West 39th Avenue,,Kansas City,Arkansas,66103,USA,560816,2017,
lixivaptan,n/a,2017-09-18,Treatment of autosomal dominant polycystic kidney disease (ADPKD),Designated,,,N/A,N/A,"Palladio Biosciences, Inc.",12 Penns Trail,Unit A,Newtown,Pennsylvania,18940,USA,589617,2017,
mRNA encoding human argininosuccinate lyase,n/a,2017-09-18,Treatment of argininosuccinate lyase deficiency,Designated,,,N/A,N/A,"PhaseRx, Inc.",410 West Harrison Street,Suite 300,Seattle,Washington,98119,USA,605617,2017,
nelatimotide and adegramotide (DSP-7888 dosing emulsion),n/a,2017-09-18,Treatment of brain cancer,Designated,,,N/A,N/A,"Boston Biomedical, Inc.",640 Memorial Drive,,Cambridge,Massachusetts,2139,USA,603617,2017,
priliximab,n/a,2017-09-18,Treatment of mycosis fungoides (MF),Designated,,,N/A,N/A,"Onco Therapies, Inc.",2265 East Foothill Boulevard,,Pasadena,California,91107,USA,600717,2017,
tucatinib,n/a,2017-09-18,Treatment of HER2+ colorectal cancer,Designated,,,N/A,N/A,"Cascadian Therapeutics, Inc.",2601 4th Avenue,Suite 500,Seattle,Washington,98121,USA,571216,2017,
"1-(3-{4-[3,4-difluoro-2-(trifluoromethyl)phenyl]piperidine-1-carbonyl}-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-6-yl)ethan-1-one",n/a,2017-09-19,Treatment of Stargardt disease,Designated,,,N/A,N/A,"Lin BioScience, LLC",3210 Merryfield Row,,San Diego,California,92121,USA,601217,2017,
4-demethyl-4-cholesteryloxycarbonylpenclomedine,n/a,2017-09-19,Treatment of non-small cell lung cancer with CNS metastases,Designated,,,N/A,N/A,"DEKK-TEC, Inc.",725 Topaz Street,,New Orleans,Louisiana,70124,USA,604017,2017,
ICG136:CD123-CD33cCAR T-cells,n/a,2017-09-19,Treatment of acute myeloid leukemia,Designated,,,N/A,N/A,iCell Gene Therapeutics,25 Health Sciences Drive,Suite 118,Stony Brook,New York,11793,USA,603117,2017,
non-replicating recombinant adeno-associated virus vector containing 4 antisense sequences designed to target exon 2 in the human DMD gene under the control of U7 small nuclear non-coding RNA,n/a,2017-09-19,Treatment of Duchenne muscular dystrophy,Designated,,,N/A,N/A,Nationwide Children's Hospital,Drug and Device Development Services,700 Children's Drive,Columbus,Ohio,43205,USA,603217,2017,
Prismocitrate 18,n/a,2017-09-19,Use as replacement solution (includes regional anticoagulation of the extracorporeal circuit) in patients undergoing continuous renal replacement therapy (CRRT),Designated,,,N/A,N/A,Baxter Healthcare Corporation,32650 Wilson Road,WG1-3,Round Lake,Illinois,60073,USA,561316,2017,
rimeporide,n/a,2017-09-19,Treatment of Duchenne muscular dystrophy,Designated,,,N/A,N/A,EspeRare Foundation,"14, Ch des Aulx",,Plan-les-Ouates,,,Switzerland,602717,2017,
efgartigimod,n/a,2017-09-20,Treatment of myasthenia gravis,Designated,,,N/A,N/A,argenx BVBA,30 Technologiepark-Zwijnaarde,,Gent,,,Belgium,527316,2017,
ex-vivo expanded placental adherent stromal cells,n/a,2017-09-20,Treatment of acute radiation syndrome,Designated,,,N/A,N/A,"Pluristem Therapeutics, Inc",MATAM Advanced Technology Park,Building # 5,Haifa,,,Israel,599117,2017,
Mitoxantrone hydrochloride liposome,n/a,2017-09-20,Treatment of peripheral T-cell lymphoma,Designated,,,N/A,N/A,"CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd.","., a subsidiary company within CSPC Pharmaceutical Group, Ltd",226 Huanghe Avenue,Shijiazhuang Shi,,,China,602317,2017,
Subcutaneous recombinant human factor IX variant with three point mutations,n/a,2017-09-20,Treatment for hemophilia B,Designated,,,N/A,N/A,"Catalyst Biosciences, Inc.",260 Littlefield Avenue,,South San Francisco,California,94080,USA,596217,2017,
Nitric oxide,n/a,2017-09-26,Treatment of non-tuberculosis mycobacterial (NTM) infections,Designated,,,N/A,N/A,Advanced Inhalation Therapies Ltd.,2 Ilan Ramon Street,Ness Ziona,,,,Israel,603917,2017,
rofecoxib,n/a,2017-09-26,Treatment of hemophilic arthropathy (HA),Designated,,,N/A,N/A,"Tremeau Pharmaceuticals, Inc.",1 Broadway,14th Floor,Cambridge,Massachusetts,2142,USA,601917,2017,
adeno-associated viral vector serotype 5 encoding a microRNA targeted to human huntingtin gene,n/a,2017-09-27,Treatment of Huntington's disease.,Designated,,,N/A,N/A,uniQure Biopharma B.V.,113 Hartwell Avenue,,Lexington,Massachusetts,2421,USA,525216,2017,
Anti-STAT3 B VHH13 single domain antibody,n/a,2017-09-27,Treatment of osteosarcoma,Designated,,,N/A,N/A,"Singh Biotechnology, LLC",4708 Rue Bordeaux,,Lutz,Florida,33558,USA,605917,2017,
fimaporfin,n/a,2017-09-27,Treatment of cholangiocarcinoma,Designated,,,N/A,N/A,PCI Biotech AS,64 Ullernchausseen,,Ullern,,,Norway,574217,2017,
"1-(2-hydroxyethyl)-8-{[5-(4-methylpiperazin-1-yl)-2-(trifluoromethoxy) phenyl]amino}-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide fumarate salt",n/a,2017-09-28,Treatment of Acute Myeloid Leukemia,Designated,,,N/A,N/A,"Trovagene, Inc.",11055 Flintkote Avenue,,San Diego,California,92121,USA,602617,2017,
Autologous CD4+/CD8+ T cells expressing a BCMA-specific chimeric antigen receptor (CAR),n/a,2017-09-28,Treatment of Multiple Myeloma (MM),Designated,,,N/A,N/A,"Juno Therapeutics, Inc.",400 Dexter Avenue North,Suite 1200,Seattle,Washington,98109,USA,606117,2017,
Givinostat,n/a,2017-09-28,Treatment of polycythemia vera (PV),Designated,,,N/A,N/A,Italfarmaco SpA,54 Via dei Lavoratori,,Cinisello Balsamo,,,Italy,604917,2017,
Recombinant humanized immunoglobulin gamma 1 monoclonal antibody (mAb) directed against the CemX segment of human membrane-bound immunoglobulin E (mIgE),n/a,2017-09-28,Treatment of hyperimmunoglobulin E syndrome (HIES),Designated,,,N/A,N/A,"Fountain Biopharma, Inc.","19F-1, No. 3",3 Yuan Qu Street,Nangang District,,,Taiwan,606617,2017,
Tazemetostat,n/a,2017-09-28,Treatment of mesothelioma,Designated,,,N/A,N/A,Epizyme Inc.,400 Technology Square,4th Floor,Cambridge,Massachusetts,2139,USA,544416,2017,
"6-{[(1R,2S)-2-aminocyclohexyl]amino}-7-fluoro-4-(1-methyl-1H-pyrazol-4-yl)-1,2-dihydro-3H-pyrrolo[3,4-c]pyridin-3-one monocitrate",n/a,2017-10-03,Treatment of acute myeloid leukemia (AML),Designated,,,N/A,N/A,"Millennium Pharmaceuticals, Inc.",40 Landsdowne Street,,Cambridge,Massachusetts,2139,USA,606817,2017,
Adeno Associated Virus carried Multi Characteristic Opsin,n/a,2017-10-03,Treatment of retinitis pigmentosa,Designated,,,N/A,N/A,NanoScope Technologies,1312 Brown Trail,,Bedford,Texas,76022,USA,604217,2017,
Gaboxadol,n/a,2017-10-03,Treatment of Fragile X syndrome,Designated,,,N/A,N/A,Ovid Therapeutics,1460 Broadway,,New York,New York,10036,USA,605517,2017,
Pembrolizumab,Keytruda,2017-10-03,Treatment of Small Cell Lung Cancer excluding those that have been identified as having a biomarker referred to as microsatellite instability-high (MSI-H) or mismatched repair deficient (dMMR),Designated,,,N/A,N/A,"Merck, Sharp, & Dohme, a subsidiary of Merck & Co., Inc.",1 Merck Drive,,Whitehouse Station,New Jersey,8889,USA,605417,2017,
humanized monoclonal antibody to CCR5,n/a,2017-10-04,Prevention of graft versus host disease,Designated,,,N/A,N/A,"CytoDyn, Inc.",1111 Main Street,Suite 660,Vancouver,Washington,98660,USA,516516,2017,
(2-(3-(4-(1H-indazol-5-ylamino)quinazolin-2-yl)phenoxy)-N-isopropylacetamide-methane sulfonic acid salt),n/a,2017-10-05,Treatment of graft versus host disease (GVHD),Designated,,,N/A,N/A,"Kadmon Corporation, LLC",450 East 29th Street,,New York,New York,10016,USA,606717,2017,
autologous T lymphocyte enriched population cultured in the rpesence of phosphatidylinositol 3-kinase inhibitor (bb007) that contains cells transduced with an anti-human B cell maturation antigen (BCMA02) chimeric antigen receptor (CAR) lentiviral vector encoding a CAR that targets human BCMA,n/a,2017-10-05,Treatment of multiple myeloma,Designated,,,N/A,N/A,"bluebird bio, Inc.",60 Binney Street,,Cambridge,Massachusetts,2142,USA,604417,2017,
filgotinib maleate,n/a,2017-10-05,Treatment of pediatric ulcerative colitis (UC),Designated,,,N/A,N/A,"Gilead Sciences, Inc.",199 E. Blaine St.,,Seattle,Washington,98102,USA,604517,2017,
autologous glioma tumor cells treated with 18-mer oligodeoxynucleotide sequence complementary to insulin-like growth factor type 1 receptor (IGF-1R) codons 2-7 in the IG-1R gene,n/a,2017-10-11,Treatment of malignant glioma,Designated,,,N/A,N/A,Thomas Jefferson University,Department of Neurological Surgery,909 Walnut Street,Philadelphia,Pennsylvania,19107,USA,546916,2017,
avelumab,Bavencio,2017-10-11,Treatment of gastric cancer (GC) including cancer of the gastroesophageal junction (GEJ),Designated,,,N/A,N/A,"EMD Serono Research & Development Institute, Inc.",45A Middlesex Turnpike,,Billerica,Massachusetts,1821,USA,604117,2017,
carmustine,n/a,2017-10-11,Conditioning treatment prior to hematopoietic progenitor cell transplantation,Designated,,,N/A,N/A,ADIENNE S.A.,"Via Zurigo, 46",6900 Lugano,,,,Switzerland,606517,2017,
adeno-associated virus (AAV2) capsid variant carrying a transgene encoding a codon-optimized human choroideremia (CHM) gene,n/a,2017-10-12,Treatment of choroideremia (CHM),Designated,,,N/A,N/A,"4D Molecular Therapeutics, Inc.",5980 Horton Street,Suite 460,Emeryville,California,94608,USA,602217,2017,
synthetic cyclic 8 amino acid analog of human unacylated ghrelin,n/a,2017-10-12,Treatment of Prader-Willi syndrome (PWS),Designated,,,N/A,N/A,"Millendo Therapeutics, Inc.",301 North Main Street,Suite 100,Ann Arbor,Michigan,48104,USA,603317,2017,
autologous human peripheral blood mononuclear cells incubated ex vivo with protein TBX-4000 (Tat-MYC),n/a,2017-10-16,Treatment of malignant melanoma Stages IIb to IV,Designated,,,N/A,N/A,"Taiga Biotechnologies, Inc.",12635 Montview Boulevard,Fitzsimmons BBioscience Park Center,Aurora,Colorado,80045,USA,607517,2017,
chimeric Antigen Receptor (CAR) directed against the target protein CD5,n/a,2017-10-16,Treatment of acute lymphoblastic leukemia,Designated,,,N/A,N/A,iCell Gene Therapeutics,25 Health Sciences Drive,Suite 118,Stony Brook,New York,11793,USA,577717,2017,
upamostat,n/a,2017-10-16,Treatment of pancreatic cancer,Designated,,,N/A,N/A,RedHill Biopharma Ltd.,21 Ha'arba'a Street,,Tel Aviv-Yafo,,,Israel,608417,2017,
a strain of modified live probiotic bacterium Escherichia coli (E.coli) Nissle 1917 that has been modified to treat phenylketonuria by consuming phenylalanine within the gastrointestinal tract,n/a,2017-10-18,Treatment of phenylketonuria (PKU),Designated,,,N/A,N/A,"Synlogic, Inc.","200 Sidney Street, Suite 320",,Cambridge,Massachusetts,2139,USA,608717,2017,
expanded human allogeneic mesenchymal adult stem cells extracted from adipose tissue,n/a,2017-10-18,Treatment of fistulizing Crohn's disease,Designated,,,N/A,N/A,TiGenix S.A.U.,"Romeinse Sraat 2, Box 2",,Leuven,,,Belgium,373012,2017,
human IgG1 anti-human cytomegalovirus monoclonal antibodies LJP538 and LJP539,n/a,2017-10-18,Prevention of congenital cytomegalovirus (CMV) infection following primary CMV infection in pregnant women,Designated,,,N/A,N/A,Novartis Pharmaceuticals Corporation,35 Lichtstrasse,,Basel,,,Switzerland,533216,2017,
vatiquinone,Vincerinone,2017-10-18,Treatment of pontocerebellar hypoplasia,Designated,,,N/A,N/A,BioElectron Technology Corporation,350 North Bernardo Avenue,,Mountain View,California,94043,USA,606317,2017,
valbenazine,Ingrezza®,2017-10-19,Treatment of pediatric patients with Tourette syndrome (TS).,Designated,,,N/A,N/A,"Neurocrine Biosciences, Inc.",12780 El Camino Real,,San Diego,California,92130,USA,608317,2017,
glasdegib,n/a,2017-10-20,Treatment of myelodysplastic syndrome,Designated,,,N/A,N/A,"Pfizer, Inc.",445 Eastern Point Road,,Groton,Connecticut,6340,USA,608617,2017,
glepaglutide,n/a,2017-10-20,Treatment of short bowel syndrome,Designated,,,N/A,N/A,Zealand Pharma A/S,36 Smedeland,,Glostrup,,,Denmark,539216,2017,
"9-cis,12-cis-11,11-D2-linoleic acid ethyl ester",n/a,2017-10-24,Treatment of PLA2G6-associated neurodegeneration,Designated,,,N/A,N/A,"Retrotope, Inc.",4300 El Camino Real,Suite 201,Los Altos,California,94022,USA,607717,2017,
cannabidiol (CBD),n/a,2017-10-24,Treatment of Lennox-Gastaut syndrome,Designated,,,N/A,N/A,"AXIUM Pharmaceuticals, Inc.",265 Eastchester Drive,"Suite 133, #201",High Point,North Carolina,27262,USA,610117,2017,
dopamine hydrochloride,n/a,2017-10-24,Prevention of intraventricular hemorrhage in hypotensive premature neonates,Designated,,,N/A,N/A,"Brepco Biopharma, Ltd.",1785 Old Mill Road,,Bethlehem,Pennsylvania,18015,USA,578817,2017,
"THIOMAB antibody drug conjugate comprised of humanized IgG1 anti-C-type lectin-like molecule-1 monoclonal antibody and DNA alkylating cross-linking agent pyrrolo [2,1-c][1,4] benzodiazepine dimer",n/a,2017-10-24,Treatment of acute myeloid leukemia,Designated,,,N/A,N/A,"Genentech, Inc.",1 DNA Way,"mail stop: B-35, 355d",South San Francisco,California,94080,USA,609217,2017,
16 base single stranded PNA oligonucleotide–7 aminoacids peptide,n/a,2017-10-25,Treatment of neuroblastoma,Designated,,,N/A,N/A,BIOGENERA SpA,46 Via Marconi,,Porretta Terme (BO),,,Italy,608517,2017,
phenobarbital,n/a,2017-10-25,Treatment of neonatal seizures,Designated,,,N/A,N/A,"Renaissance SSA, LLC",411 South State Street,Suite E100,Newtown,Pennsylvania,18940,USA,601717,2017,
seribantumab,n/a,2017-10-25,Treatment of heregulin-positive non-small cell lung cancer,Designated,,,N/A,N/A,"Merrimack Pharmaceuticals, Inc.",1 Kendall Square,Suite B7201,Cambridge,Massachusetts,2139,USA,545516,2017,
copper sulfate,n/a,2017-10-26,Treatment of keratoconus,Designated,,,N/A,N/A,"iVeena Drug Delivery Systems, Inc.",391 Chipeta Way,Suite I,Salt Lake City,Utah,84108,USA,586117,2017,
indoximod,n/a,2017-10-26,Treatment of Stage IIB to IV melanoma,Designated,,,N/A,N/A,NewLink Genetics Corporation,2503 South Loop Drive,Suite 5100,Ames,Iowa,50010,USA,608917,2017,
ravulizumab subcutaneous,n/a,2017-10-27,Treatment of atypical hemolytic uremic syndrome (aHUS),Designated,,,N/A,N/A,"Alexion Pharmaceuticals, Inc.",100 College Street,,New Haven,Connecticut,6510,USA,606917,2017,
(+)-1-(3-(aminomethyl) phenyl)-N-(5-((3-cyanophenyl)(cyclopropylmethylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide dihydrochloride,n/a,2017-11-01,Treatment of C1-inhibitor-dependent angioedema (including prevention and treatment of attacks),Designated,,,N/A,N/A,"BioCryst Pharmaceuticals, Inc.",4505 Emperor Blvd,Suite 200200,Durham,North Carolina,27703,USA,607617,2017,
"1-(fluoro-18F)-3-((2-((1E,3E)-4-(6-(methylamino)pyridin-3-yl)buta-1,3-dien-1-yl)benzo[d]thiazol-6-yl)oxy)propan-2-ol",n/a,2017-11-01,A diagnostic for the management of progressive supranuclear palsy,Designated,,,N/A,N/A,Aprinoia Therapeutics,"17F, No. 3 Yuanqu Street",,Nangang District,,,Taiwan,610917,2017,
ozanimod,n/a,2017-11-01,Treatment of pediatric Crohn’s disease,Designated,,,N/A,N/A,Celgene International II Sarl,4 Rue des Moulins,,Val-de-Travers,,,Switzerland,611517,2017,
recombinant fragment human surfactant protein-D,n/a,2017-11-01,Prevention of bronchopulmonary dysplasia,Designated,,,N/A,N/A,Trimunocor Ltd.,2 Victoria Road,,Hertfordshire,,,United Kingdom,588317,2017,
vigabatrin and cosyntropin,n/a,2017-11-01,Treatment of infantile spasms,Designated,,,N/A,N/A,"West Therapeutic Development, LLC",540 Ziegler Drive,,Grayslake,Illinois,60030,USA,609817,2017,
"(2S,4R)-1-(2-(3-acetyl-5-(2-methylpyrimidin-5-yl)-1H-indazol-1-yl)acetyl)-N-(6-bromopyridin-2-yl)-4-fluoropyrrolidine-2-carboxamide",n/a,2017-11-02,Treatment of paroxysmal nocturnal hemoglobinuria,Designated,,,N/A,N/A,"Achillion Pharmaceuticals, Inc",300 George Street,,New Haven,Connecticut,6511,USA,512715,2017,
arimoclomol,n/a,2017-11-02,Treatment of inclusion body myositis,Designated,,,N/A,N/A,Orphazyme ApS,Ole Maaloes Vej 3,2200 Copenhagen,,,,Denmark,611317,2017,
baricitinib,Olumiant,2017-11-02,Treatment of pediatric systemic lupus erythematosus,Designated,,,N/A,N/A,Eli Lilly and Company,Lilly Corporate Center,,Indianapolis,Indiana,46285,USA,610017,2017,
live bacterial product consisting of defined consortia of Clostridium clusters live bacterial product consisting of defined consortia of Clostridium clusters,n/a,2017-11-02,Prevention of recurrent Clostridium difficile infection in individuals with prior recurrent Clostridium difficile infection,Designated,,,N/A,N/A,"Vedanta Biosciences, Inc.",19 Blackstone Street,Third Floor,Cambridge,Massachusetts,2139,USA,573717,2017,
replication defective herpes simplex type 1 virus (HSV-1) vector expressing human COL7 protein,n/a,2017-11-02,Treatment of dystrophic epidermolysis bullosa,Designated,,,N/A,N/A,"Krystal Biotech, LLC",2100 Wharton Street,Suite 701,Pittsburgh,Pennsylvania,15203,USA,558816,2017,
alanyl-glutamine dipeptide,Pd-Protectm,2017-11-06,Prevention of complications associated with peritoneal dialysis (PD) treatment in end stage renal disease (ESRD),Designated,,,N/A,N/A,Zytoprotec GmbH,28/2 Mariannengasse,,Vienna,,,Austria,611617,2017,
palovarotene,n/a,2017-11-06,Treatment of multiple osteochondromas,Designated,,,N/A,N/A,"Clementia Pharmaceuticals, Inc.",4150 Rue Sainte-Catherine West,Suite 550,Montreal,Quebec,,Canada,612117,2017,
polyhexanide,n/a,2017-11-06,Treatment of Acanthamoeba keratitis,Designated,,,N/A,N/A,Società Industria Farmaceutica Italiana S.p.A.,36 Via Ercole Patti,,Lavinaio,,,Italy,610317,2017,
"(3R,3aS,9R,9aS,9bS)-3-((dimethylamino)methyl)-9-hydroxy-6,9-dimethyl-3,3a,4,5,7,8,9,9a-octahydroazuleno[4,5-b]furan-2(9bH)-one fumarate",n/a,2017-11-08,Treatment of glioblastoma multiforme,Designated,,,N/A,N/A,Accendatech USA Incorporated,3730 Kirby Drive,Suite 1200,Houston,Texas,77098,USA,610217,2017,
3-aminopyridine-2-carboxaldehyde thiosemicarbazone,Triapine,2017-11-08,Treatment of stage 1B to IV cervical cancer,Designated,,,N/A,N/A,"National Cancer Institute, Div of Cancer Treatment & Diagnosis (DCTD)",9609 Medical Center Drive,"Room 5-W520, MSC 9740",Rockville,Maryland,20850,USA,588817,2017,
corticotropin-releasing factor receptor-1 antagonist containing an unfused thiazole ring,n/a,2017-11-08,Treatment of congenital adrenal hyperplasia,Designated,,,N/A,N/A,Spruce Biosciences,548 Market Street,Suite 74598,San Francisco,California,94104,USA,612217,2017,
ubidecarenone,n/a,2017-11-08,Treatment of pancreatic cancer,Designated,,,N/A,N/A,"Berg, LLC",500 Old Connecticut Path,Building B,Framingham,Massachusetts,1701,USA,610717,2017,
VLA-4 and LFA-1 integrin activator,n/a,2017-11-08,Treatment of malignant melanoma stages IIB to IV,Designated,,,N/A,N/A,"7 Hills Pharma, LLC",8285 El Rio Street,Suite 130,Houston,Texas,77054,USA,611917,2017,
adeno-associated virus type 2 encoding human aromatic L-amino acid decarboxylase,n/a,2017-11-14,Treatment of aromatic L-amino acid decarboxylase deficiency,Designated,,,N/A,N/A,University of California San Francisco,Department of Neurosurgery,1855 Folsom Street,San Francisco,California,94103,USA,613317,2017,
Recombinant adeno-associated virus serotype 2/1 vector encoding human beta-hexosaminidase alpha & beta subunits (rAAV2/1 Hex alpha & beta),n/a,2017-11-14,Treatment of GM2 gangliosidosis (Tay-Sachs & Sandhoff diseases),Designated,,,N/A,N/A,University of Cambridge,Hills Road,Addenbroke's Hospital,Cambridge,,,United Kingdom,614617,2017,
tazemetostat,n/a,2017-11-14,Treatment of follicular lymphoma (FL),Designated,,,N/A,N/A,"Epizyme, Inc.",400 Technology Square,4th Floor,Cambridge,Massachusetts,2139,USA,607017,2017,
cholera toxin B subunit,n/a,2017-11-16,Treatment of ulcerative colitis in pediatric patients,Designated,,,N/A,N/A,Aliment Wellness LLC,9462 Brownsboro Road,Suite 340,Louisville,Kentucky,40241,USA,603817,2017,
daxibotulinumtoxinA,n/a,2017-11-16,Treatment of cervical dystonia,Designated,,,N/A,N/A,"Revance Therapeutics, Inc.",7555 Gateway Boulevard,,Newark,California,94560,USA,579317,2017,
human IgG2 anti-monoclonal antibody directed against mucosal addressin cell adhesion molecule (MAdCAM),n/a,2017-11-16,Treatment of pediatric patients with Ulcerative Colitis (UC),Designated,,,N/A,N/A,"Shire Human Genetic Therapies, Inc. (Shire)",300 Shire Way,,Lexington,Massachusetts,2421,USA,608217,2017,
2’-O-(2-methoxyethyl) modified antisense oligonucleotide targeting exon 13 in the USH2A gene,n/a,2017-11-20,Treatment of retinitis pigmentosa,Designated,,,N/A,N/A,ProQR Therapeutics IV B.V.,9 Zernikedreef,,Leiden,,,Netherlands,613017,2017,
"(1R,2R)-1,2-cyclohexane-diaminepyrophosphato-platinum(II)",n/a,2017-11-22,Treatment of multiple myeloma,Designated,,,N/A,N/A,Phosplatin Therapeutics LLC,1350 6th Avenue,3rd Floor,New York,New York,10019,USA,613617,2017,
eflornithine,n/a,2017-11-22,Treatment of neuroblastoma,Designated,,,N/A,N/A,"KC Pharma, LLC",Towers Office Building,11300 U.S. 1,Palm Beach Gardens,Florida,33408,USA,613217,2017,
Synthetic PreImplantation Factor (H-Met-Val-Arg-Ile-Lys-Pro-Gly-Ser-Ala-Asn-Lys-Pro-Ser-Asp-Asp-OH,Spif,2017-11-22,Treatment of autoimmune hepatitis (AIH),Designated,,,N/A,N/A,"BioIncept, LLC",140 East 40th Street,Suite 11E,New York,New York,10016,USA,613417,2017,
povidone iodine,n/a,2017-11-27,Treatment of endophthalmitis,Designated,,,N/A,N/A,Veloce BioPharma LLC,7008 Lafayette Avenue,,Fort Washington,Pennsylvania,19034,USA,564916,2017,
CD4-mediated activated regulatory T cells,Atreg,2017-11-27,Treatment of graft-versus-host disease,Designated,,,N/A,N/A,Universitatsmedizin der Johannes Gutenberg-Universitat Mainz,1 Langenbeckstraße,,Mainz,,,Germany,613517,2017,
"Eubacterial Spores, Purified Suspension, Encapsulated",n/a,2017-11-27,Treatment of pediatric ulcerative colitis,Designated,,,N/A,N/A,"Seres Therapeutics, Inc.",200 Sidney Street,,Cambridge,Massachusetts,2139,USA,617517,2017,
setmelanotide,n/a,2017-11-27,Treatment of leptin receptor deficiency,Designated,,,N/A,N/A,"Rhythm Pharmaceuticals, Inc.",500 Boylston Street,11th Floor,Boston,Massachusetts,2116,USA,613717,2017,
cholesterol 24S-hydroxylase inhibitor,n/a,2017-11-29,Treatment of Dravet syndrome,Designated,,,N/A,N/A,"Takeda Development Center Americas, Inc.",Takeda Parkway,,Deerfield,Illinois,60015,USA,614917,2017,
cotsiranib,n/a,2017-11-29,Treatment of cholangiocarcinoma (CCA),Designated,,,N/A,N/A,"Sirnaomics, Inc.",401 Professional Drive,Suite 280,Gaithersburg,Maryland,20879,USA,614817,2017,
idasanutlin,n/a,2017-11-29,Treatment of polycythemia vera,Designated,,,N/A,N/A,Hoffmann-La Roche Inc.,430 East 29th Street,,New York,New York,10016,USA,615017,2017,
3-(1’-butyloxy)ethyl-3-deacetyl-bacteriopurpurin-18-N-butylimide methyl ester,Photobac,2017-12-06,Treatment of glioma,Designated,,,N/A,N/A,"Photolitec, LLC",6220 Creekhaven Drive,,East Amherst,New York,14051,USA,615317,2017,
cholesterol 24S-hydroxylase inhibitor,n/a,2017-12-06,Treatment of Lennox-Gastaut syndrome,Designated,,,N/A,N/A,"Takeda Development Center Americas, Inc.",Takeda Parkway,,Deerfield,Illinois,60015,USA,615817,2017,
D-amino acid oxidase inhibitor,n/a,2017-12-06,Treatment of Friedreich's ataxia (FRDA),Designated,,,N/A,N/A,"Takeda Development Center Americas, Inc.",Takeda Parkway,,Deerfield,Illinois,60015,USA,615417,2017,
gemfibrozil and vitamin A,n/a,2017-12-06,Treatment of neuronal ceroid lipofuscinoses,Designated,,,N/A,N/A,"Polaryx Therapeutics, Inc.",140 East Ridgewood Avenue,"Suite 415, South Tower",Paramus,New Jersey,7652,USA,546216,2017,
dual signaling protein fusing cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) to the Fas-ligand (FasL),n/a,2017-12-13,Treatment of diffuse large B-cell lymphoma,Designated,,,N/A,N/A,"KAHR Medical, LTD",P. O. Box 12000,,Jerusalem,,,Israel,517316,2017,
"(2S,4R)-1-(2-(3-acetyl-5-(2-methylpyrimidin-5-yl)-1H-indazol-1-yl)acetyl)-N-(6-bromopyridin-2-yl)-4-fluoropyrrolidine-2-carboxamide",n/a,2017-12-14,Treatment of C3 glomerulopathy (C3G),Designated,,,N/A,N/A,"Achillion Pharmaceuticals, Inc",300 George Street,,New Haven,Connecticut,6511,USA,617117,2017,
"2-(4-(2,4-dichlorophenethyl)-3,6-dioxo-1-(2-(thiophen-2-yl)ethyl)piperazin-2-yl)-N-(2-(5-methoxy-1H-indol-3-yl)ethyl) acetamide",n/a,2017-12-14,Prevention of platinum-induced ototoxicity in pediatric patients,Designated,,,N/A,N/A,Spiral Therapeutics,1467 Dolores Street,,San Francisco,California,94110,USA,618517,2017,
lentiviral transfected chimeric antigen receptor T-cells modified to target B-cell maturation antigen and CS1,n/a,2017-12-14,Treatment of multiple myeloma,Designated,,,N/A,N/A,iCell Gene Therapeutics,25 Health Sciences Drive,Suite 118,Stony Brook,New York,11793,USA,612717,2017,
metformin,n/a,2017-12-14,Treatment of progressive myoclonus epilepsy type 2 (Lafora disease),Designated,,,N/A,N/A,"Consorcio Centro de Investigación Biomédica en Red, M.P. (CIBER)",Monforte de Lemos,3-5 Pabellon 11,Madrid,,,Spain,616117,2017,
plasminogen (Human),Ryplazim™ Plasminogen (Human),2017-12-14,Treatment of idiopathic pulmonary fibrosis (IPF),Designated,,,N/A,N/A,"ProMetic BioTherapeutics, Inc",1330 Piccard Drive,Suite 201,Rockville,Maryland,20850,USA,609317,2017,
(S)-2-(1-(9H-purin-6-ylamino)propyl)-3-(3-fluorophenyl)-4H-chromen-4-one),n/a,2017-12-18,Treatment of peripheral T-cell lymphoma,Designated,,,N/A,N/A,Rhizen Pharmaceuticals SA,40 Rue Fritz-Courvoisier,,La Chaux-de-Fonds,,,Switzerland,616417,2017,
diacetyl(N(4)-methylthiosemicarbazonato) copper (II),n/a,2017-12-18,Treatment of amyotrophic lateral sclerosis (ALS),Designated,,,N/A,N/A,Collaborative Medicinal Development Pty. Ltd. (CMD),c/o Shaw Downie,Level 11,Sydney,,,Australia,611117,2017,
fenretinide,n/a,2017-12-19,Treatment of cutaneous T-cell lymphoma,Designated,,,N/A,N/A,"SciTech Development, LLC",281 Kercheval Avenue,,Grosse Pointe Farms,Michigan,48236,USA,615217,2017,
"methyl (2R,3S)-3-[(methylsulfonyl)amino]-2-{[(cis-4-phenylcyclohexyl)oxy]methyl}piperidine-1-carboxylate",n/a,2017-12-19,Treatment of narcolepsy,Designated,,,N/A,N/A,"Takeda Development Center Americas, Inc.",Takeda Parkway,,Deerfield,Illinois,60015,USA,616717,2017,
mosedipimod,n/a,2017-12-19,Treatment of acute radiation syndrome,Designated,,,N/A,N/A,Enzychem Lifesciences Corporation,"59, Bio valley-ro",,Jecheon-si,,,"Korea, Republic of",616517,2017,
"sodium sulfate, magnesium sulfate, potassium chloride",n/a,2017-12-19,For the cleansing of the colon in preparation for colonoscopic diagnosis of colonic disease in pediatric patients,Designated,,,N/A,N/A,"Braintree Laboratories, Inc.",60 Columbian Street West,P.O. Box 850929,Braintree,Massachusetts,2185,USA,616817,2017,
"2-O, 3-O, desulfated heparin",n/a,2017-12-21,Treatment of acute myeloid leukemia,Designated,,,N/A,N/A,"Cantex Pharmaceuticals, Inc.",1792 Bell Tower Lane,,Weston,Florida,33326,USA,477815,2017,
cannabidiol,n/a,2017-12-21,Treatment of Dravet syndrome,Designated,,,N/A,N/A,"AXIUM Pharmaceuticals, Inc.",265 Eastchester Drive,"Suite 133, #201",High Point,North Carolina,27262,USA,617417,2017,
rapamycin,n/a,2017-12-21,Treatment of perivascular epithelioid cell tumors (PEComa),Designated,,,N/A,N/A,"Aadi Bioscience, Inc.",1343 Luna Vista Drive,,Los Angeles,California,90272,USA,616217,2017,
three-dimensional bioprinted therapeutic liver tissue,n/a,2017-12-21,Treatment of alpha-1 antitrypsin deficiency,Designated,,,N/A,N/A,Organovo Inc.,6275 Nancy Ridge Drive,,San Diego,California,92121,USA,617317,2017,
trafermin in combination with plasma and platelet rich plasma,n/a,2017-12-21,Treatment of alopecia areata in pediatric patients,Designated,,,N/A,N/A,"HCell, Inc.",314 East Highland Mall Boulevard,Suite 406,Austin,Texas,78752,USA,595317,2017,
"1-{3-fluoro-4-[7-(5-methyl-lH-imidazol-2-yl)- 1-oxo-2,3-dihydro-lH-isoindo 1-4-yl]-phenyl}-3-(3-trifluoromethyl-phenyl)-urea",n/a,2017-12-22,Treatment of acute myeloid leukemia (AML),Designated,,,N/A,N/A,"Aptose Biosciences, Inc.",12770 High Bluff Drive,Suite 120,San Diego,California,92130,USA,618417,2017,
fenretinide,n/a,2017-12-22,Treatment of peripheral T-cell lymphoma (including follicular T-cell lymphoma),Designated,,,N/A,N/A,"SciTech Development, LLC",281 Kercheval Avenue,,Grosse Pointe Farms,Michigan,48236,USA,621117,2017,
soraprazan,n/a,2017-12-22,Treatment of Stargardt Disease (StD),Designated,,,N/A,N/A,Katairo GmbH,21 Lederstraße,,Kusterdingen,,,Germany,617617,2017,
(+)-(2S)-2-(4-chloro-2-methoxyphenyl)-2-{[3-methoxy-5-(methylsulfonyl)phenyl]amino}-1-[5-(trifluoromethoxy)-1H-indol-3-yl]ethanone,n/a,2017-12-26,Treatment of dengue virus infection,Designated,,,N/A,N/A,"Janssen Research & Development, LLC",125 Trenton-Harbourton Road,,Titusville,New Jersey,8560,USA,618217,2017,
abatacept,Orencia,2017-12-26,Prevention of Graft versus Host Disease,Designated,,,N/A,N/A,Bristol-Myers Squibb Co.,P.O Box 4000,,Princeton,New Jersey,8543,USA,614117,2017,
"ICG140:CD19-CD123 cCAR T-cells, a chimeric antigen receptor (CAR) on the surface of T-cells directed against the target proteins CD19 and CD 123",n/a,2017-12-26,Treatment of acute lymphoblastic leukemia,Designated,,,N/A,N/A,iCell Gene Therapeutics,25 Health Sciences Drive,Suite 118,Stony Brook,New York,11793,USA,614017,2017,
NP-CSIC002,n/a,2017-12-26,Treatment of anterior ischemic optic neuropathy (AION),Designated,,,N/A,N/A,Neurizon Pharma,15 Paul-Ehrlich-Straße,,Tübingen,,,Germany,618617,2017,
partial myostatin antigen displayed on the surface of Lactobacillus casei,n/a,2017-12-28,Treatment of Duchenne Muscular Dystrophy (DMD),Designated,,,N/A,N/A,BioLeaders Corporation,"7F, U-Tower, 767, Sinsu-ro, Suji-gu",,Yongin-si,,,"Korea, Republic of",619017,2017,
resatorvid,n/a,2018-01-02,Treatment of acute-on-chronic liver failure,Designated,,,N/A,N/A,"Takeda Development Center Americas, Inc.",One Takeda Parkway,,Deerfield,Illinois,60015,USA,503515,2018,
antibody drug conjugate targeting dipeptidase 3 (DPEP3),n/a,2018-01-08,"Treatment of DPEP3-positive ovarian, fallopian tube, and primary peritoneal cancers",Designated,,,N/A,N/A,"AbbVie Stemcentrx, LLC",1 North Waukegan Road,,Chicago,Illinois,60064,USA,555816,2018,
Atezolizumab + Bevacizumab,n/a,2018-01-08,Treatment of hepatocellular carcinoma (HCC),Designated,,,N/A,N/A,"Genentech, Inc.",1 DNA Way,Mail Stop # 355e,South San Francisco,California,94080,USA,619317,2018,
cannabidiol (CBD) and Delta-9-tetrahydrocannabinol (THC),n/a,2018-01-08,Treatment of glioblastoma multiforme,Designated,,,N/A,N/A,"AXIUM Pharmaceuticals, Inc.",265 Eastchester Drive,"Suite 133, #201",High Point,North Carolina,27262,USA,620417,2018,
cryopreserved human umbilical cord,n/a,2018-01-08,Treatment of spina bifida,Designated,,,N/A,N/A,"TissueTech, Inc.",7300 Corporate Center Drive,Suite 700,Miami,Florida,33126,USA,611717,2018,
eflornithine + sulindac,n/a,2018-01-08,Treatment of pancreatic cancer,Designated,,,N/A,N/A,"Cancer Prevention Pharmaceutical, Inc.",1760 East River Road,Suite 250,Tucson,Arizona,85718,USA,619917,2018,
"genetically modified, non-self replicating Adeno-Associated Virus serotype 9 expressing shRNA to knock down mutant PABP1 as well as a codon optimized, shRNA-insensitive, wildtype PABN1",n/a,2018-01-08,Treatment of oculopharyngeal muscular dystrophy (OPMD),Designated,,,N/A,N/A,Benitec Biopharma,99 Mount Street,Suite 1201,North Sydney,,,Australia,617717,2018,
milrinone,n/a,2018-01-08,Treatment of right heart failure (RHF) in left ventricular assist device (LVAD) patients,Designated,,,N/A,N/A,Cardiora Pty Ltd,"Level 9, 278 Collins Street",,Melbourne,,,Australia,565916,2018,
sodium oxybate extended-release oral suspension,n/a,2018-01-08,Treatment of narcolepsy,Designated,,,N/A,N/A,Flamel Ireland Limited,Block 10-1 Blanchardstown Corporate Park,Ballycoolin,Dublin,,,Ireland,530216,2018,
recombinant adeno-associated viral (AAV) vector that contains a bioengineered capsid (AAV-Spark200) and a codon-optimized expression cassette to drive expression of the SQ form of a B-domain deleted human coagulation factor VIII (hFVIII),n/a,2018-01-16,Treatment of hemophilia A,Designated,,,N/A,N/A,"Spark Therapeutics, Inc.",3737 Market Street,Suite 1300,Philadelphia,Pennsylvania,19104,USA,569916,2018,
tin ethyl etiopurpurin,n/a,2018-01-16,Treatment of basal cell carcinoma nevus syndrome (BCCNS),Designated,,,N/A,N/A,"Adgero Biopharmaceuticals, Inc",4365 US Highway 1,Suite 211,Princeton,New Jersey,8540,USA,620517,2018,
apremilast,Otezla®,2018-01-17,Treatment of pediatric patients with ulcerative colitis,Designated,,,N/A,N/A,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,USA,622417,2018,
cyclocreatine phosphate,Nourexal,2018-01-17,Prevention of ischemic injury to enhance cardiac graft recovery and survival in heart transplantation.,Designated,,,N/A,N/A,"Nour Heart Therapeutics, LLC","121 Locust Street, SW",,Vienna,Virginia,22180,USA,495115,2018,
dihydroxyphenylalanine F 18/Fluorodopa (F18),n/a,2018-01-22,Diagnostic for the management of congenital hyperinsulinism,Designated,,,N/A,N/A,Society of Nuclear Medicine and Molecular Imaging,1850 Samuel Morse Drive,,Reston,Virginia,20190,USA,621017,2018,
humanized immunoglobulin G1 (IgG1) T-cell bispecific (TCB) antibody targeting carcinoembryonic antigen (CEA),n/a,2018-01-22,"Treatment of gastric cancer, including gastroesophageal junction cancer",Designated,,,N/A,N/A,"Genentech, Inc.",1 DNA Way,MS 35-5E,South San Francisco,California,94080,USA,618817,2018,
inclisiran,n/a,2018-01-22,Treatment of homozygous familial hypercholesterolemia (HoFH),Designated,,,N/A,N/A,The Medicines Company,8 Sylvan Way,,Parsippany-Troy Hills,New Jersey,7054,USA,618017,2018,
2-{4-[(9R)-9-Hydroxy-2-(3-hydroxy-3-methylbutyloxy)-9-(trifluoromethyl)-9H-fluoren-4-yl]-1H-pyrazol-1-yl}-2-methylpropanamide monohydrate,n/a,2018-01-23,Treatment of pulmonary arterial hypertension,Designated,,,N/A,N/A,Akros Pharma Inc.,302 Carnegie Center,Suite 300,Princeton,New Jersey,8540,USA,620017,2018,
branaplam,n/a,2018-01-23,Treatment of spinal muscular atrophy (SMA),Designated,,,N/A,N/A,Novartis Pharmaceuticals Corporation,1 Health Plaza,,East Hanover,New Jersey,7936,USA,620117,2018,
octreotide acetate (intranasal),n/a,2018-01-23,Treatment of acromegaly,Designated,,,N/A,N/A,"Dauntless Pharmaceuticals, Inc.",12390 El Camino Real,Suite 170,San Diego,California,92130,USA,606217,2018,
riluzole oral soluble film (ROSF),n/a,2018-01-23,Treatment of amytrophic lateral sclerosis (ALS),Designated,,,N/A,N/A,Aquestive Therapeutics,30 Technology Drive South,,Warren,New Jersey,7059,USA,563216,2018,
SF-RI-1 bovine surfactant for inhalation,Aerofact™,2018-01-23,Treatment of respiratory distress syndrome (RDS),Designated,,,N/A,N/A,Aerogen Pharma Corporation,1660 South Amphlett Boulevard,,San Mateo,California,94402,USA,593817,2018,
glucagon (ready-to-use),n/a,2018-01-24,Treatment of hyperinsulinemic hypoglycemia (HH),Designated,,,N/A,N/A,"Xeris Pharmaceuticals, Inc.",3208 Red River Street,Suite 300,Austin,Texas,78705,USA,616317,2018,
"6,8-bis(benzylthio)octanoic acid",n/a,2018-01-25,Treatment of Burkitt’s Lymphoma (BL),Designated,,,N/A,N/A,"Rafael Pharmaceuticals, Inc.",1 Duncan Drive,,Cranbury Township,New Jersey,8512,USA,621617,2018,
humanized IgG4-based anti-CD20 x anti-CD3 bispecific monoclonal antibody,n/a,2018-01-25,Treatment of follicular lymphoma (FL),Designated,,,N/A,N/A,"Regeneron Pharmaceuticals, Inc.",777 Old Saw Mill River Road,,Tarrytown,New York,10591,USA,623317,2018,
neihulizumab,n/a,2018-01-25,Treatment of acute graft-versus-host disease (aGvHD),Designated,,,N/A,N/A,"AbGenomics International, Inc.",5050 El Camino Real,Suite #105,Los Altos,California,94022,USA,622617,2018,
leniolisib,n/a,2018-01-30,"Activated P13Kdelta Syndrome/p110delta-activating mutation causing senescent T cells, lymphadenopathy, and immunodeficiency",Designated,,,N/A,N/A,Novartis Pharmaceuticals Corporation,1 Health Plaza Drive,Bld 125 2110C,East Hanover,New Jersey,7936,USA,504315,2018,
midazolam,Zeneo®-Midazolam,2018-01-30,Treatment of status epilepticus,Designated,,,N/A,N/A,Crossject SA,6 Rue Pauline Kergomard,,Dijon,,,France,622817,2018,
recombinant humanized monoclonal antibody targeting the anti-müllerian hormone receptor II,n/a,2018-01-30,Treatment of Anti -Mullerian Hormone Receptor II (AMHRII)-expressing ovarian cancer,Designated,,,N/A,N/A,GamaMabs Pharma SA,"Centre Pierre Potier, 1 place Pierre Potier",Oncopole entree B,,,,France,578617,2018,
fostamatinib,n/a,2018-01-31,Treatment of autoimmune hemolytic anemia (AIHA),Designated,,,N/A,N/A,"Rigel Pharmaceuticals, INc.",1180 Veterans Blvd,,South San Francisco,California,94080,USA,544516,2018,
"2-(3,7-Dimethyl-octa-2, 6-dienyl)—6-ethylamino-3-hydroxy-5-pentyl-[1,4]benzoquinone",n/a,2018-02-01,Treatment of Huntington’s Disease (HD),Designated,,,N/A,N/A,Emerald Health Pharmaceuticals Inc.,5820 Nancy Ridge Drive,,San Diego,California,92121,USA,623717,2018,
adenovirus associated viral vector serotype 8 containing the human AIPL1 gene,n/a,2018-02-01,"Treatment of inherited retinal dystrophy due to defects in AIPL1 gene, including Leber congenital amaurosis, retinitis pigmentosa, and cone-rod dystrophy",Designated,,,N/A,N/A,MeiraGTx UK II Ltd,92 Britannia Walk,N1 7NQ,London,,,United Kingdom,622217,2018,
anti-human epidermal growth factor receptor 2 (HER2) antibody drug conjugate,n/a,2018-02-01,Treatment of gastric cancer including cancer of gastroesophageal junction,Designated,,,N/A,N/A,"CSPC Dophen Corporation, subsidiary within CSPC Pharmaceutical Group",4070 Truxel Road,,Sacramento,California,95834,USA,620617,2018,
glucagon analog conjugated with human immunoglobulin G4 fragment,n/a,2018-02-01,Treatment of congenital hyperinsulinism (CHI),Designated,,,N/A,N/A,"Hanmi Pharmaceutical Company, Ltd.","14, Wiryeseong-daero",,Seoul,,,"Korea, Republic of",620717,2018,
humanized non-fucosylated anti-siglec-8 monoclonal antibody (IgG1),n/a,2018-02-01,Treatment of eosinophilic gastritis,Designated,,,N/A,N/A,"Allakos, Inc.",75 Shoreway Road,Suite A,San Carlos,California,94070,USA,628417,2018,
humanized non-fucosylated Anti-Siglec-8 Monoclonal Antibody (IgG1),n/a,2018-02-01,Treatment of eosinophilic gastroenteritis,Designated,,,N/A,N/A,"Allakos, Inc.",75 Shoreway Road,Suite A,San Carlos,California,94070,USA,623017,2018,
ibrutinib,Imbruvica,2018-02-01,"Treatment of gastric cancer, including gastroesophageal junction adenocarcinoma",Designated,,,N/A,N/A,"Pharmacyclics, LLC",995 East Arques Avenue,,Sunnyvale,California,94085,USA,622317,2018,
a self-complementary adeno-associated virus serotype 9 expressing human codon-optimized CLN1 under control of CBh,n/a,2018-02-07,Treatment of neuronal ceroid lipofuscinosis type 1 (CLN1),Designated,,,N/A,N/A,Abeona Therapeutics,6555 Carnegie Blvd,Suite 401,Cleveland,Ohio,44103,USA,628718,2018,
human IgG2 monoclonal antibody directed against the mucosal addressin cell adhesion molecule,n/a,2018-02-07,Treatment of Crohn’s Disease (CD) in the pediatric population,Designated,,,N/A,N/A,"Shire Human Genetic Therapies, Inc. (Shire)",300 Shire Way,,Lexington,Massachusetts,2421,USA,608117,2018,
tilorone dihydrochloride,n/a,2018-02-07,Treatment of Ebola infection,Designated,,,N/A,N/A,"Collaborations Pharmaceuticals, Inc.",840 Main Campus Drive,Lab 3510,Raleigh,North Carolina,27606,USA,624717,2018,
inter-Alpha-Inhibitor-Proteins (IaIp) (Human),n/a,2018-02-13,Treatment of necrotizing enterocolitis (NEC),Designated,,,N/A,N/A,"ProMetic BioTherapeutics, Inc",1330 Piccard Drive,Suite 201,Rockville,Maryland,20850,USA,626518,2018,
double stranded oligomer ADS-001 RNA interference-based liver targeted therapeutic,n/a,2018-02-14,Treatment of alpha-1 antitrypsin deficiency,Designated,,,N/A,N/A,Arrowhead Research Corporation,225 South Lake Avenue,Suite 1050,Pasadena,California,91101,USA,623617,2018,
imlifidase,n/a,2018-02-14,Treatment of Guillain-Barré Syndrome (GBS),Designated,,,N/A,N/A,Hansa Medical AB,P. O. Box 785,SE-220 07 Lund,,,,Sweden,623817,2018,
recombinant humanized IgG4 monoclonal antibody against pHERV-W Envelope protein,n/a,2018-02-14,Treatment of chronic inflammatory demyelinating polyradiculoneuropathy/polyneuropathy (CIDP),Designated,,,N/A,N/A,GeNeuro S.A.,3 Chemin du Pré-Fleuri,,Plan-les-Ouates,,,Switzerland,625517,2018,
selumetinib,n/a,2018-02-14,Treatment of Neurofibromatosis Type 1,Designated,,,N/A,N/A,AstraZeneca Pharmaceuticals LP,1800 Concord Pike,P.O. Box 8355,Wilmington,Delaware,19803,USA,624017,2018,
adeno-associated virus serotype 6 containing human LAMAN cDNA,n/a,2018-02-15,Treatment of alpha-mannosidosis,Designated,,,N/A,N/A,"Stephen G. Kaler, MD",Eunice Kennedy Shriver NICHD,Porter Neuroscience Research Center II,Bethesda,Maryland,20892,USA,623417,2018,
human coagulation factor XI,n/a,2018-02-15,Treatment of congenital factor XI deficiency,Designated,,,N/A,N/A,Bio Products Laboratory,Dagger Lane,"Hertfordshire, WD6 3BX",,,,United Kingdom,625417,2018,
humanized IgG1 low affinity allergic reactivity inhibiting (LARI) monoclonal antibody,n/a,2018-02-15,Treatment for mastocytosis,Designated,,,N/A,N/A,Sixal Inc.,416 15th Street,,Santa Monica,California,90402,USA,613817,2018,
"Inactivated purified rabies virus (IPRV) and the PIKA adjuvant (Polyinosinic-polycyidylic acid, kanamycin and calcium)",n/a,2018-02-15,Treatment of Pancreatic Cancer,Designated,,,N/A,N/A,"Yisheng US Biopharma, Inc.",11 Firstfield Road,Suite A,Gaithersburg,Maryland,20878,USA,625117,2018,
"self-complementary non-replicating, recombinant adeno-associated virus serotype rhesus 74 (rh 74) expressing the human beta-sarcoglycan gene under the control of the muscle creatine kinase (MHCK7) promoter",n/a,2018-02-15,Treatment of Limb Girdle Muscular Dystrophy Type 2E (LGMD2E),Designated,,,N/A,N/A,Nationwide Children's Hospital,700 Children's Drive,Rm WA2025,Columbus,Ohio,43205,USA,625818,2018,
Siplizumab,Vicalex,2018-02-15,Prevention of solid organ transplant rejection,Designated,,,N/A,N/A,ITB-MED AB,15 Västra Trädgårdsgatan,,Norrmalm,,,Sweden,623917,2018,
tenofovir exalidex,n/a,2018-02-20,Treatment of pediatric chronic hepatitis B infection (age 0 through 11 years of age),Designated,,,N/A,N/A,"ContraVir Pharmaceuticals, Inc.",399 Thornall Street,First Floor,Edison,New Jersey,8837,USA,583917,2018,
"5-(6,6-dimethyl-4-morpholino-8,9-dihydro-6H-[1,4]oxazino[3,4-e]purin-2-yl)pyrimidin-2-amine",n/a,2018-02-21,Treatment of glioblastoma multiforme (GBM),Designated,,,N/A,N/A,Kazia Therapeutics Limited,20 George Street,Suite 207,Hornsby,,,Australia,624217,2018,
16 base single stranded peptide nucleic acid oligonucleotide – 7 aminoacids peptide,n/a,2018-02-22,Treatment of Small Cell Lung Cancer,Designated,,,N/A,N/A,BIOGENERA SpA,46 Via Marconi,,Porretta Terme (BO),,,Italy,626018,2018,
davunetide,n/a,2018-02-22,Treatment of Activity-Dependent Neuroprotective Protein (ADNP) Syndrome,Designated,,,N/A,N/A,Coronis Neurosciences Ltd.,5 Golda Me'ir Street Lev-Hanevet Building,"3rd Floor, Weizmann Science Park",Ness Ziona,,,Israel,624317,2018,
N-acetyl-DL-leucine,n/a,2018-02-22,"Treatment of Niemann-Pick disease, type C",Designated,,,N/A,N/A,IntraBio Inc.,270 Devon Road,,Tenafly,New Jersey,7670,USA,626218,2018,
taurolidine,n/a,2018-02-22,Treatment of neuroblastoma,Designated,,,N/A,N/A,"CorMedix, Inc.",1430 U.S. 206,Suite 200,Bedminster Township,New Jersey,7921,USA,528816,2018,
"6,8-bis(benzylthio)octanoic acid",n/a,2018-02-28,Treatment of Peripheral T-cell Lymphoma (PTCL),Designated,,,N/A,N/A,"Rafael Pharmaceuticals, Inc.",1 Duncan Drive,,Cranbury Township,New Jersey,8512,USA,623117,2018,
allogeneic Fecal Microbiota,n/a,2018-02-28,Treatment of Graft-Versus-Host Disease,Designated,,,N/A,N/A,MaaT Pharma,317 Avenue Jean Jaurès,,Lyon-7E-Arrondissement,,,France,627418,2018,
DL-3-n-butylphthalide,n/a,2018-02-28,Treatment of amyotrophic lateral sclerosis (ALS),Designated,,,N/A,N/A,"CSPC NBP Pharmaceutical Co, Ltd, subsidiary of CSPC Pharma Group",No. 88 Yangzi Road,,Shijiazhuang Shi,,,China,623217,2018,
hepcidin mimetic peptide,n/a,2018-03-01,Treatment of ß-thalassemia,Designated,,,N/A,N/A,Protagonist Therapeutics,521 Cottonwood Drive,Suite 100,Milpitas,California,95035,USA,584117,2018,
"N-(tert-butylcarbamoyl)-5-cyano-2-((4'-(difluoromethoxy)-[1,1'-biphenyl]-3-yl)oxy)benzenesulfonamide",n/a,2018-03-01,Treatment of pulmonary arterial hypertension,Designated,,,N/A,N/A,ATXA Therapeutics Limited,75 Avoca Avenue,Avoca Avenue,Blackrock,,,Ireland,628618,2018,
anhydrous enol-oxaloacetate,n/a,2018-03-07,Treatment of hepatocellular carcinoma,Designated,,,N/A,N/A,Terra Biological LLC,3830 Valley Centre Drive,Suite 705-561,San Diego,California,92130,USA,628018,2018,
Bacillus thuringiensis crystal protein (Cry5B),n/a,2018-03-07,"Treatment of gastroinstestinal infections caused by ascaris lumbricoides (roundworm), trichuris trichiura (whipworm), ancylostoma duodenale, necator americanus, and ancylostoma ceylanicum (hookworms)",Designated,,,N/A,N/A,University of Massachusetts Medical School,373 Plantation Street,"Two Biotech, Suite 219",Worcester,Massachusetts,1605,USA,562816,2018,
delta-9-tetrahydrocannabinol and cannabidiol,n/a,2018-03-07,Treatment of complex regional pain syndrome,Designated,,,N/A,N/A,PhytoPain Pharma Inc.,9315-4466 Quebec Inc,1230 Boise Street,Boucherville,Quebec,,Canada,549616,2018,
Granaticin B,n/a,2018-03-07,Treatment of Acute Lymphoblastic Leukemia (ALL),Designated,,,N/A,N/A,"Lin BioScience, LLC",3210 Merryfield Row,,San Diego,California,92121,USA,625017,2018,
messanger ribonucleic acid (mRNA)-based therapeutic agent encoding human methylmalonyl-coenzyme A mutase,n/a,2018-03-07,Treatment of isolated methylmalonic academia (MMA) due to methylmalonyl-Coenzyme A mutase (MUT) deficiency,Designated,,,N/A,N/A,"Moderna Therapeutics, Inc.",320 Bent Street,,Cambridge,Massachusetts,2141,USA,625717,2018,
"N-(trans-3-(5-((R)-1-hydroxyethyl)-1,3,4-oxadiazol-2-yl)cyclobutyl)-3-phenylisoxazole-5-carboxamide",n/a,2018-03-07,Treatment of cystic fibrosis,Designated,,,N/A,N/A,"Proteostasis Therapeutics, Inc.",200 Technology Square,,Cambridge,Massachusetts,2139,USA,544916,2018,
"1-118-signal regulatory protein alpha (human) fusion protein with immunoglobulin G1 (human Fc fragment), dimer",n/a,2018-03-08,Treatment of Cutaneous T-Cell Lymphoma,Designated,,,N/A,N/A,Trillium Therapeutics Inc.,2488 Dunwin Drive,,Mississauga,Ontario,,Canada,624917,2018,
autologous CD34+ cells transduced with lentiviral vector which encodes for the aryl Sulfatase A complimentary deoxyribonucleic acid sequence,n/a,2018-03-08,Treatment of the Metachromatic Leukodystrophy (including pre-symptomatic metachromatic leukodystrophy),Designated,,,N/A,N/A,"GlaxoSmithKline Intellectual Property Development Limited, England",980 Great West Road,Brentford,Middlesex,,,United Kingdom,631518,2018,
melatonin,Survivis 100®,2018-03-08,Treatment of perinatal asphyxia,Designated,,,N/A,N/A,Therapicon SrL,21 Via Malachia Marchesi de Taddei,,Milano,,,Italy,628518,2018,
Recombinant Human Monoclonal Antibody To Vascular Endothelial Growth Factor Receptor-2,n/a,2018-03-08,Treatment of Glioblastoma,Designated,,,N/A,N/A,PharmAbcine Inc.,"#307, Daedeok Tech-Biz Center","593, Daedeok-daero",Yuseong-gu,,,"Korea, Republic of",628118,2018,
tianeptine,n/a,2018-03-08,Treatment of Rett syndrome (RTT),Designated,,,N/A,N/A,AMO Pharma Ltd.,Throwsters,The Street,Wonersh,,,United Kingdom,627918,2018,
"3-(5-amino-2-methyl-4-oxoquinazolin-3(4H)-yl) piperidine-2,6-dione hydrochloride",n/a,2018-03-12,Treatment of follicular lymphoma,Designated,,,N/A,N/A,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,USA,629418,2018,
Pemigatinib,n/a,2018-03-12,Treatment of cholangiocarcinoma,Designated,,,N/A,N/A,Incyte Corporation,1801 Augustine Cut-Off,,Wilmington,Delaware,19803,USA,624117,2018,
sirolimus,n/a,2018-03-13,Treatment of sickle cell disease,Designated,,,N/A,N/A,Rare Partners srl Impresa Sociale,31 Corso Magenta,,Milano,,,Italy,628918,2018,
18-(p-[131]-iodophenyl)octadecyl phosphocholine,n/a,2018-03-15,Treatment of neuroblastoma,Designated,,,N/A,N/A,"Cellectar Biosciences, Inc.",3301 Agriculture Drive,,Madison,Wisconsin,53716,USA,629018,2018,
"2-[(2S)-2-methyl-1,4-dioxa-8-azaspiro[4.5]dec-8-yl]-8-nitro-6-trifluoromethyl-4H-1,3-benzothiazin-4-one",n/a,2018-03-15,Treatment of Tuberculosis (TB),Designated,,,N/A,N/A,Klinikum der Universität München,15 Marchioninistr.,,München,,,Germany,630318,2018,
antisense oligonucleotide specific to the antisense transcript of UBE3A,n/a,2018-03-15,Treatment of Angelman Syndrome,Designated,,,N/A,N/A,"GeneTx Biotherapeutics, LLC",1918 Sweetbriar Lane,,Darien,Illinois,60561,USA,630218,2018,
Cannabidiol and delta-9-tetrahydrocannabinol,n/a,2018-03-15,Treatment of amyotrophic lateral sclerosis,Designated,,,N/A,N/A,"AXIUM Pharmaceuticals, Inc.",265 Eastchester Drive,"Suite 133, #201",High Point,North Carolina,27262,USA,628818,2018,
PEGASEMP™(doxorubicin hydrochloride in a lipid-based pegylated nanoparticle modified with a 31 aminoacid peptide targeting nucleolin),n/a,2018-03-15,Treatment of Mesothelioma,Designated,,,N/A,N/A,"TREAT U, S.A.",Parque Industrial de Taveiro,Lote 44,Taveiro,,,Portugal,628318,2018,
Trimetazidine,n/a,2018-03-15,Treatment of acute-on-chronic liver failure,Designated,,,N/A,N/A,"Martin Pharmaceuticals, Inc.",233 Broadway,Suite 1750,New York,New York,10279,USA,629618,2018,
nicotinamide riboside and pterostilbene,n/a,2018-03-19,Treatment of Amyotrophic Lateral Sclerosis,Designated,,,N/A,N/A,Elysium Health Inc.,434 Broadway,Floor 2,New York,New York,10013,USA,628218,2018,
Sleeping Beauty Transposon-Engineered Autologous Plasmablasts for Expression and Delivery of Alpha-L-Iduronidase,Iduronicrin Genleukocel-T (Iduroicel),2018-03-19,Treatment of mucopolysaccharidosis type I (MPS I),Designated,,,N/A,N/A,Immusoft Corporation,454 North 34th Street,,Seattle,Washington,98103,USA,626918,2018,
elamipretide,Bendavia™,2018-03-22,Treatment of Barth syndrome,Designated,,,N/A,N/A,Stealth BioTherapeutics,275 Grove Street,Suite 3-107,Newton,Massachusetts,2466,USA,607817,2018,
fully human anti-proMyostatin monoclonal antibody of the IgG4/lambda isotype that binds to human pro- and latent myostatin with high affinity,n/a,2018-03-22,Treatment of spinal muscular atrophy,Designated,,,N/A,N/A,Scholar Rock,620 Memorial Drive,Suite E,Cambridge,Massachusetts,2139,USA,629218,2018,
perfluorooctyl-bromide (PFOB),n/a,2018-03-22,Treatment of respiratory distress syndrome (RDS),Designated,,,N/A,N/A,Children’s Hospital of Philadelphia,Clinical Research Support,"Colket Translational Research Building, 11th Floor, Room 11101",Philadelphia,Pennsylvania,19104,USA,631018,2018,
"Powdered extracts of the herbs Scutellaria baicalensis Geori, Glycyrrhiza uralensis Fisch, Paeonia lactiflora Pall, and Ziziphus jujuba Mill",n/a,2018-03-22,Treatment of hepatocellular carcinoma,Designated,,,N/A,N/A,Yiviva Inc.,"447 Broadway, 2FL",,New York,New York,10013,USA,624817,2018,
"7-(4-fluoro-2-methoxyphenyl)-6-methyl-N-(1-(piperidin-4-yl)-1H-pyrazol-4-yl) thieno [3,2-d]pyrimidin-2-amine semi-fumarate",n/a,2018-03-26,Treatment of acute myeloid leukemia,Designated,,,N/A,N/A,"MaxiNovel Pharmaceutical Co.,Ltd",Building A4-1005,181 Science Boulevard,Guangzhou,,,China,629118,2018,
Allogeneic mesenchymoangioblast-derived mesenchymal stem cells,n/a,2018-03-26,Treatment of acute graft versus host disease,Designated,,,N/A,N/A,Cynata Therapeutics Limited,"Level 3, 62 Lygon Street",,Carlton,,,Australia,632018,2018,
dexamethasone,n/a,2018-03-26,Treatment of multiple myeloma (MM),Designated,,,N/A,N/A,Dexcel Pharma Technologies Ltd,Dexcel Street,,Or Akiva,,,Israel,626318,2018,
N-acetyl-DL-leucine,n/a,2018-03-26,Treatment of GM2 Gangliosidosis,Designated,,,N/A,N/A,IntraBio Inc.,270 Devon Road,,Tenafly,New Jersey,7670,USA,631918,2018,
Small molecule allosteric inhibitor of the phosphodiesterase-4D enzyme,n/a,2018-03-26,Treatment of Fragile X Syndrome,Designated,,,N/A,N/A,"Tetra Discovery Partners, Inc.",38 Fulton Street West,Suite 303,Grand Rapids,Michigan,49503,USA,631618,2018,
(3R)-3-Methyl-6-[2-({5-methyl-2-[4-(trifluoromethyl)phenyl]-1H-imidazol-1-yl}methyl)phenoxy]hexanoic acid hemisulfate,n/a,2018-03-28,Treatment of Duchenne muscular dystrophy,Designated,,,N/A,N/A,"Astellas Pharma Global Development, Inc.",1 Astellas Way,,Northbrook,Illinois,60062,USA,633018,2018,
Autologous Activated T Lymphocytes (ATL),n/a,2018-03-28,Treatment of hepatocellular carcinoma (HCC),Designated,,,N/A,N/A,Lukas Biomedical Inc.,"3F, No. 2, Ln. 265, Sec. 4, Xin-Yi Rd",,Da’an,,,Taiwan,631218,2018,
fluasterone,n/a,2018-03-28,"Treatment of Cushing syndrome (including hyperglycemia, nonalcoholic fatty liver disease, and nonalcoholic steatosis)",Designated,,,N/A,N/A,"Sterotherapeutics, LLC",716 North Bethlehem Pike,Suite 203,Spring House,Pennsylvania,19002,USA,527116,2018,
"Humanized IgG4 monoclonal antibody against total complement component 1, subcomponent s",n/a,2018-03-28,Treatment of immune thrombocytopenia,Designated,,,N/A,N/A,Bioverativ USA Inc.,225 2nd Avenue,,Waltham,Massachusetts,2451,USA,614317,2018,
melatonin,Survivis®,2018-03-28,Treatment of subarachnoid hemorrhage,Designated,,,N/A,N/A,Therapicon SrL,21 Via Malachia Marchesi de Taddei,,Milano,,,Italy,600317,2018,
Nanoparticle suspension containing biosynthetic codon-optimized human ornithine transcarbamylase messenger RNA,n/a,2018-03-28,Treatment of ornithine transcarbamylase (OTC) deficiency,Designated,,,N/A,N/A,"Translate Bio, Inc.",200 Sidney Street,,Cambridge,Massachusetts,2139,USA,632618,2018,
Phenobarbital sodium,n/a,2018-03-28,Treatment of neonatal seizures,Designated,,,N/A,N/A,Genus Lifesciences,514 North 12th Street,,Allentown,Pennsylvania,18102,USA,633118,2018,
anti-EGFRvIII x anti-CD3 bispecific T cell engager antibody construct,n/a,2018-04-02,Treatment of glioblastoma,Designated,,,N/A,N/A,Amgen Inc.,One Amgen Center Drive,Mail Stop: 27-3-A,Thousand Oaks,California,91320,USA,634718,2018,
Brevenal,n/a,2018-04-02,Treatment of cystic fibrosis,Designated,,,N/A,N/A,"Silurian Pharmaceuticals, Inc.",6490 Doyle Street,,Emeryville,California,94608,USA,632318,2018,
elamipretide,Ocuvia™,2018-04-02,Treatment of Leber’s Hereditary Optic Neuropathy,Designated,,,N/A,N/A,Stealth BioTherapeutics Inc.,275 Grove Street 3-107,,Newton,Massachusetts,2466,USA,609417,2018,
tinostamustine hydrochloride,n/a,2018-04-02,Treatment of multiple myeloma,Designated,,,N/A,N/A,Mundipharma EDO GmbH,74 Sankt Alban-Rheinweg,,Basel,,,Switzerland,634018,2018,
"6-(4-(4-(2,3-Dicholorophenyl) piperazin-1-yl) butoxy)-2H-benzo [b] [1,4] oxazin-3(4H)-one hydrochloride",n/a,2018-04-04,Treatment of Idiopathic Pulmonary Fibrosis,Designated,,,N/A,N/A,"Reviva Pharmaceuticals, Inc.","1250 Oakmead Parkway, Suite 210",,Sunnyvale,California,94085,USA,633718,2018,
"humanized anti-CD40LG IgG1, kappa monoclonal antibody with heavy chain C220S/C226S/C229S/P238S substitutions to attenuate effector function",n/a,2018-04-04,Treatment of Amyotrophic Lateral Sclerosis (ALS),Designated,,,N/A,N/A,Anelixis Therapeutics,300 Technology Square,,Cambridge,Massachusetts,2139,USA,633818,2018,
pomalidomide,Pomalyst®,2018-04-04,Treatment of Kaposi sarcoma,Designated,,,N/A,N/A,Celgene Corporation,86 Morris Ave.,,Summit,New Jersey,7901,USA,635818,2018,
tenalisib,n/a,2018-04-04,Treatment of Cutaneous T-Cell Lymphoma,Designated,,,N/A,N/A,Rhizen Pharmaceuticals SA,40 Rue Fritz-Courvoisier,,La Chaux-de-Fonds,,,Switzerland,630618,2018,
"C1 esterase inhibitor, human",n/a,2018-04-05,Treatment of antibody mediated rejection (AMR) of solid organ transplants,Designated,,,N/A,N/A,CSL Behring,1020 First Avenue,PO Box 61501,King of Prussia,Pennsylvania,19406,USA,602117,2018,
human immunoglobulin (IgG1K) monoclonal antibody that binds to interleukin 15,n/a,2018-04-10,Treatment of refractory celiac disease.,Designated,,,N/A,N/A,Amgen Inc.,1 Amgen Center Drive,,Thousand Oaks,California,91320,USA,574517,2018,
"4-{[4-Amino-3-(4-cyclohexylpiperazin-1-yl)-9,10-dioxo-9,10-dihydroanthracen-1-yl]amino}benzoic acid",n/a,2018-04-11,Treatment of pancreatic cancer,Designated,,,N/A,N/A,"VM Oncology, LLC",45535 Northport Loop East,,Fremont,California,94538,USA,633518,2018,
Allogeneic umbilical cord blood (UCB) cell therapy product consisting of two cell fractions (CD34 enriched and CD34 depleted) derived from the same UCB unit,n/a,2018-04-11,For the enhancement of cell engraftment in patients receiving hematopoietic stem cell transplantation (HSCT),Designated,,,N/A,N/A,Magenta Therapeutics,50 Hampshire Street,,Cambridge,Massachusetts,2139,USA,635618,2018,
human glial restricted progenitor cells and their progeny,Q-Cells®,2018-04-11,Treatment of transverse myelitis,Designated,,,N/A,N/A,"Q Therapeutics, Inc.",417 Wakara Way,Ste. 3510,Salt Lake City,Utah,84108,USA,635118,2018,
methotrexate,n/a,2018-04-11,Prevention of proliferative vitreoretinopathy (PVR),Designated,,,N/A,N/A,"Helio Vision, Inc.","1000 Winter Street, 4th Floor",,Waltham,Massachusetts,2451,USA,630518,2018,
small Molecule rearranged during transfection (RET) Inhibitor,n/a,2018-04-11,"Treatment of rearranged during transfection (RET)-rearranged non-small cell lung cancer (NSCLC), JAK1/2-positive NSCLC, or TRKC-positive NSCLC.",Designated,,,N/A,N/A,Blueprint Medicines Corporation,45 Sidney Street,,Cambridge,Massachusetts,2139,USA,634318,2018,
tegavivint,n/a,2018-04-11,Treatment of Desmoid Tumors,Designated,,,N/A,N/A,Beta Cat Pharmaceuticals,"2450 Holcombe Blvd, Suite J606",,Houston,Texas,77021,USA,634118,2018,
"2-isopropyl-3H-naphtho[1,2-d]imidazole-4,5-dione",n/a,2018-04-16,Treatment of inherited mitochondrial respiratory chain disease,Designated,,,N/A,N/A,NeuroVive Pharmaceutical AB,Medicon Village,,Lund,,,Sweden,621217,2018,
Oraxol,n/a,2018-04-16,Treatment of angiosarcoma,Designated,,,N/A,N/A,"Athenex, Inc. dba Kinex Pharmaceuticals, Inc.",1001 Main Street,Suite 600,Buffalo,New York,14203,USA,594217,2018,
ubidecarenone,n/a,2018-04-16,Treatment of Epidermolysis Bullosa,Designated,,,N/A,N/A,"Berg, LLC (BERG)",500 Old Connecticut Path,Building B,Framingham,Massachusetts,1701,USA,635318,2018,
Ciclopirox,n/a,2018-04-17,Treatment of congenital erythropoietic porphyria,Designated,,,N/A,N/A,Atlas Molecular Pharma S.L.,Parque Tecnológico de Bizkaia,Building 800,Derio,,,Spain,629718,2018,
gemcitabine intra-arterial infusion via the RenovoCath RC120 catheter,,2018-04-24,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,RenovoRx,4546 El Camino Real,Suite 203,Los Altos,California,94022,United States,620917,,
Ursodeoxycholic acid,,2018-04-26,"Treatment of Niemann-Pick disease, type C",Designated,Not FDA Approved for Orphan Indication,,,,IntraBio Inc.,270 Devon Road,,Tenafly,New Jersey,7670,United States,636718,,
ex vivo expanded autologous human corneal epithelial cells containing stem cells,,2018-04-26,Treatment of limbal stem cell deficiency,Designated,Not FDA Approved for Orphan Indication,,,,Holostem Terapie Avanzate S.r.l.,Via Glauco Gottardi 100,,Modena,,,Italy,632218,,
"6'-(R)-methyl-5-O-(5-amino-5,6-dideoxy-alpha-L-talofuranosyl)-paromamine sulfate",,2018-04-26,Treatment of Cystinosis,Designated,Not FDA Approved for Orphan Indication,,,,"ELOXX Pharmaceuticals, Inc.","950 Winter Street, North",,Waltham,Massachusetts,2451,United States,636218,,
"5-{(1R,2R)-2-[(Cyclopropylmethyl)amino]cyclopropyl}-N-(tetrahydro-2H-pyran-4-yl)thiophene-3-carboxamide monohydrochloride",,2018-04-26,Treatment of Kabuki Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,"Takeda Development Center Americas, Inc.",Takeda Parkway,,Deerfield,Illinois,60015,United States,635718,,
Rozanolixizumab,,2018-04-30,Treatment of immune thrombocytopenic purpura (ITP),Designated,Not FDA Approved for Orphan Indication,,,,"UCB, Inc.",1950 Lake Park Drive Building 2100,,Smyrna,Georgia,30080,United States,636618,,
Cell-penetrating activating transcription factor 5 mimetic,,2018-04-30,Treatment of Acute Myeloid Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,"Sapience Therapeutics, Inc",500 Mamaroneck Avenue,Suite 320,Harrison,New York,10528,United States,637418,,
autologous tumor infiltrating lymphocytes (TIL),,2018-04-30,Treatment of cervical cancer with a tumor size greater than 2 cm. in diameter,Designated,Not FDA Approved for Orphan Indication,,,,"Iovance Biotherapeutics, Inc.",999 Skyway Road,Suite 150,San Carlos,California,94070,United States,601517,,
BN-Brachyury; a heterologous prime/boost therapeutic cancer vaccine composed of MVA-BN-Brachyury (prime) and FPV-Brachyury (boost),,2018-04-30,Treatment of chordoma,Designated,Not FDA Approved for Orphan Indication,,,,Bavarian Nordic A/S,3025 Carrington Mill Boulevard,Suite 100,Morrisville,North Carolina,27560,United States,634818,,
venglustat,,2018-05-01,Treatment of Autosomal Dominant Polycystic Kidney Disease,Designated,Not FDA Approved for Orphan Indication,,,,"Genzyme Corporation, a SANOFI COMPANY",50 Binney Street,,Cambridge,Massachusetts,2142,United States,637218,,
ivosidenib,,2018-05-01,Treatment of glioma.,Designated,Not FDA Approved for Orphan Indication,,,,Servier Pharmaceuticals LLC,200 Pier Four Blvd,,Boston,Massachusetts,2210,United States,637718,,
Indolino-benzodiazepine compound (sulfonated DGN462) conjugated to the humanized anti-CD33 monoclonal antibody (Z4681A) via the sulfo-SPDB linker,,2018-05-02,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,"ImmunoGen, Inc.",830 Winter Street,,Waltham,Massachusetts,2451,United States,635518,,
peptide fraction derived from porcine brain protein,,2018-05-08,Treatment of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL),Designated,Not FDA Approved for Orphan Indication,,,,EVER Neuro Pharma GmbH,3 Oberburgau,,4866 Unterach,Salzburg,,Austria,582617,,
synthetic preImplantation factor,,2018-05-08,Prevention of graft versus host disease,Designated,Not FDA Approved for Orphan Indication,,,,"BioIncept, LLC",140 East 40th Street,Suite 11E,New York,New York,10016,United States,622517,,
18-(p-[131I]-iodophenyl)octadecyl phosphocholine,,2018-05-08,Treatment of soft tissue sarcomas including rhabdomyosarcoma,Designated,Not FDA Approved for Orphan Indication,,,,"Cellectar Biosciences, Inc.",3301 Agriculture Drive,,Madison,Wisconsin,53716,United States,638418,,
galinpepimut-S,,2018-05-08,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,"SELLAS Life Sciences Group, Inc.",315 Madison Avenue,4th floor,New York,New York,10017,United States,636918,,
budesonide,,2018-05-08,Treatment of eosinophilic esophagitis,Designated,Not FDA Approved for Orphan Indication,,,,"Salix Pharmaceuticals, Inc., division of Valeant Pharmaceuticals North America",400 Somerset Corporate Boulevard,,Bridgewater,New Jersey,8807,United States,634418,,
20-hydroxyecdysone,,2018-05-10,Treatment of Duchenne Muscular Dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,Biophytis SA,14 Avenue de lOpera,,Paris,,,France,639318,,
carboxyamidotriazole orotate,,2018-05-10,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,"Tactical Therapeutics, Inc.","48 Wall Street, 12th Floor",,New York,New York,10005,United States,637318,,
olaparib,Lynparza,2018-05-15,Treatment of primary peritoneal cancer,Designated/Approved,,"Lynparza is indicated for the maintenance treatment of adult patients with deleterious or suspected deleterious germline or somatic BRCA-mutated (gBRCAm or sBRCAm) advanced epithelial ovarian, fallopian tube or primary peritoneal cancer who are in complete or partial response to first-line platinum based chemotherapy. Select patients with gBRCAm advanced epithelial ovarian, fallopian tube or primary peritoneal cancer for therapy based on FDA-approved companion diagnostic for Lynparza.",2018-12-19,2025-12-19,AstraZeneca Pharmaceuticals LP,1800 Concord Pike,P. O. Box 8355,Wilmington,Delaware,19803,United States,419013,,
olaparib,Lynparza,2018-05-15,Treatment of Fallopian Tube Cancer,Designated/Approved,,"Lynparza is indicated for the maintenance treatment of adult patients with deleterious or suspected deleterious germline or somatic BRCA-mutated (gBRCAm or sBRCAm) advanced epithelial ovarian, fallopian tube or primary peritoneal cancer who are in complete or partial response to first-line platinum based chemotherapy. Select patients with gBRCAm advanced epithelial ovarian, fallopian tube or primary peritoneal cancer for therapy based on FDA-approved companion diagnostic for Lynparza.",2018-12-19,2025-12-19,AstraZeneca Pharmaceuticals LP,1800 Concord Pike,P. O. Box 8355,Wilmington,Delaware,19803,United States,417613,,
diosmin,,2018-05-15,Treatment of systemic sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,"Primus Pharmaceuticals, Inc.",7373 North Scottsdale Road,Suite B-200,Scottsdale,Alaska,85253,United States,582417,,
olaparib,Lynparza,2018-05-15,Treatment of primary peritoneal cancer,Designated/Approved,,"Maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer, who are in a complete or partial response to platinum-based chemotherapy; and treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated advanced ovarian cancer who have been treated with three or more prior lines of chemotherapy.",2017-08-17,2024-08-17,AstraZeneca Pharmaceuticals LP,1800 Concord Pike,P. O. Box 8355,Wilmington,Delaware,19803,United States,419013,,
olaparib,Lynparza,2018-05-15,Treatment of Fallopian Tube Cancer,Designated/Approved,,"Maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer, who are in a complete or partial response to platinum-based chemotherapy; and treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated advanced ovarian cancer who have been treated with three or more prior lines of chemotherapy.",2017-08-17,2024-08-17,AstraZeneca Pharmaceuticals LP,1800 Concord Pike,P. O. Box 8355,Wilmington,Delaware,19803,United States,417613,,
synthetic double-stranded RNA oligonucleotide conjugated to N-acetyl-D-galactosamine aminosugar residues,,2018-05-15,Treatment of primary hyperoxaluria,Designated,Not FDA Approved for Orphan Indication,,,,"Dicerna Pharmaceuticals, Inc.",87 Cambridge Park Drive,,Cambridge,Massachusetts,2140,United States,635418,,
olaparib,Lynparza,2018-05-15,Treatment of Fallopian Tube Cancer,Designated/Approved,,"Lynparza is indicated in combination with bevacizumab for the maintenance treatment of adult patients with advanced epithelial ovarian, fallopian tube or primary peritoneal cancer who are in complete or partial response to first-line platinum-based chemotherapy and whose cancer is associated with homologous recombination deficiency (HRD) positive status defined by either: a deleterious or suspected deleterious BRCA mutation, and/or genomic instability. Select patients for therapy based on an FD",2020-05-08,2027-05-08,AstraZeneca Pharmaceuticals LP,1800 Concord Pike,P. O. Box 8355,Wilmington,Delaware,19803,United States,417613,,
olaparib,Lynparza,2018-05-15,Treatment of primary peritoneal cancer,Designated/Approved,,"Lynparza is indicated in combination with bevacizumab for the maintenance treatment of adult patients with advanced epithelial ovarian, fallopian tube or primary peritoneal cancer who are in complete or partial response to first-line platinum-based chemotherapy and whose cancer is associated with homologous recombination deficiency (HRD) positive status defined by either: a deleterious or suspected deleterious BRCA mutation, and/or genomic instability. Select patients for therapy based on an FD",2020-05-08,2027-05-08,AstraZeneca Pharmaceuticals LP,1800 Concord Pike,P. O. Box 8355,Wilmington,Delaware,19803,United States,419013,,
"8-(6-iodobenzo[1,3]dioxol-5-ylsufanyl)-9-(3-isopropylamino propyl)adenine dihydrochloride",,2018-05-16,Treatment of Myelofibrosis,Designated,Not FDA Approved for Orphan Indication,,,,"Samus Therapeutics, Inc.",10 South Main Street,,Topsfield,Massachusetts,1983,United States,638018,,
golodirsen,VYONDYS 53,2018-05-22,Treatment of Duchenne muscular dystrophy (DMD),Designated/Approved,,VYONDYS 53 is indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 53 skipping.,2019-12-12,2026-12-12,"Sarepta Therapeutics, Inc.",215 First Street,,Cambridge,Massachusetts,2142,United States,636818,,
autologous human adipose perivascular stromal cells genetically modified to secrete soluble Tumor Necrosis Factor-related Apoptosis-inducing Ligand (sTRAIL),,2018-05-22,Treatment of Pancreatic Cancer,Designated,Not FDA Approved for Orphan Indication,,,,Rigenerand Srl,"4, Via Maestri del Lavoro",,,Medolla (Modena),,Italy,638218,,
"potassium (benzenesulfonyl)({[6-(3-{2-[1-(trifluoromethyl)cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-2-[(4S)-2,2,4-trimethylpyrrolidin-1-yl]pyridin-3-yl]carbonyl})azanide/tezacaftor/ivacaftor",,2018-05-23,Treatment of Cystic Fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,Vertex Pharmaceuticals Inc.,50 Northern Avenue,,Boston,Massachusetts,2210,United States,638618,,
tazemetostat,,2018-05-23,Treatment of chordoma,Designated,Not FDA Approved for Orphan Indication,,,,"Epizyme, Inc.",400 Technology Square,4th Floor,Cambridge,Massachusetts,2139,United States,637118,,
rebastinib,,2018-05-23,Treatment of Facioscapulohumeral Muscular Dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,Genea Biocells US Inc.,11099 North Torrey Pines Road,,San Diego,California,92037,United States,637018,,
"Allogeneic, ex vivo expanded, umbilical cord blood-derived, hematopoietic CD34+ progenitor cells and Allogeneic, non-expanded, umbilical cord blood-derived, hematopoietic mature myeloid and lymphoid cells (Non-cultured fraction)",,2018-05-23,Enhancement of cell engraftment and immune reconstitution in patients receiving hematopoietic stem cell transplant,Designated,Not FDA Approved for Orphan Indication,,,,Gamida Cell Ltd.,P. O. Box 34670,,Jerusalem,,,Israel,637518,,
"trans-4-({2-(aminocarbonyl)-5-[6,6-dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl]phenyl}amino)cyclohexyl glycinate mesylate",,2018-05-23,Treatment of neuroendocrine tumors (NETs).,Designated,Not FDA Approved for Orphan Indication,,,,Esanex Inc.,115 West Washington Street,South Tower Suite 1680,Indianapolis,Indiana,46240,United States,637818,,
"1-[(3S)-[4-amino-3-[(3,5-dimethoxyphenyl)ethynyl]-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-pyrrolidinyl]-2-propen-1-one",,2018-05-23,Treatment of cholangiocarcinoma (CCA),Designated,Not FDA Approved for Orphan Indication,,,,"Taiho Oncology, Inc.",101 Carnegie Center Drive,Suite 101,Princeton,New Jersey,8540,United States,635018,,
diazepam,,2018-05-23,Treatment of Dravet syndrome,Designated,Not FDA Approved for Orphan Indication,,,,"Xeris Pharmaceutical, Inc.",180 North LaSalle Street,Suite 1800,Chicago,Illinois,60601,United States,638118,,
"N-(2-chloro-6-propoxypyridin-4-yl)-2-(2-hydroxyethyl)-2-(4-isopropyl-1,3-dimethyl-1H-pyrazolo[3,4-b]pyridin-6-yl)hydrazinecarboxamide",,2018-05-23,Treatment of Idiopathic pulmonary fibrosis (IPF),Designated,Not FDA Approved for Orphan Indication,,,,"Arroyo Biosciences, LLC",1812 Pelling Court,,Silver Spring,Maryland,20905,United States,618717,,
photochlor,,2018-05-24,Treatment of Esophageal Cancer,Designated,Not FDA Approved for Orphan Indication,,,,"Ami Onco-Theranostics, LLC",701 Ellicott Street,Center of Excellence,Buffalo,New York,14203,United States,640418,,
teicoplanin,,2018-05-24,Treatment of Staphylococcus aureus lung infections in patients with cystic fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,Neupharma srl,8 Piazza del Duomo,,Imola,Emilia-Romagna,,Italy,631418,,
romiplostim,Nplate,2018-05-24,Treatment of patients acutely exposed to myelosuppressive doses of radiation following radiological/nuclear incident,Designated/Approved,,to increase survival in adults and pediatric patients (including term neonates) acutely exposed to myelosuppressive doses of radiation (Hematopoietic Syndrome of Acute Radiation Syndrome [HS-ARS]),2021-01-28,2028-01-28,Amgen Inc.,1 Amgen Center Drive,,Thousand Oaks,California,91320,United States,639818,,
vutrisiran,,2018-05-25,Treatment of transthyretin-mediated amyloidosis (ATTR amyloidosis),Designated,Not FDA Approved for Orphan Indication,,,,"Alnylam Pharmaceuticals, Inc.",300 Third Street,,Cambridge,Massachusetts,2142,United States,637618,,
apomorphine palmitate,,2018-06-04,Treatment of Acute Myeloid Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,Leukos Biotech,"Muntaner 383, 32",,Barcelona,Catalonia,,Spain,640618,,
liposomal mannose-1-phosphate,,2018-06-04,Treatment of Phosphomannomutase 2-Congenital Disorder of Glycosylation,Designated,Not FDA Approved for Orphan Indication,,,,"Glycomine, Inc.",QB3@953,953 Indiana Street,San Francisco,California,94107,United States,640318,,
olinciguat,,2018-06-04,Treatment of Sickle Cell Disease,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,"Cyclerion Therapeutics, Inc.",245 First Street,"Riverview II, 18th Floor",Cambridge,Massachusetts,2142,United States,639718,,
L-cystine bis(N'-methylpiperazide),,2018-06-04,Treatment of cystinuria.,Designated,Not FDA Approved for Orphan Indication,,,,PharmaKrysto Ltd,Rmt Accountants & Business Advisors Ltd.,Gosforth Park Avenue,,England,,United Kingdom,639418,,
TransCon Parathyroid Hormone (mPEG conjugated parathyroid hormone 1-34),,2018-06-04,Treatment of hypoparathyroidism,Designated,Not FDA Approved for Orphan Indication,,,,Ascendis Pharma Bone Diseases A/S,Tuborg Boulevard 5,DK-2900,Hellerup,,,Denmark,638818,,
"7-benzyl-4-(2-methylbenzyl)-1,2,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(4H)-one",,2018-06-04,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,"Chimerix, Inc.","2505 Meridian Parkway, Suite 100",,Durham,North Carolina,27713,United States,640218,,
nitric oxide,,2018-06-05,Treatment of non-tuberculous mycobacterial lung disease,Designated,Not FDA Approved for Orphan Indication,,,,"Novoteris, LLC",7245 Garden Grove Blvd.,Suite C,Garden Grove,California,92841,United States,638918,,
brincidofovir,Tembexa,2018-06-05,Treatment of smallpox,Designated/Approved,,"Treatment of human smallpox disease caused by variola virus in adult and pediatric patients, including neonates",2021-06-04,2028-06-04,"Chimerix, Inc.",2505 Meridian Parkway,Suite 100,Durham,North Carolina,27713,United States,640518,,
N-acetyl-DL-leucine,,2018-06-06,Treatment of Spinocerebellar Ataxia (SCA),Designated,Not FDA Approved for Orphan Indication,,,,IntraBio Inc.,270 Devon Road,,Tenafly,New Jersey,7670,United States,640818,,
nirogacestat,,2018-06-07,Treatment of desmoid tumor (aggressive fibromatosis),Designated,Not FDA Approved for Orphan Indication,,,,"SpringWorks Subsidiary 2, PBC",575 5th Avenue,,New York,New York,10017,United States,636518,,
Recombinant humanized IgG1 anti-HER2 monoclonal antibody conjugated to Duostatin-5,,2018-06-07,Treatment of gastric cancer.,Designated,Not FDA Approved for Orphan Indication,,,,"Klus Pharma, Inc.",8 Clarke Drive,Suite 4,Cranbury Township,New Jersey,8512,United States,641118,,
extracellular domain of Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 fused to the Fc region of human IgG1,,2018-06-11,Treatment of ectonucleotide pyrophosphatase/phosphodiesterase 1 deficiency (generalized arterial calcification of infancy and autosomal recessive hypophosphatemic rickets type 2),Designated,Not FDA Approved for Orphan Indication,,,,Inozyme Pharma Inc.,700 Technology Square,,Cambridge,Massachusetts,2139,United States,637918,,
indralin,,2018-06-13,Prevention of acute radiation syndrome (ARS),Designated,Not FDA Approved for Orphan Indication,,,,"Advanced Innovative Partners, Inc.",7947 Brookside Court,,Lake Worth,Florida,33467,United States,636318,,
deuterated S-lisofylline,,2018-06-18,Treatment of Necrobiosis Lipoidica,Designated,Not FDA Approved for Orphan Indication,,,,Processa Pharmaceuticals Inc,7380 Coca Cola Drive,Suite 106,Hanover,Maryland,21076,United States,640918,,
Fixed dose combination of relatlimab and nivolumab,,2018-06-18,Treatment of gastric cancer (GC) and gastro-esophageal junction cancer (GEJ).,Designated,Not FDA Approved for Orphan Indication,,,,Bristol-Myers Squibb Co.,P. O. Box 4000,,Princeton,New Jersey,8543,United States,641718,,
"recombinant human anti-human Sortilin (SORT1) monoclonal IgG1 G1m17,1 [or G1m (z,a)] kappa monoclonal antibody",,2018-06-18,Treatment of Frontotemporal Dementia,Designated,Not FDA Approved for Orphan Indication,,,,Alector,151 Oyster Point Boulevard,Suite 300,South San Francisco,California,94080,United States,605817,,
Autologous Cytokine-Induced Killer Cells (Cytokine-Induced Killer Cells plus Cytotoxic T Lymphocytes),,2018-06-21,Treatment of Hepatocellular Carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,Green Cross Cell Corporation,"4, 6th floor, SJ Technovile 278","Beotkkot-ro, Geumcheon-gu",Seoul,Seoul,,South Korea,642418,,
ezogabine,,2018-06-21,Treatment of KCNQ2 epileptic encephalopathy,Designated,Not FDA Approved for Orphan Indication,,,,"Xenon Pharmaceuticals, Inc.",200-3650 Gilmore Way,,Burnaby,,,Canada,639118,,
L-alanoyl-D-glutamate endopeptidase from Bacillus-infected bacteriophages,,2018-06-21,Treatment of inhalational anthrax,Designated,Not FDA Approved for Orphan Indication,,,,"iNtRON Biotechnology, Inc.","137 Sagimakgol-ro, Seongnam-si",,,Gyeonggi-do,,South Korea,642118,,
recombinant adeno-associated virus vector encoding human CYP4V2 protein,,2018-06-21,Treatment of Bietti's crystalline dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,Reflection Biotechnologies Limited,"Unit 601, 6/F, Core Building 1",No. 1 Science Park East Avenue,Pak Shek Kok,New Territories,,,609917,,
Recombinant adeno-associated virus serotype rh74 vector expressing the micro-dystrophin gene,,2018-06-21,Treatment of Duchenne Muscular Dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,"Sarepta Therapeutics, Inc.",215 First Street,,Cambridge,Massachusetts,2142,United States,641318,,
cannabidiol,,2018-06-25,Treatment of autoimmune hepatitis,Designated,Not FDA Approved for Orphan Indication,,,,Revive Therapeutics Ltd.,5 Director Court,Suite 105,Vaughan,,,Canada,609617,,
small molecule selective inhibitor of c-Jun N-terminal kinase,,2018-06-27,Treatment of idiopathic pulmonary fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,United States,573116,,
allogeneic anti-CD19 chimeric antigen receptor (CAR)-T cells,,2018-07-02,Treatment of acute lymphoblastic leukemia (ALL),Designated,Not FDA Approved for Orphan Indication,,,,"Precision BioSciences, Inc.",302 East Pettigrew Street,Suite A-100,Durham,North Carolina,27701,United States,606017,,
Imlifidase,,2018-07-03,Treatment of anti-glomerular basement membrane (anti-GBM) disease,Designated,Not FDA Approved for Orphan Indication,,,,Hansa Medical AB,"Scheelev䧥n 22, P. O. Box 785",SE-220 07,Lund,,,Sweden,643118,,
"3-[5-[(1R)-1-[bis(aziridin-1-yl(phosphoryloxy]ethyl]-2-nitrophenoxy]-N,N-dimethylbenzamide",,2018-07-03,Treatment of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,"OBI Pharma USA, Inc.","6020 Cornerstone Court W, Suite 200",,San Diego,California,92121,United States,643218,,
18-(p-[131I]-iodophenyl)octadecyl phosphocholine,,2018-07-03,Treatment of Ewings Sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,"Cellectar Biosciences, Inc.",3301 Agriculture Drive,,Madison,Wisconsin,53716,United States,646918,,
Follistatin291-IgG2 Fc fusion protein,,2018-07-03,Treatment of facioscapulohumeral muscular dystrophy,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,Acceleron Pharma Inc.,128 Sidney Street,,Cambridge,Massachusetts,2139,United States,573617,,
Dilanubicel,,2018-07-09,Reduction of morbidity and mortality associated with hematopoietic stem cell transplantation,Designated,Not FDA Approved for Orphan Indication,,,,"Nohla Therapeutics, Inc.",1616 Fairview Avenue East,Suite 100,Seattle,Washington,98102,United States,642818,,
ivabradine,,2018-07-09,Treatment of post-cardiac transplant heart dysfunction,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,"Amgen, Inc.,",1 Amgen Center Drive,Mail Stop 27-2-D,Thousand Oaks,California,91320,United States,631818,,
"soidum (5-(3-cyanopyrazolo[1,5-a]pyridin-5-yl)-2-methoxypyridin-3-yl)((2,4-difluorophenyl)sulfonyl)amide",,2018-07-09,Treatment of idiopathic pulmonary fibrosis (IPF),Designated,Not FDA Approved for Orphan Indication,,,,"Sunshine Lake Pharma Co., Ltd",Northern Industry Road #1,Song Shan Lake,Dongguan,Guangdong,,China,642518,,
competitive and reversible small molecule inhibitor of the O-linked-B-N-acetylglucosaminidase enzyme,,2018-07-10,Treatment of progressive supranuclear palsy,Designated,Not FDA Approved for Orphan Indication,,,,Asceneuron S.A.,EPFL Innovation Park,B⴩ment B,Lausanne,Vaud,,Switzerland,644318,,
Daromun,,2018-07-10,Treatment of Melanoma Stages IIb through IV.,Designated,Not FDA Approved for Orphan Indication,,,,Philogen S.p.A.,La Lizza 7,I-53100 Siena,Siena,Tuscany,,Italy,640018,,
lisocabtagene maraleucel,Breyanzi,2018-07-12,Treatment of primary mediastinal large B-cell lymphoma,Designated/Approved,,"treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy, including diffuse large B-cell lymphoma (DLBCL) not otherwise specified (including DLBCL arising from indolent lymphoma), high-grade B cell lymphoma, primary mediastinal large B-cell lymphoma, and follicular lymphoma grade 3B",2021-02-05,2028-02-05,"Juno Therapeutics, Inc.",400 Dexter Avenue N,,Seattle,Washington,98109,United States,644018,,
Recombinant human insulin receptor monoclonal antibody-N-heparan sulfamidase fusion protein,,2018-07-12,"Treatment of Mucopolysaccharidosis Type IIIA, Sanfilippo A Syndrome",Designated,Not FDA Approved for Orphan Indication,,,,"ArmaGen, Inc.","26679 Agoura Road, Suite #100",,Calabasas,California,91302,United States,643818,,
recombinant adeno-associated viral vector containing a single-stranded transgene encoding a codon-optimized human SMN1 complementary deoxyribonucleic acid under the control of the chicken beta actin promoter,,2018-07-16,Treatment of Spinal Muscular Atrophy,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,Biogen Inc.,225 Binney Street,,Cambridge,Massachusetts,2142,United States,644718,,
lenabasum,,2018-07-18,Treatment of dermatomyositis,Designated,Not FDA Approved for Orphan Indication,,,,"Corbus Pharmaceuticals, Inc.",500 River Ridge Drive,Second Floor,Norwood,Massachusetts,2062,United States,643618,,
ascorbic acid,,2018-07-30,Treatment of cystic fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,"Renovion, Inc.",112 South Duke Street,,Durham,North Carolina,27701,United States,645618,,
arsenic trioxide,,2018-07-30,Treatment of Graft-versus-host disease,Designated,Not FDA Approved for Orphan Indication,,,,Medsenic,204 avenue de Colmar,,Strasbourg,Grand Est,,France,645318,,
human Alpha1-Proteinase inhibitor,,2018-07-30,Prevention of graft-versus-host disease (GVHD),Designated,Not FDA Approved for Orphan Indication,,,,CSL Behring LLC,1020 First Ave.,PO Box 61501,King of Prussia,Pennsylvania,19406,United States,644118,,
antibody drug conjugate of metal-binding motif-introduced trastuzumab antibody variant and monomethyl auristatin E,,2018-07-30,Treatment of Gastric Cancer,Designated,Not FDA Approved for Orphan Indication,,,,"Alteogen, Inc.",62 Yuseong-daero 1628beon-gil,Yuseong-gu,Daejeon,Daejeon,,South Korea,643918,,
anti-CD47 monoclonal antibody,,2018-07-30,Treatment of multiple myeloma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,"Surface Oncology, Inc.","50 Hampshire St, 8th Floor",,Cambridge,Massachusetts,1239,United States,643718,,
carbon monoxide,,2018-08-01,Prevention of delayed graft function in renal transplant recipients,Designated,Not FDA Approved for Orphan Indication,,,,"Proterris, Inc.",197 West Springfield Street,,Boston,Massachusetts,2118,United States,573917,,
small molecule inhibitor of integrins avb6 and avb1,,2018-08-01,Treatment of Idiopathic Pulmonary Fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,"Pliant Therapeutics, Inc.",260 Littlefield Avenue,,South San Francisco,California,94080,United States,646518,,
lenzumestrocel,,2018-08-01,Treatment of amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,"Corestem, Inc.","2F, 24, Pangyo-ro 255 beon-gil",Bundang-gu,Seongnam-si,Gyeonggi-do,,South Korea,646618,,
"4-amino-1-[(2R,3S,4S,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrothiophen-2-yl] pyrimidin-2(1H)-one",,2018-08-01,Treatment of cholangiocarcinoma,Designated,Not FDA Approved for Orphan Indication,,,,"FUJIFILM Pharmaceutical U.S.A., Inc.",1 Broadway,,Cambridge,Massachusetts,2142,United States,646118,,
Autologous Cytokine-Induced Killer Cells (Cytokine-Induced Killer Cells Plus Cytotoxic T Lymphocytes),,2018-08-01,Treatment of glioblastoma,Designated,Not FDA Approved for Orphan Indication,,,,Green Cross Cell Corporation,"4, 6th floor, SJ Technovile 278","Beotkkot-ro, Geumcheon-gu",Seoul,Seoul,,South Korea,645818,,
lurbinectedin,Zepzelca,2018-08-01,Treatment of small cell lung cancer (SCLC),Designated/Approved,,Zepzelca (lurbinectedin) is indicated for the treatment of adult patients with metastatic small cell lung cancer (SCLC) with disease progression on or after prior platinum-based chemotherapy.,2020-06-15,2027-06-15,Jazz Pharmaceuticals Ireland Limited,5th Floor Waterloo Exchange,Waterloo Road,Dublin,,,Ireland,646018,,
trimetazidine,,2018-08-07,Treatment of pulmonary arterial hypertension,Designated,Not FDA Approved for Orphan Indication,,,,"Martin Pharmaceuticals, Inc.",233 Broadway,Suite 1750,New York,New York,10279,United States,642918,,
"interleukin-1 receptor antagonist (IL-1Ra, sequence-homologous anakinra)",,2018-08-07,Treatment of Bronchiolitis Obliterans,Designated,Not FDA Approved for Orphan Indication,,,,"Onspira Therapeutics, Inc.",101 Lindenwood Drive,Suite 400,Malvern,Pennsylvania,19355,United States,636118,,
"A replication-incompetent, non-integrating Herpes simplex type 1 (HSV-1) vector expressing the human transglutaminase-1 (TGM-1) enzyme",,2018-08-07,Treatment of TGM-1-deficient autosomal recessive congenital ichthyosis (ARCI),Designated,Not FDA Approved for Orphan Indication,,,,"Krystal Biotech, Inc.",2100 Wharton Street,,Pittsburgh,Pennsylvania,15203,United States,648718,,
adenovirus associated viral vector serotype 8 containing the human Cyclic Nucleotide Gated Channel Alpha 3 subunit (CNGA3) gene,,2018-08-07,Treatment of achromatopsia due to CNGA3 gene mutations.,Designated,Not FDA Approved for Orphan Indication,,,,MeiraGTx UK II Ltd,92 Britannia Walk,N1 7NQ,London,England,,United Kingdom,648118,,
Synthetic stereopure antisense oligonucleotide specific for human dystrophin pre-messenger ribonucleic acid (mRNA),,2018-08-07,Treatment of Duchenne muscular dystrophy,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,Wave Life Sciences Ltd.,733 Concord Avenue,,Cambridge,Massachusetts,2138,United States,602417,,
monosialotetrahexosylganglioside,,2018-08-07,Treatment of Huntingtons Disease,Designated,Not FDA Approved for Orphan Indication,,,,"Qilu Pharmaceutical Co., Ltd.",243 Gong Ye Bei Road Jinan,,,Shandong,,China,648018,,
[(4-benzylpiperazin-1-yl)(2-(isopentylamino)pyridin-3-yl)methanone]-phosphate,,2018-08-07,Treatment of Angelman Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,"Seneca Biopharma, Inc.",20271 Goldenrod Lane,Suite 2024,Germantown,Maryland,20876,United States,647018,,
(1-hydroxy-2-oxopiperidin-3-yl)phosphonic acid,,2018-08-09,Treatment of Glioblastoma,Designated,Not FDA Approved for Orphan Indication,,,,The University of Texas MD Anderson Cancer Center,1515 Holcombe Blvd #2,,Houston,Texas,77030,United States,646218,,
"2-(3,5-difluoro-3'-methoxybiphenyl-4-ylamino)nicotinic acid",,2018-08-16,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,"ASLAN Pharmaceuticals Pte, Ltd.",83 Clemenceau Avenue,#12-03,Singapore,,,Singapore,647118,,
bertilimumab,,2018-08-17,Treatment of bullous pemphigoid,Designated,Not FDA Approved for Orphan Indication,,,,"Alexion Pharmaceuticals, Inc.",121 Seaport Boulevard,,Boston,Massachusetts,2210,United States,578517,,
clofazimine,,2018-08-17,Treatment of Pulmonary Nontuberculous Mycobacterial Infections,Designated,Not FDA Approved for Orphan Indication,,,,MannKind Corporation,1 Casper Street,,Danbury,Connecticut,6810,United States,646318,,
"4-[(7-Methoxy-2,3-dihydro-1,4-benzothiazepin-4(5H)-yl)methyl]benzoic acid, hemifumarate",,2018-08-17,Treatment of Ryanodine receptor type 1-related myopathies,Designated,Not FDA Approved for Orphan Indication,,,,"ARMGO Pharma, Inc.",PMB #260,923 Saw Mill River Road,Ardsley,New York,10502,United States,558016,,
fully human nicotine-specific monoclonal antibody,,2018-08-22,Treatment of thromboangiitis obliterans (Buergers disease),Designated,Not FDA Approved for Orphan Indication,,,,"Antidote Therapeutics, Inc.",708 Quince Orchard Rd.,Suite 250-C,Gaithersburg,Maryland,20878,United States,647218,,
Adeno-Associated Viral Vector encoding C1 Esterase Inhibitor,,2018-08-22,Treatment of Angioedema due to C1-Inhibitor Deficiency,Designated,Not FDA Approved for Orphan Indication,,,,"Adverum Biotechnologies, Inc.",800 Saginaw Drive,,Redwood City,California,94063,United States,648218,,
"elexacaftor, tezacaftor, and ivacaftor; ivacaftor",Trikafta,2018-08-29,Treatment of Cystic Fibrosis,Designated/Approved,,treatment of cystic fibrosis (CF) in patients aged 12 years and older who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene or a mutation in the CFTR gene that is responsive based on in vitro data,2020-12-21,2027-12-21,Vertex Pharmaceuticals Inc.,50 Northern Avenue,,Boston,Massachusetts,2210,United States,647618,,
elexacaftor/tezacaftor/ivacaftor,TRIKAFTA,2018-08-29,Treatment of Cystic Fibrosis,Designated/Approved,,TRIKAFTA is indicated for the treatment of cystic fibrosis (CF) in patients aged 12 years and older who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene,2019-10-21,2026-10-21,Vertex Pharmaceuticals Inc.,50 Northern Avenue,,Boston,Massachusetts,2210,United States,647618,,
"elexacaftor, tezacaftor, and ivacaftor; ivacaftor",Trikafta,2018-08-29,Treatment of cystic fibrosis,Designated/Approved,,Treatment of cystic fibrosis (CF) in patients aged 6 years and older who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene or a mutation in the CFTR gene that is responsive based on in vitro data,2021-06-08,2028-06-08,Vertex Pharmaceuticals Inc.,50 Northern Avenue,,Boston,Massachusetts,2210,United States,647618,,
adeno-associated virus vector expressing human 21-hydroxylase,,2018-08-30,Treatment of congenital adrenal hyperplasia 21-hydroxylase deficiency,Designated,Not FDA Approved for Orphan Indication,,,,Adrenas Therapeutics Inc,421 Kipling St,,Palo Alto,California,94301,United States,648918,,
autologous engineered T-cell product that targets B-cell maturation antigen (BCMA),,2018-09-10,Treatment of multiple myeloma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,"Kite Pharma, Inc.",2225 Colorado Avenue,,Santa Monica,California,90404,United States,648418,,
orilanolimab,,2018-09-10,Treatment of pemphigus,Designated,Not FDA Approved for Orphan Indication,,,,"Alexion Pharmaceuticals, Inc.",121 Seaport Blvd.,,Boston,Massachusetts,2210,United States,649018,,
vorasidenib,,2018-09-10,Treatment of glioma,Designated,Not FDA Approved for Orphan Indication,,,,Servier Pharmaceuticals LLC,200 Pier Four Blvd,,Boston,Massachusetts,2210,United States,649318,,
autologous Cytokine-Induced Killer Cells (Cytokine-induced Killer Cells plus Cytotoxic T Lymphocytes),,2018-09-10,Treatment of Pancreatic Cancer.,Designated,Not FDA Approved for Orphan Indication,,,,Green Cross Cell Corporation,"4, 6th floor, SJ Technovile 278","Beotkkot-ro, Geumcheon-gu",Seoul,Seoul,,South Korea,649218,,
recombinant humanized anti-HER2 monoclonal antibody-monomethyl auristatin E (MMAE) antibody-drug conjugate,,2018-09-10,Treatment of Gastric Cancer,Designated,Not FDA Approved for Orphan Indication,,,,"RemeGen, Ltd.",58 Middle Beijing Road,"Yantai Economic & Technological Development Area, Yantai",,Shandong,,China,649418,,
"4-Chloro-N-[5-methyl-2-(7H-pyrrolo[2,3-d]pyrimidin-4-ylcarbonyl)-3-pyridinyl]-3-(trifluoromethyl)benzenesulfonamide, sodium salt",,2018-09-12,Treatment of focal segmental glomerulosclerosis,Designated,Not FDA Approved for Orphan Indication,,,,"ChemoCentryx, Inc.",850 Maude Avenue,,Mountain View,California,94043,United States,604317,,
docetaxel encapsulated in an albumin-stabilized liposome,,2018-09-12,Treatment of small cell lung cancer (SCLC),Designated,Not FDA Approved for Orphan Indication,,,,"Plus Therapeutics, Inc.",12500 Network Blvd #207,,San Antonio,Texas,78249,United States,649918,,
immune globulin subcutaneous (Human),,2018-09-12,Treatment of Dermatomyositis,Designated,Not FDA Approved for Orphan Indication,,,,CSL Behring,1020 First Avenue,PO Box 61501,King of Prussia,Pennsylvania,19406,United States,649518,,
Methanesulfonate-1-sec-butoxycarbonyloxymethyl-1-methyl-4-{4-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenylcarbamoyl]-benzyl}-piperazin-1-ium,,2018-09-13,Treatment of chronic myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,"Inhibikase Therapeutics, Inc.",3350 Riverwood Parkway,,Atlanta,Georgia,30339,United States,591517,,
"3-[5-[(1R)-1-[bis(aziridin-1-yl(phosphoryloxy]ethyl]-2-nitrophenoxy]-N,N-dimethylbenzamide",,2018-09-17,Treatment of Acute Lymphoblastic Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,"OBI Pharma USA, Inc.","6020 Cornerstone Court W, Suite 200",,San Diego,California,92121,United States,650818,,
imidazolyl ethanamide pentandioic acid,,2018-09-17,Treatment of Acute Radiation Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,Myelo Therapeutics GmbH,Rheinsberger Str. 7,,Berlin,Berlin,,Germany,650218,,
cerdulatinib,,2018-09-21,Treatment of peripheral T-cell lymphoma (PTCL).,Designated,Not FDA Approved for Orphan Indication,,,,"Portola Pharmaceuticals, Inc.",270 East Grand Avenue,,South San Francisco,California,94080,United States,651118,,
"(13E,14E,22R,6R)-35-fluoro-6-methyl-7-aza-1(5,3)-pyrazolo[1,5-a]pyrimidina-3(3,2)-pyridina-2(1,2)-pyrrolidinacyclooctaphan-8-one",,2018-09-24,Treatment of solid tumors with neurotrophic tyrosine receptor kinase (NTRK)-fusion proteins,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,"Bayer Healthcare Pharmaceuticals, Inc.",100 Bayer Blvd.,,Whippany,New Jersey,7981,United States,651318,,
ex-vivo expanded placental adherent stromal cells,,2018-09-24,"Treatment of graft failure and incomplete hematopoietic recovery, following hematopoietic cell transplantation (HCT)",Designated,Not FDA Approved for Orphan Indication,,,,Pluristem Ltd.,MATAM Advanced Technology Park,Building # 5,Haifa,,,Israel,626418,,
18-(p-[131I]-iodophenyl)octadecyl phosphocholine,,2018-09-24,Treatment of osteosarcoma,Designated,Not FDA Approved for Orphan Indication,,,,"Cellectar Biosciences, Inc.",3301 Agriculture Drive,,Madison,Wisconsin,53716,United States,651018,,
Autologous dendritic cells ex vivo incubated with zebularine and factor VIII,,2018-09-24,Treatment to reduce factor VIII neutralizing antibodies (inhibitors),Designated,Not FDA Approved for Orphan Indication,,,,Idogen AB,2 Scheelev䧥n,,,Sk宥 l䮍,,Sweden,603717,,
sodium 2-hydroxylinoleate,,2018-09-27,Treatment of biliary tract cancer,Designated,Not FDA Approved for Orphan Indication,,,,"Ability Pharmaceuticals, SL",Edifici Eureka,Campus de la UAB,Bellaterra,,,Spain,652418,,
fixed combination of dimethyl fumarate and aspirin (162mg),,2018-09-27,Treatment of multiple sclerosis in patients who experience dimethyl fumarate flushing,Designated,Not FDA Approved for Orphan Indication,,,,"Vitalis, LLC",93 4th Avenue,#19,New York,New York,10003,United States,607917,,
relacorilant,,2018-09-27,Treatment of Pancreatic Cancer,Designated,Not FDA Approved for Orphan Indication,,,,"Corcept Therapeutics, Inc.",149 Commonwealth Drive,,Menlo Park,California,94025,United States,652118,,
Adeno-associated viral vector serotype 8 containing the human RPGR gene,,2018-09-27,Treatment of inherited retinal dystrophies due to defects in the RPGR gene,Designated,Not FDA Approved for Orphan Indication,,,,Biogen,300 Binney Street,,Cambridge,Massachusetts,2142,United States,632818,,
fixed dose combination of pyronaridine tetraphosphate and artesunate,,2018-09-27,Treatment of malaria,Designated,Not FDA Approved for Orphan Indication,,,,"Shin Poong Pharmaceutical Co., Ltd.","161 Yoksam-Ro, Gangnam-Gu",,Seoul,Seoul,,South Korea,651218,,
clenbuterol,,2018-10-02,Treatment of amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,Duke University Medical Center,Department of Pediatrics,Box 103856,Durham,North Carolina,27710,United States,653918,,
Ibudilast,,2018-10-02,Treatment of Glioblastoma,Designated,Not FDA Approved for Orphan Indication,,,,"MediciNova, Inc.",4275 Executive Square,Suite 300,La Jolla,California,92037,United States,587717,,
progerinin,,2018-10-02,Treatment of Hutchinson-Gilford progeria syndrome,Designated,Not FDA Approved for Orphan Indication,,,,"PRG S&T Co., Ltd.",306 Hyowon Industry-Cooperation Bldg.,Pusan National University,Geumjeong-gu,Busan,,South Korea,653718,,
"poly (acetyl, arginyl) glucosamine",,2018-10-02,Treatment of cystic fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,"Synedgen, Inc.",1420 North Claremont Boulevard,Suite 105D,Claremont,California,91711,United States,492115,,
N-Acetyl-Leucine,,2018-10-02,Treatment of Ataxia Telangiectasia,Designated,Not FDA Approved for Orphan Indication,,,,IntraBio Inc.,270 Devon Road,,Tenafly,New Jersey,7670,United States,653218,,
"3-(3-(3,5-Dimethyl-1H-pyrazol-4- yl)propoxy)-4-fluorobenzoic acid",,2018-10-02,Treatment of transthyretin amyloidosis,Designated,Not FDA Approved for Orphan Indication,,,,"Eidos Therapeutics, Inc.",101 Montgomery Street,Suite 2550,San Francisco,California,94104,United States,593117,,
selexipag,,2018-10-02,Treatment of Chronic Thromboembolic Pulmonary Hypertension,Designated,Not FDA Approved for Orphan Indication,,,,Janssen Research & Development LLC,1820 Chapel Ave West,Suite 300,Cherry Hill,New Jersey,8002,United States,652018,,
S-[+]-apomorphine,,2018-10-02,Treatment of amyotrophic lateral sclerosis (ALS).,Designated,Not FDA Approved for Orphan Indication,,,,Aclipse One Inc,170 North Radnor Chester Road,Suite 350,Wayne,Pennsylvania,19087,United States,652718,,
humanized monoclonal IgG1 antibody (mAb) against human interleukin (IL)36R,,2018-10-03,Treatment of generalized pustular psoriasis,Designated,Not FDA Approved for Orphan Indication,,,,"Boehringer Ingelheim Pharmaceuticals, Inc. (BI)",900 Ridgebury Road,P.O. Box 368,Ridgefield,Connecticut,6877,United States,651618,,
clervonafusp alfa,,2018-10-04,Treatment of Pompe Disease,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,"Valerion Therapeutics, LLC",100 Main Street,,Concord,Massachusetts,1742,United States,651518,,
N-[5-(6-fluoro-8-{[4-(2-hydroxypropan-2-yl)piperidin-1-yl]methyl}-2-morpholinoquinazolin-4-yl)-2-methoxypyridin-3-yl]methanesulfonamide,,2018-10-10,Treatment Follicular Lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,"Shanghai Yingli Pharmaceutical Co., Ltd.","No.1 Building, 998 Halei Road","Zhangiiang Hi-tech Park, Pudong New Area",Shanghai,Shanghai,,China,654518,,
"6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile",,2018-10-10,Treatment of pancreatic cancer.,Designated,Not FDA Approved for Orphan Indication,,,,"Loxo Oncology, Inc.","701 Gateway Blvd, Suite 420",,"South San Francisco,",California,94080,United States,652318,,
antibody-drug conjugate comprised of a human aglycosylated anti-CD74 IgG1 antibody (SP7219) and two non-cleavable maytansinoid linker warheads,,2018-10-10,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,"Sutro Biopharma, Inc.",111 Oyster Point,,South San Francisco,California,94080,United States,654118,,
bispecific T-cell engager antibody with a single chain Fc moiety that binds to B cell maturation antigen surface receptor and CD3,,2018-10-10,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,Amgen Inc.,One Amgen Center Drive,Mail Stop: 27-3-F,Thousand Oaks,California,91320,United States,644818,,
Indolino-benzodiazepine compound (sulfonated DGN549-C) conjugated to the humanized anti-CD123 monoclonal antibody (G4723A),,2018-10-10,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,"ImmunoGen, Inc.",830 Winter Street,,Waltham,Massachusetts,2451,United States,654018,,
"N1-(1H-benzimidazol-2-ylmethyl)-N1-((S)-5,6,7,8-tetrahydroquinolin-8-yl)-butane-1,4-diamine",,2018-10-10,"Treatment of warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome",Designated,Not FDA Approved for Orphan Indication,,,,"X4 Pharmaceuticals, Inc.",1 Broadway,14th Floor,Cambridge,Massachusetts,2142,United States,500115,,
N-[5-(6-fluoro-8-{[4-(2-hydroxypropan-2-yl) piperidin-1-yl]methyl}-2-morpholinoquinazolin-4-yl)-2-methoxypyridin-3-]methanesulfonamide,,2018-10-11,Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,"Shanghai Yingli Pharmaceutical Co., Ltd.","No.1 Building, 998 Halei Road","Zhangiiang Hi-tech Park, Pudong New Area",Shanghai,Shanghai,,China,654418,,
Glucagon-Like Peptide 2 fused to hyFc,,2018-10-11,Treatment of short bowel syndrome,Designated,Not FDA Approved for Orphan Indication,,,,Genexine,700 Daewangpangyo-ro,Korea Bio Park Bldg. B,Seongnam-si,Gyeonggi-do,,South Korea,655218,,
olaparib,Lynparza,2018-10-11,Treatment of pancreatic cancer,Designated/Approved,,Lynparza is indicated for the maintenance treatment of adult patients with deleterious or suspected deleterious gBRCAm metastatic pancreatic adenocarcinoma whose disease has not progressed on at least 16 weeks of a first-line platinum-based chemotherapy regimen. Select patients for therapy based on an FDA-approved companion diagnostic for Lynparza.,2019-12-27,2026-12-27,AstraZeneca Pharmaceuticals LP,1800 Concord Pike,P.O. Box 8355,Wilmington,Delaware,19803,United States,655318,,
Monoclonal antibody targeting CCL24,,2018-10-11,Treatment of primary sclerosing cholangitis,Designated,Not FDA Approved for Orphan Indication,,,,"ChemomAb, Ltd.",6 Hanehoset St.,,Tel Aviv,,,Israel,618317,,
Lead-212 DOTAMTATE,,2018-10-11,Treatment of neuroendocrine tumors,Designated,Not FDA Approved for Orphan Indication,,,,"RadioMedix, Inc.",9701 Richmond Avenue,Suite 222,Houston,Texas,77042,United States,653318,,
reboxetine,,2018-10-15,Treatment of narcolepsy,Designated,Not FDA Approved for Orphan Indication,,,,"Axsome Therapeutics, Inc.","25 Broadway, 9th Floor",Suite 2000,New York,New York,10004,United States,656118,,
rilzabrutinib,,2018-10-15,Treatment of immune thrombocytopenic purpura (ITP),Designated,Not FDA Approved for Orphan Indication,,,,Principia Biopharma Inc.,400 East Jamie Court,,South San Francisco,California,94080,United States,605717,,
Humanized IgG-1 antibody targeting human transferrin receptor conjugated to human iduronate-2-sulfatase,,2018-10-15,Treatment of Mucopolysaccharidosis Type II (MPS II) or Hunter Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,"JCR Pharmaceuticals Co., Ltd.",2-4 Kasuga-cho,,Ashiya,Hyogo Prefecture,,Japan,652518,,
heterodimeric fusion protein that binds to IL-1 beta consisting of human extracellular domain of IL1 receptor and a mutant Fc fragment of human IgG1 and part of human IL1 receptor accessory protein,,2018-10-15,Treatment of Schnitzler Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,R-Pharm Overseas,505 Cost Boulevard South,Suite #102,San Diego,California,92037,United States,657018,,
relacorilant,,2018-10-15,Treatment of endogenous Cushing syndrome,Designated,Not FDA Approved for Orphan Indication,,,,"Corcept Therapeutics, Inc.",149 Commonwealth Drive,,Menlo Park,California,94025,United States,656518,,
recombinant lentivirus vector expressing the human phenylalanine hydroxylase (PAH) gene under control of a liver-specific promoter,,2018-10-15,Treatment of Phenylketonuria,Designated,Not FDA Approved for Orphan Indication,,,,American Gene Technologies International Inc.,9640 Medical Center Drive,,Rockville,Maryland,20850,United States,657218,,
"(2S)-2-{[(2R)-2-[({[3,3-dibutyl-7-(methylthio)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,2,5-benzothiadiazepin-8-yl]oxy}acetyl)amino]-2-(4-hydroxyphenyl)acetyl]amino}butanoic acid",,2018-10-15,Treatment of Alagille syndrome,Designated,Not FDA Approved for Orphan Indication,,,,"Albireo AB c/o Albireo Pharma, Inc.",10 Post Office Square,Suite 502 South,Boston,Massachusetts,2109,United States,370812,,
"[4-(4-{1-[2-(2-{2-[2-(2-{2-[2-(4-guanidinomethyl-phenoxy)-ethoxy]-ethoxy}-ethoxy)-ethoxy]-ethoxy}-ethoxy)-ethyl]-1H-[1,2,3]triazol-4-ylmethoxy}-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]-acetic acid",,2018-10-17,Treatment of neuroblastoma,Designated,Not FDA Approved for Orphan Indication,,,,"NanoPharmaceuticals, LLC",1 Discovery Place,,Rensselaer,New York,12144,United States,655018,,
spartalizumab,,2018-10-18,Treatment of Stage IIB-IV melanoma,Designated,Not FDA Approved for Orphan Indication,,,,Novartis Pharmaceuticals Corporation,One Health Plaza,Office 337 A13.5B,East Hanover,New Jersey,7936,United States,653418,,
human monoclonal antibody inhibitor of mannan binding lectin-associated serine protease-2 (MASP-2),,2018-10-22,Treatment of Hematopoietic Stem-Cell Transplant-Associated Thrombotic Microangiopathy,Designated,Not FDA Approved for Orphan Indication,,,,Omeros Corporation,201 Elliott Avenue West,,Seattle,Washington,98119,United States,655418,,
melatonin,,2018-10-22,Treatment of Acute Radiation Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,WORPHMED Srl,"Via Malachia Marchesi de Taddei, 21",,Milan,Lombardy,,Italy,644918,,
sargramostim,,2018-10-22,Treatment of pulmonary alveolar proteinosis (PAP).,Designated,Not FDA Approved for Orphan Indication,,,,"Partner Therapeutics, Inc.",19 Muzzey Street,,Lexington,Massachusetts,2421,United States,654318,,
concizumab,,2018-10-22,Treatment of hemophilia A,Designated,Not FDA Approved for Orphan Indication,,,,"Novo Nordisk, Inc.",P.O Box 846,,Plainsboro,New Jersey,8536,United States,653618,,
adipose-derived mesenchymal stem cells in a hydrogel sheet,,2018-10-25,Treatment of Epidermolysis Bullosa,Designated,Not FDA Approved for Orphan Indication,,,,"Anterogen Co., Ltd.","405, Namsung Plaza",130 Digital-ro,Seoul,Seoul,,South Korea,658218,,
"5-Chloro-N-(3-cyclopropyl-5-(((3R,5S)-3,5-dimethylpiperazine-1-yl)methyl)phenyl)-4-(6-methyl-1H-indol-3-yl)pyrimidin-2-aminemonohydrate",,2018-10-25,Treatment of Acute Myeloid Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,"Hanmi Pharmaceutical Company, Ltd.","14, Wiryeseong-daero",,Seoul,Songpa-gu,,South Korea,657918,,
autologous dendritic cells pulsed with hepatitis B virus antigens,,2018-10-25,Treatment of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,"Jiangsu Antae Biological Technology Co., Ltd.","No. 1, G01 Medical City of China Avenue,",,Taizhou,Jiangsu Province,,China,656718,,
"non-replicating, recombinant adeno-associated virus (AAV) serotype 9 (AAV9) vector containing an hCLN2 expression cassette encoding for the soluble lysosomal enzyme tripeptidyl peptidase I (TPP1)",,2018-10-25,Treatment of neuronal ceroid lipofuscinosis type 2 (CLN2) disease.,Designated,Not FDA Approved for Orphan Indication,,,,REGENXBIO Inc. (REGENXBIO),9600 Medical Center Drive,,Rockville,Maryland,20850,United States,663718,,
"2-[3-(2-chloro-4-{[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]methoxy}phenyl)-3-hydroxyazetidin-1-yl]pyridine-4-carboxylic acid2-amino-2-(hydroxymethyl)propane-1,3-diol (1/1)",,2018-10-25,Treatment of Primary Sclerosing Cholangitis (PSC),Designated,Not FDA Approved for Orphan Indication,,,,"Gilead Sciences, Inc.",333 Lakeside Drive,,Foster City,California,94404,United States,658018,,
humanized monoclonal antibody targeting interleukin-15,,2018-10-25,Treatment of eosinophilic esophagitis,Designated,Not FDA Approved for Orphan Indication,,,,CALYPSO BIOTECH BV,Gustav Mahlerplein 102,1082 MA Amsterdam,Amsterdam,North Holland,,Netherlands,655518,,
"(1R,2R)-1,2-cyclohexane-diaminepyrophosphato-platinum(II)",,2018-10-25,Treatment of thymoma and thymic carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,Phosplatin Therapeutics LLC,1350 6th Avenue,3rd Floor,New York,New York,10019,United States,654818,,
trimetazidine,,2018-10-30,Treatment of dilated cardiomyopathy,Designated,Not FDA Approved for Orphan Indication,,,,"Martin Pharmaceuticals, Inc.",233 Broadway,Suite 1750,New York,New York,10279,United States,658318,,
"N-[(2R)-2,3 dihydroxypropoxyl]-3,4 difluro-2 -[(2-fluoro-4-iodophenyl)amino] benzamide",,2018-10-30,Treatment of Neurofibromatosis type I,Designated,Not FDA Approved for Orphan Indication,,,,"SpringWorks Subsidiary 3, PBC (Spring Works)","575 5th Avenue, 16th Floor",,New York,New York,10017,United States,655618,,
human astrocytes derived from astrocyte progenitor cells originating from clincial-grade human embryonic stem cells,,2018-11-01,Treatment of amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,"Kadimastem, Ltd.",7 Pinhas Sapir Street,Weizmann Science Park,Ness Ziona,Center District,,Israel,658618,,
Diacerein,,2018-11-02,Treatment of epidermolysis bullosa,Designated,Not FDA Approved for Orphan Indication,,,,WORPHMED Srl,"Via Malachia Marchesi de Taddei, 21",,Milan,Lombardy,,Italy,660318,,
Rose bengal disodium,,2018-11-02,Treatment of Neuroblastoma,Designated,Not FDA Approved for Orphan Indication,,,,"Provectus BioPharmaceuticals, Inc.",10025 Investment Drive,Suite 250,Knoxville,Tennessee,37932,United States,657518,,
cannabidiol,,2018-11-05,Prevention of ischemia/reperfusion Injury resulting from solid organ transplantation,Designated,Not FDA Approved for Orphan Indication,,,,Revive Therapeutics Ltd.,5 Director Court,Suite 105,Vaughan,,,Canada,656618,,
ipilimumab,,2018-11-07,Treatment of small cell lung cancer,Designated,Not FDA Approved for Orphan Indication,,,,Bristol-Myers Squibb Company,P.O. Box 5326,,Princeton,New Jersey,8543,United States,657418,,
"N-[(2S)-5-{[(1R, 2S)-2-(4-fluorophenyl)cyclopropyl]amino}-1-(4-methylpiperazin-1-yl)-1-oxopentan-2-yl]-4-(1H-1,2,3-triazol-1-yl)benzamide, bis-tosylate salt",,2018-11-07,Treatment of essential thrombocythemia.,Designated,Not FDA Approved for Orphan Indication,,,,"Imago Biosciences, Inc.",2729 Debbie Court,,San Carlos,California,94070,United States,660418,,
brentuximab vedotin,,2018-11-13,Treatment of extranodal NK/T-cell lymphoma (ENKTL),Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,"Seattle Genetics, Inc.",21823 30th Drive Southeast,,Bothell,Washington,98021,United States,656818,,
ceramide,,2018-11-13,Treatment of Pancreatic Cancer,Designated,Not FDA Approved for Orphan Indication,,,,"Keystone Nano, Inc.",1981 Pine Hall Road,,State College,Pennsylvania,16801,United States,660618,,
small molecule inhibitor of integrins av߶ and av߱,,2018-11-19,Treatment of primary sclerosing cholangitis,Designated,Not FDA Approved for Orphan Indication,,,,"Pliant Therapeutics, Inc.",260 Littlefield Avenue,,South San Francisco,California,94080,United States,660718,,
humanized IgG1 antibody specifific for the AXL tyrosine kinase conjugated to monomethyl auristatin E,,2018-11-19,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,BioAtla LLC,11085 Torreyana Road,Suite 100,San Diego,California,92121,United States,659718,,
hydromethylthionine mesylate,,2018-11-20,Treatment of frontotemporal dementia,Designated,Not FDA Approved for Orphan Indication,,,,TauRx Therapeutics Ltd,395 King Street,,Aberdeen,Scotland,,United Kingdom,661118,,
humanized anti-Globo H monoclonal antibody,,2018-11-20,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,"OBI Pharma USA, Inc.","6020 Cornerstone Court W, Suite 200",,San Diego,California,92121,United States,661218,,
flunarizine,,2018-11-20,Treatment of Alternating Hemiplegia,Designated,Not FDA Approved for Orphan Indication,,,,"Xenon Pharmaceuticals, Inc.",200-3650 Gilmore Way,,Burnaby,,,Canada,665818,,
recombinant adeno-associated virus (AAV) vector based on the AAV serotype hu37 containing a single stranded DNA genome encoding a form of human Factor VIII,,2018-11-20,Treatment of Hemophilia A,Designated,Not FDA Approved for Orphan Indication,,,,Bayer HealthCare LLC,100 Bayer Boulevard,P.O. Box 915,Hanover,New Jersey,7981,United States,659618,,
"8-bromo-2-(1-methylpiperidin-4-yl) amino)-4-(4-phenoxyphenyl) amino) pyrido[4,3-d] pyrimidin-5(6H)-one hydrochloride",,2018-11-20,Treatment of Acute Myeloid Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,Oscotec Inc.,"Korea Bio-Park Bldg A, 9th Floor","700 Dawwangpangyo-ro, Bundang-gu",Seongnam-si,Gyeonggi-do,,South Korea,661018,,
"peptide-drug conjugate combining [(Tyr3,Cys8) octreotate amide] and N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl) maytansine",,2018-11-20,Treatment of neuroendocrine tumors,Designated,Not FDA Approved for Orphan Indication,,,,"Tarveda Therapeutics, Inc.",134 Coolidge Ave.,,Watertown,Massachusetts,2472,United States,630018,,
humanized connexin 43 monoclonal antibody,,2018-11-20,Treatment of acute spinal cord injury,Designated,Not FDA Approved for Orphan Indication,,,,"AlaMab Therapeutics, Inc.",11550 IH 10 West,Suite 250,San Antonio,Texas,78249,United States,611417,,
benralizumab,,2018-11-21,Treatment of eosinophilic granulomatosis with polyangiitis,Designated,Not FDA Approved for Orphan Indication,,,,AstraZeneca Pharmaceuticals LP,P. O. Box 8355,1800 Concord Pike,Wilmington,Delaware,19803,United States,660018,,
terlipressin,,2018-11-21,Treatment of hepatorenal syndrome,Designated,Not FDA Approved for Orphan Indication,,,,BioVie Inc.,100 Cummings Center,Suite 247-C,Beverly,Massachusetts,1915,United States,580417,,
recombinant adeno-associated virus vector containing DNA encoding INT41 intrabody,,2018-11-30,Treatment of Huntingtons Disease,Designated,Not FDA Approved for Orphan Indication,,,,Vybion Inc.,584 Oak Street,,Monterey,California,93940,United States,662518,,
povidone iodine,,2018-11-30,Treatment of Endophthalmitis,Designated,Not FDA Approved for Orphan Indication,,,,Cumulus Pharmaceutical LLC,1712 Pioneer Avenue,Suite 1377,Cheyenne,Wyoming,82001,United States,647518,,
"(1S, 4R, 5R, 7S)-3, 4-dibenzyl-2-oxo-6, 8-dioxa- 3-azabyciclo [3.2.1] octane-7-carboxylic acid-L-lysine",,2018-11-30,Treatment of Neurotrophic keratopathy,Designated,Not FDA Approved for Orphan Indication,,,,"Recordati Rare Diseases, SARL","Immeuble le ""Wilson""",70 Avenue du General de Gaulle,Puteaux,,,France,662818,,
doranidazole,,2018-11-30,radiosensitizer to be used during radiation treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,"Shuttle Pharmaceuticals, Inc.",1 Research Court,Suite 450,Rockville,Maryland,20850,United States,665218,,
"99mTc-HYNIC-[D-Phe1,Tyr3-Octreotide] trifluoroacetate",,2018-12-05,Diagnostic for the management of neuroendocrine tumors,Designated,Not FDA Approved for Orphan Indication,,,,Narodowe Centrum Badan Jadrowych,ul. Andrzeja Soltana 7,,Otwock,Masovian Voivodeship,05-400,Poland,661918,,
"self-complementary non-replicating, recombinant adeno-associated virus serotype rhesus 74 expressing the human alpha-sarcoglycan gene under a triple E-box muscle creatine kinase muscle specific promoter (scAAVrh74.tMCK.hSGCA)",,2018-12-05,Treatment of limb girdle muscular dystrophy Type 2D,Designated,Not FDA Approved for Orphan Indication,,,,Sarepta Therapeutics,215 First Street,,Cambridge,Massachusetts,2142,United States,668418,,
messenger ribonucleic acid-based therapeutic agent encoding human propionyl-CoA carboxylase alpha and beta subunits,,2018-12-05,Treatment of propionic acidemia.,Designated,Not FDA Approved for Orphan Indication,,,,"Moderna Therapeutics, Inc.",200 Technology Square,,Cambridge,Massachusetts,2139,United States,668518,,
recombinant human interleukin 12,,2018-12-05,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,TherapyX Inc.,108 Biomedical Research Building,3435 Main Street,Buffalo,New York,14214,United States,663218,,
(+)-alpha-dihydrotetrabenazine,,2018-12-05,Treatment of Huntington's disease.,Designated,Not FDA Approved for Orphan Indication,,,,"Adeptio Pharmaceuticals, Ltd",22 Bedford Row,WC1R 4JS,London,,,United Kingdom,607417,,
transforming growth factor beta trap/anti-programmed death ligand-1 antibody bifunctional fusion protein,,2018-12-07,Treatment of biliary tract cancer,Designated,Not FDA Approved for Orphan Indication,,,,"EMD Serono Research & Development Institute, Inc.",45 Middlesex Turnpike,,Billerica,Massachusetts,1821,United States,663818,,
"5-(3,5-Dimethyl-4-hydroxybenzylamino)-3-(4-morpholin-4-yl-phenylamino)-1H-pyrazole-4-carboxylic acid amide",,2018-12-07,Treatment of Idiopathic Pulmonary Fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,Metagone Biotech Inc.,"3F., No. 11, Ln. 77, Xing-Ai Rd",Neihu Dist,Taipei,,,Taiwan,644218,,
"((1r, 4r)-N1-(2-benzyl-7-(2-methyl-2H-tetrazol-5-yl)-9H-pyrimido[4,5-b]indol-4-yl)cyclohexane-1,4-diamine dihydrobromide dihydrate)-Expanded cord blood",,2018-12-13,Prevention of Graft-versus-Host-Disease,Designated,Not FDA Approved for Orphan Indication,,,,ExCellThera Inc.,2950 chemin de Polythechnique,,Montreal,,,Canada,661418,,
autologous CD34+ cell- enriched population transduced with lentiviral vector encoding the codon-optimized human alpha-galactosidase A complementary deoxyribonucleic acid sequence.,,2018-12-17,Treatment of Fabry Disease,Designated,Not FDA Approved for Orphan Indication,,,,"AVROBIO, Inc.",One Kendall Square,Building 300,Cambridge,Massachusetts,2139,United States,664318,,
"15(S)-hydroxy-(5Z,8Z,11Z,13E,17Z)-eicosapentaenoic acid ethyl ester",,2018-12-17,Treatment of idiopathic pulmonary fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,Afimmune,Trintech Building,South County Business Park,Dublin,County Dublin,,Ireland,667918,,
CDC-like kinase inhibitor of the Wnt Pathway,,2018-12-17,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,"Biosplice Therapeutics, Inc.",9360 Towne Centre Drive,,San Diego,California,92121,United States,662318,,
"(1S,3S)-3-((2-methyl-6-(1-methyl-5-(((methyl(propyl)carbamoyl)oxy)methyl)-1H-1,2,3-triazol-4-yl)pyridin-3-yl)oxy)cyclohexane-1-carboxylic acid",,2018-12-17,Treatment of Idiopathic Pulmonary Fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,Bristol-Myers Squibb Company,P.O. Box 4000,3551 Lawrenceville Road,Princeton,New Jersey,8540,United States,668018,,
venetoclax + idasanutlin,,2018-12-17,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,Genentech Inc. (A Member of the Roche Group),1 DNA Way,MS# 355d,South San Francisco,California,94080,United States,664118,,
mosunetuzumab,,2018-12-17,Treatment of follicular lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,"Genentech, Inc.",1 DNA Way,MS 355G,South San Francisco,California,94080,United States,663418,,
poly (lactide-co-glycolide)-polyethylene glycol nanoparticles encapsulating quercetin,,2018-12-17,Treatment of glioblastoma,Designated,Not FDA Approved for Orphan Indication,,,,Cancer Research and Life Foundation,2015 Placentia Ave.,,Costa Mesa,California,92627,United States,664018,,
autologous T cells genetically modified to express CD123 specific hinge-optimized CD28-costimulatory chimeric receptor and a truncated human epidermal growth factor receptor,,2018-12-17,Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm,Designated,Not FDA Approved for Orphan Indication,,,,"Mustang Bio, Inc.",377 Plantation Street,,Worcester,Massachusetts,1605,United States,663118,,
Fibromun,,2018-12-18,Treatment of Soft Tissue Sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,Philogen S.p.A.,La Lizza 7,I-53100 Siena,Siena,Tuscany,,Italy,662918,,
conditionally active biologics-anti-ROR2-antibody drug conjugate consisting of a humanized IgG1 antibody specific for ROR2 tyrosine kinase conjugated to a peptide linker coupled with monomethyl auristatin E,,2018-12-18,Treatment of soft tissue sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,BioAtla LLC,11085 Torreyana Road,Suite 100,San Diego,California,92121,United States,663018,,
ceramide,,2018-12-18,Treatment of Acute Myeloid Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,"Keystone Nano, Inc.",1981 Pine Hall Road,,State College,Pennsylvania,16801,United States,662618,,
PEGylated peptide inhibitor of complement C3,,2018-12-19,Treatment of C3 glomerulopathy,Designated,Not FDA Approved for Orphan Indication,,,,"Apellis Pharmaceuticals, Inc.",6400 Westwind Way,Suite A,Crestwood,Kentucky,40014,United States,633418,,
Synthetic PreImplantation Factor,,2018-12-19,Treatment of Acute Radiation Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,"BioIncept, LLC",140 East 40th Street,Suite 11E,New York,New York,10016,United States,664918,,
small interfering RNA agent that targets human transforming growth factor-߱ messenger RNA,,2018-12-19,Treatment of Idiopathic pulmonary fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,Bonac Corporation,Fukuoka BIO Factory,"1488-4 Aikawa, Kurume",Fukuoka,Fukuoka Prefecture,,Japan,663918,,
iberdomide,,2018-12-19,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,United States,665718,,
Autologous adult live cultured osteoblasts,,2018-12-20,Treatment of osteonecrosis,Designated,Not FDA Approved for Orphan Indication,,,,Regrow Biosciences Pvt. Ltd.,"2 ABC, Acme Plaza",Andheri Kurla Road,Mumbai,Maharashtra,,India,664218,,
apraglutide,,2018-12-20,Treatment of short bowel syndrome (SBS),Designated,Not FDA Approved for Orphan Indication,,,,VectivBio AG,36 Aeschenvorstadt,,Basel,Basel-Stadt,,Switzerland,639518,,
bromelain + acetylcysteine,,2018-12-27,Treatment of pseudomyxoma peritonei with Bromelain and Acetylcysteine,Designated,Not FDA Approved for Orphan Indication,,,,MUCPharm Pty Ltd.,13/53 High Street,,Malvern,Victoria,,Australia,664418,,
bispecific T-cell engager antibody consisting of 2 single chain variable fragment binding domains specific for antigen Delta-like protein 3 (DLL3) and for TCR-associated complex CD3,,2018-12-27,Treatment of small cell lung cancer (SCLC),Designated,Not FDA Approved for Orphan Indication,,,,Amgen Inc.,1 Amgen Center Drive,Mail Stop 27-2-D,Thousand Oaks,California,91320,United States,665418,,
Autotaxin inhibitor,,2019-01-14,Treatment of Idiopathic Pulmonary Fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,"Bridge Biotherapeutics, Inc","253 Pangyo-ro, Bundang-gu","Suite 903-2, Building B, Pangyo Innovalley",Seongnam-si,Gyeonggi-do,,South Korea,665918,,
D-mannose,,2019-01-14,Treatment of Mannose Phosphate Isomerase Deficiency,Designated,Not FDA Approved for Orphan Indication,,,,Cerecor Inc.,1500 Liberty Ridge Drive,Suite 321,Wayne,Pennsylvania,19087,United States,666918,,
L-fucose,,2019-01-14,Treatment of Congenital Disorder of Glycosylation IIc,Designated,Not FDA Approved for Orphan Indication,,,,Cerecor Inc.,1500 Liberty Ridge Drive,Suite 321,Wayne,Pennsylvania,19087,United States,667018,,
D-Galactose,,2019-01-14,Treatment of Phosphoglucomutase 1 Deficiency,Designated,Not FDA Approved for Orphan Indication,,,,Cerecor Inc.,1500 Liberty Ridge Drive,Suite 321,Wayne,Pennsylvania,19087,United States,666818,,
cusatuzumab,,2019-01-14,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,"Janssen Research & Development, LLC",920 Route 202 South,,Raritan,New Jersey,8869,United States,614717,,
odevixibat,,2019-01-16,Treatment of Biliary Atresia,Designated,Not FDA Approved for Orphan Indication,,,,"Albireo AB c/o Albireo Pharma, Inc.",10 Post Office Square,Suite 502,Boston,Massachusetts,2109,United States,658118,,
tiratricol,,2019-01-16,Treatment of Monocarboxylate 8 Transporter (MCT8) Deficiency (Allan-Herndon-Dudley-Syndrome),Designated,Not FDA Approved for Orphan Indication,,,,Rare Thyroid Therapeutics,3 Teatergatan,SE-111 48,Stockholm,,,Sweden,666618,,
adeno-associated viral vector 9-containing the human heparan-alpha-glucosaminide N-acetyltransferase (HGSNAT) gene (AAV9- HGSNAT),,2019-01-16,Treatment of Sanfilippo Syndrome IIIC (also known as Mucopolysaccharidosis IIIC/MPS IIIC),Designated,Not FDA Approved for Orphan Indication,,,,"Phoenix Nest, Inc.","710 6th Avenue, #2",,Brooklyn,New York,11215,United States,667518,,
"N-(bromoacetyl)-3,3-dinitroazetidine",,2019-01-16,Treatment of glioblastoma multiforme,Designated,Not FDA Approved for Orphan Indication,,,,EpicentRx Inc.,"11099 North Torrey Pines Road, Suite 160",La Jolla,San Diego,California,92037,United States,666718,,
ribitol,,2019-01-16,Treatment of limb-girdle muscular dystrophy type 2I,Designated,Not FDA Approved for Orphan Indication,,,,"ML Bio Solutions, Inc.","1100 S. Mint Street, Suite 102",,Charlotte,North Carolina,28203,United States,666518,,
recombinant Mitsugumin 53,,2019-01-17,Treatment of Duchenne Muscular Dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,"Axolo Pharma, Inc.",6425 Nieman Road,,Shawnee,Arkansas,66203,United States,667618,,
Human IgG1 monoclonal antibody to human CD38,,2019-01-22,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,"Takeda Development Center Americas, Inc.",95 Hayden Avenue,,Lexington,Massachusetts,2421,United States,667418,,
[2-amino-3-[3-[[4-(2-pyridyloxymethyl)phenyl]methyl]isoxazol-5-yl]pyridin-1-ium-1-yl]methyl hydrogen phosphate,,2019-01-22,Treatment of cryptococcosis,Designated,Not FDA Approved for Orphan Indication,,,,"Pfizer, Inc.",235 East 42nd Street,,New York,New York,10017,United States,667318,,
clofarabine,,2019-01-24,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,"Boyen Therapeutics, Inc.","333 Section 1, Keelung Road",Suite 1212,Taipei,Taipei,110208,Taiwan,668118,,
Fully human immunoglobulin G1 monoclonal antibody that targets CD32b,,2019-01-29,Treatment of mantle cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,BioInvent International AB,Ideon Science Park,,Lund,Sk宥 County,,Sweden,669218,,
delta-9-tetrahydrocannabinol and cannabidiol,,2019-01-29,Treatment of Huntington's Disease,Designated,Not FDA Approved for Orphan Indication,,,,MMJ International Holdings,1895 Preston White Drive,Suite 101,Reston,Virginia,20191,United States,668918,,
"5,7-Dichloro-2-((ethylamino)methyl)-8-hydroxy-3-methylquinazolin-4(3H)-one mesylate",,2019-01-29,Treatment of multiple system atrophy,Designated,Not FDA Approved for Orphan Indication,,,,"Alterity Therapeutics, Limited",460 Bourke Street,,Melbourne,Victoria,,Australia,669118,,
Losartan,,2019-01-29,Treatment of epidermolysis bullosa,Designated,Not FDA Approved for Orphan Indication,,,,3R Pharma Consulting GmbH,3 Wildbader Straߥ,,Dobel,Baden-Wrttemberg,,Germany,668618,,
internalized-arginylglycylaspartic acid cyclic peptide,,2019-01-29,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,"Cend Therapeutics, Inc.","12544 High Bluff Drive, Suite 400",,San Diego,California,92130,United States,669518,,
itolizumab,,2019-02-01,Treatment of acute graft versus host disease,Designated,Not FDA Approved for Orphan Indication,,,,"Equillium, Inc.",2223 Avenida De La Playa,Suite 108,San Diego,California,92037,United States,646718,,
autologous T-cells genetically engineered via lentiviral vector technology to express a synthetic receptor directed against B-cell maturation antigen (BCMA) protein target,,2019-02-01,Treatment of multiple myeloma (MM),Designated,Not FDA Approved for Orphan Indication,,,,"Janssen Research & Development, LLC",920 Route 202 South,,Raritan,New Jersey,8869,United States,672118,,
(E)-3-(6-Bromo-pyridin-2-yl)-2-cyano-N-((S)-1-phenyl-ethyl)-acryl amide,,2019-02-01,Treatment of glioblastoma,Designated,Not FDA Approved for Orphan Indication,,,,"Moleculin Biotech, Inc.","5300 Memorial Drive,",Suite 950,Houston,Texas,77007,United States,671018,,
nivolumab,,2019-02-01,Treatment of primary mediastinal B-cell lymphoma.,Designated,Not FDA Approved for Orphan Indication,,,,Bristol-Myers Squibb Company,P.O. Box 4000,,Princeton,New Jersey,8543,United States,670918,,
autologous genetically engineered T cells that express a single-domain antibody that recognizes human mesothelin fused to the cluster of differentiation 3e subunit of the T cell receptor,,2019-02-01,Treatment of mesothelioma,Designated,Not FDA Approved for Orphan Indication,,,,"TCR2 Therapeutics, Inc.",100 Binney Street,Suite 710,Cambridge,Massachusetts,2142,United States,670718,,
benralizumab,,2019-02-01,Treatment of hypereosinophilic syndrome,Designated,Not FDA Approved for Orphan Indication,,,,AstraZeneca Pharmaceuticals LP,P. O. Box 8355,1800 Concord Pike,Wilmington,Delaware,19803,United States,670518,,
Adeno-associated virus serotype 9 vector containing the human lysosome-associated membrane glycoprotein 2 isoform B transgene (AAV9.LAMP2B),,2019-02-01,Treatment of Danon Disease,Designated,Not FDA Approved for Orphan Indication,,,,"Rocket Pharmaceuticals, Inc.",The Empire State Building,"350 Fifth Avenue, Suite 7530",New York,New York,10118,United States,670218,,
budesonide,,2019-02-01,Treatment of Autoimmune Hepatitis,Designated,Not FDA Approved for Orphan Indication,,,,Calliditas Therapeutics AB,26B Wallingatan,,Norrmalm,Stockholms l䮍,,Sweden,670118,,
rozanolixizumab,,2019-02-01,Treatment of myasthenia gravis,Designated,Not FDA Approved for Orphan Indication,,,,"UCB, Inc.",1950 Lake Park Drive Building 2100,,Smyrna,Georgia,30080,United States,669918,,
ketamine,,2019-02-01,Treatment of Complex Regional Pain Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,"Bexson Biomedical, Inc.",856 Chelham Way,,Santa Barbara,California,93108,United States,669318,,
pegcetacoplan,,2019-02-01,Treatment of autoimmune hemolytic anemia,Designated,Not FDA Approved for Orphan Indication,,,,"Apellis Pharmaceuticals, Inc.",6400 Westwind Way,Suite A,Crestwood,Kentucky,40014,United States,627018,,
efgartigimod,,2019-02-01,Treatment of Primary Immune Thrombocytopenia (ITP),Designated,Not FDA Approved for Orphan Indication,,,,argenx BVBA,7 Industriepark-Zwijnaarde,,Gent,Vlaanderen,,Belgium,633218,,
recombinant adeno-associated viral (AAV) vector that contains a bio-engineered capsid (AAV-Spark100) and a codon-optimized expression cassette to drive expression of a secretable form of human acid a-glucosidase (GAA),,2019-02-01,Treatment of Pompe Disease,Designated,Not FDA Approved for Orphan Indication,,,,"Spark Therapeutics, Inc.",3737 Market Street,Suite 1300,Philadelphia,Pennsylvania,19104,United States,674118,,
autologous adult bone marrow-derived and unexpanded CD133+ hematopoietic stem cells (CD133+ BMDSCs) mobilized from peripheral blood (PB),,2019-02-01,Treatment of women with infertility and a thin endometrium seeking pregnancy,Designated,Not FDA Approved for Orphan Indication,,,,Asherman Therapy S.L.U.,Ronda Narc�Monturiol Estarriol,"n11 Parcela B, Edificio Europark",Valencia,,,Spain,613117,,
motixafortide,,2019-02-01,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,"BioLineRx, Ltd.",Modiin Technology Park,2 HaMaayan Street,Modiin,,,Israel,669818,,
itolizumab,,2019-02-05,Prevention of acute graft versus host disease,Designated,Not FDA Approved for Orphan Indication,,,,"Equillium, Inc.",2223 Avenida De La Playa,Suite 108,San Diego,California,92037,United States,676618,,
adeno-associated virus serotype 5 capsid containing the gene for human Nuclear Hormone Receptor NR2E3,,2019-02-08,Treatment of NR2E3 mutation-associated retinal degenerative disease,Designated,Not FDA Approved for Orphan Indication,,,,Ocugen Inc.,5 Great Valley Parkway,Suite 160,Malvern,Pennsylvania,19355,United States,652918,,
Bispecific T-cell engager (BiTE) containing two single-chain variable fragment (scFv) domains directed against the B cell maturation antigen (BCMA) surface receptor on tumor cells and the cluster of differentiation 3 (CD3) receptor on T-cells,,2019-02-08,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,"Amgen, Inc.",One Amgen Center Drive,,Thousand Oaks,California,91320,United States,669618,,
budesonide,,2019-02-11,Treatment of primary biliary cholangitis,Designated,Not FDA Approved for Orphan Indication,,,,Calliditas Therapeutics AB,26B Wallingatan,,Norrmalm,Stockholms l䮍,,Sweden,673818,,
"Extracts of herbs Scutellaria baicalensis Geori, Glycyrrhiza uralensis Fisch, Paeonia lactiflora Pall, and Ziziphus jujuba Mill",,2019-02-11,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,Yiviva Inc.,"447 Broadway, 2FL",,New York,New York,10013,United States,673718,,
"2-[(2S)-1-azabicyclo[2.2.2]oct-2-yl]-6-(3-methyl-1H-pyrazol-4-yl)thieno[3,2-d]pyrimidin-4(3H)-one hemihydrate",,2019-02-11,Treatment of esophageal cancer,Designated,Not FDA Approved for Orphan Indication,,,,"Millennium Pharmaceuticals, Inc.",40 Landsdowne Street,,Cambridge,Massachusetts,2139,United States,673218,,
rose bengal disodium,,2019-02-11,Treatment of ocular melanoma,Designated,Not FDA Approved for Orphan Indication,,,,"Provectus BioPharmaceuticals, Inc.",10025 Investment Drive,Suite 250,Knoxville,Tennessee,37932,United States,670618,,
"2,4-dinitrophenol",,2019-02-11,Treatment of Huntington disease,Designated,Not FDA Approved for Orphan Indication,,,,"Mitochon Pharmaceuticals, Inc.",970 Cross Lane,,Blue Bell,Pennsylvania,19422,United States,672818,,
etoposide toniribate,,2019-02-11,Treatment of biliary tract cancer,Designated,Not FDA Approved for Orphan Indication,,,,Mundipharma EDO GmbH,74 Sankt Alban-Rheinweg,,Basel,Basel-Stadt,,Switzerland,671318,,
A small molecule inhibitor of the pro-survival protein Myeloid Cell Leukemia sequence 1 (MCL 1),,2019-02-15,Treatment of Acute Myeloid Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,Amgen Inc.,One Amgen Center Drive,Mail Stop 27-2-D,Thousand Oaks,California,91320-1799,United States,675018,,
"peptide-drug conjugate combining [(Tyr3,Cys8) octreotate amide] and N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl) maytansine",,2019-02-15,Treatment of small cell lung cancer,Designated,Not FDA Approved for Orphan Indication,,,,"Tarveda Therapeutics, Inc.",134 Coolidge Ave.,,Watertown,Massachusetts,2472,United States,673318,,
verdiperstat,,2019-02-15,Treatment of multiple system atrophy (MSA).,Designated,Not FDA Approved for Orphan Indication,,,,"Biohaven Pharmaceuticals, Inc.",215 Church Street,,New Haven,Connecticut,6510,United States,671418,,
recombinant adeno-associated viral vector serotype S3 containing codon-optimized expression cassette encoding human coagulation factor IX variant,,2019-02-15,Treatment of hemophilia B,Designated,Not FDA Approved for Orphan Indication,,,,Freeline Therapeutics Limited,Stevenage Bioscience Catalyst,Gunnels Wood Road,Stevenage,Hertfordshire,,United Kingdom,672318,,
enzyme transport vehicle specific for the transferrin receptor fused to iduronate 2-sulfatase,,2019-02-19,Treatment of mucopolysaccharidosis type II,Designated,Not FDA Approved for Orphan Indication,,,,Denali Therapeutics Inc.,"151 Oyster Point Blvd, Second Floor",,South San Francisco,California,94080,United States,671118,,
peritoneal dialysis solution containing combination of D-glucose and L-carnitine,,2019-02-21,Treatment of patients with end stage renal disease who require peritoneal dialysis,Designated,Not FDA Approved for Orphan Indication,,,,CoreQuest Sagl,Stabile Suglio Via Cantonale 18,,Manno TI,Tessin,,Switzerland,599517,,
"5-(4-((2S,5S)-5-(4-chlorobenzyl)-2-methylmorpholino)piperidin-1-yl)-1H-1,2,4-triazol-3-amine",,2019-02-25,Treatment of idiopathic pulmonary fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,Galapagos NV,Generaal De Wittelaan L11 A3,,Mechelen,,2800,Belgium,671618,,
"6-{[(1R,2S)-2-aminocyclohexyl]amino-7-fluoro-4-(1-methyl-1H-pyrazol-4-yl)-1,2-dihydro-3H-pyrrolo[3,4-c]pyridin-3-one monocitrate",,2019-02-25,Treatment of follicular lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,"Takeda Development Center Americas, Inc.",95 Hayden Avenue,,Lexington,Massachusetts,2421,United States,671718,,
autologous CD34+ Cells Enriched with Blood Derived Mitochondria,,2019-02-26,Treatment of Pearson Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,Minovia Therapeutics Ltd.,3 Hasadna Street,,Tirat,HaCarmel,,Israel,673118,,
dexamethasone,,2019-02-26,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,Fera Pharmaceuticals,134 Birch Hill Road,,Locust Valley,New York,11560,United States,674718,,
recombinant botulinum vaccine A/B,,2019-02-26,"Prevention of botulism caused by inhalational intoxication with botulinum neurotoxin (BoNT) serotype A, subtype A1, and BoNT serotype B, subtype B1.",Designated,Not FDA Approved for Orphan Indication,,,,"The Surgeon General, Department of the Army",Medical Research and Materiel Command 1430 Veterans Drive,,Fort Detrick,Maryland,21702-5009,United States,652618,,
C-type natriuretic peptide conjugated to a multi-arm polyethylene glycol carrier molecule through a cleavable linker,,2019-02-27,Treatment of Achondroplasia,Designated,Not FDA Approved for Orphan Indication,,,,Ascendis Pharma Growth Disorders A/S,Tuborg Boulevard 5,DK-2900,Hellerup,,,Denmark,673418,,
pyronaridine tetraphosphate,,2019-02-28,Treatment of Ebola infection,Designated,Not FDA Approved for Orphan Indication,,,,"Collaborations Pharmaceuticals, Inc.","5616 Hilltop Needmore Rd,",,Fuquay Varina,North Carolina,27526,United States,677019,,
src homology region 2-containing protein tyrosine phosphatase 2 (SHP2) inhibitor JAB-3068,,2019-02-28,Treatment of esophageal cancer,Designated,Not FDA Approved for Orphan Indication,,,,"Jacobio Pharmaceuticals Co., Ltd.","Bld-F2, No 88, 6th Kechuang St, BDA",,Beijing,,,China,676318,,
nanatinostat and valganciclovir,,2019-02-28,Treatment of plasmablastic lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,"Viracta Therapeutics, Inc.",2533 South Coast Highway,Suite 210,Cardiff,California,92007,United States,676118,,
nanatinostat and valganciclovir,,2019-02-28,Treatment of post-transplant lymphoproliferative disorder,Designated,Not FDA Approved for Orphan Indication,,,,"Viracta Therapeutics, Inc.",2533 South Coast Highway,Suite 210,Cardiff,California,92007,United States,676018,,
[11C]Acetic Acid,,2019-02-28,Diagnostic for the management of hepatoblastoma,Designated,Not FDA Approved for Orphan Indication,,,,"Advanced Imaging Projects, LLC",7947 Brookside Ct.,,Lake Worth,Florida,33467,United States,662018,,
Ac-225-4-PHenylbutyryl-His-D-Phe-Arg-Trp-Gly-Lys(eAhx-DOTA)-NH2,,2019-02-28,Treatment of Uveal Melanoma,Designated,Not FDA Approved for Orphan Indication,,,,Modulation Therapeutics Incorporated,1 Medical Center Drive,MBRCC room 1817,Morgantown,West Virginia,26506,United States,675618,,
efmitermant alfa,,2019-02-28,Treatment of Charcot-Marie-Tooth disease,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,Acceleron Pharma Inc.,128 Sidney Street,,Cambridge,Massachusetts,2139,United States,674918,,
humanized IgG4 kappa monoclonal antibody comprised of 2 identical light chains and 2 identical heavy chains fused to attenuated interferon alpha 2b,,2019-02-28,Treatment of Multiple Myeloma,Designated,Not FDA Approved for Orphan Indication,,,,"Takeda Development Center Americas, Inc.",95 Hayden Avenue,,Lexington,Massachusetts,2421,United States,675518,,
small molecule inhibitor of the pro-survival protein Myeloid Cell Leukemia sequence 1 (MCL 1),,2019-02-28,Treatment of Multiple Myeloma,Designated,Not FDA Approved for Orphan Indication,,,,Amgen Inc.,One Amgen Center Drive,Mail Stop 27-2-D,Thousand Oaks,California,91320-1799,United States,674818,,
"4-(((3-chloro-1,4-dioxo-1,4 dihydronaphthalen-2-yl)amino)methyl)-N-(pyridine-3-yl)benzamide",,2019-02-28,Treatment of Multiple Myeloma,Designated,Not FDA Approved for Orphan Indication,,,,Sino-American Cancer Foundation,4978 Santa Anita Ave,Suite 104,Temple City,California,91780,United States,678619,,
Autologous genetically modified CD34+ hematopoietic cells transduced with a lentiviral vector (LV-EFS-TCIRG1-WPRE) that encodes for the human TCIRG1 transgene,,2019-02-28,Treatment of infantile malignant osteopetrosis,Designated,Not FDA Approved for Orphan Indication,,,,"Rocket Pharmaceuticals, Inc.",The Empire State Building,"350 Fifth Avenue, Suite 7530",New York,New York,10118,United States,679919,,
melatonin,,2019-02-28,Treatment of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,WORPHMED Srl,"Via Malachia Marchesi de Taddei, 21",,Milan,Lombardy,,Italy,677519,,
sorafenib,,2019-02-28,Treatment of desmoid tumors/aggressive fibromatosis,Designated,Not FDA Approved for Orphan Indication,,,,"Bayer HealthCare Pharmaceuticals, Inc.",100 Bayer Boulevard,P.O. Box 915,Whippany,New Jersey,7981,United States,675918,,
tecarfarin,,2019-03-07,Prevention of systemic thromboembolism of cardiac origin in patients with End Stage Renal Disease and atrial fibrillation,Designated,Not FDA Approved for Orphan Indication,,,,"Espero BioPharma, Inc.",14286-19 Beach Blvd #270,,Jacksonville,Florida,,United States,659818,,
saracatinib,,2019-03-11,Treatment of idiopathic pulmonary fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,"AstraZeneca Pharmaceuticals, LP","Emerging Innovations, AstraZeneca, R&D Boston",35 Gatehouse Drive,Waltham,Massachusetts,2451,United States,674218,,
calmangafodipir,,2019-03-15,Treatment of acetaminophen overdose.,Designated,Not FDA Approved for Orphan Indication,,,,PledPharma AB,Grev Turegatan 11c,,Stockholm,,,Sweden,676418,,
nanatinostat and valganciclovir,,2019-03-15,Treatment of angioimmunoblastic T-cell lymphoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,"Viracta Therapeutics, Inc.",2533 South Coast Highway,Suite 210,Cardiff,California,92007,United States,675818,,
meplazumab,,2019-03-15,Treatment of malaria,Designated,Not FDA Approved for Orphan Indication,,,,"Jiangsu Pacific-Meinuoke Bio-pharmaceutical Co., Ltd.","No. 128, Hehai West Rd",Xinbei District,Changzhou,Jiangsu,,China,676218,,
"recombinant adeno-associated virus, serotype 1, containing a transgene that encodes a microRNA targeting huntingtin messenger RNA",,2019-03-15,Treatment of Huntingtons Disease.,Designated,Not FDA Approved for Orphan Indication,,,,Voyager Therapeutics,75 Sidney Street,,Cambridge,Massachusetts,2139,United States,678519,,
capmatinib,,2019-03-15,Treatment of non-small cell lung cancer with MET genomic tumor aberrations,Designated/Approved,,Tabrecta (capmatinib) is indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have a mutation that leads to mesenchymal-epithelial transition (MET) exon 14 skipping as detected by an FDA-approved test.,2020-05-06,2027-05-06,Novartis Pharmaceuticals Corp.,One Health Plaza,,East Hanover,New Jersey,7936,United States,644518,,
corticotropin releasing factor 1 receptor antagonist,,2019-03-15,Treatment of congenital adrenal hyperplasia,Designated,Not FDA Approved for Orphan Indication,,,,"Neurocrine Biosciences, Inc.",12780 El Camino Real,,San Diego,California,92130,United States,639018,,
tinostamustine hydrochloride,,2019-03-15,Treatment of T-cell prolymphocytic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,Mundipharma EDO GmbH,St. Alban-Rheinweg 74,,Basel,Basel City,,Switzerland,636418,,
deferoxamine,,2019-03-15,Treatment of sickle cell leg ulcers,Designated,Not FDA Approved for Orphan Indication,,,,Theris Medical,604 Fifth Avenue,Suite D,Redwood City,California,94063,United States,633618,,
encapsulated rapamycin,,2019-03-15,Treatment of familial adenomatous polyposis,Designated,Not FDA Approved for Orphan Indication,,,,Emtora Biosciences Inc,16601 Blanco Road,Suite 120,San Antonio,Texas,78232,United States,678319,,
methotrexate,,2019-03-25,Treatment of ectopic pregnancy,Designated,Not FDA Approved for Orphan Indication,,,,"Antares Pharma, Inc",Princeton Crossroads Corporate Center,100 Princeton South Suite 300,"Ewing,",New Jersey,8628,United States,679019,,
human monoclonal IgG2 antibody against tissue factor pathway inhibitor (TFPI),,2019-03-25,Treatment of Hemophilia A,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,Bayer HealthCare LLC,100 Bayer Boulevard,P.O. Box 915,Hanover,New Jersey,7981,United States,678219,,
Anti-transforming growth factor beta (TGF-ߩ trap fusion protein,,2019-03-25,Treatment of systemic sclerosis.,Designated,Not FDA Approved for Orphan Indication,,,,Formation Biologics,101 W 6th Street,Suite 501,Austin,Texas,8701,United States,678419,,
Varespladib,,2019-03-25,Treatment of snakebite,Designated,Not FDA Approved for Orphan Indication,,,,"Ophirex, Inc.",5643 Paradise Dr #2,,Corte Madera,California,94925,United States,677919,,
"expanded human autologous chondrocytes in a biopolymer (sodium alginate, gellan gum) matrix",,2019-03-25,Treatment of microtia (including anotia),Designated,Not FDA Approved for Orphan Indication,,,,Auregen BioTherapeutics SA,Avenue Giuseppe Motta 31-33,Case Postale 145 CH-1211,Geneva,,,Switzerland,681919,,
alpha tocopherol and ascorbic acid,,2019-03-28,Treatment of Fragile X syndrome,Designated,Not FDA Approved for Orphan Indication,,,,GenCo Pharmaceuticals LLC,371 Lake Surprise Road,,Cold Spring,New York,10516,United States,678719,,
sodium bispiperidine-carboxamido-dimethylpenatnamido-methoxycarbonyl-indol-propanamidohexanoate,,2019-03-28,Treatment of malignant melanoma stages IIB to IV,Designated,Not FDA Approved for Orphan Indication,,,,"ENB Therapeutics, INC","Alexandria Center for Life Sciences, Launch Labs","430 E 29th St, 14th Floor",New York,New York,10016,United States,679519,,
estetrol,,2019-03-28,Treatment of neonatal hypoxic ischemic encephalopathy,Designated,Not FDA Approved for Orphan Indication,,,,Mithra Pharmaceuticals S.A.,5-7 Rue St Georges,,Li觥,,,Belgium,678119,,
allogeneic ABCB5-positive limbal stem cells,,2019-03-28,Treatment of limbal stem cell deficiency,Designated,Not FDA Approved for Orphan Indication,,,,RHEACELL GmbH & Co. KG,Im Neuenheimer Feld 517,,Heidelberg,Baden-Wrttemberg,,Germany,664518,,
autologous chimeric antigen receptor (CAR) T cells targeting intercellular adhesion molecule-1 (ICAM-1),,2019-04-09,"Treatment of anaplastic thyroid cancer, medullary thyroid cancer, and recurrent or metastatic follicular or papillary thyroid cancer",Designated,Not FDA Approved for Orphan Indication,,,,"AffyImmune Therapeutics, Inc.",12 Michigan Dr.,,Natick,Massachusetts,1760,United States,634518,,
umbralisib,Ukoniq,2019-04-11,Treatment of splenic marginal zone lymphoma,Designated/Approved,,treatment of adult patients with relapsed or refractory marginal zone lymphoma (MZL) who have received at least one prior anti-CD20-based regimen,2021-02-05,2028-02-05,"TG Therapeutics, Inc.",2 Gansevoort Street,9th Floor,New York,New York,10014,United States,680019,,
umbralisib,Ukoniq,2019-04-11,Treatment of extranodal marginal zone lymphoma,Designated/Approved,,Treatment of adult patients with relapsed or refractory marginal zone lymphoma (MZL) who have received at least one prior anti-CD20-based regimen.,2021-02-05,2028-02-05,"TG Therapeutics, Inc.",2 Gansevoort Street,9th Floor,New York,New York,10014,United States,687419,,
umbralisib,Ukoniq,2019-04-11,Treatment of nodal marginal zone lymphoma,Designated/Approved,,Treatment of adult patients with relapsed or refractory marginal zone lymphoma (MZL) who have received at least one prior anti-CD20-based regimen,2021-02-05,2028-02-05,"TG Therapeutics, Inc.",2 Gansevoort Street,9th Floor,New York,New York,10014,United States,687519,,
"2-hydroxymethyl-2-methoxymethyl-1-azabicyclo[2,2,2]octan-3-one",,2019-04-11,Treatment of Myelodysplastic Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,Aprea Therapeutics AB,Nobels Vag 3,,"Solna,",,,Sweden,673518,,
Recombinant human interleukin-7 fused to a hybrid crystallizable fragment region of a human antibody (rhIL-7-hyFc),,2019-04-11,Treatment of Idiopathic CD4+ Lymphocytopenia.,Designated,Not FDA Approved for Orphan Indication,,,,"NeoImmuneTech, Inc.",2400 Research Boulevard,Suite 250,Rockville,Maryland,20850,United States,666218,,
cromolyn solution,,2019-04-11,Treatment of idiopathic pulmonary fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,"Respivant Sciences, Inc.","11455 El Camino Real, Suite 460",,San Diego,California,92130,United States,602817,,
pamrevlumab,,2019-04-11,Treatment of Duchenne Muscular Dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,"FibroGen, Inc.",409 Illinois Street,,San Francisco,California,94158,United States,680319,,
6-[18F] fluoro-L-m-tyrosine,,2019-04-17,Diagnostic for the management of Aromatic L-Amino Acid Decarboxylase Deficiency,Designated,Not FDA Approved for Orphan Indication,,,,"Advanced Imaging Projects, LLC",7947 Brookside Ct.,,Lake Worth,Florida,33467,United States,686619,,
Autologous enriched T-cells genetically modified with a retroviral vector to express two chimeric antigen receptors (CARs) targeting cluster of differentiation (CD) 19 and CD 22.,,2019-04-17,Treatment of Acute Lymphoblastic Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,Autolus Limited,Forest House,58 Wood Lane,London,,,United Kingdom,680119,,
"a non-replicating, recombinant adeno-associated virus serotype 9 (AAV9) containing the human Methyl CpG Binding Protein 2B (MECP2B) cDNA under the control of a segment of the murine MECP2 promoter.",,2019-04-17,Treatment of Rett Syndrome (RTT),Designated,Not FDA Approved for Orphan Indication,,,,"AveXis, Inc.",2275 Half Day Road,,Bannockburn,Illinois,60015,United States,681219,,
a long-acting interleukin-11 analog comprised of 178 amino acids covalently modified wiht a 40-kDa branched maleimide-polyethylene glycol at the added cysteine residue following the carboxy-terminal amino acid,,2019-04-17,Treatment of acute radiation syndrome,Designated,Not FDA Approved for Orphan Indication,,,,"Bolder BioTechnology, Inc.","2425 55th Street, Suite 210",,Boulder,Colorado,80301,United States,680919,,
adeno associated viral vector containing Padua derivative of the human coagulation factor IX cDNA,,2019-04-17,Treatment of Hemophilia B,Designated,Not FDA Approved for Orphan Indication,,,,uniQure Inc.,113 Hartwell Avenue,,Lexington,Massachusetts,2421,United States,632918,,
recombinant adeno-associated viral vector with human methylmalonyl-COA mutase (MUT) gene,,2019-04-22,Treatment of methylmalonic acidemia,Designated,Not FDA Approved for Orphan Indication,,,,"LogicBio Therapeutics, Inc.",610 Main St,,Cambridge,Massachusetts,2139,United States,681419,,
"3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-pyrazol-1-yl) propanoic acid",,2019-04-22,Treatment of Stargardts disease.,Designated,Not FDA Approved for Orphan Indication,,,,"Stargazer Pharmaceuticals, Inc.",200 Clarendon Street,"45th Floor, Mailbox 30",Boston,Massachusetts,2116,United States,681519,,
Melatonin,,2019-04-22,Treatment of heat stroke,Designated,Not FDA Approved for Orphan Indication,,,,WORPHMED Srl,"Via Malachia Marchesi de Taddei, 21",,Milan,Lombardy,,Italy,680719,,
Dexpramipexole,,2019-04-22,Treatment of hypereosinophilic syndrome (HES),Designated,Not FDA Approved for Orphan Indication,,,,Knopp Biosciences LLC,2100 Wharton Street,Suite 615,Pittsburgh,Pennsylvania,15203,United States,681319,,
vardenafil,,2019-04-22,Treatment of Pulmonary Arterial Hypertension,Designated,Not FDA Approved for Orphan Indication,,,,"Respira Therapeutics, Inc",5901 Indian School Road NE,#107,Albuquerque,New Mexico,87110,United States,679319,,
N-{2-[N-((3S)(3-piperidyl))carbamoyl]-5-[2-(3-fluorophenyl)ethynyl](3-thienyl)}aminoamide,,2019-04-29,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,"Pharos iBio Co., Ltd.","#1408, 38, Heungan-daero 427 beon-gil","Gwanyang-dong, Sungji Starwith),",Dongan-gu,Anyang-si Gyeonggi-do,,South Korea,681819,,
human glucagon-like peptide-2 analogue linked to a human immunoglobulin Fc fragment (ready to use pre-filled syringe),,2019-05-01,Treatment of short bowel syndrome,Designated,Not FDA Approved for Orphan Indication,,,,Hanmi Pharmaceutical Co. Ltd.,"14, Wiryeseong-daero",,Songpa-gu,Seoul,,South Korea,658818,,
allogeneic skin-derived ABCB5-positive mesenchymal stem cells,,2019-05-01,Treatment of Epidermolysis Bullosa,Designated,Not FDA Approved for Orphan Indication,,,,RHEACELL GmbH & Co. KG,Im Neuenheimer Feld 517,,Heidelberg,Baden-Wrttemberg,,Germany,682719,,
sotorasib,Lumakras,2019-05-01,Treatment of KRAS p.G12C-positive non-small cell lung cancer,Designated/Approved,,"Treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC), as determined by an FDA-approved test, who have received at least one prior systemic therapy.",2021-05-28,2028-05-28,Amgen Inc.,1 Amgen Center Drive,Mail Stop 27-3-A,Thousand Oaks,California,91320,United States,653818,,
allogeniec Human Pancreatic Islets of Langerhans,,2019-05-01,Treatment of brittle type 1 diabetes,Designated,Not FDA Approved for Orphan Indication,,,,"Diabetes Research Institute & Cell Transplant Center, Univ of Miami",1450 NW 10th Avenue,,Miami,Florida,33136,United States,685919,,
Purified Allogeneic Human Pancreatic Islets of Langerhans,,2019-05-01,Treatment of Brittle Type 1 Diabetes,Designated,Not FDA Approved for Orphan Indication,,,,University of Chicago,"5801 S Ellis Ave, Suite 619",,Chicago,Illinois,60637,United States,687819,,
ansuvimab-zykl,EBANGA,2019-05-08,Treatment of Ebola Virus Disease,Designated/Approved,,"treatment of infection caused by Zaire ebolavirus in adult and pediatric patients, including neonates born to a mother who is RT-PCR positive for Zaire ebolavirus infection",2020-12-21,2027-12-21,"Ridgeback Biotherapeutics, LP","3480 Main Highway, Unit 402",,Miami,Florida,33133,United States,683019,,
O-18F-fluoroethyl-L-tyrosine,,2019-05-08,Diagnostic for the management of Malignant Rhabdoid Tumors,Designated,Not FDA Approved for Orphan Indication,,,,"Advanced Imaging Projects, LLC",7947 Brookside Ct.,,Lake Worth,Florida,33467,United States,683619,,
A potent and selective inhibitor of Gamma Secretase-mediated NOTCH signaling,,2019-05-08,Treatment of Adenoid cystic carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,"Ayala Pharmaceuticals, Inc.","7 Oppenheimer St.,",,Rehovot,,,Israel,683819,,
"(6-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)pyrimidin-2-yl)-1-methyl-1H-indol-2-yl)(3,3-difluoroazetidin-1-yl)methanone",,2019-05-08,Treatment of Idiopathic Pulmonary Fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,"Beijing Tide Pharmaceutical Co., Ltd",No.8 East Rongjing Street,Beijing Econnomic-technological Development Area (BDA),Beijing,,,China,683419,,
faceted gold nanocrystals,,2019-05-08,Treatment of Amyotrophic Lateral Sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,"Clene Nanomedicine, Inc.",3165 East Millrock Drive,Suite 325,Salt Lake City,Utah,84121,United States,682119,,
Autologous T cells transfected with PiggyBac transposon plasmid vector expressing B-cell maturation antigen (CAR-T cells),,2019-05-08,Treatment of Multiple Myeloma,Designated,Not FDA Approved for Orphan Indication,,,,"Poseida Therapeutics, Inc.","4242 Campus Point Court, Suite 700",,San Diego,California,92121,United States,684019,,
iloprost,,2019-05-09,Treatment of systemic sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,"Eicos Sciences, Inc., a CiVi Biopharma, Inc. affiliated company",200 Four Falls Corporate Center,Suite 107,West Conshohocken,Pennsylvania,19528,United States,655118,,
Human cytomegalovirus (HCMV) internal repeat short 1 (IRS1)-expressing oncolytic Herpes Simplex Virus,,2019-05-09,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,Nationwide Children's Hospital,700 Children's Drive,Rm W210,Columbus,Ohio,43205,United States,683219,,
genetically engineered herpes simplex virus,,2019-05-09,Treatment of medulloblastoma,Designated,Not FDA Approved for Orphan Indication,,,,"Aettis, Inc.",128 Penarth Road,,Bala Cynwyd,Pennsylvania,19004,United States,682419,,
genetically engineered herpes simplex virus,,2019-05-09,Treatment of primitive neuroectodermal brain tumors,Designated,Not FDA Approved for Orphan Indication,,,,"Aettis, Inc.",128 Penarth Road,,Bala Cynwyd,Pennsylvania,19004,United States,692219,,
cereblon enzyme 3 (E3) ubiquitin ligase modulating agent,,2019-05-14,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,United States,685019,,
cytarabine-beta-L-aspartic acid,,2019-05-14,Treatment of Acute Myeloid Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,BioSight Ltd.,1 Hayarden St.,P.O.B 1083,Airport City,Lod,,Israel,684419,,
"(1E,6E)-1,7-Bis(3,4-dimethoxyphenyl)-4-cyclobutylmethyl-1,6-heptadiene-3,5-dione OR [(1E,4Z,6E)-4-(cyclobutylmethyl)-1,7-bis(3,4-dimethoxyphenyl)-5-hydroxyhepta-1,4,6-trien-3-one]",,2019-05-14,Treatment of Huntingtons Disease,Designated,Not FDA Approved for Orphan Indication,,,,Allianz Pharmascience Ltd.,"7F-2, No. 77, Section 2, Duan Hua",,South Road,Taipei,,Taiwan,686419,,
Murine IgG1 monoclonal antibody binding to site II on G protein of rabies virus envelope and murine IgG2b monoclonal antibody binding to site III on G protein of rabies virus envelope,,2019-05-15,Post-exposure prophylaxis against rabies virus infection.,Designated,Not FDA Approved for Orphan Indication,,,,"Cadila Healthcare Limited, India",Zydus Tower,Satellite Cross Roads,Ahmedabad,,,India,684319,,
esomeprazole,,2019-05-15,Treatment of Eosinophilic Esophagitis,Designated,Not FDA Approved for Orphan Indication,,,,"Adare Pharmaceuticals US, L.P.",Princeton Pike Corporate Center,"1200 Lenox Drive, Suite 100",Lawrenceville,New Jersey,8648,United States,684119,,
"N-(4,4-difluorocyclohexyl)-2-(3-methyl-1H-pyrazol-1-yl)-6-morpholinopyrimidin-4-amine",,2019-05-22,Treatment of spinocerebellar ataxia,Designated,Not FDA Approved for Orphan Indication,,,,Novartis Pharmaceuticals Corporation,One Health Plaza,Building 337/03/A13L1-22,East Hanover,New Jersey,7936,United States,686219,,
"2-(4-oxo-3-((5-(trifluoromethyl)benzo[d]thiazol-2-yl)methyl)-3,4-dihydrothieno[3,4-d]pyridazin-1-yl)acetic acid",,2019-05-23,Treatment of Galactosemia,Designated,Not FDA Approved for Orphan Indication,,,,Applied Therapeutics Inc.,"340 Madison Avenue, 19th Floor",,"New York,",New York,10173,United States,685219,,
"6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-(1M)-1-[4-methyl-2-(propan-2-yl)pyridin-3-yl]-4-[(2S)-2- methyl-4-(prop-2-enoyl)piperazin-1-yl]pyrido[2,3-d]pyrimidin-2(1H)-one",,2019-05-23,Treatment of KRAS (Kirsten rat sarcoma viral oncogene homolog) p.G12C-positive Colorectal Cancer.,Designated,Not FDA Approved for Orphan Indication,,,,Amgen Inc.,1 Amgen Center Drive,Mail Stop 27-3-A,Thousand Oaks,California,91320,United States,654918,,
bardoxolone methyl,,2019-06-03,Treatment of autosomal dominant polycystic kidney disease,Designated,Not FDA Approved for Orphan Indication,,,,"Reata Pharmaceuticals, Inc.",2801 Gateway Dr.,Suite 150,Irving,Texas,75063,United States,687219,,
Ac-Nle-cyclo-(Glu-His-D-Phe-Arg-Dap)-Trp-NH2,,2019-06-03,"Treatment of non-infectious intermediate, posterior, pan, and chronic anterior uveitis",Designated,Not FDA Approved for Orphan Indication,,,,"Palatin Technologies, Inc.",4b Cedarbrook Drive,,Cranbury Township,New Jersey,8512,United States,670418,,
4-Methyl-3-quinolin-3-ylethynylbenzoic acid N'-(2-chloro-6- methylbenzoyl) hydrazide,,2019-06-03,Treatment of chronic myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,Sun Pharma Advanced Research Company Ltd.,"17/B, Mahal Industrial Estate",Mahakali Caves Road,Andheri (E),Mumbai,,India,687119,,
casimersen,Amondys 45,2019-06-04,Treatment of Duchenne muscular dystrophy,Designated/Approved,,treatment of Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 45 skipping,2021-02-25,2028-02-25,"Sarepta Therapeutics, Inc.",215 First Street,,Cambridge,Massachusetts,2142,United States,690019,,
flubrobenguane (18F),,2019-06-04,Diagnostic for the management of neuroendocrine tumors,Designated,Not FDA Approved for Orphan Indication,,,,"Lantheus Medical Imaging, Inc.",331 Treble Cove Road,,North Billerica,Massachusetts,1862,United States,695819,,
Allogeneic Human Pancreatic Islets of Langerhans,,2019-06-04,Treatment of Brittle Type 1 Diabetes,Designated,Not FDA Approved for Orphan Indication,,,,"University of California, San Francico",3333 California Street,3333 California Street,San Francisco,California,94118,United States,689619,,
autologous CD34+ hematopoietic stem and progenitor cells transfected with zinc finger nuclease messenger RNAs SB-mRENH1 and SB-mRENH2,,2019-06-04,Treatment of ߭thalassemia,Designated,Not FDA Approved for Orphan Indication,,,,"Sangamo Therapeutics, Inc.",7000 Marina Boulevard,,Brisbane,California,94005,United States,673618,,
72 amino acid proprietary recombinant protein antagonist for the CXCR1 and CXCR2 receptors of interleukin-8,,2019-06-04,Treatment of Pancreatic Cancer,Designated,Not FDA Approved for Orphan Indication,,,,Rise Biopharmaceutical Ltd.,"Room B405, Zhongguancun Shangdi Bio-medical Park","No.5 Kaituo Road, Haidian District",Beijing,Beijing,,China,660218,,
dornase alfa,,2019-06-04,Treatment of sarcoidosis,Designated,Not FDA Approved for Orphan Indication,,,,"SarcoMed USA, LLC",1300 Post Oak Boulevard,Suite 760,Houston,Texas,77056,United States,616617,,
adeno-associated virus serotype rh10 encoding artificial anti-SOD1 miRNA,,2019-06-11,Treatment of Amyotrophic Lateral Sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,"Apic Bio, Inc.",c/o LabCentral,"700 Main Street, North",Cambridge,Massachusetts,2139,United States,688119,,
humanized anti CD20 monoclonal antibody,,2019-06-11,Treatment of Dermatomyositis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,Biocon Limited,"20th KM, Hosur Main Road",Electronics City,Bangalore,Karnataka,,India,642318,,
fosgemcitabine palabenamide,,2019-06-11,Treatment of biliary tract cancer,Designated,Not FDA Approved for Orphan Indication,,,,NuCana plc,3 Lochside Way,,Edinburgh,Scotland,,United Kingdom,644618,,
"Insulin producing cells (autologous liver cells transduced by Ad5-CMV-MafA, Ad5-CMV-NeuroD1, and Ad5-CMV-PDX1)",,2019-06-11,Treatment of diabetes due to total pancreatectomy.,Designated,Not FDA Approved for Orphan Indication,,,,"Orgenesis, Ltd.",36 Harimon Street,,Ge'alya,Center District,,Israel,654218,,
Autologous CD34+ hematopoietic stem and progenitor cells transfected with zinc finger nuclease messenger RNAs SB-mRENH1 and SB-mRENH2,,2019-06-11,Treatment of Sickle Cell Disease,Designated,Not FDA Approved for Orphan Indication,,,,"Bioverativ Therapeutics, Inc.",225 2nd Avenue,,Waltham,Massachusetts,2451,United States,674318,,
parsaclisib,,2019-06-12,Treatment of mantle cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,Incyte Corporation,1801 Augustine Cut-Off,,Wilmington,Delaware,19803,United States,688519,,
Venetoclax,,2019-06-12,Treatment of myelodysplastic syndromes,Designated,Not FDA Approved for Orphan Indication,,,,AbbVie Inc.,1 North Waukegan Road,"Dept #PA72, Bldg. AP30-4",North Chicago,Illinois,60064,United States,689119,,
4-((L-valyl)oxy)butanoic acid,,2019-06-12,Treatment of Narcolepsy,Designated,Not FDA Approved for Orphan Indication,,,,XWPharma Incorporated,"19F-1, No. 99, Sec. 1",Xintai 5th Road,New Taipei City,Xizhi District,,Taiwan,669418,,
Balipodect,,2019-06-13,Treatment of Fragile X Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,"Millennium Pharmaceuticals, Inc.",40 Landsdowne St.,,Cambridge,Massachusetts,2139,United States,689319,,
"adoptive, anti-FLT3 chimeric antigen receptor T cell therapy generated through transduction of autologous T-cells with a self-inactivating human immunodeficiency virus-1 based lentiviral vector",,2019-06-13,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,Amgen Inc.,One Amgen Center Drive,Mail Stop 27-2-D,Thousand Oaks,California,91320,United States,688619,,
"2-(2-{[2-(1H-benzimidazol-2-yl)ethyl]amino}ethyl)-N-[(3-fluoropyridin-2-yl)methyl]-1,3-oxazole-4-carboxamide trihydrochloride",,2019-06-17,Treatment of beta-thalassemia,Designated,Not FDA Approved for Orphan Indication,,,,"Vifor Pharma, Inc.",200 Cardinal Way,,Redwood City,California,94063,United States,688419,,
rexlemestrocel-L,,2019-06-19,Prevention of post-LVAD (left ventricular assist device) implantation mucosal bleeding,Designated,Not FDA Approved for Orphan Indication,,,,Mesoblast,505 5th Avenue,3rd Floor,New York,New York,10017,United States,661518,,
"L-Leucyl-L-prolyl-L-prolyl-L-leucyl-L-prolyl-L-tyrosyl-L-proline, acetate salt",,2019-06-19,Treatment of Amyotrophic Lateral Sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,"Immunity Pharma, Ltd.","6 Rabbi Binyamin st,",,Jerusalem,,,Israel,689819,,
Balipodect,,2019-06-19,Treatment of CDKL5 deficiency disorder,Designated,Not FDA Approved for Orphan Indication,,,,"Millennium Pharmaceuticals, Inc.",40 Landsdowne St.,,Cambridge,Massachusetts,2139,United States,689219,,
Double stranded oligomer ARO-APOC3 RNA interference-based liver targeted therapeutic,,2019-06-20,Treatment of Familial Chylomicronemia Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,"Arrowhead Pharmaceuticals, Inc.",177 East Colorado Boulevard,Suite 700,Pasadena,California,91105,United States,690119,,
gallium citrate,,2019-06-24,Treatment of lung infections in patients with cystic fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,"Aridis Pharmaceuticals, Inc.",5941 Optical Court,,San Jose,California,95138,United States,689419,,
Human monoclonal IgG2 antibody against tissue factor pathway inhibitor,,2019-06-25,Treatment of Hemophilia B,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,Bayer HealthCare LLC,100 Bayer Boulevard,P.O. Box 915,Hanover,New Jersey,7981,United States,685719,,
CD34+ hematopoietic stem and progenitor cells with CD3+ T-cells,,2019-06-25,Prevention of graft rejection following solid organ transplantation,Designated,Not FDA Approved for Orphan Indication,,,,"Medeor Therapeutics, Inc.","1 Tower Place, 9th Floor",,South San Francisco,California,94080,United States,690519,,
5-iodo-2-pyrimidinone-2deoxyribose,,2019-06-25,Treatment of glioblastoma,Designated,Not FDA Approved for Orphan Indication,,,,"Shuttle Pharmaceuticals, LLC",1 Research Court,Suite 450,Rockville,Maryland,20850,United States,690919,,
Kallikrein 7 and elastase 2 inhibitor,,2019-06-25,Treatment of Netherton Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,"LifeMax Laboratories, Inc.","1731 Embarcadero Road, Suite 200",,Palo Alto,California,94303,United States,695519,,
riociguat,,2019-06-26,Treatment of Fontan-palliated patients,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,Bayer U.S. LLC,100 Bayer Boulevard,P.O. Box 915,Hanover,New Jersey,7981,United States,669718,,
mometasone furoate,,2019-06-26,Treatment of eosinophilic esophagitis,Designated,Not FDA Approved for Orphan Indication,,,,EsoCap AG,Malzgasse 9,,Basel,,,Switzerland,691019,,
Ornithine transcarbamylase messenger RNA,,2019-06-26,Treatment of Ornithine Transcarbamylase Deficiency,Designated,Not FDA Approved for Orphan Indication,,,,"Arcturus Therapeutics, Inc.",10628 Science Center Drive,Suite 250,San Diego,California,92121,United States,690819,,
bispecific T-cell engager (BiTE) antibody targeting CD33 and CD3,,2019-07-01,Treatment of Acute Myeloid Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,Amgen Inc.,One Amgen Center Drive,Mail Stop 17-1-A,Thousand Oaks,California,91320,United States,691519,,
Regorafenib,,2019-07-01,Treatment of glioblastoma multiforme,Designated,Not FDA Approved for Orphan Indication,,,,"Bayer HealthCare Pharmaceuticals, Inc.",100 Bayer Boulevard,P.O. Box 915,Whippany,New Jersey,7981,United States,690619,,
apilimod dimesylate,,2019-07-01,Treatment of follicular lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,"AI Therapeutics, Inc.",530 Old Whitfield Street,,Guilford,Connecticut,6437,United States,691619,,
"non-replicating, recombinant adeno-associated virus serotype 9 (AAV9) containing the short hairpin RNA (shRNA) sequence against human SOD1 under the H1 promoter",,2019-07-01,Treatment of Amyotrophic Lateral Sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,"AveXis, Inc.",2275 Half Day Road,,Bannockburn,Illinois,60015,United States,691719,,
afatinib,,2019-07-09,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,"Boehringer Ingelheim Pharmaceuticals, Inc.",900 Ridgebury Road,P. O. Box 368,Ridgefield,Connecticut,6877,United States,690419,,
durvalumab,IMFINZI,2019-07-10,Treatment of small cell lung cancer,Designated/Approved,,"IMFINZI is indicated for use, in combination with etoposide and either carboplatin or cisplatin, for the first-line treatment of adult patients with extensive-stage small cell lung cancer (ES-SCLC).",2020-03-27,2027-03-27,AstraZeneca Pharmaceuticals LP,1800 Concord Pike,,Wilmington,Delaware,19803,United States,691319,,
Zamicastat,,2019-07-15,Treatment of pulmonary arterial hypertension (PAH) (pulmonary hypertension WHO Group 1),Designated,Not FDA Approved for Orphan Indication,,,,"Bial-Portela & C., S.A.",Av. da Siderurgia Nacional,4745-457 S. Mamede do Coronado,Coronado,,,Portugal,693619,,
humanized non-fucosylated anti-Siglec-8 monoclonal antibody (IgG1),,2019-07-15,Treatment of Mastocytosis,Designated,Not FDA Approved for Orphan Indication,,,,Allakos Inc.,"975 Island Drive, Suite 201",,Redwood City,California,94065,United States,693519,,
Double stranded oligomer RNA interference-based liver targeted therapeutic directed against the ANGPTL3 gene,,2019-07-15,Treatment of homozygous familial hypercholesterolemia,Designated,Not FDA Approved for Orphan Indication,,,,"Arrowhead Pharmaceuticals, Inc.",177 East Colorado Boulevard,Suite 700,Pasadena,California,91105,United States,692719,,
"PEGylated 24-amino acid peptide inhibitor of Interleukin-2, Interleukin-9 and Interleukin-15",,2019-07-15,Treatment of cutaneous T-cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,"BIONIZ THERAPEUTICS, INC.","5 MASON, SUITE 200",,Irvine,California,92618,United States,693019,,
"(R)-N-(1-(1-(1H-indazol-5-yl)-3-methyl-2,4-dioxo-1,3,8-triazaspiro[4,5]decan-8-yl)-3-methyl-1-oxobutan-2-yl)-2-fluoro-5-(trifluoromethyl)benzamide",,2019-07-18,Treatment of idiopathic pulmonary fibrosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,"X-Rx, Inc.",100 Beaver Street,,Waltham,Massachusetts,2453,United States,693119,,
"autologous T-cells genetically modified to express a CD123-specific, hinge-optimized, CD28-costimulatory chimeric receptor and a truncated human epidermal growth factor receptor",,2019-07-22,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,"Mustang Bio, Inc.",377 Plantation Street,,Worcester,Massachusetts,1605,United States,693319,,
Aripiprazole,,2019-07-22,Treatment of N-glycanase 1 (NGLY1) deficiency,Designated,Not FDA Approved for Orphan Indication,,,,Perlara PBC,"2625 Alcatraz Ave, #435",,Berkeley,California,94705,United States,694219,,
Allogeneic Human Pancreatic Islets of Langerhans,,2019-07-22,Treatment of Brittle Type 1 Diabetes,Designated,Not FDA Approved for Orphan Indication,,,,Hospital of the University of Pennsylvania (Penn Medicine),3400 Spruce Street,2 Ravdin Courtyard,Philadelphia,Pennsylvania,19104,United States,678919,,
Imidazopyridine,,2019-07-22,Treatment of Amyotrophic Lateral Sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,"1ST Biotherapeutics, Inc.",240 Pangyoyeok-ro A-306,Bundang-gu Seongnam-si,Gyeonggi-do,,,South Korea,699719,,
"N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-4-(2-fluorophenyl)-2-methyloxazole-5-carboxamide",,2019-07-22,Treatment of Idiopathic Pulmonary Fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,"Blade Therapeutics, Inc.",442 Littlefield Avenue,,South San Francisco,California,94080,United States,698719,,
"(S)-4-methyl-5-((4-((2-(methylamino)-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)methyl)-1-(2-(4-(methylsulfonyl)piperazin-1-yl)propyl)-1H-indole-2-carbonitrile",,2019-07-22,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,Kura Oncology,Clinical Development,55 Cambridge Parkway,Cambridge,Massachusetts,2142,United States,697819,,
concizumab,,2019-07-22,Treatment of hemophilia B,Designated,Not FDA Approved for Orphan Indication,,,,"Novo Nordisk, Inc.",P.O Box 846,,Plainsboro,New Jersey,8536,United States,663618,,
pozelimab,,2019-07-22,Treatment of Paroxysmal Nocturnal Hemoglobinuria,Designated,Not FDA Approved for Orphan Indication,,,,Regeneron Pharmaceuticals Inc,777 Old Saw Mill River Road,,Tarrytown,New York,10591,United States,660518,,
artesunate,,2019-07-22,Treatment of malaria,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,La Jolla Pharmaceutical Company,4550 Towne Centre Court,,"San Diego,",California,92121,United States,693719,,
"recombinant human anti-human sortilin (SORT1) IgG1 G1m17,1 [or G1m (z,a)] kappa monoclonal antibody",,2019-07-22,Treatment of Frontotemporal Dementia,Designated,Not FDA Approved for Orphan Indication,,,,"Alector, Inc.","151 Oyster Point Boulevard, Suite 300",,South San Francisco,California,94080,United States,680219,,
Sodium (4-{(E)-3-(4-fluorophenyl)-3-[4-(3-morpholin-4-yl-prop-1ynyl)phenyl]allyloxy}-2-methylphenoxy)acetate,,2019-07-22,Treatment of fatty acid oxidation disorders,Designated,Not FDA Approved for Orphan Indication,,,,Reneo Pharma Ltd,"Innovation House, Office 12B","Discovery Park, Ramsgate Road",Sandwich,Kent,,United Kingdom,693819,,
aflibercept,,2019-07-23,Treatment of Retinopathy of Prematurity,Designated,Not FDA Approved for Orphan Indication,,,,"Regeneron Pharmaceuticals, Inc.",777 Old Saw Mill River Road,,Tarrytown,New York,10591,United States,694319,,
a recombinant adeno-associated virus pseudotyped with serotype 5 viral capsid encoding CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats associated protein 9) gene editing constructs,,2019-07-23,Treatment of CEP290 gene mutations including Leber congenital amaurosis.,Designated,Not FDA Approved for Orphan Indication,,,,Editas Medicine,11 Hurley Street,,Cambridge,Massachusetts,2141,United States,693419,,
"(S)-4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 4-(2-(5-(3-(2,4-dihydroxy-5-isopropylphenyl)-5-hydroxy-4H-1,2,4-triazol-4-yl)-1H-indol-1-yl)ethyl)piperidine-1-carboxylate",,2019-07-24,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,"Tarveda Therapeutics, Inc.",134 Coolidge Ave.,,Watertown,Massachusetts,2472,United States,694919,,
"(R)-6-((3,3-difluoro-1-methylpiperidine-4-yl)oxy-N-(3-ethynyl-2-fluorophenyl)-7-methoxyquinazolin-4-amine-,fumerate (2:1) (salt)",,2019-07-24,Treatment of glioma (including glioblastoma and anaplastic astrocytoma),Designated,Not FDA Approved for Orphan Indication,,,,Wayshine Biopharm Inc.,"957 Ferndale Dr,",,Corona,California,92881,United States,695019,,
Episcleral Topotecan,,2019-07-24,Treatment of retinoblastoma,Designated,Not FDA Approved for Orphan Indication,,,,"Targeted Therapy Technologies, LLC., DBA: 3T Ophthalmics",3972 Barranca Parkway,Suite J-185,Irvine,California,92606,United States,694519,,
elafibranor,,2019-07-25,Treatment of Primary Biliary Cholangitis,Designated,Not FDA Approved for Orphan Indication,,,,Genfit SA,Parc Eurasant鬠885 Avenue Eug讥 Avin饍,,Loos,,,France,693919,,
heparin sodium,,2019-07-29,Treatment of Cystic Fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,Vectura Limited,One Prospect West,Chippenham,Wiltshire,,,United Kingdom,694019,,
"calcium, magnesium, potassium, and sodium oxybates",Xywav,2019-07-31,Treatment of idiopathic hypersomnia,Designated/Approved,,Treatment of idiopathic hypersomnia (IH) in adults,2021-08-12,2028-08-12,Jazz Pharmaceuticals Ireland Limited,5th Floor Waterloo Exchange,Waterloo Road,Dublin,,,Ireland,694619,,
leriglitazone,,2019-08-01,Treatment of Friedreichs ataxia,Designated,Not FDA Approved for Orphan Indication,,,,Minoryx Therapeutics S.L.,TecnoCampus Mataro-Maresme. TCM3 602,"Av. Ernest Lluch, 32.",Matar󍊠,Catalunya,,Spain,700919,,
1-{4-[2-(5-ethoxymethyl-2-methyl-phenylamino)-oxazol-5-yl]-phenyl}-imidazolidin-2-one,,2019-08-01,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,AB Science,"3, avenue George V",,Paris,,,France,695919,,
"(2S,3R,4R,5S)-2-(hydroxymethyl)-1-pentylpiperidine-3,4,5-triol",,2019-08-01,Treatment of GM2 gangliosidosis,Designated,Not FDA Approved for Orphan Indication,,,,Idorsia Pharmaceuticals Ltd,91 Hegenheimermattweg,,Allschwil,Basel-Landschaft,,Switzerland,701719,,
Temozolomide,,2019-08-01,Treatment of neuroblastoma,Designated,Not FDA Approved for Orphan Indication,,,,ORPHELIA Pharma,85 Blvd Saint-Michel,,Paris,,,France,698519,,
"(2R,3S)-2-(3-(4,5-dichloro-1H-benzo[d]imidazol-1-yl)propyl)piperidin-3-ol Hydrogen Chloride",,2019-08-05,Treatment of idiopathic pulmonary fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,"Daewoong Pharmaceutical Co., Ltd.","12, Bongeunsa-ro 114 gil",Gangnam-gu,Seoul,Korea,,South Korea,701419,,
18-mer antisense oligonucleotide complementary to SCN1A mRNA,,2019-08-05,Treatment of Dravet syndrome,Designated,Not FDA Approved for Orphan Indication,,,,"Stoke Therapeutics, Inc.",45 Wiggins Ave,,Bedford,Massachusetts,1730,United States,695319,,
5-cEtG-sp-cEt5MeU-sp-cEt5MeU-sp-dT-sp-dA-sp-dT-sp-dT-sp-dA-sp-dT-sp-dA-sp-dG-sp-dG-sp-dG-sp-cEt5MeC-sp-cEt5MeU-sp-cEt5MeU-3,,2019-08-05,Treatment of centronuclear myopathies,Designated,Not FDA Approved for Orphan Indication,,,,Dynacure SAS,300 Boulevard Sebastien Brant,,Illkirch Graffenstaden,,,France,702819,,
clazakizumab,,2019-08-08,Treatment of chronic antibody-mediated rejection in kidney transplant recipients,Designated,Not FDA Approved for Orphan Indication,,,,CSL Behring,1020 First Avenue,P.O. Box 61501,King of Prussia,Pennsylvania,19406,United States,612317,,
"4-(4-((4-chloro-3-(trifluoromethyl)phenyl)sulfonyl)phenyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione",,2019-08-08,Treatment of amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,"Neuropore Therapies, Inc.","10835 Road to the Cure, Suite 230",,San Diego,California,92121,United States,704119,,
Lentiviral vector expressing human fumarylacetoacetate hydrolase,,2019-08-08,Treatment of hereditary tyrosinemia type I,Designated,Not FDA Approved for Orphan Indication,,,,"Castle Creek Biosciences, LLC",405 Eagleview Blvd,,Exton,Pennsylvania,19341,United States,696319,,
sargramostim,,2019-08-08,Treatment of Stage IIb-IV melanoma,Designated,Not FDA Approved for Orphan Indication,,,,"Partner Therapeutics, Inc.",19 Muzzey Street,,Lexington,Massachusetts,2421,United States,674618,,
"(R)-tetrahydrofuran-3-yl 4-(6-(5-(4-ethoxy-1-isopropylpiperidin-4-yl)pyridin-2-yl)pyrrolo[1,2-b]pyridazin-4-yl)piperazine-1-carboxylate sesquisuccinate",,2019-08-08,Treatment of fibrodysplasia ossificans progressiva,Designated,Not FDA Approved for Orphan Indication,,,,"Clementia Pharmaceuticals, Inc.","1000 De La Gauchetiere West, Suite 1200",,Montreal,,,Canada,698319,,
perfluorooctyl-bromide,,2019-08-08,Treatment of congenital pulmonary hypoplasia in infancy,Designated,Not FDA Approved for Orphan Indication,,,,Childrens Hospital of Pennsylvania,Clinical Research Support,"Colket Translational Research Building, 11th Floor, Room 11101",Philadelphia,Pennsylvania,19104,United States,630718,,
"1-(((Z)-hexadec-1-en-1-yl)oxy)-3-((2-oxido-1,3,2-oxazaphospholidin-2-yl)oxy)propan-2-yl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate",,2019-08-08,Treatment of Rhizomelic Chondrodysplasia Punctata,Designated,Not FDA Approved for Orphan Indication,,,,"Med-Life Discoveries, LP",407-15 Innovation Boulevard,,Saskatoon,,,Canada,696219,,
cannabidiol,,2019-08-15,Treatment of childhood absence epilepsy,Designated,Not FDA Approved for Orphan Indication,,,,"Radius Pharmaceuticals, Inc.",950 Winter Street,,Waltham,Massachusetts,2451,United States,696519,,
neutralizing equine anti-Stx hyperimmune immunoglobulin F(ab')2 fragment,,2019-08-19,Treatment of Shiga-toxin producing bacterial infection as it relates to the prevention of hemolytic uremic syndrome,Designated,Not FDA Approved for Orphan Indication,,,,Inmunova SA,"Av. 25 de Mayo 1021, San Martin (1650)",,Buenos Aires,Buenos Aires,,Argentina,644418,,
"DNA, (Cm-Gm-Gm-Gm-G-T-G-T-G-G-G-T-T-C-G-T-C-G-T-T-A-G-C-T-T-G-A-T-T-T-G-G-C-A-G-C-Um-Gm-Cm-Cm-(3'3')-dT), 5'-ester with [[5-(phosphoonoxy) pentyl] amino] carbonyl-oxy-1, 2-ethanediyl, sodium salt",,2019-08-19,Treatment of Osteogenesis Imperfecta,Designated,Not FDA Approved for Orphan Indication,,,,Aptacure Therapeutics Limited,"West Wing 2/F, 822 Lai Chi Kok Road",Cheung Sha Wan,Kowloon,,,,696619,,
Adeno-Associated Virus containing the gene for human Nuclear Hormone Receptor NR2E3 (AAV-hNR2E3),,2019-08-20,Treatment of CEP290 mutation associated retinal disease.,Designated,Not FDA Approved for Orphan Indication,,,,Ocugen Inc.,5 Great Valley Parkway,Suite 160,Malvern,Pennsylvania,19355,United States,697519,,
dupilumab,,2019-08-21,Treatment of bullous pemphigoid,Designated,Not FDA Approved for Orphan Indication,,,,"Regeneron Pharmaceuticals, Inc.",777 Old Saw Mill River Road,,Tarrytown,New York,10591,United States,697319,,
"Cultured human retinal pigment epithelial cell line (ARPE-19) genetically modified with a non-viral vector to express B domain deleted human factor VIII protein, encapsulated within two-layer modified alginate spheres",,2019-08-21,Treatment of Hemophilia A,Designated,Not FDA Approved for Orphan Indication,,,,"Sigilon Therapeutics, Inc.","100 Binney Street, STE 600",,Cambridge,Massachusetts,2142,United States,697219,,
Talabostat,,2019-08-21,Treatment of acute myelogenous leukemia,Designated,Not FDA Approved for Orphan Indication,,,,"BioXcel Therapeutics, Inc.",555 Long Wharf Drive,5th Floor,New Haven,Connecticut,6511,United States,697119,,
Pemigatinib,,2019-08-21,"Treatment of myeloid/lymphoid neoplasms with eosinophilia and rearrangement of PDGFRA, PDGFRB, or FGFR1, or with PCM1-JAK2",Designated,Not FDA Approved for Orphan Indication,,,,Incyte Corporation,1801 Augustine Cut-Off,,Wilmington,Delaware,19803,United States,696419,,
small molecule inhibitor of the pro-survival protein Myeloid Cell Leukemia sequence 1 (MCL1),,2019-08-21,Treatment of Multiple Myeloma,Designated,Not FDA Approved for Orphan Indication,,,,Amgen Inc.,One Amgen Center Drive,Mail Stop 27-2-D,Thousand Oaks,California,91320-1799,United States,698019,,
Romilkimab,,2019-08-21,Treatment of systemic sclerosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,Sanofi U.S. Service Inc.,55 Corporate Drive,Mail Stop: 55C-300,Bridgewater,New Jersey,8807,United States,629518,,
cedazuridine and decitabine,Inqovi,2019-08-21,Treatment of myelodysplastic syndromes (including chronic myelomonocytic leukemia),Designated/Approved,,"Indicated for the treatment of adult patients with myelodysplastic syndromes (MDS), including previously treated and untreated, de novo and secondary MDS with the following French-American-British subtypes (refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, and chronic myelomonocytic leukemia [CMML]) and intermediate-1, intermediate-2, and high-risk International Prognostic Scoring System groups.",2020-07-07,2027-07-07,"Astex Pharmaceuticals, Inc.",4420 Rosewood Drive,Suite 200,Pleasanton,California,94588,United States,697019,,
"Bismuth-1,2-ethanedithiol; 1,2-Bis-((1,3-dithia-2-bismolan)-2-yl) thioethane",,2019-08-21,Treatment (management) of pulmonary infections in patients with Cystic Fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,Microbion Corporation,1102 West Babcock Street,Suite B,Bozeman,Montana,59715,United States,621817,,
18F-meta-fluorobenzylguanidine,,2019-08-21,Diagnostic for the management of neuroblastoma,Designated,Not FDA Approved for Orphan Indication,,,,Illumina Radiopharmaceuticals LLC,175 Elm Road,,Englewood,New Jersey,7631,United States,702419,,
"(1E,6E)-1,7-Bis(3,4-dimethoxyphenyl)-4-cyclobutylmethyl-1,6-heptadiene-3,5-dione and [(1E,4Z,6E)-4-(cyclobutylmethyl)-1,7-bis(3,4-dimethoxyphenyl)-5-hydroxyhepta-1,4,6-trien-3-one]",,2019-08-23,Treatment of glioblastoma,Designated,Not FDA Approved for Orphan Indication,,,,Allianz Pharmascience Limited,"7F-2, No. 77, Section 2, Duan Hua",,South Road,Taipei,,Taiwan,704319,,
Propranolol,,2019-08-23,Treatment of retinopathy of prematurity,Designated,Not FDA Approved for Orphan Indication,,,,"Recordati Rare Diseases, SARL","Immeuble le ""Wilson""",70 Avenue du General de Gaulle,Puteaux,,,France,703319,,
neratinib,,2019-08-26,Treatment of breast cancer patients with brain metastases,Designated,Not FDA Approved for Orphan Indication,,,,Puma Biotechnology Inc.,"10880 Wilshire Blvd., Suite 2150",,Los Angeles,California,90024,United States,699119,,
Zilucoplan,,2019-08-26,Treatment of myasthenia gravis,Designated,Not FDA Approved for Orphan Indication,,,,"Ra Pharmaceuticals, Inc.",87 Cambridge Park Drive,,Cambridge,Massachusetts,2140,United States,699319,,
benralizumab,,2019-08-26,Treatment of eosinophilic esophagitis,Designated,Not FDA Approved for Orphan Indication,,,,AstraZeneca Pharmaceuticals LP,1800 Concord Pike,P.O. Box 8355,Wilmington,Delaware,19803,United States,670018,,
sirolimus,,2019-08-26,Treatment of tuberous sclerosis complex,Designated,Not FDA Approved for Orphan Indication,,,,"AI Therapeutics, Inc.",530 Old Whitfield Street,,Guilford,Connecticut,6437,United States,698619,,
(E)-N1-(3-(dimethylamino)propyl)-N8-hydroxy-2-((naphthalen-1-yloxy)methyl)oct-2-enediamide phosphate,,2019-08-26,Treatment of Pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,"CrystalGenomics, Inc.","5th F. Bldg.A, Korea Bio Park","700 Daewangpangyoro, Bundanggu, Seongnamsi",Gyeonggido,,,South Korea,699019,,
Specific Peptide Enhanced Affinity Receptor T cell product comprised of autologous CD4 and CD8 positive T cells genetically engineered with an affinity-enhanced T cell receptor to target cancer-testis antigen MAGE-A4,,2019-08-26,Treatment of Soft Tissue Sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,"Adaptimmune, LLC",351 Rouse Blvd,,Philadelphia,Pennsylvania,19112,United States,666018,,
Fully Human Anti-BCMA (B-Cell Maturation Antigen) Autologous Chimeric Antigen Receptor (CAR) T Cell,,2019-08-28,Treatment of Multiple Myeloma,Designated,Not FDA Approved for Orphan Indication,,,,CARsgen Therapeutics Corporation,"6575 West Loop South, Suite 455",,Bellaire,Texas,77401,United States,699819,,
Chimeric locked nucleic acid and ribonucleic-deoxyribonucleic antisense oligonucleotide specific for the human UBE3A-antisense transcript,,2019-08-28,Treatment of Angelman syndrome,Designated,Not FDA Approved for Orphan Indication,,,,"GeneTx Biotherapeutics, LLC","5020 Clark Road, #240",,Sarasota,Florida,34233,United States,702619,,
nomacopan,,2019-08-28,Treatment of hematopoietic stem cell transplantation-associated thrombotic microangiopathy,Designated,Not FDA Approved for Orphan Indication,,,,Akari Therapeutics Plc,24 West 40th Street,8th Floor,New York,New York,10018,United States,698219,,
"An asymmetric immunoglobulin G1 (IgG1)-based, B-cell maturation antigen (BCMA) x CD3 T-cell bispecific monoclonal antibody",,2019-08-28,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,CELGENE INTERNATIONAL II SARL,c/o Celgene Corporation,86 Morris Avenue,Summit,New Jersey,7901,United States,698119,,
PEGylated recombinant human tumor necrosis factor-related apoptosis inducing ligand,,2019-09-05,Treatment of chronic pancreatitis.,Designated,Not FDA Approved for Orphan Indication,,,,"Theraly Fibrosis, Inc.","20271 Goldenrod Lane, Suite 2046",,Germantown,Maryland,20876,United States,699619,,
fasudil,,2019-09-05,Treatment of subarachnoid hemorrhage,Designated,Not FDA Approved for Orphan Indication,,,,"Aneuryst, Inc.",211 East 43rd Street,Suite 710,New York,New York,10017-8601,United States,700019,,
sotatercept,,2019-09-05,Treatment of pulmonary arterial hypertension,Designated,Not FDA Approved for Orphan Indication,,,,Acceleron Pharma Inc.,128 Sidney Street,,Cambridge,Massachusetts,2139,United States,700219,,
deoxynucleogen,,2019-09-10,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,"CLS Therapeutics, Inc",101 6th Ave,,New York,New York,10013,United States,699519,,
"drug component, inhaled nitric oxide, of the inhaled nitric oxice/INOpulse Device combination product",,2019-09-10,Treatment of idiopathic pulmonary fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,Bellerophon Therapeutics,184 Liberty Corner Road,Suite 302,Warren,New Jersey,7059,United States,621517,,
quinacrine,,2019-09-10,Treatment of Ebola Infection,Designated,Not FDA Approved for Orphan Indication,,,,"Collaborations Pharmaceuticals, Inc.","5616 Hilltop Needmore Rd,",,Fuquay Varina,North Carolina,27526,United States,701119,,
glycerol tribenzoate,,2019-09-10,Treatment of Huntingtons disease,Designated,Not FDA Approved for Orphan Indication,,,,"Curyx Bio, Inc.",140 E. Ridgewood Avenue,Suite 415 South Tower,Paramus,New Jersey,7652,United States,703419,,
parsaclisib,,2019-09-10,Treatment of splenic marginal zone lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,Incyte Corporation,1801 Augustine Cut-Off,,Wilmington,Delaware,19803,United States,688319,,
bispecific Antibody simultaneously targeting CD38 and CD3,,2019-09-11,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,"Ichnos Sciences, Inc.",One World Trade Center,"76th Floor, Suite D",New York,New York,10007,United States,700119,,
bispecific T cell engager antibody construct with a half-life extension Fc moiety capable of binding to the neonatal Fc receptor,,2019-09-11,Treatment of Acute Myeloid Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,Amgen Inc.,One Amgen Center Drive,Mail Stop 17-1-A,Thousand Oaks,California,91320,United States,655818,,
infigratinib,Truseltiq,2019-09-11,Treatment of cholangiocarcinoma,Designated/Approved,,"Treatment of adults with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (FGFR2) fusion or other rearrangement as detected by an FDA-approved test.",2021-05-28,2028-05-28,"QED Therapeutics, Inc.",8000 Marina Boulevard,Suite 400,Brisbane,California,94005,United States,707019,,
allogeneic gene edited CD20-directed CAR (Chimeric Antigen Receptor) T cells,,2019-09-11,Treatment of Mantle Cell Lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,"Precision BioSciences, Inc.",302 East Pettigrew Street,Suite A-100,Durham,North Carolina,27701,United States,700519,,
"2-hydroxy-N,N,N-trimethylethan-1-aminium (Z)-4-(5-((3-benzyl-4-oxo-2-thioxothiazolidin-5-ylidene)methyl)furan-2-yl)benzoate",,2019-09-11,Treatment of Pancreatic Cancer,Designated,Not FDA Approved for Orphan Indication,,,,"GB006, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.",3013 Science Park Road,,San Diego,California,92121,United States,701219,,
nomacopan,,2019-09-12,Treatment of bullous pemphigoid,Designated,Not FDA Approved for Orphan Indication,,,,Akari Therapeutics Plc,24 West 40th Street,8th Floor,New York,New York,10018,United States,669018,,
10-nitro-9(E)-octadec-9-enoic acid,,2019-09-12,Treatment of pulmonary arterial hypertension,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,"Complexa, Inc.",1055 Westlakes Dr,Suite 200,Berwyn,Pennsylvania,19312,United States,701019,,
tacrolimus,Prograf,2019-09-12,Prevention of rejection in lung transplantation,Designated/Approved,,"Prophylaxis of organ rejection in adult and pediatric patients receiving allogeneic kidney transplant, liver transplant, heart transplant, or lung transplant in combination with other immunosuppressants",2021-07-16,2028-07-16,"Astellas Pharma Global Development, Inc.",1 Astellas Way,,Northbrook,Illinois,60062,United States,701319,,
Humanized connexin 43 (hCx43) monoclonal antibody,,2019-09-18,Treatment of Osteosarcoma,Designated,Not FDA Approved for Orphan Indication,,,,"AlaMab Therapeutics, Inc.",11550 West Interstate 10,Suite 250,San Antonio,Texas,78230,United States,710019,,
linerixibat,,2019-09-18,Treatment of Primary Biliary Cholangitis,Designated,Not FDA Approved for Orphan Indication,,,,GlaxoSmithKline,1250 South Collegeville Road,"Building 4, Mail Stop 4400",Collegeville,Pennsylvania,19426,United States,701919,,
"L-Lysinamide,N2,N6-bis(L-lysylglycyl-L-valyl-L-seryl-L-leucyl-L-seryl-L-tyrosyl-L-arginyl)-hexa-acetate salt",,2019-09-18,Treatment of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,TCM Biotech International Corp.,"24F-8, No. 97","Sec. 1, Xintai 5th Rd., Xizhi Dist.",New Taipei City,Taiwan,,Taiwan,703719,,
setmelanotide,,2019-09-19,Treatment of Bardet-Biedl syndrome,Designated,Not FDA Approved for Orphan Indication,,,,"Rhythm Pharmaceuticals, Inc",222 Berkeley Street,Suite 1200,Boston,Massachusetts,2116,United States,700719,,
"(1E,6E)-1,7-Bis(3,4-dimethoxyphenyl)-4-cyclobutylmethyl-1,6-heptadiene-3,5-dione and [(1E,4Z,6E)-4-(cyclobutylmethyl)-1,7-bis(3,4-dimethoxyphenyl)-5-hydroxyhepta-1,4,6-trien-3-one]",,2019-09-24,Treatment of spinocerebellar ataxia,Designated,Not FDA Approved for Orphan Indication,,,,Allianz Pharmascience Limited,"7F-2, No. 77, Section 2, Duan Hua",,South Road,Taipei,,Taiwan,701819,,
autologous CD34+ cell enriched hematopoietic stem cells genetically modified ex vivo with a lentiviral vector to contain codon-optimized complementary deoxyribonucleic acid that encodes human beta-glucocerebrosidase,,2019-09-25,Treatment of Gaucher disease,Designated,Not FDA Approved for Orphan Indication,,,,"AVROBIO, Inc.",One Kendall Square,Building 300,Cambridge,Massachusetts,2139,United States,702319,,
Caflanone,,2019-09-25,Treatment of Pancreatic Cancer,Designated,Not FDA Approved for Orphan Indication,,,,Flavocure Biotech,701 East Pratt Street,Suite 2033,Baltimore,Maryland,21202,United States,702719,,
Parsaclisib,,2019-09-25,Treatment of Follicular Lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,Incyte Corporation,1801 Augustine Cut-Off,,Wilmington,Delaware,19803,United States,703919,,
duvelisib,,2019-10-02,Treatment of T-Cell Lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,"Secura Bio, Inc.",1995 Village Center Cir.,,Las Vegas,Nevada,89134-6360,United States,703019,,
phenobarbital,,2019-10-02,Treatment of neonatal seizures,Designated,Not FDA Approved for Orphan Indication,,,,Sun Pharma Advanced Research Company Ltd.,"17/B, Mahal Industrial Estate",Mahakali Caves Road,Andheri (E),Mumbai,,India,703819,,
Encochleated oral Amphotericin B suspension,,2019-10-03,Treatment of cryptococcosis,Designated,Not FDA Approved for Orphan Indication,,,,"Matinas BioPharma Nanobiotechnologies, Inc.",1545 Route 206 South,Suite 302,Bedminster Township,New Jersey,7921,United States,703119,,
parsaclisib,,2019-10-07,Treatment of nodal marginal zone lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,Incyte Corporation,1801 Augustine Cut-Off,,Wilmington,Delaware,19803,United States,707319,,
a small molecule tissue-nonspecific alkaline phosphatase inhibitor,,2019-10-07,Treatment of Pseudoxanthoma elasticum,Designated,Not FDA Approved for Orphan Indication,,,,"Daiichi Sankyo, Inc.",211 Mount Airy Road,,Basking Ridge,New Jersey,7920,United States,705419,,
cyclo(-L-Glycyl-L-2-Allylproline),,2019-10-09,Treatment of Angelman syndrome,Designated,Not FDA Approved for Orphan Indication,,,,"Neuren Pharmaceuticals, Ltd.","Ste 201, 697 Burke Rd",,Camberwel,,,Australia,705719,,
parsaclisib,,2019-10-09,Treatment of extranodal marginal zone lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,Incyte Corporation,1801 Augustine Cut-Off,,Wilmington,Delaware,19803,United States,707419,,
pazopanib,,2019-10-09,Treatment of hereditary hemorrhagic telangiectasia,Designated,Not FDA Approved for Orphan Indication,,,,HHT Foundation International (d/b/a Cure HHT),8 Henderson Hill Ct,,Monkton,Maryland,21111,United States,705819,,
pembrolizumab,,2019-10-09,Treatment of Biliary Tract Carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,"Merck, Sharp & Dohme Corp",1 Merck Drive,,Whitehouse Station,New Jersey,8889,United States,705319,,
melatonin,,2019-10-09,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,WORPHMED Srl,"Via Malachia Marchesi de Taddei, 21",,Milan,Lombardy,,Italy,704519,,
"(S)-4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 4-(2-(5-(3-(2,4-dihydroxy-5-isopropylphenyl)-5-hydroxy-4H-1,2,4-triazol-4-yl)-1H-indol-1-yl)ethyl)piperidine-1-carboxylate",,2019-10-10,Treatment of Small Cell Lung Cancer,Designated,Not FDA Approved for Orphan Indication,,,,"Tarveda Therapeutics, Inc.",134 Coolidge Ave.,,Watertown,Massachusetts,2472,United States,713419,,
Cyclo(-L-Glycyl-L-2-Allylproline),,2019-10-15,Treatment of Phelan-McDermid syndrome,Designated,Not FDA Approved for Orphan Indication,,,,"Neuren Pharmaceuticals, Ltd.","Ste 201, 697 Burke Rd",,Camberwel,,,Australia,706019,,
glyceryl tribenzoate,,2019-10-15,Treatment of nonketotic hyperglycinemia,Designated,Not FDA Approved for Orphan Indication,,,,Liberyx Therapeutics Limited,"Unit 805, 8/F Mirror Tower","61 Mody Road, Tsim Sha Tsui",Kowloon,,,Hong Kong,705019,,
Cyclo(-L-Glycyl-L-2-Allylproline),,2019-10-15,Treatment of Pitt-Hopkins Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,"Neuren Pharmaceuticals, Ltd.","Ste 201, 697 Burke Rd",,Camberwel,,,Australia,706119,,
CD3 and B-cell maturation antigen T-cell engaging bispecific antibody,,2019-10-17,Treatment of Multiple Myeloma,Designated,Not FDA Approved for Orphan Indication,,,,"TeneoOne, Inc.",1 North Waukegan Road,,North Chicago,Illinois,60064,United States,706319,,
Pyronaridine,,2019-10-21,Treatment of Chagas Disease,Designated,Not FDA Approved for Orphan Indication,,,,"Collaborations Pharmaceuticals, Inc.","5616 Hilltop Needmore Rd,",,Fuquay Varina,North Carolina,27526,United States,696919,,
Recombinant complement-specific multimerized human IgG1 Fc,,2019-10-21,Treatment of autoimmune hemolytic anemia,Designated,Not FDA Approved for Orphan Indication,,,,"Gliknik, Inc.",801 W. Baltimore Street,Suite 501A,Baltimore,Maryland,21201,United States,705619,,
crenolanib,,2019-10-21,"Treatment of gastric cancer, including cancer of the gastroesophageal junction",Designated,Not FDA Approved for Orphan Indication,,,,"AROG Pharmaceuticals, Inc.","5420 LBJ Freeway, Suite 410",,Dallas,Texas,75240,United States,706819,,
recombinant human interleukin 22-human immunoglobulin Fc fusion protein,,2019-10-21,Treatment of acute graft versus host disease,Designated,Not FDA Approved for Orphan Indication,,,,Generon (Shanghai) Corporation Ltd.,"Building 9, 787 Kangqiao Road",,Pudong Xinqu,Shanghai Shi,,China,581117,,
adeno-associated virus vector encoding human phenylalanine hydroxylase,,2019-10-21,Treatment of phenylketonuria,Designated,Not FDA Approved for Orphan Indication,,,,"BioMarin Pharmaceutical, Inc.",105 Digital Drive,,Novato,California,94949,United States,707819,,
adeno-associated virus serotype 2/6 encoding a human alpha-galactosidase A cDNA,,2019-10-21,Treatment of Fabry Disease,Designated,Not FDA Approved for Orphan Indication,,,,"Sangamo Therapeutics, Inc.",7000 Marina Boulevard,,Brisbane,California,94005,United States,707219,,
Human Alpha1-proteinase inhibitor,,2019-10-22,Treatment of graft versus host disease,Designated,Not FDA Approved for Orphan Indication,,,,CSL Behring,1020 First Avenue,PO Box 61501,King of Prussia,Pennsylvania,19406,United States,708519,,
"acetic acid, propionic acid, and butyric acid",,2019-10-22,Treatment of Hepatocellular Carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,"SFA Therapeutics, Inc.","610 Old York Rd, Suite 400",,Jenkintown,Pennsylvania,19046,United States,706219,,
hydroxypropyl-B-cyclodextrin-panobinostat complex,,2019-10-22,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,Midatech Ltd.,Oddfellows House,19 Newport Road,Cardiff,,,United Kingdom,705919,,
monobenzone and imiquimod,,2019-10-28,Treatment of stage IIB-IV melanoma,Designated,Not FDA Approved for Orphan Indication,,,,"Learmont Pharmaceuticals, Inc.",233 Broadway,Suite 1750,New York,New York,10279,United States,707519,,
"Lu-177(3+),2-[[5-(2,6-dimethoxyphenyl)-1-[2-isopropyl-4-[methyl-[3-[methyl-[3-[methyl-[2-[4,7,10- tris(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetyl]amino]propyl]amino]propyl]carbamoyl]phenyl]pyrazole-3-carbonyl]amino]adamantane-2-carboxylic acid",,2019-10-28,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,Fusion Pharmaceuticals Inc.,"Two International Place, Ste 2310",,Boston,Massachusetts,2110,United States,708119,,
selpercatinib,RETEVMO,2019-10-30,Treatment of RET-fusion-positive non-small cell lung cancer,Designated/Approved,,RETEVMO is indicated for the treatment of adult patients with metastatic RET fusion-positive non-small cell lung cancer (NSCLC),2020-05-08,2027-05-08,Loxo Oncolocy at Lilly,"701 Gateway Boulevard, Suite 420",,South San Francisco,California,94080,United States,675218,,
vasopressin 1a receptor antagonist,,2019-10-30,Treatment of Huntington's disease,Designated,Not FDA Approved for Orphan Indication,,,,"Azevan Pharmaceuticals, Inc.",116 Research Drive,,Bethlehem,Pennsylvania,18015,United States,532016,,
"Recombinant humanized, non-fucosylated IgG1 anti-Siglec-8 monoclonal antibody",,2019-10-30,Treatment of eosinophilic esophagitis,Designated,Not FDA Approved for Orphan Indication,,,,"Allakos, Inc.",75 Shoreway Road,Suite A,San Carlos,California,94070,United States,668818,,
Proliferation arrested myelomonocytic leukemic cell line-derived cells with a mature dendritic cell phenotype,,2019-10-30,Treatment of Acute Myeloid Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,DCPrime BV,Galile﷥g 8,,BD Leiden,,,Netherlands,709019,,
autologous enriched T cells transduced with a lentiviral vector to express an anti-CD19 Chimeric Antigen Receptor,,2019-11-04,Treatment of acute lymphoblastic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,"Autolus Incorporated, US subsidiary of Autolus Limited",805 King Farm Boulevard,Suite 550,Rockville,Maryland,20850,United States,708319,,
Tislelizumab,,2019-11-06,Treatment of Esophageal Cancer,Designated,Not FDA Approved for Orphan Indication,,,,"BeiGene USA, Inc.",2955 Campus Drive,Suite 200,San Mateo,California,94403,United States,708919,,
Autologous auricular cartilage construct for subcutaneous implantation,,2019-11-06,Treatment of microtia (including anotia),Designated,Not FDA Approved for Orphan Indication,,,,"3D Bio Holdings, Inc.",51-36 35th Street,,Long Island City,New York,11101,United States,714219,,
"4-(5-(2-chlorophenyl)-3-methyl-2,10-dihydropyrazolo[4,3-b] pyrido[4,3-e][1,4]diazepin-8-yl) morpholine",,2019-11-06,treatment of cholangiocarcinoma,Designated,Not FDA Approved for Orphan Indication,,,,"TransThera Sciences (Nanjing), Inc.","F3, Bld 9, Accelerator Phase 2","Biotech and Pharmaceutical Valley, Jiangbei New Area",Nanjing,,210032,China,711719,,
humanized bi-specific XmAb(R) T cell recruiting antibody construct directed against CD3 and CD38,,2019-11-14,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,"Xencor, Inc.",111 W. Lemon Ave.,,Monrovia,California,91016,United States,648318,,
Single stranded adeno-associated virus vector encoding beta-galactosidase-1,,2019-11-14,Treatment of GM1 gangliosidosis,Designated,Not FDA Approved for Orphan Indication,,,,Axovant Sciences,"11 Times Square, 33rd Floor",,"New York,",New York,10036,United States,714719,,
navitoclax,,2019-11-18,Treatment of myelofibrosis,Designated,Not FDA Approved for Orphan Indication,,,,AbbVie Inc.,1 North Waukegan Road,"Dept #PA72, Bldg. AP30-4",North Chicago,Illinois,60064,United States,709319,,
alpelisib,,2019-11-18,Treatment of PIK3CA-related overgrowth spectrum,Designated,Not FDA Approved for Orphan Indication,,,,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,United States,710819,,
antisense oligonucleotide targeting the P23H mutation of the RHO gene,,2019-11-18,Treatment of retinal dystrophy dut to the P23H gene mutation (retinitis pigmentosa),Designated,Not FDA Approved for Orphan Indication,,,,ProQR Therapeutics IV B.V.,Zernikedreef 9,,Leiden,,2333 CK,Netherlands,709219,,
"2-((4S)-6-(4-chlorophenyl)-1-methyl-4H-benzo[c]isoxazolo[4,5-e]azepin-4-yl) acetamide monohydrate",,2019-11-20,Treatment of myelofibrosis,Designated,Not FDA Approved for Orphan Indication,,,,Constellation Pharmaceuticals,"215 First Street, Suite 200",,Cambridge,Massachusetts,2142,United States,710219,,
Purified bovine Type V Collagen,,2019-11-20,Prevention of Primary Graft Dysfunction in Lung Transplant Patients.,Designated,Not FDA Approved for Orphan Indication,,,,Magnolia Therapeutics LLC,"605 Crescent Blvd., Suite 200",,Ridgeland,Mississippi,39157,United States,710119,,
Tislelizumab,,2019-11-20,Treatment of Hepatocellular Carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,"BeiGene USA, Inc.",2955 Campus Drive,Suite 200,San Mateo,California,94403,United States,709919,,
zotiraciclib,,2019-11-21,Treatment of glioma,Designated,Not FDA Approved for Orphan Indication,,,,"Cothera Bioscience, Inc.","2929 Campus Drive, Suite 230",,San Mateo,California,94403,United States,710719,,
selpercatinib,RETEVMO,2019-11-21,"Treatment of RET fusion-positive or RET mutant thyroid cancers including poorly differentiated thyroid cancer, undifferentiated or anaplastic thyroid cancer, medullary thyroid cancer, and locally advanced or metastatic follicular or papillary thyroid canc",Designated/Approved,,RETEVMO is indicated for the treatment of: Adult and pediatric patients 12 years of age and older with advanced or metastatic RET-mutant medullary thyroid cancer (MTC) who require systemic therapy; Adult and pediatric patients 12 years of age and older with advanced or metastatic RET fusion-positive thyroid cancer who require systemic therapy and who are radioactive iodine-refractory (if radioactive iodine is appropriate),2020-05-08,2027-05-08,Loxo Oncolocy at Lilly,"701 Gateway Boulevard, Suite 420",,South San Francisco,California,94080,United States,653118,,
"5-(3,6-dibromo-9H-carbazol-9-yl)-N,N,N-trimethylpentan-1-aminium chloride",,2019-11-21,Treatment of Dercums disease (adiposis dolorosa),Designated,Not FDA Approved for Orphan Indication,,,,"Raziel Therapeutics, Inc.","High-Tech Village, Givat Ram Campus",Hebrew University,Jerusalem,,,Israel,688219,,
surufatinib,,2019-11-21,Treatment of pancreatic neuroendocrine tumors,Designated,Not FDA Approved for Orphan Indication,,,,Hutchison MediPharma Ltd.,"Building 4, 720 Cailun Road",Zhangjiang Hi-Tech Park,Shanghai,,,China,710319,,
dalfampridine,,2019-11-25,Treatment of Transverse Myelitis,Designated,Not FDA Approved for Orphan Indication,,,,Magnum Therapeutics,243 W. 259th Street,,Riverdale,New York,10471,United States,713019,,
"4-((7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-N-(4-((4- methylpiperazin-1-yl)methyl)phenyl)-1H-pyrazole-3-carboxamide, (2Z)-2-butenedioate (1:2), Sesquihydrate",,2019-11-26,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,"Shanghai Fosun Pharmaceutical Development Co., Ltd.",16 Esquire Rd (Breas),,Billerica,Massachusetts,1862,United States,713619,,
Recombinant Bispecific antibody targeting CD123 and CD3,,2019-11-26,Treatment of acute myelogenous leukemia,Designated,Not FDA Approved for Orphan Indication,,,,Aptevo Research and Development,2401 Fourth Avenue,Suite 1050,Seattle,Washington,98121,United States,711019,,
"Non-replicating recombinant, self-complementary adeno-associated virus serotype 9 containing the human CLN3 gene",,2019-11-26,Treatment of CLN3 Batten Disease,Designated,Not FDA Approved for Orphan Indication,,,,"Amicus Therapeutics, Inc.",3675 Market Street,,Philadelphia,Pennsylvania,19104,United States,713119,,
"Hypotonic, acid oxidizing solution containing hypochlorous acid (HClO)",,2019-11-26,Treatment of Epidermolysis Bullosa,Designated,Not FDA Approved for Orphan Indication,,,,APR Applied Pharma Research s.a.,Via Corti 5,,Balerna,,,Switzerland,711819,,
nicardipine,,2019-11-26,Treatment of Pitt-Hopkins Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,"Collaborations Pharmaceuticals, Inc.","5616 Hilltop Needmore Rd,",,Fuquay Varina,North Carolina,27526,United States,712819,,
"1-(4-Chloro-3,5-diphenyl-pyrazolo[3,4-c]pyridazin-1-yl)-2-methyl-propan-2-ol",,2019-11-26,Treatment of Usher syndrome,Designated,Not FDA Approved for Orphan Indication,,,,"Usher III Initiative, Inc.","191 N. Wacker Dr., Suite 1790",,Chicago,Illinois,60606,United States,711419,,
delta-9-tetrahydrocannabinol,,2019-11-27,Treatment of Hepatocellular Carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,Tetra Bio-Pharma Inc.,365 St.-Jean Street,Suite 122,Longueuil,,,Canada,652218,,
"Non-replicating recombinant, self-complementary adeno-associated virus serotype 9 containing the human CLN6 gene",,2019-11-27,Treatment of CLN6 Batten Disease,Designated,Not FDA Approved for Orphan Indication,,,,"Amicus Therapeutics, Inc.",3675 Market Street,,Philadelphia,Pennsylvania,19104,United States,714419,,
Romiplostim,,2019-11-27,Treatment of aplastic anemia,Designated,Not FDA Approved for Orphan Indication,,,,Amgen Inc.,One Amgen Center Drive,Mail Stop 27-2-D,Thousand Oaks,California,91320,United States,712019,,
brivaracetam,,2019-12-03,Treatment of Juvenile Absence Epilepsy,Designated,Not FDA Approved for Orphan Indication,,,,"UCB, Inc.",1950 Lake Park Drive,Building 2100,Smyrna,Georgia,30080,United States,724019,,
brivaracetam,,2019-12-03,Treatment of Childhood Absence Epilepsy,Designated,Not FDA Approved for Orphan Indication,,,,"UCB, Inc.",1950 Lake Park Drive,Building 2100,Smyrna,Georgia,30080,United States,711119,,
nandrolone,,2019-12-04,Treatment of limb-girdle muscular dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,Sarcomed AB,25 St��oppsv䧥n,,H䧥rsten-Liljeholmen,Stockholms l䮍,,Sweden,712219,,
nipocalimab,,2019-12-05,Treatment of autoimmune hemolytic anemia,Designated,Not FDA Approved for Orphan Indication,,,,"Momenta Pharmaceuticals, Inc.",301 Binney Street,,Cambridge,Massachusetts,2142,United States,711519,,
Non-replicating recombinant adeno-associated virus serotype 9 containing the progranulin gene,,2019-12-05,Treatment of frontotemporal dementia,Designated,Not FDA Approved for Orphan Indication,,,,Prevail Therapeutics,430 East 29th Street,Suite 940,New York,New York,10016,United States,712719,,
Placenta-Derived Decidua Stromal Cells,,2019-12-09,Treatment of graft versus host disease,Designated,Not FDA Approved for Orphan Indication,,,,"ASC Therapeutics, Inc.",521 Cottonwood Dr.,,Milpitas,California,95035,United States,711919,,
Oncolytic Herpes Simplex Virus Expressing IL-12 - M032,,2019-12-11,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,University of Alabama at Birmingham,1720 2nd Avenue South,Suite 1170 AB,Birmingham,Alabama,35294,United States,712319,,
Reldesemtiv,,2019-12-11,Treatment of Amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,"Cytokinetics, Inc.",280 East Grand Avenue,,South San Francisco,California,94080,United States,712519,,
pioglitazone,,2019-12-12,Treatment of sudden sensorineural hearing loss,Designated,Not FDA Approved for Orphan Indication,,,,Strekin AG,60C Hochbergerstrasse,,Basel,Basel-Stadt,,Switzerland,583017,,
dantrolene,,2019-12-12,Treatment of organophosphate exposure,Designated,Not FDA Approved for Orphan Indication,,,,"Eagle Pharmaceuticals, Inc.",50 Tice Blvd,Suite 315,Woodcliff Lake,New Jersey,7677,United States,713319,,
Salinomycin,,2019-12-12,Treatment of small cell lung cancer,Designated,Not FDA Approved for Orphan Indication,,,,"Hillstream Biopharma, Inc.",245 Main Street,Suite 204,Chester,New Jersey,7930,United States,713219,,
mobocertinib,Exkivity,2019-12-17,"Treatment of non-small cell lung cancer with genetic alterations in EGFR including EGFR mutations and/or EGFR gene amplifications, HER2 mutations, or BRAF G466V mutations",Designated/Approved,,"Treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutations, as detected by an FDA-approved test, whose disease has progressed on or after platinum-based chemotherapy",2021-09-15,2028-09-15,"Takeda Development Center Americas, Inc.",95 Hayden Avenue,,Lexington,Massachusetts,2421,United States,653018,,
Allogeneic gene edited BCMA-directed CAR T cells,,2019-12-18,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,"Precision BioSciences, Inc.",302 East Pettigrew Street,Suite A-100,Durham,North Carolina,27701,United States,715319,,
"humanized, bispecific IgG1-like antibody directed against HER2",,2019-12-18,Treatment of Biliary Tract Cancer,Designated,Not FDA Approved for Orphan Indication,,,,Zymeworks Inc.,"1385 West 8th Street, Suite 540",,Vancouver,BC,V6H 3V9,Canada,715119,,
autologous T cells expressing a transmembrane chimeric antigen receptor (CAR) to target anti-delta-like ligand 3,,2019-12-18,Treatment of small cell lung cancer,Designated,Not FDA Approved for Orphan Indication,,,,Amgen Inc.,1 Amgen Center Drive,Mail Stop 27-3-A,Thousand Oaks,California,91320,United States,664618,,
Magrolimab,,2019-12-18,Treatment of Myelodysplastic Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,"Gilead Sciences, Inc.",333 Lakeside Drive,,Foster City,California,94404,United States,716319,,
avatrombopag maleate,,2019-12-19,Treatment of chemotherapy-induced thrombocytopenia,Designated,Not FDA Approved for Orphan Indication,,,,"Dova Pharmaceuticals, Inc.",240 Leigh Farm Road,Suite 245,Durham,North Carolina,27707,United States,699419,,
recombinant human growth hormone fused to alpha1-antitrypsin variant,,2019-12-19,Treatment of Growth Hormone Deficiency,Designated,Not FDA Approved for Orphan Indication,,,,"Alteogen, Inc.",62 Yuseong-daero 1628 beon-gil,Yuseong-gu,Daejeon,Daejeon,,South Korea,713719,,
fusion protein comprised of an enzymatically active Shiga-like toxin-I A1 subunit fused to a human single chain variable fragment with affinity for human CD38 cell surface protein,,2019-12-19,Treatment of Multiple Myeloma,Designated,Not FDA Approved for Orphan Indication,,,,"Molecular Templates, Inc.",9301 Amberglen Blvd. Suite 100,,Austin,Texas,78729,United States,713819,,
"atoltivimab, odesivimab and maftivimab",,2019-12-23,Post-exposure prophylaxis against Ebola virus infection,Designated,Not FDA Approved for Orphan Indication,,,,"Regeneron Pharmaceuticals, Inc.",777 Old Saw Mill River Road,,Tarrytown,New York,10591,United States,714619,,
"Natural Regulatory T Cells (T-Regs), Expanded with Interleukin-2, ExpAct Beads (CD3/CD28; Miltenyi), Rapamycin and Transforming Growth Factor-beta",,2019-12-23,Prevention of graft rejection following solid organ transplantation,Designated,Not FDA Approved for Orphan Indication,,,,"TRACT Therapeutics, Inc.",212 W. Superior Street,Suite 130,Chicago,Illinois,60654,United States,715719,,
Self complimentary adeno-associated virus serotype 9 expressing human aspartoacylase transgene,,2019-12-23,Treatment of Canavan Disease,Designated,Not FDA Approved for Orphan Indication,,,,"Aspa Therapeutics, Inc.",421 Kipling Street,,Palo Alto,California,94301,United States,715219,,
Mycobacterium vaccae,,2019-12-23,Treatment of Tuberculosis,Designated,Not FDA Approved for Orphan Indication,,,,Immunitor Inc.,365-2912 West Broadway,,Vancouver,,,Canada,714519,,
Humanized Anti-Globo H Monoclonal Antibody Monomethyl Auristatin E Conjugate,,2019-12-23,Treatment of Pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,"OBI Pharma USA, Inc.","6020 Cornerstone Court W, Suite 200",,San Diego,California,92121,United States,716219,,
"Anti-vascular endothelial growth factor, anti-hepatocyte growth factor Designed Ankyrin Repeat Protein",,2019-12-23,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,Molecular Partners AG,Wagistrasse 14,,Zrich,Schlieren,,Switzerland,716519,,
18-(p-[131I]-iodophenyl)octadecyl phosphocholine,,2019-12-23,Treatment of Lymphoplasmacytic Lymphoma/Waldenstrom macroglobulinemia,Designated,Not FDA Approved for Orphan Indication,,,,"Cellectar Biosciences, Inc.","100 Campus Drive, Suite 207",,Florham Park,New Jersey,7932,United States,716119,,
upadacitinib,,2019-12-30,Treatment of pediatric ulcerative colitis,Designated,Not FDA Approved for Orphan Indication,,,,AbbVie,1 North Waukegan Road,,North Chicago,Illinois,60044,United States,524116,,
recombinant adeno-associated viral vector serotype 8 encoding human acid alpha-glucosidase,,2019-12-31,Treatment of Pompe Disease,Designated,Not FDA Approved for Orphan Indication,,,,"Audentes Therapeutics, Inc.",600 California Street,17th Floor,San Francisco,California,94108,United States,717119,,
"Autologous CD3+ T cells genetically modified using a non-viral system to express a CD33 CAR, membrane bound Interleukin-15, and a truncated form of human HER1t (kill switch) on the cell surface.",,2019-12-31,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,Precigen,20358 Seneca Meadows Parkway,,Germantown,Maryland,20876,United States,717019,,
fixed-dose combination of celecoxib and ciprofloxacin.,,2020-01-08,Treatment of amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,NeuroSense Therapeutics,85 Medinat Ha-Yehudim,,Herzliya,,,Israel,718519,,
Manganese butoxyethyl pyridyl porphyrin,,2020-01-09,Treatment of glioma,Designated,Not FDA Approved for Orphan Indication,,,,"BioMimetix JV, LLC",5340 South Quebec Street,Suite 345N,Greenwood Village,Colorado,80111,United States,717419,,
An Adeno-Associated Virus Serotype 8 (AAV8) Vector Expressing FIX Padua (AAV8.ss-3xCRM8-TTRFIX_R338Lopt),,2020-01-13,Treatment of Hemophilia B,Designated,Not FDA Approved for Orphan Indication,,,,Baxalta US Inc.,300 Shire Way,,Lexington,Massachusetts,2421,United States,717719,,
Autologous CD34+ cells transduced with gamma globin lentiviral vector,,2020-01-14,Treatment of sickle cell disease,Designated,Not FDA Approved for Orphan Indication,,,,Aruvant Sciences GmbH,"Viaduktstrasse 8, 4051",,Basel,Switzerland,,Switzerland,720419,,
(R)-3-[(4-{1-[1-(3-Carboxy-1-cyclopropyl-7-fluoro-9-methyl-4-oxo-4H-quinolizine-8-yl)-pyrrolidin-3-yl-cyclopropyl]-methylamino}-piperidin-1-ylimino)-methylenyl]-rifamycin,,2020-01-14,Treatment of prosthetic joint infection,Designated,Not FDA Approved for Orphan Indication,,,,TenNor Therapeutics Limited,"218 Xinghu Street, Building B2, Suite 711",Suzhou Industrial Park,Suzhou,,,China,704419,,
"5-(4-((2S,5S)-5-(4-chlorobenzyl)-2-methylmorpholino)piperidin-1-yl)-1H-1,2,4-triazol-3-amine",,2020-01-14,Treatment of sarcoidosis,Designated,Not FDA Approved for Orphan Indication,,,,Galapagos NV,Generaal De Wittelaan L11 A3,,Mechelen,,2800,Belgium,706419,,
Olorofim,,2020-01-15,Treatment of lomentospora/scedosporium infections,Designated,Not FDA Approved for Orphan Indication,,,,F2G Limited,Lankro Way,Eccles,Manchester,,,United Kingdom,704219,,
Fasudil,,2020-01-15,Treatment of Amyotrophic Lateral Sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,"Woolsey Pharmaceuticals, Inc.",233 Broadway,Suite 1750,New York,New York,10279,United States,719119,,
Humanized Anti-Globo H Monoclonal Antibody Monomethyl Auristatin E Conjugate,,2020-01-15,Treatment of Gastric cancer,Designated,Not FDA Approved for Orphan Indication,,,,"OBI Pharma USA, Inc.","6020 Cornerstone Court W, Suite 200",,San Diego,California,92121,United States,722619,,
durvalumab,,2020-01-15,Treatment of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,AstraZeneca Pharmaceuticals LP,1800 Concord Pike,,Wilmington,Delaware,19803,United States,721519,,
tremelimumab,,2020-01-15,Treatment of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,AstraZeneca Pharmaceuticals LP,1800 Concord Pike,,Wilmington,Delaware,19803,United States,721419,,
Adeno-associated virus serotype 9 vector containing human Nacetylgalactosamine-6-sulfate sulfatase gene,,2020-01-15,Treatment of mucopolysaccharidosis type IVA (Morquio A Syndrome),Designated,Not FDA Approved for Orphan Indication,,,,"Esteve Pharmaceuticals, S.A.",109 Passeig de la Zona Franca,4th Floor,Barcelona,Catalunya,,Spain,725119,,
Allogeneic CD3+ T lymphocytes ex vivo expanded expressing the Vgamma9Vdelta2 T-cell receptor,,2020-01-16,Treatment of Acute Myeloid Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,TC BioPharm Ltd,"Maxim 1, 2 Parklands Way",,Motherwell,,,United Kingdom,684619,,
Envafolimab,,2020-01-16,Treatment of biliary tract cancer,Designated,Not FDA Approved for Orphan Indication,,,,"3D Medicines (Sichuan) Co., Ltd","64-66, Jiaogui Second Lane, Jinniu District",,Chengdu,Sichuan,,China,718819,,
Autologous CD34+ enriched cell population that contains hematopoietic stem and progenitor cells transduced ex vivo using a lentiviral vector encoding the human gp91phox gene,,2020-01-16,Treatment of X-linked chronic granulomatous disease (X-CGD),Designated,Not FDA Approved for Orphan Indication,,,,Orchard Therapeutics (Europe) Limited,108 Cannon Street,,London,,,United Kingdom,718919,,
olorofim,,2020-01-16,Treatment of invasive aspergillosis,Designated,Not FDA Approved for Orphan Indication,,,,F2G Limited,Lankro Way,Eccles,Manchester,,,United Kingdom,702219,,
luspatercept,,2020-01-16,Treatment of myelofibrosis,Designated,Not FDA Approved for Orphan Indication,,,,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,United States,718419,,
Melatonin,,2020-01-22,Treatment of primary intracerebral hemorrhage,Designated,Not FDA Approved for Orphan Indication,,,,WORPHMED Srl,"Via Malachia Marchesi de Taddei, 21",,Milan,Lombardy,,Italy,719519,,
Adeno-associated virus serotype 9 vector encoding the Dok7 protein,,2020-01-23,Treatment of Dok7 Myasthenia,Designated,Not FDA Approved for Orphan Indication,,,,Amplo Biotechnology Inc.,"2637 E. Atlantic Blvd., #43644",,Pompano Beach,Florida,33062,United States,720119,,
losmapimod,,2020-01-27,Treatment of Facioscapulohumeral muscular dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,"Fulcrum Therapeutics, Inc.",26 Landsdowne Street,5th Floor,Cambridge,Massachusetts,2139,United States,721919,,
Ziritaxestat,,2020-01-27,Treatment of systemic sclerosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,Galapagos NV,Generaal De Wittelaan,L11 A3,Mechelen,,,Belgium,723919,,
recombinant adeno-associated virus serotype 9 constitutively expressing codon optimized coding sequence of human GBA1,,2020-01-27,Treatment of Gaucher disease,Designated,Not FDA Approved for Orphan Indication,,,,Prevail Therapeutics,430 East 29th Street,Suite 940,New York,New York,10016,United States,726019,,
dual E-selectin and C-X-C chemokine receptor Type 4 (CXCR4) antagonist that targets both E-selectin and CXCR4,,2020-01-27,Treatment of osteosarcoma,Designated,Not FDA Approved for Orphan Indication,,,,"GlycoMimetics, Inc.",9708 Medical Center Drive,,Rockville,Maryland,20850,United States,721819,,
"(1S)-6-chloro-1,3,4,9-tetrahydro-1-(4-methoxyphenyl)-2H-pyrido[3,4-b]indole-2-carboxylic acid, 4-chlorophenyl ester",,2020-01-27,Treatment of Acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,"PTC Therapeutics, Inc.",100 Corporate Court,,South Plainfield,New Jersey,7080,United States,720919,,
Recombinant adeno-associated virus serotype 8 (rAAV2/8) vector expressing bioengineered B domain deleted liver-codon-optimized human factor VIII,,2020-01-27,Treatment of Hemophilia A,Designated,Not FDA Approved for Orphan Indication,,,,"ASC Therapeutics, Inc.",521 Cottonwood Dr.,,Milpitas,California,95035,United States,720819,,
di-deuterated linoleic acid,,2020-01-28,Treatment of Progressive Supranuclear Palsy,Designated,Not FDA Approved for Orphan Indication,,,,"Retrotope, Inc.",4300 El Camino Real,Suite 201,Los Altos,California,94022,United States,721019,,
Immune Globulin Intravenous (Human),,2020-01-28,Treatment of systemic sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,CSL Behring,1020 First Avenue,PO Box 61501,King of Prussia,Pennsylvania,19406,United States,720719,,
Umbilical Cord Mesenchymal Stem Cells,,2020-01-28,Treatment of Huntingtons disease,Designated,Not FDA Approved for Orphan Indication,,,,"Acen Regenerative Medicine Sci-Tech Co., Ltd.","No.8 Building, No. 14 Jinhui Road, Pingshan District",,Shenzhen,Guangdong,,China,720619,,
Autologous Desmoglein 3 (DSG3) Chimeric Autoantibody Receptor-directed (CAAR) T cells,,2020-01-28,Treatment of pemphigus vulgaris,Designated,Not FDA Approved for Orphan Indication,,,,"Cabaletta Bio, Inc.","2929 Arch Street, Suite 600",,Philadelphia,Pennsylvania,19104,United States,720519,,
Peptide Inhibitor of Complement C1,,2020-01-29,Treatment of neonatal hypoxic-ischemic encephalopathy,Designated,Not FDA Approved for Orphan Indication,,,,"ReAlta Life Sciences, Inc.","4211 Monarch Way, Suite 102",,Norfolk,Virginia,23508,United States,722719,,
"(2R,4R)-1-(3-chloro-2-fluorobenzyl)-4-((3-fluoro-6-((5-methyl-1H-pyrazol-3-yl)amino)pyridin-2-yl)methyl)-2-methylpiperidine-4-carboxylic acid; 2- methylpropan-2-amine",,2020-01-29,Treatment of Neuroblastoma,Designated,Not FDA Approved for Orphan Indication,,,,Eli Lilly and Company,Lilly Corporate Center,,Indianapolis,Indiana,46285,United States,724119,,
Aggregated polymer of protein magnesium ammonium phospholinoleate-palmitoleate anhydride,,2020-02-04,Treatment of Schistosomiasis,Designated,Not FDA Approved for Orphan Indication,,,,Farmabrasilis,"Avenida H鬩o P�s de Camargo, 181",,Valinhos,S㯠Paulo,,Brazil,721319,,
"4-fluoro-5-((6-methylhexahydropyrrolo[3,4-b] pyrrol-5(1H)-yl) sulfonyl) isoquinoline",,2020-02-05,Treatment of idiopathic pulmonary fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,"The National Institutes of Pharmaceutical R&D Co., Ltd","No. 27, Zhansimen Road","Shahe, Changping District",Beijing,,,China,727519,,
small interfering RNA targeting TGF-Beta1 and COX-2 mRNA,,2020-02-05,Treatment of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,"Sirnaomics, Inc.",401 Professional Drive,Suite 280,Gaithersburg,Maryland,20879,United States,726219,,
cell-penetrating CCAAT-enhancer-binding protein ߠantagonist,,2020-02-05,Treatment of Glioma,Designated,Not FDA Approved for Orphan Indication,,,,"Sapience Therapeutics, Inc",500 Mamaroneck Avenue,Suite 320,Harrison,New York,10528,United States,723419,,
Progerinin,,2020-02-05,Treatment of Werner syndrome,Designated,Not FDA Approved for Orphan Indication,,,,"PRG S&T Co., Ltd.",306 Hyowon Industry-Cooperation Bldg.,Pusan National University,Geumjeong-gu,Busan,,South Korea,661818,,
Progranulin,,2020-02-10,Treatment of amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,"Alpha Cognition, Inc.",439 Helmcken Street,,Vancouver,BC,V6B 2E6,Canada,725319,,
Pyronaridine tetraphosphate,,2020-02-11,Treatment of Malaria,Designated,Not FDA Approved for Orphan Indication,,,,"Collaborations Pharmaceuticals, Inc.","5616 Hilltop Needmore Rd,",,Fuquay Varina,North Carolina,27526,United States,723819,,
"5-fluoro-2-(6-fluoro-2-methyl-1H-benzo[d]imidazole-1-yl)-N4-(4-(trifluoromethyl)phenyl)pyrimidine-4,6-diamine",,2020-02-13,Treatment of soft tissue sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,"PTC Therapeutics, Inc.",100 Corporate Court,,South Plainfield,New Jersey,7080,United States,724319,,
sodium fusidate,,2020-02-13,Treatment of cystic fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,Arrevus Inc.,"2443 Lynn Road, Suite 210",,Raleigh,North Carolina,27612,United States,723519,,
A recombinant humanized IgG1 monoclonal antibody targeting programmed death-ligand 1,,2020-02-13,Treatment of Nasopharyngeal carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,"Harbour BioMed US, Inc.",1209 Orange Street,,Wilmington,Delaware,19801,United States,723119,,
sepiapterin,,2020-02-19,Treatment of primary tetrahydrobiopterin deficiency,Designated,Not FDA Approved for Orphan Indication,,,,"PTC Therapeutics, Inc. (PTC)","65 William Street, Suite 200",,Wellesley,Massachusetts,2481,United States,729519,,
Recombinant human alpha-1 antitrypsin from Oryza sativa,,2020-02-19,Treatment of alpha-1 antitrypsin deficiency,Designated,Not FDA Approved for Orphan Indication,,,,Wuhan Healthgen Biotechnology Corporation,"D3-2, #666, Gaoxin Avenue",East Lake High-Tech Development Zone,Wuhan,Hubei,,China,724219,,
pyruvate kinase red blood cell isozyme activator,,2020-02-19,Treatment of Sickle Cell Disease,Designated,Not FDA Approved for Orphan Indication,,,,"FORMA Therapeutics, Inc.",500 Arsenal Street,Suite 100,Watertown,Massachusetts,2472,United States,728919,,
Adeno Associated Virus Serotype 8 Encoding the Collagen Q Gene,,2020-02-24,Treatment of Collagen Q Congenital Myasthenia,Designated,Not FDA Approved for Orphan Indication,,,,Amplo Biotechnology Inc.,"2637 E. Atlantic Blvd., #43644",,Pompano Beach,Florida,33062,United States,725219,,
fibrinogen-depleted human platelet lysate,,2020-02-24,Treatment of ocular graft-versus-host disease,Designated,Not FDA Approved for Orphan Indication,,,,Cambium Medical Technologies LLC,1055 Brookhaven Walk Northeast,,Atlanta,Georgia,30319,United States,620817,,
Phenobarbital,,2020-02-26,Treatment of Neonatal seizures,Designated,Not FDA Approved for Orphan Indication,,,,Accord Healthcare Inc.,"1009 Slater Road, Suite 210-B",,Durham,North Carolina,27703,United States,725519,,
phenobarbital sodium,,2020-02-26,Treatment of status epilepticus,Designated,Not FDA Approved for Orphan Indication,,,,Accord Healthcare Inc.,"1009 Slater Road, Suite 210-B",,Durham,North Carolina,27703,United States,725419,,
anti-EGFR VHH Fragment Fused to Cytosine Deaminase,,2020-02-26,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,"Lumosa Therapeutics Co., Ltd.","4F, No. 3-2, Park Street",Nangang District,Taipei,,,Taiwan,729119,,
a Toll-like receptor (TLR) 9 agonist,,2020-02-26,Treatment of Stage IIb to IV Melanoma,Designated,Not FDA Approved for Orphan Indication,,,,"Checkmate Pharmaceuticals, Inc.","245 Main St, 2nd Floor",,Cambridge,Massachusetts,2142,United States,724819,,
Autologous T lymphocyte-enriched population of cells transduced with a lentiviral vector encoding a chimeric antigen receptor targeting human B cell maturation antigen with 4-1BB and CD3-zeta intracellular signaling domains,,2020-02-26,Treatment of Multiple Myeloma,Designated,Not FDA Approved for Orphan Indication,,,,"Arcellx, Inc.","25 West Watkins Mill Road, Suite A",,Gaithersburg,Maryland,20878,United States,725919,,
"Particles comprised ofmethacrylic acid based co-polymer, cross-linked with a bi-functional cross-linker, purified to bind L-phenylalanine and L-phenylalanine containing peptides",,2020-02-27,Treatment of hyperphenylalaninemia,Designated,Not FDA Approved for Orphan Indication,,,,MipSalus ApS,AgemAlle 3,,Hrsholm,,,Denmark,726119,,
phenobarbital sodium,,2020-02-27,Treatment of neonatal seizures,Designated,Not FDA Approved for Orphan Indication,,,,"Nivagen Pharmaceuticals, Inc.","3050 Fite Circle, Suite 100",,Sacramento,California,95827,United States,725819,,
umbralisib,Ukoniq,2020-03-04,Treatment of Follicular Lymphoma,Designated/Approved,,Treatment of adult patients with relapsed or refractory follicular lymphoma (FL) who have received at least three prior lines of systemic therapy.,2021-02-05,2028-02-05,"TG Therapeutics, Inc.",2 Gansevoort Street,9th Floor,New York,New York,10014,United States,726819,,
Glucagon-like peptide-1/Glucagon/Gastric inhibitory polypeptide triple agonist linked to human IgG4 Fc fragment,,2020-03-04,Treatment of primary sclerosing cholangitis,Designated,Not FDA Approved for Orphan Indication,,,,"Hanmi Pharmaceutical Company, Ltd.","14, Wiryeseong-daero",,Seoul,Songpa-gu,,South Korea,728019,,
autologous CD34+ enriched cells transduced with a lentiviral vector containing RNA resulting in codon-optimized cDNA encoding for functional human cystinosin,,2020-03-04,Treatment of cystinosis,Designated,Not FDA Approved for Orphan Indication,,,,"AVROBIO, Inc.",One Kendall Square,Building 300,Cambridge,Massachusetts,2139,United States,727319,,
Phosphorodiamidate morpholino oligomer (5- CTATATATAGTTATTCAACA -3),,2020-03-04,Treatment of Spinal Muscular Atrophy,Designated,Not FDA Approved for Orphan Indication,,,,"Shift Pharmaceuticals Holdings, Inc.",8318 West 102nd Street,,Overland Park,Kansas,66212,United States,727019,,
setmelanotide,,2020-03-04,Treatment of Alstr��yndrome,Designated,Not FDA Approved for Orphan Indication,,,,"Rhythm Pharmaceuticals, Inc",222 Berkeley Street,Suite 1200,Boston,Massachusetts,2116,United States,726419,,
Glucagon-like peptide-1/Glucagon/Gastric inhibitory polypeptide triple agonist linked to human IgG4 Fc fragment,,2020-03-09,Treatment of primary biliary cholangitis,Designated,Not FDA Approved for Orphan Indication,,,,"Hanmi Pharmaceutical Company, Ltd.","14, Wiryeseong-daero",,Seoul,Songpa-gu,,South Korea,727919,,
Adeno-associated viral vector serotype 8 containing cDNA of the human PDE6A protein,,2020-03-09,Treatment of Retinitis Pigmentosa,Designated,Not FDA Approved for Orphan Indication,,,,Universit䴳klinikum Tbingen (UKT),Geissweg 3,,Tbingen,,,Germany,728419,,
humanized immunoglobulin (Ig)G1k-agonistic monoclonal antibody (mAb) that binds to CD40,,2020-03-09,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,"Apexigen, Inc.","75 Shoreway Road, Suite C",,San Carlos,California,94070,United States,726619,,
Adeno-Associated Virus Serotype 2 capsid variant (4D-C102) carrying a transgene encoding a codon-optimized human alpha-galactosidase A gene,,2020-03-09,Treatment of Fabry Disease,Designated,Not FDA Approved for Orphan Indication,,,,"4D Molecular Therapeutics, Inc.",5858 Horton St. Suite 455,,Emeryville,California,94608,United States,727119,,
Purified Human Allogeneic Pancreatic Islets of Langerhans,,2020-03-09,Treatment of Brittle Type 1 Diabetes,Designated,Not FDA Approved for Orphan Indication,,,,University of Minnesota,"420 Delaware Street, S.E.",MMC 195,Minneapolis,Minnesota,55455,United States,672918,,
sodium valproate,,2020-03-09,Treatment of pulmonary arterial hypertension,Designated,Not FDA Approved for Orphan Indication,,,,Cereno Scientific AB,Pepparedsleden 1,,M��al,,,Sweden,729920,,
Sodium (R)-2-(5-(2-(3-ethylureido)-5-fluoro-4-(tetrahydrofuran-2-yl)-1Hbenzo[d]imidazole-6-yl)pyrimidin-2-yl)propan-2-yl hydrogen phosphate,,2020-03-09,Treatment of Nontuberculous mycobacteria infection,Designated,Not FDA Approved for Orphan Indication,,,,"Spero Therapeutics, Inc.","675 Massachusetts Ave., 14th Floor",,Cambridge,Massachusetts,2139,United States,727819,,
pirfenidone,,2020-03-11,Treatment of Unclassifiable-interstitial lung disease,Designated,Not FDA Approved for Orphan Indication,,,,"Genentech Inc., A Member of the Roche Group",1 DNA Way,MS# 355F,South San Francisco,California,94080,United States,727219,,
olorofim,,2020-03-11,Treatment of coccidioidomycosis,Designated,Not FDA Approved for Orphan Indication,,,,F2G Limited,Lankro Way,Eccles,Manchester,,,United Kingdom,721719,,
4-Methylumbelliferone,,2020-03-13,Treatment of Pancreatic Cancer,Designated,Not FDA Approved for Orphan Indication,,,,RNR BioMedical Inc.,c/o Noa Avtalion,161 Jefferson Av,Tenefly,New Jersey,7670,United States,732620,,
Adeno-associated viral vector encoding human multidrug resistance protein 3A (MDR3A),,2020-03-16,Treatment of progressive familial intrahepatic cholestasis,Designated,Not FDA Approved for Orphan Indication,,,,Vivet Therapeutics SAS,80 boulevard Haussmann,,Paris,άe-de-France,,France,729019,,
Fc fusion protein of a human inducible T cell costimulator ligand variant immunoglobulin domain designed to inhibit simultaneously the CD28 and ICOS inflammation pathways,,2020-03-16,Prevention of acute graft versus host disease,Designated,Not FDA Approved for Orphan Indication,,,,Alpine Immune Sciences,201 Elliott Ave. West,Suite 230,Seattle,Washington,98119,United States,738919,,
Fc fusion protein of a human inducible T cell costimulator ligand variant immunoglobulin domain designed to inhibit simultaneously the CD28 and ICOS inflammation pathways,,2020-03-16,Treatment of Acute Graft versus Host Disease,Designated,Not FDA Approved for Orphan Indication,,,,Alpine Immune Sciences,201 Elliott Ave. West,Suite 230,Seattle,Washington,98119,United States,712619,,
"Autologous modified RNA transfected myeloid cells that express a fusion protein composed of humanized scFv that recognizes human CD5, a CD8 alpha transmembrane domain, and Fc gamma and PI3K intracellular signaling domains (CD5-ATAK-Fcy-PI3K Myeloid Cells)",,2020-03-16,Treatment of T-cell Lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,"Myeloid Therapeutics, Inc.",One Kendall Square,"Bld 200, Ste 101",Cambridge,Massachusetts,2139,United States,730320,,
mexiletine,,2020-03-16,Treatment of myotonic disorders,Designated,Not FDA Approved for Orphan Indication,,,,Lupin Europe GmbH,Hanauer Landstr. 139 -143,,Frankfurt am Main,,,Germany,728219,,
a synthetic double-stranded RNA oligonucleotide conjugated to N-acetyl-D-galactosamine aminosugar residues,,2020-03-16,Treatment of alpha-1 antitrypsin deficiency,Designated,Not FDA Approved for Orphan Indication,,,,"Dicerna Pharmaceuticals, Inc.",33 Hayden Avenue,,Lexington,Massachusetts,2421,United States,727619,,
elezanumab,,2020-03-17,Treatment of acute spinal cord injury,Designated,Not FDA Approved for Orphan Indication,,,,AbbVie Inc.,1 North Waukegan Road,,North Chicago,Illinois,60044,United States,729419,,
highly selective histone deacetylase 6 inhibitor,,2020-03-17,Treatment of Charcot-Marie-Tooth disease,Designated,Not FDA Approved for Orphan Indication,,,,"Chong Kun Dang Pharmaceutical Co., Ltd.","8, Chungjeong-ro, Seodaemun-gu,",,Seoul,,,South Korea,728619,,
colistimethate sodium,,2020-03-19,Treatment of respiratory infection in patients with Cystic Fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,"EnBiotix, Inc.",197 W. Springfield St.,,Boston,Massachusetts,2118,United States,672418,,
remdesivir,,2020-03-23,Treatment of coronavirus disease 2019 (COVID-19),Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,"Gilead Sciences, Inc.",333 Lakeside Drive,,Foster City,California,94404,United States,739020,,
axicabtagene ciloleucel,,2020-03-23,Treatment of extranodal marginal zone lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,"Kite Pharma, Inc.",2400 Broadway,,Santa Monica,California,90404,United States,735920,,
"L-serine, L-threonine, L-leucine, glycine, L-alanine, L-arginine, L-cysteine, L-glutamine, L-histidine, L-aspartic acid, L-proline, L-isoleucine, L-lysine, L-tryptophan, L-valine, L-methionine, L-tyrosine, carnitine and taurine",,2020-03-23,Treatment of phenylketonuria,Designated,Not FDA Approved for Orphan Indication,,,,APR Applied Pharma Research,Via Corti 5,,Balerna,,,Switzerland,687719,,
interleukin mutein fused to the C-terminus of an immunoglobulin G Fc domain by way of a G4S linker,,2020-03-23,Treatment of Graft-Versus-Host-Disease,Designated,Not FDA Approved for Orphan Indication,,,,Amgen Inc.,1 Amgen Center Drive,,Thousand Oaks,California,91320,United States,620217,,
"benzeneacetamide, 2-[2-[2-[[2-methoxy-4-(1-methyl-4-piperidinyl)phenyl]amino]-5-(trifluoromethyl)-4-pyrimidinyl]ethyl]-",,2020-03-23,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,Amplia Therapeutics,55 Flemington Road,Suite 226,North Melbourne,VIC,,Australia,730620,,
sintilimab,,2020-03-24,Treatment of T-cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,Innovent Biologics (Suzhou) Co. Ltd,168 Dongping Street,,Suzhou Industrial Park,Jiangsu Province,,China,733120,,
axicabtagene ciloleucel,,2020-03-24,Treatment of nodal marginal zone lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,"Kite Pharma, Inc.",2400 Broadway,,Santa Monica,California,90404,United States,740320,,
retifanlimab,,2020-03-24,Treatment of anal cancer,Designated,Not FDA Approved for Orphan Indication,,,,Incyte Corporation,1801 Augustine Cut-Off,,Wilmington,Delaware,19803,United States,691419,,
technetium-99m radiolabeled heparin,,2020-03-25,Diagnostic for the management of Eosinophilic Esophagitis,Designated,Not FDA Approved for Orphan Indication,,,,"NexEos Diagnostics, Inc.","640 Lee Road, Suite 115",,Wayne,Pennsylvania,19087,United States,730020,,
Sodium Nitrite,,2020-03-25,Treatment of Sickle Cell Disease,Designated,Not FDA Approved for Orphan Indication,,,,AdimaBio LLC,19 Garrison Road,,Wellesley,Massachusetts,2482,United States,729719,,
toripalimab in combination with axitinib,,2020-03-25,Treatment of mucosal melanoma,Designated,Not FDA Approved for Orphan Indication,,,,"TopAlliance Biosciences, Inc.","9430 Key West Ave, Suite 125",,Rockville,Maryland,20850,United States,730120,,
epalrestat,,2020-03-26,"Treatment of phosphomannomutase-2 deficiency, a congenital disorder of glycosylation",Designated,Not FDA Approved for Orphan Indication,,,,Maggie's Pearl,903 Independence Street,,Sturgis,Michigan,49091,United States,735820,,
"7,8-dibromo-5,6-dihydro-9-methyl-2-(1-piperazinyl)-4H-imidazo[4,5,1-ij] quinoline hydrochloride",,2020-03-26,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,Ryvu Therapeutics S.A.,Bobrzynskiego 14,,Krakow,,,Poland,733220,,
Cerium dioxide nanoparticles,,2020-03-26,Treatment of Amyotrophic Lateral Sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,Cerion Nanomaterials,1 Blossom Road,,Rochester,New York,14610,United States,731920,,
"Sodium (4Z,7Z,10R,11E,13E,15Z,17S,19Z) 10,17-dihydroxy-docosa-4,7,11,13,15,19-hexaenoate",,2020-03-30,Prevention of retinopathy of prematurity,Designated,Not FDA Approved for Orphan Indication,,,,Anida Pharma Inc.,"155 Brookline Street, Suite 005",,Cambridge,Massachusetts,2139,United States,731720,,
Magnesium lysinate bis Resolvin E1,,2020-03-30,Treatment of pediatric ulcerative colitis,Designated,Not FDA Approved for Orphan Indication,,,,Thetis Pharmaceuticals,23 Business Park Drive,,Branford,Connecticut,6405,United States,629818,,
ansuvimab,,2020-03-30,Post-exposure prophylaxis against Ebola virus infection,Designated,Not FDA Approved for Orphan Indication,,,,Ridgeback Biotherapeutics LP,"3480 Main Highway, Unit 402",,Miami,Florida,33133,United States,730820,,
combination of p-Tolylmethylcarbinol nicotinic acid ester and a-naphthylacetic acid,,2020-03-30,Treatment of primary biliary cholangitis,Designated,Not FDA Approved for Orphan Indication,,,,RNR BioMedical Inc.,c/o Noa Avtalion,161 Jefferson Av,Tenefly,New Jersey,7670,United States,731020,,
Thymidine phosphorylase-cCPP-PEG,,2020-03-30,Treatment of mitochondrial neurogastrointestinal encephalomyopathy,Designated,Not FDA Approved for Orphan Indication,,,,"Entrada Therapeutics, Inc.",50 Northern Avenue,,Boston,Massachusetts,2210,United States,730220,,
4-Methylumbelliferone,,2020-03-30,Treatment of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,RNR BioMedical Inc.,c/o Noa Avtalion,161 Jefferson Av,Tenefly,New Jersey,7670,United States,733820,,
tetravalent bispecific chimeric anti-human CD30 x anti-human CD16A recombinant antibody construct,,2020-04-01,Treatment of T-cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,Affimed GmbH,Im Neuenheimer Feld 582,,Heidelberg,,,Germany,736120,,
Gallium-68 DOTANOC,,2020-04-01,Diagnostic for the management of neuroblastoma,Designated,Not FDA Approved for Orphan Indication,,,,"Advanced Imaging Projects, LLC",3651 FAU Blvd.,,Boca Raton,Florida,33467,United States,734120,,
lisocabtagene maraleucel,,2020-04-01,Treatment of mantle cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,"Juno Therapeutics, Inc.",400 Dexter Avenue N,400 Dexter Avenue N,Seattle,Washington,98109,United States,730920,,
bis-choline tetrathiomolybdate,,2020-04-06,Treatment of primary biliary cholangitis,Designated,Not FDA Approved for Orphan Indication,,,,"Alexion Pharmaceuticals, Inc.",121 Seaport Boulevard,,Boston,Massachusetts,2210,United States,733720,,
(+)-Epicatechin,,2020-04-06,Treatment of Duchenne and Becker muscular dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,Epirium Bio Inc.,"9171 Towne Centre Dr.,",Suite 270,San Diego,California,92122,United States,732020,,
tipifarnib,,2020-04-06,Treatment of T-cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,"Kura Oncology, Inc.","12730 High Bluff Drive, Suite 400",,San Diego,California,92130,United States,730720,,
fixed combination of diroximel fumarate and aspirin,,2020-04-06,Treatment of patients with multiple sclerosis who experience the fumarate flush,Designated,Not FDA Approved for Orphan Indication,,,,"Vitalis, LLC",93 4th Avenue,#19,New York,New York,10003,United States,724719,,
Fixed combination of monomethyl fumarate and aspirin,,2020-04-06,Treatment of patients with multiple sclerosis who experience the fumarate flush,Designated,Not FDA Approved for Orphan Indication,,,,"Vitalis, LLC",93 4th Avenue,#19,New York,New York,10003,United States,724619,,
synthetic double-stranded small interfering RNA (siRNA) oligonucleotide directed against TMPRSS6 mRNA,,2020-04-06,Treatment of Myelodysplastic Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,Silence Therapeutics GmbH,Robert-Rossle-Str. 10,,Berlin,,,Germany,709619,,
florbetaben F18,,2020-04-07,Diagnostic for the management of amyloid light chain (AL) amyloidosis,Designated,Not FDA Approved for Orphan Indication,,,,Life Molecular Imaging Ltd.,"Iceni Centre, Warwick Technology Park",,Warwick,,CV34 6DA,United Kingdom,732420,,
"{(3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-1-[(2S)-3-methyl-1-(propan-2- ylsulfonyl)butan-2-yl]-2-oxopiperidin-3-yl}acetic acid",,2020-04-08,Treatment of Merkel cell carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,"Kartos Therapeutics, Inc.",275 Shoreline Drive,,Redwood City,California,94065,United States,735120,,
"[(1S,2S,5S)-2-[2,6-dimethoxy-4-(2-methyloctan-2-yl)phenyl]-6,6-dimethyl-4-bicyclo[3.1.1]hept-3-enyl]methanol",,2020-04-13,Prevention of proliferative vitreoretinopathy,Designated,Not FDA Approved for Orphan Indication,,,,Tetra Bio-Pharma Inc.,365 St.-Jean Street,Suite 122,Longueuil,,,Canada,734920,,
pozelimab,,2020-04-13,Treatment of CD55-deficient protein-losing enteropathy,Designated,Not FDA Approved for Orphan Indication,,,,"Regeneron Pharamecuticals, Inc.",777 Old Saw Mill River Road,,Tarrytown,New York,10591,United States,736820,,
lonapegsomatropin-tcgd,Skytrofa,2020-04-13,Treatment of growth hormone deficiency,Designated/Approved,,Treatment of pediatric patients 1 year and older who weigh at least 11.5 kg and have growth failure due to inadequate secretion of endogenous growth hormone (GH),2021-08-25,,Ascendis Pharma Endocrinology Division A/S,12 Tuborg Boulevard,,Hellerup,,,Denmark,654718,,
racecadotril,,2020-04-13,Treatment of Microvillus inclusion disease,Designated,Not FDA Approved for Orphan Indication,,,,RNR BioMedical Inc.,c/o Noa Avtalion,161 Jefferson Av,Tenefly,New Jersey,7670,United States,732920,,
carbon monoxide,,2020-04-14,Prevention of Primary Graft Dysfunction in transplant recipients receiving a lung or heart+ lung transplant.,Designated,Not FDA Approved for Orphan Indication,,,,"Proterris, Inc.",197 West Springfield Street,,Boston,Massachusetts,2118,United States,733620,,
[67Cu]Cu-[MeCOSar0-Tyr3]-octreotate,,2020-04-14,Treatment of neuroblastoma,Designated,Not FDA Approved for Orphan Indication,,,,Clarity Pharmaceuticals Ltd.,National Innovation Centre,4 Cornwallis Street,Eveleigh Sydney,NSW,,Australia,718619,,
delta-9-tetrahydrocannabinol and cannabidiol,,2020-04-14,Treatment of Epidermolysis Bullosa,Designated,Not FDA Approved for Orphan Indication,,,,Tetra Bio-Pharma Inc.,365 St.-Jean Street,Suite 122,Longueuil,,,Canada,734820,,
Sintilimab,,2020-04-14,Treatment of esophageal cancer,Designated,Not FDA Approved for Orphan Indication,,,,Innovent Biologics (Suzhou) Co. Ltd,168 Dongping Street,,Suzhou Industrial Park,Jiangsu Province,,China,737320,,
docarpamine,,2020-04-14,Treatment of ascites due to all etiologies except cancer,Designated,Not FDA Approved for Orphan Indication,,,,"Martin Pharmaceuticals, Inc.",233 Broadway,Suite 1750,New York,New York,10279,United States,701519,,
"N-(bromoacetyl)-3,3-dinitroazetidine",,2020-04-15,Prevention of acute radiation syndrome,Designated,Not FDA Approved for Orphan Indication,,,,"EpicentRx, Inc.",11099 North Torrey Pines Rd,Suite 160,La Jolla,California,92037,United States,737520,,
Monoclonal anti-IL-7R alpha antibody,,2020-04-15,Treatment of Acute Lymphoblastic Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,Allterum Therapeutics,"3900 Essex Lane, Suite 575",,Houston,Texas,77027,United States,656018,,
Near-infrared monoamine oxidase inhibitor (conjugate of clorgyline and cyanine dye MHI-148),,2020-04-15,Treatment of glioma,Designated,Not FDA Approved for Orphan Indication,,,,"Jean C. Shih, Ph.D.",Department of Pharmacology and Pharmaceutical Sciences,University of Southern California,Los Angeles,California,90089,United States,740420,,
"non-replicating recombinant adeno-associated virus serotype hu68 vector, which contains human GLB1 transgene encoding the galactosidase beta 1 enzyme",,2020-04-16,Treatment of GM1 gangliosidosis,Designated,Not FDA Approved for Orphan Indication,,,,"Passage Bio, Inc.",Commerce Square Two,2001 Market Street,Philadelphia,Pennsylvania,19103,United States,742720,,
bempegaldesleukin,,2020-04-17,Treatment of Stage IIb to Stage IV melanoma,Designated,Not FDA Approved for Orphan Indication,,,,Nektar Therapeutics,"455 Mission Bay Blvd, South",,San Francisco,California,94158,United States,732720,,
4-Methylumbelliferone,,2020-04-20,Treatment of Esophageal Carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,RNR BioMedical Inc.,c/o Noa Avtalion,161 Jefferson Av,Tenefly,New Jersey,7670,United States,735220,,
epoprostenol,,2020-04-20,Treatment of Frostbite,Designated,Not FDA Approved for Orphan Indication,,,,"Aurora Research Institute, LLC",960 N 12th St,Discovery Lab,Milwaukee,Wisconsin,53233,United States,705119,,
cannabidiol,,2020-04-20,Treatment of Epidermolysis Bullosa,Designated,Not FDA Approved for Orphan Indication,,,,Tetra Bio-Pharma Inc.,365 St.-Jean Street,Suite 122,Longueuil,,,Canada,734620,,
Melatonin,,2020-04-20,Prevention of retinopathy of prematurity,Designated,Not FDA Approved for Orphan Indication,,,,WORPHMED Srl,"Via Malachia Marchesi de Taddei, 21",,Milan,Lombardy,,Italy,734420,,
Melatonin,,2020-04-20,Treatment of retinopathy of prematurity,Designated,Not FDA Approved for Orphan Indication,,,,WORPHMED Srl,"Via Malachia Marchesi de Taddei, 21",,Milan,Lombardy,,Italy,734320,,
intravenous baclofen,,2020-04-20,Prevention of baclofen withdrawal syndrome,Designated,Not FDA Approved for Orphan Indication,,,,"Allaysis, LLC",525 Route 73 North,Suite 104,Marlton,New Jersey,8503,United States,480215,,
solution stable glucagon analog,,2020-04-20,Treatment of congenital hyperinsulinism,Designated,Not FDA Approved for Orphan Indication,,,,AmideBio,331 South 104th Street,,Louisville,Colorado,80027,United States,716419,,
"trans N-ethyl-2-((4-(7-((4-(ethylsulfonamido)cyclohexyl)methyl)-2,7-diazaspiro[3.5]nonan-2-yl)pyrimidin-5-yl)oxy)-5-fluoro-N-isopropylbenzamide sesquifumarate salt",,2020-04-20,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,"Syndax Pharmaceuticals, Inc.",35 Gatehouse Drive,,Waltham,Massachusetts,2451,United States,734520,,
pentagastrin,,2020-04-21,Diagnostic for the management of medullary thyroid cancer,Designated,Not FDA Approved for Orphan Indication,,,,"Exela Pharma Sciences, LLC",1245 Blowing Rock Blvd.,,Lenoir,North Carolina,28645,United States,689719,,
olverembatinib,,2020-04-22,Treatment of chronic myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,Ascentage Pharma Group Inc.,"800 King Farm Blvd., Suite 300",,Rockville,Maryland,20850,United States,735620,,
Aldesleukin,,2020-04-22,Treatment of Amyotrophic Lateral Sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,"Clinigen, Inc.",790 Township Line Road,Suite 120,Yardley,Pennsylvania,19067,United States,742920,,
Recombinant adeno-associated viral vector serotype S3 containing DNA encoding for human alpha-galactosidase A,,2020-04-22,Treatment of Fabry disease,Designated,Not FDA Approved for Orphan Indication,,,,Freeline Therapeutics Limited,Stevenage Bioscience Catalyst,Gunnels Wood Road,Stevenage,Herts,,United Kingdom,734220,,
Allogeneic multi-tumor-associated antigen-specific T cell product,,2020-04-28,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,"Marker Therapeutics, Inc.",3200 Southwest Freeway Suite 2240,,Houston,Texas,77027,United States,736320,,
nanovesicle containing Saposin C and dioleoylphosphatidylserine,,2020-04-28,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,"Bexion Pharmaceuticals, Inc",632 Russell St,,Covington,Kentucky,41011,United States,735720,,
cannabidiol,,2020-04-28,Treatment of glioblastoma,Designated,Not FDA Approved for Orphan Indication,,,,"Diverse Biotech, Inc.","3805 Old Easton Road, Suite 111",,Doylestown,Pennsylvania,18902,United States,736020,,
pentosan polysulfate,,2020-04-28,Treatment of mucopolysaccharidosis type 1,Designated,Not FDA Approved for Orphan Indication,,,,Paradigm Biopharmaceuticals Ltd.,"Level 2, 517 Flinders Lane",,Melbourne,Victoria,,Australia,741920,,
A cellular product consisting of autologous CD34+ human hematopoietic stem and progenitor cells modified by clustered regularly interspaced short palindromic repeats-associated 9 nuclease (CRISPR-Cas9)-mediated gene editing,,2020-04-28,Treatment of ߭thalassemia,Designated,Not FDA Approved for Orphan Indication,,,,Vertex Pharmaceuticals Inc.,50 Northern Avenue,,Boston,Massachusetts,2210,United States,714319,,
Trehalose,,2020-04-29,"Treatment of mucopolysaccharidosis type III (MPS III), or Sanfilippo syndrome",Designated,Not FDA Approved for Orphan Indication,,,,"Seelos Therapeutics, Inc.","300 Park Avenue, 12th Floor",,New York,New York,10022,United States,740920,,
garadacimab,,2020-04-30,Treatment of bradykinin-mediated angioedema,Designated,Not FDA Approved for Orphan Indication,,,,CSL Behring,1020 First Avenue,PO Box 61501,King of Prussia,Pennsylvania,19406,United States,715419,,
3-bromo-2-oxopropanoic acid,,2020-05-01,Treatment of stage IIb-IV melanoma,Designated,Not FDA Approved for Orphan Indication,,,,"NewG Lab Pharma, Inc.",701 E Pratt St.,,Baltimore,Maryland,21202,United States,736920,,
cipargamin,,2020-05-01,Treatment of malaria,Designated,Not FDA Approved for Orphan Indication,,,,Novartis Pharmaceuticals Corporation,One Health Plaza,Bldg. 315 / 1650D,East Hanover,New Jersey,7936,United States,746820,,
"1-((2S,4S)-2-((((S) -(4-bromophenoxy)(((S)-1-oxo-1-(((S)- pentan-2-yl)oxy)propan-2-yl)amino)phosphoryl)oxy)methyl)-1,3-dioxolan-4-yl)-2-oxo-1,2-dihydropyrimidin-4- aminium chloride",,2020-05-04,Treatment of Hepatocellular Carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,Medivir AB,Box 1086s,,Huddinge,,,Sweden,745020,,
"4-[(7-Methoxy-2,3-dihydro-1,4-benzothiazepin-4(5H)-yl)methyl]benzoic acid, hemifumarate",,2020-05-05,Treatment of Catecholaminergic Polymorphic Ventricular Tachycardia,Designated,Not FDA Approved for Orphan Indication,,,,"ARMGO Pharma, Inc.",PMB #260,923 Saw Mill River Road,Ardsley,New York,10502,United States,736220,,
"3,5-diamino-6-chloro-N-(N-(4-(4-(2-(hexyl((2S,3R,4R, 5R)-2,3,4,5,6-pentahydroxyhexyl)amino)ethoxy)phenyl)butyl)-carbamimidoyl)pyrazine-2-carboxamide",,2020-05-05,Treatment of Primary Ciliary Dyskinesia,Designated,Not FDA Approved for Orphan Indication,,,,"Parion Sciences, Inc.",2800 Meridian Parkway Suite 195,,Durham,North Carolina,27713,United States,746320,,
spherical carbon absorbent,,2020-05-05,Treatment of urea cycle disorders,Designated,Not FDA Approved for Orphan Indication,,,,"CT Development One, LLC","187 Pavilion Parkway, Suite 200",,Newport,Kentucky,41071,United States,727419,,
[64Cu]Cu-[MeCOSar0-Tyr3]-octreotate,,2020-05-06,Diagnostic for the clinical management of neuroblastoma,Designated,Not FDA Approved for Orphan Indication,,,,Clarity Pharmaceuticals Ltd.,National Innovation Centre,4 Cornwallis Street,Eveleigh Sydney,NSW,,Australia,737720,,
human platelet derived hemostatic agent,,2020-05-07,Treatment of Acute Radiation Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,"Cellphire, Inc.","9430 Key West Avenue, Suite 250",,Rockville,Maryland,20850,United States,677219,,
Nafamostat,,2020-05-11,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,RNR BioMedical Inc.,c/o Noa Avtalion,161 Jefferson Av,Tenefly,New Jersey,7670,United States,742120,,
A cellular product consisting of autologous CD34+ human hematopoietic stem and progenitor cells modified by CRISPR-Cas9-mediated gene editing,,2020-05-11,Treatment of sickle cell disease,Designated,Not FDA Approved for Orphan Indication,,,,Vertex Pharmaceuticals Inc.,50 Northern Avenue,,Boston,Massachusetts,2210,United States,715519,,
fixed dose combination of Pyronaridine and Benznidazole,,2020-05-11,Treatment of Chagas Disease,Designated,Not FDA Approved for Orphan Indication,,,,"Collaborations Pharmaceuticals, Inc.",840 Main Campus Drive,Lab 3510,Raleigh,North Carolina,27606,United States,719219,,
Autologous T-cells genetically modified using a lentiviral vector encoding for CD19 CD3e TRuC,,2020-05-11,Treatment of acute lymphoblastic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,"TCR2 Therapeutics, Inc.",100 Binney Street,Suite 710,Cambridge,Massachusetts,2142,United States,737420,,
hydrocortisone,,2020-05-13,Prevention of bronchopulmonary dysplasia,Designated,Not FDA Approved for Orphan Indication,,,,LABORATOIRE AGUETTANT,"1, rue Alexander Fleming",,Lyon,,,France,716719,,
"{(3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-1-[ (2S)-3 -methyl-1-(propan-2- ylsulfonyl)butan-2-yl]-2-oxopiperidin-3-yl}acetic acid",,2020-05-13,Treatment of myelofibrosis.,Designated,Not FDA Approved for Orphan Indication,,,,"Kartos Therapeutics, Inc.",275 Shoreline Drive,,Redwood City,California,94065,United States,737220,,
Allogeneic gene-edited CD19-directed CAR T cells/azercabtagene zapreleucel,,2020-05-13,Treatment of mantle cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,"Precision BioSciences, Inc.",302 East Pettigrew Street,Suite A-100,Durham,North Carolina,27701,United States,738020,,
"non-replicating recombinant adeno associated viral vector, serotype 9, designed to promote increased transcription of SCN1A gene",,2020-05-14,Treatment of Dravet Syndrome.,Designated,Not FDA Approved for Orphan Indication,,,,Encoded Therapeutics,341 Oyster Point Blvd.,Suite 100,South San Francisco,California,94080,United States,744920,,
Poly (Phenyl Sulfoglucuronate Galactoside),,2020-05-14,Treatment of anti-myelin-associated glycoprotein (MAG) neuropathy,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,Polyneuron Pharmaceuticals AG,c/o Basel Inkubator,Hochbergerstrasse 60C,Basel,Basel City,,Switzerland,641918,,
defibrotide,,2020-05-14,Prevention of acute graft versus host disease,Designated,Not FDA Approved for Orphan Indication,,,,Jazz Pharmaceuticals Ireland Limited,5th Floor Waterloo Exchange,Waterloo Road,Dublin,,,Ireland,738720,,
tislelizumab,,2020-05-14,"Treatment of gastric cancer, including cancer of the gastroesophageal junction",Designated,Not FDA Approved for Orphan Indication,,,,"BeiGene USA, Inc.",2955 Campus Drive,Suite 200,San Mateo,California,94403,United States,738120,,
"Benzeneacetamide, 2-[2-[2-[[2-methoxy-4-(1-methyl-4-piperidinyl)phenyl]amino]-5-(trifluoromethyl)-4-pyrimidinyl]ethyl]-",,2020-05-18,Treatment of idiopathic pulmonary fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,Amplia Therapeutics,55 Flemington Road,Suite 226,North Melbourne,VIC,,Australia,742020,,
"4-((2S,4S)-4-ethoxy-1-((5-methoxy-7-methyl-1H-indol-4-yl)methyl)piperidin-2-yl) benzoic acid",,2020-05-18,Treatment of C3 glomerulopathy,Designated,Not FDA Approved for Orphan Indication,,,,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,United States,692819,,
Gemcitabine,,2020-05-18,Treatment of cholangiocarcinoma,Designated,Not FDA Approved for Orphan Indication,,,,RenovoRx,4546 El Camino Real,Suite 203,Los Altos,California,94022,United States,737820,,
Toripalimab,,2020-05-18,Treatment of nasopharyngeal carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,"TopAlliance Biosciences, Inc.","9430 Key West Ave, Suite 125",,Rockville,Maryland,20850,United States,738620,,
GRObeta (a truncated form of the human CXC motif chemokine 2),,2020-05-18,Mobilization of hematopoietic stem cells to the peripheral blood for collection and subsequent transplant,Designated,Not FDA Approved for Orphan Indication,,,,Magenta Therapeutics,100 Technology Square,Fifth Floor,Cambridge,Massachusetts,2139,United States,738320,,
ivosidenib,,2020-05-20,Treatment of myelodysplastic syndromes,Designated,Not FDA Approved for Orphan Indication,,,,Servier Pharmaceuticals LLC,200 Pier Four Blvd,,Boston,Massachusetts,2210,United States,739720,,
fam-trastuzumab deruxtecan-nxki,Enhertu,2020-05-20,"Treatment of gastric cancer, including gastroesophageal junction cancer",Designated/Approved,,treatment of adult patients with locally advanced or metastatic HER2-positive gastric or gastroesophageal junction (GEJ) adenocarcinoma who have received a prior trastuzumab-based regimen,2021-01-15,2028-01-15,"Daiichi Sankyo, Inc.",211 Mount Airy Road,,Basking Ridge,New Jersey,7920,United States,738420,,
PEGylated recombinant human tumor necrosis factor-related apoptosis inducing ligand,,2020-05-20,Treatment of systemic sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,"Theraly Fibrosis, Inc.","20271 Goldenrod Lane, Suite 2046",,Germantown,Maryland,20876,United States,737920,,
pralsetinib,Gavreto,2020-05-26,"Treatment of RET-fusion, RET-mutation, and TRKC-positive poorly differentiated thyroid cancer, undifferentiated or anaplastic thyroid cancer, medullary thyroid cancer, and locally advanced or metastatic follicular or papillary thyroid cancer",Designated/Approved,,Treatment of (1) Adult and pediatric patients 12 years of age and older with advanced or metastatic RET-mutant medullary thyroid cancer (MTC) who require systemic therapy; and; (2) Adult and pediatric patients 12 years of age and older with advanced or metastatic RET fusion-positive thyroid cancer who require systemic therapy and who are radioactive iodine-refractory (if radioactive iodine is appropriate),2020-12-01,2027-12-01,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080-4990,United States,728519,,
Amitriptyline,,2020-05-27,Treatment of Erythromelalgia,Designated,Not FDA Approved for Orphan Indication,,,,Algo Therapeutix S.A.S,49 rue des Nouvelles,,Suresnes,,,France,739620,,
nilotinib oral tablets,,2020-05-28,Treatment of chronic myelogenous leukemia,Designated,Not FDA Approved for Orphan Indication,,,,"Nanocopoeia, LLC",1246 West University Avenue,Suite 463,St. Paul,Minnesota,55104,United States,743720,,
Human Placental Extract,,2020-05-28,Prevention of necrotizing enterocolitis in early preterm infants (gestational age less than 34 weeks).,Designated,Not FDA Approved for Orphan Indication,,,,"Plakous Therapeutics, Inc.",755 Highland Oaks Dr.,Suite 103,Winston-Salem,North Carolina,27103,United States,733520,,
Telomerase Specific Replication-competent Oncolytic Adenovirus,,2020-06-01,Treatment of esophageal cancer,Designated,Not FDA Approved for Orphan Indication,,,,Oncolys BioPharma Inc.,4-1-28 Toranomon,Minato-ku,Tokyo,,,Japan,694719,,
Sodium (4-{(E)-3-(4-fluorophenyl)-3-[4-(3-morpholin-4-yl-prop-1ynyl)phenyl]allyloxy}-2-methylphenoxy)acetate,,2020-06-02,Treatment of primary mitochondrial myopathy,Designated,Not FDA Approved for Orphan Indication,,,,Reneo Pharmaceuticals Inc.,12230 El Camino Real,Suite 230,San Diego,California,92130,United States,740220,,
half-life extended bispecific T-cell engager antibody construct targeting MUC17 and CD3,,2020-06-02,"Treatment of gastric cancer, including cancer of gastroesophageal junction",Designated,Not FDA Approved for Orphan Indication,,,,Amgen Inc.,One Amgen Center Drive,Mail Stop 27-2-D,Thousand Oaks,California,91320,United States,741120,,
progesterone,,2020-06-03,Treatment of ocular graft versus host disease,Designated,Not FDA Approved for Orphan Indication,,,,"GLIA, LLC",134 Saint Botolph Street,,Boston,Massachusetts,2115,United States,664818,,
Tacrolimus,,2020-06-03,Treatment of vernal keratoconjunctivitis,Designated,Not FDA Approved for Orphan Indication,,,,"CN2 Therapeutics, Inc.",2764 Treasure Cove Circle,,Fort Lauderdale,Florida,33312,United States,753620,,
Adeno-associated virus serotype 9 vector with engineered transgene encoding the human CLN5 gene,,2020-06-03,Treatment of neuronal ceroid lipofuscinosis type 5,Designated,Not FDA Approved for Orphan Indication,,,,Neurogene Inc.,"535 W 24th St,",5th Floor,New York,New York,10011,United States,740020,,
margetuximab,,2020-06-03,Treatment of gastric and gastroesophageal junction cancer.,Designated,Not FDA Approved for Orphan Indication,,,,"MacroGenics, Inc.",9704 Medical Center Drive,,Rockville,Maryland,20850,United States,739820,,
sivelestat,,2020-06-05,Treatment of gastric cancer,Designated,Not FDA Approved for Orphan Indication,,,,RNR BioMedical Inc.,c/o Noa Avtalion,161 Jefferson Av,Tenefly,New Jersey,7670,United States,746220,,
treprostinil,,2020-06-08,Treatment of Systemic sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,"Aurora Research Institute, LLC",960 N 12th St,Discovery Lab,Milwaukee,Wisconsin,53233,United States,711319,,
obinutuzumab,,2020-06-08,Treatment of Membranous Nephropathy,Designated,Not FDA Approved for Orphan Indication,,,,"Genentech, Inc., A Member of the Roche Group",1 DNA Way,MS# 241B,South San Francisco,California,94080,United States,727719,,
Mitapivat,,2020-06-08,Treatment of thalassemia,Designated,Not FDA Approved for Orphan Indication,,,,"Agios Pharmaceuticals, Inc.",88 Sidney Street,,Cambridge,Massachusetts,2139,United States,739920,,
"(1-{2-[(3S,4R)-1-[(3R,4R)-1-cyclopentyl-3-fluoro-4-(4-methoxyphenyl)pyrrolidine-3-carbonyl]-4-(methoxymethyl)pyrrolidin-3-yl]-5-(trifluoromethyl)phenyl}piperidine-4-caroxylic acid-phosphoric acid (1/1)",,2020-06-08,treatment of cutaneous variants of porphyria (which includes treatment and prevention of cutaneous manifestations of disease),Designated,Not FDA Approved for Orphan Indication,,,,"Mitsubishi Tanabe Pharma Development America, Inc.",525 Washington Blvd,Suite 400,Jersey City,New Jersey,7310,United States,645518,,
L-fucose,,2020-06-08,Treatment of Leukocyte Adhesion Deficiency Type- II,Designated,Not FDA Approved for Orphan Indication,,,,"Orpha Labs, AG",Haldenstrasse 5,,Baar,Zug,,Switzerland,753120,,
Berubicin,,2020-06-09,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,"CNS Pharmaceuticals, Inc.",2100 West Loop South,Suite 900,Houston,Texas,77027,United States,748420,,
guadecitabine SC,,2020-06-10,Treatment of myelodysplastic syndromes including chronic myelomonocytic leukemia,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,"Astex Pharmaceuticals, Inc.",4420 Rosewood Drive,Suite 200,Pleasanton,California,94588,United States,627818,,
geranylgeranylacetone,,2020-06-10,Prevention of Acute Radiation Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,RNR BioMedical Inc.,c/o Noa Avtalion,161 Jefferson Av,Tenefly,New Jersey,7670,United States,743920,,
"humanized IgG4 monoclonal antibody optimized for neutralizing activity against DKK1, a secreted modulator of Wnt signaling",,2020-06-10,Treatment of gastric and gastroesophageal junction cancer,Designated,Not FDA Approved for Orphan Indication,,,,"Leap Therapeutics, Inc",47 Thorndike Street,Suite B-1,Cambridge,Massachusetts,2141,United States,744020,,
Recombinant human interleukin-7 fused to a hybrid crystallizable fragment region of a human antibody (rhIL-7-hyFc).,,2020-06-11,Treatment of progressive multifocal leukoencephalopathy,Designated,Not FDA Approved for Orphan Indication,,,,"NeoImmuneTech, Inc.",2400 Research Boulevard,Suite 250,Rockville,Maryland,20850,United States,741620,,
Ulinastatin,,2020-06-12,Treatment of Kawasaki Disease,Designated,Not FDA Approved for Orphan Indication,,,,RNR BioMedical Inc.,c/o Noa Avtalion,161 Jefferson Av,Tenefly,New Jersey,7670,United States,742320,,
Hepcidin mimetic peptide,,2020-06-12,Treatment of Polycythemia vera,Designated,Not FDA Approved for Orphan Indication,,,,"Protagonist Therapeutics, Inc.","7707 Gateway Blvd, Suite 140",,Newark,California,94560,United States,715819,,
Ubenimex,,2020-06-12,Treatment of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,RNR BioMedical Inc.,c/o Noa Avtalion,161 Jefferson Av,Tenefly,New Jersey,7670,United States,749020,,
(-)-huperzine A,,2020-06-15,Treatment of Lennox-Gastaut Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,"Supernus Pharmaceuticals, Inc.",9715 Key West Avenue,,Rockville,Maryland,20850,United States,744420,,
imatinib mesylate,,2020-06-15,Treatment of pulmonary arterial hypertension,Designated,Not FDA Approved for Orphan Indication,,,,"PHPrecisionMed, LLC",3621 Grove Street,,Skokie,Illinois,60076,United States,741420,,
Humanized IgG4 S228P monoclonal antibody targeting the cis conformation of the phosphorylated Thr231-Pro232 motif in tau,,2020-06-16,Treatment of Progressive supranuclear palsy,Designated,Not FDA Approved for Orphan Indication,,,,Pinteon Therapeutics Inc.,1188 Centre Street,,Newton Centre,Massachusetts,2459,United States,720319,,
tacrolimus,,2020-06-16,Prophylaxis of lung allograft rejection,Designated,Not FDA Approved for Orphan Indication,,,,"TFF Pharmaceuticals, Inc.","2600 Via Fortuna, Suite 360",,Austin,Texas,78746,United States,743220,,
Proglumide,,2020-06-16,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,"Jill P Smith, MD","Department of Medicine, Georgetown University",Building D Room 338,Washington,District of Columbia,20007,United States,743020,,
Geranylgeranylacetone,,2020-06-16,Prevention of post-hepatectomy liver failure,Designated,Not FDA Approved for Orphan Indication,,,,RNR BioMedical Inc.,c/o Noa Avtalion,161 Jefferson Av,Tenefly,New Jersey,7670,United States,742220,,
nanatinostat and valganciclovir,,2020-06-22,Treatment of T-cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,"Viracta Therapeutics, Inc.",2533 South Coast Highway,Suite 210,Cardiff,California,92007,United States,733420,,
Autologous CD34+ enriched cell population that contains hematopoietic stem and progenitor cells transduced ex-vivo using a lentiviral vector encoding alpha-L-iduronidase gene,,2020-06-22,Treatment of Mucopolysaccharidosis Type I (MPS-I),Designated,Not FDA Approved for Orphan Indication,,,,Orchard Therapeutics (Europe) Limited,108 Cannon Street,,London,,,United Kingdom,750120,,
"6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3- tetrahydropyran-4-yl-7H-imidazo[1,5-a]pyrazin-8-one",,2020-06-22,Treatment of ߭thalassemia,Designated,Not FDA Approved for Orphan Indication,,,,"IMARA, Inc.",116 Huntington Avenue,6th Floor,Boston,Massachusetts,2116,United States,748620,,
cirmtuzumab,,2020-06-22,Treatment of mantle cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,"Oncternal Therapeutics, Inc.",12230 El Camino Real,Suite 300,SanDiego,California,92130,United States,744220,,
cirmtuzumab,,2020-06-22,Treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma.,Designated,Not FDA Approved for Orphan Indication,,,,"Oncternal Therapeutics, Inc.",12230 El Camino Real,Suite 300,SanDiego,California,92130,United States,744120,,
belzutifan,Welireg,2020-06-24,Treatment of von Hippel-Lindau disease,Designated/Approved,,"Treatment of adult patients with von Hippel-Lindau (VHL) disease who require therapy for associated renal cell carcinoma (RCC), central nervous system (CNS) hemangioblastomas, or pancreatic neuroendocrine tumors (pNET), not requiring immediate surgery",2021-08-13,2028-08-13,"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.",One Merck Drive,,Whitehouse Station,New Jersey,8889,United States,745820,,
Humanized immunoglobulin G1 kappa monoclonal antibody targeting PAUF,,2020-06-24,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,Prestige Biopharma Ltd,2 Science Park #04-13/14,Ascent Tower B,Science Park,,,Singapore,749620,,
nipocalimab,,2020-06-26,Prevention of hemolytic disease of the fetus and newborn,Designated,Not FDA Approved for Orphan Indication,,,,"Momenta Pharmaceuticals, Inc.",301 Binney Street,,Cambridge,Massachusetts,2142,United States,712419,,
Synthetic double-stranded siRNA oligonucleotide directed against TMPRSS6 mRNA and covalently linked to a ligand containing 3 N-acetylgalactosamine residues,,2020-06-26,Treatment of ߭thalassemia,Designated,Not FDA Approved for Orphan Indication,,,,Silence Therapeutics GmbH,Robert-Rossle-Str. 10,,Berlin,,,Germany,709119,,
geranylgeranylacetone,,2020-06-26,Treatment of spinal and bulbar muscular atrophy,Designated,Not FDA Approved for Orphan Indication,,,,RNR BioMedical Inc.,c/o Noa Avtalion,161 Jefferson Av,Tenefly,New Jersey,7670,United States,744620,,
A therapeutic vaccine targeting the HPV16 E6/E7 proteins,,2020-06-26,Treatment of HPV16-positive cervical cancer,Designated,Not FDA Approved for Orphan Indication,,,,ISA Therapeutics BV,J.H. Oortweg 19,2333 CH Leiden,CH Leiden,,,Netherlands,744820,,
anakinra,Kineret,2020-06-29,Treatment of Deficiency of IL-1 Receptor Antagonist,Designated/Approved,,treatment of Deficiency of Interleukin-1 Receptor Antagonist (DIRA),2020-12-18,2027-12-18,Swedish Orphan Biovitrum AB (PUBL),Tomtebodav䧥n 23A,,Stockholm,,,Sweden,745420,,
"[6-(4-Chlorophenyl)-spiro[3.5]non-6-en-7-yl]methyl}-piperazin-1-yl}-N-{{3-nitro-4-[((2S)-1,4-dioxan-2-ylmethyl)amino]phenyl}sulfonyl}-2-(1H- pyrrolo[2,3-b]pyridin-5-yloxy)benzamide",,2020-07-01,Treatment of Waldenstr��acroglobulinemia,Designated,Not FDA Approved for Orphan Indication,,,,Ascentage Pharma Group Inc.,"800 King Farm Blvd., Suite 300",,Rockville,Maryland,20850,United States,745620,,
Enriched CD34+ hematopoietic stem and progenitor cells/highly puridied CD34-CD25+CD4+CD127-regulatory T cells/conventional T cells,,2020-07-01,Treatment to enhance cell engraftment in patients receiving hematopoietic stem cell transplant.,Designated,Not FDA Approved for Orphan Indication,,,,Orca Biosystems Inc.,"3475 Edison Way, Suite B",,Menlo Park,California,94025,United States,746020,,
Engineered cationic antibiotic peptide,,2020-07-01,Treatment of prosthetic joint infections,Designated,Not FDA Approved for Orphan Indication,,,,"Peptilogics, Inc.","2730 Sidney Street, Suite 300",,Pittsburgh,Pennsylvania,15203,United States,723219,,
recombinant human IgG monoclonal HPA-1a antibody,,2020-07-01,Prevention of fetal and neonatal alloimmune thrombocytopenia,Designated,Not FDA Approved for Orphan Indication,,,,"Rallybio IPA, LLC",234 Church Street,Suite 1020,New Haven,Connecticut,6510,United States,735020,,
"N,N-dimethyl-N-(2-{[(2R,3R,4S,5R,6R)-3,4,5-tris(acetyloxy)-6-[(acetyloxy)methyl]oxan-2-yl]oxy}ethyl)cyclopropylammonium",,2020-07-07,Treatment of Trimethylaminuria,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,"Kintai Therapeutics, Inc.",26 Landsdowne St,Suite 450,Cambridge,Massachusetts,2139,United States,761020,,
"N-[[(1,2,3,5,6,7-hexahydro-s-indacen-4-yl) amino]carbonyl]-1-(1-methylethyl)-1H-Pyrazole-3-sulfonamide",,2020-07-07,Treatment of cryopyrin-associated periodic syndromes,Designated,Not FDA Approved for Orphan Indication,,,,"Genentech, Inc., a Member of the Roche Group",1 DNA Way,,South San Francisco,California,94080-4990,United States,757720,,
Paltusotine,,2020-07-07,Treatment of acromegaly,Designated,Not FDA Approved for Orphan Indication,,,,"Crinetics Pharmaceuticals, Inc.",6197 Cornerstone Court East,,San Diego,California,92121,United States,576617,,
imsidolimab,,2020-07-07,Treatment of generalized pustular psoriasis,Designated,Not FDA Approved for Orphan Indication,,,,"AnaptysBio, Inc.",10421 Pacific Center Court,Suite 200,San Diego,California,92121,United States,673918,,
Humanized afucosylated IgG1 monoclonal antibody binding to KLRG1,,2020-07-07,Treatment of inclusion body myositis,Designated,Not FDA Approved for Orphan Indication,,,,"Abcuro, Inc.",90 Bridge Street,Suite 100,Newton,Massachusetts,2458,United States,681119,,
a novel humanized bispecific XmAb T cell recruiting antibody cross-reactive to human and nonhuman primate STEAP1 and CD3,,2020-07-07,Treatment of Ewing Sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,"Amgen, Inc.",One Amgen Center Drive,Mail Stop: 27-3-F,Thousand Oaks,California,91320,United States,760020,,
"5-fluoro-2-(6-fluoro-2-methyl-1H-benzo[d]imidazole-1-yl)-N4-(4-(trifluoromethyl)phenyl)pyrimidine-4,6-diamine",,2020-07-07,Treatment of glioma,Designated,Not FDA Approved for Orphan Indication,,,,"PTC Therapeutics, Inc.",100 Corporate Court,,South Plainfield,New Jersey,7080,United States,755420,,
Nadofaragene firadenovec,,2020-07-07,Treatment of malignant mesothelioma,Designated,Not FDA Approved for Orphan Indication,,,,Trizell Ltd,Sanderum House,"Oakley Road, Chinnor",Oxon,,,United Kingdom,748120,,
Dihydrotestosterone Gel,,2020-07-09,Treatment of micropenis,Designated,Not FDA Approved for Orphan Indication,,,,Besins Healthcare Ireland Ltd.,16 Pembroke Street Upper,DO2HE63,Dublin 2,,,Ireland,747120,,
Dehydrated alcohol,,2020-07-10,Treatment of methanol poisoning,Designated,Not FDA Approved for Orphan Indication,,,,Eton Pharmaceuticals,21925 W. Field Pkwy,Suite 235,Deer Park,Illinois,60010,United States,746720,,
Mitochondria,,2020-07-10,Prevention of ischemia-reperfusion injury during solid organ transplantation,Designated,Not FDA Approved for Orphan Indication,,,,cellvie Inc.,4326B Scotland Street,,Houston,Texas,77007,United States,747420,,
(Z)-3-fluoro-4-(quinolin-8-ylsulfonyl)but-2-en-1-amine,,2020-07-10,Treatment of myelofibrosis,Designated,Not FDA Approved for Orphan Indication,,,,Pharmaxis Ltd.,20 Rodborough Rd.,,Frenchs Forest,NSW,,Australia,747520,,
Humanized Recombinant IgG4 Anti-PD-1 Monoclonal Antibody,,2020-07-14,Treatment of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,"CStone Pharmaceuticals (Suzhou) Co., Ltd.",1000 Zhangheng Road,Building 25,Shanghai,,201203,China,722919,,
rilonacept,Arcalyst,2020-07-14,Treatment of pericarditis,Designated/Approved,,Treatment of recurrent pericarditis (RP) and reduction in risk of recurrence in adults and pediatric patients 12 years and older,2021-03-18,2028-03-18,"Kiniksa Pharmaceuticals, Ltd.",c/o Kiniksa Pharmaceuticals Corp.,100 Hayden Avenue,Lexington,Massachusetts,2421,United States,649718,,
adeno-associated viral vector serotype 9 (AAV9) carrying both HEXA and HEXB,,2020-07-17,Treatment of GM2 Gangliosidosis,Designated,Not FDA Approved for Orphan Indication,,,,Taysha Gene Therapies,BioCenter at UT Southwestern,2280 Inwood Road,Dallas,Texas,75235,United States,763120,,
adeno-associated viral vector serotype 9 encoding a codon-optimized human SLC6A1 transgene,,2020-07-17,Treatment of SLC6A1-related disorder.,Designated,Not FDA Approved for Orphan Indication,,,,Taysha Gene Therapies,BioCenter at UT Southwestern,2280 Inwood Road,Dallas,Texas,75235,United States,766420,,
Alidornase alfa,,2020-07-21,Treatment of sarcoidosis,Designated,Not FDA Approved for Orphan Indication,,,,"SarcoMed USA, Inc.",1300 Post Oak Boulevard,Suite 760,Houston,Texas,77056,United States,754820,,
"2-Amino-N-(4-hydroxybicyclo[2.2.2]octan-1-yl)-5-(4-((1R,5S)-3-(tetrahydro-2H-pyran-4-yl)-3-azabicyclo[3.1.0]hexan-1-yl)phenyl)nicotinamide fumarate dihydrate",,2020-07-21,Treatment of fibrodysplasia ossificans progressiva,Designated,Not FDA Approved for Orphan Indication,,,,Incyte Corporation,1801 Augustine Cut-Off,,Wilmington,Delaware,19803,United States,750320,,
cobomarsen,,2020-07-21,Treatment of adult T-cell leukemia/lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,"Viridian Therapeutics, Inc.",6200 Lookout Road,Suite 100,Boulder,Colorado,80301,United States,748520,,
Pax7+ Satellite Stem Cell Therapy,,2020-07-21,Treatment of Duchenne Muscular Dystrophy.,Designated,Not FDA Approved for Orphan Indication,,,,Vita Therapeutics,1812 Ashland Street,Suite 110,Baltimore,Maryland,21205,United States,749920,,
Zenocutuzumab,,2020-07-22,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,Merus N.V.,139 Main Street,,Cambridge,Massachusetts,2142,United States,750020,,
Aviptadil,,2020-07-23,Treatment of sarcoidosis,Designated,Not FDA Approved for Orphan Indication,,,,AdVita Lifescience GmbH,Alte Bundesstraߥ 20,,Gundelfingen,,79194,Germany,751520,,
Proglumide,,2020-07-23,Treatment of gastric cancer,Designated,Not FDA Approved for Orphan Indication,,,,RNR BioMedical Inc.,c/o Noa Avtalion,161 Jefferson Av,Tenefly,New Jersey,7670,United States,756620,,
adeno-Associated Virus containing human Nuclear Hormone Receptor NR2E3 (AAV-hNR2E3) gene therapy,,2020-07-23,Treatment of RHO gene mutation associated retinal degenerative disease,Designated,Not FDA Approved for Orphan Indication,,,,Ocugen Inc.,5 Great Valley Parkway,Suite 160,Malvern,Pennsylvania,19355,United States,722119,,
a chemically modified full phosphorothioate-backboned anti-miR-17 oligonucleotide.,,2020-07-28,Treatment of autosomal dominant polycystic kidney disease,Designated,Not FDA Approved for Orphan Indication,,,,"Regulus Therapeutics, Inc.",10628 Science Center Drive,Suite 225,San Diego,California,92121,United States,750820,,
parsaclisib,,2020-07-28,Treatment of autoimmune hemolytic anemia,Designated,Not FDA Approved for Orphan Indication,,,,Incyte Corporation,1801 Augustine Cut-Off,,Wilmington,Delaware,19803,United States,758420,,
"3,5-diiodothyropropionic acid",,2020-07-28,Treatment of monocarboxylate transporter (MCT) 8 deficiency (Allan-Herndon-Dudley syndrome),Designated,Not FDA Approved for Orphan Indication,,,,"Prizm, LLC","3377 S. Price Road, Suite 3031",,Chandler,Arizona,85248,United States,764420,,
A recombinant plasmid-derived DNA-based vaccine targeting the E6 and E7 antigens of both HPV6 and HPV11,,2020-07-28,Treatment of recurrent respiratory papillomatosis,Designated,Not FDA Approved for Orphan Indication,,,,"Inovio Pharmaceuticals, Inc.",660 West Germantown Pike,Suite 110,Plymouth Meeting,Pennsylvania,19462,United States,751220,,
Low molecular weight dextran sulfate,,2020-07-28,Treatment of amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,TikoMed AB,79 T.W. Alexander Drive,"4401 Research Commons, Suite 300",Durham,North Carolina,27709,United States,752220,,
"trans-4-[4-Amino-5-(7-methoxy-1H-indol-2-yl)-imidazo[5,1-f][1,2,4]triazine-7-yl]-cyclohexanecarboxylic acid, tromethamine salt",,2020-07-30,Treatment of lymphatic malformations,Designated,Not FDA Approved for Orphan Indication,,,,Aevi Genomic Medicine,1500 Liberty Ridge Drive,Suite 321,Wayne,Pennsylvania,19087,United States,759820,,
Celecoxib,,2020-07-30,Treatment of hemophilic arthropathy,Designated,Not FDA Approved for Orphan Indication,,,,"Upex-Med Co., Ltd.","Rm1117, Geumgangpenterium IT Tower B","Hagui-ro 282, Dongan-gu, Anyang-si,",Gyeonggi-do,,,South Korea,751420,,
Racemetyrosine,,2020-07-31,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,"Tyme Technologies, Inc.",17 State Street,7th Floor,New York,New York,10004,United States,677819,,
"Cl-CAR-135 (FLT3 CAR), RRV-FLT3-CAR-tCD19 transduced autologous T cells derived from patients with acute myeloid leukemia",,2020-07-31,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,Cytoimmune Therapeutics,1333 S Mayflower Avenue,,Monrovia,California,91016,United States,752420,,
oral protease inhibitor that binds to complement factor B and inhibits the C3- and C5 convertases of the alternative pathway,,2020-07-31,Treatment of paroxysmal nocturnal hemoglobinuria,Designated,Not FDA Approved for Orphan Indication,,,,Novartis Pharmaceuticals Corporation,One Health Plaza,Bldg. 315/5150A,East Hanover,New Jersey,7936,United States,751920,,
half-life extended bispecific T cell engager (BiTE) antibody construct designed to target both CLDN18.2 and CD3,,2020-07-31,"Treatment of gastric cancer, including cancer of gastroesophageal junction",Designated,Not FDA Approved for Orphan Indication,,,,"Amgen, Inc.",One Amgen Center Drive,,Thousand Oaks,California,91320,United States,752720,,
"6'-(R)-Methyl-5-O-(5-amino-5,6-dideoxy-a-L-talofuranosyl)-paromamine sulfate",,2020-07-31,Treatment of cystic fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,"ELOXX Pharmaceuticals, Inc.",950 Winter Street,,Waltham,Massachusetts,2451,United States,751820,,
An adeno-associated virus serotype 9 (AAV9) vector with engineered transgene encoding the human CLN7/MFSD8 gene for expression of active human major facilitator superfamily domain containing 8,,2020-07-31,Treatment of neuronal ceroid lipofuscinosis type 7,Designated,Not FDA Approved for Orphan Indication,,,,Neurogene Inc.,"535 W 24th St,",5th Floor,New York,New York,10011,United States,751620,,
Prosetin,,2020-08-04,Treatment of Amyotrophic Lateral Sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,Project ALS,"801 Riverside Drive, Suite 6G",,New York,New York,10032,United States,754220,,
sulindac,,2020-08-04,Treatment of retinitis pigmentosa,Designated,Not FDA Approved for Orphan Indication,,,,"Prolindox, Inc.",8008 Desmond Dr.,,Boynton Beach,Florida,33472,United States,752620,,
Nedaplatin,,2020-08-05,Treatment of Small Cell Lung Cancer,Designated,Not FDA Approved for Orphan Indication,,,,RNR BioMedical Inc.,c/o Noa Avtalion,161 Jefferson Av,Tenefly,New Jersey,7670,United States,753320,,
Dystrophin Expressing Chimeric Cells derived from allogenic normal human myoblast and autologous DMD myoblast from Duchenne muscular dystrophy affected donor,,2020-08-05,Treatment of Duchenne Muscular Dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,Dystrogen Therapeutics Corporation,1415 W 37th Street,,Chicago,Illinois,60609,United States,758720,,
Adeno-Associated Virus containing the gene for human Nuclear Hormone Receptor NR2E3 (AAV-hNR2E3),,2020-08-07,Treatment of retinal dystrophies due to mutations in PDE6B gene,Designated,Not FDA Approved for Orphan Indication,,,,Ocugen Inc.,5 Great Valley Parkway,Suite 160,Malvern,Pennsylvania,19355,United States,753920,,
Ubenimex,,2020-08-07,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,RNR BioMedical Inc.,c/o Noa Avtalion,161 Jefferson Av,Tenafly,New Jersey,7670,United States,755720,,
allogeneic CRISPR/Cas9-mediated genetically modified CAR T cells targeting B-cell maturation antigen,,2020-08-10,Treatment of multiple myeloma.,Designated,Not FDA Approved for Orphan Indication,,,,"CRISPR Therapeutics, Inc.",610 Main Street,,Cambridge,Massachusetts,2139,United States,754120,,
Trehalose + miglustat,,2020-08-10,Treatment of CLN Batten disease,Designated,Not FDA Approved for Orphan Indication,,,,Beyond Batten Disease Foundation,P.O. Box 50221,,Austin,Texas,78763,United States,756020,,
vatiquinone,,2020-08-10,Treatment of mitochondrial disease,Designated,Not FDA Approved for Orphan Indication,,,,"PTC Therapeutics, Inc.",100 Corporate Court,,South Plainfield,New Jersey,7080,United States,759620,,
Adeno-associated virus serotype HSC15 expressing human arylsulfatase A,,2020-08-11,Treatment of Metachromatic Leukodystrophy,Designated,Not FDA Approved for Orphan Indication,,,,"Homology Medicines, Inc.",1 Patriots Park,,Bedford,Massachusetts,1730,United States,761420,,
Edaravone and (+)-Borneol,,2020-08-11,Treatment of Amyotrophic Lateral Sclerosis.,Designated,Not FDA Approved for Orphan Indication,,,,"Yantai Yenepharma. Co., Ltd","Inner No. 2, No.32 Zhujiang Road",Yantai Economic and Technological Development Zone,Yantai,Shandong Province,264006,China,754420,,
Urinary-derived human chorionic gonadotropin and epidermal growth factor,,2020-08-12,Treatment of acute graft-versus-host disease,Designated,Not FDA Approved for Orphan Indication,,,,University of Minnesota,"420 Delaware Street, MMC 480",MMC 195,Minneapolis,Minnesota,55455,United States,735420,,
venglustat malate,,2020-08-13,Treatment of GM2 gangliosidosis,Designated,Not FDA Approved for Orphan Indication,,,,"Genzyme Corporation, a SANOFI COMPANY",50 Binney Street,,Cambridge,Massachusetts,2142,United States,755820,,
cannabidiol covalently linked to temozlomide,,2020-08-14,Treatment of malignant glioma.,Designated,Not FDA Approved for Orphan Indication,,,,"Diverse Biotech, Inc.",3805 Old Easton Road,Suite 111,Doylestown,Pennsylvania,18902,United States,755620,,
Small molecule activator of pantothenate kinases,,2020-08-14,Treatment of Propionic Acidemia,Designated,Not FDA Approved for Orphan Indication,,,,CoA Therapeutics,21 Kipling Street,,Palo Alto,California,94301,United States,770620,,
Disufenton sodium,,2020-08-14,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,"Oblato, Inc.",116 Village Boulevard,Suite 200,Princeton,New Jersey,8540,United States,757820,,
"A replication-defective, non-integrating herpes simplex virus type 1 vector expressing human cystic fibrosis transmembrane conductance regulator",,2020-08-17,Treatment of Cystic Fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,"Krystal Biotech, Inc.",2100 Wharton Street,,Pittsburgh,Pennsylvania,15203,United States,755320,,
"(R)-(1-(4-fluorophenyl)-6-((4-(trifluoromethyl)phenyl)sulfonyl)-1,4,5,6,7,8-hexahydro-4aH-pyrazolo[3,4-g]isoquinolin-4a-yl)(pyridin-2-yl)methanone",,2020-08-18,Treatment of amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,"Corcept Therapeutics, Inc.",149 Commonwealth Drive,,Menlo Park,California,94025,United States,756420,,
Paxalisib,,2020-08-21,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,Kazia Therapeutics Limited,ACN 063 259 754,"Level 24, 300 Barangaroo Avenue",Sydney,NSW,2000,Australia,759220,,
cannabidiol,,2020-08-21,Treatment of Prader Willi Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,"Radius Pharmaceuticals, Inc.",950 Winter Street,,Waltham,Massachusetts,2451,United States,538916,,
Ivaltinostat,,2020-08-21,Treatment of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,"CrystalGenomics, Inc.","5th F. Bldg.A, Korea Bio Park","700 Daewangpangyoro, Bundanggu, Seongnamsi",Gyeonggido,Korea,13488,Republic of Korea,760420,,
zanubrutinib,Brukinsa,2020-08-24,Treatment of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue,Designated/Approved,,Treatment of adult patients with relapsed or refractory marginal zone lymphoma (MZL) who have received at least one anti-CD20-based regimen,2021-09-14,2028-09-14,"BeiGene USA, Inc.",2955 Campus Drive,Suite 200,San Mateo,California,94403,United States,756920,,
zanubrutinib,Brukinsa,2020-08-24,Treatment of nodal marginal zone lymphoma,Designated/Approved,,Treatment of adult patients with relapsed or refractory marginal zone lymphoma (MZL) who have received at least one anti-CD20-based regimen,2021-09-14,2028-09-14,"BeiGene USA, Inc.",2955 Campus Drive,Suite 200,San Mateo,California,94403,United States,757120,,
zanubrutinib,Brukinsa,2020-08-24,Treatment of splenic marginal zone lymphoma,Designated/Approved,,Treatment of adult patients with relapsed or refractory marginal zone lymphoma (MZL) who have received at least one anti-CD20-based regimen,2021-09-14,2028-09-14,"BeiGene USA, Inc.",2955 Campus Drive,Suite 200,San Mateo,California,94403,United States,757020,,
fasudil HCL,,2020-08-25,Treatment of Huntingtons Disease,Designated,Not FDA Approved for Orphan Indication,,,,"Woolsey Pharmaceuticals, Inc.",233 Broadway,Suite 1750,New York,New York,10279,United States,715919,,
Autologous ex-vivo-expanded peripheral polyclonal lymphocytes enriched in activated natural killer cells,,2020-08-25,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,XNK Therapeutics AB,H䬳ov䧥n 7,,Huddinge Municipality,Stockholm County,,Sweden,639218,,
"Bis-(3-deoxy-3-(4-(3-fluorophenyl)-1H-1,2,3-triazol-1-yl)-B-D-galactopyranosyl) sulfane",,2020-08-25,Treatment of idiopathic pulmonary fibrosis (IPF),Designated,Not FDA Approved for Orphan Indication,,,,Galecto Biotech AB,Ole Maaloes Vej 3,,Copenhagen N,,,Denmark,757320,,
BMEDA-chelated Rhenium-186 nanoliposomes,,2020-08-26,Treatment of glioblastoma,Designated,Not FDA Approved for Orphan Indication,,,,University of Texas Health Science Center at San Antonio,7979 Wurzbach Rd.,Suite Z416,San Antonio,Texas,78229,United States,757420,,
"Antibody-drug conjugate (ADC) comprising an anti-ROR1 monoclonal antibody (UC-961), a proteolytically cleavable maleimidocaproyl-valine-citrulline-para-aminobenzoate linker (mc-vc-PAB), and a monomethyl auristatin E (MMAE) cytotoxin.",,2020-08-26,Treatment of mantle cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,"Merck & Co., Inc.","351 N. Sumneytown Pike, UG2C-50,",,North Wales,Pennsylvania,19454,United States,757520,,
Adeno-Associated Viral Vector Expressing Codon-optimized Human PCCA cDNA,,2020-08-26,Treatment of Propionic Acidemia,Designated,Not FDA Approved for Orphan Indication,,,,Mayo Clinic,200 First Street SW,,Rochester,Minnesota,55905,United States,759920,,
211At-4-astato-L-phenylalanine (4-[211At]APA),,2020-08-28,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,Telix Pharmaceuticals Limited (Telix),55 Flemington Road,Suite 401,North Melbourne,Victoria,3015,Australia,758520,,
"2-(4-(4-((1-(107-(4-(fluorophenyl)methoxy)-polyethyleneglycol36))-1H-1,2,3-triazol-4-yl)methoxy)-3,5-diiodophenoxy)-3,5-diiodophenyl)acetic acid",,2020-08-28,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,"NanoPharmaceuticals, LLC",1 Discovery Place,,Rensselaer,New York,12144,United States,759520,,
"(S)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl) -1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazole-4-carboxamide",,2020-08-28,Treatment of mantle cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,"Loxo Oncology, Inc.",701 Gateway Boulevard,Suite 420,South San Francisco,California,94080,United States,758120,,
"1-{6-[(4-fluorophenyl)methyl]-5-(hydroxymethyl)-3,3-dimethyl-1H,2H,3H-pyrrolo[3,2-b]pyridin-1-yl}-2-[(2R,5R)-5-methyl-2-{[(3R)-3-methylmorpholin-4-yl]methyl}piperazin-1-yl]ethan-1-one, L-(+)-lactic acid salt",,2020-08-28,Treatment of T-Cell Lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,"Astex Pharmaceuticals, Inc.",4420 Rosewood Drive,Suite 200,Pleasanton,California,94588,United States,758020,,
"4-{4-{[6-(4-Chlorophenyl)-spiro[3.5]non-6-en-7-yl]methyl}-piperazin-1-yl}-N-{{3-nitro-4-[((2S)-1,4-dioxan-2-ylmethyl)amino]phenyl}sulfonyl}-2-(1H- pyrrolo[2,3-b]pyridin-5-yloxy)benzamide",,2020-08-28,Treatment of Chronic Lymphocytic Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,Ascentage Pharma Group Inc.,800 King Farm Blvd.,Suite 300,Rockville,Maryland,20850,United States,757920,,
small molecule inhibitor of human complement factor D.,,2020-08-28,Treatment of paroxysmal nocturnal hemoglobinuria,Designated,Not FDA Approved for Orphan Indication,,,,"BioCryst Pharmaceuticals, Inc.",4505 Emperor Blvd,Suite 200200,Durham,North Carolina,27703,United States,758220,,
"2-(4-(4-((1-(107-(4-(fluorophenyl)methoxy)-(polyethyleneglycol36))-1H-1,2,3-triazol-4-yl)methoxy)-3,5-diiodophenoxy)-3,5-diiodophenyl)acetic acid",,2020-08-28,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,"NanoPharmaceuticals, LLC",1 Discovery Place,,Rensselaer,New York,12144,United States,759420,,
"2-(4-(4-((1-(107-(4-(guanidinomethyl)phenoxy)-(polyethyleneglycol36))-1H-1,2,3-triazol-4-yl)methoxy)-3,5-diiodophenoxy)-3,5-diiodophenyl)acetic acid",,2020-08-28,Treatment of neuroblastoma,Designated,Not FDA Approved for Orphan Indication,,,,"NanoPharmaceuticals, LLC",1 Discovery Place,,Rensselaer,New York,12144,United States,759320,,
nedaplatin,,2020-08-31,Treatment of esophageal cancer,Designated,Not FDA Approved for Orphan Indication,,,,RNR BioMedical Inc.,c/o Noa Avtalion,161 Jefferson Av,Tenafly,New Jersey,7670,United States,747220,,
20-alphaHydroxycholesterol,,2020-08-31,Prevention of White Matter Injury in Preterm Infants less than or equal to 32 Weeks Gestational Age,Designated,Not FDA Approved for Orphan Indication,,,,"Tellus Therapeutics, Inc.",517 Summit Trail Drive,,Hillsborough,North Carolina,27278,United States,761620,,
firolimogene autotemcel,,2020-08-31,treatment X-linked severe combined immunodeficiency.,Designated,Not FDA Approved for Orphan Indication,,,,"Mustang Bio, Inc.",377 Plantation Street,,Worcester,Massachusetts,1605,United States,759720,,
Lorcaserin,,2020-08-31,Treatment of Dravet syndrome,Designated,Not FDA Approved for Orphan Indication,,,,Eisai Inc.,100 Tice Boulevard,,Woodcliff Lake,New Jersey,7677,United States,758920,,
chemically synthesized molecule which is composed of two binding sites (a CD38 binder and a universal antibody binding terminus binder) connected by a linker chain.,,2020-08-31,Treatment of Multiple Myeloma,Designated,Not FDA Approved for Orphan Indication,,,,Kleo Pharmaceuticals,25 Science Park,,New Haven,Connecticut,6511,United States,758820,,
"4-((3'R,4'S,5'R)-6''-chloro-4'-(3-chloro-2-fluorophenyl)-1'-ethyl-2''-oxodispiro[cyclohexane-1,2'- pyrrolidine-3',3''-indoline]-5'-carboxamido)bicyclo [2.2.2]octane-1-carboxylic acid",,2020-09-02,Treatment of Gastric Cancer,Designated,Not FDA Approved for Orphan Indication,,,,Ascentage Pharma Group Inc.,800 King Farm Blvd.,Suite 300,Rockville,Maryland,20850,United States,762520,,
humanized bispecific IgG1 antibody that can simultaneously bind to both programmed death-ligand 1 and cytotoxic T-lymphocyte-associated protein 4,,2020-09-02,Treatment of Thymic Epithelial Tumors,Designated,Not FDA Approved for Orphan Indication,,,,"Jiangsu Alphamab Biopharmaceuticals Co., Ltd.","Bldg. C23, 218 Xinghu Street,",SIP,SuZhou,Jiangsu,,China,759120,,
Belumosudil,,2020-09-04,Treatment of systemic sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,Kadmon Corporation,450 East 29th Street,,New York,New York,10016,United States,760520,,
Small molecule mitofusin allosteric activator,,2020-09-04,Treatment of Charcot-Marie-Tooth Disease Type 2A,Designated,Not FDA Approved for Orphan Indication,,,,"Mitochondria in Motion, Inc.",4340 Duncan Avenue,Suite 216,Saint Louis,Montana,63110,United States,760320,,
Pozelimab/Cemdisiran Combination,,2020-09-08,Treatment of Paroxysmal Nocturnal Hemoglobinuria,Designated,Not FDA Approved for Orphan Indication,,,,"Regeneron Pharamecuticals, Inc.",777 Old Saw Mill River Road,,Tarrytown,New York,10591,United States,760920,,
peptide conjugated phosphorodiamidate morpholino oligomer,,2020-09-08,Treatment for Hutchinson-Gilford Progeria Syndrome and Progeroid Laminopathies,Designated,Not FDA Approved for Orphan Indication,,,,,,,,,,,768520,,
"5-fluoro-4-(7''-fluoro-2''-methylspiro[cyclopentane-1,3''-indol]-5''-yl)-N-(5-(1-methylpiperidin-4-yl)pyridin-2-yl)pyrimidin-2-amine fumarate",,2020-09-08,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,Gan & Lee Pharmaceuticals USA Corporation,520 US Highway 22 East,Suite 302,Bridgewater,New Jersey,8807,United States,760620,,
"2,4 dinitrophenol",,2020-09-08,Treatment of Amyotrophic Lateral Sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,"Mitochon Phannaceuticals, Inc.",970 Cross Lane,,Blue Bell,Pennsylvania,19422,United States,764820,,
Adeno-associated viral vector expressing a cystic fibrosis transmembrane conductance regulator with a partial deletion in the R domain gene,,2020-09-08,Treatment of Cystic Fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,"Spirovant Sciences, Inc.",3675 Market Street,2nd Floor,Philadelphia,Pennsylvania,19104,United States,760820,,
Biotin,,2020-09-08,Treatment of Charcot-Marie-Tooth disease,Designated,Not FDA Approved for Orphan Indication,,,,MedDay Pharmaceuticals,6880 Commerce Blvd.,,Canton,Michigan,48187,United States,760720,,
encapsulated human Hep G2 hepatoblastoma cells,,2020-09-09,Treatment of Acute Liver failure.,Designated,Not FDA Approved for Orphan Indication,,,,ESPL Regulatory Consulting Limited,67 Park Place East,,Morristown,New Jersey,7960,United States,761120,,
Proglumide,,2020-09-09,Treatment of Chronic Pancreatitis,Designated,Not FDA Approved for Orphan Indication,,,,RNR BioMedical Inc.,c/o Noa Avtalion,161 Jefferson Av,Tenefly,New Jersey,7670,United States,762120,,
Autologous Osteogenic Stem Cells,,2020-09-09,Treatment of Congenital Pseudarthrosis of Long Bones,Designated,Not FDA Approved for Orphan Indication,,,,Novadip Biosciences,265 Streaker Road,,Sykesville,Maryland,21784,United States,761220,,
Aminolevulinic acid hydrochloride,,2020-09-09,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,"SonALAsense, Inc.",2600 Tenth Street,Suite 435,Berkeley,California,94710,United States,761520,,
Fasudil,,2020-09-09,Treatment of Frontotemporal Dementia,Designated,Not FDA Approved for Orphan Indication,,,,"Woolsey Pharmaceuticals, Inc.Woolsey Pharmaceuticals, Inc.",233 Broadway,Suite 1750,New York,New York,10279,United States,761320,,
Caveolin-1 Scaffolding Domain 7-Mer,,2020-09-09,Treatment of idiopathic pulmonary fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,"Lung Therapeutics, Inc.","2801 Via Fortuna, Suite 425",,Austin,Texas,78746,United States,761920,,
Lumacaftor,,2020-09-09,Treatment of Non-Traumatic Subarachnoid Hemorrhage,Designated,Not FDA Approved for Orphan Indication,,,,Qanatpharma AG,Alter Postplatz 2,,Stans,,6370,Switzerland,761720,,
(S)-4-((1-Benzylpyrrolidin-3-yl)(methyl)amino)-2-fluoro-5-methyl-N-(thiazol-4-yl)benzenesulfonamide,,2020-09-10,"Treatment of Sodium channel, voltage-gated, type VIII, alpha subunit (SCN8A) developmental and epileptic encephalopathy syndrome '||CHR(13)||CHR(10)||CHR(13)||CHR(10)||'",Designated,Not FDA Approved for Orphan Indication,,,,Neurocrine Biosciences Inc.,12780 El Camino Real,,San Diego,California,92130,United States,762220,,
glycolate oxidase inhibitor,,2020-09-10,Treatment of Primary Hyperoxaluria Type 1 (PH1),Designated,Not FDA Approved for Orphan Indication,,,,"Cantero Therapeutics, Inc.","1800 Owens Street, Suite C-1200",,San Francisco,California,94158,United States,762420,,
(R)-N-(3-(2-((3-methoxy-1-methyl-1H-pyrazol-4-yl)amino)pyrimidin-4-yl)-1H-indol-7-yl)-2-(4-methylpiperazin-1-yl)propenamide hemi ethyl acetate solvate,,2020-09-10,Treatment of T-cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,"Dizal (Jiangsu) Pharmaceutical Co., Ltd.",199 Liangjing Road,Zhangjiang High-Tec Park,Shanghai,,,China,763220,,
Pexastimogene Devacirepvec,,2020-09-14,Treatment of stage IIB-IV melanoma,Designated,Not FDA Approved for Orphan Indication,,,,"SillaJen, Inc.","6F, 111, Hyoyeol-ro",Suite 200,Buk-gu,Busan,,South Korea,762820,,
mavrilimumab,,2020-09-14,Treatment of Giant Cell Arteritis,Designated,Not FDA Approved for Orphan Indication,,,,"Kiniksa Pharmaceuticals, Ltd.",c/o Kiniksa Pharmaceuticals Corp.,100 Hayden Avenue,Lexington,Massachusetts,2421,United States,764620,,
Autologous Anti-CD22 CAR T-Cells,,2020-09-14,Treatment of acute lymphoblastic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,"Center for Cancer Research, National Cancer Institute",National Institutes of Health,,Bethesda,Maryland,20892,United States,762620,,
"(S)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl) -1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazole-4-carboxamide",,2020-09-14,Treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,"Loxo Oncology, Inc., a wholly owned subsidiary of Eli Lilly and Company",701 Gateway Boulevard,Suite 420,South San Francisco,California,94080,United States,763420,,
"4-((3'R,4'S,5'R)-6''-chloro-4'-(3-chloro-2-fluorophenyl)-1'-ethyl-2''-oxodispiro[cyclohexane-1,2'-pyrrolidine-3',3''-indoline]-5'-carboxamido)bicyclo [2.2.2]octane-1-carboxylic acid",,2020-09-14,Treatment of acute myeloid leukemia.,Designated,Not FDA Approved for Orphan Indication,,,,Ascentage Pharma Group Inc.,800 King Farm Blvd.,Suite 300,Rockville,Maryland,20850,United States,763020,,
"N-[4-[[2-(1,1-Dimethylethyl)phenyl]sulfonyl]phenyl]-2,3,4-trihydroxy-5-[[2-(1-methylethyl)phenyl]methyl]benzamide",,2020-09-14,Treatment of retinoblastoma,Designated,Not FDA Approved for Orphan Indication,,,,Oxular Ltd,Magadalen Centre,1 Robert Robinson Avenue,Oxford,,OX4 4GA,United Kingdom,764020,,
Autologous blood derived natural killer cells,,2020-09-14,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,"CHA Biotech. Co., Ltd","335, Pangyo-r",Bundang-gu,Seongnam-si,Gyeonggi-do,13488,Republic of Korea,764520,,
Toripalimab,,2020-09-15,Treatment of soft tissue sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,"TopAlliance Biosciences, Inc.",9430 Key West Ave,Suite 125,Rockville,Maryland,20850,United States,762720,,
tisagenlecleucel,,2020-09-16,Treatment of follicular lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,United States,765120,,
Cannabidiol,,2020-09-16,Treatment of 22q.11.2 deletion syndrome,Designated,Not FDA Approved for Orphan Indication,,,,"Zynerba Pharmaceuticals, Inc.",80 West Lancaster Avenue,Suite 300,Devon,Pennsylvania,19333,United States,763820,,
2-O-(2-methoxyethyl) modified antisense oligonucleotide targeting glial fibrillary acidic protein pre mRNA,,2020-09-18,Treatment of Alexander disease,Designated,Not FDA Approved for Orphan Indication,,,,Ionis Pharmaceuticals,2855 Gazelle Court,,Carlsbad,California,92010,United States,765520,,
Gabexate,,2020-09-18,Treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis,Designated,Not FDA Approved for Orphan Indication,,,,RNR BioMedical Inc.,c/o Noa Avtalion,161 Jefferson Av,Tenafly,New Jersey,7670,United States,764320,,
recombinant humanized Fc effector function null IgG1 antibody with kappa light chains that selectively binds to E-selectin,,2020-09-18,Treatment of Sickle Cell Disease,Designated,Not FDA Approved for Orphan Indication,,,,Pfizer Inc.,500 Arcola Road,,Collegeville,Pennsylvania,19426,United States,765320,,
"Mobilized peripheral blood-derived autologous CD34+ hematopoietic stem cells, that have been genetically modified, ex vivo, with self-inactivating lentiviral vector CL20-4i-EF1a-hyc-OPT containing a normal version of the coding region of the IL2RG gene.",,2020-09-18,Treatment of severe combined immunodeficiency,Designated,Not FDA Approved for Orphan Indication,,,,"Mustang Bio, Inc.",377 Plantation Street,,Worcester,Massachusetts,1605,United States,765220,,
6-{(1S)-1-[(2-Amino-6-fluoroquinolin-3-yl)oxy]ethyl}-5-(1H-pyrazol-1-yl)pyridin-2(1H)-one,,2020-09-18,Treatment for Sickle Cell Disease.,Designated,Not FDA Approved for Orphan Indication,,,,"Pfizer, Inc.",500 Arcola Road,,Collegeville,Pennsylvania,19426,United States,766020,,
aspirin for injection (acetylsalicylic acid),,2020-09-18,Treatment of Kawasaki Disease,Designated,Not FDA Approved for Orphan Indication,,,,Rhoshan Pharmaceuticals Inc.,"225 Wilmington-West Chester Pike, Suite 200",,Chadds Ford,Pennsylvania,19317,United States,764120,,
Src homology region 2-containing protein tyrosine phosphatase 2 (SHP2) inhibitor,,2020-09-18,Treatment of Esophageal Cancer,Designated,Not FDA Approved for Orphan Indication,,,,"Jacobio Pharmaceuticals Co., Ltd.","Bld-F2, No 88, 6th Kechuang St, BDA",,Beijing,,101111,China,764720,,
Small molecule melanocortin 4 receptor agonist,,2020-09-21,Treatment for leptin receptor deficiency,Designated,Not FDA Approved for Orphan Indication,,,,"LG Chem, Ltd.",LG Twin Towers,"128, Yeoui-daero, Yeongdeungpo-gu",Seoul,,7336,Republic of Korea,765720,,
"2-(4-oxo-3-((5-(trifluoromethyl)benzo[d]thiazol-2-yl)methyl)-3,4-dihydrothieno[3,4-d]pyridazin-1-yl)acetic acid",,2020-09-21,Treatment of phosphomannomutase 2 deficiency,Designated,Not FDA Approved for Orphan Indication,,,,Applied Therapeutics Inc.,340 Madison Avenue,19th Floor,New York,New York,10173,United States,765620,,
Recombinant Human Adeno-Associated Virus Serotype 2 Containing Human Mitochondrial ND4 gene (rAAV2-ND4),,2020-09-22,Treatment of Leber's Hereditary Optic Neuropathy,Designated,Not FDA Approved for Orphan Indication,,,,"Neurophth Therapeutics, Inc.",200 Continental Drive,"Suite 401, Room 411",New Castle,Delaware,19713,United States,765420,,
Cepharanthine,,2020-09-22,Treatment of immune thrombocytopenia (ITP),Designated,Not FDA Approved for Orphan Indication,,,,RNR BioMedical Inc.,c/o Noa Avtalion,161 Jefferson Av,Tenafly,New Jersey,7670,United States,766520,,
Excindogen,,2020-09-23,Treatment of Pancreatic Cancer,Designated,Not FDA Approved for Orphan Indication,,,,CarcinEx Inc.,820 Grape St.,,Denver,Colorado,80220,United States,768020,,
Hemopexin (Human),,2020-09-23,Treatment of Sickle Cell Disease,Designated,Not FDA Approved for Orphan Indication,,,,CSL Behring,1020 First Avenue,PO Box 61501,King of Prussia,Pennsylvania,19406,United States,768120,,
N-Acetylglucosamine,,2020-09-23,Treatment for Duchenne Muscular Dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,"Wellesley Therapeutics, Inc.","200 Gerrard St., East",,Toronto,Ontario,M5A 2E6,Canada,767420,,
Pelcitoclax,,2020-09-23,Treatment of Small Cell Lung Cancer,Designated,Not FDA Approved for Orphan Indication,,,,Ascentage Pharma Group Inc.,800 King Farm Blvd.,Suite 300,Rockville,Maryland,20850,United States,766320,,
"Human Engrailed-1 homeoprotein, recombinant",,2020-09-24,Treatment of amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,BrainEver SAS,"74, Rue du Faubourg Saint Antoine",,PARIS,,75012,France,766620,,
"6-amino-5-chloro-N-[(1R)-1-(5-{[5-chloro-4-(trifluoromethyl)pyridin-2- yl]carbamoyl}-1,3-thiazol-2-yl)ethyl]pyrimidine-4-carboxamide",,2020-09-24,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,DOT Therapeutics-1 Inc.,2765 Sand Hill Rd,Suite 115,Menlo Park,California,94025,United States,768320,,
Synthetic adrenocorticotropic hormone,,2020-09-25,Treatment of infantile spasms,Designated,Not FDA Approved for Orphan Indication,,,,Amzell B.V.,Siriusdreef 41,,2132 WT Hoofddorp,,,Netherlands,740820,,
DNA plasmid encoding the human transferrin gene,,2020-09-25,Treatment of retinitis pigmentosa,Designated,Not FDA Approved for Orphan Indication,,,,"Eyevensys, Inc.",185 Alewife Brook Parkway,Suite 210,Cambridge,Massachusetts,2138,United States,766920,,
Emapalumab,,2020-09-25,Prevention of graft failure following hematopoietic stem cell transplantation,Designated,Not FDA Approved for Orphan Indication,,,,Sobi AG,12 Chemin des Aulx,Plan-Les-Ouates,Geneva,,1228,Switzerland,766720,,
Nivatrotamab,,2020-09-25,Treatment of neuroblastoma,Designated,Not FDA Approved for Orphan Indication,,,,"Y-mAbs Therapeutics, Inc.","230 Park Avenue, Suite 3350",,New York,New York,10169,United States,767020,,
apadamtase alfa,,2020-09-28,Treatment of Sickle Cell Disease,Designated,Not FDA Approved for Orphan Indication,,,,Baxalta US Inc.,300 Shire Way,,Lexington,Massachusetts,2421,United States,768720,,
Vactosertib,,2020-09-28,Treatment of gastric cancer,Designated,Not FDA Approved for Orphan Indication,,,,"MedPacto, Inc",145 Gwanggyo-ro,"Advanced Institutes of Convergence Technology, Building C, Room 506",Suwon,Gyeonggi-do,16229,Republic of Korea,767320,,
Sodium phenylbutyrate and tauroursodeoxycholic acid dihydrate,,2020-09-30,Treatment of Wolfram syndrome,Designated,Not FDA Approved for Orphan Indication,,,,Amylyx Pharmaceuticals Inc.,43 Thorndike Street,,Cambridge,Massachusetts,2139,United States,767720,,
Allogeneic ex vivo-generated natural killer cells from CD34+ umbilical cord blood progenitor cells,,2020-09-30,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,Glycostem Therapeutics B.V.,Kloosterstraat 9,,AB Oss,,5349,Netherlands,768920,,
"allogeneic, expanded, engineered human umbilical cord E4ORF1+ CD31+ cells (E-CEL UVEC cells)",,2020-09-30,Prevention (reduction) of morbidity and mortality associated with hematopoietic stem cell transplantation,Designated,Not FDA Approved for Orphan Indication,,,,"Angiocrine Bioscience, Inc.",11575 Sorrento Valley Road,Suite 217,San Diego,California,92121,United States,767620,,
Phenobarbital Sodium,,2020-09-30,Treatment of neonatal seizures,Designated,Not FDA Approved for Orphan Indication,,,,"Hikma Pharmaceuticals USA, Inc.",2 Esterbrook Lane,,Cherry Hill,New Jersey,8003,United States,768420,,
Humanized Anti-claudin18.2 Autologous Chimeric Antigen Receptor (CAR) T Cells,,2020-09-30,Treatment of gastric cancer including cancer of the gastroesophageal junction,Designated,Not FDA Approved for Orphan Indication,,,,CARsgen Therapeutics Corporation,6575 West Loop South,Suite 455,Bellaire,Texas,77401,United States,768620,,
Humanized IgG1K-agonistic monoclonal antibody that binds to CD40,,2020-10-05,Treatment of esophageal and gastroesophageal junction cancer,Designated,Not FDA Approved for Orphan Indication,,,,"Apexigen, Inc.",75 Shoreway Road,Suite C,San Carlos,California,94070,United States,768220,,
O-(2-[18F]fluoroethyl)-L-tyrosine,,2020-10-05,Diagnostic for the management of glioma,Designated,Not FDA Approved for Orphan Indication,,,,Telix Pharmaceuticals Limited (Telix),55 Flemington Road,Suite 401,North Melbourne,Victoria,3015,Australia,767920,,
daratumumab and hyaluronidase-fihj,Darzalex Faspro,2020-10-06,treatment of light-chain (AL) amyloidosis,Designated/Approved,,"in combination with bortezomib, cyclophosphamide and dexamethasone for the treatment of adult patients with newly diagnosed light chain (AL) amyloidosis",2021-01-15,2028-01-15,"Janssen Research & Development, LLC",1400 McKean Road,PO Box 776,Spring House,Pennsylvania,19477,United States,769220,,
Fibromun / Onfekafusp alfa,,2020-10-07,treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,Philogen S.p.A.,Localitࠂellaria 35,,Sovicille,,I-53018,Italy,771020,,
recombinant serotype 9 adeno-associated virus encoding a codon-optimized human MECP2 gene,,2020-10-07,Treatment for Rett syndrome,Designated,Not FDA Approved for Orphan Indication,,,,Taysha Gene Therapies,BioCenter at UT Southwestern,2280 Inwood Road,Dallas,Texas,75235,United States,770520,,
Small molecule activator of pantothenate kinases,,2020-10-07,treatment for pantothenate kinase-associated neurodegeneration,Designated,Not FDA Approved for Orphan Indication,,,,CoA Therapeutics,421 Kipling Street,,Palo Alto,California,94301,United States,770320,,
L-citrulline,,2020-10-07,Treatment of sickle cell disease,Designated,Not FDA Approved for Orphan Indication,,,,"Asklepion Pharmaceuticals, LLC",729 E. Pratt Street,Suite 360,Baltimore,Maryland,21202,United States,769820,,
sacituzumab govitecan,,2020-10-08,treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,"Immunomedics, Inc.",300 The American Rd,,Morris Plains,New Jersey,7950,United States,769520,,
Disulfiram and Copper,,2020-10-08,treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,"Cantex Pharmaceuticals, Inc.",1792 Bell Tower Lane,,Weston,Florida,33326,United States,771520,,
sulfo butyl ether beta-cyclodextrin,,2020-10-08,treatment of Stargardt disease,Designated,Not FDA Approved for Orphan Indication,,,,"reVision Therapeutics, Inc.",Attention: Paul Fehlner,125 Brookside Avenue,Ridgewood,New Jersey,7450,United States,771720,,
O-(3-piperidino-2-hydroxy-1-propyl)-nicotinic acid amidoxime dihydrochloride,,2020-10-08,Treatment of familial dysautonomia,Designated,Not FDA Approved for Orphan Indication,,,,Mitochon Technologies Kft.,Rizling t 3,,,Balatonvil᧯s,8171,Hungary,769720,,
Pre-Morula Stem Cells,,2020-10-08,treatment for amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,ReoStem L.L.C.,8 The Green,Suite #10862,Dover,Delaware,19901,United States,769420,,
Volasertib,,2020-10-08,treatment of soft tissue sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,Oncoheroes Biosciences Inc.,"43 Kent Street, #1",,Brookline,Massachusetts,2445,United States,771420,,
2-O-(2-methoxyethyl) modified antisense oligonucleotide targeting glycogen synthase 1 (GYS1) pre mRNA,,2020-10-08,treatment of Lafora disease,Designated,Not FDA Approved for Orphan Indication,,,,"Ionis Pharmaceuticals, Inc.",2855 Gazelle Court,,Carlsbad,California,92010,United States,771320,,
Atezolizumab,,2020-10-08,treatment of soft tissue sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080-4990,United States,769320,,
"fully human, antagonistic IgG1 monoclonal antibody targeting IL-27 subunit alpha (p28)",,2020-10-08,Treatment of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,Surface Oncology,"50 Hampshire Street, 8th Floor",,Cambridge,Massachusetts,2139,United States,771820,,
sugemalimab,,2020-10-08,treatment of T-cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,EQRx Inc.,50 Hampshire Street,,Cambridge,Massachusetts,2139,United States,772220,,
"an antibiotic combination product consisting of 3 antimicrobial agents (clarithromycin, rifabutin, and clofazimine).",,2020-10-13,Treatment for Nontuberculous Mycobacteria Disease,Designated,Not FDA Approved for Orphan Indication,,,,RedHill Biopharma Ltd.,21 Ha'arba'a St.,,Tel-Aviv,,64739,Israel,770820,,
Bacteriophage,,2020-10-14,Treatment for prosthetic Joint Infection,Designated,Not FDA Approved for Orphan Indication,,,,"Adaptive Phage Therapeutics, Inc.",22 Firstfield Road; Suite 125,,Gaithersburg,Maryland,20878,United States,772020,,
"4-{4-{[6-(4-Chlorophenyl)-spiro[3.5]non-6-en-7-yl]methyl}-piperazin-1-yl}-N-{{3-nitro-4-[((2S)-1,4-dioxan-2-ylmethyl)amino]phenyl}sulfonyl}-2-(1H- pyrrolo[2,3-b]pyridin-5-yloxy)benzamide",,2020-10-14,treatment for multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,Ascentage Pharma Group Inc.,"800 King Farm Blvd., Suite 300",,Rockville,Maryland,20850,United States,772320,,
"(R)-2-allyl-1-(7-ethyl-7-hydroxy-6,7-dihydro-5H-cyclopenta[b]pyridin-2-yl)-6-((4-(4-methylpiperazin-1-yl)phenyl)amino)-1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-3-one",,2020-10-14,Treatment of osteosarcoma,Designated,Not FDA Approved for Orphan Indication,,,,"K-Group Beta, Inc.","10835 Road to the Cure, Suite #205",,San Diego,California,92121,United States,772420,,
humanized secreted frizzled-related protein-2 monoclonal antibody,,2020-10-15,treatment of osteosarcoma,Designated,Not FDA Approved for Orphan Indication,,,,Innova Therapeutics,10 Tabby Lane,,Isle of Palms,South Carolina,29451,United States,772620,,
immunoglobulin G (IgG) polyclonal antibody that binds to human T cells,,2020-10-15,Prevention of graft rejection following solid organ transplantation,Designated,Not FDA Approved for Orphan Indication,,,,Xenothera,1 Rue Vauban,,Nantes,,44000,France,772520,,
"synthetic 2?-O-(2-methoxyethyl)-modified antisense oligonucleotide linked to a tri-antennary cluster of N-acetyl galactosamine (GalNAc3) sugars targeting transmembrane protease, serine 6 messenger ribonucleic acid",,2020-10-15,Treatment of beta-thalassemia,Designated,Not FDA Approved for Orphan Indication,,,,"Ionis Pharmaceuticals, Inc.",2855 Gazelle Court,,Carlsbad,California,92010,United States,772120,,
adeno-associated virus 2/9 expressing human BBS1 gene,,2020-10-16,treatment of Bardet-Biedl Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,Axovia Therapeutics,1209 Orange Street,,Wilmington,Delaware,19801,United States,773020,,
Setanaxib,,2020-10-16,treatment of primary biliary cholangitis,Designated,Not FDA Approved for Orphan Indication,,,,Genkyotex SA,"218 Route Marie Curie, Technopole dArchamps, Forum 2",,Archamps,,74160,France,773220,,
adeno-associated virus 2/8 expressing human BBS1 gene,,2020-10-16,treatment of Bardet-Biedl Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,Axovia Therapeutics,1209 Orange Street,,Wilmington,Delaware,19801,United States,772920,,
Dabrafenib,,2020-10-19,treatment of Kabuki Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,Rescindo Therapeutics Inc.,1034 Kennicott Ave,,Cary,North Carolina,27513,United States,775820,,
Branaplam,,2020-10-19,treatment of Huntingtons disease,Designated,Not FDA Approved for Orphan Indication,,,,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,07936-1080,United States,773320,,
CHO cell line produced human alpha-1 antitrypsin (CHO-AAT) protein,,2020-10-19,treatment of alpha-1 antitrypsin deficiency,Designated,Not FDA Approved for Orphan Indication,,,,Caravella Biopharma SA,Route de lIle-aux-Bois 1A,,Monthey,,1870,Switzerland,773920,,
adeno-associated viral vector type 9 with S1S3 gene encoding S1S3 variant of N-acetylglucosamine-1-phosphotransferase,,2020-10-20,treatment of mucolipidosis,Designated,Not FDA Approved for Orphan Indication,,,,M6P Therapeutics,20 S. Sarah Street,,St. Louis,Missouri,63108,United States,774320,,
a self-complementary adeno-associated virus serotype 9 (AAV9) vector expressing codon-optimized human SURF1 DNA coding sequence,,2020-10-20,Treatment of Leigh Syndrome.,Designated,Not FDA Approved for Orphan Indication,,,,Taysha Gene Therapies,BioCenter at UT Southwestern,2280 Inwood Road,Dallas,Texas,75235,United States,773520,,
Trehalose,,2020-10-21,Treatment of CLN Batten disease,Designated,Not FDA Approved for Orphan Indication,,,,Beyond Batten Disease Foundation,P.O. Box 50221,,Austin,Texas,78763,United States,774620,,
maralixibat,,2020-10-21,treatment of biliary atresia,Designated,Not FDA Approved for Orphan Indication,,,,"Mirum Pharmaceuticals, Inc.",950 Tower Lane,Suite 1050,Foster City,California,94404,United States,705519,,
"(2S,3R)-N-[(2S)-3-(cyclopent-1-en-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[(2S)-2-[2-(morpholin-4-yl)acetamido]propanamido]propanamide maleate",,2020-10-21,treatment of polymyositis,Designated,Not FDA Approved for Orphan Indication,,,,"Kezar Life Sciences, Inc.","4000 Shoreline Court, Suite 300",,South San Francisco,California,94080,United States,663518,,
AAV9 capsid encapsulating a bicistronic vector encoding for a unique combination of a recombinant human ?-glucocerebrosidase enzyme with the S1S3 variant of the N-acetylglucosamine-Phosphotransferase (S1S3 PTase),,2020-10-21,treatment of Gaucher disease,Designated,Not FDA Approved for Orphan Indication,,,,M6P Therapeutics,20 S. Sarah Street,,St. Louis,Missouri,63108,United States,775220,,
CD34+ cells that have been transduced in vitro with a lentiviral vector carrying a codon-optimized sequence for expressing the wild type RPS19 protein,,2020-10-21,Treatment Diamond-Blackfan Anemia,Designated,Not FDA Approved for Orphan Indication,,,,Apriligen LLC,"200 Central Park South, Suite 12Q",,New York,New York,10019,United States,774520,,
"a highly purified unmodified carbohydrate polymer which consists of (1,3) and (1,4)-beta-glycosidic linkages",,2020-10-21,Treatment of Osteosarcoma,Designated,Not FDA Approved for Orphan Indication,,,,University Hospitals Cleveland Medical Center,"10532 Euclid Avenue, Walker 3000",,Cleveland,Ohio,44106,United States,774420,,
2'-O-(2-methoxyethyl) phosphorothioate antisense oligonucleotide targeting CD49d RNA,,2020-10-21,treatment of Duchenne muscular dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,Antisense Therapeutics Limited,6 Wallace Avenue Toorak,,Victoria,,3142,Australia,774720,,
Anti-LILRB4 humanized IgG1 monoclonal antibody,,2020-10-21,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,"Immune-Onc Therapeutics, Inc.",795 San Antonio Road,,Palo Alto,California,94303,United States,773820,,
"3alpha,6beta,7beta,12alpha-tetrahydroxy-5beta-cholan-24-oic acid",,2020-10-22,Treatment of Progressive Familial Intrahepatic Cholestasis,Designated,Not FDA Approved for Orphan Indication,,,,"Qing Bile Therapeutics, Inc.",5671 Trafalgar Street,,Vancouver,British Columbia,V6N 1C2,Canada,777320,,
"PEGylated, Engineered, Human Cystathionine ?-Lyase",,2020-10-22,Treatment of Homocystinuria,Designated,Not FDA Approved for Orphan Indication,,,,Aeglea Biotherapeutics Inc.,"805 Las Cimas Parkway, Suite 100",,Austin,Texas,78746,United States,774220,,
Recombinant adeno-associated virus vector containing the active biological substance AAV-GTX-hUBE3A,,2020-10-22,Treatment of Angelman Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,"PTC Therapeutics, Inc.",100 Corporate Court,,South Plainfield,New Jersey,7080,United States,777420,,
a single-stranded adeno-associated virus serotype 8 gene therapy containing codon optimized human alpha-1-iduronidase cDNA.,,2020-10-22,Treatment of mucopolysaccharidosis type I (MPS I),Designated,Not FDA Approved for Orphan Indication,,,,"Rain Bio, Inc.",8628 Valley Brook Drive,,Raleigh,North Carolina,27613,United States,774120,,
"(2S,3R)-N-[(2S)-3-(cyclopent-1-en-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[(2S)-2-[2-(morpholin-4-yl)acetamido]propanamido]propanamide maleate",,2020-10-22,treatment of dermatomyositis,Designated,Not FDA Approved for Orphan Indication,,,,"Kezar Life Sciences, Inc.","4000 Shoreline Court, Suite 300",,South San Francisco,California,94080,United States,672018,,
Methoxyamine hydrochloride,,2020-10-22,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,"TRACON Pharmaceuticals, Inc.","4350 La Jolla Village Dr., Suite 800",,San Diego,California,92122,United States,777120,,
"a non-replicating recombinant adeno-associated virus serotype hu68 vector, containing a transgene encoding the human galactosylceramidase (GALC) enzyme",,2020-10-22,Treatment of Krabbe disease (globoid cell leukodystrophy),Designated,Not FDA Approved for Orphan Indication,,,,"Passage Bio, Inc.","Commerce Square Two, 2001 Market Street",,Philadelphia,Pennsylvania,19103,United States,776620,,
Venetoclax,,2020-10-26,Treatment of acute lymphoblastic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,AbbVie Inc.,1 North Waukegan Road,,North Chicago,Illinois,60064,United States,777520,,
VX-121/tezacaftor/deutivacaftor,,2020-10-26,treatment of cystic fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,Vertex Pharmaceuticals Incorporated,50 Northern Avenue,,Boston,Massachusetts,2210,United States,777220,,
Recombinant adeno-associated virus vector-based gene therapy expressing the methylmalonyl-CoA mutase (MMUT) transgene,,2020-10-26,Treatment of methylmalonic acidemia,Designated,Not FDA Approved for Orphan Indication,,,,"Selecta Biosciences, Inc.",65 Grove Street,,Watertown,Massachusetts,2472,United States,775520,,
Dasatinib,,2020-10-26,Treatment of Noonan syndrome-associated hypertrophic cardiomyopathy,Designated,Not FDA Approved for Orphan Indication,,,,"IGIA Pharmaceuticals, Inc.",1125 Boone Aire Road,,Florence,Kentucky,41042,United States,775320,,
Devimistat,,2020-10-26,Treatment of soft tissues sarcoma.,Designated,Not FDA Approved for Orphan Indication,,,,"Rafael Pharmaceuticals, Inc.",1 Duncan Drive,,Cranbury,New Jersey,8512,United States,777920,,
tepotinib,Tepmetko,2020-10-26,Treatment of non-small cell lung cancer with MET genomic tumor aberrations,Designated/Approved,,treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) harboring mesenchymal-epithelial transition (MET) exon 14 skipping alterations,2021-02-03,2028-02-03,"EMD Serono, Inc.",One Technology Place,,Rockland,Massachusetts,2370,United States,679719,,
autologous patients CD4+ T cells that have been subjected to lentivirus mediated gene transfer of healthy FOXP3,,2020-10-26,Treatment of Immune dysregulation Polyendocrinopathy Enteropathy X-linked (IPEX) Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,Stanford University,"265 Campus Dr., Office G3039",Lorry I Lokey Stem Cell Research Building,Stanford,California,94305-5101,United States,776420,,
Retifanlimab,,2020-10-26,Treatment of Merkel cell carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,Incyte Corporation,1801 Augustine Cut-Off,,Wilmington,Delaware,19803,United States,695719,,
tricaprilin,,2020-10-27,Treatment of infantile spasms also known as West's syndrome,Designated,Not FDA Approved for Orphan Indication,,,,"Cerecin, Inc.","44 Cook Street, Suite 100-71",,Denver,Colorado,80206,United States,777020,,
Rifaximin,,2020-10-28,treatment of sickle cell disease,Designated,Not FDA Approved for Orphan Indication,,,,"Salix Pharmaceuticals, Inc. (a division of Bausch Health US, LLC)",400 Somerset Corporate Boulevard,,Bridgewater,New Jersey,8807,United States,778520,,
"4-((3'R,4'S,5'R)-6''-chloro-4'-(3-chloro-2-fluorophenyl)-1'-ethyl-2''-oxodispiro[cyclohexane-1,2'-pyrrolidine-3',3''-indoline]-5'-carboxamido)bicyclo [2.2.2]octane-1-carboxylic acid",,2020-10-28,Treatment of soft tissue sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,Ascentage Pharma Group Inc.,"800 King Farm Blvd., Suite 300",,Rockville,Maryland,20850,United States,778720,,
Pirarubicin,,2020-10-29,Treatment of osteosarcoma,Designated,Not FDA Approved for Orphan Indication,,,,"Hillstream BioPharma, Inc.",245 Main Street,Suite 204,Chester,New Jersey,7930,United States,778820,,
"EXE-346, a Live Biotherapeutic Product (LBP), contains eight strains of probiotic bacteria.",,2020-11-02,Treatment of pouchitis,Designated,Not FDA Approved for Orphan Indication,,,,"ExeGi Pharma, LLC.",90 Church St.,,Rockville,Maryland,20850,United States,778120,,
butyl ((2-(5-((1H-imidazol-1-yl)methyl)pyridin-2-yl)-4-(trifluoromethoxy)phenyl)sulfonyl) carbamate,,2020-11-02,Treatment of amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,"RASRx, LLC","231 Bonetti Dr., Suite 240",,San Luis Obispo,California,93401,United States,779020,,
"D,L-3-hydroxybutyrate",,2020-11-03,Treatment of multiple acyl-CoA dehydrogenase deficiency,Designated,Not FDA Approved for Orphan Indication,,,,"Orpha Labs, AG",Haldenstrasse 5,,Baar,,CH-6340,Switzerland,779220,,
L-Citrulline,,2020-11-03,Treatment of Ornithine Transcarbamylase deficiency,Designated,Not FDA Approved for Orphan Indication,,,,"Orpha Labs, AG",Haldenstrasse 5,,Baar,,CH-6340,Switzerland,779420,,
allosteric MEK 1/2 inhibitor,,2020-11-03,Treatment of neurofibromatosis type 1,Designated,Not FDA Approved for Orphan Indication,,,,AlloMek Therapeutics LLC,4 Research Drive,,Woodbridge,Connecticut,6525,United States,780120,,
Venetoclax,,2020-11-05,Treatment for small cell lung cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080-4990,United States,780920,,
"Immunotherapeutic vaccine consisting of pAc/emm55, a plasmid DNA (pDNA), which codes for a modified immunogenic, streptococcal Emm55 protein, complexed with in vivo-jetPEI polymer-based reagent linear polyethylenimine)",,2020-11-05,Treatment of stage IIB to stage IV melanoma,Designated,Not FDA Approved for Orphan Indication,,,,"Morphogenesis, Inc.","10500 University Center Dr., Ste. 110",,Tampa,Florida,33612,United States,780520,,
Recombinant humanized IgG1 monoclonal antibody directed against human soluble cytokine interferon beta.,,2020-11-05,Treatment of dermatomyositis,Designated,Not FDA Approved for Orphan Indication,,,,Pfizer Inc.,445 Eastern Point Road,,Groton,Connecticut,6340,United States,779620,,
epidermal stem cells genetically modified with a gamma-retroviral (rv) vector expressing the full-length LAMB3 cDNA,,2020-11-05,Treatment of Epidermolysis Bullosa,Designated,Not FDA Approved for Orphan Indication,,,,Holostem Terapie Avanzate S.r.l.,Via Glauco Gottardi 100,,Modena,,41125,Italy,780320,,
"2-(4-(4-((1-(107- (4-(fluorophenyl)methoxy)-polyethyleneglycol36))-1H-1,2,3-triazol-4-yl)methoxy)-3,5- diiodophenoxy)-3,5-diiodophenyl)acetic acid",,2020-11-05,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,NanoPharmaceuticals LLC,1 Discovery Drive,,Rensselaer,New York,12144,United States,780420,,
"peritoneal dialysis solution containing combination of D-xylitol, D-glucose, L-carnitine",,2020-11-09,Treatment of patients with end stage renal disease who are undergoing peritoneal dialysis,Designated,Not FDA Approved for Orphan Indication,,,,CoreQuest Sagl,"Stabile Suglio, Via Cantonale 18",,Manno,,CH-6928,Switzerland,780220,,
Mizoribine,,2020-11-09,Treatment of membranous nephropathy,Designated,Not FDA Approved for Orphan Indication,,,,RNR BioMedical Inc.,161 Jefferson Avenue,,Tenafly,New Jersey,7670,United States,780820,,
rituximab,,2020-11-12,Treatment of autoimmune hemolytic anemia,Designated,Not FDA Approved for Orphan Indication,,,,Taxon Therapeutics Ltd.,"122 Bar Kokhva St,",,Herzliya,,4600728,Israel,781520,,
afatanib and palbociclib,,2020-11-12,Treatment of chordoma,Designated,Not FDA Approved for Orphan Indication,,,,"Collaborations Pharmaceuticals, Inc",5616 Hilltop Needmore Rd,,Fuquay Varina,North Carolina,27526,United States,781420,,
mitapivat,,2020-11-12,Treatment of sickle cell disease,Designated,Not FDA Approved for Orphan Indication,,,,"Agios Pharmaceuticals, Inc.",88 Sidney Street,,Cambridge,Massachusetts,2139,United States,781120,,
5-aminolevulinic acid,,2020-11-12,Diagnostic for the visualization of tumor tissue in patients undergoing surgical resection for meningioma,Designated,Not FDA Approved for Orphan Indication,,,,NX Development Corp.,870 Corporate Drive,Suite 403,Lexington,Kentucky,40503,United States,710519,,
peptide conjugated phosphorodiamidate morpholino oligomer,,2020-11-12,treatment of Duchenne muscular dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,"Sarepta Therapeutics, Inc.",215 First Street,,Cambridge,Massachusetts,2142,United States,745120,,
"(R)-6-(2-hydroxy-3-(4-(4-(trifluoromethyl)phenyl)piperazin- 1-yl)propoxy)-3,4-dihydroquinolin-2(1H)-one",,2020-11-17,treatment of subarachnoid hemorrhage,Designated,Not FDA Approved for Orphan Indication,,,,NeurOp Inc.,58 Edgewood Ave,,Atlanta,Georgia,30303,United States,781020,,
Indolino-benzodiazepine compound (sulfonated DGN549-C) conjugated to the humanized anti-CD123 monoclonal antibody (G4723A),,2020-11-17,Treatment for Blastic Plasmacytoid Dendritic Cell Neoplasm,Designated,Not FDA Approved for Orphan Indication,,,,"ImmunoGen, Inc.",830 Winter Street,,Waltham,Massachusetts,2451,United States,781620,,
itraconazole,,2020-11-17,Treatment of coccidioidomycosis,Designated,Not FDA Approved for Orphan Indication,,,,Mayne Pharma International Pty Ltd. c/o Mayne Pharma Inc.,1240 Sugg Parkway,,Greenville,North Carolina,27834,United States,781320,,
trehalose,,2020-11-18,Treatment of amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,"Seelos Therapeutics, Inc.","300 Park Avenue, 12th Floor",,New York,New York,10022,United States,781920,,
Antibody-drug conjugate consisting of humanized anti-HLA-DR IgG4 monoclonal antibody specific for alpha-chain linked to SN-38 via a CL2A linker,,2020-11-18,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,"Immunomedics, Inc.",300 The American Rd,,Morris Plains,New Jersey,7950,United States,781720,,
IL13 E13K mutation linked to portion of pseudomonas exotoxin,,2020-11-18,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,Targepeutics,"1214 Research Boulevard, Suite 1011",,Hummelstown,Pennsylvania,17036,United States,781820,,
"Anti-Claudin 18.2 antibody drug conjugate comprised of a Claudin 18.2 targeting monoclonal IgG1 antibody, a linker LND1002, and monomethyl auristatin E",,2020-11-19,Treatment for gastric cancer including cancer of gastroesophageal junction,Designated,Not FDA Approved for Orphan Indication,,,,Conjupro Biotherapeutics Inc.,"302 Carnegie Center, Ste 100",,Princeton,New Jersey,8540,United States,782320,,
AAV9 gene therapy encoding the Dok7 protein,,2020-11-19,Treatment of congenital myasthenic syndrome,Designated,Not FDA Approved for Orphan Indication,,,,Amplo Biotechnology Inc.,"2637 E. Atlantic Ave., Ste 43644",,Pompano Beach,Florida,33062,United States,781220,,
"Single-stranded, non-replicating recombinant adeno-associated viral vector serotype 9 containing the human immunoglobulin ?-binding protein 2 cDNA",,2020-11-24,Treatment of spinal muscular atrophy with respiratory distress type 1 (SMARD1),Designated,Not FDA Approved for Orphan Indication,,,,"Alcyone Lifesciences, Inc.",116 John St.,Suite 300,Lowell,Massachusetts,1852,United States,783220,,
UBE3A antisense oligonucleotide with locked nucleic acids,,2020-11-24,Treatment of Angelman Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080-4990,United States,783120,,
Teclistamab,,2020-11-24,Treatment of Multiple Myeloma,Designated,Not FDA Approved for Orphan Indication,,,,"Janssen Research & Development, LLC",920 Route 202,,Raritan,New Jersey,8869,United States,782920,,
Trans-Cinnamic Acid,,2020-11-24,Treatment of GM2 gangliosidosis,Designated,Not FDA Approved for Orphan Indication,,,,"Polaryx Therapeutics, Inc.","140 E. Ridgewood Avenue, Suite 415, South Tower",,Paramus,New Jersey,7652,United States,782820,,
Trans-Cinnamic Acid,,2020-11-24,treatment for Niemann-Pick disease Type A and Type B,Designated,Not FDA Approved for Orphan Indication,,,,"Polaryx Therapeutics, Inc.",140 E. Ridgewood Avenue,"Suite 415, South Tower",Paramus,New Jersey,7652,United States,783920,,
Encaleret sulfate,,2020-11-24,Treatment for Autosomal Dominant Hypocalcemia Type 1 (ADH1),Designated,Not FDA Approved for Orphan Indication,,,,"Calcilytix Therapeutics, Inc.","1800 Owens Street, Suite C-1200",,San Francisco,California,94014,United States,782120,,
Humanized Recombinant Anti-Tumor Necrosis Factor ? Monoclonal Antibody,,2020-11-24,Treatment of sarcoidosis,Designated,Not FDA Approved for Orphan Indication,,,,"Xentria, Inc.","8700 W. Bryn Mawr, Suite 600S",,Chicago,Illinois,60631,United States,782020,,
Murine double minute-2 (MDM2) or Human double minute-2 (HDM2) inhibitor,,2020-11-24,Treatment of Retinoblastoma,Designated,Not FDA Approved for Orphan Indication,,,,Ascentage Pharma Group Inc.,"800 King Farm Blvd., Suite 300",,Rockville,Maryland,20850,United States,784720,,
Homodimeric fragment crystallizable fusion protein comprised of the extracellular domain of the human transforming growth factor beta receptor type II linked to a human IgG1 Fc domain,,2020-11-25,Treatment of systemic sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,Acceleron Pharma Inc.,128 Sidney Street,,Cambridge,Massachusetts,2139,United States,782620,,
Ravulizumab,,2020-11-25,Treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy,Designated,Not FDA Approved for Orphan Indication,,,,"Alexion Pharmaceuticals, Inc.",121 Seaport Boulevard,,Boston,Massachusetts,2210,United States,783320,,
"5-{[(5-amino-3,3-dihydroxyoxolan-2-yl)oxy][5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl}-N-(4-butylphenyl)-4,7-dimethyl-6-oxocyclohept-1-ene-1-carboxamide",,2020-12-01,Treatment of Tuberculosis,Designated,Not FDA Approved for Orphan Indication,,,,PAI Life Sciences Inc.,"1616 Eastlake Ave E, Suite 550",Attn: Darrick Carter,Seattle,Washington,98102,United States,783820,,
Human autologous CD4+ and CD8+ T cells engineered ex vivo to express a T cell receptor that recognizes amino acids 11-19 of the human papillomavirus (HPV)16 E7 protein when bound to human leukocyte antigen-A*02:01,,2020-12-01,Treatment of patients with human papillomavirus (HPV)+ cervical cancer who are human leukocyte antigen (HLA)-A*02+,Designated,Not FDA Approved for Orphan Indication,,,,"Kite Pharma, Inc.",2400 Broadway,,Santa Monica,California,90404,United States,784120,,
Anti-Claudin 18.2 Antibody consisting of a fully human monoclonal IgG1 antibody to the type 2 isoform of human Claudin 18 protein,,2020-12-01,Treatment of Pancreatic Cancer,Designated,Not FDA Approved for Orphan Indication,,,,Flame Biosciences,280 Union Square Drive,,New Hope,Pennsylvania,18938,United States,784020,,
Adeno-associated viral vector serotype 9 encoding human ATP7B,,2020-12-07,Treatment of Wilson's Disease,Designated,Not FDA Approved for Orphan Indication,,,,Ultragenyx Pharmaceutical Inc.,840 Memorial Drive,,Cambridge,Massachusetts,2139,United States,784920,,
Treprostinil,,2020-12-07,Treatment of Idiopathic Pulmonary Fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,United Therapeutics Corporation,55 T.W. Alexander Drive,PO Box 14186,Research Triangle Park,North Carolina,27709,United States,787620,,
"(2-chloro-4-phenoxyphenyl)(4-(((3R,6S)-6- (hydroxymethyl)tetrahydro-2H-pyran-3-yl)amino)-7H-pyrrolo[2,3-d]pyrimidin-5- yl)methanone",,2020-12-07,Treatment of chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL),Designated,Not FDA Approved for Orphan Indication,,,,"ArQule, Inc., a wholly owned subsidiary of Merck & Co. Inc.",One Wall Street,,Whitehouse Station,New Jersey,8889,United States,787120,,
Teduglutide,,2020-12-08,Prevention of acute graft versus host disease,Designated,Not FDA Approved for Orphan Indication,,,,9 Meters Biopharma Inc.,"8480 Honeycutt Road, Suite 120",,Raleigh,North Carolina,27615,United States,784820,,
"2,2-dimethylbutanoic acid",,2020-12-10,Treatment of methylmalonic acidemia,Designated,Not FDA Approved for Orphan Indication,,,,"HemoShear Therapeutics, LLC",501 Locust Avenue,,Charlottesville,Virginia,22902,United States,751020,,
Durvalumab,,2020-12-10,Treatment of Biliary Tract Cancer,Designated,Not FDA Approved for Orphan Indication,,,,AstraZeneca Pharmaceuticals LP,1800 Concord Pike,,Wilmington,Delaware,19803,United States,785220,,
"2,2-dimethylbutanoic acid",,2020-12-10,Treatment of propionic acidemia,Designated,Not FDA Approved for Orphan Indication,,,,"HemoShear Therapeutics, LLC",501 Locust Avenue,,Charlottesville,Virginia,22902,United States,746120,,
"Cultured human retinal pigment epithelial cells (ARPE-19) genetically modified with a non-viral vector to express human native alpha-L-iduronidase enzyme (hIDUA), encapsulated within two-layer modified alginate spheres",,2020-12-14,Treatment of Mucopolysaccharidosis I,Designated,Not FDA Approved for Orphan Indication,,,,"Sigilon Therapeutics, Inc.","100 Binney Street, STE 600",,Cambridge,Massachusetts,2142,United States,786420,,
Jaktinib,,2020-12-14,Treatment of myelofibrosis,Designated,Not FDA Approved for Orphan Indication,,,,"Suzhou Zelgen Biopharmaceuticals Co., Ltd.","No. 209, Chenfeng Road",Kunshan,Suzhou,Jiangsu Province,215300,China,786020,,
H-Ala-Val-Ala-Glu-Ile-Gln-Leu-Met-His-Gln-Arg-Ala-Lys-Trp-Ile-Gln-Asp-Ala-Arg-Arg-Arg-Ala-Phe-Leu-His-Lys-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-Glu-Ile-OH,,2020-12-14,Treatment of Hypoparathyroidism,Designated,Not FDA Approved for Orphan Indication,,,,Amolyt Pharma SAS (formerly Alize Pharma III SAS),"15, chemin du Saquin, Espace Europeen",Building G,Ecully,,619 130,France,786220,,
Rintatolimod,,2020-12-17,Treatment of Pancreatic Cancer,Designated,Not FDA Approved for Orphan Indication,,,,AIM ImmunoTech Inc.,2117 SW Highway 484,,Ocala,Florida,34473,United States,785520,,
Adeno-associated virus serotype 5 containing the human RDH12 gene,,2020-12-18,Treatment of RDH12 mutation associated retinal dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,MeiraGTx UK II Limited,92 Britannia Walk,,London,,N1 7NQ,United Kingdom,786120,,
Highly branched poly(beta-amino ester) complexed with a nanoplasmid containing the human COL7A1 gene,,2020-12-21,Treatment of dystrophic epidermolysis bullosa,Designated,Not FDA Approved for Orphan Indication,,,,Amryt Genetics Limited,90 Harcourt Street,,Dublin,,"2, D02 CR98",Ireland,787820,,
Imatinib,,2020-12-21,Treatment of Pulmonary Arterial Hypertension,Designated,Not FDA Approved for Orphan Indication,,,,"Aerovate Therapeutics, Inc","200 Berkeley Street, Floor 18",,Boston,Massachusetts,2116,United States,787520,,
Fasudil,,2020-12-21,Treatment of progressive supranuclear palsy,Designated,Not FDA Approved for Orphan Indication,,,,"Woolsey Pharmaceuticals, Inc.","233 Broadway, Suite 1750",,New York,New York,10279,United States,787220,,
FC-fusion bispecific antibody targeting extracellular domains II and IV of HER 2 and FC-fusion bispecific IgG1 antibody inhibiting PD-L1 and CTLA-4,,2020-12-21,"Treatment of Gastric Cancer, including Cancer of the Gastroesophageal Junction",Designated,Not FDA Approved for Orphan Indication,,,,"Jiangsu Alphamab Biopharmaceuticals Co., Ltd.","Bldg. C23, 218 Xinghu Street",SIP,SuZhou,,,China,786920,,
Nilotinib ONCORE,,2020-12-23,Treatment of Chronic Myeloid Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,"Handa Oncology, LLC","1732 N. First Street, Suite 200",,San Jose,California,95112,United States,786820,,
"4-{4-{[6-(4-Chlorophenyl)spiro[3.5]non-6-en-7-yl]methyl}-piperazin-1-yl}-N-{{3-nitro-4-[((2S)-1,4-dioxan-2-ylmethyl)amino]phenyl}sulfonyl}-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide",,2020-12-28,Treatment of Acute Myeloid Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,Ascentage Pharma Group Inc.,"800 King Farm Blvd., Suite 300",,Rockville,Maryland,20850,United States,787920,,
nilotinib oral capsules,,2020-12-28,Treatment of chronic myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,Xspray Pharma AB,R峵ndav䧥n 12,,Solna,,16967,Sweden,788520,,
liposomal annamycin,,2020-12-28,Treatment of soft tissue sarcomas,Designated,Not FDA Approved for Orphan Indication,,,,"Moleculin Biotech, Inc.","5300 Memorial Drive, Suite 950",,Houston,Texas,77007,United States,787720,,
Glucagon like peptide-1 Elastin like peptide-120 fusion protein,,2020-12-30,Treatment of Duchenne Muscular Dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,"ImmunoForge Co., Ltd.","307-1, 105 Bldg., Seoul National University","1 Gwanak-ro, Gwanak-gu",Seoul,,,South Korea,789220,,
N-Benzothiazol-2-yl-4-(2-hydroxy-3-methoxy-benzylamino)-bezenesulfonamide,,2020-12-30,Prophylaxis of thrombosis in patients with heparin-induced thrombocytopenia,Designated,Not FDA Approved for Orphan Indication,,,,Veralox Therapeutics,4539 Metropolitan Ct.,,Frederick,Maryland,21704,United States,736720,,
Ilixadencel,,2020-12-30,Treatment of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,Immunicum AB,ֳtermalmstorg 5,,Stockholm,,SE-114 42,Sweden,788320,,
Adeno Associate Virus carried Multi Characteristic Opsin,,2020-12-30,Treatment of Stargardt Disease,Designated,Not FDA Approved for Orphan Indication,,,,Nanoscope Therapeutics Inc.,"1312 Brown Trail, Ste A,",,Bedford,Texas,76022,United States,769620,,
Orelabrutinib,,2020-12-30,Treatment of Mantle Cell Lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,InnoCare Pharma Inc.,"103 Carnegie Center, Suite 209",,Princeton,New Jersey,8540,United States,788920,,
baclofen,,2020-12-31,Prevention of baclofen withdrawal syndrome,Designated,Not FDA Approved for Orphan Indication,,,,Saol Therapeutics Research Limited,"Peter Street, Unit G04",Adelaide Chambers,Dublin,,8,Ireland,685619,,
Adeno-associated virus serotype 9 (AAV9) vector with engineered transgene encoding the human SLC13A5 protein.,,2021-01-04,Treatment of SLC13A5 Deficiency,Designated,Not FDA Approved for Orphan Indication,,,,Taysha Gene Therapies,BioCenter at UT Southwestern,2280 Inwood Road,Dallas,Texas,75235,United States,789020,,
18F-PI-2620,,2021-01-05,Diagnostic for the clinical management of progressive supranuclear palsy.,Designated,Not FDA Approved for Orphan Indication,,,,Life Molecular Imaging Ltd.,"Iceni Centre, Warwick Technology Park",,Warwick,,CV34 6DA,United Kingdom,755520,,
SCN2A mRNA knockdown antisense oligonucleotide,,2021-01-05,Treatment of SCN2A Developmental and Epileptic Encephalopathy,Designated,Not FDA Approved for Orphan Indication,,,,"Praxis Precision Medicines, Inc.","One Broadway, 16th Floor",,Cambridge,Massachusetts,2142,United States,789720,,
cardiac sarcomere inhibitor,,2021-01-05,Treatment of symptomatic hypertrophic cardiomyopathy,Designated,Not FDA Approved for Orphan Indication,,,,Cytokinetics Inc.,280 East Grand Avenue,,South San Francisco,California,94080,United States,688819,,
Cu-64 anti CD99,,2021-01-05,Diagnostic for the clinical management of Ewing Sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,"Advanced Imaging Projects, LLC",9429 Harding Ave,,Surfside,Florida,33154,United States,790520,,
Non-replicating recombinant adeno-associated virus serotype 1 vector delivering human GRN gene encoding the protein progranulin,,2021-01-07,Treatment of frontotemporal dementia,Designated,Not FDA Approved for Orphan Indication,,,,"Passage Bio, Inc.",Commerce Square Two,2001 Market Street,Philadelphia,Pennsylvania,19103,United States,793020,,
"(R)-2-((1-(2-(4-methoxy-3-(2-morpholinoethoxy) phenyl)-5-methylthiazol-4-yl)ethyl)thio)pyrimidine-4,6-diamine",,2021-01-07,Treatment of acute disseminated encephalomyelitis,Designated,Not FDA Approved for Orphan Indication,,,,Trethera Corporation,"13547 Ventura Boulevard, Suite 363",,Sherman Oaks,California,91423,United States,792220,,
tafasitamab-cxix,,2021-01-07,Treatment of follicular lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,MorphoSys US Inc.,"470 Atlantic Avenue 14th Floor, Suite 1401",,Boston,Massachusetts,2210,United States,790920,,
Atezolizumab,,2021-01-07,Treatment of esophageal cancer,Designated,Not FDA Approved for Orphan Indication,,,,Genentech Inc.,"1 DNA Way, MS #45-1A",,South San Francisco,California,94080-4990,United States,792320,,
Tiragolumab,,2021-01-07,Treatment of Esophageal Cancer,Designated,Not FDA Approved for Orphan Indication,,,,Genentech Inc.,"1 DNA Way, MS #45-1A",,South San Francisco,California,94080-4990,United States,792420,,
Fasudil hydrochloride,,2021-01-07,Treatment of Corticobasal Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,"Woolsey Pharmaceuticals, Inc.",233 Broadway,Suite 1750,New York,New York,10279,United States,792720,,
pyrindinyl benzaldehyde,,2021-01-07,Treatment of sickle cell disease,Designated,Not FDA Approved for Orphan Indication,,,,"Illexcor Therapeutics, LLC","800 East Leigh Street, Suite 19",,Richmond,Virginia,23219,United States,791020,,
zinflavonoids,,2021-01-07,Treatment of anatomical sites of squamous cell carcinoma of oral cavity and oropharynx accessible for local and topical administration,Designated,Not FDA Approved for Orphan Indication,,,,"Aveta Biomics, Inc.",110 Great Road,Suite 302,Bedford,Massachusetts,1730,United States,740720,,
"genetically recombinant, non-pathogenic polio:rhinovirus chimera with a tumor--specific conditional replication phenotype",,2021-01-08,Treatment of stage IIB-IV melanoma,Designated,Not FDA Approved for Orphan Indication,,,,"Istari Oncology, Inc.","430 Davis Drive, Suite 560",,Morrisville,North Carolina,27560,United States,793620,,
Ivaltinostat,,2021-01-08,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,"CrystalGenomics, Inc.","5th F. Bldg.A, Korea Bio Park","700 Daewangpangyoro, Bundanggu, Seongnamsi",Gyeonggido,Korea,13488,South Korea,793520,,
"Trispecific T cell activating construct targeting BCMA, HSA, and CD3",,2021-01-08,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,"Harpoon Therapeutics, Inc.","131 Oyster Point Boulevard, Suite 300",,South San Francisco,California,94080,United States,793820,,
sparsentan,,2021-01-11,Treatment of immunoglobulin A (IgA) nephropathy,Designated,Not FDA Approved for Orphan Indication,,,,"Travere Therapeutics, Inc.","3611 Valley Centre Drive, Suite 300",,San Diego,California,92130,United States,614417,,
Sitaxentan (also known as sitaxsentan),,2021-01-11,Treatment of Systemic Sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,"Timber Pharmaceuticals, Inc.","50 Tice Boulevard, Suite A26",,Woodcliff Lake,New Jersey,7677,United States,793420,,
chimeric IgG4 monoclonal antibody targeting CD14,,2021-01-11,Treatment of amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,Implicit Bioscience Ltd.,32 Logan Rd,Woolloongabba,,Queensland,,Australia,650418,,
alitretinoin,,2021-01-12,Treatment of systemic (non-cutaneous) kaposi sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,"Galephar Pharmaceutical Research, Inc.",Carr 925 Km 6.1 Bo. Junquito,HC-04 BOX 4540,Humacao,Puerto Rico,791,United States,708819,,
Telacebec,,2021-01-13,Treatment of Buruli ulcer,Designated,Not FDA Approved for Orphan Indication,,,,"Qurient Co., Ltd.","C-dong 8th Floor 242, Pangyo-ro, Bundang-gu, Seongnam-si",,Gyeonggi-do,Korea,463-400,South Korea,793920,,
humanized HER2 targeting monoclonal antibody conjugated to a cytotoxic tubulin inhibitor amberstatin,,2021-01-14,Treatment of gastric cancer including cancer at the gastroesophageal junction,Designated,Not FDA Approved for Orphan Indication,,,,"Ambrx, Inc.",10975 N. Torrey Pines Road,,La Jolla,California,92037,United States,794820,,
Cepharanthine,,2021-01-14,Treatment of Esophageal Cancer,Designated,Not FDA Approved for Orphan Indication,,,,Sairiyo Therapeutics Inc.,"77 King Street West, Suite 2905",,Toronto,Ontario,M5K 1H1,Canada,794320,,
"N-((2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-(4-nitrophenoxy)tetrahydro-2H-pyran-3-yl)acetamide",,2021-01-18,Prevention of bronchopulmonary dysplasia.,Designated,Not FDA Approved for Orphan Indication,,,,"AyuVis Research, Inc.","1120 South Fwy, #121",,Fort Worth,Texas,76104,United States,723619,,
uttroside B,,2021-01-19,Treatment of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,Q BioMed,366 Madison Ave,,New York,New York,10017,United States,795820,,
"4-{4-{[6-(4-Chlorophenyl)spiro[3.5]non-6-en-7-yl]methyl}-piperazin-1-yl}-N-{{3-nitro-4-[((2S)-1,4-dioxan-2-ylmethyl)amino]phenyl}sulfonyl}-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide",,2021-01-19,Treatment of follicular lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,Ascentage Pharma Group Inc.,"800 King Farm Blvd., Suite 300",,Rockville,Maryland,20850,United States,796420,,
L-pyroglutamyl-L-asparaginyl-L-prolyl-D-tyrosyl-D-tryptophan amide,,2021-01-19,Treatment of amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,Neuropath Therapeutics Limited,26 Upper Pembroke Street,Suite 2006,Dublin,,2,Ireland,796220,,
miglustat,,2021-01-19,Treatment of CLN Batten Disease,Designated,Not FDA Approved for Orphan Indication,,,,Beyond Batten Disease Foundation,P.O. Box 50221,,Austin,Texas,78763,United States,795420,,
human T-lymphoid progenitors derived from CD34+ hematopoietic stem and progenitor cells,,2021-01-19,Treatment to enhance cell engraftment in patients receiving hematopoietic stem cell transplant,Designated,Not FDA Approved for Orphan Indication,,,,Smart Immune,67 rue de Seine,,Paris,,75006,France,774820,,
carfilzomib,,2021-01-21,Treatment of Acute Lymphoblastic Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,Amgen Inc.,One Amgen Center Drive,Mail Stop 27-2-D,Thousand Oaks,California,91320-1799,United States,795120,,
Adeno-associated virus isoform 9 gene vector construct expressing the human Frataxin gene,,2021-01-21,Treatment of Friedreich`s Ataxia.,Designated,Not FDA Approved for Orphan Indication,,,,Novartis Gene Therapies,"2275 Half Day Road, Suite 300",,Bannockburn,Illinois,60015,United States,794920,,
"(P)-3-chloro-4-((3,5-difluoropyridin-2-yl)methoxy)-2'-(2-(2-hydroxypropan-2-yl)pyrimidin-4yl)-5',6-dimethyl-2H-[1,4'-bipyridin]-2-one",,2021-01-21,Treatment of cryopyrin-associated periodic syndrome,Designated,Not FDA Approved for Orphan Indication,,,,Aclaris Theapeutics Inc.,"640 Lee Road, Suite 200",,Wayne,Pennsylvania,19087,United States,795720,,
suramin,,2021-01-25,Treatment of human African trypanosomiasis,Designated,Not FDA Approved for Orphan Indication,,,,"PaxMedica, Inc.","50 Tice Blvd., Suite A26",,Woodcliff Lake,New Jersey,7677,United States,797220,,
ferroportin inhibitor,,2021-01-25,Treatment of sickle cell disease,Designated,Not FDA Approved for Orphan Indication,,,,"Vifor Pharma, Inc.",200 Cardinal Way,,Redwood City,California,94063,United States,796320,,
romiplostim,,2021-01-25,Treatment of chemotherapy-induced thrombocytopenia,Designated,Not FDA Approved for Orphan Indication,,,,Amgen Inc.,One Amgen Center Drive,Mail Stop 27-2-D,Thousand Oaks,California,91320,United States,751320,,
ilixadencel,,2021-01-25,Treatment of soft tissue sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,Immunicum AB,ֳtermalmstorg 5,,Stockholm,,114 42,Sweden,796120,,
saroglitazar magnesium,,2021-01-26,Treatment of Primary Biliary Cholangitis,Designated,Not FDA Approved for Orphan Indication,,,,Zydus Discovery DMCC,"Unit no 909, Armada 2","Plot no : JLT-PH2-P2A,",Dubai,,,United Arab Emirates,686819,,
dexamethasone,,2021-01-26,Prevention of Proliferative Vitreoretinopathy (PVR),Designated,Not FDA Approved for Orphan Indication,,,,"TherOptix, Inc.","689 Main Street, #305",,Walpole,Massachusetts,2081,United States,795620,,
Talabostat,,2021-01-26,Treatment of soft tissue sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,BioXcel Therapeutics,"555 Long Wharf Drive, 5th Floor",,New Haven,Connecticut,6511,United States,796720,,
Sivelestat,,2021-01-27,Treatment of Acute Radiation Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,RNR BioMedical,c/o Noa Avtalion,161 Jefferson Avenue,Tenafly,New Jersey,07670-1627,United States,796020,,
"(2R,3R,4S)-2-(2-chloro-6-(3-chlorobenzylamino)-9H-purin-9-yl)tetrahydrothiophene-3,4-diol",,2021-02-01,Treatment of Primary Biliary Cholangitis,Designated,Not FDA Approved for Orphan Indication,,,,"Future Medicine Co., Ltd.","Rm616, LH Business Growth Center, 54 Changeop-ro, Sujeong-gu",,Seongnam,Gyeonggi-do,,South Korea,796620,,
N-(N-(4-(trifluoromethoxy)phenyl) carbamimidoyl)pyrrolidine-1-carboximidamide acetate (Or N1-(4-trifluoromethoxy)phenyl-N5-pyrrolidine biguanide acetate),,2021-02-01,Treatment of Idiopathic Pulmonary Fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,ImmunoMet Therapeutics Inc.,2450 Holcombe,,Houston,Texas,77021,United States,796920,,
Miglustat,,2021-02-02,Treatment of Niemann-Pick Disease Type C,Designated,Not FDA Approved for Orphan Indication,,,,Edenbridge Pharmaceuticals LLC,"169 Lackawanna Ave, Suite 110",,Parsippany,New Jersey,7054,United States,798620,,
denosumab,,2021-02-02,Treatment of osteogenesis imperfecta,Designated,Not FDA Approved for Orphan Indication,,,,Amgen Inc.,One Amgen Center Drive,Mail Stop: 27-2-D,Thousand Oaks,California,91320-1799,United States,798920,,
Rivoceranib,,2021-02-02,Treatment of Adenoid Cystic Carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,"Elevar Therapeutics, Inc.","2825 E Cottonwood Pkwy, Suite 180",,Salt Lake City,Utah,84121,United States,798720,,
Chimeric Antigen Receptor immunotherapy directed against CLL-1 and CD33,,2021-02-02,Treatment of Acute Myeloid Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,"iCell Gene Therapeutics, LLC","25 Health Sciences Dr., Suite 118",,Stony Brook,New York,11790,United States,798220,,
cevostamab,,2021-02-03,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,United States,799220,,
Trans-Cinnamic Acid,,2021-02-03,Treatment of Krabbe disease,Designated,Not FDA Approved for Orphan Indication,,,,"Polaryx Therapeutics, Inc.","140 E. Ridgewood Avenue, Suite 415, South Tower",,Paramus,New Jersey,7652,United States,802320,,
Recombinant human ectonucleotide pyrophosphatase/phosphodiesterase 1 fused to the Fc fragment of IgG1,,2021-02-04,Treatment of adenosine triphosphate binding cassette subfamily C member 6 deficiency (ABCC6 deficiency),Designated,Not FDA Approved for Orphan Indication,,,,"Inozyme Pharma, Inc.","321 Summer Street, Suite 400",,Boston,Massachusetts,2210,United States,660118,,
A chimeric antigen receptor (CAR) immunotherapy directed against the target protein CD7,,2021-02-08,Treatment of acute lymphoblastic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,"iCell Gene Therapeutics, LLC","25 Health Sciences Dr., Suite 118",,Stony Brook,New York,11790,United States,800320,,
"hexasodium salt of myo-inositol hexaphosphate (IP6, phytate) hexasodium phytate",,2021-02-08,Treatment of peripheral arterial disease in patients with end-stage kidney disease,Designated,Not FDA Approved for Orphan Indication,,,,Sanifit Therapeutics S.A.,"3655 Nobel Drive, Ste 540",,San Diego,California,92122,United States,799020,,
Mesenchymal Stem Cell-derived Extracellular Vesicles,,2021-02-08,Prevention of Bronchopulmonary Dysplasia in neonates,Designated,Not FDA Approved for Orphan Indication,,,,United Therapeutics Corporation,55 T.W. Alexander Drive,P.O. Box 14186,Research Triangle Park,North Carolina,27709,United States,713919,,
"(1R,3S,5R)-2-(2-(3-acetyl-5-(2-methylpyrimidin-5-yl)-1H-indazol-1-yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)-5-methyl-2-azabicyclo[3.1.0]hexane-3-carboxamide",,2021-02-08,Treatment of paroxysmal nocturnal hemoglobinuria,Designated,Not FDA Approved for Orphan Indication,,,,Alexion Pharmaceuticals Inc.,121 Seaport Blvd,,Boston,Massachusetts,2210,United States,722519,,
Recombinant fusion protein of human ?-L-iduronidase (IDUA) and Fab fragment of a humanized monoclonal antibody targeting human transferrin receptor (hTfR),,2021-02-08,Treatment of Mucopolysaccharidosis Type I,Designated,Not FDA Approved for Orphan Indication,,,,"JCR Pharmaceuticals Co., Ltd.","3-19 Kasuga-cho Ashiya,",,Hyogo,,659-0021,Japan,798120,,
iadademstat,,2021-02-10,Treatment of Acute Myeloid Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,Oryzon Genomics S.A.,"Carrera de San Jeronimo 15, 2 planta",,Madrid,Spain,28014,Spain,800020,,
adeno-associated virus serotype rhesus 10 vector expressing the human galactocerebrosidase (GALC) gene,,2021-02-10,Treatment of Krabbe disease,Designated,Not FDA Approved for Orphan Indication,,,,"Forge Biologics, Inc.",3900 Gantz Road,,Grove City,Ohio,42123,United States,803220,,
nipocalimab,,2021-02-11,Treatment of myasthenia gravis,Designated,Not FDA Approved for Orphan Indication,,,,"Momenta Pharmaceuticals, Inc.",301 Binney Street,,Cambridge,Massachusetts,2142,United States,799320,,
adeno-associated virus serotype 9 gene transfer vector expressing human AP4B1 cDNA,,2021-02-16,Treatment of hereditary spastic paraplegia 47,Designated,Not FDA Approved for Orphan Indication,,,,Cure AP-4,"24R Pleasant St, Unit 2",,Newburyport,Massachusetts,1950,United States,802120,,
allogeneic CRISPR/Cas9-mediated genetically modified CAR T cells targeting CD19 antigen,,2021-02-16,Treatment of acute lymphoblastic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,"CRISPR Therapeutics, Inc.",610 Main Street,,Cambridge,Massachusetts,2139,United States,799420,,
"3-Acetyl-1-cyclopentyl-7-{[(3S,4R)-3-hydroxyoxan-4-yl]amino }-4-methyl-1,6-naphthyridin-2(1H)-one",,2021-02-18,Treatment of pulmonary arterial hypertension,Designated,Not FDA Approved for Orphan Indication,,,,"Pfizer, Inc.",235 East 42nd Street,,New York,New York,10017,United States,800720,,
recombinant bispecific humanized anti-programmed cell death 1 (PD-1) and anti-cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) monoclonal antibody,,2021-02-18,Treatment of Stage IA2-IV cervical cancer,Designated,Not FDA Approved for Orphan Indication,,,,"Akeso Biopharma, Inc.","6 Shennong Road, Torch Development Zone",,Zhongshan,Guangdong,,China,729219,,
Carmustine,,2021-02-18,Conditioning treatment prior to hematopoietic cell transplantation,Designated,Not FDA Approved for Orphan Indication,,,,Emcure Pharmaceuticals Ltd.,"T-184, M.I.D.C. Bhosari",,Pune,Maharashtra,411026,India,801420,,
Chemically induced photoreceptor-like cells,,2021-02-18,Treatment of retinitis pigmentosa,Designated,Not FDA Approved for Orphan Indication,,,,"CiRC Biosciences, Inc.","330 N Wabash Avenue, Suite 3500",,Chicago,Illinois,60611,United States,801020,,
"1-[(3aS,4R,9bR)-4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-8-yl] ethanone",,2021-02-19,Treatment of uveal melanoma,Designated,Not FDA Approved for Orphan Indication,,,,"Linnaeus Therapeutics, Inc.",30 Washington Avenue,Suite F,Haddonfield,New Jersey,8033,United States,801620,,
Trodusquemine HCl,,2021-02-19,Treatment of Dystrophinopathies,Designated,Not FDA Approved for Orphan Indication,,,,Novo Biosciences,415 Water Street,,Ellsworth,Maine,4605,United States,800120,,
Stiripentol,,2021-02-22,Treatment of Primary Hyperoxaluria,Designated,Not FDA Approved for Orphan Indication,,,,Biocodex,7 avenue Gallieni,,Gentilly,Gentilly,94250,France,800820,,
Fc-fusion protein comprised of an anti-CXCR4 i-body tethered at its C-terminus to constant domains 2 and 3 of the Fc region of a mutated human IgG1,,2021-02-22,Treatment of idiopathic pulmonary fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,AdAlta Limited,15/2 Park Drive,,Bundoora,Victoria,3083,Australia,800420,,
Penpulimab,,2021-02-23,Treatment of nasopharyngeal carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,"Akeso Biopharma, Inc.","6 Shennong Road, Torch Development Zone",,Zhongshan,Guangdong,528437,China,802020,,
"Sodium-3-((2,6-dichloro-7-fluoro-1-(1-propyl-1H-pyrazol-4-yl)-1H-indol-3-yl)thio)-2-fluorobenzoate",,2021-02-23,Treatment of Idiopathic Pulmonary Fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,"Blade Therapeutics, Inc.",442 Littlefield Avenue,,South San Francisco,California,94080,United States,801820,,
satralizumab-mwge,,2021-02-23,Treatment of myasthenia gravis,Designated,Not FDA Approved for Orphan Indication,,,,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080-4990,United States,802720,,
antibody drug conjugate comprised of an anti-B cell maturation (BCMA) IgG1 humanized antibody conjugated covalently to the dibenzocyclooctyne (DBCO) noncleavable linker maytansinoid warhead,,2021-02-23,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,United States,802520,,
Gadolinium-chelated polysiloxane based nanoparticles,,2021-02-25,Radiosensitizer to be used during radiation treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,Nh TherAguix,"29, chemin du Vieux Chꮥ",,Meylan,,38240,France,803120,,
cavrotolimod,,2021-03-01,Treatment of merkel cell carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,"Exicure, Inc.","2430 N. Halsted Street, 4th Floor",,Chicago,Illinois,60614,United States,677419,,
humanized IgG1anti-AXL-antibody conjugated to monomethyl auristatin E,,2021-03-01,Treatment of Soft Tissue Sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,"BioAtla, Inc.",11085 Torreyana Road,Suite 100,San Diego,California,92121,United States,802920,,
Allogeneic enriched variable delta 1 gamma delta T-cell therapy,,2021-03-01,Treatment of Acute Myeloid Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,GammaDelta Therapeutics Limited,West Works. 195 Wood Lane White City Place,,London,,W12 7FQ,United Kingdom,803620,,
Fomepizole,,2021-03-02,Treatment of acetaminophen overdose,Designated,Not FDA Approved for Orphan Indication,,,,Denver Health - Rocky Mountain Poison & Drug Safety,777 Bannock St. MC 0180,,Denver,Colorado,80204,United States,801320,,
"6-(4-((5-oxo-1,2,3,4,5,6-hexahydrobenzo[h][1,6]naphthyridin-8-yl)methyl)piperazin-1-yl)nicotinonitrile mono citrate",,2021-03-02,Treatment of Pancreatic Cancer,Designated,Not FDA Approved for Orphan Indication,,,,Onconic Therapeutics,"1F, 12 Tehranro-26-gil",,Gangnam,Seoul,6236,South Korea,802220,,
Tesofensine plus metoprolol in a fixed-dose combination,,2021-03-02,Treatment of Prader-Willi Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,Saniona S/A,Smedeland 26B,,Glostrup,,DK-2600,Denmark,804320,,
"Cultured human retinal pigment epithelial cells (ARPE-19) genetically modified with a non-viral vector to express Human ?-galactosidase A (h?-Gal A), encapsulated within two-layer modified alginate spheres",,2021-03-02,Treatment of Alpha-galactosidase A deficiency (Fabrys Disease),Designated,Not FDA Approved for Orphan Indication,,,,"Sigilon Therapeutics, Inc.","100 Binney Street, STE 600",,Cambridge,Massachusetts,2142,United States,805720,,
padeliporfin,,2021-03-02,Treatment of upper tract urothelial cancer,Designated,Not FDA Approved for Orphan Indication,,,,Steba Biotech S.A,7 Place du Th颴re,,,Luxembourg,L-2613,Luxembourg,803320,,
CDK inhibitor (CDKI) of CDK2/4/6,,2021-03-03,"Treatment of patients with malignant gliomas (including glioblastoma, astrocytoma, and oligodendroglioma)",Designated,Not FDA Approved for Orphan Indication,,,,"Nuvation Bio, Inc.","1500 Broadway, Suite 1401",,New York,New York,10036,United States,805820,,
GCSF-mobilized autologous CD34+ cells,,2021-03-04,Treatment of Buerger's disease (thromboangiitis obliterans),Designated,Not FDA Approved for Orphan Indication,,,,"Caladrius Biosciences, Inc.",110 Allen Road,Second Floor,Basking Ridge,New Jersey,7920,United States,805020,,
sepiapterin,,2021-03-04,Treatment of hyperphenylalaninemia,Designated,Not FDA Approved for Orphan Indication,,,,"PTC Therapeutics, Inc.",100 Corporate Court,,South Plainfield,New Jersey,7080,United States,805320,,
Ubenimex,,2021-03-08,Treatment of Chronic Myeloid Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,RNR BioMedical inc,161 Jefferson Ave.,,tenafly,New Jersey,7670,United States,806720,,
fusion protein comprised of a circularly-permuted interleukin-2 (IL-2) with the extracellular domain of IL-2 receptor alpha,,2021-03-09,Treatment of mucosal melanoma,Designated,Not FDA Approved for Orphan Indication,,,,"Alkermes, Inc.",852 Winter Street,,Waltham,Massachusetts,02451-1420,United States,806020,,
Dodecyl Creatine Ester,,2021-03-09,Treatment of Creatine Transporter Deficiency,Designated,Not FDA Approved for Orphan Indication,,,,CERES BRAIN Therapeutics,Paris Biotech Sant鍊,"24, rue du Faubourg Saint Jacques",Paris,,75014,France,803720,,
monosialotetrahexosylganglioside,,2021-03-09,Treatment of Amyotrophic Lateral Sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,Innomedica Schweiz AG,Gesellschaftsstrasse 16,,Bern,,CH- 3012,Switzerland,805620,,
vedolizumab,,2021-03-15,Treatment of Pouchitis,Designated,Not FDA Approved for Orphan Indication,,,,"Takeda Development Center Americas, Inc.",95 Hayden Avenue,,Lexington,Massachusetts,2421,United States,804920,,
(+)-5-chloro-1-ethyl-3-(2-hydroxy-3-methoxybenzyl)-2-oxoindolin-3-yl dimethylcarbamate,,2021-03-16,Treatment of Retinitis Pigmentosa,Designated,Not FDA Approved for Orphan Indication,,,,"MitoChem Therapeutics, Inc.",645 Meeting Street,,Charleston,South Carolina,29403,United States,806520,,
Adenoviral Vector Expressing HPV 6 and HPV 11 Antigens,,2021-03-17,Treatment of Recurrent Respiratory Papillomatosis,Designated,Not FDA Approved for Orphan Indication,,,,Precigen,20358 Seneca Meadows Pkwy,,Germantown,Maryland,20876,United States,805520,,
"Retinyl Palmitate, Alisitol (herbal extract), Zn Gluconate",,2021-03-18,Treatment of Microvillus Inclusion Disease.,Designated,Not FDA Approved for Orphan Indication,,,,"Dmitry V. Kravtsov, M.D.","925 Sherman Avenue, Hamden, CT 06514, USA",,Hamden,Connecticut,6514,United States,805420,,
Cannabidiol,,2021-03-22,Treatment of Angelman syndrome,Designated,Not FDA Approved for Orphan Indication,,,,Biom Therapeutics,2203 Industrial Blvd.,,Sarasota,Florida,34239,United States,806620,,
canakinumab,,2021-03-24,Treatment of Pancreatic Cancer,Designated,Not FDA Approved for Orphan Indication,,,,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,07936-1080,United States,805920,,
spartalizumab,,2021-03-24,Treatment of Pancreatic Cancer,Designated,Not FDA Approved for Orphan Indication,,,,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,07936-1080,United States,819321,,
cereblon enzyme 3 (E3) ligase modulating agent,,2021-03-25,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,United States,808421,,
axatilimab,,2021-03-29,Treatment of chronic graft versus host disease.,Designated,Not FDA Approved for Orphan Indication,,,,"Syndax Pharmaceuticals, Inc.",35 Gatehouse Drive,,Waltham,Massachusetts,2451,United States,732320,,
?-CD39 IgG4 monoclonal antibody,,2021-03-29,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,"Surface Oncology, Inc.",50 Hampshire Street,8th Floor,Cambridge,Massachusetts,2139,United States,808821,,
5-Aminolevulinic Acid,,2021-03-29,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,Hemerion Therapeutics,12 rue Denis Papin,NEO 2 - Building A,Villeneuve dAscq,,59650,France,811521,,
lithium carbonate,,2021-03-29,Treatment of idiopathic pulmonary fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,Lispiro LLC,4 Betsy Lane,,Dover,Massachusetts,2030,United States,808921,,
"(5-(3-(2-amino-4-oxo-4,7-dihydro-3 H-pyrrolo[2,3- d]pyrimidin-6-yl)propyl)thiophene-2-carbonyl)- L-glutamic acid)",,2021-03-30,Treatment of Mesothelioma,Designated,Not FDA Approved for Orphan Indication,,,,"FLAG Therapeutics, Inc.",9168 Wooden Road,,Raleigh,North Carolina,27617-8203,United States,806920,,
Synthetic DNA aptamer-nucleoside drug conjugate targeting nucleolin-expression cancer cells,,2021-03-31,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,"Samjin Pharmaceutical Co., Ltd.","121 Wausan-ro, Mapo-gu",,Seoul,Republic of Korea,4054,South Korea,809821,,
bempedoic acid,,2021-04-05,Treatment of homozygous familial hypercholesterolemia,Designated,Not FDA Approved for Orphan Indication,,,,"Esperion Therapeutics, Inc.","3891 Ranchero Drive, Suite 150",,Ann Arbor,Michigan,48108,United States,812621,,
"(R)-N-(5-(3-hydroxypyrrolidin-1-yl)-2-morpholinooxazolo[4,5-b]pyridin-6-yl)-2-(2-methylpyridin-4-yl)oxazole-4-carboxamide",,2021-04-05,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,"Curis, Inc.","128 Spring Street, Building C, Suite 500",,Lexington,Massachusetts,2421,United States,810321,,
fully human monoclonal IgG1 antibody against the type 2 isoform of human Claudin 18 protein (Claudin 18.2).,,2021-04-06,"Treatment of gastric cancer, including cancer of gastroesophageal junction",Designated,Not FDA Approved for Orphan Indication,,,,"NovaRock Biotherapeutics, Ltd.",801 Charles Ewing Blvd.,,Ewing,New Jersey,8628,United States,810021,,
taniraleucel,,2021-04-06,Treatment of Malignant Glioma,Designated,Not FDA Approved for Orphan Indication,,,,Celularity Inc.,170 Park Avenue,,Florham Park,New Jersey,7932,United States,809021,,
autologous CD34+ hematopoietic stem and progenitor cells modified ex-vivo with a lentiviral vector that restores expression of Gp91phox,,2021-04-07,Treatment of Chronic Granulomatous Disease,Designated,Not FDA Approved for Orphan Indication,,,,ImmunoVec,570 Westwood Plaza Building 114,,Los Angeles,California,90095,United States,810721,,
axatilimab,,2021-04-07,Treatment of Idiopathic Pulmonary Fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,"Syndax Pharmaceuticals, Inc.",35 Gatehouse Drive,"Building D, Floor 3",Waltham,Massachusetts,2451,United States,807821,,
eprenetapopt,,2021-04-07,Treatment of Acute Myeloid Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,"Aprea Therapeutics, Inc.",535 Boylston Street,2nd Floor,Boston,Massachusetts,2116,United States,797420,,
a peptidomimetic protein peptide with sequence H-Gly-Arg-Arg-Ala-Ala-Pro-Gly-Arg-Aib-Gly-Gly-NH2,,2021-04-08,Treatment of Lennox- Gastaut Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,CuroNZ Ltd,173 Cames Road,,Mangawhai,,975,New Zealand,810621,,
N-[1-(5-Cyano-pyridin-2-ylmethyl)-1H-pyrazol-3-yl]-2-[4-(1-trifluoromethyl-cyclopropyl-phenyl]-acetamide,,2021-04-08,Treatment of epileptic encephalopathy with continuous spike-wave discharges during sleep (EECSWS),Designated,Not FDA Approved for Orphan Indication,,,,Neurocrine Biosciences Inc.,12780 El Camino Real,,San Diego,California,92130,United States,808621,,
"Small molecule, non-isoform selective NaV persistent current inhibitor",,2021-04-08,Treatment of SCN8A Developmental and Epileptic Encephalopathy,Designated,Not FDA Approved for Orphan Indication,,,,"Praxis Precision Medicines, Inc.","One Broadway, 16th Floor",,Cambridge,Massachusetts,2142,United States,789620,,
18F-PI-2620,,2021-04-12,Diagnostic for the clinical management of corticobasal degeneration.,Designated,Not FDA Approved for Orphan Indication,,,,Life Molecular Imaging Ltd.,"Iceni Centre, Warwick Technology Park",,Warwick,,CV34 6DA,United Kingdom,763320,,
A recombinant adeno-associated viral (AAV) vector encoding the human otoferlin (hOTOF) gene.,,2021-04-12,Treatment of otoferlin gene (OTOF)-mediated hearing loss,Designated,Not FDA Approved for Orphan Indication,,,,"Akouos, Inc.",645 Summer Street,Suite 200,Boston,Massachusetts,2210,United States,811221,,
Small molecule inhibitor of kinase mediators of the Wnt pathway,,2021-04-16,Treatment of Retinitis Pigmentosa,Designated,Not FDA Approved for Orphan Indication,,,,"Endogena Therapeutics, Inc,",111 Pine Street,,San Francisco,California,94111,United States,812321,,
"(R)-N-(5-(3-hydroxypyrrolidin-1-yl)-2-morpholinooxazolo[4,5-b]pyridin-6-yl)-2-(2-methylpyridin-4-yl)oxazole-4-carboxamide",,2021-04-16,Treatment of myelodysplastic syndrome,Designated,Not FDA Approved for Orphan Indication,,,,"Curis, Inc.","128 Spring Street, Building C, Suite 500",,Lexington,Massachusetts,2421,United States,810221,,
copanlisib,,2021-04-16,Treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,Bayer HealthCare Pharmaceuticals Inc.,100 Bayer Blvd,P.O.Box 915,Whippany,New Jersey,07981-0915,United States,811321,,
Cobimetinib,,2021-04-26,Treatment for histiocytic neoplasms,Designated,Not FDA Approved for Orphan Indication,,,,"Genentech, Inc.",1 DNA Way MS#451b,,South San Francisco,California,94080,United States,752820,,
an autologous cell therapy product manufactured from tumor-infiltrating lymphocytes (TILs) that have been harvested from surgically resected tumor tissue and expanded ex vivo.,,2021-04-26,Treatment of malignant melanoma stages IIB to IV,Designated,Not FDA Approved for Orphan Indication,,,,"Instil Bio, Inc.",3963 Maple Avenue,Suite 350,Dallas,Texas,75219,United States,812121,,
autologous CD34+ hematopoietic stem and progenitor cells modified ex-vivo with a lentiviral vector which restores endogenously regulated expression of FOXP3,,2021-04-27,Treatment of Immune Dysregulation Polyendocrinopathy X-linked (IPEX) Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,ImmunoVec,570 Westwood Plaza Building 114,,Los Angeles,California,90095,United States,815321,,
olorofim,,2021-04-27,Treatment of invasive scopulariopsis/microascus,Designated,Not FDA Approved for Orphan Indication,,,,F2G Limited,Lankro Way Eccles,,Manchester,Manchester,M30 OLX,United Kingdom,814021,,
"Small molecule, non-isoform selective NaV persistent current inhibitor",,2021-04-27,Treatment of SCN2A Developmental and Epileptic Encephalopathy,Designated,Not FDA Approved for Orphan Indication,,,,"Praxis Precision Medicines, Inc.","One Broadway, 16th Floor",,Cambridge,Massachusetts,2142,United States,789420,,
camrelizumab,,2021-04-27,Treatment of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,"Jiangsu Hengrui Medicine Co., Ltd",7 Kunlunshan Road,Economic and Technological Development Zone,Lianyungang,Jiangsu,,China,675718,,
dimethyltryptamine,,2021-04-27,Prevention of ischemia-reperfusion injury in patients undergoing solid organ transplantation.,Designated,Not FDA Approved for Orphan Indication,,,,Sairiyo Therapeutics Inc.,"77 King Street West, Suite 2905",,Toronto,Ontario,M5K 1H1,Canada,813521,,
Sodium trans-[tetrachlorobis(1H-indazole)ruthenate(III)],,2021-04-27,Treatment of Gastric Cancer,Designated,Not FDA Approved for Orphan Indication,,,,"Bold Therapeutics, Inc.","170 - 422 Richards Street,",,Vancouver,BC,V6B 2Z4,Canada,813421,,
copanlisib,,2021-05-03,Treatment of patients with Lymphoplasmacytoid lymphoma/ Waldenstr��acroglobulinemia,Designated,Not FDA Approved for Orphan Indication,,,,Bayer HealthCare Pharmaceuticals Inc.,100 Bayer Blvd,P.O.Box 915,Whippany,New Jersey,07981-0915,United States,811421,,
Talquetamab,,2021-05-03,Treatment of Multiple Myeloma,Designated,Not FDA Approved for Orphan Indication,,,,"Janssen Research & Development, LLC",920 Route 202,,Raritan,New Jersey,8869,United States,814921,,
Anti-Claudin 18.2 Antibody Drug Conjugate with MMAE and LND1002 linker,,2021-05-05,Treatment of Pancreatic Cancer,Designated,Not FDA Approved for Orphan Indication,,,,Conjupro Biotherapeutics Inc.,302 Carnegie Center,Ste 100,PRINCETON,New Jersey,8540,United States,814521,,
glucagon-like peptide-1/glucagon/gastric inhibitory polypeptide triple agonist linked to human IgG4 Fc fragment,,2021-05-10,Treatment of idiopathic pulmonary fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,"Hanmi Pharmaceutical Co., Ltd.",14 Wiryeseong-daero,Songpa-gu,Seoul,,5545,South Korea,815521,,
Pre-Morula Stem Cells,,2021-05-10,Treatment of Duchenne Muscular Dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,ReoStem L.L.C.,8 The Green,Suite #10862,Dover,Delaware,19901,United States,816521,,
Sulindac,,2021-05-10,Treatment of Fragile X syndrome,Designated,Not FDA Approved for Orphan Indication,,,,Healx Limited,"Charter House, 66-68 Hills Rd",,Cambridge,,CB2 1LA,United Kingdom,818421,,
Melatonin,,2021-05-10,Treatment of Retinitis Pigmentosa,Designated,Not FDA Approved for Orphan Indication,,,,WORPHMED Srl,Via Malachia Marchesi de Taddei 21,,Milan,,I-20146,Italy,816621,,
recombinant bispecific human IgG4 antibody which functionally mimics the procoagulant properties of activated FVIII,,2021-05-10,Treatment of Hemophilia A,Designated,Not FDA Approved for Orphan Indication,,,,"Novo Nordisk, Inc.",800 Scudders Mill Rd.,,Plainsboro,New Jersey,8536,United States,814121,,
Gadolinium-chelated polysiloxane based nanoparticles,,2021-05-10,Radiosensitizer to be used during radiation treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,NH TherAguix,"29, Chemin de Vieux Chꮥ",,Meylan,,38240,France,816121,,
romosozumab,,2021-05-10,Treatment of Osteogenesis Imperfecta,Designated,Not FDA Approved for Orphan Indication,,,,Amgen Inc.,One Amgen Center Drive,Mail Stop: 27-2-D,Thousand Oaks,California,91320-1799,United States,816321,,
ketamine,,2021-05-10,Treatment of Complex Regional Pain Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,iX Biopharma Ltd.,1 Kim Seng Promenade #14-01,Great World City East Tower,Singapore,,237994,Singapore,812221,,
"6-fluoro-9-methyl-9H-pyrido[3,4-b]-indole",,2021-05-10,Treatment of Sudden Sensorineural Hearing Loss,Designated,Not FDA Approved for Orphan Indication,,,,AudioCure Pharma GmbH,Schlegelstr 9,,Berlin,,10115,Germany,797920,,
flunarizine,,2021-05-12,Treatment of Childhood Absence Epilepsy,Designated,Not FDA Approved for Orphan Indication,,,,Xenon Pharmaceuticals Inc.,200-3650 Gilmore Way,,Burnaby,BC,V5G 4W8,Canada,823521,,
a native AAV9 capsid with a genomic cassette containing a cardiomyocyte-specific promoter and the wild-type human MYBPC3 gene,,2021-05-12,Treatment of hypertrophic cardiomyopathy (HCM) due to loss-of-function mutations in the MYBPC3 gene encoding cardiac myosin-binding protein C,Designated,Not FDA Approved for Orphan Indication,,,,Tenaya Therapeutics,701 Oyster Point Blvd,Suite 500,South San Francisco,California,94080,United States,813221,,
Hyaluronic Acid-Paclitaxel Conjugate,,2021-05-12,Treatment of Malignant Mesothelioma,Designated,Not FDA Approved for Orphan Indication,,,,Fidia Farmaceutici S.p.A.,Via Ponte della Fabbrica 3/A,,Abano Terme,,35031,Italy,813721,,
an autologous Chimeric Antigen Receptors (CAR) T-cell therapy expressing CD19/CD20 bi-specific CAR,,2021-05-17,Treatment of Follicular Lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,"Cellular Biomedicine Group Co., Ltd",209 Perry Pkway Ste 13,,Gaithersburg,Maryland,20877,United States,814421,,
Pegylated Glucagon Receptor Agonist,,2021-05-17,Treatment of Congenital Hyperinsulinism,Designated,Not FDA Approved for Orphan Indication,,,,Pegbio Co. Ltd.,"Suite 420, Building A3","Biobay, 218 Xing Hu Street",Suzhou,Jiangsu,215123,China,815621,,
RCH4 synthesized dimer peptide that links a lipid raft receptor to the extracellular matrix,,2021-05-19,Treatment of Amyotrophic Lateral Sclerosis (ALS) also known as Motor Neurone Disease (MND),Designated,Not FDA Approved for Orphan Indication,,,,R. Curran (a.k.a. The RC Charity),"56, Amanda Close",,Chigwell,Essex,IG7 5JG,United Kingdom,795520,,
"(2R,3S)-2-(3-(4,5-dichloro-1H-benzo[d]imidazol-1-yl)propyl)piperidin-3-ol hydrogen chloride",,2021-05-20,Treatment of systemic sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,"Daewoong Pharmaceutical Co., Ltd.","12, Bongeunsa-ro 114 gil, Gangnam-gu",,Seoul,,137-715,South Korea,817121,,
2-(2-{2-(2-{4-Benzothiazol-2- y1-phenoxy}-ethoxy]-ethoxy}-ethoxy}-ethanol,,2021-05-24,Treatment of Amyotrophic Lateral Sclerosis (ALS),Designated,Not FDA Approved for Orphan Indication,,,,"Spinogenix, Inc","10210 Campus Point Drive, Suite 150",,San Diego,California,92121,United States,802820,,
Bone Marrow Derived Mesenchymal Stem Cell Secretome,,2021-05-24,Treatment of Persistent Corneal Epithelial Defects,Designated,Not FDA Approved for Orphan Indication,,,,"Combangio, Inc.","1440 OBrien Drive, Suite D",,Menlo Park,California,94025,United States,743520,,
apraglutide,,2021-05-25,Prevention of acute graft-versus-host disease,Designated,Not FDA Approved for Orphan Indication,,,,VectivBio AG,Aeschenvorstadt 36,,Basel,,4051,Switzerland,817021,,
"(7S)-3-Amino-14-ethyl-11-fluoro-7-methyl-4-oxo-4,5,6,7,13,14-hexahydro-1,15-ethenopyrazolo[4,3-f][1,4,8,10]benzoxatriazacyclotridecine-12-carbonitrile",,2021-05-25,"Treatment of gastric cancer, including gastroesophageal junction adenocarcinoma",Designated,Not FDA Approved for Orphan Indication,,,,"Turning Point Therapeutics, Inc.",10628 Science Center Drive,Suite 200,San Diego,California,92121,United States,817821,,
UCART cells targeting CD7,,2021-05-25,Treatment of acute lymphoblastic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,"Nanjing Bioheng Biotech Co., Ltd","Block B1-2, 73 Tanmi Road,",,Nanjing,Pukou District,0,China,817921,,
an antibody drug conjugate composed of a humanized monoclonal antibody targeting CLDN18.2 and linker-payload MC-VC-PAB-MMAE,,2021-05-26,"Treatment of gastric cancer, including cancer of the gastroesophageal junction",Designated,Not FDA Approved for Orphan Indication,,,,LaNova Medicines Limited,2889 Jinke Road,"Suite 318, Floor 3, Building 10",Shanghai,,201203,China,819121,,
Diazoxide choline,,2021-05-26,Treatment of Glycogen Storage Disease Type 1,Designated,Not FDA Approved for Orphan Indication,,,,"Soleno Therapeutics, Inc.",203 Redwood Shores Parkway,Suite 500,Redwood City,California,94065,United States,818621,,
tesevatinib,,2021-05-26,Treatment of autosomal dominant polycystic kidney disease,Designated,Not FDA Approved for Orphan Indication,,,,Kadmon Corporation,450 East 29th Street,,New York,New York,10016,United States,802420,,
an antibody drug conjugate composed of a humanized monoclonal antibody targeting CLDN18.2 and linker-payload MC-VC-PAB-MMAE,,2021-05-26,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,LaNova Medicines Limited,2889 Jinke Road,"Suite 318, Floor 3, Building 10",Shanghai,,201203,China,819021,,
linperlisib,,2021-05-26,Treatment of T-cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,"Shanghai Yingli Pharmaceutical Co., Ltd.","Room 01, 4th Floor, Building A","2829 Jinke Road, Zhangjiang Hi-Tech Park, Pudong New Area",Shanghai,,,China,818221,,
Adeno-associated virus serotype 9 virus particle containing viral DNA that includes an expression cassette containing the human NGLY1 gene coding sequence,,2021-05-28,Treatment of NGLY1 deficiency,Designated,Not FDA Approved for Orphan Indication,,,,"Grace Science, LLC",1142 Crane Street,Ste 4,Menlo Park,California,94025,United States,815921,,
Small molecule inhibitor of KRAS G12C (Kirsten rat sarcoma viral oncogene homolog) mutant protein,,2021-06-07,Treatment for KRAS G12C Positive NSCLC,Designated,Not FDA Approved for Orphan Indication,,,,"Mirati Therapeutics, Inc.",3545 Cray Court,,San Diego,California,92121,United States,756320,,
gunagratinib,,2021-06-07,Treatment of Cholangiocarcinoma,Designated,Not FDA Approved for Orphan Indication,,,,InnoCare Pharma Inc.,"103 Carnegie Center, Suite 209",,Princeton,New Jersey,8540,United States,820521,,
a humanized aglycosylated IgG1 kappa monoclonal antibody targeting CD117 (cKit),,2021-06-07,conditioning treatment prior to hematopoietic stem cell transplantation,Designated,Not FDA Approved for Orphan Indication,,,,"Jasper Therapeutics, Inc.","2200 Bridge Parkway, Suite #102",,Redwood City,California,94065,United States,820121,,
cannabidiol,,2021-06-07,Treatment of epilepsy with myoclonic-atonic seizures,Designated,Not FDA Approved for Orphan Indication,,,,GW Research Ltd,5750 Fleet Street Suite 200,Sovereign House,Histon,Cambridge,CB24 9BZ,United Kingdom,819221,,
quinacrine,,2021-06-07,Treatment of pulmonary arterial hypertension,Designated,Not FDA Approved for Orphan Indication,,,,Pulmosim Therapeutics,1 Sansome Street,Suite 3500,San Francisco,California,94104,United States,820321,,
Adeno-associated virus serotype 5 encoding human retinal guanylate cyclase 1 gene (AAV5-GUCY2D),,2021-06-07,Treatment of retinal disease due to autosomal recessive mutations in the human retinal guanylate cyclase 1 (GUCY2D) gene,Designated,Not FDA Approved for Orphan Indication,,,,Atsena Therapeutics Inc.,701 W Main Street,Suite 200,Durham,North Carolina,27701,United States,726919,,
Etrasimod L-arginine,,2021-06-08,Treatment of Eosinophilic Esophagitis (EoE),Designated,Not FDA Approved for Orphan Indication,,,,"Arena Pharmaceuticals, Inc.",6154 Nancy Ridge Drive,,San Diego,California,92121,United States,723019,,
Allogeneic CRISPR/Cas9-mediated genetically modified CAR T cells targeting CD70 antigen,,2021-06-08,Treatment of T-cell Lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,"CRISPR Therapeutics, Inc.",610 Main Street,,Cambridge,Massachusetts,2139,United States,820421,,
Doxorubicin,,2021-06-08,Treatment of Malignant Glioma,Designated,Not FDA Approved for Orphan Indication,,,,Bionaut Labs,"3767 Overland Avenue, Suite 114",,Los Angeles,California,90046,United States,820821,,
Sivelestat,,2021-06-09,Treatment of ELANE gene related neutropenia,Designated,Not FDA Approved for Orphan Indication,,,,RNR Biomedical inc,161 Jefferson Ave.,,tenafly,New Jersey,7670,United States,812921,,
"Genetically engineered (alpha-1,3-galactosyltransferase knock-out}, live cell porcine (Sus scrofa) xenotransplantation skin graft",,2021-06-14,"Treatment of severe and extensive, deep partial and full-thickness burn wounds requiring hospitalization, surgical excision, and skin grafting.",Designated,Not FDA Approved for Orphan Indication,,,,"XenoTherapeutics, Inc.",359 Newbury St,Unit 526,Boston,Massachusetts,2115,United States,819421,,
Naltrexone,,2021-06-14,Treatment of Complex Regional Pain Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,Soin Theraputics,10601 Sunderland Woods CT,,Dayton,Ohio,45458,United States,819621,,
asparaginase erwinia chrysanthemi (recombinant)-rywn,Rylaze,2021-06-22,Treatment of Acute lymphoblastic leukemia,Designated/Approved,,As a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL) in adult and pediatric patients 1 month or older who have developed hypersensitivity to E. coli-derived asparaginase.,2021-06-30,,Jazz Pharmaceuticals Ireland Limited,"Waterloo Exchange, Waterloo Road",Fifth floor,Dublin,,D04 E5W7,Ireland,773420,,
"2'-O-methylphosphorothioate RNAoligonucleotide, 5'- m5CUGm5CUGm5CUGm5CUGm5CUGm5CUGm5CUG-3'""",,2021-06-22,Treatment of spinocerebellar ataxia,Designated,Not FDA Approved for Orphan Indication,,,,Vico Therapeutics B.V.,J. H. Oortweg 21,,Leiden,,2333 CH,Netherlands,821421,,
cinrebafusp,,2021-06-22,Treatment of gastric cancer including cancer of the gastroesophageal junction,Designated,Not FDA Approved for Orphan Indication,,,,"Pieris Pharmaceuticals, Inc.",255 State Street,9th Floor,Boston,Massachusetts,2109,United States,821221,,
devimistat,,2021-06-24,Treatment of liver and intrahepatic bile duct cancer (also known as biliary tract cancer; cholangiocarcinomas of the bile duct and the gall bladder),Designated,Not FDA Approved for Orphan Indication,,,,"Rafael Pharmaceuticals, Inc.",1 Duncan Drive,,Cranbury,New Jersey,8512,United States,808021,,
"(1S,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E)-33-(((2S,3S,4S,6R)-4-amino-3,5-dihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-1,3,4,7,9,11,17,37-octahydroxy-15,16,18,36-tetramethyl-14,39-dioxabicyclo[33. 3.1] nonatriaconta-19,21,23,25,27,29,31-heptaen-1",,2021-06-24,Treatment of invasive aspergillosis,Designated,Not FDA Approved for Orphan Indication,,,,Biosergen AS,7092 Tiller,,Trondheim,,PB 217,Norway,803420,,
mRNA encoding the human glycogen debranching enzyme,,2021-06-24,Treatment of glycogen storage disease type III,Designated,Not FDA Approved for Orphan Indication,,,,Ultragenyx Pharmaceutical Inc.,60 Leveroni Court,,Novato,California,94949,United States,821921,,
Bevantolol,,2021-06-24,Treatment of Huntington's Disease,Designated,Not FDA Approved for Orphan Indication,,,,SOM Innovation Biotech S.A.,"Baldiri Reixac, 4",,Barcelona,Barcelona,8028,Spain,822821,,
Ubidecarenone,,2021-06-24,Treatment of Malignant Glioma,Designated,Not FDA Approved for Orphan Indication,,,,Berg LLC,500 Old Connecticut Path,Building B,Framingham,Massachusetts,1701,United States,822521,,
Fully human anti-human neonatal Fc receptor (hFcRn) IgG1 monoclonal antibody,,2021-06-24,Treatment of Myasthenia Gravis,Designated,Not FDA Approved for Orphan Indication,,,,"Immunovant Sciences, GmbH",Viaduktstrasse 8,4051 Basel,Basel,Basel-Stadt,4501,Switzerland,809421,,
Adeno-associated viral vector encoding the human frataxin (FXN) gene,,2021-06-24,Treatment of Friedreichs Ataxia,Designated,Not FDA Approved for Orphan Indication,,,,Lexeo Therapeutics,430 East 29th Str,14th Floor,New York,New York,10016,United States,822221,,
Norucholic acid,,2021-06-24,Treatment of Primary Sclerosing Cholangitis,Designated,Not FDA Approved for Orphan Indication,,,,Dr. Falk Pharma GmbH,Leinenweberstrasse 5,79108 Freiburg,Freiburg,,,Germany,821121,,
envafolimab,,2021-06-28,Treatment of soft tissue sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,"Tracon Pharmaceuticals, Inc.",4350 LaJolla Village Dr.,Suite 800,San Diego,California,92122,United States,745320,,
Ulinastatin,,2021-06-28,Treatment of Acute Radiation Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,RNR Biomedical inc,161 Jefferson Ave.,,tenafly,New Jersey,7670,United States,822421,,
T regulatory cells,,2021-06-30,Treatment of Amyotrophic Lateral Sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,"Coya Therapeutics, Inc.","5850 San Felipe St., Suite 500",,Houston,Texas,77057,United States,823321,,
Iniparib,,2021-07-01,Treatment of Malignant Glioma,Designated,Not FDA Approved for Orphan Indication,,,,TriAct Therapeutics,2717 Baker Street,,San Francisco,California,94123,United States,823921,,
Sodium meta-arsenite,,2021-07-01,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,Komipharm International Australia Pty Ltd.,11 Monterey Road,Dandenong South,Victoria,,3175,Australia,823621,,
opelconazole,,2021-07-01,Treatment of invasive aspergillosis,Designated,Not FDA Approved for Orphan Indication,,,,Pulmocide Inc.,177 Huntington Ave Ste 1703,PBM 58659,Boston,Massachusetts,02115-3153,United States,824121,,
"a liposomal formulation of CEBPA-51, an saRNA duplex in sucrose/phosphate buffer",,2021-07-06,Treatment of hepatocellular carcinoma (HCC),Designated,Not FDA Approved for Orphan Indication,,,,"MiNA Alpha, Ltd",84 Wood Lane,,London,,W12 0BZ,United Kingdom,823821,,
mecasermin rinfabate,,2021-07-07,Prevention of bronchopulmonary dysplasia,Designated,Not FDA Approved for Orphan Indication,,,,"Premacure AB, A Member of the Shire Group of Companies",650 E. Kendall Street,,Cambridge,Massachusetts,2142,United States,824321,,
Pridopidine,,2021-07-07,Treatment of amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,Prilenia Neurotherapeutics LTD,"10 Hamenofim St, #317-318",,Herzliya,Merkaz,4672561,Israel,824621,,
Adeno-associated viral vector encoding the human ceroid lipofuscinosis neuronal type 2 (CLN2) gene,,2021-07-12,"Treatment of neuronal ceroid lipofuscinosis type 2 (CLN2) disease, Batten disease",Designated,Not FDA Approved for Orphan Indication,,,,Lexeo Therapeutics,430 East 29th Str,14th Floor,New York,New York,10016,United States,825521,,
Alrizomadlin,,2021-07-14,Treatment of Stage IIB-IV Melanoma,Designated,Not FDA Approved for Orphan Indication,,,,Ascentage Pharma Group Inc.,"800 King Farm Blvd., Suite 300",,Rockville,Maryland,20850,United States,826021,,
(2S)-2-[(2S)-4-cyclohexyl-2-{[(2S)-1-(4-fluorobenzoyl)pyrrolidin-2-yl]formamido}butanamido]-N-(1-{[(1S)-1-{[(1S)-1-({1-[(1-{[2-({1-[(dimethylamino)methyl]cyclobutyl}carbamoyl)ethyl]carbamoyl}-1-methylethyl)carbamoyl]-1-methylethyl}carbamoyl)-3-methylbutyl,,2021-07-19,Treatment of cutaneous leishmaniasis (Old World and New World),Designated,Not FDA Approved for Orphan Indication,,,,Bacoba AG,Elisabethenstrasse 15,,Basel,Basel-Stadt,4051,Switzerland,825621,,
methotrexate (intravitreal),,2021-07-19,Treatment of Primary Vitreoretinal Lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,"Aldeyra Therapeutics, Inc.",131 Hartwell Avenue,Suite 320,Lexington,Massachusetts,2421,United States,754320,,
Octreotide Acetate,,2021-07-19,Treatment of Idiopathic Intracranial Hypertension,Designated,Not FDA Approved for Orphan Indication,,,,NBO Pharma LLC,64 Quarry Lane,,Bedford,New York,10506,United States,826221,,
magnesium lysinate-bis-resolvin E1,,2021-07-20,Treatment of Pancreatic Cancer,Designated,Not FDA Approved for Orphan Indication,,,,Thetis Pharmaceuticals,"54 Danbury Rd., Suite 285",,Ridgefield,Connecticut,6877,United States,826721,,
Vactosertib,,2021-07-20,Treatment of Pancreatic Cancer,Designated,Not FDA Approved for Orphan Indication,,,,"MedPacto, Inc.","92 Myeongdal-ro, Seocho-Gu",,Seoul,,6668,South Korea,827321,,
"an antibody oligonucleotide conjugate (AOC), comprised of a human transferrin receptor 1 (TfR1) targeting, effector function null, humanized IgG1 antibody (AV01mAb) conjugated to one small interfering RNA (siRNA).",,2021-07-21,Treatment of Myotonic Dystrophy Type 1 (DM1),Designated,Not FDA Approved for Orphan Indication,,,,Avidity Biosciences,"10975 N. Torrey Pines Road, Ste. 150",,La Jolla,California,92037,United States,806820,,
"3,4-dimethyl-N-(2-phenyl-1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazole-5- carboxamide",,2021-07-21,Treatment of gastrointestinal stromal tumors,Designated,Not FDA Approved for Orphan Indication,,,,"Cogent Biosciences, Inc.",200 Cambridge Park Drive,Suite 2500,Cambridge,Massachusetts,2140,United States,827121,,
Anti-C1s Humanized IgG4 Monoclonal Antibody,,2021-07-21,Treatment of chronic inflammatory demyelinating polyneuropathy,Designated,Not FDA Approved for Orphan Indication,,,,Sanofi Genzyme,50 Binney Street,,Cambridge,Massachusetts,2124,United States,810521,,
Lorcaserin,,2021-07-21,Treatment of Lennox-Gastaut syndrome,Designated,Not FDA Approved for Orphan Indication,,,,"Epygenix Therapeutics, Inc.",140 E Ridgewood Avenue,"Suite 415, South Tower",Paramus,New Jersey,7652,United States,828021,,
Methotrexate,,2021-07-21,Treatment of retinitis pigmentosa,Designated,Not FDA Approved for Orphan Indication,,,,"Aldeyra Therapeutics, Inc.","131 Hartwell Avenue, Suite 320",,Lexington,Massachusetts,2421,United States,829121,,
Tesofensine plus metoprolol in a fixed-dose combination,,2021-07-21,Treatment of Hypothalamic Obesity,Designated,Not FDA Approved for Orphan Indication,,,,Saniona S/A,Smedeland 26B,,Glostrup,,DK-2600,Denmark,804220,,
Tempol,,2021-07-21,Treatment of Ataxia Telangiectasia,Designated,Not FDA Approved for Orphan Indication,,,,"Matrix Biomed, Inc.",2600 Michelson Dr.,Suite 1700,Irvine,California,92612,United States,827721,,
"recombinant human anti-TGFBeta IgG2 monoclonal antibody that belongs to the IgG2/Gamma isotype subclass and binds TGFBeta1 and TGFBeta2 with high affinity and, to a lesser extent, TGFBeta3",,2021-07-21,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hannover,New Jersey,7936,United States,828421,,
Amisodin,,2021-07-21,Treatment of Amyotrophic Lateral Sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,"PRG S&T Co., Ltd","9F, Sejung Tower, 252, Geumjeong-ro, Geumjeong-gu",,Busan,Busan,46274,South Korea,827921,,
"2?(3,5?dichloro?4?([4?hydroxy?3?(propan?2?yl)phenyl]methyl)phenoxy)?N?methylacetamide",,2021-07-22,Treatment of X-linked Adrenoleukodystrophy,Designated,Not FDA Approved for Orphan Indication,,,,"Autobahn Therapeutics, Inc.",9880 Campus Point Drive Suite 370,,San Diego,California,92121,United States,827821,,
19 amino acid synthetic peptide NOS-enhancer,,2021-07-26,Treatment of anterior ischemic optic neuropathy,Designated,Not FDA Approved for Orphan Indication,,,,Biozeus Biopharmaceutical SA,Rua Visconde de Pirajᠶ23 9,"andar, Ipanema",Rio de Janeiro,RJ,CEP 22410-003,Brazil,806120,,
imatinib,,2021-07-26,Treatment of pulmonary arterial hypertension,Designated,Not FDA Approved for Orphan Indication,,,,Aerami Therapeutics,"2520 Meridian Parkway, Suite 400",,Durham,North Carolina,27713,United States,831721,,
"Humanized, Low-fucose Anti-Claudin 18.2 IgG1 Antibody with Enhanced Antibody Dependent Cell-mediated Cytotoxicity",,2021-07-26,Treatment of gastric cancer including cancer of gastroesophageal junction,Designated,Not FDA Approved for Orphan Indication,,,,"Mabspace Biosciences (Suzhou) Co., Limited","218 Xinghu Street,Biobay, building B6-501",,Suzhou,Jiangsu,215123,China,824721,,
an antisense oligonucleotide that has been developed to target expanded CAG repeats in messenger ribonucleic acid (mRNA),,2021-07-27,Treatment of Huntingtons disease,Designated,Not FDA Approved for Orphan Indication,,,,Vico Therapeutics B.V.,J. H. Oortweg 21,,Leiden,,2333 CH,Netherlands,828721,,
Lisavanbulin,,2021-07-27,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,Basilea Pharmaceutical International Ltd.,Grenzacherstrasse 487,,Basel,BS,4058,Switzerland,828321,,
Sirolimus,,2021-07-27,Treatment of Sarcoidosis,Designated,Not FDA Approved for Orphan Indication,,,,AI Therapeutics,530 Old Whitfield Street,,Guildord,Connecticut,6437,United States,828521,,
Azacitidine,,2021-07-28,Treatment of Juvenile myelomonocytic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,Celgene Corporation,86 Morris Ave,,Summit,New Jersey,7901,United States,829021,,
"an antibody-drug conjugate of humanized, cysteine-engineered IgG1 monoclonal antibody targeting seizure-related 6 homolog conjugated to N-acetyl-gamma-calicheamicin",,2021-07-29,Treatment of Small Cell Lung Cancer,Designated,Not FDA Approved for Orphan Indication,,,,AbbVie Inc.,1 North Waukegan Road,,North Chicago,Illinois,60064,United States,829621,,
ketamine,,2021-08-03,Treatment of Amyotrophic Lateral Sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,PharmaTher Inc.,82 Richmond Street East,,Toronto,Ontario,,Canada,829921,,
sirolimus,,2021-08-03,Treatment of Lymphatic Malformations,Designated,Not FDA Approved for Orphan Indication,,,,"Palvella Therapeutics, Inc.","125 Stafford Ave., Suite 360",,Wayne,Pennsylvania,19087,United States,829421,,
Olorofim,,2021-08-03,Treatment of invasive fusariosis,Designated,Not FDA Approved for Orphan Indication,,,,F2G Limited,Lankro Way Eccles,,Manchester,Manchester,M30 OLX,United Kingdom,829821,,
Recombinant anti-claudin 18.2 monoclonal antibody,,2021-08-03,Treatment of Gastric Cancer,Designated,Not FDA Approved for Orphan Indication,,,,"Hengenix Biotech, Inc.",430 N. McCarthy Blvd.,,Milpitas,California,95035,United States,829321,,
a humanized immunoglobulin IgG1k-agonistic monoclonal antibody that binds to CD40,,2021-08-03,Treatment of Soft Tissue Sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,"Apexigen, Inc.","75 Shoreway Road, Suite C",,San Carlos,California,94070,United States,830321,,
IL13 E13K mutation linked to portion of mutated pseudomonas exotoxin,,2021-08-03,Treatment of Soft Tissue Sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,Targepeutics,475 W Governors Rd,,Hershey,Pennsylvania,17033,United States,829221,,
a recombinant human monoclonal antibody targeting hantavirus,,2021-08-05,Treatment of hantavirus Infection,Designated,Not FDA Approved for Orphan Indication,,,,Ichor Biologics,423 West 127th Street,,New York,New York,10027,United States,830721,,
Rapamycin-resistant Autologous Th1/Tc1 T cells,,2021-08-05,Treatment of Multiple Myeloma,Designated,Not FDA Approved for Orphan Indication,,,,Rapa Therapeutics LLC,12712 Rock Creek Mill Road,Suite 5B,ROCKVILLE,Maryland,20852,United States,830821,,
"3', 3, Diseleno Dipropionic Acid",,2021-08-09,Prevention of acute radiation syndrome,Designated,Not FDA Approved for Orphan Indication,,,,"Advanced Innovative Partners, Inc.",7947 BROOKSIDE CT,,Lake Worth,Florida,33467,United States,832321,,
Adeno-associated viral 2/5 (AAV2/5) vector expressing the human KCNJ13 gene,,2021-08-09,Treatment of inherited retinal dystrophy due to KCNJ13 biallelic mutations,Designated,Not FDA Approved for Orphan Indication,,,,Hubble Therapeutics,536 Bay Rd.,,Duxbury,Massachusetts,2332,United States,743320,,
N-hydroxy-N-(methylacylfulvene)urea,,2021-08-09,Treatment of Pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,"Lantern Pharma, Inc.",1920 MCKINNEY AVE,7TH FLOOR,DALLAS,Texas,75201,United States,832821,,
Recombinant adeno-associated virus vector carrying human CYP4V2 gene,,2021-08-09,Treatment of Bietti crystalline dystrophy (BCD),Designated,Not FDA Approved for Orphan Indication,,,,"Chigenovo Co., Ltd.","402, Building 1, Yard 9, Shengshengyuan Road","Zhongguancun Life Science Park, Changping Distric",Beijing,,,China,831621,,
Mixture of delta 9-tetrahydrocannabinol glycosides,,2021-08-09,Treatment of pediatric ulcerative colitis between the ages of 0-18 years,Designated,Not FDA Approved for Orphan Indication,,,,"Vitality Biopharma, Inc.",1901 Avenue of the Stars,2nd Floor,Los Angeles,California,90067,United States,627218,,
cereblon E3 ubiquitin ligase modulating agent,,2021-08-10,Treatment of Multiple Myeloma,Designated,Not FDA Approved for Orphan Indication,,,,"C4 Therapeutics, Inc.",490 Arsenal Way,Suite 200,Watertown,Massachusetts,2742,United States,831921,,
Allogenic Chimeric Antigen Receptor T Cells Targeting B Cell Maturation Antigen (BCMA),,2021-08-10,Treatment of Multiple Myeloma,Designated,Not FDA Approved for Orphan Indication,,,,Allogene Therapeutics,210 E Grand Ave,,South San Francisco,California,94080,United States,831421,,
Adeno-Associated Viral Vector Serotype 1 containing the human otoferlin gene,,2021-08-11,Rescue of hearing function in patients diagnosed with congenital deafness due to biallelic mutations of the OTOF gene,Designated,Not FDA Approved for Orphan Indication,,,,"Decibel Therapeutics, Inc.",1325 Boylston Street,,Boston,Massachusetts,2215,United States,832721,,
"Samarium (Sm-153) chelate of DOTMP (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephophonate))",,2021-08-11,Treatment of osteosarcoma,Designated,Not FDA Approved for Orphan Indication,,,,"QSAM Therapeutics, Inc.","9442 N Capital of Texas Hwy, Plaza One, Suite 500",,Austin,Texas,78759-7228,United States,773120,,
Recombinant adeno-associated viral vector serotype S3 containing codon optimised expression cassette encoding human beta-glucocerebrosidase variant,,2021-08-11,Treatment of Gaucher Disease,Designated,Not FDA Approved for Orphan Indication,,,,Freeline Therapeutics Inc,180 Varick Street,6th Floor,New York,New York,10014,United States,831121,,
Infigratinib,,2021-08-12,Treatment of achondroplasia,Designated,Not FDA Approved for Orphan Indication,,,,"QED Therapeutics, Inc.",8000 Marina Blvd #400,,Brisbane,California,94005,United States,833221,,
"2-((2-fluoro-4-iodophenyl)amino)-N-(2-hydroxyethoxy)-1-methyl-1H-pyrrolo[2,3-b]pyridine-3-carboxamide",,2021-08-12,Treatment of Neurofibromatosis type 1,Designated,Not FDA Approved for Orphan Indication,,,,"Nflection Therapeutics, Inc.",714 Woodcrest Road,,Wayne,Pennsylvania,19087,United States,746520,,
ganaxolone,,2021-08-12,Treatment of Tuberous Sclerosis Complex,Designated,Not FDA Approved for Orphan Indication,,,,"Marinus Pharmaceuticals, Inc.",5 Radnor Corporate Center,,Radnor,Pennsylvania,19087,United States,833521,,
omadacycline,,2021-08-18,Treatment of infections caused by Nontuberculous Mycobacteria (NTM),Designated,Not FDA Approved for Orphan Indication,,,,"Paratek Pharmaceuticals, Inc.",75 Park Plaza,4th floor,Boston,Massachusetts,2116,United States,741020,,
cemiplimab-rwlc,,2021-08-19,Treatment of stage IA2 to stage IV cervical cancer,Designated,Not FDA Approved for Orphan Indication,,,,"Regeneron Pharmaceuticals, Inc.",777 Old Saw Mill River Road,,Tarrytown,New York,10591,United States,671518,,
a pre-formulated vaccine which contains the cell-free filtrates of B. anthracis non-encapsulated strain V-770-NP1-R adsorbed to Al(OH)3 with CPG 7909 as adjuvant,,2021-08-19,Post-exposure prophylaxis of anthrax disease resulting from suspected or confirmed Bacillus anthracis exposure,Designated,Not FDA Approved for Orphan Indication,,,,"Emergent Product Development Gaithersburg, Inc.",300 Professional Drive,,Gaitherburg,Maryland,20879,United States,832521,,
begelomab,,2021-08-20,Treatment of dermatomyositis,Designated,Not FDA Approved for Orphan Indication,,,,ADIENNE SA,Via Zurigo 46,,Lugano,Europe,6900,Switzerland,833021,,
Hydroxyurea methylacylfulvene,,2021-08-20,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,"Lantern Pharma, Inc.",1920 McKinney Avenue,,Dallas,Texas,75201,United States,833721,,
Sivelestat,,2021-08-26,Treatment of Myelodysplastic Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,RNR Biomedical inc,161 Jefferson Ave.,,tenafly,New Jersey,7670,United States,813321,,
Gemfibrozil,,2021-08-27,Treatment of GM2 gangliosidoses,Designated,Not FDA Approved for Orphan Indication,,,,"Polaryx Therapeutics, Inc.","140 E. Ridgewood Avenue, Suite 415, South Tower",,Paramus,New Jersey,7652,United States,834821,,
vactosertib,,2021-08-27,Treatment of osteosarcoma,Designated,Not FDA Approved for Orphan Indication,,,,"MedPacto, Inc.",92 Myeongdal-ro Seocho-Gu,,Seoul,Republic of Korea,6668,South Korea,834121,,
Modified mRNA that encodes human glucose-6-phosphatase-alpha,,2021-08-27,Treatment of glycogen storage disease type 1a (GSD1a),Designated,Not FDA Approved for Orphan Indication,,,,"ModernaTX, Inc.",200 Technology Square,,"Cambridge,",Massachusetts,2139,United States,833921,,
Gemfibrozil,,2021-08-30,Treatment of Krabbe Disease,Designated,Not FDA Approved for Orphan Indication,,,,"Polaryx Therapeutics, Inc.","140 E. Ridgewood Avenue, Suite 415, South Tower",,Paramus,New Jersey,7652,United States,834921,,
citric acid,,2021-08-30,Treatment of hyperammonemia in inborn errors of metabolism,Designated,Not FDA Approved for Orphan Indication,,,,Versantis AG,Technoparkstrasse 1,,Zrich,,,Switzerland,731120,,
Glucagon like peptide-1 (GLP-1) Elastin like peptide (ELP)-120 fusion protein,,2021-08-31,Treatment of polymyositis,Designated,Not FDA Approved for Orphan Indication,,,,"ImmunoForge Co., Ltd.","307-1, 105-1 Bldg, Seoul National University","1 Gwanak-ro, Gwanak-gu,",Seoul,,,South Korea,808321,,
Nafamostat,,2021-09-01,Treatment of Dengue Fever,Designated,Not FDA Approved for Orphan Indication,,,,RNR Biomedical inc,161 Jefferson Ave.,,tenafly,New Jersey,7670,United States,835721,,
gavocabtagene autoleucel (gavo-cel),,2021-09-01,Treatment of Cholangiocarcinoma,Designated,Not FDA Approved for Orphan Indication,,,,"TCR2 Therapeutics, Inc.","100 Binney St, Ste 710",,Cambridge,Massachusetts,2142,United States,689519,,
Stabilized sulforaphane,,2021-09-01,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,Evgen Pharma plc,"Liverpool Science Park, Innovation Centre 2",146 Brownlow Hill,Liverpool,,L3 5RF,United Kingdom,836021,,
chiauranib,,2021-09-02,Treatment of small cell lung cancer,Designated,Not FDA Approved for Orphan Indication,,,,"Shenzhen Chipscreen Biosciences Co., Ltd.","2-601, BIO-Incubator, Gaoxin C, 1st Ave.,","Hi-Tech Industrial Park, Nanshan District",Shenzhen,Guangdong,518057,China,836221,,
Eliglustat Tartrate,,2021-09-02,"Treatment of Gaucher Disease Type 1 patients who are CYP2D6 ultra-rapid metabolizers and patients whose CYP2D6 genotype cannot be determined (i.e., indeterminate metabolizers).",Designated,Not FDA Approved for Orphan Indication,,,,"Kashiv Biosciences, LLC",20 New England Avenue,,Piscataway,New Jersey,8854,United States,816821,,
Hypericin,,2021-09-02,Treatment of T-cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,"Soligenix, Inc.","29 Emmons Drive, Suite B-10",,Princeton,New Jersey,8054,United States,835521,,
Synthetic analogue of cyclic Glycine-Proline,,2021-09-02,Treatment of Prader-Willi Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,"Neuren Pharmaceuticals, Ltd.","Ste 201, 697 Burke Rd",,Camberwell,VIC3124,xxxxx,Australia,835121,,
N-acetylcysteine amide,,2021-09-07,Treatment of cystinosis.,Designated,Not FDA Approved for Orphan Indication,,,,"Nacuity Pharmaceuticals, Inc.","306 W. 7th Street, Suite 310",,Fort Worth,Texas,76102,United States,768820,,
"N-[(3-fluoro-4-methoxypyridin-2-yl) methyl]-3-(methoxymethyl)-1-({4-[(2-oxo-1,2-dihydropyridin-1-yl) methyl]phenyl}methyl)-1H-pyrazole-4-carboxamide",,2021-09-07,Treatment of bradykinin-mediated angioedema,Designated,Not FDA Approved for Orphan Indication,,,,KalVista Pharmaceuticals Ltd,Porton Science Park Bybrook Road,Porton Down,Salisbury,,SP4 0BF,United Kingdom,770420,,
Encorafenib,,2021-09-08,Treatment of BRAF-mutant Non-Small Cell Lung Cancer,Designated,Not FDA Approved for Orphan Indication,,,,Array BioPharma Inc. (a wholly owned subsidiary of Pfizer Inc.),3200 Walnut Street,,Boulder,Colorado,80301,United States,788820,,
N-acetyl-L-leucine,,2021-09-08,"Treatment of Niemann-Pick Disease, Type C",Designated,Not FDA Approved for Orphan Indication,,,,IntraBio Inc.,270 Devon Road,,Tenafly,New Jersey,7670,United States,836121,,
"3-(4-((3-endo)-3-((5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4- yl)methoxy)-8-azabicyclo[3.2.1]octan-8-yl)-2-fluorophenyl)-1,2,4-oxadiazol-5(4H)-one",,2021-09-13,Treatment of Primary Sclerosing Cholangitis,Designated,Not FDA Approved for Orphan Indication,,,,"Cascade Pharmaceuticals, Inc","Building No. 6, Lane 908, Ziping Road,",Pudong New District,Shanghai,,201321,China,836821,,
dextromethadone hydrochloride,,2021-09-13,Treatment of Amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,"Relmada Therapeutics, Inc.",880 Third Avenue,12th Floor,New York,New York,10022,United States,836721,,
"fixed set of four ribonucleic acid lipoplex (RNA-LPX) drug products (RBL001.3, RBL002.4, RBL003.3, RBL004.3) which code for four melanoma tumor-associated antigens",,2021-09-15,Treatment of stage IIB through IV melanoma,Designated,Not FDA Approved for Orphan Indication,,,,BioNTech SE,An der Goldgrube 12,,,Mainz,55131,Germany,837221,,
octreotide,,2021-09-15,Treatment of autosomal dominant polycystic liver disease,Designated,Not FDA Approved for Orphan Indication,,,,Camurus AB,Ideon Science Park,,Lund,NA,SE-223 70,Sweden,836621,,
bis-cyclopropylcarbamoyl-bis-indanedione sulfone,,2021-09-15,Treatment of Heparin Induced Thrombocytopenia,Designated,Not FDA Approved for Orphan Indication,,,,"Fox Chase Chemical Diversity Center, Inc.",3805 Old Easton Road,,Doylestown,Pennsylvania,18902,United States,837021,,
nadunolimab,,2021-09-21,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,Cantargia AB,Scheelev䧥n 27,,Lund,,SE-223 63,Sweden,815221,,
anti-thymocyte globulin (rabbit),,2021-09-21,Prophylaxis of graft-versus-host-disease,Designated,Not FDA Approved for Orphan Indication,,,,Genzyme Corporation,50 Binney Street,,Cambridge,Massachusetts,2142,United States,838821,,
Fasudil hydrochloride,,2021-09-21,Treatment of 16p11.2 Deletion Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,"Woolsey Pharmaceuticals, Inc.",233 Broadway,Suite 1750,New York,New York,10279,United States,815421,,
Melatonin,,2021-09-21,Treatment of optic neuritis,Designated,Not FDA Approved for Orphan Indication,,,,WORPHMED Srl,Via Malachia Marchesi de Taddei 21,,Milan,MI,I-20146,Italy,845921,,
luspatercept,,2021-09-21,Treatment of Alpha-thalassemia,Designated,Not FDA Approved for Orphan Indication,,,,Celgene Corporation,86 Morris Ave,,Summit,New Jersey,7901,United States,837321,,
riboflavin 5'-phosphate sodium,,2021-09-21,Treatment of corneal ulcers,Designated,Not FDA Approved for Orphan Indication,,,,Glaukos Corporation,229 Avenida Fabricante,,San Clemente,California,92672,United States,812721,,
"Adeno-Associated Virus 9 human Propionyl-CoA Carboxylase, alpha subunit (AAV9-hPCCA)",,2021-09-27,Treatment of propionic acidemia,Designated,Not FDA Approved for Orphan Indication,,,,"National Institutes of Health, National Center for Advancing Translational Sciences",9800 Medical Center Dr.,,Rockville,Maryland,20850,United States,838121,,
PEGylated aptamer targeting Von Willebrand Factor A1 domain,,2021-09-27,Treatment of Von Willebrand Disease,Designated,Not FDA Approved for Orphan Indication,,,,"Band Therapeutics, LLC",101 Hartwell Ave,Suite #2,Lexington,Massachusetts,2421,United States,838021,,
Marzeptacog alfa (activated),,2021-09-27,Treatment of Factor VII Deficiency,Designated,Not FDA Approved for Orphan Indication,,,,"Catalyst Biosciences, Inc",611 Gateway Blvd. Suite 710,,South San Francisco,California,94080,United States,837721,,
Polymeric polyethylene glycol-phosphatidyl ethanolamine (PEG-PE) micelles containing Curcumin C3 complex (CUR) and doxorubicin hydrochloride (DOX),,2021-09-27,Treatment of Soft Tissue Sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,"Immix Biopharma, Inc",10573 W. Pico Blve,#58,Los Angeles,California,90064,United States,808221,,
N-acetylcysteine amide,,2021-09-27,"Treatment for Gain-of-Function Mutation in ACOX1, Mitchells Syndrome.",Designated,Not FDA Approved for Orphan Indication,,,,"Nacuity Pharmaceuticals, Inc.","306 W 7th St., Ste 310",,Fort Worth,Texas,76102,United States,771920,,
"3-[(2R)-2,3-dihydroxypropyl]-6-fluoro-5-[(2-fluoro-4-iodophenyl)amino]-8-methylpyrido[2,3-d]pyrimidine-4,7(3H,8H)-dione",,2021-09-28,Treatment of familial adenomatous polyposis,Designated,Not FDA Approved for Orphan Indication,,,,"Recursion Pharmaceuticals, Inc.",41 S. Rio Grande Street,,Salt Lake City,Utah,84101,United States,817621,,
Adeno-associated virus 2/9 expressing human GALT gene (AAV2/9-hGALT),,2021-09-28,Treatment of galactosemia,Designated,Not FDA Approved for Orphan Indication,,,,"Jaguar Gene Therapy, LLC",Two Conway Park,"150 N. Field Drive, Suite 300",Lake Forest,Illinois,60045,United States,839921,,
"Allogeneic multi-virus specific T lymphocytes targeting BK virus, cytomegalovirus, human herpes virus-6, Epstein Barr virus, and adenovirus",,2021-09-29,Treatment for Virus-associated hemorrhagic cystitis,Designated,Not FDA Approved for Orphan Indication,,,,"AlloVir, Inc.",2925 Richmond Avenue,Suite 1200,Houston,Texas,77098,United States,747920,,
Dasatinib,,2021-10-05,Treatment of chronic myelogenous leukemia,Designated,Not FDA Approved for Orphan Indication,,,,"Nanocopoeia, LLC",639 Campus Drive,,New Brighton,Minnesota,55112,United States,750420,,
Dasatinib,,2021-10-05,Treatment of acute lymphoblastic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,"Nanocopoeia, LLC",639 Campus Drive,,New Brighton,Minnesota,55112,United States,750520,,
tezepelumab,,2021-10-07,Treatment of Eosinophilic Esophagitis,Designated,Not FDA Approved for Orphan Indication,,,,AstraZeneca Pharmaceuticals LP,1800 Concord Pike,P.O. Box 8355,Wilmington,Delaware,19803,United States,839721,,
Aminouridyl phenoxypiperidinbenzyl butamide,,2021-10-12,Treatment of Pancreatic Cancer,Designated,Not FDA Approved for Orphan Indication,,,,Anviron Corporation,4 Trouville,,Newport Coast,California,92657,United States,840521,,
"haptoglobin (Hp1-1), (Human)",,2021-10-12,Treatment of subarachnoid hemorrhage,Designated,Not FDA Approved for Orphan Indication,,,,CSL Behring,1020 First Avenue,PO Box 61501,King of Prussia,Pennsylvania,19406-0901,United States,841121,,
cudetaxestat,,2021-10-12,Treatment of systemic sclerosis.,Designated,Not FDA Approved for Orphan Indication,,,,"Blade Therapeutics, Inc.",442 Littlefield Avenue,,South San Francisco,California,94080,United States,841021,,
Gentulizumab,,2021-10-12,Treatment of Acute Myeloid Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,"Changchun GeneScience Pharmaceutical Co., Ltd.",No. 1718 Yueda Road,Changchun High-Tech Dev. Zone,Changchun City,Jilin Province,130012,China,841321,,
"2-[(3-Methylbutyl)amino]-1,4-naphthalenedione",,2021-10-12,Treatment of Dravet Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,Neuroene Therapeutics,"645 Meeting Street, 201-I",,Charleston,South Carolina,29403,United States,841521,,
Ketamine,,2021-10-12,Treatment of Complex Regional Pain Syndrome (CRPS),Designated,Not FDA Approved for Orphan Indication,,,,PharmaTher Inc.,82 Richmond Street East,,Toronto,Ontario,,Canada,840821,,
elranatamab,,2021-10-12,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,Pfizer Inc.,445 Eastern Point Road,,Groton,Connecticut,6340,United States,840721,,
"5,6-dibromo-4-nitro-2-(piperidin-4-yl)-1-(propan-2-yl)-1H-1,3-benzodiazole hydrochloride",,2021-10-12,Treatment of Acute Myeloid Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,Menarini Ricerche S.p.A.,Tito Speri 10,,Pomezia (Rome),,71,Italy,840121,,
Rituximab,,2021-10-12,Treatment of Myasthenia Gravis,Designated,Not FDA Approved for Orphan Indication,,,,Taxon Therapeutics Ltd.,122 Bar Kokhva St.,,Herzliya 4600728,Herzliya,4600728,Israel,840621,,
E-selectin/Adeno-Associated Virus (E-sel/AAV2) Gene Therapy,,2021-10-12,Treatment of Buerger disease,Designated,Not FDA Approved for Orphan Indication,,,,Ambulero Inc,1951 NW 7th Avenue,Suite 6000,Miami,Florida,33136,United States,840421,,
single chain recombinant trispecific killer engager consistent of anti-CD16 scFV spliced to anti-CD33 scFV with a modified IL-15 linker,,2021-10-12,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,"GT Biopharma, Inc.","9350 Wilshire Blvd, Suite 203",,Beverly Hills,California,90212,United States,840921,,
Recombinant human interleukin-15/IL-15 receptor alpha complex with linked integrin binding motif,,2021-10-12,Treatment of cholangiocarcinoma,Designated,Not FDA Approved for Orphan Indication,,,,BJ Bioscience Inc.,1500 Wenyi West Road,"Floor 15, Building 4",Hangzhou,Zhejiang,,China,749420,,
Biocompatible polymeric PLGA nanofiber membrane containing the active substance 7-ethyl-10-hydroxycamptothecin,,2021-10-13,Treatment of Soft Tissue Sarcoma (STS),Designated,Not FDA Approved for Orphan Indication,,,,Cebiotex S.L.,"Pla硠Pau Vila, 1; Block A, 3rd Floor",Barcelona Tech City,Barcelona,,8039,Spain,840021,,
"immunoglobulin VHH fragment-linker-VHH fragment, anti-CD1d and anti-[Vdelta2 T-cell receptor], humanized monoclonal antibody",,2021-10-13,Treatment of chronic lymphocytic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,LAVA Therapeutics,"2929 Arch Street, Suite 1700",,Philadelphia,Pennsylvania,19104,United States,821821,,
nipocalimab,,2021-10-14,Treatment of chronic inflammatory demyelinating polyneuropathy,Designated,Not FDA Approved for Orphan Indication,,,,"Janssen Research & Development, LLC",1125 Trenton-Harbourton Road,,Titusville,New Jersey,8560,United States,840221,,
Clemizole,,2021-10-14,Treatment of Lennox-Gastaut Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,"Epygenix Therapeutics, Inc.",140 E Ridgewood Avenue,"Suite 415, South Tower",Paramus,New Jersey,7652,United States,841821,,
clustered regularly interspaced short palindromic repeats CRISPR/ Cas9-based gene therapy consisting of a single guide RNA targeting the human TTR gene and a messenger RNA encoding Cas9,,2021-10-19,Treatment of transthyretin amyloidosis,Designated,Not FDA Approved for Orphan Indication,,,,"Intellia Therapeutics, Inc.",40 Erie Street,,Cambridge,Massachusetts,2139,United States,842521,,
optimized human tissue-type plasminogen activator,,2021-10-21,Treatment of intracerebral hemorrhage,Designated,Not FDA Approved for Orphan Indication,,,,Op2Lysis SAS,117 Avenue,,Victore Hugo,Boulogne-Billancourt,92100,France,841221,,
Alvelestat,,2021-10-25,Treatment of Alpha-1 Antitrypsin Deficiency,Designated,Not FDA Approved for Orphan Indication,,,,Mereo Biopharma 4 Limited,1 Cavendish Place,,London,,W1G 0QF,United Kingdom,804020,,
Heterodimeric multi-specific IgG1 antibody targeting human epidermal growth factor receptor 2 (HER2) and NKG2D on natural killer (NK) and cytotoxic T-cells,,2021-10-25,Treatment of Esophageal Cancer,Designated,Not FDA Approved for Orphan Indication,,,,"Dragonfly Therapeutics, Inc.",35 Gatehouse Drive,,Waltham,Massachusetts,2451,United States,844121,,
humanized recombinant immunoglobulin G (IgG) 4 monoclonal antibody against C1q,,2021-10-25,Treatment of Huntington's Disease,Designated,Not FDA Approved for Orphan Indication,,,,"Annexon, Inc.",180 Kimball Way,"2nd Floor, Suite 200",South San Francisco,California,94080,United States,843121,,
Psilocybin,,2021-10-25,Treatment of Fragile X Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,Nova Mentis Life Science Corp.,700-838 West Hasting Street,,Vancouver,British Columbia,V6C 0A6,Canada,843421,,
human anti-LIGHT monoclonal antibody,,2021-10-26,Treatment of pediatric Crohns disease,Designated,Not FDA Approved for Orphan Indication,,,,Cerecor Inc.,"540 Gaither Road, Suite 400",Suite 715,Rockville,Maryland,20850,United States,643018,,
satralizumab-mwge,,2021-10-26,Treatment of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD),Designated,Not FDA Approved for Orphan Indication,,,,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080-4990,United States,824521,,
Idroxioleic acid,,2021-10-26,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,Laminar Pharma Inc,"360 Massachusettes Avenue, Suite 203",,Acton,Massachusetts,1720,United States,844021,,
"AAV8/TTR-hFVa - Adeno Associated Virus, Serotype 8 with a transthyretin promotor and encoded transgene for human clotting Factor Va.",,2021-10-27,Treatment of Hemophilia A or Hemophilia B with or without Inhibitors,Designated,Not FDA Approved for Orphan Indication,,,,"GeneVentiv Therapeutics, Inc.",312 Buncombe Street,,Raleigh,North Carolina,27609,United States,843221,,
mocravimod,,2021-10-27,Prevention of graft-versus-host disease,Designated,Not FDA Approved for Orphan Indication,,,,Priothera SAS,57 Avenue G鮩ral De Gaulle,,Saint-Louis,,68300,France,843321,,
Benralizumab,,2021-11-01,Treatment of Eosinophilic Gastritis (EG),Designated,Not FDA Approved for Orphan Indication,,,,AstraZeneca Pharmaceuticals LP,1800 Concord Pike,P.O. Box 8355,Wilmington,Delaware,19803,United States,828221,,
Benralizumab,,2021-11-01,Treatment of eosinophilic gastroenteritis,Designated,Not FDA Approved for Orphan Indication,,,,AstraZeneca Pharmaceuticals LP,1800 Concord Pike,P.O. Box 8355,Wilmington,Delaware,19803,United States,838521,,
Miltefosine,,2021-11-01,Treatment invasive candidiasis,Designated,Not FDA Approved for Orphan Indication,,,,"Profounda, lnc.",10501 S. Orange Ave,STE 124,Orlando,Florida,32824,United States,843921,,
L-S-(3-Amino-3-carboxypropyl)-S-methylsulfoximine,,2021-11-02,Treatment of Amyotrophic Lateral Sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,"William S. Brusilow, Ph.D.",30 Rivard Blvd.,,Gross Pointe,Michigan,48230,United States,844521,,
synthetic 23 amino acid peptide AASSGVSTPGSAGHDIITEQPRS derived from the Huntingtin protein,,2021-11-04,Treatment of Huntingtons disease,Designated,Not FDA Approved for Orphan Indication,,,,centre national de la recherche scientifique,4101 Reservoir Rd NW,,Washington,District of Columbia,20007,United States,847121,,
rivoceranib,,2021-11-04,Treatment of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,"Elevar Therapeutics, Inc.",2825 E. Cottonwood Pkwy. Ste 180,,Salt Lake City,Utah,84121,United States,682618,,
"[10-(4,5-dimethyl-3,6-dioxocyclohexa-1,4-dien-1-yl)decyl](triphenyl)phosphonium bromide",,2021-11-04,Treatment of Leber Hereditary Optic Neuropathy,Designated,Not FDA Approved for Orphan Indication,,,,Mitotech S.A.,42 rue de la Vallee,,Luxembourg,Luxembourg,2661,Luxembourg,846221,,
Ivaltinostat,,2021-11-04,Treatment of Alport Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,"Machaon Biotherapeutics, Inc.",70 Osongsaengmyeong 6-ro,,Cheongju-si,Chungcheongbuk-do,28158,South Korea,846121,,
Autologous chimeric antigen receptor (CAR)-positive T cells targeting cluster of differentiation 19 (CD19) and B cell maturation antigen (BCMA),,2021-11-04,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,"Gracell Biopharmaceuticals, Inc.",530 Lytton Avenue,2nd Floor,Palo Alto,California,94301,United States,845421,,
edaravone,,2021-11-04,Treatment of Amyotrophic Lateral Sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,"Suzhou Auzone Biological Technology Co., Ltd","Room 406, A7 Building, BioBay, No. 218 Xinghu Street",Suzhou Industrial Park,Suzhou,Jiangsu,215000,China,847021,,
H-Arg-Pro-Lys-Pro-Gln-Gln-Phe-2Thi-Gly-Leu-Met(O2)-NH2-DOTA-225-actinium,,2021-11-05,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,NovaCurie AG,Spitalgasse 32,,Bern,N/A,3011,Switzerland,820221,,
Pegylated Liposomal Alendronate with Doxorubicin,,2021-11-08,Treatment of soft tissue sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,LEVCO Pharmaceuticals Ltd.,Shlomo Momo Halevi St. 5,,Jerusalem,Israel,9777019,Israel,844921,,
"N-(4-methyl-3-(7-methyl-2-((6-methylpyridin-3-yl)amino)-8-oxo-7,8-dihydropyrido[3,4-d]pyrimidin-6-yl)phenyl)-3-(trifluoromethyl)benzamide",,2021-11-08,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,"Pharos iBio Co., Ltd.","1407 & 1408, 38, Heungan-daero 427 beon-gil",,Anyang,Gyeonggi,N/a,South Korea,847921,,
Adeno-associated viral vector expressing human retinitis pigmentosa GTPase regulator-interacting protein 1 (AAV.Anc80.hRPGRIP1),,2021-11-08,RPGRIP1 Mutation-Associated Retinal Dystrophies,Designated,Not FDA Approved for Orphan Indication,,,,Odylia Therapeutics,1447 Peachtree St. NE,,Atlanta,Georgia,30309,United States,849421,,
Toripalimab,,2021-11-08,Treatment of esophageal cancer,Designated,Not FDA Approved for Orphan Indication,,,,"TopAlliance Biosciences, Inc.","9430 Key West Ave, Suite 125",,Rockville,Maryland,20850,United States,836421,,
efgartigimod coformulated with recombinant human hyaluronidase PH20 (rHuPH20),,2021-11-08,Treatment of Chronic Inflammatory Demyelinating Polyneuropathy,Designated,Not FDA Approved for Orphan Indication,,,,argenx BV,Industriepark Zwijnaarde 7,,Zwijnaarde,East Flanders,9052,Belgium,851421,,
recombinant AAV8 that contains a vector genome encoding a miniaturized dystrophin protein (microdystrophin),,2021-11-08,Treatment of Duchenne muscular dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,REGENXBIO Inc.,9804 Medical Center Drive,,Rockville,Maryland,20850,United States,847521,,
Anti-Beta1 Integrin Monoclonal Antibody,,2021-11-08,Treatment of Acute Myeloid Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,"OncoSynergy, Inc","850 Pacific Street, Unit 1802",,Stamford,Connecticut,6902,United States,845021,,
Zandelisib,,2021-11-09,Treatment of follicular lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,"MEI Pharma, Inc.",11455 El Camino Real,Suite 250,San Diego,California,92130,United States,849021,,
"(R)-2-((1-(2-(4-methoxy-3-(2-morpholinoethoxy) phenyl)-5-methylthiazol-4-yl)ethyl)thio)pyrimidine-4,6-diamine",,2021-11-09,Treatment of Optic Neuritis,Designated,Not FDA Approved for Orphan Indication,,,,Trethera Corporation,"13547 Ventura Boulevard, Suite 363",,Sherman Oaks,California,91423,United States,845721,,
Chimeric Antigen Receptor T Cells targeting CD7,,2021-11-09,Treatment of acute lymphoblastic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,PersonGen BioTherapeutics (Suzhou) Co. Ltd.,218 Xinghu St. BioBay Build.B1 Suite412 SIP,,Suzhou City,Jiangsu Province,,China,845121,,
sodium salt of 19-bp single stranded RNA uniformly modified 2-O-(2-methoxyethyl) phosphorothioate Antisense Oligonucleotide (ASO) consisting of 19 nucleotide residues with the sequence 5'-5MeC-5MeU-G-5MeC-A-A-5MeC-A-G-A-5MeU-G-G-A-A-G-A-5MeC-5MeU-3,,2021-11-10,Treatment of cystic fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,SpliSense Ltd.,"Biohouse Labs Jerusalem Bio Park, 1st Floor",Haddasah Ein Kerem,Jerusalem,Israel,9112101,Israel,845221,,
Fully human anti-galectin-9 IgG4 monoclonal antibody,,2021-11-10,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,"PureTech Health, LLC.",6 Tide Street,,Boston,Massachusetts,2210,United States,845321,,
obinutuzumab,,2021-11-22,"Treatment of childhood-onset idiopathic nephrotic syndrome (NS), defined as steroid dependent or frequently relapsing NS.",Designated,Not FDA Approved for Orphan Indication,,,,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080-4990,United States,824921,,
autologous anti-CLL-1 CAR T-cell therapy,,2021-11-23,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,"Guangzhou Bio-gene Technology Co., Ltd","206 Kaiyuan Blvd, Huangpu District",,Guangzhou,Guangdong,510530,China,847421,,
autologous CD34+ hematopoietic stem and progenitor cells with a HBB gene corrected by CRISPR/Cas9 in combination with a gcSCD-AAV6 vector,,2021-11-23,Treatment of sickle cell disease,Designated,Not FDA Approved for Orphan Indication,,,,"Graphite Bio, Inc.","201 Haskins Way, Suite 210",,South San Francisco,California,94080,United States,846821,,
Fully Human CD19 / CD22 Dual Target Chimeric Antigen Receptor Autologous T Cell Injection,,2021-11-24,Treatment of Acute Lymphoblastic Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,"Nanjing IASO Biotherapeutics Co., Ltd.","10th floor, Building D, Phase II","Zhongdan Eco Life Science Industrial Park, No. 3-1 Xinjinhu Rd.","Jiangbei New District, Nanjing",Jiangsu,210000,China,848821,,
Tetravalent recombinant humanized IgG1 agonist antibody targeting the human TRAIL death receptor 5 (DR5).,,2021-11-24,Treatment of Chondrosarcoma,Designated,Not FDA Approved for Orphan Indication,,,,"Inhibrx, Inc.",11025 North Torrey Pines Road,Suite 140,La Jolla,California,92037,United States,848721,,
Autologous CD34+ enriched hematopoietic stem cells transduced ex vivo with a lentiviral vector encoding for human IDS,,2021-11-24,"Treatment of Hunter syndrome (Mucopolysaccharidosis type II, MPS II)",Designated,Not FDA Approved for Orphan Indication,,,,"AVROBIO, Inc.","One Kendall Square, Building 300",Suite 201,Cambridge,Massachusetts,2139,United States,848221,,
nanatinostat and valganciclovir,,2021-11-24,"Treatment of Epstein Barr Virus-positive diffuse large B-cell lymphoma, not otherwise specified (EBV+ DLBCL, NOS)",Designated,Not FDA Approved for Orphan Indication,,,,"Viracta Subsidiary, Inc.",2533 S. Coast Hwy 101,Suite 210,Cardiff,California,92007,United States,847721,,
recombinant adeno-associated virus serotype 9 vector encoding the human progranulin gene,,2021-11-24,Treatment of frontotemporal dementia,Designated,Not FDA Approved for Orphan Indication,,,,NeuroGeneUs Ltd,86 Hatton Garden,Floor 5,London,London,EC1N 8QQ,United Kingdom,847621,,
berbamine,,2021-11-29,Treatment of T-cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,IsoQ Therapeutics Inc.,2140 S. Dupont Hwy,,Camden,Delaware,19934,United States,848121,,
"an ADC drug against CLDN18.2, containing a recombinant humanized anti-CLDN18.2 IgG1 monoclonal antibody and linker-payload MC-VC-PAB-MMAE",,2021-11-30,Treatment of Cholangiocarcinoma (intrahepatic bile duct cancer),Designated,Not FDA Approved for Orphan Indication,,,,LaNova Medicines Limited,"5th Floor, 1 Building, 999 Cailun Road",,Shanghai,Shanghai,201203,China,849221,,
Valemetostat tosylate,,2021-12-01,Treatment of Peripheral T-cell lymphoma (PTCL),Designated,Not FDA Approved for Orphan Indication,,,,"Daiichi Sankyo, Inc.",211 Mount Airy Road,,Basking Ridge,New Jersey,07920-2311,United States,850021,,
"cancer vaccine consisting of p719-20, p728, and p725 synthetic peptides representing fragments of the hTERT subunit",,2021-12-02,Treatment of Stage IIB - IV melanoma,Designated,Not FDA Approved for Orphan Indication,,,,Ultimovacs ASA,Ullernchauss饮 64,,Oslo,,379,Norway,818321,,
selinexor,,2021-12-02,Treatment of glioblastoma,Designated,Not FDA Approved for Orphan Indication,,,,"Karyopharm Therapeutics, Inc.",85 Wells Avenue,,Newton,Massachusetts,2459,United States,825721,,
Allogeneic bone marrow-derived mesenchymal stromal cells (MSCs),,2021-12-02,Treatment of Hypoplastic Left Heart Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,"Longeveron, Inc.","1951 NW 7th Ave., Suite 520",,Miami,Florida,33136,United States,849521,,
tacrolimus,,2021-12-07,"Treatment of non-infectious intermediate, posterior, pan, and chronic anterior uveitis",Designated,Not FDA Approved for Orphan Indication,,,,BioNanoSim Ltd.,Minrav Building,Hadassah ein Kerem Campus,Jerusalem,Jerusalem,9112101,Israel,849321,,
enzastaurin,,2021-12-07,Treatment of Ehlers-Danlos Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,"Aytu BioPharma, Inc.","373 Inverness Parkway, Suite 206",,Englewood,Colorado,80112,United States,849821,,
recombinant humanized IgG1-based monoclonal antibody which binds to human latent myostatin in a pH dependent manner,,2021-12-07,Treatment of spinal muscular atrophy,Designated,Not FDA Approved for Orphan Indication,,,,Genentech Inc.,1 DNA Way,,South San Francisco,California,94080-4990,United States,850121,,
"an allogeneic, fratricide-resistant genetically modified T cell transduced with a 2nd generation 4-1BB-CD3z chimeric antigen receptor targeting human CD7",,2021-12-08,Treatment of acute lymphoblastic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,"Wugen, Inc.","4340 Duncan Ave, Suite 302",,St. Louis,Missouri,63110-1110,United States,849721,,
Posaconazole,,2021-12-13,Treatment of Mucormycosis (previously called zygomycosis),Designated,Not FDA Approved for Orphan Indication,,,,"AET Pharma US, Inc.",9841 Washingtonian Boulevard,Suite 200,Gaithersburg,Maryland,20878,United States,850521,,
"(R)-N2-(4-cyclopropyl-5-fluoro-6-methylpyridin-2-yl)-N4-(1, 5-dimethyl-1H-pyrazol-3-yl)-5-(3,4-dimethylpiperazin-1-yl) pyrimidine-2,4-diamine",,2021-12-14,Treatment of malaria,Designated,Not FDA Approved for Orphan Indication,,,,Cadila Healthcare Limited,"Zydus Research Centre,","Survey No. 396/403, Sharkhej-Bavla N.H. No. 8A, Village Moraiya, Changodar,",Ahmedabad,Gujarat,382213,India,853221,,
Olverembatinib,,2021-12-14,Treatment of acute myeloid leukemia (AML),Designated,Not FDA Approved for Orphan Indication,,,,Ascentage Pharma Group Inc.,"800 King Farm Blvd., Suite 300",,Rockville,Maryland,20850,United States,852921,,
allogeneic CRISPR/Cas9 genome-edited hematopoietic stem and progenitor cell (HSPC) therapy product lacking the CD33 protein,,2021-12-14,Treatment of Acute Myeloid Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,Vor Biopharma,100 Cambridgepark Dr.,Suite 400,Cambridge,Massachusetts,2140,United States,832621,,
thiostrepton,,2021-12-14,Treatment of Mesothelioma,Designated,Not FDA Approved for Orphan Indication,,,,"RS Oncology, LLC","One Broadway, 14th Floor",,Cambridge,Massachusetts,2142,United States,851321,,
N-hydroxy-N-(methylacylfulvene)urea,,2021-12-14,Treatment of Atypical Teratoid/Rhabdoid Tumor (ATRT),Designated,Not FDA Approved for Orphan Indication,,,,Lantern Pharma Inc.,1920 MCKINNEY AVE,7TH FLOOR,Dallas,Texas,75201-2483,United States,850721,,
"a fourth generation activating chimeric receptor (ACR) natural killer (NK) cell therapy engineered with an NKG2D ACR, OX40 costimulatory domain, CD3zeta signaling moiety, and membrane bound IL-15 (mb-IL15)",,2021-12-14,Treatment of acute myeloid lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,"Nkarta, Inc.","6000 Shoreline Court, Suite 102",,South San Francisco,California,94080,United States,851121,,
an adeno-associated viral vector delivering human FIX Padua gene,,2021-12-14,Treatment of Hemophilia B,Designated,Not FDA Approved for Orphan Indication,,,,"Shanghai Vitalgen BioPharma Co., Ltd.","Building 2, No.11 Jia Lilue Road,",Pudong New District,Shanghai,,CN201210,China,850921,,
Dornase alpha,,2021-12-14,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,"CLS Therapeutics, Inc",101 Avenue of the Americas (floor 3),,New York,New York,10013,United States,851921,,
silmitasertib,,2021-12-15,Treatment of Medulloblastoma,Designated,Not FDA Approved for Orphan Indication,,,,"Senhwa Biosciences, Inc.","10F, No. 225, Sec. 3, Peihsin Road",,Hsintien District,New Taipei City,23143,Taiwan,851021,,
Marzeptacog alfa (activated),,2021-12-15,"Treatment of Bleeding Episodes in Patients with Hemophilia A or B, Including those with Inhibitors",Designated,Not FDA Approved for Orphan Indication,,,,"Catalyst Biosciences, Inc.",611 Gateway Blvd. Suite 710,,South San Francisco,California,94080,United States,820721,,
Nonfucosylated humanized immunoglobulin G1 (IgG1) monoclonal antibody targeting B-cell maturation antigen (SEA-BCMA),,2021-12-16,Treatment of Multiple Myeloma,Designated,Not FDA Approved for Orphan Indication,,,,Seagen Inc.,21823 30th Drive SE,,Bothell,Washington,98021,United States,852321,,
crizotinib,,2021-12-20,Treatment of inflammatory myofibroblastic tumor,Designated,Not FDA Approved for Orphan Indication,,,,Pfizer Inc.,10646 Science Center Drive,,San Diego,California,92121,United States,834721,,
adeno-associated virus serotype 5 (AAV5) vector containing the hSERPING cDNA sequence encoding human C1-esterase inhibitor (C1-INH),,2021-12-20,Treatment of hereditary angioedema,Designated,Not FDA Approved for Orphan Indication,,,,"BioMarin Pharmaceutical, Inc.",105 Digital Drive,,Novato,California,94949,United States,852221,,
IgG-like bispecific monoclonal antibody (mAb) composed of the anti-IL-1beta mAb canakinumab and the anti-IL-18 mAb CMK389,,2021-12-20,"Treatment of nucleotide-binding oligomerization domain-like receptor family CARD domain-containing protein 4 - Gain of Function (NLRC4-GOF), also described as autoinflammation with infantile enterocolitis (AIFEC)",Designated,Not FDA Approved for Orphan Indication,,,,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,07936-1080,United States,853521,,
Sirolimus,,2021-12-21,Treatment of Bronchiolitis Obliterans Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,"AI Therapeutics, Inc.",530 Old Whitfield Street,,Guilford,Connecticut,6437,United States,833821,,
PEGylated aptamer targeting Von Willebrand Factor A1 domain,,2021-12-27,Treatment of Hemophilia A,Designated,Not FDA Approved for Orphan Indication,,,,"Band Therapeutics, LLC",101 Hartwell Ave,Suite #2,Lexington,Massachusetts,2421,United States,853621,,
zapnometinib,,2021-12-28,Treatment of Hantavirus infection,Designated,Not FDA Approved for Orphan Indication,,,,Atriva Therapeutics GmbH,Eisenbahnstr. 1,,Tbingen,,72072,Germany,853921,,
humanized anti-CD-47 mAb,,2022-01-03,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,"ARCH Oncology, Inc.","2000 Sierra Point Parkway, Suite 700",,Brisbane,California,94005,United States,855321,,
"Glycine, L-prolyl-L-prolyl-L-leucyl-L-seryl-L-glutaminyl-L-alpha-glutamyl-L-threonyl-Lphenylalanyl- L-seryl-L-alpha-aspartyl-L-leucyl-L-tryptophyl-L-lysyl-L-leucyl-L-leucyl-L-lysyl-Llysyl- L-tryptophyl-L-lysyl-L-methionyl-L-arginyl-L-arginyl-L-asparaginyl",,2022-01-03,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,"Oncolyze, Inc.",845 UN Plaza,61b,New York City,New York,10017,United States,855021,,
Adeno-associated virus vector carrying complementary deoxyribonucleic acid encoding the human long-wave-sensitive opsin 1 (AAV.7m8-L-opsin),,2022-01-03,Treatment of blue cone monochromacy (X-linked incomplete achromatopsia),Designated,Not FDA Approved for Orphan Indication,,,,"Adverum Biotechnologies, Inc.",800 Saginaw Drive,,Redwood City,California,94063,United States,854121,,
Human IgG1Fc- iMod domain (amino acids 2-60) of human HARS fusion protein,,2022-01-05,Treatment of sarcoidosis,Designated,Not FDA Approved for Orphan Indication,,,,aTyr Pharma,3545 John Hopkins Court,Suite 250,San Diego,California,92121,United States,708419,,
eplontersen,,2022-01-06,Treatment of transthyretin-mediated amyloidosis,Designated,Not FDA Approved for Orphan Indication,,,,"Ionis Pharmaceuticals, Inc.",2855 Gazelle Ct,,Carlsbad,California,92010,United States,827521,,
"2-(4-oxo-3-((5-(trifluoromethyl)benzo[d]thiazol-2-yl)methyl)-3,4-dihydrothieno[3,4-d]pyridazin-1-yl)acetic acid",,2022-01-06,Treatment of sorbitol dehydrogenase deficiency (SORD deficiency),Designated,Not FDA Approved for Orphan Indication,,,,Applied Therapeutics Inc.,"545 Fifth Avenue, Suite 1400",,New York,New York,10017,United States,777720,,
nandrolone,,2022-01-06,Treatment of facioscapulohumeral muscular dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,Sarcomed AB,St��oppsv䧥n,25,H䧥rsten,Select...,12947,Sweden,855521,,